data_4beh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 4beh _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.576 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 3.8 p . . . . . 0 C--O 1.235 0.34 0 CA-C-O 120.985 0.421 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.514 ' CG2' HG13 ' A' ' 37' ' ' VAL . 2.8 p -63.87 -33.02 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.649 -172.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.9 m -58.71 -66.1 0.55 Allowed 'General case' 0 C--O 1.244 0.781 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.132 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -64.91 -30.85 71.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.3 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 3' ' ' SER . 54.1 mt -57.27 -60.18 4.01 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.592 173.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.89 -45.55 78.59 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.854 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 48.6 t -63.3 -36.78 84.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.848 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.482 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 0.9 OUTLIER -73.87 -40.04 52.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 120.621 0.248 . . . . 0.0 111.347 -179.003 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 1.623 ' HD2' ' CD1' ' A' ' 11' ' ' TYR . 22.1 m-85 -68.69 -37.69 79.74 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.472 ' OG ' ' HA ' ' A' ' 28' ' ' ILE . 46.1 t -64.36 -44.28 91.94 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.659 175.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.49 -57.51 11.08 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.129 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.487 HD12 ' CB ' ' B' ' 205' ' ' ALA . 3.7 pp -70.43 -22.1 62.75 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.623 -0.431 . . . . 0.0 112.038 -177.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.407 ' N ' HD13 ' A' ' 14' ' ' LEU . 13.4 mt -71.3 -33.92 52.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.233 174.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.6 mt -86.94 -8.51 57.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.062 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -17.27 -78.26 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 115.319 1.599 . . . . 0.0 115.319 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -158.97 73.61 0.61 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.261 0.553 . . . . 0.0 109.951 -168.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.417 ' HB2' HG13 ' A' ' 21' ' ' VAL . 3.7 m-20 -132.46 -158.56 0.9 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.637 -174.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -69.11 -13.57 62.51 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.264 0.554 . . . . 0.0 109.782 172.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.473 ' HB ' HG12 ' B' ' 232' ' ' ILE . 5.1 p -96.28 160.85 2.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.528 -174.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.9 p -107.61 143.14 36.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.135 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.3 t -78.28 83.91 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.0 p -131.95 163.58 28.05 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -52.2 -49.96 62.86 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.93 -176.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -54.81 -36.19 64.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.317 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.515 ' HD2' ' HB ' ' B' ' 230' ' ' VAL . 75.4 mmtt -79.9 -44.03 21.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.315 -171.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.472 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 9.1 mt -62.02 -46.07 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.037 173.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -57.8 -39.07 76.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.488 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.25 -40.35 86.27 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.817 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.411 HD23 HG21 ' B' ' 226' ' ' ILE . 60.8 mt -70.35 -42.61 71.62 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 120.939 0.399 . . . . 0.0 110.391 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.453 HD11 ' O ' ' A' ' 28' ' ' ILE . 1.7 mp -59.84 -37.95 74.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.156 174.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -70.76 -37.53 73.4 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.771 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.41 -34.51 77.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.244 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.82 -31.73 16.36 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.659 -0.417 . . . . 0.0 111.813 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.66 35.48 6.86 Favored Glycine 0 CA--C 1.517 0.162 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.958 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.514 HG13 ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -97.32 173.77 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.025 0.441 . . . . 0.0 111.698 -178.017 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -121.46 106.43 11.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.571 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.4 p -129.66 137.94 55.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 174.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.536 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 12.8 pt-20 -67.16 135.24 93.65 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.75 -11.57 1.42 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 124.097 3.198 . . . . 0.0 113.745 -173.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 1.653 ' HE1' ' CE2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -68.04 -41.23 82.38 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.056 -178.702 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.417 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 89.4 m95 -68.08 -58.24 8.05 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.236 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.536 ' HD2' ' O ' ' A' ' 40' ' ' GLU . 12.5 Cg_endo -56.43 -43.83 51.76 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.411 2.074 . . . . 0.0 112.753 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.94 -52.98 46.57 Favored Glycine 0 C--O 1.24 0.493 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.913 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 52.4 tp -59.94 -48.49 81.5 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.522 ' CD2' HD13 ' A' ' 51' ' ' LEU . 1.7 m-85 -56.42 -46.8 80.07 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.286 0.367 . . . . 0.0 111.865 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.62 -30.11 66.68 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -89.33 -12.69 39.79 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.442 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.5 -32.29 10.02 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.653 ' HA ' ' CG2' ' A' ' 54' ' ' VAL . 52.6 mt -88.38 -131.02 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.293 -176.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 68.97 -12.61 0.38 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.953 0.901 . . . . 0.0 112.901 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.425 ' H ' ' C ' ' A' ' 51' ' ' LEU . 64.8 t30 -143.76 6.02 1.39 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.904 0.859 . . . . 0.0 110.171 177.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.653 ' CG2' ' HA ' ' A' ' 51' ' ' LEU . 1.5 t -103.05 87.55 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.802 -174.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -7.46 -95.55 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.724 1.61 . . . . 0.0 114.689 -168.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.705 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 1.2 tp -153.69 -66.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.278 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -59.03 -14.72 25.82 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.799 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.521 ' CB ' HG11 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -47.73 -42.63 25.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.567 -0.816 . . . . 0.0 111.598 175.205 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.705 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 0.9 OUTLIER -65.15 -12.33 49.82 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -174.507 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.564 HG12 ' HB ' ' B' ' 259' ' ' ILE . 65.2 mt -68.29 -29.01 42.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 121.2 0.524 . . . . 0.0 110.239 176.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 83.7 m -135.5 34.08 2.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.364 -176.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -70.63 -21.08 62.67 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.212 0.53 . . . . 0.0 110.721 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.4 t . . . . . 0 C--N 1.322 -0.607 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.393 179.888 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 C--O 1.233 0.196 0 CA-C-O 121.057 0.456 . . . . 0.0 110.019 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.521 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 58.2 t -62.33 -50.68 78.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.708 -173.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 205' ' ' ALA . . . . . 0.553 ' O ' HD21 ' B' ' 209' ' ' LEU . . . -69.34 -18.61 63.82 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.174 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 206' ' ' SER . . . . . 0.468 ' OG ' HG22 ' B' ' 223' ' ' ILE . 9.4 t -73.01 -40.08 65.47 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 207' ' ' TYR . . . . . 0.426 ' CE1' HD12 ' B' ' 251' ' ' ILE . 57.0 t80 -61.01 -37.45 82.57 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 171.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.558 ' O ' ' HB3' ' B' ' 212' ' ' LEU . 83.1 mt -66.18 -40.46 90.45 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.728 176.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 209' ' ' LEU . . . . . 0.553 HD21 ' O ' ' B' ' 205' ' ' ALA . 3.2 mm? -57.27 -45.26 84.21 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 174.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -63.37 -48.96 75.75 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.587 0.232 . . . . 0.0 111.562 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.93 -50.09 52.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.757 0.313 . . . . 0.0 111.611 -176.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 212' ' ' LEU . . . . . 0.558 ' HB3' ' O ' ' B' ' 208' ' ' LEU . 0.0 OUTLIER -67.22 -25.0 65.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.048 -178.873 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . 0.511 ' HA2' HG11 ' A' ' 37' ' ' VAL . . . -56.79 -22.07 39.18 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.344 -0.455 . . . . 0.0 112.54 175.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 112.47 22.65 5.72 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.562 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 215' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -138.83 95.05 2.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.126 0.488 . . . . 0.0 110.201 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 17.7 m -78.04 57.61 1.82 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.806 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 17.6 t -147.06 100.28 3.92 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . 0.409 ' HB3' ' HE2' ' B' ' 207' ' ' TYR . 51.6 Cg_exo -59.82 92.69 0.09 OUTLIER 'Trans proline' 0 N--CA 1.474 0.353 0 C-N-CA 123.478 2.785 . . . . 0.0 113.992 -176.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 50.1 m -96.14 103.15 15.02 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 171.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . 0.429 ' HB3' ' CD1' ' B' ' 239' ' ' LEU . . . -54.18 -31.16 52.08 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.376 0.608 . . . . 0.0 110.706 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -62.4 -36.58 82.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.877 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -80.47 -28.02 37.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.116 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.468 HG22 ' OG ' ' B' ' 206' ' ' SER . 1.8 mp -62.0 -48.68 87.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 168.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 224' ' ' LYS . . . . . 0.446 ' HE2' ' O ' ' B' ' 234' ' ' ALA . 3.3 tppp? -57.02 -41.1 77.92 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.328 173.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -58.31 -46.13 86.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.023 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.411 HG21 HD23 ' A' ' 31' ' ' LEU . 1.3 mp -65.23 -40.41 88.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.737 178.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.26 -42.93 92.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.023 0.439 . . . . 0.0 111.273 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -79.92 -22.11 43.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.585 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 99.3 p -53.14 -41.19 64.85 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.968 0.413 . . . . 0.0 111.482 -177.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 230' ' ' VAL . . . . . 0.515 ' HB ' ' HD2' ' A' ' 27' ' ' LYS . 8.1 m -100.9 -12.88 8.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.233 -176.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 100.58 67.99 0.84 Allowed Glycine 0 C--O 1.228 -0.267 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.107 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . 0.473 HG12 ' HB ' ' A' ' 21' ' ' VAL . 12.9 mt -129.19 141.22 47.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 175.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -79.23 83.89 5.24 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.384 0.611 . . . . 0.0 111.524 -176.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . 0.446 ' O ' ' HE2' ' B' ' 224' ' ' LYS . . . -93.68 143.01 26.71 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.738 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . 0.49 ' OD2' ' HG3' ' B' ' 238' ' ' ARG . 17.3 t70 -107.51 129.99 54.9 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.242 0.544 . . . . 0.0 110.991 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.85 -38.44 90.82 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.487 -172.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 237' ' ' ASP . . . . . 0.505 ' CG ' ' HZ3' ' B' ' 241' ' ' LYS . 24.8 t70 -71.63 -51.03 25.29 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.49 ' HG3' ' OD2' ' B' ' 235' ' ' ASP . 77.5 mtp180 -57.64 -41.53 81.61 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.461 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 239' ' ' LEU . . . . . 0.552 HD13 ' N ' ' B' ' 240' ' ' ASN . 4.5 pp -68.55 -44.04 75.35 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.996 -177.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 240' ' ' ASN . . . . . 0.552 ' N ' HD13 ' B' ' 239' ' ' LEU . 50.0 t30 -66.96 -32.1 73.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.0 0.428 . . . . 0.0 110.201 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 241' ' ' LYS . . . . . 0.514 ' O ' ' HG3' ' B' ' 245' ' ' GLU . 1.0 OUTLIER -67.13 -45.25 77.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.948 178.21 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 242' ' ' VAL . . . . . . . . . . . . . 18.1 m -71.79 -27.16 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.386 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . 0.506 HG13 ' O ' ' B' ' 239' ' ' LEU . 27.7 mt -71.48 -36.52 60.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.607 177.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 5.1 p -78.95 -14.48 59.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.79 0.329 . . . . 0.0 111.025 176.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 245' ' ' GLU . . . . . 0.514 ' HG3' ' O ' ' B' ' 241' ' ' LYS . 51.5 mt-10 -82.17 -30.76 30.82 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.988 0.423 . . . . 0.0 110.392 169.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . 0.622 ' O ' HD11 ' B' ' 246' ' ' LEU . 1.1 pp -99.58 2.56 44.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.343 -176.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -58.84 109.43 0.82 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.578 0.704 . . . . 0.0 112.045 -171.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 71.52 30.48 66.6 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.885 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -90.16 -160.93 0.74 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 110.493 -0.188 . . . . 0.0 110.493 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . 0.415 ' HB3' ' HB2' ' B' ' 253' ' ' ASP . 14.0 m-20 -72.9 81.33 1.18 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.929 0.395 . . . . 0.0 111.913 -174.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . 0.502 ' O ' HG13 ' B' ' 254' ' ' VAL . 2.0 mm -72.29 -54.4 16.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.827 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -61.53 -29.64 70.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.634 0.731 . . . . 0.0 110.448 -177.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . 0.415 ' HB2' ' HB3' ' B' ' 250' ' ' ASN . 5.6 m-20 -77.22 -44.81 28.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.711 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 254' ' ' VAL . . . . . 0.502 HG13 ' O ' ' B' ' 251' ' ' ILE . 7.0 p -66.73 -23.79 31.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 121.054 0.454 . . . . 0.0 110.155 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 255' ' ' ILE . . . . . 0.55 ' HA ' ' OH ' ' A' ' 11' ' ' TYR . 44.8 mt -76.89 -55.61 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.933 175.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -66.3 -45.3 80.86 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -173.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -139.19 50.14 1.82 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.268 0.556 . . . . 0.0 111.156 -174.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -141.97 55.4 0.6 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.358 -178.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 259' ' ' ILE . . . . . 0.564 ' HB ' HG12 ' A' ' 60' ' ' ILE . 1.2 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.888 0.375 . . . . 0.0 111.073 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 t . . . . . 0 CA--C 1.534 0.365 0 CA-C-O 121.456 0.646 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.423 HG11 ' HG ' ' B' ' 212' ' ' LEU . 45.1 t -67.11 -33.73 65.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.895 -174.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.1 m -62.15 -51.33 68.28 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.528 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.471 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 39.4 tt0 -63.87 -49.42 72.83 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.822 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.4 mp -51.98 -46.64 64.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.485 174.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.75 -52.05 65.85 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.672 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.471 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 26.2 p -64.51 -26.76 68.57 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.982 -177.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.57 -36.07 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.115 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 1.66 ' HD1' ' CD2' ' A' ' 11' ' ' TYR . 16.3 m-85 -74.96 -24.54 58.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.279 0.562 . . . . 0.0 109.929 177.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.9 m -75.26 -42.05 55.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.132 173.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.12 -39.86 63.77 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.384 169.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.451 HD11 ' HA ' ' A' ' 11' ' ' TYR . 83.2 mt -61.01 -56.97 14.83 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.646 175.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.6 mt -58.42 -31.65 43.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.64 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 46.5 mt -115.81 12.27 15.82 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -173.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -44.86 -48.5 11.13 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.785 0.326 . . . . 0.0 111.608 174.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.42 ' O ' HG13 ' A' ' 21' ' ' VAL . 11.2 t70 -154.31 -84.68 0.07 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 46.3 42.46 10.37 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.501 176.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 64.41 25.43 13.37 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.295 178.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.456 HG23 ' H ' ' A' ' 22' ' ' THR . 5.4 p -149.62 173.03 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.456 ' H ' HG23 ' A' ' 21' ' ' VAL . 5.3 p -107.49 127.43 53.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.808 0.337 . . . . 0.0 111.786 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.64 ' HB ' ' O ' ' A' ' 16' ' ' LEU . 3.9 p -67.17 95.21 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.368 0.604 . . . . 0.0 110.587 176.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.478 ' OG1' ' HG2' ' A' ' 27' ' ' LYS . 39.0 p -123.46 167.22 14.14 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.315 0.579 . . . . 0.0 112.14 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -49.22 -52.74 25.15 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.591 -174.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -62.13 -30.52 71.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.368 -177.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.478 ' HG2' ' OG1' ' A' ' 24' ' ' THR . 45.0 mmtm -71.48 -49.69 38.88 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.48 ' O ' HD11 ' A' ' 32' ' ' ILE . 9.5 mt -62.94 -44.4 99.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.939 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -56.05 -45.52 79.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.776 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.77 -41.63 95.73 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.408 HD13 HG21 ' B' ' 226' ' ' ILE . 0.2 OUTLIER -66.82 -41.97 86.64 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.516 0.674 . . . . 0.0 109.919 -178.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.48 HD11 ' O ' ' A' ' 28' ' ' ILE . 1.6 mp -62.17 -39.46 84.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.274 176.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -66.03 -31.98 73.18 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.087 0.47 . . . . 0.0 110.287 177.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.439 ' HB3' ' HA ' ' B' ' 226' ' ' ILE . . . -65.64 -47.21 76.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.498 176.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.447 ' HA ' HD12 ' B' ' 226' ' ' ILE . . . -84.79 -17.1 39.27 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -177.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.38 12.89 83.33 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.541 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.6 t -81.7 154.14 4.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -108.95 105.23 14.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.121 0.486 . . . . 0.0 111.219 -173.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.7 p -120.99 135.25 61.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.406 174.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -59.89 124.49 76.91 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.483 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.529 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 81.0 Cg_exo -47.13 -17.11 0.41 Allowed 'Trans proline' 0 N--CA 1.481 0.776 0 C-N-CA 124.554 3.503 . . . . 0.0 115.434 -171.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -75.3 -26.47 58.73 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -175.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.557 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 95.8 m95 -65.66 -54.24 31.12 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.332 174.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.557 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 75.6 Cg_exo -51.08 -52.47 9.02 Favored 'Trans proline' 0 C--N 1.364 1.381 0 C-N-CA 122.315 2.01 . . . . 0.0 112.773 173.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.29 -50.48 66.17 Favored Glycine 0 C--O 1.241 0.576 0 C-N-CA 120.571 -0.824 . . . . 0.0 112.086 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 56.5 tp -56.37 -52.49 64.41 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.29 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.419 ' O ' HD11 ' A' ' 51' ' ' LEU . 3.2 m-85 -57.53 -44.03 84.79 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -177.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.31 -39.65 95.16 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.297 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -97.42 7.3 46.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.978 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -112.38 -43.27 3.54 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.676 ' HA ' HG21 ' A' ' 54' ' ' VAL . 2.6 mp -83.16 -128.29 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.826 -175.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 65.41 -1.47 0.96 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -144.56 -46.74 0.25 Allowed 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.676 HG21 ' HA ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -55.91 119.26 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 113.626 -1.624 . . . . 0.0 111.323 177.334 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -52.96 146.27 11.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.765 174.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.441 ' O ' HD11 ' A' ' 59' ' ' LEU . 1.7 tp -45.86 -37.34 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -169.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -54.8 -22.12 25.29 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.788 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.5 p -51.46 -31.65 24.1 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 122.987 0.515 . . . . 0.0 111.321 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.441 HD11 ' O ' ' A' ' 56' ' ' ILE . 9.6 mp -49.53 -39.94 36.29 Favored 'General case' 0 CA--C 1.519 -0.22 0 O-C-N 123.721 0.638 . . . . 0.0 112.359 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.3 tt -87.73 23.07 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 122.052 0.93 . . . . 0.0 110.744 -174.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.8 t -126.02 2.95 7.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.04 173.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -88.75 34.18 0.77 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.664 -176.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.2 t . . . . . 0 C--N 1.321 -0.655 0 CA-C-O 121.91 0.862 . . . . 0.0 109.876 -178.564 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 203' ' ' TYR . . . . . 1.619 ' HD1' ' CD2' ' B' ' 203' ' ' TYR . 32.9 m-85 . . . . . 0 C--O 1.24 0.562 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.768 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 11.9 p -62.84 -49.83 82.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.041 -174.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 205' ' ' ALA . . . . . 0.506 ' HA ' HD13 ' B' ' 208' ' ' LEU . . . -72.58 -18.86 61.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.619 0.247 . . . . 0.0 111.09 -176.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 206' ' ' SER . . . . . 0.412 ' HB3' HG21 ' B' ' 223' ' ' ILE . 45.8 m -70.37 -47.39 61.17 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 120.93 0.395 . . . . 0.0 109.968 174.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 207' ' ' TYR . . . . . 1.641 ' HE2' ' CE1' ' B' ' 207' ' ' TYR . 29.5 t80 -62.51 -35.95 81.01 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.768 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 62.9 mt -60.83 -53.42 57.59 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.003 178.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 209' ' ' LEU . . . . . 0.612 ' CD2' ' HB2' ' A' ' 11' ' ' TYR . 78.7 mt -58.79 -50.84 72.43 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.054 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -61.16 -33.22 73.08 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.99 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 211' ' ' ALA . . . . . 0.663 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -76.97 -40.14 48.0 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.889 178.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 212' ' ' LEU . . . . . 0.423 ' HG ' HG11 ' A' ' 4' ' ' VAL . 52.0 tp -59.97 -55.33 35.36 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.492 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -126.26 53.37 0.79 Allowed Glycine 0 CA--C 1.507 -0.421 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.855 -174.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . -166.08 -77.85 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.494 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 215' ' ' ASN . . . . . 0.663 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 44.4 t30 -148.56 140.63 23.97 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.741 0.305 . . . . 0.0 110.201 -175.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 216' ' ' SER . . . . . 0.453 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 8.3 m -63.95 -23.92 67.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.329 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 5.2 p -120.05 70.55 15.1 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.18 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . 0.554 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 82.8 Cg_exo -52.56 131.69 42.12 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.541 2.827 . . . . 0.0 113.28 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 219' ' ' SER . . . . . 0.466 ' HB3' ' OD2' ' B' ' 222' ' ' ASP . 38.9 t -87.02 145.75 26.37 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.335 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -59.15 -21.32 59.19 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.042 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 221' ' ' LYS . . . . . 0.482 ' HZ2' ' HB3' ' B' ' 221' ' ' LYS . 9.0 mtpm? -69.6 -50.09 47.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.363 177.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 222' ' ' ASP . . . . . 0.466 ' OD2' ' HB3' ' B' ' 219' ' ' SER . 20.0 m-20 -67.27 -40.78 86.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.952 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.475 HD12 ' HB3' ' B' ' 218' ' ' PRO . 1.8 mp -60.34 -45.58 96.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 175.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 224' ' ' LYS . . . . . 0.558 ' HZ1' ' CG ' ' B' ' 236' ' ' ASP . 37.7 tptt -52.35 -46.2 66.03 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.45 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . 0.484 ' O ' ' HD3' ' B' ' 225' ' ' LYS . 7.8 tmtm? -63.68 -36.32 83.46 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 123.273 0.358 . . . . 0.0 110.469 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.447 HD12 ' HA ' ' A' ' 35' ' ' ALA . 1.3 mp -60.89 -44.18 97.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.098 176.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 6.8 mp -75.74 -23.76 56.07 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.984 177.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 228' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' B' ' 224' ' ' LYS . 0.0 OUTLIER -78.45 -28.1 46.56 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.78 -177.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 80.8 p -52.76 -56.81 12.94 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.973 0.416 . . . . 0.0 111.125 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 7.3 m -79.83 -27.24 12.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.883 175.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 67.9 64.65 3.05 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.97 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 55.1 mt -99.25 -89.13 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.738 0.304 . . . . 0.0 110.431 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -148.51 142.1 25.46 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 175.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -160.93 93.06 0.96 Allowed 'General case' 0 C--N 1.33 -0.262 0 O-C-N 123.298 0.374 . . . . 0.0 111.05 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . 0.486 ' OD2' ' HD2' ' B' ' 238' ' ' ARG . 25.6 m-20 -62.84 126.49 27.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.0 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 236' ' ' ASP . . . . . 0.558 ' CG ' ' HZ1' ' B' ' 224' ' ' LYS . 7.0 m-20 -74.64 -12.1 60.35 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -175.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -92.37 -52.53 4.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.181 0.515 . . . . 0.0 109.765 175.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.486 ' HD2' ' OD2' ' B' ' 235' ' ' ASP . 86.3 mtt180 -65.94 -33.16 75.19 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.18 -176.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 239' ' ' LEU . . . . . . . . . . . . . 8.8 tt -59.94 -62.99 1.46 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.822 0.344 . . . . 0.0 111.052 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -74.43 -19.24 60.47 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 121.993 -0.442 . . . . 0.0 110.671 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -71.63 -48.65 46.46 Favored 'General case' 0 C--O 1.244 0.781 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.831 173.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 242' ' ' VAL . . . . . 0.597 ' O ' ' HB3' ' B' ' 246' ' ' LEU . 28.4 m -66.13 -33.43 63.51 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.885 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 30.8 mt -73.19 -31.79 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 O-C-N 123.627 0.579 . . . . 0.0 111.271 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 18.3 t -64.73 -28.5 69.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.679 0.276 . . . . 0.0 110.663 176.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -87.78 -47.88 8.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.651 0.738 . . . . 0.0 109.628 172.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . 0.665 ' O ' ' HG ' ' B' ' 246' ' ' LEU . 8.8 tp -79.5 56.37 2.16 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 124.716 1.206 . . . . 0.0 109.89 177.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -100.25 37.29 1.69 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.986 -174.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . 0.423 ' HA2' ' CG2' ' B' ' 251' ' ' ILE . . . 99.54 2.81 56.47 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.594 -0.813 . . . . 0.0 114.043 173.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -74.98 -1.68 23.72 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -177.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -159.32 8.11 0.11 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . 0.507 ' O ' HG12 ' B' ' 255' ' ' ILE . 5.2 tp -65.87 -46.93 87.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -172.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -58.59 -43.87 89.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.308 0.575 . . . . 0.0 110.972 -176.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -74.54 -38.7 62.69 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.874 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 254' ' ' VAL . . . . . 0.502 HG11 ' O ' ' B' ' 251' ' ' ILE . 6.6 p -71.06 -21.37 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 120.992 0.425 . . . . 0.0 110.351 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 255' ' ' ILE . . . . . 0.507 HG12 ' O ' ' B' ' 251' ' ' ILE . 35.2 mm -76.95 -48.48 25.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 171.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -62.83 -35.28 79.42 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -174.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -147.5 28.92 0.96 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.845 -176.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 258' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' B' ' 254' ' ' VAL . . . -110.51 56.64 0.45 Allowed Glycine 0 C--O 1.226 -0.376 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.238 -174.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 26.8 mt . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 121.35 0.595 . . . . 0.0 110.674 177.724 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.426 ' O ' HD11 ' A' ' 7' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 121.021 0.439 . . . . 0.0 110.858 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.459 HG13 ' CD1' ' B' ' 212' ' ' LEU . 6.0 m -62.91 -27.52 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.277 -176.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.8 m -61.64 -63.16 1.36 Allowed 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.408 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -59.24 -50.23 74.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.348 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.587 ' O ' HG23 ' A' ' 10' ' ' ILE . 9.8 mp -47.99 -54.65 12.22 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.69 0.281 . . . . 0.0 110.666 178.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.67 -52.77 64.11 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -177.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 40.6 t -66.0 -30.61 71.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.761 0.315 . . . . 0.0 110.92 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.587 HG23 ' O ' ' A' ' 7' ' ' LEU . 2.4 tp -74.75 -35.77 38.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.154 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 1.637 ' HD1' ' CD2' ' A' ' 11' ' ' TYR . 19.5 m-30 -66.43 -36.17 82.13 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 177.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.1 m -69.35 -46.47 66.95 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.128 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.4 ' HB3' HD22 ' A' ' 59' ' ' LEU . . . -54.65 -49.6 70.18 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.562 176.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.533 HD12 ' CB ' ' B' ' 205' ' ' ALA . 4.5 pp -75.67 -29.03 58.92 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.213 -177.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -65.14 -38.68 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.796 0.331 . . . . 0.0 110.788 175.287 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 23' ' ' VAL . 93.1 mt -78.23 -28.28 47.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.759 178.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.8 m80 -79.21 68.85 5.29 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -165.21 -49.11 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.903 0.382 . . . . 0.0 110.429 173.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -83.69 -172.17 4.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.722 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -89.3 16.45 7.39 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.1 0.476 . . . . 0.0 110.307 175.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.432 HG23 HG12 ' B' ' 232' ' ' ILE . 41.3 t -88.8 125.94 41.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.095 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 p -77.59 147.34 35.71 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.198 -172.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.438 ' HA ' HD12 ' A' ' 16' ' ' LEU . 32.6 m -83.69 41.74 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.06 -174.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.419 ' OG1' ' HG2' ' A' ' 27' ' ' LYS . 39.1 p -67.13 159.85 28.01 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -177.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -57.72 -42.65 84.26 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -176.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -49.78 -42.65 47.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.331 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.419 ' HG2' ' OG1' ' A' ' 24' ' ' THR . 45.8 mmtm -77.74 -47.75 18.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.394 -173.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.436 ' O ' HD11 ' A' ' 32' ' ' ILE . 5.2 mt -61.55 -44.81 99.23 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.154 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.332 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -60.05 -40.61 90.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.634 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.92 -40.93 99.11 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.83 -41.79 78.08 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.337 0.589 . . . . 0.0 110.05 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.436 HD11 ' O ' ' A' ' 28' ' ' ILE . 1.7 mp -59.94 -37.73 73.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.601 175.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -75.58 -30.43 59.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.108 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.45 -51.2 70.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.448 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.418 ' HA ' HD12 ' B' ' 226' ' ' ILE . . . -85.88 -27.21 25.17 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.777 -177.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.7 22.02 56.7 Favored Glycine 0 C--N 1.321 -0.264 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.777 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.9 t -82.34 137.17 21.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.848 0.356 . . . . 0.0 110.119 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -88.21 92.03 9.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.997 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -102.41 136.18 35.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.573 175.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.441 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -54.2 125.3 49.72 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.046 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.76 -6.15 2.3 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.6 2.866 . . . . 0.0 113.507 -171.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.49 -31.25 47.65 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -177.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -65.99 -60.72 6.59 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.622 175.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.441 ' HD2' ' O ' ' A' ' 40' ' ' GLU . 19.6 Cg_endo -58.86 -40.91 67.69 Favored 'Trans proline' 0 C--N 1.361 1.197 0 C-N-CA 121.783 1.656 . . . . 0.0 112.178 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.38 -55.04 32.33 Favored Glycine 0 C--O 1.241 0.552 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.159 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.7 tt -59.87 -50.54 73.38 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 1.613 ' HD2' ' CD1' ' A' ' 47' ' ' PHE . 2.6 m-85 -53.61 -53.6 49.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.01 0.433 . . . . 0.0 111.832 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.91 -27.94 67.07 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -173.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm -93.59 -11.62 31.37 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.451 -0.5 . . . . 0.0 112.15 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -106.54 -26.26 11.48 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.608 ' HA ' ' CG2' ' A' ' 54' ' ' VAL . 4.8 mp -81.23 -132.53 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 57.27 6.49 0.37 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.372 0.669 . . . . 0.0 112.095 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.414 ' H ' ' C ' ' A' ' 51' ' ' LEU . 37.2 m-80 -143.67 -40.76 0.29 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.608 ' CG2' ' HA ' ' A' ' 51' ' ' LEU . 58.7 t -45.14 108.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 113.881 -1.509 . . . . 0.0 111.622 173.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -67.51 169.71 8.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.678 173.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.6 tp -54.62 -53.25 33.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.954 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.63 -43.35 86.12 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.457 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.4 m -58.54 -28.55 65.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.662 0.268 . . . . 0.0 111.141 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.49 HD11 ' O ' ' A' ' 59' ' ' LEU . 2.5 tm? -64.06 -22.74 67.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.678 -176.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.631 HG12 ' HB ' ' B' ' 259' ' ' ILE . 18.3 mt -92.25 -5.28 10.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.301 0.572 . . . . 0.0 110.682 -176.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 22.4 t -137.55 51.22 1.93 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.351 0.596 . . . . 0.0 110.017 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -90.99 -34.21 15.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.548 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 C--N 1.311 -1.107 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.176 178.794 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 203' ' ' TYR . . . . . 1.651 ' HE2' ' CE1' ' B' ' 203' ' ' TYR . 99.1 m-85 . . . . . 0 C--O 1.238 0.478 0 CA-C-O 120.913 0.387 . . . . 0.0 111.805 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.784 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 18.1 m -58.28 -51.94 65.02 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.529 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.783 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 205' ' ' ALA . . . . . 0.533 ' CB ' HD12 ' A' ' 14' ' ' LEU . . . -64.7 -25.33 67.89 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -176.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 206' ' ' SER . . . . . 0.561 ' CB ' HG21 ' B' ' 223' ' ' ILE . 6.0 m -67.11 -48.91 66.69 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 173.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 207' ' ' TYR . . . . . 0.486 ' CZ ' ' HD2' ' B' ' 218' ' ' PRO . 17.0 t80 -61.68 -35.22 77.36 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.383 175.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.784 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 39.5 mt -63.26 -53.34 54.44 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.963 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 209' ' ' LEU . . . . . 0.607 HD23 ' HB2' ' A' ' 11' ' ' TYR . 15.2 mt -52.57 -50.62 62.59 Favored 'General case' 0 C--O 1.245 0.864 0 CA-C-O 121.264 0.554 . . . . 0.0 110.003 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -62.5 -41.13 98.62 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.668 -178.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 211' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -77.77 -24.68 48.87 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.929 -0.482 . . . . 0.0 111.481 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 212' ' ' LEU . . . . . 0.459 ' CD1' HG13 ' A' ' 4' ' ' VAL . 33.5 tp -71.23 -47.84 54.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.669 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -141.16 20.56 2.64 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 118.954 -1.593 . . . . 0.0 114.628 -176.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . -121.05 -66.07 0.26 Allowed Glycine 0 C--N 1.321 -0.284 0 C-N-CA 119.959 -1.115 . . . . 0.0 112.772 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 215' ' ' ASN . . . . . 0.496 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 34.0 t30 -154.42 146.66 23.8 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -177.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 7.0 m -67.95 -21.62 65.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.355 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 5.6 p -125.19 70.91 62.74 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.618 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . 0.486 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 65.2 Cg_exo -57.75 132.99 53.38 Favored 'Trans proline' 0 N--CA 1.477 0.552 0 C-N-CA 122.989 2.459 . . . . 0.0 112.152 176.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 219' ' ' SER . . . . . 0.452 ' HB3' ' OD1' ' B' ' 222' ' ' ASP . 28.3 t -110.18 172.96 6.55 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.919 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -56.1 -38.9 71.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.007 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -65.98 -43.33 88.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.685 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 222' ' ' ASP . . . . . 0.452 ' OD1' ' HB3' ' B' ' 219' ' ' SER . 3.3 m-20 -62.23 -49.48 75.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.138 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.561 HG21 ' CB ' ' B' ' 206' ' ' SER . 1.8 mp -63.79 -40.23 88.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.586 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -54.43 -50.9 66.55 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.187 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -63.71 -42.64 97.91 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.075 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' A' ' 35' ' ' ALA . 1.0 OUTLIER -58.14 -36.04 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 120.686 0.279 . . . . 0.0 110.73 176.882 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . 0.458 ' CD1' ' HB ' ' B' ' 232' ' ' ILE . 0.2 OUTLIER -75.82 -43.85 44.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.68 -178.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -86.64 -0.77 56.86 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.631 -177.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 15.4 t -55.07 -44.74 75.06 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.987 0.422 . . . . 0.0 110.51 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 230' ' ' VAL . . . . . 0.541 HG21 HG13 ' B' ' 232' ' ' ILE . 12.5 m -95.88 0.74 10.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.218 0.532 . . . . 0.0 111.16 178.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 81.65 54.98 3.3 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.616 -0.72 . . . . 0.0 113.739 175.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . 0.541 HG13 HG21 ' B' ' 230' ' ' VAL . 4.3 mt -115.64 140.07 39.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 172.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -70.74 119.85 15.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.302 0.573 . . . . 0.0 111.576 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -118.18 132.64 56.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.383 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -83.78 111.95 19.65 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -60.67 -33.69 73.22 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.458 -174.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -67.91 -58.31 4.77 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.456 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -63.92 -30.85 71.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.688 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 239' ' ' LEU . . . . . . . . . . . . . 8.7 tt -57.42 -60.72 3.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.313 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -64.25 -32.46 74.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.897 -178.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 241' ' ' LYS . . . . . 0.466 ' O ' ' HG3' ' B' ' 245' ' ' GLU . 84.3 mttt -67.77 -41.54 83.14 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 242' ' ' VAL . . . . . 0.436 ' HA ' ' OE1' ' B' ' 245' ' ' GLU . 32.9 m -73.92 -31.15 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 119.969 -0.693 . . . . 0.0 109.559 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . 0.448 ' HA ' ' CD2' ' B' ' 246' ' ' LEU . 7.5 mt -65.16 -37.09 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.077 173.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 12.1 t -63.56 -40.22 96.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.241 174.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 245' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' B' ' 241' ' ' LYS . 47.0 mt-10 -59.42 -45.54 91.25 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.439 0.638 . . . . 0.0 110.266 176.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . 0.487 ' O ' HD11 ' B' ' 246' ' ' LEU . 2.9 pp -87.6 -0.11 56.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.831 -175.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -67.04 -8.23 28.7 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.051 0.453 . . . . 0.0 111.719 -170.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -80.33 -170.93 42.54 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.149 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -82.31 67.4 8.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.922 0.391 . . . . 0.0 110.688 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -131.72 27.68 4.62 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.686 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . 0.411 ' O ' HG13 ' B' ' 255' ' ' ILE . 23.9 mm -53.46 -66.42 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -173.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 252' ' ' GLU . . . . . 0.447 ' O ' ' HB ' ' B' ' 255' ' ' ILE . 5.0 tp10 -62.03 -32.51 73.01 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 121.138 0.494 . . . . 0.0 111.412 -174.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' B' ' 257' ' ' GLN . 8.4 t70 -67.73 -47.27 69.79 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.11 -178.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 254' ' ' VAL . . . . . . . . . . . . . 30.0 m -67.95 -24.46 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.065 0 C-N-CA 120.239 -0.585 . . . . 0.0 110.455 177.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 255' ' ' ILE . . . . . 0.66 HG21 ' OH ' ' A' ' 11' ' ' TYR . 40.1 mt -61.47 -37.71 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 CA-C-O 121.468 0.651 . . . . 0.0 109.433 172.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -94.78 -2.91 50.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.42 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 257' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' B' ' 253' ' ' ASP . 0.9 OUTLIER -106.72 76.29 1.11 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.138 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -143.08 -99.16 0.3 Allowed Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.266 -0.969 . . . . 0.0 112.011 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 259' ' ' ILE . . . . . 0.631 ' HB ' HG12 ' A' ' 60' ' ' ILE . 1.0 OUTLIER . . . . . 0 C--N 1.346 0.451 0 CA-C-O 122.167 0.984 . . . . 0.0 108.59 171.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.557 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 23.3 t . . . . . 0 C--O 1.236 0.356 0 CA-C-O 121.162 0.506 . . . . 0.0 111.289 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.0 p -69.55 -26.27 30.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.842 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.422 ' HA ' HG23 ' A' ' 39' ' ' VAL . 8.4 p -66.83 -55.47 14.67 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.528 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.615 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 35.3 mt-10 -62.67 -39.49 94.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.733 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 3' ' ' SER . 38.3 mt -54.99 -55.41 31.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.111 0.481 . . . . 0.0 109.922 175.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.3 -44.79 95.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.994 -175.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.615 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 26.7 p -70.94 -34.62 71.65 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.416 -176.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.464 HG12 ' CG2' ' B' ' 259' ' ' ILE . 0.8 OUTLIER -75.26 -33.94 29.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.973 0.416 . . . . 0.0 110.888 -179.404 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 1.663 ' HE1' ' CE2' ' A' ' 11' ' ' TYR . 23.0 m-30 -77.51 -26.47 51.19 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 177.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 t -65.62 -51.71 57.52 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.01 -42.82 29.1 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.4 171.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.511 HD13 ' O ' ' B' ' 259' ' ' ILE . 82.6 mt -59.01 -58.29 9.32 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.781 0.324 . . . . 0.0 110.914 175.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 69.6 mt -56.62 -29.84 30.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.275 -176.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.9 mt -100.95 -9.58 21.39 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.68 -35.64 76.77 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -176.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -164.32 116.83 1.34 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -174.7 43.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.286 170.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 57.02 28.37 14.72 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.192 -174.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.0 p -126.44 161.53 32.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.651 -176.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.0 p -106.27 132.55 52.19 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -173.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.411 HG12 HD22 ' A' ' 51' ' ' LEU . 61.9 t -75.15 108.24 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -152.62 158.94 43.15 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-O 121.309 0.576 . . . . 0.0 111.894 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -43.77 -61.67 1.35 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.206 -173.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -62.86 -24.77 67.96 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.5 -173.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -77.43 -45.81 24.61 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.388 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.7 mt -62.46 -45.53 98.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.214 -0.595 . . . . 0.0 109.926 175.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -53.61 -45.78 70.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.194 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.0 -44.36 92.87 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.6 tp -71.22 -30.03 65.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.342 0.592 . . . . 0.0 110.316 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.66 -31.56 49.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.917 173.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -70.44 -29.83 66.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.87 -67.47 0.45 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.013 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.78 23.66 5.38 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -174.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -101.66 99.27 1.88 Allowed Glycine 0 C--N 1.314 -0.662 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.076 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.581 ' CG2' ' HA2' ' B' ' 213' ' ' GLY . 57.8 t -42.49 -70.07 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 122.516 0.326 . . . . 0.0 111.43 177.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -161.98 113.72 1.69 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 177.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.422 HG23 ' HA ' ' A' ' 5' ' ' SER . 11.8 t -121.65 137.52 55.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.481 ' C ' ' H ' ' A' ' 42' ' ' PHE . 0.7 OUTLIER -70.09 128.17 91.79 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.69 0.57 0.38 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.14 2.56 . . . . 0.0 113.116 -174.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 1.662 ' HD2' ' CD1' ' A' ' 42' ' ' PHE . 2.6 t80 -71.42 -39.72 70.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.014 176.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.477 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 68.2 m95 -72.42 -56.72 3.9 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.928 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.477 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 73.5 Cg_exo -49.95 -46.22 28.96 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 122.015 1.81 . . . . 0.0 112.321 173.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.46 -41.61 99.25 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.36 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.2 tp -61.87 -42.57 99.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.975 0.417 . . . . 0.0 110.096 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.442 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 3.2 m-85 -66.56 -40.05 88.8 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.992 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.61 -28.27 65.79 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -95.1 -30.74 13.9 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.79 -18.15 7.17 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -169.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.575 ' C ' ' H ' ' A' ' 53' ' ' ASN . 2.2 tp -89.54 -134.46 0.1 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.6 -176.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.461 ' H ' ' CG ' ' A' ' 51' ' ' LEU . . . 60.07 -13.28 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -176.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.575 ' H ' ' C ' ' A' ' 51' ' ' LEU . 48.0 m-80 -127.09 -31.38 2.6 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.559 ' CG2' ' HA ' ' A' ' 51' ' ' LEU . 61.0 t -49.99 103.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.382 172.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -46.74 146.32 1.62 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.671 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.437 HD12 HD21 ' A' ' 14' ' ' LEU . 4.0 tp -49.71 -51.77 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -170.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.27 -24.21 63.14 Favored Glycine 0 C--O 1.24 0.474 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.041 -176.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.3 t -68.81 -2.83 10.39 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 122.107 0.163 . . . . 0.0 111.225 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 46.3 mt -62.35 -26.02 68.22 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.192 0.52 . . . . 0.0 109.961 172.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.436 HG12 ' HB ' ' B' ' 259' ' ' ILE . 8.9 mt -95.74 16.26 2.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.607 0.718 . . . . 0.0 110.092 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.0 t -108.98 -45.01 3.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.381 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -87.74 5.89 37.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.036 -177.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 0 C--N 1.321 -0.671 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.897 179.644 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 203' ' ' TYR . . . . . 1.665 ' HD1' ' CD2' ' B' ' 203' ' ' TYR . 85.0 m-85 . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 121.402 0.62 . . . . 0.0 111.432 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.623 ' O ' HD11 ' B' ' 208' ' ' LEU . 60.8 t -60.09 -56.76 15.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.538 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 205' ' ' ALA . . . . . 0.516 ' HA ' ' HB2' ' B' ' 208' ' ' LEU . . . -69.31 -14.53 62.98 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.729 0.299 . . . . 0.0 111.27 -176.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 8.5 m -76.61 -45.07 31.7 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 174.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 207' ' ' TYR . . . . . 0.445 ' CE2' ' HB2' ' B' ' 218' ' ' PRO . 36.1 t80 -62.87 -41.91 99.57 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 174.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.623 HD11 ' O ' ' B' ' 204' ' ' VAL . 2.7 mp -56.77 -49.25 75.85 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.523 175.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 209' ' ' LEU . . . . . 0.484 ' CD1' ' HB2' ' A' ' 11' ' ' TYR . 3.6 tp -59.39 -49.65 76.99 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.603 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -66.46 -28.44 68.59 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 211' ' ' ALA . . . . . 0.583 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -73.94 -43.24 58.92 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.257 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 212' ' ' LEU . . . . . . . . . . . . . 4.3 pp -75.15 -35.64 61.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.765 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . 0.581 ' HA2' ' CG2' ' A' ' 37' ' ' VAL . . . -124.02 47.55 1.01 Allowed Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.312 -0.947 . . . . 0.0 114.07 -172.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . -175.95 -66.63 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.206 0 C-N-CA 119.683 -1.246 . . . . 0.0 113.309 176.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 215' ' ' ASN . . . . . 0.583 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 54.9 t30 -153.12 149.28 27.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.91 0.386 . . . . 0.0 110.533 -173.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 7.6 m -71.45 -18.52 62.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.256 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 17.6 p -125.76 69.99 65.05 Favored Pre-proline 0 N--CA 1.443 -0.808 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.848 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . 0.445 ' HB2' ' CE2' ' B' ' 207' ' ' TYR . 76.3 Cg_exo -54.18 135.83 65.94 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.072 2.515 . . . . 0.0 112.162 178.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 15.9 m -107.84 154.18 21.93 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.789 -177.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -49.22 -49.26 43.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.13 0.49 . . . . 0.0 111.757 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -64.76 -32.28 73.89 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.116 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -70.47 -43.64 69.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.898 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 1.8 mp -61.74 -39.56 83.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.252 0.549 . . . . 0.0 109.75 174.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 224' ' ' LYS . . . . . 0.439 ' HZ3' ' HB3' ' B' ' 236' ' ' ASP . 72.7 tttt -60.33 -38.1 82.67 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.564 177.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . 0.648 ' O ' ' HD3' ' B' ' 225' ' ' LYS . 6.4 tmtm? -70.32 -36.74 74.46 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.36 -36.52 73.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.502 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 97.2 mt -77.04 -34.37 57.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.838 0.352 . . . . 0.0 110.272 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 228' ' ' ASP . . . . . 0.485 ' HB3' ' HA ' ' B' ' 225' ' ' LYS . 0.8 OUTLIER -56.01 -36.23 67.7 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.377 173.707 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 23.8 m -55.81 -46.89 77.96 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.789 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 1.2 m -90.06 -4.08 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 83.33 29.3 33.75 Favored Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.293 176.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 41.9 mt -98.07 130.84 46.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 176.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -77.59 159.43 29.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.658 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -154.66 121.35 5.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.491 -175.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . 0.443 ' HB3' ' OD1' ' B' ' 237' ' ' ASP . 5.0 m-20 -66.7 111.2 3.56 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 171.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 236' ' ' ASP . . . . . 0.467 ' HA ' ' HB3' ' B' ' 239' ' ' LEU . 2.5 p30 -69.21 -16.92 63.72 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.71 -174.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 237' ' ' ASP . . . . . 0.443 ' OD1' ' HB3' ' B' ' 235' ' ' ASP . 6.9 p-10 -69.48 -48.96 59.03 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 174.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.597 ' O ' HG22 ' B' ' 242' ' ' VAL . 15.9 mmt180 -66.4 -43.76 84.9 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.929 177.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 239' ' ' LEU . . . . . 0.467 ' HB3' ' HA ' ' B' ' 236' ' ' ASP . 9.6 tt -54.38 -57.58 10.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.882 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -68.12 -25.96 65.56 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 122.438 -0.163 . . . . 0.0 110.773 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -69.64 -46.07 67.0 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.266 0.555 . . . . 0.0 110.338 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 242' ' ' VAL . . . . . 0.597 HG22 ' O ' ' B' ' 238' ' ' ARG . 57.3 t -66.78 -27.82 41.13 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.679 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 39.0 mt -84.18 -25.29 7.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.935 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 63.6 p -75.21 -27.02 59.4 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.642 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -86.52 -55.96 3.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.565 0.698 . . . . 0.0 109.712 173.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . 0.676 ' O ' HD12 ' B' ' 246' ' ' LEU . 0.0 OUTLIER -90.63 111.44 22.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.919 176.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 247' ' ' ASN . . . . . 0.419 ' C ' ' H ' ' B' ' 249' ' ' LYS . 4.9 t-20 -153.99 -143.23 0.13 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -176.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -73.2 37.82 0.8 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.209 -0.519 . . . . 0.0 113.412 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . 0.419 ' H ' ' C ' ' B' ' 247' ' ' ASN . 32.7 mmtp -107.92 95.76 5.91 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . 0.45 ' HB3' ' HB3' ' B' ' 253' ' ' ASP . 16.9 m120 61.81 52.71 3.37 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.559 0.537 . . . . 0.0 110.835 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . 0.499 ' O ' HG13 ' B' ' 254' ' ' VAL . 1.4 mm -59.92 -51.01 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -175.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -75.56 -11.6 60.05 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.974 -176.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . 0.45 ' HB3' ' HB3' ' B' ' 250' ' ' ASN . 22.6 t70 -84.31 -42.23 16.01 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 254' ' ' VAL . . . . . 0.499 HG13 ' O ' ' B' ' 251' ' ' ILE . 9.1 p -67.34 -22.35 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 255' ' ' ILE . . . . . . . . . . . . . 37.8 mt -71.97 -57.55 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.567 170.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -59.64 -36.19 75.9 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -175.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -105.13 6.2 32.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.878 0.371 . . . . 0.0 110.848 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -116.76 46.42 1.15 Allowed Glycine 0 C--O 1.229 -0.204 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.267 -174.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 259' ' ' ILE . . . . . 0.511 ' O ' HD13 ' A' ' 14' ' ' LEU . 18.9 mt . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 120.92 0.391 . . . . 0.0 111.087 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.536 ' O ' HD11 ' A' ' 7' ' ' LEU . 3.7 p . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 120.83 0.347 . . . . 0.0 111.391 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.5 m -69.67 -21.3 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.191 -176.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.43 ' HB3' HG21 ' A' ' 39' ' ' VAL . 2.3 m -65.34 -54.58 26.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.735 0.778 . . . . 0.0 110.065 177.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -65.6 -43.33 89.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.699 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.536 HD11 ' O ' ' A' ' 3' ' ' SER . 6.4 mp -55.71 -53.59 54.68 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.629 177.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.64 -50.55 72.8 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.488 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 45.6 t -63.69 -37.37 87.08 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.323 -176.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.435 HG13 HD11 ' A' ' 59' ' ' LEU . 0.6 OUTLIER -72.63 -40.89 62.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 120.564 0.221 . . . . 0.0 111.013 -177.749 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.528 ' HB2' ' CD2' ' B' ' 209' ' ' LEU . 21.0 m-85 -69.76 -27.86 65.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.508 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.405 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 8.9 t -64.72 -48.7 73.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.826 174.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.72 -42.5 62.29 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.636 172.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.517 HD22 HD12 ' A' ' 56' ' ' ILE . 95.2 mt -57.58 -59.16 5.61 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.238 0.542 . . . . 0.0 110.892 176.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.482 HG23 ' CD1' ' A' ' 31' ' ' LEU . 98.2 mt -52.29 -43.56 40.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.601 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 12' ' ' SER . 73.1 mt -75.14 -27.02 59.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.906 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -88.1 41.14 0.99 Allowed 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.836 -0.54 . . . . 0.0 111.485 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -127.1 -26.7 3.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.749 0.309 . . . . 0.0 110.683 174.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 20' ' ' GLU . 7.5 t70 -118.21 -161.87 0.86 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.424 ' H ' ' CG ' ' A' ' 19' ' ' ASP . 10.8 pt-20 -100.05 25.82 7.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.559 0.695 . . . . 0.0 110.687 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -81.19 143.49 12.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.0 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.1 p -83.06 144.8 29.66 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.825 0.345 . . . . 0.0 111.545 -177.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.9 m -91.62 48.24 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 121.146 0.498 . . . . 0.0 111.77 -176.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.0 p -84.5 159.28 20.75 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.32 -178.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -55.27 -36.53 66.2 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -54.37 -44.75 72.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.434 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.403 ' HD2' HG11 ' B' ' 230' ' ' VAL . 75.5 mmtt -77.98 -41.73 35.04 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 120.838 0.352 . . . . 0.0 110.369 -174.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.6 mt -60.13 -45.6 95.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.647 175.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.53 -36.8 84.87 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 111.364 0.135 . . . . 0.0 111.364 176.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.12 -54.17 50.02 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 120.978 0.418 . . . . 0.0 111.122 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.514 ' CD2' ' HG ' ' B' ' 209' ' ' LEU . 5.8 tt -68.93 -35.31 76.65 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.978 -178.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.65 -36.3 59.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.848 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -78.4 -30.26 47.65 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.874 0.368 . . . . 0.0 110.719 177.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.22 -31.56 72.12 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.624 172.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.12 -73.46 0.42 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.745 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.08 -49.69 0.48 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.787 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.413 HG23 HD23 ' B' ' 212' ' ' LEU . 34.7 m -81.72 154.14 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.957 0.408 . . . . 0.0 110.616 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -121.88 -174.82 2.96 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.597 -174.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.43 HG21 ' HB3' ' A' ' 5' ' ' SER . 7.6 p -151.31 137.7 12.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.842 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 12.2 pt-20 -59.39 134.4 88.49 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-O 120.533 0.206 . . . . 0.0 110.845 -175.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 40' ' ' GLU . 73.5 Cg_exo -50.66 -13.76 0.94 Allowed 'Trans proline' 0 N--CA 1.484 0.94 0 C-N-CA 124.485 3.457 . . . . 0.0 115.574 -166.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -74.47 -31.3 62.18 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.776 0.322 . . . . 0.0 110.341 -176.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.517 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 86.7 m95 -71.03 -54.3 7.55 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-O 119.058 -0.496 . . . . 0.0 111.258 176.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.517 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 50.2 Cg_exo -55.21 -37.21 94.45 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 121.73 1.62 . . . . 0.0 111.68 173.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.61 -51.04 61.23 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.821 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 56.1 mt -60.95 -44.39 97.34 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 120.635 0.255 . . . . 0.0 111.117 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.564 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 8.3 m-85 -62.81 -47.68 82.38 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.057 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.86 -34.59 76.98 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -112.33 1.07 15.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -170.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.76 -17.71 1.44 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 177.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.564 ' HB3' ' O ' ' A' ' 47' ' ' PHE . 3.4 tp -86.73 -132.42 0.06 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.441 ' H ' ' CG ' ' A' ' 51' ' ' LEU . . . 58.31 1.04 0.15 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.446 ' H ' ' C ' ' A' ' 51' ' ' LEU . 3.7 t-20 -143.22 -41.07 0.3 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.526 ' CG2' ' HA ' ' A' ' 51' ' ' LEU . 59.1 t -38.56 108.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 114.132 -1.394 . . . . 0.0 110.609 169.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -53.19 129.59 31.78 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 121.836 0.827 . . . . 0.0 109.274 176.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.517 HD12 HD22 ' A' ' 14' ' ' LEU . 7.3 tp -48.98 -38.63 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 114.25 -1.341 . . . . 0.0 113.731 -166.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.16 -28.22 68.69 Favored Glycine 0 C--O 1.242 0.597 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.434 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.4 t -65.78 -5.24 8.26 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.774 -0.213 . . . . 0.0 110.562 -177.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 31.5 mt -54.73 -38.59 67.31 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 120.812 0.339 . . . . 0.0 110.725 173.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.8 tt -82.19 4.99 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.533 0.683 . . . . 0.0 110.822 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.2 m -129.47 7.03 5.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.842 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.02 -0.54 44.72 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.969 0.414 . . . . 0.0 111.798 -173.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.806 -177.152 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 203' ' ' TYR . . . . . 1.65 ' HE1' ' CE2' ' B' ' 203' ' ' TYR . 41.9 m-85 . . . . . 0 C--O 1.238 0.491 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.599 ' O ' HD11 ' B' ' 208' ' ' LEU . 11.7 p -66.41 -47.13 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.044 -177.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 205' ' ' ALA . . . . . 0.472 ' HA ' ' HB2' ' B' ' 208' ' ' LEU . . . -74.6 -14.71 60.81 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.538 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 37.6 m -74.83 -38.13 62.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.026 172.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 207' ' ' TYR . . . . . 0.401 ' CE1' ' HD2' ' B' ' 218' ' ' PRO . 14.5 t80 -65.16 -42.85 93.34 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 173.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.599 HD11 ' O ' ' B' ' 204' ' ' VAL . 8.1 mp -54.52 -52.12 63.02 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.784 173.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 209' ' ' LEU . . . . . 0.528 ' CD2' ' HB2' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -56.16 -48.08 77.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.443 -178.443 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -62.55 -35.3 79.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.696 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 211' ' ' ALA . . . . . 0.72 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -67.13 -57.76 6.17 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.862 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 212' ' ' LEU . . . . . 0.485 HD13 ' O ' ' B' ' 208' ' ' LEU . 0.0 OUTLIER -74.53 -14.27 60.78 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.262 -178.81 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.88 -14.91 68.53 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.661 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 129.85 1.41 5.45 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.955 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 215' ' ' ASN . . . . . 0.72 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 84.2 m-20 -113.08 95.32 5.33 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 3.9 m -57.14 -31.06 64.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.356 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 10.2 t -126.67 77.96 73.34 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.745 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . 0.401 ' HD2' ' CE1' ' B' ' 207' ' ' TYR . 52.7 Cg_exo -56.3 140.82 88.79 Favored 'Trans proline' 0 N--CA 1.476 0.452 0 C-N-CA 123.759 2.973 . . . . 0.0 113.579 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 33.6 p -107.1 146.27 31.44 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -54.49 -31.83 56.7 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.066 0.46 . . . . 0.0 111.594 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -67.99 -39.23 83.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.504 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -72.79 -39.01 67.07 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.72 -46.17 93.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 174.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -58.04 -38.89 77.11 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.483 176.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . 0.46 ' NZ ' HD13 ' B' ' 226' ' ' ILE . 14.7 ttpp -57.85 -49.5 76.46 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.626 0.25 . . . . 0.0 110.673 174.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.46 HD13 ' NZ ' ' B' ' 225' ' ' LYS . 0.6 OUTLIER -58.54 -37.28 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.938 -177.477 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 94.9 mt -75.72 -38.79 58.23 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.869 0.366 . . . . 0.0 111.238 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -69.66 -28.66 66.07 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.967 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 46.8 m -62.51 -31.65 72.45 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.654 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 230' ' ' VAL . . . . . 0.403 HG11 ' HD2' ' A' ' 27' ' ' LYS . 99.1 t -92.27 -34.75 6.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.745 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 109.91 29.58 3.76 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.007 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 11.6 mt -98.41 126.56 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -67.42 136.67 55.08 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.857 0.36 . . . . 0.0 110.198 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -138.02 114.45 10.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.177 -174.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -66.2 121.28 14.86 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -70.27 -27.22 64.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.272 -173.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -74.84 -46.96 32.99 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -64.79 -37.57 88.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.761 0.315 . . . . 0.0 110.163 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 239' ' ' LEU . . . . . . . . . . . . . 8.3 tt -58.5 -62.02 2.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.68 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -65.72 -28.71 69.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.907 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -66.09 -46.0 79.24 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 120.656 0.265 . . . . 0.0 111.488 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 242' ' ' VAL . . . . . 0.531 HG23 ' HB2' ' B' ' 203' ' ' TYR . 27.1 m -75.12 -25.73 18.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -178.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 13.5 mt -70.49 -41.86 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.248 173.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 46.7 p -70.62 -22.88 62.48 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.304 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -69.26 -46.14 67.98 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.71 171.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 2.2 pp -87.7 -17.11 32.49 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.148 -174.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -55.23 125.79 22.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.026 0.441 . . . . 0.0 111.843 -171.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 174.98 -168.79 41.53 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.688 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.98 12.37 28.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.122 0.487 . . . . 0.0 110.304 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -88.46 25.55 1.66 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.721 0.772 . . . . 0.0 110.061 -175.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . 0.499 ' O ' HG13 ' B' ' 254' ' ' VAL . 34.2 mm -58.66 -62.75 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.768 -177.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -66.0 -29.64 70.05 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.437 -173.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.07 -51.68 66.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.166 175.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 254' ' ' VAL . . . . . 0.499 HG13 ' O ' ' B' ' 251' ' ' ILE . 8.9 p -71.09 -22.81 22.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.981 -176.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 255' ' ' ILE . . . . . . . . . . . . . 44.2 mm -75.21 -50.59 23.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.274 0.559 . . . . 0.0 110.528 173.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -71.48 -25.96 62.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.342 -173.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -140.44 46.49 1.81 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.346 0.593 . . . . 0.0 110.802 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 258' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' B' ' 254' ' ' VAL . . . -130.94 53.39 0.81 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.666 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 20.0 mt . . . . . 0 C--N 1.327 -0.401 0 CA-C-O 121.172 0.51 . . . . 0.0 110.625 178.317 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.8 m . . . . . 0 N--CA 1.45 -0.475 0 CA-C-O 120.809 0.338 . . . . 0.0 111.494 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.497 ' O ' HD12 ' B' ' 212' ' ' LEU . 41.3 t -68.43 -34.35 65.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 122.052 0.93 . . . . 0.0 108.801 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.52 ' HB3' HG21 ' A' ' 39' ' ' VAL . 4.2 m -66.93 -54.62 20.22 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.041 -178.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.477 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 37.4 mt-10 -62.96 -37.11 85.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.573 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.422 ' HB3' ' HG ' ' B' ' 212' ' ' LEU . 4.3 mp -60.75 -50.66 72.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.384 174.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.64 -49.6 74.53 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.041 0.448 . . . . 0.0 110.799 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 48.9 t -65.56 -31.55 72.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.633 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 1.2 tp -74.73 -41.28 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.826 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 1.658 ' HD1' ' CD2' ' A' ' 11' ' ' TYR . 21.3 m-85 -64.36 -37.84 88.94 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.3 m -67.59 -46.66 71.99 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.472 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 17' ' ' HIS . . . -48.95 -52.58 23.96 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.467 176.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.465 HD12 ' CB ' ' B' ' 205' ' ' ALA . 4.1 pp -77.93 -30.23 50.39 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.797 -176.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.441 ' N ' HD13 ' A' ' 14' ' ' LEU . 9.8 mt -56.35 -40.6 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.333 0.587 . . . . 0.0 110.185 173.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.8 mt -77.25 -31.62 55.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.29 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.498 ' HB2' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -82.85 50.85 1.78 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -175.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -146.32 -45.72 0.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.875 0.369 . . . . 0.0 110.775 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -86.87 -160.89 0.62 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.736 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -88.52 -17.09 31.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.325 0.583 . . . . 0.0 109.589 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.4 t -59.2 130.48 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.116 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.2 p -83.98 147.36 27.49 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.691 -176.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.4 m -78.05 116.05 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.601 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.424 ' OG1' ' HD3' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -150.7 162.49 40.59 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -176.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 53.0 mp0 -48.58 -54.95 12.54 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 123.369 0.418 . . . . 0.0 111.334 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -50.92 -34.81 30.1 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 124.0 0.812 . . . . 0.0 110.778 -178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.424 ' HD3' ' OG1' ' A' ' 24' ' ' THR . 14.2 mptt -78.39 -50.43 11.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.182 -175.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.42 ' O ' HD11 ' A' ' 32' ' ' ILE . 7.8 mt -64.33 -40.69 89.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.131 0.491 . . . . 0.0 110.125 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.57 -46.19 89.63 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.351 175.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.19 -46.99 87.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.148 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.8 mt -65.26 -43.55 90.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.521 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.42 HD11 ' O ' ' A' ' 28' ' ' ILE . 1.5 mp -59.09 -47.59 89.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 120.868 0.366 . . . . 0.0 110.786 176.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -71.56 -22.09 61.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.012 0.434 . . . . 0.0 110.915 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.36 -39.13 62.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.835 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.59 -47.1 10.17 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 138.96 -61.92 0.57 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 119.978 -1.106 . . . . 0.0 114.025 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.558 ' CG1' ' HA2' ' B' ' 213' ' ' GLY . 8.3 p -61.03 129.77 24.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.216 0.531 . . . . 0.0 111.912 -175.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -105.72 104.98 14.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.375 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.52 HG21 ' HB3' ' A' ' 5' ' ' SER . 3.1 p -76.12 140.89 16.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.322 172.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 11.4 pt-20 -52.94 125.93 41.25 Favored Pre-proline 0 CA--C 1.531 0.242 0 O-C-N 123.212 0.32 . . . . 0.0 110.593 -178.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 40' ' ' GLU . 75.7 Cg_exo -50.76 -13.19 0.75 Allowed 'Trans proline' 0 N--CA 1.485 0.98 0 C-N-CA 124.367 3.378 . . . . 0.0 115.229 -167.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -68.76 -35.07 76.62 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.48 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 76.6 m95 -69.59 -54.22 11.17 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.007 177.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 83.3 Cg_exo -50.85 -48.54 20.33 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 122.223 1.949 . . . . 0.0 112.868 175.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.47 -47.65 87.82 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.216 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.2 tp -58.68 -49.5 77.33 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 1.637 ' HD2' ' CD1' ' A' ' 47' ' ' PHE . 2.6 m-85 -54.04 -54.94 32.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.867 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.2 -39.41 92.66 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -175.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -88.49 -12.21 43.6 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.88 -18.23 14.11 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.625 ' HA ' HG22 ' A' ' 54' ' ' VAL . 26.6 mt -83.89 -131.99 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 119.331 -0.948 . . . . 0.0 109.98 177.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 59.3 7.42 0.91 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.17 0.51 . . . . 0.0 111.979 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -143.56 -42.15 0.29 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.625 HG22 ' HA ' ' A' ' 51' ' ' LEU . 7.5 t -54.88 115.84 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.609 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.245 177.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -53.63 152.6 5.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.697 171.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.699 ' O ' HD13 ' A' ' 59' ' ' LEU . 2.0 tp -46.5 -71.87 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -174.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.17 -23.8 66.55 Favored Glycine 0 C--O 1.24 0.516 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.781 -172.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.3 t -59.54 -21.24 59.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.236 -0.482 . . . . 0.0 110.579 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.699 HD13 ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -59.18 -19.24 43.56 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.567 -177.454 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.568 ' N ' HD11 ' A' ' 59' ' ' LEU . 48.1 mt -64.96 -27.59 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 121.173 -0.211 . . . . 0.0 111.32 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 75.2 m -139.26 23.4 2.55 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -175.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -132.82 51.32 2.17 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.409 HG12 ' CZ3' ' A' ' 43' ' ' TRP . 85.4 t . . . . . 0 C--N 1.323 -0.58 0 CA-C-O 121.063 0.458 . . . . 0.0 110.255 173.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 203' ' ' TYR . . . . . 1.61 ' HD2' ' CD1' ' B' ' 203' ' ' TYR . 4.3 m-85 . . . . . 0 N--CA 1.463 0.2 0 CA-C-O 120.736 0.303 . . . . 0.0 111.654 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.745 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 3.8 m -52.84 -54.45 16.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.295 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 205' ' ' ALA . . . . . 0.465 ' CB ' HD12 ' A' ' 14' ' ' LEU . . . -80.14 -15.52 56.91 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.126 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 206' ' ' SER . . . . . 0.488 ' CB ' HG21 ' B' ' 223' ' ' ILE . 14.9 m -68.14 -42.17 80.51 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 170.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 207' ' ' TYR . . . . . 0.448 ' CD1' HD12 ' B' ' 251' ' ' ILE . 24.1 t80 -66.27 -40.25 90.0 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.268 174.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.745 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 54.3 mt -63.12 -36.01 82.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.544 176.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 209' ' ' LEU . . . . . . . . . . . . . 1.2 mp -62.37 -44.8 95.63 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.855 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -56.58 -39.15 73.0 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.501 177.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 211' ' ' ALA . . . . . . . . . . . . . . . -87.12 -63.35 1.32 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 212' ' ' LEU . . . . . 0.497 HD12 ' O ' ' A' ' 4' ' ' VAL . 3.4 tm? -54.11 -39.82 66.76 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . 0.558 ' HA2' ' CG1' ' A' ' 37' ' ' VAL . . . -52.39 -20.42 7.21 Favored Glycine 0 C--N 1.33 0.244 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.165 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 99.4 26.68 8.55 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.147 174.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 215' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -117.48 -29.47 5.8 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.959 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 37.9 m 60.66 35.08 19.93 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.027 172.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 217' ' ' SER . . . . . 0.43 ' C ' ' H ' ' B' ' 219' ' ' SER . 32.2 p -120.03 104.48 43.89 Favored Pre-proline 0 C--N 1.314 -0.968 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.275 -172.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -70.9 19.22 0.23 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.929 2.42 . . . . 0.0 113.256 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 219' ' ' SER . . . . . 0.43 ' H ' ' C ' ' B' ' 217' ' ' SER . 1.1 m -63.52 119.27 9.47 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.436 0.636 . . . . 0.0 110.46 -176.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . 0.422 ' O ' HD13 ' B' ' 239' ' ' LEU . . . -56.2 -29.35 60.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.86 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -73.46 -30.11 62.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.495 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 222' ' ' ASP . . . . . 0.419 ' CG ' ' HB2' ' B' ' 219' ' ' SER . 93.5 m-20 -70.94 -43.93 67.17 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.488 HG21 ' CB ' ' B' ' 206' ' ' SER . 1.8 mp -58.69 -52.42 60.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-O 121.056 0.455 . . . . 0.0 110.013 174.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -56.5 -40.83 75.62 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.878 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -65.23 -37.48 87.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.284 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 1.1 mp -62.58 -42.83 97.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.539 175.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 66.0 mt -75.83 -35.71 59.89 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.447 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.37 -20.7 62.94 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.723 0.297 . . . . 0.0 110.72 177.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 16.2 t -58.26 -26.87 63.45 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.313 0.577 . . . . 0.0 109.559 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 98.8 t -110.11 -39.51 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.025 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 108.35 27.03 5.19 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.545 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 5.3 mt -83.28 147.4 5.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -57.81 114.48 2.32 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.124 0.488 . . . . 0.0 112.075 -174.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . 0.48 ' HB2' ' OH ' ' B' ' 203' ' ' TYR . . . -138.66 91.01 2.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.248 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -73.24 155.38 39.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.36 -177.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 236' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' B' ' 239' ' ' LEU . 24.0 t70 -69.01 -48.34 63.26 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.635 0.255 . . . . 0.0 111.425 -175.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 237' ' ' ASP . . . . . 0.698 ' O ' ' HB2' ' B' ' 241' ' ' LYS . 8.0 t70 -58.56 -54.39 47.6 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.392 0.615 . . . . 0.0 109.627 176.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.6 ' O ' HG23 ' B' ' 242' ' ' VAL . 25.0 ttm180 -58.6 -31.92 68.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.149 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 239' ' ' LEU . . . . . 0.798 ' HA ' ' CE2' ' B' ' 203' ' ' TYR . 3.0 tp -50.6 -76.52 0.02 OUTLIER 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.353 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -73.78 -20.14 60.56 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.528 -174.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 241' ' ' LYS . . . . . 0.698 ' HB2' ' O ' ' B' ' 237' ' ' ASP . 15.9 tttt -61.71 -58.44 8.01 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-O 121.303 0.573 . . . . 0.0 110.775 176.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 242' ' ' VAL . . . . . 0.6 HG23 ' O ' ' B' ' 238' ' ' ARG . 34.1 m -73.27 -32.37 37.64 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -174.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . 0.668 ' HA ' ' CD1' ' B' ' 246' ' ' LEU . 6.9 mt -60.83 -41.61 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.609 174.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 19.5 t -63.82 -32.17 73.59 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 177.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -76.32 -48.42 20.12 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . 0.668 ' CD1' ' HA ' ' B' ' 243' ' ' ILE . 0.0 OUTLIER -88.33 -10.01 50.86 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.433 0.56 . . . . 0.0 112.338 -173.115 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 247' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' B' ' 243' ' ' ILE . 63.5 t30 -44.69 -73.22 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 O-C-N 123.688 0.617 . . . . 0.0 111.725 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 58.55 -163.53 9.52 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.51 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -135.62 20.94 3.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.298 0.57 . . . . 0.0 109.734 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -115.81 38.78 3.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.411 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . 0.487 ' O ' HG11 ' B' ' 254' ' ' VAL . 1.1 mm -62.79 -51.36 72.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.322 -177.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -60.36 -30.36 69.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.115 0.483 . . . . 0.0 109.771 -177.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -76.09 -51.91 11.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.942 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 254' ' ' VAL . . . . . 0.487 HG11 ' O ' ' B' ' 251' ' ' ILE . 9.5 p -57.88 -30.7 38.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.758 0.313 . . . . 0.0 110.888 -177.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 255' ' ' ILE . . . . . . . . . . . . . 64.9 mt -85.05 -47.32 17.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.481 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -68.17 -15.32 63.53 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -176.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -57.28 -70.83 0.11 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.917 175.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 176.84 -99.72 0.13 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.243 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 5.4 mp . . . . . 0 C--N 1.325 -0.461 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 176.14 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.484 ' O ' HD11 ' A' ' 7' ' ' LEU . 23.1 p . . . . . 0 C--O 1.239 0.527 0 CA-C-O 121.238 0.542 . . . . 0.0 112.162 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.425 ' HA ' ' HB2' ' A' ' 7' ' ' LEU . 3.5 m -67.26 -16.74 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.557 -177.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.45 ' HB2' HG21 ' A' ' 39' ' ' VAL . 3.3 p -64.77 -62.02 1.82 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.558 176.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -58.2 -45.42 87.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.12 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.484 HD11 ' O ' ' A' ' 3' ' ' SER . 7.0 mp -51.47 -58.01 7.45 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.621 176.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.42 -47.12 76.45 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.065 -177.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 49.1 t -65.98 -34.67 78.64 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.948 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -74.03 -33.65 36.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.617 0.246 . . . . 0.0 111.234 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 1.664 ' HE1' ' CE2' ' A' ' 11' ' ' TYR . 21.4 m-85 -79.06 -23.62 44.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.187 0.518 . . . . 0.0 110.025 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.45 ' HA ' HD21 ' A' ' 31' ' ' LEU . 19.3 t -68.89 -47.24 66.35 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 171.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.5 -42.09 63.99 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.712 172.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 20.0 mt -58.54 -54.49 46.43 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 120.922 0.391 . . . . 0.0 111.108 176.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.44 HD13 HD22 ' A' ' 31' ' ' LEU . 10.3 mt -59.54 -40.76 82.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.166 -177.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.8 mt -77.83 -22.56 49.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.414 ' CE1' ' HB ' ' A' ' 56' ' ' ILE . 25.1 t-80 -61.87 -36.35 80.97 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -73.28 -69.7 0.41 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -168.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 21' ' ' VAL . 23.1 t70 -64.83 148.1 51.95 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.088 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -77.23 46.24 0.49 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.903 0.859 . . . . 0.0 110.451 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.48 ' H ' ' C ' ' A' ' 19' ' ' ASP . 9.9 p -81.3 157.37 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.303 175.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.6 t -59.02 -20.16 50.51 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -168.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.6 t 55.14 78.45 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 121.403 0.62 . . . . 0.0 109.732 -175.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.1 p -136.05 168.17 19.86 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -174.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -51.55 -48.06 63.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.568 -1.197 . . . . 0.0 110.707 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -52.45 -39.29 60.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.197 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.418 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 2.8 mptp? -80.88 -41.35 23.25 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.431 -173.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.8 mt -64.03 -45.39 96.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.054 174.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -60.17 -40.9 91.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.696 178.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.29 -52.55 65.17 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 111.394 177.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.472 HD11 ' CG2' ' B' ' 230' ' ' VAL . 45.4 tp -66.54 -40.98 89.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.265 0.555 . . . . 0.0 111.182 -176.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.73 -37.21 78.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.399 177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -74.4 -29.11 61.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 0.0 110.137 177.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.51 -45.86 92.42 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.582 175.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.435 ' HA ' HD12 ' B' ' 226' ' ' ILE . . . -80.74 -33.06 35.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.797 0.332 . . . . 0.0 111.547 177.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.52 23.43 28.75 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.812 173.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.5 t -94.89 130.15 44.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 117.327 0.563 . . . . 0.0 110.708 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -79.72 90.8 5.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.98 -177.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.45 HG21 ' HB2' ' A' ' 5' ' ' SER . 10.7 p -98.52 130.09 47.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 169.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -63.28 136.49 96.72 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.04 -177.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -48.75 -14.08 0.34 Allowed 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 124.716 3.611 . . . . 0.0 115.021 -171.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.19 -36.87 77.76 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -177.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -67.44 -58.96 7.77 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 121.011 -0.275 . . . . 0.0 111.359 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.54 -46.1 35.95 Favored 'Trans proline' 0 C--N 1.361 1.237 0 C-N-CA 122.286 1.991 . . . . 0.0 112.754 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.73 -45.99 95.11 Favored Glycine 0 C--O 1.242 0.639 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.033 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.4 tp -51.99 -59.37 4.43 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 176.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -58.99 -40.39 84.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.711 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.0 -44.61 91.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.217 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -95.62 -11.7 26.81 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.772 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 54' ' ' VAL . . . -104.15 -12.28 16.81 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -175.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.577 ' HA ' HG21 ' A' ' 54' ' ' VAL . 42.9 mt -101.79 -132.34 0.27 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.429 173.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 65.96 -12.61 0.17 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 51' ' ' LEU . 11.8 m120 -144.69 12.74 1.49 Allowed 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.577 HG21 ' HA ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -128.23 120.81 54.24 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.944 -170.082 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -55.07 155.52 4.57 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.034 -1.439 . . . . 0.0 112.448 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.536 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 3.7 tp -44.53 -41.91 2.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -173.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -54.29 -23.81 27.31 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 121.611 -0.328 . . . . 0.0 113.494 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.6 t -53.84 -26.71 25.69 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 122.542 0.337 . . . . 0.0 111.264 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 34.3 mt -56.9 -36.06 69.71 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.664 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.404 HG12 HD11 ' B' ' 259' ' ' ILE . 1.1 mp -103.27 18.38 4.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.445 0.64 . . . . 0.0 109.539 -175.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 69.7 m -119.91 -6.53 10.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.393 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -100.56 -17.4 17.11 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.145 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.879 177.981 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 203' ' ' TYR . . . . . 1.641 ' HE2' ' CE1' ' B' ' 203' ' ' TYR . 67.5 m-85 . . . . . 0 C--O 1.237 0.415 0 CA-C-O 121.578 0.704 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.649 ' O ' HD11 ' B' ' 208' ' ' LEU . 94.3 t -59.67 -62.1 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.158 177.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 205' ' ' ALA . . . . . 0.604 ' O ' ' HG ' ' B' ' 209' ' ' LEU . . . -61.7 -21.49 64.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.561 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 206' ' ' SER . . . . . 0.404 ' CB ' HG21 ' B' ' 223' ' ' ILE . 5.7 m -66.87 -47.9 70.45 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.003 0.43 . . . . 0.0 109.88 173.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 207' ' ' TYR . . . . . 1.659 ' HD2' ' CD1' ' B' ' 207' ' ' TYR . 34.0 t80 -59.98 -38.89 83.87 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.65 ' O ' ' HG ' ' B' ' 212' ' ' LEU . 9.3 mp -56.57 -56.49 20.7 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.778 175.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 209' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' B' ' 205' ' ' ALA . 58.0 mt -52.36 -47.5 66.1 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 123.532 0.52 . . . . 0.0 111.066 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -63.98 -32.81 74.49 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.264 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 211' ' ' ALA . . . . . 0.645 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -68.8 -44.82 72.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.494 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 212' ' ' LEU . . . . . 0.65 ' HG ' ' O ' ' B' ' 208' ' ' LEU . 15.1 mt -64.81 -29.01 69.96 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.733 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -62.68 -7.18 14.13 Favored Glycine 0 C--N 1.337 0.603 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.957 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 110.66 20.82 7.1 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.485 174.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 215' ' ' ASN . . . . . 0.645 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 27.5 m-80 -130.32 111.67 12.59 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 6.3 m -65.89 -20.77 66.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.279 0.561 . . . . 0.0 110.684 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 12.0 p -123.71 70.58 47.9 Favored Pre-proline 0 N--CA 1.443 -0.806 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.859 -175.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . 0.491 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 50.4 Cg_exo -60.39 135.68 63.02 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.069 2.512 . . . . 0.0 112.599 173.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 49.4 m -102.66 157.22 17.09 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.736 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -51.4 -41.68 60.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.198 0.523 . . . . 0.0 111.224 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -60.79 -42.55 97.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.972 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -67.82 -39.55 83.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.506 -177.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.421 HD12 ' CB ' ' B' ' 218' ' ' PRO . 1.7 mp -68.03 -39.8 82.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 120.867 0.365 . . . . 0.0 110.553 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -62.07 -42.99 99.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.953 0.406 . . . . 0.0 110.35 176.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 16.6 ttpp -64.42 -39.57 94.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.371 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -62.65 -41.21 91.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.392 178.295 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.93 -45.39 61.29 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -176.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.98 -24.35 62.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.831 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 18.5 t -56.68 -42.41 78.99 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.792 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 230' ' ' VAL . . . . . 0.472 ' CG2' HD11 ' A' ' 31' ' ' LEU . 7.0 t -64.28 -29.39 47.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.526 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 105.65 10.35 31.11 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.424 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . 0.417 HD11 HG22 ' B' ' 232' ' ' ILE . 24.9 mt -104.57 139.37 25.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -71.74 151.48 43.53 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -173.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -132.07 143.49 50.07 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.757 -176.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -91.27 114.97 27.63 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.089 0.471 . . . . 0.0 110.249 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -58.07 -51.89 67.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.407 -175.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -54.9 -56.76 16.02 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.167 0.508 . . . . 0.0 110.953 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.419 ' O ' HG11 ' B' ' 242' ' ' VAL . 18.7 mmt180 -61.39 -32.77 72.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.862 -175.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 239' ' ' LEU . . . . . . . . . . . . . 6.9 tt -61.83 -60.87 3.0 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.051 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -67.16 -29.81 69.61 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.578 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -60.12 -53.73 54.31 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 120.786 0.327 . . . . 0.0 110.94 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 242' ' ' VAL . . . . . 0.503 ' HA ' ' OE2' ' B' ' 245' ' ' GLU . 22.2 m -72.87 -25.95 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-O 121.327 0.584 . . . . 0.0 110.134 -175.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 34.9 mt -74.54 -31.18 26.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.504 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 23.3 t -64.87 -34.99 79.7 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 173.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 245' ' ' GLU . . . . . 0.503 ' OE2' ' HA ' ' B' ' 242' ' ' VAL . 36.0 mt-10 -67.42 -45.19 76.82 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.237 171.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 52.1 mt -70.61 -95.34 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.083 -177.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 58.66 174.21 0.07 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.068 0.547 . . . . 0.0 110.448 -175.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -76.14 50.54 2.73 Favored Glycine 0 CA--C 1.516 0.127 0 O-C-N 122.091 -0.381 . . . . 0.0 113.383 -173.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -109.29 -64.84 1.2 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.508 0.67 . . . . 0.0 110.21 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -103.7 8.29 37.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.413 -174.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . 0.455 ' HA ' HG13 ' B' ' 254' ' ' VAL . 6.0 tp -57.58 -45.57 86.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.519 -173.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -60.58 -40.08 90.39 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.258 0.551 . . . . 0.0 110.606 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -70.03 -45.25 67.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.838 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 254' ' ' VAL . . . . . 0.455 HG13 ' HA ' ' B' ' 251' ' ' ILE . 8.9 p -66.36 -27.96 42.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.916 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 255' ' ' ILE . . . . . 0.483 HG12 ' HG ' ' B' ' 208' ' ' LEU . 96.4 mt -70.86 -52.1 30.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 121.1 0.476 . . . . 0.0 110.219 173.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -76.23 -5.36 46.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.01 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -52.59 -59.6 4.26 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.43 0.456 . . . . 0.0 111.708 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 178.73 -102.39 0.17 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.152 -1.023 . . . . 0.0 113.412 175.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 259' ' ' ILE . . . . . 0.404 HD11 HG12 ' A' ' 60' ' ' ILE . 3.4 mp . . . . . 0 N--CA 1.467 0.407 0 CA-C-N 117.061 0.43 . . . . 0.0 112.011 -175.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.235 0.315 0 CA-C-O 121.253 0.549 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.9 t -65.81 -28.44 44.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.461 -174.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.492 ' HB2' HG21 ' A' ' 39' ' ' VAL . 1.5 p -61.94 -64.11 1.04 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.36 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -56.66 -49.63 74.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.577 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.412 HD21 HD11 ' B' ' 212' ' ' LEU . 7.3 mp -54.96 -44.91 74.8 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.445 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.71 -45.46 89.88 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.749 0.309 . . . . 0.0 110.949 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.87 -39.0 92.84 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.694 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 tp -73.26 -39.24 55.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.353 -176.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 1.658 ' HD1' ' CD2' ' A' ' 11' ' ' TYR . 22.1 m-30 -63.99 -42.23 97.26 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.474 ' HA ' ' CD2' ' A' ' 31' ' ' LEU . 42.1 m -60.74 -43.06 98.41 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.126 0.489 . . . . 0.0 110.011 176.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.44 -56.54 18.95 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.124 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.524 HD12 ' CB ' ' B' ' 205' ' ' ALA . 3.8 pp -78.77 -7.33 57.7 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.234 -177.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 35.5 mt -83.33 -26.26 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.178 0.513 . . . . 0.0 110.105 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.474 HD13 HG13 ' A' ' 28' ' ' ILE . 56.1 mt -100.4 -3.04 31.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.957 175.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.44 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 8.1 t-80 -31.19 -70.69 0.06 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.52 20.32 1.34 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.422 0.629 . . . . 0.0 109.435 -173.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.469 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 2.3 m-20 -83.45 54.21 2.76 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.349 -171.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 19' ' ' ASP . 9.2 pt-20 47.41 29.87 1.44 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.233 1.013 . . . . 0.0 111.913 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.403 HG22 HD12 ' B' ' 232' ' ' ILE . 73.2 t -143.71 150.54 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.205 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.4 p -88.69 142.09 27.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.96 0.41 . . . . 0.0 111.846 -176.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.6 m -75.03 39.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.047 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.5 p -74.44 151.06 39.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.002 0.43 . . . . 0.0 111.736 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.58 -31.25 70.39 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.174 -177.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -53.77 -44.32 69.96 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 123.696 0.623 . . . . 0.0 110.407 173.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -81.09 -40.83 23.49 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.096 -174.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.474 HG13 HD13 ' A' ' 16' ' ' LEU . 1.5 mt -60.27 -48.08 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 174.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -57.2 -42.84 82.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.79 175.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.77 -43.21 90.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.281 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.474 ' CD2' ' HA ' ' A' ' 12' ' ' SER . 14.3 tp -72.44 -39.79 67.57 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 120.97 0.414 . . . . 0.0 110.458 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -54.87 -43.16 66.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.29 175.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -82.54 -17.53 44.66 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.214 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.452 ' HB2' ' HA ' ' B' ' 226' ' ' ILE . . . -62.24 -47.52 84.04 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 172.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.27 -31.9 24.7 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.354 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.08 38.65 5.07 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.001 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.4 t -104.43 157.01 5.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -121.41 112.53 18.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.931 0.396 . . . . 0.0 110.782 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.492 HG21 ' HB2' ' A' ' 5' ' ' SER . 3.0 p -119.29 135.13 60.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.077 175.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.456 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 8.0 tp10 -42.95 111.41 1.02 Allowed Pre-proline 0 N--CA 1.464 0.256 0 O-C-N 123.965 0.791 . . . . 0.0 110.656 173.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -49.25 -15.01 0.61 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 124.438 3.425 . . . . 0.0 114.682 -172.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 1.669 ' HD1' ' CD2' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -69.11 -34.89 75.79 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -179.343 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.519 ' O ' ' HB2' ' A' ' 47' ' ' PHE . 95.7 m95 -68.03 -61.31 4.25 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.375 177.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.456 ' HD2' ' O ' ' A' ' 40' ' ' GLU . 13.6 Cg_endo -57.56 -38.21 94.52 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 121.913 1.742 . . . . 0.0 112.117 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.38 -59.25 9.69 Favored Glycine 0 C--O 1.24 0.481 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.786 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 27.9 tp -55.51 -47.91 75.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.722 0.296 . . . . 0.0 110.246 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.714 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -56.32 -62.19 1.88 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.462 -177.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.97 -30.18 71.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.609 -173.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -83.85 -22.85 31.57 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.559 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.17 -4.62 17.48 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -173.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.714 ' HG ' ' O ' ' A' ' 47' ' ' PHE . 73.4 mt -79.13 -131.93 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.811 176.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 68.21 -10.64 0.42 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.645 0.778 . . . . 0.0 113.086 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.403 ' H ' ' C ' ' A' ' 51' ' ' LEU . 65.7 t30 -141.18 12.03 2.18 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.6 ' CG2' ' HA ' ' A' ' 51' ' ' LEU . 31.9 t -103.08 107.46 22.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.383 -173.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -54.09 150.11 8.57 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.875 172.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.82 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 1.9 tp -52.56 -60.96 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -170.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.518 ' O ' HG23 ' A' ' 60' ' ' ILE . . . -52.96 -30.47 37.45 Favored Glycine 0 C--O 1.239 0.449 0 C-N-CA 121.043 -0.598 . . . . 0.0 113.319 -173.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.3 t -50.1 -33.43 18.64 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.911 0.484 . . . . 0.0 111.965 -176.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.82 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 0.6 OUTLIER -66.45 -14.13 61.78 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -170.915 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.518 HG23 ' O ' ' A' ' 57' ' ' GLY . 11.3 tt -82.48 -2.62 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.763 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.6 p -150.27 47.5 0.9 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.429 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.583 ' OD1' ' HA ' ' A' ' 59' ' ' LEU . 7.9 m120 -93.41 -1.04 56.26 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.7 t . . . . . 0 C--N 1.326 -0.441 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 -178.609 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 203' ' ' TYR . . . . . 1.62 ' HD2' ' CD1' ' B' ' 203' ' ' TYR . 33.6 m-85 . . . . . 0 C--O 1.238 0.47 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.533 ' O ' HD11 ' B' ' 208' ' ' LEU . 2.4 p -57.17 -62.31 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 205' ' ' ALA . . . . . 0.575 ' HA ' ' HB2' ' B' ' 208' ' ' LEU . . . -71.81 -12.15 61.15 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.96 -177.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 3.0 m -68.3 -44.93 74.35 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 172.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 207' ' ' TYR . . . . . 0.425 ' CD1' HD12 ' B' ' 251' ' ' ILE . 24.5 t80 -63.64 -45.94 87.93 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.507 173.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.575 ' HB2' ' HA ' ' B' ' 205' ' ' ALA . 7.6 mp -52.98 -50.69 63.63 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.173 177.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 209' ' ' LEU . . . . . 0.471 HD13 ' CB ' ' A' ' 11' ' ' TYR . 1.2 tt -64.7 -46.5 82.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.808 -176.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -57.13 -37.24 71.71 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.861 176.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 211' ' ' ALA . . . . . 0.719 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -79.76 -34.85 39.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.996 0.426 . . . . 0.0 111.025 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 212' ' ' LEU . . . . . 0.412 HD11 HD21 ' A' ' 7' ' ' LEU . 50.2 tp -56.65 -51.62 68.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.003 177.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -143.65 76.03 0.3 Allowed Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.049 -1.072 . . . . 0.0 112.438 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 176.19 -72.77 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.495 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 215' ' ' ASN . . . . . 0.719 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 94.0 m-20 -134.91 138.24 43.92 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -176.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 3.7 m -67.24 -28.02 67.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.342 0.592 . . . . 0.0 110.483 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 12.5 m -127.87 74.76 78.6 Favored Pre-proline 0 N--CA 1.442 -0.833 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.8 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.52 117.43 3.81 Favored 'Trans proline' 0 N--CA 1.474 0.369 0 C-N-CA 123.388 2.725 . . . . 0.0 112.577 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 89.1 p -88.19 164.21 15.78 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.148 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -52.14 -36.16 50.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.225 0.536 . . . . 0.0 110.449 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -67.0 -40.94 87.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.654 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -63.14 -45.37 92.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.342 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 1.8 mp -67.29 -40.39 84.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.124 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 224' ' ' LYS . . . . . 0.415 ' HD3' HD23 ' B' ' 239' ' ' LEU . 11.6 mmmm -57.13 -47.23 81.64 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 175.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' B' ' 229' ' ' SER . 9.0 tmtm? -62.12 -41.72 98.52 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.452 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . 1.0 OUTLIER -63.17 -42.86 98.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.737 0.303 . . . . 0.0 110.833 178.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . 0.551 ' HG ' ' HB ' ' B' ' 232' ' ' ILE . 13.7 tp -76.93 -40.29 47.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.239 0.543 . . . . 0.0 110.116 -174.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.11 -32.34 73.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.865 176.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 229' ' ' SER . . . . . 0.48 ' HB2' ' O ' ' B' ' 225' ' ' LYS . 5.1 t -55.08 -42.61 73.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.438 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 94.0 t -79.9 -40.51 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-O 121.291 0.567 . . . . 0.0 110.629 176.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 115.94 33.97 1.45 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.033 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . 0.551 ' HB ' ' HG ' ' B' ' 227' ' ' LEU . 1.9 mm -91.38 128.29 43.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -57.41 119.63 6.82 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -110.81 128.38 55.74 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.162 0.506 . . . . 0.0 111.86 -175.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -93.1 102.7 15.03 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 174.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -55.15 -30.76 60.49 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -176.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 237' ' ' ASP . . . . . 0.423 ' OD1' ' HD3' ' B' ' 238' ' ' ARG . 6.3 t70 -62.1 -63.11 1.35 Allowed 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.494 0.664 . . . . 0.0 110.164 174.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.653 ' O ' HG21 ' B' ' 242' ' ' VAL . 20.8 mmt180 -64.46 -26.7 68.56 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.115 -175.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 239' ' ' LEU . . . . . 0.415 HD23 ' HD3' ' B' ' 224' ' ' LYS . 8.0 tp -53.54 -63.65 1.08 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.782 174.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -66.64 -24.21 66.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.379 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -66.93 -48.0 69.96 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.251 0.548 . . . . 0.0 110.818 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 242' ' ' VAL . . . . . 0.653 HG21 ' O ' ' B' ' 238' ' ' ARG . 60.4 t -69.72 -30.18 43.82 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 43.2 mt -81.89 -24.42 9.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.994 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 6.5 p -75.91 -31.8 59.33 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 121.557 -0.715 . . . . 0.0 110.428 172.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -73.28 -56.53 4.96 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.15 0.5 . . . . 0.0 110.608 169.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . 0.685 ' O ' HD12 ' B' ' 246' ' ' LEU . 0.0 OUTLIER -100.83 122.77 43.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.574 0.702 . . . . 0.0 110.079 -176.255 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -159.7 -164.79 1.39 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.528 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . 0.438 ' HA2' HG12 ' B' ' 251' ' ' ILE . . . -75.82 37.09 1.24 Allowed Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.48 -0.39 . . . . 0.0 113.876 -175.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -81.39 -57.5 3.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.093 0.473 . . . . 0.0 110.089 176.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -131.63 51.9 2.11 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . 0.471 HD11 ' HA ' ' B' ' 251' ' ' ILE . 1.0 OUTLIER -64.81 -51.98 60.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -170.444 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -65.39 -24.31 67.19 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.397 -175.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.19 -52.68 13.22 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.102 175.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 254' ' ' VAL . . . . . 0.449 HG23 ' HA ' ' B' ' 251' ' ' ILE . 29.7 m -66.33 -19.93 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.213 -178.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 255' ' ' ILE . . . . . . . . . . . . . 38.7 mt -84.69 -42.84 16.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.714 176.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -63.64 -43.2 97.49 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -177.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -112.36 32.45 5.57 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.286 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -100.65 54.38 0.86 Allowed Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.438 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 259' ' ' ILE . . . . . 0.422 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.1 mt . . . . . 0 C--N 1.33 -0.242 0 CA-C-O 121.242 0.544 . . . . 0.0 111.028 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.471 ' O ' HD11 ' A' ' 7' ' ' LEU . 7.7 t . . . . . 0 CA--C 1.536 0.431 0 CA-C-O 121.123 0.487 . . . . 0.0 111.484 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.52 ' HA ' ' HB2' ' A' ' 7' ' ' LEU . 1.7 m -67.27 -16.06 20.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.213 0.53 . . . . 0.0 110.204 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.551 ' OG ' HG22 ' A' ' 39' ' ' VAL . 30.8 t -60.67 -67.79 0.36 Allowed 'General case' 0 C--O 1.25 1.115 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.349 176.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -66.21 -34.92 79.12 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.818 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.52 ' HB2' ' HA ' ' A' ' 4' ' ' VAL . 6.1 mp -51.27 -54.64 24.04 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.659 173.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.05 -44.46 91.82 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.501 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.421 ' SG ' ' HB3' ' A' ' 43' ' ' TRP . 57.0 m -61.07 -38.08 84.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.097 0.475 . . . . 0.0 111.302 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.663 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -72.71 -42.36 62.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.671 -178.169 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.643 ' HB2' ' CD2' ' B' ' 209' ' ' LEU . 31.2 m-85 -75.37 -21.95 57.9 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.643 -176.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.6 p -75.33 -40.36 58.43 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.238 171.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -49.38 -51.01 37.67 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.471 0.653 . . . . 0.0 109.887 169.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' A' ' 10' ' ' ILE . 56.0 mt -59.99 -49.86 76.0 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.241 -179.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.8 mt -54.54 -64.87 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.974 0.416 . . . . 0.0 111.381 178.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 86.8 mt -63.27 -24.72 67.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.316 -170.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.525 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 55.3 t-80 -63.54 -36.78 84.93 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -104.0 -7.86 20.01 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.194 0.521 . . . . 0.0 111.615 -167.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.485 ' HB3' HG22 ' B' ' 232' ' ' ILE . 1.1 m-20 -85.53 37.96 0.72 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.43 -175.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 50.58 29.2 3.91 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.929 0.395 . . . . 0.0 110.723 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -136.3 148.96 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.034 -169.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.1 p -86.62 136.21 33.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.733 175.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.418 HG11 ' O ' ' A' ' 23' ' ' VAL . 7.2 p -76.44 116.6 19.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.985 0.421 . . . . 0.0 110.518 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.2 p -133.19 163.62 28.87 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.488 ' HG3' ' H ' ' A' ' 26' ' ' ASP . 6.6 pt-20 -45.29 -54.01 7.66 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.864 0.727 . . . . 0.0 111.958 -177.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.488 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 2.7 t70 -55.73 -40.06 71.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.473 -178.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -78.75 -41.57 30.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.394 -171.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.2 mt -63.47 -47.59 90.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.997 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -61.79 -33.39 74.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.265 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.77 -52.57 35.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.842 0.353 . . . . 0.0 110.891 176.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.46 HD13 HG21 ' B' ' 226' ' ' ILE . 0.2 OUTLIER -61.89 -32.31 72.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.226 0.536 . . . . 0.0 110.21 177.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.3 mp -69.47 -33.88 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.128 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -74.15 -27.74 60.98 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.052 174.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.73 -50.15 46.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.936 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.439 ' HB1' ' HB3' ' B' ' 209' ' ' LEU . . . -133.85 16.21 3.91 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -175.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.05 93.95 1.86 Allowed Glycine 0 C--N 1.314 -0.661 0 C-N-CA 120.317 -0.944 . . . . 0.0 111.657 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.7 p -56.43 -42.12 73.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 120.648 0.261 . . . . 0.0 111.537 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -160.97 127.4 3.98 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.029 0.442 . . . . 0.0 110.527 172.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.551 HG22 ' OG ' ' A' ' 5' ' ' SER . 8.0 p -165.07 120.45 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.795 178.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.414 ' C ' ' H ' ' A' ' 42' ' ' PHE . 1.7 pm0 -65.89 129.63 94.31 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.79 -8.87 0.96 Allowed 'Trans proline' 0 N--CA 1.485 0.991 0 C-N-CA 123.778 2.985 . . . . 0.0 113.755 -172.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.414 ' H ' ' C ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -69.77 -38.16 76.65 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.649 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.436 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 70.2 m95 -69.4 -55.03 10.21 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.979 177.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.436 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 85.0 Cg_exo -49.01 -51.0 11.38 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 122.364 2.043 . . . . 0.0 113.003 176.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.55 -49.6 68.23 Favored Glycine 0 C--O 1.243 0.683 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.738 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.415 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 15.9 tp -54.05 -48.52 70.47 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 115.449 -0.375 . . . . 0.0 110.599 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.683 ' O ' HD11 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -67.86 -44.48 77.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.879 -173.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.1 -35.28 74.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.12 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -93.39 -1.97 55.23 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.819 175.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 46' ' ' LEU . . . -82.83 -42.39 17.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.552 177.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.683 HD11 ' O ' ' A' ' 47' ' ' PHE . 2.1 mp -86.99 -131.7 0.06 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 118.7 -1.2 . . . . 0.0 109.654 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 65.59 -9.96 0.23 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.213 0.605 . . . . 0.0 112.293 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.498 ' H ' ' C ' ' A' ' 51' ' ' LEU . 23.5 t-20 -127.59 -41.4 1.7 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.664 HG21 ' HA ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -81.77 117.16 27.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.314 168.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.441 ' OD1' HG23 ' A' ' 56' ' ' ILE . 8.6 t-20 -43.95 -67.9 0.24 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.874 0.734 . . . . 0.0 112.73 -172.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.578 ' O ' HD13 ' A' ' 59' ' ' LEU . 2.4 tp -156.24 -48.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.291 -177.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.39 -21.52 8.9 Favored Glycine 0 N--CA 1.469 0.866 0 O-C-N 123.32 0.388 . . . . 0.0 113.689 -173.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.2 t -60.97 -14.51 23.29 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 122.545 0.338 . . . . 0.0 111.155 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.578 HD13 ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -68.2 -18.64 64.64 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.107 -178.27 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.484 ' O ' HG23 ' A' ' 60' ' ' ILE . 29.9 mt -100.91 29.94 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 122.254 1.026 . . . . 0.0 109.511 174.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.9 t -71.96 132.29 44.12 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 121.743 -0.598 . . . . 0.0 110.307 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -73.69 64.37 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.064 0.459 . . . . 0.0 110.678 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.6 t . . . . . 0 C--N 1.322 -0.614 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.653 176.185 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 203' ' ' TYR . . . . . 1.658 ' HE2' ' CE1' ' B' ' 203' ' ' TYR . 30.5 m-85 . . . . . 0 C--O 1.242 0.671 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.695 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 6.5 p -58.44 -50.5 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.536 -177.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 205' ' ' ALA . . . . . 0.572 ' HA ' HD11 ' B' ' 208' ' ' LEU . . . -72.65 -15.63 61.71 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.703 0.287 . . . . 0.0 110.902 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 1.7 m -70.47 -48.51 55.47 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.087 0.47 . . . . 0.0 109.736 174.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 207' ' ' TYR . . . . . 1.631 ' HE1' ' CE2' ' B' ' 207' ' ' TYR . 33.0 t80 -61.97 -41.21 97.75 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.695 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 88.4 mt -56.82 -53.49 57.25 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.101 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 209' ' ' LEU . . . . . 0.643 ' CD2' ' HB2' ' A' ' 11' ' ' TYR . 56.0 mt -57.74 -54.83 42.43 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.956 0.408 . . . . 0.0 111.067 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -58.22 -32.94 68.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.287 -176.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 211' ' ' ALA . . . . . 0.463 ' HB1' HD12 ' B' ' 255' ' ' ILE . . . -76.88 -44.58 31.39 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.158 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 212' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' B' ' 209' ' ' LEU . 2.8 pp -64.66 -22.96 67.11 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.875 0.369 . . . . 0.0 110.405 177.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.09 -13.96 58.41 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.822 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 118.49 10.87 8.33 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.348 -0.93 . . . . 0.0 113.227 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 215' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -121.48 100.42 7.01 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 122.33 -0.512 . . . . 0.0 111.216 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 2.0 m -44.74 -49.81 10.37 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -168.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 19.0 m -114.24 85.37 10.4 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 123.495 0.497 . . . . 0.0 110.446 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . 0.557 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 73.6 Cg_exo -46.01 121.91 4.77 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 123.821 3.014 . . . . 0.0 113.57 176.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 46.8 t -76.39 148.42 37.37 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.808 178.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.84 -29.11 59.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.319 176.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -66.45 -38.41 87.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.389 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -73.31 -42.53 62.24 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.127 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.481 HD12 ' CB ' ' B' ' 218' ' ' PRO . 1.7 mp -64.26 -43.88 97.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -52.15 -60.43 3.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.313 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -52.07 -50.32 61.76 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.174 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.46 HG21 HD13 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -56.25 -38.04 52.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.51 -177.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . 0.465 HD21 ' HB1' ' B' ' 234' ' ' ALA . 13.5 tp -75.91 -46.92 27.43 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.87 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -87.36 12.15 12.74 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 119.761 -0.775 . . . . 0.0 111.826 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 72.5 m -57.15 -34.14 68.13 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.324 165.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 54.1 t -93.5 -52.31 9.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.475 175.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 138.93 30.38 0.21 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.903 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . 0.485 HG22 ' HB3' ' A' ' 19' ' ' ASP . 3.4 mp -101.92 149.65 6.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 174.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -86.8 150.54 24.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.313 0.578 . . . . 0.0 111.742 -171.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . 0.465 ' HB1' HD21 ' B' ' 227' ' ' LEU . . . -134.68 160.85 36.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.749 -177.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -112.87 125.82 54.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.119 0.485 . . . . 0.0 110.286 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -62.36 -51.15 68.76 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 114.766 -1.106 . . . . 0.0 113.146 -170.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -75.08 -33.46 61.67 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.494 -173.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 26.5 tpt180 -68.21 -44.97 74.6 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.886 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 239' ' ' LEU . . . . . 0.481 HD13 ' N ' ' B' ' 240' ' ' ASN . 4.5 pp -66.27 -37.59 85.81 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.363 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 240' ' ' ASN . . . . . 0.481 ' N ' HD13 ' B' ' 239' ' ' LEU . 26.1 t-20 -67.78 -36.91 81.33 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 121.311 -0.156 . . . . 0.0 110.651 178.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -65.36 -45.58 83.6 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 120.612 0.244 . . . . 0.0 110.94 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 242' ' ' VAL . . . . . 0.416 ' O ' ' HG ' ' B' ' 246' ' ' LEU . 33.9 m -70.89 -32.26 48.15 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 CA-C-O 121.493 0.663 . . . . 0.0 109.616 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 32.1 mt -72.36 -29.58 32.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.538 175.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 47.1 t -66.01 -32.08 73.35 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 172.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -74.28 -31.42 62.52 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.084 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' B' ' 242' ' ' VAL . 32.2 mt -85.88 1.36 50.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.553 178.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -78.87 -11.31 59.99 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -166.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -88.08 -132.82 4.07 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.828 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -98.93 -156.67 0.56 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 18.9 m120 75.37 -25.38 0.2 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.081 0.552 . . . . 0.0 112.456 174.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . 0.585 ' O ' HG11 ' B' ' 254' ' ' VAL . 5.9 tp -56.52 -38.67 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.466 0.651 . . . . 0.0 110.416 175.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -54.28 -50.88 66.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.037 176.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.2 -45.91 75.46 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.063 -177.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 254' ' ' VAL . . . . . 0.585 HG11 ' O ' ' B' ' 251' ' ' ILE . 9.6 p -62.5 -33.9 61.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.259 -175.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 255' ' ' ILE . . . . . 0.463 HD12 ' HB1' ' B' ' 211' ' ' ALA . 63.4 mt -80.07 -40.33 20.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.815 176.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -57.18 -51.71 68.23 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.749 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -160.78 75.65 0.55 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.918 0.39 . . . . 0.0 110.448 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -176.32 56.37 0.11 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.733 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 27.7 mt . . . . . 0 N--CA 1.48 1.044 0 C-N-CA 123.808 0.843 . . . . 0.0 111.898 -178.978 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.468 ' O ' HD11 ' A' ' 7' ' ' LEU . 3.4 p . . . . . 0 CA--C 1.533 0.302 0 CA-C-O 121.281 0.563 . . . . 0.0 111.457 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.4 -22.78 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.955 -175.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.4 p -61.67 -63.68 1.19 Allowed 'General case' 0 C--O 1.242 0.667 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.111 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -62.43 -41.75 98.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.088 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.468 HD11 ' O ' ' A' ' 3' ' ' SER . 5.2 mp -49.45 -59.27 3.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.341 176.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.8 -53.18 60.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.668 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 35.7 t -64.79 -37.52 87.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.775 -175.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.3 tp -75.77 -35.46 30.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.898 0.38 . . . . 0.0 110.951 -175.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.754 ' OH ' ' HA2' ' B' ' 258' ' ' GLY . 17.3 m-30 -74.55 -28.32 60.9 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.769 177.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 64.3 m -66.04 -41.98 90.17 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 173.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.412 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -53.74 -45.09 70.43 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.101 171.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.8 mt -59.46 -55.15 38.27 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.788 177.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 73.4 mt -52.35 -45.62 45.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.243 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.3 mt -76.19 -18.42 59.08 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.365 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -98.3 18.37 16.55 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.957 -0.464 . . . . 0.0 112.162 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.408 ' C ' ' H ' ' A' ' 20' ' ' GLU . 15.9 t70 -117.48 -51.98 2.49 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.009 178.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -74.42 29.22 0.08 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.408 ' H ' ' C ' ' A' ' 18' ' ' ASP . 53.6 mt-10 50.86 40.29 24.48 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.742 0.417 . . . . 0.0 111.864 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.8 p -121.72 164.69 18.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.79 0.329 . . . . 0.0 111.026 -173.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.2 p -90.48 135.25 33.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.021 0.438 . . . . 0.0 111.777 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.421 ' HB ' ' HA ' ' A' ' 52' ' ' ALA . 91.8 t -77.82 123.34 34.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.414 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.26 158.49 43.81 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 177.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -50.91 -55.29 17.85 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.48 -177.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -51.73 -33.7 35.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.594 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -73.76 -50.34 21.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.534 0.207 . . . . 0.0 110.64 -176.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.416 ' O ' HD11 ' A' ' 32' ' ' ILE . 9.1 mt -65.34 -43.3 94.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.13 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -60.63 -36.61 79.06 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.988 175.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.57 -44.33 87.04 Favored 'General case' 0 C--O 1.227 -0.111 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.95 -42.98 89.29 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.239 0.542 . . . . 0.0 110.774 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.416 HD11 ' O ' ' A' ' 28' ' ' ILE . 1.6 mp -60.88 -44.0 96.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.411 177.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -73.31 -27.96 61.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.662 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.4 -37.63 85.66 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.361 176.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.39 -35.89 27.27 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.674 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.9 31.39 4.8 Favored Glycine 0 N--CA 1.454 -0.144 0 C-N-CA 120.755 -0.736 . . . . 0.0 113.428 175.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.481 HG11 ' HA2' ' B' ' 213' ' ' GLY . 22.3 m -114.52 175.08 2.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 122.725 -0.279 . . . . 0.0 110.732 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -132.96 106.94 7.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.902 0.382 . . . . 0.0 110.612 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -102.64 135.25 40.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 174.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.412 ' C ' ' H ' ' A' ' 42' ' ' PHE . 14.4 pt-20 -53.8 130.28 56.36 Favored Pre-proline 0 C--O 1.236 0.361 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.51 -2.82 1.11 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.41 2.74 . . . . 0.0 113.721 -170.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 1.659 ' HE1' ' CE2' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -71.8 -37.48 70.39 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.032 178.47 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.537 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 94.9 m95 -70.7 -54.38 8.24 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 119.194 -0.431 . . . . 0.0 110.74 177.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 75.4 Cg_exo -51.88 -45.31 39.31 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 121.705 1.603 . . . . 0.0 112.213 175.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.77 -43.68 95.88 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.333 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.0 -43.26 95.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.196 0.522 . . . . 0.0 110.286 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.474 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 2.8 m-85 -70.24 -41.08 74.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.803 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.81 -35.95 81.26 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -98.77 -23.14 15.52 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -174.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.08 -24.8 5.46 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -174.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.573 ' C ' ' H ' ' A' ' 53' ' ' ASN . 2.0 tp -86.65 -133.35 0.06 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.485 ' H ' ' CG ' ' A' ' 51' ' ' LEU . . . 60.7 -12.13 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.615 0.766 . . . . 0.0 112.773 -177.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.573 ' H ' ' C ' ' A' ' 51' ' ' LEU . 18.3 m120 -125.99 -34.94 2.51 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.509 ' CG2' ' HA ' ' A' ' 51' ' ' LEU . 61.2 t -45.0 108.26 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.517 174.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -47.39 140.21 5.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.735 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.9 tp -52.39 -48.58 45.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.896 -173.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.93 -40.67 93.57 Favored Glycine 0 C--O 1.239 0.457 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.601 177.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.4 t -59.0 -17.81 28.5 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 122.76 0.424 . . . . 0.0 111.012 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.412 HD22 ' HB1' ' A' ' 13' ' ' ALA . 15.4 tp -62.01 -21.52 64.94 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.193 -176.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.407 HG13 HG13 ' B' ' 259' ' ' ILE . 15.3 tt -71.18 -13.4 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.117 0.484 . . . . 0.0 110.893 -178.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 62.5 m -103.41 55.52 0.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.124 0.488 . . . . 0.0 110.304 177.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -74.97 -4.47 38.39 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.753 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 C--N 1.322 -0.618 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.399 -177.134 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 203' ' ' TYR . . . . . 1.662 ' HE1' ' CE2' ' B' ' 203' ' ' TYR . 28.9 m-85 . . . . . 0 N--CA 1.473 0.701 0 CA-C-O 121.169 0.509 . . . . 0.0 111.628 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.588 ' O ' HD11 ' B' ' 208' ' ' LEU . 57.7 t -59.1 -54.35 35.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.144 177.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 205' ' ' ALA . . . . . 0.457 ' HA ' HD21 ' B' ' 208' ' ' LEU . . . -65.53 -20.61 66.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.727 0.299 . . . . 0.0 111.069 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 206' ' ' SER . . . . . 0.423 ' CB ' HG21 ' B' ' 223' ' ' ILE . 1.5 m -68.14 -43.61 77.92 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 173.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 207' ' ' TYR . . . . . 1.668 ' HD2' ' CD1' ' B' ' 207' ' ' TYR . 35.7 t80 -62.3 -39.96 94.73 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.588 HD11 ' O ' ' B' ' 204' ' ' VAL . 8.8 mp -56.69 -52.81 63.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.955 175.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 209' ' ' LEU . . . . . 0.527 ' CD2' ' HB2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -55.15 -52.75 62.31 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.87 -178.688 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 210' ' ' ALA . . . . . 0.405 ' CB ' ' HB3' ' B' ' 218' ' ' PRO . . . -65.72 -31.09 71.88 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.57 -177.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 211' ' ' ALA . . . . . 0.569 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -69.77 -47.87 61.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.003 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 212' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' B' ' 209' ' ' LEU . 4.6 pp -67.21 -22.15 65.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.978 0.418 . . . . 0.0 109.897 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . 0.481 ' HA2' HG11 ' A' ' 37' ' ' VAL . . . -55.22 -25.79 41.08 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.909 174.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 123.86 17.21 3.15 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.633 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 215' ' ' ASN . . . . . 0.569 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 34.2 t30 -133.1 124.0 26.76 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.817 0.341 . . . . 0.0 110.587 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 216' ' ' SER . . . . . 0.493 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 15.5 m -75.41 -21.96 57.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.11 -178.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 8.4 t -121.44 68.02 20.12 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.999 -176.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . 0.493 ' HD3' ' C ' ' B' ' 216' ' ' SER . 75.4 Cg_exo -56.54 -60.78 0.41 Allowed 'Trans proline' 0 N--CA 1.481 0.762 0 C-N-CA 123.731 2.954 . . . . 0.0 113.24 177.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 219' ' ' SER . . . . . 0.585 ' O ' HD11 ' B' ' 223' ' ' ILE . 21.0 t 59.52 -174.87 0.1 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.204 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . 0.608 ' O ' ' HB2' ' B' ' 224' ' ' LYS . . . -54.07 -34.87 61.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.196 -176.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -58.32 -59.82 4.73 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.454 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -71.75 -35.0 69.98 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -175.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.585 HD11 ' O ' ' B' ' 219' ' ' SER . 1.7 mp -69.48 -40.61 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 120.166 -0.613 . . . . 0.0 110.173 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 224' ' ' LYS . . . . . 0.608 ' HB2' ' O ' ' B' ' 220' ' ' ALA . 14.7 mmtt -60.23 -43.76 95.76 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 174.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -55.57 -49.25 73.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.56 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 1.2 mp -65.98 -40.73 88.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.012 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . 0.414 HD12 ' HG ' ' B' ' 206' ' ' SER . 4.1 mp -71.74 -43.17 66.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.731 0.301 . . . . 0.0 111.603 -178.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.34 -21.15 61.36 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.883 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 33.3 t -57.08 -43.5 82.21 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.039 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -90.17 -31.95 5.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -176.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 103.63 69.65 0.8 Allowed Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.165 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.98 -174.04 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 170.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -80.17 -169.18 1.94 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -172.15 -22.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 119.435 -0.317 . . . . 0.0 111.6 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 50.11 96.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 O-C-N 123.515 0.51 . . . . 0.0 111.678 177.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -57.63 -25.43 60.12 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -172.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -64.07 -66.45 0.54 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.395 0.616 . . . . 0.0 110.243 171.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.475 ' O ' HG21 ' B' ' 242' ' ' VAL . 96.4 mtt180 -57.16 -40.58 77.56 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.315 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 239' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -48.97 -64.5 0.79 Allowed 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.425 0.631 . . . . 0.0 110.762 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -72.42 -25.74 61.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.685 -176.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -65.94 -46.99 76.18 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.299 -0.56 . . . . 0.0 109.973 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 242' ' ' VAL . . . . . 0.475 HG21 ' O ' ' B' ' 238' ' ' ARG . 80.7 t -66.29 -41.05 88.35 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . 0.559 ' HA ' ' CD2' ' B' ' 246' ' ' LEU . 19.7 mt -65.71 -42.62 92.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.769 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 244' ' ' SER . . . . . 0.409 ' HA ' ' HB2' ' B' ' 247' ' ' ASN . 28.2 t -71.87 -22.15 61.56 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.756 0.313 . . . . 0.0 110.825 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -86.55 -22.87 26.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.281 0.562 . . . . 0.0 109.955 177.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . 0.638 ' O ' HD11 ' B' ' 246' ' ' LEU . 1.3 pp -101.1 2.62 40.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.735 176.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 247' ' ' ASN . . . . . 0.409 ' HB2' ' HA ' ' B' ' 244' ' ' SER . 6.7 t30 -72.86 69.44 0.94 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.688 -173.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -134.6 -175.49 13.9 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.032 -178.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -89.41 -3.35 58.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.175 0.512 . . . . 0.0 110.646 -176.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . 0.474 ' HA ' ' OD1' ' B' ' 253' ' ' ASP . 4.4 p-10 -79.33 12.16 2.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.805 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . 0.452 ' O ' HG13 ' B' ' 255' ' ' ILE . 6.2 tp -67.06 -37.3 79.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 176.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -61.52 -42.08 98.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.583 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . 0.474 ' OD1' ' HA ' ' B' ' 250' ' ' ASN . 2.7 m-20 -60.46 -49.96 75.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.662 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 254' ' ' VAL . . . . . 0.436 HG11 ' HA ' ' B' ' 251' ' ' ILE . 8.3 p -70.58 -25.49 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.444 -176.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 255' ' ' ILE . . . . . 0.579 ' HA ' ' HH ' ' A' ' 11' ' ' TYR . 59.7 mt -77.46 -38.33 26.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.112 0.482 . . . . 0.0 110.278 176.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -78.24 -20.27 52.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.548 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -113.26 27.26 9.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.112 176.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 258' ' ' GLY . . . . . 0.754 ' HA2' ' OH ' ' A' ' 11' ' ' TYR . . . 20.38 -96.56 0.01 OUTLIER Glycine 0 C--N 1.336 0.543 0 N-CA-C 116.781 1.472 . . . . 0.0 116.781 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 259' ' ' ILE . . . . . 0.54 HD11 ' H ' ' B' ' 259' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.393 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -172.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 121.426 0.632 . . . . 0.0 111.44 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.4 t -65.76 -26.74 39.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.48 0.657 . . . . 0.0 109.843 -176.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.412 ' HB3' HG22 ' A' ' 39' ' ' VAL . 3.3 m -58.06 -66.65 0.44 Allowed 'General case' 0 C--O 1.242 0.709 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.591 -178.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.575 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -77.06 -20.62 55.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.764 -176.884 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 17.7 tp -57.09 -57.51 12.24 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 169.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.33 -48.72 79.63 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.413 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 49.3 t -65.43 -34.62 78.73 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.364 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.575 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 0.7 OUTLIER -70.2 -38.99 76.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 120.898 0.38 . . . . 0.0 110.352 -179.711 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 1.643 ' HE1' ' CE2' ' A' ' 11' ' ' TYR . 19.5 m-30 -67.65 -31.75 71.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.049 177.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.2 m -64.33 -46.17 84.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.188 174.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.49 ' HB2' HD22 ' A' ' 59' ' ' LEU . . . -53.49 -44.72 69.25 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.981 174.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.0 mt -61.34 -49.54 76.54 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.788 177.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 11' ' ' TYR . 30.5 mm -54.75 -42.38 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.531 -178.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -68.23 -35.33 77.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.988 0.423 . . . . 0.0 111.227 175.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -80.29 10.79 4.1 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -174.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -81.87 -79.61 0.17 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 118.452 0.569 . . . . 0.0 111.085 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.12 40.45 0.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 50.01 44.97 25.67 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.689 0.756 . . . . 0.0 111.623 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 79.7 t -92.34 138.74 19.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.55 177.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 p -62.21 111.86 2.15 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -171.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.2 t -56.56 107.56 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.794 172.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.2 p -139.92 155.65 47.07 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -176.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -52.07 -54.48 29.75 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.532 -177.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -51.5 -35.02 38.45 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.396 177.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.448 ' HG3' HG11 ' B' ' 230' ' ' VAL . 13.1 mptt -75.95 -45.05 36.99 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.404 -173.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.457 ' O ' HD11 ' A' ' 32' ' ' ILE . 5.4 mt -63.43 -42.35 95.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.306 -0.558 . . . . 0.0 109.825 176.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -58.72 -41.07 85.53 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.949 175.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.47 -49.48 77.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.241 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.47 -38.84 92.67 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.0 0.429 . . . . 0.0 111.164 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.457 HD11 ' O ' ' A' ' 28' ' ' ILE . 1.5 mp -59.61 -37.19 69.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.699 176.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -74.12 -30.88 62.52 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.703 0.287 . . . . 0.0 110.64 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.439 ' HB2' ' HA ' ' B' ' 226' ' ' ILE . . . -63.58 -44.32 94.39 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.958 176.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.466 ' HB3' ' CD1' ' B' ' 209' ' ' LEU . . . -77.01 -50.51 12.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.551 177.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.45 -4.53 31.21 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.646 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.406 HG21 ' HA2' ' B' ' 213' ' ' GLY . 48.2 t -82.63 131.31 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.627 0.251 . . . . 0.0 110.443 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -97.97 98.67 9.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.823 0.82 . . . . 0.0 110.377 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.412 HG22 ' HB3' ' A' ' 5' ' ' SER . 7.3 p -83.85 140.54 16.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.985 177.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -44.53 111.38 1.21 Allowed Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.046 174.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -46.49 -16.06 0.23 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 124.483 3.455 . . . . 0.0 115.108 -174.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 1.667 ' HE1' ' CE2' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -70.18 -32.25 70.09 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -179.356 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.43 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 84.3 m95 -71.9 -51.76 8.4 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.43 177.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.43 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 81.1 Cg_exo -49.64 -47.13 24.08 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 122.258 1.972 . . . . 0.0 112.19 170.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.28 -49.81 63.73 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.933 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -52.69 -53.1 52.12 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.684 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -61.93 -38.13 87.27 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.57 -34.71 78.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.735 -0.212 . . . . 0.0 111.19 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -100.47 -7.16 24.53 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -99.33 -37.66 9.16 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 121.951 -0.468 . . . . 0.0 112.224 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.609 ' HA ' ' CG1' ' A' ' 54' ' ' VAL . 1.6 mp -93.74 -128.51 0.12 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.41 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 66.7 -11.65 0.24 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.455 ' H ' ' C ' ' A' ' 51' ' ' LEU . 27.2 t-20 -137.34 3.62 2.6 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.609 ' CG1' ' HA ' ' A' ' 51' ' ' LEU . 34.1 m -89.88 121.11 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.037 -170.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -40.0 -87.6 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.957 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.3 tp -157.81 -57.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 121.222 -0.191 . . . . 0.0 111.458 175.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.41 -21.87 60.54 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.242 -0.504 . . . . 0.0 112.55 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.43 ' HB2' ' HB ' ' A' ' 54' ' ' VAL . 1.5 m -52.97 -20.09 3.13 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.034 0.534 . . . . 0.0 110.997 176.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.49 HD22 ' HB2' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -49.51 -42.99 45.2 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.848 176.714 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.454 HG21 HD11 ' B' ' 259' ' ' ILE . 37.2 mt -83.48 -7.13 10.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.604 0.716 . . . . 0.0 110.461 -173.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 47.5 t -89.18 -26.79 21.08 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.785 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -82.91 -16.3 48.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.35 0.595 . . . . 0.0 111.044 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 C--N 1.319 -0.721 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.793 -179.538 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 203' ' ' TYR . . . . . 1.61 ' HE2' ' CE1' ' B' ' 203' ' ' TYR . 76.4 m-85 . . . . . 0 C--O 1.239 0.51 0 CA-C-O 121.282 0.563 . . . . 0.0 111.412 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.662 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 64.6 t -64.08 -54.27 33.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.262 177.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 205' ' ' ALA . . . . . 0.51 ' HA ' HD11 ' B' ' 208' ' ' LEU . . . -70.45 -12.81 61.82 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 -178.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 206' ' ' SER . . . . . 0.618 ' OG ' HG21 ' B' ' 223' ' ' ILE . 9.5 t -79.39 -39.86 31.47 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 175.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 207' ' ' TYR . . . . . 0.468 ' CZ ' ' HD2' ' B' ' 218' ' ' PRO . 34.4 t80 -63.1 -40.35 97.37 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 173.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.662 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 33.3 mt -59.01 -51.96 67.84 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.154 176.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 209' ' ' LEU . . . . . 0.471 ' O ' HD11 ' B' ' 212' ' ' LEU . 0.2 OUTLIER -51.6 -50.74 59.62 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.627 179.533 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -65.48 -32.97 74.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.415 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 211' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -65.57 -55.08 19.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.901 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 212' ' ' LEU . . . . . 0.548 ' C ' HD21 ' B' ' 212' ' ' LEU . 0.0 OUTLIER -76.24 -13.01 60.18 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.366 -179.278 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . 0.406 ' HA2' HG21 ' A' ' 37' ' ' VAL . . . -57.2 -16.82 21.46 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.271 170.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 121.35 4.81 9.78 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.621 -0.591 . . . . 0.0 111.621 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 215' ' ' ASN . . . . . 0.576 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 38.6 t30 -117.95 100.95 7.89 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.97 0.414 . . . . 0.0 110.183 -175.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 216' ' ' SER . . . . . 0.432 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 15.2 m -72.22 -7.98 52.26 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.269 -177.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 217' ' ' SER . . . . . 0.4 ' N ' ' HD3' ' B' ' 218' ' ' PRO . 31.2 m -130.01 64.37 72.04 Favored Pre-proline 0 C--N 1.319 -0.718 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.399 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . 0.468 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 53.2 Cg_exo -57.12 137.36 81.48 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.315 2.677 . . . . 0.0 113.209 -177.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 28.9 t -115.33 165.76 12.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.281 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -53.73 -42.58 68.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.134 0.492 . . . . 0.0 110.784 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -59.34 -43.77 92.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.466 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -65.2 -52.34 55.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.933 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.618 HG21 ' OG ' ' B' ' 206' ' ' SER . 1.8 mp -58.08 -48.27 84.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.87 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 224' ' ' LYS . . . . . 0.525 ' HE3' ' CG ' ' B' ' 236' ' ' ASP . 60.1 tttm -68.5 -22.65 64.52 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 122.258 -0.276 . . . . 0.0 111.448 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -69.79 -42.99 73.03 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.466 HG21 HD11 ' B' ' 226' ' ' ILE . 1.5 mm -66.36 -38.26 81.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 113.797 -1.547 . . . . 0.0 111.299 176.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . 0.464 ' CD1' ' HB ' ' B' ' 232' ' ' ILE . 0.2 OUTLIER -71.96 -42.03 67.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.888 0.375 . . . . 0.0 110.487 179.455 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 228' ' ' ASP . . . . . 0.444 ' OD2' ' HG2' ' B' ' 224' ' ' LYS . 10.2 m-20 -75.08 -20.63 59.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.578 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 61.2 p -56.39 -35.1 67.37 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.751 0.31 . . . . 0.0 111.157 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 230' ' ' VAL . . . . . 0.448 HG11 ' HG3' ' A' ' 27' ' ' LYS . 63.4 t -89.68 -41.07 13.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.163 0.506 . . . . 0.0 111.145 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 110.3 34.96 2.2 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.332 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . 0.464 ' HB ' ' CD1' ' B' ' 227' ' ' LEU . 3.9 mt -98.02 123.76 50.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -61.87 107.99 0.94 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.003 0.43 . . . . 0.0 111.9 -170.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -106.16 132.26 52.43 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.824 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . 0.552 ' O ' HD13 ' B' ' 239' ' ' LEU . 10.9 m-20 -79.3 121.51 25.19 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 236' ' ' ASP . . . . . 0.525 ' CG ' ' HE3' ' B' ' 224' ' ' LYS . 3.3 m-20 -59.78 -14.33 14.18 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.514 0.509 . . . . 0.0 112.229 -178.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 237' ' ' ASP . . . . . 0.486 ' CG ' ' HZ1' ' B' ' 241' ' ' LYS . 19.2 t70 -98.98 -49.61 4.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.301 0.572 . . . . 0.0 110.683 177.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.573 ' O ' HG22 ' B' ' 242' ' ' VAL . 19.4 mmm180 -66.8 -36.43 82.37 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.346 -172.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 239' ' ' LEU . . . . . 0.571 HD11 ' H ' ' B' ' 240' ' ' ASN . 0.0 OUTLIER -65.38 -34.83 79.22 Favored 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.279 -176.125 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 240' ' ' ASN . . . . . 0.571 ' H ' HD11 ' B' ' 239' ' ' LEU . 55.0 t30 -79.91 -32.62 40.17 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 241' ' ' LYS . . . . . 0.486 ' HZ1' ' CG ' ' B' ' 237' ' ' ASP . 50.7 mttp -65.05 -40.25 94.49 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.486 174.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 242' ' ' VAL . . . . . 0.652 ' O ' ' HB3' ' B' ' 246' ' ' LEU . 87.7 t -64.02 -49.35 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . 0.502 HG13 ' O ' ' B' ' 239' ' ' LEU . 35.4 mt -53.96 -39.04 39.01 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.753 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.522 174.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 56.1 m -59.43 -42.43 91.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.754 0.311 . . . . 0.0 110.749 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -77.82 -21.29 51.76 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.443 0.64 . . . . 0.0 110.968 176.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . 0.652 ' HB3' ' O ' ' B' ' 242' ' ' VAL . 0.3 OUTLIER -102.92 -12.23 17.66 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.919 -168.042 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 247' ' ' ASN . . . . . 0.433 ' C ' HD21 ' B' ' 247' ' ' ASN . 0.3 OUTLIER -78.26 48.15 0.73 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.351 0.596 . . . . 0.0 111.402 -179.574 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -93.11 156.59 22.92 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.143 -0.551 . . . . 0.0 111.822 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . 0.574 ' HD3' ' H ' ' B' ' 249' ' ' LYS . 0.3 OUTLIER -80.1 39.65 0.45 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.045 0.45 . . . . 0.0 111.966 -175.075 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -118.59 27.61 8.82 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . 0.417 HD11 ' HA ' ' B' ' 251' ' ' ILE . 3.5 mm -64.57 -50.79 74.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -172.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -63.65 -30.08 71.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.231 0.539 . . . . 0.0 110.652 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.5 -48.7 63.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.976 176.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 254' ' ' VAL . . . . . . . . . . . . . 34.9 m -65.34 -27.37 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.046 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 255' ' ' ILE . . . . . 0.621 ' HA ' ' OH ' ' A' ' 11' ' ' TYR . 30.2 mt -69.63 -52.92 27.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.119 0.485 . . . . 0.0 110.583 174.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -69.38 -15.79 63.38 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.768 -177.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -82.91 40.44 0.69 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.427 174.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 20.34 -98.97 0.01 OUTLIER Glycine 0 N--CA 1.472 1.069 0 N-CA-C 115.833 1.093 . . . . 0.0 115.833 -172.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 259' ' ' ILE . . . . . 0.454 HD11 HG21 ' A' ' 60' ' ' ILE . 2.7 mp . . . . . 0 N--CA 1.465 0.284 0 CA-C-O 121.035 0.445 . . . . 0.0 111.117 -174.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.435 ' HB2' ' HG2' ' A' ' 6' ' ' GLU . 3.8 p . . . . . 0 N--CA 1.45 -0.458 0 CA-C-O 121.566 0.698 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.465 HG12 ' HB2' ' B' ' 212' ' ' LEU . 21.1 t -67.47 -27.22 37.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.398 -172.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.438 ' HB3' HG21 ' A' ' 39' ' ' VAL . 7.0 m -61.68 -57.99 9.82 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.21 -177.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.435 ' HG2' ' HB2' ' A' ' 3' ' ' SER . 9.6 pt-20 -72.98 -29.3 62.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.596 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 39.8 mt -53.91 -52.92 59.02 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 170.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.3 -53.18 59.31 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.122 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.456 ' SG ' HG22 ' A' ' 39' ' ' VAL . 31.6 m -63.48 -33.21 75.08 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.548 -177.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.401 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 1.1 tp -72.65 -40.36 62.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.689 0.28 . . . . 0.0 111.309 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 1.659 ' HE1' ' CE2' ' A' ' 11' ' ' TYR . 21.9 m-85 -75.64 -18.69 59.59 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.306 -0.558 . . . . 0.0 109.662 177.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.451 ' HB3' HG12 ' A' ' 28' ' ' ILE . 47.8 m -72.24 -44.89 62.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 170.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -50.58 -46.27 57.7 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 171.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.454 HD22 HD12 ' A' ' 56' ' ' ILE . 67.9 mt -59.38 -52.95 63.41 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.586 178.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.409 HD13 HD22 ' A' ' 31' ' ' LEU . 30.2 mt -62.02 -31.19 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -177.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.528 ' HB3' ' HA ' ' A' ' 23' ' ' VAL . 3.4 mm? -98.75 -0.98 41.58 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -124.9 53.18 1.51 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.379 0.609 . . . . 0.0 110.278 174.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -136.96 -58.3 0.72 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.871 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 20' ' ' GLU . 24.0 t70 -73.72 -174.51 1.79 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.58 175.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.484 ' H ' ' CG ' ' A' ' 19' ' ' ASP . 33.0 tt0 -77.25 -17.48 58.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.436 0.636 . . . . 0.0 109.659 178.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 79.7 t -61.19 124.25 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.941 174.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.6 p -82.61 149.98 27.11 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.076 -177.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.528 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 2.5 m -60.81 124.73 15.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.198 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.1 p -145.89 143.61 29.69 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.942 -174.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.453 ' HG3' ' H ' ' A' ' 26' ' ' ASP . 7.7 pt-20 -45.96 -50.85 14.31 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 123.706 0.629 . . . . 0.0 111.234 -177.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.453 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 13.5 t70 -53.68 -43.67 69.07 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.531 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.504 ' O ' HG13 ' B' ' 230' ' ' VAL . 2.9 mptp? -78.35 -40.68 35.68 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.33 -172.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.739 ' O ' HG12 ' A' ' 32' ' ' ILE . 5.7 mt -62.98 -50.06 81.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 119.774 -0.771 . . . . 0.0 109.947 176.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -54.41 -44.79 72.66 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.866 0.365 . . . . 0.0 110.576 177.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.404 ' HA ' ' HZ1' ' A' ' 33' ' ' LYS . . . -57.33 -45.94 83.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.983 176.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.568 ' HB2' ' CG1' ' B' ' 230' ' ' VAL . 44.0 tp -69.06 -40.14 78.68 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 121.194 0.521 . . . . 0.0 111.03 -176.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.739 HG12 ' O ' ' A' ' 28' ' ' ILE . 18.5 mm -62.52 -38.27 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.941 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.404 ' HZ1' ' HA ' ' A' ' 30' ' ' ALA . 19.1 pttm -82.72 -17.49 44.16 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.579 176.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.413 ' HB1' ' O ' ' A' ' 31' ' ' LEU . . . -62.62 -46.35 88.63 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 174.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.35 -47.77 11.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.9 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.2 64.84 0.98 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.934 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.0 m -120.86 179.26 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.879 0.371 . . . . 0.0 111.012 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -113.38 113.6 25.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.224 -177.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.456 HG22 ' SG ' ' A' ' 9' ' ' CYS . 4.4 p -145.91 137.18 19.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.765 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -56.78 123.87 60.71 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.221 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -56.41 -8.55 2.79 Favored 'Trans proline' 0 C--O 1.241 0.629 0 C-N-CA 123.57 2.847 . . . . 0.0 113.004 -174.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 1.664 ' HE1' ' CE2' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -77.45 -25.52 50.68 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.598 -177.771 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.41 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 97.0 m95 -66.84 -60.05 6.87 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.393 175.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.41 ' CD ' ' HB2' ' A' ' 43' ' ' TRP . 10.3 Cg_endo -55.87 -42.17 69.79 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 121.882 1.721 . . . . 0.0 112.276 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.73 -54.26 39.36 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.75 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.9 tt -59.12 -45.34 91.17 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 1.668 ' HE2' ' CE1' ' A' ' 47' ' ' PHE . 4.0 m-85 -54.58 -54.59 39.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.697 0.284 . . . . 0.0 111.643 -178.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.27 -24.79 61.4 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.959 -176.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -99.95 -1.68 36.57 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.03 -17.38 4.86 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.54 HD11 ' O ' ' A' ' 47' ' ' PHE . 8.4 mp -80.25 -113.46 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.958 -0.464 . . . . 0.0 109.819 175.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 59.39 2.79 0.34 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 177.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -145.01 -52.68 0.28 Allowed 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 122.21 1.005 . . . . 0.0 108.593 -173.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.47 HG12 ' HG ' ' A' ' 51' ' ' LEU . 2.4 p -18.42 110.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 111.861 -2.427 . . . . 0.0 114.553 173.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -56.71 130.98 47.77 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 163.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.507 ' O ' HD23 ' A' ' 59' ' ' LEU . 5.5 tp -47.63 -58.62 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -166.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.62 -29.11 60.71 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.005 -0.617 . . . . 0.0 113.297 -176.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.2 m -59.36 -16.8 24.9 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.507 HD23 ' O ' ' A' ' 56' ' ' ILE . 1.0 OUTLIER -60.63 -17.71 48.85 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.389 0.144 . . . . 0.0 111.389 -179.45 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.444 ' N ' HD21 ' A' ' 59' ' ' LEU . 15.7 tt -65.21 -22.16 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 120.882 0.373 . . . . 0.0 111.004 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.4 t -127.69 73.22 1.44 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.232 0.539 . . . . 0.0 110.22 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -107.48 -12.75 15.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.067 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.7 t . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.518 -175.024 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 203' ' ' TYR . . . . . 1.641 ' HD2' ' CD1' ' B' ' 203' ' ' TYR . 93.0 m-85 . . . . . 0 C--O 1.235 0.3 0 CA-C-O 121.579 0.704 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.567 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 31.5 t -68.51 -54.52 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.418 -176.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 205' ' ' ALA . . . . . 0.473 ' HA ' HD13 ' B' ' 208' ' ' LEU . . . -72.13 -13.9 61.69 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.558 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 206' ' ' SER . . . . . 0.419 ' HB3' HG21 ' B' ' 223' ' ' ILE . 3.5 m -72.3 -43.02 64.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 172.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 207' ' ' TYR . . . . . 0.463 ' CE1' HD12 ' B' ' 251' ' ' ILE . 24.4 t80 -62.64 -44.14 97.03 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 174.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 64.1 mt -59.51 -46.84 87.67 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.018 177.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 209' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' B' ' 205' ' ' ALA . 0.1 OUTLIER -57.09 -53.45 57.89 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.575 -179.67 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -62.96 -34.68 78.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.291 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 211' ' ' ALA . . . . . 0.624 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -63.27 -53.54 51.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.218 177.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 212' ' ' LEU . . . . . 0.491 HD13 ' C ' ' B' ' 212' ' ' LEU . 4.3 pp -65.76 -21.65 66.53 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.759 0.314 . . . . 0.0 110.753 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.97 -16.05 38.28 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.676 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 120.37 4.98 10.65 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.448 178.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 215' ' ' ASN . . . . . 0.624 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 28.1 t30 -117.66 108.8 15.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.188 0.518 . . . . 0.0 110.274 -178.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 216' ' ' SER . . . . . 0.41 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 5.8 m -68.05 -15.2 63.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.799 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 17.6 p -125.66 67.75 59.55 Favored Pre-proline 0 N--CA 1.441 -0.881 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.417 -175.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . 0.41 ' HD3' ' C ' ' B' ' 216' ' ' SER . 50.9 Cg_exo -59.85 121.09 9.27 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.72 2.28 . . . . 0.0 112.025 177.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 89.2 p -102.33 -178.95 3.84 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.782 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -58.93 -36.67 75.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.02 0.438 . . . . 0.0 110.84 -177.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 221' ' ' LYS . . . . . 0.53 ' HZ2' ' HB3' ' B' ' 221' ' ' LYS . 0.5 OUTLIER -74.54 -35.25 63.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.76 -176.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -59.35 -54.99 40.46 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.256 0.551 . . . . 0.0 109.746 175.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.419 HG21 ' HB3' ' B' ' 206' ' ' SER . 1.8 mp -63.47 -42.14 95.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.209 -178.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 224' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' B' ' 228' ' ' ASP . 27.7 tptp -57.06 -50.85 71.48 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 121.312 -0.155 . . . . 0.0 110.752 178.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -60.99 -41.16 95.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.909 0.385 . . . . 0.0 110.708 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.42 HG21 HD12 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -63.93 -42.94 97.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.543 -178.039 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . 0.417 HD21 ' HB1' ' B' ' 234' ' ' ALA . 26.9 tp -81.16 -23.22 38.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.23 0.538 . . . . 0.0 110.413 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 228' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' B' ' 224' ' ' LYS . 2.7 t70 -72.37 -28.27 62.91 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.636 176.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 8.4 t -65.25 -53.33 45.87 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.556 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 230' ' ' VAL . . . . . 0.568 ' CG1' ' HB2' ' A' ' 31' ' ' LEU . 22.2 m -61.6 -33.13 55.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-O 120.802 0.334 . . . . 0.0 111.744 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 102.94 39.06 2.76 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.944 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 16.9 mt -116.01 125.53 73.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -54.65 143.6 24.39 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.089 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . 0.417 ' HB1' HD21 ' B' ' 227' ' ' LEU . . . -140.93 117.08 10.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.028 0.442 . . . . 0.0 111.932 -173.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . 0.405 ' HB2' ' HB2' ' B' ' 238' ' ' ARG . 1.7 m-20 -67.88 113.41 5.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.495 174.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -56.75 -40.18 75.31 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.913 0.387 . . . . 0.0 110.986 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 237' ' ' ASP . . . . . 0.46 ' CG ' ' HZ1' ' B' ' 241' ' ' LYS . 6.8 t70 -63.41 -58.55 6.7 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.241 0.543 . . . . 0.0 111.04 178.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.666 ' O ' HG21 ' B' ' 242' ' ' VAL . 4.7 mpt_? -63.97 -29.44 70.6 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.914 -177.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 239' ' ' LEU . . . . . 0.513 ' HA ' ' CD2' ' B' ' 203' ' ' TYR . 9.3 tt -57.59 -61.42 2.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.168 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -64.38 -27.31 68.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.797 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 241' ' ' LYS . . . . . 0.46 ' HZ1' ' CG ' ' B' ' 237' ' ' ASP . 38.1 mttp -63.46 -47.91 79.88 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.694 175.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 242' ' ' VAL . . . . . 0.666 HG21 ' O ' ' B' ' 238' ' ' ARG . 46.6 t -70.13 -33.16 53.68 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . 0.62 ' HA ' ' CD1' ' B' ' 246' ' ' LEU . 4.7 mt -64.2 -35.97 75.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.153 178.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 21.8 m -75.62 -25.92 57.34 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.317 0.58 . . . . 0.0 109.938 172.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 245' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' B' ' 242' ' ' VAL . 44.2 tt0 -71.3 -40.88 70.55 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.129 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . 0.62 ' CD1' ' HA ' ' B' ' 243' ' ' ILE . 0.0 OUTLIER -108.22 18.1 21.49 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.262 0.553 . . . . 0.0 111.578 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -61.99 120.39 10.71 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.049 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -153.09 147.43 16.96 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.527 -0.845 . . . . 0.0 112.479 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -84.42 -24.16 29.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.071 0.462 . . . . 0.0 110.101 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . 0.455 ' HB3' ' HB3' ' B' ' 253' ' ' ASP . 4.9 m-20 -80.25 55.71 2.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.779 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . 0.5 ' O ' HG13 ' B' ' 254' ' ' VAL . 1.3 mm -68.2 -49.52 66.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.159 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -67.95 -25.32 65.39 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.188 0.518 . . . . 0.0 110.01 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . 0.455 ' HB3' ' HB3' ' B' ' 250' ' ' ASN . 20.4 t70 -73.33 -48.61 32.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.104 174.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 254' ' ' VAL . . . . . 0.632 ' O ' ' HA3' ' B' ' 258' ' ' GLY . 2.3 p -66.53 -18.2 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.171 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 255' ' ' ILE . . . . . . . . . . . . . 66.4 mt -84.77 -52.27 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.856 0.36 . . . . 0.0 110.598 174.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -61.12 -31.72 71.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.082 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -126.83 35.69 4.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.833 0.349 . . . . 0.0 111.294 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 258' ' ' GLY . . . . . 0.632 ' HA3' ' O ' ' B' ' 254' ' ' VAL . . . -133.67 55.03 0.75 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.721 -175.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 49.7 mt . . . . . 0 C--N 1.325 -0.473 0 CA-C-O 121.617 0.722 . . . . 0.0 109.477 171.928 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.453 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 25.6 p . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 112.26 0.466 . . . . 0.0 112.26 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.453 ' HA ' HD13 ' A' ' 7' ' ' LEU . 5.6 m -72.45 -24.67 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.692 -176.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.5 m -64.64 -55.92 17.12 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.724 177.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -59.79 -43.42 94.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.306 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 3' ' ' SER . 90.6 mt -52.61 -52.51 55.04 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.896 0.379 . . . . 0.0 110.594 175.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.04 -51.0 71.92 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.621 -176.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.6 t -72.06 -23.8 61.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.376 -176.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.5 tp -82.72 -39.1 15.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.282 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 1.659 ' HE2' ' CE1' ' A' ' 11' ' ' TYR . 20.9 m-85 -68.63 -38.76 80.76 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.3 p -64.65 -46.58 81.89 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.038 174.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -44.74 -53.81 6.96 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.625 0.37 . . . . 0.0 111.496 173.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.493 ' HA ' ' HB2' ' A' ' 17' ' ' HIS . 3.6 pp -79.43 -27.11 41.7 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.505 -178.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.48 ' N ' HD13 ' A' ' 14' ' ' LEU . 17.2 mt -65.0 -41.03 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.051 0.453 . . . . 0.0 110.621 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.92 -27.75 55.03 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 174.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.493 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -78.4 13.95 1.39 Allowed 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 176.54 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -83.92 -31.22 25.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.316 0.579 . . . . 0.0 109.75 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.56 ' CG ' ' H ' ' A' ' 20' ' ' GLU . 19.7 t70 -126.92 -157.01 0.78 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.5 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.56 ' H ' ' CG ' ' A' ' 19' ' ' ASP . 31.5 mt-10 -86.57 -5.64 59.09 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.184 0.516 . . . . 0.0 110.668 -178.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.5 t -57.7 132.54 22.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.913 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.39 151.25 47.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.345 -175.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.5 m -100.83 35.85 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.48 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.9 p -88.14 179.35 6.41 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.252 -173.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.495 ' HG3' ' N ' ' A' ' 26' ' ' ASP . 14.0 pt-20 -43.84 -50.66 7.84 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.631 -177.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.495 ' N ' ' HG3' ' A' ' 25' ' ' GLU . 10.6 t70 -55.86 -41.3 74.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.151 -175.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.568 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 3.4 mptp? -83.83 -45.33 13.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.552 -170.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.538 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 9.3 mt -66.33 -42.9 91.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.35 178.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -61.75 -46.4 89.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.133 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.29 -44.08 97.35 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.48 -39.3 62.57 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-O 121.598 0.713 . . . . 0.0 110.595 -175.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.538 ' HB ' ' O ' ' A' ' 28' ' ' ILE . 1.1 mp -60.52 -34.03 56.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.119 173.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -75.5 -29.04 59.41 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.679 174.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.04 -36.29 83.52 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.774 178.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -94.33 -41.39 9.45 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.178 -0.609 . . . . 0.0 112.039 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.76 46.07 4.37 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.639 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.476 HG21 ' HA2' ' B' ' 213' ' ' GLY . 0.2 OUTLIER -97.68 164.44 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.959 0.409 . . . . 0.0 110.857 -176.288 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -102.42 98.91 8.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.365 -176.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.0 p -131.7 129.03 61.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.517 176.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.421 ' C ' ' H ' ' A' ' 42' ' ' PHE . 16.8 pt-20 -62.25 133.88 94.48 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -178.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.43 -7.92 0.59 Allowed 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 123.969 3.113 . . . . 0.0 113.828 -174.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 1.62 ' HD2' ' CD1' ' A' ' 42' ' ' PHE . 0.5 OUTLIER -69.4 -36.8 77.1 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.072 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.529 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 89.1 m95 -70.93 -54.37 7.7 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 119.248 -0.406 . . . . 0.0 111.227 178.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.529 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 78.4 Cg_exo -49.98 -50.3 13.7 Favored 'Trans proline' 0 C--N 1.363 1.33 0 C-N-CA 122.004 1.803 . . . . 0.0 112.839 174.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.48 -50.06 71.73 Favored Glycine 0 C--O 1.24 0.523 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.209 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.8 tp -55.96 -53.11 60.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.511 -0.345 . . . . 0.0 110.776 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -59.92 -40.8 90.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.791 -177.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.59 -38.21 90.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.663 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -92.18 -8.51 45.31 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.65 -46.62 4.29 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.632 ' HA ' HG21 ' A' ' 54' ' ' VAL . 2.0 mp -84.05 -130.41 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.231 -175.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 66.94 3.62 3.17 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.375 0.67 . . . . 0.0 112.735 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -145.7 -51.4 0.25 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.632 HG21 ' HA ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -53.07 121.92 2.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 113.901 -1.499 . . . . 0.0 111.512 174.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.403 HD21 ' C ' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -58.01 158.36 6.82 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.481 175.461 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.466 ' O ' HD11 ' A' ' 59' ' ' LEU . 3.8 tp -40.53 -46.46 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 124.828 1.251 . . . . 0.0 114.371 -172.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.41 -20.3 22.17 Favored Glycine 0 N--CA 1.467 0.705 0 C-N-CA 121.272 -0.489 . . . . 0.0 113.587 -174.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 43.5 t -55.44 -25.34 35.66 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 122.467 0.307 . . . . 0.0 111.066 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.466 HD11 ' O ' ' A' ' 56' ' ' ILE . 9.8 mp -55.61 -32.29 62.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.311 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.3 mt -94.14 -3.64 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.522 0.677 . . . . 0.0 110.722 -175.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 55.1 m -114.85 -56.67 2.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.025 0.44 . . . . 0.0 111.187 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -97.25 66.47 2.07 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.155 -173.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.446 -0.636 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.77 176.551 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 203' ' ' TYR . . . . . 1.64 ' HD2' ' CD1' ' B' ' 203' ' ' TYR . 48.0 m-85 . . . . . 0 N--CA 1.469 0.523 0 CA-C-O 120.962 0.411 . . . . 0.0 112.014 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.586 ' O ' HD11 ' B' ' 208' ' ' LEU . 5.4 p -56.46 -55.47 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.209 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 205' ' ' ALA . . . . . 0.484 ' CB ' HD12 ' A' ' 14' ' ' LEU . . . -74.12 -8.15 55.12 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.989 -176.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 206' ' ' SER . . . . . 0.6 ' OG ' HG21 ' B' ' 223' ' ' ILE . 8.0 t -78.96 -37.8 38.59 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 173.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 207' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -64.25 -42.84 96.32 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 172.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.586 HD11 ' O ' ' B' ' 204' ' ' VAL . 7.5 mp -56.82 -48.28 78.35 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.927 174.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 209' ' ' LEU . . . . . 0.41 ' CD2' ' HB2' ' A' ' 11' ' ' TYR . 0.3 OUTLIER -54.93 -53.43 55.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.356 -179.75 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -61.67 -39.33 91.01 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.094 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 211' ' ' ALA . . . . . 0.717 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -69.32 -51.87 32.83 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.04 0.448 . . . . 0.0 110.931 -178.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.8 -35.86 69.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.645 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . 0.476 ' HA2' HG21 ' A' ' 37' ' ' VAL . . . -54.49 -52.43 45.02 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.294 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 163.08 31.29 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.279 -0.963 . . . . 0.0 112.336 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 215' ' ' ASN . . . . . 0.717 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 50.5 m-20 -136.02 105.24 5.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.699 0.285 . . . . 0.0 110.479 -176.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 16.4 m -61.21 -21.69 64.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.944 0.402 . . . . 0.0 111.339 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 20.3 m -128.54 73.99 80.36 Favored Pre-proline 0 N--CA 1.443 -0.788 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.563 -174.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -58.69 121.12 9.43 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.62 2.88 . . . . 0.0 112.72 175.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 15.1 m -89.95 158.57 17.33 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.46 -36.01 66.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.512 0.672 . . . . 0.0 109.738 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -62.05 -34.82 76.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.921 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 222' ' ' ASP . . . . . 0.404 ' HA ' ' HZ1' ' B' ' 225' ' ' LYS . 31.6 m-20 -73.58 -47.54 39.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.702 -178.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.6 HG21 ' OG ' ' B' ' 206' ' ' SER . 1.8 mp -59.78 -45.41 94.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 224' ' ' LYS . . . . . 0.401 ' HG3' ' OD1' ' B' ' 228' ' ' ASP . 7.3 ttmm -62.25 -36.7 82.83 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.117 175.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' B' ' 229' ' ' SER . 6.4 ttpm? -60.48 -45.55 93.32 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.764 176.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.07 -38.35 82.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.7 0.286 . . . . 0.0 111.149 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 87.6 mt -76.44 -46.25 27.86 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 228' ' ' ASP . . . . . 0.401 ' OD1' ' HG3' ' B' ' 224' ' ' LYS . 1.3 m-20 -74.59 -14.57 60.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.883 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 229' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' B' ' 225' ' ' LYS . 23.0 t -54.35 -47.1 72.94 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.089 0.471 . . . . 0.0 109.938 172.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 29.0 t -90.29 -34.05 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 121.471 0.653 . . . . 0.0 109.612 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 91.87 72.68 1.23 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.539 176.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 8.4 mt -95.53 -97.46 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 122.522 -0.399 . . . . 0.0 109.926 176.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -136.09 -78.17 0.42 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 173.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . 60.41 81.64 0.18 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.623 0.577 . . . . 0.0 112.231 174.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' B' ' 237' ' ' ASP . 0.6 OUTLIER -62.15 133.12 54.82 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.357 179.533 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.81 36.69 0.11 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.697 0.761 . . . . 0.0 111.255 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 237' ' ' ASP . . . . . 0.503 ' H ' ' C ' ' B' ' 235' ' ' ASP . 15.9 t70 -147.92 -57.65 0.24 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.669 -1.15 . . . . 0.0 107.914 176.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.433 ' O ' HG21 ' B' ' 242' ' ' VAL . 8.5 ttm-85 -57.56 -42.0 82.15 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.52 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 239' ' ' LEU . . . . . 0.588 ' HA ' ' CD2' ' B' ' 203' ' ' TYR . 10.1 tt -57.85 -62.22 1.96 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.381 -176.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -67.83 -20.0 65.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.362 -178.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -66.91 -47.2 72.5 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.288 0.566 . . . . 0.0 109.945 174.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 242' ' ' VAL . . . . . 0.519 ' O ' HD13 ' B' ' 246' ' ' LEU . 91.7 t -66.35 -39.26 83.7 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.393 179.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . 0.589 ' HA ' ' CD1' ' B' ' 246' ' ' LEU . 13.1 mt -65.52 -32.87 60.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.401 177.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 34.4 t -61.59 -39.24 90.48 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 171.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 245' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' B' ' 242' ' ' VAL . 93.1 mt-10 -63.91 -58.05 7.93 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.844 174.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . 0.603 ' O ' HD23 ' B' ' 246' ' ' LEU . 0.0 OUTLIER -103.65 37.18 2.09 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -170.033 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -57.6 154.74 10.86 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.043 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -51.69 107.62 0.48 Allowed Glycine 0 CA--C 1.519 0.294 0 CA-C-N 115.556 -0.747 . . . . 0.0 114.315 -173.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -135.07 -74.39 0.46 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -108.94 58.91 0.6 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.545 0.688 . . . . 0.0 109.191 175.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . 0.5 ' O ' HG13 ' B' ' 254' ' ' VAL . 0.3 OUTLIER -64.81 -39.7 86.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.698 -176.036 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -66.63 -37.14 84.23 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.435 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.49 -49.43 75.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.943 0.402 . . . . 0.0 110.179 175.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 254' ' ' VAL . . . . . 0.5 HG13 ' O ' ' B' ' 251' ' ' ILE . 6.2 p -68.3 -22.28 27.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.893 -176.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 255' ' ' ILE . . . . . . . . . . . . . 56.1 mt -79.19 -45.25 24.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 120.938 0.399 . . . . 0.0 110.631 173.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -61.55 -28.47 69.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.854 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -120.33 50.66 1.28 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 258' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' B' ' 254' ' ' VAL . . . -71.0 -47.16 39.8 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.377 -0.829 . . . . 0.0 113.784 -171.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 6.6 pt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.869 0.334 . . . . 0.0 111.043 -179.073 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.431 ' HB3' ' HG2' ' A' ' 6' ' ' GLU . 24.7 m . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 121.341 0.591 . . . . 0.0 111.575 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.424 HG11 ' CD2' ' B' ' 212' ' ' LEU . 20.7 t -67.1 -26.61 36.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.342 0.591 . . . . 0.0 109.684 -175.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.563 ' OG ' HG21 ' A' ' 39' ' ' VAL . 31.9 t -61.02 -65.62 0.66 Allowed 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.928 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.689 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 10.7 pt-20 -68.57 -31.55 70.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.64 -175.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 35.7 mt -55.92 -53.63 54.55 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 172.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.416 ' HB1' HG12 ' A' ' 37' ' ' VAL . . . -56.91 -52.69 64.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.91 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.689 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 24.6 p -70.73 -26.87 63.57 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.586 -173.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 1.1 tp -78.26 -38.52 23.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.698 0.285 . . . . 0.0 111.408 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 1.633 ' HE2' ' CE1' ' A' ' 11' ' ' TYR . 21.8 m-85 -72.34 -26.78 62.05 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.8 t -69.59 -51.6 33.73 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.219 171.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -47.96 -54.03 14.13 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.353 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.542 HD13 ' N ' ' A' ' 15' ' ' ILE . 2.9 pp -76.54 -29.95 56.92 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.651 -176.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.542 ' N ' HD13 ' A' ' 14' ' ' LEU . 3.8 mt -59.47 -31.0 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 118.522 0.601 . . . . 0.0 110.487 173.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.7 mp -86.73 -25.59 24.65 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.205 176.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -85.17 62.54 7.56 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -177.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -138.29 -57.27 0.65 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 120.856 -0.337 . . . . 0.0 111.506 172.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.603 ' CG ' ' H ' ' A' ' 20' ' ' GLU . 17.3 t70 -91.47 -151.3 0.26 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.743 0.306 . . . . 0.0 111.393 -176.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.603 ' H ' ' CG ' ' A' ' 19' ' ' ASP . 16.9 tp10 -88.67 -6.6 57.37 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.584 0.707 . . . . 0.0 109.634 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 68.7 t -64.76 106.61 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.655 178.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.565 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 2.7 p -66.11 150.63 48.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.075 -177.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.8 m -84.31 49.51 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.358 -174.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.4 p -81.83 164.12 21.85 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -49.77 -46.25 50.47 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.415 -178.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -58.57 -34.94 71.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.059 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.565 ' HG3' ' O ' ' A' ' 22' ' ' THR . 32.7 mmtp -75.71 -51.36 12.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.759 -175.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.1 mt -62.07 -41.28 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.151 176.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.441 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 6.9 t30 -53.81 -52.2 61.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.812 173.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.19 -44.95 79.92 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.761 0.315 . . . . 0.0 111.815 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.466 HD23 HG21 ' B' ' 226' ' ' ILE . 2.6 tm? -65.09 -46.03 82.76 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.495 0.665 . . . . 0.0 109.883 -178.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.04 -33.25 57.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.959 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 31.2 mmmt -77.68 -25.06 49.21 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.756 0.312 . . . . 0.0 111.006 176.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.13 -42.38 72.68 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.239 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.74 -41.66 11.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.702 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.51 10.92 56.42 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 121.034 -0.603 . . . . 0.0 113.253 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.472 HG21 ' HA3' ' B' ' 213' ' ' GLY . 3.2 t -70.7 140.77 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 O-C-N 122.467 -0.431 . . . . 0.0 110.577 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.69 89.72 5.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.296 -177.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.563 HG21 ' OG ' ' A' ' 5' ' ' SER . 7.6 p -110.93 127.58 67.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 172.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 12.3 pt-20 -59.53 134.71 88.93 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.261 -174.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 40' ' ' GLU . 50.5 Cg_exo -54.31 -5.2 0.36 Allowed 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 124.398 3.399 . . . . 0.0 114.634 -172.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 1.659 ' HD1' ' CD2' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -70.36 -41.72 72.76 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.685 177.521 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.571 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 94.8 m95 -68.73 -57.42 8.13 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.796 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.571 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 56.8 Cg_exo -52.15 -41.28 66.11 Favored 'Trans proline' 0 C--N 1.366 1.5 0 C-N-CA 121.749 1.633 . . . . 0.0 112.324 174.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.513 ' O ' ' HG2' ' A' ' 49' ' ' LYS . . . -59.71 -54.79 34.66 Favored Glycine 0 C--O 1.242 0.639 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.488 -179.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 57.6 mt -58.47 -50.6 73.16 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.652 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 6.2 m-85 -55.35 -51.01 68.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.365 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.09 -47.99 81.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.751 -0.658 . . . . 0.0 112.165 -176.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 45' ' ' GLY . 22.2 pttm -100.79 5.57 43.57 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 119.56 -0.856 . . . . 0.0 113.136 -174.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.24 1.85 3.24 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 47' ' ' PHE . 57.9 mt -84.99 -133.04 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 118.476 -1.29 . . . . 0.0 109.345 170.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 62.59 -13.16 0.07 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.543 ' H ' ' C ' ' A' ' 51' ' ' LEU . 18.5 m120 -128.2 3.99 5.8 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.564 ' CG2' ' HA ' ' A' ' 51' ' ' LEU . 61.5 t -95.88 103.03 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.154 -174.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -52.19 132.19 33.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.482 173.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.1 tp -45.04 -45.42 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -170.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.14 -26.01 57.93 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.364 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.0 t -65.49 -11.89 47.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.804 0.335 . . . . 0.0 110.492 -176.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 64.8 mt -57.69 -28.05 63.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.71 0.29 . . . . 0.0 110.675 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.3 tt -103.13 31.22 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.851 0.834 . . . . 0.0 110.926 -178.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.9 p -83.79 -177.45 6.69 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.966 173.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -78.15 48.37 0.73 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.718 0.294 . . . . 0.0 110.981 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.084 -178.532 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 203' ' ' TYR . . . . . 1.648 ' HD2' ' CD1' ' B' ' 203' ' ' TYR . 8.1 m-85 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.769 0.318 . . . . 0.0 111.633 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.577 ' O ' HD11 ' B' ' 208' ' ' LEU . 47.0 t -56.54 -65.36 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.63 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 205' ' ' ALA . . . . . 0.551 ' HA ' ' HB2' ' B' ' 208' ' ' LEU . . . -69.38 -6.56 30.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.215 -177.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 206' ' ' SER . . . . . 0.534 ' OG ' HG21 ' B' ' 223' ' ' ILE . 8.6 t -78.94 -42.44 26.93 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 207' ' ' TYR . . . . . 0.532 ' CZ ' ' HD2' ' B' ' 218' ' ' PRO . 29.3 t80 -65.47 -39.18 91.66 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 172.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.577 HD11 ' O ' ' B' ' 204' ' ' VAL . 9.1 mp -55.3 -51.11 67.77 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.416 173.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 209' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.51 -59.81 4.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.952 -178.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -60.75 -32.33 71.62 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -177.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 211' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -81.19 -32.0 33.73 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 122.015 -0.428 . . . . 0.0 111.308 178.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 212' ' ' LEU . . . . . 0.424 ' CD2' HG11 ' A' ' 4' ' ' VAL . 2.3 tm? -64.84 -43.12 94.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.718 177.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . 0.472 ' HA3' HG21 ' A' ' 37' ' ' VAL . . . -152.82 90.15 0.13 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.239 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 172.33 -62.91 0.14 Allowed Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 111.829 -0.508 . . . . 0.0 111.829 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 215' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 56.4 t30 -161.4 142.61 11.37 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 8.6 m -64.4 -24.56 67.68 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.23 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 12.3 t -124.04 73.15 56.15 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.708 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . 0.532 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 57.9 Cg_exo -56.57 116.54 3.27 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.183 2.589 . . . . 0.0 112.438 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 83.4 p -82.84 162.21 21.7 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.048 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -54.91 -35.53 64.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.016 0.436 . . . . 0.0 110.332 177.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -68.76 -34.87 76.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.467 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -70.28 -43.71 69.88 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.359 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.534 HG21 ' OG ' ' B' ' 206' ' ' SER . 1.8 mp -64.85 -44.39 96.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 123.271 0.357 . . . . 0.0 110.085 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -55.56 -43.49 75.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.162 173.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . 0.505 ' HZ1' ' HB3' ' B' ' 225' ' ' LYS . 7.6 ttpm? -56.6 -51.25 69.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.077 178.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.466 HG21 HD23 ' A' ' 31' ' ' LEU . 1.1 mp -68.47 -35.47 70.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.771 -177.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . 0.401 ' CD1' ' HB ' ' B' ' 232' ' ' ILE . 0.2 OUTLIER -75.43 -35.11 61.02 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.549 0.69 . . . . 0.0 109.947 -179.431 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -76.19 -30.04 57.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.584 -177.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 85.5 p -55.33 -45.3 76.38 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.556 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 59.4 t -75.84 -33.3 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 121.117 0.484 . . . . 0.0 110.663 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 103.98 38.83 2.62 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.862 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . 0.401 ' HB ' ' CD1' ' B' ' 227' ' ' LEU . 4.3 mt -109.38 135.41 48.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -66.54 118.33 10.0 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.655 0.74 . . . . 0.0 112.219 -173.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -117.5 135.55 53.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.03 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . 0.468 ' HB2' ' HB2' ' B' ' 238' ' ' ARG . 51.4 m-20 -86.43 115.21 23.79 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.185 -176.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 236' ' ' ASP . . . . . 0.594 ' O ' ' HG ' ' B' ' 239' ' ' LEU . 9.5 t70 -45.86 -60.53 2.18 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.131 0.894 . . . . 0.0 112.415 -170.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -63.92 -42.61 97.34 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.468 ' HB2' ' HB2' ' B' ' 235' ' ' ASP . 77.5 mtt180 -66.21 -36.0 81.92 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.15 -172.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 239' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' B' ' 236' ' ' ASP . 4.4 pp -68.44 -44.85 74.03 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.689 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 240' ' ' ASN . . . . . 0.485 ' N ' HD13 ' B' ' 239' ' ' LEU . 3.9 t-20 -66.14 -33.21 75.26 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 121.34 -0.144 . . . . 0.0 110.759 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -62.15 -52.45 63.79 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-O 121.224 0.535 . . . . 0.0 110.315 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 242' ' ' VAL . . . . . 0.568 HG12 ' HB2' ' B' ' 203' ' ' TYR . 12.5 p -66.48 -37.84 80.45 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.654 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -176.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . 0.551 ' HA ' ' HB2' ' B' ' 246' ' ' LEU . 57.3 mt -66.6 -31.61 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.513 176.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 8.8 t -65.06 -33.69 76.63 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 175.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -86.65 -26.16 24.48 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.731 175.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . 0.551 ' HB2' ' HA ' ' B' ' 243' ' ' ILE . 9.5 mt -75.45 -19.5 59.42 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.666 0.386 . . . . 0.0 110.657 175.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -63.49 97.85 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.874 -173.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 175.66 -175.78 47.34 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.135 -177.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -85.89 0.68 52.47 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -79.62 -0.52 34.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.956 0.408 . . . . 0.0 110.797 -175.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . 0.489 ' HA ' HG23 ' B' ' 254' ' ' VAL . 7.7 tp -61.72 -38.31 80.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.289 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -65.11 -34.91 79.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.106 0.479 . . . . 0.0 110.153 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -67.58 -45.45 75.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.632 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 254' ' ' VAL . . . . . 0.489 HG23 ' HA ' ' B' ' 251' ' ' ILE . 26.0 m -74.64 -10.94 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.2 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 255' ' ' ILE . . . . . 0.477 HG12 ' O ' ' B' ' 251' ' ' ILE . 24.0 mm -78.25 -53.15 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.003 0.43 . . . . 0.0 109.881 168.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -63.05 -42.41 99.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.328 -176.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -119.51 56.99 0.92 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.585 0.707 . . . . 0.0 109.887 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -105.79 -99.36 2.6 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.034 177.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 23.4 mt . . . . . 0 N--CA 1.481 1.098 0 C-N-CA 124.998 1.319 . . . . 0.0 113.334 -179.637 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.578 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 5.6 m . . . . . 0 N--CA 1.453 -0.321 0 CA-C-O 120.767 0.318 . . . . 0.0 110.543 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.417 HG21 ' HB2' ' B' ' 212' ' ' LEU . 13.3 p -71.68 -29.79 35.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.246 0.546 . . . . 0.0 109.753 -174.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.493 ' CB ' ' HA ' ' A' ' 39' ' ' VAL . 51.7 m -64.62 -52.06 59.39 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.944 176.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.408 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 35.6 tt0 -57.85 -45.45 86.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.04 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 3' ' ' SER . 82.6 mt -54.03 -53.78 48.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.356 176.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.07 -55.34 24.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.895 -177.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 21.6 p -67.43 -31.22 71.25 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.73 -176.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.434 HG13 HD21 ' A' ' 59' ' ' LEU . 0.9 OUTLIER -77.65 -37.64 24.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.921 0.391 . . . . 0.0 111.068 -176.892 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.626 ' O ' HG12 ' A' ' 15' ' ' ILE . 23.1 m-85 -74.61 -26.37 59.86 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.7 t -69.56 -44.78 70.16 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 172.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.94 -40.29 60.58 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.387 171.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.3 mt -60.48 -59.97 4.56 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 173.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.626 HG12 ' O ' ' A' ' 11' ' ' TYR . 36.3 mm -46.09 -34.4 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.3 mt -115.13 7.26 15.34 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -174.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -48.25 -62.47 1.47 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 19' ' ' ASP . 2.0 p-10 -120.73 -82.12 0.64 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.356 -176.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.558 ' OD2' HG22 ' B' ' 232' ' ' ILE . 5.2 t0 47.37 -152.59 0.09 Allowed 'General case' 0 CA--C 1.536 0.431 0 O-C-N 123.628 0.58 . . . . 0.0 111.28 178.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -112.05 22.52 14.74 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 168.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.426 HG12 HD13 ' B' ' 232' ' ' ILE . 4.1 p -128.41 158.67 40.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.59 -177.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.1 p -105.49 130.86 53.48 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 121.241 -0.183 . . . . 0.0 111.332 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -65.38 105.11 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.408 0.623 . . . . 0.0 110.52 175.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.4 ' OG1' ' HG2' ' A' ' 27' ' ' LYS . 22.3 p -133.91 168.48 18.69 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.379 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.427 ' HG3' ' N ' ' A' ' 26' ' ' ASP . 9.1 pt-20 -48.18 -48.53 34.56 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 123.659 0.599 . . . . 0.0 111.648 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.427 ' N ' ' HG3' ' A' ' 25' ' ' GLU . 7.5 p-10 -68.31 -27.84 66.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.251 -175.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.4 ' HG2' ' OG1' ' A' ' 24' ' ' THR . 46.2 mmtm -78.21 -45.1 23.93 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -176.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.5 mt -67.48 -41.7 86.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.779 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -55.57 -45.85 77.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.705 175.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.81 -49.6 72.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.324 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.411 ' CD1' ' HG ' ' B' ' 209' ' ' LEU . 0.2 OUTLIER -65.69 -38.6 89.7 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.211 0.529 . . . . 0.0 110.24 -177.276 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.3 mp -63.97 -35.86 74.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.255 176.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.582 ' HB3' ' HZ2' ' A' ' 33' ' ' LYS . 6.1 ttpm? -76.02 -21.69 56.57 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.919 0.39 . . . . 0.0 110.351 175.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.51 -48.71 21.35 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.444 ' HB3' HD13 ' B' ' 226' ' ' ILE . . . -143.27 8.27 1.6 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.38 89.93 1.55 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.115 -176.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.2 p -50.17 -50.8 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -175.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -161.63 126.52 3.47 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.946 0.403 . . . . 0.0 111.246 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.493 ' HA ' ' CB ' ' A' ' 5' ' ' SER . 7.2 p -139.17 127.53 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.431 173.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -57.07 125.62 70.8 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.029 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.99 -11.12 1.3 Allowed 'Trans proline' 0 N--CA 1.481 0.792 0 C-N-CA 124.042 3.162 . . . . 0.0 115.046 -168.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 1.617 ' HD1' ' CD2' ' A' ' 42' ' ' PHE . 0.7 OUTLIER -80.12 -28.18 39.02 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -174.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.413 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 98.7 m95 -64.68 -60.48 8.21 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.293 175.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.413 ' CD ' ' HB2' ' A' ' 43' ' ' TRP . 19.3 Cg_endo -59.74 -34.45 96.04 Favored 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 121.835 1.69 . . . . 0.0 111.939 178.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.91 -49.17 81.53 Favored Glycine 0 C--O 1.241 0.562 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.253 176.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 42' ' ' PHE . 89.8 mt -64.08 -47.18 81.09 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.401 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 5.2 m-85 -60.72 -47.02 88.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.843 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.72 -37.52 86.64 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.608 -176.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -91.49 -26.76 18.64 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 119.8 -0.76 . . . . 0.0 113.033 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -116.11 -20.13 10.0 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -171.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.572 ' HA ' ' CG2' ' A' ' 54' ' ' VAL . 2.2 tp -83.99 -133.87 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 58.08 3.16 0.22 Allowed 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -176.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.427 ' H ' ' C ' ' A' ' 51' ' ' LEU . 48.1 t-20 -145.57 -44.15 0.21 Allowed 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -177.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.572 ' CG2' ' HA ' ' A' ' 51' ' ' LEU . 48.7 t -40.91 112.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 114.0 -1.454 . . . . 0.0 110.745 172.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -54.67 140.47 35.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.071 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.603 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 3.4 tp -43.85 -51.94 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 124.043 0.84 . . . . 0.0 112.903 -173.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.28 -30.89 75.23 Favored Glycine 0 C--O 1.243 0.688 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.661 -176.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.5 t -65.25 -11.55 42.38 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -176.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.603 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 1.7 mp -43.06 -48.38 6.13 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.164 170.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.425 HD12 HG22 ' B' ' 259' ' ' ILE . 24.7 mm -110.05 44.46 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.628 0.728 . . . . 0.0 109.82 -178.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 48.9 t -119.58 -36.47 3.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.117 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -100.36 4.0 43.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.43 -177.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 CA--C 1.533 0.297 0 CA-C-O 121.015 0.436 . . . . 0.0 111.299 179.028 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 203' ' ' TYR . . . . . 1.662 ' HD2' ' CD1' ' B' ' 203' ' ' TYR . 29.3 m-85 . . . . . 0 C--O 1.236 0.37 0 CA-C-O 121.305 0.574 . . . . 0.0 110.647 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.629 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 38.7 t -65.24 -44.54 95.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.235 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 205' ' ' ALA . . . . . 0.51 ' HA ' HD13 ' B' ' 208' ' ' LEU . . . -72.74 -20.19 61.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.901 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 206' ' ' SER . . . . . 0.505 ' CB ' HG21 ' B' ' 223' ' ' ILE . 4.0 m -70.62 -42.42 70.93 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 173.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 207' ' ' TYR . . . . . 0.485 ' CE1' HD12 ' B' ' 251' ' ' ILE . 20.7 t80 -60.42 -41.58 94.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.163 174.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 75.7 mt -62.59 -42.06 99.34 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.814 177.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 209' ' ' LEU . . . . . 0.411 ' HG ' ' CD1' ' A' ' 31' ' ' LEU . 0.6 OUTLIER -55.8 -54.52 43.44 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.741 177.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -67.15 -27.33 67.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.376 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 211' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -65.81 -50.04 66.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.16 177.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 212' ' ' LEU . . . . . 0.417 ' HB2' HG21 ' A' ' 4' ' ' VAL . 4.1 pp -73.78 -24.85 59.9 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.727 0.299 . . . . 0.0 110.783 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.91 -13.68 53.19 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 116.005 -0.543 . . . . 0.0 113.265 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 118.65 35.48 0.98 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.886 177.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 215' ' ' ASN . . . . . 0.638 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 33.9 t30 -152.42 114.83 4.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.912 0.387 . . . . 0.0 110.31 176.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 216' ' ' SER . . . . . 0.466 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 8.1 m -76.28 -11.24 59.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.176 -178.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 26.4 t -123.55 63.48 26.78 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.674 -176.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . 0.466 ' HD3' ' C ' ' B' ' 216' ' ' SER . 52.4 Cg_exo -60.22 144.96 99.48 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.029 2.486 . . . . 0.0 111.88 175.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 219' ' ' SER . . . . . 0.439 ' O ' HD11 ' B' ' 223' ' ' ILE . 21.5 m -129.51 168.53 16.23 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.794 178.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -47.76 -40.37 20.47 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.922 0.392 . . . . 0.0 111.659 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 221' ' ' LYS . . . . . 0.48 ' HZ2' ' HB3' ' B' ' 221' ' ' LYS . 4.2 ttpm? -58.1 -49.99 75.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.727 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.03 -39.4 69.15 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.281 -173.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.505 HG21 ' CB ' ' B' ' 206' ' ' SER . 1.7 mp -64.55 -40.28 88.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.584 176.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 224' ' ' LYS . . . . . 0.611 ' HZ3' ' CG ' ' B' ' 236' ' ' ASP . 16.3 tppt? -56.25 -45.65 79.95 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.198 173.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -58.9 -43.98 91.11 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.151 0.5 . . . . 0.0 111.337 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.444 HD13 ' HB3' ' A' ' 35' ' ' ALA . 1.3 mp -63.57 -40.23 88.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.156 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 76.7 mt -76.54 -19.28 58.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.199 0.523 . . . . 0.0 110.581 176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -73.84 -36.51 64.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.297 178.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 94.6 p -55.43 -40.96 72.17 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.634 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 3.3 m -90.02 -14.42 9.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 111.9 0.334 . . . . 0.0 111.9 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 77.7 32.84 44.51 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.586 175.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . 0.558 HG22 ' OD2' ' A' ' 19' ' ' ASP . 61.6 mt -90.48 130.43 39.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 177.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -67.01 100.22 0.72 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.318 0.58 . . . . 0.0 110.787 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -89.78 111.69 22.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.22 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . 0.419 ' HB2' ' HG2' ' B' ' 238' ' ' ARG . 5.3 m-20 -53.56 104.52 0.1 Allowed 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.727 0.642 . . . . 0.0 110.607 177.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 236' ' ' ASP . . . . . 0.611 ' CG ' ' HZ3' ' B' ' 224' ' ' LYS . 5.6 m-20 -54.95 -38.14 67.35 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -174.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 237' ' ' ASP . . . . . 0.433 ' O ' ' HG2' ' B' ' 241' ' ' LYS . 15.9 t70 -55.81 -68.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.052 0.453 . . . . 0.0 111.276 178.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.459 ' HA ' ' HB2' ' B' ' 241' ' ' LYS . 13.7 ptp180 -68.76 -17.02 63.97 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.821 0.343 . . . . 0.0 111.039 -174.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 239' ' ' LEU . . . . . 0.43 HD21 ' CD1' ' B' ' 203' ' ' TYR . 3.3 tm? -61.22 -67.94 0.36 Allowed 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.854 176.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -75.1 -16.25 60.56 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.369 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 241' ' ' LYS . . . . . 0.459 ' HB2' ' HA ' ' B' ' 238' ' ' ARG . 29.9 mmtp -64.07 -56.02 17.95 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.257 171.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 242' ' ' VAL . . . . . 0.503 ' O ' ' HB3' ' B' ' 246' ' ' LEU . 34.7 m -67.26 -34.98 72.6 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.81 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -175.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 58.4 mt -74.03 -23.87 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.473 178.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 25.3 t -72.0 -31.66 66.45 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 172.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -83.1 -22.7 33.33 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.35 0.595 . . . . 0.0 110.454 173.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . 0.57 ' O ' ' HG ' ' B' ' 246' ' ' LEU . 9.3 tp -116.11 71.44 0.78 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.466 -174.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -125.3 80.91 1.92 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.145 0.498 . . . . 0.0 111.949 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 87.04 -15.96 50.36 Favored Glycine 0 CA--C 1.52 0.406 0 CA-C-N 115.773 -0.649 . . . . 0.0 113.412 175.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -67.46 110.21 3.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.995 0.426 . . . . 0.0 111.524 -176.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 60.27 42.22 15.39 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.808 174.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . 0.485 HD12 ' CE1' ' B' ' 207' ' ' TYR . 2.5 mm -58.25 -53.07 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -176.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -67.42 -26.18 66.29 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.378 -176.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -72.91 -46.03 54.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.4 177.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 254' ' ' VAL . . . . . . . . . . . . . 22.9 m -68.28 -20.57 25.67 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.989 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 255' ' ' ILE . . . . . 0.41 ' HA ' ' OH ' ' A' ' 11' ' ' TYR . 54.5 mt -74.04 -56.02 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-O 121.026 0.441 . . . . 0.0 110.759 172.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -67.98 -38.4 82.65 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -173.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 17.0 tp60 -101.54 -14.73 17.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.87 0.367 . . . . 0.0 111.701 -174.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -105.63 56.82 0.51 Allowed Glycine 0 C--O 1.227 -0.298 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.275 -172.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 259' ' ' ILE . . . . . 0.425 HG22 HD12 ' A' ' 60' ' ' ILE . 1.3 mt . . . . . 0 C--N 1.327 -0.387 0 CA-C-O 120.893 0.378 . . . . 0.0 111.668 -179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.59 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 5.8 p . . . . . 0 CA--C 1.529 0.167 0 CA-C-O 120.946 0.403 . . . . 0.0 111.997 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.444 ' HA ' HD13 ' A' ' 7' ' ' LEU . 21.9 t -66.09 -31.02 51.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.213 0.53 . . . . 0.0 110.005 -174.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.1 m -61.76 -55.54 29.05 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.417 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -61.15 -42.06 97.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.97 178.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 3' ' ' SER . 96.0 mt -56.15 -55.61 30.97 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.619 178.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.26 -49.73 76.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.086 -178.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.1 t -66.15 -38.36 87.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.291 -176.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.405 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 1.3 tp -75.16 -39.56 43.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.932 0.396 . . . . 0.0 110.998 -177.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 1.66 ' HE1' ' CE2' ' A' ' 11' ' ' TYR . 20.1 m-85 -74.91 -19.31 60.19 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.2 t -70.94 -50.97 28.84 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 170.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -49.43 -48.21 47.57 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.109 175.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.582 ' HG ' ' HA ' ' A' ' 11' ' ' TYR . 4.2 pp -81.09 -18.16 47.49 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 11' ' ' TYR . 2.8 mt -62.14 -41.98 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.274 0.559 . . . . 0.0 109.543 168.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.7 mt -80.82 -27.56 36.5 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.183 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.486 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 10.2 m80 -79.78 64.73 4.72 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 177.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -129.93 -51.35 1.13 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 171.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.483 ' OD1' HG22 ' B' ' 232' ' ' ILE . 8.8 m-20 -102.32 10.67 38.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.406 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 54.18 51.26 14.78 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.398 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.402 HG23 ' N ' ' A' ' 22' ' ' THR . 14.9 p -87.11 162.12 2.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.214 176.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.467 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 10.6 p -56.31 110.98 0.85 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.31 0.576 . . . . 0.0 112.246 -175.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.9 m -84.87 47.35 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.556 0.693 . . . . 0.0 110.935 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.1 t -87.31 169.32 12.39 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.071 -171.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -52.93 -42.26 65.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.903 -177.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -49.82 -45.58 50.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.677 177.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 22' ' ' THR . 66.4 mmtt -76.48 -48.92 17.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.945 -173.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.3 mt -62.45 -46.1 97.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.019 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -60.37 -46.09 91.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.902 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.49 ' HB1' HG12 ' B' ' 230' ' ' VAL . . . -71.21 -34.37 70.78 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.436 HD13 HG21 ' B' ' 226' ' ' ILE . 0.1 OUTLIER -70.69 -46.02 63.93 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.712 0.768 . . . . 0.0 109.478 178.568 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.65 -37.3 64.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.53 175.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -74.39 -31.38 62.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.177 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.34 -45.4 91.48 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.471 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.488 ' HA ' HD12 ' B' ' 226' ' ' ILE . . . -76.32 -31.82 58.36 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.169 177.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.07 16.48 47.36 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.27 175.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.555 ' CG2' ' HA2' ' B' ' 213' ' ' GLY . 53.1 t -95.19 138.98 19.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.822 0.344 . . . . 0.0 110.71 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -93.41 97.47 10.59 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.873 0.368 . . . . 0.0 111.461 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -97.09 136.68 27.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 171.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -59.92 126.24 82.85 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.65 -5.65 0.48 Allowed 'Trans proline' 0 N--CA 1.482 0.815 0 C-N-CA 124.053 3.169 . . . . 0.0 114.146 -172.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 1.669 ' HE1' ' CE2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -67.64 -36.36 80.63 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.673 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.577 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 94.6 m95 -71.69 -56.6 4.78 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.995 177.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.577 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 74.0 Cg_exo -51.12 -43.77 46.42 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.093 1.862 . . . . 0.0 112.334 176.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.88 -57.1 15.18 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.143 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 45.5 tp -57.37 -43.61 83.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.659 0.266 . . . . 0.0 110.348 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 1.65 ' HD1' ' CD2' ' A' ' 47' ' ' PHE . 3.0 m-85 -59.97 -49.73 76.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.295 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.42 -34.27 76.44 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.043 -178.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -97.49 -1.71 43.54 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.86 -16.55 7.07 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.546 HD11 ' HA ' ' A' ' 47' ' ' PHE . 9.4 mp -84.75 -131.77 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 O-C-N 121.945 -0.472 . . . . 0.0 110.098 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.412 ' H ' ' HB3' ' A' ' 51' ' ' LEU . . . 61.02 2.22 0.54 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.502 0.721 . . . . 0.0 112.887 -178.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.457 ' H ' HG13 ' A' ' 54' ' ' VAL . 9.3 m120 -139.49 -58.49 0.58 Allowed 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.52 HG12 ' HG ' ' A' ' 51' ' ' LEU . 2.5 p -1.01 96.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 113.217 -1.81 . . . . 0.0 114.48 164.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -59.38 128.75 38.65 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.205 169.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.426 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 5.1 tp -47.73 -45.25 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -169.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.408 ' O ' HG23 ' A' ' 60' ' ' ILE . . . -58.85 -37.38 90.52 Favored Glycine 0 C--O 1.239 0.407 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.595 -177.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.9 m -61.57 -11.01 9.38 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.474 -0.363 . . . . 0.0 111.599 -178.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 9.2 tp -63.04 -24.86 68.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.802 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.492 ' O ' HG12 ' A' ' 60' ' ' ILE . 11.0 tt -99.86 22.43 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 121.991 0.901 . . . . 0.0 110.301 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 81.8 m -140.94 -62.38 0.48 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.16 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -101.1 66.33 1.13 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.978 0.418 . . . . 0.0 110.701 -176.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.137 177.979 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 203' ' ' TYR . . . . . 1.652 ' HD1' ' CD2' ' B' ' 203' ' ' TYR . 68.3 m-85 . . . . . 0 C--O 1.24 0.567 0 CA-C-O 121.355 0.598 . . . . 0.0 111.026 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.534 ' O ' HD11 ' B' ' 208' ' ' LEU . 8.6 p -58.28 -47.79 86.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.147 -174.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 205' ' ' ALA . . . . . 0.516 ' HA ' ' HB2' ' B' ' 208' ' ' LEU . . . -72.95 -19.22 61.28 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.471 -177.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 206' ' ' SER . . . . . 0.554 ' OG ' HG21 ' B' ' 223' ' ' ILE . 24.4 t -66.09 -43.33 87.63 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 207' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -60.47 -44.31 96.04 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.721 173.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.534 HD11 ' O ' ' B' ' 204' ' ' VAL . 6.3 mp -56.26 -49.07 75.23 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.035 177.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 209' ' ' LEU . . . . . 0.422 ' HA ' ' HG ' ' B' ' 212' ' ' LEU . 3.7 mp -62.54 -43.13 99.57 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.56 0.219 . . . . 0.0 111.379 -178.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -62.74 -34.0 76.3 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.19 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 211' ' ' ALA . . . . . 0.705 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -71.44 -53.77 12.9 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.701 0.286 . . . . 0.0 111.05 178.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 212' ' ' LEU . . . . . 0.438 HD11 ' C ' ' B' ' 212' ' ' LEU . 4.6 pp -68.61 -17.79 64.18 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.045 0.45 . . . . 0.0 110.904 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . 0.555 ' HA2' ' CG2' ' A' ' 37' ' ' VAL . . . -66.88 -19.63 69.81 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.103 177.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 130.71 6.91 3.55 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.111 177.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 215' ' ' ASN . . . . . 0.705 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 7.9 m-20 -119.52 119.05 32.7 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.841 0.353 . . . . 0.0 110.996 -178.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 8.5 m -81.74 -0.87 44.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.71 0.29 . . . . 0.0 111.365 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 217' ' ' SER . . . . . 0.454 ' N ' ' HD3' ' B' ' 218' ' ' PRO . 24.5 m -135.98 62.16 44.75 Favored Pre-proline 0 N--CA 1.444 -0.764 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.342 -176.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . 0.454 ' HD3' ' N ' ' B' ' 217' ' ' SER . 35.0 Cg_exo -63.87 130.98 29.31 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.987 2.458 . . . . 0.0 112.483 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 219' ' ' SER . . . . . 0.519 ' O ' HD11 ' B' ' 223' ' ' ILE . 33.0 t -110.25 169.53 8.67 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.762 0.315 . . . . 0.0 110.49 177.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -56.02 -29.1 59.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.72 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -62.39 -53.1 59.92 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.612 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -62.36 -48.04 81.54 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.252 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.554 HG21 ' OG ' ' B' ' 206' ' ' SER . 1.7 mp -61.18 -48.49 88.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.784 -178.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -62.21 -38.11 87.9 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.499 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -56.93 -52.52 64.86 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.049 176.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.488 HD12 ' HA ' ' A' ' 35' ' ' ALA . 1.0 OUTLIER -60.25 -43.73 94.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.222 -177.673 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 1.1 tt -69.99 -43.02 72.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.68 0.276 . . . . 0.0 110.497 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -69.43 -25.51 64.15 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.998 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 58.7 m -51.08 -49.41 60.71 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 230' ' ' VAL . . . . . 0.49 HG12 ' HB1' ' A' ' 30' ' ' ALA . 3.4 p -171.46 19.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.914 -175.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -82.93 -94.75 0.57 Allowed Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 119.973 -1.108 . . . . 0.0 112.04 -173.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . 0.483 HG22 ' OD1' ' A' ' 19' ' ' ASP . 51.4 mt -143.17 -88.87 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 120.543 0.211 . . . . 0.0 110.549 -176.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -148.17 160.7 42.65 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 174.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -151.21 98.91 2.61 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.054 0.454 . . . . 0.0 111.676 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . 0.466 ' CG ' ' HD3' ' B' ' 238' ' ' ARG . 0.0 OUTLIER -67.74 127.54 33.18 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.77 174.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -65.69 -39.86 91.73 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -165.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -80.71 -38.62 28.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.312 0.577 . . . . 0.0 110.21 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.466 ' HD3' ' CG ' ' B' ' 235' ' ' ASP . 68.2 ttt180 -66.68 -39.47 88.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.677 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 239' ' ' LEU . . . . . . . . . . . . . 8.6 tt -59.01 -51.84 68.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.07 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -69.3 -29.53 67.41 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -67.15 -46.37 74.26 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 242' ' ' VAL . . . . . . . . . . . . . 35.8 m -70.13 -32.17 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . 0.469 ' HA ' ' CD2' ' B' ' 246' ' ' LEU . 12.5 mt -64.25 -38.54 82.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.981 170.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 28.1 t -72.07 -13.64 61.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.616 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -89.31 -30.29 18.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.036 0.446 . . . . 0.0 110.402 172.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . 0.589 ' O ' HD11 ' B' ' 246' ' ' LEU . 1.4 pp -98.84 3.72 47.4 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.617 -178.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -78.16 40.02 0.33 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -171.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -86.63 -121.23 1.32 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.17 -175.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -139.15 -174.44 3.86 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . 0.489 ' HB3' ' CB ' ' B' ' 253' ' ' ASP . 89.6 m-20 64.5 49.63 2.37 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.625 0.578 . . . . 0.0 111.428 176.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . 0.489 ' O ' HG13 ' B' ' 255' ' ' ILE . 1.3 mm -60.19 -48.39 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.297 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -68.96 -22.27 64.12 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.422 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . 0.489 ' CB ' ' HB3' ' B' ' 250' ' ' ASN . 5.8 t70 -70.88 -47.01 61.56 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 254' ' ' VAL . . . . . 0.472 HG23 ' O ' ' B' ' 251' ' ' ILE . 11.4 m -69.67 -25.11 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.119 178.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 255' ' ' ILE . . . . . 0.489 HG13 ' O ' ' B' ' 251' ' ' ILE . 61.4 mt -78.98 -32.04 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.782 174.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -77.84 -41.69 36.15 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -127.1 36.96 4.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.271 0.558 . . . . 0.0 111.123 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -124.66 36.57 2.84 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.218 -0.992 . . . . 0.0 111.955 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--O 1.222 -0.383 0 CA-C-O 120.814 0.34 . . . . 0.0 110.724 -178.573 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 CA--C 1.537 0.472 0 CA-C-O 121.208 0.528 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.461 HG13 ' HB2' ' B' ' 212' ' ' LEU . 2.4 m -66.09 -18.01 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.481 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.7 m -61.37 -62.67 1.66 Allowed 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.51 176.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.56 ' O ' HG22 ' A' ' 10' ' ' ILE . 9.9 pt-20 -69.93 -34.9 74.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.446 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.46 ' HB2' ' HA ' ' A' ' 4' ' ' VAL . 66.6 mt -49.19 -64.72 0.72 Allowed 'General case' 0 C--O 1.222 -0.348 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 172.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.31 86.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.683 -176.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.2 t -62.21 -51.79 66.37 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -176.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.56 HG22 ' O ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -83.19 -16.58 11.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 119.166 -1.013 . . . . 0.0 111.158 -177.869 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 1.655 ' HD1' ' CD2' ' A' ' 11' ' ' TYR . 15.9 m-30 -69.89 -32.41 70.73 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 169.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.1 t -66.58 -43.91 83.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.298 169.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.528 ' HB1' ' O ' ' A' ' 10' ' ' ILE . . . -48.96 -45.19 41.59 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 120.98 0.419 . . . . 0.0 110.376 171.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 10' ' ' ILE . 85.7 mt -58.46 -56.03 27.41 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.614 177.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.468 HD13 HD22 ' A' ' 31' ' ' LEU . 56.5 mt -60.15 -32.45 50.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.619 -174.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -88.79 -24.34 22.64 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 121.758 -0.589 . . . . 0.0 112.41 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.541 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 54.6 t-80 -59.38 -51.25 70.73 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -174.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -92.52 -21.19 20.26 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -164.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.435 ' O ' HG21 ' A' ' 21' ' ' VAL . 3.7 m-20 -86.12 29.08 0.76 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -171.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 65.32 8.26 4.81 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.846 0.459 . . . . 0.0 111.933 174.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 19' ' ' ASP . 71.7 t -104.74 141.23 20.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.138 0.494 . . . . 0.0 110.721 -176.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 7.1 p -73.02 126.75 30.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.079 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.6 p -76.44 87.0 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.564 0.697 . . . . 0.0 110.917 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.1 p -112.46 175.6 5.37 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.353 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -59.74 -36.53 76.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.768 -178.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -53.14 -45.02 68.19 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.897 176.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 22' ' ' THR . 69.2 mmtt -78.29 -47.59 17.5 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.678 -169.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.441 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 21.6 mt -65.47 -46.49 89.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.362 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -63.15 -38.81 92.64 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.86 -43.6 75.08 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.128 0.489 . . . . 0.0 111.232 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.468 HD22 HD13 ' A' ' 15' ' ' ILE . 27.3 tp -70.87 -31.92 68.74 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.336 0.589 . . . . 0.0 110.011 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.441 ' HB ' ' O ' ' A' ' 28' ' ' ILE . 1.4 mp -73.05 -27.99 25.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.092 174.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -69.71 -34.32 73.72 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 172.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.96 -63.06 1.15 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.161 178.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.45 26.22 5.38 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -175.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -100.96 94.72 1.3 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.27 -0.967 . . . . 0.0 111.339 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.461 ' HB ' ' HA2' ' B' ' 213' ' ' GLY . 7.7 p -55.05 -50.15 65.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -161.91 130.03 4.15 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.226 0.536 . . . . 0.0 111.725 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.9 p -157.56 131.95 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.06 174.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -73.0 132.1 83.08 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.56 -4.84 0.59 Allowed 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.846 3.031 . . . . 0.0 114.462 -171.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 1.668 ' HE2' ' CE1' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -69.55 -37.75 77.19 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.236 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.533 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 93.2 m95 -68.4 -55.01 12.98 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.839 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.533 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 87.5 Cg_exo -50.25 -50.77 12.52 Favored 'Trans proline' 0 C--N 1.364 1.366 0 C-N-CA 121.99 1.793 . . . . 0.0 112.972 174.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.8 -49.91 72.89 Favored Glycine 0 C--O 1.242 0.622 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.092 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 56.9 tp -53.57 -62.16 1.83 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.239 177.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -52.41 -46.19 66.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.237 -177.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.26 -38.52 91.5 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.732 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -105.52 10.33 33.18 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.894 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -115.38 -32.82 5.49 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 175.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.659 ' HA ' ' CG2' ' A' ' 54' ' ' VAL . 47.5 mt -80.86 -133.61 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.411 -177.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 66.66 -12.45 0.21 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.827 0.851 . . . . 0.0 113.245 177.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.445 ' H ' ' C ' ' A' ' 51' ' ' LEU . 52.2 m-80 -141.17 7.38 1.99 Allowed 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.833 0.825 . . . . 0.0 108.87 178.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.659 ' CG2' ' HA ' ' A' ' 51' ' ' LEU . 0.6 OUTLIER -112.92 114.45 47.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.814 -173.411 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -43.95 136.91 3.47 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.635 1.209 . . . . 0.0 110.101 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.757 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 4.9 tp -47.7 -43.52 9.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.186 -169.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -53.35 -22.78 16.22 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.556 -177.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.2 t -53.36 -34.83 59.11 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 122.527 0.331 . . . . 0.0 111.535 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.757 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -61.23 -13.44 18.51 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -175.037 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.521 ' N ' HD11 ' A' ' 59' ' ' LEU . 18.5 mt -66.09 -24.81 34.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.902 0.382 . . . . 0.0 110.421 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.5 t -159.69 72.0 0.51 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.421 0.629 . . . . 0.0 109.833 174.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -94.08 37.12 1.1 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.679 0.752 . . . . 0.0 110.099 -178.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.93 177.563 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 203' ' ' TYR . . . . . 1.663 ' HD1' ' CD2' ' B' ' 203' ' ' TYR . 1.3 m-85 . . . . . 0 C--O 1.236 0.376 0 CA-C-O 121.115 0.483 . . . . 0.0 111.678 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.652 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 26.8 m -65.19 -42.48 94.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.664 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 205' ' ' ALA . . . . . 0.693 ' O ' ' HG ' ' B' ' 209' ' ' LEU . . . -73.8 -22.23 59.88 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.319 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 206' ' ' SER . . . . . 0.466 ' CB ' HG21 ' B' ' 223' ' ' ILE . 6.9 m -64.26 -47.74 78.43 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 171.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 207' ' ' TYR . . . . . 1.622 ' HE1' ' CE2' ' B' ' 207' ' ' TYR . 36.9 t80 -60.53 -40.42 91.41 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.313 176.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 82.5 mt -57.96 -51.07 71.15 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.8 178.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 209' ' ' LEU . . . . . 0.693 ' HG ' ' O ' ' B' ' 205' ' ' ALA . 70.4 mt -59.01 -56.04 27.35 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.816 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 210' ' ' ALA . . . . . 0.439 ' HB1' ' HB3' ' B' ' 218' ' ' PRO . . . -58.13 -31.29 67.04 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.599 -178.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 211' ' ' ALA . . . . . 0.645 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -74.58 -50.83 16.43 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.408 178.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 212' ' ' LEU . . . . . 0.466 HD11 ' C ' ' B' ' 212' ' ' LEU . 4.0 pp -66.17 -20.12 66.04 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.64 0.257 . . . . 0.0 110.719 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . 0.461 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -68.22 -20.03 72.77 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.595 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 128.22 33.3 0.59 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.784 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 215' ' ' ASN . . . . . 0.645 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 18.3 m120 -144.74 114.25 7.15 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 6.3 m -70.24 -17.87 63.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.846 0.355 . . . . 0.0 111.478 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 54.6 p -125.46 71.98 66.18 Favored Pre-proline 0 N--CA 1.444 -0.749 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.969 -175.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . 0.556 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 42.5 Cg_exo -62.54 112.12 1.51 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.131 2.554 . . . . 0.0 112.167 176.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 29.2 p -75.74 137.12 40.39 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.344 0.592 . . . . 0.0 110.444 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -54.29 -30.16 49.91 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.85 -177.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -68.25 -37.08 80.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.809 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -78.69 -30.84 46.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.982 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.466 HG21 ' CB ' ' B' ' 206' ' ' SER . 1.7 mp -62.15 -45.57 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.282 0.563 . . . . 0.0 109.507 171.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -61.11 -42.37 98.41 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.037 177.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -57.4 -42.72 82.79 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.31 174.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.48 -35.9 69.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.815 178.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . 0.435 HD21 ' CB ' ' B' ' 234' ' ' ALA . 11.8 tp -75.96 -39.22 56.45 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.53 -32.0 71.05 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.211 174.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 28.2 t -52.18 -54.69 27.77 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.742 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 230' ' ' VAL . . . . . 0.401 ' CG2' ' HB2' ' A' ' 31' ' ' LEU . 40.9 t -74.4 -34.27 35.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.355 0.598 . . . . 0.0 110.803 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 104.52 43.95 1.63 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.836 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 2.5 mm -104.01 145.72 12.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -69.56 118.02 11.91 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.025 0.44 . . . . 0.0 110.213 -178.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . 0.435 ' CB ' HD21 ' B' ' 227' ' ' LEU . . . -99.21 99.41 10.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.208 -175.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . 0.521 ' HB2' ' OH ' ' B' ' 203' ' ' TYR . 2.2 m-20 -61.52 109.84 1.3 Allowed 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 170.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.77 -38.29 90.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.698 -172.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.55 -60.15 4.31 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.769 177.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -62.38 -35.74 80.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.662 -172.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 239' ' ' LEU . . . . . . . . . . . . . 9.3 tt -55.71 -61.34 2.42 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.108 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -70.03 -26.38 64.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.679 -177.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -61.89 -52.71 62.98 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.284 175.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 242' ' ' VAL . . . . . 0.533 ' O ' ' HG ' ' B' ' 246' ' ' LEU . 34.0 m -72.5 -30.98 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.581 -175.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . 0.409 ' HA ' HD11 ' B' ' 246' ' ' LEU . 30.0 mt -69.3 -36.2 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.636 174.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 30.3 t -60.34 -38.17 82.96 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 174.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -70.29 -37.06 74.74 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.298 174.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' B' ' 242' ' ' VAL . 64.1 mt -71.26 -31.74 67.88 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.96 0.41 . . . . 0.0 111.056 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -53.38 -34.88 59.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.374 -175.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -108.81 35.46 4.93 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.892 -177.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -134.62 153.54 51.92 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.631 0.253 . . . . 0.0 110.412 178.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -74.54 83.35 2.01 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.894 0.854 . . . . 0.0 111.614 -176.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . 0.657 ' O ' HG11 ' B' ' 254' ' ' VAL . 5.2 tp -57.68 -39.03 67.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 114.446 -1.252 . . . . 0.0 112.265 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -63.7 -38.42 91.06 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.874 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . 0.508 ' O ' ' HG2' ' B' ' 257' ' ' GLN . 43.4 m-20 -73.78 -40.08 63.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.801 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 254' ' ' VAL . . . . . 0.657 HG11 ' O ' ' B' ' 251' ' ' ILE . 3.1 p -62.29 -31.22 50.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.271 -177.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 255' ' ' ILE . . . . . 0.412 ' CG2' HD11 ' A' ' 7' ' ' LEU . 77.0 mt -78.79 -37.97 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 173.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -64.84 -19.9 66.11 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 257' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' B' ' 253' ' ' ASP . 31.2 mm-40 -71.55 -80.69 0.06 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.586 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 177.31 -59.53 0.1 OUTLIER Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.344 -0.931 . . . . 0.0 113.168 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.256 0 CA-C-O 120.857 0.36 . . . . 0.0 110.71 -177.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.407 ' O ' HD11 ' A' ' 7' ' ' LEU . 3.4 p . . . . . 0 CA--C 1.533 0.31 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.411 ' HA ' ' HB2' ' A' ' 7' ' ' LEU . 6.4 m -65.4 -17.19 21.59 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.957 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.495 ' HB3' HG22 ' A' ' 39' ' ' VAL . 14.2 m -62.43 -67.13 0.44 Allowed 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.517 0.675 . . . . 0.0 110.447 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -67.25 -31.92 72.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.703 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 4' ' ' VAL . 5.4 mp -60.41 -49.52 77.23 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.115 0.483 . . . . 0.0 110.224 176.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.85 -49.77 74.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.113 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.731 ' SG ' HG23 ' A' ' 39' ' ' VAL . 48.9 m -62.11 -35.86 79.98 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.701 -0.4 . . . . 0.0 112.055 -178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -74.35 -36.54 42.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.989 -0.285 . . . . 0.0 111.288 -178.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.604 ' O ' HG12 ' A' ' 15' ' ' ILE . 22.5 m-85 -77.52 -25.19 50.03 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.364 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.9 m -73.44 -38.7 65.43 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 172.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.25 -43.86 71.28 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.6 171.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.0 mt -57.04 -58.62 7.38 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.381 173.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.604 HG12 ' O ' ' A' ' 11' ' ' TYR . 36.6 mm -49.83 -35.86 10.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.279 -176.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.426 ' HB2' HG13 ' A' ' 23' ' ' VAL . 58.5 mt -106.08 -2.64 22.44 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -175.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.57 -20.79 66.09 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.822 -0.549 . . . . 0.0 112.309 -178.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.477 ' HB3' ' H ' ' A' ' 19' ' ' ASP . 0.2 OUTLIER -125.88 -117.76 0.27 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.648 -174.535 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.477 ' H ' ' HB3' ' A' ' 18' ' ' ASP . 1.0 OUTLIER 20.2 -138.93 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -170.397 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -117.14 23.46 11.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.98 0.895 . . . . 0.0 109.039 177.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.403 HG22 HG12 ' B' ' 232' ' ' ILE . 78.3 t -116.26 122.49 69.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.573 -176.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.42 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 4.5 p -80.08 147.13 31.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.077 -176.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.569 ' O ' HG21 ' A' ' 23' ' ' VAL . 30.9 m -75.03 103.66 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 121.507 0.67 . . . . 0.0 111.062 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.9 p -130.11 157.78 41.45 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 121.746 -0.596 . . . . 0.0 111.204 177.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -51.95 -49.55 62.93 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.709 0.631 . . . . 0.0 109.871 -177.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -34.09 65.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.886 -176.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.42 ' HD2' ' O ' ' A' ' 22' ' ' THR . 69.1 mttm -85.18 -41.74 15.37 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.24 -172.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.407 HG13 HD13 ' A' ' 16' ' ' LEU . 3.2 mt -63.37 -43.94 98.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 173.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.572 ' OD1' ' HE3' ' A' ' 33' ' ' LYS . 19.6 t-20 -58.07 -44.38 87.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.753 176.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.0 -44.41 94.56 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.492 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.2 mt -64.93 -44.29 89.97 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.677 0.275 . . . . 0.0 111.308 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 mp -59.27 -44.94 93.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.106 0.479 . . . . 0.0 110.426 178.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.572 ' HE3' ' OD1' ' A' ' 29' ' ' ASN . 97.7 mttt -66.43 -32.32 73.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.796 178.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.483 ' HB2' ' HA ' ' B' ' 226' ' ' ILE . . . -64.44 -38.07 89.73 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.265 177.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.403 ' HA ' HD12 ' B' ' 226' ' ' ILE . . . -79.93 -27.43 39.84 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.986 177.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.7 6.5 56.25 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.28 173.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.448 HG11 ' HA2' ' B' ' 213' ' ' GLY . 6.8 m -91.32 -178.93 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.05 0.452 . . . . 0.0 111.643 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -134.52 120.86 20.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.541 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.731 HG23 ' SG ' ' A' ' 9' ' ' CYS . 12.6 p -119.99 144.28 29.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.855 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.34 122.96 58.48 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -52.29 -13.32 2.03 Favored 'Trans proline' 0 N--CA 1.484 0.921 0 C-N-CA 123.735 2.956 . . . . 0.0 114.699 -170.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 1.665 ' HD2' ' CD1' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -79.01 -24.72 43.51 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -175.108 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.46 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 95.2 m95 -67.86 -59.57 6.44 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 175.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.46 ' CD ' ' HB2' ' A' ' 43' ' ' TRP . 11.3 Cg_endo -56.48 -37.29 97.54 Favored 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 121.862 1.708 . . . . 0.0 112.11 176.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.452 ' O ' ' HG2' ' A' ' 49' ' ' LYS . . . -66.0 -50.67 50.9 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.593 178.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.2 tt -59.23 -46.39 88.59 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.6 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 11.3 m-85 -60.05 -42.81 95.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.942 0.401 . . . . 0.0 110.844 177.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.98 -49.64 76.62 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -177.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 45' ' ' GLY . 19.0 ptmt -105.03 0.42 27.62 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -172.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.04 -11.55 3.32 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.6 ' HB3' ' O ' ' A' ' 47' ' ' PHE . 3.4 tp -90.47 -133.16 0.11 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.486 ' H ' ' CG ' ' A' ' 51' ' ' LEU . . . 61.65 -12.68 0.05 Allowed 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.585 ' H ' ' C ' ' A' ' 51' ' ' LEU . 88.2 m-20 -128.23 -34.42 2.09 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -178.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.505 ' HB ' HD11 ' A' ' 51' ' ' LEU . 41.0 t -50.92 109.45 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-N 114.407 -1.269 . . . . 0.0 109.848 170.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -51.12 150.01 3.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.727 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.529 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 2.6 tp -53.83 -49.48 58.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -173.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.17 -26.43 65.89 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.781 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 61' ' ' CYS . 19.3 m -65.97 -2.19 3.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.661 -0.269 . . . . 0.0 111.484 -178.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 42.6 mt -57.36 -24.99 58.72 Favored 'General case' 0 N--CA 1.46 0.074 0 CA-C-O 120.771 0.319 . . . . 0.0 110.483 171.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.8 mt -89.69 28.15 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 121.421 0.629 . . . . 0.0 109.787 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 58' ' ' SER . 33.1 t -63.59 154.58 32.28 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.642 176.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -77.17 54.34 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.88 0.848 . . . . 0.0 110.017 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 C--N 1.319 -0.728 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.504 178.076 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.621 ' O ' HD11 ' B' ' 208' ' ' LEU . 58.5 t -65.25 -53.48 40.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.49 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 205' ' ' ALA . . . . . 0.489 ' HA ' HD23 ' B' ' 208' ' ' LEU . . . -70.54 -16.4 62.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.163 0.506 . . . . 0.0 110.673 -178.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 206' ' ' SER . . . . . 0.407 ' CB ' HG21 ' B' ' 223' ' ' ILE . 5.8 m -69.59 -47.23 64.24 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 171.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 207' ' ' TYR . . . . . 0.466 ' CZ ' ' HD2' ' B' ' 218' ' ' PRO . 32.3 t80 -57.17 -39.68 75.78 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.254 174.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.621 HD11 ' O ' ' B' ' 204' ' ' VAL . 7.0 mp -60.71 -49.49 77.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.324 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 209' ' ' LEU . . . . . 0.486 ' CD2' ' HB2' ' A' ' 11' ' ' TYR . 25.3 mt -56.29 -48.78 75.97 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 120.936 0.398 . . . . 0.0 110.585 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 210' ' ' ALA . . . . . 0.461 ' HB1' ' HB3' ' B' ' 218' ' ' PRO . . . -66.56 -29.76 69.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.328 -177.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 211' ' ' ALA . . . . . 0.644 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -72.65 -52.26 16.07 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.933 0.396 . . . . 0.0 111.055 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 212' ' ' LEU . . . . . 0.411 HD23 ' HB3' ' A' ' 7' ' ' LEU . 2.9 pp -69.13 -19.97 64.04 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . 0.448 ' HA2' HG11 ' A' ' 37' ' ' VAL . . . -60.15 -19.68 52.33 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.824 176.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 127.73 3.9 5.84 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.665 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 215' ' ' ASN . . . . . 0.644 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 28.3 t30 -122.56 114.01 20.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.92 0.391 . . . . 0.0 110.654 -177.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 216' ' ' SER . . . . . 0.406 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 18.6 m -70.76 -12.51 61.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.636 -178.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 10.1 p -122.98 67.49 32.63 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.492 -178.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . 0.466 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 80.7 Cg_exo -53.38 106.33 0.15 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.261 2.641 . . . . 0.0 113.09 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 16.0 m -77.9 148.74 34.44 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.158 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -56.63 -29.49 62.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.348 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -68.62 -30.05 68.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.342 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -86.64 -30.46 21.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.342 -177.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.407 HG21 ' CB ' ' B' ' 206' ' ' SER . 1.8 mp -66.47 -44.78 90.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 171.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 224' ' ' LYS . . . . . 0.535 ' HZ1' ' CG ' ' B' ' 236' ' ' ASP . 38.7 tttp -60.47 -43.4 96.96 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.799 175.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -56.72 -45.59 81.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.903 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.483 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . 1.0 OUTLIER -61.26 -44.88 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.071 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . 0.403 ' HG ' ' HB ' ' B' ' 232' ' ' ILE . 10.0 tp -76.36 -32.65 58.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.686 0.279 . . . . 0.0 110.652 -176.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 228' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' B' ' 224' ' ' LYS . 1.1 t0 -72.15 -29.78 64.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.319 0.58 . . . . 0.0 109.635 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 32.2 t -60.08 -37.79 80.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.051 177.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 9.6 p -98.74 -23.67 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 120.997 0.427 . . . . 0.0 111.313 -174.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 102.32 57.36 0.8 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.777 -0.725 . . . . 0.0 114.214 172.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . 0.403 ' HB ' ' HG ' ' B' ' 227' ' ' LEU . 0.7 OUTLIER -130.51 147.33 33.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 173.069 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -66.1 130.23 42.54 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.72 0.295 . . . . 0.0 111.742 -175.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -128.04 106.99 9.45 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.904 -177.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -81.72 124.07 29.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.745 178.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 236' ' ' ASP . . . . . 0.535 ' CG ' ' HZ1' ' B' ' 224' ' ' LYS . 21.2 m-20 -63.38 -43.69 96.89 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.497 -171.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.29 -45.19 81.27 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -63.61 -49.94 71.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.015 -177.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 239' ' ' LEU . . . . . 0.593 HD11 ' N ' ' B' ' 240' ' ' ASN . 4.5 pp -64.03 -41.3 97.47 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 121.152 -0.219 . . . . 0.0 111.339 -176.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 240' ' ' ASN . . . . . 0.593 ' N ' HD11 ' B' ' 239' ' ' LEU . 25.5 t-20 -70.36 -34.99 73.28 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.658 -178.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 241' ' ' LYS . . . . . 0.69 ' O ' ' HG2' ' B' ' 245' ' ' GLU . 5.1 mmmp? -71.43 -39.74 70.86 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.808 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 242' ' ' VAL . . . . . . . . . . . . . 19.9 m -69.84 -31.51 48.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 119.566 -0.853 . . . . 0.0 108.949 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . 0.477 ' HA ' ' CD2' ' B' ' 246' ' ' LEU . 20.5 mt -68.79 -36.42 74.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.945 175.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 97.0 p -71.4 -32.46 68.45 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.638 178.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 245' ' ' GLU . . . . . 0.69 ' HG2' ' O ' ' B' ' 241' ' ' LYS . 7.1 mm-40 -74.76 -34.97 62.57 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.444 178.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . 0.511 ' O ' HD11 ' B' ' 246' ' ' LEU . 1.0 OUTLIER -85.4 -10.1 56.68 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.139 0.495 . . . . 0.0 110.639 178.75 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -52.44 -54.01 37.84 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.596 -176.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -94.4 58.35 1.96 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.596 -176.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -135.77 163.03 31.13 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.01 84.52 0.51 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.581 -178.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . 0.486 ' O ' HG23 ' B' ' 254' ' ' VAL . 0.6 OUTLIER -55.27 -39.26 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.674 0.749 . . . . 0.0 111.112 176.57 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.02 -35.76 82.23 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.075 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -72.0 -45.56 60.51 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.576 0.227 . . . . 0.0 110.54 177.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 254' ' ' VAL . . . . . 0.486 HG23 ' O ' ' B' ' 251' ' ' ILE . 12.3 m -64.63 -32.36 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.326 -176.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 255' ' ' ILE . . . . . 0.528 ' HA ' ' OH ' ' A' ' 11' ' ' TYR . 56.3 mt -82.45 -36.14 13.36 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-O 120.985 0.421 . . . . 0.0 111.139 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -68.5 -54.17 18.54 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.72 -178.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -152.33 38.19 0.55 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -175.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 258' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' B' ' 254' ' ' VAL . . . -104.08 37.76 3.6 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.144 -1.026 . . . . 0.0 112.792 -177.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 13.0 mt . . . . . 0 N--CA 1.467 0.414 0 CA-C-O 120.988 0.423 . . . . 0.0 110.818 -178.415 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 120.771 0.319 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.8 m -70.02 -25.06 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 CA-C-O 120.992 0.425 . . . . 0.0 110.537 -177.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.43 ' HB2' HG22 ' A' ' 39' ' ' VAL . 3.4 p -68.36 -52.73 29.93 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 121.48 0.657 . . . . 0.0 110.015 175.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.544 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 41.8 tt0 -62.56 -41.57 99.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.174 178.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.474 HD11 ' CG2' ' B' ' 255' ' ' ILE . 49.2 mt -53.98 -47.31 71.51 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.314 174.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.34 -53.12 61.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.685 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.544 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 7.2 p -67.54 -28.3 67.69 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.7 -176.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.419 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 0.7 OUTLIER -76.06 -40.76 37.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 120.895 0.379 . . . . 0.0 111.09 179.708 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 1.654 ' HD1' ' CD2' ' A' ' 11' ' ' TYR . 19.9 m-85 -71.03 -28.63 64.53 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.5 m -68.66 -45.86 70.63 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.102 173.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.5 -51.18 28.59 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.057 0.456 . . . . 0.0 110.572 173.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 10' ' ' ILE . 35.5 mt -61.23 -48.82 79.72 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.921 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.455 HD12 ' HA ' ' B' ' 206' ' ' SER . 83.8 mt -62.57 -37.29 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.789 0.328 . . . . 0.0 111.453 -178.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.452 HD22 ' HA ' ' A' ' 23' ' ' VAL . 10.8 mp -74.11 -22.14 59.6 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.895 177.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.486 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 51.4 t-80 -94.16 61.03 2.85 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.831 172.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -124.81 -55.62 1.6 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 174.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -117.19 -161.88 0.83 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -81.48 43.65 0.75 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.482 0.658 . . . . 0.0 111.845 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.431 HG12 ' CD1' ' B' ' 232' ' ' ILE . 7.6 p -94.05 128.54 45.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.099 0.476 . . . . 0.0 110.102 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.44 ' C ' ' H ' ' A' ' 24' ' ' THR . 33.5 p -56.08 123.69 15.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.81 -178.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.452 ' HA ' HD22 ' A' ' 16' ' ' LEU . 8.6 p -76.87 24.73 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-O 121.643 0.735 . . . . 0.0 111.144 -177.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.44 ' H ' ' C ' ' A' ' 22' ' ' THR . 6.6 t -92.49 168.13 11.48 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 121.679 0.752 . . . . 0.0 110.938 -174.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -25.83 67.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.778 -168.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -49.04 -50.89 34.17 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.521 0.677 . . . . 0.0 109.311 170.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -82.13 -38.14 25.2 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.931 -172.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.5 mt -62.93 -48.77 86.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.519 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -63.62 -39.58 94.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.125 177.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.92 -49.01 76.91 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.036 0.446 . . . . 0.0 110.914 176.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.425 HD22 HD13 ' A' ' 15' ' ' ILE . 44.0 tp -67.68 -36.01 79.9 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.294 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.3 mp -58.72 -37.04 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.193 174.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -77.06 -29.78 55.23 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.645 176.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.402 ' HB2' ' HA ' ' B' ' 226' ' ' ILE . . . -57.7 -45.27 85.89 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.936 176.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.44 -51.54 6.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.096 178.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.74 38.9 2.65 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.029 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.479 HG21 ' HA3' ' B' ' 213' ' ' GLY . 3.5 t -98.37 135.01 34.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.769 0.319 . . . . 0.0 110.688 -177.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -86.61 94.59 9.51 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.232 0.539 . . . . 0.0 110.504 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.43 HG22 ' HB2' ' A' ' 5' ' ' SER . 5.1 p -113.51 135.05 54.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.196 177.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -48.29 108.92 1.01 Allowed Pre-proline 0 N--CA 1.466 0.371 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.473 174.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -47.53 -18.49 0.9 Allowed 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 124.189 3.259 . . . . 0.0 114.266 -173.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 1.66 ' HE2' ' CE1' ' A' ' 42' ' ' PHE . 0.5 OUTLIER -68.03 -38.74 82.9 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.723 -178.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.549 ' O ' ' HB2' ' A' ' 47' ' ' PHE . 62.8 m95 -66.38 -59.08 8.98 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.387 178.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.493 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 73.0 Cg_exo -52.09 -47.69 25.4 Favored 'Trans proline' 0 C--N 1.363 1.324 0 C-N-CA 122.253 1.969 . . . . 0.0 112.715 177.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.17 -57.48 18.24 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.054 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.74 -43.91 85.7 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.618 ' O ' HD11 ' A' ' 51' ' ' LEU . 1.1 t80 -59.61 -55.23 37.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.092 0.473 . . . . 0.0 110.678 -177.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.99 -32.4 72.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.53 -176.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.465 ' HA ' ' HE2' ' A' ' 49' ' ' LYS . 9.1 mmpt? -87.04 -14.94 40.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.607 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.89 -27.85 16.85 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.618 HD11 ' O ' ' A' ' 47' ' ' PHE . 5.8 mp -75.21 -113.32 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.817 177.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 61.42 -6.93 0.11 Allowed 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 178.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.464 ' H ' ' C ' ' A' ' 51' ' ' LEU . 47.3 t30 -144.08 -39.2 0.29 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.58 HG21 ' HA ' ' A' ' 51' ' ' LEU . 16.0 t -44.95 104.43 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.838 174.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -39.99 -82.66 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 O-C-N 124.312 1.007 . . . . 0.0 111.515 -176.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.605 ' O ' HD13 ' A' ' 59' ' ' LEU . 0.9 OUTLIER -157.08 -66.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.58 172.408 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.21 -23.87 53.88 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.287 -0.482 . . . . 0.0 113.603 -171.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.475 ' HB2' ' CG1' ' A' ' 54' ' ' VAL . 14.5 m -60.69 -14.21 19.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.595 0.236 . . . . 0.0 111.587 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.605 HD13 ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -62.88 -14.54 47.52 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.983 0.42 . . . . 0.0 110.543 179.386 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.588 ' N ' HD11 ' A' ' 59' ' ' LEU . 9.0 tt -77.61 -4.6 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.055 -178.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 98.9 m -69.22 104.2 2.14 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.336 0.589 . . . . 0.0 110.866 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -75.88 65.33 1.96 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.218 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 63' ' ' VAL . 5.1 t . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.213 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 203' ' ' TYR . . . . . 1.638 ' HE2' ' CE1' ' B' ' 203' ' ' TYR . 59.0 m-85 . . . . . 0 N--CA 1.471 0.617 0 CA-C-O 121.097 0.475 . . . . 0.0 111.669 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.744 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 15.5 m -59.52 -49.05 85.05 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.193 177.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 205' ' ' ALA . . . . . 0.483 ' HA ' HD13 ' B' ' 208' ' ' LEU . . . -73.31 -15.59 61.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.064 0.459 . . . . 0.0 110.618 -177.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 206' ' ' SER . . . . . 0.455 ' HA ' HD12 ' A' ' 15' ' ' ILE . 6.5 m -71.02 -49.22 47.45 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 172.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 207' ' ' TYR . . . . . 0.516 ' CZ ' ' HD2' ' B' ' 218' ' ' PRO . 24.4 t80 -60.76 -40.87 94.09 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 174.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.744 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 79.3 mt -59.71 -51.68 68.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.168 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 209' ' ' LEU . . . . . . . . . . . . . 8.4 tp -59.7 -49.75 76.51 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.862 0.363 . . . . 0.0 110.612 -178.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -61.84 -34.03 75.22 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.2 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 211' ' ' ALA . . . . . . . . . . . . . . . -79.4 -36.25 39.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.032 0.444 . . . . 0.0 110.79 178.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 212' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.32 -46.69 85.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.202 177.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . 0.479 ' HA3' HG21 ' A' ' 37' ' ' VAL . . . -150.38 69.59 0.32 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.694 -1.241 . . . . 0.0 112.929 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . -168.71 -66.51 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.276 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 215' ' ' ASN . . . . . 0.613 HD21 ' N ' ' B' ' 216' ' ' SER . 0.2 OUTLIER -156.89 132.05 9.09 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -178.681 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 216' ' ' SER . . . . . 0.613 ' N ' HD21 ' B' ' 215' ' ' ASN . 2.1 m -51.34 -30.83 19.87 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.652 -178.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 18.0 p -121.79 76.62 38.28 Favored Pre-proline 0 N--CA 1.442 -0.867 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.667 -177.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . 0.516 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 75.6 Cg_exo -54.41 108.53 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.579 2.853 . . . . 0.0 112.651 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 30.8 m -84.66 155.93 21.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.695 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -51.62 -40.04 59.15 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.174 0.512 . . . . 0.0 110.706 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -60.55 -32.5 71.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.566 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -85.42 -30.75 23.32 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -177.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.45 HG21 ' HB3' ' B' ' 206' ' ' SER . 1.8 mp -66.91 -42.06 88.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 172.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 224' ' ' LYS . . . . . 0.421 ' HZ3' ' CG ' ' B' ' 236' ' ' ASP . 53.8 mtpt -60.71 -46.14 91.55 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.097 174.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . 0.502 ' HZ1' ' HB3' ' B' ' 225' ' ' LYS . 5.6 ttpm? -55.99 -43.92 78.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.375 177.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . 0.402 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . 1.0 OUTLIER -60.42 -42.39 90.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 178.706 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 93.5 mt -71.91 -39.02 69.81 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 121.214 -0.195 . . . . 0.0 111.378 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -67.45 -30.49 70.23 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.769 0.318 . . . . 0.0 111.146 177.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 56.1 m -69.36 -47.57 63.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.293 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 11.4 p -79.53 -27.21 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.075 0.464 . . . . 0.0 111.362 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 103.55 56.98 0.76 Allowed Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.374 174.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . 0.431 ' CD1' HG12 ' A' ' 21' ' ' VAL . 31.5 mt -133.65 125.98 50.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 176.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -60.17 131.1 49.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.917 0.389 . . . . 0.0 110.769 176.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -118.24 152.62 35.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.904 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -117.04 114.97 24.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.144 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 236' ' ' ASP . . . . . 0.421 ' CG ' ' HZ3' ' B' ' 224' ' ' LYS . 1.9 m-20 -55.33 -37.65 67.7 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.64 -173.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.37 -62.0 1.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.01 0.433 . . . . 0.0 110.312 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.661 ' O ' HG21 ' B' ' 242' ' ' VAL . 86.5 mtm180 -63.62 -34.34 77.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.665 -177.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 239' ' ' LEU . . . . . 0.498 ' HA ' ' CD2' ' B' ' 203' ' ' TYR . 9.9 tt -62.6 -57.66 10.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.07 0.462 . . . . 0.0 110.939 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -66.62 -23.34 66.16 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.127 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -68.34 -46.88 68.98 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 120.983 0.421 . . . . 0.0 110.74 176.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 242' ' ' VAL . . . . . 0.661 HG21 ' O ' ' B' ' 238' ' ' ARG . 52.2 t -67.44 -32.95 59.46 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 40.1 mt -75.9 -22.57 15.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.704 176.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 36.1 t -71.19 -37.41 72.14 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.656 174.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -85.86 -26.0 25.91 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.325 0.583 . . . . 0.0 110.353 175.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . 0.66 ' O ' HD12 ' B' ' 246' ' ' LEU . 0.0 OUTLIER -121.51 97.56 5.56 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.88 0.848 . . . . 0.0 109.678 -177.41 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 247' ' ' ASN . . . . . 0.533 ' CG ' ' H ' ' B' ' 248' ' ' GLY . 25.2 p-10 -146.79 -74.92 0.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.108 177.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . 0.533 ' H ' ' CG ' ' B' ' 247' ' ' ASN . . . -106.72 55.06 0.55 Allowed Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -177.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -117.07 57.85 0.78 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.731 -0.234 . . . . 0.0 110.83 -177.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 60.81 67.5 0.82 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.655 0.597 . . . . 0.0 111.477 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . 0.474 HD12 ' CD1' ' B' ' 207' ' ' TYR . 1.8 mm -60.93 -48.79 87.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.97 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -60.44 -29.4 68.99 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.524 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . 0.517 ' O ' ' HG2' ' B' ' 257' ' ' GLN . 27.9 t70 -76.66 -47.49 21.95 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.961 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 254' ' ' VAL . . . . . 0.445 HG23 ' HA ' ' B' ' 251' ' ' ILE . 28.8 m -62.47 -29.86 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.597 0.237 . . . . 0.0 111.164 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 255' ' ' ILE . . . . . 0.474 ' CG2' HD11 ' A' ' 7' ' ' LEU . 61.9 mt -88.03 -24.89 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-O 120.827 0.346 . . . . 0.0 110.746 175.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -66.74 -38.99 87.75 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.018 -0.426 . . . . 0.0 111.281 177.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 257' ' ' GLN . . . . . 0.563 ' HG3' ' H ' ' B' ' 258' ' ' GLY . 4.6 pt20 -69.5 -81.96 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 258' ' ' GLY . . . . . 0.563 ' H ' ' HG3' ' B' ' 257' ' ' GLN . . . 175.44 -90.39 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.249 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 259' ' ' ILE . . . . . 0.438 HD11 ' N ' ' B' ' 259' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 114.91 -0.645 . . . . 0.0 110.732 -179.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.533 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 36.7 m . . . . . 0 N--CA 1.469 0.522 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.475 HG13 ' CD1' ' B' ' 212' ' ' LEU . 15.4 m -72.26 -16.26 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.76 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -68.67 0.36 Allowed 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.674 176.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.487 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 3.2 pm0 -56.2 -43.03 78.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.46 178.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 3' ' ' SER . 38.2 mt -54.32 -57.89 9.51 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.327 176.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.93 -50.33 69.11 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -176.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.487 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 26.4 p -70.7 -33.8 71.27 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.763 -173.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.36 -25.49 12.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.946 0.403 . . . . 0.0 110.576 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.549 ' OH ' HG22 ' B' ' 255' ' ' ILE . 20.7 m-30 -76.05 -28.78 57.8 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 172.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.416 ' OG ' HG12 ' A' ' 28' ' ' ILE . 7.5 t -68.3 -50.64 52.15 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.669 174.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.21 -47.95 68.52 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 173.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.501 HD23 HG21 ' B' ' 259' ' ' ILE . 11.4 mt -52.06 -61.64 2.13 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.057 177.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.451 HD13 ' HA ' ' B' ' 206' ' ' SER . 56.5 mt -62.72 -46.29 96.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.197 0.522 . . . . 0.0 111.297 -176.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.42 ' HG ' HG13 ' A' ' 23' ' ' VAL . 25.1 tp -70.65 -15.29 62.72 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.601 -173.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -125.62 37.92 4.27 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 119.362 -0.935 . . . . 0.0 112.112 173.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -81.21 -57.75 3.36 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 167.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -81.5 174.1 11.76 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.332 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -84.23 39.04 0.69 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.33 0.586 . . . . 0.0 111.171 -175.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.407 HG12 ' CD1' ' B' ' 232' ' ' ILE . 14.6 p -92.57 142.72 12.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.028 177.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.0 p -72.17 133.88 45.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.43 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.42 HG13 ' HG ' ' A' ' 16' ' ' LEU . 16.0 m -87.8 132.67 32.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.359 -179.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.5 p -147.06 158.39 43.92 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.907 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -45.76 -55.91 5.95 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.909 0.755 . . . . 0.0 111.361 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.43 -31.52 64.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.807 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -80.14 -39.1 30.13 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.494 -177.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.416 HG12 ' OG ' ' A' ' 12' ' ' SER . 4.0 mt -63.88 -47.03 92.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -55.1 -43.75 74.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.767 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.87 -47.88 83.95 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.682 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.4 mt -63.4 -39.49 94.65 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.855 0.359 . . . . 0.0 111.007 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 mp -60.01 -45.5 95.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.433 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -72.35 -25.41 61.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.811 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.81 -37.25 81.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.3 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.68 -37.73 19.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.035 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 123.0 -41.95 1.7 Allowed Glycine 0 CA--C 1.519 0.322 0 C-N-CA 119.946 -1.121 . . . . 0.0 114.005 173.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.2 m -95.01 151.63 3.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.754 0.277 . . . . 0.0 111.235 -176.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -109.47 -176.05 2.92 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.605 0.717 . . . . 0.0 111.391 -171.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.0 p -153.46 152.76 9.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.919 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -47.37 116.46 4.3 Favored Pre-proline 0 N--CA 1.47 0.535 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 175.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.404 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 88.8 Cg_exo -49.31 -14.49 0.56 Allowed 'Trans proline' 0 N--CA 1.485 0.986 0 C-N-CA 124.175 3.25 . . . . 0.0 114.863 -172.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 1.659 ' HE1' ' CE2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -79.57 -21.0 45.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.015 -175.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.412 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 69.0 m95 -72.75 -52.41 6.12 Favored Pre-proline 0 CA--C 1.537 0.448 0 O-C-N 123.003 0.189 . . . . 0.0 110.548 175.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 74.5 Cg_exo -51.45 -51.5 11.06 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 122.137 1.891 . . . . 0.0 111.569 171.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.45 -37.85 92.66 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.117 177.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 39.3 tp -60.98 -56.62 18.93 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -60.01 -36.29 76.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.588 0.232 . . . . 0.0 111.022 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.6 -39.54 94.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.871 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -92.72 -11.43 33.97 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.45 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.33 -50.87 5.43 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.648 ' HA ' HG21 ' A' ' 54' ' ' VAL . 9.2 mt -85.61 -130.94 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.904 -175.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 75.79 -10.61 1.24 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.842 0.857 . . . . 0.0 113.047 175.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -143.8 -45.55 0.27 Allowed 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.648 HG21 ' HA ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -51.2 129.62 10.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 113.428 -1.714 . . . . 0.0 111.609 174.78 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -51.7 157.53 1.14 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.84 -1.527 . . . . 0.0 111.381 175.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.4 tp -46.98 -50.82 5.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.803 -175.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.15 -15.48 10.77 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.627 -0.32 . . . . 0.0 113.722 -173.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.6 t -62.18 -23.3 66.53 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -74.33 -10.36 59.51 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.359 -177.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.575 HG12 ' HB ' ' B' ' 259' ' ' ILE . 14.7 mt -86.86 -6.59 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-O 121.757 0.789 . . . . 0.0 109.527 176.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 66.0 m -82.72 90.45 6.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.563 176.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -77.67 69.91 3.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.121 0.962 . . . . 0.0 110.259 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.4 t . . . . . 0 C--N 1.32 -0.685 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.023 178.798 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 203' ' ' TYR . . . . . 0.514 ' CD1' ' HA ' ' B' ' 239' ' ' LEU . 71.8 m-85 . . . . . 0 C--O 1.239 0.514 0 CA-C-O 121.177 0.513 . . . . 0.0 110.52 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.787 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 2.5 m -58.11 -65.2 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.635 178.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 205' ' ' ALA . . . . . 0.534 ' HA ' HD13 ' B' ' 208' ' ' LEU . . . -64.6 -13.67 54.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 206' ' ' SER . . . . . 0.451 ' HA ' HD13 ' A' ' 15' ' ' ILE . 4.1 m -75.74 -50.68 14.6 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 175.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 207' ' ' TYR . . . . . 0.422 ' CZ ' ' HD2' ' B' ' 218' ' ' PRO . 15.7 t80 -62.71 -35.21 79.0 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 174.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.787 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 71.3 mt -64.3 -49.3 72.34 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.983 176.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 209' ' ' LEU . . . . . 0.493 HD22 ' HB2' ' A' ' 11' ' ' TYR . 11.4 mt -54.64 -49.91 69.43 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.785 0.326 . . . . 0.0 110.857 177.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 210' ' ' ALA . . . . . 0.453 ' HB1' ' HB3' ' B' ' 218' ' ' PRO . . . -59.93 -48.69 80.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.233 -177.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 211' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -65.18 -43.87 90.3 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.831 0.348 . . . . 0.0 110.977 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 212' ' ' LEU . . . . . 0.475 ' CD1' HG13 ' A' ' 4' ' ' VAL . 2.3 tp -61.44 -32.46 72.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.162 178.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -76.09 -11.78 84.57 Favored Glycine 0 N--CA 1.454 -0.135 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.769 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 122.22 1.14 10.38 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.278 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 215' ' ' ASN . . . . . 0.647 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 93.8 m-20 -98.44 102.91 14.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.115 0.458 . . . . 0.0 110.758 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 5.3 m -66.34 -17.78 64.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.213 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 14.2 t -128.07 69.74 77.67 Favored Pre-proline 0 N--CA 1.443 -0.816 0 CA-C-O 120.96 0.409 . . . . 0.0 110.355 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . 0.453 ' HB3' ' HB1' ' B' ' 210' ' ' ALA . 50.2 Cg_exo -58.85 102.49 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.072 2.515 . . . . 0.0 112.738 178.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 18.0 m -72.32 144.03 48.46 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.267 178.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -56.52 -28.64 60.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.723 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -73.65 -27.03 61.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.494 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -79.8 -38.63 32.59 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.441 HG21 ' HB3' ' B' ' 206' ' ' SER . 1.8 mp -63.45 -45.2 98.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 173.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -58.02 -41.2 82.66 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.244 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -61.32 -41.7 97.44 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.317 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.73 -25.31 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.593 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -78.04 -44.7 25.69 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.765 0.316 . . . . 0.0 110.94 173.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -70.29 -15.79 62.93 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.489 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 86.8 p -51.47 -51.65 53.18 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.91 0.386 . . . . 0.0 110.633 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 60.9 t -87.28 -23.85 6.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.347 0.594 . . . . 0.0 110.371 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 101.92 41.0 2.55 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.143 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 232' ' ' ILE . . . . . 0.407 ' CD1' HG12 ' A' ' 21' ' ' VAL . 36.5 mt -103.84 136.7 35.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -73.66 145.87 44.97 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -143.0 121.65 12.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.383 -175.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . 0.466 ' HB2' ' HB2' ' B' ' 238' ' ' ARG . 8.0 m-20 -58.26 113.82 2.12 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.105 177.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 236' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' B' ' 239' ' ' LEU . 6.8 m-20 -61.75 -37.48 84.42 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.816 0.341 . . . . 0.0 111.648 -177.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -73.76 -46.77 43.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.921 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.466 ' HB2' ' HB2' ' B' ' 235' ' ' ASP . 41.8 mtp-105 -64.54 -29.03 70.05 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 239' ' ' LEU . . . . . 0.514 ' HA ' ' CD1' ' B' ' 203' ' ' TYR . 13.5 tp -54.07 -69.54 0.12 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.96 175.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -66.47 -24.28 66.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.463 -176.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -60.96 -53.91 51.5 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 120.866 0.365 . . . . 0.0 111.173 175.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 242' ' ' VAL . . . . . 0.427 HG22 ' H ' ' B' ' 203' ' ' TYR . 33.0 m -73.62 -28.37 24.7 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -176.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . 0.415 ' HA ' HD13 ' B' ' 246' ' ' LEU . 37.4 mt -70.67 -31.41 45.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.438 175.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 71.6 m -66.71 -35.25 79.69 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 172.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.79 -40.7 75.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.219 175.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 246' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' B' ' 243' ' ' ILE . 39.9 mt -67.48 -29.78 69.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.488 174.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -59.77 -32.8 70.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.131 -171.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -112.41 17.43 23.77 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.346 -175.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -124.41 151.97 43.82 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -64.91 119.71 11.2 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 121.241 0.543 . . . . 0.0 110.875 -178.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . 0.474 ' O ' HG13 ' B' ' 255' ' ' ILE . 0.4 OUTLIER -59.16 -31.8 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.67 -177.818 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -69.88 -40.93 75.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.814 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -65.8 -38.16 88.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.802 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 254' ' ' VAL . . . . . 0.4 HG23 ' HA ' ' B' ' 251' ' ' ILE . 17.7 m -76.2 -22.11 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.457 176.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 255' ' ' ILE . . . . . 0.549 HG22 ' OH ' ' A' ' 11' ' ' TYR . 27.9 mt -64.12 -43.43 97.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-O 121.431 0.634 . . . . 0.0 109.613 169.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -78.06 -27.27 48.64 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.981 -178.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -130.52 76.17 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -176.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -108.31 -66.85 0.6 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 172.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 259' ' ' ILE . . . . . 0.575 ' HB ' HG12 ' A' ' 60' ' ' ILE . 1.6 pt . . . . . 0 C--N 1.331 -0.2 0 CA-C-O 122.181 0.991 . . . . 0.0 108.665 169.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ppp? . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 110.546 -0.168 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.0 -7.6 1.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 172.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.576 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 3.8 p -86.03 52.29 2.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.985 0.421 . . . . 0.0 111.276 -175.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.514 ' CG2' HG13 ' A' ' 37' ' ' VAL . 2.8 p -63.87 -33.02 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.649 -172.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.9 m -58.71 -66.1 0.55 Allowed 'General case' 0 C--O 1.244 0.781 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.132 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -64.91 -30.85 71.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.3 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 3' ' ' SER . 54.1 mt -57.27 -60.18 4.01 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.592 173.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.89 -45.55 78.59 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.854 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 48.6 t -63.3 -36.78 84.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.848 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.482 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 0.9 OUTLIER -73.87 -40.04 52.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 120.621 0.248 . . . . 0.0 111.347 -179.003 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 1.623 ' HD2' ' CD1' ' A' ' 11' ' ' TYR . 22.1 m-85 -68.69 -37.69 79.74 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.472 ' OG ' ' HA ' ' A' ' 28' ' ' ILE . 46.1 t -64.36 -44.28 91.94 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.659 175.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.49 -57.51 11.08 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.129 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.487 HD12 ' CB ' ' B' ' 205' ' ' ALA . 3.7 pp -70.43 -22.1 62.75 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.623 -0.431 . . . . 0.0 112.038 -177.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.407 ' N ' HD13 ' A' ' 14' ' ' LEU . 13.4 mt -71.3 -33.92 52.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.233 174.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.6 mt -86.94 -8.51 57.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.062 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -17.27 -78.26 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 115.319 1.599 . . . . 0.0 115.319 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -158.97 73.61 0.61 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.261 0.553 . . . . 0.0 109.951 -168.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.417 ' HB2' HG13 ' A' ' 21' ' ' VAL . 3.7 m-20 -132.46 -158.56 0.9 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.637 -174.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -69.11 -13.57 62.51 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.264 0.554 . . . . 0.0 109.782 172.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.473 ' HB ' HG12 ' B' ' 232' ' ' ILE . 5.1 p -96.28 160.85 2.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.528 -174.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.9 p -107.61 143.14 36.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.135 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.3 t -78.28 83.91 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.0 p -131.95 163.58 28.05 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -52.2 -49.96 62.86 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.93 -176.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -54.81 -36.19 64.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.317 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.515 ' HD2' ' HB ' ' B' ' 230' ' ' VAL . 75.4 mmtt -79.9 -44.03 21.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.315 -171.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.472 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 9.1 mt -62.02 -46.07 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.037 173.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -57.8 -39.07 76.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.488 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.25 -40.35 86.27 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.817 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.411 HD23 HG21 ' B' ' 226' ' ' ILE . 60.8 mt -70.35 -42.61 71.62 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 120.939 0.399 . . . . 0.0 110.391 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.453 HD11 ' O ' ' A' ' 28' ' ' ILE . 1.7 mp -59.84 -37.95 74.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.156 174.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -70.76 -37.53 73.4 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.771 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.41 -34.51 77.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.244 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.82 -31.73 16.36 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.659 -0.417 . . . . 0.0 111.813 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.66 35.48 6.86 Favored Glycine 0 CA--C 1.517 0.162 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.958 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.514 HG13 ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -97.32 173.77 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.025 0.441 . . . . 0.0 111.698 -178.017 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -121.46 106.43 11.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.571 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.4 p -129.66 137.94 55.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 174.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.536 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 12.8 pt-20 -67.16 135.24 93.65 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.75 -11.57 1.42 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 124.097 3.198 . . . . 0.0 113.745 -173.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 1.653 ' HE1' ' CE2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -68.04 -41.23 82.38 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.056 -178.702 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.417 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 89.4 m95 -68.08 -58.24 8.05 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.236 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.536 ' HD2' ' O ' ' A' ' 40' ' ' GLU . 12.5 Cg_endo -56.43 -43.83 51.76 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.411 2.074 . . . . 0.0 112.753 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.94 -52.98 46.57 Favored Glycine 0 C--O 1.24 0.493 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.913 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 52.4 tp -59.94 -48.49 81.5 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.522 ' CD2' HD13 ' A' ' 51' ' ' LEU . 1.7 m-85 -56.42 -46.8 80.07 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.286 0.367 . . . . 0.0 111.865 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.62 -30.11 66.68 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -89.33 -12.69 39.79 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.442 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.5 -32.29 10.02 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.653 ' HA ' ' CG2' ' A' ' 54' ' ' VAL . 52.6 mt -88.38 -131.02 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.293 -176.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 68.97 -12.61 0.38 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.953 0.901 . . . . 0.0 112.901 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.425 ' H ' ' C ' ' A' ' 51' ' ' LEU . 64.8 t30 -143.76 6.02 1.39 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.904 0.859 . . . . 0.0 110.171 177.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.653 ' CG2' ' HA ' ' A' ' 51' ' ' LEU . 1.5 t -103.05 87.55 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.802 -174.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -7.46 -95.55 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.724 1.61 . . . . 0.0 114.689 -168.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.705 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 1.2 tp -153.69 -66.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.278 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -59.03 -14.72 25.82 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.799 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.521 ' CB ' HG11 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -47.73 -42.63 25.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.567 -0.816 . . . . 0.0 111.598 175.205 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.705 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 0.9 OUTLIER -65.15 -12.33 49.82 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -174.507 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.564 HG12 ' HB ' ' B' ' 259' ' ' ILE . 65.2 mt -68.29 -29.01 42.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 121.2 0.524 . . . . 0.0 110.239 176.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 83.7 m -135.5 34.08 2.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.364 -176.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -70.63 -21.08 62.67 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.212 0.53 . . . . 0.0 110.721 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.4 t -76.04 -20.48 15.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.393 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.78 -56.44 0.67 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.573 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -165.89 -70.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.039 0.447 . . . . 0.0 110.441 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.6 -138.12 11.7 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.723 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 165.57 178.41 38.59 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.81 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -86.71 -177.76 2.4 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.781 2.321 . . . . 0.0 112.456 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.52 124.72 9.76 Favored Pre-proline 0 N--CA 1.45 -0.434 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.23 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.73 146.69 54.87 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.915 2.41 . . . . 0.0 112.337 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -134.66 176.47 8.6 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.656 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.62 163.78 37.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.36 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.81 152.29 21.65 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.905 -0.665 . . . . 0.0 111.75 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.46 138.32 38.62 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.919 0.39 . . . . 0.0 110.778 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -112.77 128.71 25.24 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.966 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 27.6 Cg_exo -69.07 158.09 59.22 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.57 2.847 . . . . 0.0 113.119 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -145.69 166.0 27.12 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.646 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -179.37 -153.33 11.6 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.606 -0.598 . . . . 0.0 111.606 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 164.19 161.08 12.63 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.97 130.42 14.39 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.845 2.363 . . . . 0.0 112.633 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.09 92.58 31.75 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.008 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -62.71 151.1 85.65 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.957 2.438 . . . . 0.0 113.114 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.0 t -149.78 130.79 14.36 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.681 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 p 54.25 168.85 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.49 1.119 . . . . 0.0 113.412 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -176.53 167.89 2.7 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.562 -177.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 67.9 143.96 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.984 0.802 . . . . 0.0 112.656 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.22 132.82 7.54 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.351 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -53.76 115.91 2.65 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.07 2.514 . . . . 0.0 112.901 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -128.3 80.08 1.94 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.373 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -70.99 98.52 1.63 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.434 0.635 . . . . 0.0 111.579 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -111.63 172.07 7.11 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.347 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.41 132.1 6.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.971 175.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -107.77 151.34 25.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.985 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.9 p -83.17 97.21 4.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.787 0.804 . . . . 0.0 110.976 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -142.27 138.49 31.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.291 176.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -120.18 -62.81 1.43 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.046 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.79 133.58 43.27 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.259 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -130.11 122.11 27.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.786 -176.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 52.97 28.57 6.79 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.198 0.599 . . . . 0.0 111.933 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -133.04 179.02 6.44 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.014 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 26.4 t -160.51 146.61 15.19 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -86.17 36.8 0.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.627 0.727 . . . . 0.0 110.013 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -170.3 122.92 0.67 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.102 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.1 t -162.95 143.17 9.27 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -139.37 -127.3 0.12 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -67.6 -39.79 84.78 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.324 0.583 . . . . 0.0 109.488 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 54.59 20.56 2.94 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.305 -1.316 . . . . 0.0 112.889 174.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 63.4 mtt -135.91 153.7 51.36 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 63.97 44.34 96.1 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.969 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 1.606 ' HE1' ' CE2' ' A' ' 110' ' ' PHE . 3.5 p90 -94.16 137.12 33.71 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.805 -0.232 . . . . 0.0 110.564 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -79.61 73.58 2.38 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.859 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.0 mt -130.15 32.09 4.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.938 0.399 . . . . 0.0 110.264 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -129.38 157.6 41.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.409 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.2 t70 . . . . . 0 C--O 1.247 0.958 0 CA-C-O 118.453 -0.784 . . . . 0.0 108.999 -179.194 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.896 0 CA-C-O 120.797 0.332 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 201' ' ' MET . . . . . 0.532 ' HE3' ' O ' ' B' ' 263' ' ' ALA . 55.4 mtp -133.39 154.79 50.45 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 202' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' B' ' 263' ' ' ALA . 73.7 mtt180 -128.34 -128.39 0.22 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.758 0.313 . . . . 0.0 111.212 -176.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -115.61 16.7 16.47 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.057 0.456 . . . . 0.0 110.019 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.521 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 58.2 t -62.33 -50.68 78.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.708 -173.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 205' ' ' ALA . . . . . 0.553 ' O ' HD21 ' B' ' 209' ' ' LEU . . . -69.34 -18.61 63.82 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.174 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 206' ' ' SER . . . . . 0.468 ' OG ' HG22 ' B' ' 223' ' ' ILE . 9.4 t -73.01 -40.08 65.47 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 207' ' ' TYR . . . . . 0.426 ' CE1' HD12 ' B' ' 251' ' ' ILE . 57.0 t80 -61.01 -37.45 82.57 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 171.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.558 ' O ' ' HB3' ' B' ' 212' ' ' LEU . 83.1 mt -66.18 -40.46 90.45 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.728 176.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 209' ' ' LEU . . . . . 0.553 HD21 ' O ' ' B' ' 205' ' ' ALA . 3.2 mm? -57.27 -45.26 84.21 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 174.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -63.37 -48.96 75.75 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.587 0.232 . . . . 0.0 111.562 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.93 -50.09 52.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.757 0.313 . . . . 0.0 111.611 -176.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 212' ' ' LEU . . . . . 0.558 ' HB3' ' O ' ' B' ' 208' ' ' LEU . 0.0 OUTLIER -67.22 -25.0 65.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.048 -178.873 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . 0.511 ' HA2' HG11 ' A' ' 37' ' ' VAL . . . -56.79 -22.07 39.18 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.344 -0.455 . . . . 0.0 112.54 175.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 112.47 22.65 5.72 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.562 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 215' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -138.83 95.05 2.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.126 0.488 . . . . 0.0 110.201 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 17.7 m -78.04 57.61 1.82 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.806 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 17.6 t -147.06 100.28 3.92 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . 0.409 ' HB3' ' HE2' ' B' ' 207' ' ' TYR . 51.6 Cg_exo -59.82 92.69 0.09 OUTLIER 'Trans proline' 0 N--CA 1.474 0.353 0 C-N-CA 123.478 2.785 . . . . 0.0 113.992 -176.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 50.1 m -96.14 103.15 15.02 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 171.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . 0.429 ' HB3' ' CD1' ' B' ' 239' ' ' LEU . . . -54.18 -31.16 52.08 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.376 0.608 . . . . 0.0 110.706 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -62.4 -36.58 82.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.877 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -80.47 -28.02 37.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.116 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.468 HG22 ' OG ' ' B' ' 206' ' ' SER . 1.8 mp -62.0 -48.68 87.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 168.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 224' ' ' LYS . . . . . 0.446 ' HE2' ' O ' ' B' ' 234' ' ' ALA . 3.3 tppp? -57.02 -41.1 77.92 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.328 173.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -58.31 -46.13 86.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.023 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.411 HG21 HD23 ' A' ' 31' ' ' LEU . 1.3 mp -65.23 -40.41 88.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.737 178.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.26 -42.93 92.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.023 0.439 . . . . 0.0 111.273 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -79.92 -22.11 43.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.585 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 99.3 p -53.14 -41.19 64.85 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.968 0.413 . . . . 0.0 111.482 -177.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 230' ' ' VAL . . . . . 0.515 ' HB ' ' HD2' ' A' ' 27' ' ' LYS . 8.1 m -100.9 -12.88 8.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.233 -176.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 100.58 67.99 0.84 Allowed Glycine 0 C--O 1.228 -0.267 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.107 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . 0.473 HG12 ' HB ' ' A' ' 21' ' ' VAL . 12.9 mt -129.19 141.22 47.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 175.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -79.23 83.89 5.24 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.384 0.611 . . . . 0.0 111.524 -176.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . 0.446 ' O ' ' HE2' ' B' ' 224' ' ' LYS . . . -93.68 143.01 26.71 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.738 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . 0.49 ' OD2' ' HG3' ' B' ' 238' ' ' ARG . 17.3 t70 -107.51 129.99 54.9 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.242 0.544 . . . . 0.0 110.991 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.85 -38.44 90.82 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.487 -172.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 237' ' ' ASP . . . . . 0.505 ' CG ' ' HZ3' ' B' ' 241' ' ' LYS . 24.8 t70 -71.63 -51.03 25.29 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.49 ' HG3' ' OD2' ' B' ' 235' ' ' ASP . 77.5 mtp180 -57.64 -41.53 81.61 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.461 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 239' ' ' LEU . . . . . 0.552 HD13 ' N ' ' B' ' 240' ' ' ASN . 4.5 pp -68.55 -44.04 75.35 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.996 -177.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 240' ' ' ASN . . . . . 0.552 ' N ' HD13 ' B' ' 239' ' ' LEU . 50.0 t30 -66.96 -32.1 73.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.0 0.428 . . . . 0.0 110.201 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 241' ' ' LYS . . . . . 0.514 ' O ' ' HG3' ' B' ' 245' ' ' GLU . 1.0 OUTLIER -67.13 -45.25 77.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.948 178.21 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 242' ' ' VAL . . . . . . . . . . . . . 18.1 m -71.79 -27.16 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.386 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . 0.506 HG13 ' O ' ' B' ' 239' ' ' LEU . 27.7 mt -71.48 -36.52 60.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.607 177.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 5.1 p -78.95 -14.48 59.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.79 0.329 . . . . 0.0 111.025 176.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 245' ' ' GLU . . . . . 0.514 ' HG3' ' O ' ' B' ' 241' ' ' LYS . 51.5 mt-10 -82.17 -30.76 30.82 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.988 0.423 . . . . 0.0 110.392 169.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . 0.622 ' O ' HD11 ' B' ' 246' ' ' LEU . 1.1 pp -99.58 2.56 44.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.343 -176.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -58.84 109.43 0.82 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.578 0.704 . . . . 0.0 112.045 -171.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 71.52 30.48 66.6 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.885 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -90.16 -160.93 0.74 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 110.493 -0.188 . . . . 0.0 110.493 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . 0.415 ' HB3' ' HB2' ' B' ' 253' ' ' ASP . 14.0 m-20 -72.9 81.33 1.18 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.929 0.395 . . . . 0.0 111.913 -174.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.502 ' O ' HG13 ' B' ' 254' ' ' VAL . 2.0 mm -72.29 -54.4 16.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.827 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -61.53 -29.64 70.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.634 0.731 . . . . 0.0 110.448 -177.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . 0.415 ' HB2' ' HB3' ' B' ' 250' ' ' ASN . 5.6 m-20 -77.22 -44.81 28.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.711 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 254' ' ' VAL . . . . . 0.502 HG13 ' O ' ' B' ' 251' ' ' ILE . 7.0 p -66.73 -23.79 31.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 121.054 0.454 . . . . 0.0 110.155 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 255' ' ' ILE . . . . . 0.55 ' HA ' ' OH ' ' A' ' 11' ' ' TYR . 44.8 mt -76.89 -55.61 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.933 175.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -66.3 -45.3 80.86 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -173.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -139.19 50.14 1.82 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.268 0.556 . . . . 0.0 111.156 -174.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . 0.531 ' O ' HD22 ' B' ' 262' ' ' LEU . . . -141.97 55.4 0.6 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.358 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 259' ' ' ILE . . . . . 0.564 ' HB ' HG12 ' A' ' 60' ' ' ILE . 1.2 mt -91.71 18.77 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.888 0.375 . . . . 0.0 111.073 -176.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -92.68 -94.21 1.44 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.808 -0.711 . . . . 0.0 114.078 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -90.39 94.57 9.79 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.551 -0.382 . . . . 0.0 110.63 -175.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 262' ' ' LEU . . . . . 0.531 HD22 ' O ' ' B' ' 258' ' ' GLY . 3.4 mm? -114.16 -98.05 0.44 Allowed 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -176.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . 0.532 ' O ' ' HE3' ' B' ' 201' ' ' MET . . . -136.76 140.83 42.85 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -175.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 264' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' B' ' 263' ' ' ALA . 32.3 t 168.98 -150.96 0.0 OUTLIER 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 3.2 p -50.09 117.13 7.24 Favored Pre-proline 0 C--O 1.239 0.509 0 O-C-N 123.542 0.526 . . . . 0.0 110.691 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.15 119.03 5.99 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.794 2.33 . . . . 0.0 112.165 -174.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . -47.08 135.49 9.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.66 -1.154 . . . . 0.0 112.204 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 143.13 -20.51 2.29 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.025 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . 83.48 -52.56 4.74 Favored Glycine 0 C--O 1.227 -0.313 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.322 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . 63.57 55.85 1.68 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 122.898 0.479 . . . . 0.0 111.587 176.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 5.2 p 43.83 112.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -150.22 116.51 5.72 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.722 -1.581 . . . . 0.0 110.706 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 46.4 t 51.98 75.36 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 121.459 0.647 . . . . 0.0 111.135 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 32.6 p -161.04 135.19 7.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.641 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -158.96 156.23 29.06 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.373 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' B' ' 277' ' ' PRO . . . -108.12 142.66 25.78 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.956 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 277' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' B' ' 276' ' ' ALA . 19.6 Cg_exo -66.11 85.92 0.25 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.837 2.358 . . . . 0.0 112.442 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -138.72 76.27 0.35 Allowed Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.21 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 2.5 p -94.59 -166.39 1.47 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.913 0.387 . . . . 0.0 111.484 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . -45.73 126.36 6.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.763 175.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -71.27 126.35 91.88 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.44 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -62.9 153.79 70.88 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.665 2.243 . . . . 0.0 111.801 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -76.12 -178.73 4.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.661 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -62.78 -23.29 67.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.091 0.472 . . . . 0.0 111.49 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 142.71 -19.92 2.38 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 25.8 t -113.1 -175.69 2.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.393 -0.404 . . . . 0.0 109.958 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . 66.32 85.87 0.15 Allowed Pre-proline 0 N--CA 1.472 0.631 0 C-N-CA 123.584 0.754 . . . . 0.0 112.175 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -80.86 155.59 20.37 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.317 2.011 . . . . 0.0 111.991 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -90.86 76.53 6.31 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.083 0.468 . . . . 0.0 110.789 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -72.85 156.86 38.45 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.645 176.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -53.89 -65.44 0.57 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.899 -174.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -117.72 65.21 0.74 Allowed 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.157 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -73.94 86.86 1.79 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.12 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' B' ' 294' ' ' LYS . 24.1 ttmm -162.4 5.5 0.05 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.495 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -119.58 110.11 16.48 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.83 0.348 . . . . 0.0 111.359 -174.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 66.61 96.06 0.06 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.682 174.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -54.02 120.33 6.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.656 175.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -121.25 125.28 46.7 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.631 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -105.83 107.86 19.07 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.779 177.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -124.53 -89.59 0.58 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 174.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 58.84 78.83 0.24 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.232 0.539 . . . . 0.0 112.241 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 35.0 p -139.52 115.58 10.32 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.222 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -150.77 -73.86 0.16 Allowed 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.037 0.446 . . . . 0.0 110.599 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -131.29 137.78 48.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.629 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 16.3 m -139.02 131.66 28.91 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.392 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -145.26 92.91 2.31 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.837 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 26.2 t70 67.55 117.26 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 124.501 1.126 . . . . 0.0 111.953 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' B' ' 310' ' ' GLY . 15.7 m-20 -101.93 22.48 12.95 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.791 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 27.6 ttt 70.32 -34.79 0.3 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.936 0.894 . . . . 0.0 111.764 -177.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 310' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' B' ' 308' ' ' ASP . . . 55.41 65.51 3.5 Favored Glycine 0 N--CA 1.457 0.039 0 C-N-CA 121.416 -0.421 . . . . 0.0 112.824 175.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 311' ' ' PHE . . . . . 1.649 ' HD1' ' CD2' ' B' ' 311' ' ' PHE . 0.4 OUTLIER -139.6 -160.33 1.05 Allowed 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -177.549 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . 153.43 36.43 0.03 OUTLIER Glycine 0 C--N 1.313 -0.702 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.99 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 20.0 tp -104.42 76.49 1.31 Allowed 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 174.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 314' ' ' PHE . . . . . 1.655 ' HD1' ' CD2' ' B' ' 314' ' ' PHE . 17.4 p90 -99.03 -2.41 37.31 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 112.764 -2.016 . . . . 0.0 110.997 -172.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 . . . . . 0 C--O 1.244 0.812 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.441 -176.183 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.9 153.58 35.56 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.54 -0.171 . . . . 0.0 110.54 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 t 57.5 52.07 8.95 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.456 0.646 . . . . 0.0 110.285 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.423 HG11 ' HG ' ' B' ' 212' ' ' LEU . 45.1 t -67.11 -33.73 65.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.895 -174.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.1 m -62.15 -51.33 68.28 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.528 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.471 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 39.4 tt0 -63.87 -49.42 72.83 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.822 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.4 mp -51.98 -46.64 64.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.485 174.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.75 -52.05 65.85 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.672 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.471 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 26.2 p -64.51 -26.76 68.57 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.982 -177.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.57 -36.07 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.115 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 1.66 ' HD1' ' CD2' ' A' ' 11' ' ' TYR . 16.3 m-85 -74.96 -24.54 58.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.279 0.562 . . . . 0.0 109.929 177.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.9 m -75.26 -42.05 55.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.132 173.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.12 -39.86 63.77 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.384 169.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.595 ' CD1' ' HG ' ' B' ' 262' ' ' LEU . 83.2 mt -61.01 -56.97 14.83 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.646 175.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.6 mt -58.42 -31.65 43.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.64 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 46.5 mt -115.81 12.27 15.82 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -173.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -44.86 -48.5 11.13 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.785 0.326 . . . . 0.0 111.608 174.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.42 ' O ' HG13 ' A' ' 21' ' ' VAL . 11.2 t70 -154.31 -84.68 0.07 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 46.3 42.46 10.37 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.501 176.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 64.41 25.43 13.37 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.295 178.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.456 HG23 ' H ' ' A' ' 22' ' ' THR . 5.4 p -149.62 173.03 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.456 ' H ' HG23 ' A' ' 21' ' ' VAL . 5.3 p -107.49 127.43 53.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.808 0.337 . . . . 0.0 111.786 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.64 ' HB ' ' O ' ' A' ' 16' ' ' LEU . 3.9 p -67.17 95.21 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.368 0.604 . . . . 0.0 110.587 176.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.478 ' OG1' ' HG2' ' A' ' 27' ' ' LYS . 39.0 p -123.46 167.22 14.14 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.315 0.579 . . . . 0.0 112.14 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -49.22 -52.74 25.15 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.591 -174.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -62.13 -30.52 71.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.368 -177.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.478 ' HG2' ' OG1' ' A' ' 24' ' ' THR . 45.0 mmtm -71.48 -49.69 38.88 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.48 ' O ' HD11 ' A' ' 32' ' ' ILE . 9.5 mt -62.94 -44.4 99.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.939 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -56.05 -45.52 79.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.776 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.77 -41.63 95.73 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.408 HD13 HG21 ' B' ' 226' ' ' ILE . 0.2 OUTLIER -66.82 -41.97 86.64 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.516 0.674 . . . . 0.0 109.919 -178.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.48 HD11 ' O ' ' A' ' 28' ' ' ILE . 1.6 mp -62.17 -39.46 84.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.274 176.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -66.03 -31.98 73.18 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.087 0.47 . . . . 0.0 110.287 177.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.439 ' HB3' ' HA ' ' B' ' 226' ' ' ILE . . . -65.64 -47.21 76.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.498 176.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.447 ' HA ' HD12 ' B' ' 226' ' ' ILE . . . -84.79 -17.1 39.27 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -177.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.38 12.89 83.33 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.541 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.6 t -81.7 154.14 4.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -108.95 105.23 14.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.121 0.486 . . . . 0.0 111.219 -173.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.7 p -120.99 135.25 61.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.406 174.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -59.89 124.49 76.91 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.483 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.529 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 81.0 Cg_exo -47.13 -17.11 0.41 Allowed 'Trans proline' 0 N--CA 1.481 0.776 0 C-N-CA 124.554 3.503 . . . . 0.0 115.434 -171.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -75.3 -26.47 58.73 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -175.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.557 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 95.8 m95 -65.66 -54.24 31.12 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.332 174.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.557 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 75.6 Cg_exo -51.08 -52.47 9.02 Favored 'Trans proline' 0 C--N 1.364 1.381 0 C-N-CA 122.315 2.01 . . . . 0.0 112.773 173.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.29 -50.48 66.17 Favored Glycine 0 C--O 1.241 0.576 0 C-N-CA 120.571 -0.824 . . . . 0.0 112.086 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 56.5 tp -56.37 -52.49 64.41 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.29 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.419 ' O ' HD11 ' A' ' 51' ' ' LEU . 3.2 m-85 -57.53 -44.03 84.79 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -177.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.31 -39.65 95.16 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.297 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -97.42 7.3 46.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.978 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -112.38 -43.27 3.54 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.676 ' HA ' HG21 ' A' ' 54' ' ' VAL . 2.6 mp -83.16 -128.29 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.826 -175.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 65.41 -1.47 0.96 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -144.56 -46.74 0.25 Allowed 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.676 HG21 ' HA ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -55.91 119.26 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 113.626 -1.624 . . . . 0.0 111.323 177.334 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -52.96 146.27 11.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.765 174.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.441 ' O ' HD11 ' A' ' 59' ' ' LEU . 1.7 tp -45.86 -37.34 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -169.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -54.8 -22.12 25.29 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.788 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.5 p -51.46 -31.65 24.1 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 122.987 0.515 . . . . 0.0 111.321 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.441 HD11 ' O ' ' A' ' 56' ' ' ILE . 9.6 mp -49.53 -39.94 36.29 Favored 'General case' 0 CA--C 1.519 -0.22 0 O-C-N 123.721 0.638 . . . . 0.0 112.359 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.3 tt -87.73 23.07 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 122.052 0.93 . . . . 0.0 110.744 -174.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.8 t -126.02 2.95 7.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.04 173.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -88.75 34.18 0.77 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.664 -176.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.2 t -80.57 68.18 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.91 0.862 . . . . 0.0 109.876 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.16 24.3 26.71 Favored Glycine 0 C--N 1.314 -0.66 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.421 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.38 74.18 3.94 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.212 0.53 . . . . 0.0 110.825 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.98 59.21 5.01 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.197 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 144.81 76.21 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 111.884 -0.486 . . . . 0.0 111.884 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -64.27 -52.33 1.61 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.689 2.259 . . . . 0.0 112.728 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 50.92 75.46 0.65 Allowed Pre-proline 0 N--CA 1.468 0.439 0 O-C-N 123.607 0.567 . . . . 0.0 112.04 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -60.88 -64.52 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.749 2.299 . . . . 0.0 112.371 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 64.3 114.87 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.97 0.794 . . . . 0.0 111.783 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -137.13 122.64 19.62 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.536 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.84 90.28 0.09 OUTLIER Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 111.184 -0.767 . . . . 0.0 111.184 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.13 143.61 40.43 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.806 0.336 . . . . 0.0 110.437 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.55 123.03 87.63 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.89 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -66.79 -7.54 18.63 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.788 2.992 . . . . 0.0 113.218 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.16 96.19 9.83 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.915 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -143.42 89.29 0.17 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.509 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -132.25 69.86 0.53 Allowed Glycine 0 CA--C 1.519 0.315 0 C-N-CA 121.166 -0.54 . . . . 0.0 111.967 176.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -94.18 178.65 0.95 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.156 2.571 . . . . 0.0 113.328 -176.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.66 78.03 71.64 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.31 175.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.32 -32.98 94.81 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.895 2.397 . . . . 0.0 112.673 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.4 t -83.26 58.59 4.55 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.854 -176.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.5 m 71.27 122.83 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.934 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.05 93.31 3.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.242 0.544 . . . . 0.0 110.443 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.18 148.0 44.22 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.841 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.85 153.75 57.89 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.22 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -63.6 73.09 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.546 2.831 . . . . 0.0 113.761 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 67.07 -85.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.388 0.675 . . . . 0.0 111.3 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 47.34 74.05 0.17 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 122.056 0.931 . . . . 0.0 111.132 -177.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.23 176.74 8.93 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.805 -175.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.54 28.87 8.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.378 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -117.13 92.02 3.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.332 0.587 . . . . 0.0 109.907 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.7 p -130.92 144.14 38.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.464 -175.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -120.45 169.92 9.87 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.581 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -163.32 88.1 0.57 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.831 178.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -65.04 138.44 58.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.618 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -132.79 -48.0 0.87 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.843 -175.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 57.85 72.23 0.53 Allowed 'General case' 0 C--O 1.238 0.479 0 O-C-N 123.706 0.629 . . . . 0.0 111.936 173.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -73.57 154.08 39.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.891 0.377 . . . . 0.0 110.707 173.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.1 m -95.58 140.31 30.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.694 -174.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -137.7 41.65 2.34 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.638 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 63.62 101.94 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.579 -176.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.8 t -148.38 139.18 22.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.668 -177.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -123.01 126.19 46.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.378 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -95.09 -26.29 16.09 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.369 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -107.34 125.82 51.68 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 173.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 58.5 mtt -113.82 27.72 9.32 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.1 -172.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.9 119.12 3.3 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.324 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -81.68 59.31 4.13 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.161 0.505 . . . . 0.0 111.389 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 153.25 128.69 1.31 Allowed Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.058 177.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -104.89 31.13 4.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.836 0.35 . . . . 0.0 110.334 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 1.66 ' HE1' ' CE2' ' A' ' 113' ' ' PHE . 2.4 p90 -106.26 138.39 42.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.023 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.5 t70 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.559 -0.734 . . . . 0.0 110.037 -175.124 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 200' ' ' ALA . . . . . 0.537 ' O ' HG13 ' B' ' 204' ' ' VAL . . . . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 119.896 -0.097 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 201' ' ' MET . . . . . 0.523 ' SD ' ' HB3' ' B' ' 263' ' ' ALA . 36.1 mmm -50.16 -59.0 4.35 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 123.828 0.705 . . . . 0.0 112.465 -171.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 202' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -34.05 -64.06 0.25 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -170.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 203' ' ' TYR . . . . . 1.619 ' HD1' ' CD2' ' B' ' 203' ' ' TYR . 32.9 m-85 -98.97 -32.5 11.27 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -163.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.768 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 11.9 p -62.84 -49.83 82.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.041 -174.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 205' ' ' ALA . . . . . 0.506 ' HA ' HD13 ' B' ' 208' ' ' LEU . . . -72.58 -18.86 61.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.619 0.247 . . . . 0.0 111.09 -176.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 206' ' ' SER . . . . . 0.412 ' HB3' HG21 ' B' ' 223' ' ' ILE . 45.8 m -70.37 -47.39 61.17 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 120.93 0.395 . . . . 0.0 109.968 174.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 207' ' ' TYR . . . . . 1.641 ' HE2' ' CE1' ' B' ' 207' ' ' TYR . 29.5 t80 -62.51 -35.95 81.01 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.768 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 62.9 mt -60.83 -53.42 57.59 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.003 178.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 209' ' ' LEU . . . . . 0.612 ' CD2' ' HB2' ' A' ' 11' ' ' TYR . 78.7 mt -58.79 -50.84 72.43 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.054 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -61.16 -33.22 73.08 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.99 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 211' ' ' ALA . . . . . 0.663 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -76.97 -40.14 48.0 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.889 178.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 212' ' ' LEU . . . . . 0.423 ' HG ' HG11 ' A' ' 4' ' ' VAL . 52.0 tp -59.97 -55.33 35.36 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.492 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -126.26 53.37 0.79 Allowed Glycine 0 CA--C 1.507 -0.421 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.855 -174.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . -166.08 -77.85 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.494 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 215' ' ' ASN . . . . . 0.663 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 44.4 t30 -148.56 140.63 23.97 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.741 0.305 . . . . 0.0 110.201 -175.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 216' ' ' SER . . . . . 0.453 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 8.3 m -63.95 -23.92 67.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.329 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 5.2 p -120.05 70.55 15.1 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.18 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . 0.554 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 82.8 Cg_exo -52.56 131.69 42.12 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.541 2.827 . . . . 0.0 113.28 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 219' ' ' SER . . . . . 0.466 ' HB3' ' OD2' ' B' ' 222' ' ' ASP . 38.9 t -87.02 145.75 26.37 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.335 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -59.15 -21.32 59.19 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.042 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 221' ' ' LYS . . . . . 0.482 ' HZ2' ' HB3' ' B' ' 221' ' ' LYS . 9.0 mtpm? -69.6 -50.09 47.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.363 177.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 222' ' ' ASP . . . . . 0.466 ' OD2' ' HB3' ' B' ' 219' ' ' SER . 20.0 m-20 -67.27 -40.78 86.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.952 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.475 HD12 ' HB3' ' B' ' 218' ' ' PRO . 1.8 mp -60.34 -45.58 96.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 175.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 224' ' ' LYS . . . . . 0.558 ' HZ1' ' CG ' ' B' ' 236' ' ' ASP . 37.7 tptt -52.35 -46.2 66.03 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.45 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . 0.484 ' O ' ' HD3' ' B' ' 225' ' ' LYS . 7.8 tmtm? -63.68 -36.32 83.46 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 123.273 0.358 . . . . 0.0 110.469 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.447 HD12 ' HA ' ' A' ' 35' ' ' ALA . 1.3 mp -60.89 -44.18 97.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.098 176.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 6.8 mp -75.74 -23.76 56.07 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.984 177.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 228' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' B' ' 224' ' ' LYS . 0.0 OUTLIER -78.45 -28.1 46.56 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.78 -177.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 80.8 p -52.76 -56.81 12.94 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.973 0.416 . . . . 0.0 111.125 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 7.3 m -79.83 -27.24 12.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.883 175.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 67.9 64.65 3.05 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.97 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 55.1 mt -99.25 -89.13 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.738 0.304 . . . . 0.0 110.431 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -148.51 142.1 25.46 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 175.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -160.93 93.06 0.96 Allowed 'General case' 0 C--N 1.33 -0.262 0 O-C-N 123.298 0.374 . . . . 0.0 111.05 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . 0.486 ' OD2' ' HD2' ' B' ' 238' ' ' ARG . 25.6 m-20 -62.84 126.49 27.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.0 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 236' ' ' ASP . . . . . 0.558 ' CG ' ' HZ1' ' B' ' 224' ' ' LYS . 7.0 m-20 -74.64 -12.1 60.35 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -175.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -92.37 -52.53 4.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.181 0.515 . . . . 0.0 109.765 175.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.486 ' HD2' ' OD2' ' B' ' 235' ' ' ASP . 86.3 mtt180 -65.94 -33.16 75.19 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.18 -176.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 239' ' ' LEU . . . . . . . . . . . . . 8.8 tt -59.94 -62.99 1.46 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.822 0.344 . . . . 0.0 111.052 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -74.43 -19.24 60.47 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 121.993 -0.442 . . . . 0.0 110.671 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -71.63 -48.65 46.46 Favored 'General case' 0 C--O 1.244 0.781 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.831 173.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 242' ' ' VAL . . . . . 0.597 ' O ' ' HB3' ' B' ' 246' ' ' LEU . 28.4 m -66.13 -33.43 63.51 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.885 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 30.8 mt -73.19 -31.79 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 O-C-N 123.627 0.579 . . . . 0.0 111.271 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 18.3 t -64.73 -28.5 69.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.679 0.276 . . . . 0.0 110.663 176.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -87.78 -47.88 8.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.651 0.738 . . . . 0.0 109.628 172.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . 0.665 ' O ' ' HG ' ' B' ' 246' ' ' LEU . 8.8 tp -79.5 56.37 2.16 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 124.716 1.206 . . . . 0.0 109.89 177.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -100.25 37.29 1.69 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.986 -174.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . 0.423 ' HA2' ' CG2' ' B' ' 251' ' ' ILE . . . 99.54 2.81 56.47 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.594 -0.813 . . . . 0.0 114.043 173.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -74.98 -1.68 23.72 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -177.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -159.32 8.11 0.11 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.507 ' O ' HG12 ' B' ' 255' ' ' ILE . 5.2 tp -65.87 -46.93 87.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -172.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -58.59 -43.87 89.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.308 0.575 . . . . 0.0 110.972 -176.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -74.54 -38.7 62.69 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.874 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 254' ' ' VAL . . . . . 0.502 HG11 ' O ' ' B' ' 251' ' ' ILE . 6.6 p -71.06 -21.37 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 120.992 0.425 . . . . 0.0 110.351 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 255' ' ' ILE . . . . . 0.507 HG12 ' O ' ' B' ' 251' ' ' ILE . 35.2 mm -76.95 -48.48 25.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 171.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -62.83 -35.28 79.42 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -174.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -147.5 28.92 0.96 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.845 -176.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . 0.5 ' O ' HD22 ' B' ' 262' ' ' LEU . . . -110.51 56.64 0.45 Allowed Glycine 0 C--O 1.226 -0.376 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.238 -174.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 26.8 mt -94.69 -11.68 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.35 0.595 . . . . 0.0 110.674 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -107.99 -45.52 1.1 Allowed Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.289 -176.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -88.64 75.93 8.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.988 0.423 . . . . 0.0 110.87 -174.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 262' ' ' LEU . . . . . 0.595 ' HG ' ' CD1' ' A' ' 14' ' ' LEU . 3.3 mm? -123.72 -73.05 0.65 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.634 0.73 . . . . 0.0 111.464 -176.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . 0.523 ' HB3' ' SD ' ' B' ' 201' ' ' MET . . . -50.33 -74.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.547 177.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 23.9 t 61.73 121.44 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.352 1.032 . . . . 0.0 112.387 176.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 2.7 p -78.39 114.23 41.07 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.395 175.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.31 143.38 17.42 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.488 2.125 . . . . 0.0 112.645 -177.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . -127.23 135.94 51.33 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.355 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 73.73 38.97 49.45 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.389 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -77.04 93.64 1.08 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.759 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -76.13 80.07 2.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.904 0.383 . . . . 0.0 110.454 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 16.9 t -79.13 141.76 14.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.565 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -140.61 130.31 24.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.095 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 37.0 t -74.8 116.8 17.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.574 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 4.9 p -77.88 129.93 35.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.675 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -100.75 146.75 26.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.628 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . 0.4 ' HA ' ' HD2' ' B' ' 277' ' ' PRO . . . -112.39 115.81 49.26 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-O 121.154 0.502 . . . . 0.0 111.188 -178.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 277' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' B' ' 276' ' ' ALA . 55.5 Cg_endo -70.46 146.71 56.59 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.176 2.584 . . . . 0.0 112.709 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -113.14 160.04 13.35 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.15 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 15.8 m -91.66 -170.68 2.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.766 0.283 . . . . 0.0 111.022 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 69.36 67.94 0.26 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.84 0.828 . . . . 0.0 111.225 174.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -95.12 160.49 30.74 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.266 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -44.95 -64.6 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.216 2.611 . . . . 0.0 113.2 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . 62.92 110.79 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 O-C-N 123.952 0.783 . . . . 0.0 112.091 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -102.64 -170.38 1.79 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.624 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -85.61 -121.3 1.13 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.955 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 58.1 p 47.34 75.45 0.13 Allowed 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.155 0.582 . . . . 0.0 111.721 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -51.68 110.62 1.92 Allowed Pre-proline 0 C--O 1.233 0.213 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.85 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.25 100.54 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.84 2.36 . . . . 0.0 112.725 -175.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -95.65 -170.1 2.08 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.585 176.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -61.61 -68.53 0.31 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.693 177.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -176.29 160.02 2.1 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.372 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 60.26 110.83 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 174.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -60.35 108.36 0.79 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.184 172.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -136.77 118.71 15.27 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -176.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -80.42 132.69 35.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.0 0.429 . . . . 0.0 111.45 -177.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -164.59 103.9 0.82 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -78.71 173.97 11.91 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -171.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -90.69 -79.4 0.36 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.456 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 57.62 63.21 1.89 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.434 0.635 . . . . 0.0 111.207 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -84.75 177.62 7.95 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.641 -175.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 63.73 97.31 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.203 0 O-C-N 123.995 0.81 . . . . 0.0 112.382 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 21.3 t -134.17 141.7 47.17 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.347 0.594 . . . . 0.0 110.949 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -98.17 107.52 20.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.678 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -94.93 65.85 2.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.67 -176.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 23.7 m -67.0 142.52 57.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.084 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.99 12.96 34.4 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.944 -177.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 18.7 t70 70.1 -64.86 0.34 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.972 0.909 . . . . 0.0 111.656 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -90.62 171.54 9.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.483 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 25.5 ptm -147.2 24.5 1.14 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.597 0.236 . . . . 0.0 111.045 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . -76.27 49.92 2.69 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.316 -0.468 . . . . 0.0 113.132 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 311' ' ' PHE . . . . . 1.649 ' HD1' ' CD2' ' B' ' 311' ' ' PHE . 96.8 m-85 -130.77 18.01 5.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.09 0.472 . . . . 0.0 110.399 -178.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . 100.62 -74.72 0.41 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.01 -177.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 1.7 mt 48.83 83.02 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 122.03 0.919 . . . . 0.0 110.714 -173.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 314' ' ' PHE . . . . . 1.636 ' HE2' ' CE1' ' B' ' 314' ' ' PHE . 2.8 p90 -131.15 18.64 4.94 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.35 -1.296 . . . . 0.0 109.908 -167.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 . . . . . 0 C--O 1.249 1.029 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.843 -174.796 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmt . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.571 0.224 . . . . 0.0 110.484 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.55 -77.09 0.37 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.802 0.334 . . . . 0.0 110.695 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.426 ' O ' HD11 ' A' ' 7' ' ' LEU . 0.9 OUTLIER -81.91 73.76 8.93 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.858 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.459 HG13 ' CD1' ' B' ' 212' ' ' LEU . 6.0 m -62.91 -27.52 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.277 -176.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.8 m -61.64 -63.16 1.36 Allowed 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.408 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -59.24 -50.23 74.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.348 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.587 ' O ' HG23 ' A' ' 10' ' ' ILE . 9.8 mp -47.99 -54.65 12.22 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.69 0.281 . . . . 0.0 110.666 178.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.67 -52.77 64.11 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -177.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 40.6 t -66.0 -30.61 71.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.761 0.315 . . . . 0.0 110.92 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.587 HG23 ' O ' ' A' ' 7' ' ' LEU . 2.4 tp -74.75 -35.77 38.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.154 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 1.637 ' HD1' ' CD2' ' A' ' 11' ' ' TYR . 19.5 m-30 -66.43 -36.17 82.13 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 177.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.1 m -69.35 -46.47 66.95 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.128 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.4 ' HB3' HD22 ' A' ' 59' ' ' LEU . . . -54.65 -49.6 70.18 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.562 176.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.669 ' O ' ' HE2' ' B' ' 201' ' ' MET . 4.5 pp -75.67 -29.03 58.92 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.213 -177.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -65.14 -38.68 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.796 0.331 . . . . 0.0 110.788 175.287 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 23' ' ' VAL . 93.1 mt -78.23 -28.28 47.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.759 178.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.8 m80 -79.21 68.85 5.29 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -165.21 -49.11 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.903 0.382 . . . . 0.0 110.429 173.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.405 ' CG ' ' H3 ' ' B' ' 200' ' ' ALA . 12.0 m-20 -83.69 -172.17 4.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.722 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -89.3 16.45 7.39 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.1 0.476 . . . . 0.0 110.307 175.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.432 HG23 HG12 ' B' ' 232' ' ' ILE . 41.3 t -88.8 125.94 41.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.095 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 p -77.59 147.34 35.71 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.198 -172.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.438 ' HA ' HD12 ' A' ' 16' ' ' LEU . 32.6 m -83.69 41.74 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.06 -174.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.419 ' OG1' ' HG2' ' A' ' 27' ' ' LYS . 39.1 p -67.13 159.85 28.01 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -177.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -57.72 -42.65 84.26 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -176.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -49.78 -42.65 47.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.331 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.419 ' HG2' ' OG1' ' A' ' 24' ' ' THR . 45.8 mmtm -77.74 -47.75 18.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.394 -173.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.436 ' O ' HD11 ' A' ' 32' ' ' ILE . 5.2 mt -61.55 -44.81 99.23 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.154 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.332 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -60.05 -40.61 90.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.634 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.92 -40.93 99.11 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.83 -41.79 78.08 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.337 0.589 . . . . 0.0 110.05 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.436 HD11 ' O ' ' A' ' 28' ' ' ILE . 1.7 mp -59.94 -37.73 73.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.601 175.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -75.58 -30.43 59.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.108 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.45 -51.2 70.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.448 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.418 ' HA ' HD12 ' B' ' 226' ' ' ILE . . . -85.88 -27.21 25.17 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.777 -177.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.7 22.02 56.7 Favored Glycine 0 C--N 1.321 -0.264 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.777 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.9 t -82.34 137.17 21.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.848 0.356 . . . . 0.0 110.119 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -88.21 92.03 9.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.997 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -102.41 136.18 35.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.573 175.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.441 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -54.2 125.3 49.72 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.046 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.76 -6.15 2.3 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.6 2.866 . . . . 0.0 113.507 -171.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.49 -31.25 47.65 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -177.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -65.99 -60.72 6.59 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.622 175.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.441 ' HD2' ' O ' ' A' ' 40' ' ' GLU . 19.6 Cg_endo -58.86 -40.91 67.69 Favored 'Trans proline' 0 C--N 1.361 1.197 0 C-N-CA 121.783 1.656 . . . . 0.0 112.178 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.38 -55.04 32.33 Favored Glycine 0 C--O 1.241 0.552 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.159 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.7 tt -59.87 -50.54 73.38 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 1.613 ' HD2' ' CD1' ' A' ' 47' ' ' PHE . 2.6 m-85 -53.61 -53.6 49.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.01 0.433 . . . . 0.0 111.832 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.91 -27.94 67.07 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -173.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm -93.59 -11.62 31.37 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.451 -0.5 . . . . 0.0 112.15 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -106.54 -26.26 11.48 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.608 ' HA ' ' CG2' ' A' ' 54' ' ' VAL . 4.8 mp -81.23 -132.53 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 57.27 6.49 0.37 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.372 0.669 . . . . 0.0 112.095 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.414 ' H ' ' C ' ' A' ' 51' ' ' LEU . 37.2 m-80 -143.67 -40.76 0.29 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.608 ' CG2' ' HA ' ' A' ' 51' ' ' LEU . 58.7 t -45.14 108.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 113.881 -1.509 . . . . 0.0 111.622 173.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -67.51 169.71 8.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.678 173.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.6 tp -54.62 -53.25 33.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.954 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.63 -43.35 86.12 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.457 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.4 m -58.54 -28.55 65.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.662 0.268 . . . . 0.0 111.141 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.49 HD11 ' O ' ' A' ' 59' ' ' LEU . 2.5 tm? -64.06 -22.74 67.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.678 -176.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.631 HG12 ' HB ' ' B' ' 259' ' ' ILE . 18.3 mt -92.25 -5.28 10.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.301 0.572 . . . . 0.0 110.682 -176.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 22.4 t -137.55 51.22 1.93 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.351 0.596 . . . . 0.0 110.017 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -90.99 -34.21 15.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.548 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.3 p -106.94 -12.57 10.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.176 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 115.37 -169.38 12.88 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -175.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -149.06 119.87 7.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 117.336 0.568 . . . . 0.0 111.193 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -96.22 -98.82 1.85 Allowed Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.748 174.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.443 ' HA2' ' HD3' ' A' ' 68' ' ' PRO . . . 150.34 144.36 3.92 Favored Glycine 0 C--O 1.227 -0.289 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.105 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.443 ' HD3' ' HA2' ' A' ' 67' ' ' GLY . 2.8 Cg_endo -80.98 82.47 2.45 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.832 2.355 . . . . 0.0 112.291 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.95 76.62 75.69 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.423 176.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.79 -42.6 0.77 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.454 2.102 . . . . 0.0 112.888 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 63.62 165.44 0.13 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.213 0.605 . . . . 0.0 111.664 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -155.9 133.17 10.79 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.898 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.77 151.42 20.44 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.88 135.08 27.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.75 0.275 . . . . 0.0 110.626 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -139.86 126.24 12.17 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.163 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -50.45 -30.09 26.28 Favored 'Trans proline' 0 CA--C 1.527 0.166 0 C-N-CA 124.226 3.284 . . . . 0.0 113.349 -177.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 58.94 75.76 0.38 Allowed 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.671 0.607 . . . . 0.0 111.892 174.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -108.32 160.22 13.89 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.324 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -146.61 173.87 26.68 Favored Glycine 0 N--CA 1.451 -0.329 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.6 164.12 26.17 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.501 2.134 . . . . 0.0 112.109 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.52 108.5 61.95 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.601 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -57.94 146.43 86.88 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.638 2.225 . . . . 0.0 112.111 178.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.0 t 62.11 77.9 0.31 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.281 0.562 . . . . 0.0 110.857 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.6 m -94.63 116.56 28.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.085 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 70.24 -73.84 0.09 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.563 0.745 . . . . 0.0 111.623 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 67.05 111.53 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.932 0.77 . . . . 0.0 112.377 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 65.23 95.26 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.326 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.077 175.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -54.7 -47.06 28.79 Favored 'Trans proline' 0 N--CA 1.473 0.282 0 C-N-CA 123.278 2.652 . . . . 0.0 112.598 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 55.49 44.52 26.76 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.375 0.607 . . . . 0.0 110.897 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -89.27 142.45 27.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.995 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -108.98 -174.86 2.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.997 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -151.14 75.13 1.18 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.992 0.901 . . . . 0.0 109.838 175.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -88.18 134.96 33.65 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.4 -174.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 13.6 p -152.92 148.5 14.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.188 175.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 73.45 144.91 0.07 Allowed 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.785 0.678 . . . . 0.0 111.887 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.44 118.28 7.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.165 -178.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.4 mttp 65.26 163.37 0.15 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.448 0.642 . . . . 0.0 112.087 -177.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -139.2 -76.3 0.36 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.463 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 50.43 56.72 7.51 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 123.823 0.702 . . . . 0.0 111.026 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.32 144.19 57.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.16 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.0 t -113.98 42.03 2.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.369 0.604 . . . . 0.0 111.192 -174.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -115.68 33.03 5.71 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.866 175.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -45.24 126.24 6.1 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.415 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.2 m -122.17 121.79 37.69 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.059 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.538 ' CG ' ' H ' ' A' ' 106' ' ' ASP . 13.9 t70 -143.41 -156.46 0.69 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -176.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.538 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 9.1 t70 59.63 73.15 0.49 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.91 0.862 . . . . 0.0 110.05 -173.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -80.47 72.52 7.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.516 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 17.1 tpt 68.48 77.61 0.24 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.808 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -82.45 -159.43 25.86 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-N 115.945 -0.57 . . . . 0.0 113.164 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 1.672 ' HD1' ' CD2' ' A' ' 110' ' ' PHE . 2.0 m-85 -58.12 130.89 48.71 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.421 0.629 . . . . 0.0 111.944 -176.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.474 ' HA2' ' CE2' ' A' ' 113' ' ' PHE . . . -83.5 72.0 2.91 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.671 -178.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.5 mt -92.69 47.87 1.33 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.241 0.543 . . . . 0.0 110.408 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.474 ' CE2' ' HA2' ' A' ' 111' ' ' GLY . 2.0 p90 -138.24 51.65 1.86 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.255 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 36.1 t70 . . . . . 0 C--O 1.248 0.995 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.752 -178.437 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 200' ' ' ALA . . . . . 0.405 ' H3 ' ' CG ' ' A' ' 19' ' ' ASP . . . . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 201' ' ' MET . . . . . 0.669 ' HE2' ' O ' ' A' ' 14' ' ' LEU . 38.5 mtt -48.73 -66.64 0.37 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.473 0.654 . . . . 0.0 111.552 -173.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 202' ' ' ARG . . . . . 0.437 ' HB3' HG21 ' B' ' 204' ' ' VAL . 7.1 tpt180 -151.68 147.04 26.24 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 203' ' ' TYR . . . . . 1.651 ' HE2' ' CE1' ' B' ' 203' ' ' TYR . 99.1 m-85 -74.83 5.67 4.79 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 120.913 0.387 . . . . 0.0 111.805 -174.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.784 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 18.1 m -58.28 -51.94 65.02 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.529 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.783 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 205' ' ' ALA . . . . . 0.533 ' CB ' HD12 ' A' ' 14' ' ' LEU . . . -64.7 -25.33 67.89 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -176.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 206' ' ' SER . . . . . 0.561 ' CB ' HG21 ' B' ' 223' ' ' ILE . 6.0 m -67.11 -48.91 66.69 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 173.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 207' ' ' TYR . . . . . 0.486 ' CZ ' ' HD2' ' B' ' 218' ' ' PRO . 17.0 t80 -61.68 -35.22 77.36 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.383 175.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.784 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 39.5 mt -63.26 -53.34 54.44 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.963 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 209' ' ' LEU . . . . . 0.607 HD23 ' HB2' ' A' ' 11' ' ' TYR . 15.2 mt -52.57 -50.62 62.59 Favored 'General case' 0 C--O 1.245 0.864 0 CA-C-O 121.264 0.554 . . . . 0.0 110.003 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -62.5 -41.13 98.62 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.668 -178.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 211' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -77.77 -24.68 48.87 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.929 -0.482 . . . . 0.0 111.481 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 212' ' ' LEU . . . . . 0.459 ' CD1' HG13 ' A' ' 4' ' ' VAL . 33.5 tp -71.23 -47.84 54.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.669 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -141.16 20.56 2.64 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 118.954 -1.593 . . . . 0.0 114.628 -176.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . -121.05 -66.07 0.26 Allowed Glycine 0 C--N 1.321 -0.284 0 C-N-CA 119.959 -1.115 . . . . 0.0 112.772 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 215' ' ' ASN . . . . . 0.496 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 34.0 t30 -154.42 146.66 23.8 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -177.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 7.0 m -67.95 -21.62 65.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.355 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 5.6 p -125.19 70.91 62.74 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.618 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . 0.486 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 65.2 Cg_exo -57.75 132.99 53.38 Favored 'Trans proline' 0 N--CA 1.477 0.552 0 C-N-CA 122.989 2.459 . . . . 0.0 112.152 176.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 219' ' ' SER . . . . . 0.452 ' HB3' ' OD1' ' B' ' 222' ' ' ASP . 28.3 t -110.18 172.96 6.55 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.919 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -56.1 -38.9 71.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.007 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -65.98 -43.33 88.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.685 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 222' ' ' ASP . . . . . 0.452 ' OD1' ' HB3' ' B' ' 219' ' ' SER . 3.3 m-20 -62.23 -49.48 75.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.138 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.561 HG21 ' CB ' ' B' ' 206' ' ' SER . 1.8 mp -63.79 -40.23 88.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.586 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -54.43 -50.9 66.55 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.187 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -63.71 -42.64 97.91 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.075 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' A' ' 35' ' ' ALA . 1.0 OUTLIER -58.14 -36.04 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 120.686 0.279 . . . . 0.0 110.73 176.882 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . 0.458 ' CD1' ' HB ' ' B' ' 232' ' ' ILE . 0.2 OUTLIER -75.82 -43.85 44.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.68 -178.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -86.64 -0.77 56.86 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.631 -177.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 15.4 t -55.07 -44.74 75.06 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.987 0.422 . . . . 0.0 110.51 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 230' ' ' VAL . . . . . 0.541 HG21 HG13 ' B' ' 232' ' ' ILE . 12.5 m -95.88 0.74 10.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.218 0.532 . . . . 0.0 111.16 178.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 81.65 54.98 3.3 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.616 -0.72 . . . . 0.0 113.739 175.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . 0.541 HG13 HG21 ' B' ' 230' ' ' VAL . 4.3 mt -115.64 140.07 39.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 172.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -70.74 119.85 15.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.302 0.573 . . . . 0.0 111.576 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -118.18 132.64 56.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.383 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -83.78 111.95 19.65 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -60.67 -33.69 73.22 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.458 -174.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -67.91 -58.31 4.77 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.456 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -63.92 -30.85 71.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.688 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 239' ' ' LEU . . . . . . . . . . . . . 8.7 tt -57.42 -60.72 3.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.313 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -64.25 -32.46 74.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.897 -178.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 241' ' ' LYS . . . . . 0.466 ' O ' ' HG3' ' B' ' 245' ' ' GLU . 84.3 mttt -67.77 -41.54 83.14 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 242' ' ' VAL . . . . . 0.436 ' HA ' ' OE1' ' B' ' 245' ' ' GLU . 32.9 m -73.92 -31.15 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 119.969 -0.693 . . . . 0.0 109.559 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . 0.448 ' HA ' ' CD2' ' B' ' 246' ' ' LEU . 7.5 mt -65.16 -37.09 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.077 173.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 12.1 t -63.56 -40.22 96.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.241 174.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 245' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' B' ' 241' ' ' LYS . 47.0 mt-10 -59.42 -45.54 91.25 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.439 0.638 . . . . 0.0 110.266 176.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . 0.487 ' O ' HD11 ' B' ' 246' ' ' LEU . 2.9 pp -87.6 -0.11 56.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.831 -175.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -67.04 -8.23 28.7 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.051 0.453 . . . . 0.0 111.719 -170.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -80.33 -170.93 42.54 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.149 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -82.31 67.4 8.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.922 0.391 . . . . 0.0 110.688 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -131.72 27.68 4.62 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.686 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.411 ' O ' HG13 ' B' ' 255' ' ' ILE . 23.9 mm -53.46 -66.42 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -173.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 252' ' ' GLU . . . . . 0.447 ' O ' ' HB ' ' B' ' 255' ' ' ILE . 5.0 tp10 -62.03 -32.51 73.01 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 121.138 0.494 . . . . 0.0 111.412 -174.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' B' ' 257' ' ' GLN . 8.4 t70 -67.73 -47.27 69.79 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.11 -178.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 254' ' ' VAL . . . . . . . . . . . . . 30.0 m -67.95 -24.46 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.065 0 C-N-CA 120.239 -0.585 . . . . 0.0 110.455 177.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 255' ' ' ILE . . . . . 0.66 HG21 ' OH ' ' A' ' 11' ' ' TYR . 40.1 mt -61.47 -37.71 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 CA-C-O 121.468 0.651 . . . . 0.0 109.433 172.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -94.78 -2.91 50.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.42 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' B' ' 253' ' ' ASP . 0.9 OUTLIER -106.72 76.29 1.11 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.138 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . 0.467 ' HA3' ' CD1' ' B' ' 262' ' ' LEU . . . -143.08 -99.16 0.3 Allowed Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.266 -0.969 . . . . 0.0 112.011 177.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 259' ' ' ILE . . . . . 0.631 ' HB ' HG12 ' A' ' 60' ' ' ILE . 1.0 OUTLIER -60.67 -38.42 78.51 Favored 'Isoleucine or valine' 0 C--N 1.346 0.451 0 CA-C-O 122.167 0.984 . . . . 0.0 108.59 171.318 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 137.43 -37.17 1.87 Allowed Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.988 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 261' ' ' LYS . . . . . 0.522 ' H ' HD13 ' B' ' 259' ' ' ILE . 28.9 mmmt -122.06 22.2 10.33 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 262' ' ' LEU . . . . . 0.559 HD13 ' CE1' ' A' ' 11' ' ' TYR . 2.3 pt? -69.06 -2.56 10.37 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.236 0.541 . . . . 0.0 111.171 -176.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -123.97 53.1 1.41 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 170.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 11.6 t -64.63 110.73 2.45 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.844 -177.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 45.4 t -107.39 104.13 51.35 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.045 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.9 118.21 3.38 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.688 2.258 . . . . 0.0 112.71 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . -78.24 57.39 1.86 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.405 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 77.99 -47.81 2.91 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 121.546 -0.359 . . . . 0.0 112.938 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . 100.14 43.75 2.34 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.621 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . 69.63 88.43 0.11 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.667 0.787 . . . . 0.0 111.379 -177.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 22.9 t -89.32 143.22 11.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.904 178.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -97.57 131.85 43.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.84 0.352 . . . . 0.0 111.146 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 58.7 t -97.95 125.91 51.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.001 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 8.0 m -76.64 123.1 25.61 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.227 0.537 . . . . 0.0 111.249 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -151.04 151.06 31.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.972 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -99.42 118.6 62.01 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 120.535 0.207 . . . . 0.0 110.705 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 277' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -70.6 145.38 52.17 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.936 2.424 . . . . 0.0 112.093 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -89.12 117.55 4.94 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.306 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 69.7 m -96.8 -165.59 1.29 Allowed 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.273 0.559 . . . . 0.0 111.47 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . -54.93 152.67 7.15 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.208 176.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' B' ' 282' ' ' PRO . . . -137.21 136.98 21.45 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.346 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' B' ' 281' ' ' ALA . 14.7 Cg_exo -67.81 95.81 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.553 2.168 . . . . 0.0 112.292 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -121.06 37.39 4.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.371 0.605 . . . . 0.0 110.652 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -149.19 177.23 9.81 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.173 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 176.5 -35.04 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.096 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 35.9 p 50.15 77.32 0.12 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.273 0.558 . . . . 0.0 111.685 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -100.02 120.44 56.88 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.349 -176.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.77 141.87 42.13 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.582 2.188 . . . . 0.0 111.922 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -90.0 -54.25 4.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.121 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . 47.33 69.39 0.51 Allowed 'General case' 0 CA--C 1.531 0.239 0 O-C-N 123.476 0.485 . . . . 0.0 112.115 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -86.29 -58.41 2.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.286 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 54.77 60.23 3.62 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.324 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -56.62 117.87 4.3 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.484 172.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -146.6 164.24 33.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.444 -175.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt 73.77 148.29 0.09 Allowed 'General case' 0 N--CA 1.473 0.722 0 O-C-N 124.064 0.852 . . . . 0.0 111.531 177.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -138.13 123.95 19.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.301 0.572 . . . . 0.0 110.714 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -75.47 145.31 41.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.38 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 298' ' ' LYS . . . . . 0.505 ' HB2' ' HZ3' ' B' ' 298' ' ' LYS . 0.2 OUTLIER -113.78 11.17 17.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.147 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -123.66 127.88 48.86 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.31 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -103.33 108.47 19.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.934 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 43.76 65.2 1.05 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.443 175.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.02 -172.73 3.4 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.936 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 65.33 78.27 0.28 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.378 0.608 . . . . 0.0 110.356 -177.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -155.8 151.6 27.42 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.186 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 68.4 m -150.69 125.79 9.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.164 0.507 . . . . 0.0 110.86 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.97 -54.76 10.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.338 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -77.77 -75.67 0.21 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.745 -172.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 18.3 t0 62.9 88.03 0.1 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.578 0.704 . . . . 0.0 111.276 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 16.1 tpt -73.31 -6.35 45.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.625 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 94.6 121.11 3.44 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.125 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -75.88 58.13 1.11 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.299 0.571 . . . . 0.0 110.954 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . -94.56 -82.27 1.57 Allowed Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.865 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 10.7 mp 46.75 64.05 1.68 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.962 0.887 . . . . 0.0 110.018 -177.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 314' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -128.77 13.34 6.37 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 113.967 -1.47 . . . . 0.0 108.804 -170.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--O 1.249 1.074 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.356 -173.588 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.6 tpp . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.4 -91.9 0.04 OUTLIER 'General case' 0 C--O 1.234 0.25 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.557 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 23.3 t -90.52 96.44 10.65 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.162 0.506 . . . . 0.0 111.289 -172.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.0 p -69.55 -26.27 30.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.842 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.422 ' HA ' HG23 ' A' ' 39' ' ' VAL . 8.4 p -66.83 -55.47 14.67 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.528 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.615 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 35.3 mt-10 -62.67 -39.49 94.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.733 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 3' ' ' SER . 38.3 mt -54.99 -55.41 31.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.111 0.481 . . . . 0.0 109.922 175.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.3 -44.79 95.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.994 -175.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.615 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 26.7 p -70.94 -34.62 71.65 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.416 -176.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.464 HG12 ' CG2' ' B' ' 259' ' ' ILE . 0.8 OUTLIER -75.26 -33.94 29.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.973 0.416 . . . . 0.0 110.888 -179.404 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 1.663 ' HE1' ' CE2' ' A' ' 11' ' ' TYR . 23.0 m-30 -77.51 -26.47 51.19 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 177.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 t -65.62 -51.71 57.52 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.01 -42.82 29.1 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.4 171.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.553 HD22 ' HA2' ' B' ' 260' ' ' GLY . 82.6 mt -59.01 -58.29 9.32 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.781 0.324 . . . . 0.0 110.914 175.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 69.6 mt -56.62 -29.84 30.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.275 -176.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.9 mt -100.95 -9.58 21.39 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.68 -35.64 76.77 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -176.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -164.32 116.83 1.34 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -174.7 43.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.286 170.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 57.02 28.37 14.72 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.192 -174.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.0 p -126.44 161.53 32.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.651 -176.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.0 p -106.27 132.55 52.19 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -173.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.411 HG12 HD22 ' A' ' 51' ' ' LEU . 61.9 t -75.15 108.24 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -152.62 158.94 43.15 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-O 121.309 0.576 . . . . 0.0 111.894 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -43.77 -61.67 1.35 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.206 -173.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -62.86 -24.77 67.96 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.5 -173.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -77.43 -45.81 24.61 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.388 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.7 mt -62.46 -45.53 98.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.214 -0.595 . . . . 0.0 109.926 175.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -53.61 -45.78 70.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.194 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.0 -44.36 92.87 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.6 tp -71.22 -30.03 65.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.342 0.592 . . . . 0.0 110.316 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.66 -31.56 49.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.917 173.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -70.44 -29.83 66.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.87 -67.47 0.45 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.013 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.78 23.66 5.38 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -174.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -101.66 99.27 1.88 Allowed Glycine 0 C--N 1.314 -0.662 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.076 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.581 ' CG2' ' HA2' ' B' ' 213' ' ' GLY . 57.8 t -42.49 -70.07 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 122.516 0.326 . . . . 0.0 111.43 177.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -161.98 113.72 1.69 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 177.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.422 HG23 ' HA ' ' A' ' 5' ' ' SER . 11.8 t -121.65 137.52 55.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.481 ' C ' ' H ' ' A' ' 42' ' ' PHE . 0.7 OUTLIER -70.09 128.17 91.79 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.69 0.57 0.38 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.14 2.56 . . . . 0.0 113.116 -174.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 1.662 ' HD2' ' CD1' ' A' ' 42' ' ' PHE . 2.6 t80 -71.42 -39.72 70.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.014 176.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.477 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 68.2 m95 -72.42 -56.72 3.9 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.928 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.477 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 73.5 Cg_exo -49.95 -46.22 28.96 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 122.015 1.81 . . . . 0.0 112.321 173.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.46 -41.61 99.25 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.36 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.2 tp -61.87 -42.57 99.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.975 0.417 . . . . 0.0 110.096 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.442 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 3.2 m-85 -66.56 -40.05 88.8 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.992 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.61 -28.27 65.79 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -95.1 -30.74 13.9 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.79 -18.15 7.17 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -169.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.575 ' C ' ' H ' ' A' ' 53' ' ' ASN . 2.2 tp -89.54 -134.46 0.1 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.6 -176.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.461 ' H ' ' CG ' ' A' ' 51' ' ' LEU . . . 60.07 -13.28 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -176.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.575 ' H ' ' C ' ' A' ' 51' ' ' LEU . 48.0 m-80 -127.09 -31.38 2.6 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.559 ' CG2' ' HA ' ' A' ' 51' ' ' LEU . 61.0 t -49.99 103.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.382 172.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -46.74 146.32 1.62 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.671 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.437 HD12 HD21 ' A' ' 14' ' ' LEU . 4.0 tp -49.71 -51.77 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -170.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.27 -24.21 63.14 Favored Glycine 0 C--O 1.24 0.474 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.041 -176.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.3 t -68.81 -2.83 10.39 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 122.107 0.163 . . . . 0.0 111.225 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 46.3 mt -62.35 -26.02 68.22 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.192 0.52 . . . . 0.0 109.961 172.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.436 HG12 ' HB ' ' B' ' 259' ' ' ILE . 8.9 mt -95.74 16.26 2.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.607 0.718 . . . . 0.0 110.092 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.0 t -108.98 -45.01 3.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.381 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -87.74 5.89 37.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.036 -177.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.9 p -61.67 -29.84 47.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.897 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.0 40.75 2.32 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.212 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.76 -34.01 52.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.813 0.34 . . . . 0.0 110.972 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.81 -141.36 16.92 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.816 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 109.04 -167.98 13.19 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.826 -177.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -89.68 177.99 2.51 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.104 2.536 . . . . 0.0 112.488 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -171.55 -50.93 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.309 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -77.53 143.85 22.03 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 121.705 1.603 . . . . 0.0 111.641 171.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 67.84 115.47 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.384 0.674 . . . . 0.0 112.279 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -155.14 178.93 9.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.218 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.78 174.61 24.96 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.507 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -137.61 140.37 40.9 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.475 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -62.39 125.75 86.5 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.157 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 32.3 Cg_exo -60.76 97.81 0.13 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.518 2.812 . . . . 0.0 113.487 -177.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.63 142.53 49.94 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.919 173.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.29 -80.16 0.35 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.494 -174.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.6 -178.09 16.49 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.955 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.41 158.87 54.81 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.756 2.304 . . . . 0.0 112.492 -178.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -99.95 116.66 64.46 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.776 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -54.09 108.58 0.29 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.446 2.764 . . . . 0.0 112.671 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.4 t -82.87 84.39 7.41 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.179 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 27.5 m -151.1 -68.73 0.18 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.756 177.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 60.32 59.4 2.3 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.643 0.589 . . . . 0.0 111.614 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 65.48 -167.2 0.22 Allowed 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.781 0.676 . . . . 0.0 111.708 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -132.9 141.39 40.86 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.802 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -47.75 -60.19 0.97 Allowed 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.176 2.584 . . . . 0.0 113.802 -174.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 72.71 -36.6 0.36 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.53 114.24 3.14 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.098 0.475 . . . . 0.0 111.996 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -70.18 173.05 7.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.284 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -132.19 -78.35 0.5 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.903 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -129.72 133.07 46.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.962 0.411 . . . . 0.0 111.047 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.4 t -108.09 -61.57 2.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.33 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 68.82 133.48 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.598 0.713 . . . . 0.0 111.845 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -174.29 -52.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.02 -177.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -145.9 140.25 26.85 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.091 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -138.9 141.11 38.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.159 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 57.87 83.0 0.12 Allowed 'General case' 0 C--O 1.234 0.246 0 O-C-N 123.953 0.783 . . . . 0.0 110.929 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -64.12 142.71 58.31 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.331 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.6 t -100.52 141.64 33.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.583 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -104.28 -164.87 1.09 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.3 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -46.26 137.01 6.6 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.991 0.424 . . . . 0.0 111.724 177.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.6 t -159.29 141.11 13.36 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.913 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -108.77 30.56 6.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.656 0.741 . . . . 0.0 109.329 173.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.2 t70 57.98 54.88 5.67 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 114.069 -1.423 . . . . 0.0 111.661 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -91.52 145.06 24.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.464 172.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -105.56 155.46 19.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.813 0.34 . . . . 0.0 110.977 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -79.23 99.17 1.68 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.195 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 1.652 ' HD2' ' CD1' ' A' ' 110' ' ' PHE . 3.1 p90 -81.34 148.49 29.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.64 0.257 . . . . 0.0 110.598 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -168.28 117.38 0.72 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.208 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.6 mp -92.1 86.59 5.84 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 1.649 ' HD1' ' CD2' ' A' ' 113' ' ' PHE . 11.8 m-85 -70.77 128.67 36.86 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.007 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.807 -0.616 . . . . 0.0 110.701 -178.791 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 121.03 0.443 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 201' ' ' MET . . . . . 0.441 ' HG3' ' O ' ' A' ' 14' ' ' LEU . 0.1 OUTLIER -89.31 -176.17 5.0 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.053 -178.02 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 202' ' ' ARG . . . . . 0.449 ' HD2' ' N ' ' B' ' 202' ' ' ARG . 8.6 mpt_? -113.38 136.61 52.58 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.096 -176.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 203' ' ' TYR . . . . . 1.665 ' HD1' ' CD2' ' B' ' 203' ' ' TYR . 85.0 m-85 -71.05 3.6 3.29 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.402 0.62 . . . . 0.0 111.432 -176.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.623 ' O ' HD11 ' B' ' 208' ' ' LEU . 60.8 t -60.09 -56.76 15.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.538 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 205' ' ' ALA . . . . . 0.516 ' HA ' ' HB2' ' B' ' 208' ' ' LEU . . . -69.31 -14.53 62.98 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.729 0.299 . . . . 0.0 111.27 -176.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 8.5 m -76.61 -45.07 31.7 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 174.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 207' ' ' TYR . . . . . 0.445 ' CE2' ' HB2' ' B' ' 218' ' ' PRO . 36.1 t80 -62.87 -41.91 99.57 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 174.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.623 HD11 ' O ' ' B' ' 204' ' ' VAL . 2.7 mp -56.77 -49.25 75.85 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.523 175.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 209' ' ' LEU . . . . . 0.484 ' CD1' ' HB2' ' A' ' 11' ' ' TYR . 3.6 tp -59.39 -49.65 76.99 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.603 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -66.46 -28.44 68.59 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 211' ' ' ALA . . . . . 0.583 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -73.94 -43.24 58.92 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.257 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 212' ' ' LEU . . . . . . . . . . . . . 4.3 pp -75.15 -35.64 61.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.765 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . 0.581 ' HA2' ' CG2' ' A' ' 37' ' ' VAL . . . -124.02 47.55 1.01 Allowed Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.312 -0.947 . . . . 0.0 114.07 -172.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . -175.95 -66.63 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.206 0 C-N-CA 119.683 -1.246 . . . . 0.0 113.309 176.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 215' ' ' ASN . . . . . 0.583 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 54.9 t30 -153.12 149.28 27.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.91 0.386 . . . . 0.0 110.533 -173.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 7.6 m -71.45 -18.52 62.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.256 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 17.6 p -125.76 69.99 65.05 Favored Pre-proline 0 N--CA 1.443 -0.808 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.848 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . 0.445 ' HB2' ' CE2' ' B' ' 207' ' ' TYR . 76.3 Cg_exo -54.18 135.83 65.94 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.072 2.515 . . . . 0.0 112.162 178.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 15.9 m -107.84 154.18 21.93 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.789 -177.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -49.22 -49.26 43.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.13 0.49 . . . . 0.0 111.757 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -64.76 -32.28 73.89 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.116 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -70.47 -43.64 69.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.898 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 1.8 mp -61.74 -39.56 83.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.252 0.549 . . . . 0.0 109.75 174.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 224' ' ' LYS . . . . . 0.439 ' HZ3' ' HB3' ' B' ' 236' ' ' ASP . 72.7 tttt -60.33 -38.1 82.67 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.564 177.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . 0.648 ' O ' ' HD3' ' B' ' 225' ' ' LYS . 6.4 tmtm? -70.32 -36.74 74.46 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.36 -36.52 73.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.502 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 97.2 mt -77.04 -34.37 57.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.838 0.352 . . . . 0.0 110.272 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 228' ' ' ASP . . . . . 0.485 ' HB3' ' HA ' ' B' ' 225' ' ' LYS . 0.8 OUTLIER -56.01 -36.23 67.7 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.377 173.707 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 23.8 m -55.81 -46.89 77.96 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.789 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 1.2 m -90.06 -4.08 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 83.33 29.3 33.75 Favored Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.293 176.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 41.9 mt -98.07 130.84 46.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 176.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -77.59 159.43 29.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.658 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -154.66 121.35 5.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.491 -175.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . 0.443 ' HB3' ' OD1' ' B' ' 237' ' ' ASP . 5.0 m-20 -66.7 111.2 3.56 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 171.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 236' ' ' ASP . . . . . 0.467 ' HA ' ' HB3' ' B' ' 239' ' ' LEU . 2.5 p30 -69.21 -16.92 63.72 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.71 -174.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 237' ' ' ASP . . . . . 0.443 ' OD1' ' HB3' ' B' ' 235' ' ' ASP . 6.9 p-10 -69.48 -48.96 59.03 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 174.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.597 ' O ' HG22 ' B' ' 242' ' ' VAL . 15.9 mmt180 -66.4 -43.76 84.9 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.929 177.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 239' ' ' LEU . . . . . 0.467 ' HB3' ' HA ' ' B' ' 236' ' ' ASP . 9.6 tt -54.38 -57.58 10.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.882 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -68.12 -25.96 65.56 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 122.438 -0.163 . . . . 0.0 110.773 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -69.64 -46.07 67.0 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.266 0.555 . . . . 0.0 110.338 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 242' ' ' VAL . . . . . 0.597 HG22 ' O ' ' B' ' 238' ' ' ARG . 57.3 t -66.78 -27.82 41.13 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.679 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 39.0 mt -84.18 -25.29 7.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.935 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 63.6 p -75.21 -27.02 59.4 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.642 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -86.52 -55.96 3.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.565 0.698 . . . . 0.0 109.712 173.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . 0.676 ' O ' HD12 ' B' ' 246' ' ' LEU . 0.0 OUTLIER -90.63 111.44 22.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.919 176.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 247' ' ' ASN . . . . . 0.419 ' C ' ' H ' ' B' ' 249' ' ' LYS . 4.9 t-20 -153.99 -143.23 0.13 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -176.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -73.2 37.82 0.8 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.209 -0.519 . . . . 0.0 113.412 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . 0.419 ' H ' ' C ' ' B' ' 247' ' ' ASN . 32.7 mmtp -107.92 95.76 5.91 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . 0.45 ' HB3' ' HB3' ' B' ' 253' ' ' ASP . 16.9 m120 61.81 52.71 3.37 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.559 0.537 . . . . 0.0 110.835 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.499 ' O ' HG13 ' B' ' 254' ' ' VAL . 1.4 mm -59.92 -51.01 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -175.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -75.56 -11.6 60.05 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.974 -176.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . 0.45 ' HB3' ' HB3' ' B' ' 250' ' ' ASN . 22.6 t70 -84.31 -42.23 16.01 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 254' ' ' VAL . . . . . 0.499 HG13 ' O ' ' B' ' 251' ' ' ILE . 9.1 p -67.34 -22.35 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 255' ' ' ILE . . . . . . . . . . . . . 37.8 mt -71.97 -57.55 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.567 170.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -59.64 -36.19 75.9 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -175.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -105.13 6.2 32.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.878 0.371 . . . . 0.0 110.848 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -116.76 46.42 1.15 Allowed Glycine 0 C--O 1.229 -0.204 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.267 -174.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 259' ' ' ILE . . . . . 0.511 ' O ' HD13 ' A' ' 14' ' ' LEU . 18.9 mt -67.57 -63.76 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.92 0.391 . . . . 0.0 111.087 178.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . 0.553 ' HA2' HD22 ' A' ' 14' ' ' LEU . . . -148.32 27.43 1.38 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.069 -1.062 . . . . 0.0 112.742 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -103.95 42.15 1.22 Allowed 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 170.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 262' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.17 88.61 1.13 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.152 -1.386 . . . . 0.0 111.312 -172.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -132.71 91.25 2.88 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.789 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 35.1 p -85.7 -161.31 0.6 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.605 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 45.2 t -48.28 123.78 10.9 Favored Pre-proline 0 CA--C 1.536 0.404 0 O-C-N 123.146 0.278 . . . . 0.0 111.095 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.26 96.5 0.47 Allowed 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.806 2.337 . . . . 0.0 112.95 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . 72.92 -32.68 0.25 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.841 0.856 . . . . 0.0 113.043 172.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 117.47 -8.05 15.63 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . 90.37 -139.46 14.96 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.057 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -151.95 145.37 24.81 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 3.7 p -131.21 142.99 42.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.694 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -137.61 141.86 41.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.316 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 24.9 t -92.35 126.98 44.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.508 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 3.0 m -74.4 67.36 1.44 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.855 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -81.97 154.29 25.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.68 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -121.31 89.19 46.58 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.651 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 277' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -61.53 105.91 0.39 Allowed 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.093 2.528 . . . . 0.0 112.367 176.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 124.93 -11.09 7.83 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.922 175.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 31.9 m -102.12 167.36 10.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.851 0.358 . . . . 0.0 111.657 -177.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 63.37 64.68 0.81 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.574 172.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -130.07 91.92 37.92 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.625 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -65.48 -53.31 0.81 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.184 2.589 . . . . 0.0 112.72 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . 51.29 55.62 9.2 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.515 0.509 . . . . 0.0 112.108 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -85.91 133.46 33.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.695 -176.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -107.82 100.57 1.51 Allowed Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 121.072 -0.585 . . . . 0.0 111.839 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 24.8 p -102.13 106.12 16.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.843 0.354 . . . . 0.0 111.247 -176.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -115.25 100.69 53.94 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.416 177.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -75.0 71.22 5.08 Favored 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 123.145 2.563 . . . . 0.0 112.861 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -112.57 55.09 0.7 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.221 0.534 . . . . 0.0 110.954 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -81.39 80.47 7.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.236 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -128.41 61.74 1.47 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.428 0.632 . . . . 0.0 110.656 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -76.09 91.55 3.13 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.086 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -84.29 132.08 34.66 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.549 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -103.13 153.34 20.42 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 176.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 14.6 mmtp -114.2 78.85 1.19 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.94 0.4 . . . . 0.0 110.891 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -146.63 99.3 3.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.17 0.509 . . . . 0.0 110.351 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -137.09 164.87 27.4 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.624 178.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 298' ' ' LYS . . . . . 0.417 ' HE2' ' HG3' ' B' ' 301' ' ' GLU . 25.6 pttm -80.85 -31.24 35.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.274 -178.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 299' ' ' LYS . . . . . 0.411 ' HG3' ' N ' ' B' ' 300' ' ' GLU . 12.5 tppt? 63.37 170.08 0.15 Allowed 'General case' 0 CA--C 1.541 0.619 0 O-C-N 123.469 0.48 . . . . 0.0 111.632 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 300' ' ' GLU . . . . . 0.411 ' N ' ' HG3' ' B' ' 299' ' ' LYS . 41.4 mt-10 56.74 -108.07 0.41 Allowed 'General case' 0 C--O 1.237 0.424 0 C-N-CA 122.904 0.482 . . . . 0.0 112.021 176.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 301' ' ' GLU . . . . . 0.417 ' HG3' ' HE2' ' B' ' 298' ' ' LYS . 19.0 mm-40 48.73 68.69 0.66 Allowed 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.598 0.561 . . . . 0.0 111.98 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 19.1 p -99.53 173.0 6.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.883 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -75.4 -60.11 2.45 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 69.16 131.95 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.917 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 16.8 m -112.72 134.76 54.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.233 -173.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -86.35 70.66 10.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.795 173.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.67 -79.39 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.092 0.472 . . . . 0.0 111.311 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -143.01 118.67 10.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.445 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -100.01 43.81 1.04 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.112 0.482 . . . . 0.0 111.01 -175.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . -78.23 69.09 2.79 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.736 -177.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 60.65 26.9 16.62 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 122.859 0.464 . . . . 0.0 111.964 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . -79.0 6.79 55.2 Favored Glycine 0 CA--C 1.521 0.469 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.607 -175.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 313' ' ' LEU . . . . . 0.59 HD23 ' N ' ' B' ' 314' ' ' PHE . 0.0 OUTLIER -83.26 -22.86 32.93 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 174.13 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 314' ' ' PHE . . . . . 1.611 ' HD1' ' CD2' ' B' ' 314' ' ' PHE . 14.7 p90 32.43 46.6 0.07 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.342 1.457 . . . . 0.0 114.248 175.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 10.8 t70 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.629 -0.7 . . . . 0.0 110.054 179.71 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 ttt . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.73 21.74 12.34 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.038 0.447 . . . . 0.0 111.265 -177.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.536 ' O ' HD11 ' A' ' 7' ' ' LEU . 3.7 p -98.46 14.07 29.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.391 -177.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.5 m -69.67 -21.3 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.191 -176.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.43 ' HB3' HG21 ' A' ' 39' ' ' VAL . 2.3 m -65.34 -54.58 26.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.735 0.778 . . . . 0.0 110.065 177.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -65.6 -43.33 89.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.699 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.536 HD11 ' O ' ' A' ' 3' ' ' SER . 6.4 mp -55.71 -53.59 54.68 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.629 177.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.64 -50.55 72.8 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.488 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 45.6 t -63.69 -37.37 87.08 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.323 -176.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.435 HG13 HD11 ' A' ' 59' ' ' LEU . 0.6 OUTLIER -72.63 -40.89 62.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 120.564 0.221 . . . . 0.0 111.013 -177.749 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.528 ' HB2' ' CD2' ' B' ' 209' ' ' LEU . 21.0 m-85 -69.76 -27.86 65.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.508 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.405 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 8.9 t -64.72 -48.7 73.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.826 174.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.72 -42.5 62.29 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.636 172.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.629 ' O ' ' HE1' ' B' ' 201' ' ' MET . 95.2 mt -57.58 -59.16 5.61 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.238 0.542 . . . . 0.0 110.892 176.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.482 HG23 ' CD1' ' A' ' 31' ' ' LEU . 98.2 mt -52.29 -43.56 40.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.601 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 12' ' ' SER . 73.1 mt -75.14 -27.02 59.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.906 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -88.1 41.14 0.99 Allowed 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.836 -0.54 . . . . 0.0 111.485 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -127.1 -26.7 3.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.749 0.309 . . . . 0.0 110.683 174.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 20' ' ' GLU . 7.5 t70 -118.21 -161.87 0.86 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.424 ' H ' ' CG ' ' A' ' 19' ' ' ASP . 10.8 pt-20 -100.05 25.82 7.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.559 0.695 . . . . 0.0 110.687 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -81.19 143.49 12.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.0 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.1 p -83.06 144.8 29.66 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.825 0.345 . . . . 0.0 111.545 -177.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.9 m -91.62 48.24 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 121.146 0.498 . . . . 0.0 111.77 -176.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.0 p -84.5 159.28 20.75 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.32 -178.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -55.27 -36.53 66.2 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -54.37 -44.75 72.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.434 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.403 ' HD2' HG11 ' B' ' 230' ' ' VAL . 75.5 mmtt -77.98 -41.73 35.04 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 120.838 0.352 . . . . 0.0 110.369 -174.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.6 mt -60.13 -45.6 95.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.647 175.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.53 -36.8 84.87 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 111.364 0.135 . . . . 0.0 111.364 176.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.12 -54.17 50.02 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 120.978 0.418 . . . . 0.0 111.122 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.514 ' CD2' ' HG ' ' B' ' 209' ' ' LEU . 5.8 tt -68.93 -35.31 76.65 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.978 -178.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.65 -36.3 59.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.848 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -78.4 -30.26 47.65 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.874 0.368 . . . . 0.0 110.719 177.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.22 -31.56 72.12 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.624 172.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.12 -73.46 0.42 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.745 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.08 -49.69 0.48 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.787 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.413 HG23 HD23 ' B' ' 212' ' ' LEU . 34.7 m -81.72 154.14 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.957 0.408 . . . . 0.0 110.616 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -121.88 -174.82 2.96 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.597 -174.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.43 HG21 ' HB3' ' A' ' 5' ' ' SER . 7.6 p -151.31 137.7 12.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.842 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 12.2 pt-20 -59.39 134.4 88.49 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-O 120.533 0.206 . . . . 0.0 110.845 -175.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 40' ' ' GLU . 73.5 Cg_exo -50.66 -13.76 0.94 Allowed 'Trans proline' 0 N--CA 1.484 0.94 0 C-N-CA 124.485 3.457 . . . . 0.0 115.574 -166.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -74.47 -31.3 62.18 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.776 0.322 . . . . 0.0 110.341 -176.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.517 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 86.7 m95 -71.03 -54.3 7.55 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-O 119.058 -0.496 . . . . 0.0 111.258 176.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.517 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 50.2 Cg_exo -55.21 -37.21 94.45 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 121.73 1.62 . . . . 0.0 111.68 173.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.61 -51.04 61.23 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.821 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 56.1 mt -60.95 -44.39 97.34 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 120.635 0.255 . . . . 0.0 111.117 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.564 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 8.3 m-85 -62.81 -47.68 82.38 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.057 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.86 -34.59 76.98 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -112.33 1.07 15.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -170.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.76 -17.71 1.44 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 177.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.564 ' HB3' ' O ' ' A' ' 47' ' ' PHE . 3.4 tp -86.73 -132.42 0.06 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.441 ' H ' ' CG ' ' A' ' 51' ' ' LEU . . . 58.31 1.04 0.15 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.446 ' H ' ' C ' ' A' ' 51' ' ' LEU . 3.7 t-20 -143.22 -41.07 0.3 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.526 ' CG2' ' HA ' ' A' ' 51' ' ' LEU . 59.1 t -38.56 108.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 114.132 -1.394 . . . . 0.0 110.609 169.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -53.19 129.59 31.78 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 121.836 0.827 . . . . 0.0 109.274 176.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.517 HD12 HD22 ' A' ' 14' ' ' LEU . 7.3 tp -48.98 -38.63 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 114.25 -1.341 . . . . 0.0 113.731 -166.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.16 -28.22 68.69 Favored Glycine 0 C--O 1.242 0.597 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.434 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.4 t -65.78 -5.24 8.26 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.774 -0.213 . . . . 0.0 110.562 -177.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 31.5 mt -54.73 -38.59 67.31 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 120.812 0.339 . . . . 0.0 110.725 173.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.8 tt -82.19 4.99 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.533 0.683 . . . . 0.0 110.822 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.2 m -129.47 7.03 5.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.842 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.02 -0.54 44.72 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.969 0.414 . . . . 0.0 111.798 -173.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.9 p -82.46 -7.75 10.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.806 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.11 148.22 19.65 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.31 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.22 52.71 2.56 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.037 0.446 . . . . 0.0 110.655 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.55 -32.91 59.04 Favored Glycine 0 CA--C 1.519 0.294 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.738 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -161.3 101.71 0.2 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.734 -177.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.05 -30.53 25.43 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.782 2.321 . . . . 0.0 112.11 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 48.27 72.08 1.38 Allowed Pre-proline 0 CA--C 1.535 0.378 0 O-C-N 123.825 0.703 . . . . 0.0 112.545 177.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.64 97.73 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.153 2.569 . . . . 0.0 112.998 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.12 -43.95 97.71 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.731 174.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.6 139.92 28.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.776 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 174.84 -131.32 1.94 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.549 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.85 153.53 25.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.04 0.448 . . . . 0.0 111.46 -177.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -93.14 118.62 67.82 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.77 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -74.82 -162.0 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 123.632 2.888 . . . . 0.0 112.876 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.33 -178.61 3.53 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.14 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -75.25 -169.43 25.35 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.006 -177.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 178.59 -72.89 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.937 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.66 164.17 23.5 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.695 2.264 . . . . 0.0 112.998 -175.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -135.23 92.38 18.02 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.398 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -45.68 -43.69 18.36 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.55 2.833 . . . . 0.0 113.085 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.7 m 52.72 68.35 0.84 Allowed 'General case' 0 CA--C 1.534 0.331 0 O-C-N 123.699 0.625 . . . . 0.0 111.472 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.7 m -61.8 -27.03 68.47 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.209 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -140.11 -65.89 0.45 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.555 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 62.29 88.16 0.09 Allowed 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.77 0.669 . . . . 0.0 111.379 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 60.77 70.57 0.94 Allowed Pre-proline 0 N--CA 1.467 0.398 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.468 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -60.57 -63.18 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.287 2.658 . . . . 0.0 113.073 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -178.7 -46.69 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.031 -177.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 57.39 63.72 1.79 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 122.013 0.911 . . . . 0.0 110.849 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.23 -38.27 4.77 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.465 177.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -59.43 125.52 23.94 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.829 175.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -134.4 126.08 28.82 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.056 178.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.7 m -71.04 120.25 18.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.275 0.56 . . . . 0.0 111.504 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.46 ' OE2' ' HG3' ' A' ' 97' ' ' LYS . 9.8 tp10 -75.14 123.92 26.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.42 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -170.78 38.79 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.443 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.46 ' HG3' ' OE2' ' A' ' 95' ' ' GLU . 52.3 mtmt -58.47 136.07 57.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.825 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -113.67 145.25 41.6 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -143.97 -47.04 0.27 Allowed 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -174.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 65.18 -162.49 0.26 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.368 170.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.7 t -67.52 137.67 55.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.881 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -86.12 -161.66 0.66 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.704 175.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.48 -176.84 1.33 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 120.727 0.299 . . . . 0.0 110.577 175.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.8 m -138.37 36.67 2.28 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.361 0.6 . . . . 0.0 110.213 -176.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -108.58 1.91 21.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.411 -177.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -79.0 134.2 36.8 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.169 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 51.1 38.1 19.89 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.671 0.607 . . . . 0.0 112.48 175.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 49.4 ttm -75.23 -33.13 61.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.203 0.525 . . . . 0.0 110.997 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 146.32 -163.19 28.45 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.833 -177.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -102.95 137.67 40.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.805 0.336 . . . . 0.0 110.62 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.03 123.22 3.39 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.229 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -86.21 77.42 9.56 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.942 0.401 . . . . 0.0 110.578 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -127.31 -171.76 2.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.013 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 C--O 1.249 1.044 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.925 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 110.576 -0.157 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 201' ' ' MET . . . . . 0.641 ' SD ' ' HB3' ' B' ' 262' ' ' LEU . 25.8 ptt? -129.77 12.32 5.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.281 0.562 . . . . 0.0 110.357 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 202' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -55.84 -21.16 18.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.97 -1.014 . . . . 0.0 113.251 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 203' ' ' TYR . . . . . 1.65 ' HE1' ' CE2' ' B' ' 203' ' ' TYR . 41.9 m-85 -115.04 -31.98 5.88 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.731 -173.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.599 ' O ' HD11 ' B' ' 208' ' ' LEU . 11.7 p -66.41 -47.13 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.044 -177.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 205' ' ' ALA . . . . . 0.472 ' HA ' ' HB2' ' B' ' 208' ' ' LEU . . . -74.6 -14.71 60.81 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.538 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 37.6 m -74.83 -38.13 62.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.026 172.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 207' ' ' TYR . . . . . 0.401 ' CE1' ' HD2' ' B' ' 218' ' ' PRO . 14.5 t80 -65.16 -42.85 93.34 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 173.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.599 HD11 ' O ' ' B' ' 204' ' ' VAL . 8.1 mp -54.52 -52.12 63.02 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.784 173.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 209' ' ' LEU . . . . . 0.528 ' CD2' ' HB2' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -56.16 -48.08 77.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.443 -178.443 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -62.55 -35.3 79.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.696 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 211' ' ' ALA . . . . . 0.72 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -67.13 -57.76 6.17 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.862 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 212' ' ' LEU . . . . . 0.485 HD13 ' O ' ' B' ' 208' ' ' LEU . 0.0 OUTLIER -74.53 -14.27 60.78 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.262 -178.81 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.88 -14.91 68.53 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.661 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 129.85 1.41 5.45 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.955 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 215' ' ' ASN . . . . . 0.72 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 84.2 m-20 -113.08 95.32 5.33 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 3.9 m -57.14 -31.06 64.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.356 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 10.2 t -126.67 77.96 73.34 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.745 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . 0.401 ' HD2' ' CE1' ' B' ' 207' ' ' TYR . 52.7 Cg_exo -56.3 140.82 88.79 Favored 'Trans proline' 0 N--CA 1.476 0.452 0 C-N-CA 123.759 2.973 . . . . 0.0 113.579 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 33.6 p -107.1 146.27 31.44 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -54.49 -31.83 56.7 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.066 0.46 . . . . 0.0 111.594 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -67.99 -39.23 83.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.504 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -72.79 -39.01 67.07 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.72 -46.17 93.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 174.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -58.04 -38.89 77.11 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.483 176.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . 0.46 ' NZ ' HD13 ' B' ' 226' ' ' ILE . 14.7 ttpp -57.85 -49.5 76.46 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.626 0.25 . . . . 0.0 110.673 174.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.46 HD13 ' NZ ' ' B' ' 225' ' ' LYS . 0.6 OUTLIER -58.54 -37.28 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.938 -177.477 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 94.9 mt -75.72 -38.79 58.23 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.869 0.366 . . . . 0.0 111.238 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -69.66 -28.66 66.07 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.967 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 46.8 m -62.51 -31.65 72.45 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.654 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 230' ' ' VAL . . . . . 0.403 HG11 ' HD2' ' A' ' 27' ' ' LYS . 99.1 t -92.27 -34.75 6.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.745 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 109.91 29.58 3.76 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.007 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 11.6 mt -98.41 126.56 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -67.42 136.67 55.08 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.857 0.36 . . . . 0.0 110.198 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -138.02 114.45 10.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.177 -174.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -66.2 121.28 14.86 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -70.27 -27.22 64.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.272 -173.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -74.84 -46.96 32.99 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -64.79 -37.57 88.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.761 0.315 . . . . 0.0 110.163 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 239' ' ' LEU . . . . . . . . . . . . . 8.3 tt -58.5 -62.02 2.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.68 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -65.72 -28.71 69.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.907 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -66.09 -46.0 79.24 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 120.656 0.265 . . . . 0.0 111.488 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 242' ' ' VAL . . . . . 0.531 HG23 ' HB2' ' B' ' 203' ' ' TYR . 27.1 m -75.12 -25.73 18.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -178.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 13.5 mt -70.49 -41.86 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.248 173.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 46.7 p -70.62 -22.88 62.48 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.304 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -69.26 -46.14 67.98 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.71 171.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 2.2 pp -87.7 -17.11 32.49 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.148 -174.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -55.23 125.79 22.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.026 0.441 . . . . 0.0 111.843 -171.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 174.98 -168.79 41.53 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.688 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.98 12.37 28.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.122 0.487 . . . . 0.0 110.304 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -88.46 25.55 1.66 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.721 0.772 . . . . 0.0 110.061 -175.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.499 ' O ' HG13 ' B' ' 254' ' ' VAL . 34.2 mm -58.66 -62.75 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.768 -177.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -66.0 -29.64 70.05 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.437 -173.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.07 -51.68 66.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.166 175.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 254' ' ' VAL . . . . . 0.499 HG13 ' O ' ' B' ' 251' ' ' ILE . 8.9 p -71.09 -22.81 22.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.981 -176.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 255' ' ' ILE . . . . . . . . . . . . . 44.2 mm -75.21 -50.59 23.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.274 0.559 . . . . 0.0 110.528 173.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -71.48 -25.96 62.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.342 -173.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -140.44 46.49 1.81 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.346 0.593 . . . . 0.0 110.802 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' B' ' 254' ' ' VAL . . . -130.94 53.39 0.81 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.666 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 20.0 mt -111.26 -20.39 6.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.172 0.51 . . . . 0.0 110.625 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -121.99 21.34 7.89 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.272 -0.966 . . . . 0.0 113.309 -176.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -130.19 44.46 2.96 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.032 0.444 . . . . 0.0 110.044 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 262' ' ' LEU . . . . . 0.641 ' HB3' ' SD ' ' B' ' 201' ' ' MET . 3.6 mm? -104.7 -97.34 0.32 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.347 -174.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . 0.435 ' HB3' ' SD ' ' B' ' 201' ' ' MET . . . -79.22 -38.61 35.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.858 0.361 . . . . 0.0 111.451 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 23.1 t -158.36 154.23 26.68 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.015 -177.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 23.0 t -116.54 123.74 30.22 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.431 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -53.22 -25.05 28.55 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.816 3.01 . . . . 0.0 113.994 -176.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . 54.07 80.65 0.11 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.142 0.496 . . . . 0.0 111.778 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 128.2 -40.66 1.69 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.09 -177.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -88.29 -61.67 1.46 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.958 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -89.41 94.22 9.81 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 7.0 p -116.82 142.94 28.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.317 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -85.4 135.8 33.72 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.436 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 15.0 p -142.95 153.84 17.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 9.3 m 60.18 49.8 6.97 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.604 0.716 . . . . 0.0 110.608 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -154.02 163.86 39.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.982 -178.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . 61.48 87.42 0.13 Allowed Pre-proline 0 C--O 1.234 0.247 0 O-C-N 123.615 0.572 . . . . 0.0 111.557 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 277' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -63.97 143.74 86.01 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.023 2.482 . . . . 0.0 112.959 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -95.02 173.24 31.58 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.39 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 31.1 m -138.82 172.16 13.27 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 55.28 45.33 25.87 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.723 0.639 . . . . 0.0 111.442 175.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -70.72 140.52 86.7 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.916 -178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.14 67.69 7.56 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.792 2.328 . . . . 0.0 112.181 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -128.67 26.75 5.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.681 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -132.29 123.87 27.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.431 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -145.08 40.81 1.1 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.22 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 23.3 t -157.22 158.37 36.06 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -153.24 145.44 17.03 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.313 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.42 110.83 0.86 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.796 2.331 . . . . 0.0 112.686 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -103.32 110.86 23.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.241 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -95.1 169.54 10.03 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.943 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -82.92 -76.48 0.27 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.839 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 177.09 -65.59 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.45 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -55.97 -66.81 0.36 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.282 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . 0.502 ' O ' ' HB2' ' B' ' 295' ' ' LYS . 24.0 tptm 75.09 140.88 0.07 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.879 0.737 . . . . 0.0 110.934 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 295' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' B' ' 294' ' ' LYS . 66.3 mttm 76.0 157.46 0.19 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.593 -174.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 52.12 72.14 0.41 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.332 0.587 . . . . 0.0 111.86 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 297' ' ' GLU . . . . . 0.46 ' O ' ' HB3' ' B' ' 298' ' ' LYS . 16.7 pt-20 -67.33 161.58 24.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.574 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 298' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' B' ' 297' ' ' GLU . 23.9 ttmm 72.18 150.91 0.1 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.953 0.783 . . . . 0.0 110.818 -174.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -140.45 129.73 23.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.194 0.521 . . . . 0.0 111.353 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.39 96.01 4.75 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.396 -177.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -56.65 119.45 6.15 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.872 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 21.5 m -130.69 65.79 1.53 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.835 -174.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -116.02 18.49 15.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.314 0.578 . . . . 0.0 110.723 175.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -105.38 116.07 31.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.657 176.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 53.2 m -154.5 83.79 1.11 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.849 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.9 55.35 1.4 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.367 0.603 . . . . 0.0 110.113 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -82.65 170.65 14.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.158 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 55.11 -115.46 0.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.637 0.375 . . . . 0.0 110.7 -172.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 20.6 ttt 44.21 41.35 4.22 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.057 0.943 . . . . 0.0 112.403 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 57.66 38.91 90.04 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.944 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 59.04 72.83 0.51 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 122.813 0.445 . . . . 0.0 111.377 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . -68.08 -68.83 1.53 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.771 176.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 44.87 64.3 1.42 Allowed 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.699 0.761 . . . . 0.0 110.152 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 314' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -125.9 39.36 3.97 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.726 -166.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.289 -0.863 . . . . 0.0 109.954 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 tmt? . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 121.318 0.58 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.0 16.54 1.93 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 170.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.8 m -90.97 68.59 6.22 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 114.097 -1.411 . . . . 0.0 111.494 -171.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.497 ' O ' HD12 ' B' ' 212' ' ' LEU . 41.3 t -68.43 -34.35 65.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 122.052 0.93 . . . . 0.0 108.801 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.52 ' HB3' HG21 ' A' ' 39' ' ' VAL . 4.2 m -66.93 -54.62 20.22 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.041 -178.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.477 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 37.4 mt-10 -62.96 -37.11 85.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.573 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.422 ' HB3' ' HG ' ' B' ' 212' ' ' LEU . 4.3 mp -60.75 -50.66 72.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.384 174.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.64 -49.6 74.53 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.041 0.448 . . . . 0.0 110.799 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 48.9 t -65.56 -31.55 72.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.633 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 1.2 tp -74.73 -41.28 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.826 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 1.658 ' HD1' ' CD2' ' A' ' 11' ' ' TYR . 21.3 m-85 -64.36 -37.84 88.94 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.3 m -67.59 -46.66 71.99 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.472 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 17' ' ' HIS . . . -48.95 -52.58 23.96 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.467 176.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.67 ' O ' ' HE2' ' B' ' 201' ' ' MET . 4.1 pp -77.93 -30.23 50.39 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.797 -176.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.441 ' N ' HD13 ' A' ' 14' ' ' LEU . 9.8 mt -56.35 -40.6 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.333 0.587 . . . . 0.0 110.185 173.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.8 mt -77.25 -31.62 55.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.29 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.498 ' HB2' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -82.85 50.85 1.78 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -175.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.425 ' CG ' ' H ' ' B' ' 200' ' ' ALA . 19.5 t70 -146.32 -45.72 0.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.875 0.369 . . . . 0.0 110.775 175.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -86.87 -160.89 0.62 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.736 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -88.52 -17.09 31.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.325 0.583 . . . . 0.0 109.589 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.4 t -59.2 130.48 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.116 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.2 p -83.98 147.36 27.49 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.691 -176.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.4 m -78.05 116.05 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.601 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.424 ' OG1' ' HD3' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -150.7 162.49 40.59 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -176.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 53.0 mp0 -48.58 -54.95 12.54 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 123.369 0.418 . . . . 0.0 111.334 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -50.92 -34.81 30.1 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 124.0 0.812 . . . . 0.0 110.778 -178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.424 ' HD3' ' OG1' ' A' ' 24' ' ' THR . 14.2 mptt -78.39 -50.43 11.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.182 -175.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.42 ' O ' HD11 ' A' ' 32' ' ' ILE . 7.8 mt -64.33 -40.69 89.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.131 0.491 . . . . 0.0 110.125 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.57 -46.19 89.63 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.351 175.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.19 -46.99 87.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.148 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.8 mt -65.26 -43.55 90.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.521 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.42 HD11 ' O ' ' A' ' 28' ' ' ILE . 1.5 mp -59.09 -47.59 89.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 120.868 0.366 . . . . 0.0 110.786 176.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -71.56 -22.09 61.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.012 0.434 . . . . 0.0 110.915 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.36 -39.13 62.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.835 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.59 -47.1 10.17 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 138.96 -61.92 0.57 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 119.978 -1.106 . . . . 0.0 114.025 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.558 ' CG1' ' HA2' ' B' ' 213' ' ' GLY . 8.3 p -61.03 129.77 24.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.216 0.531 . . . . 0.0 111.912 -175.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -105.72 104.98 14.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.375 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.52 HG21 ' HB3' ' A' ' 5' ' ' SER . 3.1 p -76.12 140.89 16.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.322 172.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 11.4 pt-20 -52.94 125.93 41.25 Favored Pre-proline 0 CA--C 1.531 0.242 0 O-C-N 123.212 0.32 . . . . 0.0 110.593 -178.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 40' ' ' GLU . 75.7 Cg_exo -50.76 -13.19 0.75 Allowed 'Trans proline' 0 N--CA 1.485 0.98 0 C-N-CA 124.367 3.378 . . . . 0.0 115.229 -167.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -68.76 -35.07 76.62 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.48 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 76.6 m95 -69.59 -54.22 11.17 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.007 177.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 83.3 Cg_exo -50.85 -48.54 20.33 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 122.223 1.949 . . . . 0.0 112.868 175.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.47 -47.65 87.82 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.216 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.2 tp -58.68 -49.5 77.33 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 1.637 ' HD2' ' CD1' ' A' ' 47' ' ' PHE . 2.6 m-85 -54.04 -54.94 32.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.867 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.2 -39.41 92.66 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -175.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -88.49 -12.21 43.6 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.88 -18.23 14.11 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.625 ' HA ' HG22 ' A' ' 54' ' ' VAL . 26.6 mt -83.89 -131.99 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 119.331 -0.948 . . . . 0.0 109.98 177.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 59.3 7.42 0.91 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.17 0.51 . . . . 0.0 111.979 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -143.56 -42.15 0.29 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.625 HG22 ' HA ' ' A' ' 51' ' ' LEU . 7.5 t -54.88 115.84 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.609 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.245 177.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -53.63 152.6 5.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.697 171.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.699 ' O ' HD13 ' A' ' 59' ' ' LEU . 2.0 tp -46.5 -71.87 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -174.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.17 -23.8 66.55 Favored Glycine 0 C--O 1.24 0.516 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.781 -172.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.3 t -59.54 -21.24 59.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.236 -0.482 . . . . 0.0 110.579 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.699 HD13 ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -59.18 -19.24 43.56 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.567 -177.454 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.568 ' N ' HD11 ' A' ' 59' ' ' LEU . 48.1 mt -64.96 -27.59 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 121.173 -0.211 . . . . 0.0 111.32 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 75.2 m -139.26 23.4 2.55 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -175.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -132.82 51.32 2.17 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.409 HG12 ' CZ3' ' A' ' 43' ' ' TRP . 85.4 t -72.03 -42.56 68.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.063 0.458 . . . . 0.0 110.255 173.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -92.65 21.45 38.74 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.506 -177.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 58.61 -156.02 0.34 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 122.495 0.318 . . . . 0.0 111.14 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 137.36 -105.78 0.52 Allowed Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.135 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 146.6 115.01 0.88 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.486 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -72.48 102.8 1.44 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.794 2.329 . . . . 0.0 111.876 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 57.27 74.14 0.7 Allowed Pre-proline 0 N--CA 1.463 0.217 0 O-C-N 123.416 0.448 . . . . 0.0 111.088 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -60.23 -21.92 68.38 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.042 2.495 . . . . 0.0 113.598 -175.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.29 -30.27 68.32 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.693 0.282 . . . . 0.0 111.553 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 66.09 4.05 2.92 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.354 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.41 153.75 21.38 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.621 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.17 115.37 16.93 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.442 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -146.49 145.05 22.18 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.229 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 24.3 Cg_exo -68.05 -10.74 29.85 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.241 2.627 . . . . 0.0 113.205 -178.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 70.4 173.05 0.31 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.011 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.93 -169.94 31.46 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.11 178.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.28 -74.41 0.41 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.9 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.45 137.34 77.41 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.78 2.32 . . . . 0.0 112.828 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -107.66 152.27 41.41 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.401 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -38.86 -53.12 2.0 Allowed 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 123.748 2.965 . . . . 0.0 113.294 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.0 m 58.91 38.35 24.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.181 0.515 . . . . 0.0 111.177 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 p -102.16 -4.18 26.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.805 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 63.51 -171.74 0.17 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.434 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -165.92 67.33 0.12 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.48 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -117.59 99.18 52.32 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.94 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -57.35 142.2 94.92 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.15 2.567 . . . . 0.0 112.605 176.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.31 50.01 1.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.96 0.41 . . . . 0.0 111.124 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -83.94 120.73 26.45 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.606 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -62.01 -58.74 6.72 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.498 175.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.545 ' HB3' ' HZ2' ' A' ' 92' ' ' LYS . 8.0 ttpm? -179.31 -60.03 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.378 -176.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.457 ' HZ3' ' HB2' ' A' ' 93' ' ' LYS . 3.6 ttmp? 70.92 141.76 0.05 Allowed 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.983 0.802 . . . . 0.0 110.368 -174.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.7 t -74.81 99.53 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.995 -175.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -83.27 121.08 26.64 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.946 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -159.39 117.86 2.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.162 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp 63.77 145.99 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.475 0.71 . . . . 0.0 111.929 -176.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.5 pttt -161.8 -47.83 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.524 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -167.05 117.96 0.9 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -148.65 135.07 19.53 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.608 -173.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 68.7 m -149.71 80.98 1.39 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.227 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -76.77 133.69 39.36 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -54.74 127.85 30.15 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.039 -175.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.1 p -133.9 177.92 7.35 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.727 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -96.57 -166.09 1.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -79.92 152.42 29.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -92.26 114.51 27.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.107 0.48 . . . . 0.0 111.037 -176.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 87.5 mtp -129.96 136.26 49.25 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.974 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -81.48 159.05 40.27 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.583 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -83.85 179.43 7.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.692 0.282 . . . . 0.0 110.796 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.08 -2.36 61.46 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.638 -176.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 53.0 tp -72.28 -29.8 64.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.338 0.59 . . . . 0.0 110.024 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 1.645 ' HD1' ' CD2' ' A' ' 113' ' ' PHE . 27.4 p90 -105.32 153.08 22.11 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.012 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.3 t70 . . . . . 0 C--O 1.248 0.978 0 O-C-N 124.52 1.137 . . . . 0.0 110.066 -176.717 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 200' ' ' ALA . . . . . 0.425 ' H ' ' CG ' ' A' ' 18' ' ' ASP . . . . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 120.701 0.286 . . . . 0.0 110.8 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 201' ' ' MET . . . . . 0.67 ' HE2' ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -124.4 156.03 37.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.625 -176.805 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 202' ' ' ARG . . . . . 0.427 ' HG3' ' H ' ' B' ' 203' ' ' TYR . 13.9 ptp180 -177.09 -64.48 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.774 -0.193 . . . . 0.0 110.917 177.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 203' ' ' TYR . . . . . 1.61 ' HD2' ' CD1' ' B' ' 203' ' ' TYR . 4.3 m-85 -57.34 -33.3 67.6 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.573 0.349 . . . . 0.0 111.654 -177.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.745 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 3.8 m -52.84 -54.45 16.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.295 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 205' ' ' ALA . . . . . 0.465 ' CB ' HD12 ' A' ' 14' ' ' LEU . . . -80.14 -15.52 56.91 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.126 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 206' ' ' SER . . . . . 0.488 ' CB ' HG21 ' B' ' 223' ' ' ILE . 14.9 m -68.14 -42.17 80.51 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 170.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 207' ' ' TYR . . . . . 0.448 ' CD1' HD12 ' B' ' 251' ' ' ILE . 24.1 t80 -66.27 -40.25 90.0 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.268 174.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.745 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 54.3 mt -63.12 -36.01 82.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.544 176.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 209' ' ' LEU . . . . . . . . . . . . . 1.2 mp -62.37 -44.8 95.63 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.855 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -56.58 -39.15 73.0 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.501 177.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 211' ' ' ALA . . . . . . . . . . . . . . . -87.12 -63.35 1.32 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 212' ' ' LEU . . . . . 0.497 HD12 ' O ' ' A' ' 4' ' ' VAL . 3.4 tm? -54.11 -39.82 66.76 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . 0.558 ' HA2' ' CG1' ' A' ' 37' ' ' VAL . . . -52.39 -20.42 7.21 Favored Glycine 0 C--N 1.33 0.244 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.165 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 99.4 26.68 8.55 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.147 174.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 215' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -117.48 -29.47 5.8 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.959 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 37.9 m 60.66 35.08 19.93 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.027 172.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 217' ' ' SER . . . . . 0.43 ' C ' ' H ' ' B' ' 219' ' ' SER . 32.2 p -120.03 104.48 43.89 Favored Pre-proline 0 C--N 1.314 -0.968 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.275 -172.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -70.9 19.22 0.23 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.929 2.42 . . . . 0.0 113.256 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 219' ' ' SER . . . . . 0.43 ' H ' ' C ' ' B' ' 217' ' ' SER . 1.1 m -63.52 119.27 9.47 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.436 0.636 . . . . 0.0 110.46 -176.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . 0.422 ' O ' HD13 ' B' ' 239' ' ' LEU . . . -56.2 -29.35 60.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.86 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -73.46 -30.11 62.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.495 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 222' ' ' ASP . . . . . 0.419 ' CG ' ' HB2' ' B' ' 219' ' ' SER . 93.5 m-20 -70.94 -43.93 67.17 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.488 HG21 ' CB ' ' B' ' 206' ' ' SER . 1.8 mp -58.69 -52.42 60.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-O 121.056 0.455 . . . . 0.0 110.013 174.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -56.5 -40.83 75.62 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.878 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -65.23 -37.48 87.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.284 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 1.1 mp -62.58 -42.83 97.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.539 175.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 66.0 mt -75.83 -35.71 59.89 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.447 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.37 -20.7 62.94 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.723 0.297 . . . . 0.0 110.72 177.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 16.2 t -58.26 -26.87 63.45 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.313 0.577 . . . . 0.0 109.559 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 98.8 t -110.11 -39.51 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.025 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 108.35 27.03 5.19 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.545 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 5.3 mt -83.28 147.4 5.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -57.81 114.48 2.32 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.124 0.488 . . . . 0.0 112.075 -174.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . 0.48 ' HB2' ' OH ' ' B' ' 203' ' ' TYR . . . -138.66 91.01 2.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.248 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -73.24 155.38 39.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.36 -177.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 236' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' B' ' 239' ' ' LEU . 24.0 t70 -69.01 -48.34 63.26 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.635 0.255 . . . . 0.0 111.425 -175.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 237' ' ' ASP . . . . . 0.698 ' O ' ' HB2' ' B' ' 241' ' ' LYS . 8.0 t70 -58.56 -54.39 47.6 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.392 0.615 . . . . 0.0 109.627 176.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.6 ' O ' HG23 ' B' ' 242' ' ' VAL . 25.0 ttm180 -58.6 -31.92 68.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.149 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 239' ' ' LEU . . . . . 0.798 ' HA ' ' CE2' ' B' ' 203' ' ' TYR . 3.0 tp -50.6 -76.52 0.02 OUTLIER 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.353 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -73.78 -20.14 60.56 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.528 -174.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 241' ' ' LYS . . . . . 0.698 ' HB2' ' O ' ' B' ' 237' ' ' ASP . 15.9 tttt -61.71 -58.44 8.01 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-O 121.303 0.573 . . . . 0.0 110.775 176.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 242' ' ' VAL . . . . . 0.6 HG23 ' O ' ' B' ' 238' ' ' ARG . 34.1 m -73.27 -32.37 37.64 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -174.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . 0.668 ' HA ' ' CD1' ' B' ' 246' ' ' LEU . 6.9 mt -60.83 -41.61 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.609 174.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 19.5 t -63.82 -32.17 73.59 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 177.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -76.32 -48.42 20.12 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . 0.668 ' CD1' ' HA ' ' B' ' 243' ' ' ILE . 0.0 OUTLIER -88.33 -10.01 50.86 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.433 0.56 . . . . 0.0 112.338 -173.115 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 247' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' B' ' 243' ' ' ILE . 63.5 t30 -44.69 -73.22 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 O-C-N 123.688 0.617 . . . . 0.0 111.725 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 58.55 -163.53 9.52 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.51 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -135.62 20.94 3.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.298 0.57 . . . . 0.0 109.734 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -115.81 38.78 3.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.411 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.487 ' O ' HG11 ' B' ' 254' ' ' VAL . 1.1 mm -62.79 -51.36 72.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.322 -177.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -60.36 -30.36 69.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.115 0.483 . . . . 0.0 109.771 -177.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -76.09 -51.91 11.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.942 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 254' ' ' VAL . . . . . 0.487 HG11 ' O ' ' B' ' 251' ' ' ILE . 9.5 p -57.88 -30.7 38.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.758 0.313 . . . . 0.0 110.888 -177.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 255' ' ' ILE . . . . . . . . . . . . . 64.9 mt -85.05 -47.32 17.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.481 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -68.17 -15.32 63.53 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -176.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -57.28 -70.83 0.11 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.917 175.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 176.84 -99.72 0.13 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.243 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 5.4 mp -93.51 -33.47 5.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 176.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' B' ' 262' ' ' LEU . . . 102.05 174.58 27.77 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.946 174.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 18.8 pttm -81.56 39.42 0.54 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.433 0.635 . . . . 0.0 110.186 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 262' ' ' LEU . . . . . 0.429 HD23 ' CG2' ' B' ' 204' ' ' VAL . 6.4 mt -99.15 -49.11 4.6 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.387 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -126.58 54.76 1.57 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.603 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 22.7 t -107.68 154.71 21.08 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.078 0.466 . . . . 0.0 110.695 -176.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 17.9 t -114.67 119.78 38.9 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.844 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.54 -24.22 30.94 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.453 2.102 . . . . 0.0 112.348 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . 59.69 -155.95 0.35 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.463 177.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . -79.57 68.5 3.17 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.436 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -70.27 -26.92 73.53 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 121.265 -0.493 . . . . 0.0 112.29 178.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -77.75 88.41 4.0 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.013 0.435 . . . . 0.0 110.488 178.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 44.2 t -106.01 145.98 13.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.902 -178.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -143.44 160.57 40.34 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.915 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.52 130.33 67.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.907 0.384 . . . . 0.0 110.223 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 7.0 p -120.94 95.75 4.83 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.153 0.501 . . . . 0.0 110.778 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -93.58 135.68 34.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.629 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -97.04 123.84 51.82 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.371 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 277' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -74.28 109.36 2.88 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.708 2.272 . . . . 0.0 112.041 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -125.34 85.59 0.35 Allowed Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.616 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 19.4 m -152.28 -176.85 5.86 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -177.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 62.58 64.33 0.93 Allowed 'General case' 0 C--N 1.331 -0.211 0 O-C-N 124.024 0.828 . . . . 0.0 111.847 174.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -112.65 99.44 47.64 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.593 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.46 116.69 2.01 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.087 2.524 . . . . 0.0 112.455 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -116.31 27.81 8.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.037 0.446 . . . . 0.0 110.785 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -148.04 162.39 39.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.661 -177.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -163.91 141.79 7.36 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 31.3 p -93.48 98.78 11.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.696 0.284 . . . . 0.0 111.393 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -85.88 133.25 41.79 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.288 175.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -81.06 63.78 8.8 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.611 2.207 . . . . 0.0 112.419 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -99.27 77.81 2.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.849 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -93.09 -5.95 49.18 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.186 0.517 . . . . 0.0 111.08 178.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . 64.3 64.38 0.72 Allowed 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.802 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -72.46 -3.42 24.2 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.514 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -59.57 107.16 0.55 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.513 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -124.45 123.06 39.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.223 0.535 . . . . 0.0 111.009 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -126.69 136.43 52.45 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.371 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 61.41 57.35 2.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.545 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -80.27 -15.18 57.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.363 0.601 . . . . 0.0 109.592 174.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 298' ' ' LYS . . . . . 0.515 ' O ' ' HD2' ' B' ' 298' ' ' LYS . 0.0 OUTLIER -76.75 143.08 40.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.138 -178.456 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -155.4 28.96 0.39 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.808 -177.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -127.26 -66.82 0.87 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 53.59 47.28 24.26 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.898 176.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 9.2 p -108.09 128.91 55.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.931 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -118.6 -78.82 0.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.148 0.499 . . . . 0.0 110.418 -177.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -127.25 151.61 48.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.199 -176.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 20.2 m -84.21 140.53 31.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.796 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -140.11 83.26 1.91 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.606 0.717 . . . . 0.0 109.539 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -129.15 120.74 26.36 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.833 -175.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.7 120.33 18.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.963 0.411 . . . . 0.0 110.782 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 24.5 ptp -80.5 -9.2 59.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.699 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . -63.58 -30.26 77.08 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.42 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -105.57 11.58 32.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.02 0.438 . . . . 0.0 110.308 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 312' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' B' ' 314' ' ' PHE . . . -148.53 39.64 0.96 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.839 -176.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 313' ' ' LEU . . . . . 0.525 HD22 ' H ' ' B' ' 313' ' ' LEU . 2.3 pt? -80.22 43.73 0.64 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 122.296 1.046 . . . . 0.0 110.476 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 314' ' ' PHE . . . . . 1.626 ' HE1' ' CE2' ' B' ' 314' ' ' PHE . 90.8 m-85 -126.64 -40.6 1.91 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.172 -1.376 . . . . 0.0 110.273 -176.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 36.3 t70 . . . . . 0 C--O 1.247 0.937 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.281 -179.954 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.451 ' H2 ' ' CD ' ' B' ' 252' ' ' GLU . 11.4 mmt . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 120.691 0.281 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.1 154.8 17.68 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.484 ' O ' HD11 ' A' ' 7' ' ' LEU . 23.1 p 44.03 60.13 2.88 Favored 'General case' 0 C--O 1.239 0.527 0 O-C-N 123.897 0.748 . . . . 0.0 112.162 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.425 ' HA ' ' HB2' ' A' ' 7' ' ' LEU . 3.5 m -67.26 -16.74 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.557 -177.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.45 ' HB2' HG21 ' A' ' 39' ' ' VAL . 3.3 p -64.77 -62.02 1.82 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.558 176.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -58.2 -45.42 87.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.12 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.484 HD11 ' O ' ' A' ' 3' ' ' SER . 7.0 mp -51.47 -58.01 7.45 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.621 176.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.42 -47.12 76.45 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.065 -177.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 49.1 t -65.98 -34.67 78.64 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.948 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -74.03 -33.65 36.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.617 0.246 . . . . 0.0 111.234 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 1.664 ' HE1' ' CE2' ' A' ' 11' ' ' TYR . 21.4 m-85 -79.06 -23.62 44.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.187 0.518 . . . . 0.0 110.025 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.45 ' HA ' HD21 ' A' ' 31' ' ' LEU . 19.3 t -68.89 -47.24 66.35 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 171.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.5 -42.09 63.99 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.712 172.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 20.0 mt -58.54 -54.49 46.43 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 120.922 0.391 . . . . 0.0 111.108 176.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.44 HD13 HD22 ' A' ' 31' ' ' LEU . 10.3 mt -59.54 -40.76 82.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.166 -177.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.8 mt -77.83 -22.56 49.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.459 ' HB3' ' HE3' ' B' ' 201' ' ' MET . 25.1 t-80 -61.87 -36.35 80.97 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.606 ' HB2' ' HG3' ' B' ' 201' ' ' MET . 31.8 t70 -73.28 -69.7 0.41 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -168.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 21' ' ' VAL . 23.1 t70 -64.83 148.1 51.95 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.088 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -77.23 46.24 0.49 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.903 0.859 . . . . 0.0 110.451 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.48 ' H ' ' C ' ' A' ' 19' ' ' ASP . 9.9 p -81.3 157.37 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.303 175.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.6 t -59.02 -20.16 50.51 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -168.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.6 t 55.14 78.45 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 121.403 0.62 . . . . 0.0 109.732 -175.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.1 p -136.05 168.17 19.86 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -174.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -51.55 -48.06 63.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.568 -1.197 . . . . 0.0 110.707 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -52.45 -39.29 60.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.197 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.418 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 2.8 mptp? -80.88 -41.35 23.25 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.431 -173.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.8 mt -64.03 -45.39 96.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.054 174.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -60.17 -40.9 91.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.696 178.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.29 -52.55 65.17 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 111.394 177.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.472 HD11 ' CG2' ' B' ' 230' ' ' VAL . 45.4 tp -66.54 -40.98 89.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.265 0.555 . . . . 0.0 111.182 -176.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.73 -37.21 78.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.399 177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -74.4 -29.11 61.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 0.0 110.137 177.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.51 -45.86 92.42 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.582 175.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.435 ' HA ' HD12 ' B' ' 226' ' ' ILE . . . -80.74 -33.06 35.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.797 0.332 . . . . 0.0 111.547 177.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.52 23.43 28.75 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.812 173.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.5 t -94.89 130.15 44.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 117.327 0.563 . . . . 0.0 110.708 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -79.72 90.8 5.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.98 -177.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.45 HG21 ' HB2' ' A' ' 5' ' ' SER . 10.7 p -98.52 130.09 47.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 169.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -63.28 136.49 96.72 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.04 -177.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -48.75 -14.08 0.34 Allowed 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 124.716 3.611 . . . . 0.0 115.021 -171.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.19 -36.87 77.76 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -177.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -67.44 -58.96 7.77 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 121.011 -0.275 . . . . 0.0 111.359 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.54 -46.1 35.95 Favored 'Trans proline' 0 C--N 1.361 1.237 0 C-N-CA 122.286 1.991 . . . . 0.0 112.754 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.73 -45.99 95.11 Favored Glycine 0 C--O 1.242 0.639 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.033 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.4 tp -51.99 -59.37 4.43 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 176.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -58.99 -40.39 84.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.711 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.0 -44.61 91.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.217 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -95.62 -11.7 26.81 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.772 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.546 ' O ' HG22 ' A' ' 54' ' ' VAL . . . -104.15 -12.28 16.81 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -175.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.577 ' HA ' HG21 ' A' ' 54' ' ' VAL . 42.9 mt -101.79 -132.34 0.27 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.429 173.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 65.96 -12.61 0.17 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 51' ' ' LEU . 11.8 m120 -144.69 12.74 1.49 Allowed 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.577 HG21 ' HA ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -128.23 120.81 54.24 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.944 -170.082 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -55.07 155.52 4.57 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.034 -1.439 . . . . 0.0 112.448 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.536 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 3.7 tp -44.53 -41.91 2.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -173.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -54.29 -23.81 27.31 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 121.611 -0.328 . . . . 0.0 113.494 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.6 t -53.84 -26.71 25.69 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 122.542 0.337 . . . . 0.0 111.264 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 34.3 mt -56.9 -36.06 69.71 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.664 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.404 HG12 HD11 ' B' ' 259' ' ' ILE . 1.1 mp -103.27 18.38 4.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.445 0.64 . . . . 0.0 109.539 -175.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 69.7 m -119.91 -6.53 10.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.393 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -100.56 -17.4 17.11 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.145 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.8 m -84.74 -3.9 8.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.879 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 166.39 148.0 5.41 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -129.08 -179.67 5.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.586 0.232 . . . . 0.0 110.624 -177.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.16 -139.5 5.36 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.185 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -98.91 165.95 21.17 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.151 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -76.36 60.3 6.36 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 122.819 2.346 . . . . 0.0 112.439 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.405 ' HB1' ' HD3' ' A' ' 70' ' ' PRO . . . -102.58 -48.52 0.17 Allowed Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -177.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.405 ' HD3' ' HB1' ' A' ' 69' ' ' ALA . 6.4 Cg_exo -73.23 92.46 0.83 Allowed 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 121.992 1.795 . . . . 0.0 112.665 -177.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -120.01 134.09 55.35 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.56 177.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -129.69 115.11 16.85 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.871 -177.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.08 149.39 18.72 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.017 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.7 136.33 33.0 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.406 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -126.43 135.07 26.69 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.83 -177.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 38.1 Cg_exo -65.12 129.15 22.22 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.403 2.735 . . . . 0.0 112.974 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 71.01 176.65 0.28 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.003 176.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 176.42 105.86 0.19 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.945 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.94 76.9 1.28 Allowed Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.559 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -90.71 103.0 0.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.975 2.45 . . . . 0.0 112.032 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -122.7 85.38 49.3 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.282 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.23 -66.54 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.635 2.223 . . . . 0.0 111.949 175.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.9 m 54.73 45.31 26.99 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.111 0.481 . . . . 0.0 111.674 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 46.5 p -83.51 107.26 15.87 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.144 178.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -112.53 -36.92 5.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.041 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.28 123.78 23.03 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.066 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.58 158.84 45.94 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.065 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -49.34 -37.98 41.69 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.644 2.229 . . . . 0.0 113.685 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 73.36 -55.16 0.68 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.696 0.798 . . . . 0.0 112.869 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 66.47 85.94 0.14 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.323 0.583 . . . . 0.0 111.459 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -100.99 161.29 13.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.464 177.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.1 mttt 54.38 64.83 1.68 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.794 0.684 . . . . 0.0 111.543 173.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -117.62 128.3 54.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.931 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.9 p -110.41 140.36 29.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.55 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' A' ' 96' ' ' ALA . 6.7 tt0 -105.37 -176.27 3.03 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.404 ' H ' ' HG2' ' A' ' 95' ' ' GLU . . . 79.37 170.01 0.18 Allowed 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.035 0.934 . . . . 0.0 110.838 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -129.64 142.03 50.81 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.051 -174.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.8 mptt 69.26 -85.76 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.994 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 54.67 -148.04 0.49 Allowed 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.495 0.497 . . . . 0.0 110.776 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -66.43 143.49 57.08 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.988 0.423 . . . . 0.0 110.725 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.5 m -154.05 106.67 2.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.137 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -90.57 -71.62 0.61 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.538 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 65.41 107.13 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.958 0.786 . . . . 0.0 111.488 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.6 p -80.48 147.35 30.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.692 -177.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 64.61 91.3 0.08 Allowed 'General case' 0 C--O 1.233 0.211 0 O-C-N 123.923 0.765 . . . . 0.0 112.334 175.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -58.13 -61.16 2.76 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.175 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 54.34 57.08 6.17 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.051 0.453 . . . . 0.0 111.209 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 53.2 ttp -61.22 -30.07 70.22 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.832 175.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.66 -91.65 1.74 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.792 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -79.69 111.1 15.66 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.15 0.5 . . . . 0.0 111.387 -175.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.26 54.57 0.16 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.099 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 67.4 mt -111.9 -2.31 15.21 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.695 0.283 . . . . 0.0 110.888 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -132.91 10.12 4.22 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.722 -173.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.295 -0.859 . . . . 0.0 110.768 -176.097 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 201' ' ' MET . . . . . 0.606 ' HG3' ' HB2' ' A' ' 18' ' ' ASP . 73.9 mtm -54.37 -33.0 58.26 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.322 -173.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 202' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' B' ' 201' ' ' MET . 55.8 ttt180 175.69 154.08 0.17 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 172.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 203' ' ' TYR . . . . . 1.641 ' HE2' ' CE1' ' B' ' 203' ' ' TYR . 67.5 m-85 -76.8 10.69 2.07 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.578 0.704 . . . . 0.0 110.944 -175.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.649 ' O ' HD11 ' B' ' 208' ' ' LEU . 94.3 t -59.67 -62.1 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.158 177.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 205' ' ' ALA . . . . . 0.604 ' O ' ' HG ' ' B' ' 209' ' ' LEU . . . -61.7 -21.49 64.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.561 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 206' ' ' SER . . . . . 0.404 ' CB ' HG21 ' B' ' 223' ' ' ILE . 5.7 m -66.87 -47.9 70.45 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.003 0.43 . . . . 0.0 109.88 173.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 207' ' ' TYR . . . . . 1.659 ' HD2' ' CD1' ' B' ' 207' ' ' TYR . 34.0 t80 -59.98 -38.89 83.87 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.65 ' O ' ' HG ' ' B' ' 212' ' ' LEU . 9.3 mp -56.57 -56.49 20.7 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.778 175.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 209' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' B' ' 205' ' ' ALA . 58.0 mt -52.36 -47.5 66.1 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 123.532 0.52 . . . . 0.0 111.066 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -63.98 -32.81 74.49 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.264 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 211' ' ' ALA . . . . . 0.645 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -68.8 -44.82 72.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.494 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 212' ' ' LEU . . . . . 0.65 ' HG ' ' O ' ' B' ' 208' ' ' LEU . 15.1 mt -64.81 -29.01 69.96 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.733 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -62.68 -7.18 14.13 Favored Glycine 0 C--N 1.337 0.603 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.957 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 110.66 20.82 7.1 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.485 174.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 215' ' ' ASN . . . . . 0.645 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 27.5 m-80 -130.32 111.67 12.59 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 6.3 m -65.89 -20.77 66.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.279 0.561 . . . . 0.0 110.684 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 12.0 p -123.71 70.58 47.9 Favored Pre-proline 0 N--CA 1.443 -0.806 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.859 -175.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . 0.491 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 50.4 Cg_exo -60.39 135.68 63.02 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.069 2.512 . . . . 0.0 112.599 173.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 49.4 m -102.66 157.22 17.09 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.736 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -51.4 -41.68 60.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.198 0.523 . . . . 0.0 111.224 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -60.79 -42.55 97.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.972 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -67.82 -39.55 83.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.506 -177.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.421 HD12 ' CB ' ' B' ' 218' ' ' PRO . 1.7 mp -68.03 -39.8 82.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 120.867 0.365 . . . . 0.0 110.553 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -62.07 -42.99 99.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.953 0.406 . . . . 0.0 110.35 176.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 16.6 ttpp -64.42 -39.57 94.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.371 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -62.65 -41.21 91.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.392 178.295 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.93 -45.39 61.29 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -176.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.98 -24.35 62.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.831 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 18.5 t -56.68 -42.41 78.99 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.792 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 230' ' ' VAL . . . . . 0.472 ' CG2' HD11 ' A' ' 31' ' ' LEU . 7.0 t -64.28 -29.39 47.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.526 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 105.65 10.35 31.11 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.424 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . 0.417 HD11 HG22 ' B' ' 232' ' ' ILE . 24.9 mt -104.57 139.37 25.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -71.74 151.48 43.53 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -173.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -132.07 143.49 50.07 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.757 -176.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -91.27 114.97 27.63 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.089 0.471 . . . . 0.0 110.249 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -58.07 -51.89 67.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.407 -175.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -54.9 -56.76 16.02 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.167 0.508 . . . . 0.0 110.953 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.419 ' O ' HG11 ' B' ' 242' ' ' VAL . 18.7 mmt180 -61.39 -32.77 72.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.862 -175.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 239' ' ' LEU . . . . . . . . . . . . . 6.9 tt -61.83 -60.87 3.0 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.051 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -67.16 -29.81 69.61 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.578 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -60.12 -53.73 54.31 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 120.786 0.327 . . . . 0.0 110.94 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 242' ' ' VAL . . . . . 0.503 ' HA ' ' OE2' ' B' ' 245' ' ' GLU . 22.2 m -72.87 -25.95 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-O 121.327 0.584 . . . . 0.0 110.134 -175.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 34.9 mt -74.54 -31.18 26.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.504 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 23.3 t -64.87 -34.99 79.7 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 173.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 245' ' ' GLU . . . . . 0.503 ' OE2' ' HA ' ' B' ' 242' ' ' VAL . 36.0 mt-10 -67.42 -45.19 76.82 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.237 171.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 52.1 mt -70.61 -95.34 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.083 -177.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 58.66 174.21 0.07 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.068 0.547 . . . . 0.0 110.448 -175.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -76.14 50.54 2.73 Favored Glycine 0 CA--C 1.516 0.127 0 O-C-N 122.091 -0.381 . . . . 0.0 113.383 -173.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -109.29 -64.84 1.2 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.508 0.67 . . . . 0.0 110.21 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -103.7 8.29 37.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.413 -174.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.455 ' HA ' HG13 ' B' ' 254' ' ' VAL . 6.0 tp -57.58 -45.57 86.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.519 -173.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 252' ' ' GLU . . . . . 0.451 ' CD ' ' H2 ' ' A' ' 1' ' ' MET . 7.6 tp10 -60.58 -40.08 90.39 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.258 0.551 . . . . 0.0 110.606 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -70.03 -45.25 67.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.838 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 254' ' ' VAL . . . . . 0.455 HG13 ' HA ' ' B' ' 251' ' ' ILE . 8.9 p -66.36 -27.96 42.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.916 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 255' ' ' ILE . . . . . 0.483 HG12 ' HG ' ' B' ' 208' ' ' LEU . 96.4 mt -70.86 -52.1 30.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 121.1 0.476 . . . . 0.0 110.219 173.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -76.23 -5.36 46.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.01 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -52.59 -59.6 4.26 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.43 0.456 . . . . 0.0 111.708 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 178.73 -102.39 0.17 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.152 -1.023 . . . . 0.0 113.412 175.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 259' ' ' ILE . . . . . 0.543 ' O ' HD11 ' B' ' 262' ' ' LEU . 3.4 mp -150.5 -75.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 117.061 0.43 . . . . 0.0 112.011 -175.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -118.62 40.9 2.15 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 119.279 -1.439 . . . . 0.0 114.834 -165.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 17.4 tptt -138.36 39.08 2.27 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 168.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 262' ' ' LEU . . . . . 0.543 HD11 ' O ' ' B' ' 259' ' ' ILE . 6.6 mp -89.77 97.01 10.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.402 -1.272 . . . . 0.0 113.006 -166.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -144.43 25.14 1.53 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.852 -1.522 . . . . 0.0 109.092 175.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 11.1 t 69.68 -155.74 0.15 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.828 -172.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 5.1 p -58.92 111.55 3.83 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 121.449 0.642 . . . . 0.0 111.154 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -85.21 33.4 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.156 2.571 . . . . 0.0 113.67 -174.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . 53.09 66.48 1.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.693 177.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 97.28 -60.25 1.1 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.478 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . 101.3 -26.29 25.12 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.625 175.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -135.19 143.83 46.65 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.112 0.482 . . . . 0.0 111.778 -174.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 22.1 t -125.57 139.37 51.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.459 174.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -118.86 159.93 22.85 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.468 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 8.4 p -118.35 138.41 49.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.2 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 1.5 p -91.5 135.23 34.0 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.791 0.329 . . . . 0.0 110.763 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.55 144.91 49.4 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.251 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' B' ' 277' ' ' PRO . . . -80.12 123.91 83.12 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.904 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 277' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' ' 276' ' ' ALA . 10.7 Cg_exo -71.97 160.87 46.49 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 123.282 2.655 . . . . 0.0 113.556 -178.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -126.2 174.33 17.86 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.512 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 10.8 m -131.23 -171.15 2.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 117.074 0.437 . . . . 0.0 111.37 -175.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 66.28 64.95 0.5 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.033 172.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . 0.446 ' H ' ' HD2' ' B' ' 282' ' ' PRO . . . -124.49 -47.76 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.191 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . 0.446 ' HD2' ' H ' ' B' ' 281' ' ' ALA . 89.3 Cg_endo -88.73 -169.55 0.42 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 121.654 1.57 . . . . 0.0 112.488 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . 66.27 40.47 3.75 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.87 177.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -132.1 177.04 7.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.638 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 110.4 130.47 5.83 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.189 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 8.3 p -134.34 139.73 45.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.559 0.219 . . . . 0.0 110.867 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -143.53 106.52 5.08 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.23 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -88.8 153.73 6.08 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.68 2.253 . . . . 0.0 111.91 175.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -156.78 -68.37 0.1 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.059 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -71.67 132.1 44.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.13 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -138.49 15.91 2.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.037 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 56.02 46.86 20.97 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.581 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -61.55 125.77 24.99 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.721 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -150.3 77.58 1.31 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.926 176.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -93.58 97.0 10.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.995 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -51.38 113.41 0.95 Allowed 'General case' 0 CA--C 1.519 -0.212 0 O-C-N 123.745 0.653 . . . . 0.0 109.409 175.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -104.67 -61.84 1.41 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.828 -173.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -98.28 108.53 21.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.147 0.499 . . . . 0.0 110.704 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -110.57 142.28 42.61 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.53 175.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -81.59 115.87 21.07 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.861 0.363 . . . . 0.0 110.458 -177.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -73.96 121.29 20.78 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.741 -178.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 16.2 p -85.43 78.04 9.8 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 175.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -80.52 -33.03 36.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.891 -175.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -71.06 149.53 46.44 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.3 -176.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 13.8 m -124.94 140.73 52.65 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.464 -177.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -106.34 68.29 0.76 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.427 0.632 . . . . 0.0 110.677 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -83.22 -39.3 21.11 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.166 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -79.32 76.68 5.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.836 0.827 . . . . 0.0 112.35 -173.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 50.1 ttp -81.39 -23.52 37.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.609 172.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 127.4 132.76 3.67 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.229 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -84.02 56.27 3.64 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.205 0.526 . . . . 0.0 110.718 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . 128.21 106.37 1.31 Allowed Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.535 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 6.4 mp -100.71 8.49 43.28 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 172.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 314' ' ' PHE . . . . . 1.597 ' HD1' ' CD2' ' B' ' 314' ' ' PHE . 82.7 m-85 -87.8 -59.55 2.21 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.01 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 9.5 t70 . . . . . 0 C--O 1.252 1.226 0 CA-C-O 117.96 -1.019 . . . . 0.0 108.385 176.127 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptm . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 120.628 0.251 . . . . 0.0 110.452 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.51 -176.13 5.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.79 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.7 m 57.71 41.02 25.91 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.635 0.584 . . . . 0.0 111.021 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.9 t -65.81 -28.44 44.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.461 -174.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.492 ' HB2' HG21 ' A' ' 39' ' ' VAL . 1.5 p -61.94 -64.11 1.04 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.36 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -56.66 -49.63 74.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.577 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.412 HD21 HD11 ' B' ' 212' ' ' LEU . 7.3 mp -54.96 -44.91 74.8 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.445 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.71 -45.46 89.88 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.749 0.309 . . . . 0.0 110.949 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.87 -39.0 92.84 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.694 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 tp -73.26 -39.24 55.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.353 -176.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 1.658 ' HD1' ' CD2' ' A' ' 11' ' ' TYR . 22.1 m-30 -63.99 -42.23 97.26 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.474 ' HA ' ' CD2' ' A' ' 31' ' ' LEU . 42.1 m -60.74 -43.06 98.41 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.126 0.489 . . . . 0.0 110.011 176.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.44 -56.54 18.95 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.124 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.58 ' O ' ' HE3' ' B' ' 201' ' ' MET . 3.8 pp -78.77 -7.33 57.7 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.234 -177.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 35.5 mt -83.33 -26.26 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.178 0.513 . . . . 0.0 110.105 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.474 HD13 HG13 ' A' ' 28' ' ' ILE . 56.1 mt -100.4 -3.04 31.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.957 175.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.44 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 8.1 t-80 -31.19 -70.69 0.06 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.52 20.32 1.34 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.422 0.629 . . . . 0.0 109.435 -173.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.469 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 2.3 m-20 -83.45 54.21 2.76 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.349 -171.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 19' ' ' ASP . 9.2 pt-20 47.41 29.87 1.44 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.233 1.013 . . . . 0.0 111.913 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.403 HG22 HD12 ' B' ' 232' ' ' ILE . 73.2 t -143.71 150.54 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.205 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.4 p -88.69 142.09 27.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.96 0.41 . . . . 0.0 111.846 -176.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.6 m -75.03 39.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.047 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.5 p -74.44 151.06 39.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.002 0.43 . . . . 0.0 111.736 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.58 -31.25 70.39 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.174 -177.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -53.77 -44.32 69.96 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 123.696 0.623 . . . . 0.0 110.407 173.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -81.09 -40.83 23.49 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.096 -174.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.474 HG13 HD13 ' A' ' 16' ' ' LEU . 1.5 mt -60.27 -48.08 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 174.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -57.2 -42.84 82.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.79 175.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.77 -43.21 90.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.281 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.474 ' CD2' ' HA ' ' A' ' 12' ' ' SER . 14.3 tp -72.44 -39.79 67.57 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 120.97 0.414 . . . . 0.0 110.458 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -54.87 -43.16 66.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.29 175.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -82.54 -17.53 44.66 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.214 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.452 ' HB2' ' HA ' ' B' ' 226' ' ' ILE . . . -62.24 -47.52 84.04 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 172.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.27 -31.9 24.7 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.354 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.08 38.65 5.07 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.001 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.4 t -104.43 157.01 5.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -121.41 112.53 18.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.931 0.396 . . . . 0.0 110.782 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.492 HG21 ' HB2' ' A' ' 5' ' ' SER . 3.0 p -119.29 135.13 60.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.077 175.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.456 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 8.0 tp10 -42.95 111.41 1.02 Allowed Pre-proline 0 N--CA 1.464 0.256 0 O-C-N 123.965 0.791 . . . . 0.0 110.656 173.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -49.25 -15.01 0.61 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 124.438 3.425 . . . . 0.0 114.682 -172.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 1.669 ' HD1' ' CD2' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -69.11 -34.89 75.79 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -179.343 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.519 ' O ' ' HB2' ' A' ' 47' ' ' PHE . 95.7 m95 -68.03 -61.31 4.25 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.375 177.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.456 ' HD2' ' O ' ' A' ' 40' ' ' GLU . 13.6 Cg_endo -57.56 -38.21 94.52 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 121.913 1.742 . . . . 0.0 112.117 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.38 -59.25 9.69 Favored Glycine 0 C--O 1.24 0.481 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.786 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 27.9 tp -55.51 -47.91 75.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.722 0.296 . . . . 0.0 110.246 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.714 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -56.32 -62.19 1.88 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.462 -177.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.97 -30.18 71.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.609 -173.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -83.85 -22.85 31.57 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.559 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.17 -4.62 17.48 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -173.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.714 ' HG ' ' O ' ' A' ' 47' ' ' PHE . 73.4 mt -79.13 -131.93 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.811 176.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 68.21 -10.64 0.42 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.645 0.778 . . . . 0.0 113.086 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.403 ' H ' ' C ' ' A' ' 51' ' ' LEU . 65.7 t30 -141.18 12.03 2.18 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.6 ' CG2' ' HA ' ' A' ' 51' ' ' LEU . 31.9 t -103.08 107.46 22.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.383 -173.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -54.09 150.11 8.57 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.875 172.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.82 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 1.9 tp -52.56 -60.96 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -170.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.518 ' O ' HG23 ' A' ' 60' ' ' ILE . . . -52.96 -30.47 37.45 Favored Glycine 0 C--O 1.239 0.449 0 C-N-CA 121.043 -0.598 . . . . 0.0 113.319 -173.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.3 t -50.1 -33.43 18.64 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.911 0.484 . . . . 0.0 111.965 -176.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.82 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 0.6 OUTLIER -66.45 -14.13 61.78 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -170.915 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.518 HG23 ' O ' ' A' ' 57' ' ' GLY . 11.3 tt -82.48 -2.62 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.763 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.6 p -150.27 47.5 0.9 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.429 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.583 ' OD1' ' HA ' ' A' ' 59' ' ' LEU . 7.9 m120 -93.41 -1.04 56.26 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.7 t -84.78 -37.56 12.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -154.87 149.04 20.21 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.503 -177.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -78.9 -50.8 10.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.681 0.277 . . . . 0.0 111.215 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 151.23 -97.67 0.18 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.4 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.54 94.73 1.52 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -173.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.82 -20.73 6.37 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.355 2.037 . . . . 0.0 113.453 -174.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 55.28 79.18 0.35 Allowed Pre-proline 0 N--CA 1.467 0.419 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -72.35 158.86 50.73 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.954 2.436 . . . . 0.0 112.346 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -170.47 -33.44 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.765 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.06 122.42 25.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.298 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.29 68.29 0.44 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.852 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -127.29 140.16 52.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.679 0.276 . . . . 0.0 110.469 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.476 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -142.31 139.08 17.21 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.95 -178.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 51.4 Cg_exo -59.17 105.71 0.26 Allowed 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 123.252 2.635 . . . . 0.0 112.744 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.5 177.59 6.33 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.993 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.76 -97.58 0.25 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.383 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 117.05 100.33 2.12 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.876 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -69.62 84.08 0.65 Allowed 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.652 2.235 . . . . 0.0 111.865 178.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.429 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . . . -84.11 -48.04 0.7 Allowed Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.241 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.429 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 82.3 Cg_exo -48.98 118.15 3.3 Favored 'Trans proline' 0 C--N 1.364 1.353 0 C-N-CA 122.125 1.884 . . . . 0.0 113.201 176.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.7 p -157.3 133.36 9.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.959 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.6 m 54.74 72.4 0.47 Allowed 'General case' 0 CA--C 1.531 0.223 0 O-C-N 123.891 0.744 . . . . 0.0 111.747 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -102.08 -2.03 30.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.421 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.3 89.41 2.07 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.322 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.89 106.62 5.34 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.523 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -53.38 119.07 5.58 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.077 2.518 . . . . 0.0 112.797 177.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -121.06 63.08 0.88 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.272 177.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -100.38 118.77 37.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.676 -178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -73.28 -60.67 2.13 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.76 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -103.53 157.72 16.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.32 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -115.91 131.73 56.85 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.23 78.38 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.983 0.42 . . . . 0.0 111.065 -176.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -106.1 -36.81 6.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.965 174.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.48 166.44 13.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.053 176.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.592 ' HB2' ' HZ2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -127.52 119.74 26.72 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp 65.11 179.93 0.19 Allowed 'General case' 0 C--N 1.323 -0.568 0 O-C-N 123.918 0.761 . . . . 0.0 109.943 -172.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -89.2 77.37 7.51 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 121.201 0.524 . . . . 0.0 110.591 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -72.1 144.56 48.63 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.187 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.9 t -101.55 145.99 28.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.209 -176.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -124.68 17.37 8.76 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.853 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -61.32 143.07 56.36 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.951 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.0 p -129.8 138.78 51.22 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -173.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -77.38 92.65 3.96 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 173.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.06 129.6 42.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.028 -173.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.4 t0 50.26 45.15 26.2 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 124.032 0.833 . . . . 0.0 111.23 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 64.5 mtt 66.75 9.76 6.98 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.129 -0.942 . . . . 0.0 112.326 178.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.47 101.96 0.96 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.198 173.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 1.624 ' HD1' ' CD2' ' A' ' 110' ' ' PHE . 1.6 p90 -78.58 177.03 8.9 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 175.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.82 -20.5 24.4 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.182 -1.009 . . . . 0.0 111.927 -178.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.431 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.1 tm? -63.19 -37.71 88.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.331 0.586 . . . . 0.0 109.729 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 1.618 ' HD2' ' CD1' ' A' ' 113' ' ' PHE . 35.4 p90 -111.5 24.97 12.17 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 174.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 38.8 t70 . . . . . 0 C--O 1.251 1.153 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.575 -173.307 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 121.018 0.437 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 201' ' ' MET . . . . . 0.58 ' HE3' ' O ' ' A' ' 14' ' ' LEU . 22.4 ttt -82.11 104.13 12.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.734 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 202' ' ' ARG . . . . . 0.558 ' HB2' ' O ' ' B' ' 201' ' ' MET . 14.4 ttp180 168.37 -19.07 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 O-C-N 124.477 1.111 . . . . 0.0 110.921 176.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 203' ' ' TYR . . . . . 1.62 ' HD2' ' CD1' ' B' ' 203' ' ' TYR . 33.6 m-85 -125.43 -27.18 3.48 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -174.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.533 ' O ' HD11 ' B' ' 208' ' ' LEU . 2.4 p -57.17 -62.31 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 205' ' ' ALA . . . . . 0.575 ' HA ' ' HB2' ' B' ' 208' ' ' LEU . . . -71.81 -12.15 61.15 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.96 -177.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 3.0 m -68.3 -44.93 74.35 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 172.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 207' ' ' TYR . . . . . 0.425 ' CD1' HD12 ' B' ' 251' ' ' ILE . 24.5 t80 -63.64 -45.94 87.93 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.507 173.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.575 ' HB2' ' HA ' ' B' ' 205' ' ' ALA . 7.6 mp -52.98 -50.69 63.63 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.173 177.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 209' ' ' LEU . . . . . 0.471 HD13 ' CB ' ' A' ' 11' ' ' TYR . 1.2 tt -64.7 -46.5 82.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.808 -176.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -57.13 -37.24 71.71 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.861 176.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 211' ' ' ALA . . . . . 0.719 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -79.76 -34.85 39.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.996 0.426 . . . . 0.0 111.025 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 212' ' ' LEU . . . . . 0.412 HD11 HD21 ' A' ' 7' ' ' LEU . 50.2 tp -56.65 -51.62 68.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.003 177.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -143.65 76.03 0.3 Allowed Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.049 -1.072 . . . . 0.0 112.438 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 176.19 -72.77 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.495 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 215' ' ' ASN . . . . . 0.719 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 94.0 m-20 -134.91 138.24 43.92 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -176.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 3.7 m -67.24 -28.02 67.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.342 0.592 . . . . 0.0 110.483 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 12.5 m -127.87 74.76 78.6 Favored Pre-proline 0 N--CA 1.442 -0.833 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.8 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.52 117.43 3.81 Favored 'Trans proline' 0 N--CA 1.474 0.369 0 C-N-CA 123.388 2.725 . . . . 0.0 112.577 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 89.1 p -88.19 164.21 15.78 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.148 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -52.14 -36.16 50.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.225 0.536 . . . . 0.0 110.449 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -67.0 -40.94 87.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.654 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -63.14 -45.37 92.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.342 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 1.8 mp -67.29 -40.39 84.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.124 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 224' ' ' LYS . . . . . 0.415 ' HD3' HD23 ' B' ' 239' ' ' LEU . 11.6 mmmm -57.13 -47.23 81.64 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 175.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' B' ' 229' ' ' SER . 9.0 tmtm? -62.12 -41.72 98.52 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.452 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . 1.0 OUTLIER -63.17 -42.86 98.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.737 0.303 . . . . 0.0 110.833 178.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . 0.551 ' HG ' ' HB ' ' B' ' 232' ' ' ILE . 13.7 tp -76.93 -40.29 47.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.239 0.543 . . . . 0.0 110.116 -174.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.11 -32.34 73.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.865 176.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 229' ' ' SER . . . . . 0.48 ' HB2' ' O ' ' B' ' 225' ' ' LYS . 5.1 t -55.08 -42.61 73.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.438 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 94.0 t -79.9 -40.51 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-O 121.291 0.567 . . . . 0.0 110.629 176.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 115.94 33.97 1.45 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.033 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . 0.551 ' HB ' ' HG ' ' B' ' 227' ' ' LEU . 1.9 mm -91.38 128.29 43.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -57.41 119.63 6.82 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -110.81 128.38 55.74 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.162 0.506 . . . . 0.0 111.86 -175.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -93.1 102.7 15.03 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 174.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -55.15 -30.76 60.49 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -176.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 237' ' ' ASP . . . . . 0.423 ' OD1' ' HD3' ' B' ' 238' ' ' ARG . 6.3 t70 -62.1 -63.11 1.35 Allowed 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.494 0.664 . . . . 0.0 110.164 174.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.653 ' O ' HG21 ' B' ' 242' ' ' VAL . 20.8 mmt180 -64.46 -26.7 68.56 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.115 -175.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 239' ' ' LEU . . . . . 0.415 HD23 ' HD3' ' B' ' 224' ' ' LYS . 8.0 tp -53.54 -63.65 1.08 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.782 174.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -66.64 -24.21 66.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.379 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -66.93 -48.0 69.96 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.251 0.548 . . . . 0.0 110.818 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 242' ' ' VAL . . . . . 0.653 HG21 ' O ' ' B' ' 238' ' ' ARG . 60.4 t -69.72 -30.18 43.82 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 43.2 mt -81.89 -24.42 9.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.994 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 6.5 p -75.91 -31.8 59.33 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 121.557 -0.715 . . . . 0.0 110.428 172.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -73.28 -56.53 4.96 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.15 0.5 . . . . 0.0 110.608 169.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . 0.685 ' O ' HD12 ' B' ' 246' ' ' LEU . 0.0 OUTLIER -100.83 122.77 43.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.574 0.702 . . . . 0.0 110.079 -176.255 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -159.7 -164.79 1.39 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.528 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . 0.438 ' HA2' HG12 ' B' ' 251' ' ' ILE . . . -75.82 37.09 1.24 Allowed Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.48 -0.39 . . . . 0.0 113.876 -175.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -81.39 -57.5 3.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.093 0.473 . . . . 0.0 110.089 176.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -131.63 51.9 2.11 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.471 HD11 ' HA ' ' B' ' 251' ' ' ILE . 1.0 OUTLIER -64.81 -51.98 60.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -170.444 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -65.39 -24.31 67.19 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.397 -175.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.19 -52.68 13.22 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.102 175.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 254' ' ' VAL . . . . . 0.449 HG23 ' HA ' ' B' ' 251' ' ' ILE . 29.7 m -66.33 -19.93 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.213 -178.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 255' ' ' ILE . . . . . . . . . . . . . 38.7 mt -84.69 -42.84 16.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.714 176.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -63.64 -43.2 97.49 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -177.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -112.36 32.45 5.57 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.286 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -100.65 54.38 0.86 Allowed Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.438 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 259' ' ' ILE . . . . . 0.422 ' HB ' HG13 ' A' ' 60' ' ' ILE . 1.1 mt -120.51 -0.38 7.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.242 0.544 . . . . 0.0 111.028 177.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -70.62 -165.37 5.75 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.854 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 16.7 pttm -69.36 83.62 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.646 0.736 . . . . 0.0 109.966 174.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 262' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.84 97.84 5.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.686 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -115.75 -5.28 12.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.322 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 6.8 p -169.12 -66.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.384 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 13.5 p -144.3 137.96 14.39 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -68.54 64.15 1.18 Allowed 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.747 2.298 . . . . 0.0 113.33 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . -122.03 15.44 10.76 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.629 174.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . -107.8 25.07 22.02 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.037 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -129.29 -166.23 11.87 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 176.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -95.78 132.09 41.38 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 15.1 t -86.74 139.43 17.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.061 -177.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -95.35 80.62 3.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.885 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 96.8 t 69.43 142.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 O-C-N 124.082 0.864 . . . . 0.0 111.632 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 20.3 m -105.49 145.38 30.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.385 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -82.69 -173.88 4.9 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.06 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . 0.4 ' HA ' ' HD2' ' B' ' 277' ' ' PRO . . . 64.38 82.82 0.21 Allowed Pre-proline 0 N--CA 1.466 0.342 0 O-C-N 123.729 0.643 . . . . 0.0 110.636 -173.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 277' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' B' ' 276' ' ' ALA . 27.5 Cg_endo -60.56 137.42 73.61 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.552 2.835 . . . . 0.0 113.344 -178.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -112.54 128.78 8.64 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.935 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 66.5 m -126.07 -167.56 1.72 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.116 0.484 . . . . 0.0 111.524 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . -50.32 117.12 2.2 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.675 175.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -86.42 -43.64 0.57 Allowed Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.616 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -52.11 120.44 7.25 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 122.206 1.937 . . . . 0.0 113.256 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -107.75 147.35 30.92 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.076 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -97.04 145.3 26.1 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.607 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 132.92 -51.41 0.85 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.231 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 5.2 p -83.72 62.35 6.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.11 0.481 . . . . 0.0 110.92 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 287' ' ' ALA . . . . . 0.411 ' HB1' ' HD3' ' B' ' 288' ' ' PRO . . . -114.52 -46.33 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.982 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 288' ' ' PRO . . . . . 0.411 ' HD3' ' HB1' ' B' ' 287' ' ' ALA . 11.7 Cg_exo -71.79 158.62 52.68 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 121.88 1.72 . . . . 0.0 111.875 176.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -115.62 169.59 9.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.767 -176.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . 63.5 -178.72 0.15 Allowed 'General case' 0 C--O 1.233 0.216 0 O-C-N 124.067 0.854 . . . . 0.0 112.285 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . 57.15 71.89 0.55 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.46 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -54.35 118.14 3.87 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.933 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -83.73 134.83 34.73 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.43 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.05 157.21 43.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.323 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -127.49 95.52 4.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.858 0.361 . . . . 0.0 110.145 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -138.78 86.89 2.18 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.082 0.468 . . . . 0.0 109.768 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -135.38 140.01 44.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.823 -174.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 298' ' ' LYS . . . . . 0.446 ' HE2' ' HB2' ' B' ' 300' ' ' GLU . 87.3 tttt -156.66 115.72 3.41 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 -178.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.44 9.84 6.71 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -175.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 300' ' ' GLU . . . . . 0.446 ' HB2' ' HE2' ' B' ' 298' ' ' LYS . 37.5 mt-10 -108.86 -3.94 17.23 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -172.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -93.71 115.63 28.08 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.148 0.499 . . . . 0.0 110.382 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 16.9 m -64.95 128.05 34.12 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.718 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -44.92 -58.88 2.86 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 123.658 0.599 . . . . 0.0 111.821 -174.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -159.17 175.76 13.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.959 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 18.2 m -94.78 156.81 16.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.138 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -49.94 -63.86 0.98 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.609 0.568 . . . . 0.0 111.838 -178.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -171.62 -79.92 0.01 OUTLIER 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.741 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -113.42 149.49 34.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.496 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 23.0 mmt -114.37 31.66 6.45 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -176.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . -58.84 -31.48 68.06 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.357 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -106.1 17.48 23.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.156 0.503 . . . . 0.0 110.626 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . -138.69 34.7 2.07 Favored Glycine 0 C--O 1.229 -0.203 0 C-N-CA 121.097 -0.573 . . . . 0.0 111.689 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 17.7 tp -80.38 42.18 0.58 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.268 0.556 . . . . 0.0 110.363 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 314' ' ' PHE . . . . . 1.613 ' HE2' ' CE1' ' B' ' 314' ' ' PHE . 32.8 m-85 -134.67 -73.35 0.47 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.915 -173.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.253 1.239 0 CA-C-O 118.488 -0.768 . . . . 0.0 111.261 -174.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.0 tmm? . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.51 44.52 0.29 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.762 0.315 . . . . 0.0 111.568 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.471 ' O ' HD11 ' A' ' 7' ' ' LEU . 7.7 t 55.76 42.21 29.42 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.484 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.52 ' HA ' ' HB2' ' A' ' 7' ' ' LEU . 1.7 m -67.27 -16.06 20.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.213 0.53 . . . . 0.0 110.204 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.551 ' OG ' HG22 ' A' ' 39' ' ' VAL . 30.8 t -60.67 -67.79 0.36 Allowed 'General case' 0 C--O 1.25 1.115 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.349 176.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -66.21 -34.92 79.12 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.818 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.52 ' HB2' ' HA ' ' A' ' 4' ' ' VAL . 6.1 mp -51.27 -54.64 24.04 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.659 173.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.05 -44.46 91.82 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.501 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.421 ' SG ' ' HB3' ' A' ' 43' ' ' TRP . 57.0 m -61.07 -38.08 84.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.097 0.475 . . . . 0.0 111.302 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.663 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -72.71 -42.36 62.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.671 -178.169 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.643 ' HB2' ' CD2' ' B' ' 209' ' ' LEU . 31.2 m-85 -75.37 -21.95 57.9 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.643 -176.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.6 p -75.33 -40.36 58.43 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.238 171.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -49.38 -51.01 37.67 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.471 0.653 . . . . 0.0 109.887 169.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' A' ' 10' ' ' ILE . 56.0 mt -59.99 -49.86 76.0 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.241 -179.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.8 mt -54.54 -64.87 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.974 0.416 . . . . 0.0 111.381 178.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 86.8 mt -63.27 -24.72 67.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.316 -170.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.525 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 55.3 t-80 -63.54 -36.78 84.93 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.6 ' HB2' ' SD ' ' B' ' 201' ' ' MET . 34.3 t70 -104.0 -7.86 20.01 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.194 0.521 . . . . 0.0 111.615 -167.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.485 ' HB3' HG22 ' B' ' 232' ' ' ILE . 1.1 m-20 -85.53 37.96 0.72 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.43 -175.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 50.58 29.2 3.91 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.929 0.395 . . . . 0.0 110.723 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -136.3 148.96 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.034 -169.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.1 p -86.62 136.21 33.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.733 175.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.418 HG11 ' O ' ' A' ' 23' ' ' VAL . 7.2 p -76.44 116.6 19.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.985 0.421 . . . . 0.0 110.518 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.2 p -133.19 163.62 28.87 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.488 ' HG3' ' H ' ' A' ' 26' ' ' ASP . 6.6 pt-20 -45.29 -54.01 7.66 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.864 0.727 . . . . 0.0 111.958 -177.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.488 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 2.7 t70 -55.73 -40.06 71.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.473 -178.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -78.75 -41.57 30.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.394 -171.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.2 mt -63.47 -47.59 90.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.997 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -61.79 -33.39 74.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.265 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.77 -52.57 35.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.842 0.353 . . . . 0.0 110.891 176.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.46 HD13 HG21 ' B' ' 226' ' ' ILE . 0.2 OUTLIER -61.89 -32.31 72.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.226 0.536 . . . . 0.0 110.21 177.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.3 mp -69.47 -33.88 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.128 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -74.15 -27.74 60.98 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.052 174.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.73 -50.15 46.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.936 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.439 ' HB1' ' HB3' ' B' ' 209' ' ' LEU . . . -133.85 16.21 3.91 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -175.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.05 93.95 1.86 Allowed Glycine 0 C--N 1.314 -0.661 0 C-N-CA 120.317 -0.944 . . . . 0.0 111.657 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.7 p -56.43 -42.12 73.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 120.648 0.261 . . . . 0.0 111.537 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -160.97 127.4 3.98 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.029 0.442 . . . . 0.0 110.527 172.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.551 HG22 ' OG ' ' A' ' 5' ' ' SER . 8.0 p -165.07 120.45 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.795 178.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.414 ' C ' ' H ' ' A' ' 42' ' ' PHE . 1.7 pm0 -65.89 129.63 94.31 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.79 -8.87 0.96 Allowed 'Trans proline' 0 N--CA 1.485 0.991 0 C-N-CA 123.778 2.985 . . . . 0.0 113.755 -172.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.414 ' H ' ' C ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -69.77 -38.16 76.65 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.649 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.436 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 70.2 m95 -69.4 -55.03 10.21 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.979 177.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.436 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 85.0 Cg_exo -49.01 -51.0 11.38 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 122.364 2.043 . . . . 0.0 113.003 176.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.55 -49.6 68.23 Favored Glycine 0 C--O 1.243 0.683 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.738 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.415 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 15.9 tp -54.05 -48.52 70.47 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 115.449 -0.375 . . . . 0.0 110.599 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.683 ' O ' HD11 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -67.86 -44.48 77.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.879 -173.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.1 -35.28 74.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.12 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -93.39 -1.97 55.23 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.819 175.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 46' ' ' LEU . . . -82.83 -42.39 17.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.552 177.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.683 HD11 ' O ' ' A' ' 47' ' ' PHE . 2.1 mp -86.99 -131.7 0.06 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 118.7 -1.2 . . . . 0.0 109.654 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 65.59 -9.96 0.23 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.213 0.605 . . . . 0.0 112.293 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.498 ' H ' ' C ' ' A' ' 51' ' ' LEU . 23.5 t-20 -127.59 -41.4 1.7 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.664 HG21 ' HA ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -81.77 117.16 27.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.314 168.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.441 ' OD1' HG23 ' A' ' 56' ' ' ILE . 8.6 t-20 -43.95 -67.9 0.24 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.874 0.734 . . . . 0.0 112.73 -172.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.578 ' O ' HD13 ' A' ' 59' ' ' LEU . 2.4 tp -156.24 -48.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.291 -177.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.39 -21.52 8.9 Favored Glycine 0 N--CA 1.469 0.866 0 O-C-N 123.32 0.388 . . . . 0.0 113.689 -173.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.2 t -60.97 -14.51 23.29 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 122.545 0.338 . . . . 0.0 111.155 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.578 HD13 ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -68.2 -18.64 64.64 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.107 -178.27 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.484 ' O ' HG23 ' A' ' 60' ' ' ILE . 29.9 mt -100.91 29.94 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 122.254 1.026 . . . . 0.0 109.511 174.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.9 t -71.96 132.29 44.12 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 121.743 -0.598 . . . . 0.0 110.307 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -73.69 64.37 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.064 0.459 . . . . 0.0 110.678 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.6 t -58.67 -73.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.653 176.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 69.87 172.66 10.22 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.843 -0.694 . . . . 0.0 113.051 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -160.1 140.02 11.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.797 0.332 . . . . 0.0 110.461 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.7 61.4 4.27 Favored Glycine 0 N--CA 1.453 -0.214 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.229 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.81 -65.97 1.52 Allowed Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 112.066 -0.414 . . . . 0.0 112.066 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.52 81.9 0.96 Allowed 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 122.761 2.307 . . . . 0.0 111.821 177.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.6 155.75 45.68 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.93 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -48.71 -59.23 1.33 Allowed 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.696 2.264 . . . . 0.0 112.958 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 63.35 112.29 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.908 0.861 . . . . 0.0 111.81 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -107.28 112.54 25.44 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.035 -176.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -119.29 67.77 0.38 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.118 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.98 134.19 17.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.469 0.176 . . . . 0.0 110.846 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.466 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -152.78 128.9 5.24 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.419 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 35.4 Cg_exo -64.49 -10.67 25.09 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 123.717 2.945 . . . . 0.0 113.077 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.75 94.71 9.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.033 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.59 -26.58 50.25 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.127 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.13 71.9 0.09 OUTLIER Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.069 -1.063 . . . . 0.0 112.708 177.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -86.3 109.35 0.93 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.232 1.955 . . . . 0.0 112.857 -177.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -127.64 83.83 65.01 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.44 176.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -60.84 95.24 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.424 2.749 . . . . 0.0 112.728 176.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.2 m -92.38 24.24 3.52 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.291 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 74.7 m 72.79 -60.11 0.54 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.366 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -137.53 147.77 45.43 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 120.684 0.278 . . . . 0.0 110.533 -178.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -159.53 102.7 1.55 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.31 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.89 151.7 76.07 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.92 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -57.11 142.08 94.28 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.833 2.356 . . . . 0.0 112.145 173.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.3 40.7 0.65 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.944 -175.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -112.29 124.4 52.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.164 0.507 . . . . 0.0 109.936 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -108.57 -149.16 0.43 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.174 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -62.14 108.62 1.1 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.531 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.6 mtpt -107.62 136.41 47.42 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 176.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.1 m -100.59 130.65 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 121.239 0.542 . . . . 0.0 111.935 -174.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -93.34 -20.76 20.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.824 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -115.72 -62.7 1.56 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -169.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.463 ' H ' ' HD2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -116.34 150.11 38.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 122.388 -0.195 . . . . 0.0 111.184 -173.748 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt 71.95 -176.92 0.19 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 124.148 0.905 . . . . 0.0 111.581 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 74.92 153.53 0.14 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.878 0.871 . . . . 0.0 111.098 -177.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -77.78 142.03 38.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.158 -172.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.1 m -134.82 -171.28 2.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.074 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.46 ' C ' ' HG3' ' A' ' 103' ' ' GLU . 12.7 pt-20 -93.15 157.9 16.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.616 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.46 ' HG3' ' C ' ' A' ' 102' ' ' GLU . 0.2 OUTLIER 39.13 46.85 1.25 Allowed 'General case' 0 N--CA 1.477 0.914 0 O-C-N 124.355 1.034 . . . . 0.0 113.122 178.473 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.3 p -154.21 163.33 40.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.037 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -134.85 -179.06 5.37 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.481 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.12 136.26 24.09 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.827 0.851 . . . . 0.0 112.874 -174.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -104.28 144.42 31.64 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 171.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -80.77 64.4 5.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.018 0.437 . . . . 0.0 110.827 -175.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -114.39 102.78 1.22 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.619 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -59.53 135.36 57.65 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 175.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.495 ' HA2' ' HB2' ' A' ' 114' ' ' ASP . . . 113.67 6.93 20.85 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -169.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.1 tp -87.49 -27.76 22.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.061 0.458 . . . . 0.0 110.127 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -125.95 20.33 7.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.544 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.495 ' HB2' ' HA2' ' A' ' 111' ' ' GLY . 4.9 m-20 . . . . . 0 C--O 1.248 0.976 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.447 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 200' ' ' ALA . . . . . 0.575 ' H3 ' ' CG ' ' A' ' 18' ' ' ASP . . . . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 120.807 0.337 . . . . 0.0 111.291 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 201' ' ' MET . . . . . 0.643 ' HE3' ' O ' ' A' ' 14' ' ' LEU . 26.4 mtp -123.23 -3.77 8.46 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.963 0.411 . . . . 0.0 110.835 -175.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 202' ' ' ARG . . . . . 0.42 ' HG3' ' OD2' ' A' ' 18' ' ' ASP . 50.1 mtm-85 -78.3 -1.46 33.27 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -167.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 203' ' ' TYR . . . . . 1.658 ' HE2' ' CE1' ' B' ' 203' ' ' TYR . 30.5 m-85 -129.88 -43.09 1.23 Allowed 'General case' 0 C--O 1.242 0.671 0 O-C-N 121.739 -0.601 . . . . 0.0 112.146 -176.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.695 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 6.5 p -58.44 -50.5 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.536 -177.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 205' ' ' ALA . . . . . 0.572 ' HA ' HD11 ' B' ' 208' ' ' LEU . . . -72.65 -15.63 61.71 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.703 0.287 . . . . 0.0 110.902 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 1.7 m -70.47 -48.51 55.47 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.087 0.47 . . . . 0.0 109.736 174.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 207' ' ' TYR . . . . . 1.631 ' HE1' ' CE2' ' B' ' 207' ' ' TYR . 33.0 t80 -61.97 -41.21 97.75 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.695 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 88.4 mt -56.82 -53.49 57.25 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.101 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 209' ' ' LEU . . . . . 0.643 ' CD2' ' HB2' ' A' ' 11' ' ' TYR . 56.0 mt -57.74 -54.83 42.43 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.956 0.408 . . . . 0.0 111.067 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -58.22 -32.94 68.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.287 -176.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 211' ' ' ALA . . . . . 0.463 ' HB1' HD12 ' B' ' 255' ' ' ILE . . . -76.88 -44.58 31.39 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.158 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 212' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' B' ' 209' ' ' LEU . 2.8 pp -64.66 -22.96 67.11 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.875 0.369 . . . . 0.0 110.405 177.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.09 -13.96 58.41 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.822 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 118.49 10.87 8.33 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.348 -0.93 . . . . 0.0 113.227 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 215' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -121.48 100.42 7.01 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 122.33 -0.512 . . . . 0.0 111.216 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 2.0 m -44.74 -49.81 10.37 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -168.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 19.0 m -114.24 85.37 10.4 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 123.495 0.497 . . . . 0.0 110.446 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . 0.557 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 73.6 Cg_exo -46.01 121.91 4.77 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 123.821 3.014 . . . . 0.0 113.57 176.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 46.8 t -76.39 148.42 37.37 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.808 178.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.84 -29.11 59.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.319 176.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -66.45 -38.41 87.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.389 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -73.31 -42.53 62.24 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.127 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.481 HD12 ' CB ' ' B' ' 218' ' ' PRO . 1.7 mp -64.26 -43.88 97.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -52.15 -60.43 3.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.313 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -52.07 -50.32 61.76 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.174 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.46 HG21 HD13 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -56.25 -38.04 52.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.51 -177.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . 0.465 HD21 ' HB1' ' B' ' 234' ' ' ALA . 13.5 tp -75.91 -46.92 27.43 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.87 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -87.36 12.15 12.74 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 119.761 -0.775 . . . . 0.0 111.826 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 72.5 m -57.15 -34.14 68.13 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.324 165.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 54.1 t -93.5 -52.31 9.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.475 175.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 138.93 30.38 0.21 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.903 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . 0.485 HG22 ' HB3' ' A' ' 19' ' ' ASP . 3.4 mp -101.92 149.65 6.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 174.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -86.8 150.54 24.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.313 0.578 . . . . 0.0 111.742 -171.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . 0.465 ' HB1' HD21 ' B' ' 227' ' ' LEU . . . -134.68 160.85 36.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.749 -177.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -112.87 125.82 54.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.119 0.485 . . . . 0.0 110.286 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -62.36 -51.15 68.76 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 114.766 -1.106 . . . . 0.0 113.146 -170.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -75.08 -33.46 61.67 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.494 -173.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 26.5 tpt180 -68.21 -44.97 74.6 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.886 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 239' ' ' LEU . . . . . 0.481 HD13 ' N ' ' B' ' 240' ' ' ASN . 4.5 pp -66.27 -37.59 85.81 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.363 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 240' ' ' ASN . . . . . 0.481 ' N ' HD13 ' B' ' 239' ' ' LEU . 26.1 t-20 -67.78 -36.91 81.33 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 121.311 -0.156 . . . . 0.0 110.651 178.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -65.36 -45.58 83.6 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 120.612 0.244 . . . . 0.0 110.94 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 242' ' ' VAL . . . . . 0.416 ' O ' ' HG ' ' B' ' 246' ' ' LEU . 33.9 m -70.89 -32.26 48.15 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 CA-C-O 121.493 0.663 . . . . 0.0 109.616 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 32.1 mt -72.36 -29.58 32.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.538 175.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 47.1 t -66.01 -32.08 73.35 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 172.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -74.28 -31.42 62.52 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.084 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' B' ' 242' ' ' VAL . 32.2 mt -85.88 1.36 50.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.553 178.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -78.87 -11.31 59.99 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -166.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -88.08 -132.82 4.07 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.828 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -98.93 -156.67 0.56 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 18.9 m120 75.37 -25.38 0.2 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.081 0.552 . . . . 0.0 112.456 174.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.585 ' O ' HG11 ' B' ' 254' ' ' VAL . 5.9 tp -56.52 -38.67 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.466 0.651 . . . . 0.0 110.416 175.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -54.28 -50.88 66.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.037 176.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.2 -45.91 75.46 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.063 -177.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 254' ' ' VAL . . . . . 0.585 HG11 ' O ' ' B' ' 251' ' ' ILE . 9.6 p -62.5 -33.9 61.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.259 -175.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 255' ' ' ILE . . . . . 0.463 HD12 ' HB1' ' B' ' 211' ' ' ALA . 63.4 mt -80.07 -40.33 20.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.815 176.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -57.18 -51.71 68.23 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.749 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -160.78 75.65 0.55 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.918 0.39 . . . . 0.0 110.448 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -176.32 56.37 0.11 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.733 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 27.7 mt -30.64 -55.01 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.808 0.843 . . . . 0.0 111.898 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 140.51 -170.78 24.29 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 119.721 -1.228 . . . . 0.0 113.529 165.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -84.89 11.41 9.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.421 -0.39 . . . . 0.0 110.23 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 262' ' ' LEU . . . . . 0.495 HD13 ' HG2' ' B' ' 201' ' ' MET . 2.8 mm? -54.55 -74.98 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.355 0.598 . . . . 0.0 110.371 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -138.75 73.76 1.45 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.065 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 3.0 p -83.37 101.02 11.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.419 0.628 . . . . 0.0 111.321 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 40.8 t -106.56 133.19 20.36 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.427 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.97 115.09 3.08 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.43 2.087 . . . . 0.0 112.223 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . -61.34 144.92 53.13 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.829 175.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . -78.38 53.48 3.9 Favored Glycine 0 CA--C 1.517 0.174 0 C-N-CA 121.378 -0.439 . . . . 0.0 113.754 -175.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . 59.62 -127.42 44.53 Favored Glycine 0 CA--C 1.517 0.193 0 C-N-CA 121.852 -0.213 . . . . 0.0 113.472 176.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . 56.59 56.91 5.19 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.365 0.602 . . . . 0.0 111.516 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 10.6 t -93.74 136.2 26.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.857 -175.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -150.33 127.78 11.47 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.017 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 40.7 t -116.46 84.02 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.212 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 8.2 p 43.08 58.82 3.15 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -79.59 84.17 5.48 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.7 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . 0.405 ' HA ' ' HD2' ' B' ' 277' ' ' PRO . . . -111.09 112.74 55.14 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.804 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 277' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' B' ' 276' ' ' ALA . 32.9 Cg_endo -66.33 142.54 66.68 Favored 'Trans proline' 0 CA--C 1.52 -0.218 0 C-N-CA 122.762 2.308 . . . . 0.0 112.103 175.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -164.14 171.79 39.79 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.171 -1.014 . . . . 0.0 112.473 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 71.9 m -159.75 -167.99 2.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.831 0.348 . . . . 0.0 110.553 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . -53.88 147.55 11.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.863 175.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -86.92 131.56 44.63 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.877 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -68.21 140.71 49.91 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.735 2.29 . . . . 0.0 112.647 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -132.91 159.05 41.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.664 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -153.46 148.87 27.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.706 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -121.66 -74.98 0.36 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.231 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 80.5 p 61.87 120.61 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.84 1.256 . . . . 0.0 112.852 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -124.13 144.8 46.38 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.517 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -70.35 139.63 38.62 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.97 2.447 . . . . 0.0 112.517 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -114.49 132.7 56.2 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.459 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -99.77 -177.81 3.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.563 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -120.53 88.49 2.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.582 0.23 . . . . 0.0 111.309 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.0 147.15 35.58 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.105 175.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 65.64 107.73 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 O-C-N 123.959 0.787 . . . . 0.0 111.54 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -129.02 -39.68 1.55 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.575 -176.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -117.45 76.22 1.04 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -173.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -161.14 130.74 4.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.375 168.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 178.24 -29.9 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.87 -174.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -133.44 114.07 13.23 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.074 -177.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 17.0 pttm -147.46 -51.18 0.19 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.565 176.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 61.99 -90.07 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.808 0.692 . . . . 0.0 110.975 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -57.62 116.02 3.14 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 123.029 0.531 . . . . 0.0 110.7 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 31.1 m -112.04 164.08 13.54 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.735 -177.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 65.76 -169.46 0.2 Allowed 'General case' 0 CA--C 1.531 0.219 0 O-C-N 123.992 0.807 . . . . 0.0 110.23 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -117.12 145.79 43.57 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 5.1 t -64.94 135.67 55.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.723 -172.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -122.81 75.14 1.25 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.236 -178.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -88.55 65.58 7.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.972 -172.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -111.81 170.27 8.26 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 173.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 23.0 ptt? -86.94 35.71 0.7 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.106 0.479 . . . . 0.0 110.811 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 70.25 19.93 76.25 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.626 -0.716 . . . . 0.0 113.166 176.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 311' ' ' PHE . . . . . 1.636 ' HE2' ' CE1' ' B' ' 311' ' ' PHE . 80.5 m-85 53.78 26.33 5.93 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 122.925 0.49 . . . . 0.0 112.035 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 312' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' B' ' 314' ' ' PHE . . . -155.79 101.06 0.2 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.911 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 1.1 pp -74.21 6.62 3.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.198 0.523 . . . . 0.0 111.42 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 314' ' ' PHE . . . . . 0.416 ' H ' ' C ' ' B' ' 312' ' ' GLY . 54.3 m-85 -72.46 -46.51 54.58 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.282 -176.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 35.4 t70 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.21 -178.31 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.4 tpt . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.1 -155.9 0.66 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 111.181 0.067 . . . . 0.0 111.181 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.468 ' O ' HD11 ' A' ' 7' ' ' LEU . 3.4 p -63.66 103.32 0.53 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.281 0.563 . . . . 0.0 111.457 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.4 -22.78 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.955 -175.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.4 p -61.67 -63.68 1.19 Allowed 'General case' 0 C--O 1.242 0.667 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.111 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -62.43 -41.75 98.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.088 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.468 HD11 ' O ' ' A' ' 3' ' ' SER . 5.2 mp -49.45 -59.27 3.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.341 176.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.8 -53.18 60.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.668 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 35.7 t -64.79 -37.52 87.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.775 -175.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.3 tp -75.77 -35.46 30.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.898 0.38 . . . . 0.0 110.951 -175.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.754 ' OH ' ' HA2' ' B' ' 258' ' ' GLY . 17.3 m-30 -74.55 -28.32 60.9 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.769 177.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 64.3 m -66.04 -41.98 90.17 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 173.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.412 ' HB1' HD22 ' A' ' 59' ' ' LEU . . . -53.74 -45.09 70.43 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.101 171.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.8 mt -59.46 -55.15 38.27 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.788 177.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 73.4 mt -52.35 -45.62 45.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.243 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.3 mt -76.19 -18.42 59.08 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.365 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -98.3 18.37 16.55 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.957 -0.464 . . . . 0.0 112.162 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.564 ' OD1' ' HG3' ' B' ' 201' ' ' MET . 15.9 t70 -117.48 -51.98 2.49 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.009 178.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -74.42 29.22 0.08 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.408 ' H ' ' C ' ' A' ' 18' ' ' ASP . 53.6 mt-10 50.86 40.29 24.48 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.742 0.417 . . . . 0.0 111.864 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.8 p -121.72 164.69 18.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.79 0.329 . . . . 0.0 111.026 -173.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.2 p -90.48 135.25 33.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.021 0.438 . . . . 0.0 111.777 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.421 ' HB ' ' HA ' ' A' ' 52' ' ' ALA . 91.8 t -77.82 123.34 34.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.414 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.26 158.49 43.81 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 177.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -50.91 -55.29 17.85 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.48 -177.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -51.73 -33.7 35.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.594 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -73.76 -50.34 21.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.534 0.207 . . . . 0.0 110.64 -176.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.416 ' O ' HD11 ' A' ' 32' ' ' ILE . 9.1 mt -65.34 -43.3 94.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.13 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -60.63 -36.61 79.06 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.988 175.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.57 -44.33 87.04 Favored 'General case' 0 C--O 1.227 -0.111 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.95 -42.98 89.29 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.239 0.542 . . . . 0.0 110.774 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.416 HD11 ' O ' ' A' ' 28' ' ' ILE . 1.6 mp -60.88 -44.0 96.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.411 177.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -73.31 -27.96 61.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.662 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.4 -37.63 85.66 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.361 176.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.39 -35.89 27.27 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.674 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.9 31.39 4.8 Favored Glycine 0 N--CA 1.454 -0.144 0 C-N-CA 120.755 -0.736 . . . . 0.0 113.428 175.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.481 HG11 ' HA2' ' B' ' 213' ' ' GLY . 22.3 m -114.52 175.08 2.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 122.725 -0.279 . . . . 0.0 110.732 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -132.96 106.94 7.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.902 0.382 . . . . 0.0 110.612 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -102.64 135.25 40.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 174.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.412 ' C ' ' H ' ' A' ' 42' ' ' PHE . 14.4 pt-20 -53.8 130.28 56.36 Favored Pre-proline 0 C--O 1.236 0.361 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.51 -2.82 1.11 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.41 2.74 . . . . 0.0 113.721 -170.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 1.659 ' HE1' ' CE2' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -71.8 -37.48 70.39 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.032 178.47 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.537 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 94.9 m95 -70.7 -54.38 8.24 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 119.194 -0.431 . . . . 0.0 110.74 177.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 75.4 Cg_exo -51.88 -45.31 39.31 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 121.705 1.603 . . . . 0.0 112.213 175.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.77 -43.68 95.88 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.333 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.0 -43.26 95.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.196 0.522 . . . . 0.0 110.286 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.474 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 2.8 m-85 -70.24 -41.08 74.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.803 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.81 -35.95 81.26 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -98.77 -23.14 15.52 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -174.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.08 -24.8 5.46 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -174.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.573 ' C ' ' H ' ' A' ' 53' ' ' ASN . 2.0 tp -86.65 -133.35 0.06 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.485 ' H ' ' CG ' ' A' ' 51' ' ' LEU . . . 60.7 -12.13 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.615 0.766 . . . . 0.0 112.773 -177.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.573 ' H ' ' C ' ' A' ' 51' ' ' LEU . 18.3 m120 -125.99 -34.94 2.51 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.509 ' CG2' ' HA ' ' A' ' 51' ' ' LEU . 61.2 t -45.0 108.26 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.517 174.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -47.39 140.21 5.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.735 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.9 tp -52.39 -48.58 45.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.896 -173.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.93 -40.67 93.57 Favored Glycine 0 C--O 1.239 0.457 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.601 177.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.4 t -59.0 -17.81 28.5 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 122.76 0.424 . . . . 0.0 111.012 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.412 HD22 ' HB1' ' A' ' 13' ' ' ALA . 15.4 tp -62.01 -21.52 64.94 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.193 -176.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.407 HG13 HG13 ' B' ' 259' ' ' ILE . 15.3 tt -71.18 -13.4 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.117 0.484 . . . . 0.0 110.893 -178.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 62.5 m -103.41 55.52 0.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.124 0.488 . . . . 0.0 110.304 177.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -74.97 -4.47 38.39 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.753 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.3 p -75.98 -12.01 14.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.399 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -80.29 52.79 4.37 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.728 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -78.65 -25.79 45.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.776 0.322 . . . . 0.0 111.24 -177.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -96.5 -9.66 56.4 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.513 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.0 134.56 3.66 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.839 -178.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.448 ' O ' ' HD3' ' A' ' 70' ' ' PRO . 7.9 Cg_exo -72.42 134.2 22.19 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.562 2.175 . . . . 0.0 112.287 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.57 92.96 12.93 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.265 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 68' ' ' PRO . 25.7 Cg_endo -92.52 -162.96 0.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.134 2.556 . . . . 0.0 112.926 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.93 152.67 35.88 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.234 177.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -91.64 91.84 8.19 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.916 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.85 -156.3 15.67 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.699 175.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -116.84 144.73 44.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.715 0.293 . . . . 0.0 110.72 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -130.51 123.06 20.15 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 121.249 0.547 . . . . 0.0 110.57 -177.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.53 -53.4 4.67 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 124.002 3.135 . . . . 0.0 112.939 -177.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 53.41 36.81 23.99 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.17 0.509 . . . . 0.0 111.632 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -114.67 28.26 8.26 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.745 -177.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.89 101.47 0.22 Allowed Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.564 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.89 84.57 0.52 Allowed 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 122.981 2.454 . . . . 0.0 112.378 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.499 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . . . -129.13 -49.36 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.275 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.499 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 71.8 Cg_exo -52.31 116.9 3.12 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 122.369 2.046 . . . . 0.0 113.05 177.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.1 t -91.78 137.68 32.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.119 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.6 m -154.98 138.63 16.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.473 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -127.98 -77.6 0.57 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.852 0.358 . . . . 0.0 110.91 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.32 138.11 47.11 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.892 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.53 108.71 8.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.609 0.243 . . . . 0.0 111.629 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -59.53 156.98 33.69 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.201 2.601 . . . . 0.0 112.262 174.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.2 21.68 0.72 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -175.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 69.99 116.45 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.757 0.823 . . . . 0.0 112.535 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.418 ' HG3' ' H ' ' A' ' 92' ' ' LYS . 6.4 pt-20 -118.41 -66.44 1.08 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.778 172.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.418 ' H ' ' HG3' ' A' ' 91' ' ' GLU . 26.4 mtpp 60.97 -167.47 0.19 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.678 0.275 . . . . 0.0 110.955 177.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt 67.04 -171.91 0.19 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.486 0.66 . . . . 0.0 111.318 176.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.4 p -56.97 119.7 2.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.665 174.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -84.05 -15.38 47.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.096 0.474 . . . . 0.0 110.277 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.68 64.52 2.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.08 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -113.41 130.54 56.27 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.526 175.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -81.3 -52.31 7.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.518 -170.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 50.58 70.13 0.55 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.658 0.599 . . . . 0.0 111.357 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -89.99 -169.05 2.3 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.601 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.5 t -47.15 134.75 10.63 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.881 0.738 . . . . 0.0 112.801 -172.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -79.54 154.33 28.87 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.881 173.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 67.61 169.8 0.26 Allowed 'General case' 0 N--CA 1.471 0.586 0 O-C-N 123.793 0.683 . . . . 0.0 111.272 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.2 m 53.07 43.36 31.77 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.446 0.641 . . . . 0.0 110.558 -176.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -73.08 -41.26 64.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.272 -175.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -118.87 -57.98 1.99 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.363 -177.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -96.22 157.68 15.79 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.879 174.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 51.9 ttm -76.07 -27.32 57.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.518 -175.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.71 176.67 41.32 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.767 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 1.632 ' HE1' ' CE2' ' A' ' 110' ' ' PHE . 4.3 p90 -101.01 153.48 19.5 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 122.245 0.218 . . . . 0.0 110.484 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -155.88 20.79 0.51 Allowed Glycine 0 C--N 1.329 0.188 0 C-N-CA 120.428 -0.891 . . . . 0.0 113.132 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 45.2 mt 47.29 48.48 16.2 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.208 0.528 . . . . 0.0 112.061 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 1.653 ' HD2' ' CD1' ' A' ' 113' ' ' PHE . 35.8 p90 -108.79 20.24 18.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.38 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.1 t70 . . . . . 0 C--O 1.255 1.364 0 CA-C-O 118.572 -0.727 . . . . 0.0 109.633 -178.393 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 201' ' ' MET . . . . . 0.572 ' O ' ' HB2' ' B' ' 202' ' ' ARG . 9.4 tpt 66.98 112.41 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.172 0.92 . . . . 0.0 111.975 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 202' ' ' ARG . . . . . 0.572 ' HB2' ' O ' ' B' ' 201' ' ' MET . 14.8 tpp180 170.21 -139.88 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 203' ' ' TYR . . . . . 1.662 ' HE1' ' CE2' ' B' ' 203' ' ' TYR . 28.9 m-85 -67.72 1.53 2.44 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.169 0.509 . . . . 0.0 111.628 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.588 ' O ' HD11 ' B' ' 208' ' ' LEU . 57.7 t -59.1 -54.35 35.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.144 177.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 205' ' ' ALA . . . . . 0.457 ' HA ' HD21 ' B' ' 208' ' ' LEU . . . -65.53 -20.61 66.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.727 0.299 . . . . 0.0 111.069 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 206' ' ' SER . . . . . 0.423 ' CB ' HG21 ' B' ' 223' ' ' ILE . 1.5 m -68.14 -43.61 77.92 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 173.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 207' ' ' TYR . . . . . 1.668 ' HD2' ' CD1' ' B' ' 207' ' ' TYR . 35.7 t80 -62.3 -39.96 94.73 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.588 HD11 ' O ' ' B' ' 204' ' ' VAL . 8.8 mp -56.69 -52.81 63.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.955 175.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 209' ' ' LEU . . . . . 0.527 ' CD2' ' HB2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -55.15 -52.75 62.31 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.87 -178.688 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 210' ' ' ALA . . . . . 0.405 ' CB ' ' HB3' ' B' ' 218' ' ' PRO . . . -65.72 -31.09 71.88 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.57 -177.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 211' ' ' ALA . . . . . 0.569 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -69.77 -47.87 61.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.003 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 212' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' B' ' 209' ' ' LEU . 4.6 pp -67.21 -22.15 65.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.978 0.418 . . . . 0.0 109.897 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . 0.481 ' HA2' HG11 ' A' ' 37' ' ' VAL . . . -55.22 -25.79 41.08 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.909 174.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 123.86 17.21 3.15 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.633 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 215' ' ' ASN . . . . . 0.569 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 34.2 t30 -133.1 124.0 26.76 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.817 0.341 . . . . 0.0 110.587 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 216' ' ' SER . . . . . 0.493 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 15.5 m -75.41 -21.96 57.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.11 -178.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 8.4 t -121.44 68.02 20.12 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.999 -176.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . 0.493 ' HD3' ' C ' ' B' ' 216' ' ' SER . 75.4 Cg_exo -56.54 -60.78 0.41 Allowed 'Trans proline' 0 N--CA 1.481 0.762 0 C-N-CA 123.731 2.954 . . . . 0.0 113.24 177.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 219' ' ' SER . . . . . 0.585 ' O ' HD11 ' B' ' 223' ' ' ILE . 21.0 t 59.52 -174.87 0.1 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.204 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . 0.608 ' O ' ' HB2' ' B' ' 224' ' ' LYS . . . -54.07 -34.87 61.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.196 -176.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -58.32 -59.82 4.73 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.454 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -71.75 -35.0 69.98 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -175.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.585 HD11 ' O ' ' B' ' 219' ' ' SER . 1.7 mp -69.48 -40.61 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 120.166 -0.613 . . . . 0.0 110.173 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 224' ' ' LYS . . . . . 0.608 ' HB2' ' O ' ' B' ' 220' ' ' ALA . 14.7 mmtt -60.23 -43.76 95.76 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 174.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -55.57 -49.25 73.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.56 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 1.2 mp -65.98 -40.73 88.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.012 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . 0.414 HD12 ' HG ' ' B' ' 206' ' ' SER . 4.1 mp -71.74 -43.17 66.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.731 0.301 . . . . 0.0 111.603 -178.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.34 -21.15 61.36 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.883 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 33.3 t -57.08 -43.5 82.21 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.039 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -90.17 -31.95 5.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -176.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 103.63 69.65 0.8 Allowed Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.165 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.98 -174.04 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 170.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -80.17 -169.18 1.94 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -172.15 -22.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 119.435 -0.317 . . . . 0.0 111.6 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 50.11 96.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 O-C-N 123.515 0.51 . . . . 0.0 111.678 177.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -57.63 -25.43 60.12 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -172.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -64.07 -66.45 0.54 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.395 0.616 . . . . 0.0 110.243 171.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.475 ' O ' HG21 ' B' ' 242' ' ' VAL . 96.4 mtt180 -57.16 -40.58 77.56 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.315 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 239' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -48.97 -64.5 0.79 Allowed 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.425 0.631 . . . . 0.0 110.762 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -72.42 -25.74 61.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.685 -176.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -65.94 -46.99 76.18 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.299 -0.56 . . . . 0.0 109.973 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 242' ' ' VAL . . . . . 0.475 HG21 ' O ' ' B' ' 238' ' ' ARG . 80.7 t -66.29 -41.05 88.35 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . 0.559 ' HA ' ' CD2' ' B' ' 246' ' ' LEU . 19.7 mt -65.71 -42.62 92.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.769 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 244' ' ' SER . . . . . 0.409 ' HA ' ' HB2' ' B' ' 247' ' ' ASN . 28.2 t -71.87 -22.15 61.56 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.756 0.313 . . . . 0.0 110.825 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -86.55 -22.87 26.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.281 0.562 . . . . 0.0 109.955 177.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . 0.638 ' O ' HD11 ' B' ' 246' ' ' LEU . 1.3 pp -101.1 2.62 40.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.735 176.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 247' ' ' ASN . . . . . 0.409 ' HB2' ' HA ' ' B' ' 244' ' ' SER . 6.7 t30 -72.86 69.44 0.94 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.688 -173.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -134.6 -175.49 13.9 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.032 -178.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -89.41 -3.35 58.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.175 0.512 . . . . 0.0 110.646 -176.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . 0.474 ' HA ' ' OD1' ' B' ' 253' ' ' ASP . 4.4 p-10 -79.33 12.16 2.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.805 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.452 ' O ' HG13 ' B' ' 255' ' ' ILE . 6.2 tp -67.06 -37.3 79.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 176.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -61.52 -42.08 98.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.583 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . 0.474 ' OD1' ' HA ' ' B' ' 250' ' ' ASN . 2.7 m-20 -60.46 -49.96 75.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.662 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 254' ' ' VAL . . . . . 0.436 HG11 ' HA ' ' B' ' 251' ' ' ILE . 8.3 p -70.58 -25.49 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.444 -176.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 255' ' ' ILE . . . . . 0.579 ' HA ' ' HH ' ' A' ' 11' ' ' TYR . 59.7 mt -77.46 -38.33 26.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.112 0.482 . . . . 0.0 110.278 176.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -78.24 -20.27 52.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.548 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -113.26 27.26 9.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.112 176.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . 0.754 ' HA2' ' OH ' ' A' ' 11' ' ' TYR . . . 20.38 -96.56 0.01 OUTLIER Glycine 0 C--N 1.336 0.543 0 N-CA-C 116.781 1.472 . . . . 0.0 116.781 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 259' ' ' ILE . . . . . 0.693 ' O ' ' HG ' ' B' ' 262' ' ' LEU . 0.0 OUTLIER -56.33 -41.05 69.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -172.131 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 54.48 -122.98 26.67 Favored Glycine 0 C--N 1.329 0.184 0 C-N-CA 121.138 -0.553 . . . . 0.0 113.24 174.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -116.83 27.75 8.96 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 262' ' ' LEU . . . . . 0.693 ' HG ' ' O ' ' B' ' 259' ' ' ILE . 0.6 OUTLIER -88.71 -25.83 22.12 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -178.243 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -92.64 134.75 34.71 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.853 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 14.7 t -149.22 -167.03 2.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.783 0.325 . . . . 0.0 110.889 -176.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 47.9 t -77.63 131.91 69.93 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.565 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.71 131.96 40.33 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.575 2.183 . . . . 0.0 112.813 175.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . -147.0 -52.5 0.21 Allowed 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.016 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . -81.93 62.49 4.53 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.412 176.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -89.91 -34.86 8.02 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.124 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -154.99 123.01 5.83 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 11.2 t -106.55 136.73 40.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . 68.85 160.54 0.19 Allowed 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.927 0.767 . . . . 0.0 110.874 -175.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 9.5 p -128.54 138.64 54.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.162 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 48.4 t -132.3 150.19 52.21 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.002 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -151.97 162.41 41.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.181 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -107.8 111.96 62.18 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 121.065 0.459 . . . . 0.0 111.02 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 277' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.1 56.86 5.59 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 123.345 2.697 . . . . 0.0 111.914 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 147.76 169.73 15.22 Favored Glycine 0 N--CA 1.436 -1.32 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.611 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 73.8 m -153.96 170.56 20.77 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.784 0.292 . . . . 0.0 110.389 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 61.24 37.11 17.57 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 123.859 0.724 . . . . 0.0 111.831 176.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -129.48 93.67 34.76 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.497 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -78.45 -55.4 0.05 OUTLIER 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.543 2.162 . . . . 0.0 113.089 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -164.64 159.64 19.18 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -84.74 115.49 22.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.687 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 149.12 -64.89 0.4 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.587 -0.815 . . . . 0.0 112.458 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 18.0 m 57.73 34.7 24.77 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.149 0.5 . . . . 0.0 111.184 -178.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 287' ' ' ALA . . . . . 0.439 ' HB2' ' HD3' ' B' ' 288' ' ' PRO . . . -82.36 -48.99 0.86 Allowed Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.795 -176.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 288' ' ' PRO . . . . . 0.439 ' HD3' ' HB2' ' B' ' 287' ' ' ALA . 6.6 Cg_exo -73.85 63.56 4.9 Favored 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 122.135 1.89 . . . . 0.0 112.315 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -127.5 136.41 51.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.62 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -154.61 160.24 41.34 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.453 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -102.64 111.35 23.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.758 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -94.38 -74.54 0.54 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.725 -175.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 48.56 30.34 2.43 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 123.685 0.615 . . . . 0.0 112.448 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -114.69 96.92 5.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.116 0.484 . . . . 0.0 110.556 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -92.82 59.55 3.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.562 0.696 . . . . 0.0 109.601 175.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -144.48 115.58 7.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.055 -177.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -157.72 83.88 0.89 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.32 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -170.83 -39.18 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -127.33 127.74 44.77 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.786 0.327 . . . . 0.0 111.036 -175.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -96.51 127.7 42.75 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.696 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -77.47 101.82 6.6 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.176 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 4.8 m -90.26 55.53 3.1 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -173.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -129.04 44.22 3.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.426 0.631 . . . . 0.0 110.431 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -85.71 85.12 7.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.832 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 8.9 t -165.31 74.73 0.23 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.313 0.577 . . . . 0.0 109.503 176.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -97.27 53.81 1.19 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.959 0.885 . . . . 0.0 109.041 -177.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -92.15 79.17 5.14 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.711 -174.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -109.33 145.6 35.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.544 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 20.3 ptp -142.3 13.21 1.99 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.338 176.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 84.35 129.53 1.84 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.793 -0.717 . . . . 0.0 113.012 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -92.05 39.62 1.02 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.0 0.429 . . . . 0.0 110.765 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 312' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' B' ' 314' ' ' PHE . . . -164.5 45.28 0.3 Allowed Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -79.18 36.66 0.3 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.836 0.827 . . . . 0.0 110.578 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 314' ' ' PHE . . . . . 1.664 ' HE1' ' CE2' ' B' ' 314' ' ' PHE . 43.1 p90 -97.25 19.54 12.93 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.632 -174.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 21.8 t70 . . . . . 0 C--O 1.246 0.908 0 CA-C-O 118.584 -0.722 . . . . 0.0 109.712 178.488 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.9 mtp . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.81 -95.96 0.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.513 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 p -125.98 84.63 2.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.426 0.632 . . . . 0.0 111.44 -175.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.4 t -65.76 -26.74 39.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.48 0.657 . . . . 0.0 109.843 -176.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.412 ' HB3' HG22 ' A' ' 39' ' ' VAL . 3.3 m -58.06 -66.65 0.44 Allowed 'General case' 0 C--O 1.242 0.709 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.591 -178.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.575 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -77.06 -20.62 55.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.764 -176.884 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 17.7 tp -57.09 -57.51 12.24 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 169.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.33 -48.72 79.63 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.413 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 49.3 t -65.43 -34.62 78.73 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.364 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.575 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 0.7 OUTLIER -70.2 -38.99 76.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 120.898 0.38 . . . . 0.0 110.352 -179.711 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 1.643 ' HE1' ' CE2' ' A' ' 11' ' ' TYR . 19.5 m-30 -67.65 -31.75 71.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.049 177.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.2 m -64.33 -46.17 84.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.188 174.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.49 ' HB2' HD22 ' A' ' 59' ' ' LEU . . . -53.49 -44.72 69.25 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.981 174.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.405 ' CD1' HD13 ' B' ' 262' ' ' LEU . 40.0 mt -61.34 -49.54 76.54 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.788 177.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 11' ' ' TYR . 30.5 mm -54.75 -42.38 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.531 -178.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -68.23 -35.33 77.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.988 0.423 . . . . 0.0 111.227 175.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -80.29 10.79 4.1 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -174.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -81.87 -79.61 0.17 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 118.452 0.569 . . . . 0.0 111.085 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.12 40.45 0.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 50.01 44.97 25.67 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.689 0.756 . . . . 0.0 111.623 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 79.7 t -92.34 138.74 19.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.55 177.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 p -62.21 111.86 2.15 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -171.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.2 t -56.56 107.56 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.794 172.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.2 p -139.92 155.65 47.07 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -176.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -52.07 -54.48 29.75 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.532 -177.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -51.5 -35.02 38.45 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.396 177.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.448 ' HG3' HG11 ' B' ' 230' ' ' VAL . 13.1 mptt -75.95 -45.05 36.99 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.404 -173.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.457 ' O ' HD11 ' A' ' 32' ' ' ILE . 5.4 mt -63.43 -42.35 95.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.306 -0.558 . . . . 0.0 109.825 176.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -58.72 -41.07 85.53 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.949 175.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.47 -49.48 77.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.241 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.47 -38.84 92.67 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.0 0.429 . . . . 0.0 111.164 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.457 HD11 ' O ' ' A' ' 28' ' ' ILE . 1.5 mp -59.61 -37.19 69.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.699 176.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -74.12 -30.88 62.52 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.703 0.287 . . . . 0.0 110.64 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.439 ' HB2' ' HA ' ' B' ' 226' ' ' ILE . . . -63.58 -44.32 94.39 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.958 176.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.466 ' HB3' ' CD1' ' B' ' 209' ' ' LEU . . . -77.01 -50.51 12.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.551 177.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.45 -4.53 31.21 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.646 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.406 HG21 ' HA2' ' B' ' 213' ' ' GLY . 48.2 t -82.63 131.31 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.627 0.251 . . . . 0.0 110.443 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -97.97 98.67 9.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.823 0.82 . . . . 0.0 110.377 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.412 HG22 ' HB3' ' A' ' 5' ' ' SER . 7.3 p -83.85 140.54 16.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.985 177.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -44.53 111.38 1.21 Allowed Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.046 174.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -46.49 -16.06 0.23 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 124.483 3.455 . . . . 0.0 115.108 -174.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 1.667 ' HE1' ' CE2' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -70.18 -32.25 70.09 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -179.356 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.43 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 84.3 m95 -71.9 -51.76 8.4 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.43 177.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.43 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 81.1 Cg_exo -49.64 -47.13 24.08 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 122.258 1.972 . . . . 0.0 112.19 170.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.28 -49.81 63.73 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.933 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -52.69 -53.1 52.12 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.684 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -61.93 -38.13 87.27 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.57 -34.71 78.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.735 -0.212 . . . . 0.0 111.19 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -100.47 -7.16 24.53 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -99.33 -37.66 9.16 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 121.951 -0.468 . . . . 0.0 112.224 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.609 ' HA ' ' CG1' ' A' ' 54' ' ' VAL . 1.6 mp -93.74 -128.51 0.12 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.41 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 66.7 -11.65 0.24 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.455 ' H ' ' C ' ' A' ' 51' ' ' LEU . 27.2 t-20 -137.34 3.62 2.6 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.609 ' CG1' ' HA ' ' A' ' 51' ' ' LEU . 34.1 m -89.88 121.11 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.037 -170.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -40.0 -87.6 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.957 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.3 tp -157.81 -57.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 121.222 -0.191 . . . . 0.0 111.458 175.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.41 -21.87 60.54 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.242 -0.504 . . . . 0.0 112.55 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.43 ' HB2' ' HB ' ' A' ' 54' ' ' VAL . 1.5 m -52.97 -20.09 3.13 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.034 0.534 . . . . 0.0 110.997 176.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.49 HD22 ' HB2' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -49.51 -42.99 45.2 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.848 176.714 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.454 HG21 HD11 ' B' ' 259' ' ' ILE . 37.2 mt -83.48 -7.13 10.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.604 0.716 . . . . 0.0 110.461 -173.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 47.5 t -89.18 -26.79 21.08 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.785 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -82.91 -16.3 48.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.35 0.595 . . . . 0.0 111.044 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.7 p -78.84 -12.04 13.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.793 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.41 -66.41 0.37 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.862 177.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.25 149.71 36.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.719 0.295 . . . . 0.0 111.058 -175.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -173.72 112.27 0.41 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.352 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.21 163.49 11.6 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.2 -0.524 . . . . 0.0 111.887 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -83.45 161.71 14.84 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.614 2.209 . . . . 0.0 112.064 179.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -117.18 107.85 44.86 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-O 120.678 0.275 . . . . 0.0 110.351 177.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.86 166.76 11.42 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.401 2.068 . . . . 0.0 112.403 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -162.25 175.95 11.11 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.351 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.84 104.67 4.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.303 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.66 -68.98 0.99 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.991 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.78 152.82 20.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.59 0.219 . . . . 0.0 111.59 -176.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -150.91 139.16 12.71 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.045 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 53.2 Cg_exo -55.82 96.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.586 2.857 . . . . 0.0 113.094 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.75 146.32 25.71 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.262 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -151.19 160.24 28.58 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.03 176.98 44.23 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.23 178.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.5 123.65 7.76 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.46 2.107 . . . . 0.0 112.441 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.416 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . . . -106.32 -46.72 0.12 Allowed Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.116 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.416 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 83.2 Cg_exo -49.19 131.08 25.83 Favored 'Trans proline' 0 C--N 1.365 1.435 0 C-N-CA 122.152 1.902 . . . . 0.0 113.039 176.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.8 t -87.97 117.94 27.17 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.908 177.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.6 p -73.96 126.14 29.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.521 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.71 146.93 46.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.155 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -172.57 178.27 2.75 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.065 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 62.67 87.24 0.13 Allowed Pre-proline 0 N--CA 1.467 0.419 0 O-C-N 123.964 0.79 . . . . 0.0 112.14 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.75 147.49 91.99 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.988 2.459 . . . . 0.0 113.049 176.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.4 92.52 8.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.843 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -83.82 112.79 20.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.504 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.64 151.86 46.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.592 176.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -97.11 -7.67 32.1 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.283 0.563 . . . . 0.0 110.366 -176.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -140.56 124.66 17.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.079 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.8 t -110.86 -65.26 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.164 0.507 . . . . 0.0 110.323 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -142.32 169.94 16.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.935 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 97' ' ' LYS . . . -137.86 -71.55 0.43 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.514 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 96' ' ' ALA . 83.8 mttt 65.74 137.25 0.02 OUTLIER 'General case' 0 C--N 1.343 0.3 0 O-C-N 123.834 0.709 . . . . 0.0 111.578 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -89.47 -18.2 27.19 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.143 -0.348 . . . . 0.0 111.346 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 59.77 -88.47 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.835 0.709 . . . . 0.0 112.059 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -88.51 -170.24 2.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.05 0.453 . . . . 0.0 111.553 -173.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.7 m -147.86 135.33 20.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.856 -177.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -86.17 73.39 10.24 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.04 0.448 . . . . 0.0 111.116 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -162.7 69.21 0.24 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.813 0.816 . . . . 0.0 109.608 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 52.5 m -147.51 147.35 30.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.543 -177.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.441 ' HB3' ' H ' ' A' ' 106' ' ' ASP . 1.3 m-20 62.08 -160.46 0.31 Allowed 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.779 0.674 . . . . 0.0 110.849 -179.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.441 ' H ' ' HB3' ' A' ' 105' ' ' ASP . 1.9 m-20 -60.23 125.46 23.77 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.804 0.335 . . . . 0.0 110.816 -177.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -90.39 69.37 6.95 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.715 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 23.0 ptp 38.08 49.01 1.17 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.342 1.057 . . . . 0.0 113.564 176.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -148.91 160.17 28.3 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.842 177.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 1.621 ' HD2' ' CD1' ' A' ' 110' ' ' PHE . 2.4 p90 -86.38 111.0 20.08 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.974 0.416 . . . . 0.0 110.318 179.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -86.27 -52.75 3.14 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.537 -0.84 . . . . 0.0 113.473 -176.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.1 mt -117.69 -6.09 11.11 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -172.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 1.646 ' HD1' ' CD2' ' A' ' 113' ' ' PHE . 37.9 m-85 -67.05 -57.21 7.27 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.471 0.175 . . . . 0.0 111.471 -176.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 . . . . . 0 C--O 1.251 1.135 0 CA-C-O 117.742 -1.123 . . . . 0.0 109.97 179.009 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 200' ' ' ALA . . . . . 0.559 ' O ' ' HG2' ' B' ' 201' ' ' MET . . . . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 119.593 -0.241 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 201' ' ' MET . . . . . 0.559 ' HG2' ' O ' ' B' ' 200' ' ' ALA . 26.1 ptm 61.63 -23.08 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 169.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 202' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -33.38 -68.78 0.1 Allowed 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -172.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 203' ' ' TYR . . . . . 1.61 ' HE2' ' CE1' ' B' ' 203' ' ' TYR . 76.4 m-85 -112.27 0.2 15.68 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.282 0.563 . . . . 0.0 111.412 -175.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.662 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 64.6 t -64.08 -54.27 33.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.262 177.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 205' ' ' ALA . . . . . 0.51 ' HA ' HD11 ' B' ' 208' ' ' LEU . . . -70.45 -12.81 61.82 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 -178.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 206' ' ' SER . . . . . 0.618 ' OG ' HG21 ' B' ' 223' ' ' ILE . 9.5 t -79.39 -39.86 31.47 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 175.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 207' ' ' TYR . . . . . 0.468 ' CZ ' ' HD2' ' B' ' 218' ' ' PRO . 34.4 t80 -63.1 -40.35 97.37 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 173.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.662 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 33.3 mt -59.01 -51.96 67.84 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.154 176.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 209' ' ' LEU . . . . . 0.471 ' O ' HD11 ' B' ' 212' ' ' LEU . 0.2 OUTLIER -51.6 -50.74 59.62 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.627 179.533 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -65.48 -32.97 74.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.415 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 211' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -65.57 -55.08 19.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.901 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 212' ' ' LEU . . . . . 0.548 ' C ' HD21 ' B' ' 212' ' ' LEU . 0.0 OUTLIER -76.24 -13.01 60.18 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.366 -179.278 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . 0.406 ' HA2' HG21 ' A' ' 37' ' ' VAL . . . -57.2 -16.82 21.46 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.271 170.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 121.35 4.81 9.78 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.621 -0.591 . . . . 0.0 111.621 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 215' ' ' ASN . . . . . 0.576 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 38.6 t30 -117.95 100.95 7.89 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.97 0.414 . . . . 0.0 110.183 -175.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 216' ' ' SER . . . . . 0.432 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 15.2 m -72.22 -7.98 52.26 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.269 -177.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 217' ' ' SER . . . . . 0.4 ' N ' ' HD3' ' B' ' 218' ' ' PRO . 31.2 m -130.01 64.37 72.04 Favored Pre-proline 0 C--N 1.319 -0.718 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.399 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . 0.468 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 53.2 Cg_exo -57.12 137.36 81.48 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.315 2.677 . . . . 0.0 113.209 -177.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 28.9 t -115.33 165.76 12.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.281 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -53.73 -42.58 68.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.134 0.492 . . . . 0.0 110.784 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -59.34 -43.77 92.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.466 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -65.2 -52.34 55.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.933 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.618 HG21 ' OG ' ' B' ' 206' ' ' SER . 1.8 mp -58.08 -48.27 84.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.87 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 224' ' ' LYS . . . . . 0.525 ' HE3' ' CG ' ' B' ' 236' ' ' ASP . 60.1 tttm -68.5 -22.65 64.52 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 122.258 -0.276 . . . . 0.0 111.448 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -69.79 -42.99 73.03 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.466 HG21 HD11 ' B' ' 226' ' ' ILE . 1.5 mm -66.36 -38.26 81.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 113.797 -1.547 . . . . 0.0 111.299 176.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . 0.464 ' CD1' ' HB ' ' B' ' 232' ' ' ILE . 0.2 OUTLIER -71.96 -42.03 67.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.888 0.375 . . . . 0.0 110.487 179.455 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 228' ' ' ASP . . . . . 0.444 ' OD2' ' HG2' ' B' ' 224' ' ' LYS . 10.2 m-20 -75.08 -20.63 59.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.578 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 61.2 p -56.39 -35.1 67.37 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.751 0.31 . . . . 0.0 111.157 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 230' ' ' VAL . . . . . 0.448 HG11 ' HG3' ' A' ' 27' ' ' LYS . 63.4 t -89.68 -41.07 13.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.163 0.506 . . . . 0.0 111.145 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 110.3 34.96 2.2 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.332 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . 0.464 ' HB ' ' CD1' ' B' ' 227' ' ' LEU . 3.9 mt -98.02 123.76 50.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -61.87 107.99 0.94 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.003 0.43 . . . . 0.0 111.9 -170.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -106.16 132.26 52.43 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.824 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . 0.552 ' O ' HD13 ' B' ' 239' ' ' LEU . 10.9 m-20 -79.3 121.51 25.19 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 236' ' ' ASP . . . . . 0.525 ' CG ' ' HE3' ' B' ' 224' ' ' LYS . 3.3 m-20 -59.78 -14.33 14.18 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.514 0.509 . . . . 0.0 112.229 -178.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 237' ' ' ASP . . . . . 0.486 ' CG ' ' HZ1' ' B' ' 241' ' ' LYS . 19.2 t70 -98.98 -49.61 4.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.301 0.572 . . . . 0.0 110.683 177.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.573 ' O ' HG22 ' B' ' 242' ' ' VAL . 19.4 mmm180 -66.8 -36.43 82.37 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.346 -172.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 239' ' ' LEU . . . . . 0.571 HD11 ' H ' ' B' ' 240' ' ' ASN . 0.0 OUTLIER -65.38 -34.83 79.22 Favored 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.279 -176.125 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 240' ' ' ASN . . . . . 0.571 ' H ' HD11 ' B' ' 239' ' ' LEU . 55.0 t30 -79.91 -32.62 40.17 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 241' ' ' LYS . . . . . 0.486 ' HZ1' ' CG ' ' B' ' 237' ' ' ASP . 50.7 mttp -65.05 -40.25 94.49 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.486 174.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 242' ' ' VAL . . . . . 0.652 ' O ' ' HB3' ' B' ' 246' ' ' LEU . 87.7 t -64.02 -49.35 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . 0.502 HG13 ' O ' ' B' ' 239' ' ' LEU . 35.4 mt -53.96 -39.04 39.01 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.753 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.522 174.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 56.1 m -59.43 -42.43 91.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.754 0.311 . . . . 0.0 110.749 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -77.82 -21.29 51.76 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.443 0.64 . . . . 0.0 110.968 176.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . 0.652 ' HB3' ' O ' ' B' ' 242' ' ' VAL . 0.3 OUTLIER -102.92 -12.23 17.66 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.919 -168.042 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 247' ' ' ASN . . . . . 0.433 ' C ' HD21 ' B' ' 247' ' ' ASN . 0.3 OUTLIER -78.26 48.15 0.73 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.351 0.596 . . . . 0.0 111.402 -179.574 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -93.11 156.59 22.92 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.143 -0.551 . . . . 0.0 111.822 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . 0.574 ' HD3' ' H ' ' B' ' 249' ' ' LYS . 0.3 OUTLIER -80.1 39.65 0.45 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.045 0.45 . . . . 0.0 111.966 -175.075 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -118.59 27.61 8.82 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.417 HD11 ' HA ' ' B' ' 251' ' ' ILE . 3.5 mm -64.57 -50.79 74.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -172.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -63.65 -30.08 71.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.231 0.539 . . . . 0.0 110.652 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.5 -48.7 63.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.976 176.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 254' ' ' VAL . . . . . . . . . . . . . 34.9 m -65.34 -27.37 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.046 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 255' ' ' ILE . . . . . 0.621 ' HA ' ' OH ' ' A' ' 11' ' ' TYR . 30.2 mt -69.63 -52.92 27.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.119 0.485 . . . . 0.0 110.583 174.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -69.38 -15.79 63.38 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.768 -177.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -82.91 40.44 0.69 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.427 174.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 20.34 -98.97 0.01 OUTLIER Glycine 0 N--CA 1.472 1.069 0 N-CA-C 115.833 1.093 . . . . 0.0 115.833 -172.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 259' ' ' ILE . . . . . 0.454 HD11 HG21 ' A' ' 60' ' ' ILE . 2.7 mp -86.1 -25.51 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.035 0.445 . . . . 0.0 111.117 -174.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 72.51 -170.05 51.22 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.205 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -87.76 25.6 1.47 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 175.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 262' ' ' LEU . . . . . 0.405 HD13 ' CD1' ' A' ' 14' ' ' LEU . 6.7 mt -80.71 -43.46 20.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.325 -176.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -99.27 62.15 1.24 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.5 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 25.6 t -130.5 124.69 32.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.061 0.458 . . . . 0.0 111.114 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 87.5 t -132.85 117.43 15.05 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.258 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.06 -26.63 12.71 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.71 2.274 . . . . 0.0 112.684 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.12 114.0 3.17 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.301 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 123.51 -48.89 0.93 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.42 -178.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -86.43 42.66 3.17 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.189 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -137.65 48.73 2.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.398 0.618 . . . . 0.0 110.453 -177.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 16.6 t -94.56 135.42 28.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.102 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -157.45 121.17 4.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.469 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 15.8 m -85.24 134.55 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.657 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 13.6 p -129.54 100.65 5.62 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.692 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -111.83 122.03 46.67 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.225 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . 0.407 ' HA ' ' HD2' ' B' ' 277' ' ' PRO . . . -93.26 117.91 67.56 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.769 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 277' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' B' ' 276' ' ' ALA . 33.7 Cg_endo -65.38 140.43 63.76 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.64 2.227 . . . . 0.0 112.102 177.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -108.97 110.37 3.0 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.423 -178.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 73.1 m -159.21 177.47 11.01 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 63.05 79.79 0.25 Allowed 'General case' 0 CA--C 1.53 0.206 0 O-C-N 123.924 0.765 . . . . 0.0 112.362 173.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -72.78 123.61 89.76 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.705 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.87 108.04 2.46 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.583 2.188 . . . . 0.0 112.356 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -160.34 133.45 6.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.605 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -148.97 172.2 15.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.075 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -165.49 -179.4 39.21 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.695 178.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 16.5 m -125.69 133.11 52.26 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.718 0.294 . . . . 0.0 110.378 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -140.07 126.12 11.89 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.382 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -85.38 158.22 10.99 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.958 2.438 . . . . 0.0 112.801 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -99.3 137.68 37.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.148 177.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -147.28 156.94 43.37 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.134 -175.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -96.47 115.53 27.58 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -57.55 136.01 56.7 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 123.681 0.613 . . . . 0.0 111.331 -177.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -69.8 139.15 53.17 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.278 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -126.87 82.28 2.07 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.819 173.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -75.01 81.09 2.2 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.89 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -92.7 167.62 11.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.724 -178.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 56.2 49.93 14.43 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.773 0.797 . . . . 0.0 110.919 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -84.24 56.54 3.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.894 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 24.1 tptm 69.67 113.81 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.674 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -96.28 -167.92 1.66 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.629 178.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -54.56 136.04 45.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.14 0.495 . . . . 0.0 110.694 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 19.5 m -93.4 113.03 25.09 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.854 -175.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -107.09 129.27 54.85 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.693 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -127.66 124.53 38.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.988 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 56.4 m 59.06 80.42 0.19 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.744 0.652 . . . . 0.0 112.648 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -103.58 76.98 1.45 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 174.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -83.23 -45.63 13.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.809 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 2.4 t70 55.29 32.69 19.15 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 123.777 0.673 . . . . 0.0 110.647 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 66.6 mtt -93.09 34.85 1.09 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.575 -175.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 64.45 40.21 97.53 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.67 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 61.68 35.29 17.08 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 122.754 0.422 . . . . 0.0 111.271 178.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . -80.73 65.97 3.82 Favored Glycine 0 C--O 1.227 -0.324 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.477 -178.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 6.8 mp -105.21 27.03 8.63 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.433 0.635 . . . . 0.0 109.533 175.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 314' ' ' PHE . . . . . 1.634 ' HD1' ' CD2' ' B' ' 314' ' ' PHE . 43.9 m-85 -99.71 -15.44 18.51 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.418 -173.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 C--O 1.252 1.2 0 CA-C-O 118.774 -0.632 . . . . 0.0 110.019 -179.494 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.429 ' HG2' ' OE2' ' B' ' 252' ' ' GLU . 16.4 mmt . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.653 0.263 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.55 -80.63 0.57 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.691 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.435 ' HB2' ' HG2' ' A' ' 6' ' ' GLU . 3.8 p -126.24 86.53 2.54 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.566 0.698 . . . . 0.0 110.857 -177.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.465 HG12 ' HB2' ' B' ' 212' ' ' LEU . 21.1 t -67.47 -27.22 37.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.398 -172.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.438 ' HB3' HG21 ' A' ' 39' ' ' VAL . 7.0 m -61.68 -57.99 9.82 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.21 -177.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.435 ' HG2' ' HB2' ' A' ' 3' ' ' SER . 9.6 pt-20 -72.98 -29.3 62.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.596 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 39.8 mt -53.91 -52.92 59.02 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 170.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.3 -53.18 59.31 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.122 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.456 ' SG ' HG22 ' A' ' 39' ' ' VAL . 31.6 m -63.48 -33.21 75.08 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.548 -177.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.401 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 1.1 tp -72.65 -40.36 62.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.689 0.28 . . . . 0.0 111.309 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 1.659 ' HE1' ' CE2' ' A' ' 11' ' ' TYR . 21.9 m-85 -75.64 -18.69 59.59 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.306 -0.558 . . . . 0.0 109.662 177.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.451 ' HB3' HG12 ' A' ' 28' ' ' ILE . 47.8 m -72.24 -44.89 62.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 170.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -50.58 -46.27 57.7 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 171.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.454 HD22 HD12 ' A' ' 56' ' ' ILE . 67.9 mt -59.38 -52.95 63.41 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.586 178.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.409 HD13 HD22 ' A' ' 31' ' ' LEU . 30.2 mt -62.02 -31.19 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -177.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.528 ' HB3' ' HA ' ' A' ' 23' ' ' VAL . 3.4 mm? -98.75 -0.98 41.58 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -124.9 53.18 1.51 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.379 0.609 . . . . 0.0 110.278 174.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.592 ' OD1' ' HA ' ' B' ' 200' ' ' ALA . 24.3 t70 -136.96 -58.3 0.72 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.871 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 20' ' ' GLU . 24.0 t70 -73.72 -174.51 1.79 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.58 175.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.484 ' H ' ' CG ' ' A' ' 19' ' ' ASP . 33.0 tt0 -77.25 -17.48 58.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.436 0.636 . . . . 0.0 109.659 178.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 79.7 t -61.19 124.25 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.941 174.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.6 p -82.61 149.98 27.11 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.076 -177.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.528 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 2.5 m -60.81 124.73 15.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.198 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.1 p -145.89 143.61 29.69 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.942 -174.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.453 ' HG3' ' H ' ' A' ' 26' ' ' ASP . 7.7 pt-20 -45.96 -50.85 14.31 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 123.706 0.629 . . . . 0.0 111.234 -177.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.453 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 13.5 t70 -53.68 -43.67 69.07 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.531 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.504 ' O ' HG13 ' B' ' 230' ' ' VAL . 2.9 mptp? -78.35 -40.68 35.68 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.33 -172.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.739 ' O ' HG12 ' A' ' 32' ' ' ILE . 5.7 mt -62.98 -50.06 81.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 119.774 -0.771 . . . . 0.0 109.947 176.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -54.41 -44.79 72.66 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.866 0.365 . . . . 0.0 110.576 177.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.404 ' HA ' ' HZ1' ' A' ' 33' ' ' LYS . . . -57.33 -45.94 83.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.983 176.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.568 ' HB2' ' CG1' ' B' ' 230' ' ' VAL . 44.0 tp -69.06 -40.14 78.68 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 121.194 0.521 . . . . 0.0 111.03 -176.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.739 HG12 ' O ' ' A' ' 28' ' ' ILE . 18.5 mm -62.52 -38.27 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.941 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.404 ' HZ1' ' HA ' ' A' ' 30' ' ' ALA . 19.1 pttm -82.72 -17.49 44.16 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.579 176.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.413 ' HB1' ' O ' ' A' ' 31' ' ' LEU . . . -62.62 -46.35 88.63 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 174.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.35 -47.77 11.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.9 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.2 64.84 0.98 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.934 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.0 m -120.86 179.26 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.879 0.371 . . . . 0.0 111.012 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -113.38 113.6 25.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.224 -177.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.456 HG22 ' SG ' ' A' ' 9' ' ' CYS . 4.4 p -145.91 137.18 19.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.765 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -56.78 123.87 60.71 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.221 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -56.41 -8.55 2.79 Favored 'Trans proline' 0 C--O 1.241 0.629 0 C-N-CA 123.57 2.847 . . . . 0.0 113.004 -174.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 1.664 ' HE1' ' CE2' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -77.45 -25.52 50.68 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.598 -177.771 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.41 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 97.0 m95 -66.84 -60.05 6.87 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.393 175.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.41 ' CD ' ' HB2' ' A' ' 43' ' ' TRP . 10.3 Cg_endo -55.87 -42.17 69.79 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 121.882 1.721 . . . . 0.0 112.276 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.73 -54.26 39.36 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.75 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.9 tt -59.12 -45.34 91.17 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 1.668 ' HE2' ' CE1' ' A' ' 47' ' ' PHE . 4.0 m-85 -54.58 -54.59 39.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.697 0.284 . . . . 0.0 111.643 -178.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.27 -24.79 61.4 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.959 -176.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -99.95 -1.68 36.57 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.03 -17.38 4.86 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.54 HD11 ' O ' ' A' ' 47' ' ' PHE . 8.4 mp -80.25 -113.46 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.958 -0.464 . . . . 0.0 109.819 175.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 59.39 2.79 0.34 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 177.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -145.01 -52.68 0.28 Allowed 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 122.21 1.005 . . . . 0.0 108.593 -173.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.47 HG12 ' HG ' ' A' ' 51' ' ' LEU . 2.4 p -18.42 110.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 111.861 -2.427 . . . . 0.0 114.553 173.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -56.71 130.98 47.77 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 163.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.507 ' O ' HD23 ' A' ' 59' ' ' LEU . 5.5 tp -47.63 -58.62 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -166.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.62 -29.11 60.71 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.005 -0.617 . . . . 0.0 113.297 -176.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.2 m -59.36 -16.8 24.9 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.507 HD23 ' O ' ' A' ' 56' ' ' ILE . 1.0 OUTLIER -60.63 -17.71 48.85 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.389 0.144 . . . . 0.0 111.389 -179.45 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.444 ' N ' HD21 ' A' ' 59' ' ' LEU . 15.7 tt -65.21 -22.16 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 120.882 0.373 . . . . 0.0 111.004 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.4 t -127.69 73.22 1.44 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.232 0.539 . . . . 0.0 110.22 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -107.48 -12.75 15.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.067 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.7 t -74.51 -42.19 49.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.518 -175.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.06 -80.52 1.23 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.654 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -123.47 -48.9 1.92 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.955 0.407 . . . . 0.0 110.797 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 162.57 -144.1 9.33 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -177.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.49 163.05 29.67 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.326 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -89.62 155.42 5.23 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.088 2.525 . . . . 0.0 112.818 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . . . -116.37 120.77 34.37 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.01 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 69' ' ' ALA . 13.9 Cg_exo -71.51 -21.6 25.73 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.457 2.105 . . . . 0.0 112.34 177.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 66.32 -158.49 0.25 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.846 176.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.36 137.45 56.9 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.091 0.472 . . . . 0.0 111.324 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.77 -34.82 17.82 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.603 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 65.56 102.46 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.13 0.572 . . . . 0.0 111.928 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.456 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . 73.86 138.66 0.06 OUTLIER Pre-proline 0 N--CA 1.471 0.588 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.437 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 32.4 Cg_exo -63.85 161.11 34.06 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.178 2.585 . . . . 0.0 113.243 -177.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 79.39 146.61 0.09 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.256 0.972 . . . . 0.0 111.342 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.98 0.07 80.22 Favored Glycine 0 C--N 1.33 0.247 0 CA-C-N 115.699 -0.682 . . . . 0.0 113.235 -175.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.0 -97.23 0.77 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.74 177.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -68.07 105.12 1.13 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.627 2.218 . . . . 0.0 112.097 -177.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -129.97 91.45 39.61 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.568 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.44 -54.38 2.59 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.878 2.385 . . . . 0.0 112.043 176.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.0 t -165.39 167.74 17.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.471 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 97.6 m -162.29 -44.95 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.421 0.629 . . . . 0.0 109.57 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -96.72 107.55 20.04 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.791 177.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 66.33 -172.54 0.19 Allowed 'General case' 0 C--O 1.235 0.307 0 O-C-N 124.083 0.864 . . . . 0.0 110.459 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.41 70.64 1.5 Allowed Pre-proline 0 CA--C 1.533 0.299 0 O-C-N 123.335 0.397 . . . . 0.0 111.673 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -57.59 140.15 92.46 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.011 2.474 . . . . 0.0 112.731 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -127.26 37.6 4.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.841 0.353 . . . . 0.0 111.376 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -83.54 161.72 21.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.018 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 92' ' ' LYS . 1.1 pm0 -88.09 -165.4 1.31 Allowed 'General case' 0 CA--C 1.536 0.404 0 O-C-N 123.277 0.36 . . . . 0.0 111.94 -173.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 91' ' ' GLU . 35.7 mmtp 74.96 174.38 0.25 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.674 0.79 . . . . 0.0 111.414 -177.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.479 ' HZ2' ' HB3' ' A' ' 93' ' ' LYS . 0.7 OUTLIER -142.36 141.35 32.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.798 176.592 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 8.9 p -84.67 -27.19 6.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.603 -172.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 54.4 86.02 0.05 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.891 0.853 . . . . 0.0 111.432 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -133.79 158.25 43.82 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.461 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -85.48 133.05 34.11 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.568 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -77.6 -26.82 50.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.549 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 56.39 86.85 0.06 Allowed 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.589 0.556 . . . . 0.0 111.653 173.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -92.38 30.33 1.51 Allowed 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.531 0.681 . . . . 0.0 111.132 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.2 m 71.04 87.64 0.11 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.283 -1.326 . . . . 0.0 113.093 171.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -146.38 145.13 30.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.992 167.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -170.9 176.9 3.95 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.375 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 83.2 p 59.78 124.51 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.944 1.403 . . . . 0.0 113.105 178.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -85.74 56.93 4.19 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.49 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.82 -56.47 11.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.823 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -68.7 128.92 38.36 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.943 0.401 . . . . 0.0 111.202 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 11.2 tpt 65.58 25.39 11.69 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.149 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -65.97 133.16 34.21 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.1 176.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -77.9 142.0 38.71 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 173.55 131.13 1.35 Allowed Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 120.033 -1.08 . . . . 0.0 112.965 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.1 tp -101.8 2.2 38.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.323 0.582 . . . . 0.0 109.733 175.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -73.48 151.21 41.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.97 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.4 t70 . . . . . 0 C--O 1.244 0.781 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.081 -179.06 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 200' ' ' ALA . . . . . 0.592 ' HA ' ' OD1' ' A' ' 18' ' ' ASP . . . . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 121.482 0.658 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 201' ' ' MET . . . . . 0.454 ' SD ' ' HA ' ' B' ' 263' ' ' ALA . 4.9 mpp? -112.07 58.97 0.63 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.936 -177.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 202' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -33.25 -76.56 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 O-C-N 124.638 1.211 . . . . 0.0 113.172 -170.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 203' ' ' TYR . . . . . 1.641 ' HD2' ' CD1' ' B' ' 203' ' ' TYR . 93.0 m-85 -134.93 14.67 3.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.579 0.704 . . . . 0.0 109.88 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.567 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 31.5 t -68.51 -54.52 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.418 -176.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 205' ' ' ALA . . . . . 0.473 ' HA ' HD13 ' B' ' 208' ' ' LEU . . . -72.13 -13.9 61.69 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.558 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 206' ' ' SER . . . . . 0.419 ' HB3' HG21 ' B' ' 223' ' ' ILE . 3.5 m -72.3 -43.02 64.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 172.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 207' ' ' TYR . . . . . 0.463 ' CE1' HD12 ' B' ' 251' ' ' ILE . 24.4 t80 -62.64 -44.14 97.03 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 174.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 64.1 mt -59.51 -46.84 87.67 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.018 177.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 209' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' B' ' 205' ' ' ALA . 0.1 OUTLIER -57.09 -53.45 57.89 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.575 -179.67 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -62.96 -34.68 78.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.291 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 211' ' ' ALA . . . . . 0.624 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -63.27 -53.54 51.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.218 177.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 212' ' ' LEU . . . . . 0.491 HD13 ' C ' ' B' ' 212' ' ' LEU . 4.3 pp -65.76 -21.65 66.53 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.759 0.314 . . . . 0.0 110.753 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.97 -16.05 38.28 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.676 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 120.37 4.98 10.65 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.448 178.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 215' ' ' ASN . . . . . 0.624 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 28.1 t30 -117.66 108.8 15.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.188 0.518 . . . . 0.0 110.274 -178.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 216' ' ' SER . . . . . 0.41 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 5.8 m -68.05 -15.2 63.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.799 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 17.6 p -125.66 67.75 59.55 Favored Pre-proline 0 N--CA 1.441 -0.881 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.417 -175.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . 0.41 ' HD3' ' C ' ' B' ' 216' ' ' SER . 50.9 Cg_exo -59.85 121.09 9.27 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.72 2.28 . . . . 0.0 112.025 177.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 89.2 p -102.33 -178.95 3.84 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.782 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -58.93 -36.67 75.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.02 0.438 . . . . 0.0 110.84 -177.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 221' ' ' LYS . . . . . 0.53 ' HZ2' ' HB3' ' B' ' 221' ' ' LYS . 0.5 OUTLIER -74.54 -35.25 63.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.76 -176.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -59.35 -54.99 40.46 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.256 0.551 . . . . 0.0 109.746 175.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.419 HG21 ' HB3' ' B' ' 206' ' ' SER . 1.8 mp -63.47 -42.14 95.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.209 -178.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 224' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' B' ' 228' ' ' ASP . 27.7 tptp -57.06 -50.85 71.48 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 121.312 -0.155 . . . . 0.0 110.752 178.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -60.99 -41.16 95.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.909 0.385 . . . . 0.0 110.708 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.42 HG21 HD12 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -63.93 -42.94 97.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.543 -178.039 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . 0.417 HD21 ' HB1' ' B' ' 234' ' ' ALA . 26.9 tp -81.16 -23.22 38.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.23 0.538 . . . . 0.0 110.413 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 228' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' B' ' 224' ' ' LYS . 2.7 t70 -72.37 -28.27 62.91 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.636 176.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 8.4 t -65.25 -53.33 45.87 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.556 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 230' ' ' VAL . . . . . 0.568 ' CG1' ' HB2' ' A' ' 31' ' ' LEU . 22.2 m -61.6 -33.13 55.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-O 120.802 0.334 . . . . 0.0 111.744 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 102.94 39.06 2.76 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.944 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 16.9 mt -116.01 125.53 73.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -54.65 143.6 24.39 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.089 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . 0.417 ' HB1' HD21 ' B' ' 227' ' ' LEU . . . -140.93 117.08 10.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.028 0.442 . . . . 0.0 111.932 -173.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . 0.405 ' HB2' ' HB2' ' B' ' 238' ' ' ARG . 1.7 m-20 -67.88 113.41 5.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.495 174.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -56.75 -40.18 75.31 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.913 0.387 . . . . 0.0 110.986 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 237' ' ' ASP . . . . . 0.46 ' CG ' ' HZ1' ' B' ' 241' ' ' LYS . 6.8 t70 -63.41 -58.55 6.7 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.241 0.543 . . . . 0.0 111.04 178.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.666 ' O ' HG21 ' B' ' 242' ' ' VAL . 4.7 mpt_? -63.97 -29.44 70.6 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.914 -177.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 239' ' ' LEU . . . . . 0.513 ' HA ' ' CD2' ' B' ' 203' ' ' TYR . 9.3 tt -57.59 -61.42 2.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.168 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -64.38 -27.31 68.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.797 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 241' ' ' LYS . . . . . 0.46 ' HZ1' ' CG ' ' B' ' 237' ' ' ASP . 38.1 mttp -63.46 -47.91 79.88 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.694 175.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 242' ' ' VAL . . . . . 0.666 HG21 ' O ' ' B' ' 238' ' ' ARG . 46.6 t -70.13 -33.16 53.68 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . 0.62 ' HA ' ' CD1' ' B' ' 246' ' ' LEU . 4.7 mt -64.2 -35.97 75.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.153 178.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 21.8 m -75.62 -25.92 57.34 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.317 0.58 . . . . 0.0 109.938 172.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 245' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' B' ' 242' ' ' VAL . 44.2 tt0 -71.3 -40.88 70.55 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.129 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . 0.62 ' CD1' ' HA ' ' B' ' 243' ' ' ILE . 0.0 OUTLIER -108.22 18.1 21.49 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.262 0.553 . . . . 0.0 111.578 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -61.99 120.39 10.71 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.049 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -153.09 147.43 16.96 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.527 -0.845 . . . . 0.0 112.479 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -84.42 -24.16 29.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.071 0.462 . . . . 0.0 110.101 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . 0.455 ' HB3' ' HB3' ' B' ' 253' ' ' ASP . 4.9 m-20 -80.25 55.71 2.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.779 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.5 ' O ' HG13 ' B' ' 254' ' ' VAL . 1.3 mm -68.2 -49.52 66.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.159 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 252' ' ' GLU . . . . . 0.429 ' OE2' ' HG2' ' A' ' 1' ' ' MET . 38.7 tt0 -67.95 -25.32 65.39 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.188 0.518 . . . . 0.0 110.01 -176.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . 0.455 ' HB3' ' HB3' ' B' ' 250' ' ' ASN . 20.4 t70 -73.33 -48.61 32.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.104 174.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 254' ' ' VAL . . . . . 0.632 ' O ' ' HA3' ' B' ' 258' ' ' GLY . 2.3 p -66.53 -18.2 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.171 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 255' ' ' ILE . . . . . . . . . . . . . 66.4 mt -84.77 -52.27 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.856 0.36 . . . . 0.0 110.598 174.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -61.12 -31.72 71.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.082 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -126.83 35.69 4.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.833 0.349 . . . . 0.0 111.294 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . 0.644 ' O ' HD23 ' B' ' 262' ' ' LEU . . . -133.67 55.03 0.75 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.721 -175.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 49.7 mt -94.03 -25.66 4.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.617 0.722 . . . . 0.0 109.477 171.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -116.89 38.79 2.88 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.598 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 261' ' ' LYS . . . . . 0.437 ' H ' HD21 ' B' ' 262' ' ' LEU . 61.0 mttp -124.44 16.39 8.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.107 0.479 . . . . 0.0 110.175 176.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 262' ' ' LEU . . . . . 0.644 HD23 ' O ' ' B' ' 258' ' ' GLY . 0.2 OUTLIER -118.98 -68.93 0.88 Allowed 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.755 0.788 . . . . 0.0 109.755 -175.845 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . 0.454 ' HA ' ' SD ' ' B' ' 201' ' ' MET . . . -61.45 -29.85 70.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.474 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 13.2 t -137.22 128.7 28.36 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.602 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 88.8 t 58.74 95.2 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.25 0 O-C-N 124.128 0.892 . . . . 0.0 111.298 -176.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.16 -21.61 36.02 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.592 2.195 . . . . 0.0 112.444 -175.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . 176.76 -40.04 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.622 -177.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 130.45 -23.37 4.55 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.067 -177.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -178.84 -168.63 38.31 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -98.71 96.14 7.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.742 0.306 . . . . 0.0 110.733 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 14.3 t -115.32 138.07 46.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -140.52 144.16 35.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.81 0.338 . . . . 0.0 111.039 -178.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 18.4 m -91.56 35.75 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.367 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 9.9 m -119.73 106.21 11.91 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.163 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -98.13 63.56 1.6 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.401 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . 68.07 100.18 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.269 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.143 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 277' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -78.73 67.36 8.47 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.074 2.516 . . . . 0.0 112.044 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 133.12 -174.65 20.5 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.91 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 25.9 m 64.2 -170.67 0.19 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.723 0.297 . . . . 0.0 110.44 -178.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 61.02 33.17 19.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.556 174.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -72.57 137.13 80.55 Favored Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.179 177.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.22 56.92 2.69 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.897 2.398 . . . . 0.0 112.575 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -127.79 31.19 5.17 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.736 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -131.6 98.36 4.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.613 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -148.96 -58.96 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.011 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 16.6 m -71.82 90.32 1.1 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.994 0.425 . . . . 0.0 110.836 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 287' ' ' ALA . . . . . 0.456 ' HB1' ' HD3' ' B' ' 288' ' ' PRO . . . -85.91 -51.95 0.47 Allowed Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 288' ' ' PRO . . . . . 0.456 ' HD3' ' HB1' ' B' ' 287' ' ' ALA . 2.5 Cg_endo -78.3 131.53 10.76 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 121.877 1.718 . . . . 0.0 111.921 -176.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -140.97 136.79 32.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.594 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -92.77 142.96 26.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.562 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -133.22 28.52 4.08 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.91 0.386 . . . . 0.0 110.52 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -63.7 97.92 0.17 Allowed 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.515 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -76.79 51.41 0.77 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.958 0.408 . . . . 0.0 110.796 175.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt 55.51 78.45 0.19 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.674 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.82 155.62 17.1 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.836 177.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -128.52 145.59 51.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.399 173.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -156.27 -31.3 0.09 Allowed 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.283 0.989 . . . . 0.0 109.098 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -142.98 30.96 1.42 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.931 -171.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 19.7 tptp -85.4 -59.17 2.4 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.73 176.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 55.86 76.15 0.3 Allowed 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.605 0.565 . . . . 0.0 111.999 171.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 301' ' ' GLU . . . . . 0.431 ' CD ' ' H ' ' B' ' 301' ' ' GLU . 0.3 OUTLIER -99.99 33.08 2.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.474 0.654 . . . . 0.0 111.306 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 19.0 t -115.49 139.87 49.66 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.121 -176.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -78.85 123.73 27.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.996 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -89.73 172.67 8.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.459 -177.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 305' ' ' SER . . . . . 0.451 ' HB3' ' OD1' ' B' ' 307' ' ' ASP . 13.8 m -104.46 107.36 18.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.854 0.359 . . . . 0.0 111.041 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -103.27 27.44 7.26 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.229 0.537 . . . . 0.0 110.478 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 307' ' ' ASP . . . . . 0.451 ' OD1' ' HB3' ' B' ' 305' ' ' SER . 8.9 p-10 -76.96 74.26 3.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.326 -174.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -81.23 72.44 8.26 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 173.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 42.72 31.18 0.28 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.688 1.195 . . . . 0.0 113.038 -176.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 54.87 46.39 76.65 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 116.024 -0.535 . . . . 0.0 113.346 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 311' ' ' PHE . . . . . 1.645 ' HE1' ' CE2' ' B' ' 311' ' ' PHE . 97.4 m-85 63.31 23.77 13.94 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.872 0.368 . . . . 0.0 111.353 176.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 312' ' ' GLY . . . . . 0.496 ' O ' ' HD2' ' B' ' 314' ' ' PHE . . . 78.94 -75.21 2.07 Favored Glycine 0 N--CA 1.441 -1.026 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 20.4 tp 54.92 28.04 9.97 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.254 0.622 . . . . 0.0 111.103 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 314' ' ' PHE . . . . . 1.63 ' HE1' ' CE2' ' B' ' 314' ' ' PHE . 17.8 m-85 -139.4 -54.21 0.56 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.916 -177.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 11.3 t70 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 117.956 -1.021 . . . . 0.0 108.811 -179.902 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 mpp? . . . . . 0 N--CA 1.477 0.908 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.29 -178.65 4.24 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.453 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 25.6 p 50.88 30.14 4.96 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.374 0.67 . . . . 0.0 112.26 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.453 ' HA ' HD13 ' A' ' 7' ' ' LEU . 5.6 m -72.45 -24.67 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.692 -176.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.5 m -64.64 -55.92 17.12 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.724 177.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -59.79 -43.42 94.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.306 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 3' ' ' SER . 90.6 mt -52.61 -52.51 55.04 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.896 0.379 . . . . 0.0 110.594 175.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.04 -51.0 71.92 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.621 -176.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.6 t -72.06 -23.8 61.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.376 -176.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.5 tp -82.72 -39.1 15.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.282 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 1.659 ' HE2' ' CE1' ' A' ' 11' ' ' TYR . 20.9 m-85 -68.63 -38.76 80.76 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.3 p -64.65 -46.58 81.89 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.038 174.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -44.74 -53.81 6.96 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.625 0.37 . . . . 0.0 111.496 173.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.494 ' HB2' ' HE1' ' B' ' 201' ' ' MET . 3.6 pp -79.43 -27.11 41.7 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.505 -178.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.48 ' N ' HD13 ' A' ' 14' ' ' LEU . 17.2 mt -65.0 -41.03 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.051 0.453 . . . . 0.0 110.621 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.92 -27.75 55.03 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 174.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.493 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -78.4 13.95 1.39 Allowed 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 176.54 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -83.92 -31.22 25.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.316 0.579 . . . . 0.0 109.75 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.56 ' CG ' ' H ' ' A' ' 20' ' ' GLU . 19.7 t70 -126.92 -157.01 0.78 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.5 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.56 ' H ' ' CG ' ' A' ' 19' ' ' ASP . 31.5 mt-10 -86.57 -5.64 59.09 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.184 0.516 . . . . 0.0 110.668 -178.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.5 t -57.7 132.54 22.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.913 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.39 151.25 47.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.345 -175.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.5 m -100.83 35.85 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.48 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.9 p -88.14 179.35 6.41 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.252 -173.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.495 ' HG3' ' N ' ' A' ' 26' ' ' ASP . 14.0 pt-20 -43.84 -50.66 7.84 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.631 -177.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.495 ' N ' ' HG3' ' A' ' 25' ' ' GLU . 10.6 t70 -55.86 -41.3 74.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.151 -175.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.568 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 3.4 mptp? -83.83 -45.33 13.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.552 -170.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.538 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 9.3 mt -66.33 -42.9 91.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.35 178.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -61.75 -46.4 89.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.133 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.29 -44.08 97.35 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.48 -39.3 62.57 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-O 121.598 0.713 . . . . 0.0 110.595 -175.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.538 ' HB ' ' O ' ' A' ' 28' ' ' ILE . 1.1 mp -60.52 -34.03 56.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.119 173.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -75.5 -29.04 59.41 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.679 174.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.04 -36.29 83.52 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.774 178.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -94.33 -41.39 9.45 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.178 -0.609 . . . . 0.0 112.039 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.76 46.07 4.37 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.639 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.476 HG21 ' HA2' ' B' ' 213' ' ' GLY . 0.2 OUTLIER -97.68 164.44 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.959 0.409 . . . . 0.0 110.857 -176.288 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -102.42 98.91 8.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.365 -176.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.0 p -131.7 129.03 61.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.517 176.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.421 ' C ' ' H ' ' A' ' 42' ' ' PHE . 16.8 pt-20 -62.25 133.88 94.48 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -178.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.43 -7.92 0.59 Allowed 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 123.969 3.113 . . . . 0.0 113.828 -174.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 1.62 ' HD2' ' CD1' ' A' ' 42' ' ' PHE . 0.5 OUTLIER -69.4 -36.8 77.1 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.072 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.529 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 89.1 m95 -70.93 -54.37 7.7 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 119.248 -0.406 . . . . 0.0 111.227 178.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.529 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 78.4 Cg_exo -49.98 -50.3 13.7 Favored 'Trans proline' 0 C--N 1.363 1.33 0 C-N-CA 122.004 1.803 . . . . 0.0 112.839 174.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.48 -50.06 71.73 Favored Glycine 0 C--O 1.24 0.523 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.209 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.421 HD23 ' HA2' ' A' ' 64' ' ' GLY . 60.8 tp -55.96 -53.11 60.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.511 -0.345 . . . . 0.0 110.776 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -59.92 -40.8 90.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.791 -177.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.59 -38.21 90.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.663 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -92.18 -8.51 45.31 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.65 -46.62 4.29 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.632 ' HA ' HG21 ' A' ' 54' ' ' VAL . 2.0 mp -84.05 -130.41 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.231 -175.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 66.94 3.62 3.17 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.375 0.67 . . . . 0.0 112.735 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -145.7 -51.4 0.25 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.632 HG21 ' HA ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -53.07 121.92 2.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 113.901 -1.499 . . . . 0.0 111.512 174.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.403 HD21 ' C ' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -58.01 158.36 6.82 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.481 175.461 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.466 ' O ' HD11 ' A' ' 59' ' ' LEU . 3.8 tp -40.53 -46.46 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 124.828 1.251 . . . . 0.0 114.371 -172.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.41 -20.3 22.17 Favored Glycine 0 N--CA 1.467 0.705 0 C-N-CA 121.272 -0.489 . . . . 0.0 113.587 -174.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 43.5 t -55.44 -25.34 35.66 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 122.467 0.307 . . . . 0.0 111.066 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.466 HD11 ' O ' ' A' ' 56' ' ' ILE . 9.8 mp -55.61 -32.29 62.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.311 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.3 mt -94.14 -3.64 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.522 0.677 . . . . 0.0 110.722 -175.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 55.1 m -114.85 -56.67 2.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.025 0.44 . . . . 0.0 111.187 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -97.25 66.47 2.07 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.155 -173.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.9 m -76.79 -16.4 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.77 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.421 ' HA2' HD23 ' A' ' 46' ' ' LEU . . . 163.63 120.82 0.54 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.303 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -156.62 -166.31 2.09 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -99.58 -84.08 1.77 Allowed Glycine 0 CA--C 1.518 0.22 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.045 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.75 79.75 0.1 Allowed Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.077 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -84.32 70.41 5.88 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.525 2.15 . . . . 0.0 112.161 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.81 135.92 74.14 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.869 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -64.72 -57.22 0.32 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.9 2.4 . . . . 0.0 112.51 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 62.79 176.57 0.15 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.504 0.502 . . . . 0.0 111.939 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -157.05 154.0 28.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.769 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 161.8 -172.05 37.88 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.06 -0.59 . . . . 0.0 111.955 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -91.66 86.05 5.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.071 0.462 . . . . 0.0 111.239 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -94.49 135.2 24.35 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.711 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 50.2 Cg_exo -58.02 163.77 9.19 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 124.016 3.144 . . . . 0.0 113.349 -178.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.31 128.66 36.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.468 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -136.79 77.0 0.36 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.678 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 163.7 -78.8 0.14 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.303 -178.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.51 155.01 70.52 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.033 2.489 . . . . 0.0 112.913 -176.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -109.19 123.76 35.91 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.497 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -68.46 56.04 0.88 Allowed 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.186 2.59 . . . . 0.0 113.358 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.3 t -133.59 141.52 47.71 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.015 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 96.5 m 72.29 123.43 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.501 0.667 . . . . 0.0 111.558 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -99.74 47.6 0.95 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.367 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 64.78 -179.28 0.18 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.153 176.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.21 115.54 3.15 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.708 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -57.41 104.7 0.16 Allowed 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 123.044 2.496 . . . . 0.0 112.772 177.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -96.56 80.65 3.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.936 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -100.4 130.1 46.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.81 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -103.11 -76.54 0.58 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 172.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 93.4 mttt 60.17 83.04 0.14 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.142 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -61.96 124.57 21.15 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.291 -178.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.0 m -64.68 142.5 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.41 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -91.06 13.48 16.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.756 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.17 109.98 9.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.113 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -64.22 146.91 53.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.847 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 99' ' ' GLU . 47.0 mmtm -81.03 -42.33 21.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.255 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 7.1 tp10 174.01 -74.57 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 O-C-N 123.757 0.661 . . . . 0.0 109.798 178.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 71.38 134.57 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.921 0.763 . . . . 0.0 111.725 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.8 t -139.79 125.93 19.92 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.364 -178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 44.5 mt-10 -128.09 12.86 6.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.065 177.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 102' ' ' GLU . 34.8 mm-40 67.43 178.19 0.24 Allowed 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.759 0.662 . . . . 0.0 110.231 -170.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.5 t -91.85 76.73 5.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.005 0.431 . . . . 0.0 110.536 -177.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -88.03 113.06 23.29 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.594 176.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -87.61 -179.75 6.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.117 0.484 . . . . 0.0 111.28 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -138.79 61.76 1.56 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.669 0.747 . . . . 0.0 109.807 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 26.3 ttt -136.43 137.56 40.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.647 178.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -70.54 125.15 13.54 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.457 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 1.627 ' HD1' ' CD2' ' A' ' 110' ' ' PHE . 0.2 OUTLIER -82.41 -174.74 5.34 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.591 0.234 . . . . 0.0 111.242 -178.626 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.18 -100.23 0.02 OUTLIER Glycine 0 C--N 1.333 0.377 0 C-N-CA 121.266 -0.492 . . . . 0.0 113.251 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.0 tp -148.36 68.26 1.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.435 -0.45 . . . . 0.0 111.31 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -92.74 8.72 38.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.224 169.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.367 -0.825 . . . . 0.0 110.25 179.655 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 201' ' ' MET . . . . . 0.494 ' HE1' ' HB2' ' A' ' 14' ' ' LEU . 81.6 mtp -117.46 163.69 16.0 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 202' ' ' ARG . . . . . 0.444 ' HD3' HG11 ' B' ' 242' ' ' VAL . 12.8 ptp180 175.89 -168.11 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 O-C-N 123.9 0.75 . . . . 0.0 109.594 -178.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 203' ' ' TYR . . . . . 1.64 ' HD2' ' CD1' ' B' ' 203' ' ' TYR . 48.0 m-85 -66.59 3.74 0.93 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.962 0.411 . . . . 0.0 112.014 -177.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.586 ' O ' HD11 ' B' ' 208' ' ' LEU . 5.4 p -56.46 -55.47 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.209 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 205' ' ' ALA . . . . . 0.484 ' CB ' HD12 ' A' ' 14' ' ' LEU . . . -74.12 -8.15 55.12 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.989 -176.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 206' ' ' SER . . . . . 0.6 ' OG ' HG21 ' B' ' 223' ' ' ILE . 8.0 t -78.96 -37.8 38.59 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 173.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 207' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -64.25 -42.84 96.32 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 172.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.586 HD11 ' O ' ' B' ' 204' ' ' VAL . 7.5 mp -56.82 -48.28 78.35 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.927 174.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 209' ' ' LEU . . . . . 0.41 ' CD2' ' HB2' ' A' ' 11' ' ' TYR . 0.3 OUTLIER -54.93 -53.43 55.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.356 -179.75 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -61.67 -39.33 91.01 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.094 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 211' ' ' ALA . . . . . 0.717 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -69.32 -51.87 32.83 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.04 0.448 . . . . 0.0 110.931 -178.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.8 -35.86 69.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.645 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . 0.476 ' HA2' HG21 ' A' ' 37' ' ' VAL . . . -54.49 -52.43 45.02 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.294 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 163.08 31.29 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.279 -0.963 . . . . 0.0 112.336 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 215' ' ' ASN . . . . . 0.717 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 50.5 m-20 -136.02 105.24 5.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.699 0.285 . . . . 0.0 110.479 -176.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 16.4 m -61.21 -21.69 64.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.944 0.402 . . . . 0.0 111.339 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 20.3 m -128.54 73.99 80.36 Favored Pre-proline 0 N--CA 1.443 -0.788 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.563 -174.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -58.69 121.12 9.43 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.62 2.88 . . . . 0.0 112.72 175.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 15.1 m -89.95 158.57 17.33 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.46 -36.01 66.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.512 0.672 . . . . 0.0 109.738 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -62.05 -34.82 76.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.921 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 222' ' ' ASP . . . . . 0.404 ' HA ' ' HZ1' ' B' ' 225' ' ' LYS . 31.6 m-20 -73.58 -47.54 39.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.702 -178.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.6 HG21 ' OG ' ' B' ' 206' ' ' SER . 1.8 mp -59.78 -45.41 94.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 224' ' ' LYS . . . . . 0.401 ' HG3' ' OD1' ' B' ' 228' ' ' ASP . 7.3 ttmm -62.25 -36.7 82.83 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.117 175.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' B' ' 229' ' ' SER . 6.4 ttpm? -60.48 -45.55 93.32 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.764 176.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.07 -38.35 82.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.7 0.286 . . . . 0.0 111.149 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 87.6 mt -76.44 -46.25 27.86 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 228' ' ' ASP . . . . . 0.401 ' OD1' ' HG3' ' B' ' 224' ' ' LYS . 1.3 m-20 -74.59 -14.57 60.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.883 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 229' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' B' ' 225' ' ' LYS . 23.0 t -54.35 -47.1 72.94 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.089 0.471 . . . . 0.0 109.938 172.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 29.0 t -90.29 -34.05 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 121.471 0.653 . . . . 0.0 109.612 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 91.87 72.68 1.23 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.539 176.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 8.4 mt -95.53 -97.46 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 122.522 -0.399 . . . . 0.0 109.926 176.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -136.09 -78.17 0.42 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 173.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . 60.41 81.64 0.18 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.623 0.577 . . . . 0.0 112.231 174.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' B' ' 237' ' ' ASP . 0.6 OUTLIER -62.15 133.12 54.82 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.357 179.533 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.81 36.69 0.11 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.697 0.761 . . . . 0.0 111.255 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 237' ' ' ASP . . . . . 0.503 ' H ' ' C ' ' B' ' 235' ' ' ASP . 15.9 t70 -147.92 -57.65 0.24 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.669 -1.15 . . . . 0.0 107.914 176.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.433 ' O ' HG21 ' B' ' 242' ' ' VAL . 8.5 ttm-85 -57.56 -42.0 82.15 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.52 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 239' ' ' LEU . . . . . 0.588 ' HA ' ' CD2' ' B' ' 203' ' ' TYR . 10.1 tt -57.85 -62.22 1.96 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.381 -176.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -67.83 -20.0 65.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.362 -178.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -66.91 -47.2 72.5 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.288 0.566 . . . . 0.0 109.945 174.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 242' ' ' VAL . . . . . 0.519 ' O ' HD13 ' B' ' 246' ' ' LEU . 91.7 t -66.35 -39.26 83.7 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.393 179.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . 0.589 ' HA ' ' CD1' ' B' ' 246' ' ' LEU . 13.1 mt -65.52 -32.87 60.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.401 177.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 34.4 t -61.59 -39.24 90.48 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 171.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 245' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' B' ' 242' ' ' VAL . 93.1 mt-10 -63.91 -58.05 7.93 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.844 174.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . 0.603 ' O ' HD23 ' B' ' 246' ' ' LEU . 0.0 OUTLIER -103.65 37.18 2.09 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -170.033 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -57.6 154.74 10.86 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.043 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -51.69 107.62 0.48 Allowed Glycine 0 CA--C 1.519 0.294 0 CA-C-N 115.556 -0.747 . . . . 0.0 114.315 -173.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -135.07 -74.39 0.46 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -108.94 58.91 0.6 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.545 0.688 . . . . 0.0 109.191 175.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.5 ' O ' HG13 ' B' ' 254' ' ' VAL . 0.3 OUTLIER -64.81 -39.7 86.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.698 -176.036 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -66.63 -37.14 84.23 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.435 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.49 -49.43 75.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.943 0.402 . . . . 0.0 110.179 175.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 254' ' ' VAL . . . . . 0.5 HG13 ' O ' ' B' ' 251' ' ' ILE . 6.2 p -68.3 -22.28 27.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.893 -176.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 255' ' ' ILE . . . . . . . . . . . . . 56.1 mt -79.19 -45.25 24.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 120.938 0.399 . . . . 0.0 110.631 173.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -61.55 -28.47 69.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.854 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -120.33 50.66 1.28 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' B' ' 254' ' ' VAL . . . -71.0 -47.16 39.8 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.377 -0.829 . . . . 0.0 113.784 -171.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 6.6 pt -64.18 -45.9 95.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.869 0.334 . . . . 0.0 111.043 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 46.89 -110.61 0.57 Allowed Glycine 0 C--N 1.335 0.492 0 O-C-N 123.626 0.579 . . . . 0.0 113.018 175.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -129.04 45.47 2.79 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 262' ' ' LEU . . . . . . . . . . . . . 9.2 mp -77.2 89.88 3.68 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 122.106 0.955 . . . . 0.0 110.926 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -139.22 17.0 2.6 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.22 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 264' ' ' SER . . . . . 0.409 ' H ' ' HG3' ' B' ' 201' ' ' MET . 8.0 t 71.09 -49.35 0.68 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.447 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 45.1 t -55.0 134.0 67.64 Favored Pre-proline 0 C--N 1.329 -0.297 0 O-C-N 123.432 0.458 . . . . 0.0 111.087 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.05 -50.49 2.91 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.223 2.615 . . . . 0.0 112.574 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . -169.21 149.92 4.27 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.886 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . -90.64 77.07 1.53 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.906 -178.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -73.39 72.4 1.2 Allowed Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.764 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -102.18 89.52 3.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.943 0.401 . . . . 0.0 110.862 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 10.5 t -95.61 137.16 24.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.223 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -116.0 141.52 48.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.62 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.66 136.47 55.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.025 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 4.8 m -105.48 148.38 27.26 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.46 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -109.5 164.56 12.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.0 0.429 . . . . 0.0 111.125 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -136.03 97.57 12.2 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.444 0.64 . . . . 0.0 110.668 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 277' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -83.93 152.62 12.87 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 123.487 2.792 . . . . 0.0 113.485 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -103.06 -176.4 26.6 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.436 177.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 58.6 m -122.84 -167.66 1.62 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.474 0.637 . . . . 0.0 112.369 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . -60.4 148.65 36.52 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.98 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -130.79 89.4 43.27 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.625 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -67.11 135.25 36.7 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.705 2.27 . . . . 0.0 112.283 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -112.39 133.89 54.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.639 -178.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.13 118.16 10.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.77 0.319 . . . . 0.0 110.604 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -88.28 -56.03 2.11 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.9 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 35.0 t 71.96 127.63 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.388 0.613 . . . . 0.0 111.573 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 287' ' ' ALA . . . . . 0.4 ' HA ' ' HD3' ' B' ' 288' ' ' PRO . . . -129.32 109.89 17.84 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.112 177.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 288' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' B' ' 287' ' ' ALA . 5.9 Cg_exo -70.11 142.42 46.36 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.924 2.416 . . . . 0.0 113.144 -174.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -100.79 119.73 39.07 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.82 122.06 16.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.288 -175.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -75.08 151.19 38.67 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . 0.515 ' O ' ' HG2' ' B' ' 294' ' ' LYS . 44.3 mt-10 -49.74 -70.72 0.08 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.248 0.342 . . . . 0.0 110.906 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 52.59 31.46 10.09 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.81 0.814 . . . . 0.0 110.694 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' B' ' 292' ' ' GLU . 31.9 mmmt -120.44 129.04 53.71 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 176.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -87.08 127.33 35.12 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.893 0.378 . . . . 0.0 110.231 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -107.83 136.69 47.13 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.342 0.592 . . . . 0.0 110.583 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -124.44 159.41 30.53 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.453 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -141.84 162.03 36.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.909 0.385 . . . . 0.0 110.705 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 299' ' ' LYS . . . . . 0.442 ' HZ2' ' HB3' ' B' ' 299' ' ' LYS . 1.2 ptpm? -121.88 -177.61 3.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.463 178.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 69.05 179.48 0.24 Allowed 'General case' 0 N--CA 1.466 0.329 0 O-C-N 124.021 0.826 . . . . 0.0 111.433 -178.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 45.3 37.18 2.64 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.348 1.059 . . . . 0.0 112.625 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 48.8 m -151.26 102.4 2.92 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.836 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -103.7 156.22 17.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.38 -177.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -92.0 166.04 12.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.427 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.41 103.15 13.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.846 0.355 . . . . 0.0 110.446 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -92.08 32.59 1.14 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.101 0.477 . . . . 0.0 110.894 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.99 -45.45 85.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.325 -176.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -62.27 -61.35 2.52 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.106 0.409 . . . . 0.0 112.106 -173.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -78.39 58.9 2.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.931 0.396 . . . . 0.0 111.425 -177.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . -86.31 -70.24 1.32 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.175 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 311' ' ' PHE . . . . . 1.629 ' HD2' ' CD1' ' B' ' 311' ' ' PHE . 85.7 m-85 -112.0 20.22 17.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.719 0.295 . . . . 0.0 111.296 -178.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . -87.69 49.31 3.84 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.137 -177.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 7.2 mp -94.65 4.53 53.72 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 175.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 314' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -98.62 -47.89 5.18 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.442 -170.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 28.6 t70 . . . . . 0 C--O 1.244 0.813 0 O-C-N 124.178 0.924 . . . . 0.0 111.104 -177.108 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.2 mtp . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.32 -106.69 0.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -175.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.431 ' HB3' ' HG2' ' A' ' 6' ' ' GLU . 24.7 m -97.41 69.04 2.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.341 0.591 . . . . 0.0 111.575 -174.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.424 HG11 ' CD2' ' B' ' 212' ' ' LEU . 20.7 t -67.1 -26.61 36.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.342 0.591 . . . . 0.0 109.684 -175.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.563 ' OG ' HG21 ' A' ' 39' ' ' VAL . 31.9 t -61.02 -65.62 0.66 Allowed 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.928 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.689 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 10.7 pt-20 -68.57 -31.55 70.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.64 -175.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 35.7 mt -55.92 -53.63 54.55 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 172.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.416 ' HB1' HG12 ' A' ' 37' ' ' VAL . . . -56.91 -52.69 64.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.91 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.689 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 24.6 p -70.73 -26.87 63.57 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.586 -173.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 1.1 tp -78.26 -38.52 23.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.698 0.285 . . . . 0.0 111.408 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 1.633 ' HE2' ' CE1' ' A' ' 11' ' ' TYR . 21.8 m-85 -72.34 -26.78 62.05 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.8 t -69.59 -51.6 33.73 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.219 171.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -47.96 -54.03 14.13 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.353 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.563 ' HB2' ' HE2' ' B' ' 201' ' ' MET . 2.9 pp -76.54 -29.95 56.92 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.651 -176.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.542 ' N ' HD13 ' A' ' 14' ' ' LEU . 3.8 mt -59.47 -31.0 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 118.522 0.601 . . . . 0.0 110.487 173.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.7 mp -86.73 -25.59 24.65 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.205 176.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -85.17 62.54 7.56 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -177.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -138.29 -57.27 0.65 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 120.856 -0.337 . . . . 0.0 111.506 172.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.603 ' CG ' ' H ' ' A' ' 20' ' ' GLU . 17.3 t70 -91.47 -151.3 0.26 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.743 0.306 . . . . 0.0 111.393 -176.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.603 ' H ' ' CG ' ' A' ' 19' ' ' ASP . 16.9 tp10 -88.67 -6.6 57.37 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.584 0.707 . . . . 0.0 109.634 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 68.7 t -64.76 106.61 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.655 178.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.565 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 2.7 p -66.11 150.63 48.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.075 -177.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.8 m -84.31 49.51 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.358 -174.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.4 p -81.83 164.12 21.85 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -49.77 -46.25 50.47 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.415 -178.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -58.57 -34.94 71.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.059 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.565 ' HG3' ' O ' ' A' ' 22' ' ' THR . 32.7 mmtp -75.71 -51.36 12.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.759 -175.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.1 mt -62.07 -41.28 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.151 176.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.441 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 6.9 t30 -53.81 -52.2 61.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.812 173.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.19 -44.95 79.92 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.761 0.315 . . . . 0.0 111.815 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.466 HD23 HG21 ' B' ' 226' ' ' ILE . 2.6 tm? -65.09 -46.03 82.76 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.495 0.665 . . . . 0.0 109.883 -178.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.04 -33.25 57.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.959 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 31.2 mmmt -77.68 -25.06 49.21 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.756 0.312 . . . . 0.0 111.006 176.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.13 -42.38 72.68 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.239 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.74 -41.66 11.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.702 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.51 10.92 56.42 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 121.034 -0.603 . . . . 0.0 113.253 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.472 HG21 ' HA3' ' B' ' 213' ' ' GLY . 3.2 t -70.7 140.77 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 O-C-N 122.467 -0.431 . . . . 0.0 110.577 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.69 89.72 5.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.296 -177.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.563 HG21 ' OG ' ' A' ' 5' ' ' SER . 7.6 p -110.93 127.58 67.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 172.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 12.3 pt-20 -59.53 134.71 88.93 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.261 -174.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 40' ' ' GLU . 50.5 Cg_exo -54.31 -5.2 0.36 Allowed 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 124.398 3.399 . . . . 0.0 114.634 -172.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 1.659 ' HD1' ' CD2' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -70.36 -41.72 72.76 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.685 177.521 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.571 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 94.8 m95 -68.73 -57.42 8.13 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.796 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.571 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 56.8 Cg_exo -52.15 -41.28 66.11 Favored 'Trans proline' 0 C--N 1.366 1.5 0 C-N-CA 121.749 1.633 . . . . 0.0 112.324 174.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.513 ' O ' ' HG2' ' A' ' 49' ' ' LYS . . . -59.71 -54.79 34.66 Favored Glycine 0 C--O 1.242 0.639 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.488 -179.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 57.6 mt -58.47 -50.6 73.16 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.652 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 6.2 m-85 -55.35 -51.01 68.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.365 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.09 -47.99 81.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.751 -0.658 . . . . 0.0 112.165 -176.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 45' ' ' GLY . 22.2 pttm -100.79 5.57 43.57 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 119.56 -0.856 . . . . 0.0 113.136 -174.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.24 1.85 3.24 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 47' ' ' PHE . 57.9 mt -84.99 -133.04 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 118.476 -1.29 . . . . 0.0 109.345 170.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 62.59 -13.16 0.07 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.543 ' H ' ' C ' ' A' ' 51' ' ' LEU . 18.5 m120 -128.2 3.99 5.8 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.564 ' CG2' ' HA ' ' A' ' 51' ' ' LEU . 61.5 t -95.88 103.03 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.154 -174.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -52.19 132.19 33.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.482 173.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.1 tp -45.04 -45.42 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -170.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.14 -26.01 57.93 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.364 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.0 t -65.49 -11.89 47.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.804 0.335 . . . . 0.0 110.492 -176.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 64.8 mt -57.69 -28.05 63.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.71 0.29 . . . . 0.0 110.675 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.3 tt -103.13 31.22 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.851 0.834 . . . . 0.0 110.926 -178.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.9 p -83.79 -177.45 6.69 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.966 173.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -78.15 48.37 0.73 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.718 0.294 . . . . 0.0 110.981 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.9 p -70.96 -34.09 54.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.084 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.98 64.03 4.34 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.741 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -129.35 152.55 48.78 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.902 0.382 . . . . 0.0 110.688 -178.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -87.36 72.03 2.59 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.893 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -163.6 165.61 36.91 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 121.1 -0.572 . . . . 0.0 111.988 -179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.02 -28.02 13.41 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 122.665 2.243 . . . . 0.0 112.839 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.451 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . . . -147.27 133.74 9.79 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.175 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 69' ' ' ALA . 2.1 Cg_endo -82.75 53.32 4.38 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.632 2.222 . . . . 0.0 112.219 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 65.78 -170.04 0.2 Allowed 'General case' 0 N--CA 1.463 0.187 0 O-C-N 123.538 0.524 . . . . 0.0 111.096 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 57.17 72.93 0.48 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.277 0.56 . . . . 0.0 111.872 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.56 38.3 3.17 Favored Glycine 0 C--O 1.229 -0.16 0 C-N-CA 120.854 -0.689 . . . . 0.0 111.587 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.38 159.43 15.01 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.469 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -122.93 117.81 28.42 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-O 120.786 0.327 . . . . 0.0 110.674 -178.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 24.0 Cg_exo -68.86 60.71 1.24 Allowed 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 123.804 3.003 . . . . 0.0 113.178 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -154.52 106.12 2.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.99 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -107.23 89.17 0.57 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.604 -176.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.6 165.03 11.13 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.005 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -78.92 -61.11 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.935 2.423 . . . . 0.0 112.207 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -140.78 90.6 9.59 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.801 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -50.47 126.2 17.24 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.144 2.563 . . . . 0.0 113.256 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.6 t -156.94 136.1 11.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.838 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.2 t -110.44 69.68 0.7 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.016 0.912 . . . . 0.0 110.221 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.04 98.99 1.03 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.822 -177.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 58.6 45.15 16.55 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.859 175.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -126.84 109.36 22.31 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.241 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -55.65 148.07 56.44 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.11 2.54 . . . . 0.0 112.463 176.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -113.04 8.52 18.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.398 0.618 . . . . 0.0 110.263 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -77.9 69.65 4.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.765 0.793 . . . . 0.0 110.646 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -87.75 174.78 8.19 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.902 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -71.91 110.23 6.28 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.392 -174.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -121.75 94.29 4.27 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.852 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.3 t -131.24 100.97 4.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.228 -178.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.8 -32.5 5.45 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.102 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 97' ' ' LYS . . . -62.87 -73.86 0.1 Allowed 'General case' 0 C--N 1.332 -0.184 0 O-C-N 123.16 0.288 . . . . 0.0 111.743 -176.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 96' ' ' ALA . 52.0 mtmt 64.09 172.44 0.18 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.38 0.61 . . . . 0.0 111.828 -175.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -145.55 150.05 35.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.771 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' A' ' 99' ' ' GLU . 1.1 pm0 -75.15 148.53 39.54 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.841 178.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.8 24.78 4.33 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.818 0.818 . . . . 0.0 111.398 178.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.3 m -108.35 127.27 53.73 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.91 -177.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -124.46 69.24 1.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.479 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 57.5 70.28 0.67 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.632 0.73 . . . . 0.0 111.955 176.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.4 p -128.1 139.1 52.7 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.117 -178.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -113.82 -165.45 1.0 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.105 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -60.52 -50.24 74.33 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.3 t70 58.25 78.09 0.26 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.683 0.754 . . . . 0.0 110.795 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 72.3 mtm -104.49 140.94 37.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.298 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -72.99 -26.04 72.11 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.606 -176.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -93.63 101.0 13.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.139 0.469 . . . . 0.0 110.5 176.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -76.17 1.93 58.26 Favored Glycine 0 CA--C 1.519 0.286 0 CA-C-N 115.791 -0.64 . . . . 0.0 113.341 -177.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.9 tp 59.67 65.47 1.14 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 121.453 0.644 . . . . 0.0 110.964 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -75.65 -33.34 60.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.201 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 . . . . . 0 C--O 1.247 0.938 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.749 178.424 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 201' ' ' MET . . . . . 0.563 ' HE2' ' HB2' ' A' ' 14' ' ' LEU . 25.5 ptt? -132.38 166.51 21.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.013 -176.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 202' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' B' ' 201' ' ' MET . 20.9 mtm180 -176.54 -65.07 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 O-C-N 123.824 0.702 . . . . 0.0 109.942 171.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 203' ' ' TYR . . . . . 1.648 ' HD2' ' CD1' ' B' ' 203' ' ' TYR . 8.1 m-85 -89.58 -21.12 23.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.633 -174.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.577 ' O ' HD11 ' B' ' 208' ' ' LEU . 47.0 t -56.54 -65.36 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.63 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 205' ' ' ALA . . . . . 0.551 ' HA ' ' HB2' ' B' ' 208' ' ' LEU . . . -69.38 -6.56 30.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.215 -177.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 206' ' ' SER . . . . . 0.534 ' OG ' HG21 ' B' ' 223' ' ' ILE . 8.6 t -78.94 -42.44 26.93 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 207' ' ' TYR . . . . . 0.532 ' CZ ' ' HD2' ' B' ' 218' ' ' PRO . 29.3 t80 -65.47 -39.18 91.66 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 172.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.577 HD11 ' O ' ' B' ' 204' ' ' VAL . 9.1 mp -55.3 -51.11 67.77 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.416 173.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 209' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.51 -59.81 4.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.952 -178.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -60.75 -32.33 71.62 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -177.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 211' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -81.19 -32.0 33.73 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 122.015 -0.428 . . . . 0.0 111.308 178.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 212' ' ' LEU . . . . . 0.424 ' CD2' HG11 ' A' ' 4' ' ' VAL . 2.3 tm? -64.84 -43.12 94.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.718 177.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . 0.472 ' HA3' HG21 ' A' ' 37' ' ' VAL . . . -152.82 90.15 0.13 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.239 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 172.33 -62.91 0.14 Allowed Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 111.829 -0.508 . . . . 0.0 111.829 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 215' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 56.4 t30 -161.4 142.61 11.37 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 8.6 m -64.4 -24.56 67.68 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.23 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 12.3 t -124.04 73.15 56.15 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.708 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . 0.532 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 57.9 Cg_exo -56.57 116.54 3.27 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.183 2.589 . . . . 0.0 112.438 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 83.4 p -82.84 162.21 21.7 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.048 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -54.91 -35.53 64.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.016 0.436 . . . . 0.0 110.332 177.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -68.76 -34.87 76.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.467 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -70.28 -43.71 69.88 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.359 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.534 HG21 ' OG ' ' B' ' 206' ' ' SER . 1.8 mp -64.85 -44.39 96.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 123.271 0.357 . . . . 0.0 110.085 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -55.56 -43.49 75.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.162 173.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . 0.505 ' HZ1' ' HB3' ' B' ' 225' ' ' LYS . 7.6 ttpm? -56.6 -51.25 69.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.077 178.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.466 HG21 HD23 ' A' ' 31' ' ' LEU . 1.1 mp -68.47 -35.47 70.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.771 -177.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . 0.401 ' CD1' ' HB ' ' B' ' 232' ' ' ILE . 0.2 OUTLIER -75.43 -35.11 61.02 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.549 0.69 . . . . 0.0 109.947 -179.431 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -76.19 -30.04 57.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.584 -177.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 85.5 p -55.33 -45.3 76.38 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.556 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 59.4 t -75.84 -33.3 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 121.117 0.484 . . . . 0.0 110.663 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 103.98 38.83 2.62 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.862 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . 0.401 ' HB ' ' CD1' ' B' ' 227' ' ' LEU . 4.3 mt -109.38 135.41 48.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -66.54 118.33 10.0 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.655 0.74 . . . . 0.0 112.219 -173.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -117.5 135.55 53.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.03 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . 0.468 ' HB2' ' HB2' ' B' ' 238' ' ' ARG . 51.4 m-20 -86.43 115.21 23.79 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.185 -176.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 236' ' ' ASP . . . . . 0.594 ' O ' ' HG ' ' B' ' 239' ' ' LEU . 9.5 t70 -45.86 -60.53 2.18 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.131 0.894 . . . . 0.0 112.415 -170.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -63.92 -42.61 97.34 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.468 ' HB2' ' HB2' ' B' ' 235' ' ' ASP . 77.5 mtt180 -66.21 -36.0 81.92 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.15 -172.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 239' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' B' ' 236' ' ' ASP . 4.4 pp -68.44 -44.85 74.03 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.689 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 240' ' ' ASN . . . . . 0.485 ' N ' HD13 ' B' ' 239' ' ' LEU . 3.9 t-20 -66.14 -33.21 75.26 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 121.34 -0.144 . . . . 0.0 110.759 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -62.15 -52.45 63.79 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-O 121.224 0.535 . . . . 0.0 110.315 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 242' ' ' VAL . . . . . 0.568 HG12 ' HB2' ' B' ' 203' ' ' TYR . 12.5 p -66.48 -37.84 80.45 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.654 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -176.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . 0.551 ' HA ' ' HB2' ' B' ' 246' ' ' LEU . 57.3 mt -66.6 -31.61 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.513 176.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 8.8 t -65.06 -33.69 76.63 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 175.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -86.65 -26.16 24.48 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.731 175.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . 0.551 ' HB2' ' HA ' ' B' ' 243' ' ' ILE . 9.5 mt -75.45 -19.5 59.42 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.666 0.386 . . . . 0.0 110.657 175.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -63.49 97.85 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.874 -173.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 175.66 -175.78 47.34 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.135 -177.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -85.89 0.68 52.47 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -79.62 -0.52 34.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.956 0.408 . . . . 0.0 110.797 -175.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.489 ' HA ' HG23 ' B' ' 254' ' ' VAL . 7.7 tp -61.72 -38.31 80.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.289 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -65.11 -34.91 79.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.106 0.479 . . . . 0.0 110.153 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -67.58 -45.45 75.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.632 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 254' ' ' VAL . . . . . 0.489 HG23 ' HA ' ' B' ' 251' ' ' ILE . 26.0 m -74.64 -10.94 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.2 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 255' ' ' ILE . . . . . 0.477 HG12 ' O ' ' B' ' 251' ' ' ILE . 24.0 mm -78.25 -53.15 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.003 0.43 . . . . 0.0 109.881 168.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -63.05 -42.41 99.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.328 -176.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -119.51 56.99 0.92 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.585 0.707 . . . . 0.0 109.887 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -105.79 -99.36 2.6 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.034 177.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 259' ' ' ILE . . . . . 0.432 ' O ' ' HG ' ' B' ' 262' ' ' LEU . 23.4 mt 20.25 -88.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.998 1.319 . . . . 0.0 113.334 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 48.99 -118.43 5.04 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-O 121.547 0.526 . . . . 0.0 114.328 170.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 261' ' ' LYS . . . . . 0.419 ' HZ2' ' HB3' ' B' ' 261' ' ' LYS . 0.1 OUTLIER -142.24 54.47 1.45 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 262' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' B' ' 259' ' ' ILE . 8.4 mt -54.62 -33.63 60.81 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.318 -173.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -58.86 -52.24 66.57 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.718 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 19.5 t 72.07 129.7 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 O-C-N 124.243 0.965 . . . . 0.0 110.249 -175.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 6.3 m -65.2 140.35 97.88 Favored Pre-proline 0 N--CA 1.448 -0.575 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.684 -177.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.85 3.63 5.88 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.342 2.695 . . . . 0.0 113.273 -174.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . 41.89 63.03 1.42 Allowed 'General case' 0 N--CA 1.466 0.345 0 O-C-N 124.098 0.874 . . . . 0.0 112.347 173.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 115.15 -48.35 0.95 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.402 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . 113.02 51.05 0.53 Allowed Glycine 0 N--CA 1.454 -0.143 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.53 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -139.62 73.66 1.44 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.197 0.522 . . . . 0.0 110.529 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 11.0 t -121.07 147.68 24.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.267 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . 60.18 45.92 11.05 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.794 0.807 . . . . 0.0 111.866 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 24.7 t -109.8 79.75 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.462 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 12.9 m -139.69 122.6 16.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.944 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . 56.38 48.98 15.91 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.912 0.757 . . . . 0.0 111.394 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -81.77 117.13 67.1 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.778 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 277' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -71.34 81.44 1.22 Allowed 'Trans proline' 0 CA--C 1.515 -0.44 0 C-N-CA 123.107 2.538 . . . . 0.0 111.765 178.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -139.73 31.49 2.3 Favored Glycine 0 N--CA 1.436 -1.357 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.348 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 25.1 m -100.22 153.59 19.15 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 177.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 64.96 -169.68 0.2 Allowed 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 124.116 0.885 . . . . 0.0 111.466 174.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . 56.59 75.29 0.59 Allowed Pre-proline 0 N--CA 1.467 0.381 0 O-C-N 123.623 0.577 . . . . 0.0 111.226 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.53 110.88 1.34 Allowed 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.894 2.396 . . . . 0.0 113.6 -173.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . 67.52 162.72 0.19 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.514 174.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -114.26 18.92 16.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.618 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -132.83 19.51 4.42 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.935 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.65 114.38 13.0 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.21 0.529 . . . . 0.0 111.22 -178.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -142.67 132.5 12.15 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.616 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -62.53 102.66 0.29 Allowed 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.965 2.443 . . . . 0.0 112.665 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -126.99 72.48 1.36 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.182 0.515 . . . . 0.0 110.911 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -85.59 129.57 34.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.753 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -147.05 68.0 1.15 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.355 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -67.6 -55.03 14.99 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.335 -177.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -75.83 78.47 2.75 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.585 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -144.44 20.25 1.7 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -126.88 117.87 23.44 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 122.324 -0.235 . . . . 0.0 110.487 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -158.97 99.92 1.55 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.929 0.395 . . . . 0.0 110.751 176.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -97.31 68.58 2.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 171.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -52.87 163.78 0.45 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.564 178.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? 65.48 34.57 7.89 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.321 0.581 . . . . 0.0 109.693 -176.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -72.71 -41.08 65.64 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.55 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -54.33 121.9 9.25 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.361 177.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 9.8 p -76.86 81.98 3.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.896 0.379 . . . . 0.0 111.286 -177.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 67.93 178.09 0.24 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.594 177.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.1 109.88 0.73 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.295 0.569 . . . . 0.0 111.335 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 24.8 p -103.55 119.01 38.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.989 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -84.03 -12.5 55.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.62 0.724 . . . . 0.0 109.869 176.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 307' ' ' ASP . . . . . 0.531 ' CG ' ' H ' ' B' ' 308' ' ' ASP . 12.4 t70 63.67 -159.04 0.31 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.829 175.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . 0.531 ' H ' ' CG ' ' B' ' 307' ' ' ASP . 27.1 t70 -142.46 26.92 1.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 122.079 0.942 . . . . 0.0 109.243 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 22.6 ptt? -86.24 -11.66 51.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.671 176.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 111.58 88.57 1.82 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.792 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 100.0 m-85 62.69 76.67 0.36 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.95 0.405 . . . . 0.0 111.745 175.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . -92.64 35.73 3.95 Favored Glycine 0 N--CA 1.453 -0.19 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 313' ' ' LEU . . . . . 0.507 ' O ' HD11 ' B' ' 313' ' ' LEU . 2.6 tm? -72.24 -14.54 61.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.536 0.684 . . . . 0.0 109.287 178.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 314' ' ' PHE . . . . . 1.669 ' HE2' ' CE1' ' B' ' 314' ' ' PHE . 45.9 m-85 -71.94 -81.25 0.05 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.108 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.218 -0.896 . . . . 0.0 109.382 178.871 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mmt . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.94 -73.52 0.62 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.787 0.327 . . . . 0.0 110.365 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.578 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 5.6 m -78.65 54.62 1.52 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.543 177.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.417 HG21 ' HB2' ' B' ' 212' ' ' LEU . 13.3 p -71.68 -29.79 35.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.246 0.546 . . . . 0.0 109.753 -174.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.493 ' CB ' ' HA ' ' A' ' 39' ' ' VAL . 51.7 m -64.62 -52.06 59.39 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.944 176.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.408 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 35.6 tt0 -57.85 -45.45 86.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.04 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 3' ' ' SER . 82.6 mt -54.03 -53.78 48.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.356 176.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.07 -55.34 24.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.895 -177.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 21.6 p -67.43 -31.22 71.25 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.73 -176.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.434 HG13 HD21 ' A' ' 59' ' ' LEU . 0.9 OUTLIER -77.65 -37.64 24.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.921 0.391 . . . . 0.0 111.068 -176.892 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.626 ' O ' HG12 ' A' ' 15' ' ' ILE . 23.1 m-85 -74.61 -26.37 59.86 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.7 t -69.56 -44.78 70.16 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 172.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.94 -40.29 60.58 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.387 171.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.752 ' O ' ' HE2' ' B' ' 201' ' ' MET . 97.3 mt -60.48 -59.97 4.56 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 173.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.626 HG12 ' O ' ' A' ' 11' ' ' TYR . 36.3 mm -46.09 -34.4 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.3 mt -115.13 7.26 15.34 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -174.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -48.25 -62.47 1.47 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 19' ' ' ASP . 2.0 p-10 -120.73 -82.12 0.64 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.356 -176.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.56 ' OD2' ' HD2' ' B' ' 202' ' ' ARG . 5.2 t0 47.37 -152.59 0.09 Allowed 'General case' 0 CA--C 1.536 0.431 0 O-C-N 123.628 0.58 . . . . 0.0 111.28 178.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -112.05 22.52 14.74 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 168.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.426 HG12 HD13 ' B' ' 232' ' ' ILE . 4.1 p -128.41 158.67 40.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.59 -177.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.1 p -105.49 130.86 53.48 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 121.241 -0.183 . . . . 0.0 111.332 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -65.38 105.11 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.408 0.623 . . . . 0.0 110.52 175.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.4 ' OG1' ' HG2' ' A' ' 27' ' ' LYS . 22.3 p -133.91 168.48 18.69 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.379 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.427 ' HG3' ' N ' ' A' ' 26' ' ' ASP . 9.1 pt-20 -48.18 -48.53 34.56 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 123.659 0.599 . . . . 0.0 111.648 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.427 ' N ' ' HG3' ' A' ' 25' ' ' GLU . 7.5 p-10 -68.31 -27.84 66.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.251 -175.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.4 ' HG2' ' OG1' ' A' ' 24' ' ' THR . 46.2 mmtm -78.21 -45.1 23.93 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -176.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.5 mt -67.48 -41.7 86.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.779 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -55.57 -45.85 77.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.705 175.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.81 -49.6 72.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.324 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.411 ' CD1' ' HG ' ' B' ' 209' ' ' LEU . 0.2 OUTLIER -65.69 -38.6 89.7 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.211 0.529 . . . . 0.0 110.24 -177.276 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.3 mp -63.97 -35.86 74.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.255 176.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.582 ' HB3' ' HZ2' ' A' ' 33' ' ' LYS . 6.1 ttpm? -76.02 -21.69 56.57 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.919 0.39 . . . . 0.0 110.351 175.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.51 -48.71 21.35 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.444 ' HB3' HD13 ' B' ' 226' ' ' ILE . . . -143.27 8.27 1.6 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.38 89.93 1.55 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.115 -176.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.2 p -50.17 -50.8 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -175.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -161.63 126.52 3.47 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.946 0.403 . . . . 0.0 111.246 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.493 ' HA ' ' CB ' ' A' ' 5' ' ' SER . 7.2 p -139.17 127.53 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.431 173.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -57.07 125.62 70.8 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.029 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.99 -11.12 1.3 Allowed 'Trans proline' 0 N--CA 1.481 0.792 0 C-N-CA 124.042 3.162 . . . . 0.0 115.046 -168.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 1.617 ' HD1' ' CD2' ' A' ' 42' ' ' PHE . 0.7 OUTLIER -80.12 -28.18 39.02 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -174.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.413 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 98.7 m95 -64.68 -60.48 8.21 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.293 175.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.413 ' CD ' ' HB2' ' A' ' 43' ' ' TRP . 19.3 Cg_endo -59.74 -34.45 96.04 Favored 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 121.835 1.69 . . . . 0.0 111.939 178.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.91 -49.17 81.53 Favored Glycine 0 C--O 1.241 0.562 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.253 176.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 42' ' ' PHE . 89.8 mt -64.08 -47.18 81.09 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.401 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 5.2 m-85 -60.72 -47.02 88.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.843 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.72 -37.52 86.64 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.608 -176.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -91.49 -26.76 18.64 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 119.8 -0.76 . . . . 0.0 113.033 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -116.11 -20.13 10.0 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -171.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.572 ' HA ' ' CG2' ' A' ' 54' ' ' VAL . 2.2 tp -83.99 -133.87 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 58.08 3.16 0.22 Allowed 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -176.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.427 ' H ' ' C ' ' A' ' 51' ' ' LEU . 48.1 t-20 -145.57 -44.15 0.21 Allowed 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -177.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.572 ' CG2' ' HA ' ' A' ' 51' ' ' LEU . 48.7 t -40.91 112.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 114.0 -1.454 . . . . 0.0 110.745 172.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -54.67 140.47 35.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.071 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.603 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 3.4 tp -43.85 -51.94 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 124.043 0.84 . . . . 0.0 112.903 -173.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.28 -30.89 75.23 Favored Glycine 0 C--O 1.243 0.688 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.661 -176.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.5 t -65.25 -11.55 42.38 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -176.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.603 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 1.7 mp -43.06 -48.38 6.13 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.164 170.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.425 HD12 HG22 ' B' ' 259' ' ' ILE . 24.7 mm -110.05 44.46 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.628 0.728 . . . . 0.0 109.82 -178.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 48.9 t -119.58 -36.47 3.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.117 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -100.36 4.0 43.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.43 -177.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.1 p -62.7 -29.95 48.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 121.015 0.436 . . . . 0.0 111.299 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.76 -78.13 1.98 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.141 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -164.84 -53.78 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.845 0.355 . . . . 0.0 110.962 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.37 -125.08 8.15 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.464 -0.655 . . . . 0.0 111.464 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -167.14 156.29 28.01 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.828 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -86.64 -68.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.658 2.239 . . . . 0.0 112.558 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.63 96.63 2.77 Favored Pre-proline 0 N--CA 1.452 -0.326 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.1 178.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.72 169.69 18.28 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.61 2.207 . . . . 0.0 112.399 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 69.58 -71.68 0.12 Allowed 'General case' 0 N--CA 1.469 0.517 0 O-C-N 123.726 0.641 . . . . 0.0 111.503 -178.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 56.49 61.94 2.5 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.196 0.522 . . . . 0.0 111.286 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.05 -68.14 3.54 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.856 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 55.07 48.53 19.53 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 122.874 0.469 . . . . 0.0 111.716 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 68.17 117.03 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.861 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -48.26 131.94 23.09 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 124.12 3.213 . . . . 0.0 113.154 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.31 -177.22 3.96 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.271 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.44 164.97 40.74 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.94 -0.647 . . . . 0.0 113.075 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 160.95 -168.44 36.3 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.68 -0.568 . . . . 0.0 111.68 177.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.83 155.54 39.18 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 123.133 2.556 . . . . 0.0 111.981 178.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.71 141.78 38.92 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.214 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -60.53 78.19 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.467 2.778 . . . . 0.0 113.949 -179.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.0 m 71.11 140.61 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.731 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.4 p -84.36 52.52 2.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.653 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -91.16 -39.94 11.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.047 177.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 60.39 -166.39 0.2 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.623 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.15 86.68 5.54 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.549 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -55.94 104.15 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.505 2.803 . . . . 0.0 112.671 177.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.48 78.98 9.72 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.932 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -82.08 128.92 34.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.72 175.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -94.62 -168.0 1.75 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.071 -175.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.422 ' HE2' ' HA ' ' A' ' 92' ' ' LYS . 12.0 mmpt? -71.51 -65.42 0.76 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.169 -175.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -141.41 139.8 33.51 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.8 p -137.56 126.47 34.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.148 0.499 . . . . 0.0 110.8 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -159.29 146.47 17.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.676 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 63.62 82.18 0.19 Allowed 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.724 0.64 . . . . 0.0 111.732 176.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.471 ' HZ3' ' HB3' ' A' ' 97' ' ' LYS . 1.7 mmmp? -64.96 146.39 55.05 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.877 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -84.45 150.41 25.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.946 177.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -146.24 148.31 32.34 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 66.49 175.96 0.23 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.707 0.629 . . . . 0.0 111.399 -172.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.5 p -144.0 19.06 1.78 Allowed 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.568 0.699 . . . . 0.0 112.657 -171.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -106.47 104.91 14.72 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.858 -176.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -85.31 54.53 3.14 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.376 -177.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.429 ' HB3' HD11 ' A' ' 112' ' ' LEU . 2.0 p -95.09 27.39 3.23 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.938 -178.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.4 t70 53.15 42.77 32.17 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.619 -178.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.0 t0 66.53 112.63 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.345 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -70.99 71.51 0.55 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.045 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 88.7 mmm -83.15 65.32 8.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.581 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.64 -25.77 25.6 Favored Glycine 0 C--O 1.227 -0.287 0 C-N-CA 120.589 -0.815 . . . . 0.0 114.119 170.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 1.627 ' HE1' ' CE2' ' A' ' 110' ' ' PHE . 4.3 p90 -94.57 -164.22 1.14 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.191 0.495 . . . . 0.0 110.945 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -117.66 -158.86 11.16 Favored Glycine 0 N--CA 1.436 -1.334 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.387 178.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.429 HD11 ' HB3' ' A' ' 104' ' ' SER . 18.0 tp -100.12 68.08 1.43 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 120.786 0.327 . . . . 0.0 111.575 -171.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -145.7 49.88 1.21 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 177.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.8 t70 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.356 -0.83 . . . . 0.0 110.196 178.079 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 201' ' ' MET . . . . . 0.752 ' HE2' ' O ' ' A' ' 14' ' ' LEU . 5.1 ppp? -135.82 -32.45 0.89 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -177.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 202' ' ' ARG . . . . . 0.56 ' HD2' ' OD2' ' A' ' 19' ' ' ASP . 49.6 ttp180 -74.95 1.29 13.18 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.039 0.447 . . . . 0.0 111.857 -172.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 203' ' ' TYR . . . . . 1.662 ' HD2' ' CD1' ' B' ' 203' ' ' TYR . 29.3 m-85 -126.07 -36.81 2.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.305 0.574 . . . . 0.0 110.647 -178.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.629 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 38.7 t -65.24 -44.54 95.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.235 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 205' ' ' ALA . . . . . 0.51 ' HA ' HD13 ' B' ' 208' ' ' LEU . . . -72.74 -20.19 61.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.901 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 206' ' ' SER . . . . . 0.505 ' CB ' HG21 ' B' ' 223' ' ' ILE . 4.0 m -70.62 -42.42 70.93 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 173.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 207' ' ' TYR . . . . . 0.485 ' CE1' HD12 ' B' ' 251' ' ' ILE . 20.7 t80 -60.42 -41.58 94.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.163 174.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 75.7 mt -62.59 -42.06 99.34 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.814 177.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 209' ' ' LEU . . . . . 0.411 ' HG ' ' CD1' ' A' ' 31' ' ' LEU . 0.6 OUTLIER -55.8 -54.52 43.44 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.741 177.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -67.15 -27.33 67.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.376 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 211' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -65.81 -50.04 66.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.16 177.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 212' ' ' LEU . . . . . 0.417 ' HB2' HG21 ' A' ' 4' ' ' VAL . 4.1 pp -73.78 -24.85 59.9 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.727 0.299 . . . . 0.0 110.783 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.91 -13.68 53.19 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 116.005 -0.543 . . . . 0.0 113.265 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 118.65 35.48 0.98 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.886 177.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 215' ' ' ASN . . . . . 0.638 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 33.9 t30 -152.42 114.83 4.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.912 0.387 . . . . 0.0 110.31 176.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 216' ' ' SER . . . . . 0.466 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 8.1 m -76.28 -11.24 59.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.176 -178.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 26.4 t -123.55 63.48 26.78 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.674 -176.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . 0.466 ' HD3' ' C ' ' B' ' 216' ' ' SER . 52.4 Cg_exo -60.22 144.96 99.48 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.029 2.486 . . . . 0.0 111.88 175.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 219' ' ' SER . . . . . 0.439 ' O ' HD11 ' B' ' 223' ' ' ILE . 21.5 m -129.51 168.53 16.23 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.794 178.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -47.76 -40.37 20.47 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.922 0.392 . . . . 0.0 111.659 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 221' ' ' LYS . . . . . 0.48 ' HZ2' ' HB3' ' B' ' 221' ' ' LYS . 4.2 ttpm? -58.1 -49.99 75.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.727 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.03 -39.4 69.15 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.281 -173.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.505 HG21 ' CB ' ' B' ' 206' ' ' SER . 1.7 mp -64.55 -40.28 88.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.584 176.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 224' ' ' LYS . . . . . 0.611 ' HZ3' ' CG ' ' B' ' 236' ' ' ASP . 16.3 tppt? -56.25 -45.65 79.95 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.198 173.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -58.9 -43.98 91.11 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.151 0.5 . . . . 0.0 111.337 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.444 HD13 ' HB3' ' A' ' 35' ' ' ALA . 1.3 mp -63.57 -40.23 88.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.156 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 76.7 mt -76.54 -19.28 58.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.199 0.523 . . . . 0.0 110.581 176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -73.84 -36.51 64.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.297 178.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 94.6 p -55.43 -40.96 72.17 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.634 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 3.3 m -90.02 -14.42 9.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 111.9 0.334 . . . . 0.0 111.9 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 77.7 32.84 44.51 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.586 175.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . 0.558 HG22 ' OD2' ' A' ' 19' ' ' ASP . 61.6 mt -90.48 130.43 39.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 177.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -67.01 100.22 0.72 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.318 0.58 . . . . 0.0 110.787 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -89.78 111.69 22.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.22 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . 0.419 ' HB2' ' HG2' ' B' ' 238' ' ' ARG . 5.3 m-20 -53.56 104.52 0.1 Allowed 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.727 0.642 . . . . 0.0 110.607 177.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 236' ' ' ASP . . . . . 0.611 ' CG ' ' HZ3' ' B' ' 224' ' ' LYS . 5.6 m-20 -54.95 -38.14 67.35 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -174.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 237' ' ' ASP . . . . . 0.433 ' O ' ' HG2' ' B' ' 241' ' ' LYS . 15.9 t70 -55.81 -68.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.052 0.453 . . . . 0.0 111.276 178.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.459 ' HA ' ' HB2' ' B' ' 241' ' ' LYS . 13.7 ptp180 -68.76 -17.02 63.97 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.821 0.343 . . . . 0.0 111.039 -174.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 239' ' ' LEU . . . . . 0.43 HD21 ' CD1' ' B' ' 203' ' ' TYR . 3.3 tm? -61.22 -67.94 0.36 Allowed 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.854 176.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -75.1 -16.25 60.56 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.369 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 241' ' ' LYS . . . . . 0.459 ' HB2' ' HA ' ' B' ' 238' ' ' ARG . 29.9 mmtp -64.07 -56.02 17.95 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.257 171.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 242' ' ' VAL . . . . . 0.503 ' O ' ' HB3' ' B' ' 246' ' ' LEU . 34.7 m -67.26 -34.98 72.6 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.81 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -175.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 58.4 mt -74.03 -23.87 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.473 178.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 25.3 t -72.0 -31.66 66.45 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 172.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -83.1 -22.7 33.33 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.35 0.595 . . . . 0.0 110.454 173.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . 0.57 ' O ' ' HG ' ' B' ' 246' ' ' LEU . 9.3 tp -116.11 71.44 0.78 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.466 -174.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -125.3 80.91 1.92 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.145 0.498 . . . . 0.0 111.949 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 87.04 -15.96 50.36 Favored Glycine 0 CA--C 1.52 0.406 0 CA-C-N 115.773 -0.649 . . . . 0.0 113.412 175.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -67.46 110.21 3.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.995 0.426 . . . . 0.0 111.524 -176.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 60.27 42.22 15.39 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.808 174.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.485 HD12 ' CE1' ' B' ' 207' ' ' TYR . 2.5 mm -58.25 -53.07 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -176.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -67.42 -26.18 66.29 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.378 -176.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -72.91 -46.03 54.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.4 177.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 254' ' ' VAL . . . . . . . . . . . . . 22.9 m -68.28 -20.57 25.67 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.989 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 255' ' ' ILE . . . . . 0.41 ' HA ' ' OH ' ' A' ' 11' ' ' TYR . 54.5 mt -74.04 -56.02 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-O 121.026 0.441 . . . . 0.0 110.759 172.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -67.98 -38.4 82.65 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -173.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 17.0 tp60 -101.54 -14.73 17.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.87 0.367 . . . . 0.0 111.701 -174.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . 0.501 ' O ' HD12 ' B' ' 262' ' ' LEU . . . -105.63 56.82 0.51 Allowed Glycine 0 C--O 1.227 -0.298 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.275 -172.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 259' ' ' ILE . . . . . 0.425 HG22 HD12 ' A' ' 60' ' ' ILE . 1.3 mt -85.2 -68.85 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.893 0.378 . . . . 0.0 111.668 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -116.03 25.28 9.51 Favored Glycine 0 C--O 1.227 -0.317 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.552 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -102.82 6.94 39.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.615 0.721 . . . . 0.0 110.602 -178.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 262' ' ' LEU . . . . . 0.501 HD12 ' O ' ' B' ' 258' ' ' GLY . 5.0 mp -84.97 -62.93 1.42 Allowed 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 122.28 1.038 . . . . 0.0 109.883 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . 0.487 ' HB1' ' CE ' ' B' ' 201' ' ' MET . . . -80.59 85.41 6.0 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 113.314 -1.766 . . . . 0.0 111.431 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 22.7 t -132.08 129.24 39.71 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.015 177.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 6.0 p -144.21 123.7 7.27 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.918 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.22 96.43 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.676 2.251 . . . . 0.0 112.787 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . 70.22 -47.76 0.63 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.186 0.994 . . . . 0.0 112.704 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 136.66 -15.52 3.84 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . 123.04 157.7 9.97 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -118.68 131.51 56.16 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 2.2 t -104.86 125.54 59.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -90.03 81.96 6.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.183 0.516 . . . . 0.0 110.804 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 59.9 t -105.84 109.52 28.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.132 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 34.9 t -132.12 136.31 47.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.054 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -135.86 133.17 37.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.44 -178.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . 0.459 ' HA ' ' HD3' ' B' ' 277' ' ' PRO . . . -132.99 128.47 20.65 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.662 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 277' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' B' ' 276' ' ' ALA . 17.4 Cg_exo -67.58 148.23 77.99 Favored 'Trans proline' 0 CA--C 1.517 -0.352 0 C-N-CA 122.939 2.426 . . . . 0.0 111.779 176.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -60.44 128.45 45.61 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.481 -178.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 2.4 p -79.96 161.56 25.42 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 71.71 174.8 0.29 Allowed 'General case' 0 N--CA 1.46 0.071 0 O-C-N 124.398 1.061 . . . . 0.0 111.928 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -147.99 109.24 3.74 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.44 -178.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -85.09 160.75 11.59 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.868 2.379 . . . . 0.0 112.428 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -126.99 113.31 16.31 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.815 0.34 . . . . 0.0 110.645 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -91.06 66.47 5.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.133 -177.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 152.55 179.66 28.3 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.561 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 21.1 p -157.84 167.75 29.12 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -139.69 112.85 7.74 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.908 -178.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.57 113.01 3.69 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.487 2.125 . . . . 0.0 111.596 178.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -122.24 52.18 1.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.119 178.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -102.15 -76.33 0.58 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.271 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -173.47 -28.55 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.37 0.605 . . . . 0.0 109.916 -175.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 66.88 20.49 10.55 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 114.393 -1.276 . . . . 0.0 112.202 171.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -126.53 -132.17 0.24 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.723 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -69.89 160.49 31.73 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -140.46 82.25 1.85 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.293 0.568 . . . . 0.0 111.749 -177.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -142.13 151.53 42.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.503 178.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -84.01 73.94 10.3 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.392 0.615 . . . . 0.0 111.279 -176.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -139.6 134.6 32.32 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.354 175.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 299' ' ' LYS . . . . . 0.57 ' HZ2' ' HB3' ' B' ' 299' ' ' LYS . 9.5 mtpm? -62.53 128.28 35.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.909 0.385 . . . . 0.0 110.861 177.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -55.36 114.31 1.76 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.6 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 62.5 93.34 0.05 Allowed 'General case' 0 N--CA 1.464 0.267 0 O-C-N 124.122 0.889 . . . . 0.0 110.792 -172.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 9.5 t -90.34 -175.77 4.6 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.634 -176.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -75.51 -82.55 0.07 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.751 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . 0.439 ' HG2' ' H ' ' B' ' 305' ' ' SER . 26.0 tt0 63.54 169.87 0.16 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.287 0.635 . . . . 0.0 111.488 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 305' ' ' SER . . . . . 0.439 ' H ' ' HG2' ' B' ' 304' ' ' GLU . 73.2 m 65.61 -178.17 0.19 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.924 -178.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -136.5 27.45 3.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.162 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -81.53 78.01 8.33 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.062 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -83.07 82.35 8.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.567 0.699 . . . . 0.0 111.064 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 23.0 mmt 55.82 28.06 11.81 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.089 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 66.01 27.89 73.22 Favored Glycine 0 CA--C 1.508 -0.372 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.671 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 62.54 19.54 11.31 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.284 0.634 . . . . 0.0 111.723 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . 135.9 125.9 2.53 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.219 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 20.3 mt -77.2 47.98 0.59 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.345 0.593 . . . . 0.0 110.083 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 314' ' ' PHE . . . . . 1.669 ' HE1' ' CE2' ' B' ' 314' ' ' PHE . 87.9 m-85 -131.22 -49.65 1.01 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.837 -173.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 25.0 t70 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.993 179.143 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.2 ttm . . . . . 0 N--CA 1.478 0.962 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.53 -67.46 0.54 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -176.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.59 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 5.8 p -78.97 62.55 3.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.997 -174.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.444 ' HA ' HD13 ' A' ' 7' ' ' LEU . 21.9 t -66.09 -31.02 51.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.213 0.53 . . . . 0.0 110.005 -174.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.1 m -61.76 -55.54 29.05 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.417 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -61.15 -42.06 97.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.97 178.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 3' ' ' SER . 96.0 mt -56.15 -55.61 30.97 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.619 178.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.26 -49.73 76.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.086 -178.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.1 t -66.15 -38.36 87.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.291 -176.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.405 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 1.3 tp -75.16 -39.56 43.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.932 0.396 . . . . 0.0 110.998 -177.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 1.66 ' HE1' ' CE2' ' A' ' 11' ' ' TYR . 20.1 m-85 -74.91 -19.31 60.19 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.2 t -70.94 -50.97 28.84 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 170.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -49.43 -48.21 47.57 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.109 175.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.582 ' HG ' ' HA ' ' A' ' 11' ' ' TYR . 4.2 pp -81.09 -18.16 47.49 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 11' ' ' TYR . 2.8 mt -62.14 -41.98 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.274 0.559 . . . . 0.0 109.543 168.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.7 mt -80.82 -27.56 36.5 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.183 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.493 ' O ' ' HE1' ' B' ' 201' ' ' MET . 10.2 m80 -79.78 64.73 4.72 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 177.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.4 ' HB2' ' HB2' ' B' ' 201' ' ' MET . 15.9 t0 -129.93 -51.35 1.13 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 171.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.483 ' OD1' HG22 ' B' ' 232' ' ' ILE . 8.8 m-20 -102.32 10.67 38.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.406 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 54.18 51.26 14.78 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.398 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.402 HG23 ' N ' ' A' ' 22' ' ' THR . 14.9 p -87.11 162.12 2.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.214 176.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.467 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 10.6 p -56.31 110.98 0.85 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.31 0.576 . . . . 0.0 112.246 -175.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.9 m -84.87 47.35 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.556 0.693 . . . . 0.0 110.935 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.1 t -87.31 169.32 12.39 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.071 -171.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -52.93 -42.26 65.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.903 -177.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -49.82 -45.58 50.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.677 177.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 22' ' ' THR . 66.4 mmtt -76.48 -48.92 17.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.945 -173.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.3 mt -62.45 -46.1 97.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.019 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -60.37 -46.09 91.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.902 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.49 ' HB1' HG12 ' B' ' 230' ' ' VAL . . . -71.21 -34.37 70.78 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.436 HD13 HG21 ' B' ' 226' ' ' ILE . 0.1 OUTLIER -70.69 -46.02 63.93 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.712 0.768 . . . . 0.0 109.478 178.568 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.65 -37.3 64.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.53 175.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -74.39 -31.38 62.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.177 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.34 -45.4 91.48 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.471 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.488 ' HA ' HD12 ' B' ' 226' ' ' ILE . . . -76.32 -31.82 58.36 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.169 177.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.07 16.48 47.36 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.27 175.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.555 ' CG2' ' HA2' ' B' ' 213' ' ' GLY . 53.1 t -95.19 138.98 19.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.822 0.344 . . . . 0.0 110.71 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -93.41 97.47 10.59 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.873 0.368 . . . . 0.0 111.461 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -97.09 136.68 27.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 171.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -59.92 126.24 82.85 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.65 -5.65 0.48 Allowed 'Trans proline' 0 N--CA 1.482 0.815 0 C-N-CA 124.053 3.169 . . . . 0.0 114.146 -172.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 1.669 ' HE1' ' CE2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -67.64 -36.36 80.63 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.673 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.577 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 94.6 m95 -71.69 -56.6 4.78 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.995 177.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.577 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 74.0 Cg_exo -51.12 -43.77 46.42 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.093 1.862 . . . . 0.0 112.334 176.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.88 -57.1 15.18 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.143 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 45.5 tp -57.37 -43.61 83.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.659 0.266 . . . . 0.0 110.348 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 1.65 ' HD1' ' CD2' ' A' ' 47' ' ' PHE . 3.0 m-85 -59.97 -49.73 76.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.295 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.42 -34.27 76.44 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.043 -178.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -97.49 -1.71 43.54 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.86 -16.55 7.07 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.546 HD11 ' HA ' ' A' ' 47' ' ' PHE . 9.4 mp -84.75 -131.77 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 O-C-N 121.945 -0.472 . . . . 0.0 110.098 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.412 ' H ' ' HB3' ' A' ' 51' ' ' LEU . . . 61.02 2.22 0.54 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.502 0.721 . . . . 0.0 112.887 -178.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.457 ' H ' HG13 ' A' ' 54' ' ' VAL . 9.3 m120 -139.49 -58.49 0.58 Allowed 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.52 HG12 ' HG ' ' A' ' 51' ' ' LEU . 2.5 p -1.01 96.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 113.217 -1.81 . . . . 0.0 114.48 164.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -59.38 128.75 38.65 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.205 169.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.426 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 5.1 tp -47.73 -45.25 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -169.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.408 ' O ' HG23 ' A' ' 60' ' ' ILE . . . -58.85 -37.38 90.52 Favored Glycine 0 C--O 1.239 0.407 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.595 -177.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.9 m -61.57 -11.01 9.38 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.474 -0.363 . . . . 0.0 111.599 -178.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 9.2 tp -63.04 -24.86 68.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.802 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.492 ' O ' HG12 ' A' ' 60' ' ' ILE . 11.0 tt -99.86 22.43 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 121.991 0.901 . . . . 0.0 110.301 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 81.8 m -140.94 -62.38 0.48 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.16 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -101.1 66.33 1.13 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.978 0.418 . . . . 0.0 110.701 -176.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.1 m -62.42 -9.29 3.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.137 177.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -84.58 -23.65 49.61 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.616 178.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -179.09 -71.82 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.95 0.405 . . . . 0.0 111.222 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.5 -135.18 11.37 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.504 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -158.2 150.37 21.13 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -88.81 100.29 0.38 Allowed 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.882 2.388 . . . . 0.0 113.331 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.02 68.36 28.02 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.952 0.406 . . . . 0.0 110.756 174.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -82.6 104.39 1.31 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.599 2.199 . . . . 0.0 112.797 -175.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.06 -36.78 9.99 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.356 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 70.35 12.37 7.53 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.251 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 106.03 167.62 23.19 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.52 176.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -100.25 84.73 2.87 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.135 0.493 . . . . 0.0 110.276 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.464 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -114.88 141.52 26.98 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.804 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 26.5 Cg_exo -68.1 76.12 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.707 2.938 . . . . 0.0 113.108 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.06 125.43 29.78 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.982 0.42 . . . . 0.0 110.891 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.93 167.1 15.1 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.1 149.55 17.97 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.369 -0.92 . . . . 0.0 112.367 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -77.12 -40.33 0.48 Allowed 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.822 2.348 . . . . 0.0 112.967 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 52.27 75.57 0.63 Allowed Pre-proline 0 N--CA 1.466 0.364 0 O-C-N 123.287 0.367 . . . . 0.0 110.887 -175.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -50.01 101.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.358 2.705 . . . . 0.0 113.132 -176.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.2 m -135.19 84.3 2.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.544 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.0 t -155.22 162.33 40.95 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.353 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 56.55 40.35 29.49 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.119 0.485 . . . . 0.0 110.963 -177.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.449 ' O ' ' HD3' ' A' ' 88' ' ' PRO . . . -56.93 134.91 55.96 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.575 -177.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -110.9 96.04 27.24 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.715 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 86' ' ' ALA . 45.8 Cg_exo -64.16 165.9 18.2 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.137 2.558 . . . . 0.0 112.42 175.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.14 25.96 3.98 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 53.64 73.54 0.37 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.532 0.682 . . . . 0.0 111.948 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -103.66 -176.27 3.04 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.608 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 61.7 mttp 65.0 102.64 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 O-C-N 123.818 0.699 . . . . 0.0 110.856 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -79.8 75.55 6.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.229 0.537 . . . . 0.0 111.282 -177.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.4 t -113.84 114.75 47.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.349 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -128.28 -79.91 0.58 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.892 0.377 . . . . 0.0 110.924 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -109.07 -47.11 3.48 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.249 0.547 . . . . 0.0 110.789 -176.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -120.97 146.96 46.11 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.413 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -88.74 170.07 11.1 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -44.06 105.63 0.06 Allowed 'General case' 0 C--O 1.233 0.228 0 O-C-N 123.248 0.343 . . . . 0.0 111.046 177.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -69.01 133.98 48.86 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 120.938 0.399 . . . . 0.0 110.522 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.4 m -79.46 74.33 6.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.712 -174.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -90.84 166.56 13.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.571 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 39.96 43.99 1.35 Allowed 'General case' 0 N--CA 1.474 0.726 0 O-C-N 124.466 1.104 . . . . 0.0 113.123 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.3 t -125.59 161.11 27.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.483 -177.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -134.11 91.21 2.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.284 0.564 . . . . 0.0 109.482 174.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.49 78.62 9.1 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.176 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 63.61 60.81 1.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.265 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 27.2 ttt 70.41 100.38 0.06 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.104 175.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -101.57 -173.79 28.29 Favored Glycine 0 CA--C 1.522 0.486 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.291 175.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 1.631 ' HE2' ' CE1' ' A' ' 110' ' ' PHE . 0.6 OUTLIER -64.3 164.82 10.51 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.942 0.401 . . . . 0.0 111.122 177.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -164.48 -96.32 0.11 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.377 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.1 mp -84.83 -1.59 56.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.694 0.283 . . . . 0.0 111.082 -177.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 1.667 ' HD1' ' CD2' ' A' ' 113' ' ' PHE . 5.8 p90 -140.8 164.59 29.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.457 178.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.7 t70 . . . . . 0 C--O 1.244 0.81 0 CA-C-O 118.622 -0.704 . . . . 0.0 110.184 -178.008 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 119.715 -0.183 . . . . 0.0 110.699 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 201' ' ' MET . . . . . 0.514 ' SD ' HD22 ' B' ' 262' ' ' LEU . 62.4 mmm -6.38 -73.46 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.577 1.551 . . . . 0.0 114.862 171.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 202' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -63.81 -20.1 65.53 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -168.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 203' ' ' TYR . . . . . 1.652 ' HD1' ' CD2' ' B' ' 203' ' ' TYR . 68.3 m-85 -95.19 -52.87 4.01 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.355 0.598 . . . . 0.0 111.026 -179.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.534 ' O ' HD11 ' B' ' 208' ' ' LEU . 8.6 p -58.28 -47.79 86.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.147 -174.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 205' ' ' ALA . . . . . 0.516 ' HA ' ' HB2' ' B' ' 208' ' ' LEU . . . -72.95 -19.22 61.28 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.471 -177.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 206' ' ' SER . . . . . 0.554 ' OG ' HG21 ' B' ' 223' ' ' ILE . 24.4 t -66.09 -43.33 87.63 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 207' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -60.47 -44.31 96.04 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.721 173.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.534 HD11 ' O ' ' B' ' 204' ' ' VAL . 6.3 mp -56.26 -49.07 75.23 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.035 177.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 209' ' ' LEU . . . . . 0.422 ' HA ' ' HG ' ' B' ' 212' ' ' LEU . 3.7 mp -62.54 -43.13 99.57 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.56 0.219 . . . . 0.0 111.379 -178.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -62.74 -34.0 76.3 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.19 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 211' ' ' ALA . . . . . 0.705 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -71.44 -53.77 12.9 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.701 0.286 . . . . 0.0 111.05 178.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 212' ' ' LEU . . . . . 0.438 HD11 ' C ' ' B' ' 212' ' ' LEU . 4.6 pp -68.61 -17.79 64.18 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.045 0.45 . . . . 0.0 110.904 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . 0.555 ' HA2' ' CG2' ' A' ' 37' ' ' VAL . . . -66.88 -19.63 69.81 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.103 177.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 130.71 6.91 3.55 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.111 177.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 215' ' ' ASN . . . . . 0.705 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 7.9 m-20 -119.52 119.05 32.7 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.841 0.353 . . . . 0.0 110.996 -178.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 8.5 m -81.74 -0.87 44.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.71 0.29 . . . . 0.0 111.365 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 217' ' ' SER . . . . . 0.454 ' N ' ' HD3' ' B' ' 218' ' ' PRO . 24.5 m -135.98 62.16 44.75 Favored Pre-proline 0 N--CA 1.444 -0.764 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.342 -176.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . 0.454 ' HD3' ' N ' ' B' ' 217' ' ' SER . 35.0 Cg_exo -63.87 130.98 29.31 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.987 2.458 . . . . 0.0 112.483 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 219' ' ' SER . . . . . 0.519 ' O ' HD11 ' B' ' 223' ' ' ILE . 33.0 t -110.25 169.53 8.67 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.762 0.315 . . . . 0.0 110.49 177.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -56.02 -29.1 59.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.72 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -62.39 -53.1 59.92 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.612 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -62.36 -48.04 81.54 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.252 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.554 HG21 ' OG ' ' B' ' 206' ' ' SER . 1.7 mp -61.18 -48.49 88.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.784 -178.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -62.21 -38.11 87.9 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.499 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -56.93 -52.52 64.86 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.049 176.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.488 HD12 ' HA ' ' A' ' 35' ' ' ALA . 1.0 OUTLIER -60.25 -43.73 94.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.222 -177.673 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 1.1 tt -69.99 -43.02 72.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.68 0.276 . . . . 0.0 110.497 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -69.43 -25.51 64.15 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.998 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 58.7 m -51.08 -49.41 60.71 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 230' ' ' VAL . . . . . 0.49 HG12 ' HB1' ' A' ' 30' ' ' ALA . 3.4 p -171.46 19.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.914 -175.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -82.93 -94.75 0.57 Allowed Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 119.973 -1.108 . . . . 0.0 112.04 -173.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . 0.483 HG22 ' OD1' ' A' ' 19' ' ' ASP . 51.4 mt -143.17 -88.87 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 120.543 0.211 . . . . 0.0 110.549 -176.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -148.17 160.7 42.65 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 174.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -151.21 98.91 2.61 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.054 0.454 . . . . 0.0 111.676 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . 0.466 ' CG ' ' HD3' ' B' ' 238' ' ' ARG . 0.0 OUTLIER -67.74 127.54 33.18 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.77 174.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -65.69 -39.86 91.73 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -165.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -80.71 -38.62 28.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.312 0.577 . . . . 0.0 110.21 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.466 ' HD3' ' CG ' ' B' ' 235' ' ' ASP . 68.2 ttt180 -66.68 -39.47 88.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.677 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 239' ' ' LEU . . . . . . . . . . . . . 8.6 tt -59.01 -51.84 68.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.07 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -69.3 -29.53 67.41 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -67.15 -46.37 74.26 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 242' ' ' VAL . . . . . . . . . . . . . 35.8 m -70.13 -32.17 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . 0.469 ' HA ' ' CD2' ' B' ' 246' ' ' LEU . 12.5 mt -64.25 -38.54 82.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.981 170.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 28.1 t -72.07 -13.64 61.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.616 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -89.31 -30.29 18.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.036 0.446 . . . . 0.0 110.402 172.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . 0.589 ' O ' HD11 ' B' ' 246' ' ' LEU . 1.4 pp -98.84 3.72 47.4 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.617 -178.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -78.16 40.02 0.33 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -171.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -86.63 -121.23 1.32 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.17 -175.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -139.15 -174.44 3.86 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . 0.489 ' HB3' ' CB ' ' B' ' 253' ' ' ASP . 89.6 m-20 64.5 49.63 2.37 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.625 0.578 . . . . 0.0 111.428 176.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.489 ' O ' HG13 ' B' ' 255' ' ' ILE . 1.3 mm -60.19 -48.39 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.297 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -68.96 -22.27 64.12 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.422 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . 0.489 ' CB ' ' HB3' ' B' ' 250' ' ' ASN . 5.8 t70 -70.88 -47.01 61.56 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 254' ' ' VAL . . . . . 0.472 HG23 ' O ' ' B' ' 251' ' ' ILE . 11.4 m -69.67 -25.11 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.119 178.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 255' ' ' ILE . . . . . 0.489 HG13 ' O ' ' B' ' 251' ' ' ILE . 61.4 mt -78.98 -32.04 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.782 174.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -77.84 -41.69 36.15 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -127.1 36.96 4.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.271 0.558 . . . . 0.0 111.123 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . 0.562 ' O ' ' HA ' ' B' ' 262' ' ' LEU . . . -124.66 36.57 2.84 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.218 -0.992 . . . . 0.0 111.955 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 67.8 mt -71.82 -77.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 CA-C-O 120.814 0.34 . . . . 0.0 110.724 -178.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -82.47 -3.23 90.61 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.111 -1.042 . . . . 0.0 112.205 -178.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 261' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' B' ' 264' ' ' SER . 32.3 mmtp -129.96 49.96 2.23 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 262' ' ' LEU . . . . . 0.562 ' HA ' ' O ' ' B' ' 258' ' ' GLY . 0.0 OUTLIER -43.79 -37.19 2.61 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.091 -1.413 . . . . 0.0 114.155 -174.152 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . 0.461 ' H ' HD23 ' B' ' 262' ' ' LEU . . . -132.07 31.57 4.13 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.004 0.431 . . . . 0.0 110.969 178.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 264' ' ' SER . . . . . 0.485 ' O ' ' HB3' ' B' ' 261' ' ' LYS . 36.6 m -141.88 87.64 2.06 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.06 0.457 . . . . 0.0 110.812 -178.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 29.4 t -68.73 116.09 37.3 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.617 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.69 -40.93 2.5 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.694 2.262 . . . . 0.0 113.006 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . 46.96 65.81 1.14 Allowed 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.655 0.597 . . . . 0.0 112.362 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 139.42 -24.17 2.8 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.214 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -73.82 -12.18 80.91 Favored Glycine 0 C--O 1.23 -0.125 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.314 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -136.02 78.55 1.72 Allowed 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 27.0 m -76.97 168.62 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.863 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -124.16 169.65 11.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.995 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 78.3 t 69.32 102.28 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 O-C-N 123.893 0.746 . . . . 0.0 111.961 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 4.8 m -79.97 135.41 36.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.309 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -104.58 80.18 1.64 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.934 0.397 . . . . 0.0 111.442 -176.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -102.81 115.11 64.76 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.722 177.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 277' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -75.6 86.6 1.46 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.252 2.635 . . . . 0.0 112.178 -178.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 88.35 38.57 7.13 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.55 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 49.2 m 67.12 -160.57 0.23 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.042 0.449 . . . . 0.0 111.365 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . -51.57 125.41 14.59 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.333 177.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . 0.444 ' HA ' ' HD3' ' B' ' 282' ' ' PRO . . . -133.75 135.04 24.08 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.599 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' B' ' 281' ' ' ALA . 16.0 Cg_exo -67.36 144.82 69.37 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.838 2.359 . . . . 0.0 112.088 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -101.99 42.89 1.1 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.064 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . 62.68 -163.84 0.26 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.862 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 145.36 -100.65 0.23 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.276 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 12.6 m -75.62 85.32 2.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.721 0.296 . . . . 0.0 110.727 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 287' ' ' ALA . . . . . 0.476 ' HB1' ' HD3' ' B' ' 288' ' ' PRO . . . -157.56 -57.12 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 178.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 288' ' ' PRO . . . . . 0.476 ' HD3' ' HB1' ' B' ' 287' ' ' ALA . 85.3 Cg_endo -78.04 69.86 7.31 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.755 1.637 . . . . 0.0 113.154 -174.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -102.07 29.11 5.27 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.237 0.541 . . . . 0.0 110.362 178.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -82.98 67.04 8.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.379 -177.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -143.67 20.52 1.84 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.147 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -68.67 -53.29 23.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.462 -178.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.55 -176.68 0.14 Allowed 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 61.63 -101.27 0.1 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.205 178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp 71.19 161.37 0.23 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.318 0.647 . . . . 0.0 111.707 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 45.74 -158.65 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.213 1.005 . . . . 0.0 112.524 -177.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -84.45 -168.66 2.26 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -172.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -70.01 134.4 48.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.415 0.626 . . . . 0.0 112.121 -174.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.55 118.02 35.89 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.453 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -69.7 134.17 48.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.883 174.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -96.91 88.19 4.48 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.074 0.464 . . . . 0.0 110.729 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 23.0 t -130.15 119.76 23.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.595 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -135.41 155.28 50.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.176 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -96.62 145.17 25.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.491 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 35.4 m -147.24 140.14 25.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.251 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -80.82 77.94 7.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 177.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.34 152.64 35.42 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 120.819 0.342 . . . . 0.0 110.519 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -112.52 135.17 53.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.36 0.6 . . . . 0.0 110.744 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 309' ' ' MET . . . . . 0.402 ' SD ' ' N ' ' B' ' 309' ' ' MET . 0.0 OUTLIER -111.57 14.39 21.32 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.901 -179.519 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 111.89 -38.45 3.26 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.84 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 311' ' ' PHE . . . . . 1.658 ' HD1' ' CD2' ' B' ' 311' ' ' PHE . 98.0 m-85 -111.08 21.93 15.84 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.541 -0.329 . . . . 0.0 110.685 -178.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 312' ' ' GLY . . . . . 0.482 ' C ' ' H ' ' B' ' 314' ' ' PHE . . . -93.67 53.25 2.33 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.323 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -78.35 28.81 0.19 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.692 0.758 . . . . 0.0 110.537 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 314' ' ' PHE . . . . . 0.482 ' H ' ' C ' ' B' ' 312' ' ' GLY . 77.9 m-85 -103.44 -39.78 6.63 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.801 -174.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.399 -173.588 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.82 -160.73 0.82 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -70.57 89.05 0.7 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.208 0.528 . . . . 0.0 110.89 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.461 HG13 ' HB2' ' B' ' 212' ' ' LEU . 2.4 m -66.09 -18.01 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.481 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.7 m -61.37 -62.67 1.66 Allowed 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.51 176.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.56 ' O ' HG22 ' A' ' 10' ' ' ILE . 9.9 pt-20 -69.93 -34.9 74.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.446 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.46 ' HB2' ' HA ' ' A' ' 4' ' ' VAL . 66.6 mt -49.19 -64.72 0.72 Allowed 'General case' 0 C--O 1.222 -0.348 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 172.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.31 86.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.683 -176.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.2 t -62.21 -51.79 66.37 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -176.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.56 HG22 ' O ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -83.19 -16.58 11.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 119.166 -1.013 . . . . 0.0 111.158 -177.869 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 1.655 ' HD1' ' CD2' ' A' ' 11' ' ' TYR . 15.9 m-30 -69.89 -32.41 70.73 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 169.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.1 t -66.58 -43.91 83.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.298 169.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.528 ' HB1' ' O ' ' A' ' 10' ' ' ILE . . . -48.96 -45.19 41.59 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 120.98 0.419 . . . . 0.0 110.376 171.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 10' ' ' ILE . 85.7 mt -58.46 -56.03 27.41 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.614 177.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.468 HD13 HD22 ' A' ' 31' ' ' LEU . 56.5 mt -60.15 -32.45 50.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.619 -174.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -88.79 -24.34 22.64 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 121.758 -0.589 . . . . 0.0 112.41 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.541 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 54.6 t-80 -59.38 -51.25 70.73 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -174.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.429 ' HB2' ' SD ' ' B' ' 201' ' ' MET . 18.5 t70 -92.52 -21.19 20.26 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -164.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.492 ' OD2' ' HD3' ' B' ' 202' ' ' ARG . 3.7 m-20 -86.12 29.08 0.76 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -171.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 65.32 8.26 4.81 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.846 0.459 . . . . 0.0 111.933 174.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 19' ' ' ASP . 71.7 t -104.74 141.23 20.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.138 0.494 . . . . 0.0 110.721 -176.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 7.1 p -73.02 126.75 30.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.079 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.6 p -76.44 87.0 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.564 0.697 . . . . 0.0 110.917 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.1 p -112.46 175.6 5.37 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.353 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -59.74 -36.53 76.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.768 -178.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -53.14 -45.02 68.19 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.897 176.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 22' ' ' THR . 69.2 mmtt -78.29 -47.59 17.5 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.678 -169.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.441 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 21.6 mt -65.47 -46.49 89.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.362 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -63.15 -38.81 92.64 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.86 -43.6 75.08 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.128 0.489 . . . . 0.0 111.232 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.468 HD22 HD13 ' A' ' 15' ' ' ILE . 27.3 tp -70.87 -31.92 68.74 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.336 0.589 . . . . 0.0 110.011 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.441 ' HB ' ' O ' ' A' ' 28' ' ' ILE . 1.4 mp -73.05 -27.99 25.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.092 174.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -69.71 -34.32 73.72 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 172.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.96 -63.06 1.15 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.161 178.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.45 26.22 5.38 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -175.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -100.96 94.72 1.3 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.27 -0.967 . . . . 0.0 111.339 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.461 ' HB ' ' HA2' ' B' ' 213' ' ' GLY . 7.7 p -55.05 -50.15 65.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -161.91 130.03 4.15 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.226 0.536 . . . . 0.0 111.725 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.9 p -157.56 131.95 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.06 174.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -73.0 132.1 83.08 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.56 -4.84 0.59 Allowed 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.846 3.031 . . . . 0.0 114.462 -171.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 1.668 ' HE2' ' CE1' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -69.55 -37.75 77.19 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.236 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.533 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 93.2 m95 -68.4 -55.01 12.98 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.839 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.533 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 87.5 Cg_exo -50.25 -50.77 12.52 Favored 'Trans proline' 0 C--N 1.364 1.366 0 C-N-CA 121.99 1.793 . . . . 0.0 112.972 174.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.8 -49.91 72.89 Favored Glycine 0 C--O 1.242 0.622 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.092 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 56.9 tp -53.57 -62.16 1.83 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.239 177.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -52.41 -46.19 66.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.237 -177.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.26 -38.52 91.5 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.732 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -105.52 10.33 33.18 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.894 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -115.38 -32.82 5.49 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 175.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.659 ' HA ' ' CG2' ' A' ' 54' ' ' VAL . 47.5 mt -80.86 -133.61 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.411 -177.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 66.66 -12.45 0.21 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.827 0.851 . . . . 0.0 113.245 177.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.445 ' H ' ' C ' ' A' ' 51' ' ' LEU . 52.2 m-80 -141.17 7.38 1.99 Allowed 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.833 0.825 . . . . 0.0 108.87 178.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.659 ' CG2' ' HA ' ' A' ' 51' ' ' LEU . 0.6 OUTLIER -112.92 114.45 47.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.814 -173.411 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -43.95 136.91 3.47 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.635 1.209 . . . . 0.0 110.101 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.757 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 4.9 tp -47.7 -43.52 9.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.186 -169.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -53.35 -22.78 16.22 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.556 -177.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.2 t -53.36 -34.83 59.11 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 122.527 0.331 . . . . 0.0 111.535 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.757 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -61.23 -13.44 18.51 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -175.037 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.521 ' N ' HD11 ' A' ' 59' ' ' LEU . 18.5 mt -66.09 -24.81 34.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.902 0.382 . . . . 0.0 110.421 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.5 t -159.69 72.0 0.51 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.421 0.629 . . . . 0.0 109.833 174.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -94.08 37.12 1.1 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.679 0.752 . . . . 0.0 110.099 -178.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.7 p -136.85 -36.2 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.93 177.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.98 -92.75 0.83 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.76 178.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 71.45 128.95 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.675 0.79 . . . . 0.0 110.969 -173.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -87.57 29.87 5.16 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.989 -176.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.24 175.29 47.67 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.835 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.93 139.67 36.65 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.187 2.591 . . . . 0.0 111.988 177.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -105.74 98.28 17.38 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.399 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -79.86 99.86 1.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.411 2.074 . . . . 0.0 112.341 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.94 117.68 7.96 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.681 174.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -126.02 164.92 19.79 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.887 -175.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.9 -159.22 9.04 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.102 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.04 138.12 31.77 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.594 0.235 . . . . 0.0 110.868 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -91.18 118.84 68.77 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.1 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -41.76 -55.32 2.4 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 124.628 3.552 . . . . 0.0 113.985 -172.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 56.29 79.81 0.16 Allowed 'General case' 0 N--CA 1.462 0.169 0 O-C-N 124.118 0.886 . . . . 0.0 111.53 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -179.67 169.81 40.91 Favored Glycine 0 N--CA 1.454 -0.152 0 N-CA-C 111.489 -0.645 . . . . 0.0 111.489 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 167.97 177.22 39.09 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.089 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -85.64 160.15 10.73 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.787 2.325 . . . . 0.0 112.611 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -116.76 151.8 47.7 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.705 177.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -36.88 -58.41 0.54 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 124.069 3.179 . . . . 0.0 114.076 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.0 t 58.14 57.45 4.0 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.125 0.488 . . . . 0.0 110.865 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.9 m -95.19 93.04 7.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.646 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -93.86 137.81 32.69 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.91 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -135.37 125.99 27.05 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.618 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.15 87.71 3.56 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.91 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -65.82 149.18 86.88 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 123.408 2.739 . . . . 0.0 112.264 173.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -121.59 12.25 10.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.786 0.327 . . . . 0.0 111.346 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 58.59 77.79 0.28 Allowed 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.493 -177.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 67.05 -172.71 0.19 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 114.451 -1.249 . . . . 0.0 112.385 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -94.1 -52.0 4.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.943 -175.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -98.73 111.53 23.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.209 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.7 t -88.07 -36.76 9.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.144 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.8 pm0 -82.7 133.84 35.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.383 0.611 . . . . 0.0 110.563 -177.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -127.4 -76.44 0.57 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.329 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -143.37 146.06 33.2 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -176.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -118.53 -5.97 10.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.041 0.448 . . . . 0.0 110.231 173.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -76.35 -40.5 51.08 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.259 176.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 61.16 -164.27 0.24 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.221 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.3 t -94.61 -173.51 3.05 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.093 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -66.93 117.58 9.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.958 177.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 65.34 -175.75 0.18 Allowed 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.54 0.525 . . . . 0.0 110.925 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.4 m -109.41 62.16 0.6 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.192 -177.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 68.03 125.25 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.78 176.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -78.01 134.9 37.72 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.674 176.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 70.7 128.79 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 O-C-N 124.056 0.848 . . . . 0.0 111.962 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 44.4 ttp -86.05 104.76 15.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.747 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -179.47 -150.16 8.86 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.459 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 1.659 ' HE2' ' CE1' ' A' ' 110' ' ' PHE . 0.4 OUTLIER -75.91 98.0 4.11 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.223 0.535 . . . . 0.0 111.038 -178.22 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.45 -115.93 4.13 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.655 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 27.4 tp -105.0 26.33 9.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.134 0.493 . . . . 0.0 110.952 -176.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -135.93 37.52 2.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.796 0.332 . . . . 0.0 111.687 -177.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.1 t70 . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.507 -0.759 . . . . 0.0 109.731 179.415 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 120.691 0.282 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 201' ' ' MET . . . . . 0.529 ' HE3' ' O ' ' A' ' 14' ' ' LEU . 23.5 ptm -134.85 2.61 3.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.745 0.307 . . . . 0.0 111.495 -174.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 202' ' ' ARG . . . . . 0.492 ' HD3' ' OD2' ' A' ' 19' ' ' ASP . 89.4 mtt180 -75.0 -74.77 0.19 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.928 -174.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 203' ' ' TYR . . . . . 1.663 ' HD1' ' CD2' ' B' ' 203' ' ' TYR . 1.3 m-85 -78.95 -19.39 51.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.115 0.483 . . . . 0.0 111.678 -170.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.652 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 26.8 m -65.19 -42.48 94.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.664 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 205' ' ' ALA . . . . . 0.693 ' O ' ' HG ' ' B' ' 209' ' ' LEU . . . -73.8 -22.23 59.88 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.319 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 206' ' ' SER . . . . . 0.466 ' CB ' HG21 ' B' ' 223' ' ' ILE . 6.9 m -64.26 -47.74 78.43 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 171.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 207' ' ' TYR . . . . . 1.622 ' HE1' ' CE2' ' B' ' 207' ' ' TYR . 36.9 t80 -60.53 -40.42 91.41 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.313 176.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 82.5 mt -57.96 -51.07 71.15 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.8 178.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 209' ' ' LEU . . . . . 0.693 ' HG ' ' O ' ' B' ' 205' ' ' ALA . 70.4 mt -59.01 -56.04 27.35 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.816 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 210' ' ' ALA . . . . . 0.439 ' HB1' ' HB3' ' B' ' 218' ' ' PRO . . . -58.13 -31.29 67.04 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.599 -178.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 211' ' ' ALA . . . . . 0.645 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -74.58 -50.83 16.43 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.408 178.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 212' ' ' LEU . . . . . 0.466 HD11 ' C ' ' B' ' 212' ' ' LEU . 4.0 pp -66.17 -20.12 66.04 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.64 0.257 . . . . 0.0 110.719 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . 0.461 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -68.22 -20.03 72.77 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.595 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 128.22 33.3 0.59 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.784 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 215' ' ' ASN . . . . . 0.645 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 18.3 m120 -144.74 114.25 7.15 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 6.3 m -70.24 -17.87 63.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.846 0.355 . . . . 0.0 111.478 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 54.6 p -125.46 71.98 66.18 Favored Pre-proline 0 N--CA 1.444 -0.749 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.969 -175.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . 0.556 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 42.5 Cg_exo -62.54 112.12 1.51 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.131 2.554 . . . . 0.0 112.167 176.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 29.2 p -75.74 137.12 40.39 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.344 0.592 . . . . 0.0 110.444 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -54.29 -30.16 49.91 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.85 -177.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -68.25 -37.08 80.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.809 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -78.69 -30.84 46.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.982 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.466 HG21 ' CB ' ' B' ' 206' ' ' SER . 1.7 mp -62.15 -45.57 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.282 0.563 . . . . 0.0 109.507 171.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -61.11 -42.37 98.41 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.037 177.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -57.4 -42.72 82.79 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.31 174.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.48 -35.9 69.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.815 178.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . 0.435 HD21 ' CB ' ' B' ' 234' ' ' ALA . 11.8 tp -75.96 -39.22 56.45 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.53 -32.0 71.05 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.211 174.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 28.2 t -52.18 -54.69 27.77 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.742 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 230' ' ' VAL . . . . . 0.401 ' CG2' ' HB2' ' A' ' 31' ' ' LEU . 40.9 t -74.4 -34.27 35.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.355 0.598 . . . . 0.0 110.803 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 104.52 43.95 1.63 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.836 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 2.5 mm -104.01 145.72 12.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -69.56 118.02 11.91 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.025 0.44 . . . . 0.0 110.213 -178.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . 0.435 ' CB ' HD21 ' B' ' 227' ' ' LEU . . . -99.21 99.41 10.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.208 -175.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . 0.521 ' HB2' ' OH ' ' B' ' 203' ' ' TYR . 2.2 m-20 -61.52 109.84 1.3 Allowed 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 170.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.77 -38.29 90.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.698 -172.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.55 -60.15 4.31 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.769 177.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -62.38 -35.74 80.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.662 -172.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 239' ' ' LEU . . . . . . . . . . . . . 9.3 tt -55.71 -61.34 2.42 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.108 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -70.03 -26.38 64.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.679 -177.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -61.89 -52.71 62.98 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.284 175.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 242' ' ' VAL . . . . . 0.533 ' O ' ' HG ' ' B' ' 246' ' ' LEU . 34.0 m -72.5 -30.98 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.581 -175.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . 0.409 ' HA ' HD11 ' B' ' 246' ' ' LEU . 30.0 mt -69.3 -36.2 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.636 174.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 30.3 t -60.34 -38.17 82.96 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 174.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -70.29 -37.06 74.74 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.298 174.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' B' ' 242' ' ' VAL . 64.1 mt -71.26 -31.74 67.88 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.96 0.41 . . . . 0.0 111.056 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -53.38 -34.88 59.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.374 -175.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -108.81 35.46 4.93 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.892 -177.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -134.62 153.54 51.92 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.631 0.253 . . . . 0.0 110.412 178.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -74.54 83.35 2.01 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.894 0.854 . . . . 0.0 111.614 -176.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.657 ' O ' HG11 ' B' ' 254' ' ' VAL . 5.2 tp -57.68 -39.03 67.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 114.446 -1.252 . . . . 0.0 112.265 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -63.7 -38.42 91.06 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.874 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . 0.508 ' O ' ' HG2' ' B' ' 257' ' ' GLN . 43.4 m-20 -73.78 -40.08 63.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.801 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 254' ' ' VAL . . . . . 0.657 HG11 ' O ' ' B' ' 251' ' ' ILE . 3.1 p -62.29 -31.22 50.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.271 -177.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 255' ' ' ILE . . . . . 0.412 ' CG2' HD11 ' A' ' 7' ' ' LEU . 77.0 mt -78.79 -37.97 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 173.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -64.84 -19.9 66.11 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' B' ' 253' ' ' ASP . 31.2 mm-40 -71.55 -80.69 0.06 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.586 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 177.31 -59.53 0.1 OUTLIER Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.344 -0.931 . . . . 0.0 113.168 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 259' ' ' ILE . . . . . 0.479 HG12 ' H ' ' B' ' 260' ' ' GLY . 0.0 OUTLIER -134.57 -70.1 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.857 0.36 . . . . 0.0 110.71 -177.466 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . 0.479 ' H ' HG12 ' B' ' 259' ' ' ILE . . . 109.0 -173.66 17.57 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.03 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -81.68 46.51 0.98 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.604 0.716 . . . . 0.0 110.564 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 262' ' ' LEU . . . . . . . . . . . . . 4.6 mt -103.9 -23.42 13.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.474 -177.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -101.66 9.03 41.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.456 -174.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 22.8 t -156.42 153.44 28.88 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 4.6 p -74.7 117.06 59.38 Favored Pre-proline 0 C--N 1.327 -0.399 0 O-C-N 123.271 0.357 . . . . 0.0 110.716 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -59.59 99.19 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.999 2.466 . . . . 0.0 112.456 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . -59.91 93.96 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.384 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 95.1 -10.39 69.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.459 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . 77.34 -80.9 1.24 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.997 -0.621 . . . . 0.0 111.851 -177.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -99.97 114.31 27.5 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.864 0.364 . . . . 0.0 110.277 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 13.0 t -120.31 141.68 39.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.866 -178.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -136.96 112.62 9.42 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.942 0.401 . . . . 0.0 110.942 -178.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 60.3 t -81.97 119.23 31.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.873 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 1.9 p -134.57 169.51 17.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.017 -176.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . 72.44 159.65 0.22 Allowed 'General case' 0 N--CA 1.467 0.379 0 O-C-N 124.069 0.856 . . . . 0.0 110.991 -177.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . 60.14 76.71 0.41 Allowed Pre-proline 0 N--CA 1.467 0.375 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.282 -177.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 277' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.74 96.6 0.06 OUTLIER 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.321 2.681 . . . . 0.0 113.218 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -121.38 -4.59 9.86 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.317 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 16.1 m -117.92 175.48 5.65 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 65.95 65.41 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 O-C-N 124.19 0.931 . . . . 0.0 111.688 172.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -68.6 124.66 90.55 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.238 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -44.32 -54.06 4.3 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.567 2.845 . . . . 0.0 113.643 -172.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . 55.1 66.98 1.09 Allowed 'General case' 0 C--O 1.234 0.248 0 O-C-N 123.575 0.547 . . . . 0.0 111.031 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -82.1 56.82 3.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.024 0.44 . . . . 0.0 110.681 -177.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 154.09 109.74 0.37 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.309 -177.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 21.9 t -76.4 84.43 3.15 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.332 0.587 . . . . 0.0 110.124 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -92.29 134.61 28.03 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.168 -178.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -77.07 107.26 2.4 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.627 2.218 . . . . 0.0 111.289 176.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -59.95 -28.19 67.43 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -175.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -80.67 -11.54 59.62 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . 56.51 29.25 15.09 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.056 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 65.27 -73.78 0.06 Allowed 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.662 0.785 . . . . 0.0 111.531 -176.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 54.59 47.34 22.86 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 123.544 0.528 . . . . 0.0 111.003 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -168.79 -44.89 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.964 -174.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -86.25 142.45 28.56 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.064 0.459 . . . . 0.0 112.054 -173.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -76.59 49.43 0.61 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.319 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 53.95 -106.66 0.32 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 122.841 0.456 . . . . 0.0 111.466 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 298' ' ' LYS . . . . . 0.509 ' O ' ' HG2' ' B' ' 299' ' ' LYS . 21.6 ttmm -131.08 13.68 5.18 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.586 0.708 . . . . 0.0 109.349 173.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 299' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' B' ' 298' ' ' LYS . 19.9 pttm 50.92 29.09 4.17 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.711 -1.132 . . . . 0.0 113.318 176.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -124.26 -50.0 1.79 Allowed 'General case' 0 C--N 1.33 -0.26 0 O-C-N 121.646 -0.659 . . . . 0.0 111.316 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -70.63 90.09 0.75 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.003 0.43 . . . . 0.0 111.933 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 16.3 t -143.88 121.63 11.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.035 178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 176.33 -30.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.249 -179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 69.81 170.95 0.31 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.56 -1.2 . . . . 0.0 113.421 167.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 1.7 t 68.84 176.62 0.27 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.32 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -121.81 23.16 10.22 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.819 -173.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -92.37 73.61 5.27 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.128 0.489 . . . . 0.0 111.674 -174.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -74.94 -1.22 21.52 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.106 177.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 81.3 mtp -70.92 -21.83 62.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.931 -174.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 78.85 -58.06 4.26 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.225 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -84.54 18.67 2.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.855 0.359 . . . . 0.0 111.326 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . -103.69 54.96 0.65 Allowed Glycine 0 C--O 1.224 -0.473 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 178.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 3.1 pp -93.56 17.97 10.76 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.755 0.788 . . . . 0.0 110.504 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 314' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -97.16 -11.34 24.41 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.348 -174.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.873 -0.584 . . . . 0.0 110.644 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.27 -4.55 45.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.855 0.359 . . . . 0.0 111.3 -175.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.407 ' O ' HD11 ' A' ' 7' ' ' LEU . 3.4 p -64.31 -20.03 65.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.793 -178.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.411 ' HA ' ' HB2' ' A' ' 7' ' ' LEU . 6.4 m -65.4 -17.19 21.59 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.957 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.495 ' HB3' HG22 ' A' ' 39' ' ' VAL . 14.2 m -62.43 -67.13 0.44 Allowed 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.517 0.675 . . . . 0.0 110.447 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -67.25 -31.92 72.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.703 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 4' ' ' VAL . 5.4 mp -60.41 -49.52 77.23 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.115 0.483 . . . . 0.0 110.224 176.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.85 -49.77 74.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.113 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.731 ' SG ' HG23 ' A' ' 39' ' ' VAL . 48.9 m -62.11 -35.86 79.98 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.701 -0.4 . . . . 0.0 112.055 -178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -74.35 -36.54 42.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.989 -0.285 . . . . 0.0 111.288 -178.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.604 ' O ' HG12 ' A' ' 15' ' ' ILE . 22.5 m-85 -77.52 -25.19 50.03 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.364 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.9 m -73.44 -38.7 65.43 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 172.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.25 -43.86 71.28 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.6 171.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.453 HD13 HD11 ' B' ' 262' ' ' LEU . 95.0 mt -57.04 -58.62 7.38 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.381 173.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.604 HG12 ' O ' ' A' ' 11' ' ' TYR . 36.6 mm -49.83 -35.86 10.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.279 -176.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.426 ' HB2' HG13 ' A' ' 23' ' ' VAL . 58.5 mt -106.08 -2.64 22.44 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -175.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.57 -20.79 66.09 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.822 -0.549 . . . . 0.0 112.309 -178.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.477 ' HB3' ' H ' ' A' ' 19' ' ' ASP . 0.2 OUTLIER -125.88 -117.76 0.27 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.648 -174.535 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.477 ' H ' ' HB3' ' A' ' 18' ' ' ASP . 1.0 OUTLIER 20.2 -138.93 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -170.397 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -117.14 23.46 11.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.98 0.895 . . . . 0.0 109.039 177.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.403 HG22 HG12 ' B' ' 232' ' ' ILE . 78.3 t -116.26 122.49 69.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.573 -176.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.42 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 4.5 p -80.08 147.13 31.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.077 -176.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.569 ' O ' HG21 ' A' ' 23' ' ' VAL . 30.9 m -75.03 103.66 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 121.507 0.67 . . . . 0.0 111.062 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.9 p -130.11 157.78 41.45 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 121.746 -0.596 . . . . 0.0 111.204 177.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -51.95 -49.55 62.93 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.709 0.631 . . . . 0.0 109.871 -177.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -34.09 65.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.886 -176.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.42 ' HD2' ' O ' ' A' ' 22' ' ' THR . 69.1 mttm -85.18 -41.74 15.37 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.24 -172.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.407 HG13 HD13 ' A' ' 16' ' ' LEU . 3.2 mt -63.37 -43.94 98.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 173.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.572 ' OD1' ' HE3' ' A' ' 33' ' ' LYS . 19.6 t-20 -58.07 -44.38 87.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.753 176.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.0 -44.41 94.56 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.492 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.2 mt -64.93 -44.29 89.97 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.677 0.275 . . . . 0.0 111.308 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 mp -59.27 -44.94 93.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.106 0.479 . . . . 0.0 110.426 178.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.572 ' HE3' ' OD1' ' A' ' 29' ' ' ASN . 97.7 mttt -66.43 -32.32 73.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.796 178.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.483 ' HB2' ' HA ' ' B' ' 226' ' ' ILE . . . -64.44 -38.07 89.73 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.265 177.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.403 ' HA ' HD12 ' B' ' 226' ' ' ILE . . . -79.93 -27.43 39.84 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.986 177.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.7 6.5 56.25 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.28 173.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.448 HG11 ' HA2' ' B' ' 213' ' ' GLY . 6.8 m -91.32 -178.93 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.05 0.452 . . . . 0.0 111.643 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -134.52 120.86 20.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.541 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.731 HG23 ' SG ' ' A' ' 9' ' ' CYS . 12.6 p -119.99 144.28 29.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.855 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.34 122.96 58.48 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -52.29 -13.32 2.03 Favored 'Trans proline' 0 N--CA 1.484 0.921 0 C-N-CA 123.735 2.956 . . . . 0.0 114.699 -170.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 1.665 ' HD2' ' CD1' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -79.01 -24.72 43.51 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -175.108 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.46 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 95.2 m95 -67.86 -59.57 6.44 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 175.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.46 ' CD ' ' HB2' ' A' ' 43' ' ' TRP . 11.3 Cg_endo -56.48 -37.29 97.54 Favored 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 121.862 1.708 . . . . 0.0 112.11 176.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.452 ' O ' ' HG2' ' A' ' 49' ' ' LYS . . . -66.0 -50.67 50.9 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.593 178.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.2 tt -59.23 -46.39 88.59 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.6 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 11.3 m-85 -60.05 -42.81 95.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.942 0.401 . . . . 0.0 110.844 177.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.98 -49.64 76.62 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -177.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 45' ' ' GLY . 19.0 ptmt -105.03 0.42 27.62 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -172.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.04 -11.55 3.32 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.6 ' HB3' ' O ' ' A' ' 47' ' ' PHE . 3.4 tp -90.47 -133.16 0.11 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.486 ' H ' ' CG ' ' A' ' 51' ' ' LEU . . . 61.65 -12.68 0.05 Allowed 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.585 ' H ' ' C ' ' A' ' 51' ' ' LEU . 88.2 m-20 -128.23 -34.42 2.09 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -178.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.505 ' HB ' HD11 ' A' ' 51' ' ' LEU . 41.0 t -50.92 109.45 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-N 114.407 -1.269 . . . . 0.0 109.848 170.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -51.12 150.01 3.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.727 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.529 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 2.6 tp -53.83 -49.48 58.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -173.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.17 -26.43 65.89 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.781 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 61' ' ' CYS . 19.3 m -65.97 -2.19 3.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.661 -0.269 . . . . 0.0 111.484 -178.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 42.6 mt -57.36 -24.99 58.72 Favored 'General case' 0 N--CA 1.46 0.074 0 CA-C-O 120.771 0.319 . . . . 0.0 110.483 171.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.8 mt -89.69 28.15 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 121.421 0.629 . . . . 0.0 109.787 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 58' ' ' SER . 33.1 t -63.59 154.58 32.28 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.642 176.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -77.17 54.34 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.88 0.848 . . . . 0.0 110.017 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.2 p -118.81 -22.75 3.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.504 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.19 -162.98 33.25 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.091 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -123.96 -46.24 1.97 Allowed 'General case' 0 C--N 1.318 -0.769 0 O-C-N 122.895 -0.179 . . . . 0.0 111.033 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.06 65.16 3.07 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.881 -177.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -86.45 130.56 10.03 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 121.11 -0.566 . . . . 0.0 112.398 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.41 166.7 23.9 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.748 2.299 . . . . 0.0 112.398 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.16 117.48 68.82 Favored Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.332 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.99 -25.04 12.26 Favored 'Trans proline' 0 CA--C 1.529 0.231 0 C-N-CA 122.476 2.118 . . . . 0.0 113.128 -176.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -170.59 -173.11 1.33 Allowed 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 67.49 -173.48 0.19 Allowed 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.733 0.645 . . . . 0.0 111.243 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 151.5 -157.5 27.25 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.894 -0.67 . . . . 0.0 111.828 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -150.7 150.62 31.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.76 0.28 . . . . 0.0 110.529 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.479 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -136.91 137.38 23.04 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.296 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 46.5 Cg_exo -60.41 97.85 0.12 Allowed 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 123.319 2.679 . . . . 0.0 112.605 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.4 91.65 1.02 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.05 0.452 . . . . 0.0 111.185 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.46 -89.17 1.29 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.697 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.27 171.38 12.94 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.685 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -82.31 171.53 12.41 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.444 2.096 . . . . 0.0 112.468 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.53 101.98 45.63 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.546 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -57.44 -55.94 2.14 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.178 2.585 . . . . 0.0 112.361 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.5 t 63.46 97.25 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.751 0.657 . . . . 0.0 111.079 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.9 p 52.29 75.87 0.21 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.039 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.09 38.7 0.61 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.209 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -120.87 84.87 2.3 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.51 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 73.02 160.02 0.16 Allowed Pre-proline 0 CA--C 1.536 0.432 0 O-C-N 124.055 0.847 . . . . 0.0 110.069 -175.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -51.63 -61.74 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.397 2.064 . . . . 0.0 113.061 -177.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -172.7 -42.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.441 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -68.82 130.38 42.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.242 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -79.22 151.9 30.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.36 177.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.1 tmtp? -144.46 105.87 4.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.098 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -117.49 141.73 48.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.719 -175.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.495 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 13.6 p -88.84 141.13 14.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 175.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 94' ' ' VAL . 10.0 pt-20 53.55 -177.47 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.629 1.172 . . . . 0.0 112.547 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.73 145.91 37.06 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.7 -175.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -88.32 139.7 30.23 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.729 -177.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -65.79 146.33 54.89 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 174.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.77 -4.06 41.48 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 120.931 0.396 . . . . 0.0 110.407 177.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 69.0 -171.88 0.18 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.159 177.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.1 m -142.57 135.94 28.74 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.011 -173.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.1 23.03 15.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.491 177.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -58.54 134.58 56.84 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.565 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.4 t 71.31 103.31 0.06 Allowed 'General case' 0 C--O 1.236 0.343 0 O-C-N 123.857 0.723 . . . . 0.0 111.151 176.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.0 t0 70.5 89.85 0.1 Allowed 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.975 0.797 . . . . 0.0 110.298 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -64.29 123.77 20.0 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.766 -175.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -67.04 128.41 36.24 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.004 -176.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -84.69 72.96 10.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.598 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -82.13 91.13 1.5 Allowed Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.351 176.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 1.635 ' HE2' ' CE1' ' A' ' 110' ' ' PHE . 0.7 OUTLIER -54.39 126.75 24.56 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.629 0.252 . . . . 0.0 110.434 176.463 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -154.91 -89.56 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.207 -176.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.2 mt -79.61 -22.32 43.82 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.044 0.45 . . . . 0.0 110.27 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 1.618 ' HD1' ' CD2' ' A' ' 113' ' ' PHE . 36.7 p90 -116.02 149.14 39.35 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.64 176.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.9 t70 . . . . . 0 C--O 1.245 0.864 0 CA-C-O 118.359 -0.829 . . . . 0.0 109.326 -178.694 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 201' ' ' MET . . . . . 0.404 ' HB3' ' H ' ' B' ' 202' ' ' ARG . 19.1 mtt -105.39 -169.82 1.65 Allowed 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 121.546 0.688 . . . . 0.0 111.077 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 202' ' ' ARG . . . . . 0.48 ' C ' ' H ' ' B' ' 204' ' ' VAL . 33.2 mtm180 -118.44 155.91 29.95 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.5 178.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -70.4 17.69 0.06 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.112 0.565 . . . . 0.0 112.284 -172.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.621 ' O ' HD11 ' B' ' 208' ' ' LEU . 58.5 t -65.25 -53.48 40.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.49 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 205' ' ' ALA . . . . . 0.489 ' HA ' HD23 ' B' ' 208' ' ' LEU . . . -70.54 -16.4 62.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.163 0.506 . . . . 0.0 110.673 -178.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 206' ' ' SER . . . . . 0.407 ' CB ' HG21 ' B' ' 223' ' ' ILE . 5.8 m -69.59 -47.23 64.24 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 171.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 207' ' ' TYR . . . . . 0.466 ' CZ ' ' HD2' ' B' ' 218' ' ' PRO . 32.3 t80 -57.17 -39.68 75.78 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.254 174.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.621 HD11 ' O ' ' B' ' 204' ' ' VAL . 7.0 mp -60.71 -49.49 77.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.324 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 209' ' ' LEU . . . . . 0.486 ' CD2' ' HB2' ' A' ' 11' ' ' TYR . 25.3 mt -56.29 -48.78 75.97 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 120.936 0.398 . . . . 0.0 110.585 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 210' ' ' ALA . . . . . 0.461 ' HB1' ' HB3' ' B' ' 218' ' ' PRO . . . -66.56 -29.76 69.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.328 -177.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 211' ' ' ALA . . . . . 0.644 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -72.65 -52.26 16.07 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.933 0.396 . . . . 0.0 111.055 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 212' ' ' LEU . . . . . 0.411 HD23 ' HB3' ' A' ' 7' ' ' LEU . 2.9 pp -69.13 -19.97 64.04 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . 0.448 ' HA2' HG11 ' A' ' 37' ' ' VAL . . . -60.15 -19.68 52.33 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.824 176.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 127.73 3.9 5.84 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.665 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 215' ' ' ASN . . . . . 0.644 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 28.3 t30 -122.56 114.01 20.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.92 0.391 . . . . 0.0 110.654 -177.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 216' ' ' SER . . . . . 0.406 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 18.6 m -70.76 -12.51 61.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.636 -178.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 10.1 p -122.98 67.49 32.63 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.492 -178.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . 0.466 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 80.7 Cg_exo -53.38 106.33 0.15 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.261 2.641 . . . . 0.0 113.09 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 16.0 m -77.9 148.74 34.44 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.158 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -56.63 -29.49 62.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.348 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -68.62 -30.05 68.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.342 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -86.64 -30.46 21.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.342 -177.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.407 HG21 ' CB ' ' B' ' 206' ' ' SER . 1.8 mp -66.47 -44.78 90.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 171.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 224' ' ' LYS . . . . . 0.535 ' HZ1' ' CG ' ' B' ' 236' ' ' ASP . 38.7 tttp -60.47 -43.4 96.96 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.799 175.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -56.72 -45.59 81.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.903 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.483 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . 1.0 OUTLIER -61.26 -44.88 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.071 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . 0.403 ' HG ' ' HB ' ' B' ' 232' ' ' ILE . 10.0 tp -76.36 -32.65 58.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.686 0.279 . . . . 0.0 110.652 -176.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 228' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' B' ' 224' ' ' LYS . 1.1 t0 -72.15 -29.78 64.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.319 0.58 . . . . 0.0 109.635 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 32.2 t -60.08 -37.79 80.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.051 177.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 9.6 p -98.74 -23.67 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 120.997 0.427 . . . . 0.0 111.313 -174.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 102.32 57.36 0.8 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.777 -0.725 . . . . 0.0 114.214 172.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . 0.403 ' HB ' ' HG ' ' B' ' 227' ' ' LEU . 0.7 OUTLIER -130.51 147.33 33.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 173.069 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -66.1 130.23 42.54 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.72 0.295 . . . . 0.0 111.742 -175.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -128.04 106.99 9.45 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.904 -177.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -81.72 124.07 29.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.745 178.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 236' ' ' ASP . . . . . 0.535 ' CG ' ' HZ1' ' B' ' 224' ' ' LYS . 21.2 m-20 -63.38 -43.69 96.89 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.497 -171.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.29 -45.19 81.27 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -63.61 -49.94 71.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.015 -177.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 239' ' ' LEU . . . . . 0.593 HD11 ' N ' ' B' ' 240' ' ' ASN . 4.5 pp -64.03 -41.3 97.47 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 121.152 -0.219 . . . . 0.0 111.339 -176.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 240' ' ' ASN . . . . . 0.593 ' N ' HD11 ' B' ' 239' ' ' LEU . 25.5 t-20 -70.36 -34.99 73.28 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.658 -178.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 241' ' ' LYS . . . . . 0.69 ' O ' ' HG2' ' B' ' 245' ' ' GLU . 5.1 mmmp? -71.43 -39.74 70.86 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.808 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 242' ' ' VAL . . . . . . . . . . . . . 19.9 m -69.84 -31.51 48.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 119.566 -0.853 . . . . 0.0 108.949 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . 0.477 ' HA ' ' CD2' ' B' ' 246' ' ' LEU . 20.5 mt -68.79 -36.42 74.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.945 175.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 97.0 p -71.4 -32.46 68.45 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.638 178.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 245' ' ' GLU . . . . . 0.69 ' HG2' ' O ' ' B' ' 241' ' ' LYS . 7.1 mm-40 -74.76 -34.97 62.57 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.444 178.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . 0.511 ' O ' HD11 ' B' ' 246' ' ' LEU . 1.0 OUTLIER -85.4 -10.1 56.68 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.139 0.495 . . . . 0.0 110.639 178.75 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -52.44 -54.01 37.84 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.596 -176.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -94.4 58.35 1.96 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.596 -176.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -135.77 163.03 31.13 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.01 84.52 0.51 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.581 -178.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.486 ' O ' HG23 ' B' ' 254' ' ' VAL . 0.6 OUTLIER -55.27 -39.26 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.674 0.749 . . . . 0.0 111.112 176.57 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.02 -35.76 82.23 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.075 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -72.0 -45.56 60.51 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.576 0.227 . . . . 0.0 110.54 177.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 254' ' ' VAL . . . . . 0.486 HG23 ' O ' ' B' ' 251' ' ' ILE . 12.3 m -64.63 -32.36 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.326 -176.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 255' ' ' ILE . . . . . 0.528 ' HA ' ' OH ' ' A' ' 11' ' ' TYR . 56.3 mt -82.45 -36.14 13.36 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-O 120.985 0.421 . . . . 0.0 111.139 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -68.5 -54.17 18.54 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.72 -178.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -152.33 38.19 0.55 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -175.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' B' ' 254' ' ' VAL . . . -104.08 37.76 3.6 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.144 -1.026 . . . . 0.0 112.792 -177.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 259' ' ' ILE . . . . . 0.405 ' O ' HD13 ' B' ' 262' ' ' LEU . 13.0 mt -62.74 -19.17 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 120.988 0.423 . . . . 0.0 110.818 -178.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -115.77 40.28 2.48 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 119.686 -1.245 . . . . 0.0 112.885 178.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 261' ' ' LYS . . . . . 0.483 ' HB3' ' HZ3' ' B' ' 261' ' ' LYS . 2.1 mmmp? -124.61 25.46 7.53 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 171.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 262' ' ' LEU . . . . . 0.453 HD11 HD13 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -128.05 -60.38 1.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.292 -173.156 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -129.62 -177.17 4.15 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.396 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 30.7 t -162.33 156.6 21.62 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.128 0.267 . . . . 0.0 110.494 -177.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 7.5 p -105.01 129.19 25.24 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.875 0.369 . . . . 0.0 110.43 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -74.2 116.01 4.5 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.552 2.168 . . . . 0.0 112.362 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . 61.35 -171.3 0.15 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.043 177.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . -90.18 62.29 3.22 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.641 -178.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -84.58 117.75 4.56 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.311 177.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.8 137.5 41.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.758 0.313 . . . . 0.0 110.692 -178.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 14.2 t -117.35 143.34 28.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.218 -177.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -90.32 118.08 29.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.698 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 20.0 m -67.12 136.39 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.234 0.54 . . . . 0.0 110.855 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 8.3 p -129.38 -178.37 4.64 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.447 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . 65.57 27.97 11.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.515 0.674 . . . . 0.0 111.286 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -121.65 105.68 38.17 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.565 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 277' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.44 58.61 7.08 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.386 2.724 . . . . 0.0 112.176 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 75.76 -138.09 22.51 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.361 175.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 50.7 m -154.97 160.62 41.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 64.24 -166.82 0.22 Allowed 'General case' 0 C--N 1.332 -0.186 0 O-C-N 123.96 0.787 . . . . 0.0 110.854 175.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -146.18 83.01 8.76 Favored Pre-proline 0 C--O 1.236 0.35 0 CA-C-O 120.646 0.26 . . . . 0.0 110.971 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -84.04 118.0 2.3 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.748 2.299 . . . . 0.0 112.154 178.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -97.04 74.34 2.58 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.607 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -136.99 154.2 50.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.761 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.76 173.74 24.68 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.896 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 8.7 p -89.59 44.63 1.22 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.007 0.432 . . . . 0.0 111.155 -177.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 287' ' ' ALA . . . . . 0.436 ' HB1' ' HD3' ' B' ' 288' ' ' PRO . . . -73.18 -51.08 6.15 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.282 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 288' ' ' PRO . . . . . 0.436 ' HD3' ' HB1' ' B' ' 287' ' ' ALA . 20.8 Cg_endo -86.36 43.42 1.08 Allowed 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.433 1.422 . . . . 0.0 111.949 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -145.43 20.31 1.53 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.691 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -77.59 133.88 38.36 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.977 -179.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -136.74 98.09 3.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.721 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -100.7 19.51 16.91 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.901 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -73.84 -179.12 3.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.203 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.25 41.52 1.92 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.249 0.547 . . . . 0.0 111.306 -174.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -133.0 116.69 16.71 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.169 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 69.64 179.88 0.24 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.245 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -142.84 -47.67 0.32 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.007 -174.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 67.5 mttm 54.35 58.51 4.88 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.458 0.647 . . . . 0.0 110.224 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.09 174.75 10.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.229 -177.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -64.79 142.88 58.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.727 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 53.64 56.54 7.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.517 -178.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 58.1 m -72.84 112.75 9.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.584 176.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -64.39 -36.41 84.06 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.433 177.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -82.94 133.62 35.1 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 20.2 m -76.09 149.6 37.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.117 -174.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -60.17 -59.99 4.53 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.27 0.356 . . . . 0.0 110.203 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 12.7 t70 66.36 108.42 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.269 0.981 . . . . 0.0 111.986 177.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -80.04 -18.98 48.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.95 -174.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 19.0 ptp -89.49 -28.67 19.5 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.688 -0.405 . . . . 0.0 112.02 -170.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 29.2 -89.23 0.01 OUTLIER Glycine 0 C--N 1.339 0.743 0 O-C-N 124.813 1.32 . . . . 0.0 115.56 173.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -123.89 35.26 4.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.066 -0.567 . . . . 0.0 110.902 -174.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . -91.63 27.26 10.0 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.865 -0.683 . . . . 0.0 113.066 -177.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.63 50.56 2.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.167 0.508 . . . . 0.0 109.812 177.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 314' ' ' PHE . . . . . 1.652 ' HE2' ' CE1' ' B' ' 314' ' ' PHE . 62.5 m-85 -132.03 -47.48 0.93 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.217 -175.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 315' ' ' ASP . . . . . 0.435 ' HB3' ' O ' ' B' ' 314' ' ' PHE . 28.4 t70 . . . . . 0 C--O 1.247 0.923 0 O-C-N 124.137 0.898 . . . . 0.0 111.334 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.9 mtp . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.25 -78.4 0.58 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.933 0.397 . . . . 0.0 111.363 -177.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 m -78.31 76.33 4.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.585 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.8 m -70.02 -25.06 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 CA-C-O 120.992 0.425 . . . . 0.0 110.537 -177.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.43 ' HB2' HG22 ' A' ' 39' ' ' VAL . 3.4 p -68.36 -52.73 29.93 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 121.48 0.657 . . . . 0.0 110.015 175.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.544 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 41.8 tt0 -62.56 -41.57 99.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.174 178.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.474 HD11 ' CG2' ' B' ' 255' ' ' ILE . 49.2 mt -53.98 -47.31 71.51 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.314 174.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.34 -53.12 61.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.685 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.544 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 7.2 p -67.54 -28.3 67.69 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.7 -176.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.419 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 0.7 OUTLIER -76.06 -40.76 37.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 120.895 0.379 . . . . 0.0 111.09 179.708 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 1.654 ' HD1' ' CD2' ' A' ' 11' ' ' TYR . 19.9 m-85 -71.03 -28.63 64.53 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.5 m -68.66 -45.86 70.63 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.102 173.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.5 -51.18 28.59 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.057 0.456 . . . . 0.0 110.572 173.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 10' ' ' ILE . 35.5 mt -61.23 -48.82 79.72 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.921 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.455 HD12 ' HA ' ' B' ' 206' ' ' SER . 83.8 mt -62.57 -37.29 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.789 0.328 . . . . 0.0 111.453 -178.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.452 HD22 ' HA ' ' A' ' 23' ' ' VAL . 10.8 mp -74.11 -22.14 59.6 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.895 177.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.486 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 51.4 t-80 -94.16 61.03 2.85 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.831 172.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -124.81 -55.62 1.6 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 174.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -117.19 -161.88 0.83 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -81.48 43.65 0.75 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.482 0.658 . . . . 0.0 111.845 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.431 HG12 ' CD1' ' B' ' 232' ' ' ILE . 7.6 p -94.05 128.54 45.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.099 0.476 . . . . 0.0 110.102 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.44 ' C ' ' H ' ' A' ' 24' ' ' THR . 33.5 p -56.08 123.69 15.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.81 -178.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.452 ' HA ' HD22 ' A' ' 16' ' ' LEU . 8.6 p -76.87 24.73 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-O 121.643 0.735 . . . . 0.0 111.144 -177.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.44 ' H ' ' C ' ' A' ' 22' ' ' THR . 6.6 t -92.49 168.13 11.48 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 121.679 0.752 . . . . 0.0 110.938 -174.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -25.83 67.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.778 -168.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -49.04 -50.89 34.17 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.521 0.677 . . . . 0.0 109.311 170.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -82.13 -38.14 25.2 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.931 -172.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.5 mt -62.93 -48.77 86.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.519 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -63.62 -39.58 94.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.125 177.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.92 -49.01 76.91 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.036 0.446 . . . . 0.0 110.914 176.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.425 HD22 HD13 ' A' ' 15' ' ' ILE . 44.0 tp -67.68 -36.01 79.9 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.294 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.3 mp -58.72 -37.04 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.193 174.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -77.06 -29.78 55.23 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.645 176.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.402 ' HB2' ' HA ' ' B' ' 226' ' ' ILE . . . -57.7 -45.27 85.89 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.936 176.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.44 -51.54 6.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.096 178.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.74 38.9 2.65 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.029 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.479 HG21 ' HA3' ' B' ' 213' ' ' GLY . 3.5 t -98.37 135.01 34.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.769 0.319 . . . . 0.0 110.688 -177.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -86.61 94.59 9.51 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.232 0.539 . . . . 0.0 110.504 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.43 HG22 ' HB2' ' A' ' 5' ' ' SER . 5.1 p -113.51 135.05 54.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.196 177.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -48.29 108.92 1.01 Allowed Pre-proline 0 N--CA 1.466 0.371 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.473 174.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -47.53 -18.49 0.9 Allowed 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 124.189 3.259 . . . . 0.0 114.266 -173.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 1.66 ' HE2' ' CE1' ' A' ' 42' ' ' PHE . 0.5 OUTLIER -68.03 -38.74 82.9 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.723 -178.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.549 ' O ' ' HB2' ' A' ' 47' ' ' PHE . 62.8 m95 -66.38 -59.08 8.98 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.387 178.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.493 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 73.0 Cg_exo -52.09 -47.69 25.4 Favored 'Trans proline' 0 C--N 1.363 1.324 0 C-N-CA 122.253 1.969 . . . . 0.0 112.715 177.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.17 -57.48 18.24 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.054 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.74 -43.91 85.7 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.618 ' O ' HD11 ' A' ' 51' ' ' LEU . 1.1 t80 -59.61 -55.23 37.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.092 0.473 . . . . 0.0 110.678 -177.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.99 -32.4 72.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.53 -176.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.465 ' HA ' ' HE2' ' A' ' 49' ' ' LYS . 9.1 mmpt? -87.04 -14.94 40.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.607 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.89 -27.85 16.85 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.618 HD11 ' O ' ' A' ' 47' ' ' PHE . 5.8 mp -75.21 -113.32 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.817 177.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 61.42 -6.93 0.11 Allowed 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 178.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.464 ' H ' ' C ' ' A' ' 51' ' ' LEU . 47.3 t30 -144.08 -39.2 0.29 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.58 HG21 ' HA ' ' A' ' 51' ' ' LEU . 16.0 t -44.95 104.43 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.838 174.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -39.99 -82.66 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 O-C-N 124.312 1.007 . . . . 0.0 111.515 -176.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.605 ' O ' HD13 ' A' ' 59' ' ' LEU . 0.9 OUTLIER -157.08 -66.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.58 172.408 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.21 -23.87 53.88 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.287 -0.482 . . . . 0.0 113.603 -171.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.475 ' HB2' ' CG1' ' A' ' 54' ' ' VAL . 14.5 m -60.69 -14.21 19.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.595 0.236 . . . . 0.0 111.587 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.605 HD13 ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -62.88 -14.54 47.52 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.983 0.42 . . . . 0.0 110.543 179.386 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.588 ' N ' HD11 ' A' ' 59' ' ' LEU . 9.0 tt -77.61 -4.6 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.055 -178.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 98.9 m -69.22 104.2 2.14 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.336 0.589 . . . . 0.0 110.866 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -75.88 65.33 1.96 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.218 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 63' ' ' VAL . 5.1 t -77.15 6.77 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.213 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -61.46 -67.09 2.27 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.745 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.85 -87.38 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.427 0.156 . . . . 0.0 110.943 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.426 ' O ' ' HD3' ' A' ' 68' ' ' PRO . . . 81.31 69.69 1.38 Allowed Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.554 177.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -102.97 102.23 2.21 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.446 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 66' ' ' GLY . 20.6 Cg_endo -88.14 104.62 0.5 Allowed 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.627 2.218 . . . . 0.0 112.46 -177.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.28 84.35 63.49 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.285 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -93.09 168.24 2.39 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.297 2.664 . . . . 0.0 112.645 176.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -166.59 157.6 12.6 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.961 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 66.11 177.72 0.22 Allowed 'General case' 0 CA--C 1.534 0.363 0 O-C-N 123.68 0.613 . . . . 0.0 111.876 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.64 62.88 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.777 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.91 137.09 32.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.561 0.22 . . . . 0.0 111.06 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.07 114.19 4.93 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.292 0.567 . . . . 0.0 110.647 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.83 128.44 30.31 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 123.988 3.125 . . . . 0.0 112.948 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.67 20.62 10.2 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.312 0.577 . . . . 0.0 110.652 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -143.22 151.55 23.32 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -138.82 -88.34 0.18 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.434 -0.888 . . . . 0.0 113.204 -178.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.09 149.51 90.13 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.664 2.243 . . . . 0.0 112.604 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -126.42 101.73 27.43 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.762 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.11 149.25 81.28 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.22 2.613 . . . . 0.0 113.138 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.6 m -137.54 21.23 2.92 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.327 0.584 . . . . 0.0 109.761 175.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.0 t -108.65 127.0 53.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.774 -176.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -163.09 119.67 1.84 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.098 177.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 68.02 167.1 0.25 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.789 0.681 . . . . 0.0 112.121 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.28 105.68 3.57 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.974 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -56.15 130.57 40.93 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.315 2.677 . . . . 0.0 113.359 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -135.95 89.63 2.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.772 175.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -106.54 126.73 52.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.662 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -83.09 176.6 9.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.444 0.64 . . . . 0.0 112.32 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -162.22 160.74 27.35 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.711 177.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm 71.03 81.99 0.15 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.343 0.657 . . . . 0.0 110.733 -172.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 m -111.33 6.53 8.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.832 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -102.58 166.0 10.77 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 178.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 97' ' ' LYS . . . -134.96 -75.82 0.46 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.802 -178.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 96' ' ' ALA . 45.4 mtmt 65.93 167.1 0.2 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.982 0.42 . . . . 0.0 111.074 -174.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -155.81 147.39 22.9 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.176 0.512 . . . . 0.0 112.15 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.86 42.94 3.23 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.083 173.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -53.32 143.91 17.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.931 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.6 t -71.88 104.58 3.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.22 0.533 . . . . 0.0 109.952 176.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -76.73 -172.05 2.11 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.371 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -55.59 122.26 10.94 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.42 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.58 56.22 1.81 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.489 0.662 . . . . 0.0 110.613 -177.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -98.88 52.52 0.98 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.481 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -68.42 114.3 6.74 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.728 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -84.78 159.71 20.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.083 0.468 . . . . 0.0 111.041 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 15.8 tpt -98.84 93.84 6.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.597 -177.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 169.21 -177.11 43.05 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.172 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.85 60.78 4.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.046 0.45 . . . . 0.0 110.904 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -132.63 59.2 0.69 Allowed Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.43 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.3 mt -117.7 20.15 13.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.282 0.563 . . . . 0.0 110.614 -175.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 1.664 ' HE1' ' CE2' ' A' ' 113' ' ' PHE . 19.9 p90 -138.32 15.89 2.78 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.206 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 C--O 1.249 1.076 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.494 -176.919 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 120.274 0.083 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 78.0 mmm -56.3 121.19 8.95 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 123.289 0.368 . . . . 0.0 110.221 176.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 202' ' ' ARG . . . . . 0.423 ' C ' ' H ' ' B' ' 204' ' ' VAL . 98.4 mtt180 -150.73 -176.32 5.47 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.148 -179.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 203' ' ' TYR . . . . . 1.638 ' HE2' ' CE1' ' B' ' 203' ' ' TYR . 59.0 m-85 -71.26 9.2 0.81 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.896 0.478 . . . . 0.0 111.669 -178.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.744 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 15.5 m -59.52 -49.05 85.05 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.193 177.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 205' ' ' ALA . . . . . 0.483 ' HA ' HD13 ' B' ' 208' ' ' LEU . . . -73.31 -15.59 61.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.064 0.459 . . . . 0.0 110.618 -177.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 206' ' ' SER . . . . . 0.455 ' HA ' HD12 ' A' ' 15' ' ' ILE . 6.5 m -71.02 -49.22 47.45 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 172.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 207' ' ' TYR . . . . . 0.516 ' CZ ' ' HD2' ' B' ' 218' ' ' PRO . 24.4 t80 -60.76 -40.87 94.09 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 174.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.744 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 79.3 mt -59.71 -51.68 68.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.168 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 209' ' ' LEU . . . . . . . . . . . . . 8.4 tp -59.7 -49.75 76.51 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.862 0.363 . . . . 0.0 110.612 -178.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -61.84 -34.03 75.22 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.2 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 211' ' ' ALA . . . . . . . . . . . . . . . -79.4 -36.25 39.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.032 0.444 . . . . 0.0 110.79 178.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 212' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.32 -46.69 85.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.202 177.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . 0.479 ' HA3' HG21 ' A' ' 37' ' ' VAL . . . -150.38 69.59 0.32 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.694 -1.241 . . . . 0.0 112.929 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . -168.71 -66.51 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.276 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 215' ' ' ASN . . . . . 0.613 HD21 ' N ' ' B' ' 216' ' ' SER . 0.2 OUTLIER -156.89 132.05 9.09 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -178.681 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 216' ' ' SER . . . . . 0.613 ' N ' HD21 ' B' ' 215' ' ' ASN . 2.1 m -51.34 -30.83 19.87 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.652 -178.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 18.0 p -121.79 76.62 38.28 Favored Pre-proline 0 N--CA 1.442 -0.867 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.667 -177.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . 0.516 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 75.6 Cg_exo -54.41 108.53 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.579 2.853 . . . . 0.0 112.651 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 30.8 m -84.66 155.93 21.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.695 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -51.62 -40.04 59.15 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.174 0.512 . . . . 0.0 110.706 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -60.55 -32.5 71.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.566 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -85.42 -30.75 23.32 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -177.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.45 HG21 ' HB3' ' B' ' 206' ' ' SER . 1.8 mp -66.91 -42.06 88.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 172.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 224' ' ' LYS . . . . . 0.421 ' HZ3' ' CG ' ' B' ' 236' ' ' ASP . 53.8 mtpt -60.71 -46.14 91.55 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.097 174.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . 0.502 ' HZ1' ' HB3' ' B' ' 225' ' ' LYS . 5.6 ttpm? -55.99 -43.92 78.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.375 177.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . 0.402 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . 1.0 OUTLIER -60.42 -42.39 90.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 178.706 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 93.5 mt -71.91 -39.02 69.81 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 121.214 -0.195 . . . . 0.0 111.378 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -67.45 -30.49 70.23 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.769 0.318 . . . . 0.0 111.146 177.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 56.1 m -69.36 -47.57 63.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.293 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 11.4 p -79.53 -27.21 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.075 0.464 . . . . 0.0 111.362 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 103.55 56.98 0.76 Allowed Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.374 174.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . 0.431 ' CD1' HG12 ' A' ' 21' ' ' VAL . 31.5 mt -133.65 125.98 50.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 176.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -60.17 131.1 49.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.917 0.389 . . . . 0.0 110.769 176.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -118.24 152.62 35.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.904 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -117.04 114.97 24.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.144 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 236' ' ' ASP . . . . . 0.421 ' CG ' ' HZ3' ' B' ' 224' ' ' LYS . 1.9 m-20 -55.33 -37.65 67.7 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.64 -173.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.37 -62.0 1.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.01 0.433 . . . . 0.0 110.312 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.661 ' O ' HG21 ' B' ' 242' ' ' VAL . 86.5 mtm180 -63.62 -34.34 77.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.665 -177.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 239' ' ' LEU . . . . . 0.498 ' HA ' ' CD2' ' B' ' 203' ' ' TYR . 9.9 tt -62.6 -57.66 10.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.07 0.462 . . . . 0.0 110.939 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -66.62 -23.34 66.16 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.127 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -68.34 -46.88 68.98 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 120.983 0.421 . . . . 0.0 110.74 176.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 242' ' ' VAL . . . . . 0.661 HG21 ' O ' ' B' ' 238' ' ' ARG . 52.2 t -67.44 -32.95 59.46 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 40.1 mt -75.9 -22.57 15.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.704 176.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 36.1 t -71.19 -37.41 72.14 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.656 174.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -85.86 -26.0 25.91 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.325 0.583 . . . . 0.0 110.353 175.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . 0.66 ' O ' HD12 ' B' ' 246' ' ' LEU . 0.0 OUTLIER -121.51 97.56 5.56 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.88 0.848 . . . . 0.0 109.678 -177.41 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 247' ' ' ASN . . . . . 0.533 ' CG ' ' H ' ' B' ' 248' ' ' GLY . 25.2 p-10 -146.79 -74.92 0.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.108 177.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . 0.533 ' H ' ' CG ' ' B' ' 247' ' ' ASN . . . -106.72 55.06 0.55 Allowed Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -177.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -117.07 57.85 0.78 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.731 -0.234 . . . . 0.0 110.83 -177.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 60.81 67.5 0.82 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.655 0.597 . . . . 0.0 111.477 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.474 HD12 ' CD1' ' B' ' 207' ' ' TYR . 1.8 mm -60.93 -48.79 87.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.97 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -60.44 -29.4 68.99 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.524 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . 0.517 ' O ' ' HG2' ' B' ' 257' ' ' GLN . 27.9 t70 -76.66 -47.49 21.95 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.961 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 254' ' ' VAL . . . . . 0.445 HG23 ' HA ' ' B' ' 251' ' ' ILE . 28.8 m -62.47 -29.86 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.597 0.237 . . . . 0.0 111.164 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 255' ' ' ILE . . . . . 0.474 ' CG2' HD11 ' A' ' 7' ' ' LEU . 61.9 mt -88.03 -24.89 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-O 120.827 0.346 . . . . 0.0 110.746 175.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -66.74 -38.99 87.75 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.018 -0.426 . . . . 0.0 111.281 177.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . 0.563 ' HG3' ' H ' ' B' ' 258' ' ' GLY . 4.6 pt20 -69.5 -81.96 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . 0.563 ' H ' ' HG3' ' B' ' 257' ' ' GLN . . . 175.44 -90.39 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.249 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 259' ' ' ILE . . . . . 0.438 HD11 ' N ' ' B' ' 259' ' ' ILE . 0.0 OUTLIER -100.57 -97.19 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.91 -0.645 . . . . 0.0 110.732 -179.018 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' B' ' 262' ' ' LEU . . . 120.8 -149.4 17.48 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.628 -178.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.54 23.61 0.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.257 0.551 . . . . 0.0 110.657 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 262' ' ' LEU . . . . . 0.408 ' H ' ' C ' ' B' ' 260' ' ' GLY . 3.1 mt -77.55 -53.05 8.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.736 -175.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -143.03 52.95 1.37 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.612 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 3.1 p -112.12 -83.14 0.59 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.321 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 15.4 t -126.93 123.39 23.61 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.022 0.439 . . . . 0.0 110.424 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -57.58 -32.6 94.8 Favored 'Trans proline' 0 N--CA 1.476 0.463 0 C-N-CA 123.988 3.125 . . . . 0.0 113.777 -174.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . -121.6 24.41 9.82 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 120.894 0.378 . . . . 0.0 111.232 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 81.14 -32.62 2.5 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 121.026 -0.607 . . . . 0.0 113.188 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . 86.72 43.8 5.97 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.872 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . 68.12 179.29 0.23 Allowed 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.219 0.608 . . . . 0.0 110.847 -176.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 7.9 t -118.74 134.26 62.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.833 0.349 . . . . 0.0 110.703 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -137.35 135.21 36.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.371 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 14.8 p -68.41 143.02 15.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.179 0.514 . . . . 0.0 110.978 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 18.8 p -108.2 179.45 4.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.384 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . 62.35 74.95 0.42 Allowed 'General case' 0 C--O 1.23 0.073 0 CA-C-O 121.283 0.563 . . . . 0.0 111.516 178.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -115.01 104.54 53.93 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.226 177.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 277' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -80.41 141.51 14.22 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.219 2.613 . . . . 0.0 112.448 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -109.26 -38.74 1.76 Allowed Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.8 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 41.6 m 66.19 -172.29 0.19 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.851 0.358 . . . . 0.0 110.922 -176.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 52.53 56.75 7.22 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.166 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . 0.487 ' H ' ' HD2' ' B' ' 282' ' ' PRO . . . -158.09 -54.36 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.853 -176.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . 0.487 ' HD2' ' H ' ' B' ' 281' ' ' ALA . 59.4 Cg_endo -70.34 155.37 64.17 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 121.548 1.499 . . . . 0.0 112.562 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -87.62 119.2 27.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.848 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -132.19 47.46 2.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.409 177.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -76.75 81.75 1.12 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.289 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 21.6 t -75.79 79.25 2.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.193 0.521 . . . . 0.0 110.232 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -139.61 77.78 27.53 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.846 176.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.91 88.97 0.29 Allowed 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.45 2.1 . . . . 0.0 112.708 -178.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -92.02 99.63 12.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.294 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -75.39 118.74 18.6 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 173.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -109.56 -81.39 0.57 Allowed 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 121.171 -0.211 . . . . 0.0 110.625 -176.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 57.2 -171.92 0.09 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.497 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 59.1 104.87 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -86.61 29.58 0.78 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.482 0.658 . . . . 0.0 110.055 177.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -138.92 110.26 6.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.535 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -94.24 -171.11 2.44 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 174.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 64.39 47.74 2.98 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -170.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -75.29 65.26 1.59 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.68 -173.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -170.64 86.15 0.11 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.188 0.518 . . . . 0.0 111.008 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -110.37 -27.83 8.86 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -57.32 98.41 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.581 176.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 12.4 p -148.61 151.74 35.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.463 -177.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -103.04 -6.2 22.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.971 0.415 . . . . 0.0 110.758 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -83.68 70.53 10.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.4 0.619 . . . . 0.0 111.673 -175.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 36.1 t -80.01 135.16 36.31 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.625 176.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -84.91 -27.75 26.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.633 -176.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -76.23 103.1 6.09 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.075 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -88.2 -49.94 6.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.052 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -86.75 45.3 1.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.196 -176.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . -64.44 -43.01 97.34 Favored Glycine 0 CA--C 1.517 0.213 0 CA-C-N 115.745 -0.661 . . . . 0.0 113.18 -176.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 311' ' ' PHE . . . . . 1.665 ' HD1' ' CD2' ' B' ' 311' ' ' PHE . 96.2 m-85 -112.53 56.0 0.68 Allowed 'General case' 0 C--N 1.327 -0.386 0 O-C-N 122.493 -0.416 . . . . 0.0 110.966 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . -134.04 53.81 0.78 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.949 -178.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.26 -39.22 17.99 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 314' ' ' PHE . . . . . . . . . . . . . 34.1 p90 52.29 17.72 0.78 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.052 1.341 . . . . 0.0 113.832 172.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 30.1 t70 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.653 -0.689 . . . . 0.0 109.868 -179.594 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.1 mtp . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.46 171.06 14.66 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.878 -0.146 . . . . 0.0 110.654 -177.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.533 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 36.7 m 60.63 28.07 17.77 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.732 0.645 . . . . 0.0 112.411 178.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.475 HG13 ' CD1' ' B' ' 212' ' ' LEU . 15.4 m -72.26 -16.26 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.76 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -68.67 0.36 Allowed 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.674 176.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.487 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 3.2 pm0 -56.2 -43.03 78.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.46 178.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 3' ' ' SER . 38.2 mt -54.32 -57.89 9.51 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.327 176.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.93 -50.33 69.11 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -176.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.487 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 26.4 p -70.7 -33.8 71.27 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.763 -173.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.432 HG22 ' O ' ' B' ' 262' ' ' LEU . 0.5 OUTLIER -79.36 -25.49 12.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.946 0.403 . . . . 0.0 110.576 -179.676 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.549 ' OH ' HG22 ' B' ' 255' ' ' ILE . 20.7 m-30 -76.05 -28.78 57.8 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 172.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.416 ' OG ' HG12 ' A' ' 28' ' ' ILE . 7.5 t -68.3 -50.64 52.15 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.669 174.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.21 -47.95 68.52 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 173.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.501 HD23 HG21 ' B' ' 259' ' ' ILE . 11.4 mt -52.06 -61.64 2.13 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.057 177.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.451 HD13 ' HA ' ' B' ' 206' ' ' SER . 56.5 mt -62.72 -46.29 96.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.197 0.522 . . . . 0.0 111.297 -176.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.42 ' HG ' HG13 ' A' ' 23' ' ' VAL . 25.1 tp -70.65 -15.29 62.72 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.601 -173.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -125.62 37.92 4.27 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 119.362 -0.935 . . . . 0.0 112.112 173.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.467 ' OD2' ' HB2' ' B' ' 201' ' ' MET . 12.3 t0 -81.21 -57.75 3.36 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 167.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -81.5 174.1 11.76 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.332 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -84.23 39.04 0.69 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.33 0.586 . . . . 0.0 111.171 -175.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.407 HG12 ' CD1' ' B' ' 232' ' ' ILE . 14.6 p -92.57 142.72 12.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.028 177.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.0 p -72.17 133.88 45.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.43 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.42 HG13 ' HG ' ' A' ' 16' ' ' LEU . 16.0 m -87.8 132.67 32.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.359 -179.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.5 p -147.06 158.39 43.92 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.907 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -45.76 -55.91 5.95 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.909 0.755 . . . . 0.0 111.361 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.43 -31.52 64.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.807 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -80.14 -39.1 30.13 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.494 -177.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.416 HG12 ' OG ' ' A' ' 12' ' ' SER . 4.0 mt -63.88 -47.03 92.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -55.1 -43.75 74.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.767 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.87 -47.88 83.95 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.682 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.4 mt -63.4 -39.49 94.65 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.855 0.359 . . . . 0.0 111.007 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 mp -60.01 -45.5 95.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.433 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -72.35 -25.41 61.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.811 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.81 -37.25 81.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.3 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.68 -37.73 19.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.035 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 123.0 -41.95 1.7 Allowed Glycine 0 CA--C 1.519 0.322 0 C-N-CA 119.946 -1.121 . . . . 0.0 114.005 173.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.2 m -95.01 151.63 3.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.754 0.277 . . . . 0.0 111.235 -176.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -109.47 -176.05 2.92 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.605 0.717 . . . . 0.0 111.391 -171.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.0 p -153.46 152.76 9.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.919 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -47.37 116.46 4.3 Favored Pre-proline 0 N--CA 1.47 0.535 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 175.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.404 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 88.8 Cg_exo -49.31 -14.49 0.56 Allowed 'Trans proline' 0 N--CA 1.485 0.986 0 C-N-CA 124.175 3.25 . . . . 0.0 114.863 -172.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 1.659 ' HE1' ' CE2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -79.57 -21.0 45.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.015 -175.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.412 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 69.0 m95 -72.75 -52.41 6.12 Favored Pre-proline 0 CA--C 1.537 0.448 0 O-C-N 123.003 0.189 . . . . 0.0 110.548 175.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 74.5 Cg_exo -51.45 -51.5 11.06 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 122.137 1.891 . . . . 0.0 111.569 171.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.45 -37.85 92.66 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.117 177.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 39.3 tp -60.98 -56.62 18.93 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -60.01 -36.29 76.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.588 0.232 . . . . 0.0 111.022 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.6 -39.54 94.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.871 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -92.72 -11.43 33.97 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.45 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.33 -50.87 5.43 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.648 ' HA ' HG21 ' A' ' 54' ' ' VAL . 9.2 mt -85.61 -130.94 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.904 -175.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 75.79 -10.61 1.24 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.842 0.857 . . . . 0.0 113.047 175.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -143.8 -45.55 0.27 Allowed 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.648 HG21 ' HA ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -51.2 129.62 10.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 113.428 -1.714 . . . . 0.0 111.609 174.78 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -51.7 157.53 1.14 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.84 -1.527 . . . . 0.0 111.381 175.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.4 tp -46.98 -50.82 5.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.803 -175.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.15 -15.48 10.77 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.627 -0.32 . . . . 0.0 113.722 -173.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.6 t -62.18 -23.3 66.53 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -74.33 -10.36 59.51 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.359 -177.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.575 HG12 ' HB ' ' B' ' 259' ' ' ILE . 14.7 mt -86.86 -6.59 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-O 121.757 0.789 . . . . 0.0 109.527 176.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 66.0 m -82.72 90.45 6.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.563 176.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -77.67 69.91 3.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.121 0.962 . . . . 0.0 110.259 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.4 t -64.96 -20.49 27.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.023 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.11 -169.96 46.48 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.223 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -121.09 116.19 24.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.063 0.432 . . . . 0.0 111.327 -177.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -97.07 137.8 13.53 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.676 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -154.77 91.27 0.12 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.952 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.66 -63.73 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.687 2.258 . . . . 0.0 111.961 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -165.76 137.82 3.24 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.756 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -67.79 -47.31 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.597 2.198 . . . . 0.0 112.014 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 61.53 176.2 0.12 Allowed 'General case' 0 N--CA 1.465 0.312 0 O-C-N 123.636 0.585 . . . . 0.0 112.574 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 54.42 66.04 1.34 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.942 176.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -135.75 102.74 0.43 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.079 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -135.03 120.55 19.27 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.695 0.283 . . . . 0.0 110.559 178.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -150.57 130.02 6.51 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.495 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 50.1 Cg_exo -57.56 -21.5 46.68 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 124.068 3.179 . . . . 0.0 114.167 -176.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.68 95.4 1.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.958 0.408 . . . . 0.0 110.959 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.01 -17.22 38.4 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.679 -178.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.33 88.34 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.478 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -82.15 119.75 3.2 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.908 2.406 . . . . 0.0 111.869 176.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -112.61 95.89 34.39 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.538 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -50.29 -51.73 10.39 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.812 3.008 . . . . 0.0 113.511 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.4 t 58.63 37.51 25.29 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.227 0.536 . . . . 0.0 110.54 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.4 p -104.52 37.64 2.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.307 -178.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.89 162.65 37.27 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.171 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 58.3 74.48 0.43 Allowed 'General case' 0 N--CA 1.464 0.268 0 O-C-N 123.742 0.651 . . . . 0.0 110.654 -175.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 73.6 82.92 0.13 Allowed Pre-proline 0 N--CA 1.468 0.439 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.359 -177.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -53.43 131.42 43.45 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.005 2.47 . . . . 0.0 112.493 174.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.51 -28.31 34.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.109 -176.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -110.63 99.73 8.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.87 0.367 . . . . 0.0 111.597 -175.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -114.73 -172.75 2.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.488 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -99.13 176.04 5.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.274 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -74.89 126.2 30.45 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.056 0.455 . . . . 0.0 110.938 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.7 t -118.56 -64.86 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.246 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -128.78 155.82 44.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.541 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 97' ' ' LYS . . . -124.0 38.43 4.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.614 178.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 96' ' ' ALA . 35.9 mtmm 68.41 154.34 0.11 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.777 -176.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -156.47 173.36 17.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.035 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 59.82 96.39 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 O-C-N 123.998 0.812 . . . . 0.0 110.973 176.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -69.65 175.37 4.23 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.357 -173.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.4 t 76.01 142.87 0.08 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.03 -173.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -82.57 77.78 9.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.901 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 68.88 167.43 0.27 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.575 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.2 m -157.21 169.06 25.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.103 -175.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.8 t0 69.63 16.42 8.02 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.098 0.874 . . . . 0.0 110.929 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.1 t70 58.47 -157.84 0.31 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.893 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -91.74 167.51 12.12 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 40.2 tpp -119.36 56.29 0.93 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.293 0.568 . . . . 0.0 110.064 -176.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -149.66 177.0 28.1 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.395 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 1.667 ' HE2' ' CE1' ' A' ' 110' ' ' PHE . 6.6 p90 -99.81 -171.05 1.98 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.681 0.277 . . . . 0.0 110.583 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 94.73 39.05 4.76 Favored Glycine 0 CA--C 1.516 0.156 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.735 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 46.8 tp -131.36 -44.23 1.02 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.395 0.617 . . . . 0.0 110.628 -175.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 1.653 ' HD2' ' CD1' ' A' ' 113' ' ' PHE . 30.2 p90 -108.64 -4.32 17.19 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.829 0.823 . . . . 0.0 109.329 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 C--O 1.251 1.146 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.449 -175.226 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.94 0 CA-C-O 120.503 0.192 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 201' ' ' MET . . . . . 0.467 ' HB2' ' OD2' ' A' ' 18' ' ' ASP . 76.9 mtm -93.36 -111.89 0.11 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.202 -179.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 202' ' ' ARG . . . . . 0.468 ' C ' ' H ' ' B' ' 204' ' ' VAL . 67.9 mtt180 -153.76 157.55 39.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -176.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 203' ' ' TYR . . . . . 0.514 ' CD1' ' HA ' ' B' ' 239' ' ' LEU . 71.8 m-85 -79.19 30.16 0.22 Allowed 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.177 0.513 . . . . 0.0 110.52 178.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.787 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 2.5 m -58.11 -65.2 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.635 178.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 205' ' ' ALA . . . . . 0.534 ' HA ' HD13 ' B' ' 208' ' ' LEU . . . -64.6 -13.67 54.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 206' ' ' SER . . . . . 0.451 ' HA ' HD13 ' A' ' 15' ' ' ILE . 4.1 m -75.74 -50.68 14.6 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 175.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 207' ' ' TYR . . . . . 0.422 ' CZ ' ' HD2' ' B' ' 218' ' ' PRO . 15.7 t80 -62.71 -35.21 79.0 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 174.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.787 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 71.3 mt -64.3 -49.3 72.34 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.983 176.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 209' ' ' LEU . . . . . 0.493 HD22 ' HB2' ' A' ' 11' ' ' TYR . 11.4 mt -54.64 -49.91 69.43 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.785 0.326 . . . . 0.0 110.857 177.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 210' ' ' ALA . . . . . 0.453 ' HB1' ' HB3' ' B' ' 218' ' ' PRO . . . -59.93 -48.69 80.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.233 -177.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 211' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -65.18 -43.87 90.3 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.831 0.348 . . . . 0.0 110.977 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 212' ' ' LEU . . . . . 0.475 ' CD1' HG13 ' A' ' 4' ' ' VAL . 2.3 tp -61.44 -32.46 72.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.162 178.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -76.09 -11.78 84.57 Favored Glycine 0 N--CA 1.454 -0.135 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.769 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 122.22 1.14 10.38 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.278 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 215' ' ' ASN . . . . . 0.647 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 93.8 m-20 -98.44 102.91 14.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.115 0.458 . . . . 0.0 110.758 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 5.3 m -66.34 -17.78 64.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.213 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 14.2 t -128.07 69.74 77.67 Favored Pre-proline 0 N--CA 1.443 -0.816 0 CA-C-O 120.96 0.409 . . . . 0.0 110.355 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . 0.453 ' HB3' ' HB1' ' B' ' 210' ' ' ALA . 50.2 Cg_exo -58.85 102.49 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.072 2.515 . . . . 0.0 112.738 178.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 18.0 m -72.32 144.03 48.46 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.267 178.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -56.52 -28.64 60.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.723 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -73.65 -27.03 61.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.494 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -79.8 -38.63 32.59 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.441 HG21 ' HB3' ' B' ' 206' ' ' SER . 1.8 mp -63.45 -45.2 98.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 173.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -58.02 -41.2 82.66 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.244 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -61.32 -41.7 97.44 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.317 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.73 -25.31 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.593 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -78.04 -44.7 25.69 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.765 0.316 . . . . 0.0 110.94 173.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -70.29 -15.79 62.93 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.489 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 86.8 p -51.47 -51.65 53.18 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.91 0.386 . . . . 0.0 110.633 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 60.9 t -87.28 -23.85 6.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.347 0.594 . . . . 0.0 110.371 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 101.92 41.0 2.55 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.143 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 232' ' ' ILE . . . . . 0.407 ' CD1' HG12 ' A' ' 21' ' ' VAL . 36.5 mt -103.84 136.7 35.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -73.66 145.87 44.97 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -143.0 121.65 12.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.383 -175.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . 0.466 ' HB2' ' HB2' ' B' ' 238' ' ' ARG . 8.0 m-20 -58.26 113.82 2.12 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.105 177.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 236' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' B' ' 239' ' ' LEU . 6.8 m-20 -61.75 -37.48 84.42 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.816 0.341 . . . . 0.0 111.648 -177.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -73.76 -46.77 43.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.921 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.466 ' HB2' ' HB2' ' B' ' 235' ' ' ASP . 41.8 mtp-105 -64.54 -29.03 70.05 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 239' ' ' LEU . . . . . 0.514 ' HA ' ' CD1' ' B' ' 203' ' ' TYR . 13.5 tp -54.07 -69.54 0.12 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.96 175.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -66.47 -24.28 66.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.463 -176.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -60.96 -53.91 51.5 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 120.866 0.365 . . . . 0.0 111.173 175.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 242' ' ' VAL . . . . . 0.427 HG22 ' H ' ' B' ' 203' ' ' TYR . 33.0 m -73.62 -28.37 24.7 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -176.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . 0.415 ' HA ' HD13 ' B' ' 246' ' ' LEU . 37.4 mt -70.67 -31.41 45.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.438 175.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 71.6 m -66.71 -35.25 79.69 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 172.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.79 -40.7 75.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.219 175.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 246' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' B' ' 243' ' ' ILE . 39.9 mt -67.48 -29.78 69.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.488 174.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -59.77 -32.8 70.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.131 -171.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -112.41 17.43 23.77 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.346 -175.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -124.41 151.97 43.82 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -64.91 119.71 11.2 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 121.241 0.543 . . . . 0.0 110.875 -178.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . 0.474 ' O ' HG13 ' B' ' 255' ' ' ILE . 0.4 OUTLIER -59.16 -31.8 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.67 -177.818 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -69.88 -40.93 75.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.814 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -65.8 -38.16 88.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.802 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 254' ' ' VAL . . . . . 0.4 HG23 ' HA ' ' B' ' 251' ' ' ILE . 17.7 m -76.2 -22.11 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.457 176.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 255' ' ' ILE . . . . . 0.549 HG22 ' OH ' ' A' ' 11' ' ' TYR . 27.9 mt -64.12 -43.43 97.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-O 121.431 0.634 . . . . 0.0 109.613 169.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 256' ' ' ALA . . . . . 0.522 ' HA ' ' HB1' ' B' ' 263' ' ' ALA . . . -78.06 -27.27 48.64 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.981 -178.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -130.52 76.17 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -176.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 258' ' ' GLY . . . . . 0.539 ' H ' ' CD2' ' B' ' 262' ' ' LEU . . . -108.31 -66.85 0.6 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 172.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 259' ' ' ILE . . . . . 0.575 ' HB ' HG12 ' A' ' 60' ' ' ILE . 1.6 pt -85.53 -28.43 6.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 122.181 0.991 . . . . 0.0 108.665 169.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . 0.412 ' H ' HD23 ' B' ' 262' ' ' LEU . . . 122.27 -55.82 0.66 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 113.751 -1.568 . . . . 0.0 110.902 -176.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 261' ' ' LYS . . . . . 0.496 ' HD2' ' O ' ' A' ' 60' ' ' ILE . 91.8 mttt -102.12 24.73 9.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.826 -0.187 . . . . 0.0 110.974 177.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 262' ' ' LEU . . . . . 0.539 ' CD2' ' H ' ' B' ' 258' ' ' GLY . 1.2 pt? -79.18 -14.59 58.99 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.524 0.678 . . . . 0.0 109.945 -178.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . 0.522 ' HB1' ' HA ' ' B' ' 256' ' ' ALA . . . -144.79 -44.13 0.24 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.768 176.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 9.8 t 74.19 161.68 0.25 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.912 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 40.6 t -131.42 116.73 16.44 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.492 -176.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.95 -22.21 23.44 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.66 2.24 . . . . 0.0 111.724 178.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . 49.5 63.46 2.15 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.127 173.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 78.57 -51.39 3.69 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.42 177.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . 92.5 42.82 4.43 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.201 -176.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . 62.16 51.97 3.37 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.191 0.52 . . . . 0.0 111.425 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 9.6 p -83.93 149.1 4.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.186 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -141.83 155.05 45.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.82 -178.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 273' ' ' VAL . . . . . 0.401 HG23 ' O ' ' B' ' 273' ' ' VAL . 13.1 p -127.63 37.42 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 122.341 1.067 . . . . 0.0 109.961 -178.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 4.7 p -82.07 118.22 22.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.093 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -97.35 135.6 39.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.391 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' B' ' 277' ' ' PRO . . . -129.75 139.54 35.97 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.801 -177.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 277' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' B' ' 276' ' ' ALA . 7.9 Cg_exo -72.44 102.84 1.44 Allowed 'Trans proline' 0 CA--C 1.516 -0.391 0 C-N-CA 122.616 2.21 . . . . 0.0 112.293 177.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -120.4 13.73 10.18 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.09 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 20.2 m -134.24 163.84 28.71 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 62.3 65.36 0.87 Allowed 'General case' 0 C--O 1.233 0.197 0 O-C-N 123.831 0.707 . . . . 0.0 112.11 171.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -133.48 79.84 59.01 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.409 176.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -76.54 126.33 8.9 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.412 2.074 . . . . 0.0 112.206 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -97.89 22.36 9.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.698 -177.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -133.06 117.34 17.45 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.497 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -158.58 21.8 0.33 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.03 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 30.8 p -141.31 97.76 3.23 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -177.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -114.78 115.44 43.78 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.116 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -60.0 149.44 84.24 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.701 2.267 . . . . 0.0 112.334 177.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -69.27 92.27 0.57 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.864 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -70.34 171.62 9.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.949 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -159.86 -169.14 2.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.277 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 61.18 33.61 19.21 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.049 0.452 . . . . 0.0 111.005 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 293' ' ' GLU . . . . . 0.417 ' O ' ' HG3' ' B' ' 295' ' ' LYS . 40.6 mt-10 -79.1 77.61 5.58 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.032 -178.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp 64.4 32.32 12.07 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.408 0.442 . . . . 0.0 111.074 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 295' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' B' ' 293' ' ' GLU . 91.9 mttt -126.2 99.62 5.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.779 -0.191 . . . . 0.0 110.812 -176.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -145.19 84.83 1.72 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.363 0.602 . . . . 0.0 111.034 178.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -101.08 92.22 4.9 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.645 172.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -141.44 169.46 17.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.651 -172.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt 71.47 84.68 0.13 Allowed 'General case' 0 C--O 1.233 0.219 0 O-C-N 123.868 0.73 . . . . 0.0 110.897 174.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 17.5 mp0 -74.68 48.15 0.35 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.753 -178.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 47.49 49.85 15.49 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.54 0.736 . . . . 0.0 112.704 174.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 5.4 p -91.04 114.81 27.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.072 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -94.35 98.95 11.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.24 0.543 . . . . 0.0 110.326 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -95.1 75.22 3.46 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.632 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 63.5 m 67.99 172.31 0.28 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.628 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -138.63 84.88 2.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.809 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 4.5 t70 65.45 -178.77 0.19 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.25 175.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -138.32 17.35 2.77 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.867 0.365 . . . . 0.0 110.671 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 14.9 tpt -67.56 87.06 0.2 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.749 174.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . -91.96 -128.75 4.49 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.942 174.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 61.2 15.89 6.77 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.041 0.536 . . . . 0.0 112.004 178.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . 103.34 -27.72 18.72 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.209 174.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 313' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' B' ' 313' ' ' LEU . 0.0 OUTLIER 65.61 3.65 2.51 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.194 0.521 . . . . 0.0 111.89 -179.453 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 314' ' ' PHE . . . . . 1.655 ' HE2' ' CE1' ' B' ' 314' ' ' PHE . 24.4 p90 -97.45 4.2 50.61 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.796 -169.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 36.4 t70 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.488 -178.868 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.578 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 3.8 p . . . . . 0 C--O 1.235 0.34 0 CA-C-O 120.985 0.421 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.8 p -63.87 -33.02 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.649 -172.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.407 ' HB3' HG23 ' A' ' 39' ' ' VAL . 3.9 m -58.71 -66.1 0.55 Allowed 'General case' 0 C--O 1.244 0.781 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.132 -177.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -64.91 -30.85 71.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.3 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 3' ' ' SER . 54.1 mt -57.27 -60.18 4.01 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.592 173.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.411 ' HB2' HD11 ' B' ' 212' ' ' LEU . . . -55.89 -45.55 78.59 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.854 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 48.6 t -63.3 -36.78 84.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.848 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.49 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 0.9 OUTLIER -73.87 -40.04 52.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 120.621 0.248 . . . . 0.0 111.347 -179.003 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.554 ' OH ' ' HA ' ' B' ' 255' ' ' ILE . 22.1 m-85 -68.69 -37.69 79.74 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.482 ' OG ' ' HA ' ' A' ' 28' ' ' ILE . 46.1 t -64.36 -44.28 91.94 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.659 175.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.49 -57.51 11.08 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.129 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.498 HD11 ' CB ' ' B' ' 205' ' ' ALA . 3.7 pp -70.43 -22.1 62.75 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.623 -0.431 . . . . 0.0 112.038 -177.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.42 ' N ' HD12 ' A' ' 14' ' ' LEU . 13.4 mt -71.3 -33.92 52.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.233 174.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.6 mt -86.94 -8.51 57.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.062 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -17.27 -78.26 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 115.319 1.599 . . . . 0.0 115.319 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -158.97 73.61 0.61 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.261 0.553 . . . . 0.0 109.951 -168.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.448 ' HB2' HG12 ' A' ' 21' ' ' VAL . 3.7 m-20 -132.46 -158.56 0.9 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.637 -174.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -69.11 -13.57 62.51 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.264 0.554 . . . . 0.0 109.782 172.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.493 ' HB ' HG12 ' B' ' 232' ' ' ILE . 5.1 p -96.28 160.85 2.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.528 -174.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.9 p -107.61 143.14 36.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.135 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.3 t -78.28 83.91 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.0 p -131.95 163.58 28.05 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -52.2 -49.96 62.86 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.93 -176.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -54.81 -36.19 64.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.317 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.541 ' HD2' ' HB ' ' B' ' 230' ' ' VAL . 75.4 mmtt -79.9 -44.03 21.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.315 -171.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.482 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 9.1 mt -62.02 -46.07 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.037 173.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -57.8 -39.07 76.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.488 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.25 -40.35 86.27 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.817 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.435 HD22 HG23 ' B' ' 226' ' ' ILE . 60.8 mt -70.35 -42.61 71.62 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 120.939 0.399 . . . . 0.0 110.391 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.454 HD13 ' O ' ' A' ' 28' ' ' ILE . 1.7 mp -59.84 -37.95 74.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.156 174.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -70.76 -37.53 73.4 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.771 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.41 -34.51 77.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.244 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.463 ' HB2' HD12 ' B' ' 209' ' ' LEU . . . -90.82 -31.73 16.36 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.659 -0.417 . . . . 0.0 111.813 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.66 35.48 6.86 Favored Glycine 0 CA--C 1.517 0.162 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.958 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.686 HG13 ' HA2' ' B' ' 213' ' ' GLY . 0.0 OUTLIER -97.32 173.77 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.025 0.441 . . . . 0.0 111.698 -178.017 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -121.46 106.43 11.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.571 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.407 HG23 ' HB3' ' A' ' 5' ' ' SER . 14.4 p -129.66 137.94 55.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 174.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.56 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 12.8 pt-20 -67.16 135.24 93.65 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.495 ' HA ' ' HG2' ' A' ' 44' ' ' PRO . 9.5 Cg_endo -52.75 -11.57 1.42 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 124.097 3.198 . . . . 0.0 113.745 -173.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.04 -41.23 82.38 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.056 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.418 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 89.4 m95 -68.08 -58.24 8.05 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.236 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HD2' ' O ' ' A' ' 40' ' ' GLU . 12.5 Cg_endo -56.43 -43.83 51.76 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.411 2.074 . . . . 0.0 112.753 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.94 -52.98 46.57 Favored Glycine 0 C--O 1.24 0.493 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.913 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 52.4 tp -59.94 -48.49 81.5 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.454 ' CD2' HD11 ' A' ' 51' ' ' LEU . 1.7 m-85 -56.42 -46.8 80.07 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.286 0.367 . . . . 0.0 111.865 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.62 -30.11 66.68 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -89.33 -12.69 39.79 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.442 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.5 -32.29 10.02 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.674 ' HA ' HG23 ' A' ' 54' ' ' VAL . 52.6 mt -88.38 -131.02 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.293 -176.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 68.97 -12.61 0.38 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.953 0.901 . . . . 0.0 112.901 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -143.76 6.02 1.39 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.904 0.859 . . . . 0.0 110.171 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.674 HG23 ' HA ' ' A' ' 51' ' ' LEU . 1.5 t -103.05 87.55 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.802 -174.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -7.46 -95.55 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.724 1.61 . . . . 0.0 114.689 -168.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.719 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 1.2 tp -153.69 -66.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.278 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.439 ' H ' HG23 ' A' ' 56' ' ' ILE . . . -59.03 -14.72 25.82 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.799 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.658 ' CB ' HG12 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -47.73 -42.63 25.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.567 -0.816 . . . . 0.0 111.598 175.205 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.719 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 0.9 OUTLIER -65.15 -12.33 49.82 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -174.507 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.563 HG12 ' HB ' ' B' ' 259' ' ' ILE . 65.2 mt -68.29 -29.01 42.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 121.2 0.524 . . . . 0.0 110.239 176.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 83.7 m -135.5 34.08 2.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.364 -176.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.438 ' HB2' ' HA ' ' A' ' 59' ' ' LEU . 64.2 t30 -70.63 -21.08 62.67 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.212 0.53 . . . . 0.0 110.721 -177.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.4 t . . . . . 0 C--N 1.322 -0.607 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.393 179.888 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 C--O 1.233 0.196 0 CA-C-O 121.057 0.456 . . . . 0.0 110.019 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.536 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 58.2 t -62.33 -50.68 78.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.708 -173.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 205' ' ' ALA . . . . . 0.504 ' HA ' HD12 ' B' ' 208' ' ' LEU . . . -69.34 -18.61 63.82 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.174 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 206' ' ' SER . . . . . 0.501 ' OG ' HG23 ' B' ' 223' ' ' ILE . 9.4 t -73.01 -40.08 65.47 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 207' ' ' TYR . . . . . 0.695 ' CE1' HD11 ' B' ' 251' ' ' ILE . 57.0 t80 -61.01 -37.45 82.57 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 171.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.568 ' O ' ' HB3' ' B' ' 212' ' ' LEU . 83.1 mt -66.18 -40.46 90.45 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.728 176.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 209' ' ' LEU . . . . . 0.463 HD12 ' HB2' ' A' ' 35' ' ' ALA . 3.2 mm? -57.27 -45.26 84.21 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 174.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -63.37 -48.96 75.75 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.587 0.232 . . . . 0.0 111.562 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.93 -50.09 52.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.757 0.313 . . . . 0.0 111.611 -176.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 212' ' ' LEU . . . . . 0.568 ' HB3' ' O ' ' B' ' 208' ' ' LEU . 0.0 OUTLIER -67.22 -25.0 65.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.048 -178.873 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 213' ' ' GLY . . . . . 0.686 ' HA2' HG13 ' A' ' 37' ' ' VAL . . . -56.79 -22.07 39.18 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.344 -0.455 . . . . 0.0 112.54 175.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 112.47 22.65 5.72 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.562 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 215' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -138.83 95.05 2.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.126 0.488 . . . . 0.0 110.201 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 17.7 m -78.04 57.61 1.82 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.806 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 17.6 t -147.06 100.28 3.92 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 218' ' ' PRO . . . . . 0.428 ' HB3' ' HE2' ' B' ' 207' ' ' TYR . 51.6 Cg_exo -59.82 92.69 0.09 OUTLIER 'Trans proline' 0 N--CA 1.474 0.353 0 C-N-CA 123.478 2.785 . . . . 0.0 113.992 -176.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 50.1 m -96.14 103.15 15.02 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 171.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 220' ' ' ALA . . . . . 0.438 ' HB1' ' CD1' ' B' ' 239' ' ' LEU . . . -54.18 -31.16 52.08 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.376 0.608 . . . . 0.0 110.706 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -62.4 -36.58 82.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.877 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -80.47 -28.02 37.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.116 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.501 HG23 ' OG ' ' B' ' 206' ' ' SER . 1.8 mp -62.0 -48.68 87.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 168.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 224' ' ' LYS . . . . . 0.46 ' HE2' ' O ' ' B' ' 234' ' ' ALA . 3.3 tppp? -57.02 -41.1 77.92 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.328 173.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -58.31 -46.13 86.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.023 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 0.435 HG23 HD22 ' A' ' 31' ' ' LEU . 1.3 mp -65.23 -40.41 88.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.737 178.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.26 -42.93 92.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.023 0.439 . . . . 0.0 111.273 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -79.92 -22.11 43.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.585 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 99.3 p -53.14 -41.19 64.85 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.968 0.413 . . . . 0.0 111.482 -177.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 230' ' ' VAL . . . . . 0.541 ' HB ' ' HD2' ' A' ' 27' ' ' LYS . 8.1 m -100.9 -12.88 8.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.233 -176.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 100.58 67.99 0.84 Allowed Glycine 0 C--O 1.228 -0.267 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.107 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 232' ' ' ILE . . . . . 0.493 HG12 ' HB ' ' A' ' 21' ' ' VAL . 12.9 mt -129.19 141.22 47.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 175.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -79.23 83.89 5.24 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.384 0.611 . . . . 0.0 111.524 -176.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 234' ' ' ALA . . . . . 0.46 ' O ' ' HE2' ' B' ' 224' ' ' LYS . . . -93.68 143.01 26.71 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.738 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 235' ' ' ASP . . . . . 0.487 ' OD2' ' HG3' ' B' ' 238' ' ' ARG . 17.3 t70 -107.51 129.99 54.9 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.242 0.544 . . . . 0.0 110.991 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.85 -38.44 90.82 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.487 -172.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -71.63 -51.03 25.29 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -177.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.487 ' HG3' ' OD2' ' B' ' 235' ' ' ASP . 77.5 mtp180 -57.64 -41.53 81.61 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.461 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 239' ' ' LEU . . . . . 0.56 HD12 ' N ' ' B' ' 240' ' ' ASN . 4.5 pp -68.55 -44.04 75.35 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.996 -177.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 240' ' ' ASN . . . . . 0.56 ' N ' HD12 ' B' ' 239' ' ' LEU . 50.0 t30 -66.96 -32.1 73.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.0 0.428 . . . . 0.0 110.201 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 241' ' ' LYS . . . . . 0.513 ' O ' ' HG3' ' B' ' 245' ' ' GLU . 1.0 OUTLIER -67.13 -45.25 77.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.948 178.21 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 242' ' ' VAL . . . . . . . . . . . . . 18.1 m -71.79 -27.16 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.386 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 243' ' ' ILE . . . . . 0.502 HG13 ' O ' ' B' ' 239' ' ' LEU . 27.7 mt -71.48 -36.52 60.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.607 177.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 5.1 p -78.95 -14.48 59.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.79 0.329 . . . . 0.0 111.025 176.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 245' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' B' ' 241' ' ' LYS . 51.5 mt-10 -82.17 -30.76 30.82 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.988 0.423 . . . . 0.0 110.392 169.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 246' ' ' LEU . . . . . 0.592 HD12 ' O ' ' B' ' 246' ' ' LEU . 1.1 pp -99.58 2.56 44.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.343 -176.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -58.84 109.43 0.82 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.578 0.704 . . . . 0.0 112.045 -171.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 71.52 30.48 66.6 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.885 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -90.16 -160.93 0.74 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 110.493 -0.188 . . . . 0.0 110.493 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 250' ' ' ASN . . . . . 0.436 ' HB3' ' HB2' ' B' ' 253' ' ' ASP . 14.0 m-20 -72.9 81.33 1.18 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.929 0.395 . . . . 0.0 111.913 -174.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.695 HD11 ' CE1' ' B' ' 207' ' ' TYR . 2.0 mm -72.29 -54.4 16.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.827 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -61.53 -29.64 70.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.634 0.731 . . . . 0.0 110.448 -177.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 253' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' B' ' 250' ' ' ASN . 5.6 m-20 -77.22 -44.81 28.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.711 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 254' ' ' VAL . . . . . 0.469 HG12 ' O ' ' B' ' 251' ' ' ILE . 7.0 p -66.73 -23.79 31.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 121.054 0.454 . . . . 0.0 110.155 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 255' ' ' ILE . . . . . 0.554 ' HA ' ' OH ' ' A' ' 11' ' ' TYR . 44.8 mt -76.89 -55.61 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.933 175.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -66.3 -45.3 80.86 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -173.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -139.19 50.14 1.82 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.268 0.556 . . . . 0.0 111.156 -174.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -141.97 55.4 0.6 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.358 -178.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 259' ' ' ILE . . . . . 0.563 ' HB ' HG12 ' A' ' 60' ' ' ILE . 1.2 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.888 0.375 . . . . 0.0 111.073 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 t . . . . . 0 CA--C 1.534 0.365 0 CA-C-O 121.456 0.646 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.44 HG13 ' HG ' ' B' ' 212' ' ' LEU . 45.1 t -67.11 -33.73 65.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.895 -174.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.589 ' HB3' HG23 ' A' ' 39' ' ' VAL . 7.1 m -62.15 -51.33 68.28 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.528 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.499 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 39.4 tt0 -63.87 -49.42 72.83 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.822 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.404 ' HB3' HD22 ' B' ' 212' ' ' LEU . 8.4 mp -51.98 -46.64 64.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.485 174.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.431 ' HB2' HG11 ' A' ' 37' ' ' VAL . . . -61.75 -52.05 65.85 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.672 -177.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.499 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 26.2 p -64.51 -26.76 68.57 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.982 -177.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.57 -36.07 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.115 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.659 ' HB2' HD21 ' B' ' 209' ' ' LEU . 16.3 m-85 -74.96 -24.54 58.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.279 0.562 . . . . 0.0 109.929 177.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.9 m -75.26 -42.05 55.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.132 173.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.12 -39.86 63.77 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.384 169.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.522 HD12 ' HA ' ' A' ' 11' ' ' TYR . 83.2 mt -61.01 -56.97 14.83 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.646 175.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.6 mt -58.42 -31.65 43.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.66 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 46.5 mt -115.81 12.27 15.82 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -173.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -44.86 -48.5 11.13 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.785 0.326 . . . . 0.0 111.608 174.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -154.31 -84.68 0.07 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 46.3 42.46 10.37 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.501 176.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 64.41 25.43 13.37 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.295 178.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.541 HG22 ' H ' ' A' ' 22' ' ' THR . 5.4 p -149.62 173.03 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.541 ' H ' HG22 ' A' ' 21' ' ' VAL . 5.3 p -107.49 127.43 53.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.808 0.337 . . . . 0.0 111.786 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.66 ' HB ' ' O ' ' A' ' 16' ' ' LEU . 3.9 p -67.17 95.21 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.368 0.604 . . . . 0.0 110.587 176.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.504 ' OG1' ' HG2' ' A' ' 27' ' ' LYS . 39.0 p -123.46 167.22 14.14 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.315 0.579 . . . . 0.0 112.14 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -49.22 -52.74 25.15 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.591 -174.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -62.13 -30.52 71.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.368 -177.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.504 ' HG2' ' OG1' ' A' ' 24' ' ' THR . 45.0 mmtm -71.48 -49.69 38.88 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.45 HG23 HD13 ' A' ' 32' ' ' ILE . 9.5 mt -62.94 -44.4 99.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.939 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -56.05 -45.52 79.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.776 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.77 -41.63 95.73 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.527 HD11 HG23 ' B' ' 226' ' ' ILE . 0.2 OUTLIER -66.82 -41.97 86.64 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.516 0.674 . . . . 0.0 109.919 -178.886 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.45 HD13 HG23 ' A' ' 28' ' ' ILE . 1.6 mp -62.17 -39.46 84.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.274 176.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -66.03 -31.98 73.18 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.087 0.47 . . . . 0.0 110.287 177.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.499 ' HB1' ' HA ' ' B' ' 226' ' ' ILE . . . -65.64 -47.21 76.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.498 176.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.585 ' HA ' HD11 ' B' ' 226' ' ' ILE . . . -84.79 -17.1 39.27 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -177.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.38 12.89 83.33 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.541 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.431 HG11 ' HB2' ' A' ' 8' ' ' ALA . 19.6 t -81.7 154.14 4.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -108.95 105.23 14.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.121 0.486 . . . . 0.0 111.219 -173.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.589 HG23 ' HB3' ' A' ' 5' ' ' SER . 12.7 p -120.99 135.25 61.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.406 174.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -59.89 124.49 76.91 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.483 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.529 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 81.0 Cg_exo -47.13 -17.11 0.41 Allowed 'Trans proline' 0 N--CA 1.481 0.776 0 C-N-CA 124.554 3.503 . . . . 0.0 115.434 -171.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -75.3 -26.47 58.73 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -175.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.603 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 95.8 m95 -65.66 -54.24 31.12 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.332 174.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.603 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 75.6 Cg_exo -51.08 -52.47 9.02 Favored 'Trans proline' 0 C--N 1.364 1.381 0 C-N-CA 122.315 2.01 . . . . 0.0 112.773 173.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.29 -50.48 66.17 Favored Glycine 0 C--O 1.241 0.576 0 C-N-CA 120.571 -0.824 . . . . 0.0 112.086 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 56.5 tp -56.37 -52.49 64.41 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.29 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.428 ' O ' HD13 ' A' ' 51' ' ' LEU . 3.2 m-85 -57.53 -44.03 84.79 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -177.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.31 -39.65 95.16 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.297 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -97.42 7.3 46.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.978 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -112.38 -43.27 3.54 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.755 ' HA ' HG23 ' A' ' 54' ' ' VAL . 2.6 mp -83.16 -128.29 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.826 -175.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 65.41 -1.47 0.96 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -144.56 -46.74 0.25 Allowed 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.755 HG23 ' HA ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -55.91 119.26 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 113.626 -1.624 . . . . 0.0 111.323 177.334 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -52.96 146.27 11.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.765 174.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.444 HD11 HD23 ' A' ' 14' ' ' LEU . 1.7 tp -45.86 -37.34 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -169.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.403 ' O ' HG22 ' A' ' 60' ' ' ILE . . . -54.8 -22.12 25.29 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.788 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.432 ' HB3' HG12 ' A' ' 54' ' ' VAL . 44.5 p -51.46 -31.65 24.1 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 122.987 0.515 . . . . 0.0 111.321 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.427 HD13 ' O ' ' A' ' 56' ' ' ILE . 9.6 mp -49.53 -39.94 36.29 Favored 'General case' 0 CA--C 1.519 -0.22 0 O-C-N 123.721 0.638 . . . . 0.0 112.359 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 60' ' ' ILE . 13.3 tt -87.73 23.07 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 122.052 0.93 . . . . 0.0 110.744 -174.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.8 t -126.02 2.95 7.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.04 173.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -88.75 34.18 0.77 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.664 -176.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.2 t . . . . . 0 C--N 1.321 -0.655 0 CA-C-O 121.91 0.862 . . . . 0.0 109.876 -178.564 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 . . . . . 0 C--O 1.24 0.562 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.779 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 11.9 p -62.84 -49.83 82.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.041 -174.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 205' ' ' ALA . . . . . 0.51 ' HA ' HD12 ' B' ' 208' ' ' LEU . . . -72.58 -18.86 61.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.619 0.247 . . . . 0.0 111.09 -176.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 206' ' ' SER . . . . . 0.443 ' HB3' HG23 ' B' ' 223' ' ' ILE . 45.8 m -70.37 -47.39 61.17 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 120.93 0.395 . . . . 0.0 109.968 174.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 207' ' ' TYR . . . . . 0.554 ' CZ ' ' HD2' ' B' ' 218' ' ' PRO . 29.5 t80 -62.51 -35.95 81.01 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.779 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 62.9 mt -60.83 -53.42 57.59 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.003 178.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 209' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 11' ' ' TYR . 78.7 mt -58.79 -50.84 72.43 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.054 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -61.16 -33.22 73.08 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.99 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 211' ' ' ALA . . . . . 0.671 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -76.97 -40.14 48.0 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.889 178.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 212' ' ' LEU . . . . . 0.44 ' HG ' HG13 ' A' ' 4' ' ' VAL . 52.0 tp -59.97 -55.33 35.36 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.492 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -126.26 53.37 0.79 Allowed Glycine 0 CA--C 1.507 -0.421 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.855 -174.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . -166.08 -77.85 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.494 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 215' ' ' ASN . . . . . 0.671 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 44.4 t30 -148.56 140.63 23.97 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.741 0.305 . . . . 0.0 110.201 -175.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 216' ' ' SER . . . . . 0.472 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 8.3 m -63.95 -23.92 67.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.329 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 5.2 p -120.05 70.55 15.1 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.18 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 218' ' ' PRO . . . . . 0.554 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 82.8 Cg_exo -52.56 131.69 42.12 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.541 2.827 . . . . 0.0 113.28 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 219' ' ' SER . . . . . 0.48 ' HB3' ' OD2' ' B' ' 222' ' ' ASP . 38.9 t -87.02 145.75 26.37 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.335 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -59.15 -21.32 59.19 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.042 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -69.6 -50.09 47.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.363 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 222' ' ' ASP . . . . . 0.48 ' OD2' ' HB3' ' B' ' 219' ' ' SER . 20.0 m-20 -67.27 -40.78 86.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.952 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.519 HD11 ' HB3' ' B' ' 218' ' ' PRO . 1.8 mp -60.34 -45.58 96.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 175.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 224' ' ' LYS . . . . . 0.422 ' O ' ' HB3' ' B' ' 228' ' ' ASP . 37.7 tptt -52.35 -46.2 66.03 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.45 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 225' ' ' LYS . . . . . 0.48 ' HD3' ' O ' ' B' ' 225' ' ' LYS . 7.8 tmtm? -63.68 -36.32 83.46 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 123.273 0.358 . . . . 0.0 110.469 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 0.585 HD11 ' HA ' ' A' ' 35' ' ' ALA . 1.3 mp -60.89 -44.18 97.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.098 176.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 6.8 mp -75.74 -23.76 56.07 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.984 177.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 228' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' B' ' 224' ' ' LYS . 0.0 OUTLIER -78.45 -28.1 46.56 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.78 -177.95 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 80.8 p -52.76 -56.81 12.94 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.973 0.416 . . . . 0.0 111.125 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 230' ' ' VAL . . . . . 0.45 HG23 HG13 ' B' ' 232' ' ' ILE . 7.3 m -79.83 -27.24 12.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.883 175.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 67.9 64.65 3.05 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.97 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 232' ' ' ILE . . . . . 0.45 HG13 HG23 ' B' ' 230' ' ' VAL . 55.1 mt -99.25 -89.13 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.738 0.304 . . . . 0.0 110.431 177.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -148.51 142.1 25.46 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 175.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -160.93 93.06 0.96 Allowed 'General case' 0 C--N 1.33 -0.262 0 O-C-N 123.298 0.374 . . . . 0.0 111.05 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 235' ' ' ASP . . . . . 0.498 ' OD2' ' HD2' ' B' ' 238' ' ' ARG . 25.6 m-20 -62.84 126.49 27.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.0 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -74.64 -12.1 60.35 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -175.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -92.37 -52.53 4.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.181 0.515 . . . . 0.0 109.765 175.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.498 ' HD2' ' OD2' ' B' ' 235' ' ' ASP . 86.3 mtt180 -65.94 -33.16 75.19 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.18 -176.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 239' ' ' LEU . . . . . . . . . . . . . 8.8 tt -59.94 -62.99 1.46 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.822 0.344 . . . . 0.0 111.052 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 240' ' ' ASN . . . . . 0.416 ' O ' ' HB2' ' B' ' 244' ' ' SER . 26.9 p-10 -74.43 -19.24 60.47 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 121.993 -0.442 . . . . 0.0 110.671 -176.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -71.63 -48.65 46.46 Favored 'General case' 0 C--O 1.244 0.781 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.831 173.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 242' ' ' VAL . . . . . 0.606 ' O ' ' HB3' ' B' ' 246' ' ' LEU . 28.4 m -66.13 -33.43 63.51 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.885 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 30.8 mt -73.19 -31.79 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 O-C-N 123.627 0.579 . . . . 0.0 111.271 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 244' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' B' ' 240' ' ' ASN . 18.3 t -64.73 -28.5 69.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.679 0.276 . . . . 0.0 110.663 176.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -87.78 -47.88 8.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.651 0.738 . . . . 0.0 109.628 172.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 246' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' B' ' 246' ' ' LEU . 8.8 tp -79.5 56.37 2.16 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 124.716 1.206 . . . . 0.0 109.89 177.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -100.25 37.29 1.69 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.986 -174.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 248' ' ' GLY . . . . . 0.479 ' HA2' HG22 ' B' ' 251' ' ' ILE . . . 99.54 2.81 56.47 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.594 -0.813 . . . . 0.0 114.043 173.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -74.98 -1.68 23.72 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -177.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -159.32 8.11 0.11 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.569 ' HA ' HG12 ' B' ' 254' ' ' VAL . 5.2 tp -65.87 -46.93 87.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -172.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -58.59 -43.87 89.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.308 0.575 . . . . 0.0 110.972 -176.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -74.54 -38.7 62.69 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.874 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 254' ' ' VAL . . . . . 0.569 HG12 ' HA ' ' B' ' 251' ' ' ILE . 6.6 p -71.06 -21.37 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 120.992 0.425 . . . . 0.0 110.351 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 255' ' ' ILE . . . . . 0.529 HG12 ' O ' ' B' ' 251' ' ' ILE . 35.2 mm -76.95 -48.48 25.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 171.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -62.83 -35.28 79.42 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -174.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -147.5 28.92 0.96 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.845 -176.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 258' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' B' ' 254' ' ' VAL . . . -110.51 56.64 0.45 Allowed Glycine 0 C--O 1.226 -0.376 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.238 -174.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 26.8 mt . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 121.35 0.595 . . . . 0.0 110.674 177.724 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.434 ' O ' HD13 ' A' ' 7' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 121.021 0.439 . . . . 0.0 110.858 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.593 HG12 HD11 ' B' ' 212' ' ' LEU . 6.0 m -62.91 -27.52 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.277 -176.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.464 ' HB3' HG23 ' A' ' 39' ' ' VAL . 1.8 m -61.64 -63.16 1.36 Allowed 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.408 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -59.24 -50.23 74.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.348 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.584 ' O ' HG22 ' A' ' 10' ' ' ILE . 9.8 mp -47.99 -54.65 12.22 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.69 0.281 . . . . 0.0 110.666 178.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.473 ' HB2' HG11 ' A' ' 37' ' ' VAL . . . -59.67 -52.77 64.11 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -177.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 40.6 t -66.0 -30.61 71.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.761 0.315 . . . . 0.0 110.92 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.584 HG22 ' O ' ' A' ' 7' ' ' LEU . 2.4 tp -74.75 -35.77 38.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.154 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.82 ' HB2' HD21 ' B' ' 209' ' ' LEU . 19.5 m-30 -66.43 -36.17 82.13 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 177.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.1 m -69.35 -46.47 66.95 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.128 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.449 ' HB1' HD21 ' A' ' 59' ' ' LEU . . . -54.65 -49.6 70.18 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.562 176.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.71 HD22 HG23 ' B' ' 259' ' ' ILE . 4.5 pp -75.67 -29.03 58.92 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.213 -177.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -65.14 -38.68 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.796 0.331 . . . . 0.0 110.788 175.287 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.562 HD13 ' HA ' ' A' ' 23' ' ' VAL . 93.1 mt -78.23 -28.28 47.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.759 178.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.8 m80 -79.21 68.85 5.29 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -165.21 -49.11 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.903 0.382 . . . . 0.0 110.429 173.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -83.69 -172.17 4.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.722 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -89.3 16.45 7.39 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.1 0.476 . . . . 0.0 110.307 175.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.492 HG21 HG12 ' B' ' 232' ' ' ILE . 41.3 t -88.8 125.94 41.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.095 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 p -77.59 147.34 35.71 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.198 -172.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.562 ' HA ' HD13 ' A' ' 16' ' ' LEU . 32.6 m -83.69 41.74 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.06 -174.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.443 ' OG1' ' HG2' ' A' ' 27' ' ' LYS . 39.1 p -67.13 159.85 28.01 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -177.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -57.72 -42.65 84.26 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -176.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -49.78 -42.65 47.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.331 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.443 ' HG2' ' OG1' ' A' ' 24' ' ' THR . 45.8 mmtm -77.74 -47.75 18.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.394 -173.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.403 ' O ' HD13 ' A' ' 32' ' ' ILE . 5.2 mt -61.55 -44.81 99.23 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.154 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.332 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -60.05 -40.61 90.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.634 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.92 -40.93 99.11 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.423 HD12 HD13 ' B' ' 209' ' ' LEU . 0.1 OUTLIER -68.83 -41.79 78.08 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.337 0.589 . . . . 0.0 110.05 -179.662 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.403 HD13 ' O ' ' A' ' 28' ' ' ILE . 1.7 mp -59.94 -37.73 73.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.601 175.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -75.58 -30.43 59.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.108 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.45 -51.2 70.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.448 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.88 -27.21 25.17 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.777 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.7 22.02 56.7 Favored Glycine 0 C--N 1.321 -0.264 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.777 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.473 HG11 ' HB2' ' A' ' 8' ' ' ALA . 12.9 t -82.34 137.17 21.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.848 0.356 . . . . 0.0 110.119 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -88.21 92.03 9.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.997 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.464 HG23 ' HB3' ' A' ' 5' ' ' SER . 7.7 p -102.41 136.18 35.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.573 175.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.47 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -54.2 125.3 49.72 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.046 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.76 -6.15 2.3 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.6 2.866 . . . . 0.0 113.507 -171.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.49 -31.25 47.65 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -177.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -65.99 -60.72 6.59 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.622 175.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.47 ' HD2' ' O ' ' A' ' 40' ' ' GLU . 19.6 Cg_endo -58.86 -40.91 67.69 Favored 'Trans proline' 0 C--N 1.361 1.197 0 C-N-CA 121.783 1.656 . . . . 0.0 112.178 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.38 -55.04 32.33 Favored Glycine 0 C--O 1.241 0.552 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.159 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.7 tt -59.87 -50.54 73.38 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.581 ' O ' HD13 ' A' ' 51' ' ' LEU . 2.6 m-85 -53.61 -53.6 49.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.01 0.433 . . . . 0.0 111.832 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.91 -27.94 67.07 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -173.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm -93.59 -11.62 31.37 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.451 -0.5 . . . . 0.0 112.15 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -106.54 -26.26 11.48 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.864 ' HA ' HG23 ' A' ' 54' ' ' VAL . 4.8 mp -81.23 -132.53 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.41 ' H ' ' HB3' ' A' ' 51' ' ' LEU . . . 57.27 6.49 0.37 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.372 0.669 . . . . 0.0 112.095 -175.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.411 ' H ' ' C ' ' A' ' 51' ' ' LEU . 37.2 m-80 -143.67 -40.76 0.29 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.864 HG23 ' HA ' ' A' ' 51' ' ' LEU . 58.7 t -45.14 108.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 113.881 -1.509 . . . . 0.0 111.622 173.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -67.51 169.71 8.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.678 173.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.6 tp -54.62 -53.25 33.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.954 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.63 -43.35 86.12 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.457 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.469 ' HB2' HG13 ' A' ' 54' ' ' VAL . 16.4 m -58.54 -28.55 65.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.662 0.268 . . . . 0.0 111.141 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.503 HD13 ' O ' ' A' ' 59' ' ' LEU . 2.5 tm? -64.06 -22.74 67.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.678 -176.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.718 HG23 HD12 ' B' ' 259' ' ' ILE . 18.3 mt -92.25 -5.28 10.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.301 0.572 . . . . 0.0 110.682 -176.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 22.4 t -137.55 51.22 1.93 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.351 0.596 . . . . 0.0 110.017 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -90.99 -34.21 15.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.548 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 C--N 1.311 -1.107 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.176 178.794 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 . . . . . 0 C--O 1.238 0.478 0 CA-C-O 120.913 0.387 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.791 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 18.1 m -58.28 -51.94 65.02 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.529 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.783 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 205' ' ' ALA . . . . . 0.541 ' CB ' HD11 ' A' ' 14' ' ' LEU . . . -64.7 -25.33 67.89 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -176.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 206' ' ' SER . . . . . 0.548 ' CB ' HG23 ' B' ' 223' ' ' ILE . 6.0 m -67.11 -48.91 66.69 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 173.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 207' ' ' TYR . . . . . 0.477 ' CZ ' ' HD2' ' B' ' 218' ' ' PRO . 17.0 t80 -61.68 -35.22 77.36 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.383 175.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.791 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 39.5 mt -63.26 -53.34 54.44 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.963 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 209' ' ' LEU . . . . . 0.82 HD21 ' HB2' ' A' ' 11' ' ' TYR . 15.2 mt -52.57 -50.62 62.59 Favored 'General case' 0 C--O 1.245 0.864 0 CA-C-O 121.264 0.554 . . . . 0.0 110.003 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -62.5 -41.13 98.62 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.668 -178.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 211' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -77.77 -24.68 48.87 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.929 -0.482 . . . . 0.0 111.481 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 212' ' ' LEU . . . . . 0.593 HD11 HG12 ' A' ' 4' ' ' VAL . 33.5 tp -71.23 -47.84 54.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.669 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -141.16 20.56 2.64 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 118.954 -1.593 . . . . 0.0 114.628 -176.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . -121.05 -66.07 0.26 Allowed Glycine 0 C--N 1.321 -0.284 0 C-N-CA 119.959 -1.115 . . . . 0.0 112.772 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 215' ' ' ASN . . . . . 0.5 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 34.0 t30 -154.42 146.66 23.8 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -177.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 7.0 m -67.95 -21.62 65.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.355 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 5.6 p -125.19 70.91 62.74 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.618 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 218' ' ' PRO . . . . . 0.477 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 65.2 Cg_exo -57.75 132.99 53.38 Favored 'Trans proline' 0 N--CA 1.477 0.552 0 C-N-CA 122.989 2.459 . . . . 0.0 112.152 176.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 219' ' ' SER . . . . . 0.463 ' HB3' ' OD1' ' B' ' 222' ' ' ASP . 28.3 t -110.18 172.96 6.55 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.919 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -56.1 -38.9 71.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.007 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -65.98 -43.33 88.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.685 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 222' ' ' ASP . . . . . 0.463 ' OD1' ' HB3' ' B' ' 219' ' ' SER . 3.3 m-20 -62.23 -49.48 75.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.138 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.548 HG23 ' CB ' ' B' ' 206' ' ' SER . 1.8 mp -63.79 -40.23 88.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.586 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -54.43 -50.9 66.55 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.187 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -63.71 -42.64 97.91 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.075 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.14 -36.04 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 120.686 0.279 . . . . 0.0 110.73 176.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 227' ' ' LEU . . . . . 0.47 ' CD1' ' HB ' ' B' ' 232' ' ' ILE . 0.2 OUTLIER -75.82 -43.85 44.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.68 -178.767 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -86.64 -0.77 56.86 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.631 -177.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 15.4 t -55.07 -44.74 75.06 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.987 0.422 . . . . 0.0 110.51 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 230' ' ' VAL . . . . . 0.56 HG23 HG13 ' B' ' 232' ' ' ILE . 12.5 m -95.88 0.74 10.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.218 0.532 . . . . 0.0 111.16 178.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 81.65 54.98 3.3 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.616 -0.72 . . . . 0.0 113.739 175.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 232' ' ' ILE . . . . . 0.56 HG13 HG23 ' B' ' 230' ' ' VAL . 4.3 mt -115.64 140.07 39.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 172.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -70.74 119.85 15.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.302 0.573 . . . . 0.0 111.576 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -118.18 132.64 56.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.383 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -83.78 111.95 19.65 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -60.67 -33.69 73.22 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.458 -174.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -67.91 -58.31 4.77 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.456 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -63.92 -30.85 71.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.688 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 239' ' ' LEU . . . . . . . . . . . . . 8.7 tt -57.42 -60.72 3.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.313 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -64.25 -32.46 74.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.897 -178.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 241' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' B' ' 245' ' ' GLU . 84.3 mttt -67.77 -41.54 83.14 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 242' ' ' VAL . . . . . 0.456 ' HA ' ' OE1' ' B' ' 245' ' ' GLU . 32.9 m -73.92 -31.15 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 119.969 -0.693 . . . . 0.0 109.559 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 243' ' ' ILE . . . . . 0.454 ' HA ' ' CD2' ' B' ' 246' ' ' LEU . 7.5 mt -65.16 -37.09 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.077 173.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 12.1 t -63.56 -40.22 96.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.241 174.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 245' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' B' ' 241' ' ' LYS . 47.0 mt-10 -59.42 -45.54 91.25 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.439 0.638 . . . . 0.0 110.266 176.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 246' ' ' LEU . . . . . 0.454 ' CD2' ' HA ' ' B' ' 243' ' ' ILE . 2.9 pp -87.6 -0.11 56.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.831 -175.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -67.04 -8.23 28.7 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.051 0.453 . . . . 0.0 111.719 -170.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -80.33 -170.93 42.54 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.149 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 249' ' ' LYS . . . . . 0.402 ' HD2' ' N ' ' B' ' 249' ' ' LYS . 11.3 mptt -82.31 67.4 8.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.922 0.391 . . . . 0.0 110.688 -177.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -131.72 27.68 4.62 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.686 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.409 ' O ' HG13 ' B' ' 255' ' ' ILE . 23.9 mm -53.46 -66.42 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -173.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 252' ' ' GLU . . . . . 0.456 ' O ' ' HB ' ' B' ' 255' ' ' ILE . 5.0 tp10 -62.03 -32.51 73.01 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 121.138 0.494 . . . . 0.0 111.412 -174.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 253' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' B' ' 257' ' ' GLN . 8.4 t70 -67.73 -47.27 69.79 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.11 -178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 254' ' ' VAL . . . . . 0.422 HG23 HD21 ' B' ' 208' ' ' LEU . 30.0 m -67.95 -24.46 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.065 0 C-N-CA 120.239 -0.585 . . . . 0.0 110.455 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 255' ' ' ILE . . . . . 0.652 HG23 ' OH ' ' A' ' 11' ' ' TYR . 40.1 mt -61.47 -37.71 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 CA-C-O 121.468 0.651 . . . . 0.0 109.433 172.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -94.78 -2.91 50.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.42 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 257' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' B' ' 253' ' ' ASP . 0.9 OUTLIER -106.72 76.29 1.11 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.138 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -143.08 -99.16 0.3 Allowed Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.266 -0.969 . . . . 0.0 112.011 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 259' ' ' ILE . . . . . 0.718 HD12 HG23 ' A' ' 60' ' ' ILE . 1.0 OUTLIER . . . . . 0 C--N 1.346 0.451 0 CA-C-O 122.167 0.984 . . . . 0.0 108.59 171.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.569 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 23.3 t . . . . . 0 C--O 1.236 0.356 0 CA-C-O 121.162 0.506 . . . . 0.0 111.289 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.0 p -69.55 -26.27 30.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.842 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.472 ' HA ' HG22 ' A' ' 39' ' ' VAL . 8.4 p -66.83 -55.47 14.67 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.528 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.618 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 35.3 mt-10 -62.67 -39.49 94.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.733 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 3' ' ' SER . 38.3 mt -54.99 -55.41 31.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.111 0.481 . . . . 0.0 109.922 175.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.3 -44.79 95.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.994 -175.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.618 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 26.7 p -70.94 -34.62 71.65 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.416 -176.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.48 HG12 ' CG2' ' B' ' 259' ' ' ILE . 0.8 OUTLIER -75.26 -33.94 29.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.973 0.416 . . . . 0.0 110.888 -179.404 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.513 ' HB2' ' CD1' ' B' ' 209' ' ' LEU . 23.0 m-30 -77.51 -26.47 51.19 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 177.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.436 ' HA ' HD23 ' A' ' 31' ' ' LEU . 23.0 t -65.62 -51.71 57.52 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.01 -42.82 29.1 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.4 171.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.518 HD11 ' O ' ' B' ' 259' ' ' ILE . 82.6 mt -59.01 -58.29 9.32 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.781 0.324 . . . . 0.0 110.914 175.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 69.6 mt -56.62 -29.84 30.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.275 -176.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.9 mt -100.95 -9.58 21.39 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.68 -35.64 76.77 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -176.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -164.32 116.83 1.34 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -174.7 43.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.286 170.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 57.02 28.37 14.72 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.192 -174.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.0 p -126.44 161.53 32.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.651 -176.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.0 p -106.27 132.55 52.19 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -173.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.731 HG11 HD23 ' A' ' 51' ' ' LEU . 61.9 t -75.15 108.24 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -152.62 158.94 43.15 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-O 121.309 0.576 . . . . 0.0 111.894 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -43.77 -61.67 1.35 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.206 -173.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -62.86 -24.77 67.96 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.5 -173.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -77.43 -45.81 24.61 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.388 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.449 HG23 HD13 ' A' ' 32' ' ' ILE . 5.7 mt -62.46 -45.53 98.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.214 -0.595 . . . . 0.0 109.926 175.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -53.61 -45.78 70.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.194 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.0 -44.36 92.87 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 12' ' ' SER . 29.6 tp -71.22 -30.03 65.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.342 0.592 . . . . 0.0 110.316 -178.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.449 HD13 HG23 ' A' ' 28' ' ' ILE . 1.4 mp -69.66 -31.56 49.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.917 173.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -70.44 -29.83 66.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.87 -67.47 0.45 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.013 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.489 ' HB2' HD11 ' B' ' 226' ' ' ILE . . . -129.78 23.66 5.38 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -174.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -101.66 99.27 1.88 Allowed Glycine 0 C--N 1.314 -0.662 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.076 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.605 ' CG2' ' HA2' ' B' ' 213' ' ' GLY . 57.8 t -42.49 -70.07 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 122.516 0.326 . . . . 0.0 111.43 177.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -161.98 113.72 1.69 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 177.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.472 HG22 ' HA ' ' A' ' 5' ' ' SER . 11.8 t -121.65 137.52 55.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.463 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 0.7 OUTLIER -70.09 128.17 91.79 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.728 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.69 0.57 0.38 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.14 2.56 . . . . 0.0 113.116 -174.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.431 ' H ' ' C ' ' A' ' 40' ' ' GLU . 2.6 t80 -71.42 -39.72 70.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.014 176.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.526 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 68.2 m95 -72.42 -56.72 3.9 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.928 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 73.5 Cg_exo -49.95 -46.22 28.96 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 122.015 1.81 . . . . 0.0 112.321 173.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.46 -41.61 99.25 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.36 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.2 tp -61.87 -42.57 99.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.975 0.417 . . . . 0.0 110.096 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.441 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 3.2 m-85 -66.56 -40.05 88.8 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.992 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.61 -28.27 65.79 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -95.1 -30.74 13.9 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.79 -18.15 7.17 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -169.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.759 ' HA ' HG23 ' A' ' 54' ' ' VAL . 2.2 tp -89.54 -134.46 0.1 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.6 -176.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.444 ' H ' ' CG ' ' A' ' 51' ' ' LEU . . . 60.07 -13.28 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -176.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.547 ' H ' ' C ' ' A' ' 51' ' ' LEU . 48.0 m-80 -127.09 -31.38 2.6 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.759 HG23 ' HA ' ' A' ' 51' ' ' LEU . 61.0 t -49.99 103.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.382 172.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -46.74 146.32 1.62 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.671 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.468 HD11 HD23 ' A' ' 14' ' ' LEU . 4.0 tp -49.71 -51.77 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -170.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.27 -24.21 63.14 Favored Glycine 0 C--O 1.24 0.474 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.041 -176.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.3 t -68.81 -2.83 10.39 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 122.107 0.163 . . . . 0.0 111.225 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 46.3 mt -62.35 -26.02 68.22 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.192 0.52 . . . . 0.0 109.961 172.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.469 HG23 HD12 ' B' ' 259' ' ' ILE . 8.9 mt -95.74 16.26 2.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.607 0.718 . . . . 0.0 110.092 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.0 t -108.98 -45.01 3.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.381 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -87.74 5.89 37.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.036 -177.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 0 C--N 1.321 -0.671 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.897 179.644 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 121.402 0.62 . . . . 0.0 111.432 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.626 ' O ' HD13 ' B' ' 208' ' ' LEU . 60.8 t -60.09 -56.76 15.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.538 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 205' ' ' ALA . . . . . 0.556 ' HA ' HD22 ' B' ' 208' ' ' LEU . . . -69.31 -14.53 62.98 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.729 0.299 . . . . 0.0 111.27 -176.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 206' ' ' SER . . . . . 0.501 ' HB3' HG23 ' B' ' 223' ' ' ILE . 8.5 m -76.61 -45.07 31.7 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 174.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 207' ' ' TYR . . . . . 0.592 ' CE1' HD11 ' B' ' 251' ' ' ILE . 36.1 t80 -62.87 -41.91 99.57 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 174.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.626 HD13 ' O ' ' B' ' 204' ' ' VAL . 2.7 mp -56.77 -49.25 75.85 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.523 175.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 209' ' ' LEU . . . . . 0.513 ' CD1' ' HB2' ' A' ' 11' ' ' TYR . 3.6 tp -59.39 -49.65 76.99 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.603 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -66.46 -28.44 68.59 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 211' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -73.94 -43.24 58.92 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.257 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 212' ' ' LEU . . . . . 0.4 HD22 ' HB3' ' A' ' 7' ' ' LEU . 4.3 pp -75.15 -35.64 61.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.765 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 213' ' ' GLY . . . . . 0.605 ' HA2' ' CG2' ' A' ' 37' ' ' VAL . . . -124.02 47.55 1.01 Allowed Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.312 -0.947 . . . . 0.0 114.07 -172.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . -175.95 -66.63 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.206 0 C-N-CA 119.683 -1.246 . . . . 0.0 113.309 176.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 215' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 54.9 t30 -153.12 149.28 27.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.91 0.386 . . . . 0.0 110.533 -173.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 7.6 m -71.45 -18.52 62.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.256 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 17.6 p -125.76 69.99 65.05 Favored Pre-proline 0 N--CA 1.443 -0.808 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.848 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 218' ' ' PRO . . . . . 0.46 ' HB3' HD11 ' B' ' 223' ' ' ILE . 76.3 Cg_exo -54.18 135.83 65.94 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.072 2.515 . . . . 0.0 112.162 178.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 15.9 m -107.84 154.18 21.93 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.789 -177.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -49.22 -49.26 43.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.13 0.49 . . . . 0.0 111.757 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -64.76 -32.28 73.89 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.116 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -70.47 -43.64 69.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.898 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.501 HG23 ' HB3' ' B' ' 206' ' ' SER . 1.8 mp -61.74 -39.56 83.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.252 0.549 . . . . 0.0 109.75 174.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -60.33 -38.1 82.67 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.564 177.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 225' ' ' LYS . . . . . 0.656 ' HD3' ' O ' ' B' ' 225' ' ' LYS . 6.4 tmtm? -70.32 -36.74 74.46 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 0.489 HD11 ' HB2' ' A' ' 35' ' ' ALA . 1.0 OUTLIER -61.36 -36.52 73.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.502 179.521 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 97.2 mt -77.04 -34.37 57.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.838 0.352 . . . . 0.0 110.272 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 228' ' ' ASP . . . . . 0.508 ' HB3' ' HA ' ' B' ' 225' ' ' LYS . 0.8 OUTLIER -56.01 -36.23 67.7 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.377 173.707 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 23.8 m -55.81 -46.89 77.96 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.789 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 230' ' ' VAL . . . . . 0.422 HG11 ' HB2' ' A' ' 31' ' ' LEU . 1.2 m -90.06 -4.08 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 83.33 29.3 33.75 Favored Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.293 176.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 41.9 mt -98.07 130.84 46.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 176.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -77.59 159.43 29.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.658 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -154.66 121.35 5.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.491 -175.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 235' ' ' ASP . . . . . 0.457 ' HB3' ' OD1' ' B' ' 237' ' ' ASP . 5.0 m-20 -66.7 111.2 3.56 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 171.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 236' ' ' ASP . . . . . 0.493 ' HA ' ' HB3' ' B' ' 239' ' ' LEU . 2.5 p30 -69.21 -16.92 63.72 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.71 -174.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 237' ' ' ASP . . . . . 0.457 ' OD1' ' HB3' ' B' ' 235' ' ' ASP . 6.9 p-10 -69.48 -48.96 59.03 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 174.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.574 ' O ' HG23 ' B' ' 242' ' ' VAL . 15.9 mmt180 -66.4 -43.76 84.9 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.929 177.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 239' ' ' LEU . . . . . 0.493 ' HB3' ' HA ' ' B' ' 236' ' ' ASP . 9.6 tt -54.38 -57.58 10.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.882 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -68.12 -25.96 65.56 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 122.438 -0.163 . . . . 0.0 110.773 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -69.64 -46.07 67.0 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.266 0.555 . . . . 0.0 110.338 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 242' ' ' VAL . . . . . 0.574 HG23 ' O ' ' B' ' 238' ' ' ARG . 57.3 t -66.78 -27.82 41.13 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.679 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 243' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' B' ' 246' ' ' LEU . 39.0 mt -84.18 -25.29 7.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.935 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 63.6 p -75.21 -27.02 59.4 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.642 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -86.52 -55.96 3.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.565 0.698 . . . . 0.0 109.712 173.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 246' ' ' LEU . . . . . 0.704 HD13 ' O ' ' B' ' 246' ' ' LEU . 0.0 OUTLIER -90.63 111.44 22.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.919 176.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -153.99 -143.23 0.13 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -176.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -73.2 37.82 0.8 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.209 -0.519 . . . . 0.0 113.412 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -107.92 95.76 5.91 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 250' ' ' ASN . . . . . 0.485 ' HB3' ' HB3' ' B' ' 253' ' ' ASP . 16.9 m120 61.81 52.71 3.37 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.559 0.537 . . . . 0.0 110.835 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.592 HD11 ' CE1' ' B' ' 207' ' ' TYR . 1.4 mm -59.92 -51.01 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -175.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -75.56 -11.6 60.05 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.974 -176.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 253' ' ' ASP . . . . . 0.485 ' HB3' ' HB3' ' B' ' 250' ' ' ASN . 22.6 t70 -84.31 -42.23 16.01 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 254' ' ' VAL . . . . . 0.516 HG12 ' O ' ' B' ' 251' ' ' ILE . 9.1 p -67.34 -22.35 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 255' ' ' ILE . . . . . 0.43 HG23 HD22 ' A' ' 7' ' ' LEU . 37.8 mt -71.97 -57.55 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.567 170.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -59.64 -36.19 75.9 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -175.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -105.13 6.2 32.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.878 0.371 . . . . 0.0 110.848 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -116.76 46.42 1.15 Allowed Glycine 0 C--O 1.229 -0.204 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.267 -174.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 259' ' ' ILE . . . . . 0.518 ' O ' HD11 ' A' ' 14' ' ' LEU . 18.9 mt . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 120.92 0.391 . . . . 0.0 111.087 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.54 ' O ' HD13 ' A' ' 7' ' ' LEU . 3.7 p . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 120.83 0.347 . . . . 0.0 111.391 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.5 m -69.67 -21.3 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.191 -176.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.465 ' HB3' HG23 ' A' ' 39' ' ' VAL . 2.3 m -65.34 -54.58 26.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.735 0.778 . . . . 0.0 110.065 177.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -65.6 -43.33 89.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.699 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.54 HD13 ' O ' ' A' ' 3' ' ' SER . 6.4 mp -55.71 -53.59 54.68 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.629 177.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.64 -50.55 72.8 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.488 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 45.6 t -63.69 -37.37 87.08 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.323 -176.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.461 HG13 HD13 ' A' ' 59' ' ' LEU . 0.6 OUTLIER -72.63 -40.89 62.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 120.564 0.221 . . . . 0.0 111.013 -177.749 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.56 ' HB2' ' CD2' ' B' ' 209' ' ' LEU . 21.0 m-85 -69.76 -27.86 65.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.508 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.423 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 8.9 t -64.72 -48.7 73.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.826 174.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.72 -42.5 62.29 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.636 172.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.588 HD23 HD11 ' A' ' 56' ' ' ILE . 95.2 mt -57.58 -59.16 5.61 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.238 0.542 . . . . 0.0 110.892 176.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.436 HG21 ' CD1' ' A' ' 31' ' ' LEU . 98.2 mt -52.29 -43.56 40.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.601 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.492 HD13 ' HA ' ' A' ' 23' ' ' VAL . 73.1 mt -75.14 -27.02 59.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.906 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -88.1 41.14 0.99 Allowed 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.836 -0.54 . . . . 0.0 111.485 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -127.1 -26.7 3.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.749 0.309 . . . . 0.0 110.683 174.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -118.21 -161.87 0.86 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -100.05 25.82 7.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.559 0.695 . . . . 0.0 110.687 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -81.19 143.49 12.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.0 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.1 p -83.06 144.8 29.66 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.825 0.345 . . . . 0.0 111.545 -177.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.612 HG21 HD23 ' A' ' 51' ' ' LEU . 35.9 m -91.62 48.24 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 121.146 0.498 . . . . 0.0 111.77 -176.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.0 p -84.5 159.28 20.75 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.32 -178.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -55.27 -36.53 66.2 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -54.37 -44.75 72.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.434 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.469 ' HD2' HG13 ' B' ' 230' ' ' VAL . 75.5 mmtt -77.98 -41.73 35.04 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 120.838 0.352 . . . . 0.0 110.369 -174.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.401 HG12 ' OG ' ' A' ' 12' ' ' SER . 4.6 mt -60.13 -45.6 95.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.647 175.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -65.53 -36.8 84.87 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 111.364 0.135 . . . . 0.0 111.364 176.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.12 -54.17 50.02 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 120.978 0.418 . . . . 0.0 111.122 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.514 ' CD2' ' HG ' ' B' ' 209' ' ' LEU . 5.8 tt -68.93 -35.31 76.65 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.978 -178.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.65 -36.3 59.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.848 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -78.4 -30.26 47.65 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.874 0.368 . . . . 0.0 110.719 177.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.22 -31.56 72.12 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.624 172.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.493 ' HB2' HD12 ' B' ' 209' ' ' LEU . . . -84.12 -73.46 0.42 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.745 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.08 -49.69 0.48 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.787 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.552 HG22 ' HA2' ' B' ' 213' ' ' GLY . 34.7 m -81.72 154.14 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.957 0.408 . . . . 0.0 110.616 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -121.88 -174.82 2.96 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.597 -174.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.465 HG23 ' HB3' ' A' ' 5' ' ' SER . 7.6 p -151.31 137.7 12.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.842 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.466 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 12.2 pt-20 -59.39 134.4 88.49 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-O 120.533 0.206 . . . . 0.0 110.845 -175.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 40' ' ' GLU . 73.5 Cg_exo -50.66 -13.76 0.94 Allowed 'Trans proline' 0 N--CA 1.484 0.94 0 C-N-CA 124.485 3.457 . . . . 0.0 115.574 -166.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -74.47 -31.3 62.18 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.776 0.322 . . . . 0.0 110.341 -176.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.575 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 86.7 m95 -71.03 -54.3 7.55 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-O 119.058 -0.496 . . . . 0.0 111.258 176.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.575 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 50.2 Cg_exo -55.21 -37.21 94.45 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 121.73 1.62 . . . . 0.0 111.68 173.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.61 -51.04 61.23 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.821 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.416 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 56.1 mt -60.95 -44.39 97.34 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 120.635 0.255 . . . . 0.0 111.117 178.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.554 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 8.3 m-85 -62.81 -47.68 82.38 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.057 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.86 -34.59 76.98 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -112.33 1.07 15.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -170.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 46' ' ' LEU . . . -136.76 -17.71 1.44 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 177.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.677 ' HA ' HG23 ' A' ' 54' ' ' VAL . 3.4 tp -86.73 -132.42 0.06 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.418 ' H ' ' CG ' ' A' ' 51' ' ' LEU . . . 58.31 1.04 0.15 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.413 ' H ' ' C ' ' A' ' 51' ' ' LEU . 63.0 t30 -143.22 -41.07 0.3 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.677 HG23 ' HA ' ' A' ' 51' ' ' LEU . 59.1 t -38.56 108.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 114.132 -1.394 . . . . 0.0 110.609 169.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -53.19 129.59 31.78 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 121.836 0.827 . . . . 0.0 109.274 176.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.588 HD11 HD23 ' A' ' 14' ' ' LEU . 7.3 tp -48.98 -38.63 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 114.25 -1.341 . . . . 0.0 113.731 -166.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.16 -28.22 68.69 Favored Glycine 0 C--O 1.242 0.597 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.434 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.4 t -65.78 -5.24 8.26 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.774 -0.213 . . . . 0.0 110.562 -177.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 31.5 mt -54.73 -38.59 67.31 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 120.812 0.339 . . . . 0.0 110.725 173.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.8 tt -82.19 4.99 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.533 0.683 . . . . 0.0 110.822 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.2 m -129.47 7.03 5.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.842 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -82.02 -0.54 44.72 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.969 0.414 . . . . 0.0 111.798 -173.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.806 -177.152 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 203' ' ' TYR . . . . . 0.592 ' HB2' HG21 ' B' ' 242' ' ' VAL . 41.9 m-85 . . . . . 0 C--O 1.238 0.491 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.619 ' O ' HD13 ' B' ' 208' ' ' LEU . 11.7 p -66.41 -47.13 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.044 -177.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 205' ' ' ALA . . . . . 0.491 ' HA ' ' HB2' ' B' ' 208' ' ' LEU . . . -74.6 -14.71 60.81 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.538 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 206' ' ' SER . . . . . 0.411 ' HB3' HG23 ' B' ' 223' ' ' ILE . 37.6 m -74.83 -38.13 62.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.026 172.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 207' ' ' TYR . . . . . 0.412 ' HE1' HD11 ' B' ' 251' ' ' ILE . 14.5 t80 -65.16 -42.85 93.34 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 173.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.619 HD13 ' O ' ' B' ' 204' ' ' VAL . 8.1 mp -54.52 -52.12 63.02 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.784 173.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 209' ' ' LEU . . . . . 0.56 ' CD2' ' HB2' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -56.16 -48.08 77.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.443 -178.443 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -62.55 -35.3 79.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.696 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 211' ' ' ALA . . . . . 0.731 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -67.13 -57.76 6.17 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.862 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 212' ' ' LEU . . . . . 0.485 HD12 ' O ' ' B' ' 208' ' ' LEU . 0.0 OUTLIER -74.53 -14.27 60.78 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.262 -178.81 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 213' ' ' GLY . . . . . 0.552 ' HA2' HG22 ' A' ' 37' ' ' VAL . . . -68.88 -14.91 68.53 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.661 175.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 129.85 1.41 5.45 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.955 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 215' ' ' ASN . . . . . 0.731 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 84.2 m-20 -113.08 95.32 5.33 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 3.9 m -57.14 -31.06 64.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.356 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 10.2 t -126.67 77.96 73.34 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.745 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 218' ' ' PRO . . . . . 0.479 ' HB3' HD11 ' B' ' 223' ' ' ILE . 52.7 Cg_exo -56.3 140.82 88.79 Favored 'Trans proline' 0 N--CA 1.476 0.452 0 C-N-CA 123.759 2.973 . . . . 0.0 113.579 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 33.6 p -107.1 146.27 31.44 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -54.49 -31.83 56.7 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.066 0.46 . . . . 0.0 111.594 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -67.99 -39.23 83.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.504 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -72.79 -39.01 67.07 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.479 HD11 ' HB3' ' B' ' 218' ' ' PRO . 1.8 mp -59.72 -46.17 93.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 174.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -58.04 -38.89 77.11 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.483 176.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 225' ' ' LYS . . . . . 0.501 ' NZ ' HD12 ' B' ' 226' ' ' ILE . 14.7 ttpp -57.85 -49.5 76.46 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.626 0.25 . . . . 0.0 110.673 174.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 0.501 HD12 ' NZ ' ' B' ' 225' ' ' LYS . 0.6 OUTLIER -58.54 -37.28 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.938 -177.477 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 94.9 mt -75.72 -38.79 58.23 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.869 0.366 . . . . 0.0 111.238 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -69.66 -28.66 66.07 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.967 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 46.8 m -62.51 -31.65 72.45 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.654 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 230' ' ' VAL . . . . . 0.469 HG13 ' HD2' ' A' ' 27' ' ' LYS . 99.1 t -92.27 -34.75 6.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.745 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 109.91 29.58 3.76 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.007 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 11.6 mt -98.41 126.56 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -67.42 136.67 55.08 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.857 0.36 . . . . 0.0 110.198 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -138.02 114.45 10.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.177 -174.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -66.2 121.28 14.86 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -70.27 -27.22 64.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.272 -173.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -74.84 -46.96 32.99 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -64.79 -37.57 88.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.761 0.315 . . . . 0.0 110.163 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 239' ' ' LEU . . . . . . . . . . . . . 8.3 tt -58.5 -62.02 2.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.68 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -65.72 -28.71 69.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.907 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -66.09 -46.0 79.24 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 120.656 0.265 . . . . 0.0 111.488 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 242' ' ' VAL . . . . . 0.592 HG21 ' HB2' ' B' ' 203' ' ' TYR . 27.1 m -75.12 -25.73 18.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -178.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 13.5 mt -70.49 -41.86 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.248 173.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 46.7 p -70.62 -22.88 62.48 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.304 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -69.26 -46.14 67.98 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.71 171.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 2.2 pp -87.7 -17.11 32.49 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.148 -174.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -55.23 125.79 22.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.026 0.441 . . . . 0.0 111.843 -171.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 174.98 -168.79 41.53 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.688 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.98 12.37 28.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.122 0.487 . . . . 0.0 110.304 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -88.46 25.55 1.66 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.721 0.772 . . . . 0.0 110.061 -175.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.501 ' O ' HG12 ' B' ' 254' ' ' VAL . 34.2 mm -58.66 -62.75 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.768 -177.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -66.0 -29.64 70.05 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.437 -173.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.07 -51.68 66.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.166 175.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 254' ' ' VAL . . . . . 0.501 HG12 ' O ' ' B' ' 251' ' ' ILE . 8.9 p -71.09 -22.81 22.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.981 -176.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 255' ' ' ILE . . . . . 0.401 HG12 ' O ' ' B' ' 251' ' ' ILE . 44.2 mm -75.21 -50.59 23.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.274 0.559 . . . . 0.0 110.528 173.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -71.48 -25.96 62.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.342 -173.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -140.44 46.49 1.81 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.346 0.593 . . . . 0.0 110.802 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 258' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' B' ' 254' ' ' VAL . . . -130.94 53.39 0.81 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.666 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 20.0 mt . . . . . 0 C--N 1.327 -0.401 0 CA-C-O 121.172 0.51 . . . . 0.0 110.625 178.317 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.8 m . . . . . 0 N--CA 1.45 -0.475 0 CA-C-O 120.809 0.338 . . . . 0.0 111.494 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.548 HG12 HG21 ' A' ' 37' ' ' VAL . 41.3 t -68.43 -34.35 65.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 122.052 0.93 . . . . 0.0 108.801 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.653 ' HB3' HG23 ' A' ' 39' ' ' VAL . 4.2 m -66.93 -54.62 20.22 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.041 -178.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.502 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 37.4 mt-10 -62.96 -37.11 85.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.573 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.478 HD23 ' CG2' ' B' ' 255' ' ' ILE . 4.3 mp -60.75 -50.66 72.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.384 174.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.64 -49.6 74.53 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.041 0.448 . . . . 0.0 110.799 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.406 ' HB2' HG11 ' A' ' 39' ' ' VAL . 48.9 t -65.56 -31.55 72.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.633 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.502 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 1.2 tp -74.73 -41.28 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.826 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -64.36 -37.84 88.94 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.3 m -67.59 -46.66 71.99 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.472 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' A' ' 17' ' ' HIS . . . -48.95 -52.58 23.96 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.467 176.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.462 HD11 ' CB ' ' B' ' 205' ' ' ALA . 4.1 pp -77.93 -30.23 50.39 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.797 -176.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.448 ' N ' HD12 ' A' ' 14' ' ' LEU . 9.8 mt -56.35 -40.6 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.333 0.587 . . . . 0.0 110.185 173.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.8 mt -77.25 -31.62 55.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.29 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.505 ' HB2' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -82.85 50.85 1.78 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -175.498 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -146.32 -45.72 0.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.875 0.369 . . . . 0.0 110.775 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -86.87 -160.89 0.62 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.736 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -88.52 -17.09 31.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.325 0.583 . . . . 0.0 109.589 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.4 t -59.2 130.48 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.116 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.2 p -83.98 147.36 27.49 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.691 -176.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.4 m -78.05 116.05 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.601 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.421 ' OG1' ' HD3' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -150.7 162.49 40.59 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -176.795 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 53.0 mp0 -48.58 -54.95 12.54 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 123.369 0.418 . . . . 0.0 111.334 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -50.92 -34.81 30.1 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 124.0 0.812 . . . . 0.0 110.778 -178.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.465 ' HG3' HG13 ' B' ' 230' ' ' VAL . 14.2 mptt -78.39 -50.43 11.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.182 -175.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.45 HG23 HD13 ' A' ' 32' ' ' ILE . 7.8 mt -64.33 -40.69 89.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.131 0.491 . . . . 0.0 110.125 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -59.57 -46.19 89.63 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.351 175.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.19 -46.99 87.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.148 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.8 mt -65.26 -43.55 90.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.521 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.45 HD13 HG23 ' A' ' 28' ' ' ILE . 1.5 mp -59.09 -47.59 89.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 120.868 0.366 . . . . 0.0 110.786 176.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -71.56 -22.09 61.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.012 0.434 . . . . 0.0 110.915 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.36 -39.13 62.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.835 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.59 -47.1 10.17 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 138.96 -61.92 0.57 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 119.978 -1.106 . . . . 0.0 114.025 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.742 HG12 ' HA2' ' B' ' 213' ' ' GLY . 8.3 p -61.03 129.77 24.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.216 0.531 . . . . 0.0 111.912 -175.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -105.72 104.98 14.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.375 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.653 HG23 ' HB3' ' A' ' 5' ' ' SER . 3.1 p -76.12 140.89 16.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.322 172.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 11.4 pt-20 -52.94 125.93 41.25 Favored Pre-proline 0 CA--C 1.531 0.242 0 O-C-N 123.212 0.32 . . . . 0.0 110.593 -178.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 40' ' ' GLU . 75.7 Cg_exo -50.76 -13.19 0.75 Allowed 'Trans proline' 0 N--CA 1.485 0.98 0 C-N-CA 124.367 3.378 . . . . 0.0 115.229 -167.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -68.76 -35.07 76.62 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.529 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 76.6 m95 -69.59 -54.22 11.17 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.007 177.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.529 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 83.3 Cg_exo -50.85 -48.54 20.33 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 122.223 1.949 . . . . 0.0 112.868 175.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.47 -47.65 87.82 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.216 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.2 tp -58.68 -49.5 77.33 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.46 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 2.6 m-85 -54.04 -54.94 32.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.867 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.2 -39.41 92.66 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -175.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -88.49 -12.21 43.6 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.88 -18.23 14.11 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.545 ' HA ' HG23 ' A' ' 54' ' ' VAL . 26.6 mt -83.89 -131.99 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 119.331 -0.948 . . . . 0.0 109.98 177.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 59.3 7.42 0.91 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.17 0.51 . . . . 0.0 111.979 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -143.56 -42.15 0.29 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.545 HG23 ' HA ' ' A' ' 51' ' ' LEU . 7.5 t -54.88 115.84 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.609 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.245 177.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -53.63 152.6 5.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.697 171.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.728 ' O ' HD12 ' A' ' 59' ' ' LEU . 2.0 tp -46.5 -71.87 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -174.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.488 ' H ' HG23 ' A' ' 56' ' ' ILE . . . -63.17 -23.8 66.55 Favored Glycine 0 C--O 1.24 0.516 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.781 -172.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.3 t -59.54 -21.24 59.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.236 -0.482 . . . . 0.0 110.579 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -59.18 -19.24 43.56 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.567 -177.454 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.577 ' N ' HD13 ' A' ' 59' ' ' LEU . 48.1 mt -64.96 -27.59 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 121.173 -0.211 . . . . 0.0 111.32 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 75.2 m -139.26 23.4 2.55 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -175.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -132.82 51.32 2.17 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.461 HG11 ' CZ3' ' A' ' 43' ' ' TRP . 85.4 t . . . . . 0 C--N 1.323 -0.58 0 CA-C-O 121.063 0.458 . . . . 0.0 110.255 173.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 203' ' ' TYR . . . . . 0.816 ' CE2' ' HA ' ' B' ' 239' ' ' LEU . 4.3 m-85 . . . . . 0 N--CA 1.463 0.2 0 CA-C-O 120.736 0.303 . . . . 0.0 111.654 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.751 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 3.8 m -52.84 -54.45 16.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.295 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 205' ' ' ALA . . . . . 0.462 ' CB ' HD11 ' A' ' 14' ' ' LEU . . . -80.14 -15.52 56.91 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.126 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 206' ' ' SER . . . . . 0.492 ' CB ' HG23 ' B' ' 223' ' ' ILE . 14.9 m -68.14 -42.17 80.51 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 170.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 207' ' ' TYR . . . . . 0.543 ' CD1' HD11 ' B' ' 251' ' ' ILE . 24.1 t80 -66.27 -40.25 90.0 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.268 174.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.751 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 54.3 mt -63.12 -36.01 82.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.544 176.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 209' ' ' LEU . . . . . . . . . . . . . 1.2 mp -62.37 -44.8 95.63 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.855 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -56.58 -39.15 73.0 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.501 177.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 211' ' ' ALA . . . . . . . . . . . . . . . -87.12 -63.35 1.32 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 212' ' ' LEU . . . . . 0.507 HD11 ' O ' ' A' ' 4' ' ' VAL . 3.4 tm? -54.11 -39.82 66.76 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 213' ' ' GLY . . . . . 0.742 ' HA2' HG12 ' A' ' 37' ' ' VAL . . . -52.39 -20.42 7.21 Favored Glycine 0 C--N 1.33 0.244 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.165 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 99.4 26.68 8.55 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.147 174.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 215' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -117.48 -29.47 5.8 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.959 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 37.9 m 60.66 35.08 19.93 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.027 172.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 217' ' ' SER . . . . . 0.404 ' C ' ' H ' ' B' ' 219' ' ' SER . 32.2 p -120.03 104.48 43.89 Favored Pre-proline 0 C--N 1.314 -0.968 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.275 -172.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 218' ' ' PRO . . . . . 0.405 ' HB3' ' OH ' ' B' ' 207' ' ' TYR . 26.2 Cg_exo -70.9 19.22 0.23 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.929 2.42 . . . . 0.0 113.256 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 219' ' ' SER . . . . . 0.418 ' HB2' ' CG ' ' B' ' 222' ' ' ASP . 1.1 m -63.52 119.27 9.47 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.436 0.636 . . . . 0.0 110.46 -176.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 220' ' ' ALA . . . . . 0.521 ' HB1' HD21 ' B' ' 239' ' ' LEU . . . -56.2 -29.35 60.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.86 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -73.46 -30.11 62.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.495 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 222' ' ' ASP . . . . . 0.418 ' CG ' ' HB2' ' B' ' 219' ' ' SER . 93.5 m-20 -70.94 -43.93 67.17 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.492 HG23 ' CB ' ' B' ' 206' ' ' SER . 1.8 mp -58.69 -52.42 60.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-O 121.056 0.455 . . . . 0.0 110.013 174.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -56.5 -40.83 75.62 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.878 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -65.23 -37.48 87.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.284 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 1.1 mp -62.58 -42.83 97.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.539 175.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 66.0 mt -75.83 -35.71 59.89 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.447 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.37 -20.7 62.94 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.723 0.297 . . . . 0.0 110.72 177.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 16.2 t -58.26 -26.87 63.45 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.313 0.577 . . . . 0.0 109.559 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 230' ' ' VAL . . . . . 0.465 HG13 ' HG3' ' A' ' 27' ' ' LYS . 98.8 t -110.11 -39.51 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.025 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 108.35 27.03 5.19 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.545 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 5.3 mt -83.28 147.4 5.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -57.81 114.48 2.32 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.124 0.488 . . . . 0.0 112.075 -174.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 234' ' ' ALA . . . . . 0.494 ' HB1' ' OH ' ' B' ' 203' ' ' TYR . . . -138.66 91.01 2.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.248 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -73.24 155.38 39.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.36 -177.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 236' ' ' ASP . . . . . 0.541 ' O ' ' HB3' ' B' ' 239' ' ' LEU . 24.0 t70 -69.01 -48.34 63.26 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.635 0.255 . . . . 0.0 111.425 -175.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 237' ' ' ASP . . . . . 0.709 ' O ' ' HB2' ' B' ' 241' ' ' LYS . 8.0 t70 -58.56 -54.39 47.6 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.392 0.615 . . . . 0.0 109.627 176.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.605 ' O ' HG22 ' B' ' 242' ' ' VAL . 25.0 ttm180 -58.6 -31.92 68.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.149 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 239' ' ' LEU . . . . . 0.816 ' HA ' ' CE2' ' B' ' 203' ' ' TYR . 3.0 tp -50.6 -76.52 0.02 OUTLIER 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.353 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -73.78 -20.14 60.56 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.528 -174.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 241' ' ' LYS . . . . . 0.709 ' HB2' ' O ' ' B' ' 237' ' ' ASP . 15.9 tttt -61.71 -58.44 8.01 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-O 121.303 0.573 . . . . 0.0 110.775 176.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 242' ' ' VAL . . . . . 0.605 HG22 ' O ' ' B' ' 238' ' ' ARG . 34.1 m -73.27 -32.37 37.64 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -174.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 243' ' ' ILE . . . . . 0.677 ' HA ' ' CD1' ' B' ' 246' ' ' LEU . 6.9 mt -60.83 -41.61 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.609 174.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 19.5 t -63.82 -32.17 73.59 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 177.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -76.32 -48.42 20.12 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 246' ' ' LEU . . . . . 0.677 ' CD1' ' HA ' ' B' ' 243' ' ' ILE . 0.0 OUTLIER -88.33 -10.01 50.86 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.433 0.56 . . . . 0.0 112.338 -173.115 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 247' ' ' ASN . . . . . 0.517 ' HB2' ' O ' ' B' ' 243' ' ' ILE . 63.5 t30 -44.69 -73.22 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 O-C-N 123.688 0.617 . . . . 0.0 111.725 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 58.55 -163.53 9.52 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.51 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -135.62 20.94 3.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.298 0.57 . . . . 0.0 109.734 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -115.81 38.78 3.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.411 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.543 HD11 ' CD1' ' B' ' 207' ' ' TYR . 1.1 mm -62.79 -51.36 72.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.322 -177.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -60.36 -30.36 69.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.115 0.483 . . . . 0.0 109.771 -177.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -76.09 -51.91 11.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.942 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 254' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' B' ' 251' ' ' ILE . 9.5 p -57.88 -30.7 38.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.758 0.313 . . . . 0.0 110.888 -177.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 255' ' ' ILE . . . . . 0.478 ' CG2' HD23 ' A' ' 7' ' ' LEU . 64.9 mt -85.05 -47.32 17.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.481 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -68.17 -15.32 63.53 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -176.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -57.28 -70.83 0.11 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.917 175.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 176.84 -99.72 0.13 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.243 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 259' ' ' ILE . . . . . 0.463 HD13 HG23 ' A' ' 60' ' ' ILE . 5.4 mp . . . . . 0 C--N 1.325 -0.461 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.464 ' O ' HD13 ' A' ' 7' ' ' LEU . 23.1 p . . . . . 0 C--O 1.239 0.527 0 CA-C-O 121.238 0.542 . . . . 0.0 112.162 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.433 ' HA ' ' HB2' ' A' ' 7' ' ' LEU . 3.5 m -67.26 -16.74 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.557 -177.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.476 ' HB2' HG23 ' A' ' 39' ' ' VAL . 3.3 p -64.77 -62.02 1.82 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.558 176.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -58.2 -45.42 87.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.12 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 3' ' ' SER . 7.0 mp -51.47 -58.01 7.45 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.621 176.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.42 -47.12 76.45 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.065 -177.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 49.1 t -65.98 -34.67 78.64 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.948 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.401 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 0.9 OUTLIER -74.03 -33.65 36.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.617 0.246 . . . . 0.0 111.234 -179.003 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.704 ' HB2' HD21 ' B' ' 209' ' ' LEU . 21.4 m-85 -79.06 -23.62 44.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.187 0.518 . . . . 0.0 110.025 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.517 ' HA ' HD23 ' A' ' 31' ' ' LEU . 19.3 t -68.89 -47.24 66.35 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 171.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.5 -42.09 63.99 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.712 172.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.425 HD11 ' O ' ' B' ' 259' ' ' ILE . 20.0 mt -58.54 -54.49 46.43 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 120.922 0.391 . . . . 0.0 111.108 176.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.538 HD12 HD21 ' A' ' 31' ' ' LEU . 10.3 mt -59.54 -40.76 82.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.166 -177.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.8 mt -77.83 -22.56 49.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.413 ' CE1' ' HB ' ' A' ' 56' ' ' ILE . 25.1 t-80 -61.87 -36.35 80.97 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -73.28 -69.7 0.41 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -168.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.436 ' C ' ' H ' ' A' ' 21' ' ' VAL . 23.1 t70 -64.83 148.1 51.95 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.088 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -77.23 46.24 0.49 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.903 0.859 . . . . 0.0 110.451 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.436 ' H ' ' C ' ' A' ' 19' ' ' ASP . 9.9 p -81.3 157.37 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.303 175.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.6 t -59.02 -20.16 50.51 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -168.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.6 t 55.14 78.45 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 121.403 0.62 . . . . 0.0 109.732 -175.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.1 p -136.05 168.17 19.86 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -174.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -51.55 -48.06 63.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.568 -1.197 . . . . 0.0 110.707 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -52.45 -39.29 60.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.197 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 2.8 mptp? -80.88 -41.35 23.25 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.431 -173.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.414 HG23 HD13 ' A' ' 32' ' ' ILE . 10.8 mt -64.03 -45.39 96.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.054 174.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -60.17 -40.9 91.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.696 178.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.29 -52.55 65.17 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 111.394 177.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.594 ' HB2' HG22 ' B' ' 230' ' ' VAL . 45.4 tp -66.54 -40.98 89.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.265 0.555 . . . . 0.0 111.182 -176.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.414 HD13 HG23 ' A' ' 28' ' ' ILE . 1.5 mp -62.73 -37.21 78.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.399 177.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -74.4 -29.11 61.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 0.0 110.137 177.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.51 -45.86 92.42 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.582 175.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.423 ' HA ' HD11 ' B' ' 226' ' ' ILE . . . -80.74 -33.06 35.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.797 0.332 . . . . 0.0 111.547 177.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.52 23.43 28.75 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.812 173.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.5 t -94.89 130.15 44.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 117.327 0.563 . . . . 0.0 110.708 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -79.72 90.8 5.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.98 -177.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.476 HG23 ' HB2' ' A' ' 5' ' ' SER . 10.7 p -98.52 130.09 47.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 169.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -63.28 136.49 96.72 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.04 -177.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.475 ' HA ' ' HG2' ' A' ' 44' ' ' PRO . 82.9 Cg_exo -48.75 -14.08 0.34 Allowed 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 124.716 3.611 . . . . 0.0 115.021 -171.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.19 -36.87 77.76 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -177.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -67.44 -58.96 7.77 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 121.011 -0.275 . . . . 0.0 111.359 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.475 ' HG2' ' HA ' ' A' ' 41' ' ' PRO . 10.9 Cg_endo -54.54 -46.1 35.95 Favored 'Trans proline' 0 C--N 1.361 1.237 0 C-N-CA 122.286 1.991 . . . . 0.0 112.754 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.73 -45.99 95.11 Favored Glycine 0 C--O 1.242 0.639 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.033 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.4 tp -51.99 -59.37 4.43 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 176.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -58.99 -40.39 84.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.711 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.0 -44.61 91.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.217 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -95.62 -11.7 26.81 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.772 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.548 ' O ' HG21 ' A' ' 54' ' ' VAL . . . -104.15 -12.28 16.81 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -175.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.586 ' HA ' HG23 ' A' ' 54' ' ' VAL . 42.9 mt -101.79 -132.34 0.27 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.429 173.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 65.96 -12.61 0.17 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -144.69 12.74 1.49 Allowed 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.586 HG23 ' HA ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -128.23 120.81 54.24 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.944 -170.082 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -55.07 155.52 4.57 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.034 -1.439 . . . . 0.0 112.448 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.545 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 3.7 tp -44.53 -41.91 2.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -173.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -54.29 -23.81 27.31 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 121.611 -0.328 . . . . 0.0 113.494 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.6 t -53.84 -26.71 25.69 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 122.542 0.337 . . . . 0.0 111.264 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 34.3 mt -56.9 -36.06 69.71 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.664 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.472 HG12 HD13 ' B' ' 259' ' ' ILE . 1.1 mp -103.27 18.38 4.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.445 0.64 . . . . 0.0 109.539 -175.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 69.7 m -119.91 -6.53 10.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.393 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -100.56 -17.4 17.11 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.145 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.879 177.981 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 . . . . . 0 C--O 1.237 0.415 0 CA-C-O 121.578 0.704 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.621 ' O ' HD13 ' B' ' 208' ' ' LEU . 94.3 t -59.67 -62.1 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.158 177.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 205' ' ' ALA . . . . . 0.611 ' O ' ' HG ' ' B' ' 209' ' ' LEU . . . -61.7 -21.49 64.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.561 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 206' ' ' SER . . . . . 0.407 ' CB ' HG23 ' B' ' 223' ' ' ILE . 5.7 m -66.87 -47.9 70.45 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.003 0.43 . . . . 0.0 109.88 173.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 207' ' ' TYR . . . . . 0.644 ' HD2' HD13 ' B' ' 251' ' ' ILE . 34.0 t80 -59.98 -38.89 83.87 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.667 ' O ' ' HG ' ' B' ' 212' ' ' LEU . 9.3 mp -56.57 -56.49 20.7 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.778 175.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 209' ' ' LEU . . . . . 0.704 HD21 ' HB2' ' A' ' 11' ' ' TYR . 58.0 mt -52.36 -47.5 66.1 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 123.532 0.52 . . . . 0.0 111.066 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -63.98 -32.81 74.49 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.264 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 211' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -68.8 -44.82 72.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.494 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 212' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' B' ' 208' ' ' LEU . 15.1 mt -64.81 -29.01 69.96 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.733 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -62.68 -7.18 14.13 Favored Glycine 0 C--N 1.337 0.603 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.957 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 110.66 20.82 7.1 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.485 174.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 215' ' ' ASN . . . . . 0.656 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 27.5 m-80 -130.32 111.67 12.59 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 6.3 m -65.89 -20.77 66.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.279 0.561 . . . . 0.0 110.684 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 12.0 p -123.71 70.58 47.9 Favored Pre-proline 0 N--CA 1.443 -0.806 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.859 -175.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 218' ' ' PRO . . . . . 0.484 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 50.4 Cg_exo -60.39 135.68 63.02 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.069 2.512 . . . . 0.0 112.599 173.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 219' ' ' SER . . . . . 0.41 ' O ' HD13 ' B' ' 223' ' ' ILE . 49.4 m -102.66 157.22 17.09 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.736 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -51.4 -41.68 60.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.198 0.523 . . . . 0.0 111.224 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -60.79 -42.55 97.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.972 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -67.82 -39.55 83.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.506 -177.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.428 HD11 ' CB ' ' B' ' 218' ' ' PRO . 1.7 mp -68.03 -39.8 82.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 120.867 0.365 . . . . 0.0 110.553 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -62.07 -42.99 99.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.953 0.406 . . . . 0.0 110.35 176.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 16.6 ttpp -64.42 -39.57 94.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.371 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 0.438 HG23 HD11 ' A' ' 31' ' ' LEU . 0.8 OUTLIER -62.65 -41.21 91.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.392 178.295 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 227' ' ' LEU . . . . . 0.426 ' HA ' HD22 ' B' ' 227' ' ' LEU . 0.5 OUTLIER -71.93 -45.39 61.29 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -176.906 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.98 -24.35 62.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.831 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 18.5 t -56.68 -42.41 78.99 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.792 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 230' ' ' VAL . . . . . 0.594 HG22 ' HB2' ' A' ' 31' ' ' LEU . 7.0 t -64.28 -29.39 47.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.526 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 105.65 10.35 31.11 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.424 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 24.9 mt -104.57 139.37 25.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -71.74 151.48 43.53 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -173.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -132.07 143.49 50.07 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.757 -176.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -91.27 114.97 27.63 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.089 0.471 . . . . 0.0 110.249 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -58.07 -51.89 67.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.407 -175.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -54.9 -56.76 16.02 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.167 0.508 . . . . 0.0 110.953 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.411 ' O ' HG13 ' B' ' 242' ' ' VAL . 18.7 mmt180 -61.39 -32.77 72.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.862 -175.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 239' ' ' LEU . . . . . . . . . . . . . 6.9 tt -61.83 -60.87 3.0 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.051 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -67.16 -29.81 69.61 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.578 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -60.12 -53.73 54.31 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 120.786 0.327 . . . . 0.0 110.94 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 242' ' ' VAL . . . . . 0.52 ' HA ' ' OE2' ' B' ' 245' ' ' GLU . 22.2 m -72.87 -25.95 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-O 121.327 0.584 . . . . 0.0 110.134 -175.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 34.9 mt -74.54 -31.18 26.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.504 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 23.3 t -64.87 -34.99 79.7 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 173.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 245' ' ' GLU . . . . . 0.52 ' OE2' ' HA ' ' B' ' 242' ' ' VAL . 36.0 mt-10 -67.42 -45.19 76.82 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.237 171.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 246' ' ' LEU . . . . . 0.551 HD11 ' HA ' ' B' ' 204' ' ' VAL . 52.1 mt -70.61 -95.34 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.083 -177.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 58.66 174.21 0.07 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.068 0.547 . . . . 0.0 110.448 -175.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -76.14 50.54 2.73 Favored Glycine 0 CA--C 1.516 0.127 0 O-C-N 122.091 -0.381 . . . . 0.0 113.383 -173.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -109.29 -64.84 1.2 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.508 0.67 . . . . 0.0 110.21 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -103.7 8.29 37.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.413 -174.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.644 HD13 ' HD2' ' B' ' 207' ' ' TYR . 6.0 tp -57.58 -45.57 86.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.519 -173.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -60.58 -40.08 90.39 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.258 0.551 . . . . 0.0 110.606 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -70.03 -45.25 67.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.838 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 254' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' B' ' 251' ' ' ILE . 8.9 p -66.36 -27.96 42.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.916 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 255' ' ' ILE . . . . . 0.521 HG12 ' HG ' ' B' ' 208' ' ' LEU . 96.4 mt -70.86 -52.1 30.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 121.1 0.476 . . . . 0.0 110.219 173.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -76.23 -5.36 46.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.01 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -52.59 -59.6 4.26 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.43 0.456 . . . . 0.0 111.708 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 178.73 -102.39 0.17 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.152 -1.023 . . . . 0.0 113.412 175.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 259' ' ' ILE . . . . . 0.472 HD13 HG12 ' A' ' 60' ' ' ILE . 3.4 mp . . . . . 0 N--CA 1.467 0.407 0 CA-C-N 117.061 0.43 . . . . 0.0 112.011 -175.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.235 0.315 0 CA-C-O 121.253 0.549 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.422 HG13 ' HG ' ' B' ' 212' ' ' LEU . 18.9 t -65.81 -28.44 44.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.461 -174.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.561 ' HB2' HG23 ' A' ' 39' ' ' VAL . 1.5 p -61.94 -64.11 1.04 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.36 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -56.66 -49.63 74.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.577 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.492 ' HB3' HD22 ' B' ' 212' ' ' LEU . 7.3 mp -54.96 -44.91 74.8 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.445 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.71 -45.46 89.88 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.749 0.309 . . . . 0.0 110.949 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.87 -39.0 92.84 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.694 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 tp -73.26 -39.24 55.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.353 -176.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.479 ' CB ' HD12 ' B' ' 209' ' ' LEU . 22.1 m-30 -63.99 -42.23 97.26 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.483 ' HA ' ' CD2' ' A' ' 31' ' ' LEU . 42.1 m -60.74 -43.06 98.41 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.126 0.489 . . . . 0.0 110.011 176.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.44 -56.54 18.95 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.124 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.529 HD11 ' CB ' ' B' ' 205' ' ' ALA . 3.8 pp -78.77 -7.33 57.7 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.234 -177.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 35.5 mt -83.33 -26.26 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.178 0.513 . . . . 0.0 110.105 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.533 HD12 HG13 ' A' ' 28' ' ' ILE . 56.1 mt -100.4 -3.04 31.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.957 175.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.491 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 8.1 t-80 -31.19 -70.69 0.06 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.52 20.32 1.34 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.422 0.629 . . . . 0.0 109.435 -173.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.487 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 2.3 m-20 -83.45 54.21 2.76 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.349 -171.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 19' ' ' ASP . 9.2 pt-20 47.41 29.87 1.44 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.233 1.013 . . . . 0.0 111.913 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.525 HG21 HD13 ' B' ' 232' ' ' ILE . 73.2 t -143.71 150.54 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.205 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.4 p -88.69 142.09 27.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.96 0.41 . . . . 0.0 111.846 -176.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.6 m -75.03 39.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.047 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.5 p -74.44 151.06 39.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.002 0.43 . . . . 0.0 111.736 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.58 -31.25 70.39 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.174 -177.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -53.77 -44.32 69.96 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 123.696 0.623 . . . . 0.0 110.407 173.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -81.09 -40.83 23.49 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.096 -174.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.533 HG13 HD12 ' A' ' 16' ' ' LEU . 1.5 mt -60.27 -48.08 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 174.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -57.2 -42.84 82.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.79 175.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.77 -43.21 90.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.281 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.576 HD11 HG23 ' B' ' 226' ' ' ILE . 14.3 tp -72.44 -39.79 67.57 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 120.97 0.414 . . . . 0.0 110.458 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -54.87 -43.16 66.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.29 175.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -82.54 -17.53 44.66 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.214 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.479 ' HB1' ' HA ' ' B' ' 226' ' ' ILE . . . -62.24 -47.52 84.04 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 172.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.578 ' HA ' HD11 ' B' ' 226' ' ' ILE . . . -84.27 -31.9 24.7 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.354 178.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.08 38.65 5.07 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.001 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.4 t -104.43 157.01 5.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -121.41 112.53 18.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.931 0.396 . . . . 0.0 110.782 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.561 HG23 ' HB2' ' A' ' 5' ' ' SER . 3.0 p -119.29 135.13 60.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.077 175.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.48 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 8.0 tp10 -42.95 111.41 1.02 Allowed Pre-proline 0 N--CA 1.464 0.256 0 O-C-N 123.965 0.791 . . . . 0.0 110.656 173.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.425 ' HA ' ' HG2' ' A' ' 44' ' ' PRO . 85.0 Cg_exo -49.25 -15.01 0.61 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 124.438 3.425 . . . . 0.0 114.682 -172.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.11 -34.89 75.79 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.525 ' O ' ' HB2' ' A' ' 47' ' ' PHE . 95.7 m95 -68.03 -61.31 4.25 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.375 177.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.48 ' HD2' ' O ' ' A' ' 40' ' ' GLU . 13.6 Cg_endo -57.56 -38.21 94.52 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 121.913 1.742 . . . . 0.0 112.117 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.38 -59.25 9.69 Favored Glycine 0 C--O 1.24 0.481 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.786 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 27.9 tp -55.51 -47.91 75.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.722 0.296 . . . . 0.0 110.246 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.727 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -56.32 -62.19 1.88 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.462 -177.77 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.97 -30.18 71.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.609 -173.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -83.85 -22.85 31.57 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.559 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.17 -4.62 17.48 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -173.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.727 ' HG ' ' O ' ' A' ' 47' ' ' PHE . 73.4 mt -79.13 -131.93 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.811 176.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 68.21 -10.64 0.42 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.645 0.778 . . . . 0.0 113.086 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -141.18 12.03 2.18 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.607 ' CG2' ' HA ' ' A' ' 51' ' ' LEU . 31.9 t -103.08 107.46 22.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.383 -173.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -54.09 150.11 8.57 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.875 172.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.832 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 1.9 tp -52.56 -60.96 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -170.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.531 ' O ' HG22 ' A' ' 60' ' ' ILE . . . -52.96 -30.47 37.45 Favored Glycine 0 C--O 1.239 0.449 0 C-N-CA 121.043 -0.598 . . . . 0.0 113.319 -173.047 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.3 t -50.1 -33.43 18.64 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.911 0.484 . . . . 0.0 111.965 -176.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.832 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 0.6 OUTLIER -66.45 -14.13 61.78 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -170.915 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.531 HG22 ' O ' ' A' ' 57' ' ' GLY . 11.3 tt -82.48 -2.62 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.763 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.6 p -150.27 47.5 0.9 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.429 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.757 ' ND2' ' HA ' ' A' ' 59' ' ' LEU . 84.2 m-20 -93.41 -1.04 56.26 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.7 t . . . . . 0 C--N 1.326 -0.441 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 -178.609 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 . . . . . 0 C--O 1.238 0.47 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.547 ' O ' HD13 ' B' ' 208' ' ' LEU . 2.4 p -57.17 -62.31 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 205' ' ' ALA . . . . . 0.609 ' HA ' ' HB2' ' B' ' 208' ' ' LEU . . . -71.81 -12.15 61.15 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.96 -177.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 3.0 m -68.3 -44.93 74.35 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 172.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 207' ' ' TYR . . . . . 0.498 ' CD1' HD11 ' B' ' 251' ' ' ILE . 24.5 t80 -63.64 -45.94 87.93 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.507 173.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.609 ' HB2' ' HA ' ' B' ' 205' ' ' ALA . 7.6 mp -52.98 -50.69 63.63 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.173 177.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 209' ' ' LEU . . . . . 0.479 HD12 ' CB ' ' A' ' 11' ' ' TYR . 1.2 tt -64.7 -46.5 82.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.808 -176.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -57.13 -37.24 71.71 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.861 176.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 211' ' ' ALA . . . . . 0.726 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -79.76 -34.85 39.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.996 0.426 . . . . 0.0 111.025 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 212' ' ' LEU . . . . . 0.492 HD22 ' HB3' ' A' ' 7' ' ' LEU . 50.2 tp -56.65 -51.62 68.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.003 177.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -143.65 76.03 0.3 Allowed Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.049 -1.072 . . . . 0.0 112.438 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 176.19 -72.77 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.495 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 215' ' ' ASN . . . . . 0.726 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 94.0 m-20 -134.91 138.24 43.92 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -176.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 3.7 m -67.24 -28.02 67.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.342 0.592 . . . . 0.0 110.483 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 12.5 m -127.87 74.76 78.6 Favored Pre-proline 0 N--CA 1.442 -0.833 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.8 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.52 117.43 3.81 Favored 'Trans proline' 0 N--CA 1.474 0.369 0 C-N-CA 123.388 2.725 . . . . 0.0 112.577 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 89.1 p -88.19 164.21 15.78 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.148 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 220' ' ' ALA . . . . . 0.414 ' HB1' HD21 ' B' ' 239' ' ' LEU . . . -52.14 -36.16 50.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.225 0.536 . . . . 0.0 110.449 177.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -67.0 -40.94 87.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.654 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -63.14 -45.37 92.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.342 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.413 ' N ' HD12 ' B' ' 223' ' ' ILE . 1.8 mp -67.29 -40.39 84.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.124 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 224' ' ' LYS . . . . . 0.455 ' HD3' HD22 ' B' ' 239' ' ' LEU . 11.6 mmmm -57.13 -47.23 81.64 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 175.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 225' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' B' ' 229' ' ' SER . 9.0 tmtm? -62.12 -41.72 98.52 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 0.578 HD11 ' HA ' ' A' ' 35' ' ' ALA . 1.0 OUTLIER -63.17 -42.86 98.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.737 0.303 . . . . 0.0 110.833 178.775 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 227' ' ' LEU . . . . . 0.589 ' HG ' ' HB ' ' B' ' 232' ' ' ILE . 13.7 tp -76.93 -40.29 47.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.239 0.543 . . . . 0.0 110.116 -174.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.11 -32.34 73.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.865 176.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 229' ' ' SER . . . . . 0.493 ' HB2' ' O ' ' B' ' 225' ' ' LYS . 5.1 t -55.08 -42.61 73.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.438 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 94.0 t -79.9 -40.51 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-O 121.291 0.567 . . . . 0.0 110.629 176.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 115.94 33.97 1.45 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.033 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 232' ' ' ILE . . . . . 0.589 ' HB ' ' HG ' ' B' ' 227' ' ' LEU . 1.9 mm -91.38 128.29 43.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -57.41 119.63 6.82 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 234' ' ' ALA . . . . . 0.548 ' HB2' HD23 ' B' ' 227' ' ' LEU . . . -110.81 128.38 55.74 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.162 0.506 . . . . 0.0 111.86 -175.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -93.1 102.7 15.03 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 174.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -55.15 -30.76 60.49 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -176.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 237' ' ' ASP . . . . . 0.43 ' OD1' ' HD3' ' B' ' 238' ' ' ARG . 6.3 t70 -62.1 -63.11 1.35 Allowed 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.494 0.664 . . . . 0.0 110.164 174.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.642 ' O ' HG23 ' B' ' 242' ' ' VAL . 20.8 mmt180 -64.46 -26.7 68.56 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.115 -175.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 239' ' ' LEU . . . . . 0.455 HD22 ' HD3' ' B' ' 224' ' ' LYS . 8.0 tp -53.54 -63.65 1.08 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.782 174.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -66.64 -24.21 66.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.379 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -66.93 -48.0 69.96 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.251 0.548 . . . . 0.0 110.818 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 242' ' ' VAL . . . . . 0.642 HG23 ' O ' ' B' ' 238' ' ' ARG . 60.4 t -69.72 -30.18 43.82 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 43.2 mt -81.89 -24.42 9.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.994 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 6.5 p -75.91 -31.8 59.33 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 121.557 -0.715 . . . . 0.0 110.428 172.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -73.28 -56.53 4.96 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.15 0.5 . . . . 0.0 110.608 169.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 246' ' ' LEU . . . . . 0.722 HD13 ' O ' ' B' ' 246' ' ' LEU . 0.0 OUTLIER -100.83 122.77 43.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.574 0.702 . . . . 0.0 110.079 -176.255 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -159.7 -164.79 1.39 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.528 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 248' ' ' GLY . . . . . 0.476 ' HA2' HG12 ' B' ' 251' ' ' ILE . . . -75.82 37.09 1.24 Allowed Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.48 -0.39 . . . . 0.0 113.876 -175.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -81.39 -57.5 3.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.093 0.473 . . . . 0.0 110.089 176.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -131.63 51.9 2.11 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.514 ' HA ' HG22 ' B' ' 254' ' ' VAL . 1.0 OUTLIER -64.81 -51.98 60.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -170.444 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -65.39 -24.31 67.19 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.397 -175.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.19 -52.68 13.22 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.102 175.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 254' ' ' VAL . . . . . 0.514 HG22 ' HA ' ' B' ' 251' ' ' ILE . 29.7 m -66.33 -19.93 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.213 -178.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 255' ' ' ILE . . . . . . . . . . . . . 38.7 mt -84.69 -42.84 16.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.714 176.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -63.64 -43.2 97.49 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -177.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -112.36 32.45 5.57 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.286 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -100.65 54.38 0.86 Allowed Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.438 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 1.1 mt . . . . . 0 C--N 1.33 -0.242 0 CA-C-O 121.242 0.544 . . . . 0.0 111.028 177.804 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.465 ' O ' HD13 ' A' ' 7' ' ' LEU . 7.7 t . . . . . 0 CA--C 1.536 0.431 0 CA-C-O 121.123 0.487 . . . . 0.0 111.484 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.534 ' HA ' ' HB2' ' A' ' 7' ' ' LEU . 1.7 m -67.27 -16.06 20.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.213 0.53 . . . . 0.0 110.204 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.655 ' OG ' HG23 ' A' ' 39' ' ' VAL . 30.8 t -60.67 -67.79 0.36 Allowed 'General case' 0 C--O 1.25 1.115 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.349 176.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -66.21 -34.92 79.12 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.818 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 4' ' ' VAL . 6.1 mp -51.27 -54.64 24.04 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.659 173.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.05 -44.46 91.82 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.501 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' A' ' 43' ' ' TRP . 57.0 m -61.07 -38.08 84.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.097 0.475 . . . . 0.0 111.302 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.685 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -72.71 -42.36 62.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.671 -178.169 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.673 ' HD1' HD12 ' A' ' 14' ' ' LEU . 31.2 m-85 -75.37 -21.95 57.9 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.643 -176.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.6 p -75.33 -40.36 58.43 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.238 171.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -49.38 -51.01 37.67 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.471 0.653 . . . . 0.0 109.887 169.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 10' ' ' ILE . 56.0 mt -59.99 -49.86 76.0 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.241 -179.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.8 mt -54.54 -64.87 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.974 0.416 . . . . 0.0 111.381 178.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 86.8 mt -63.27 -24.72 67.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.316 -170.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.531 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 55.3 t-80 -63.54 -36.78 84.93 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -104.0 -7.86 20.01 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.194 0.521 . . . . 0.0 111.615 -167.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.476 ' HB3' HG21 ' B' ' 232' ' ' ILE . 1.1 m-20 -85.53 37.96 0.72 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.43 -175.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 50.58 29.2 3.91 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.929 0.395 . . . . 0.0 110.723 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -136.3 148.96 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.034 -169.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.1 p -86.62 136.21 33.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.733 175.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -76.44 116.6 19.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.985 0.421 . . . . 0.0 110.518 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.2 p -133.19 163.62 28.87 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.512 ' HG3' ' H ' ' A' ' 26' ' ' ASP . 6.6 pt-20 -45.29 -54.01 7.66 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.864 0.727 . . . . 0.0 111.958 -177.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.512 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 2.7 t70 -55.73 -40.06 71.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.473 -178.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -78.75 -41.57 30.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.394 -171.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.518 HG23 HD13 ' A' ' 32' ' ' ILE . 3.2 mt -63.47 -47.59 90.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.997 175.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -61.79 -33.39 74.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.265 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.77 -52.57 35.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.842 0.353 . . . . 0.0 110.891 176.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.508 HD11 HG23 ' B' ' 226' ' ' ILE . 0.2 OUTLIER -61.89 -32.31 72.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.226 0.536 . . . . 0.0 110.21 177.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.518 HD13 HG23 ' A' ' 28' ' ' ILE . 1.3 mp -69.47 -33.88 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.128 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -74.15 -27.74 60.98 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.052 174.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.73 -50.15 46.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.936 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.482 ' HB3' ' HB3' ' B' ' 209' ' ' LEU . . . -133.85 16.21 3.91 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -175.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.05 93.95 1.86 Allowed Glycine 0 C--N 1.314 -0.661 0 C-N-CA 120.317 -0.944 . . . . 0.0 111.657 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.7 p -56.43 -42.12 73.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 120.648 0.261 . . . . 0.0 111.537 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -160.97 127.4 3.98 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.029 0.442 . . . . 0.0 110.527 172.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.655 HG23 ' OG ' ' A' ' 5' ' ' SER . 8.0 p -165.07 120.45 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.795 178.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.431 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 1.7 pm0 -65.89 129.63 94.31 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.79 -8.87 0.96 Allowed 'Trans proline' 0 N--CA 1.485 0.991 0 C-N-CA 123.778 2.985 . . . . 0.0 113.755 -172.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.77 -38.16 76.65 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.649 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.482 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 70.2 m95 -69.4 -55.03 10.21 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.979 177.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.482 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 85.0 Cg_exo -49.01 -51.0 11.38 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 122.364 2.043 . . . . 0.0 113.003 176.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.55 -49.6 68.23 Favored Glycine 0 C--O 1.243 0.683 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.738 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.9 tp -54.05 -48.52 70.47 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 115.449 -0.375 . . . . 0.0 110.599 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.69 ' O ' HD12 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -67.86 -44.48 77.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.879 -173.898 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.1 -35.28 74.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.12 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -93.39 -1.97 55.23 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.819 175.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.83 -42.39 17.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.552 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.717 ' HA ' HG23 ' A' ' 54' ' ' VAL . 2.1 mp -86.99 -131.7 0.06 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 118.7 -1.2 . . . . 0.0 109.654 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 65.59 -9.96 0.23 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.213 0.605 . . . . 0.0 112.293 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.472 ' H ' ' C ' ' A' ' 51' ' ' LEU . 23.5 t-20 -127.59 -41.4 1.7 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.717 HG23 ' HA ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -81.77 117.16 27.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.314 168.636 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.437 ' OD1' HG22 ' A' ' 56' ' ' ILE . 8.6 t-20 -43.95 -67.9 0.24 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.874 0.734 . . . . 0.0 112.73 -172.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.635 ' O ' HD12 ' A' ' 59' ' ' LEU . 2.4 tp -156.24 -48.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.291 -177.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.39 -21.52 8.9 Favored Glycine 0 N--CA 1.469 0.866 0 O-C-N 123.32 0.388 . . . . 0.0 113.689 -173.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.2 t -60.97 -14.51 23.29 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 122.545 0.338 . . . . 0.0 111.155 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -68.2 -18.64 64.64 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.107 -178.27 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.506 ' O ' HG22 ' A' ' 60' ' ' ILE . 29.9 mt -100.91 29.94 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 122.254 1.026 . . . . 0.0 109.511 174.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.9 t -71.96 132.29 44.12 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 121.743 -0.598 . . . . 0.0 110.307 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -73.69 64.37 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.064 0.459 . . . . 0.0 110.678 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.6 t . . . . . 0 C--N 1.322 -0.614 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.653 176.185 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 203' ' ' TYR . . . . . 0.43 ' CE1' ' HB3' ' B' ' 239' ' ' LEU . 30.5 m-85 . . . . . 0 C--O 1.242 0.671 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.713 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 6.5 p -58.44 -50.5 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.536 -177.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 205' ' ' ALA . . . . . 0.62 ' HA ' HD12 ' B' ' 208' ' ' LEU . . . -72.65 -15.63 61.71 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.703 0.287 . . . . 0.0 110.902 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 1.7 m -70.47 -48.51 55.47 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.087 0.47 . . . . 0.0 109.736 174.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 207' ' ' TYR . . . . . 0.551 ' CZ ' ' HD2' ' B' ' 218' ' ' PRO . 33.0 t80 -61.97 -41.21 97.75 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.713 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 88.4 mt -56.82 -53.49 57.25 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.101 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 209' ' ' LEU . . . . . 0.673 ' CD2' ' HB2' ' A' ' 11' ' ' TYR . 56.0 mt -57.74 -54.83 42.43 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.956 0.408 . . . . 0.0 111.067 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 210' ' ' ALA . . . . . 0.401 ' HB3' ' HB3' ' B' ' 218' ' ' PRO . . . -58.22 -32.94 68.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.287 -176.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 211' ' ' ALA . . . . . 0.463 ' HB3' HD11 ' B' ' 255' ' ' ILE . . . -76.88 -44.58 31.39 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.158 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 212' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' B' ' 209' ' ' LEU . 2.8 pp -64.66 -22.96 67.11 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.875 0.369 . . . . 0.0 110.405 177.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.09 -13.96 58.41 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.822 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 118.49 10.87 8.33 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.348 -0.93 . . . . 0.0 113.227 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 215' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -121.48 100.42 7.01 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 122.33 -0.512 . . . . 0.0 111.216 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 2.0 m -44.74 -49.81 10.37 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -168.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 19.0 m -114.24 85.37 10.4 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 123.495 0.497 . . . . 0.0 110.446 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 218' ' ' PRO . . . . . 0.551 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 73.6 Cg_exo -46.01 121.91 4.77 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 123.821 3.014 . . . . 0.0 113.57 176.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 46.8 t -76.39 148.42 37.37 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.808 178.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.84 -29.11 59.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.319 176.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -66.45 -38.41 87.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.389 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -73.31 -42.53 62.24 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.127 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.484 HD11 ' CB ' ' B' ' 218' ' ' PRO . 1.7 mp -64.26 -43.88 97.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -52.15 -60.43 3.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.313 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -52.07 -50.32 61.76 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.174 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 0.508 HG23 HD11 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -56.25 -38.04 52.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.51 -177.798 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 227' ' ' LEU . . . . . 0.766 HD23 ' HB2' ' B' ' 234' ' ' ALA . 13.5 tp -75.91 -46.92 27.43 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.87 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -87.36 12.15 12.74 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 119.761 -0.775 . . . . 0.0 111.826 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 72.5 m -57.15 -34.14 68.13 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.324 165.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 54.1 t -93.5 -52.31 9.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.475 175.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 138.93 30.38 0.21 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.903 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 232' ' ' ILE . . . . . 0.476 HG21 ' HB3' ' A' ' 19' ' ' ASP . 3.4 mp -101.92 149.65 6.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 174.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -86.8 150.54 24.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.313 0.578 . . . . 0.0 111.742 -171.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 234' ' ' ALA . . . . . 0.766 ' HB2' HD23 ' B' ' 227' ' ' LEU . . . -134.68 160.85 36.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.749 -177.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -112.87 125.82 54.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.119 0.485 . . . . 0.0 110.286 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -62.36 -51.15 68.76 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 114.766 -1.106 . . . . 0.0 113.146 -170.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -75.08 -33.46 61.67 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.494 -173.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 26.5 tpt180 -68.21 -44.97 74.6 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.886 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 239' ' ' LEU . . . . . 0.497 HD12 ' N ' ' B' ' 240' ' ' ASN . 4.5 pp -66.27 -37.59 85.81 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.363 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 240' ' ' ASN . . . . . 0.497 ' N ' HD12 ' B' ' 239' ' ' LEU . 26.1 t-20 -67.78 -36.91 81.33 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 121.311 -0.156 . . . . 0.0 110.651 178.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -65.36 -45.58 83.6 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 120.612 0.244 . . . . 0.0 110.94 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 242' ' ' VAL . . . . . 0.427 ' O ' ' HG ' ' B' ' 246' ' ' LEU . 33.9 m -70.89 -32.26 48.15 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 CA-C-O 121.493 0.663 . . . . 0.0 109.616 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 32.1 mt -72.36 -29.58 32.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.538 175.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 47.1 t -66.01 -32.08 73.35 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 172.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -74.28 -31.42 62.52 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.084 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 246' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' B' ' 242' ' ' VAL . 32.2 mt -85.88 1.36 50.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.553 178.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -78.87 -11.31 59.99 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -166.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -88.08 -132.82 4.07 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.828 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -98.93 -156.67 0.56 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 18.9 m120 75.37 -25.38 0.2 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.081 0.552 . . . . 0.0 112.456 174.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.636 ' HA ' HG12 ' B' ' 254' ' ' VAL . 5.9 tp -56.52 -38.67 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.466 0.651 . . . . 0.0 110.416 175.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -54.28 -50.88 66.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.037 176.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.2 -45.91 75.46 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.063 -177.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 254' ' ' VAL . . . . . 0.636 HG12 ' HA ' ' B' ' 251' ' ' ILE . 9.6 p -62.5 -33.9 61.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.259 -175.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 255' ' ' ILE . . . . . 0.463 HD11 ' HB3' ' B' ' 211' ' ' ALA . 63.4 mt -80.07 -40.33 20.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.815 176.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -57.18 -51.71 68.23 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.749 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -160.78 75.65 0.55 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.918 0.39 . . . . 0.0 110.448 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -176.32 56.37 0.11 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.733 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 259' ' ' ILE . . . . . 0.451 HG13 ' H ' ' B' ' 259' ' ' ILE . 27.7 mt . . . . . 0 N--CA 1.48 1.044 0 C-N-CA 123.808 0.843 . . . . 0.0 111.898 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.476 ' O ' HD13 ' A' ' 7' ' ' LEU . 3.4 p . . . . . 0 CA--C 1.533 0.302 0 CA-C-O 121.281 0.563 . . . . 0.0 111.457 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.4 -22.78 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.955 -175.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.474 ' HB2' HG23 ' A' ' 39' ' ' VAL . 3.4 p -61.67 -63.68 1.19 Allowed 'General case' 0 C--O 1.242 0.667 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.111 178.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -62.43 -41.75 98.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.088 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.476 HD13 ' O ' ' A' ' 3' ' ' SER . 5.2 mp -49.45 -59.27 3.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.341 176.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.8 -53.18 60.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.668 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 35.7 t -64.79 -37.52 87.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.775 -175.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.419 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 1.3 tp -75.77 -35.46 30.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.898 0.38 . . . . 0.0 110.951 -175.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.766 ' OH ' ' HA2' ' B' ' 258' ' ' GLY . 17.3 m-30 -74.55 -28.32 60.9 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.769 177.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 64.3 m -66.04 -41.98 90.17 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 173.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.441 ' HB3' HD21 ' A' ' 59' ' ' LEU . . . -53.74 -45.09 70.43 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.101 171.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 10' ' ' ILE . 72.8 mt -59.46 -55.15 38.27 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.788 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.404 HD11 ' HA ' ' B' ' 206' ' ' SER . 73.4 mt -52.35 -45.62 45.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.243 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.3 mt -76.19 -18.42 59.08 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.365 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -98.3 18.37 16.55 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.957 -0.464 . . . . 0.0 112.162 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -117.48 -51.98 2.49 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.009 178.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -74.42 29.22 0.08 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 50.86 40.29 24.48 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.742 0.417 . . . . 0.0 111.864 178.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.8 p -121.72 164.69 18.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.79 0.329 . . . . 0.0 111.026 -173.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.2 p -90.48 135.25 33.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.021 0.438 . . . . 0.0 111.777 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.627 HG11 HD23 ' A' ' 51' ' ' LEU . 91.8 t -77.82 123.34 34.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.414 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.26 158.49 43.81 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 177.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -50.91 -55.29 17.85 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.48 -177.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -51.73 -33.7 35.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.594 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -73.76 -50.34 21.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.534 0.207 . . . . 0.0 110.64 -176.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.409 ' O ' HD13 ' A' ' 32' ' ' ILE . 9.1 mt -65.34 -43.3 94.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.13 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -60.63 -36.61 79.06 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.988 175.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.57 -44.33 87.04 Favored 'General case' 0 C--O 1.227 -0.111 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.95 -42.98 89.29 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.239 0.542 . . . . 0.0 110.774 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.409 HD13 ' O ' ' A' ' 28' ' ' ILE . 1.6 mp -60.88 -44.0 96.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.411 177.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -73.31 -27.96 61.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.662 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.407 ' HB3' HG13 ' B' ' 226' ' ' ILE . . . -66.4 -37.63 85.66 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.361 176.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.423 ' HB2' HD12 ' B' ' 209' ' ' LEU . . . -82.39 -35.89 27.27 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.674 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.9 31.39 4.8 Favored Glycine 0 N--CA 1.454 -0.144 0 C-N-CA 120.755 -0.736 . . . . 0.0 113.428 175.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.511 HG13 ' HA2' ' B' ' 213' ' ' GLY . 22.3 m -114.52 175.08 2.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 122.725 -0.279 . . . . 0.0 110.732 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -132.96 106.94 7.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.902 0.382 . . . . 0.0 110.612 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.474 HG23 ' HB2' ' A' ' 5' ' ' SER . 7.4 p -102.64 135.25 40.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 174.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -53.8 130.28 56.36 Favored Pre-proline 0 C--O 1.236 0.361 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.51 -2.82 1.11 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.41 2.74 . . . . 0.0 113.721 -170.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.8 -37.48 70.39 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.032 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.578 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 94.9 m95 -70.7 -54.38 8.24 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 119.194 -0.431 . . . . 0.0 110.74 177.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.578 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 75.4 Cg_exo -51.88 -45.31 39.31 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 121.705 1.603 . . . . 0.0 112.213 175.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.77 -43.68 95.88 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.333 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.0 -43.26 95.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.196 0.522 . . . . 0.0 110.286 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.474 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 2.8 m-85 -70.24 -41.08 74.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.803 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.81 -35.95 81.26 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -98.77 -23.14 15.52 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -174.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.08 -24.8 5.46 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -174.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.709 ' HA ' HG23 ' A' ' 54' ' ' VAL . 2.0 tp -86.65 -133.35 0.06 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.475 ' H ' ' CG ' ' A' ' 51' ' ' LEU . . . 60.7 -12.13 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.615 0.766 . . . . 0.0 112.773 -177.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.538 ' H ' ' C ' ' A' ' 51' ' ' LEU . 18.3 m120 -125.99 -34.94 2.51 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.709 HG23 ' HA ' ' A' ' 51' ' ' LEU . 61.2 t -45.0 108.26 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.517 174.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -47.39 140.21 5.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.735 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.9 tp -52.39 -48.58 45.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.896 -173.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.93 -40.67 93.57 Favored Glycine 0 C--O 1.239 0.457 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.601 177.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.4 t -59.0 -17.81 28.5 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 122.76 0.424 . . . . 0.0 111.012 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.441 HD21 ' HB3' ' A' ' 13' ' ' ALA . 15.4 tp -62.01 -21.52 64.94 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.193 -176.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.3 tt -71.18 -13.4 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.117 0.484 . . . . 0.0 110.893 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 62.5 m -103.41 55.52 0.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.124 0.488 . . . . 0.0 110.304 177.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -74.97 -4.47 38.39 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.753 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 C--N 1.322 -0.618 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.399 -177.134 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 . . . . . 0 N--CA 1.473 0.701 0 CA-C-O 121.169 0.509 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.557 ' O ' HD13 ' B' ' 208' ' ' LEU . 57.7 t -59.1 -54.35 35.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.144 177.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 205' ' ' ALA . . . . . 0.459 ' HA ' HD22 ' B' ' 208' ' ' LEU . . . -65.53 -20.61 66.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.727 0.299 . . . . 0.0 111.069 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 206' ' ' SER . . . . . 0.404 ' HA ' HD11 ' A' ' 15' ' ' ILE . 1.5 m -68.14 -43.61 77.92 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 173.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 207' ' ' TYR . . . . . 0.507 ' HD2' HD13 ' B' ' 251' ' ' ILE . 35.7 t80 -62.3 -39.96 94.73 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.557 HD13 ' O ' ' B' ' 204' ' ' VAL . 8.8 mp -56.69 -52.81 63.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.955 175.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 209' ' ' LEU . . . . . 0.551 ' CD2' ' HB2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -55.15 -52.75 62.31 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.87 -178.688 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 210' ' ' ALA . . . . . 0.422 ' CB ' ' HB3' ' B' ' 218' ' ' PRO . . . -65.72 -31.09 71.88 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.57 -177.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 211' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -69.77 -47.87 61.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.003 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 212' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' B' ' 209' ' ' LEU . 4.6 pp -67.21 -22.15 65.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.978 0.418 . . . . 0.0 109.897 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 213' ' ' GLY . . . . . 0.511 ' HA2' HG13 ' A' ' 37' ' ' VAL . . . -55.22 -25.79 41.08 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.909 174.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 123.86 17.21 3.15 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.633 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 215' ' ' ASN . . . . . 0.579 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 34.2 t30 -133.1 124.0 26.76 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.817 0.341 . . . . 0.0 110.587 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 216' ' ' SER . . . . . 0.517 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 15.5 m -75.41 -21.96 57.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.11 -178.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 8.4 t -121.44 68.02 20.12 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.999 -176.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 218' ' ' PRO . . . . . 0.517 ' HD3' ' C ' ' B' ' 216' ' ' SER . 75.4 Cg_exo -56.54 -60.78 0.41 Allowed 'Trans proline' 0 N--CA 1.481 0.762 0 C-N-CA 123.731 2.954 . . . . 0.0 113.24 177.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 219' ' ' SER . . . . . 0.558 ' O ' HD13 ' B' ' 223' ' ' ILE . 21.0 t 59.52 -174.87 0.1 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.204 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 220' ' ' ALA . . . . . 0.603 ' O ' ' HB2' ' B' ' 224' ' ' LYS . . . -54.07 -34.87 61.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.196 -176.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -58.32 -59.82 4.73 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.454 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -71.75 -35.0 69.98 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -175.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.558 HD13 ' O ' ' B' ' 219' ' ' SER . 1.7 mp -69.48 -40.61 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 120.166 -0.613 . . . . 0.0 110.173 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 224' ' ' LYS . . . . . 0.603 ' HB2' ' O ' ' B' ' 220' ' ' ALA . 14.7 mmtt -60.23 -43.76 95.76 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 174.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -55.57 -49.25 73.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.56 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 0.407 HG13 ' HB3' ' A' ' 34' ' ' ALA . 1.2 mp -65.98 -40.73 88.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.012 -177.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 4.1 mp -71.74 -43.17 66.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.731 0.301 . . . . 0.0 111.603 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.34 -21.15 61.36 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.883 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 33.3 t -57.08 -43.5 82.21 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.039 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -90.17 -31.95 5.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -176.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 103.63 69.65 0.8 Allowed Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.165 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.98 -174.04 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 170.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -80.17 -169.18 1.94 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -172.15 -22.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 119.435 -0.317 . . . . 0.0 111.6 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 50.11 96.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 O-C-N 123.515 0.51 . . . . 0.0 111.678 177.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -57.63 -25.43 60.12 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -172.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -64.07 -66.45 0.54 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.395 0.616 . . . . 0.0 110.243 171.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.46 ' O ' HG23 ' B' ' 242' ' ' VAL . 96.4 mtt180 -57.16 -40.58 77.56 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.315 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 239' ' ' LEU . . . . . 0.401 HD21 HG22 ' B' ' 223' ' ' ILE . 2.4 tm? -48.97 -64.5 0.79 Allowed 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.425 0.631 . . . . 0.0 110.762 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -72.42 -25.74 61.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.685 -176.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -65.94 -46.99 76.18 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.299 -0.56 . . . . 0.0 109.973 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 242' ' ' VAL . . . . . 0.46 HG23 ' O ' ' B' ' 238' ' ' ARG . 80.7 t -66.29 -41.05 88.35 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 243' ' ' ILE . . . . . 0.571 ' HA ' ' CD2' ' B' ' 246' ' ' LEU . 19.7 mt -65.71 -42.62 92.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.769 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 244' ' ' SER . . . . . 0.437 ' HA ' ' HB2' ' B' ' 247' ' ' ASN . 28.2 t -71.87 -22.15 61.56 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.756 0.313 . . . . 0.0 110.825 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -86.55 -22.87 26.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.281 0.562 . . . . 0.0 109.955 177.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 246' ' ' LEU . . . . . 0.613 HD12 ' O ' ' B' ' 246' ' ' LEU . 1.3 pp -101.1 2.62 40.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.735 176.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 247' ' ' ASN . . . . . 0.437 ' HB2' ' HA ' ' B' ' 244' ' ' SER . 6.7 t30 -72.86 69.44 0.94 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.688 -173.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -134.6 -175.49 13.9 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.032 -178.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -89.41 -3.35 58.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.175 0.512 . . . . 0.0 110.646 -176.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 250' ' ' ASN . . . . . 0.486 ' HA ' ' OD1' ' B' ' 253' ' ' ASP . 4.4 p-10 -79.33 12.16 2.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.805 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.527 ' HA ' HG12 ' B' ' 254' ' ' VAL . 6.2 tp -67.06 -37.3 79.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 176.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -61.52 -42.08 98.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.583 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 253' ' ' ASP . . . . . 0.486 ' OD1' ' HA ' ' B' ' 250' ' ' ASN . 2.7 m-20 -60.46 -49.96 75.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.662 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 254' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' B' ' 251' ' ' ILE . 8.3 p -70.58 -25.49 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.444 -176.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 255' ' ' ILE . . . . . 0.448 HG13 ' O ' ' B' ' 251' ' ' ILE . 59.7 mt -77.46 -38.33 26.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.112 0.482 . . . . 0.0 110.278 176.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -78.24 -20.27 52.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.548 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.26 27.26 9.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.112 176.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 258' ' ' GLY . . . . . 0.766 ' HA2' ' OH ' ' A' ' 11' ' ' TYR . . . 20.38 -96.56 0.01 OUTLIER Glycine 0 C--N 1.336 0.543 0 N-CA-C 116.781 1.472 . . . . 0.0 116.781 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 259' ' ' ILE . . . . . 0.623 ' H ' HD13 ' B' ' 259' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.393 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -172.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 121.426 0.632 . . . . 0.0 111.44 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.4 t -65.76 -26.74 39.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.48 0.657 . . . . 0.0 109.843 -176.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.444 ' HB3' HG23 ' A' ' 39' ' ' VAL . 3.3 m -58.06 -66.65 0.44 Allowed 'General case' 0 C--O 1.242 0.709 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.591 -178.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.596 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -77.06 -20.62 55.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.764 -176.884 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.44 ' CD2' HG23 ' B' ' 255' ' ' ILE . 17.7 tp -57.09 -57.51 12.24 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 169.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.587 ' HB2' HD21 ' B' ' 212' ' ' LEU . . . -58.33 -48.72 79.63 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.413 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 49.3 t -65.43 -34.62 78.73 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.364 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.596 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 0.7 OUTLIER -70.2 -38.99 76.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 120.898 0.38 . . . . 0.0 110.352 -179.711 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.629 ' OH ' ' HA ' ' B' ' 255' ' ' ILE . 19.5 m-30 -67.65 -31.75 71.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.049 177.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.2 m -64.33 -46.17 84.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.188 174.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.609 ' HB1' HD21 ' A' ' 59' ' ' LEU . . . -53.49 -44.72 69.25 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.981 174.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.0 mt -61.34 -49.54 76.54 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.788 177.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 11' ' ' TYR . 30.5 mm -54.75 -42.38 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.531 -178.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 16' ' ' LEU . 4.4 mm? -68.23 -35.33 77.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.988 0.423 . . . . 0.0 111.227 175.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -80.29 10.79 4.1 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -174.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -81.87 -79.61 0.17 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 118.452 0.569 . . . . 0.0 111.085 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.12 40.45 0.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 50.01 44.97 25.67 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.689 0.756 . . . . 0.0 111.623 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 79.7 t -92.34 138.74 19.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.55 177.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 p -62.21 111.86 2.15 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -171.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.411 HG11 ' HB2' ' A' ' 51' ' ' LEU . 57.2 t -56.56 107.56 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.794 172.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.2 p -139.92 155.65 47.07 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -176.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -52.07 -54.48 29.75 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.532 -177.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -51.5 -35.02 38.45 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.396 177.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.581 ' HG3' HG13 ' B' ' 230' ' ' VAL . 13.1 mptt -75.95 -45.05 36.99 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.404 -173.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.467 ' O ' HD13 ' A' ' 32' ' ' ILE . 5.4 mt -63.43 -42.35 95.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.306 -0.558 . . . . 0.0 109.825 176.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -58.72 -41.07 85.53 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.949 175.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.47 -49.48 77.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.241 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.47 -38.84 92.67 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.0 0.429 . . . . 0.0 111.164 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.467 HD13 ' O ' ' A' ' 28' ' ' ILE . 1.5 mp -59.61 -37.19 69.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.699 176.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -74.12 -30.88 62.52 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.703 0.287 . . . . 0.0 110.64 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.587 ' CB ' HD13 ' B' ' 226' ' ' ILE . . . -63.58 -44.32 94.39 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.958 176.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.478 ' HB2' ' CD1' ' B' ' 209' ' ' LEU . . . -77.01 -50.51 12.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.551 177.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.45 -4.53 31.21 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.646 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.414 HG23 ' HA2' ' B' ' 213' ' ' GLY . 48.2 t -82.63 131.31 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.627 0.251 . . . . 0.0 110.443 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -97.97 98.67 9.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.823 0.82 . . . . 0.0 110.377 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.444 HG23 ' HB3' ' A' ' 5' ' ' SER . 7.3 p -83.85 140.54 16.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.985 177.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.41 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 10.1 tp10 -44.53 111.38 1.21 Allowed Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.046 174.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -46.49 -16.06 0.23 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 124.483 3.455 . . . . 0.0 115.108 -174.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.474 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -70.18 -32.25 70.09 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -179.356 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.485 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 84.3 m95 -71.9 -51.76 8.4 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.43 177.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 81.1 Cg_exo -49.64 -47.13 24.08 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 122.258 1.972 . . . . 0.0 112.19 170.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.28 -49.81 63.73 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.933 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -52.69 -53.1 52.12 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.684 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.404 ' CZ ' HD12 ' A' ' 10' ' ' ILE . 5.9 m-85 -61.93 -38.13 87.27 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.57 -34.71 78.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.735 -0.212 . . . . 0.0 111.19 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -100.47 -7.16 24.53 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -99.33 -37.66 9.16 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 121.951 -0.468 . . . . 0.0 112.224 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.619 ' HA ' ' CG1' ' A' ' 54' ' ' VAL . 1.6 mp -93.74 -128.51 0.12 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.41 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 66.7 -11.65 0.24 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.421 ' H ' ' C ' ' A' ' 51' ' ' LEU . 27.2 t-20 -137.34 3.62 2.6 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.619 ' CG1' ' HA ' ' A' ' 51' ' ' LEU . 34.1 m -89.88 121.11 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.037 -170.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -40.0 -87.6 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.957 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.3 tp -157.81 -57.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 121.222 -0.191 . . . . 0.0 111.458 175.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.41 -21.87 60.54 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.242 -0.504 . . . . 0.0 112.55 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.461 ' HB2' ' HB ' ' A' ' 54' ' ' VAL . 1.5 m -52.97 -20.09 3.13 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.034 0.534 . . . . 0.0 110.997 176.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.609 HD21 ' HB1' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -49.51 -42.99 45.2 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.848 176.714 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.549 HG23 HD13 ' B' ' 259' ' ' ILE . 37.2 mt -83.48 -7.13 10.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.604 0.716 . . . . 0.0 110.461 -173.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 47.5 t -89.18 -26.79 21.08 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.785 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -82.91 -16.3 48.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.35 0.595 . . . . 0.0 111.044 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 C--N 1.319 -0.721 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.793 -179.538 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 203' ' ' TYR . . . . . 0.421 ' HD2' HG21 ' B' ' 242' ' ' VAL . 76.4 m-85 . . . . . 0 C--O 1.239 0.51 0 CA-C-O 121.282 0.563 . . . . 0.0 111.412 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.673 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 64.6 t -64.08 -54.27 33.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.262 177.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 205' ' ' ALA . . . . . 0.653 ' HA ' HD12 ' B' ' 208' ' ' LEU . . . -70.45 -12.81 61.82 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 -178.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 206' ' ' SER . . . . . 0.625 ' OG ' HG23 ' B' ' 223' ' ' ILE . 9.5 t -79.39 -39.86 31.47 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 175.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 207' ' ' TYR . . . . . 0.802 ' HB2' HD21 ' B' ' 246' ' ' LEU . 34.4 t80 -63.1 -40.35 97.37 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 173.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 33.3 mt -59.01 -51.96 67.84 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.154 176.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 209' ' ' LEU . . . . . 0.914 HD12 HD12 ' B' ' 226' ' ' ILE . 0.2 OUTLIER -51.6 -50.74 59.62 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.627 179.533 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -65.48 -32.97 74.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.415 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 211' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -65.57 -55.08 19.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.901 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 212' ' ' LEU . . . . . 0.587 HD21 ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -76.24 -13.01 60.18 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.366 -179.278 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 213' ' ' GLY . . . . . 0.414 ' HA2' HG23 ' A' ' 37' ' ' VAL . . . -57.2 -16.82 21.46 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.271 170.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 121.35 4.81 9.78 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.621 -0.591 . . . . 0.0 111.621 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 215' ' ' ASN . . . . . 0.589 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 38.6 t30 -117.95 100.95 7.89 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.97 0.414 . . . . 0.0 110.183 -175.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 216' ' ' SER . . . . . 0.45 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 15.2 m -72.22 -7.98 52.26 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.269 -177.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 217' ' ' SER . . . . . 0.402 ' N ' ' HD3' ' B' ' 218' ' ' PRO . 31.2 m -130.01 64.37 72.04 Favored Pre-proline 0 C--N 1.319 -0.718 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.399 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 218' ' ' PRO . . . . . 0.458 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 53.2 Cg_exo -57.12 137.36 81.48 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.315 2.677 . . . . 0.0 113.209 -177.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 28.9 t -115.33 165.76 12.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.281 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -53.73 -42.58 68.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.134 0.492 . . . . 0.0 110.784 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -59.34 -43.77 92.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.466 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -65.2 -52.34 55.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.933 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.625 HG23 ' OG ' ' B' ' 206' ' ' SER . 1.8 mp -58.08 -48.27 84.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.87 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 224' ' ' LYS . . . . . 0.537 ' HE3' ' CG ' ' B' ' 236' ' ' ASP . 60.1 tttm -68.5 -22.65 64.52 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 122.258 -0.276 . . . . 0.0 111.448 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -69.79 -42.99 73.03 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 0.914 HD12 HD12 ' B' ' 209' ' ' LEU . 1.5 mm -66.36 -38.26 81.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 113.797 -1.547 . . . . 0.0 111.299 176.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 227' ' ' LEU . . . . . 0.476 ' CD1' ' HB ' ' B' ' 232' ' ' ILE . 0.2 OUTLIER -71.96 -42.03 67.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.888 0.375 . . . . 0.0 110.487 179.455 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 228' ' ' ASP . . . . . 0.461 ' OD2' ' HG2' ' B' ' 224' ' ' LYS . 10.2 m-20 -75.08 -20.63 59.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.578 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 61.2 p -56.39 -35.1 67.37 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.751 0.31 . . . . 0.0 111.157 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 230' ' ' VAL . . . . . 0.581 HG13 ' HG3' ' A' ' 27' ' ' LYS . 63.4 t -89.68 -41.07 13.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.163 0.506 . . . . 0.0 111.145 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 110.3 34.96 2.2 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.332 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 232' ' ' ILE . . . . . 0.476 ' HB ' ' CD1' ' B' ' 227' ' ' LEU . 3.9 mt -98.02 123.76 50.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -61.87 107.99 0.94 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.003 0.43 . . . . 0.0 111.9 -170.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -106.16 132.26 52.43 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.824 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 235' ' ' ASP . . . . . 0.57 ' O ' HD12 ' B' ' 239' ' ' LEU . 10.9 m-20 -79.3 121.51 25.19 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 236' ' ' ASP . . . . . 0.537 ' CG ' ' HE3' ' B' ' 224' ' ' LYS . 3.3 m-20 -59.78 -14.33 14.18 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.514 0.509 . . . . 0.0 112.229 -178.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -98.98 -49.61 4.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.301 0.572 . . . . 0.0 110.683 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.559 ' O ' HG23 ' B' ' 242' ' ' VAL . 19.4 mmm180 -66.8 -36.43 82.37 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.346 -172.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 239' ' ' LEU . . . . . 0.591 HD13 ' H ' ' B' ' 240' ' ' ASN . 0.0 OUTLIER -65.38 -34.83 79.22 Favored 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.279 -176.125 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 240' ' ' ASN . . . . . 0.591 ' H ' HD13 ' B' ' 239' ' ' LEU . 55.0 t30 -79.91 -32.62 40.17 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -65.05 -40.25 94.49 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.486 174.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 242' ' ' VAL . . . . . 0.659 ' O ' ' HB3' ' B' ' 246' ' ' LEU . 87.7 t -64.02 -49.35 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 243' ' ' ILE . . . . . 0.544 ' HA ' HD23 ' B' ' 246' ' ' LEU . 35.4 mt -53.96 -39.04 39.01 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.753 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.522 174.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 56.1 m -59.43 -42.43 91.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.754 0.311 . . . . 0.0 110.749 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -77.82 -21.29 51.76 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.443 0.64 . . . . 0.0 110.968 176.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 246' ' ' LEU . . . . . 0.802 HD21 ' HB2' ' B' ' 207' ' ' TYR . 0.3 OUTLIER -102.92 -12.23 17.66 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.919 -168.042 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -78.26 48.15 0.73 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.351 0.596 . . . . 0.0 111.402 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -93.11 156.59 22.92 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.143 -0.551 . . . . 0.0 111.822 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 249' ' ' LYS . . . . . 0.669 ' H ' ' HD3' ' B' ' 249' ' ' LYS . 0.3 OUTLIER -80.1 39.65 0.45 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.045 0.45 . . . . 0.0 111.966 -175.075 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -118.59 27.61 8.82 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.49 HD11 ' CE1' ' B' ' 207' ' ' TYR . 3.5 mm -64.57 -50.79 74.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -172.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -63.65 -30.08 71.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.231 0.539 . . . . 0.0 110.652 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.5 -48.7 63.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.976 176.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 254' ' ' VAL . . . . . 0.415 HG22 ' HA ' ' B' ' 251' ' ' ILE . 34.9 m -65.34 -27.37 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.046 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 255' ' ' ILE . . . . . 0.629 ' HA ' ' OH ' ' A' ' 11' ' ' TYR . 30.2 mt -69.63 -52.92 27.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.119 0.485 . . . . 0.0 110.583 174.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -69.38 -15.79 63.38 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.768 -177.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -82.91 40.44 0.69 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.427 174.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 20.34 -98.97 0.01 OUTLIER Glycine 0 N--CA 1.472 1.069 0 N-CA-C 115.833 1.093 . . . . 0.0 115.833 -172.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 259' ' ' ILE . . . . . 0.549 HD13 HG23 ' A' ' 60' ' ' ILE . 2.7 mp . . . . . 0 N--CA 1.465 0.284 0 CA-C-O 121.035 0.445 . . . . 0.0 111.117 -174.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.436 ' HB2' ' HG2' ' A' ' 6' ' ' GLU . 3.8 p . . . . . 0 N--CA 1.45 -0.458 0 CA-C-O 121.566 0.698 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.536 HG13 ' HB2' ' B' ' 212' ' ' LEU . 21.1 t -67.47 -27.22 37.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.398 -172.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.677 ' HB3' HG23 ' A' ' 39' ' ' VAL . 7.0 m -61.68 -57.99 9.82 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.21 -177.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.436 ' HG2' ' HB2' ' A' ' 3' ' ' SER . 9.6 pt-20 -72.98 -29.3 62.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.596 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.536 HD12 ' HA ' ' A' ' 4' ' ' VAL . 39.8 mt -53.91 -52.92 59.02 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 170.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.446 ' HA ' HD21 ' B' ' 212' ' ' LEU . . . -55.3 -53.18 59.31 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.122 178.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.604 ' SG ' HG21 ' A' ' 39' ' ' VAL . 31.6 m -63.48 -33.21 75.08 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.548 -177.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.419 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 1.1 tp -72.65 -40.36 62.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.689 0.28 . . . . 0.0 111.309 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -75.64 -18.69 59.59 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.306 -0.558 . . . . 0.0 109.662 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.499 ' HB3' HG12 ' A' ' 28' ' ' ILE . 47.8 m -72.24 -44.89 62.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 170.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.405 ' HB3' HD12 ' A' ' 59' ' ' LEU . . . -50.58 -46.27 57.7 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 171.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.586 HD23 HD11 ' A' ' 56' ' ' ILE . 67.9 mt -59.38 -52.95 63.41 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.586 178.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.522 HD12 HD21 ' A' ' 31' ' ' LEU . 30.2 mt -62.02 -31.19 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -177.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.572 ' HB3' ' HA ' ' A' ' 23' ' ' VAL . 3.4 mm? -98.75 -0.98 41.58 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -124.9 53.18 1.51 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.379 0.609 . . . . 0.0 110.278 174.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -136.96 -58.3 0.72 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.871 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.429 ' CG ' ' H ' ' A' ' 20' ' ' GLU . 24.0 t70 -73.72 -174.51 1.79 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.58 175.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.429 ' H ' ' CG ' ' A' ' 19' ' ' ASP . 33.0 tt0 -77.25 -17.48 58.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.436 0.636 . . . . 0.0 109.659 178.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 79.7 t -61.19 124.25 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.941 174.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.6 p -82.61 149.98 27.11 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.076 -177.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.572 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 2.5 m -60.81 124.73 15.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.198 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.1 p -145.89 143.61 29.69 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.942 -174.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.447 ' HG3' ' H ' ' A' ' 26' ' ' ASP . 7.7 pt-20 -45.96 -50.85 14.31 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 123.706 0.629 . . . . 0.0 111.234 -177.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.447 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 13.5 t70 -53.68 -43.67 69.07 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.531 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.508 ' O ' HG12 ' B' ' 230' ' ' VAL . 2.9 mptp? -78.35 -40.68 35.68 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.33 -172.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.745 ' O ' HG12 ' A' ' 32' ' ' ILE . 5.7 mt -62.98 -50.06 81.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 119.774 -0.771 . . . . 0.0 109.947 176.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -54.41 -44.79 72.66 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.866 0.365 . . . . 0.0 110.576 177.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.33 -45.94 83.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.983 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.574 ' HB2' ' CG1' ' B' ' 230' ' ' VAL . 44.0 tp -69.06 -40.14 78.68 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 121.194 0.521 . . . . 0.0 111.03 -176.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.745 HG12 ' O ' ' A' ' 28' ' ' ILE . 18.5 mm -62.52 -38.27 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.941 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -82.72 -17.49 44.16 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.579 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 31' ' ' LEU . . . -62.62 -46.35 88.63 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 174.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.35 -47.77 11.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.9 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.2 64.84 0.98 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.934 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.0 m -120.86 179.26 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.879 0.371 . . . . 0.0 111.012 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -113.38 113.6 25.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.224 -177.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.677 HG23 ' HB3' ' A' ' 5' ' ' SER . 4.4 p -145.91 137.18 19.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.765 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -56.78 123.87 60.71 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.221 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -56.41 -8.55 2.79 Favored 'Trans proline' 0 C--O 1.241 0.629 0 C-N-CA 123.57 2.847 . . . . 0.0 113.004 -174.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.45 -25.52 50.68 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.598 -177.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.425 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 97.0 m95 -66.84 -60.05 6.87 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.393 175.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.425 ' CD ' ' HB2' ' A' ' 43' ' ' TRP . 10.3 Cg_endo -55.87 -42.17 69.79 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 121.882 1.721 . . . . 0.0 112.276 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.73 -54.26 39.36 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.75 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.9 tt -59.12 -45.34 91.17 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.582 ' HA ' HD13 ' A' ' 51' ' ' LEU . 4.0 m-85 -54.58 -54.59 39.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.697 0.284 . . . . 0.0 111.643 -178.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.27 -24.79 61.4 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.959 -176.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -99.95 -1.68 36.57 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.03 -17.38 4.86 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.582 HD13 ' HA ' ' A' ' 47' ' ' PHE . 8.4 mp -80.25 -113.46 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.958 -0.464 . . . . 0.0 109.819 175.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 59.39 2.79 0.34 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 177.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -145.01 -52.68 0.28 Allowed 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 122.21 1.005 . . . . 0.0 108.593 -173.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.488 HG11 ' HG ' ' A' ' 51' ' ' LEU . 2.4 p -18.42 110.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 111.861 -2.427 . . . . 0.0 114.553 173.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -56.71 130.98 47.77 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 163.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.64 ' O ' HD22 ' A' ' 59' ' ' LEU . 5.5 tp -47.63 -58.62 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -166.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.62 -29.11 60.71 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.005 -0.617 . . . . 0.0 113.297 -176.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.2 m -59.36 -16.8 24.9 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.64 HD22 ' O ' ' A' ' 56' ' ' ILE . 1.0 OUTLIER -60.63 -17.71 48.85 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.389 0.144 . . . . 0.0 111.389 -179.45 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.508 ' N ' HD23 ' A' ' 59' ' ' LEU . 15.7 tt -65.21 -22.16 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 120.882 0.373 . . . . 0.0 111.004 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.4 t -127.69 73.22 1.44 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.232 0.539 . . . . 0.0 110.22 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -107.48 -12.75 15.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.067 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.7 t . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.518 -175.024 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 203' ' ' TYR . . . . . 0.506 ' CD2' ' HA ' ' B' ' 239' ' ' LEU . 93.0 m-85 . . . . . 0 C--O 1.235 0.3 0 CA-C-O 121.579 0.704 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.578 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 31.5 t -68.51 -54.52 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.418 -176.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 205' ' ' ALA . . . . . 0.527 ' HA ' HD12 ' B' ' 208' ' ' LEU . . . -72.13 -13.9 61.69 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.558 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 206' ' ' SER . . . . . 0.451 ' HB3' HG23 ' B' ' 223' ' ' ILE . 3.5 m -72.3 -43.02 64.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 172.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 207' ' ' TYR . . . . . 0.485 ' CE1' HD11 ' B' ' 251' ' ' ILE . 24.4 t80 -62.64 -44.14 97.03 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 174.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 64.1 mt -59.51 -46.84 87.67 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.018 177.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 209' ' ' LEU . . . . . 0.422 ' O ' ' HG ' ' B' ' 212' ' ' LEU . 0.1 OUTLIER -57.09 -53.45 57.89 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.575 -179.67 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -62.96 -34.68 78.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.291 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 211' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -63.27 -53.54 51.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.218 177.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 212' ' ' LEU . . . . . 0.536 ' HB2' HG13 ' A' ' 4' ' ' VAL . 4.3 pp -65.76 -21.65 66.53 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.759 0.314 . . . . 0.0 110.753 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.97 -16.05 38.28 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.676 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 120.37 4.98 10.65 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.448 178.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 215' ' ' ASN . . . . . 0.633 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 28.1 t30 -117.66 108.8 15.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.188 0.518 . . . . 0.0 110.274 -178.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 216' ' ' SER . . . . . 0.428 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 5.8 m -68.05 -15.2 63.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.799 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 17.6 p -125.66 67.75 59.55 Favored Pre-proline 0 N--CA 1.441 -0.881 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.417 -175.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 218' ' ' PRO . . . . . 0.428 ' HD3' ' C ' ' B' ' 216' ' ' SER . 50.9 Cg_exo -59.85 121.09 9.27 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.72 2.28 . . . . 0.0 112.025 177.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 89.2 p -102.33 -178.95 3.84 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.782 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -58.93 -36.67 75.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.02 0.438 . . . . 0.0 110.84 -177.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.54 -35.25 63.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.76 -176.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -59.35 -54.99 40.46 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.256 0.551 . . . . 0.0 109.746 175.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.451 HG23 ' HB3' ' B' ' 206' ' ' SER . 1.8 mp -63.47 -42.14 95.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.209 -178.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 224' ' ' LYS . . . . . 0.548 ' O ' ' HB2' ' B' ' 228' ' ' ASP . 27.7 tptp -57.06 -50.85 71.48 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 121.312 -0.155 . . . . 0.0 110.752 178.01 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -60.99 -41.16 95.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.909 0.385 . . . . 0.0 110.708 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 0.504 HG23 HD11 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -63.93 -42.94 97.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.543 -178.039 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 227' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' B' ' 234' ' ' ALA . 26.9 tp -81.16 -23.22 38.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.23 0.538 . . . . 0.0 110.413 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 228' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' B' ' 224' ' ' LYS . 2.7 t70 -72.37 -28.27 62.91 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.636 176.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 8.4 t -65.25 -53.33 45.87 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.556 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 230' ' ' VAL . . . . . 0.574 ' CG1' ' HB2' ' A' ' 31' ' ' LEU . 22.2 m -61.6 -33.13 55.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-O 120.802 0.334 . . . . 0.0 111.744 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 102.94 39.06 2.76 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.944 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 232' ' ' ILE . . . . . 0.421 HG13 HG23 ' B' ' 230' ' ' VAL . 16.9 mt -116.01 125.53 73.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -54.65 143.6 24.39 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.089 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 234' ' ' ALA . . . . . 0.569 ' HB2' HD23 ' B' ' 227' ' ' LEU . . . -140.93 117.08 10.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.028 0.442 . . . . 0.0 111.932 -173.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 235' ' ' ASP . . . . . 0.444 ' HB2' ' HB2' ' B' ' 238' ' ' ARG . 1.7 m-20 -67.88 113.41 5.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.495 174.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -56.75 -40.18 75.31 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.913 0.387 . . . . 0.0 110.986 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.41 -58.55 6.7 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.241 0.543 . . . . 0.0 111.04 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.666 ' O ' HG23 ' B' ' 242' ' ' VAL . 4.7 mpt_? -63.97 -29.44 70.6 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.914 -177.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 239' ' ' LEU . . . . . 0.506 ' HA ' ' CD2' ' B' ' 203' ' ' TYR . 9.3 tt -57.59 -61.42 2.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.168 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -64.38 -27.31 68.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.797 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 241' ' ' LYS . . . . . 0.45 ' HB2' ' HA ' ' B' ' 238' ' ' ARG . 38.1 mttp -63.46 -47.91 79.88 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.694 175.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 242' ' ' VAL . . . . . 0.703 ' O ' HD12 ' B' ' 246' ' ' LEU . 46.6 t -70.13 -33.16 53.68 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 243' ' ' ILE . . . . . 0.633 ' HA ' ' CD1' ' B' ' 246' ' ' LEU . 4.7 mt -64.2 -35.97 75.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.153 178.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 21.8 m -75.62 -25.92 57.34 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.317 0.58 . . . . 0.0 109.938 172.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 245' ' ' GLU . . . . . 0.448 ' HB3' ' O ' ' B' ' 242' ' ' VAL . 44.2 tt0 -71.3 -40.88 70.55 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.129 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 246' ' ' LEU . . . . . 0.703 HD12 ' O ' ' B' ' 242' ' ' VAL . 0.0 OUTLIER -108.22 18.1 21.49 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.262 0.553 . . . . 0.0 111.578 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -61.99 120.39 10.71 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.049 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -153.09 147.43 16.96 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.527 -0.845 . . . . 0.0 112.479 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -84.42 -24.16 29.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.071 0.462 . . . . 0.0 110.101 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 250' ' ' ASN . . . . . 0.482 ' HB3' ' HB3' ' B' ' 253' ' ' ASP . 4.9 m-20 -80.25 55.71 2.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.779 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.498 ' O ' HG12 ' B' ' 254' ' ' VAL . 1.3 mm -68.2 -49.52 66.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.159 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -67.95 -25.32 65.39 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.188 0.518 . . . . 0.0 110.01 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 253' ' ' ASP . . . . . 0.482 ' HB3' ' HB3' ' B' ' 250' ' ' ASN . 20.4 t70 -73.33 -48.61 32.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.104 174.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 254' ' ' VAL . . . . . 0.635 ' O ' ' HA3' ' B' ' 258' ' ' GLY . 2.3 p -66.53 -18.2 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.171 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 255' ' ' ILE . . . . . 0.424 HG21 HD13 ' A' ' 7' ' ' LEU . 66.4 mt -84.77 -52.27 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.856 0.36 . . . . 0.0 110.598 174.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -61.12 -31.72 71.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.082 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -126.83 35.69 4.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.833 0.349 . . . . 0.0 111.294 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 258' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' B' ' 254' ' ' VAL . . . -133.67 55.03 0.75 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.721 -175.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 49.7 mt . . . . . 0 C--N 1.325 -0.473 0 CA-C-O 121.617 0.722 . . . . 0.0 109.477 171.928 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.473 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 25.6 p . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 112.26 0.466 . . . . 0.0 112.26 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.494 ' HA ' HD12 ' A' ' 7' ' ' LEU . 5.6 m -72.45 -24.67 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.692 -176.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.559 ' HB3' HG23 ' A' ' 39' ' ' VAL . 14.5 m -64.64 -55.92 17.12 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.724 177.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.418 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 35.1 tt0 -59.79 -43.42 94.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.306 178.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 4' ' ' VAL . 90.6 mt -52.61 -52.51 55.04 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.896 0.379 . . . . 0.0 110.594 175.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.04 -51.0 71.92 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.621 -176.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.6 t -72.06 -23.8 61.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.376 -176.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.418 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 1.5 tp -82.72 -39.1 15.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.282 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.465 ' CZ ' HD23 ' B' ' 208' ' ' LEU . 20.9 m-85 -68.63 -38.76 80.76 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.3 p -64.65 -46.58 81.89 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.038 174.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -44.74 -53.81 6.96 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.625 0.37 . . . . 0.0 111.496 173.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.539 ' HA ' ' HB2' ' A' ' 17' ' ' HIS . 3.6 pp -79.43 -27.11 41.7 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.505 -178.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.498 HD11 ' HA ' ' B' ' 206' ' ' SER . 17.2 mt -65.0 -41.03 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.051 0.453 . . . . 0.0 110.621 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.92 -27.75 55.03 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 174.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.539 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -78.4 13.95 1.39 Allowed 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 176.54 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -83.92 -31.22 25.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.316 0.579 . . . . 0.0 109.75 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.523 ' CG ' ' H ' ' A' ' 20' ' ' GLU . 19.7 t70 -126.92 -157.01 0.78 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.5 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.523 ' H ' ' CG ' ' A' ' 19' ' ' ASP . 31.5 mt-10 -86.57 -5.64 59.09 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.184 0.516 . . . . 0.0 110.668 -178.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.5 t -57.7 132.54 22.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.913 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.39 151.25 47.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.345 -175.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.5 m -100.83 35.85 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.48 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.9 p -88.14 179.35 6.41 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.252 -173.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.506 ' HG3' ' N ' ' A' ' 26' ' ' ASP . 14.0 pt-20 -43.84 -50.66 7.84 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.631 -177.198 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.506 ' N ' ' HG3' ' A' ' 25' ' ' GLU . 10.6 t70 -55.86 -41.3 74.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.151 -175.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.576 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 3.4 mptp? -83.83 -45.33 13.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.552 -170.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.55 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 9.3 mt -66.33 -42.9 91.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.35 178.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -61.75 -46.4 89.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.133 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.29 -44.08 97.35 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.403 HD21 ' HG ' ' B' ' 209' ' ' LEU . 0.7 OUTLIER -74.48 -39.3 62.57 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-O 121.598 0.713 . . . . 0.0 110.595 -175.976 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.55 ' HB ' ' O ' ' A' ' 28' ' ' ILE . 1.1 mp -60.52 -34.03 56.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.119 173.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -75.5 -29.04 59.41 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.679 174.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.04 -36.29 83.52 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.774 178.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -94.33 -41.39 9.45 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.178 -0.609 . . . . 0.0 112.039 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.76 46.07 4.37 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.639 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.594 HG22 ' HA2' ' B' ' 213' ' ' GLY . 0.2 OUTLIER -97.68 164.44 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.959 0.409 . . . . 0.0 110.857 -176.288 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -102.42 98.91 8.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.365 -176.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.559 HG23 ' HB3' ' A' ' 5' ' ' SER . 9.0 p -131.7 129.03 61.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.517 176.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 16.8 pt-20 -62.25 133.88 94.48 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -178.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 40' ' ' GLU . 53.5 Cg_exo -53.43 -7.92 0.59 Allowed 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 123.969 3.113 . . . . 0.0 113.828 -174.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.4 -36.8 77.1 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.072 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.58 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 89.1 m95 -70.93 -54.37 7.7 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 119.248 -0.406 . . . . 0.0 111.227 178.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.58 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 78.4 Cg_exo -49.98 -50.3 13.7 Favored 'Trans proline' 0 C--N 1.363 1.33 0 C-N-CA 122.004 1.803 . . . . 0.0 112.839 174.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.48 -50.06 71.73 Favored Glycine 0 C--O 1.24 0.523 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.209 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.8 tp -55.96 -53.11 60.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.511 -0.345 . . . . 0.0 110.776 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -59.92 -40.8 90.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.791 -177.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.59 -38.21 90.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.663 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -92.18 -8.51 45.31 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.65 -46.62 4.29 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.714 ' HA ' HG23 ' A' ' 54' ' ' VAL . 2.0 mp -84.05 -130.41 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.231 -175.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 66.94 3.62 3.17 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.375 0.67 . . . . 0.0 112.735 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -145.7 -51.4 0.25 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.714 HG23 ' HA ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -53.07 121.92 2.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 113.901 -1.499 . . . . 0.0 111.512 174.904 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -58.01 158.36 6.82 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.481 175.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.461 ' O ' HD13 ' A' ' 59' ' ' LEU . 3.8 tp -40.53 -46.46 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 124.828 1.251 . . . . 0.0 114.371 -172.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.41 -20.3 22.17 Favored Glycine 0 N--CA 1.467 0.705 0 C-N-CA 121.272 -0.489 . . . . 0.0 113.587 -174.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 43.5 t -55.44 -25.34 35.66 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 122.467 0.307 . . . . 0.0 111.066 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 56' ' ' ILE . 9.8 mp -55.61 -32.29 62.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.311 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.442 HG23 HD12 ' B' ' 259' ' ' ILE . 33.3 mt -94.14 -3.64 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.522 0.677 . . . . 0.0 110.722 -175.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 55.1 m -114.85 -56.67 2.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.025 0.44 . . . . 0.0 111.187 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -97.25 66.47 2.07 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.155 -173.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.446 -0.636 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.77 176.551 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 203' ' ' TYR . . . . . 0.593 ' CD2' ' HA ' ' B' ' 239' ' ' LEU . 48.0 m-85 . . . . . 0 N--CA 1.469 0.523 0 CA-C-O 120.962 0.411 . . . . 0.0 112.014 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.59 ' O ' HD13 ' B' ' 208' ' ' LEU . 5.4 p -56.46 -55.47 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.209 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 205' ' ' ALA . . . . . 0.504 ' CB ' HD11 ' A' ' 14' ' ' LEU . . . -74.12 -8.15 55.12 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.989 -176.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 206' ' ' SER . . . . . 0.611 ' OG ' HG23 ' B' ' 223' ' ' ILE . 8.0 t -78.96 -37.8 38.59 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 173.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 207' ' ' TYR . . . . . 0.549 ' HD1' HD11 ' B' ' 251' ' ' ILE . 21.3 t80 -64.25 -42.84 96.32 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 172.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.59 HD13 ' O ' ' B' ' 204' ' ' VAL . 7.5 mp -56.82 -48.28 78.35 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.927 174.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 209' ' ' LEU . . . . . 0.437 ' CD2' ' HB2' ' A' ' 11' ' ' TYR . 0.3 OUTLIER -54.93 -53.43 55.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.356 -179.75 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -61.67 -39.33 91.01 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.094 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 211' ' ' ALA . . . . . 0.727 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -69.32 -51.87 32.83 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.04 0.448 . . . . 0.0 110.931 -178.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.8 -35.86 69.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.645 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 213' ' ' GLY . . . . . 0.594 ' HA2' HG22 ' A' ' 37' ' ' VAL . . . -54.49 -52.43 45.02 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.294 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 163.08 31.29 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.279 -0.963 . . . . 0.0 112.336 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 215' ' ' ASN . . . . . 0.727 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 50.5 m-20 -136.02 105.24 5.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.699 0.285 . . . . 0.0 110.479 -176.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 16.4 m -61.21 -21.69 64.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.944 0.402 . . . . 0.0 111.339 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 20.3 m -128.54 73.99 80.36 Favored Pre-proline 0 N--CA 1.443 -0.788 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.563 -174.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -58.69 121.12 9.43 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.62 2.88 . . . . 0.0 112.72 175.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 15.1 m -89.95 158.57 17.33 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.46 -36.01 66.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.512 0.672 . . . . 0.0 109.738 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -62.05 -34.82 76.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.921 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -73.58 -47.54 39.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.702 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.611 HG23 ' OG ' ' B' ' 206' ' ' SER . 1.8 mp -59.78 -45.41 94.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 224' ' ' LYS . . . . . 0.413 ' HG3' ' OD1' ' B' ' 228' ' ' ASP . 7.3 ttmm -62.25 -36.7 82.83 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.117 175.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 225' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' B' ' 229' ' ' SER . 6.4 ttpm? -60.48 -45.55 93.32 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.764 176.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.07 -38.35 82.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.7 0.286 . . . . 0.0 111.149 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 87.6 mt -76.44 -46.25 27.86 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 228' ' ' ASP . . . . . 0.413 ' OD1' ' HG3' ' B' ' 224' ' ' LYS . 1.3 m-20 -74.59 -14.57 60.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.883 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 229' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' B' ' 225' ' ' LYS . 23.0 t -54.35 -47.1 72.94 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.089 0.471 . . . . 0.0 109.938 172.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 29.0 t -90.29 -34.05 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 121.471 0.653 . . . . 0.0 109.612 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 91.87 72.68 1.23 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.539 176.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 8.4 mt -95.53 -97.46 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 122.522 -0.399 . . . . 0.0 109.926 176.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -136.09 -78.17 0.42 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 173.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . 60.41 81.64 0.18 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.623 0.577 . . . . 0.0 112.231 174.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 235' ' ' ASP . . . . . 0.475 ' C ' ' H ' ' B' ' 237' ' ' ASP . 0.6 OUTLIER -62.15 133.12 54.82 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.357 179.533 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.81 36.69 0.11 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.697 0.761 . . . . 0.0 111.255 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 237' ' ' ASP . . . . . 0.475 ' H ' ' C ' ' B' ' 235' ' ' ASP . 15.9 t70 -147.92 -57.65 0.24 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.669 -1.15 . . . . 0.0 107.914 176.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.427 ' O ' HG23 ' B' ' 242' ' ' VAL . 8.5 ttm-85 -57.56 -42.0 82.15 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.52 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 239' ' ' LEU . . . . . 0.593 ' HA ' ' CD2' ' B' ' 203' ' ' TYR . 10.1 tt -57.85 -62.22 1.96 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.381 -176.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -67.83 -20.0 65.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.362 -178.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -66.91 -47.2 72.5 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.288 0.566 . . . . 0.0 109.945 174.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 242' ' ' VAL . . . . . 0.649 ' O ' HD12 ' B' ' 246' ' ' LEU . 91.7 t -66.35 -39.26 83.7 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.393 179.154 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 243' ' ' ILE . . . . . 0.596 ' HA ' ' CD1' ' B' ' 246' ' ' LEU . 13.1 mt -65.52 -32.87 60.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.401 177.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 34.4 t -61.59 -39.24 90.48 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 171.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 245' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' B' ' 242' ' ' VAL . 93.1 mt-10 -63.91 -58.05 7.93 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.844 174.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 246' ' ' LEU . . . . . 0.649 HD12 ' O ' ' B' ' 242' ' ' VAL . 0.0 OUTLIER -103.65 37.18 2.09 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -170.033 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -57.6 154.74 10.86 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.043 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -51.69 107.62 0.48 Allowed Glycine 0 CA--C 1.519 0.294 0 CA-C-N 115.556 -0.747 . . . . 0.0 114.315 -173.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -135.07 -74.39 0.46 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -108.94 58.91 0.6 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.545 0.688 . . . . 0.0 109.191 175.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.549 HD11 ' HD1' ' B' ' 207' ' ' TYR . 0.3 OUTLIER -64.81 -39.7 86.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.698 -176.036 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -66.63 -37.14 84.23 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.435 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.49 -49.43 75.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.943 0.402 . . . . 0.0 110.179 175.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 254' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' B' ' 251' ' ' ILE . 6.2 p -68.3 -22.28 27.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.893 -176.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 255' ' ' ILE . . . . . . . . . . . . . 56.1 mt -79.19 -45.25 24.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 120.938 0.399 . . . . 0.0 110.631 173.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -61.55 -28.47 69.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.854 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -120.33 50.66 1.28 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 258' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' B' ' 254' ' ' VAL . . . -71.0 -47.16 39.8 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.377 -0.829 . . . . 0.0 113.784 -171.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 259' ' ' ILE . . . . . 0.442 HD12 HG23 ' A' ' 60' ' ' ILE . 6.6 pt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.869 0.334 . . . . 0.0 111.043 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.466 ' HB3' ' HG2' ' A' ' 6' ' ' GLU . 24.7 m . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 121.341 0.591 . . . . 0.0 111.575 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.422 HG13 ' CD2' ' B' ' 212' ' ' LEU . 20.7 t -67.1 -26.61 36.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.342 0.591 . . . . 0.0 109.684 -175.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.586 ' OG ' HG23 ' A' ' 39' ' ' VAL . 31.9 t -61.02 -65.62 0.66 Allowed 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.928 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.696 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 10.7 pt-20 -68.57 -31.55 70.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.64 -175.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 35.7 mt -55.92 -53.63 54.55 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 172.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.624 ' HB2' HG11 ' A' ' 37' ' ' VAL . . . -56.91 -52.69 64.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.91 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.696 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 24.6 p -70.73 -26.87 63.57 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.586 -173.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.508 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 1.1 tp -78.26 -38.52 23.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.698 0.285 . . . . 0.0 111.408 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.43 ' HB2' HD22 ' B' ' 209' ' ' LEU . 21.8 m-85 -72.34 -26.78 62.05 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.8 t -69.59 -51.6 33.73 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.219 171.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -47.96 -54.03 14.13 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.353 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 15' ' ' ILE . 2.9 pp -76.54 -29.95 56.92 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.651 -176.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.558 ' N ' HD12 ' A' ' 14' ' ' LEU . 3.8 mt -59.47 -31.0 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 118.522 0.601 . . . . 0.0 110.487 173.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.455 HD12 HG22 ' A' ' 15' ' ' ILE . 6.7 mp -86.73 -25.59 24.65 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.205 176.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -85.17 62.54 7.56 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -177.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -138.29 -57.27 0.65 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 120.856 -0.337 . . . . 0.0 111.506 172.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.589 ' CG ' ' H ' ' A' ' 20' ' ' GLU . 17.3 t70 -91.47 -151.3 0.26 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.743 0.306 . . . . 0.0 111.393 -176.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.589 ' H ' ' CG ' ' A' ' 19' ' ' ASP . 16.9 tp10 -88.67 -6.6 57.37 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.584 0.707 . . . . 0.0 109.634 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.414 HG21 HG12 ' B' ' 232' ' ' ILE . 68.7 t -64.76 106.61 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.655 178.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.572 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 2.7 p -66.11 150.63 48.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.075 -177.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.448 ' HA ' HD23 ' A' ' 16' ' ' LEU . 29.8 m -84.31 49.51 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.358 -174.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.4 p -81.83 164.12 21.85 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -49.77 -46.25 50.47 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.415 -178.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -58.57 -34.94 71.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.059 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.572 ' HG3' ' O ' ' A' ' 22' ' ' THR . 32.7 mmtp -75.71 -51.36 12.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.759 -175.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.439 HG23 HD13 ' A' ' 32' ' ' ILE . 5.1 mt -62.07 -41.28 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.151 176.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.458 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 6.9 t30 -53.81 -52.2 61.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.812 173.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.19 -44.95 79.92 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.761 0.315 . . . . 0.0 111.815 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.447 HD21 HG23 ' B' ' 226' ' ' ILE . 2.6 tm? -65.09 -46.03 82.76 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.495 0.665 . . . . 0.0 109.883 -178.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.439 HD13 HG23 ' A' ' 28' ' ' ILE . 1.6 mp -62.04 -33.25 57.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.959 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.458 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 31.2 mmmt -77.68 -25.06 49.21 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.756 0.312 . . . . 0.0 111.006 176.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.13 -42.38 72.68 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.239 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.74 -41.66 11.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.702 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.51 10.92 56.42 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 121.034 -0.603 . . . . 0.0 113.253 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.662 HG22 ' HA3' ' B' ' 213' ' ' GLY . 3.2 t -70.7 140.77 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 O-C-N 122.467 -0.431 . . . . 0.0 110.577 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -94.69 89.72 5.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.296 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.586 HG23 ' OG ' ' A' ' 5' ' ' SER . 7.6 p -110.93 127.58 67.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 172.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.487 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 12.3 pt-20 -59.53 134.71 88.93 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.261 -174.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 40' ' ' GLU . 50.5 Cg_exo -54.31 -5.2 0.36 Allowed 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 124.398 3.399 . . . . 0.0 114.634 -172.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.36 -41.72 72.76 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.685 177.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.624 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 94.8 m95 -68.73 -57.42 8.13 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.796 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.624 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 56.8 Cg_exo -52.15 -41.28 66.11 Favored 'Trans proline' 0 C--N 1.366 1.5 0 C-N-CA 121.749 1.633 . . . . 0.0 112.324 174.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.531 ' O ' ' HG2' ' A' ' 49' ' ' LYS . . . -59.71 -54.79 34.66 Favored Glycine 0 C--O 1.242 0.639 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.488 -179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.449 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 57.6 mt -58.47 -50.6 73.16 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.664 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 6.2 m-85 -55.35 -51.01 68.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.365 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.09 -47.99 81.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.751 -0.658 . . . . 0.0 112.165 -176.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 45' ' ' GLY . 22.2 pttm -100.79 5.57 43.57 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 119.56 -0.856 . . . . 0.0 113.136 -174.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 46' ' ' LEU . . . -134.24 1.85 3.24 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' A' ' 47' ' ' PHE . 57.9 mt -84.99 -133.04 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 118.476 -1.29 . . . . 0.0 109.345 170.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 62.59 -13.16 0.07 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.507 ' H ' ' C ' ' A' ' 51' ' ' LEU . 18.5 m120 -128.2 3.99 5.8 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.575 ' CG2' ' HA ' ' A' ' 51' ' ' LEU . 61.5 t -95.88 103.03 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.154 -174.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -52.19 132.19 33.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.482 173.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.42 HD11 ' HB3' ' A' ' 14' ' ' LEU . 4.1 tp -45.04 -45.42 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -170.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.14 -26.01 57.93 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.364 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.0 t -65.49 -11.89 47.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.804 0.335 . . . . 0.0 110.492 -176.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 64.8 mt -57.69 -28.05 63.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.71 0.29 . . . . 0.0 110.675 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.3 tt -103.13 31.22 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.851 0.834 . . . . 0.0 110.926 -178.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.9 p -83.79 -177.45 6.69 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.966 173.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -78.15 48.37 0.73 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.718 0.294 . . . . 0.0 110.981 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.084 -178.532 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 203' ' ' TYR . . . . . 0.6 ' HB2' HG11 ' B' ' 242' ' ' VAL . 8.1 m-85 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.769 0.318 . . . . 0.0 111.633 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.58 ' O ' HD13 ' B' ' 208' ' ' LEU . 47.0 t -56.54 -65.36 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.63 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 205' ' ' ALA . . . . . 0.587 ' HA ' ' HB2' ' B' ' 208' ' ' LEU . . . -69.38 -6.56 30.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.215 -177.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 206' ' ' SER . . . . . 0.542 ' OG ' HG23 ' B' ' 223' ' ' ILE . 8.6 t -78.94 -42.44 26.93 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 207' ' ' TYR . . . . . 0.593 ' HD1' HD13 ' B' ' 251' ' ' ILE . 29.3 t80 -65.47 -39.18 91.66 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 172.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.587 ' HB2' ' HA ' ' B' ' 205' ' ' ALA . 9.1 mp -55.3 -51.11 67.77 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.416 173.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 209' ' ' LEU . . . . . 0.43 HD22 ' HB2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -56.51 -59.81 4.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.952 -178.354 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -60.75 -32.33 71.62 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -177.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 211' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -81.19 -32.0 33.73 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 122.015 -0.428 . . . . 0.0 111.308 178.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 212' ' ' LEU . . . . . 0.422 ' CD2' HG13 ' A' ' 4' ' ' VAL . 2.3 tm? -64.84 -43.12 94.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.718 177.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 213' ' ' GLY . . . . . 0.662 ' HA3' HG22 ' A' ' 37' ' ' VAL . . . -152.82 90.15 0.13 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.239 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 172.33 -62.91 0.14 Allowed Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 111.829 -0.508 . . . . 0.0 111.829 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 215' ' ' ASN . . . . . 0.455 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 56.4 t30 -161.4 142.61 11.37 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 216' ' ' SER . . . . . 0.408 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 8.6 m -64.4 -24.56 67.68 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.23 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 12.3 t -124.04 73.15 56.15 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.708 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 218' ' ' PRO . . . . . 0.53 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 57.9 Cg_exo -56.57 116.54 3.27 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.183 2.589 . . . . 0.0 112.438 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 83.4 p -82.84 162.21 21.7 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.048 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -54.91 -35.53 64.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.016 0.436 . . . . 0.0 110.332 177.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -68.76 -34.87 76.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.467 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -70.28 -43.71 69.88 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.359 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.542 HG23 ' OG ' ' B' ' 206' ' ' SER . 1.8 mp -64.85 -44.39 96.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 123.271 0.357 . . . . 0.0 110.085 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 224' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' B' ' 228' ' ' ASP . 26.7 tptp -55.56 -43.49 75.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.162 173.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -56.6 -51.25 69.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.077 178.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 0.447 HG23 HD21 ' A' ' 31' ' ' LEU . 1.1 mp -68.47 -35.47 70.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.771 -177.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 227' ' ' LEU . . . . . 0.414 ' CD1' ' HB ' ' B' ' 232' ' ' ILE . 0.2 OUTLIER -75.43 -35.11 61.02 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.549 0.69 . . . . 0.0 109.947 -179.431 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 228' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' B' ' 224' ' ' LYS . 5.2 t70 -76.19 -30.04 57.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.584 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 85.5 p -55.33 -45.3 76.38 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.556 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 59.4 t -75.84 -33.3 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 121.117 0.484 . . . . 0.0 110.663 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 103.98 38.83 2.62 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.862 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 232' ' ' ILE . . . . . 0.414 HG12 HG21 ' A' ' 21' ' ' VAL . 4.3 mt -109.38 135.41 48.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -66.54 118.33 10.0 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.655 0.74 . . . . 0.0 112.219 -173.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -117.5 135.55 53.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.03 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 235' ' ' ASP . . . . . 0.496 ' HB2' ' HB2' ' B' ' 238' ' ' ARG . 51.4 m-20 -86.43 115.21 23.79 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.185 -176.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 236' ' ' ASP . . . . . 0.598 ' O ' ' HG ' ' B' ' 239' ' ' LEU . 9.5 t70 -45.86 -60.53 2.18 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.131 0.894 . . . . 0.0 112.415 -170.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -63.92 -42.61 97.34 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.496 ' HB2' ' HB2' ' B' ' 235' ' ' ASP . 77.5 mtt180 -66.21 -36.0 81.92 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.15 -172.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 239' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' B' ' 236' ' ' ASP . 4.4 pp -68.44 -44.85 74.03 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.689 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 240' ' ' ASN . . . . . 0.499 ' N ' HD12 ' B' ' 239' ' ' LEU . 51.3 t30 -66.14 -33.21 75.26 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 121.34 -0.144 . . . . 0.0 110.759 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -62.15 -52.45 63.79 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-O 121.224 0.535 . . . . 0.0 110.315 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 242' ' ' VAL . . . . . 0.6 HG11 ' HB2' ' B' ' 203' ' ' TYR . 12.5 p -66.48 -37.84 80.45 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.654 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -176.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 243' ' ' ILE . . . . . 0.602 ' HA ' ' HB2' ' B' ' 246' ' ' LEU . 57.3 mt -66.6 -31.61 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.513 176.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 8.8 t -65.06 -33.69 76.63 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 175.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -86.65 -26.16 24.48 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.731 175.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 246' ' ' LEU . . . . . 0.602 ' HB2' ' HA ' ' B' ' 243' ' ' ILE . 9.5 mt -75.45 -19.5 59.42 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.666 0.386 . . . . 0.0 110.657 175.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -63.49 97.85 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.874 -173.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 175.66 -175.78 47.34 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.135 -177.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -85.89 0.68 52.47 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -79.62 -0.52 34.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.956 0.408 . . . . 0.0 110.797 -175.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.593 HD13 ' HD1' ' B' ' 207' ' ' TYR . 7.7 tp -61.72 -38.31 80.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.289 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -65.11 -34.91 79.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.106 0.479 . . . . 0.0 110.153 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -67.58 -45.45 75.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.632 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 254' ' ' VAL . . . . . 0.533 HG22 ' HA ' ' B' ' 251' ' ' ILE . 26.0 m -74.64 -10.94 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.2 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 255' ' ' ILE . . . . . 0.496 HG12 ' O ' ' B' ' 251' ' ' ILE . 24.0 mm -78.25 -53.15 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.003 0.43 . . . . 0.0 109.881 168.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -63.05 -42.41 99.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.328 -176.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -119.51 56.99 0.92 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.585 0.707 . . . . 0.0 109.887 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -105.79 -99.36 2.6 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.034 177.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 23.4 mt . . . . . 0 N--CA 1.481 1.098 0 C-N-CA 124.998 1.319 . . . . 0.0 113.334 -179.637 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.593 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 5.6 m . . . . . 0 N--CA 1.453 -0.321 0 CA-C-O 120.767 0.318 . . . . 0.0 110.543 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.439 HG23 ' HB2' ' B' ' 212' ' ' LEU . 13.3 p -71.68 -29.79 35.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.246 0.546 . . . . 0.0 109.753 -174.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.512 ' HB3' HG23 ' A' ' 39' ' ' VAL . 51.7 m -64.62 -52.06 59.39 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.944 176.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.427 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 35.6 tt0 -57.85 -45.45 86.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.04 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 3' ' ' SER . 82.6 mt -54.03 -53.78 48.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.356 176.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.07 -55.34 24.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.895 -177.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 21.6 p -67.43 -31.22 71.25 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.73 -176.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.553 HG13 HD23 ' A' ' 59' ' ' LEU . 0.9 OUTLIER -77.65 -37.64 24.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.921 0.391 . . . . 0.0 111.068 -176.892 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.636 ' O ' HG12 ' A' ' 15' ' ' ILE . 23.1 m-85 -74.61 -26.37 59.86 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.7 t -69.56 -44.78 70.16 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 172.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.94 -40.29 60.58 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.387 171.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.3 mt -60.48 -59.97 4.56 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 173.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.636 HG12 ' O ' ' A' ' 11' ' ' TYR . 36.3 mm -46.09 -34.4 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.3 mt -115.13 7.26 15.34 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -174.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -48.25 -62.47 1.47 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -120.73 -82.12 0.64 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.356 -176.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.554 ' OD2' HG21 ' B' ' 232' ' ' ILE . 5.2 t0 47.37 -152.59 0.09 Allowed 'General case' 0 CA--C 1.536 0.431 0 O-C-N 123.628 0.58 . . . . 0.0 111.28 178.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -112.05 22.52 14.74 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 168.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.561 HG11 HD11 ' B' ' 232' ' ' ILE . 4.1 p -128.41 158.67 40.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.59 -177.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.1 p -105.49 130.86 53.48 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 121.241 -0.183 . . . . 0.0 111.332 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.548 HG21 HD23 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -65.38 105.11 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.408 0.623 . . . . 0.0 110.52 175.562 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.419 ' OG1' ' HG2' ' A' ' 27' ' ' LYS . 22.3 p -133.91 168.48 18.69 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.379 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 26' ' ' ASP . 9.1 pt-20 -48.18 -48.53 34.56 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 123.659 0.599 . . . . 0.0 111.648 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.435 ' N ' ' HG3' ' A' ' 25' ' ' GLU . 7.5 p-10 -68.31 -27.84 66.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.251 -175.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.419 ' HG2' ' OG1' ' A' ' 24' ' ' THR . 46.2 mmtm -78.21 -45.1 23.93 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -176.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.511 HG23 HD13 ' A' ' 32' ' ' ILE . 6.5 mt -67.48 -41.7 86.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.779 176.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -55.57 -45.85 77.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.705 175.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.81 -49.6 72.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.324 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.407 ' CD1' ' HG ' ' B' ' 209' ' ' LEU . 0.2 OUTLIER -65.69 -38.6 89.7 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.211 0.529 . . . . 0.0 110.24 -177.276 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.511 HD13 HG23 ' A' ' 28' ' ' ILE . 1.3 mp -63.97 -35.86 74.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.255 176.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.453 ' NZ ' ' HB3' ' A' ' 33' ' ' LYS . 6.1 ttpm? -76.02 -21.69 56.57 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.919 0.39 . . . . 0.0 110.351 175.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.51 -48.71 21.35 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.659 ' HB3' HD12 ' B' ' 209' ' ' LEU . . . -143.27 8.27 1.6 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.38 89.93 1.55 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.115 -176.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.2 p -50.17 -50.8 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -175.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -161.63 126.52 3.47 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.946 0.403 . . . . 0.0 111.246 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.512 HG23 ' HB3' ' A' ' 5' ' ' SER . 7.2 p -139.17 127.53 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.431 173.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 24.8 mm-40 -57.07 125.62 70.8 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.029 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 40' ' ' GLU . 50.3 Cg_exo -52.99 -11.12 1.3 Allowed 'Trans proline' 0 N--CA 1.481 0.792 0 C-N-CA 124.042 3.162 . . . . 0.0 115.046 -168.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.571 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 0.7 OUTLIER -80.12 -28.18 39.02 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -174.94 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.428 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 98.7 m95 -64.68 -60.48 8.21 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.293 175.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.428 ' CD ' ' HB2' ' A' ' 43' ' ' TRP . 19.3 Cg_endo -59.74 -34.45 96.04 Favored 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 121.835 1.69 . . . . 0.0 111.939 178.016 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.91 -49.17 81.53 Favored Glycine 0 C--O 1.241 0.562 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.253 176.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 42' ' ' PHE . 89.8 mt -64.08 -47.18 81.09 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -60.72 -47.02 88.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.843 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.72 -37.52 86.64 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.608 -176.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -91.49 -26.76 18.64 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 119.8 -0.76 . . . . 0.0 113.033 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -116.11 -20.13 10.0 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -171.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.76 ' HA ' HG23 ' A' ' 54' ' ' VAL . 2.2 tp -83.99 -133.87 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.425 ' HA ' HG13 ' A' ' 23' ' ' VAL . . . 58.08 3.16 0.22 Allowed 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -176.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -145.57 -44.15 0.21 Allowed 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -177.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.76 HG23 ' HA ' ' A' ' 51' ' ' LEU . 48.7 t -40.91 112.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 114.0 -1.454 . . . . 0.0 110.745 172.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -54.67 140.47 35.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.071 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.602 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 3.4 tp -43.85 -51.94 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 124.043 0.84 . . . . 0.0 112.903 -173.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.28 -30.89 75.23 Favored Glycine 0 C--O 1.243 0.688 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.661 -176.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.5 t -65.25 -11.55 42.38 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -176.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.602 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 1.7 mp -43.06 -48.38 6.13 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.164 170.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.583 HD11 HG21 ' B' ' 259' ' ' ILE . 24.7 mm -110.05 44.46 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.628 0.728 . . . . 0.0 109.82 -178.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 48.9 t -119.58 -36.47 3.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.117 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -100.36 4.0 43.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.43 -177.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 CA--C 1.533 0.297 0 CA-C-O 121.015 0.436 . . . . 0.0 111.299 179.028 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 203' ' ' TYR . . . . . 0.419 ' CD1' HD23 ' B' ' 239' ' ' LEU . 29.3 m-85 . . . . . 0 C--O 1.236 0.37 0 CA-C-O 121.305 0.574 . . . . 0.0 110.647 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.639 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 38.7 t -65.24 -44.54 95.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.235 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 205' ' ' ALA . . . . . 0.545 ' HA ' HD12 ' B' ' 208' ' ' LEU . . . -72.74 -20.19 61.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.901 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 206' ' ' SER . . . . . 0.497 ' CB ' HG23 ' B' ' 223' ' ' ILE . 4.0 m -70.62 -42.42 70.93 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 173.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 207' ' ' TYR . . . . . 0.653 ' CE1' HD11 ' B' ' 251' ' ' ILE . 20.7 t80 -60.42 -41.58 94.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.163 174.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 75.7 mt -62.59 -42.06 99.34 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.814 177.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 209' ' ' LEU . . . . . 0.659 HD12 ' HB3' ' A' ' 35' ' ' ALA . 0.6 OUTLIER -55.8 -54.52 43.44 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.741 177.767 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -67.15 -27.33 67.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.376 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 211' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -65.81 -50.04 66.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.16 177.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 212' ' ' LEU . . . . . 0.439 ' HB2' HG23 ' A' ' 4' ' ' VAL . 4.1 pp -73.78 -24.85 59.9 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.727 0.299 . . . . 0.0 110.783 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.91 -13.68 53.19 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 116.005 -0.543 . . . . 0.0 113.265 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 118.65 35.48 0.98 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.886 177.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 215' ' ' ASN . . . . . 0.647 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 33.9 t30 -152.42 114.83 4.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.912 0.387 . . . . 0.0 110.31 176.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 216' ' ' SER . . . . . 0.49 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 8.1 m -76.28 -11.24 59.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.176 -178.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 217' ' ' SER . . . . . 0.406 ' N ' ' HD3' ' B' ' 218' ' ' PRO . 26.4 t -123.55 63.48 26.78 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.674 -176.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 218' ' ' PRO . . . . . 0.49 ' HD3' ' C ' ' B' ' 216' ' ' SER . 52.4 Cg_exo -60.22 144.96 99.48 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.029 2.486 . . . . 0.0 111.88 175.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 219' ' ' SER . . . . . 0.414 ' O ' HD13 ' B' ' 223' ' ' ILE . 21.5 m -129.51 168.53 16.23 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.794 178.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -47.76 -40.37 20.47 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.922 0.392 . . . . 0.0 111.659 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 221' ' ' LYS . . . . . 0.581 ' HB3' ' HZ3' ' B' ' 221' ' ' LYS . 4.2 ttpm? -58.1 -49.99 75.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.727 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.03 -39.4 69.15 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.281 -173.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.497 HG23 ' CB ' ' B' ' 206' ' ' SER . 1.7 mp -64.55 -40.28 88.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.584 176.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -56.25 -45.65 79.95 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.198 173.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -58.9 -43.98 91.11 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.151 0.5 . . . . 0.0 111.337 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 0.647 HD11 ' HB2' ' A' ' 35' ' ' ALA . 1.3 mp -63.57 -40.23 88.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.156 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 76.7 mt -76.54 -19.28 58.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.199 0.523 . . . . 0.0 110.581 176.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -73.84 -36.51 64.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.297 178.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 94.6 p -55.43 -40.96 72.17 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.634 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 3.3 m -90.02 -14.42 9.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 111.9 0.334 . . . . 0.0 111.9 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 77.7 32.84 44.51 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.586 175.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 232' ' ' ILE . . . . . 0.561 HD11 HG11 ' A' ' 21' ' ' VAL . 61.6 mt -90.48 130.43 39.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 177.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -67.01 100.22 0.72 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.318 0.58 . . . . 0.0 110.787 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -89.78 111.69 22.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.22 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 235' ' ' ASP . . . . . 0.466 ' HB2' ' HG2' ' B' ' 238' ' ' ARG . 5.3 m-20 -53.56 104.52 0.1 Allowed 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.727 0.642 . . . . 0.0 110.607 177.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -54.95 -38.14 67.35 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -174.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 237' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' B' ' 241' ' ' LYS . 15.9 t70 -55.81 -68.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.052 0.453 . . . . 0.0 111.276 178.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.481 ' HA ' ' HB2' ' B' ' 241' ' ' LYS . 13.7 ptp180 -68.76 -17.02 63.97 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.821 0.343 . . . . 0.0 111.039 -174.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 239' ' ' LEU . . . . . 0.455 HD13 HD12 ' B' ' 243' ' ' ILE . 3.3 tm? -61.22 -67.94 0.36 Allowed 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.854 176.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -75.1 -16.25 60.56 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.369 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 241' ' ' LYS . . . . . 0.481 ' HB2' ' HA ' ' B' ' 238' ' ' ARG . 29.9 mmtp -64.07 -56.02 17.95 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.257 171.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 242' ' ' VAL . . . . . 0.51 ' O ' ' HB3' ' B' ' 246' ' ' LEU . 34.7 m -67.26 -34.98 72.6 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.81 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -175.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 243' ' ' ILE . . . . . 0.455 HD12 HD13 ' B' ' 239' ' ' LEU . 58.4 mt -74.03 -23.87 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.473 178.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 25.3 t -72.0 -31.66 66.45 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 172.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -83.1 -22.7 33.33 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.35 0.595 . . . . 0.0 110.454 173.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 246' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' B' ' 246' ' ' LEU . 9.3 tp -116.11 71.44 0.78 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.466 -174.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -125.3 80.91 1.92 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.145 0.498 . . . . 0.0 111.949 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 87.04 -15.96 50.36 Favored Glycine 0 CA--C 1.52 0.406 0 CA-C-N 115.773 -0.649 . . . . 0.0 113.412 175.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -67.46 110.21 3.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.995 0.426 . . . . 0.0 111.524 -176.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 60.27 42.22 15.39 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.808 174.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.653 HD11 ' CE1' ' B' ' 207' ' ' TYR . 2.5 mm -58.25 -53.07 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -176.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -67.42 -26.18 66.29 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.378 -176.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -72.91 -46.03 54.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.4 177.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 254' ' ' VAL . . . . . . . . . . . . . 22.9 m -68.28 -20.57 25.67 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.989 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 255' ' ' ILE . . . . . 0.405 ' HA ' ' OH ' ' A' ' 11' ' ' TYR . 54.5 mt -74.04 -56.02 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-O 121.026 0.441 . . . . 0.0 110.759 172.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -67.98 -38.4 82.65 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -173.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 17.0 tp60 -101.54 -14.73 17.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.87 0.367 . . . . 0.0 111.701 -174.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -105.63 56.82 0.51 Allowed Glycine 0 C--O 1.227 -0.298 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.275 -172.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 259' ' ' ILE . . . . . 0.583 HG21 HD11 ' A' ' 60' ' ' ILE . 1.3 mt . . . . . 0 C--N 1.327 -0.387 0 CA-C-O 120.893 0.378 . . . . 0.0 111.668 -179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.611 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 5.8 p . . . . . 0 CA--C 1.529 0.167 0 CA-C-O 120.946 0.403 . . . . 0.0 111.997 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.504 ' HA ' HD12 ' A' ' 7' ' ' LEU . 21.9 t -66.09 -31.02 51.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.213 0.53 . . . . 0.0 110.005 -174.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.508 ' HB3' HG23 ' A' ' 39' ' ' VAL . 1.1 m -61.76 -55.54 29.05 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.417 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -61.15 -42.06 97.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.97 178.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 3' ' ' SER . 96.0 mt -56.15 -55.61 30.97 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.619 178.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.26 -49.73 76.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.086 -178.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.427 ' HA ' HD11 ' A' ' 32' ' ' ILE . 24.1 t -66.15 -38.36 87.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.291 -176.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.419 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 1.3 tp -75.16 -39.56 43.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.932 0.396 . . . . 0.0 110.998 -177.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.741 ' HD1' HD21 ' A' ' 14' ' ' LEU . 20.1 m-85 -74.91 -19.31 60.19 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.2 t -70.94 -50.97 28.84 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 170.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.452 ' HB3' HD21 ' A' ' 59' ' ' LEU . . . -49.43 -48.21 47.57 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.109 175.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.741 HD21 ' HD1' ' A' ' 11' ' ' TYR . 4.2 pp -81.09 -18.16 47.49 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.101 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 11' ' ' TYR . 2.8 mt -62.14 -41.98 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.274 0.559 . . . . 0.0 109.543 168.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 23' ' ' VAL . 57.7 mt -80.82 -27.56 36.5 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.183 -178.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.534 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 10.2 m80 -79.78 64.73 4.72 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 177.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -129.93 -51.35 1.13 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 171.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.49 ' OD1' HG21 ' B' ' 232' ' ' ILE . 8.8 m-20 -102.32 10.67 38.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.406 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 54.18 51.26 14.78 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.398 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -87.11 162.12 2.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.214 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.484 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 10.6 p -56.31 110.98 0.85 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.31 0.576 . . . . 0.0 112.246 -175.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.431 ' HA ' HD13 ' A' ' 16' ' ' LEU . 33.9 m -84.87 47.35 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.556 0.693 . . . . 0.0 110.935 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.414 HG22 ' HG2' ' A' ' 27' ' ' LYS . 10.1 t -87.31 169.32 12.39 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.071 -171.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -52.93 -42.26 65.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.903 -177.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -49.82 -45.58 50.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.677 177.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 22' ' ' THR . 66.4 mmtt -76.48 -48.92 17.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.945 -173.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.3 mt -62.45 -46.1 97.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.019 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -60.37 -46.09 91.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.902 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.65 ' HB3' HG11 ' B' ' 230' ' ' VAL . . . -71.21 -34.37 70.78 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.708 HD11 HG23 ' B' ' 226' ' ' ILE . 0.1 OUTLIER -70.69 -46.02 63.93 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.712 0.768 . . . . 0.0 109.478 178.568 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.427 HD11 ' HA ' ' A' ' 9' ' ' CYS . 1.5 mp -58.65 -37.3 64.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.53 175.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -74.39 -31.38 62.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.177 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.34 -45.4 91.48 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.471 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.579 ' HA ' HD11 ' B' ' 226' ' ' ILE . . . -76.32 -31.82 58.36 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.169 177.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.07 16.48 47.36 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.27 175.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.568 ' CG2' ' HA2' ' B' ' 213' ' ' GLY . 53.1 t -95.19 138.98 19.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.822 0.344 . . . . 0.0 110.71 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -93.41 97.47 10.59 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.873 0.368 . . . . 0.0 111.461 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.508 HG23 ' HB3' ' A' ' 5' ' ' SER . 7.7 p -97.09 136.68 27.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 171.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -59.92 126.24 82.85 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.65 -5.65 0.48 Allowed 'Trans proline' 0 N--CA 1.482 0.815 0 C-N-CA 124.053 3.169 . . . . 0.0 114.146 -172.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.64 -36.36 80.63 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.64 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 94.6 m95 -71.69 -56.6 4.78 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.995 177.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.64 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 74.0 Cg_exo -51.12 -43.77 46.42 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.093 1.862 . . . . 0.0 112.334 176.087 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.88 -57.1 15.18 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.143 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 45.5 tp -57.37 -43.61 83.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.659 0.266 . . . . 0.0 110.348 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.585 ' HA ' HD13 ' A' ' 51' ' ' LEU . 3.0 m-85 -59.97 -49.73 76.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.295 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.42 -34.27 76.44 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.043 -178.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -97.49 -1.71 43.54 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.86 -16.55 7.07 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.585 HD13 ' HA ' ' A' ' 47' ' ' PHE . 9.4 mp -84.75 -131.77 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 O-C-N 121.945 -0.472 . . . . 0.0 110.098 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 61.02 2.22 0.54 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.502 0.721 . . . . 0.0 112.887 -178.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.495 ' H ' HG12 ' A' ' 54' ' ' VAL . 87.5 m-20 -139.49 -58.49 0.58 Allowed 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.542 HG11 ' HG ' ' A' ' 51' ' ' LEU . 2.5 p -1.01 96.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 113.217 -1.81 . . . . 0.0 114.48 164.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -59.38 128.75 38.65 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.205 169.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 5.1 tp -47.73 -45.25 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -169.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.414 ' O ' HG22 ' A' ' 60' ' ' ILE . . . -58.85 -37.38 90.52 Favored Glycine 0 C--O 1.239 0.407 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.595 -177.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.9 m -61.57 -11.01 9.38 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.474 -0.363 . . . . 0.0 111.599 -178.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 13' ' ' ALA . 9.2 tp -63.04 -24.86 68.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.802 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 60' ' ' ILE . 11.0 tt -99.86 22.43 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 121.991 0.901 . . . . 0.0 110.301 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 81.8 m -140.94 -62.38 0.48 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.16 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -101.1 66.33 1.13 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.978 0.418 . . . . 0.0 110.701 -176.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.137 177.979 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 . . . . . 0 C--O 1.24 0.567 0 CA-C-O 121.355 0.598 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.529 ' O ' HD13 ' B' ' 208' ' ' LEU . 8.6 p -58.28 -47.79 86.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.147 -174.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 205' ' ' ALA . . . . . 0.565 ' HB1' ' HB3' ' A' ' 11' ' ' TYR . . . -72.95 -19.22 61.28 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.471 -177.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 206' ' ' SER . . . . . 0.563 ' OG ' HG23 ' B' ' 223' ' ' ILE . 24.4 t -66.09 -43.33 87.63 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 207' ' ' TYR . . . . . 0.559 ' CE1' HD11 ' B' ' 251' ' ' ILE . 21.5 t80 -60.47 -44.31 96.04 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.721 173.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.541 ' HB2' ' HA ' ' B' ' 205' ' ' ALA . 6.3 mp -56.26 -49.07 75.23 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.035 177.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 209' ' ' LEU . . . . . 0.506 HD22 HD12 ' A' ' 31' ' ' LEU . 3.7 mp -62.54 -43.13 99.57 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.56 0.219 . . . . 0.0 111.379 -178.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -62.74 -34.0 76.3 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.19 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 211' ' ' ALA . . . . . 0.716 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -71.44 -53.77 12.9 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.701 0.286 . . . . 0.0 111.05 178.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 212' ' ' LEU . . . . . 0.451 HD22 ' HB3' ' A' ' 7' ' ' LEU . 4.6 pp -68.61 -17.79 64.18 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.045 0.45 . . . . 0.0 110.904 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 213' ' ' GLY . . . . . 0.568 ' HA2' ' CG2' ' A' ' 37' ' ' VAL . . . -66.88 -19.63 69.81 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.103 177.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 130.71 6.91 3.55 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.111 177.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 215' ' ' ASN . . . . . 0.716 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 7.9 m-20 -119.52 119.05 32.7 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.841 0.353 . . . . 0.0 110.996 -178.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 8.5 m -81.74 -0.87 44.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.71 0.29 . . . . 0.0 111.365 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 217' ' ' SER . . . . . 0.452 ' N ' ' HD3' ' B' ' 218' ' ' PRO . 24.5 m -135.98 62.16 44.75 Favored Pre-proline 0 N--CA 1.444 -0.764 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.342 -176.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 218' ' ' PRO . . . . . 0.452 ' HD3' ' N ' ' B' ' 217' ' ' SER . 35.0 Cg_exo -63.87 130.98 29.31 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.987 2.458 . . . . 0.0 112.483 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 219' ' ' SER . . . . . 0.496 ' O ' HD13 ' B' ' 223' ' ' ILE . 33.0 t -110.25 169.53 8.67 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.762 0.315 . . . . 0.0 110.49 177.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -56.02 -29.1 59.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.72 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -62.39 -53.1 59.92 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.612 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -62.36 -48.04 81.54 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.252 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.563 HG23 ' OG ' ' B' ' 206' ' ' SER . 1.7 mp -61.18 -48.49 88.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.784 -178.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -62.21 -38.11 87.9 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.499 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -56.93 -52.52 64.86 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.049 176.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 0.708 HG23 HD11 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -60.25 -43.73 94.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.222 -177.673 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 227' ' ' LEU . . . . . 0.406 HD13 ' HB2' ' B' ' 234' ' ' ALA . 1.1 tt -69.99 -43.02 72.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.68 0.276 . . . . 0.0 110.497 -177.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -69.43 -25.51 64.15 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.998 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 58.7 m -51.08 -49.41 60.71 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 230' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' A' ' 30' ' ' ALA . 3.4 p -171.46 19.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.914 -175.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -82.93 -94.75 0.57 Allowed Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 119.973 -1.108 . . . . 0.0 112.04 -173.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 232' ' ' ILE . . . . . 0.49 HG21 ' OD1' ' A' ' 19' ' ' ASP . 51.4 mt -143.17 -88.87 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 120.543 0.211 . . . . 0.0 110.549 -176.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -148.17 160.7 42.65 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 174.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 234' ' ' ALA . . . . . 0.406 ' HB2' HD13 ' B' ' 227' ' ' LEU . . . -151.21 98.91 2.61 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.054 0.454 . . . . 0.0 111.676 -177.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 235' ' ' ASP . . . . . 0.479 ' CG ' ' HD3' ' B' ' 238' ' ' ARG . 0.0 OUTLIER -67.74 127.54 33.18 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.77 174.422 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -65.69 -39.86 91.73 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -165.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -80.71 -38.62 28.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.312 0.577 . . . . 0.0 110.21 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.479 ' HD3' ' CG ' ' B' ' 235' ' ' ASP . 68.2 ttt180 -66.68 -39.47 88.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.677 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 239' ' ' LEU . . . . . 0.421 HD11 HG22 ' B' ' 223' ' ' ILE . 8.6 tt -59.01 -51.84 68.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.07 178.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -69.3 -29.53 67.41 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -67.15 -46.37 74.26 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 242' ' ' VAL . . . . . . . . . . . . . 35.8 m -70.13 -32.17 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 243' ' ' ILE . . . . . 0.476 ' HA ' ' CD2' ' B' ' 246' ' ' LEU . 12.5 mt -64.25 -38.54 82.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.981 170.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 28.1 t -72.07 -13.64 61.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.616 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -89.31 -30.29 18.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.036 0.446 . . . . 0.0 110.402 172.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 246' ' ' LEU . . . . . 0.559 HD12 ' O ' ' B' ' 246' ' ' LEU . 1.4 pp -98.84 3.72 47.4 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.617 -178.064 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -78.16 40.02 0.33 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -171.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -86.63 -121.23 1.32 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.17 -175.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -139.15 -174.44 3.86 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 250' ' ' ASN . . . . . 0.509 ' HB3' ' HB3' ' B' ' 253' ' ' ASP . 89.6 m-20 64.5 49.63 2.37 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.625 0.578 . . . . 0.0 111.428 176.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.559 HD11 ' CE1' ' B' ' 207' ' ' TYR . 1.3 mm -60.19 -48.39 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.297 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -68.96 -22.27 64.12 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.422 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 253' ' ' ASP . . . . . 0.509 ' HB3' ' HB3' ' B' ' 250' ' ' ASN . 5.8 t70 -70.88 -47.01 61.56 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 254' ' ' VAL . . . . . 0.487 HG22 ' O ' ' B' ' 251' ' ' ILE . 11.4 m -69.67 -25.11 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.119 178.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 255' ' ' ILE . . . . . 0.512 ' CG2' HD13 ' A' ' 7' ' ' LEU . 61.4 mt -78.98 -32.04 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.782 174.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -77.84 -41.69 36.15 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -127.1 36.96 4.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.271 0.558 . . . . 0.0 111.123 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -124.66 36.57 2.84 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.218 -0.992 . . . . 0.0 111.955 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--O 1.222 -0.383 0 CA-C-O 120.814 0.34 . . . . 0.0 110.724 -178.573 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 CA--C 1.537 0.472 0 CA-C-O 121.208 0.528 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.604 ' HA ' HD12 ' A' ' 7' ' ' LEU . 2.4 m -66.09 -18.01 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.481 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.451 ' HB3' HG23 ' A' ' 39' ' ' VAL . 16.7 m -61.37 -62.67 1.66 Allowed 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.51 176.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.602 ' O ' HG23 ' A' ' 10' ' ' ILE . 9.9 pt-20 -69.93 -34.9 74.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.446 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.604 HD12 ' HA ' ' A' ' 4' ' ' VAL . 66.6 mt -49.19 -64.72 0.72 Allowed 'General case' 0 C--O 1.222 -0.348 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 172.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.31 86.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.683 -176.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.2 t -62.21 -51.79 66.37 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -176.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.602 HG23 ' O ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -83.19 -16.58 11.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 119.166 -1.013 . . . . 0.0 111.158 -177.869 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.415 ' HB2' HD21 ' B' ' 209' ' ' LEU . 15.9 m-30 -69.89 -32.41 70.73 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 169.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.412 ' HA ' HD23 ' A' ' 31' ' ' LEU . 28.1 t -66.58 -43.91 83.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.298 169.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 10' ' ' ILE . . . -48.96 -45.19 41.59 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 120.98 0.419 . . . . 0.0 110.376 171.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 10' ' ' ILE . 85.7 mt -58.46 -56.03 27.41 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.614 177.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.627 HD12 HD21 ' A' ' 31' ' ' LEU . 56.5 mt -60.15 -32.45 50.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.619 -174.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.429 HD11 HG11 ' B' ' 230' ' ' VAL . 2.5 mm? -88.79 -24.34 22.64 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 121.758 -0.589 . . . . 0.0 112.41 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.549 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 54.6 t-80 -59.38 -51.25 70.73 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -174.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -92.52 -21.19 20.26 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -164.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.44 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.7 m-20 -86.12 29.08 0.76 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -171.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 65.32 8.26 4.81 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.846 0.459 . . . . 0.0 111.933 174.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 19' ' ' ASP . 71.7 t -104.74 141.23 20.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.138 0.494 . . . . 0.0 110.721 -176.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.483 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 7.1 p -73.02 126.75 30.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.079 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.6 p -76.44 87.0 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.564 0.697 . . . . 0.0 110.917 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.1 p -112.46 175.6 5.37 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.353 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -59.74 -36.53 76.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.768 -178.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -53.14 -45.02 68.19 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.897 176.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 22' ' ' THR . 69.2 mmtt -78.29 -47.59 17.5 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.678 -169.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.444 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 21.6 mt -65.47 -46.49 89.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.362 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -63.15 -38.81 92.64 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.86 -43.6 75.08 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.128 0.489 . . . . 0.0 111.232 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.627 HD21 HD12 ' A' ' 15' ' ' ILE . 27.3 tp -70.87 -31.92 68.74 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.336 0.589 . . . . 0.0 110.011 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 28' ' ' ILE . 1.4 mp -73.05 -27.99 25.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.092 174.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -69.71 -34.32 73.72 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 172.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.96 -63.06 1.15 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.161 178.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.504 ' HB2' HD11 ' B' ' 226' ' ' ILE . . . -129.45 26.22 5.38 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -175.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -100.96 94.72 1.3 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.27 -0.967 . . . . 0.0 111.339 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.495 ' HB ' ' HA2' ' B' ' 213' ' ' GLY . 7.7 p -55.05 -50.15 65.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -161.91 130.03 4.15 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.226 0.536 . . . . 0.0 111.725 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.451 HG23 ' HB3' ' A' ' 5' ' ' SER . 10.9 p -157.56 131.95 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.06 174.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -73.0 132.1 83.08 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.56 -4.84 0.59 Allowed 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.846 3.031 . . . . 0.0 114.462 -171.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.55 -37.75 77.19 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.236 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 93.2 m95 -68.4 -55.01 12.98 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.839 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.589 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 87.5 Cg_exo -50.25 -50.77 12.52 Favored 'Trans proline' 0 C--N 1.364 1.366 0 C-N-CA 121.99 1.793 . . . . 0.0 112.972 174.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.8 -49.91 72.89 Favored Glycine 0 C--O 1.242 0.622 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.092 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 56.9 tp -53.57 -62.16 1.83 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.239 177.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.481 ' CZ ' HG22 ' A' ' 10' ' ' ILE . 3.5 m-85 -52.41 -46.19 66.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.237 -177.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.26 -38.52 91.5 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.732 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -105.52 10.33 33.18 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.894 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -115.38 -32.82 5.49 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 175.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.671 ' HA ' ' CG2' ' A' ' 54' ' ' VAL . 47.5 mt -80.86 -133.61 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.411 -177.281 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 66.66 -12.45 0.21 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.827 0.851 . . . . 0.0 113.245 177.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 51' ' ' LEU . 52.2 m-80 -141.17 7.38 1.99 Allowed 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.833 0.825 . . . . 0.0 108.87 178.003 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.671 ' CG2' ' HA ' ' A' ' 51' ' ' LEU . 0.6 OUTLIER -112.92 114.45 47.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.814 -173.411 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -43.95 136.91 3.47 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.635 1.209 . . . . 0.0 110.101 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.773 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 4.9 tp -47.7 -43.52 9.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.186 -169.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -53.35 -22.78 16.22 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.556 -177.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.2 t -53.36 -34.83 59.11 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 122.527 0.331 . . . . 0.0 111.535 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.773 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -61.23 -13.44 18.51 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -175.037 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.433 ' N ' HD12 ' A' ' 59' ' ' LEU . 18.5 mt -66.09 -24.81 34.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.902 0.382 . . . . 0.0 110.421 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.5 t -159.69 72.0 0.51 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.421 0.629 . . . . 0.0 109.833 174.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -94.08 37.12 1.1 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.679 0.752 . . . . 0.0 110.099 -178.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.93 177.563 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 203' ' ' TYR . . . . . 0.523 ' OH ' ' HB2' ' B' ' 235' ' ' ASP . 1.3 m-85 . . . . . 0 C--O 1.236 0.376 0 CA-C-O 121.115 0.483 . . . . 0.0 111.678 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.663 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 26.8 m -65.19 -42.48 94.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.664 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 205' ' ' ALA . . . . . 0.71 ' O ' ' HG ' ' B' ' 209' ' ' LEU . . . -73.8 -22.23 59.88 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.319 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 206' ' ' SER . . . . . 0.489 ' CB ' HG23 ' B' ' 223' ' ' ILE . 6.9 m -64.26 -47.74 78.43 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 171.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 207' ' ' TYR . . . . . 0.557 ' CZ ' ' HD2' ' B' ' 218' ' ' PRO . 36.9 t80 -60.53 -40.42 91.41 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.313 176.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 82.5 mt -57.96 -51.07 71.15 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.8 178.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 209' ' ' LEU . . . . . 0.71 ' HG ' ' O ' ' B' ' 205' ' ' ALA . 70.4 mt -59.01 -56.04 27.35 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.816 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 210' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' B' ' 218' ' ' PRO . . . -58.13 -31.29 67.04 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.599 -178.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 211' ' ' ALA . . . . . 0.654 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -74.58 -50.83 16.43 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.408 178.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 212' ' ' LEU . . . . . 0.472 ' HB2' HG12 ' A' ' 4' ' ' VAL . 4.0 pp -66.17 -20.12 66.04 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.64 0.257 . . . . 0.0 110.719 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 213' ' ' GLY . . . . . 0.495 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -68.22 -20.03 72.77 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.595 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 128.22 33.3 0.59 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.784 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 215' ' ' ASN . . . . . 0.654 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 18.3 m120 -144.74 114.25 7.15 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 216' ' ' SER . . . . . 0.407 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 6.3 m -70.24 -17.87 63.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.846 0.355 . . . . 0.0 111.478 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 54.6 p -125.46 71.98 66.18 Favored Pre-proline 0 N--CA 1.444 -0.749 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.969 -175.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 218' ' ' PRO . . . . . 0.557 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 42.5 Cg_exo -62.54 112.12 1.51 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.131 2.554 . . . . 0.0 112.167 176.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 29.2 p -75.74 137.12 40.39 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.344 0.592 . . . . 0.0 110.444 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -54.29 -30.16 49.91 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.85 -177.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -68.25 -37.08 80.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.809 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -78.69 -30.84 46.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.982 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.489 HG23 ' CB ' ' B' ' 206' ' ' SER . 1.7 mp -62.15 -45.57 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.282 0.563 . . . . 0.0 109.507 171.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -61.11 -42.37 98.41 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.037 177.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -57.4 -42.72 82.79 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.31 174.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 0.504 HD11 ' HB2' ' A' ' 35' ' ' ALA . 1.0 OUTLIER -61.48 -35.9 69.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.815 178.644 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 227' ' ' LEU . . . . . 0.536 HD23 ' HB2' ' B' ' 234' ' ' ALA . 11.8 tp -75.96 -39.22 56.45 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.53 -32.0 71.05 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.211 174.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 28.2 t -52.18 -54.69 27.77 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.742 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 230' ' ' VAL . . . . . 0.429 HG11 HD11 ' A' ' 16' ' ' LEU . 40.9 t -74.4 -34.27 35.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.355 0.598 . . . . 0.0 110.803 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 104.52 43.95 1.63 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.836 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 232' ' ' ILE . . . . . 0.406 ' HB ' ' HG ' ' B' ' 227' ' ' LEU . 2.5 mm -104.01 145.72 12.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -69.56 118.02 11.91 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.025 0.44 . . . . 0.0 110.213 -178.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 234' ' ' ALA . . . . . 0.536 ' HB2' HD23 ' B' ' 227' ' ' LEU . . . -99.21 99.41 10.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.208 -175.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 235' ' ' ASP . . . . . 0.523 ' HB2' ' OH ' ' B' ' 203' ' ' TYR . 2.2 m-20 -61.52 109.84 1.3 Allowed 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 170.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.77 -38.29 90.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.698 -172.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.55 -60.15 4.31 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.769 177.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -62.38 -35.74 80.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.662 -172.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 239' ' ' LEU . . . . . . . . . . . . . 9.3 tt -55.71 -61.34 2.42 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.108 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -70.03 -26.38 64.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.679 -177.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -61.89 -52.71 62.98 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.284 175.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 242' ' ' VAL . . . . . 0.545 ' O ' ' HG ' ' B' ' 246' ' ' LEU . 34.0 m -72.5 -30.98 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.581 -175.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 243' ' ' ILE . . . . . 0.421 ' HA ' HD12 ' B' ' 246' ' ' LEU . 30.0 mt -69.3 -36.2 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.636 174.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 30.3 t -60.34 -38.17 82.96 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 174.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -70.29 -37.06 74.74 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.298 174.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 246' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' B' ' 242' ' ' VAL . 64.1 mt -71.26 -31.74 67.88 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.96 0.41 . . . . 0.0 111.056 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -53.38 -34.88 59.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.374 -175.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -108.81 35.46 4.93 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.892 -177.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -134.62 153.54 51.92 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.631 0.253 . . . . 0.0 110.412 178.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 250' ' ' ASN . . . . . 0.404 ' ND2' ' HB2' ' B' ' 253' ' ' ASP . 8.8 p-10 -74.54 83.35 2.01 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.894 0.854 . . . . 0.0 111.614 -176.248 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.622 ' O ' HG12 ' B' ' 254' ' ' VAL . 5.2 tp -57.68 -39.03 67.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 114.446 -1.252 . . . . 0.0 112.265 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -63.7 -38.42 91.06 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.874 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 253' ' ' ASP . . . . . 0.52 ' O ' ' HG2' ' B' ' 257' ' ' GLN . 43.4 m-20 -73.78 -40.08 63.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.801 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 254' ' ' VAL . . . . . 0.622 HG12 ' O ' ' B' ' 251' ' ' ILE . 3.1 p -62.29 -31.22 50.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.271 -177.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 255' ' ' ILE . . . . . 0.583 ' CG2' HD13 ' A' ' 7' ' ' LEU . 77.0 mt -78.79 -37.97 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 173.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -64.84 -19.9 66.11 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 257' ' ' GLN . . . . . 0.52 ' HG2' ' O ' ' B' ' 253' ' ' ASP . 31.2 mm-40 -71.55 -80.69 0.06 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.586 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 177.31 -59.53 0.1 OUTLIER Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.344 -0.931 . . . . 0.0 113.168 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 259' ' ' ILE . . . . . 0.423 ' CD1' HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.256 0 CA-C-O 120.857 0.36 . . . . 0.0 110.71 -177.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.409 ' O ' HD13 ' A' ' 7' ' ' LEU . 3.4 p . . . . . 0 CA--C 1.533 0.31 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.425 ' HA ' ' HB2' ' A' ' 7' ' ' LEU . 6.4 m -65.4 -17.19 21.59 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.957 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.562 ' HB3' HG23 ' A' ' 39' ' ' VAL . 14.2 m -62.43 -67.13 0.44 Allowed 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.517 0.675 . . . . 0.0 110.447 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -67.25 -31.92 72.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.703 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.438 ' HB3' HD22 ' B' ' 212' ' ' LEU . 5.4 mp -60.41 -49.52 77.23 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.115 0.483 . . . . 0.0 110.224 176.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.85 -49.77 74.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.113 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.714 ' SG ' HG21 ' A' ' 39' ' ' VAL . 48.9 m -62.11 -35.86 79.98 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.701 -0.4 . . . . 0.0 112.055 -178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -74.35 -36.54 42.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.989 -0.285 . . . . 0.0 111.288 -178.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.622 ' O ' HG12 ' A' ' 15' ' ' ILE . 22.5 m-85 -77.52 -25.19 50.03 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.364 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.9 m -73.44 -38.7 65.43 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 172.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.25 -43.86 71.28 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.6 171.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.0 mt -57.04 -58.62 7.38 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.381 173.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.622 HG12 ' O ' ' A' ' 11' ' ' TYR . 36.6 mm -49.83 -35.86 10.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.279 -176.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.464 ' HB2' HG12 ' A' ' 23' ' ' VAL . 58.5 mt -106.08 -2.64 22.44 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -175.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.57 -20.79 66.09 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.822 -0.549 . . . . 0.0 112.309 -178.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.441 ' HB3' ' H ' ' A' ' 19' ' ' ASP . 0.2 OUTLIER -125.88 -117.76 0.27 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.648 -174.535 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.441 ' H ' ' HB3' ' A' ' 18' ' ' ASP . 1.0 OUTLIER 20.2 -138.93 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -170.397 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.424 ' H ' ' HB3' ' A' ' 19' ' ' ASP . 32.1 tt0 -117.14 23.46 11.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.98 0.895 . . . . 0.0 109.039 177.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.42 HG21 HG12 ' B' ' 232' ' ' ILE . 78.3 t -116.26 122.49 69.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.573 -176.031 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.437 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 4.5 p -80.08 147.13 31.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.077 -176.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 23' ' ' VAL . 30.9 m -75.03 103.66 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 121.507 0.67 . . . . 0.0 111.062 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.9 p -130.11 157.78 41.45 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 121.746 -0.596 . . . . 0.0 111.204 177.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -51.95 -49.55 62.93 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.709 0.631 . . . . 0.0 109.871 -177.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -34.09 65.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.886 -176.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.437 ' HD2' ' O ' ' A' ' 22' ' ' THR . 69.1 mttm -85.18 -41.74 15.37 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.24 -172.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.421 HG13 HD12 ' A' ' 16' ' ' LEU . 3.2 mt -63.37 -43.94 98.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 173.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.578 ' OD1' ' HE3' ' A' ' 33' ' ' LYS . 19.6 t-20 -58.07 -44.38 87.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.753 176.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.0 -44.41 94.56 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.492 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.2 mt -64.93 -44.29 89.97 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.677 0.275 . . . . 0.0 111.308 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 mp -59.27 -44.94 93.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.106 0.479 . . . . 0.0 110.426 178.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.578 ' HE3' ' OD1' ' A' ' 29' ' ' ASN . 97.7 mttt -66.43 -32.32 73.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.796 178.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.501 ' HB1' ' HA ' ' B' ' 226' ' ' ILE . . . -64.44 -38.07 89.73 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.265 177.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.419 ' HA ' HD11 ' B' ' 226' ' ' ILE . . . -79.93 -27.43 39.84 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.986 177.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.7 6.5 56.25 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.28 173.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.522 HG13 ' HA2' ' B' ' 213' ' ' GLY . 6.8 m -91.32 -178.93 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.05 0.452 . . . . 0.0 111.643 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -134.52 120.86 20.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.541 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.714 HG21 ' SG ' ' A' ' 9' ' ' CYS . 12.6 p -119.99 144.28 29.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.855 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.34 122.96 58.48 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -52.29 -13.32 2.03 Favored 'Trans proline' 0 N--CA 1.484 0.921 0 C-N-CA 123.735 2.956 . . . . 0.0 114.699 -170.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.01 -24.72 43.51 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -175.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.477 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 95.2 m95 -67.86 -59.57 6.44 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 175.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.477 ' CD ' ' HB2' ' A' ' 43' ' ' TRP . 11.3 Cg_endo -56.48 -37.29 97.54 Favored 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 121.862 1.708 . . . . 0.0 112.11 176.389 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.462 ' O ' ' HG2' ' A' ' 49' ' ' LYS . . . -66.0 -50.67 50.9 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.593 178.361 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.2 tt -59.23 -46.39 88.59 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.597 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 11.3 m-85 -60.05 -42.81 95.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.942 0.401 . . . . 0.0 110.844 177.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.98 -49.64 76.62 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -177.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 45' ' ' GLY . 19.0 ptmt -105.03 0.42 27.62 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -172.019 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.04 -11.55 3.32 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.688 ' HA ' HG23 ' A' ' 54' ' ' VAL . 3.4 tp -90.47 -133.16 0.11 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.464 ' H ' ' CG ' ' A' ' 51' ' ' LEU . . . 61.65 -12.68 0.05 Allowed 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.555 ' H ' ' C ' ' A' ' 51' ' ' LEU . 88.2 m-20 -128.23 -34.42 2.09 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -178.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.688 HG23 ' HA ' ' A' ' 51' ' ' LEU . 41.0 t -50.92 109.45 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-N 114.407 -1.269 . . . . 0.0 109.848 170.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -51.12 150.01 3.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.727 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.541 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 2.6 tp -53.83 -49.48 58.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -173.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.17 -26.43 65.89 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.781 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 61' ' ' CYS . 19.3 m -65.97 -2.19 3.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.661 -0.269 . . . . 0.0 111.484 -178.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 42.6 mt -57.36 -24.99 58.72 Favored 'General case' 0 N--CA 1.46 0.074 0 CA-C-O 120.771 0.319 . . . . 0.0 110.483 171.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.8 mt -89.69 28.15 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 121.421 0.629 . . . . 0.0 109.787 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 58' ' ' SER . 33.1 t -63.59 154.58 32.28 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.642 176.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -77.17 54.34 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.88 0.848 . . . . 0.0 110.017 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 C--N 1.319 -0.728 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.504 178.076 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 203' ' ' TYR . . . . . 0.408 ' OH ' ' HA ' ' B' ' 234' ' ' ALA . 73.6 m-85 . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.613 ' O ' HD13 ' B' ' 208' ' ' LEU . 58.5 t -65.25 -53.48 40.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.49 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 205' ' ' ALA . . . . . 0.495 ' HA ' HD22 ' B' ' 208' ' ' LEU . . . -70.54 -16.4 62.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.163 0.506 . . . . 0.0 110.673 -178.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 206' ' ' SER . . . . . 0.414 ' CB ' HG23 ' B' ' 223' ' ' ILE . 5.8 m -69.59 -47.23 64.24 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 171.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 207' ' ' TYR . . . . . 0.552 ' CD1' HD11 ' B' ' 251' ' ' ILE . 32.3 t80 -57.17 -39.68 75.78 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.254 174.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.613 HD13 ' O ' ' B' ' 204' ' ' VAL . 7.0 mp -60.71 -49.49 77.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.324 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 209' ' ' LEU . . . . . 0.515 ' CD2' ' HB2' ' A' ' 11' ' ' TYR . 25.3 mt -56.29 -48.78 75.97 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 120.936 0.398 . . . . 0.0 110.585 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 210' ' ' ALA . . . . . 0.536 ' HB3' ' HB3' ' B' ' 218' ' ' PRO . . . -66.56 -29.76 69.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.328 -177.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 211' ' ' ALA . . . . . 0.659 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -72.65 -52.26 16.07 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.933 0.396 . . . . 0.0 111.055 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 212' ' ' LEU . . . . . 0.438 HD22 ' HB3' ' A' ' 7' ' ' LEU . 2.9 pp -69.13 -19.97 64.04 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 213' ' ' GLY . . . . . 0.522 ' HA2' HG13 ' A' ' 37' ' ' VAL . . . -60.15 -19.68 52.33 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.824 176.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 127.73 3.9 5.84 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.665 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 215' ' ' ASN . . . . . 0.659 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 28.3 t30 -122.56 114.01 20.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.92 0.391 . . . . 0.0 110.654 -177.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 216' ' ' SER . . . . . 0.427 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 18.6 m -70.76 -12.51 61.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.636 -178.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 10.1 p -122.98 67.49 32.63 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.492 -178.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 218' ' ' PRO . . . . . 0.536 ' HB3' ' HB3' ' B' ' 210' ' ' ALA . 80.7 Cg_exo -53.38 106.33 0.15 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.261 2.641 . . . . 0.0 113.09 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 16.0 m -77.9 148.74 34.44 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.158 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -56.63 -29.49 62.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.348 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -68.62 -30.05 68.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.342 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -86.64 -30.46 21.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.342 -177.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.414 HG23 ' CB ' ' B' ' 206' ' ' SER . 1.8 mp -66.47 -44.78 90.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 171.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 224' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' B' ' 228' ' ' ASP . 38.7 tttp -60.47 -43.4 96.96 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.799 175.261 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -56.72 -45.59 81.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.903 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 0.501 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . 1.0 OUTLIER -61.26 -44.88 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.071 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 227' ' ' LEU . . . . . 0.436 HD23 ' HB2' ' B' ' 234' ' ' ALA . 10.0 tp -76.36 -32.65 58.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.686 0.279 . . . . 0.0 110.652 -176.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 228' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' B' ' 224' ' ' LYS . 1.1 t0 -72.15 -29.78 64.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.319 0.58 . . . . 0.0 109.635 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 32.2 t -60.08 -37.79 80.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.051 177.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 9.6 p -98.74 -23.67 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 120.997 0.427 . . . . 0.0 111.313 -174.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 102.32 57.36 0.8 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.777 -0.725 . . . . 0.0 114.214 172.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 232' ' ' ILE . . . . . 0.42 HG12 HG21 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -130.51 147.33 33.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 173.069 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -66.1 130.23 42.54 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.72 0.295 . . . . 0.0 111.742 -175.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 234' ' ' ALA . . . . . 0.436 ' HB2' HD23 ' B' ' 227' ' ' LEU . . . -128.04 106.99 9.45 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.904 -177.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -81.72 124.07 29.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.745 178.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -63.38 -43.69 96.89 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.497 -171.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.29 -45.19 81.27 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -63.61 -49.94 71.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.015 -177.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 239' ' ' LEU . . . . . 0.607 HD12 ' N ' ' B' ' 240' ' ' ASN . 4.5 pp -64.03 -41.3 97.47 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 121.152 -0.219 . . . . 0.0 111.339 -176.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 240' ' ' ASN . . . . . 0.607 ' N ' HD12 ' B' ' 239' ' ' LEU . 25.5 t-20 -70.36 -34.99 73.28 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.658 -178.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 241' ' ' LYS . . . . . 0.691 ' O ' ' HG2' ' B' ' 245' ' ' GLU . 5.1 mmmp? -71.43 -39.74 70.86 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.808 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 242' ' ' VAL . . . . . . . . . . . . . 19.9 m -69.84 -31.51 48.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 119.566 -0.853 . . . . 0.0 108.949 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 243' ' ' ILE . . . . . 0.483 ' HA ' ' CD2' ' B' ' 246' ' ' LEU . 20.5 mt -68.79 -36.42 74.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.945 175.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 97.0 p -71.4 -32.46 68.45 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.638 178.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 245' ' ' GLU . . . . . 0.691 ' HG2' ' O ' ' B' ' 241' ' ' LYS . 7.1 mm-40 -74.76 -34.97 62.57 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.444 178.04 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 246' ' ' LEU . . . . . 0.483 ' CD2' ' HA ' ' B' ' 243' ' ' ILE . 1.0 OUTLIER -85.4 -10.1 56.68 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.139 0.495 . . . . 0.0 110.639 178.75 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -52.44 -54.01 37.84 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.596 -176.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -94.4 58.35 1.96 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.596 -176.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -135.77 163.03 31.13 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 250' ' ' ASN . . . . . 0.402 ' O ' HG13 ' B' ' 254' ' ' VAL . 5.4 m-20 -70.01 84.52 0.51 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.581 -178.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.552 HD11 ' CD1' ' B' ' 207' ' ' TYR . 0.6 OUTLIER -55.27 -39.26 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.674 0.749 . . . . 0.0 111.112 176.57 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.02 -35.76 82.23 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.075 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -72.0 -45.56 60.51 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.576 0.227 . . . . 0.0 110.54 177.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 254' ' ' VAL . . . . . 0.459 HG22 ' HA ' ' B' ' 251' ' ' ILE . 12.3 m -64.63 -32.36 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.326 -176.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 255' ' ' ILE . . . . . 0.533 ' HA ' ' OH ' ' A' ' 11' ' ' TYR . 56.3 mt -82.45 -36.14 13.36 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-O 120.985 0.421 . . . . 0.0 111.139 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -68.5 -54.17 18.54 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.72 -178.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -152.33 38.19 0.55 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -175.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 258' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' B' ' 254' ' ' VAL . . . -104.08 37.76 3.6 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.144 -1.026 . . . . 0.0 112.792 -177.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 259' ' ' ILE . . . . . 0.41 ' H ' HG13 ' B' ' 259' ' ' ILE . 13.0 mt . . . . . 0 N--CA 1.467 0.414 0 CA-C-O 120.988 0.423 . . . . 0.0 110.818 -178.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 120.771 0.319 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.571 ' HA ' HD12 ' A' ' 7' ' ' LEU . 2.8 m -70.02 -25.06 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 CA-C-O 120.992 0.425 . . . . 0.0 110.537 -177.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.602 ' HB2' HG23 ' A' ' 39' ' ' VAL . 3.4 p -68.36 -52.73 29.93 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 121.48 0.657 . . . . 0.0 110.015 175.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.558 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 41.8 tt0 -62.56 -41.57 99.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.174 178.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.633 HD13 ' CG2' ' B' ' 255' ' ' ILE . 49.2 mt -53.98 -47.31 71.51 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.314 174.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.418 ' HB2' HG11 ' A' ' 37' ' ' VAL . . . -57.34 -53.12 61.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.685 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.558 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 7.2 p -67.54 -28.3 67.69 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.7 -176.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.446 HG13 HD23 ' A' ' 59' ' ' LEU . 0.7 OUTLIER -76.06 -40.76 37.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 120.895 0.379 . . . . 0.0 111.09 179.708 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.409 ' HB2' ' CD1' ' B' ' 209' ' ' LEU . 19.9 m-85 -71.03 -28.63 64.53 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.5 m -68.66 -45.86 70.63 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.102 173.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.5 -51.18 28.59 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.057 0.456 . . . . 0.0 110.572 173.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 10' ' ' ILE . 35.5 mt -61.23 -48.82 79.72 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.921 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.492 HD11 ' HA ' ' B' ' 206' ' ' SER . 83.8 mt -62.57 -37.29 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.789 0.328 . . . . 0.0 111.453 -178.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.706 HD23 ' HA ' ' A' ' 23' ' ' VAL . 10.8 mp -74.11 -22.14 59.6 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.895 177.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.496 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 51.4 t-80 -94.16 61.03 2.85 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.831 172.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -124.81 -55.62 1.6 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 174.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -117.19 -161.88 0.83 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -81.48 43.65 0.75 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.482 0.658 . . . . 0.0 111.845 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.522 HG11 HD11 ' B' ' 232' ' ' ILE . 7.6 p -94.05 128.54 45.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.099 0.476 . . . . 0.0 110.102 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.403 ' C ' ' H ' ' A' ' 24' ' ' THR . 33.5 p -56.08 123.69 15.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.81 -178.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.706 ' HA ' HD23 ' A' ' 16' ' ' LEU . 8.6 p -76.87 24.73 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-O 121.643 0.735 . . . . 0.0 111.144 -177.164 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.403 ' H ' ' C ' ' A' ' 22' ' ' THR . 6.6 t -92.49 168.13 11.48 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 121.679 0.752 . . . . 0.0 110.938 -174.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -25.83 67.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.778 -168.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -49.04 -50.89 34.17 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.521 0.677 . . . . 0.0 109.311 170.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -82.13 -38.14 25.2 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.931 -172.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.59 HG13 HD22 ' A' ' 16' ' ' LEU . 1.5 mt -62.93 -48.77 86.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.519 177.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -63.62 -39.58 94.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.125 177.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.92 -49.01 76.91 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.036 0.446 . . . . 0.0 110.914 176.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.407 HD21 HD12 ' A' ' 15' ' ' ILE . 44.0 tp -67.68 -36.01 79.9 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.294 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.3 mp -58.72 -37.04 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.193 174.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -77.06 -29.78 55.23 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.645 176.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.423 ' HB1' ' HA ' ' B' ' 226' ' ' ILE . . . -57.7 -45.27 85.89 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.936 176.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.44 -51.54 6.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.096 178.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.74 38.9 2.65 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.029 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.57 HG22 ' HA3' ' B' ' 213' ' ' GLY . 3.5 t -98.37 135.01 34.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.769 0.319 . . . . 0.0 110.688 -177.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -86.61 94.59 9.51 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.232 0.539 . . . . 0.0 110.504 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.602 HG23 ' HB2' ' A' ' 5' ' ' SER . 5.1 p -113.51 135.05 54.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.196 177.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -48.29 108.92 1.01 Allowed Pre-proline 0 N--CA 1.466 0.371 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.473 174.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -47.53 -18.49 0.9 Allowed 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 124.189 3.259 . . . . 0.0 114.266 -173.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -68.03 -38.74 82.9 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.723 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.566 ' O ' ' HB2' ' A' ' 47' ' ' PHE . 62.8 m95 -66.38 -59.08 8.98 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.387 178.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.552 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 73.0 Cg_exo -52.09 -47.69 25.4 Favored 'Trans proline' 0 C--N 1.363 1.324 0 C-N-CA 122.253 1.969 . . . . 0.0 112.715 177.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.17 -57.48 18.24 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.054 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.74 -43.91 85.7 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.63 ' O ' HD13 ' A' ' 51' ' ' LEU . 1.1 t80 -59.61 -55.23 37.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.092 0.473 . . . . 0.0 110.678 -177.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.475 ' HB2' HD12 ' A' ' 28' ' ' ILE . . . -61.99 -32.4 72.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.53 -176.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.486 ' HE2' ' HA ' ' A' ' 49' ' ' LYS . 9.1 mmpt? -87.04 -14.94 40.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.607 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.89 -27.85 16.85 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.656 ' HA ' HG23 ' A' ' 54' ' ' VAL . 5.8 mp -75.21 -113.32 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.817 177.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 61.42 -6.93 0.11 Allowed 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 178.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.434 ' H ' ' C ' ' A' ' 51' ' ' LEU . 47.3 t30 -144.08 -39.2 0.29 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.656 HG23 ' HA ' ' A' ' 51' ' ' LEU . 16.0 t -44.95 104.43 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.838 174.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -39.99 -82.66 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 O-C-N 124.312 1.007 . . . . 0.0 111.515 -176.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.592 ' O ' HD12 ' A' ' 59' ' ' LEU . 0.9 OUTLIER -157.08 -66.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.58 172.408 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.21 -23.87 53.88 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.287 -0.482 . . . . 0.0 113.603 -171.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.495 ' HB2' ' CG1' ' A' ' 54' ' ' VAL . 14.5 m -60.69 -14.21 19.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.595 0.236 . . . . 0.0 111.587 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.602 HD13 ' N ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -62.88 -14.54 47.52 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.983 0.42 . . . . 0.0 110.543 179.386 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.602 ' N ' HD13 ' A' ' 59' ' ' LEU . 9.0 tt -77.61 -4.6 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.055 -178.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 98.9 m -69.22 104.2 2.14 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.336 0.589 . . . . 0.0 110.866 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -75.88 65.33 1.96 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.218 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 63' ' ' VAL . 5.1 t . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.213 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 203' ' ' TYR . . . . . 0.495 ' CD2' ' HA ' ' B' ' 239' ' ' LEU . 59.0 m-85 . . . . . 0 N--CA 1.471 0.617 0 CA-C-O 121.097 0.475 . . . . 0.0 111.669 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.755 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 15.5 m -59.52 -49.05 85.05 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.193 177.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 205' ' ' ALA . . . . . 0.491 ' HA ' HD12 ' B' ' 208' ' ' LEU . . . -73.31 -15.59 61.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.064 0.459 . . . . 0.0 110.618 -177.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 206' ' ' SER . . . . . 0.493 ' HB3' HG23 ' B' ' 223' ' ' ILE . 6.5 m -71.02 -49.22 47.45 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 172.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 207' ' ' TYR . . . . . 0.507 ' CZ ' ' HD2' ' B' ' 218' ' ' PRO . 24.4 t80 -60.76 -40.87 94.09 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 174.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.755 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 79.3 mt -59.71 -51.68 68.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.168 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 209' ' ' LEU . . . . . 0.409 ' CD1' ' HB2' ' A' ' 11' ' ' TYR . 8.4 tp -59.7 -49.75 76.51 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.862 0.363 . . . . 0.0 110.612 -178.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -61.84 -34.03 75.22 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.2 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 211' ' ' ALA . . . . . . . . . . . . . . . -79.4 -36.25 39.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.032 0.444 . . . . 0.0 110.79 178.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 212' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.32 -46.69 85.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.202 177.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 213' ' ' GLY . . . . . 0.57 ' HA3' HG22 ' A' ' 37' ' ' VAL . . . -150.38 69.59 0.32 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.694 -1.241 . . . . 0.0 112.929 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . -168.71 -66.51 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.276 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 215' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -156.89 132.05 9.09 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -178.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 2.1 m -51.34 -30.83 19.87 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.652 -178.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 18.0 p -121.79 76.62 38.28 Favored Pre-proline 0 N--CA 1.442 -0.867 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.667 -177.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 218' ' ' PRO . . . . . 0.507 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 75.6 Cg_exo -54.41 108.53 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.579 2.853 . . . . 0.0 112.651 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 30.8 m -84.66 155.93 21.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.695 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -51.62 -40.04 59.15 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.174 0.512 . . . . 0.0 110.706 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -60.55 -32.5 71.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.566 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -85.42 -30.75 23.32 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -177.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.53 HG22 HD11 ' B' ' 239' ' ' LEU . 1.8 mp -66.91 -42.06 88.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 172.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -60.71 -46.14 91.55 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.097 174.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -55.99 -43.92 78.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.375 177.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 226' ' ' ILE . . . . . 0.423 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . 1.0 OUTLIER -60.42 -42.39 90.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 178.706 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 93.5 mt -71.91 -39.02 69.81 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 121.214 -0.195 . . . . 0.0 111.378 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -67.45 -30.49 70.23 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.769 0.318 . . . . 0.0 111.146 177.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 56.1 m -69.36 -47.57 63.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.293 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 11.4 p -79.53 -27.21 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.075 0.464 . . . . 0.0 111.362 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 103.55 56.98 0.76 Allowed Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.374 174.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 232' ' ' ILE . . . . . 0.522 HD11 HG11 ' A' ' 21' ' ' VAL . 31.5 mt -133.65 125.98 50.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 176.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -60.17 131.1 49.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.917 0.389 . . . . 0.0 110.769 176.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -118.24 152.62 35.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.904 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -117.04 114.97 24.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.144 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -55.33 -37.65 67.7 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.64 -173.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.37 -62.0 1.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.01 0.433 . . . . 0.0 110.312 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.664 ' O ' HG23 ' B' ' 242' ' ' VAL . 86.5 mtm180 -63.62 -34.34 77.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.665 -177.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 239' ' ' LEU . . . . . 0.53 HD11 HG22 ' B' ' 223' ' ' ILE . 9.9 tt -62.6 -57.66 10.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.07 0.462 . . . . 0.0 110.939 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -66.62 -23.34 66.16 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.127 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 241' ' ' LYS . . . . . 0.412 ' HB2' ' HE3' ' B' ' 241' ' ' LYS . 35.3 ttmt -68.34 -46.88 68.98 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 120.983 0.421 . . . . 0.0 110.74 176.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 242' ' ' VAL . . . . . 0.664 HG23 ' O ' ' B' ' 238' ' ' ARG . 52.2 t -67.44 -32.95 59.46 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 40.1 mt -75.9 -22.57 15.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.704 176.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 36.1 t -71.19 -37.41 72.14 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.656 174.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -85.86 -26.0 25.91 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.325 0.583 . . . . 0.0 110.353 175.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 246' ' ' LEU . . . . . 0.687 HD13 ' O ' ' B' ' 246' ' ' LEU . 0.0 OUTLIER -121.51 97.56 5.56 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.88 0.848 . . . . 0.0 109.678 -177.41 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 247' ' ' ASN . . . . . 0.505 ' CG ' ' H ' ' B' ' 248' ' ' GLY . 25.2 p-10 -146.79 -74.92 0.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.108 177.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 248' ' ' GLY . . . . . 0.505 ' H ' ' CG ' ' B' ' 247' ' ' ASN . . . -106.72 55.06 0.55 Allowed Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -177.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -117.07 57.85 0.78 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.731 -0.234 . . . . 0.0 110.83 -177.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 60.81 67.5 0.82 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.655 0.597 . . . . 0.0 111.477 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.501 ' HA ' HG22 ' B' ' 254' ' ' VAL . 1.8 mm -60.93 -48.79 87.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.97 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -60.44 -29.4 68.99 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.524 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 253' ' ' ASP . . . . . 0.531 ' O ' ' HG2' ' B' ' 257' ' ' GLN . 27.9 t70 -76.66 -47.49 21.95 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.961 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 254' ' ' VAL . . . . . 0.501 HG22 ' HA ' ' B' ' 251' ' ' ILE . 28.8 m -62.47 -29.86 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.597 0.237 . . . . 0.0 111.164 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 255' ' ' ILE . . . . . 0.633 ' CG2' HD13 ' A' ' 7' ' ' LEU . 61.9 mt -88.03 -24.89 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-O 120.827 0.346 . . . . 0.0 110.746 175.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -66.74 -38.99 87.75 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.018 -0.426 . . . . 0.0 111.281 177.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 257' ' ' GLN . . . . . 0.557 ' HG3' ' H ' ' B' ' 258' ' ' GLY . 4.6 pt20 -69.5 -81.96 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 258' ' ' GLY . . . . . 0.557 ' H ' ' HG3' ' B' ' 257' ' ' GLN . . . 175.44 -90.39 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.249 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 259' ' ' ILE . . . . . 0.447 ' CD1' HG13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 114.91 -0.645 . . . . 0.0 110.732 -179.018 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.548 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 36.7 m . . . . . 0 N--CA 1.469 0.522 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.465 HG12 ' CD1' ' B' ' 212' ' ' LEU . 15.4 m -72.26 -16.26 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.76 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -68.67 0.36 Allowed 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.674 176.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.478 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 3.2 pm0 -56.2 -43.03 78.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.46 178.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.55 HD22 ' OH ' ' A' ' 11' ' ' TYR . 38.2 mt -54.32 -57.89 9.51 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.327 176.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.44 ' HB2' HD21 ' B' ' 212' ' ' LEU . . . -54.93 -50.33 69.11 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -176.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.478 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 26.4 p -70.7 -33.8 71.27 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.763 -173.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.36 -25.49 12.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.946 0.403 . . . . 0.0 110.576 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.581 ' OH ' HG23 ' B' ' 255' ' ' ILE . 20.7 m-30 -76.05 -28.78 57.8 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 172.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.415 ' OG ' HG12 ' A' ' 28' ' ' ILE . 7.5 t -68.3 -50.64 52.15 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.669 174.086 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.21 -47.95 68.52 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 173.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.658 HD21 HG22 ' B' ' 259' ' ' ILE . 11.4 mt -52.06 -61.64 2.13 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.057 177.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.588 HD11 ' HA ' ' B' ' 206' ' ' SER . 56.5 mt -62.72 -46.29 96.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.197 0.522 . . . . 0.0 111.297 -176.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.451 ' HG ' HG12 ' A' ' 23' ' ' VAL . 25.1 tp -70.65 -15.29 62.72 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.601 -173.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -125.62 37.92 4.27 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 119.362 -0.935 . . . . 0.0 112.112 173.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -81.21 -57.75 3.36 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 167.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -81.5 174.1 11.76 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.332 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -84.23 39.04 0.69 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.33 0.586 . . . . 0.0 111.171 -175.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.401 HG11 ' CD1' ' B' ' 232' ' ' ILE . 14.6 p -92.57 142.72 12.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.028 177.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.0 p -72.17 133.88 45.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.43 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.451 HG12 ' HG ' ' A' ' 16' ' ' LEU . 16.0 m -87.8 132.67 32.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.359 -179.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.5 p -147.06 158.39 43.92 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.907 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -45.76 -55.91 5.95 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.909 0.755 . . . . 0.0 111.361 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.43 -31.52 64.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.807 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -80.14 -39.1 30.13 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.494 -177.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.415 HG12 ' OG ' ' A' ' 12' ' ' SER . 4.0 mt -63.88 -47.03 92.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -55.1 -43.75 74.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.767 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.87 -47.88 83.95 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.682 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.4 mt -63.4 -39.49 94.65 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.855 0.359 . . . . 0.0 111.007 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 mp -60.01 -45.5 95.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.433 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -72.35 -25.41 61.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.811 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.81 -37.25 81.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.3 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.68 -37.73 19.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.035 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 123.0 -41.95 1.7 Allowed Glycine 0 CA--C 1.519 0.322 0 C-N-CA 119.946 -1.121 . . . . 0.0 114.005 173.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.2 m -95.01 151.63 3.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.754 0.277 . . . . 0.0 111.235 -176.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -109.47 -176.05 2.92 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.605 0.717 . . . . 0.0 111.391 -171.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.0 p -153.46 152.76 9.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.919 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -47.37 116.46 4.3 Favored Pre-proline 0 N--CA 1.47 0.535 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 175.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.406 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 88.8 Cg_exo -49.31 -14.49 0.56 Allowed 'Trans proline' 0 N--CA 1.485 0.986 0 C-N-CA 124.175 3.25 . . . . 0.0 114.863 -172.001 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.475 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -79.57 -21.0 45.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.015 -175.734 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.463 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 69.0 m95 -72.75 -52.41 6.12 Favored Pre-proline 0 CA--C 1.537 0.448 0 O-C-N 123.003 0.189 . . . . 0.0 110.548 175.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 74.5 Cg_exo -51.45 -51.5 11.06 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 122.137 1.891 . . . . 0.0 111.569 171.521 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.45 -37.85 92.66 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.117 177.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 39.3 tp -60.98 -56.62 18.93 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -60.01 -36.29 76.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.588 0.232 . . . . 0.0 111.022 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.6 -39.54 94.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.871 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -92.72 -11.43 33.97 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.45 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.33 -50.87 5.43 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.748 ' HA ' HG23 ' A' ' 54' ' ' VAL . 9.2 mt -85.61 -130.94 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.904 -175.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 75.79 -10.61 1.24 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.842 0.857 . . . . 0.0 113.047 175.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -143.8 -45.55 0.27 Allowed 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.748 HG23 ' HA ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -51.2 129.62 10.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 113.428 -1.714 . . . . 0.0 111.609 174.78 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -51.7 157.53 1.14 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.84 -1.527 . . . . 0.0 111.381 175.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.514 ' O ' HD22 ' A' ' 59' ' ' LEU . 3.4 tp -46.98 -50.82 5.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.803 -175.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.15 -15.48 10.77 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.627 -0.32 . . . . 0.0 113.722 -173.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.6 t -62.18 -23.3 66.53 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.514 HD22 ' O ' ' A' ' 56' ' ' ILE . 1.1 pt? -74.33 -10.36 59.51 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.359 -177.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.577 HG12 HD12 ' B' ' 259' ' ' ILE . 14.7 mt -86.86 -6.59 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-O 121.757 0.789 . . . . 0.0 109.527 176.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 66.0 m -82.72 90.45 6.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.563 176.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -77.67 69.91 3.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.121 0.962 . . . . 0.0 110.259 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.4 t . . . . . 0 C--N 1.32 -0.685 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.023 178.798 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 203' ' ' TYR . . . . . 0.523 ' CD1' ' HA ' ' B' ' 239' ' ' LEU . 71.8 m-85 . . . . . 0 C--O 1.239 0.514 0 CA-C-O 121.177 0.513 . . . . 0.0 110.52 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.802 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 2.5 m -58.11 -65.2 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.635 178.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 205' ' ' ALA . . . . . 0.577 ' H ' HG23 ' B' ' 204' ' ' VAL . . . -64.6 -13.67 54.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 206' ' ' SER . . . . . 0.588 ' HA ' HD11 ' A' ' 15' ' ' ILE . 4.1 m -75.74 -50.68 14.6 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 175.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 207' ' ' TYR . . . . . 0.498 ' HD1' HD11 ' B' ' 251' ' ' ILE . 15.7 t80 -62.71 -35.21 79.0 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 174.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.802 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 71.3 mt -64.3 -49.3 72.34 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.983 176.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 209' ' ' LEU . . . . . 0.53 HD21 ' HB2' ' A' ' 11' ' ' TYR . 11.4 mt -54.64 -49.91 69.43 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.785 0.326 . . . . 0.0 110.857 177.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 210' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' B' ' 218' ' ' PRO . . . -59.93 -48.69 80.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.233 -177.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 211' ' ' ALA . . . . . 0.651 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -65.18 -43.87 90.3 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.831 0.348 . . . . 0.0 110.977 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 212' ' ' LEU . . . . . 0.465 ' CD1' HG12 ' A' ' 4' ' ' VAL . 2.3 tp -61.44 -32.46 72.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.162 178.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -76.09 -11.78 84.57 Favored Glycine 0 N--CA 1.454 -0.135 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.769 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 122.22 1.14 10.38 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.278 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 215' ' ' ASN . . . . . 0.651 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 93.8 m-20 -98.44 102.91 14.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.115 0.458 . . . . 0.0 110.758 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 216' ' ' SER . . . . . 0.408 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 5.3 m -66.34 -17.78 64.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.213 178.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 14.2 t -128.07 69.74 77.67 Favored Pre-proline 0 N--CA 1.443 -0.816 0 CA-C-O 120.96 0.409 . . . . 0.0 110.355 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 218' ' ' PRO . . . . . 0.453 ' HB3' ' HB3' ' B' ' 210' ' ' ALA . 50.2 Cg_exo -58.85 102.49 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.072 2.515 . . . . 0.0 112.738 178.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 18.0 m -72.32 144.03 48.46 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.267 178.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 220' ' ' ALA . . . . . 0.456 ' HB1' HD21 ' B' ' 239' ' ' LEU . . . -56.52 -28.64 60.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.723 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -73.65 -27.03 61.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.494 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -79.8 -38.63 32.59 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.508 HG23 ' HB3' ' B' ' 206' ' ' SER . 1.8 mp -63.45 -45.2 98.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 173.088 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -58.02 -41.2 82.66 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.244 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -61.32 -41.7 97.44 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.317 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.73 -25.31 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.593 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -78.04 -44.7 25.69 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.765 0.316 . . . . 0.0 110.94 173.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -70.29 -15.79 62.93 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.489 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 86.8 p -51.47 -51.65 53.18 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.91 0.386 . . . . 0.0 110.633 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 60.9 t -87.28 -23.85 6.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.347 0.594 . . . . 0.0 110.371 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 101.92 41.0 2.55 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.143 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 232' ' ' ILE . . . . . 0.401 ' CD1' HG11 ' A' ' 21' ' ' VAL . 36.5 mt -103.84 136.7 35.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -73.66 145.87 44.97 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -143.0 121.65 12.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.383 -175.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 235' ' ' ASP . . . . . 0.495 ' HB2' ' HB2' ' B' ' 238' ' ' ARG . 8.0 m-20 -58.26 113.82 2.12 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.105 177.123 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 236' ' ' ASP . . . . . 0.52 ' O ' ' HB3' ' B' ' 239' ' ' LEU . 6.8 m-20 -61.75 -37.48 84.42 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.816 0.341 . . . . 0.0 111.648 -177.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -73.76 -46.77 43.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.921 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.495 ' HB2' ' HB2' ' B' ' 235' ' ' ASP . 41.8 mtp-105 -64.54 -29.03 70.05 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 239' ' ' LEU . . . . . 0.523 ' HA ' ' CD1' ' B' ' 203' ' ' TYR . 13.5 tp -54.07 -69.54 0.12 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.96 175.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -66.47 -24.28 66.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.463 -176.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -60.96 -53.91 51.5 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 120.866 0.365 . . . . 0.0 111.173 175.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 242' ' ' VAL . . . . . . . . . . . . . 33.0 m -73.62 -28.37 24.7 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -176.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 243' ' ' ILE . . . . . 0.472 ' HA ' HD12 ' B' ' 246' ' ' LEU . 37.4 mt -70.67 -31.41 45.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.438 175.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 71.6 m -66.71 -35.25 79.69 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 172.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.79 -40.7 75.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.219 175.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 246' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' B' ' 243' ' ' ILE . 39.9 mt -67.48 -29.78 69.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.488 174.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -59.77 -32.8 70.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.131 -171.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -112.41 17.43 23.77 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.346 -175.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -124.41 151.97 43.82 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 250' ' ' ASN . . . . . 0.401 HD21 ' HB3' ' B' ' 252' ' ' GLU . 48.8 t30 -64.91 119.71 11.2 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 121.241 0.543 . . . . 0.0 110.875 -178.059 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.498 HD11 ' HD1' ' B' ' 207' ' ' TYR . 0.4 OUTLIER -59.16 -31.8 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.67 -177.818 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 252' ' ' GLU . . . . . 0.401 ' HB3' HD21 ' B' ' 250' ' ' ASN . 40.9 tt0 -69.88 -40.93 75.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.814 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -65.8 -38.16 88.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.802 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 254' ' ' VAL . . . . . 0.41 HG22 ' HA ' ' B' ' 251' ' ' ILE . 17.7 m -76.2 -22.11 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.457 176.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 255' ' ' ILE . . . . . 0.581 HG23 ' OH ' ' A' ' 11' ' ' TYR . 27.9 mt -64.12 -43.43 97.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-O 121.431 0.634 . . . . 0.0 109.613 169.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -78.06 -27.27 48.64 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.981 -178.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -130.52 76.17 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -176.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -108.31 -66.85 0.6 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 172.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 259' ' ' ILE . . . . . 0.658 HG22 HD21 ' A' ' 14' ' ' LEU . 1.6 pt . . . . . 0 C--N 1.331 -0.2 0 CA-C-O 122.181 0.991 . . . . 0.0 108.665 169.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ppp? . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 110.546 -0.168 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.0 -7.6 1.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 172.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.578 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 3.8 p -86.03 52.29 2.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.985 0.421 . . . . 0.0 111.276 -175.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.8 p -63.87 -33.02 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.649 -172.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.407 ' HB3' HG23 ' A' ' 39' ' ' VAL . 3.9 m -58.71 -66.1 0.55 Allowed 'General case' 0 C--O 1.244 0.781 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.132 -177.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -64.91 -30.85 71.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.3 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 3' ' ' SER . 54.1 mt -57.27 -60.18 4.01 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.592 173.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.411 ' HB2' HD11 ' B' ' 212' ' ' LEU . . . -55.89 -45.55 78.59 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.854 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 48.6 t -63.3 -36.78 84.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.848 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.49 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 0.9 OUTLIER -73.87 -40.04 52.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 120.621 0.248 . . . . 0.0 111.347 -179.003 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.554 ' OH ' ' HA ' ' B' ' 255' ' ' ILE . 22.1 m-85 -68.69 -37.69 79.74 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.482 ' OG ' ' HA ' ' A' ' 28' ' ' ILE . 46.1 t -64.36 -44.28 91.94 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.659 175.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.49 -57.51 11.08 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.129 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.498 HD11 ' CB ' ' B' ' 205' ' ' ALA . 3.7 pp -70.43 -22.1 62.75 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.623 -0.431 . . . . 0.0 112.038 -177.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.42 ' N ' HD12 ' A' ' 14' ' ' LEU . 13.4 mt -71.3 -33.92 52.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.233 174.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.6 mt -86.94 -8.51 57.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.062 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -17.27 -78.26 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 115.319 1.599 . . . . 0.0 115.319 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -158.97 73.61 0.61 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.261 0.553 . . . . 0.0 109.951 -168.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.448 ' HB2' HG12 ' A' ' 21' ' ' VAL . 3.7 m-20 -132.46 -158.56 0.9 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.637 -174.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -69.11 -13.57 62.51 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.264 0.554 . . . . 0.0 109.782 172.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.493 ' HB ' HG12 ' B' ' 232' ' ' ILE . 5.1 p -96.28 160.85 2.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.528 -174.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.9 p -107.61 143.14 36.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.135 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.3 t -78.28 83.91 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.0 p -131.95 163.58 28.05 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -52.2 -49.96 62.86 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.93 -176.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -54.81 -36.19 64.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.317 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.541 ' HD2' ' HB ' ' B' ' 230' ' ' VAL . 75.4 mmtt -79.9 -44.03 21.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.315 -171.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.482 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 9.1 mt -62.02 -46.07 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.037 173.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -57.8 -39.07 76.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.488 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.25 -40.35 86.27 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.817 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.435 HD22 HG23 ' B' ' 226' ' ' ILE . 60.8 mt -70.35 -42.61 71.62 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 120.939 0.399 . . . . 0.0 110.391 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.454 HD13 ' O ' ' A' ' 28' ' ' ILE . 1.7 mp -59.84 -37.95 74.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.156 174.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -70.76 -37.53 73.4 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.771 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.41 -34.51 77.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.244 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.463 ' HB2' HD12 ' B' ' 209' ' ' LEU . . . -90.82 -31.73 16.36 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.659 -0.417 . . . . 0.0 111.813 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.66 35.48 6.86 Favored Glycine 0 CA--C 1.517 0.162 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.958 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.686 HG13 ' HA2' ' B' ' 213' ' ' GLY . 0.0 OUTLIER -97.32 173.77 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.025 0.441 . . . . 0.0 111.698 -178.017 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -121.46 106.43 11.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.571 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.407 HG23 ' HB3' ' A' ' 5' ' ' SER . 14.4 p -129.66 137.94 55.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 174.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.56 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 12.8 pt-20 -67.16 135.24 93.65 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.495 ' HA ' ' HG2' ' A' ' 44' ' ' PRO . 9.5 Cg_endo -52.75 -11.57 1.42 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 124.097 3.198 . . . . 0.0 113.745 -173.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.04 -41.23 82.38 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.056 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.418 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 89.4 m95 -68.08 -58.24 8.05 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.236 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HD2' ' O ' ' A' ' 40' ' ' GLU . 12.5 Cg_endo -56.43 -43.83 51.76 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.411 2.074 . . . . 0.0 112.753 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.94 -52.98 46.57 Favored Glycine 0 C--O 1.24 0.493 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.913 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 52.4 tp -59.94 -48.49 81.5 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.454 ' CD2' HD11 ' A' ' 51' ' ' LEU . 1.7 m-85 -56.42 -46.8 80.07 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.286 0.367 . . . . 0.0 111.865 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.62 -30.11 66.68 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -89.33 -12.69 39.79 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.442 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.5 -32.29 10.02 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.674 ' HA ' HG23 ' A' ' 54' ' ' VAL . 52.6 mt -88.38 -131.02 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.293 -176.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 68.97 -12.61 0.38 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.953 0.901 . . . . 0.0 112.901 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -143.76 6.02 1.39 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.904 0.859 . . . . 0.0 110.171 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.674 HG23 ' HA ' ' A' ' 51' ' ' LEU . 1.5 t -103.05 87.55 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.802 -174.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -7.46 -95.55 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.724 1.61 . . . . 0.0 114.689 -168.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.719 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 1.2 tp -153.69 -66.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.278 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.439 ' H ' HG23 ' A' ' 56' ' ' ILE . . . -59.03 -14.72 25.82 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.799 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.658 ' CB ' HG12 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -47.73 -42.63 25.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.567 -0.816 . . . . 0.0 111.598 175.205 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.719 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 0.9 OUTLIER -65.15 -12.33 49.82 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -174.507 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.563 HG12 ' HB ' ' B' ' 259' ' ' ILE . 65.2 mt -68.29 -29.01 42.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 121.2 0.524 . . . . 0.0 110.239 176.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 83.7 m -135.5 34.08 2.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.364 -176.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.438 ' HB2' ' HA ' ' A' ' 59' ' ' LEU . 64.2 t30 -70.63 -21.08 62.67 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.212 0.53 . . . . 0.0 110.721 -177.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.4 t -76.04 -20.48 15.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.393 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.78 -56.44 0.67 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.573 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -165.89 -70.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.039 0.447 . . . . 0.0 110.441 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.6 -138.12 11.7 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.723 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 165.57 178.41 38.59 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.81 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -86.71 -177.76 2.4 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.781 2.321 . . . . 0.0 112.456 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.52 124.72 9.76 Favored Pre-proline 0 N--CA 1.45 -0.434 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.23 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.73 146.69 54.87 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.915 2.41 . . . . 0.0 112.337 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -134.66 176.47 8.6 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.656 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.62 163.78 37.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.36 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.81 152.29 21.65 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.905 -0.665 . . . . 0.0 111.75 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.46 138.32 38.62 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.919 0.39 . . . . 0.0 110.778 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.432 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -112.77 128.71 25.24 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.966 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 27.6 Cg_exo -69.07 158.09 59.22 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.57 2.847 . . . . 0.0 113.119 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -145.69 166.0 27.12 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.646 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -179.37 -153.33 11.6 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.606 -0.598 . . . . 0.0 111.606 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 164.19 161.08 12.63 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.97 130.42 14.39 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.845 2.363 . . . . 0.0 112.633 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.09 92.58 31.75 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.008 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -62.71 151.1 85.65 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.957 2.438 . . . . 0.0 113.114 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.0 t -149.78 130.79 14.36 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.681 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 p 54.25 168.85 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.49 1.119 . . . . 0.0 113.412 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -176.53 167.89 2.7 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.562 -177.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 67.9 143.96 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.984 0.802 . . . . 0.0 112.656 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.22 132.82 7.54 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.351 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -53.76 115.91 2.65 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.07 2.514 . . . . 0.0 112.901 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -128.3 80.08 1.94 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.373 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -70.99 98.52 1.63 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.434 0.635 . . . . 0.0 111.579 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -111.63 172.07 7.11 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.347 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.41 132.1 6.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.971 175.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -107.77 151.34 25.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.985 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.9 p -83.17 97.21 4.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.787 0.804 . . . . 0.0 110.976 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -142.27 138.49 31.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.291 176.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -120.18 -62.81 1.43 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.046 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.79 133.58 43.27 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.259 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -130.11 122.11 27.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.786 -176.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 52.97 28.57 6.79 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.198 0.599 . . . . 0.0 111.933 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -133.04 179.02 6.44 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.014 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 26.4 t -160.51 146.61 15.19 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -86.17 36.8 0.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.627 0.727 . . . . 0.0 110.013 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -170.3 122.92 0.67 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.102 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.1 t -162.95 143.17 9.27 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -139.37 -127.3 0.12 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -67.6 -39.79 84.78 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.324 0.583 . . . . 0.0 109.488 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 54.59 20.56 2.94 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.305 -1.316 . . . . 0.0 112.889 174.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 63.4 mtt -135.91 153.7 51.36 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 63.97 44.34 96.1 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.969 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -94.16 137.12 33.71 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.805 -0.232 . . . . 0.0 110.564 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -79.61 73.58 2.38 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.859 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.0 mt -130.15 32.09 4.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.938 0.399 . . . . 0.0 110.264 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -129.38 157.6 41.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.409 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.2 t70 . . . . . 0 C--O 1.247 0.958 0 CA-C-O 118.453 -0.784 . . . . 0.0 108.999 -179.194 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 200' ' ' ALA . . . . . 0.503 ' HB1' ' HB2' ' B' ' 267' ' ' ALA . . . . . . . . 0 N--CA 1.477 0.896 0 CA-C-O 120.797 0.332 . . . . 0.0 110.336 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 55.4 mtp -133.39 154.79 50.45 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 202' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' B' ' 263' ' ' ALA . 73.7 mtt180 -128.34 -128.39 0.22 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.758 0.313 . . . . 0.0 111.212 -176.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -115.61 16.7 16.47 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.057 0.456 . . . . 0.0 110.019 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.536 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 58.2 t -62.33 -50.68 78.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.708 -173.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 205' ' ' ALA . . . . . 0.8 ' HB2' ' HB3' ' B' ' 262' ' ' LEU . . . -69.34 -18.61 63.82 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.174 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 206' ' ' SER . . . . . 0.501 ' OG ' HG23 ' B' ' 223' ' ' ILE . 9.4 t -73.01 -40.08 65.47 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 207' ' ' TYR . . . . . 0.695 ' CE1' HD11 ' B' ' 251' ' ' ILE . 57.0 t80 -61.01 -37.45 82.57 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 171.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.568 ' O ' ' HB3' ' B' ' 212' ' ' LEU . 83.1 mt -66.18 -40.46 90.45 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.728 176.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 209' ' ' LEU . . . . . 0.463 HD12 ' HB2' ' A' ' 35' ' ' ALA . 3.2 mm? -57.27 -45.26 84.21 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 174.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -63.37 -48.96 75.75 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.587 0.232 . . . . 0.0 111.562 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.93 -50.09 52.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.757 0.313 . . . . 0.0 111.611 -176.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 212' ' ' LEU . . . . . 0.568 ' HB3' ' O ' ' B' ' 208' ' ' LEU . 0.0 OUTLIER -67.22 -25.0 65.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.048 -178.873 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 213' ' ' GLY . . . . . 0.686 ' HA2' HG13 ' A' ' 37' ' ' VAL . . . -56.79 -22.07 39.18 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.344 -0.455 . . . . 0.0 112.54 175.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 112.47 22.65 5.72 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.562 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 215' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -138.83 95.05 2.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.126 0.488 . . . . 0.0 110.201 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 17.7 m -78.04 57.61 1.82 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.806 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 17.6 t -147.06 100.28 3.92 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 218' ' ' PRO . . . . . 0.428 ' HB3' ' HE2' ' B' ' 207' ' ' TYR . 51.6 Cg_exo -59.82 92.69 0.09 OUTLIER 'Trans proline' 0 N--CA 1.474 0.353 0 C-N-CA 123.478 2.785 . . . . 0.0 113.992 -176.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 50.1 m -96.14 103.15 15.02 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 171.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 220' ' ' ALA . . . . . 0.438 ' HB1' ' CD1' ' B' ' 239' ' ' LEU . . . -54.18 -31.16 52.08 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.376 0.608 . . . . 0.0 110.706 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -62.4 -36.58 82.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.877 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -80.47 -28.02 37.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.116 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.501 HG23 ' OG ' ' B' ' 206' ' ' SER . 1.8 mp -62.0 -48.68 87.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 168.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 224' ' ' LYS . . . . . 0.46 ' HE2' ' O ' ' B' ' 234' ' ' ALA . 3.3 tppp? -57.02 -41.1 77.92 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.328 173.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -58.31 -46.13 86.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.023 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 0.435 HG23 HD22 ' A' ' 31' ' ' LEU . 1.3 mp -65.23 -40.41 88.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.737 178.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.26 -42.93 92.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.023 0.439 . . . . 0.0 111.273 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -79.92 -22.11 43.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.585 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 99.3 p -53.14 -41.19 64.85 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.968 0.413 . . . . 0.0 111.482 -177.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 230' ' ' VAL . . . . . 0.541 ' HB ' ' HD2' ' A' ' 27' ' ' LYS . 8.1 m -100.9 -12.88 8.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.233 -176.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 100.58 67.99 0.84 Allowed Glycine 0 C--O 1.228 -0.267 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.107 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 232' ' ' ILE . . . . . 0.493 HG12 ' HB ' ' A' ' 21' ' ' VAL . 12.9 mt -129.19 141.22 47.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 175.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -79.23 83.89 5.24 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.384 0.611 . . . . 0.0 111.524 -176.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 234' ' ' ALA . . . . . 0.46 ' O ' ' HE2' ' B' ' 224' ' ' LYS . . . -93.68 143.01 26.71 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.738 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 235' ' ' ASP . . . . . 0.487 ' OD2' ' HG3' ' B' ' 238' ' ' ARG . 17.3 t70 -107.51 129.99 54.9 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.242 0.544 . . . . 0.0 110.991 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.85 -38.44 90.82 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.487 -172.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -71.63 -51.03 25.29 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -177.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.487 ' HG3' ' OD2' ' B' ' 235' ' ' ASP . 77.5 mtp180 -57.64 -41.53 81.61 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.461 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 239' ' ' LEU . . . . . 0.56 HD12 ' N ' ' B' ' 240' ' ' ASN . 4.5 pp -68.55 -44.04 75.35 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.996 -177.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 240' ' ' ASN . . . . . 0.56 ' N ' HD12 ' B' ' 239' ' ' LEU . 50.0 t30 -66.96 -32.1 73.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.0 0.428 . . . . 0.0 110.201 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 241' ' ' LYS . . . . . 0.513 ' O ' ' HG3' ' B' ' 245' ' ' GLU . 1.0 OUTLIER -67.13 -45.25 77.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.948 178.21 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 242' ' ' VAL . . . . . . . . . . . . . 18.1 m -71.79 -27.16 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.386 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 243' ' ' ILE . . . . . 0.502 HG13 ' O ' ' B' ' 239' ' ' LEU . 27.7 mt -71.48 -36.52 60.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.607 177.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 5.1 p -78.95 -14.48 59.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.79 0.329 . . . . 0.0 111.025 176.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 245' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' B' ' 241' ' ' LYS . 51.5 mt-10 -82.17 -30.76 30.82 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.988 0.423 . . . . 0.0 110.392 169.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 246' ' ' LEU . . . . . 0.592 HD12 ' O ' ' B' ' 246' ' ' LEU . 1.1 pp -99.58 2.56 44.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.343 -176.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -58.84 109.43 0.82 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.578 0.704 . . . . 0.0 112.045 -171.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 71.52 30.48 66.6 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.885 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -90.16 -160.93 0.74 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 110.493 -0.188 . . . . 0.0 110.493 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 250' ' ' ASN . . . . . 0.436 ' HB3' ' HB2' ' B' ' 253' ' ' ASP . 14.0 m-20 -72.9 81.33 1.18 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.929 0.395 . . . . 0.0 111.913 -174.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.695 HD11 ' CE1' ' B' ' 207' ' ' TYR . 2.0 mm -72.29 -54.4 16.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.827 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -61.53 -29.64 70.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.634 0.731 . . . . 0.0 110.448 -177.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 253' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' B' ' 250' ' ' ASN . 5.6 m-20 -77.22 -44.81 28.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.711 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 254' ' ' VAL . . . . . 0.469 HG12 ' O ' ' B' ' 251' ' ' ILE . 7.0 p -66.73 -23.79 31.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 121.054 0.454 . . . . 0.0 110.155 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 255' ' ' ILE . . . . . 0.554 ' HA ' ' OH ' ' A' ' 11' ' ' TYR . 44.8 mt -76.89 -55.61 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.933 175.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -66.3 -45.3 80.86 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -173.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -139.19 50.14 1.82 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.268 0.556 . . . . 0.0 111.156 -174.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 258' ' ' GLY . . . . . 0.531 ' O ' HD21 ' B' ' 262' ' ' LEU . . . -141.97 55.4 0.6 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.358 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 259' ' ' ILE . . . . . 0.563 ' HB ' HG12 ' A' ' 60' ' ' ILE . 1.2 mt -91.71 18.77 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.888 0.375 . . . . 0.0 111.073 -176.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -92.68 -94.21 1.44 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.808 -0.711 . . . . 0.0 114.078 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -90.39 94.57 9.79 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.551 -0.382 . . . . 0.0 110.63 -175.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 262' ' ' LEU . . . . . 0.8 ' HB3' ' HB2' ' B' ' 205' ' ' ALA . 3.4 mm? -114.16 -98.05 0.44 Allowed 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -176.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 263' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' B' ' 202' ' ' ARG . . . -136.76 140.83 42.85 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -175.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 264' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' B' ' 263' ' ' ALA . 32.3 t 168.98 -150.96 0.0 OUTLIER 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 3.2 p -50.09 117.13 7.24 Favored Pre-proline 0 C--O 1.239 0.509 0 O-C-N 123.542 0.526 . . . . 0.0 110.691 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.15 119.03 5.99 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.794 2.33 . . . . 0.0 112.165 -174.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 267' ' ' ALA . . . . . 0.503 ' HB2' ' HB1' ' B' ' 200' ' ' ALA . . . -47.08 135.49 9.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.66 -1.154 . . . . 0.0 112.204 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 143.13 -20.51 2.29 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.025 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . 83.48 -52.56 4.74 Favored Glycine 0 C--O 1.227 -0.313 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.322 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . 63.57 55.85 1.68 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 122.898 0.479 . . . . 0.0 111.587 176.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 5.2 p 43.83 112.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -150.22 116.51 5.72 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.722 -1.581 . . . . 0.0 110.706 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 46.4 t 51.98 75.36 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 121.459 0.647 . . . . 0.0 111.135 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 32.6 p -161.04 135.19 7.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.641 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -158.96 156.23 29.06 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.373 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 276' ' ' ALA . . . . . 0.466 ' HA ' ' HD3' ' B' ' 277' ' ' PRO . . . -108.12 142.66 25.78 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.956 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 277' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' B' ' 276' ' ' ALA . 19.6 Cg_exo -66.11 85.92 0.25 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.837 2.358 . . . . 0.0 112.442 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -138.72 76.27 0.35 Allowed Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.21 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 2.5 p -94.59 -166.39 1.47 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.913 0.387 . . . . 0.0 111.484 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . -45.73 126.36 6.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.763 175.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 281' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' B' ' 282' ' ' PRO . . . -71.27 126.35 91.88 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.44 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 282' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' B' ' 281' ' ' ALA . 25.5 Cg_exo -62.9 153.79 70.88 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.665 2.243 . . . . 0.0 111.801 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -76.12 -178.73 4.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.661 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -62.78 -23.29 67.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.091 0.472 . . . . 0.0 111.49 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 142.71 -19.92 2.38 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 25.8 t -113.1 -175.69 2.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.393 -0.404 . . . . 0.0 109.958 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . 66.32 85.87 0.15 Allowed Pre-proline 0 N--CA 1.472 0.631 0 C-N-CA 123.584 0.754 . . . . 0.0 112.175 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -80.86 155.59 20.37 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.317 2.011 . . . . 0.0 111.991 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -90.86 76.53 6.31 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.083 0.468 . . . . 0.0 110.789 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -72.85 156.86 38.45 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.645 176.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -53.89 -65.44 0.57 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.899 -174.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -117.72 65.21 0.74 Allowed 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.157 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -73.94 86.86 1.79 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.12 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 294' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' B' ' 294' ' ' LYS . 24.1 ttmm -162.4 5.5 0.05 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.495 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -119.58 110.11 16.48 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.83 0.348 . . . . 0.0 111.359 -174.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 66.61 96.06 0.06 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.682 174.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -54.02 120.33 6.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.656 175.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -121.25 125.28 46.7 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.631 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -105.83 107.86 19.07 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.779 177.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -124.53 -89.59 0.58 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 174.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 58.84 78.83 0.24 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.232 0.539 . . . . 0.0 112.241 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 35.0 p -139.52 115.58 10.32 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.222 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -150.77 -73.86 0.16 Allowed 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.037 0.446 . . . . 0.0 110.599 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -131.29 137.78 48.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.629 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 16.3 m -139.02 131.66 28.91 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.392 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -145.26 92.91 2.31 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.837 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 26.2 t70 67.55 117.26 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 124.501 1.126 . . . . 0.0 111.953 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 308' ' ' ASP . . . . . 0.418 ' C ' ' H ' ' B' ' 310' ' ' GLY . 15.7 m-20 -101.93 22.48 12.95 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.791 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 27.6 ttt 70.32 -34.79 0.3 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.936 0.894 . . . . 0.0 111.764 -177.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 310' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' B' ' 308' ' ' ASP . . . 55.41 65.51 3.5 Favored Glycine 0 N--CA 1.457 0.039 0 C-N-CA 121.416 -0.421 . . . . 0.0 112.824 175.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -139.6 -160.33 1.05 Allowed 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -177.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . 153.43 36.43 0.03 OUTLIER Glycine 0 C--N 1.313 -0.702 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.99 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 20.0 tp -104.42 76.49 1.31 Allowed 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 174.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 314' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -99.03 -2.41 37.31 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 112.764 -2.016 . . . . 0.0 110.997 -172.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 . . . . . 0 C--O 1.244 0.812 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.441 -176.183 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.9 153.58 35.56 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.54 -0.171 . . . . 0.0 110.54 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 t 57.5 52.07 8.95 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.456 0.646 . . . . 0.0 110.285 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.44 HG13 ' HG ' ' B' ' 212' ' ' LEU . 45.1 t -67.11 -33.73 65.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.895 -174.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.589 ' HB3' HG23 ' A' ' 39' ' ' VAL . 7.1 m -62.15 -51.33 68.28 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.528 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.499 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 39.4 tt0 -63.87 -49.42 72.83 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.822 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.404 ' HB3' HD22 ' B' ' 212' ' ' LEU . 8.4 mp -51.98 -46.64 64.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.485 174.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.431 ' HB2' HG11 ' A' ' 37' ' ' VAL . . . -61.75 -52.05 65.85 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.672 -177.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.499 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 26.2 p -64.51 -26.76 68.57 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.982 -177.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.57 -36.07 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.115 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.659 ' HB2' HD21 ' B' ' 209' ' ' LEU . 16.3 m-85 -74.96 -24.54 58.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.279 0.562 . . . . 0.0 109.929 177.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.9 m -75.26 -42.05 55.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.132 173.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.12 -39.86 63.77 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.384 169.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.615 ' CD1' ' HG ' ' B' ' 262' ' ' LEU . 83.2 mt -61.01 -56.97 14.83 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.646 175.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.6 mt -58.42 -31.65 43.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.66 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 46.5 mt -115.81 12.27 15.82 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -173.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -44.86 -48.5 11.13 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.785 0.326 . . . . 0.0 111.608 174.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -154.31 -84.68 0.07 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 46.3 42.46 10.37 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.501 176.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 64.41 25.43 13.37 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.295 178.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.541 HG22 ' H ' ' A' ' 22' ' ' THR . 5.4 p -149.62 173.03 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.541 ' H ' HG22 ' A' ' 21' ' ' VAL . 5.3 p -107.49 127.43 53.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.808 0.337 . . . . 0.0 111.786 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.66 ' HB ' ' O ' ' A' ' 16' ' ' LEU . 3.9 p -67.17 95.21 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.368 0.604 . . . . 0.0 110.587 176.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.504 ' OG1' ' HG2' ' A' ' 27' ' ' LYS . 39.0 p -123.46 167.22 14.14 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.315 0.579 . . . . 0.0 112.14 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -49.22 -52.74 25.15 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.591 -174.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -62.13 -30.52 71.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.368 -177.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.504 ' HG2' ' OG1' ' A' ' 24' ' ' THR . 45.0 mmtm -71.48 -49.69 38.88 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.45 HG23 HD13 ' A' ' 32' ' ' ILE . 9.5 mt -62.94 -44.4 99.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.939 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -56.05 -45.52 79.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.776 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.77 -41.63 95.73 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.527 HD11 HG23 ' B' ' 226' ' ' ILE . 0.2 OUTLIER -66.82 -41.97 86.64 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.516 0.674 . . . . 0.0 109.919 -178.886 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.45 HD13 HG23 ' A' ' 28' ' ' ILE . 1.6 mp -62.17 -39.46 84.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.274 176.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -66.03 -31.98 73.18 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.087 0.47 . . . . 0.0 110.287 177.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.499 ' HB1' ' HA ' ' B' ' 226' ' ' ILE . . . -65.64 -47.21 76.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.498 176.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.585 ' HA ' HD11 ' B' ' 226' ' ' ILE . . . -84.79 -17.1 39.27 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -177.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.38 12.89 83.33 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.541 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.431 HG11 ' HB2' ' A' ' 8' ' ' ALA . 19.6 t -81.7 154.14 4.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -108.95 105.23 14.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.121 0.486 . . . . 0.0 111.219 -173.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.589 HG23 ' HB3' ' A' ' 5' ' ' SER . 12.7 p -120.99 135.25 61.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.406 174.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -59.89 124.49 76.91 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.483 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.529 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 81.0 Cg_exo -47.13 -17.11 0.41 Allowed 'Trans proline' 0 N--CA 1.481 0.776 0 C-N-CA 124.554 3.503 . . . . 0.0 115.434 -171.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -75.3 -26.47 58.73 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -175.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.603 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 95.8 m95 -65.66 -54.24 31.12 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.332 174.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.603 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 75.6 Cg_exo -51.08 -52.47 9.02 Favored 'Trans proline' 0 C--N 1.364 1.381 0 C-N-CA 122.315 2.01 . . . . 0.0 112.773 173.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.29 -50.48 66.17 Favored Glycine 0 C--O 1.241 0.576 0 C-N-CA 120.571 -0.824 . . . . 0.0 112.086 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 56.5 tp -56.37 -52.49 64.41 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.29 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.428 ' O ' HD13 ' A' ' 51' ' ' LEU . 3.2 m-85 -57.53 -44.03 84.79 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -177.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.31 -39.65 95.16 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.297 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -97.42 7.3 46.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.978 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -112.38 -43.27 3.54 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.755 ' HA ' HG23 ' A' ' 54' ' ' VAL . 2.6 mp -83.16 -128.29 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.826 -175.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 65.41 -1.47 0.96 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -144.56 -46.74 0.25 Allowed 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.755 HG23 ' HA ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -55.91 119.26 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 113.626 -1.624 . . . . 0.0 111.323 177.334 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -52.96 146.27 11.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.765 174.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.444 HD11 HD23 ' A' ' 14' ' ' LEU . 1.7 tp -45.86 -37.34 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -169.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.403 ' O ' HG22 ' A' ' 60' ' ' ILE . . . -54.8 -22.12 25.29 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.788 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.432 ' HB3' HG12 ' A' ' 54' ' ' VAL . 44.5 p -51.46 -31.65 24.1 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 122.987 0.515 . . . . 0.0 111.321 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.427 HD13 ' O ' ' A' ' 56' ' ' ILE . 9.6 mp -49.53 -39.94 36.29 Favored 'General case' 0 CA--C 1.519 -0.22 0 O-C-N 123.721 0.638 . . . . 0.0 112.359 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 60' ' ' ILE . 13.3 tt -87.73 23.07 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 122.052 0.93 . . . . 0.0 110.744 -174.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.8 t -126.02 2.95 7.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.04 173.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -88.75 34.18 0.77 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.664 -176.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.2 t -80.57 68.18 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.91 0.862 . . . . 0.0 109.876 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.16 24.3 26.71 Favored Glycine 0 C--N 1.314 -0.66 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.421 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.38 74.18 3.94 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.212 0.53 . . . . 0.0 110.825 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.98 59.21 5.01 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.197 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 144.81 76.21 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 111.884 -0.486 . . . . 0.0 111.884 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -64.27 -52.33 1.61 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.689 2.259 . . . . 0.0 112.728 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 50.92 75.46 0.65 Allowed Pre-proline 0 N--CA 1.468 0.439 0 O-C-N 123.607 0.567 . . . . 0.0 112.04 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -60.88 -64.52 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.749 2.299 . . . . 0.0 112.371 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 64.3 114.87 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.97 0.794 . . . . 0.0 111.783 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -137.13 122.64 19.62 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.536 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.84 90.28 0.09 OUTLIER Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 111.184 -0.767 . . . . 0.0 111.184 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.13 143.61 40.43 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.806 0.336 . . . . 0.0 110.437 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -76.55 123.03 87.63 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.89 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 30.8 Cg_exo -66.79 -7.54 18.63 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.788 2.992 . . . . 0.0 113.218 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.16 96.19 9.83 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.915 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -143.42 89.29 0.17 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.509 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -132.25 69.86 0.53 Allowed Glycine 0 CA--C 1.519 0.315 0 C-N-CA 121.166 -0.54 . . . . 0.0 111.967 176.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -94.18 178.65 0.95 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.156 2.571 . . . . 0.0 113.328 -176.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.66 78.03 71.64 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.31 175.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.32 -32.98 94.81 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.895 2.397 . . . . 0.0 112.673 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.4 t -83.26 58.59 4.55 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.854 -176.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.5 m 71.27 122.83 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.934 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.05 93.31 3.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.242 0.544 . . . . 0.0 110.443 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.18 148.0 44.22 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.841 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.85 153.75 57.89 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.22 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -63.6 73.09 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.546 2.831 . . . . 0.0 113.761 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 67.07 -85.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.388 0.675 . . . . 0.0 111.3 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 47.34 74.05 0.17 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 122.056 0.931 . . . . 0.0 111.132 -177.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.23 176.74 8.93 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.805 -175.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.54 28.87 8.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.378 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -117.13 92.02 3.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.332 0.587 . . . . 0.0 109.907 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.7 p -130.92 144.14 38.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.464 -175.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -120.45 169.92 9.87 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.581 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -163.32 88.1 0.57 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.831 178.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -65.04 138.44 58.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.618 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -132.79 -48.0 0.87 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.843 -175.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 57.85 72.23 0.53 Allowed 'General case' 0 C--O 1.238 0.479 0 O-C-N 123.706 0.629 . . . . 0.0 111.936 173.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -73.57 154.08 39.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.891 0.377 . . . . 0.0 110.707 173.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.1 m -95.58 140.31 30.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.694 -174.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -137.7 41.65 2.34 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.638 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 63.62 101.94 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.579 -176.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.8 t -148.38 139.18 22.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.668 -177.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -123.01 126.19 46.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.378 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -95.09 -26.29 16.09 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.369 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -107.34 125.82 51.68 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 173.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 58.5 mtt -113.82 27.72 9.32 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.1 -172.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.9 119.12 3.3 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.324 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -81.68 59.31 4.13 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.161 0.505 . . . . 0.0 111.389 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 153.25 128.69 1.31 Allowed Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.058 177.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -104.89 31.13 4.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.836 0.35 . . . . 0.0 110.334 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -106.26 138.39 42.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.023 176.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.5 t70 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.559 -0.734 . . . . 0.0 110.037 -175.124 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 200' ' ' ALA . . . . . 0.492 ' O ' HG12 ' B' ' 204' ' ' VAL . . . . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 119.896 -0.097 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.517 ' SD ' ' HB2' ' B' ' 263' ' ' ALA . 36.1 mmm -50.16 -59.0 4.35 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 123.828 0.705 . . . . 0.0 112.465 -171.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 202' ' ' ARG . . . . . 0.431 HH11 HD23 ' B' ' 227' ' ' LEU . 4.2 mmp_? -34.05 -64.06 0.25 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -170.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -98.97 -32.5 11.27 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -163.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.779 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 11.9 p -62.84 -49.83 82.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.041 -174.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 205' ' ' ALA . . . . . 0.51 ' HA ' HD12 ' B' ' 208' ' ' LEU . . . -72.58 -18.86 61.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.619 0.247 . . . . 0.0 111.09 -176.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 206' ' ' SER . . . . . 0.443 ' HB3' HG23 ' B' ' 223' ' ' ILE . 45.8 m -70.37 -47.39 61.17 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 120.93 0.395 . . . . 0.0 109.968 174.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 207' ' ' TYR . . . . . 0.554 ' CZ ' ' HD2' ' B' ' 218' ' ' PRO . 29.5 t80 -62.51 -35.95 81.01 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.779 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 62.9 mt -60.83 -53.42 57.59 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.003 178.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 209' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 11' ' ' TYR . 78.7 mt -58.79 -50.84 72.43 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.054 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -61.16 -33.22 73.08 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.99 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 211' ' ' ALA . . . . . 0.671 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -76.97 -40.14 48.0 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.889 178.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 212' ' ' LEU . . . . . 0.44 ' HG ' HG13 ' A' ' 4' ' ' VAL . 52.0 tp -59.97 -55.33 35.36 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.492 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -126.26 53.37 0.79 Allowed Glycine 0 CA--C 1.507 -0.421 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.855 -174.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . -166.08 -77.85 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.494 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 215' ' ' ASN . . . . . 0.671 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 44.4 t30 -148.56 140.63 23.97 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.741 0.305 . . . . 0.0 110.201 -175.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 216' ' ' SER . . . . . 0.472 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 8.3 m -63.95 -23.92 67.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.329 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 5.2 p -120.05 70.55 15.1 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.18 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 218' ' ' PRO . . . . . 0.554 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 82.8 Cg_exo -52.56 131.69 42.12 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.541 2.827 . . . . 0.0 113.28 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 219' ' ' SER . . . . . 0.48 ' HB3' ' OD2' ' B' ' 222' ' ' ASP . 38.9 t -87.02 145.75 26.37 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.335 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -59.15 -21.32 59.19 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.042 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -69.6 -50.09 47.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.363 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 222' ' ' ASP . . . . . 0.48 ' OD2' ' HB3' ' B' ' 219' ' ' SER . 20.0 m-20 -67.27 -40.78 86.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.952 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.519 HD11 ' HB3' ' B' ' 218' ' ' PRO . 1.8 mp -60.34 -45.58 96.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 175.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 224' ' ' LYS . . . . . 0.422 ' O ' ' HB3' ' B' ' 228' ' ' ASP . 37.7 tptt -52.35 -46.2 66.03 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.45 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 225' ' ' LYS . . . . . 0.48 ' HD3' ' O ' ' B' ' 225' ' ' LYS . 7.8 tmtm? -63.68 -36.32 83.46 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 123.273 0.358 . . . . 0.0 110.469 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 0.585 HD11 ' HA ' ' A' ' 35' ' ' ALA . 1.3 mp -60.89 -44.18 97.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.098 176.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 227' ' ' LEU . . . . . 0.431 HD23 HH11 ' B' ' 202' ' ' ARG . 6.8 mp -75.74 -23.76 56.07 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.984 177.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 228' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' B' ' 224' ' ' LYS . 0.0 OUTLIER -78.45 -28.1 46.56 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.78 -177.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 80.8 p -52.76 -56.81 12.94 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.973 0.416 . . . . 0.0 111.125 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 230' ' ' VAL . . . . . 0.45 HG23 HG13 ' B' ' 232' ' ' ILE . 7.3 m -79.83 -27.24 12.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.883 175.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 67.9 64.65 3.05 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.97 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 232' ' ' ILE . . . . . 0.45 HG13 HG23 ' B' ' 230' ' ' VAL . 55.1 mt -99.25 -89.13 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.738 0.304 . . . . 0.0 110.431 177.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -148.51 142.1 25.46 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 175.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -160.93 93.06 0.96 Allowed 'General case' 0 C--N 1.33 -0.262 0 O-C-N 123.298 0.374 . . . . 0.0 111.05 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 235' ' ' ASP . . . . . 0.498 ' OD2' ' HD2' ' B' ' 238' ' ' ARG . 25.6 m-20 -62.84 126.49 27.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.0 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -74.64 -12.1 60.35 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -175.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -92.37 -52.53 4.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.181 0.515 . . . . 0.0 109.765 175.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.498 ' HD2' ' OD2' ' B' ' 235' ' ' ASP . 86.3 mtt180 -65.94 -33.16 75.19 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.18 -176.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 239' ' ' LEU . . . . . . . . . . . . . 8.8 tt -59.94 -62.99 1.46 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.822 0.344 . . . . 0.0 111.052 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 240' ' ' ASN . . . . . 0.416 ' O ' ' HB2' ' B' ' 244' ' ' SER . 26.9 p-10 -74.43 -19.24 60.47 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 121.993 -0.442 . . . . 0.0 110.671 -176.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -71.63 -48.65 46.46 Favored 'General case' 0 C--O 1.244 0.781 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.831 173.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 242' ' ' VAL . . . . . 0.606 ' O ' ' HB3' ' B' ' 246' ' ' LEU . 28.4 m -66.13 -33.43 63.51 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.885 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 30.8 mt -73.19 -31.79 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 O-C-N 123.627 0.579 . . . . 0.0 111.271 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 244' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' B' ' 240' ' ' ASN . 18.3 t -64.73 -28.5 69.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.679 0.276 . . . . 0.0 110.663 176.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -87.78 -47.88 8.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.651 0.738 . . . . 0.0 109.628 172.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 246' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' B' ' 246' ' ' LEU . 8.8 tp -79.5 56.37 2.16 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 124.716 1.206 . . . . 0.0 109.89 177.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -100.25 37.29 1.69 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.986 -174.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 248' ' ' GLY . . . . . 0.479 ' HA2' HG22 ' B' ' 251' ' ' ILE . . . 99.54 2.81 56.47 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.594 -0.813 . . . . 0.0 114.043 173.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -74.98 -1.68 23.72 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -177.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -159.32 8.11 0.11 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.569 ' HA ' HG12 ' B' ' 254' ' ' VAL . 5.2 tp -65.87 -46.93 87.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -172.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -58.59 -43.87 89.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.308 0.575 . . . . 0.0 110.972 -176.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -74.54 -38.7 62.69 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.874 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 254' ' ' VAL . . . . . 0.569 HG12 ' HA ' ' B' ' 251' ' ' ILE . 6.6 p -71.06 -21.37 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 120.992 0.425 . . . . 0.0 110.351 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 255' ' ' ILE . . . . . 0.529 HG12 ' O ' ' B' ' 251' ' ' ILE . 35.2 mm -76.95 -48.48 25.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 171.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -62.83 -35.28 79.42 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -174.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -147.5 28.92 0.96 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.845 -176.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 258' ' ' GLY . . . . . 0.502 ' O ' HD21 ' B' ' 262' ' ' LEU . . . -110.51 56.64 0.45 Allowed Glycine 0 C--O 1.226 -0.376 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.238 -174.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 26.8 mt -94.69 -11.68 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.35 0.595 . . . . 0.0 110.674 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -107.99 -45.52 1.1 Allowed Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.289 -176.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -88.64 75.93 8.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.988 0.423 . . . . 0.0 110.87 -174.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 262' ' ' LEU . . . . . 0.615 ' HG ' ' CD1' ' A' ' 14' ' ' LEU . 3.3 mm? -123.72 -73.05 0.65 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.634 0.73 . . . . 0.0 111.464 -176.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 263' ' ' ALA . . . . . 0.517 ' HB2' ' SD ' ' B' ' 201' ' ' MET . . . -50.33 -74.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.547 177.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 23.9 t 61.73 121.44 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.352 1.032 . . . . 0.0 112.387 176.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 2.7 p -78.39 114.23 41.07 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.395 175.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.31 143.38 17.42 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.488 2.125 . . . . 0.0 112.645 -177.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . -127.23 135.94 51.33 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.355 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 73.73 38.97 49.45 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.389 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -77.04 93.64 1.08 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.759 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -76.13 80.07 2.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.904 0.383 . . . . 0.0 110.454 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 16.9 t -79.13 141.76 14.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.565 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -140.61 130.31 24.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.095 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 37.0 t -74.8 116.8 17.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.574 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 4.9 p -77.88 129.93 35.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.675 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -100.75 146.75 26.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.628 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 276' ' ' ALA . . . . . 0.428 ' HA ' ' HD2' ' B' ' 277' ' ' PRO . . . -112.39 115.81 49.26 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-O 121.154 0.502 . . . . 0.0 111.188 -178.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 277' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' B' ' 276' ' ' ALA . 55.5 Cg_endo -70.46 146.71 56.59 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.176 2.584 . . . . 0.0 112.709 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -113.14 160.04 13.35 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.15 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 15.8 m -91.66 -170.68 2.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.766 0.283 . . . . 0.0 111.022 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 69.36 67.94 0.26 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.84 0.828 . . . . 0.0 111.225 174.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -95.12 160.49 30.74 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.266 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -44.95 -64.6 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.216 2.611 . . . . 0.0 113.2 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . 62.92 110.79 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 O-C-N 123.952 0.783 . . . . 0.0 112.091 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -102.64 -170.38 1.79 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.624 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -85.61 -121.3 1.13 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.955 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 58.1 p 47.34 75.45 0.13 Allowed 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.155 0.582 . . . . 0.0 111.721 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -51.68 110.62 1.92 Allowed Pre-proline 0 C--O 1.233 0.213 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.85 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.25 100.54 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.84 2.36 . . . . 0.0 112.725 -175.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -95.65 -170.1 2.08 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.585 176.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -61.61 -68.53 0.31 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.693 177.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -176.29 160.02 2.1 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.372 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 60.26 110.83 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 174.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -60.35 108.36 0.79 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.184 172.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -136.77 118.71 15.27 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -176.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -80.42 132.69 35.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.0 0.429 . . . . 0.0 111.45 -177.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -164.59 103.9 0.82 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -78.71 173.97 11.91 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -171.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -90.69 -79.4 0.36 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.456 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 57.62 63.21 1.89 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.434 0.635 . . . . 0.0 111.207 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -84.75 177.62 7.95 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.641 -175.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 63.73 97.31 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.203 0 O-C-N 123.995 0.81 . . . . 0.0 112.382 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 21.3 t -134.17 141.7 47.17 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.347 0.594 . . . . 0.0 110.949 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -98.17 107.52 20.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.678 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -94.93 65.85 2.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.67 -176.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 23.7 m -67.0 142.52 57.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.084 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.99 12.96 34.4 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.944 -177.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 18.7 t70 70.1 -64.86 0.34 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.972 0.909 . . . . 0.0 111.656 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -90.62 171.54 9.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.483 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 25.5 ptm -147.2 24.5 1.14 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.597 0.236 . . . . 0.0 111.045 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . -76.27 49.92 2.69 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.316 -0.468 . . . . 0.0 113.132 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -130.77 18.01 5.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.09 0.472 . . . . 0.0 110.399 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . 100.62 -74.72 0.41 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.01 -177.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 313' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' B' ' 313' ' ' LEU . 1.7 mt 48.83 83.02 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 122.03 0.919 . . . . 0.0 110.714 -173.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 314' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -131.15 18.64 4.94 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.35 -1.296 . . . . 0.0 109.908 -167.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 . . . . . 0 C--O 1.249 1.029 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.843 -174.796 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmt . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.571 0.224 . . . . 0.0 110.484 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.55 -77.09 0.37 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.802 0.334 . . . . 0.0 110.695 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.434 ' O ' HD13 ' A' ' 7' ' ' LEU . 0.9 OUTLIER -81.91 73.76 8.93 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.858 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.593 HG12 HD11 ' B' ' 212' ' ' LEU . 6.0 m -62.91 -27.52 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.277 -176.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.464 ' HB3' HG23 ' A' ' 39' ' ' VAL . 1.8 m -61.64 -63.16 1.36 Allowed 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.408 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -59.24 -50.23 74.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.348 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.584 ' O ' HG22 ' A' ' 10' ' ' ILE . 9.8 mp -47.99 -54.65 12.22 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.69 0.281 . . . . 0.0 110.666 178.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.473 ' HB2' HG11 ' A' ' 37' ' ' VAL . . . -59.67 -52.77 64.11 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -177.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 40.6 t -66.0 -30.61 71.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.761 0.315 . . . . 0.0 110.92 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.584 HG22 ' O ' ' A' ' 7' ' ' LEU . 2.4 tp -74.75 -35.77 38.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.154 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.82 ' HB2' HD21 ' B' ' 209' ' ' LEU . 19.5 m-30 -66.43 -36.17 82.13 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 177.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.1 m -69.35 -46.47 66.95 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.128 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.449 ' HB1' HD21 ' A' ' 59' ' ' LEU . . . -54.65 -49.6 70.18 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.562 176.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.71 HD22 HG23 ' B' ' 259' ' ' ILE . 4.5 pp -75.67 -29.03 58.92 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.213 -177.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -65.14 -38.68 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.796 0.331 . . . . 0.0 110.788 175.287 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.562 HD13 ' HA ' ' A' ' 23' ' ' VAL . 93.1 mt -78.23 -28.28 47.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.759 178.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.8 m80 -79.21 68.85 5.29 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -165.21 -49.11 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.903 0.382 . . . . 0.0 110.429 173.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -83.69 -172.17 4.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.722 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -89.3 16.45 7.39 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.1 0.476 . . . . 0.0 110.307 175.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.492 HG21 HG12 ' B' ' 232' ' ' ILE . 41.3 t -88.8 125.94 41.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.095 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 p -77.59 147.34 35.71 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.198 -172.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.562 ' HA ' HD13 ' A' ' 16' ' ' LEU . 32.6 m -83.69 41.74 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.06 -174.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.443 ' OG1' ' HG2' ' A' ' 27' ' ' LYS . 39.1 p -67.13 159.85 28.01 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -177.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -57.72 -42.65 84.26 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -176.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -49.78 -42.65 47.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.331 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.443 ' HG2' ' OG1' ' A' ' 24' ' ' THR . 45.8 mmtm -77.74 -47.75 18.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.394 -173.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.403 ' O ' HD13 ' A' ' 32' ' ' ILE . 5.2 mt -61.55 -44.81 99.23 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.154 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.332 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -60.05 -40.61 90.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.634 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.92 -40.93 99.11 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.423 HD12 HD13 ' B' ' 209' ' ' LEU . 0.1 OUTLIER -68.83 -41.79 78.08 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.337 0.589 . . . . 0.0 110.05 -179.662 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.403 HD13 ' O ' ' A' ' 28' ' ' ILE . 1.7 mp -59.94 -37.73 73.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.601 175.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -75.58 -30.43 59.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.108 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.45 -51.2 70.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.448 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.88 -27.21 25.17 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.777 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.7 22.02 56.7 Favored Glycine 0 C--N 1.321 -0.264 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.777 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.473 HG11 ' HB2' ' A' ' 8' ' ' ALA . 12.9 t -82.34 137.17 21.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.848 0.356 . . . . 0.0 110.119 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -88.21 92.03 9.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.997 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.464 HG23 ' HB3' ' A' ' 5' ' ' SER . 7.7 p -102.41 136.18 35.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.573 175.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.47 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -54.2 125.3 49.72 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.046 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.76 -6.15 2.3 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.6 2.866 . . . . 0.0 113.507 -171.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.49 -31.25 47.65 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -177.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -65.99 -60.72 6.59 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.622 175.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.47 ' HD2' ' O ' ' A' ' 40' ' ' GLU . 19.6 Cg_endo -58.86 -40.91 67.69 Favored 'Trans proline' 0 C--N 1.361 1.197 0 C-N-CA 121.783 1.656 . . . . 0.0 112.178 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.38 -55.04 32.33 Favored Glycine 0 C--O 1.241 0.552 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.159 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.7 tt -59.87 -50.54 73.38 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.581 ' O ' HD13 ' A' ' 51' ' ' LEU . 2.6 m-85 -53.61 -53.6 49.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.01 0.433 . . . . 0.0 111.832 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.91 -27.94 67.07 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -173.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm -93.59 -11.62 31.37 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.451 -0.5 . . . . 0.0 112.15 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -106.54 -26.26 11.48 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.864 ' HA ' HG23 ' A' ' 54' ' ' VAL . 4.8 mp -81.23 -132.53 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.41 ' H ' ' HB3' ' A' ' 51' ' ' LEU . . . 57.27 6.49 0.37 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.372 0.669 . . . . 0.0 112.095 -175.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.411 ' H ' ' C ' ' A' ' 51' ' ' LEU . 37.2 m-80 -143.67 -40.76 0.29 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.864 HG23 ' HA ' ' A' ' 51' ' ' LEU . 58.7 t -45.14 108.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 113.881 -1.509 . . . . 0.0 111.622 173.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -67.51 169.71 8.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.678 173.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.6 tp -54.62 -53.25 33.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.954 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.63 -43.35 86.12 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.457 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.469 ' HB2' HG13 ' A' ' 54' ' ' VAL . 16.4 m -58.54 -28.55 65.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.662 0.268 . . . . 0.0 111.141 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.503 HD13 ' O ' ' A' ' 59' ' ' LEU . 2.5 tm? -64.06 -22.74 67.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.678 -176.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.718 HG23 HD12 ' B' ' 259' ' ' ILE . 18.3 mt -92.25 -5.28 10.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.301 0.572 . . . . 0.0 110.682 -176.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 22.4 t -137.55 51.22 1.93 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.351 0.596 . . . . 0.0 110.017 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -90.99 -34.21 15.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.548 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.3 p -106.94 -12.57 10.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.176 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 115.37 -169.38 12.88 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -175.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -149.06 119.87 7.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 117.336 0.568 . . . . 0.0 111.193 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -96.22 -98.82 1.85 Allowed Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.748 174.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.457 ' HA2' ' HD3' ' A' ' 68' ' ' PRO . . . 150.34 144.36 3.92 Favored Glycine 0 C--O 1.227 -0.289 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.105 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.457 ' HD3' ' HA2' ' A' ' 67' ' ' GLY . 2.8 Cg_endo -80.98 82.47 2.45 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.832 2.355 . . . . 0.0 112.291 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.95 76.62 75.69 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.423 176.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.79 -42.6 0.77 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.454 2.102 . . . . 0.0 112.888 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 63.62 165.44 0.13 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.213 0.605 . . . . 0.0 111.664 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -155.9 133.17 10.79 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.898 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.77 151.42 20.44 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.88 135.08 27.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.75 0.275 . . . . 0.0 110.626 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -139.86 126.24 12.17 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.163 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -50.45 -30.09 26.28 Favored 'Trans proline' 0 CA--C 1.527 0.166 0 C-N-CA 124.226 3.284 . . . . 0.0 113.349 -177.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 58.94 75.76 0.38 Allowed 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.671 0.607 . . . . 0.0 111.892 174.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -108.32 160.22 13.89 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.324 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -146.61 173.87 26.68 Favored Glycine 0 N--CA 1.451 -0.329 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.6 164.12 26.17 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.501 2.134 . . . . 0.0 112.109 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.52 108.5 61.95 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.601 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -57.94 146.43 86.88 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.638 2.225 . . . . 0.0 112.111 178.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.0 t 62.11 77.9 0.31 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.281 0.562 . . . . 0.0 110.857 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.6 m -94.63 116.56 28.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.085 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 70.24 -73.84 0.09 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.563 0.745 . . . . 0.0 111.623 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 67.05 111.53 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.932 0.77 . . . . 0.0 112.377 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 65.23 95.26 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.326 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.077 175.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -54.7 -47.06 28.79 Favored 'Trans proline' 0 N--CA 1.473 0.282 0 C-N-CA 123.278 2.652 . . . . 0.0 112.598 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 55.49 44.52 26.76 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.375 0.607 . . . . 0.0 110.897 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -89.27 142.45 27.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.995 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -108.98 -174.86 2.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.997 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -151.14 75.13 1.18 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.992 0.901 . . . . 0.0 109.838 175.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -88.18 134.96 33.65 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.4 -174.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 13.6 p -152.92 148.5 14.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.188 175.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 73.45 144.91 0.07 Allowed 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.785 0.678 . . . . 0.0 111.887 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.44 118.28 7.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.165 -178.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.4 mttp 65.26 163.37 0.15 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.448 0.642 . . . . 0.0 112.087 -177.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -139.2 -76.3 0.36 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.463 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 50.43 56.72 7.51 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 123.823 0.702 . . . . 0.0 111.026 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.32 144.19 57.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.16 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.0 t -113.98 42.03 2.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.369 0.604 . . . . 0.0 111.192 -174.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -115.68 33.03 5.71 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.866 175.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -45.24 126.24 6.1 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.415 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.2 m -122.17 121.79 37.69 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.059 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.509 ' CG ' ' H ' ' A' ' 106' ' ' ASP . 13.9 t70 -143.41 -156.46 0.69 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -176.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.509 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 9.1 t70 59.63 73.15 0.49 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.91 0.862 . . . . 0.0 110.05 -173.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -80.47 72.52 7.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.516 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 17.1 tpt 68.48 77.61 0.24 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.808 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -82.45 -159.43 25.86 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-N 115.945 -0.57 . . . . 0.0 113.164 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -58.12 130.89 48.71 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.421 0.629 . . . . 0.0 111.944 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.481 ' HA2' ' CE2' ' A' ' 113' ' ' PHE . . . -83.5 72.0 2.91 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.671 -178.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.5 mt -92.69 47.87 1.33 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.241 0.543 . . . . 0.0 110.408 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.481 ' CE2' ' HA2' ' A' ' 111' ' ' GLY . 2.0 p90 -138.24 51.65 1.86 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.255 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 36.1 t70 . . . . . 0 C--O 1.248 0.995 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.752 -178.437 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.689 ' HE3' ' O ' ' A' ' 14' ' ' LEU . 38.5 mtt -48.73 -66.64 0.37 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.473 0.654 . . . . 0.0 111.552 -173.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 202' ' ' ARG . . . . . 0.509 ' HB3' HG22 ' B' ' 204' ' ' VAL . 7.1 tpt180 -151.68 147.04 26.24 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -74.83 5.67 4.79 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 120.913 0.387 . . . . 0.0 111.805 -174.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.791 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 18.1 m -58.28 -51.94 65.02 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.529 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.783 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 205' ' ' ALA . . . . . 0.541 ' CB ' HD11 ' A' ' 14' ' ' LEU . . . -64.7 -25.33 67.89 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -176.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 206' ' ' SER . . . . . 0.548 ' CB ' HG23 ' B' ' 223' ' ' ILE . 6.0 m -67.11 -48.91 66.69 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 173.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 207' ' ' TYR . . . . . 0.477 ' CZ ' ' HD2' ' B' ' 218' ' ' PRO . 17.0 t80 -61.68 -35.22 77.36 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.383 175.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.791 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 39.5 mt -63.26 -53.34 54.44 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.963 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 209' ' ' LEU . . . . . 0.82 HD21 ' HB2' ' A' ' 11' ' ' TYR . 15.2 mt -52.57 -50.62 62.59 Favored 'General case' 0 C--O 1.245 0.864 0 CA-C-O 121.264 0.554 . . . . 0.0 110.003 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -62.5 -41.13 98.62 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.668 -178.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 211' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -77.77 -24.68 48.87 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.929 -0.482 . . . . 0.0 111.481 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 212' ' ' LEU . . . . . 0.593 HD11 HG12 ' A' ' 4' ' ' VAL . 33.5 tp -71.23 -47.84 54.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.669 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -141.16 20.56 2.64 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 118.954 -1.593 . . . . 0.0 114.628 -176.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . -121.05 -66.07 0.26 Allowed Glycine 0 C--N 1.321 -0.284 0 C-N-CA 119.959 -1.115 . . . . 0.0 112.772 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 215' ' ' ASN . . . . . 0.5 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 34.0 t30 -154.42 146.66 23.8 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -177.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 7.0 m -67.95 -21.62 65.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.355 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 5.6 p -125.19 70.91 62.74 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.618 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 218' ' ' PRO . . . . . 0.477 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 65.2 Cg_exo -57.75 132.99 53.38 Favored 'Trans proline' 0 N--CA 1.477 0.552 0 C-N-CA 122.989 2.459 . . . . 0.0 112.152 176.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 219' ' ' SER . . . . . 0.463 ' HB3' ' OD1' ' B' ' 222' ' ' ASP . 28.3 t -110.18 172.96 6.55 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.919 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -56.1 -38.9 71.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.007 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -65.98 -43.33 88.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.685 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 222' ' ' ASP . . . . . 0.463 ' OD1' ' HB3' ' B' ' 219' ' ' SER . 3.3 m-20 -62.23 -49.48 75.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.138 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.548 HG23 ' CB ' ' B' ' 206' ' ' SER . 1.8 mp -63.79 -40.23 88.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.586 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -54.43 -50.9 66.55 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.187 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -63.71 -42.64 97.91 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.075 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.14 -36.04 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 120.686 0.279 . . . . 0.0 110.73 176.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 227' ' ' LEU . . . . . 0.47 ' CD1' ' HB ' ' B' ' 232' ' ' ILE . 0.2 OUTLIER -75.82 -43.85 44.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.68 -178.767 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -86.64 -0.77 56.86 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.631 -177.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 15.4 t -55.07 -44.74 75.06 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.987 0.422 . . . . 0.0 110.51 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 230' ' ' VAL . . . . . 0.56 HG23 HG13 ' B' ' 232' ' ' ILE . 12.5 m -95.88 0.74 10.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.218 0.532 . . . . 0.0 111.16 178.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 81.65 54.98 3.3 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.616 -0.72 . . . . 0.0 113.739 175.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 232' ' ' ILE . . . . . 0.56 HG13 HG23 ' B' ' 230' ' ' VAL . 4.3 mt -115.64 140.07 39.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 172.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -70.74 119.85 15.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.302 0.573 . . . . 0.0 111.576 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -118.18 132.64 56.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.383 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -83.78 111.95 19.65 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -60.67 -33.69 73.22 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.458 -174.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -67.91 -58.31 4.77 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.456 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -63.92 -30.85 71.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.688 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 239' ' ' LEU . . . . . . . . . . . . . 8.7 tt -57.42 -60.72 3.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.313 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -64.25 -32.46 74.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.897 -178.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 241' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' B' ' 245' ' ' GLU . 84.3 mttt -67.77 -41.54 83.14 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 242' ' ' VAL . . . . . 0.456 ' HA ' ' OE1' ' B' ' 245' ' ' GLU . 32.9 m -73.92 -31.15 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 119.969 -0.693 . . . . 0.0 109.559 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 243' ' ' ILE . . . . . 0.454 ' HA ' ' CD2' ' B' ' 246' ' ' LEU . 7.5 mt -65.16 -37.09 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.077 173.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 12.1 t -63.56 -40.22 96.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.241 174.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 245' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' B' ' 241' ' ' LYS . 47.0 mt-10 -59.42 -45.54 91.25 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.439 0.638 . . . . 0.0 110.266 176.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 246' ' ' LEU . . . . . 0.454 ' CD2' ' HA ' ' B' ' 243' ' ' ILE . 2.9 pp -87.6 -0.11 56.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.831 -175.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -67.04 -8.23 28.7 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.051 0.453 . . . . 0.0 111.719 -170.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -80.33 -170.93 42.54 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.149 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 249' ' ' LYS . . . . . 0.402 ' HD2' ' N ' ' B' ' 249' ' ' LYS . 11.3 mptt -82.31 67.4 8.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.922 0.391 . . . . 0.0 110.688 -177.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -131.72 27.68 4.62 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.686 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.409 ' O ' HG13 ' B' ' 255' ' ' ILE . 23.9 mm -53.46 -66.42 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -173.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 252' ' ' GLU . . . . . 0.456 ' O ' ' HB ' ' B' ' 255' ' ' ILE . 5.0 tp10 -62.03 -32.51 73.01 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 121.138 0.494 . . . . 0.0 111.412 -174.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 253' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' B' ' 257' ' ' GLN . 8.4 t70 -67.73 -47.27 69.79 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.11 -178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 254' ' ' VAL . . . . . 0.422 HG23 HD21 ' B' ' 208' ' ' LEU . 30.0 m -67.95 -24.46 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.065 0 C-N-CA 120.239 -0.585 . . . . 0.0 110.455 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 255' ' ' ILE . . . . . 0.652 HG23 ' OH ' ' A' ' 11' ' ' TYR . 40.1 mt -61.47 -37.71 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 CA-C-O 121.468 0.651 . . . . 0.0 109.433 172.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -94.78 -2.91 50.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.42 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 257' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' B' ' 253' ' ' ASP . 0.9 OUTLIER -106.72 76.29 1.11 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.138 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 258' ' ' GLY . . . . . 0.634 ' HA3' HD13 ' B' ' 262' ' ' LEU . . . -143.08 -99.16 0.3 Allowed Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.266 -0.969 . . . . 0.0 112.011 177.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 259' ' ' ILE . . . . . 0.718 HD12 HG23 ' A' ' 60' ' ' ILE . 1.0 OUTLIER -60.67 -38.42 78.51 Favored 'Isoleucine or valine' 0 C--N 1.346 0.451 0 CA-C-O 122.167 0.984 . . . . 0.0 108.59 171.318 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 260' ' ' GLY . . . . . 0.408 ' H ' HD22 ' B' ' 262' ' ' LEU . . . 137.43 -37.17 1.87 Allowed Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.988 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 261' ' ' LYS . . . . . 0.543 ' H ' HD12 ' B' ' 259' ' ' ILE . 28.9 mmmt -122.06 22.2 10.33 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 262' ' ' LEU . . . . . 0.634 HD13 ' HA3' ' B' ' 258' ' ' GLY . 2.3 pt? -69.06 -2.56 10.37 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.236 0.541 . . . . 0.0 111.171 -176.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -123.97 53.1 1.41 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 170.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 11.6 t -64.63 110.73 2.45 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.844 -177.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 45.4 t -107.39 104.13 51.35 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.045 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.9 118.21 3.38 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.688 2.258 . . . . 0.0 112.71 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . -78.24 57.39 1.86 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.405 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 77.99 -47.81 2.91 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 121.546 -0.359 . . . . 0.0 112.938 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . 100.14 43.75 2.34 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.621 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . 69.63 88.43 0.11 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.667 0.787 . . . . 0.0 111.379 -177.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 22.9 t -89.32 143.22 11.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.904 178.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -97.57 131.85 43.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.84 0.352 . . . . 0.0 111.146 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 58.7 t -97.95 125.91 51.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.001 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 8.0 m -76.64 123.1 25.61 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.227 0.537 . . . . 0.0 111.249 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -151.04 151.06 31.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.972 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -99.42 118.6 62.01 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 120.535 0.207 . . . . 0.0 110.705 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 277' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -70.6 145.38 52.17 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.936 2.424 . . . . 0.0 112.093 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -89.12 117.55 4.94 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.306 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 69.7 m -96.8 -165.59 1.29 Allowed 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.273 0.559 . . . . 0.0 111.47 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . -54.93 152.67 7.15 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.208 176.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 281' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' B' ' 282' ' ' PRO . . . -137.21 136.98 21.45 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.346 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 282' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' B' ' 281' ' ' ALA . 14.7 Cg_exo -67.81 95.81 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.553 2.168 . . . . 0.0 112.292 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -121.06 37.39 4.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.371 0.605 . . . . 0.0 110.652 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -149.19 177.23 9.81 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.173 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 176.5 -35.04 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.096 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 35.9 p 50.15 77.32 0.12 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.273 0.558 . . . . 0.0 111.685 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -100.02 120.44 56.88 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.349 -176.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.77 141.87 42.13 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.582 2.188 . . . . 0.0 111.922 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -90.0 -54.25 4.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.121 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . 47.33 69.39 0.51 Allowed 'General case' 0 CA--C 1.531 0.239 0 O-C-N 123.476 0.485 . . . . 0.0 112.115 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -86.29 -58.41 2.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.286 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 54.77 60.23 3.62 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.324 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -56.62 117.87 4.3 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.484 172.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -146.6 164.24 33.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.444 -175.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt 73.77 148.29 0.09 Allowed 'General case' 0 N--CA 1.473 0.722 0 O-C-N 124.064 0.852 . . . . 0.0 111.531 177.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -138.13 123.95 19.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.301 0.572 . . . . 0.0 110.714 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -75.47 145.31 41.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.38 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.78 11.17 17.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.147 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -123.66 127.88 48.86 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.31 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -103.33 108.47 19.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.934 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 43.76 65.2 1.05 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.443 175.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.02 -172.73 3.4 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.936 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 65.33 78.27 0.28 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.378 0.608 . . . . 0.0 110.356 -177.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -155.8 151.6 27.42 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.186 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 68.4 m -150.69 125.79 9.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.164 0.507 . . . . 0.0 110.86 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.97 -54.76 10.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.338 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -77.77 -75.67 0.21 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.745 -172.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 18.3 t0 62.9 88.03 0.1 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.578 0.704 . . . . 0.0 111.276 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 16.1 tpt -73.31 -6.35 45.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.625 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 94.6 121.11 3.44 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.125 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -75.88 58.13 1.11 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.299 0.571 . . . . 0.0 110.954 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . -94.56 -82.27 1.57 Allowed Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.865 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 10.7 mp 46.75 64.05 1.68 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.962 0.887 . . . . 0.0 110.018 -177.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 314' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -128.77 13.34 6.37 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 113.967 -1.47 . . . . 0.0 108.804 -170.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--O 1.249 1.074 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.356 -173.588 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.6 tpp . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.4 -91.9 0.04 OUTLIER 'General case' 0 C--O 1.234 0.25 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.569 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 23.3 t -90.52 96.44 10.65 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.162 0.506 . . . . 0.0 111.289 -172.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.0 p -69.55 -26.27 30.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.842 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.472 ' HA ' HG22 ' A' ' 39' ' ' VAL . 8.4 p -66.83 -55.47 14.67 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.528 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.618 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 35.3 mt-10 -62.67 -39.49 94.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.733 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 3' ' ' SER . 38.3 mt -54.99 -55.41 31.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.111 0.481 . . . . 0.0 109.922 175.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.3 -44.79 95.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.994 -175.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.618 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 26.7 p -70.94 -34.62 71.65 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.416 -176.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.48 HG12 ' CG2' ' B' ' 259' ' ' ILE . 0.8 OUTLIER -75.26 -33.94 29.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.973 0.416 . . . . 0.0 110.888 -179.404 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.513 ' HB2' ' CD1' ' B' ' 209' ' ' LEU . 23.0 m-30 -77.51 -26.47 51.19 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 177.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.436 ' HA ' HD23 ' A' ' 31' ' ' LEU . 23.0 t -65.62 -51.71 57.52 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.01 -42.82 29.1 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.4 171.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.61 HD21 ' HA2' ' B' ' 260' ' ' GLY . 82.6 mt -59.01 -58.29 9.32 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.781 0.324 . . . . 0.0 110.914 175.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 69.6 mt -56.62 -29.84 30.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.275 -176.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.9 mt -100.95 -9.58 21.39 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.68 -35.64 76.77 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -176.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -164.32 116.83 1.34 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -174.7 43.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.286 170.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 57.02 28.37 14.72 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.192 -174.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.0 p -126.44 161.53 32.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.651 -176.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.0 p -106.27 132.55 52.19 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -173.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.731 HG11 HD23 ' A' ' 51' ' ' LEU . 61.9 t -75.15 108.24 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -152.62 158.94 43.15 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-O 121.309 0.576 . . . . 0.0 111.894 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -43.77 -61.67 1.35 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.206 -173.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -62.86 -24.77 67.96 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.5 -173.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -77.43 -45.81 24.61 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.388 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.449 HG23 HD13 ' A' ' 32' ' ' ILE . 5.7 mt -62.46 -45.53 98.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.214 -0.595 . . . . 0.0 109.926 175.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -53.61 -45.78 70.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.194 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.0 -44.36 92.87 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 12' ' ' SER . 29.6 tp -71.22 -30.03 65.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.342 0.592 . . . . 0.0 110.316 -178.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.449 HD13 HG23 ' A' ' 28' ' ' ILE . 1.4 mp -69.66 -31.56 49.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.917 173.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -70.44 -29.83 66.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.87 -67.47 0.45 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.013 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.489 ' HB2' HD11 ' B' ' 226' ' ' ILE . . . -129.78 23.66 5.38 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -174.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -101.66 99.27 1.88 Allowed Glycine 0 C--N 1.314 -0.662 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.076 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.605 ' CG2' ' HA2' ' B' ' 213' ' ' GLY . 57.8 t -42.49 -70.07 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 122.516 0.326 . . . . 0.0 111.43 177.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -161.98 113.72 1.69 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 177.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.472 HG22 ' HA ' ' A' ' 5' ' ' SER . 11.8 t -121.65 137.52 55.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.463 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 0.7 OUTLIER -70.09 128.17 91.79 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.728 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.69 0.57 0.38 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.14 2.56 . . . . 0.0 113.116 -174.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.431 ' H ' ' C ' ' A' ' 40' ' ' GLU . 2.6 t80 -71.42 -39.72 70.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.014 176.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.526 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 68.2 m95 -72.42 -56.72 3.9 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.928 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 73.5 Cg_exo -49.95 -46.22 28.96 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 122.015 1.81 . . . . 0.0 112.321 173.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.46 -41.61 99.25 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.36 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.2 tp -61.87 -42.57 99.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.975 0.417 . . . . 0.0 110.096 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.441 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 3.2 m-85 -66.56 -40.05 88.8 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.992 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.61 -28.27 65.79 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -95.1 -30.74 13.9 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.79 -18.15 7.17 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -169.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.759 ' HA ' HG23 ' A' ' 54' ' ' VAL . 2.2 tp -89.54 -134.46 0.1 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.6 -176.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.444 ' H ' ' CG ' ' A' ' 51' ' ' LEU . . . 60.07 -13.28 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -176.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.547 ' H ' ' C ' ' A' ' 51' ' ' LEU . 48.0 m-80 -127.09 -31.38 2.6 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.759 HG23 ' HA ' ' A' ' 51' ' ' LEU . 61.0 t -49.99 103.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.382 172.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -46.74 146.32 1.62 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.671 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.468 HD11 HD23 ' A' ' 14' ' ' LEU . 4.0 tp -49.71 -51.77 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -170.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.27 -24.21 63.14 Favored Glycine 0 C--O 1.24 0.474 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.041 -176.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.3 t -68.81 -2.83 10.39 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 122.107 0.163 . . . . 0.0 111.225 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 46.3 mt -62.35 -26.02 68.22 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.192 0.52 . . . . 0.0 109.961 172.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.469 HG23 HD12 ' B' ' 259' ' ' ILE . 8.9 mt -95.74 16.26 2.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.607 0.718 . . . . 0.0 110.092 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.0 t -108.98 -45.01 3.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.381 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -87.74 5.89 37.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.036 -177.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.9 p -61.67 -29.84 47.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.897 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.0 40.75 2.32 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.212 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.76 -34.01 52.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.813 0.34 . . . . 0.0 110.972 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.81 -141.36 16.92 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.816 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 109.04 -167.98 13.19 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.826 -177.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -89.68 177.99 2.51 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.104 2.536 . . . . 0.0 112.488 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.42 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . . . -171.55 -50.93 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.309 177.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.42 ' HD3' ' HB3' ' A' ' 69' ' ' ALA . 81.5 Cg_endo -77.53 143.85 22.03 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 121.705 1.603 . . . . 0.0 111.641 171.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 67.84 115.47 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.384 0.674 . . . . 0.0 112.279 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -155.14 178.93 9.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.218 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.78 174.61 24.96 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.507 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -137.61 140.37 40.9 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.504 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -62.39 125.75 86.5 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.157 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 32.3 Cg_exo -60.76 97.81 0.13 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.518 2.812 . . . . 0.0 113.487 -177.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.63 142.53 49.94 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.919 173.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.29 -80.16 0.35 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.494 -174.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.6 -178.09 16.49 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.955 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.41 158.87 54.81 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.756 2.304 . . . . 0.0 112.492 -178.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -99.95 116.66 64.46 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.776 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -54.09 108.58 0.29 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.446 2.764 . . . . 0.0 112.671 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.4 t -82.87 84.39 7.41 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.179 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 27.5 m -151.1 -68.73 0.18 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.756 177.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 60.32 59.4 2.3 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.643 0.589 . . . . 0.0 111.614 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 65.48 -167.2 0.22 Allowed 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.781 0.676 . . . . 0.0 111.708 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -132.9 141.39 40.86 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.802 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -47.75 -60.19 0.97 Allowed 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.176 2.584 . . . . 0.0 113.802 -174.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 72.71 -36.6 0.36 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.53 114.24 3.14 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.098 0.475 . . . . 0.0 111.996 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -70.18 173.05 7.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.284 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -132.19 -78.35 0.5 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.903 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -129.72 133.07 46.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.962 0.411 . . . . 0.0 111.047 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.4 t -108.09 -61.57 2.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.33 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 68.82 133.48 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.598 0.713 . . . . 0.0 111.845 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -174.29 -52.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.02 -177.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -145.9 140.25 26.85 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.091 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -138.9 141.11 38.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.159 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 57.87 83.0 0.12 Allowed 'General case' 0 C--O 1.234 0.246 0 O-C-N 123.953 0.783 . . . . 0.0 110.929 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -64.12 142.71 58.31 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.331 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.6 t -100.52 141.64 33.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.583 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -104.28 -164.87 1.09 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.3 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -46.26 137.01 6.6 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.991 0.424 . . . . 0.0 111.724 177.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.6 t -159.29 141.11 13.36 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.913 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -108.77 30.56 6.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.656 0.741 . . . . 0.0 109.329 173.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.2 t70 57.98 54.88 5.67 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 114.069 -1.423 . . . . 0.0 111.661 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -91.52 145.06 24.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.464 172.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -105.56 155.46 19.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.813 0.34 . . . . 0.0 110.977 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -79.23 99.17 1.68 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.195 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -81.34 148.49 29.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.64 0.257 . . . . 0.0 110.598 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -168.28 117.38 0.72 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.208 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.6 mp -92.1 86.59 5.84 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -70.77 128.67 36.86 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.007 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.807 -0.616 . . . . 0.0 110.701 -178.791 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 121.03 0.443 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.455 ' HG3' ' O ' ' A' ' 14' ' ' LEU . 0.1 OUTLIER -89.31 -176.17 5.0 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.053 -178.02 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 202' ' ' ARG . . . . . 0.457 ' HD2' ' N ' ' B' ' 202' ' ' ARG . 8.6 mpt_? -113.38 136.61 52.58 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.096 -176.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -71.05 3.6 3.29 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.402 0.62 . . . . 0.0 111.432 -176.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.626 ' O ' HD13 ' B' ' 208' ' ' LEU . 60.8 t -60.09 -56.76 15.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.538 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 205' ' ' ALA . . . . . 0.556 ' HA ' HD22 ' B' ' 208' ' ' LEU . . . -69.31 -14.53 62.98 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.729 0.299 . . . . 0.0 111.27 -176.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 206' ' ' SER . . . . . 0.501 ' HB3' HG23 ' B' ' 223' ' ' ILE . 8.5 m -76.61 -45.07 31.7 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 174.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 207' ' ' TYR . . . . . 0.592 ' CE1' HD11 ' B' ' 251' ' ' ILE . 36.1 t80 -62.87 -41.91 99.57 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 174.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.626 HD13 ' O ' ' B' ' 204' ' ' VAL . 2.7 mp -56.77 -49.25 75.85 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.523 175.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 209' ' ' LEU . . . . . 0.513 ' CD1' ' HB2' ' A' ' 11' ' ' TYR . 3.6 tp -59.39 -49.65 76.99 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.603 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -66.46 -28.44 68.59 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 211' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -73.94 -43.24 58.92 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.257 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 212' ' ' LEU . . . . . 0.4 HD22 ' HB3' ' A' ' 7' ' ' LEU . 4.3 pp -75.15 -35.64 61.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.765 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 213' ' ' GLY . . . . . 0.605 ' HA2' ' CG2' ' A' ' 37' ' ' VAL . . . -124.02 47.55 1.01 Allowed Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.312 -0.947 . . . . 0.0 114.07 -172.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . -175.95 -66.63 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.206 0 C-N-CA 119.683 -1.246 . . . . 0.0 113.309 176.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 215' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 54.9 t30 -153.12 149.28 27.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.91 0.386 . . . . 0.0 110.533 -173.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 7.6 m -71.45 -18.52 62.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.256 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 17.6 p -125.76 69.99 65.05 Favored Pre-proline 0 N--CA 1.443 -0.808 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.848 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 218' ' ' PRO . . . . . 0.46 ' HB3' HD11 ' B' ' 223' ' ' ILE . 76.3 Cg_exo -54.18 135.83 65.94 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.072 2.515 . . . . 0.0 112.162 178.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 15.9 m -107.84 154.18 21.93 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.789 -177.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -49.22 -49.26 43.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.13 0.49 . . . . 0.0 111.757 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -64.76 -32.28 73.89 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.116 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -70.47 -43.64 69.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.898 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.501 HG23 ' HB3' ' B' ' 206' ' ' SER . 1.8 mp -61.74 -39.56 83.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.252 0.549 . . . . 0.0 109.75 174.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -60.33 -38.1 82.67 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.564 177.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 225' ' ' LYS . . . . . 0.656 ' HD3' ' O ' ' B' ' 225' ' ' LYS . 6.4 tmtm? -70.32 -36.74 74.46 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 0.489 HD11 ' HB2' ' A' ' 35' ' ' ALA . 1.0 OUTLIER -61.36 -36.52 73.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.502 179.521 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 97.2 mt -77.04 -34.37 57.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.838 0.352 . . . . 0.0 110.272 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 228' ' ' ASP . . . . . 0.508 ' HB3' ' HA ' ' B' ' 225' ' ' LYS . 0.8 OUTLIER -56.01 -36.23 67.7 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.377 173.707 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 23.8 m -55.81 -46.89 77.96 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.789 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 230' ' ' VAL . . . . . 0.422 HG11 ' HB2' ' A' ' 31' ' ' LEU . 1.2 m -90.06 -4.08 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 83.33 29.3 33.75 Favored Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.293 176.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 41.9 mt -98.07 130.84 46.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 176.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -77.59 159.43 29.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.658 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -154.66 121.35 5.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.491 -175.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 235' ' ' ASP . . . . . 0.457 ' HB3' ' OD1' ' B' ' 237' ' ' ASP . 5.0 m-20 -66.7 111.2 3.56 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 171.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 236' ' ' ASP . . . . . 0.493 ' HA ' ' HB3' ' B' ' 239' ' ' LEU . 2.5 p30 -69.21 -16.92 63.72 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.71 -174.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 237' ' ' ASP . . . . . 0.457 ' OD1' ' HB3' ' B' ' 235' ' ' ASP . 6.9 p-10 -69.48 -48.96 59.03 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 174.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.574 ' O ' HG23 ' B' ' 242' ' ' VAL . 15.9 mmt180 -66.4 -43.76 84.9 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.929 177.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 239' ' ' LEU . . . . . 0.493 ' HB3' ' HA ' ' B' ' 236' ' ' ASP . 9.6 tt -54.38 -57.58 10.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.882 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -68.12 -25.96 65.56 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 122.438 -0.163 . . . . 0.0 110.773 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -69.64 -46.07 67.0 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.266 0.555 . . . . 0.0 110.338 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 242' ' ' VAL . . . . . 0.574 HG23 ' O ' ' B' ' 238' ' ' ARG . 57.3 t -66.78 -27.82 41.13 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.679 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 243' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' B' ' 246' ' ' LEU . 39.0 mt -84.18 -25.29 7.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.935 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 63.6 p -75.21 -27.02 59.4 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.642 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -86.52 -55.96 3.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.565 0.698 . . . . 0.0 109.712 173.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 246' ' ' LEU . . . . . 0.704 HD13 ' O ' ' B' ' 246' ' ' LEU . 0.0 OUTLIER -90.63 111.44 22.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.919 176.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -153.99 -143.23 0.13 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -176.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -73.2 37.82 0.8 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.209 -0.519 . . . . 0.0 113.412 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -107.92 95.76 5.91 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 250' ' ' ASN . . . . . 0.485 ' HB3' ' HB3' ' B' ' 253' ' ' ASP . 16.9 m120 61.81 52.71 3.37 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.559 0.537 . . . . 0.0 110.835 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.592 HD11 ' CE1' ' B' ' 207' ' ' TYR . 1.4 mm -59.92 -51.01 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -175.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -75.56 -11.6 60.05 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.974 -176.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 253' ' ' ASP . . . . . 0.485 ' HB3' ' HB3' ' B' ' 250' ' ' ASN . 22.6 t70 -84.31 -42.23 16.01 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 254' ' ' VAL . . . . . 0.516 HG12 ' O ' ' B' ' 251' ' ' ILE . 9.1 p -67.34 -22.35 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 255' ' ' ILE . . . . . 0.43 HG23 HD22 ' A' ' 7' ' ' LEU . 37.8 mt -71.97 -57.55 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.567 170.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -59.64 -36.19 75.9 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -175.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -105.13 6.2 32.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.878 0.371 . . . . 0.0 110.848 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -116.76 46.42 1.15 Allowed Glycine 0 C--O 1.229 -0.204 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.267 -174.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 259' ' ' ILE . . . . . 0.518 ' O ' HD11 ' A' ' 14' ' ' LEU . 18.9 mt -67.57 -63.76 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.92 0.391 . . . . 0.0 111.087 178.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 260' ' ' GLY . . . . . 0.61 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . -148.32 27.43 1.38 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.069 -1.062 . . . . 0.0 112.742 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -103.95 42.15 1.22 Allowed 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 170.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 262' ' ' LEU . . . . . 0.547 HD22 HD13 ' A' ' 14' ' ' LEU . 1.0 OUTLIER -72.17 88.61 1.13 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.152 -1.386 . . . . 0.0 111.312 -172.894 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -132.71 91.25 2.88 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.789 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 35.1 p -85.7 -161.31 0.6 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.605 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 45.2 t -48.28 123.78 10.9 Favored Pre-proline 0 CA--C 1.536 0.404 0 O-C-N 123.146 0.278 . . . . 0.0 111.095 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.26 96.5 0.47 Allowed 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.806 2.337 . . . . 0.0 112.95 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . 72.92 -32.68 0.25 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.841 0.856 . . . . 0.0 113.043 172.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 117.47 -8.05 15.63 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . 90.37 -139.46 14.96 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.057 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -151.95 145.37 24.81 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 3.7 p -131.21 142.99 42.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.694 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -137.61 141.86 41.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.316 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 24.9 t -92.35 126.98 44.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.508 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 3.0 m -74.4 67.36 1.44 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.855 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -81.97 154.29 25.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.68 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -121.31 89.19 46.58 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.651 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 277' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -61.53 105.91 0.39 Allowed 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.093 2.528 . . . . 0.0 112.367 176.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 124.93 -11.09 7.83 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.922 175.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 31.9 m -102.12 167.36 10.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.851 0.358 . . . . 0.0 111.657 -177.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 63.37 64.68 0.81 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.574 172.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -130.07 91.92 37.92 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.625 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -65.48 -53.31 0.81 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.184 2.589 . . . . 0.0 112.72 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . 51.29 55.62 9.2 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.515 0.509 . . . . 0.0 112.108 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -85.91 133.46 33.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.695 -176.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -107.82 100.57 1.51 Allowed Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 121.072 -0.585 . . . . 0.0 111.839 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 24.8 p -102.13 106.12 16.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.843 0.354 . . . . 0.0 111.247 -176.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -115.25 100.69 53.94 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.416 177.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -75.0 71.22 5.08 Favored 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 123.145 2.563 . . . . 0.0 112.861 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -112.57 55.09 0.7 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.221 0.534 . . . . 0.0 110.954 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -81.39 80.47 7.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.236 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -128.41 61.74 1.47 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.428 0.632 . . . . 0.0 110.656 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -76.09 91.55 3.13 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.086 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -84.29 132.08 34.66 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.549 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -103.13 153.34 20.42 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 176.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 14.6 mmtp -114.2 78.85 1.19 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.94 0.4 . . . . 0.0 110.891 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -146.63 99.3 3.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.17 0.509 . . . . 0.0 110.351 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -137.09 164.87 27.4 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.624 178.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 298' ' ' LYS . . . . . 0.428 ' HE2' ' HG3' ' B' ' 301' ' ' GLU . 25.6 pttm -80.85 -31.24 35.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.274 -178.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 299' ' ' LYS . . . . . 0.402 ' HG3' ' N ' ' B' ' 300' ' ' GLU . 12.5 tppt? 63.37 170.08 0.15 Allowed 'General case' 0 CA--C 1.541 0.619 0 O-C-N 123.469 0.48 . . . . 0.0 111.632 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 300' ' ' GLU . . . . . 0.402 ' N ' ' HG3' ' B' ' 299' ' ' LYS . 41.4 mt-10 56.74 -108.07 0.41 Allowed 'General case' 0 C--O 1.237 0.424 0 C-N-CA 122.904 0.482 . . . . 0.0 112.021 176.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 301' ' ' GLU . . . . . 0.428 ' HG3' ' HE2' ' B' ' 298' ' ' LYS . 19.0 mm-40 48.73 68.69 0.66 Allowed 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.598 0.561 . . . . 0.0 111.98 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 19.1 p -99.53 173.0 6.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.883 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -75.4 -60.11 2.45 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 69.16 131.95 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.917 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 16.8 m -112.72 134.76 54.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.233 -173.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -86.35 70.66 10.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.795 173.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.67 -79.39 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.092 0.472 . . . . 0.0 111.311 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -143.01 118.67 10.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.445 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -100.01 43.81 1.04 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.112 0.482 . . . . 0.0 111.01 -175.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . -78.23 69.09 2.79 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.736 -177.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 60.65 26.9 16.62 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 122.859 0.464 . . . . 0.0 111.964 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . -79.0 6.79 55.2 Favored Glycine 0 CA--C 1.521 0.469 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.607 -175.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 313' ' ' LEU . . . . . 0.789 HD13 ' H ' ' B' ' 313' ' ' LEU . 0.0 OUTLIER -83.26 -22.86 32.93 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 174.13 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 314' ' ' PHE . . . . . 0.579 ' N ' HD22 ' B' ' 313' ' ' LEU . 14.7 p90 32.43 46.6 0.07 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.342 1.457 . . . . 0.0 114.248 175.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 10.8 t70 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.629 -0.7 . . . . 0.0 110.054 179.71 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 ttt . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.73 21.74 12.34 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.038 0.447 . . . . 0.0 111.265 -177.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.54 ' O ' HD13 ' A' ' 7' ' ' LEU . 3.7 p -98.46 14.07 29.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.391 -177.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.5 m -69.67 -21.3 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.191 -176.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.465 ' HB3' HG23 ' A' ' 39' ' ' VAL . 2.3 m -65.34 -54.58 26.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.735 0.778 . . . . 0.0 110.065 177.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -65.6 -43.33 89.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.699 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.54 HD13 ' O ' ' A' ' 3' ' ' SER . 6.4 mp -55.71 -53.59 54.68 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.629 177.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.64 -50.55 72.8 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.488 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 45.6 t -63.69 -37.37 87.08 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.323 -176.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.461 HG13 HD13 ' A' ' 59' ' ' LEU . 0.6 OUTLIER -72.63 -40.89 62.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 120.564 0.221 . . . . 0.0 111.013 -177.749 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.56 ' HB2' ' CD2' ' B' ' 209' ' ' LEU . 21.0 m-85 -69.76 -27.86 65.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.508 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.423 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 8.9 t -64.72 -48.7 73.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.826 174.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.72 -42.5 62.29 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.636 172.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.588 HD23 HD11 ' A' ' 56' ' ' ILE . 95.2 mt -57.58 -59.16 5.61 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.238 0.542 . . . . 0.0 110.892 176.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.436 HG21 ' CD1' ' A' ' 31' ' ' LEU . 98.2 mt -52.29 -43.56 40.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.601 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.492 HD13 ' HA ' ' A' ' 23' ' ' VAL . 73.1 mt -75.14 -27.02 59.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.906 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -88.1 41.14 0.99 Allowed 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.836 -0.54 . . . . 0.0 111.485 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -127.1 -26.7 3.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.749 0.309 . . . . 0.0 110.683 174.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -118.21 -161.87 0.86 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -100.05 25.82 7.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.559 0.695 . . . . 0.0 110.687 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -81.19 143.49 12.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.0 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.1 p -83.06 144.8 29.66 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.825 0.345 . . . . 0.0 111.545 -177.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.612 HG21 HD23 ' A' ' 51' ' ' LEU . 35.9 m -91.62 48.24 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 121.146 0.498 . . . . 0.0 111.77 -176.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.0 p -84.5 159.28 20.75 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.32 -178.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -55.27 -36.53 66.2 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -54.37 -44.75 72.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.434 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.469 ' HD2' HG13 ' B' ' 230' ' ' VAL . 75.5 mmtt -77.98 -41.73 35.04 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 120.838 0.352 . . . . 0.0 110.369 -174.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.401 HG12 ' OG ' ' A' ' 12' ' ' SER . 4.6 mt -60.13 -45.6 95.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.647 175.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -65.53 -36.8 84.87 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 111.364 0.135 . . . . 0.0 111.364 176.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.12 -54.17 50.02 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 120.978 0.418 . . . . 0.0 111.122 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.514 ' CD2' ' HG ' ' B' ' 209' ' ' LEU . 5.8 tt -68.93 -35.31 76.65 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.978 -178.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.65 -36.3 59.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.848 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -78.4 -30.26 47.65 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.874 0.368 . . . . 0.0 110.719 177.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.22 -31.56 72.12 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.624 172.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.493 ' HB2' HD12 ' B' ' 209' ' ' LEU . . . -84.12 -73.46 0.42 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.745 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.08 -49.69 0.48 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.787 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.552 HG22 ' HA2' ' B' ' 213' ' ' GLY . 34.7 m -81.72 154.14 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.957 0.408 . . . . 0.0 110.616 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -121.88 -174.82 2.96 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.597 -174.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.465 HG23 ' HB3' ' A' ' 5' ' ' SER . 7.6 p -151.31 137.7 12.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.842 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.466 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 12.2 pt-20 -59.39 134.4 88.49 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-O 120.533 0.206 . . . . 0.0 110.845 -175.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 40' ' ' GLU . 73.5 Cg_exo -50.66 -13.76 0.94 Allowed 'Trans proline' 0 N--CA 1.484 0.94 0 C-N-CA 124.485 3.457 . . . . 0.0 115.574 -166.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -74.47 -31.3 62.18 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.776 0.322 . . . . 0.0 110.341 -176.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.575 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 86.7 m95 -71.03 -54.3 7.55 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-O 119.058 -0.496 . . . . 0.0 111.258 176.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.575 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 50.2 Cg_exo -55.21 -37.21 94.45 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 121.73 1.62 . . . . 0.0 111.68 173.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.61 -51.04 61.23 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.821 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.416 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 56.1 mt -60.95 -44.39 97.34 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 120.635 0.255 . . . . 0.0 111.117 178.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.554 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 8.3 m-85 -62.81 -47.68 82.38 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.057 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.86 -34.59 76.98 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -112.33 1.07 15.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -170.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 46' ' ' LEU . . . -136.76 -17.71 1.44 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 177.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.677 ' HA ' HG23 ' A' ' 54' ' ' VAL . 3.4 tp -86.73 -132.42 0.06 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.418 ' H ' ' CG ' ' A' ' 51' ' ' LEU . . . 58.31 1.04 0.15 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.413 ' H ' ' C ' ' A' ' 51' ' ' LEU . 63.0 t30 -143.22 -41.07 0.3 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.677 HG23 ' HA ' ' A' ' 51' ' ' LEU . 59.1 t -38.56 108.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 114.132 -1.394 . . . . 0.0 110.609 169.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -53.19 129.59 31.78 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 121.836 0.827 . . . . 0.0 109.274 176.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.588 HD11 HD23 ' A' ' 14' ' ' LEU . 7.3 tp -48.98 -38.63 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 114.25 -1.341 . . . . 0.0 113.731 -166.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.16 -28.22 68.69 Favored Glycine 0 C--O 1.242 0.597 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.434 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.4 t -65.78 -5.24 8.26 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.774 -0.213 . . . . 0.0 110.562 -177.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 31.5 mt -54.73 -38.59 67.31 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 120.812 0.339 . . . . 0.0 110.725 173.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.8 tt -82.19 4.99 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.533 0.683 . . . . 0.0 110.822 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.2 m -129.47 7.03 5.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.842 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -82.02 -0.54 44.72 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.969 0.414 . . . . 0.0 111.798 -173.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.9 p -82.46 -7.75 10.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.806 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.11 148.22 19.65 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.31 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.22 52.71 2.56 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.037 0.446 . . . . 0.0 110.655 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.55 -32.91 59.04 Favored Glycine 0 CA--C 1.519 0.294 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.738 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -161.3 101.71 0.2 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.734 -177.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.05 -30.53 25.43 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.782 2.321 . . . . 0.0 112.11 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 48.27 72.08 1.38 Allowed Pre-proline 0 CA--C 1.535 0.378 0 O-C-N 123.825 0.703 . . . . 0.0 112.545 177.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.64 97.73 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.153 2.569 . . . . 0.0 112.998 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.12 -43.95 97.71 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.731 174.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.6 139.92 28.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.776 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 174.84 -131.32 1.94 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.549 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.85 153.53 25.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.04 0.448 . . . . 0.0 111.46 -177.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.413 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -93.14 118.62 67.82 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.77 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 15.5 Cg_exo -74.82 -162.0 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 123.632 2.888 . . . . 0.0 112.876 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.33 -178.61 3.53 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.14 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -75.25 -169.43 25.35 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.006 -177.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 178.59 -72.89 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.937 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.66 164.17 23.5 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.695 2.264 . . . . 0.0 112.998 -175.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -135.23 92.38 18.02 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.398 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -45.68 -43.69 18.36 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.55 2.833 . . . . 0.0 113.085 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.7 m 52.72 68.35 0.84 Allowed 'General case' 0 CA--C 1.534 0.331 0 O-C-N 123.699 0.625 . . . . 0.0 111.472 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.7 m -61.8 -27.03 68.47 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.209 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.451 ' HB1' ' HG3' ' A' ' 88' ' ' PRO . . . -140.11 -65.89 0.45 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.555 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 62.29 88.16 0.09 Allowed 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.77 0.669 . . . . 0.0 111.379 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 60.77 70.57 0.94 Allowed Pre-proline 0 N--CA 1.467 0.398 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.468 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.451 ' HG3' ' HB1' ' A' ' 85' ' ' ALA . 47.4 Cg_exo -60.57 -63.18 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.287 2.658 . . . . 0.0 113.073 -178.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -178.7 -46.69 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.031 -177.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 57.39 63.72 1.79 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 122.013 0.911 . . . . 0.0 110.849 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.23 -38.27 4.77 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.465 177.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -59.43 125.52 23.94 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.829 175.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -134.4 126.08 28.82 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.056 178.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.7 m -71.04 120.25 18.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.275 0.56 . . . . 0.0 111.504 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.453 ' OE2' ' HG3' ' A' ' 97' ' ' LYS . 9.8 tp10 -75.14 123.92 26.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.42 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -170.78 38.79 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.443 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HG3' ' OE2' ' A' ' 95' ' ' GLU . 52.3 mtmt -58.47 136.07 57.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.825 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -113.67 145.25 41.6 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -143.97 -47.04 0.27 Allowed 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -174.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 65.18 -162.49 0.26 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.368 170.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.7 t -67.52 137.67 55.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.881 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -86.12 -161.66 0.66 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.704 175.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.48 -176.84 1.33 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 120.727 0.299 . . . . 0.0 110.577 175.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.8 m -138.37 36.67 2.28 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.361 0.6 . . . . 0.0 110.213 -176.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -108.58 1.91 21.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.411 -177.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -79.0 134.2 36.8 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.169 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 51.1 38.1 19.89 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.671 0.607 . . . . 0.0 112.48 175.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 49.4 ttm -75.23 -33.13 61.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.203 0.525 . . . . 0.0 110.997 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 146.32 -163.19 28.45 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.833 -177.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -102.95 137.67 40.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.805 0.336 . . . . 0.0 110.62 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.03 123.22 3.39 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.229 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -86.21 77.42 9.56 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.942 0.401 . . . . 0.0 110.578 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -127.31 -171.76 2.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.013 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 C--O 1.249 1.044 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.925 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 110.576 -0.157 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.652 ' SD ' ' HB3' ' B' ' 262' ' ' LEU . 25.8 ptt? -129.77 12.32 5.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.281 0.562 . . . . 0.0 110.357 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 202' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -55.84 -21.16 18.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.97 -1.014 . . . . 0.0 113.251 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 203' ' ' TYR . . . . . 0.592 ' HB2' HG21 ' B' ' 242' ' ' VAL . 41.9 m-85 -115.04 -31.98 5.88 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.731 -173.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.619 ' O ' HD13 ' B' ' 208' ' ' LEU . 11.7 p -66.41 -47.13 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.044 -177.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 205' ' ' ALA . . . . . 0.491 ' HA ' ' HB2' ' B' ' 208' ' ' LEU . . . -74.6 -14.71 60.81 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.538 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 206' ' ' SER . . . . . 0.411 ' HB3' HG23 ' B' ' 223' ' ' ILE . 37.6 m -74.83 -38.13 62.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.026 172.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 207' ' ' TYR . . . . . 0.412 ' HE1' HD11 ' B' ' 251' ' ' ILE . 14.5 t80 -65.16 -42.85 93.34 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 173.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.619 HD13 ' O ' ' B' ' 204' ' ' VAL . 8.1 mp -54.52 -52.12 63.02 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.784 173.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 209' ' ' LEU . . . . . 0.56 ' CD2' ' HB2' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -56.16 -48.08 77.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.443 -178.443 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -62.55 -35.3 79.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.696 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 211' ' ' ALA . . . . . 0.731 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -67.13 -57.76 6.17 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.862 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 212' ' ' LEU . . . . . 0.485 HD12 ' O ' ' B' ' 208' ' ' LEU . 0.0 OUTLIER -74.53 -14.27 60.78 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.262 -178.81 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 213' ' ' GLY . . . . . 0.552 ' HA2' HG22 ' A' ' 37' ' ' VAL . . . -68.88 -14.91 68.53 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.661 175.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 129.85 1.41 5.45 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.955 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 215' ' ' ASN . . . . . 0.731 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 84.2 m-20 -113.08 95.32 5.33 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 3.9 m -57.14 -31.06 64.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.356 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 10.2 t -126.67 77.96 73.34 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.745 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 218' ' ' PRO . . . . . 0.479 ' HB3' HD11 ' B' ' 223' ' ' ILE . 52.7 Cg_exo -56.3 140.82 88.79 Favored 'Trans proline' 0 N--CA 1.476 0.452 0 C-N-CA 123.759 2.973 . . . . 0.0 113.579 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 33.6 p -107.1 146.27 31.44 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -54.49 -31.83 56.7 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.066 0.46 . . . . 0.0 111.594 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -67.99 -39.23 83.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.504 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -72.79 -39.01 67.07 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.479 HD11 ' HB3' ' B' ' 218' ' ' PRO . 1.8 mp -59.72 -46.17 93.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 174.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -58.04 -38.89 77.11 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.483 176.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 225' ' ' LYS . . . . . 0.501 ' NZ ' HD12 ' B' ' 226' ' ' ILE . 14.7 ttpp -57.85 -49.5 76.46 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.626 0.25 . . . . 0.0 110.673 174.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 0.501 HD12 ' NZ ' ' B' ' 225' ' ' LYS . 0.6 OUTLIER -58.54 -37.28 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.938 -177.477 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 94.9 mt -75.72 -38.79 58.23 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.869 0.366 . . . . 0.0 111.238 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -69.66 -28.66 66.07 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.967 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 46.8 m -62.51 -31.65 72.45 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.654 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 230' ' ' VAL . . . . . 0.469 HG13 ' HD2' ' A' ' 27' ' ' LYS . 99.1 t -92.27 -34.75 6.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.745 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 109.91 29.58 3.76 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.007 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 11.6 mt -98.41 126.56 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -67.42 136.67 55.08 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.857 0.36 . . . . 0.0 110.198 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -138.02 114.45 10.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.177 -174.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -66.2 121.28 14.86 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -70.27 -27.22 64.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.272 -173.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -74.84 -46.96 32.99 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -64.79 -37.57 88.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.761 0.315 . . . . 0.0 110.163 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 239' ' ' LEU . . . . . . . . . . . . . 8.3 tt -58.5 -62.02 2.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.68 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -65.72 -28.71 69.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.907 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -66.09 -46.0 79.24 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 120.656 0.265 . . . . 0.0 111.488 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 242' ' ' VAL . . . . . 0.592 HG21 ' HB2' ' B' ' 203' ' ' TYR . 27.1 m -75.12 -25.73 18.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -178.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 13.5 mt -70.49 -41.86 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.248 173.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 46.7 p -70.62 -22.88 62.48 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.304 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -69.26 -46.14 67.98 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.71 171.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 2.2 pp -87.7 -17.11 32.49 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.148 -174.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -55.23 125.79 22.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.026 0.441 . . . . 0.0 111.843 -171.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 174.98 -168.79 41.53 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.688 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.98 12.37 28.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.122 0.487 . . . . 0.0 110.304 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -88.46 25.55 1.66 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.721 0.772 . . . . 0.0 110.061 -175.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.501 ' O ' HG12 ' B' ' 254' ' ' VAL . 34.2 mm -58.66 -62.75 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.768 -177.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -66.0 -29.64 70.05 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.437 -173.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.07 -51.68 66.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.166 175.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 254' ' ' VAL . . . . . 0.501 HG12 ' O ' ' B' ' 251' ' ' ILE . 8.9 p -71.09 -22.81 22.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.981 -176.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 255' ' ' ILE . . . . . 0.401 HG12 ' O ' ' B' ' 251' ' ' ILE . 44.2 mm -75.21 -50.59 23.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.274 0.559 . . . . 0.0 110.528 173.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -71.48 -25.96 62.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.342 -173.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -140.44 46.49 1.81 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.346 0.593 . . . . 0.0 110.802 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 258' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' B' ' 254' ' ' VAL . . . -130.94 53.39 0.81 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.666 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 20.0 mt -111.26 -20.39 6.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.172 0.51 . . . . 0.0 110.625 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -121.99 21.34 7.89 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.272 -0.966 . . . . 0.0 113.309 -176.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -130.19 44.46 2.96 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.032 0.444 . . . . 0.0 110.044 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 262' ' ' LEU . . . . . 0.652 ' HB3' ' SD ' ' B' ' 201' ' ' MET . 3.6 mm? -104.7 -97.34 0.32 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.347 -174.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 263' ' ' ALA . . . . . 0.425 ' HB2' ' SD ' ' B' ' 201' ' ' MET . . . -79.22 -38.61 35.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.858 0.361 . . . . 0.0 111.451 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 23.1 t -158.36 154.23 26.68 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.015 -177.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 265' ' ' VAL . . . . . 0.406 ' HA ' ' HD3' ' B' ' 266' ' ' PRO . 23.0 t -116.54 123.74 30.22 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.431 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 266' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' B' ' 265' ' ' VAL . 66.2 Cg_exo -53.22 -25.05 28.55 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.816 3.01 . . . . 0.0 113.994 -176.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . 54.07 80.65 0.11 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.142 0.496 . . . . 0.0 111.778 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 128.2 -40.66 1.69 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.09 -177.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -88.29 -61.67 1.46 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.958 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -89.41 94.22 9.81 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 7.0 p -116.82 142.94 28.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.317 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -85.4 135.8 33.72 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.436 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 15.0 p -142.95 153.84 17.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 9.3 m 60.18 49.8 6.97 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.604 0.716 . . . . 0.0 110.608 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -154.02 163.86 39.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.982 -178.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 276' ' ' ALA . . . . . 0.401 ' HA ' ' HD2' ' B' ' 277' ' ' PRO . . . 61.48 87.42 0.13 Allowed Pre-proline 0 C--O 1.234 0.247 0 O-C-N 123.615 0.572 . . . . 0.0 111.557 178.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 277' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' B' ' 276' ' ' ALA . 36.1 Cg_endo -63.97 143.74 86.01 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.023 2.482 . . . . 0.0 112.959 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -95.02 173.24 31.58 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.39 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 31.1 m -138.82 172.16 13.27 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 55.28 45.33 25.87 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.723 0.639 . . . . 0.0 111.442 175.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -70.72 140.52 86.7 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.916 -178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.14 67.69 7.56 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.792 2.328 . . . . 0.0 112.181 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -128.67 26.75 5.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.681 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -132.29 123.87 27.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.431 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -145.08 40.81 1.1 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.22 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 23.3 t -157.22 158.37 36.06 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -153.24 145.44 17.03 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.313 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.42 110.83 0.86 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.796 2.331 . . . . 0.0 112.686 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -103.32 110.86 23.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.241 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -95.1 169.54 10.03 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.943 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -82.92 -76.48 0.27 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.839 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 177.09 -65.59 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.45 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -55.97 -66.81 0.36 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.282 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 294' ' ' LYS . . . . . 0.499 ' O ' ' HB2' ' B' ' 295' ' ' LYS . 24.0 tptm 75.09 140.88 0.07 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.879 0.737 . . . . 0.0 110.934 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 295' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' B' ' 294' ' ' LYS . 66.3 mttm 76.0 157.46 0.19 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.593 -174.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 52.12 72.14 0.41 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.332 0.587 . . . . 0.0 111.86 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 297' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' B' ' 298' ' ' LYS . 16.7 pt-20 -67.33 161.58 24.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.574 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 298' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' B' ' 297' ' ' GLU . 23.9 ttmm 72.18 150.91 0.1 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.953 0.783 . . . . 0.0 110.818 -174.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -140.45 129.73 23.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.194 0.521 . . . . 0.0 111.353 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.39 96.01 4.75 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.396 -177.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -56.65 119.45 6.15 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.872 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 21.5 m -130.69 65.79 1.53 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.835 -174.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -116.02 18.49 15.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.314 0.578 . . . . 0.0 110.723 175.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -105.38 116.07 31.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.657 176.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 53.2 m -154.5 83.79 1.11 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.849 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.9 55.35 1.4 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.367 0.603 . . . . 0.0 110.113 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -82.65 170.65 14.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.158 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 55.11 -115.46 0.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.637 0.375 . . . . 0.0 110.7 -172.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 20.6 ttt 44.21 41.35 4.22 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.057 0.943 . . . . 0.0 112.403 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 57.66 38.91 90.04 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.944 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 59.04 72.83 0.51 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 122.813 0.445 . . . . 0.0 111.377 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . -68.08 -68.83 1.53 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.771 176.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 44.87 64.3 1.42 Allowed 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.699 0.761 . . . . 0.0 110.152 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 314' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -125.9 39.36 3.97 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.726 -166.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.289 -0.863 . . . . 0.0 109.954 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 tmt? . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 121.318 0.58 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.0 16.54 1.93 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 170.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.8 m -90.97 68.59 6.22 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 114.097 -1.411 . . . . 0.0 111.494 -171.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.548 HG12 HG21 ' A' ' 37' ' ' VAL . 41.3 t -68.43 -34.35 65.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 122.052 0.93 . . . . 0.0 108.801 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.653 ' HB3' HG23 ' A' ' 39' ' ' VAL . 4.2 m -66.93 -54.62 20.22 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.041 -178.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.502 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 37.4 mt-10 -62.96 -37.11 85.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.573 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.478 HD23 ' CG2' ' B' ' 255' ' ' ILE . 4.3 mp -60.75 -50.66 72.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.384 174.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.64 -49.6 74.53 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.041 0.448 . . . . 0.0 110.799 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.406 ' HB2' HG11 ' A' ' 39' ' ' VAL . 48.9 t -65.56 -31.55 72.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.633 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.502 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 1.2 tp -74.73 -41.28 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.826 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -64.36 -37.84 88.94 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.3 m -67.59 -46.66 71.99 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.472 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' A' ' 17' ' ' HIS . . . -48.95 -52.58 23.96 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.467 176.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.658 ' O ' ' HE1' ' B' ' 201' ' ' MET . 4.1 pp -77.93 -30.23 50.39 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.797 -176.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.448 ' N ' HD12 ' A' ' 14' ' ' LEU . 9.8 mt -56.35 -40.6 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.333 0.587 . . . . 0.0 110.185 173.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.8 mt -77.25 -31.62 55.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.29 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.505 ' HB2' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -82.85 50.85 1.78 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -175.498 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -146.32 -45.72 0.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.875 0.369 . . . . 0.0 110.775 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -86.87 -160.89 0.62 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.736 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -88.52 -17.09 31.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.325 0.583 . . . . 0.0 109.589 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.4 t -59.2 130.48 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.116 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.2 p -83.98 147.36 27.49 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.691 -176.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.4 m -78.05 116.05 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.601 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.421 ' OG1' ' HD3' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -150.7 162.49 40.59 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -176.795 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 53.0 mp0 -48.58 -54.95 12.54 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 123.369 0.418 . . . . 0.0 111.334 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -50.92 -34.81 30.1 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 124.0 0.812 . . . . 0.0 110.778 -178.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.465 ' HG3' HG13 ' B' ' 230' ' ' VAL . 14.2 mptt -78.39 -50.43 11.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.182 -175.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.45 HG23 HD13 ' A' ' 32' ' ' ILE . 7.8 mt -64.33 -40.69 89.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.131 0.491 . . . . 0.0 110.125 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -59.57 -46.19 89.63 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.351 175.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.19 -46.99 87.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.148 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.8 mt -65.26 -43.55 90.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.521 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.45 HD13 HG23 ' A' ' 28' ' ' ILE . 1.5 mp -59.09 -47.59 89.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 120.868 0.366 . . . . 0.0 110.786 176.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -71.56 -22.09 61.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.012 0.434 . . . . 0.0 110.915 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.36 -39.13 62.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.835 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.59 -47.1 10.17 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 138.96 -61.92 0.57 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 119.978 -1.106 . . . . 0.0 114.025 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.742 HG12 ' HA2' ' B' ' 213' ' ' GLY . 8.3 p -61.03 129.77 24.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.216 0.531 . . . . 0.0 111.912 -175.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -105.72 104.98 14.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.375 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.653 HG23 ' HB3' ' A' ' 5' ' ' SER . 3.1 p -76.12 140.89 16.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.322 172.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 11.4 pt-20 -52.94 125.93 41.25 Favored Pre-proline 0 CA--C 1.531 0.242 0 O-C-N 123.212 0.32 . . . . 0.0 110.593 -178.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 40' ' ' GLU . 75.7 Cg_exo -50.76 -13.19 0.75 Allowed 'Trans proline' 0 N--CA 1.485 0.98 0 C-N-CA 124.367 3.378 . . . . 0.0 115.229 -167.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -68.76 -35.07 76.62 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.529 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 76.6 m95 -69.59 -54.22 11.17 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.007 177.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.529 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 83.3 Cg_exo -50.85 -48.54 20.33 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 122.223 1.949 . . . . 0.0 112.868 175.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.47 -47.65 87.82 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.216 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.2 tp -58.68 -49.5 77.33 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.46 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 2.6 m-85 -54.04 -54.94 32.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.867 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.2 -39.41 92.66 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -175.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -88.49 -12.21 43.6 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.88 -18.23 14.11 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.545 ' HA ' HG23 ' A' ' 54' ' ' VAL . 26.6 mt -83.89 -131.99 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 119.331 -0.948 . . . . 0.0 109.98 177.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 59.3 7.42 0.91 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.17 0.51 . . . . 0.0 111.979 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -143.56 -42.15 0.29 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.545 HG23 ' HA ' ' A' ' 51' ' ' LEU . 7.5 t -54.88 115.84 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.609 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.245 177.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -53.63 152.6 5.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.697 171.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.728 ' O ' HD12 ' A' ' 59' ' ' LEU . 2.0 tp -46.5 -71.87 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -174.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.488 ' H ' HG23 ' A' ' 56' ' ' ILE . . . -63.17 -23.8 66.55 Favored Glycine 0 C--O 1.24 0.516 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.781 -172.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.3 t -59.54 -21.24 59.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.236 -0.482 . . . . 0.0 110.579 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -59.18 -19.24 43.56 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.567 -177.454 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.577 ' N ' HD13 ' A' ' 59' ' ' LEU . 48.1 mt -64.96 -27.59 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 121.173 -0.211 . . . . 0.0 111.32 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 75.2 m -139.26 23.4 2.55 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -175.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -132.82 51.32 2.17 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.461 HG11 ' CZ3' ' A' ' 43' ' ' TRP . 85.4 t -72.03 -42.56 68.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.063 0.458 . . . . 0.0 110.255 173.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -92.65 21.45 38.74 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.506 -177.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 58.61 -156.02 0.34 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 122.495 0.318 . . . . 0.0 111.14 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 137.36 -105.78 0.52 Allowed Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.135 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 146.6 115.01 0.88 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.486 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -72.48 102.8 1.44 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.794 2.329 . . . . 0.0 111.876 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 57.27 74.14 0.7 Allowed Pre-proline 0 N--CA 1.463 0.217 0 O-C-N 123.416 0.448 . . . . 0.0 111.088 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -60.23 -21.92 68.38 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.042 2.495 . . . . 0.0 113.598 -175.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.29 -30.27 68.32 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.693 0.282 . . . . 0.0 111.553 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 66.09 4.05 2.92 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.354 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.41 153.75 21.38 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.621 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.17 115.37 16.93 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.458 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -146.49 145.05 22.18 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.229 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 24.3 Cg_exo -68.05 -10.74 29.85 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.241 2.627 . . . . 0.0 113.205 -178.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 70.4 173.05 0.31 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.011 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.93 -169.94 31.46 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.11 178.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.28 -74.41 0.41 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.9 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.45 137.34 77.41 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.78 2.32 . . . . 0.0 112.828 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -107.66 152.27 41.41 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.401 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -38.86 -53.12 2.0 Allowed 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 123.748 2.965 . . . . 0.0 113.294 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.0 m 58.91 38.35 24.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.181 0.515 . . . . 0.0 111.177 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 p -102.16 -4.18 26.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.805 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 63.51 -171.74 0.17 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.434 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -165.92 67.33 0.12 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.48 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -117.59 99.18 52.32 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.94 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -57.35 142.2 94.92 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.15 2.567 . . . . 0.0 112.605 176.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.31 50.01 1.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.96 0.41 . . . . 0.0 111.124 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -83.94 120.73 26.45 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.606 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -62.01 -58.74 6.72 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.498 175.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -179.31 -60.03 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.378 -176.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? 70.92 141.76 0.05 Allowed 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.983 0.802 . . . . 0.0 110.368 -174.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.7 t -74.81 99.53 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.995 -175.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -83.27 121.08 26.64 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.946 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -159.39 117.86 2.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.162 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp 63.77 145.99 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.475 0.71 . . . . 0.0 111.929 -176.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.5 pttt -161.8 -47.83 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.524 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -167.05 117.96 0.9 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -148.65 135.07 19.53 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.608 -173.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 68.7 m -149.71 80.98 1.39 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.227 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -76.77 133.69 39.36 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -54.74 127.85 30.15 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.039 -175.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.1 p -133.9 177.92 7.35 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.727 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -96.57 -166.09 1.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -79.92 152.42 29.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -92.26 114.51 27.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.107 0.48 . . . . 0.0 111.037 -176.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 87.5 mtp -129.96 136.26 49.25 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.974 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -81.48 159.05 40.27 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.583 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -83.85 179.43 7.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.692 0.282 . . . . 0.0 110.796 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.08 -2.36 61.46 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.638 -176.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 53.0 tp -72.28 -29.8 64.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.338 0.59 . . . . 0.0 110.024 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -105.32 153.08 22.11 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.012 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.3 t70 . . . . . 0 C--O 1.248 0.978 0 O-C-N 124.52 1.137 . . . . 0.0 110.066 -176.717 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 120.701 0.286 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.658 ' HE1' ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -124.4 156.03 37.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.625 -176.805 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 202' ' ' ARG . . . . . 0.436 ' HG3' ' H ' ' B' ' 203' ' ' TYR . 13.9 ptp180 -177.09 -64.48 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.774 -0.193 . . . . 0.0 110.917 177.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 203' ' ' TYR . . . . . 0.816 ' CE2' ' HA ' ' B' ' 239' ' ' LEU . 4.3 m-85 -57.34 -33.3 67.6 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.573 0.349 . . . . 0.0 111.654 -177.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.751 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 3.8 m -52.84 -54.45 16.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.295 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 205' ' ' ALA . . . . . 0.462 ' CB ' HD11 ' A' ' 14' ' ' LEU . . . -80.14 -15.52 56.91 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.126 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 206' ' ' SER . . . . . 0.492 ' CB ' HG23 ' B' ' 223' ' ' ILE . 14.9 m -68.14 -42.17 80.51 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 170.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 207' ' ' TYR . . . . . 0.543 ' CD1' HD11 ' B' ' 251' ' ' ILE . 24.1 t80 -66.27 -40.25 90.0 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.268 174.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.751 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 54.3 mt -63.12 -36.01 82.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.544 176.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 209' ' ' LEU . . . . . . . . . . . . . 1.2 mp -62.37 -44.8 95.63 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.855 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -56.58 -39.15 73.0 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.501 177.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 211' ' ' ALA . . . . . . . . . . . . . . . -87.12 -63.35 1.32 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 212' ' ' LEU . . . . . 0.507 HD11 ' O ' ' A' ' 4' ' ' VAL . 3.4 tm? -54.11 -39.82 66.76 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 213' ' ' GLY . . . . . 0.742 ' HA2' HG12 ' A' ' 37' ' ' VAL . . . -52.39 -20.42 7.21 Favored Glycine 0 C--N 1.33 0.244 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.165 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 99.4 26.68 8.55 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.147 174.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 215' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -117.48 -29.47 5.8 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.959 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 37.9 m 60.66 35.08 19.93 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.027 172.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 217' ' ' SER . . . . . 0.404 ' C ' ' H ' ' B' ' 219' ' ' SER . 32.2 p -120.03 104.48 43.89 Favored Pre-proline 0 C--N 1.314 -0.968 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.275 -172.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 218' ' ' PRO . . . . . 0.405 ' HB3' ' OH ' ' B' ' 207' ' ' TYR . 26.2 Cg_exo -70.9 19.22 0.23 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.929 2.42 . . . . 0.0 113.256 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 219' ' ' SER . . . . . 0.418 ' HB2' ' CG ' ' B' ' 222' ' ' ASP . 1.1 m -63.52 119.27 9.47 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.436 0.636 . . . . 0.0 110.46 -176.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 220' ' ' ALA . . . . . 0.521 ' HB1' HD21 ' B' ' 239' ' ' LEU . . . -56.2 -29.35 60.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.86 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -73.46 -30.11 62.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.495 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 222' ' ' ASP . . . . . 0.418 ' CG ' ' HB2' ' B' ' 219' ' ' SER . 93.5 m-20 -70.94 -43.93 67.17 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.492 HG23 ' CB ' ' B' ' 206' ' ' SER . 1.8 mp -58.69 -52.42 60.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-O 121.056 0.455 . . . . 0.0 110.013 174.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -56.5 -40.83 75.62 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.878 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -65.23 -37.48 87.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.284 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 1.1 mp -62.58 -42.83 97.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.539 175.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 66.0 mt -75.83 -35.71 59.89 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.447 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.37 -20.7 62.94 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.723 0.297 . . . . 0.0 110.72 177.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 16.2 t -58.26 -26.87 63.45 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.313 0.577 . . . . 0.0 109.559 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 230' ' ' VAL . . . . . 0.465 HG13 ' HG3' ' A' ' 27' ' ' LYS . 98.8 t -110.11 -39.51 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.025 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 108.35 27.03 5.19 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.545 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 5.3 mt -83.28 147.4 5.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -57.81 114.48 2.32 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.124 0.488 . . . . 0.0 112.075 -174.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 234' ' ' ALA . . . . . 0.494 ' HB1' ' OH ' ' B' ' 203' ' ' TYR . . . -138.66 91.01 2.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.248 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -73.24 155.38 39.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.36 -177.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 236' ' ' ASP . . . . . 0.541 ' O ' ' HB3' ' B' ' 239' ' ' LEU . 24.0 t70 -69.01 -48.34 63.26 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.635 0.255 . . . . 0.0 111.425 -175.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 237' ' ' ASP . . . . . 0.709 ' O ' ' HB2' ' B' ' 241' ' ' LYS . 8.0 t70 -58.56 -54.39 47.6 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.392 0.615 . . . . 0.0 109.627 176.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.605 ' O ' HG22 ' B' ' 242' ' ' VAL . 25.0 ttm180 -58.6 -31.92 68.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.149 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 239' ' ' LEU . . . . . 0.816 ' HA ' ' CE2' ' B' ' 203' ' ' TYR . 3.0 tp -50.6 -76.52 0.02 OUTLIER 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.353 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -73.78 -20.14 60.56 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.528 -174.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 241' ' ' LYS . . . . . 0.709 ' HB2' ' O ' ' B' ' 237' ' ' ASP . 15.9 tttt -61.71 -58.44 8.01 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-O 121.303 0.573 . . . . 0.0 110.775 176.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 242' ' ' VAL . . . . . 0.605 HG22 ' O ' ' B' ' 238' ' ' ARG . 34.1 m -73.27 -32.37 37.64 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -174.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 243' ' ' ILE . . . . . 0.677 ' HA ' ' CD1' ' B' ' 246' ' ' LEU . 6.9 mt -60.83 -41.61 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.609 174.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 19.5 t -63.82 -32.17 73.59 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 177.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -76.32 -48.42 20.12 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 246' ' ' LEU . . . . . 0.677 ' CD1' ' HA ' ' B' ' 243' ' ' ILE . 0.0 OUTLIER -88.33 -10.01 50.86 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.433 0.56 . . . . 0.0 112.338 -173.115 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 247' ' ' ASN . . . . . 0.517 ' HB2' ' O ' ' B' ' 243' ' ' ILE . 63.5 t30 -44.69 -73.22 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 O-C-N 123.688 0.617 . . . . 0.0 111.725 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 58.55 -163.53 9.52 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.51 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -135.62 20.94 3.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.298 0.57 . . . . 0.0 109.734 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -115.81 38.78 3.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.411 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.543 HD11 ' CD1' ' B' ' 207' ' ' TYR . 1.1 mm -62.79 -51.36 72.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.322 -177.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -60.36 -30.36 69.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.115 0.483 . . . . 0.0 109.771 -177.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -76.09 -51.91 11.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.942 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 254' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' B' ' 251' ' ' ILE . 9.5 p -57.88 -30.7 38.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.758 0.313 . . . . 0.0 110.888 -177.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 255' ' ' ILE . . . . . 0.478 ' CG2' HD23 ' A' ' 7' ' ' LEU . 64.9 mt -85.05 -47.32 17.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.481 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -68.17 -15.32 63.53 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -176.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -57.28 -70.83 0.11 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.917 175.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 176.84 -99.72 0.13 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.243 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 259' ' ' ILE . . . . . 0.463 HD13 HG23 ' A' ' 60' ' ' ILE . 5.4 mp -93.51 -33.47 5.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 176.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 102.05 174.58 27.77 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.946 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 18.8 pttm -81.56 39.42 0.54 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.433 0.635 . . . . 0.0 110.186 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 262' ' ' LEU . . . . . 0.483 HD22 HG21 ' B' ' 204' ' ' VAL . 6.4 mt -99.15 -49.11 4.6 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.387 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -126.58 54.76 1.57 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.603 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 22.7 t -107.68 154.71 21.08 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.078 0.466 . . . . 0.0 110.695 -176.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 17.9 t -114.67 119.78 38.9 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.844 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.54 -24.22 30.94 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.453 2.102 . . . . 0.0 112.348 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . 59.69 -155.95 0.35 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.463 177.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . -79.57 68.5 3.17 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.436 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -70.27 -26.92 73.53 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 121.265 -0.493 . . . . 0.0 112.29 178.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -77.75 88.41 4.0 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.013 0.435 . . . . 0.0 110.488 178.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 44.2 t -106.01 145.98 13.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.902 -178.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -143.44 160.57 40.34 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.915 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.52 130.33 67.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.907 0.384 . . . . 0.0 110.223 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 7.0 p -120.94 95.75 4.83 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.153 0.501 . . . . 0.0 110.778 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -93.58 135.68 34.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.629 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 276' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' B' ' 277' ' ' PRO . . . -97.04 123.84 51.82 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.371 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 277' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' B' ' 276' ' ' ALA . 3.0 Cg_exo -74.28 109.36 2.88 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.708 2.272 . . . . 0.0 112.041 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -125.34 85.59 0.35 Allowed Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.616 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 19.4 m -152.28 -176.85 5.86 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -177.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 62.58 64.33 0.93 Allowed 'General case' 0 C--N 1.331 -0.211 0 O-C-N 124.024 0.828 . . . . 0.0 111.847 174.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -112.65 99.44 47.64 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.593 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.46 116.69 2.01 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.087 2.524 . . . . 0.0 112.455 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -116.31 27.81 8.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.037 0.446 . . . . 0.0 110.785 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -148.04 162.39 39.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.661 -177.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -163.91 141.79 7.36 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 31.3 p -93.48 98.78 11.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.696 0.284 . . . . 0.0 111.393 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -85.88 133.25 41.79 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.288 175.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -81.06 63.78 8.8 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.611 2.207 . . . . 0.0 112.419 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -99.27 77.81 2.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.849 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -93.09 -5.95 49.18 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.186 0.517 . . . . 0.0 111.08 178.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . 64.3 64.38 0.72 Allowed 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.802 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -72.46 -3.42 24.2 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.514 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -59.57 107.16 0.55 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.513 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -124.45 123.06 39.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.223 0.535 . . . . 0.0 111.009 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -126.69 136.43 52.45 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.371 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 61.41 57.35 2.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.545 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -80.27 -15.18 57.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.363 0.601 . . . . 0.0 109.592 174.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 298' ' ' LYS . . . . . 0.523 ' HD2' ' O ' ' B' ' 298' ' ' LYS . 0.0 OUTLIER -76.75 143.08 40.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.138 -178.456 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 299' ' ' LYS . . . . . 0.406 ' HB3' ' HE2' ' B' ' 299' ' ' LYS . 16.3 ptpt -155.4 28.96 0.39 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.808 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -127.26 -66.82 0.87 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 53.59 47.28 24.26 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.898 176.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 9.2 p -108.09 128.91 55.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.931 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -118.6 -78.82 0.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.148 0.499 . . . . 0.0 110.418 -177.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -127.25 151.61 48.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.199 -176.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 20.2 m -84.21 140.53 31.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.796 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -140.11 83.26 1.91 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.606 0.717 . . . . 0.0 109.539 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -129.15 120.74 26.36 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.833 -175.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.7 120.33 18.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.963 0.411 . . . . 0.0 110.782 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 24.5 ptp -80.5 -9.2 59.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.699 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . -63.58 -30.26 77.08 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.42 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -105.57 11.58 32.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.02 0.438 . . . . 0.0 110.308 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . -148.53 39.64 0.96 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.839 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 313' ' ' LEU . . . . . 0.737 HD23 ' H ' ' B' ' 313' ' ' LEU . 2.3 pt? -80.22 43.73 0.64 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 122.296 1.046 . . . . 0.0 110.476 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 314' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -126.64 -40.6 1.91 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.172 -1.376 . . . . 0.0 110.273 -176.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 36.3 t70 . . . . . 0 C--O 1.247 0.937 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.281 -179.954 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 mmt . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 120.691 0.281 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.1 154.8 17.68 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.464 ' O ' HD13 ' A' ' 7' ' ' LEU . 23.1 p 44.03 60.13 2.88 Favored 'General case' 0 C--O 1.239 0.527 0 O-C-N 123.897 0.748 . . . . 0.0 112.162 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.433 ' HA ' ' HB2' ' A' ' 7' ' ' LEU . 3.5 m -67.26 -16.74 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.557 -177.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.476 ' HB2' HG23 ' A' ' 39' ' ' VAL . 3.3 p -64.77 -62.02 1.82 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.558 176.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -58.2 -45.42 87.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.12 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 3' ' ' SER . 7.0 mp -51.47 -58.01 7.45 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.621 176.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.42 -47.12 76.45 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.065 -177.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 49.1 t -65.98 -34.67 78.64 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.948 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.401 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 0.9 OUTLIER -74.03 -33.65 36.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.617 0.246 . . . . 0.0 111.234 -179.003 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.704 ' HB2' HD21 ' B' ' 209' ' ' LEU . 21.4 m-85 -79.06 -23.62 44.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.187 0.518 . . . . 0.0 110.025 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.517 ' HA ' HD23 ' A' ' 31' ' ' LEU . 19.3 t -68.89 -47.24 66.35 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 171.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.5 -42.09 63.99 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.712 172.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.429 ' O ' ' HE2' ' B' ' 201' ' ' MET . 20.0 mt -58.54 -54.49 46.43 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 120.922 0.391 . . . . 0.0 111.108 176.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.538 HD12 HD21 ' A' ' 31' ' ' LEU . 10.3 mt -59.54 -40.76 82.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.166 -177.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.8 mt -77.83 -22.56 49.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.413 ' CE1' ' HB ' ' A' ' 56' ' ' ILE . 25.1 t-80 -61.87 -36.35 80.97 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.65 ' HB2' ' HG3' ' B' ' 201' ' ' MET . 31.8 t70 -73.28 -69.7 0.41 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -168.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.436 ' C ' ' H ' ' A' ' 21' ' ' VAL . 23.1 t70 -64.83 148.1 51.95 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.088 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -77.23 46.24 0.49 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.903 0.859 . . . . 0.0 110.451 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.436 ' H ' ' C ' ' A' ' 19' ' ' ASP . 9.9 p -81.3 157.37 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.303 175.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.6 t -59.02 -20.16 50.51 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -168.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.6 t 55.14 78.45 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 121.403 0.62 . . . . 0.0 109.732 -175.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.1 p -136.05 168.17 19.86 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -174.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -51.55 -48.06 63.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.568 -1.197 . . . . 0.0 110.707 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -52.45 -39.29 60.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.197 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 2.8 mptp? -80.88 -41.35 23.25 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.431 -173.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.414 HG23 HD13 ' A' ' 32' ' ' ILE . 10.8 mt -64.03 -45.39 96.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.054 174.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -60.17 -40.9 91.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.696 178.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.29 -52.55 65.17 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 111.394 177.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.594 ' HB2' HG22 ' B' ' 230' ' ' VAL . 45.4 tp -66.54 -40.98 89.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.265 0.555 . . . . 0.0 111.182 -176.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.414 HD13 HG23 ' A' ' 28' ' ' ILE . 1.5 mp -62.73 -37.21 78.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.399 177.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -74.4 -29.11 61.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 0.0 110.137 177.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.51 -45.86 92.42 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.582 175.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.423 ' HA ' HD11 ' B' ' 226' ' ' ILE . . . -80.74 -33.06 35.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.797 0.332 . . . . 0.0 111.547 177.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.52 23.43 28.75 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.812 173.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.5 t -94.89 130.15 44.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 117.327 0.563 . . . . 0.0 110.708 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -79.72 90.8 5.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.98 -177.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.476 HG23 ' HB2' ' A' ' 5' ' ' SER . 10.7 p -98.52 130.09 47.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 169.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -63.28 136.49 96.72 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.04 -177.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.475 ' HA ' ' HG2' ' A' ' 44' ' ' PRO . 82.9 Cg_exo -48.75 -14.08 0.34 Allowed 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 124.716 3.611 . . . . 0.0 115.021 -171.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.19 -36.87 77.76 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -177.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -67.44 -58.96 7.77 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 121.011 -0.275 . . . . 0.0 111.359 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.475 ' HG2' ' HA ' ' A' ' 41' ' ' PRO . 10.9 Cg_endo -54.54 -46.1 35.95 Favored 'Trans proline' 0 C--N 1.361 1.237 0 C-N-CA 122.286 1.991 . . . . 0.0 112.754 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.73 -45.99 95.11 Favored Glycine 0 C--O 1.242 0.639 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.033 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.4 tp -51.99 -59.37 4.43 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 176.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -58.99 -40.39 84.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.711 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.0 -44.61 91.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.217 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -95.62 -11.7 26.81 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.772 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.548 ' O ' HG21 ' A' ' 54' ' ' VAL . . . -104.15 -12.28 16.81 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -175.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.586 ' HA ' HG23 ' A' ' 54' ' ' VAL . 42.9 mt -101.79 -132.34 0.27 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.429 173.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 65.96 -12.61 0.17 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -144.69 12.74 1.49 Allowed 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.586 HG23 ' HA ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -128.23 120.81 54.24 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.944 -170.082 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -55.07 155.52 4.57 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.034 -1.439 . . . . 0.0 112.448 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.545 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 3.7 tp -44.53 -41.91 2.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -173.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -54.29 -23.81 27.31 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 121.611 -0.328 . . . . 0.0 113.494 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.6 t -53.84 -26.71 25.69 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 122.542 0.337 . . . . 0.0 111.264 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 34.3 mt -56.9 -36.06 69.71 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.664 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.472 HG12 HD13 ' B' ' 259' ' ' ILE . 1.1 mp -103.27 18.38 4.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.445 0.64 . . . . 0.0 109.539 -175.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 69.7 m -119.91 -6.53 10.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.393 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -100.56 -17.4 17.11 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.145 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.8 m -84.74 -3.9 8.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.879 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 166.39 148.0 5.41 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -129.08 -179.67 5.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.586 0.232 . . . . 0.0 110.624 -177.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.16 -139.5 5.36 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.185 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -98.91 165.95 21.17 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.151 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -76.36 60.3 6.36 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 122.819 2.346 . . . . 0.0 112.439 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.414 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . . . -102.58 -48.52 0.17 Allowed Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -177.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' A' ' 69' ' ' ALA . 6.4 Cg_exo -73.23 92.46 0.83 Allowed 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 121.992 1.795 . . . . 0.0 112.665 -177.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -120.01 134.09 55.35 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.56 177.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -129.69 115.11 16.85 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.871 -177.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.08 149.39 18.72 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.017 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.7 136.33 33.0 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.433 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -126.43 135.07 26.69 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.83 -177.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 38.1 Cg_exo -65.12 129.15 22.22 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.403 2.735 . . . . 0.0 112.974 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 71.01 176.65 0.28 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.003 176.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 176.42 105.86 0.19 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.945 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.94 76.9 1.28 Allowed Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.559 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -90.71 103.0 0.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.975 2.45 . . . . 0.0 112.032 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -122.7 85.38 49.3 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.282 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.23 -66.54 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.635 2.223 . . . . 0.0 111.949 175.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.9 m 54.73 45.31 26.99 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.111 0.481 . . . . 0.0 111.674 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 46.5 p -83.51 107.26 15.87 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.144 178.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -112.53 -36.92 5.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.041 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.28 123.78 23.03 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.066 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.58 158.84 45.94 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.065 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -49.34 -37.98 41.69 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.644 2.229 . . . . 0.0 113.685 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 73.36 -55.16 0.68 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.696 0.798 . . . . 0.0 112.869 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 66.47 85.94 0.14 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.323 0.583 . . . . 0.0 111.459 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -100.99 161.29 13.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.464 177.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.1 mttt 54.38 64.83 1.68 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.794 0.684 . . . . 0.0 111.543 173.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -117.62 128.3 54.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.931 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.9 p -110.41 140.36 29.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.55 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.43 ' HG2' ' H ' ' A' ' 96' ' ' ALA . 6.7 tt0 -105.37 -176.27 3.03 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.43 ' H ' ' HG2' ' A' ' 95' ' ' GLU . . . 79.37 170.01 0.18 Allowed 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.035 0.934 . . . . 0.0 110.838 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 98' ' ' LYS . 25.3 pttm -129.64 142.03 50.81 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.051 -174.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 13.8 mptt 69.26 -85.76 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.994 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 54.67 -148.04 0.49 Allowed 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.495 0.497 . . . . 0.0 110.776 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -66.43 143.49 57.08 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.988 0.423 . . . . 0.0 110.725 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.5 m -154.05 106.67 2.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.137 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -90.57 -71.62 0.61 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.538 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 65.41 107.13 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.958 0.786 . . . . 0.0 111.488 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.6 p -80.48 147.35 30.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.692 -177.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 64.61 91.3 0.08 Allowed 'General case' 0 C--O 1.233 0.211 0 O-C-N 123.923 0.765 . . . . 0.0 112.334 175.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -58.13 -61.16 2.76 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.175 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 54.34 57.08 6.17 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.051 0.453 . . . . 0.0 111.209 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 53.2 ttp -61.22 -30.07 70.22 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.832 175.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.66 -91.65 1.74 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.792 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -79.69 111.1 15.66 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.15 0.5 . . . . 0.0 111.387 -175.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.26 54.57 0.16 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.099 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 67.4 mt -111.9 -2.31 15.21 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.695 0.283 . . . . 0.0 110.888 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -132.91 10.12 4.22 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.722 -173.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.295 -0.859 . . . . 0.0 110.768 -176.097 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.65 ' HG3' ' HB2' ' A' ' 18' ' ' ASP . 73.9 mtm -54.37 -33.0 58.26 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.322 -173.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 202' ' ' ARG . . . . . 0.49 ' HB2' ' O ' ' B' ' 201' ' ' MET . 55.8 ttt180 175.69 154.08 0.17 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 172.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -76.8 10.69 2.07 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.578 0.704 . . . . 0.0 110.944 -175.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.621 ' O ' HD13 ' B' ' 208' ' ' LEU . 94.3 t -59.67 -62.1 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.158 177.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 205' ' ' ALA . . . . . 0.611 ' O ' ' HG ' ' B' ' 209' ' ' LEU . . . -61.7 -21.49 64.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.561 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 206' ' ' SER . . . . . 0.407 ' CB ' HG23 ' B' ' 223' ' ' ILE . 5.7 m -66.87 -47.9 70.45 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.003 0.43 . . . . 0.0 109.88 173.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 207' ' ' TYR . . . . . 0.644 ' HD2' HD13 ' B' ' 251' ' ' ILE . 34.0 t80 -59.98 -38.89 83.87 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.667 ' O ' ' HG ' ' B' ' 212' ' ' LEU . 9.3 mp -56.57 -56.49 20.7 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.778 175.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 209' ' ' LEU . . . . . 0.704 HD21 ' HB2' ' A' ' 11' ' ' TYR . 58.0 mt -52.36 -47.5 66.1 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 123.532 0.52 . . . . 0.0 111.066 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -63.98 -32.81 74.49 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.264 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 211' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -68.8 -44.82 72.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.494 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 212' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' B' ' 208' ' ' LEU . 15.1 mt -64.81 -29.01 69.96 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.733 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -62.68 -7.18 14.13 Favored Glycine 0 C--N 1.337 0.603 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.957 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 110.66 20.82 7.1 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.485 174.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 215' ' ' ASN . . . . . 0.656 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 27.5 m-80 -130.32 111.67 12.59 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 6.3 m -65.89 -20.77 66.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.279 0.561 . . . . 0.0 110.684 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 12.0 p -123.71 70.58 47.9 Favored Pre-proline 0 N--CA 1.443 -0.806 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.859 -175.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 218' ' ' PRO . . . . . 0.484 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 50.4 Cg_exo -60.39 135.68 63.02 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.069 2.512 . . . . 0.0 112.599 173.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 219' ' ' SER . . . . . 0.41 ' O ' HD13 ' B' ' 223' ' ' ILE . 49.4 m -102.66 157.22 17.09 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.736 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -51.4 -41.68 60.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.198 0.523 . . . . 0.0 111.224 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -60.79 -42.55 97.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.972 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -67.82 -39.55 83.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.506 -177.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.428 HD11 ' CB ' ' B' ' 218' ' ' PRO . 1.7 mp -68.03 -39.8 82.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 120.867 0.365 . . . . 0.0 110.553 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -62.07 -42.99 99.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.953 0.406 . . . . 0.0 110.35 176.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 16.6 ttpp -64.42 -39.57 94.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.371 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 0.438 HG23 HD11 ' A' ' 31' ' ' LEU . 0.8 OUTLIER -62.65 -41.21 91.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.392 178.295 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 227' ' ' LEU . . . . . 0.426 ' HA ' HD22 ' B' ' 227' ' ' LEU . 0.5 OUTLIER -71.93 -45.39 61.29 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -176.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.98 -24.35 62.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.831 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 18.5 t -56.68 -42.41 78.99 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.792 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 230' ' ' VAL . . . . . 0.594 HG22 ' HB2' ' A' ' 31' ' ' LEU . 7.0 t -64.28 -29.39 47.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.526 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 105.65 10.35 31.11 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.424 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 24.9 mt -104.57 139.37 25.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -71.74 151.48 43.53 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -173.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -132.07 143.49 50.07 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.757 -176.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -91.27 114.97 27.63 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.089 0.471 . . . . 0.0 110.249 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -58.07 -51.89 67.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.407 -175.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -54.9 -56.76 16.02 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.167 0.508 . . . . 0.0 110.953 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.411 ' O ' HG13 ' B' ' 242' ' ' VAL . 18.7 mmt180 -61.39 -32.77 72.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.862 -175.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 239' ' ' LEU . . . . . . . . . . . . . 6.9 tt -61.83 -60.87 3.0 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.051 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -67.16 -29.81 69.61 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.578 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -60.12 -53.73 54.31 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 120.786 0.327 . . . . 0.0 110.94 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 242' ' ' VAL . . . . . 0.52 ' HA ' ' OE2' ' B' ' 245' ' ' GLU . 22.2 m -72.87 -25.95 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-O 121.327 0.584 . . . . 0.0 110.134 -175.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 34.9 mt -74.54 -31.18 26.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.504 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 23.3 t -64.87 -34.99 79.7 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 173.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 245' ' ' GLU . . . . . 0.52 ' OE2' ' HA ' ' B' ' 242' ' ' VAL . 36.0 mt-10 -67.42 -45.19 76.82 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.237 171.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 246' ' ' LEU . . . . . 0.551 HD11 ' HA ' ' B' ' 204' ' ' VAL . 52.1 mt -70.61 -95.34 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.083 -177.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 58.66 174.21 0.07 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.068 0.547 . . . . 0.0 110.448 -175.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -76.14 50.54 2.73 Favored Glycine 0 CA--C 1.516 0.127 0 O-C-N 122.091 -0.381 . . . . 0.0 113.383 -173.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -109.29 -64.84 1.2 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.508 0.67 . . . . 0.0 110.21 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -103.7 8.29 37.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.413 -174.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.644 HD13 ' HD2' ' B' ' 207' ' ' TYR . 6.0 tp -57.58 -45.57 86.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.519 -173.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -60.58 -40.08 90.39 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.258 0.551 . . . . 0.0 110.606 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -70.03 -45.25 67.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.838 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 254' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' B' ' 251' ' ' ILE . 8.9 p -66.36 -27.96 42.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.916 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 255' ' ' ILE . . . . . 0.521 HG12 ' HG ' ' B' ' 208' ' ' LEU . 96.4 mt -70.86 -52.1 30.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 121.1 0.476 . . . . 0.0 110.219 173.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -76.23 -5.36 46.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.01 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -52.59 -59.6 4.26 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.43 0.456 . . . . 0.0 111.708 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 178.73 -102.39 0.17 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.152 -1.023 . . . . 0.0 113.412 175.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 259' ' ' ILE . . . . . 0.566 ' O ' HD13 ' B' ' 262' ' ' LEU . 3.4 mp -150.5 -75.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 117.061 0.43 . . . . 0.0 112.011 -175.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -118.62 40.9 2.15 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 119.279 -1.439 . . . . 0.0 114.834 -165.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 17.4 tptt -138.36 39.08 2.27 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 168.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 262' ' ' LEU . . . . . 0.566 HD13 ' O ' ' B' ' 259' ' ' ILE . 6.6 mp -89.77 97.01 10.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.402 -1.272 . . . . 0.0 113.006 -166.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -144.43 25.14 1.53 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.852 -1.522 . . . . 0.0 109.092 175.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 11.1 t 69.68 -155.74 0.15 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.828 -172.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 5.1 p -58.92 111.55 3.83 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 121.449 0.642 . . . . 0.0 111.154 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -85.21 33.4 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.156 2.571 . . . . 0.0 113.67 -174.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . 53.09 66.48 1.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.693 177.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 97.28 -60.25 1.1 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.478 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . 101.3 -26.29 25.12 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.625 175.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -135.19 143.83 46.65 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.112 0.482 . . . . 0.0 111.778 -174.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 22.1 t -125.57 139.37 51.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.459 174.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -118.86 159.93 22.85 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.468 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 8.4 p -118.35 138.41 49.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.2 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 1.5 p -91.5 135.23 34.0 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.791 0.329 . . . . 0.0 110.763 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.55 144.91 49.4 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.251 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 276' ' ' ALA . . . . . 0.443 ' HA ' ' HD3' ' B' ' 277' ' ' PRO . . . -80.12 123.91 83.12 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.904 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 277' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' B' ' 276' ' ' ALA . 10.7 Cg_exo -71.97 160.87 46.49 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 123.282 2.655 . . . . 0.0 113.556 -178.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -126.2 174.33 17.86 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.512 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 10.8 m -131.23 -171.15 2.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 117.074 0.437 . . . . 0.0 111.37 -175.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 66.28 64.95 0.5 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.033 172.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 281' ' ' ALA . . . . . 0.531 ' H ' ' HD2' ' B' ' 282' ' ' PRO . . . -124.49 -47.76 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.191 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 282' ' ' PRO . . . . . 0.531 ' HD2' ' H ' ' B' ' 281' ' ' ALA . 89.3 Cg_endo -88.73 -169.55 0.42 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 121.654 1.57 . . . . 0.0 112.488 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . 66.27 40.47 3.75 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.87 177.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -132.1 177.04 7.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.638 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 110.4 130.47 5.83 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.189 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 8.3 p -134.34 139.73 45.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.559 0.219 . . . . 0.0 110.867 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -143.53 106.52 5.08 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.23 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -88.8 153.73 6.08 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.68 2.253 . . . . 0.0 111.91 175.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -156.78 -68.37 0.1 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.059 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -71.67 132.1 44.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.13 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -138.49 15.91 2.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.037 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 56.02 46.86 20.97 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.581 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -61.55 125.77 24.99 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.721 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -150.3 77.58 1.31 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.926 176.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -93.58 97.0 10.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.995 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -51.38 113.41 0.95 Allowed 'General case' 0 CA--C 1.519 -0.212 0 O-C-N 123.745 0.653 . . . . 0.0 109.409 175.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -104.67 -61.84 1.41 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.828 -173.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -98.28 108.53 21.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.147 0.499 . . . . 0.0 110.704 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -110.57 142.28 42.61 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.53 175.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -81.59 115.87 21.07 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.861 0.363 . . . . 0.0 110.458 -177.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -73.96 121.29 20.78 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.741 -178.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 16.2 p -85.43 78.04 9.8 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 175.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -80.52 -33.03 36.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.891 -175.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -71.06 149.53 46.44 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.3 -176.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 13.8 m -124.94 140.73 52.65 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.464 -177.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -106.34 68.29 0.76 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.427 0.632 . . . . 0.0 110.677 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -83.22 -39.3 21.11 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.166 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -79.32 76.68 5.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.836 0.827 . . . . 0.0 112.35 -173.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 50.1 ttp -81.39 -23.52 37.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.609 172.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 127.4 132.76 3.67 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.229 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -84.02 56.27 3.64 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.205 0.526 . . . . 0.0 110.718 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . 128.21 106.37 1.31 Allowed Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.535 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 6.4 mp -100.71 8.49 43.28 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 172.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 314' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -87.8 -59.55 2.21 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.01 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 9.5 t70 . . . . . 0 C--O 1.252 1.226 0 CA-C-O 117.96 -1.019 . . . . 0.0 108.385 176.127 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptm . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 120.628 0.251 . . . . 0.0 110.452 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.51 -176.13 5.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.79 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.7 m 57.71 41.02 25.91 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.635 0.584 . . . . 0.0 111.021 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.422 HG13 ' HG ' ' B' ' 212' ' ' LEU . 18.9 t -65.81 -28.44 44.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.461 -174.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.561 ' HB2' HG23 ' A' ' 39' ' ' VAL . 1.5 p -61.94 -64.11 1.04 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.36 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -56.66 -49.63 74.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.577 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.492 ' HB3' HD22 ' B' ' 212' ' ' LEU . 7.3 mp -54.96 -44.91 74.8 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.445 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.71 -45.46 89.88 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.749 0.309 . . . . 0.0 110.949 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.87 -39.0 92.84 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.694 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 tp -73.26 -39.24 55.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.353 -176.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.479 ' CB ' HD12 ' B' ' 209' ' ' LEU . 22.1 m-30 -63.99 -42.23 97.26 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.483 ' HA ' ' CD2' ' A' ' 31' ' ' LEU . 42.1 m -60.74 -43.06 98.41 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.126 0.489 . . . . 0.0 110.011 176.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.44 -56.54 18.95 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.124 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.529 HD11 ' CB ' ' B' ' 205' ' ' ALA . 3.8 pp -78.77 -7.33 57.7 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.234 -177.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 35.5 mt -83.33 -26.26 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.178 0.513 . . . . 0.0 110.105 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.533 HD12 HG13 ' A' ' 28' ' ' ILE . 56.1 mt -100.4 -3.04 31.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.957 175.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.491 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 8.1 t-80 -31.19 -70.69 0.06 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.52 20.32 1.34 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.422 0.629 . . . . 0.0 109.435 -173.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.487 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 2.3 m-20 -83.45 54.21 2.76 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.349 -171.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 19' ' ' ASP . 9.2 pt-20 47.41 29.87 1.44 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.233 1.013 . . . . 0.0 111.913 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.525 HG21 HD13 ' B' ' 232' ' ' ILE . 73.2 t -143.71 150.54 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.205 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.4 p -88.69 142.09 27.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.96 0.41 . . . . 0.0 111.846 -176.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.6 m -75.03 39.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.047 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.5 p -74.44 151.06 39.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.002 0.43 . . . . 0.0 111.736 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.58 -31.25 70.39 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.174 -177.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -53.77 -44.32 69.96 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 123.696 0.623 . . . . 0.0 110.407 173.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -81.09 -40.83 23.49 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.096 -174.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.533 HG13 HD12 ' A' ' 16' ' ' LEU . 1.5 mt -60.27 -48.08 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 174.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -57.2 -42.84 82.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.79 175.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.77 -43.21 90.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.281 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.576 HD11 HG23 ' B' ' 226' ' ' ILE . 14.3 tp -72.44 -39.79 67.57 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 120.97 0.414 . . . . 0.0 110.458 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -54.87 -43.16 66.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.29 175.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -82.54 -17.53 44.66 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.214 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.479 ' HB1' ' HA ' ' B' ' 226' ' ' ILE . . . -62.24 -47.52 84.04 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 172.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.578 ' HA ' HD11 ' B' ' 226' ' ' ILE . . . -84.27 -31.9 24.7 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.354 178.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.08 38.65 5.07 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.001 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.4 t -104.43 157.01 5.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -121.41 112.53 18.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.931 0.396 . . . . 0.0 110.782 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.561 HG23 ' HB2' ' A' ' 5' ' ' SER . 3.0 p -119.29 135.13 60.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.077 175.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.48 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 8.0 tp10 -42.95 111.41 1.02 Allowed Pre-proline 0 N--CA 1.464 0.256 0 O-C-N 123.965 0.791 . . . . 0.0 110.656 173.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.425 ' HA ' ' HG2' ' A' ' 44' ' ' PRO . 85.0 Cg_exo -49.25 -15.01 0.61 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 124.438 3.425 . . . . 0.0 114.682 -172.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.11 -34.89 75.79 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.525 ' O ' ' HB2' ' A' ' 47' ' ' PHE . 95.7 m95 -68.03 -61.31 4.25 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.375 177.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.48 ' HD2' ' O ' ' A' ' 40' ' ' GLU . 13.6 Cg_endo -57.56 -38.21 94.52 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 121.913 1.742 . . . . 0.0 112.117 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.38 -59.25 9.69 Favored Glycine 0 C--O 1.24 0.481 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.786 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 27.9 tp -55.51 -47.91 75.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.722 0.296 . . . . 0.0 110.246 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.727 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -56.32 -62.19 1.88 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.462 -177.77 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.97 -30.18 71.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.609 -173.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -83.85 -22.85 31.57 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.559 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.17 -4.62 17.48 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -173.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.727 ' HG ' ' O ' ' A' ' 47' ' ' PHE . 73.4 mt -79.13 -131.93 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.811 176.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 68.21 -10.64 0.42 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.645 0.778 . . . . 0.0 113.086 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -141.18 12.03 2.18 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.607 ' CG2' ' HA ' ' A' ' 51' ' ' LEU . 31.9 t -103.08 107.46 22.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.383 -173.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -54.09 150.11 8.57 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.875 172.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.832 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 1.9 tp -52.56 -60.96 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -170.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.531 ' O ' HG22 ' A' ' 60' ' ' ILE . . . -52.96 -30.47 37.45 Favored Glycine 0 C--O 1.239 0.449 0 C-N-CA 121.043 -0.598 . . . . 0.0 113.319 -173.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.3 t -50.1 -33.43 18.64 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.911 0.484 . . . . 0.0 111.965 -176.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.832 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 0.6 OUTLIER -66.45 -14.13 61.78 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -170.915 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.531 HG22 ' O ' ' A' ' 57' ' ' GLY . 11.3 tt -82.48 -2.62 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.763 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.6 p -150.27 47.5 0.9 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.429 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.757 ' ND2' ' HA ' ' A' ' 59' ' ' LEU . 84.2 m-20 -93.41 -1.04 56.26 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.7 t -84.78 -37.56 12.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -154.87 149.04 20.21 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.503 -177.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -78.9 -50.8 10.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.681 0.277 . . . . 0.0 111.215 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 151.23 -97.67 0.18 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.4 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.54 94.73 1.52 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -173.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.82 -20.73 6.37 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.355 2.037 . . . . 0.0 113.453 -174.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 55.28 79.18 0.35 Allowed Pre-proline 0 N--CA 1.467 0.419 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -72.35 158.86 50.73 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.954 2.436 . . . . 0.0 112.346 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -170.47 -33.44 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.765 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.06 122.42 25.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.298 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.29 68.29 0.44 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.852 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -127.29 140.16 52.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.679 0.276 . . . . 0.0 110.469 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.502 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -142.31 139.08 17.21 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.95 -178.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 51.4 Cg_exo -59.17 105.71 0.26 Allowed 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 123.252 2.635 . . . . 0.0 112.744 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.5 177.59 6.33 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.993 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.76 -97.58 0.25 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.383 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 117.05 100.33 2.12 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.876 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -69.62 84.08 0.65 Allowed 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.652 2.235 . . . . 0.0 111.865 178.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.456 ' HB3' ' HD3' ' A' ' 82' ' ' PRO . . . -84.11 -48.04 0.7 Allowed Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.241 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.456 ' HD3' ' HB3' ' A' ' 81' ' ' ALA . 82.3 Cg_exo -48.98 118.15 3.3 Favored 'Trans proline' 0 C--N 1.364 1.353 0 C-N-CA 122.125 1.884 . . . . 0.0 113.201 176.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.7 p -157.3 133.36 9.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.959 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.6 m 54.74 72.4 0.47 Allowed 'General case' 0 CA--C 1.531 0.223 0 O-C-N 123.891 0.744 . . . . 0.0 111.747 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -102.08 -2.03 30.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.421 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.3 89.41 2.07 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.322 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.89 106.62 5.34 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.523 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -53.38 119.07 5.58 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.077 2.518 . . . . 0.0 112.797 177.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -121.06 63.08 0.88 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.272 177.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -100.38 118.77 37.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.676 -178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -73.28 -60.67 2.13 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.76 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -103.53 157.72 16.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.32 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -115.91 131.73 56.85 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.23 78.38 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.983 0.42 . . . . 0.0 111.065 -176.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -106.1 -36.81 6.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.965 174.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.48 166.44 13.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.053 176.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.495 ' HD3' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -127.52 119.74 26.72 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp 65.11 179.93 0.19 Allowed 'General case' 0 C--N 1.323 -0.568 0 O-C-N 123.918 0.761 . . . . 0.0 109.943 -172.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -89.2 77.37 7.51 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 121.201 0.524 . . . . 0.0 110.591 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -72.1 144.56 48.63 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.187 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.9 t -101.55 145.99 28.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.209 -176.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -124.68 17.37 8.76 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.853 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -61.32 143.07 56.36 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.951 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.0 p -129.8 138.78 51.22 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -173.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -77.38 92.65 3.96 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 173.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.06 129.6 42.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.028 -173.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.4 t0 50.26 45.15 26.2 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 124.032 0.833 . . . . 0.0 111.23 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 64.5 mtt 66.75 9.76 6.98 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.129 -0.942 . . . . 0.0 112.326 178.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.47 101.96 0.96 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.198 173.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -78.58 177.03 8.9 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 175.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.82 -20.5 24.4 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.182 -1.009 . . . . 0.0 111.927 -178.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.436 HD13 ' O ' ' A' ' 112' ' ' LEU . 2.1 tm? -63.19 -37.71 88.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.331 0.586 . . . . 0.0 109.729 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -111.5 24.97 12.17 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 174.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 38.8 t70 . . . . . 0 C--O 1.251 1.153 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.575 -173.307 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 121.018 0.437 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.562 ' O ' ' HB2' ' B' ' 202' ' ' ARG . 22.4 ttt -82.11 104.13 12.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.734 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 202' ' ' ARG . . . . . 0.562 ' HB2' ' O ' ' B' ' 201' ' ' MET . 14.4 ttp180 168.37 -19.07 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 O-C-N 124.477 1.111 . . . . 0.0 110.921 176.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -125.43 -27.18 3.48 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -174.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.547 ' O ' HD13 ' B' ' 208' ' ' LEU . 2.4 p -57.17 -62.31 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 205' ' ' ALA . . . . . 0.609 ' HA ' ' HB2' ' B' ' 208' ' ' LEU . . . -71.81 -12.15 61.15 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.96 -177.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 3.0 m -68.3 -44.93 74.35 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 172.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 207' ' ' TYR . . . . . 0.498 ' CD1' HD11 ' B' ' 251' ' ' ILE . 24.5 t80 -63.64 -45.94 87.93 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.507 173.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.609 ' HB2' ' HA ' ' B' ' 205' ' ' ALA . 7.6 mp -52.98 -50.69 63.63 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.173 177.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 209' ' ' LEU . . . . . 0.479 HD12 ' CB ' ' A' ' 11' ' ' TYR . 1.2 tt -64.7 -46.5 82.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.808 -176.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -57.13 -37.24 71.71 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.861 176.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 211' ' ' ALA . . . . . 0.726 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -79.76 -34.85 39.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.996 0.426 . . . . 0.0 111.025 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 212' ' ' LEU . . . . . 0.492 HD22 ' HB3' ' A' ' 7' ' ' LEU . 50.2 tp -56.65 -51.62 68.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.003 177.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -143.65 76.03 0.3 Allowed Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.049 -1.072 . . . . 0.0 112.438 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 176.19 -72.77 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.495 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 215' ' ' ASN . . . . . 0.726 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 94.0 m-20 -134.91 138.24 43.92 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -176.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 3.7 m -67.24 -28.02 67.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.342 0.592 . . . . 0.0 110.483 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 12.5 m -127.87 74.76 78.6 Favored Pre-proline 0 N--CA 1.442 -0.833 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.8 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.52 117.43 3.81 Favored 'Trans proline' 0 N--CA 1.474 0.369 0 C-N-CA 123.388 2.725 . . . . 0.0 112.577 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 89.1 p -88.19 164.21 15.78 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.148 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 220' ' ' ALA . . . . . 0.414 ' HB1' HD21 ' B' ' 239' ' ' LEU . . . -52.14 -36.16 50.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.225 0.536 . . . . 0.0 110.449 177.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -67.0 -40.94 87.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.654 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -63.14 -45.37 92.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.342 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.413 ' N ' HD12 ' B' ' 223' ' ' ILE . 1.8 mp -67.29 -40.39 84.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.124 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 224' ' ' LYS . . . . . 0.455 ' HD3' HD22 ' B' ' 239' ' ' LEU . 11.6 mmmm -57.13 -47.23 81.64 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 175.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 225' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' B' ' 229' ' ' SER . 9.0 tmtm? -62.12 -41.72 98.52 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 0.578 HD11 ' HA ' ' A' ' 35' ' ' ALA . 1.0 OUTLIER -63.17 -42.86 98.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.737 0.303 . . . . 0.0 110.833 178.775 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 227' ' ' LEU . . . . . 0.589 ' HG ' ' HB ' ' B' ' 232' ' ' ILE . 13.7 tp -76.93 -40.29 47.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.239 0.543 . . . . 0.0 110.116 -174.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.11 -32.34 73.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.865 176.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 229' ' ' SER . . . . . 0.493 ' HB2' ' O ' ' B' ' 225' ' ' LYS . 5.1 t -55.08 -42.61 73.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.438 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 94.0 t -79.9 -40.51 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-O 121.291 0.567 . . . . 0.0 110.629 176.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 115.94 33.97 1.45 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.033 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 232' ' ' ILE . . . . . 0.589 ' HB ' ' HG ' ' B' ' 227' ' ' LEU . 1.9 mm -91.38 128.29 43.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -57.41 119.63 6.82 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 234' ' ' ALA . . . . . 0.548 ' HB2' HD23 ' B' ' 227' ' ' LEU . . . -110.81 128.38 55.74 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.162 0.506 . . . . 0.0 111.86 -175.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -93.1 102.7 15.03 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 174.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -55.15 -30.76 60.49 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -176.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 237' ' ' ASP . . . . . 0.43 ' OD1' ' HD3' ' B' ' 238' ' ' ARG . 6.3 t70 -62.1 -63.11 1.35 Allowed 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.494 0.664 . . . . 0.0 110.164 174.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.642 ' O ' HG23 ' B' ' 242' ' ' VAL . 20.8 mmt180 -64.46 -26.7 68.56 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.115 -175.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 239' ' ' LEU . . . . . 0.455 HD22 ' HD3' ' B' ' 224' ' ' LYS . 8.0 tp -53.54 -63.65 1.08 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.782 174.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -66.64 -24.21 66.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.379 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -66.93 -48.0 69.96 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.251 0.548 . . . . 0.0 110.818 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 242' ' ' VAL . . . . . 0.642 HG23 ' O ' ' B' ' 238' ' ' ARG . 60.4 t -69.72 -30.18 43.82 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 43.2 mt -81.89 -24.42 9.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.994 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 6.5 p -75.91 -31.8 59.33 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 121.557 -0.715 . . . . 0.0 110.428 172.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -73.28 -56.53 4.96 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.15 0.5 . . . . 0.0 110.608 169.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 246' ' ' LEU . . . . . 0.722 HD13 ' O ' ' B' ' 246' ' ' LEU . 0.0 OUTLIER -100.83 122.77 43.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.574 0.702 . . . . 0.0 110.079 -176.255 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -159.7 -164.79 1.39 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.528 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 248' ' ' GLY . . . . . 0.476 ' HA2' HG12 ' B' ' 251' ' ' ILE . . . -75.82 37.09 1.24 Allowed Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.48 -0.39 . . . . 0.0 113.876 -175.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -81.39 -57.5 3.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.093 0.473 . . . . 0.0 110.089 176.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -131.63 51.9 2.11 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.514 ' HA ' HG22 ' B' ' 254' ' ' VAL . 1.0 OUTLIER -64.81 -51.98 60.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -170.444 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -65.39 -24.31 67.19 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.397 -175.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.19 -52.68 13.22 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.102 175.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 254' ' ' VAL . . . . . 0.514 HG22 ' HA ' ' B' ' 251' ' ' ILE . 29.7 m -66.33 -19.93 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.213 -178.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 255' ' ' ILE . . . . . . . . . . . . . 38.7 mt -84.69 -42.84 16.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.714 176.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -63.64 -43.2 97.49 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -177.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -112.36 32.45 5.57 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.286 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -100.65 54.38 0.86 Allowed Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.438 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 1.1 mt -120.51 -0.38 7.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.242 0.544 . . . . 0.0 111.028 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -70.62 -165.37 5.75 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.854 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 16.7 pttm -69.36 83.62 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.646 0.736 . . . . 0.0 109.966 174.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 262' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.84 97.84 5.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.686 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -115.75 -5.28 12.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.322 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 6.8 p -169.12 -66.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.384 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 13.5 p -144.3 137.96 14.39 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -68.54 64.15 1.18 Allowed 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.747 2.298 . . . . 0.0 113.33 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . -122.03 15.44 10.76 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.629 174.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . -107.8 25.07 22.02 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.037 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -129.29 -166.23 11.87 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 176.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -95.78 132.09 41.38 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 15.1 t -86.74 139.43 17.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.061 -177.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -95.35 80.62 3.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.885 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 96.8 t 69.43 142.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 O-C-N 124.082 0.864 . . . . 0.0 111.632 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 20.3 m -105.49 145.38 30.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.385 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -82.69 -173.88 4.9 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.06 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 276' ' ' ALA . . . . . 0.41 ' HA ' ' HD2' ' B' ' 277' ' ' PRO . . . 64.38 82.82 0.21 Allowed Pre-proline 0 N--CA 1.466 0.342 0 O-C-N 123.729 0.643 . . . . 0.0 110.636 -173.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 277' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' B' ' 276' ' ' ALA . 27.5 Cg_endo -60.56 137.42 73.61 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.552 2.835 . . . . 0.0 113.344 -178.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -112.54 128.78 8.64 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.935 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 66.5 m -126.07 -167.56 1.72 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.116 0.484 . . . . 0.0 111.524 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . -50.32 117.12 2.2 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.675 175.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -86.42 -43.64 0.57 Allowed Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.616 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -52.11 120.44 7.25 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 122.206 1.937 . . . . 0.0 113.256 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -107.75 147.35 30.92 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.076 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -97.04 145.3 26.1 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.607 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 132.92 -51.41 0.85 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.231 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 5.2 p -83.72 62.35 6.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.11 0.481 . . . . 0.0 110.92 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 287' ' ' ALA . . . . . 0.437 ' H ' ' CD ' ' B' ' 288' ' ' PRO . . . -114.52 -46.33 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.982 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 288' ' ' PRO . . . . . 0.437 ' CD ' ' H ' ' B' ' 287' ' ' ALA . 11.7 Cg_exo -71.79 158.62 52.68 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 121.88 1.72 . . . . 0.0 111.875 176.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -115.62 169.59 9.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.767 -176.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . 63.5 -178.72 0.15 Allowed 'General case' 0 C--O 1.233 0.216 0 O-C-N 124.067 0.854 . . . . 0.0 112.285 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . 57.15 71.89 0.55 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.46 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -54.35 118.14 3.87 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.933 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -83.73 134.83 34.73 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.43 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.05 157.21 43.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.323 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -127.49 95.52 4.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.858 0.361 . . . . 0.0 110.145 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -138.78 86.89 2.18 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.082 0.468 . . . . 0.0 109.768 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -135.38 140.01 44.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.823 -174.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 298' ' ' LYS . . . . . 0.491 ' HE2' ' HB2' ' B' ' 300' ' ' GLU . 87.3 tttt -156.66 115.72 3.41 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 -178.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.44 9.84 6.71 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -175.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 300' ' ' GLU . . . . . 0.491 ' HB2' ' HE2' ' B' ' 298' ' ' LYS . 37.5 mt-10 -108.86 -3.94 17.23 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -172.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -93.71 115.63 28.08 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.148 0.499 . . . . 0.0 110.382 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 16.9 m -64.95 128.05 34.12 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.718 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -44.92 -58.88 2.86 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 123.658 0.599 . . . . 0.0 111.821 -174.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -159.17 175.76 13.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.959 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 18.2 m -94.78 156.81 16.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.138 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -49.94 -63.86 0.98 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.609 0.568 . . . . 0.0 111.838 -178.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -171.62 -79.92 0.01 OUTLIER 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.741 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -113.42 149.49 34.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.496 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 23.0 mmt -114.37 31.66 6.45 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -176.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . -58.84 -31.48 68.06 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.357 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -106.1 17.48 23.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.156 0.503 . . . . 0.0 110.626 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . -138.69 34.7 2.07 Favored Glycine 0 C--O 1.229 -0.203 0 C-N-CA 121.097 -0.573 . . . . 0.0 111.689 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 17.7 tp -80.38 42.18 0.58 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.268 0.556 . . . . 0.0 110.363 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 314' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -134.67 -73.35 0.47 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.915 -173.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.253 1.239 0 CA-C-O 118.488 -0.768 . . . . 0.0 111.261 -174.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.0 tmm? . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.51 44.52 0.29 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.762 0.315 . . . . 0.0 111.568 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.465 ' O ' HD13 ' A' ' 7' ' ' LEU . 7.7 t 55.76 42.21 29.42 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.484 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.534 ' HA ' ' HB2' ' A' ' 7' ' ' LEU . 1.7 m -67.27 -16.06 20.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.213 0.53 . . . . 0.0 110.204 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.655 ' OG ' HG23 ' A' ' 39' ' ' VAL . 30.8 t -60.67 -67.79 0.36 Allowed 'General case' 0 C--O 1.25 1.115 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.349 176.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -66.21 -34.92 79.12 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.818 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 4' ' ' VAL . 6.1 mp -51.27 -54.64 24.04 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.659 173.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.05 -44.46 91.82 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.501 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' A' ' 43' ' ' TRP . 57.0 m -61.07 -38.08 84.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.097 0.475 . . . . 0.0 111.302 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.685 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -72.71 -42.36 62.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.671 -178.169 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.673 ' HD1' HD12 ' A' ' 14' ' ' LEU . 31.2 m-85 -75.37 -21.95 57.9 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.643 -176.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.6 p -75.33 -40.36 58.43 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.238 171.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -49.38 -51.01 37.67 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.471 0.653 . . . . 0.0 109.887 169.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 10' ' ' ILE . 56.0 mt -59.99 -49.86 76.0 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.241 -179.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.8 mt -54.54 -64.87 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.974 0.416 . . . . 0.0 111.381 178.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 86.8 mt -63.27 -24.72 67.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.316 -170.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.679 ' HB3' ' HE1' ' B' ' 201' ' ' MET . 55.3 t-80 -63.54 -36.78 84.93 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.606 ' HB2' ' SD ' ' B' ' 201' ' ' MET . 34.3 t70 -104.0 -7.86 20.01 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.194 0.521 . . . . 0.0 111.615 -167.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.476 ' HB3' HG21 ' B' ' 232' ' ' ILE . 1.1 m-20 -85.53 37.96 0.72 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.43 -175.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 50.58 29.2 3.91 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.929 0.395 . . . . 0.0 110.723 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -136.3 148.96 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.034 -169.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.1 p -86.62 136.21 33.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.733 175.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -76.44 116.6 19.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.985 0.421 . . . . 0.0 110.518 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.2 p -133.19 163.62 28.87 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.512 ' HG3' ' H ' ' A' ' 26' ' ' ASP . 6.6 pt-20 -45.29 -54.01 7.66 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.864 0.727 . . . . 0.0 111.958 -177.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.512 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 2.7 t70 -55.73 -40.06 71.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.473 -178.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -78.75 -41.57 30.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.394 -171.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.518 HG23 HD13 ' A' ' 32' ' ' ILE . 3.2 mt -63.47 -47.59 90.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.997 175.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -61.79 -33.39 74.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.265 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.77 -52.57 35.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.842 0.353 . . . . 0.0 110.891 176.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.508 HD11 HG23 ' B' ' 226' ' ' ILE . 0.2 OUTLIER -61.89 -32.31 72.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.226 0.536 . . . . 0.0 110.21 177.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.518 HD13 HG23 ' A' ' 28' ' ' ILE . 1.3 mp -69.47 -33.88 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.128 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -74.15 -27.74 60.98 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.052 174.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.73 -50.15 46.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.936 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.482 ' HB3' ' HB3' ' B' ' 209' ' ' LEU . . . -133.85 16.21 3.91 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -175.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.05 93.95 1.86 Allowed Glycine 0 C--N 1.314 -0.661 0 C-N-CA 120.317 -0.944 . . . . 0.0 111.657 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.7 p -56.43 -42.12 73.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 120.648 0.261 . . . . 0.0 111.537 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -160.97 127.4 3.98 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.029 0.442 . . . . 0.0 110.527 172.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.655 HG23 ' OG ' ' A' ' 5' ' ' SER . 8.0 p -165.07 120.45 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.795 178.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.431 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 1.7 pm0 -65.89 129.63 94.31 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.79 -8.87 0.96 Allowed 'Trans proline' 0 N--CA 1.485 0.991 0 C-N-CA 123.778 2.985 . . . . 0.0 113.755 -172.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.77 -38.16 76.65 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.649 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.482 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 70.2 m95 -69.4 -55.03 10.21 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.979 177.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.482 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 85.0 Cg_exo -49.01 -51.0 11.38 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 122.364 2.043 . . . . 0.0 113.003 176.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.55 -49.6 68.23 Favored Glycine 0 C--O 1.243 0.683 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.738 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.9 tp -54.05 -48.52 70.47 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 115.449 -0.375 . . . . 0.0 110.599 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.69 ' O ' HD12 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -67.86 -44.48 77.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.879 -173.898 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.1 -35.28 74.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.12 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -93.39 -1.97 55.23 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.819 175.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.83 -42.39 17.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.552 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.717 ' HA ' HG23 ' A' ' 54' ' ' VAL . 2.1 mp -86.99 -131.7 0.06 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 118.7 -1.2 . . . . 0.0 109.654 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 65.59 -9.96 0.23 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.213 0.605 . . . . 0.0 112.293 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.472 ' H ' ' C ' ' A' ' 51' ' ' LEU . 23.5 t-20 -127.59 -41.4 1.7 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.717 HG23 ' HA ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -81.77 117.16 27.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.314 168.636 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.437 ' OD1' HG22 ' A' ' 56' ' ' ILE . 8.6 t-20 -43.95 -67.9 0.24 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.874 0.734 . . . . 0.0 112.73 -172.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.635 ' O ' HD12 ' A' ' 59' ' ' LEU . 2.4 tp -156.24 -48.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.291 -177.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.39 -21.52 8.9 Favored Glycine 0 N--CA 1.469 0.866 0 O-C-N 123.32 0.388 . . . . 0.0 113.689 -173.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.2 t -60.97 -14.51 23.29 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 122.545 0.338 . . . . 0.0 111.155 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -68.2 -18.64 64.64 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.107 -178.27 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.506 ' O ' HG22 ' A' ' 60' ' ' ILE . 29.9 mt -100.91 29.94 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 122.254 1.026 . . . . 0.0 109.511 174.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.9 t -71.96 132.29 44.12 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 121.743 -0.598 . . . . 0.0 110.307 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -73.69 64.37 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.064 0.459 . . . . 0.0 110.678 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.6 t -58.67 -73.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.653 176.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 69.87 172.66 10.22 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.843 -0.694 . . . . 0.0 113.051 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -160.1 140.02 11.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.797 0.332 . . . . 0.0 110.461 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.7 61.4 4.27 Favored Glycine 0 N--CA 1.453 -0.214 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.229 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.81 -65.97 1.52 Allowed Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 112.066 -0.414 . . . . 0.0 112.066 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.52 81.9 0.96 Allowed 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 122.761 2.307 . . . . 0.0 111.821 177.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.6 155.75 45.68 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.93 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -48.71 -59.23 1.33 Allowed 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.696 2.264 . . . . 0.0 112.958 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 63.35 112.29 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.908 0.861 . . . . 0.0 111.81 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -107.28 112.54 25.44 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.035 -176.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -119.29 67.77 0.38 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.118 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.98 134.19 17.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.469 0.176 . . . . 0.0 110.846 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.478 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -152.78 128.9 5.24 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.419 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 35.4 Cg_exo -64.49 -10.67 25.09 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 123.717 2.945 . . . . 0.0 113.077 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.75 94.71 9.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.033 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.59 -26.58 50.25 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.127 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.13 71.9 0.09 OUTLIER Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.069 -1.063 . . . . 0.0 112.708 177.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -86.3 109.35 0.93 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.232 1.955 . . . . 0.0 112.857 -177.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -127.64 83.83 65.01 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.44 176.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -60.84 95.24 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.424 2.749 . . . . 0.0 112.728 176.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.2 m -92.38 24.24 3.52 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.291 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 74.7 m 72.79 -60.11 0.54 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.366 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -137.53 147.77 45.43 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 120.684 0.278 . . . . 0.0 110.533 -178.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -159.53 102.7 1.55 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.31 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.89 151.7 76.07 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.92 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -57.11 142.08 94.28 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.833 2.356 . . . . 0.0 112.145 173.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.3 40.7 0.65 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.944 -175.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -112.29 124.4 52.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.164 0.507 . . . . 0.0 109.936 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -108.57 -149.16 0.43 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.174 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -62.14 108.62 1.1 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.531 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.6 mtpt -107.62 136.41 47.42 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 176.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.1 m -100.59 130.65 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 121.239 0.542 . . . . 0.0 111.935 -174.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -93.34 -20.76 20.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.824 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -115.72 -62.7 1.56 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -169.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.555 ' H ' ' HD2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -116.34 150.11 38.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 122.388 -0.195 . . . . 0.0 111.184 -173.748 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt 71.95 -176.92 0.19 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 124.148 0.905 . . . . 0.0 111.581 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 74.92 153.53 0.14 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.878 0.871 . . . . 0.0 111.098 -177.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -77.78 142.03 38.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.158 -172.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.1 m -134.82 -171.28 2.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.074 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.453 ' C ' ' HG3' ' A' ' 103' ' ' GLU . 12.7 pt-20 -93.15 157.9 16.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.616 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.453 ' HG3' ' C ' ' A' ' 102' ' ' GLU . 0.2 OUTLIER 39.13 46.85 1.25 Allowed 'General case' 0 N--CA 1.477 0.914 0 O-C-N 124.355 1.034 . . . . 0.0 113.122 178.473 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.3 p -154.21 163.33 40.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.037 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -134.85 -179.06 5.37 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.481 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.12 136.26 24.09 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.827 0.851 . . . . 0.0 112.874 -174.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -104.28 144.42 31.64 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 171.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -80.77 64.4 5.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.018 0.437 . . . . 0.0 110.827 -175.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -114.39 102.78 1.22 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.619 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -59.53 135.36 57.65 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 175.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.504 ' HA2' ' HB2' ' A' ' 114' ' ' ASP . . . 113.67 6.93 20.85 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -169.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.1 tp -87.49 -27.76 22.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.061 0.458 . . . . 0.0 110.127 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -125.95 20.33 7.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.544 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.504 ' HB2' ' HA2' ' A' ' 111' ' ' GLY . 4.9 m-20 . . . . . 0 C--O 1.248 0.976 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.447 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 120.807 0.337 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.679 ' HE1' ' HB3' ' A' ' 17' ' ' HIS . 26.4 mtp -123.23 -3.77 8.46 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.963 0.411 . . . . 0.0 110.835 -175.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 202' ' ' ARG . . . . . 0.448 ' HD3' ' HA ' ' A' ' 19' ' ' ASP . 50.1 mtm-85 -78.3 -1.46 33.27 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -167.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 203' ' ' TYR . . . . . 0.43 ' CE1' ' HB3' ' B' ' 239' ' ' LEU . 30.5 m-85 -129.88 -43.09 1.23 Allowed 'General case' 0 C--O 1.242 0.671 0 O-C-N 121.739 -0.601 . . . . 0.0 112.146 -176.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.713 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 6.5 p -58.44 -50.5 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.536 -177.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 205' ' ' ALA . . . . . 0.62 ' HA ' HD12 ' B' ' 208' ' ' LEU . . . -72.65 -15.63 61.71 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.703 0.287 . . . . 0.0 110.902 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 1.7 m -70.47 -48.51 55.47 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.087 0.47 . . . . 0.0 109.736 174.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 207' ' ' TYR . . . . . 0.551 ' CZ ' ' HD2' ' B' ' 218' ' ' PRO . 33.0 t80 -61.97 -41.21 97.75 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.713 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 88.4 mt -56.82 -53.49 57.25 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.101 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 209' ' ' LEU . . . . . 0.673 ' CD2' ' HB2' ' A' ' 11' ' ' TYR . 56.0 mt -57.74 -54.83 42.43 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.956 0.408 . . . . 0.0 111.067 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 210' ' ' ALA . . . . . 0.401 ' HB3' ' HB3' ' B' ' 218' ' ' PRO . . . -58.22 -32.94 68.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.287 -176.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 211' ' ' ALA . . . . . 0.463 ' HB3' HD11 ' B' ' 255' ' ' ILE . . . -76.88 -44.58 31.39 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.158 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 212' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' B' ' 209' ' ' LEU . 2.8 pp -64.66 -22.96 67.11 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.875 0.369 . . . . 0.0 110.405 177.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.09 -13.96 58.41 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.822 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 118.49 10.87 8.33 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.348 -0.93 . . . . 0.0 113.227 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 215' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -121.48 100.42 7.01 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 122.33 -0.512 . . . . 0.0 111.216 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 2.0 m -44.74 -49.81 10.37 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -168.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 19.0 m -114.24 85.37 10.4 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 123.495 0.497 . . . . 0.0 110.446 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 218' ' ' PRO . . . . . 0.551 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 73.6 Cg_exo -46.01 121.91 4.77 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 123.821 3.014 . . . . 0.0 113.57 176.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 46.8 t -76.39 148.42 37.37 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.808 178.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.84 -29.11 59.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.319 176.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -66.45 -38.41 87.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.389 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -73.31 -42.53 62.24 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.127 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.484 HD11 ' CB ' ' B' ' 218' ' ' PRO . 1.7 mp -64.26 -43.88 97.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -52.15 -60.43 3.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.313 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -52.07 -50.32 61.76 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.174 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 0.508 HG23 HD11 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -56.25 -38.04 52.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.51 -177.798 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 227' ' ' LEU . . . . . 0.766 HD23 ' HB2' ' B' ' 234' ' ' ALA . 13.5 tp -75.91 -46.92 27.43 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.87 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -87.36 12.15 12.74 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 119.761 -0.775 . . . . 0.0 111.826 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 72.5 m -57.15 -34.14 68.13 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.324 165.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 54.1 t -93.5 -52.31 9.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.475 175.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 138.93 30.38 0.21 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.903 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 232' ' ' ILE . . . . . 0.476 HG21 ' HB3' ' A' ' 19' ' ' ASP . 3.4 mp -101.92 149.65 6.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 174.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -86.8 150.54 24.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.313 0.578 . . . . 0.0 111.742 -171.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 234' ' ' ALA . . . . . 0.766 ' HB2' HD23 ' B' ' 227' ' ' LEU . . . -134.68 160.85 36.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.749 -177.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -112.87 125.82 54.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.119 0.485 . . . . 0.0 110.286 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -62.36 -51.15 68.76 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 114.766 -1.106 . . . . 0.0 113.146 -170.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -75.08 -33.46 61.67 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.494 -173.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 26.5 tpt180 -68.21 -44.97 74.6 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.886 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 239' ' ' LEU . . . . . 0.497 HD12 ' N ' ' B' ' 240' ' ' ASN . 4.5 pp -66.27 -37.59 85.81 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.363 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 240' ' ' ASN . . . . . 0.497 ' N ' HD12 ' B' ' 239' ' ' LEU . 26.1 t-20 -67.78 -36.91 81.33 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 121.311 -0.156 . . . . 0.0 110.651 178.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -65.36 -45.58 83.6 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 120.612 0.244 . . . . 0.0 110.94 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 242' ' ' VAL . . . . . 0.427 ' O ' ' HG ' ' B' ' 246' ' ' LEU . 33.9 m -70.89 -32.26 48.15 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 CA-C-O 121.493 0.663 . . . . 0.0 109.616 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 32.1 mt -72.36 -29.58 32.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.538 175.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 47.1 t -66.01 -32.08 73.35 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 172.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -74.28 -31.42 62.52 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.084 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 246' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' B' ' 242' ' ' VAL . 32.2 mt -85.88 1.36 50.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.553 178.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -78.87 -11.31 59.99 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -166.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -88.08 -132.82 4.07 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.828 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -98.93 -156.67 0.56 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 18.9 m120 75.37 -25.38 0.2 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.081 0.552 . . . . 0.0 112.456 174.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.636 ' HA ' HG12 ' B' ' 254' ' ' VAL . 5.9 tp -56.52 -38.67 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.466 0.651 . . . . 0.0 110.416 175.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -54.28 -50.88 66.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.037 176.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.2 -45.91 75.46 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.063 -177.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 254' ' ' VAL . . . . . 0.636 HG12 ' HA ' ' B' ' 251' ' ' ILE . 9.6 p -62.5 -33.9 61.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.259 -175.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 255' ' ' ILE . . . . . 0.463 HD11 ' HB3' ' B' ' 211' ' ' ALA . 63.4 mt -80.07 -40.33 20.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.815 176.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -57.18 -51.71 68.23 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.749 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -160.78 75.65 0.55 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.918 0.39 . . . . 0.0 110.448 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -176.32 56.37 0.11 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.733 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 259' ' ' ILE . . . . . 0.451 HG13 ' H ' ' B' ' 259' ' ' ILE . 27.7 mt -30.64 -55.01 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.808 0.843 . . . . 0.0 111.898 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 140.51 -170.78 24.29 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 119.721 -1.228 . . . . 0.0 113.529 165.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -84.89 11.41 9.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.421 -0.39 . . . . 0.0 110.23 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 262' ' ' LEU . . . . . 0.677 ' HG ' HD13 ' A' ' 14' ' ' LEU . 2.8 mm? -54.55 -74.98 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.355 0.598 . . . . 0.0 110.371 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -138.75 73.76 1.45 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.065 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 3.0 p -83.37 101.02 11.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.419 0.628 . . . . 0.0 111.321 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 40.8 t -106.56 133.19 20.36 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.427 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.97 115.09 3.08 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.43 2.087 . . . . 0.0 112.223 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . -61.34 144.92 53.13 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.829 175.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . -78.38 53.48 3.9 Favored Glycine 0 CA--C 1.517 0.174 0 C-N-CA 121.378 -0.439 . . . . 0.0 113.754 -175.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . 59.62 -127.42 44.53 Favored Glycine 0 CA--C 1.517 0.193 0 C-N-CA 121.852 -0.213 . . . . 0.0 113.472 176.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . 56.59 56.91 5.19 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.365 0.602 . . . . 0.0 111.516 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 10.6 t -93.74 136.2 26.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.857 -175.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -150.33 127.78 11.47 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.017 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 40.7 t -116.46 84.02 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.212 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 8.2 p 43.08 58.82 3.15 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -79.59 84.17 5.48 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.7 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 276' ' ' ALA . . . . . 0.429 ' HA ' ' HD2' ' B' ' 277' ' ' PRO . . . -111.09 112.74 55.14 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.804 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 277' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' B' ' 276' ' ' ALA . 32.9 Cg_endo -66.33 142.54 66.68 Favored 'Trans proline' 0 CA--C 1.52 -0.218 0 C-N-CA 122.762 2.308 . . . . 0.0 112.103 175.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -164.14 171.79 39.79 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.171 -1.014 . . . . 0.0 112.473 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 71.9 m -159.75 -167.99 2.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.831 0.348 . . . . 0.0 110.553 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . -53.88 147.55 11.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.863 175.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -86.92 131.56 44.63 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.877 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -68.21 140.71 49.91 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.735 2.29 . . . . 0.0 112.647 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -132.91 159.05 41.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.664 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -153.46 148.87 27.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.706 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -121.66 -74.98 0.36 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.231 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 80.5 p 61.87 120.61 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.84 1.256 . . . . 0.0 112.852 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 287' ' ' ALA . . . . . 0.42 ' HA ' ' HD3' ' B' ' 288' ' ' PRO . . . -124.13 144.8 46.38 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.517 178.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 288' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' B' ' 287' ' ' ALA . 8.1 Cg_exo -70.35 139.63 38.62 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.97 2.447 . . . . 0.0 112.517 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -114.49 132.7 56.2 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.459 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -99.77 -177.81 3.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.563 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -120.53 88.49 2.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.582 0.23 . . . . 0.0 111.309 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.0 147.15 35.58 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.105 175.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 65.64 107.73 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 O-C-N 123.959 0.787 . . . . 0.0 111.54 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -129.02 -39.68 1.55 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.575 -176.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -117.45 76.22 1.04 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -173.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -161.14 130.74 4.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.375 168.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 178.24 -29.9 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.87 -174.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -133.44 114.07 13.23 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.074 -177.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 17.0 pttm -147.46 -51.18 0.19 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.565 176.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 61.99 -90.07 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.808 0.692 . . . . 0.0 110.975 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -57.62 116.02 3.14 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 123.029 0.531 . . . . 0.0 110.7 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 31.1 m -112.04 164.08 13.54 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.735 -177.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 65.76 -169.46 0.2 Allowed 'General case' 0 CA--C 1.531 0.219 0 O-C-N 123.992 0.807 . . . . 0.0 110.23 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -117.12 145.79 43.57 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 5.1 t -64.94 135.67 55.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.723 -172.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -122.81 75.14 1.25 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.236 -178.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -88.55 65.58 7.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.972 -172.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -111.81 170.27 8.26 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 173.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 23.0 ptt? -86.94 35.71 0.7 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.106 0.479 . . . . 0.0 110.811 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 70.25 19.93 76.25 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.626 -0.716 . . . . 0.0 113.166 176.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 53.78 26.33 5.93 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 122.925 0.49 . . . . 0.0 112.035 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . -155.79 101.06 0.2 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.911 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 313' ' ' LEU . . . . . 0.415 ' HG ' ' H ' ' B' ' 313' ' ' LEU . 1.1 pp -74.21 6.62 3.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.198 0.523 . . . . 0.0 111.42 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 314' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -72.46 -46.51 54.58 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.282 -176.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 35.4 t70 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.21 -178.31 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.4 tpt . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.1 -155.9 0.66 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 111.181 0.067 . . . . 0.0 111.181 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.476 ' O ' HD13 ' A' ' 7' ' ' LEU . 3.4 p -63.66 103.32 0.53 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.281 0.563 . . . . 0.0 111.457 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.4 -22.78 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.955 -175.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.474 ' HB2' HG23 ' A' ' 39' ' ' VAL . 3.4 p -61.67 -63.68 1.19 Allowed 'General case' 0 C--O 1.242 0.667 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.111 178.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -62.43 -41.75 98.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.088 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.476 HD13 ' O ' ' A' ' 3' ' ' SER . 5.2 mp -49.45 -59.27 3.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.341 176.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.8 -53.18 60.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.668 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 35.7 t -64.79 -37.52 87.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.775 -175.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.419 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 1.3 tp -75.77 -35.46 30.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.898 0.38 . . . . 0.0 110.951 -175.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.766 ' OH ' ' HA2' ' B' ' 258' ' ' GLY . 17.3 m-30 -74.55 -28.32 60.9 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.769 177.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 64.3 m -66.04 -41.98 90.17 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 173.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.441 ' HB3' HD21 ' A' ' 59' ' ' LEU . . . -53.74 -45.09 70.43 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.101 171.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 10' ' ' ILE . 72.8 mt -59.46 -55.15 38.27 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.788 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.404 HD11 ' HA ' ' B' ' 206' ' ' SER . 73.4 mt -52.35 -45.62 45.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.243 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.3 mt -76.19 -18.42 59.08 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.365 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -98.3 18.37 16.55 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.957 -0.464 . . . . 0.0 112.162 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.574 ' OD1' ' HG3' ' B' ' 201' ' ' MET . 15.9 t70 -117.48 -51.98 2.49 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.009 178.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -74.42 29.22 0.08 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 50.86 40.29 24.48 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.742 0.417 . . . . 0.0 111.864 178.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.8 p -121.72 164.69 18.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.79 0.329 . . . . 0.0 111.026 -173.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.2 p -90.48 135.25 33.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.021 0.438 . . . . 0.0 111.777 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.627 HG11 HD23 ' A' ' 51' ' ' LEU . 91.8 t -77.82 123.34 34.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.414 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.26 158.49 43.81 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 177.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -50.91 -55.29 17.85 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.48 -177.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -51.73 -33.7 35.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.594 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -73.76 -50.34 21.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.534 0.207 . . . . 0.0 110.64 -176.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.409 ' O ' HD13 ' A' ' 32' ' ' ILE . 9.1 mt -65.34 -43.3 94.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.13 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -60.63 -36.61 79.06 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.988 175.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.57 -44.33 87.04 Favored 'General case' 0 C--O 1.227 -0.111 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.95 -42.98 89.29 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.239 0.542 . . . . 0.0 110.774 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.409 HD13 ' O ' ' A' ' 28' ' ' ILE . 1.6 mp -60.88 -44.0 96.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.411 177.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -73.31 -27.96 61.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.662 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.407 ' HB3' HG13 ' B' ' 226' ' ' ILE . . . -66.4 -37.63 85.66 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.361 176.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.423 ' HB2' HD12 ' B' ' 209' ' ' LEU . . . -82.39 -35.89 27.27 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.674 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.9 31.39 4.8 Favored Glycine 0 N--CA 1.454 -0.144 0 C-N-CA 120.755 -0.736 . . . . 0.0 113.428 175.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.511 HG13 ' HA2' ' B' ' 213' ' ' GLY . 22.3 m -114.52 175.08 2.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 122.725 -0.279 . . . . 0.0 110.732 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -132.96 106.94 7.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.902 0.382 . . . . 0.0 110.612 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.474 HG23 ' HB2' ' A' ' 5' ' ' SER . 7.4 p -102.64 135.25 40.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 174.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -53.8 130.28 56.36 Favored Pre-proline 0 C--O 1.236 0.361 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.51 -2.82 1.11 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.41 2.74 . . . . 0.0 113.721 -170.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.8 -37.48 70.39 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.032 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.578 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 94.9 m95 -70.7 -54.38 8.24 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 119.194 -0.431 . . . . 0.0 110.74 177.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.578 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 75.4 Cg_exo -51.88 -45.31 39.31 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 121.705 1.603 . . . . 0.0 112.213 175.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.77 -43.68 95.88 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.333 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.0 -43.26 95.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.196 0.522 . . . . 0.0 110.286 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.474 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 2.8 m-85 -70.24 -41.08 74.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.803 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.81 -35.95 81.26 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -98.77 -23.14 15.52 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -174.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.08 -24.8 5.46 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -174.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.709 ' HA ' HG23 ' A' ' 54' ' ' VAL . 2.0 tp -86.65 -133.35 0.06 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.475 ' H ' ' CG ' ' A' ' 51' ' ' LEU . . . 60.7 -12.13 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.615 0.766 . . . . 0.0 112.773 -177.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.538 ' H ' ' C ' ' A' ' 51' ' ' LEU . 18.3 m120 -125.99 -34.94 2.51 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.709 HG23 ' HA ' ' A' ' 51' ' ' LEU . 61.2 t -45.0 108.26 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.517 174.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -47.39 140.21 5.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.735 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.9 tp -52.39 -48.58 45.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.896 -173.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.93 -40.67 93.57 Favored Glycine 0 C--O 1.239 0.457 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.601 177.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.4 t -59.0 -17.81 28.5 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 122.76 0.424 . . . . 0.0 111.012 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.441 HD21 ' HB3' ' A' ' 13' ' ' ALA . 15.4 tp -62.01 -21.52 64.94 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.193 -176.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.3 tt -71.18 -13.4 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.117 0.484 . . . . 0.0 110.893 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 62.5 m -103.41 55.52 0.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.124 0.488 . . . . 0.0 110.304 177.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -74.97 -4.47 38.39 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.753 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.3 p -75.98 -12.01 14.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.399 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -80.29 52.79 4.37 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.728 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -78.65 -25.79 45.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.776 0.322 . . . . 0.0 111.24 -177.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -96.5 -9.66 56.4 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.513 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.407 ' HA2' ' HD3' ' A' ' 68' ' ' PRO . . . 131.0 134.56 3.66 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.839 -178.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.461 ' O ' ' HD3' ' A' ' 70' ' ' PRO . 7.9 Cg_exo -72.42 134.2 22.19 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.562 2.175 . . . . 0.0 112.287 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.57 92.96 12.93 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.265 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 68' ' ' PRO . 25.7 Cg_endo -92.52 -162.96 0.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.134 2.556 . . . . 0.0 112.926 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.93 152.67 35.88 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.234 177.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -91.64 91.84 8.19 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.916 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.85 -156.3 15.67 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.699 175.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -116.84 144.73 44.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.715 0.293 . . . . 0.0 110.72 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -130.51 123.06 20.15 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 121.249 0.547 . . . . 0.0 110.57 -177.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 50.9 Cg_exo -57.53 -53.4 4.67 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 124.002 3.135 . . . . 0.0 112.939 -177.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 53.41 36.81 23.99 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.17 0.509 . . . . 0.0 111.632 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -114.67 28.26 8.26 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.745 -177.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.89 101.47 0.22 Allowed Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.564 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.89 84.57 0.52 Allowed 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 122.981 2.454 . . . . 0.0 112.378 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.534 ' H ' ' HD2' ' A' ' 82' ' ' PRO . . . -129.13 -49.36 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.275 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.534 ' HD2' ' H ' ' A' ' 81' ' ' ALA . 71.8 Cg_exo -52.31 116.9 3.12 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 122.369 2.046 . . . . 0.0 113.05 177.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.1 t -91.78 137.68 32.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.119 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.6 m -154.98 138.63 16.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.473 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -127.98 -77.6 0.57 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.852 0.358 . . . . 0.0 110.91 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.32 138.11 47.11 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.892 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.53 108.71 8.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.609 0.243 . . . . 0.0 111.629 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -59.53 156.98 33.69 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.201 2.601 . . . . 0.0 112.262 174.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.2 21.68 0.72 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -175.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 69.99 116.45 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.757 0.823 . . . . 0.0 112.535 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.418 ' HG3' ' H ' ' A' ' 92' ' ' LYS . 6.4 pt-20 -118.41 -66.44 1.08 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.778 172.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.418 ' H ' ' HG3' ' A' ' 91' ' ' GLU . 26.4 mtpp 60.97 -167.47 0.19 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.678 0.275 . . . . 0.0 110.955 177.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt 67.04 -171.91 0.19 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.486 0.66 . . . . 0.0 111.318 176.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.4 p -56.97 119.7 2.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.665 174.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -84.05 -15.38 47.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.096 0.474 . . . . 0.0 110.277 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.68 64.52 2.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.08 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -113.41 130.54 56.27 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.526 175.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -81.3 -52.31 7.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.518 -170.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 50.58 70.13 0.55 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.658 0.599 . . . . 0.0 111.357 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -89.99 -169.05 2.3 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.601 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.5 t -47.15 134.75 10.63 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.881 0.738 . . . . 0.0 112.801 -172.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -79.54 154.33 28.87 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.881 173.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 67.61 169.8 0.26 Allowed 'General case' 0 N--CA 1.471 0.586 0 O-C-N 123.793 0.683 . . . . 0.0 111.272 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.2 m 53.07 43.36 31.77 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.446 0.641 . . . . 0.0 110.558 -176.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -73.08 -41.26 64.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.272 -175.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -118.87 -57.98 1.99 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.363 -177.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -96.22 157.68 15.79 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.879 174.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 51.9 ttm -76.07 -27.32 57.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.518 -175.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.71 176.67 41.32 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.767 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -101.01 153.48 19.5 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 122.245 0.218 . . . . 0.0 110.484 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -155.88 20.79 0.51 Allowed Glycine 0 C--N 1.329 0.188 0 C-N-CA 120.428 -0.891 . . . . 0.0 113.132 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 45.2 mt 47.29 48.48 16.2 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.208 0.528 . . . . 0.0 112.061 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -108.79 20.24 18.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.38 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.1 t70 . . . . . 0 C--O 1.255 1.364 0 CA-C-O 118.572 -0.727 . . . . 0.0 109.633 -178.393 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.574 ' HG3' ' OD1' ' A' ' 18' ' ' ASP . 9.4 tpt 66.98 112.41 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.172 0.92 . . . . 0.0 111.975 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 202' ' ' ARG . . . . . 0.571 ' HB2' ' O ' ' B' ' 201' ' ' MET . 14.8 tpp180 170.21 -139.88 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 203' ' ' TYR . . . . . 0.436 ' H ' ' HG3' ' B' ' 202' ' ' ARG . 28.9 m-85 -67.72 1.53 2.44 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.169 0.509 . . . . 0.0 111.628 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.557 ' O ' HD13 ' B' ' 208' ' ' LEU . 57.7 t -59.1 -54.35 35.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.144 177.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 205' ' ' ALA . . . . . 0.459 ' HA ' HD22 ' B' ' 208' ' ' LEU . . . -65.53 -20.61 66.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.727 0.299 . . . . 0.0 111.069 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 206' ' ' SER . . . . . 0.404 ' HA ' HD11 ' A' ' 15' ' ' ILE . 1.5 m -68.14 -43.61 77.92 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 173.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 207' ' ' TYR . . . . . 0.507 ' HD2' HD13 ' B' ' 251' ' ' ILE . 35.7 t80 -62.3 -39.96 94.73 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.557 HD13 ' O ' ' B' ' 204' ' ' VAL . 8.8 mp -56.69 -52.81 63.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.955 175.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 209' ' ' LEU . . . . . 0.551 ' CD2' ' HB2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -55.15 -52.75 62.31 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.87 -178.688 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 210' ' ' ALA . . . . . 0.422 ' CB ' ' HB3' ' B' ' 218' ' ' PRO . . . -65.72 -31.09 71.88 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.57 -177.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 211' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -69.77 -47.87 61.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.003 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 212' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' B' ' 209' ' ' LEU . 4.6 pp -67.21 -22.15 65.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.978 0.418 . . . . 0.0 109.897 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 213' ' ' GLY . . . . . 0.511 ' HA2' HG13 ' A' ' 37' ' ' VAL . . . -55.22 -25.79 41.08 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.909 174.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 123.86 17.21 3.15 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.633 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 215' ' ' ASN . . . . . 0.579 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 34.2 t30 -133.1 124.0 26.76 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.817 0.341 . . . . 0.0 110.587 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 216' ' ' SER . . . . . 0.517 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 15.5 m -75.41 -21.96 57.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.11 -178.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 8.4 t -121.44 68.02 20.12 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.999 -176.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 218' ' ' PRO . . . . . 0.517 ' HD3' ' C ' ' B' ' 216' ' ' SER . 75.4 Cg_exo -56.54 -60.78 0.41 Allowed 'Trans proline' 0 N--CA 1.481 0.762 0 C-N-CA 123.731 2.954 . . . . 0.0 113.24 177.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 219' ' ' SER . . . . . 0.558 ' O ' HD13 ' B' ' 223' ' ' ILE . 21.0 t 59.52 -174.87 0.1 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.204 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 220' ' ' ALA . . . . . 0.603 ' O ' ' HB2' ' B' ' 224' ' ' LYS . . . -54.07 -34.87 61.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.196 -176.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -58.32 -59.82 4.73 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.454 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -71.75 -35.0 69.98 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -175.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.558 HD13 ' O ' ' B' ' 219' ' ' SER . 1.7 mp -69.48 -40.61 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 120.166 -0.613 . . . . 0.0 110.173 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 224' ' ' LYS . . . . . 0.603 ' HB2' ' O ' ' B' ' 220' ' ' ALA . 14.7 mmtt -60.23 -43.76 95.76 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 174.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -55.57 -49.25 73.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.56 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 0.407 HG13 ' HB3' ' A' ' 34' ' ' ALA . 1.2 mp -65.98 -40.73 88.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.012 -177.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 4.1 mp -71.74 -43.17 66.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.731 0.301 . . . . 0.0 111.603 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.34 -21.15 61.36 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.883 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 33.3 t -57.08 -43.5 82.21 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.039 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -90.17 -31.95 5.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -176.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 103.63 69.65 0.8 Allowed Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.165 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.98 -174.04 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 170.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -80.17 -169.18 1.94 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -172.15 -22.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 119.435 -0.317 . . . . 0.0 111.6 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 50.11 96.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 O-C-N 123.515 0.51 . . . . 0.0 111.678 177.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -57.63 -25.43 60.12 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -172.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -64.07 -66.45 0.54 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.395 0.616 . . . . 0.0 110.243 171.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.46 ' O ' HG23 ' B' ' 242' ' ' VAL . 96.4 mtt180 -57.16 -40.58 77.56 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.315 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 239' ' ' LEU . . . . . 0.401 HD21 HG22 ' B' ' 223' ' ' ILE . 2.4 tm? -48.97 -64.5 0.79 Allowed 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.425 0.631 . . . . 0.0 110.762 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -72.42 -25.74 61.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.685 -176.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -65.94 -46.99 76.18 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.299 -0.56 . . . . 0.0 109.973 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 242' ' ' VAL . . . . . 0.46 HG23 ' O ' ' B' ' 238' ' ' ARG . 80.7 t -66.29 -41.05 88.35 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 243' ' ' ILE . . . . . 0.571 ' HA ' ' CD2' ' B' ' 246' ' ' LEU . 19.7 mt -65.71 -42.62 92.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.769 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 244' ' ' SER . . . . . 0.437 ' HA ' ' HB2' ' B' ' 247' ' ' ASN . 28.2 t -71.87 -22.15 61.56 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.756 0.313 . . . . 0.0 110.825 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -86.55 -22.87 26.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.281 0.562 . . . . 0.0 109.955 177.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 246' ' ' LEU . . . . . 0.613 HD12 ' O ' ' B' ' 246' ' ' LEU . 1.3 pp -101.1 2.62 40.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.735 176.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 247' ' ' ASN . . . . . 0.437 ' HB2' ' HA ' ' B' ' 244' ' ' SER . 6.7 t30 -72.86 69.44 0.94 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.688 -173.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -134.6 -175.49 13.9 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.032 -178.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -89.41 -3.35 58.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.175 0.512 . . . . 0.0 110.646 -176.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 250' ' ' ASN . . . . . 0.486 ' HA ' ' OD1' ' B' ' 253' ' ' ASP . 4.4 p-10 -79.33 12.16 2.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.805 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.527 ' HA ' HG12 ' B' ' 254' ' ' VAL . 6.2 tp -67.06 -37.3 79.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 176.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -61.52 -42.08 98.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.583 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 253' ' ' ASP . . . . . 0.486 ' OD1' ' HA ' ' B' ' 250' ' ' ASN . 2.7 m-20 -60.46 -49.96 75.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.662 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 254' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' B' ' 251' ' ' ILE . 8.3 p -70.58 -25.49 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.444 -176.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 255' ' ' ILE . . . . . 0.448 HG13 ' O ' ' B' ' 251' ' ' ILE . 59.7 mt -77.46 -38.33 26.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.112 0.482 . . . . 0.0 110.278 176.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -78.24 -20.27 52.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.548 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.26 27.26 9.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.112 176.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 258' ' ' GLY . . . . . 0.766 ' HA2' ' OH ' ' A' ' 11' ' ' TYR . . . 20.38 -96.56 0.01 OUTLIER Glycine 0 C--N 1.336 0.543 0 N-CA-C 116.781 1.472 . . . . 0.0 116.781 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 259' ' ' ILE . . . . . 0.706 ' O ' ' HG ' ' B' ' 262' ' ' LEU . 0.0 OUTLIER -56.33 -41.05 69.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -172.131 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 54.48 -122.98 26.67 Favored Glycine 0 C--N 1.329 0.184 0 C-N-CA 121.138 -0.553 . . . . 0.0 113.24 174.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -116.83 27.75 8.96 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 262' ' ' LEU . . . . . 0.706 ' HG ' ' O ' ' B' ' 259' ' ' ILE . 0.6 OUTLIER -88.71 -25.83 22.12 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -178.243 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -92.64 134.75 34.71 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.853 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 14.7 t -149.22 -167.03 2.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.783 0.325 . . . . 0.0 110.889 -176.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 47.9 t -77.63 131.91 69.93 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.565 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.71 131.96 40.33 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.575 2.183 . . . . 0.0 112.813 175.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . -147.0 -52.5 0.21 Allowed 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.016 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . -81.93 62.49 4.53 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.412 176.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -89.91 -34.86 8.02 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.124 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -154.99 123.01 5.83 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 11.2 t -106.55 136.73 40.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . 68.85 160.54 0.19 Allowed 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.927 0.767 . . . . 0.0 110.874 -175.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 9.5 p -128.54 138.64 54.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.162 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 48.4 t -132.3 150.19 52.21 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.002 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -151.97 162.41 41.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.181 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -107.8 111.96 62.18 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 121.065 0.459 . . . . 0.0 111.02 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 277' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.1 56.86 5.59 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 123.345 2.697 . . . . 0.0 111.914 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 147.76 169.73 15.22 Favored Glycine 0 N--CA 1.436 -1.32 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.611 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 73.8 m -153.96 170.56 20.77 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.784 0.292 . . . . 0.0 110.389 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 61.24 37.11 17.57 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 123.859 0.724 . . . . 0.0 111.831 176.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -129.48 93.67 34.76 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.497 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -78.45 -55.4 0.05 OUTLIER 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.543 2.162 . . . . 0.0 113.089 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -164.64 159.64 19.18 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -84.74 115.49 22.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.687 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 149.12 -64.89 0.4 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.587 -0.815 . . . . 0.0 112.458 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 18.0 m 57.73 34.7 24.77 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.149 0.5 . . . . 0.0 111.184 -178.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 287' ' ' ALA . . . . . 0.455 ' HB3' ' HD3' ' B' ' 288' ' ' PRO . . . -82.36 -48.99 0.86 Allowed Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.795 -176.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 288' ' ' PRO . . . . . 0.455 ' HD3' ' HB3' ' B' ' 287' ' ' ALA . 6.6 Cg_exo -73.85 63.56 4.9 Favored 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 122.135 1.89 . . . . 0.0 112.315 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -127.5 136.41 51.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.62 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -154.61 160.24 41.34 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.453 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -102.64 111.35 23.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.758 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -94.38 -74.54 0.54 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.725 -175.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 48.56 30.34 2.43 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 123.685 0.615 . . . . 0.0 112.448 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -114.69 96.92 5.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.116 0.484 . . . . 0.0 110.556 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -92.82 59.55 3.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.562 0.696 . . . . 0.0 109.601 175.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -144.48 115.58 7.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.055 -177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -157.72 83.88 0.89 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.32 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -170.83 -39.18 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -127.33 127.74 44.77 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.786 0.327 . . . . 0.0 111.036 -175.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -96.51 127.7 42.75 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.696 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -77.47 101.82 6.6 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.176 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 4.8 m -90.26 55.53 3.1 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -173.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -129.04 44.22 3.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.426 0.631 . . . . 0.0 110.431 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -85.71 85.12 7.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.832 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 8.9 t -165.31 74.73 0.23 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.313 0.577 . . . . 0.0 109.503 176.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -97.27 53.81 1.19 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.959 0.885 . . . . 0.0 109.041 -177.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -92.15 79.17 5.14 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.711 -174.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -109.33 145.6 35.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.544 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 20.3 ptp -142.3 13.21 1.99 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.338 176.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 84.35 129.53 1.84 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.793 -0.717 . . . . 0.0 113.012 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -92.05 39.62 1.02 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.0 0.429 . . . . 0.0 110.765 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 312' ' ' GLY . . . . . 0.403 ' C ' ' H ' ' B' ' 314' ' ' PHE . . . -164.5 45.28 0.3 Allowed Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 313' ' ' LEU . . . . . 0.469 ' H ' ' CD2' ' B' ' 313' ' ' LEU . 1.7 pt? -79.18 36.66 0.3 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.836 0.827 . . . . 0.0 110.578 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 314' ' ' PHE . . . . . 0.403 ' H ' ' C ' ' B' ' 312' ' ' GLY . 43.1 p90 -97.25 19.54 12.93 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.632 -174.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 21.8 t70 . . . . . 0 C--O 1.246 0.908 0 CA-C-O 118.584 -0.722 . . . . 0.0 109.712 178.488 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.9 mtp . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.81 -95.96 0.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.513 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 p -125.98 84.63 2.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.426 0.632 . . . . 0.0 111.44 -175.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.4 t -65.76 -26.74 39.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.48 0.657 . . . . 0.0 109.843 -176.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.444 ' HB3' HG23 ' A' ' 39' ' ' VAL . 3.3 m -58.06 -66.65 0.44 Allowed 'General case' 0 C--O 1.242 0.709 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.591 -178.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.596 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -77.06 -20.62 55.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.764 -176.884 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.44 ' CD2' HG23 ' B' ' 255' ' ' ILE . 17.7 tp -57.09 -57.51 12.24 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 169.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.587 ' HB2' HD21 ' B' ' 212' ' ' LEU . . . -58.33 -48.72 79.63 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.413 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 49.3 t -65.43 -34.62 78.73 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.364 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.596 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 0.7 OUTLIER -70.2 -38.99 76.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 120.898 0.38 . . . . 0.0 110.352 -179.711 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.629 ' OH ' ' HA ' ' B' ' 255' ' ' ILE . 19.5 m-30 -67.65 -31.75 71.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.049 177.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.2 m -64.33 -46.17 84.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.188 174.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.609 ' HB1' HD21 ' A' ' 59' ' ' LEU . . . -53.49 -44.72 69.25 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.981 174.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.408 ' CD1' HD12 ' B' ' 262' ' ' LEU . 40.0 mt -61.34 -49.54 76.54 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.788 177.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 11' ' ' TYR . 30.5 mm -54.75 -42.38 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.531 -178.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 16' ' ' LEU . 4.4 mm? -68.23 -35.33 77.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.988 0.423 . . . . 0.0 111.227 175.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -80.29 10.79 4.1 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -174.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.408 ' OD1' ' HG2' ' B' ' 202' ' ' ARG . 27.2 t70 -81.87 -79.61 0.17 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 118.452 0.569 . . . . 0.0 111.085 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.12 40.45 0.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 50.01 44.97 25.67 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.689 0.756 . . . . 0.0 111.623 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 79.7 t -92.34 138.74 19.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.55 177.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 p -62.21 111.86 2.15 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -171.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.411 HG11 ' HB2' ' A' ' 51' ' ' LEU . 57.2 t -56.56 107.56 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.794 172.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.2 p -139.92 155.65 47.07 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -176.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -52.07 -54.48 29.75 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.532 -177.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -51.5 -35.02 38.45 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.396 177.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.581 ' HG3' HG13 ' B' ' 230' ' ' VAL . 13.1 mptt -75.95 -45.05 36.99 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.404 -173.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.467 ' O ' HD13 ' A' ' 32' ' ' ILE . 5.4 mt -63.43 -42.35 95.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.306 -0.558 . . . . 0.0 109.825 176.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -58.72 -41.07 85.53 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.949 175.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.47 -49.48 77.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.241 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.47 -38.84 92.67 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.0 0.429 . . . . 0.0 111.164 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.467 HD13 ' O ' ' A' ' 28' ' ' ILE . 1.5 mp -59.61 -37.19 69.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.699 176.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -74.12 -30.88 62.52 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.703 0.287 . . . . 0.0 110.64 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.587 ' CB ' HD13 ' B' ' 226' ' ' ILE . . . -63.58 -44.32 94.39 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.958 176.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.478 ' HB2' ' CD1' ' B' ' 209' ' ' LEU . . . -77.01 -50.51 12.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.551 177.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.45 -4.53 31.21 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.646 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.414 HG23 ' HA2' ' B' ' 213' ' ' GLY . 48.2 t -82.63 131.31 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.627 0.251 . . . . 0.0 110.443 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -97.97 98.67 9.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.823 0.82 . . . . 0.0 110.377 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.444 HG23 ' HB3' ' A' ' 5' ' ' SER . 7.3 p -83.85 140.54 16.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.985 177.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.41 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 10.1 tp10 -44.53 111.38 1.21 Allowed Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.046 174.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -46.49 -16.06 0.23 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 124.483 3.455 . . . . 0.0 115.108 -174.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.474 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -70.18 -32.25 70.09 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -179.356 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.485 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 84.3 m95 -71.9 -51.76 8.4 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.43 177.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 81.1 Cg_exo -49.64 -47.13 24.08 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 122.258 1.972 . . . . 0.0 112.19 170.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.28 -49.81 63.73 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.933 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -52.69 -53.1 52.12 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.684 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.404 ' CZ ' HD12 ' A' ' 10' ' ' ILE . 5.9 m-85 -61.93 -38.13 87.27 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.57 -34.71 78.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.735 -0.212 . . . . 0.0 111.19 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -100.47 -7.16 24.53 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -99.33 -37.66 9.16 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 121.951 -0.468 . . . . 0.0 112.224 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.619 ' HA ' ' CG1' ' A' ' 54' ' ' VAL . 1.6 mp -93.74 -128.51 0.12 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.41 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 66.7 -11.65 0.24 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.421 ' H ' ' C ' ' A' ' 51' ' ' LEU . 27.2 t-20 -137.34 3.62 2.6 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.619 ' CG1' ' HA ' ' A' ' 51' ' ' LEU . 34.1 m -89.88 121.11 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.037 -170.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -40.0 -87.6 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.957 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.3 tp -157.81 -57.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 121.222 -0.191 . . . . 0.0 111.458 175.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.41 -21.87 60.54 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.242 -0.504 . . . . 0.0 112.55 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.461 ' HB2' ' HB ' ' A' ' 54' ' ' VAL . 1.5 m -52.97 -20.09 3.13 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.034 0.534 . . . . 0.0 110.997 176.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.609 HD21 ' HB1' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -49.51 -42.99 45.2 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.848 176.714 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.549 HG23 HD13 ' B' ' 259' ' ' ILE . 37.2 mt -83.48 -7.13 10.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.604 0.716 . . . . 0.0 110.461 -173.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 47.5 t -89.18 -26.79 21.08 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.785 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -82.91 -16.3 48.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.35 0.595 . . . . 0.0 111.044 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.7 p -78.84 -12.04 13.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.793 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.41 -66.41 0.37 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.862 177.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.25 149.71 36.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.719 0.295 . . . . 0.0 111.058 -175.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -173.72 112.27 0.41 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.352 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.21 163.49 11.6 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.2 -0.524 . . . . 0.0 111.887 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -83.45 161.71 14.84 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.614 2.209 . . . . 0.0 112.064 179.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -117.18 107.85 44.86 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-O 120.678 0.275 . . . . 0.0 110.351 177.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.86 166.76 11.42 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.401 2.068 . . . . 0.0 112.403 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -162.25 175.95 11.11 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.351 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.84 104.67 4.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.303 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.66 -68.98 0.99 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.991 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.78 152.82 20.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.59 0.219 . . . . 0.0 111.59 -176.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -150.91 139.16 12.71 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.045 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 53.2 Cg_exo -55.82 96.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.586 2.857 . . . . 0.0 113.094 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.75 146.32 25.71 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.262 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -151.19 160.24 28.58 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.03 176.98 44.23 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.23 178.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.5 123.65 7.76 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.46 2.107 . . . . 0.0 112.441 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.438 ' H ' ' HD2' ' A' ' 82' ' ' PRO . . . -106.32 -46.72 0.12 Allowed Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.116 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.438 ' HD2' ' H ' ' A' ' 81' ' ' ALA . 83.2 Cg_exo -49.19 131.08 25.83 Favored 'Trans proline' 0 C--N 1.365 1.435 0 C-N-CA 122.152 1.902 . . . . 0.0 113.039 176.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.8 t -87.97 117.94 27.17 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.908 177.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.6 p -73.96 126.14 29.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.521 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.71 146.93 46.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.155 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -172.57 178.27 2.75 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.065 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 62.67 87.24 0.13 Allowed Pre-proline 0 N--CA 1.467 0.419 0 O-C-N 123.964 0.79 . . . . 0.0 112.14 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.75 147.49 91.99 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.988 2.459 . . . . 0.0 113.049 176.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.4 92.52 8.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.843 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -83.82 112.79 20.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.504 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.64 151.86 46.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.592 176.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -97.11 -7.67 32.1 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.283 0.563 . . . . 0.0 110.366 -176.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -140.56 124.66 17.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.079 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.8 t -110.86 -65.26 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.164 0.507 . . . . 0.0 110.323 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -142.32 169.94 16.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.935 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 97' ' ' LYS . . . -137.86 -71.55 0.43 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.514 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 96' ' ' ALA . 83.8 mttt 65.74 137.25 0.02 OUTLIER 'General case' 0 C--N 1.343 0.3 0 O-C-N 123.834 0.709 . . . . 0.0 111.578 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -89.47 -18.2 27.19 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.143 -0.348 . . . . 0.0 111.346 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 59.77 -88.47 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.835 0.709 . . . . 0.0 112.059 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -88.51 -170.24 2.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.05 0.453 . . . . 0.0 111.553 -173.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.7 m -147.86 135.33 20.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.856 -177.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -86.17 73.39 10.24 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.04 0.448 . . . . 0.0 111.116 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -162.7 69.21 0.24 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.813 0.816 . . . . 0.0 109.608 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 52.5 m -147.51 147.35 30.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.543 -177.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 62.08 -160.46 0.31 Allowed 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.779 0.674 . . . . 0.0 110.849 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.23 125.46 23.77 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.804 0.335 . . . . 0.0 110.816 -177.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -90.39 69.37 6.95 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.715 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 23.0 ptp 38.08 49.01 1.17 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.342 1.057 . . . . 0.0 113.564 176.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -148.91 160.17 28.3 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.842 177.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -86.38 111.0 20.08 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.974 0.416 . . . . 0.0 110.318 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -86.27 -52.75 3.14 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.537 -0.84 . . . . 0.0 113.473 -176.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.1 mt -117.69 -6.09 11.11 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -172.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -67.05 -57.21 7.27 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.471 0.175 . . . . 0.0 111.471 -176.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 . . . . . 0 C--O 1.251 1.135 0 CA-C-O 117.742 -1.123 . . . . 0.0 109.97 179.009 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 200' ' ' ALA . . . . . 0.573 ' O ' ' HG2' ' B' ' 201' ' ' MET . . . . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 119.593 -0.241 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.573 ' HG2' ' O ' ' B' ' 200' ' ' ALA . 26.1 ptm 61.63 -23.08 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 169.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 202' ' ' ARG . . . . . 0.408 ' HG2' ' OD1' ' A' ' 18' ' ' ASP . 73.0 mtp180 -33.38 -68.78 0.1 Allowed 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -172.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 203' ' ' TYR . . . . . 0.421 ' HD2' HG21 ' B' ' 242' ' ' VAL . 76.4 m-85 -112.27 0.2 15.68 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.282 0.563 . . . . 0.0 111.412 -175.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.673 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 64.6 t -64.08 -54.27 33.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.262 177.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 205' ' ' ALA . . . . . 0.653 ' HA ' HD12 ' B' ' 208' ' ' LEU . . . -70.45 -12.81 61.82 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 -178.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 206' ' ' SER . . . . . 0.625 ' OG ' HG23 ' B' ' 223' ' ' ILE . 9.5 t -79.39 -39.86 31.47 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 175.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 207' ' ' TYR . . . . . 0.802 ' HB2' HD21 ' B' ' 246' ' ' LEU . 34.4 t80 -63.1 -40.35 97.37 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 173.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 33.3 mt -59.01 -51.96 67.84 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.154 176.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 209' ' ' LEU . . . . . 0.914 HD12 HD12 ' B' ' 226' ' ' ILE . 0.2 OUTLIER -51.6 -50.74 59.62 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.627 179.533 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -65.48 -32.97 74.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.415 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 211' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -65.57 -55.08 19.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.901 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 212' ' ' LEU . . . . . 0.587 HD21 ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -76.24 -13.01 60.18 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.366 -179.278 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 213' ' ' GLY . . . . . 0.414 ' HA2' HG23 ' A' ' 37' ' ' VAL . . . -57.2 -16.82 21.46 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.271 170.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 121.35 4.81 9.78 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.621 -0.591 . . . . 0.0 111.621 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 215' ' ' ASN . . . . . 0.589 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 38.6 t30 -117.95 100.95 7.89 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.97 0.414 . . . . 0.0 110.183 -175.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 216' ' ' SER . . . . . 0.45 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 15.2 m -72.22 -7.98 52.26 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.269 -177.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 217' ' ' SER . . . . . 0.402 ' N ' ' HD3' ' B' ' 218' ' ' PRO . 31.2 m -130.01 64.37 72.04 Favored Pre-proline 0 C--N 1.319 -0.718 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.399 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 218' ' ' PRO . . . . . 0.458 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 53.2 Cg_exo -57.12 137.36 81.48 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.315 2.677 . . . . 0.0 113.209 -177.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 28.9 t -115.33 165.76 12.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.281 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -53.73 -42.58 68.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.134 0.492 . . . . 0.0 110.784 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -59.34 -43.77 92.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.466 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -65.2 -52.34 55.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.933 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.625 HG23 ' OG ' ' B' ' 206' ' ' SER . 1.8 mp -58.08 -48.27 84.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.87 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 224' ' ' LYS . . . . . 0.537 ' HE3' ' CG ' ' B' ' 236' ' ' ASP . 60.1 tttm -68.5 -22.65 64.52 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 122.258 -0.276 . . . . 0.0 111.448 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -69.79 -42.99 73.03 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 0.914 HD12 HD12 ' B' ' 209' ' ' LEU . 1.5 mm -66.36 -38.26 81.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 113.797 -1.547 . . . . 0.0 111.299 176.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 227' ' ' LEU . . . . . 0.476 ' CD1' ' HB ' ' B' ' 232' ' ' ILE . 0.2 OUTLIER -71.96 -42.03 67.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.888 0.375 . . . . 0.0 110.487 179.455 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 228' ' ' ASP . . . . . 0.461 ' OD2' ' HG2' ' B' ' 224' ' ' LYS . 10.2 m-20 -75.08 -20.63 59.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.578 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 61.2 p -56.39 -35.1 67.37 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.751 0.31 . . . . 0.0 111.157 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 230' ' ' VAL . . . . . 0.581 HG13 ' HG3' ' A' ' 27' ' ' LYS . 63.4 t -89.68 -41.07 13.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.163 0.506 . . . . 0.0 111.145 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 110.3 34.96 2.2 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.332 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 232' ' ' ILE . . . . . 0.476 ' HB ' ' CD1' ' B' ' 227' ' ' LEU . 3.9 mt -98.02 123.76 50.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -61.87 107.99 0.94 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.003 0.43 . . . . 0.0 111.9 -170.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -106.16 132.26 52.43 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.824 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 235' ' ' ASP . . . . . 0.57 ' O ' HD12 ' B' ' 239' ' ' LEU . 10.9 m-20 -79.3 121.51 25.19 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 236' ' ' ASP . . . . . 0.537 ' CG ' ' HE3' ' B' ' 224' ' ' LYS . 3.3 m-20 -59.78 -14.33 14.18 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.514 0.509 . . . . 0.0 112.229 -178.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -98.98 -49.61 4.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.301 0.572 . . . . 0.0 110.683 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.559 ' O ' HG23 ' B' ' 242' ' ' VAL . 19.4 mmm180 -66.8 -36.43 82.37 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.346 -172.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 239' ' ' LEU . . . . . 0.591 HD13 ' H ' ' B' ' 240' ' ' ASN . 0.0 OUTLIER -65.38 -34.83 79.22 Favored 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.279 -176.125 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 240' ' ' ASN . . . . . 0.591 ' H ' HD13 ' B' ' 239' ' ' LEU . 55.0 t30 -79.91 -32.62 40.17 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -65.05 -40.25 94.49 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.486 174.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 242' ' ' VAL . . . . . 0.659 ' O ' ' HB3' ' B' ' 246' ' ' LEU . 87.7 t -64.02 -49.35 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 243' ' ' ILE . . . . . 0.544 ' HA ' HD23 ' B' ' 246' ' ' LEU . 35.4 mt -53.96 -39.04 39.01 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.753 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.522 174.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 56.1 m -59.43 -42.43 91.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.754 0.311 . . . . 0.0 110.749 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -77.82 -21.29 51.76 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.443 0.64 . . . . 0.0 110.968 176.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 246' ' ' LEU . . . . . 0.802 HD21 ' HB2' ' B' ' 207' ' ' TYR . 0.3 OUTLIER -102.92 -12.23 17.66 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.919 -168.042 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -78.26 48.15 0.73 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.351 0.596 . . . . 0.0 111.402 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -93.11 156.59 22.92 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.143 -0.551 . . . . 0.0 111.822 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 249' ' ' LYS . . . . . 0.669 ' H ' ' HD3' ' B' ' 249' ' ' LYS . 0.3 OUTLIER -80.1 39.65 0.45 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.045 0.45 . . . . 0.0 111.966 -175.075 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -118.59 27.61 8.82 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.49 HD11 ' CE1' ' B' ' 207' ' ' TYR . 3.5 mm -64.57 -50.79 74.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -172.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -63.65 -30.08 71.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.231 0.539 . . . . 0.0 110.652 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.5 -48.7 63.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.976 176.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 254' ' ' VAL . . . . . 0.415 HG22 ' HA ' ' B' ' 251' ' ' ILE . 34.9 m -65.34 -27.37 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.046 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 255' ' ' ILE . . . . . 0.629 ' HA ' ' OH ' ' A' ' 11' ' ' TYR . 30.2 mt -69.63 -52.92 27.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.119 0.485 . . . . 0.0 110.583 174.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -69.38 -15.79 63.38 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.768 -177.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -82.91 40.44 0.69 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.427 174.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 20.34 -98.97 0.01 OUTLIER Glycine 0 N--CA 1.472 1.069 0 N-CA-C 115.833 1.093 . . . . 0.0 115.833 -172.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 259' ' ' ILE . . . . . 0.549 HD13 HG23 ' A' ' 60' ' ' ILE . 2.7 mp -86.1 -25.51 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.035 0.445 . . . . 0.0 111.117 -174.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 72.51 -170.05 51.22 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.205 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -87.76 25.6 1.47 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 175.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 262' ' ' LEU . . . . . 0.408 HD12 ' CD1' ' A' ' 14' ' ' LEU . 6.7 mt -80.71 -43.46 20.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.325 -176.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -99.27 62.15 1.24 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.5 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 25.6 t -130.5 124.69 32.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.061 0.458 . . . . 0.0 111.114 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 87.5 t -132.85 117.43 15.05 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.258 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.06 -26.63 12.71 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.71 2.274 . . . . 0.0 112.684 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.12 114.0 3.17 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.301 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 123.51 -48.89 0.93 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.42 -178.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -86.43 42.66 3.17 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.189 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -137.65 48.73 2.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.398 0.618 . . . . 0.0 110.453 -177.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 16.6 t -94.56 135.42 28.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.102 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -157.45 121.17 4.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.469 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 15.8 m -85.24 134.55 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.657 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 13.6 p -129.54 100.65 5.62 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.692 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -111.83 122.03 46.67 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.225 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -93.26 117.91 67.56 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.769 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 277' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.38 140.43 63.76 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.64 2.227 . . . . 0.0 112.102 177.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -108.97 110.37 3.0 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.423 -178.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 73.1 m -159.21 177.47 11.01 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 63.05 79.79 0.25 Allowed 'General case' 0 CA--C 1.53 0.206 0 O-C-N 123.924 0.765 . . . . 0.0 112.362 173.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -72.78 123.61 89.76 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.705 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.87 108.04 2.46 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.583 2.188 . . . . 0.0 112.356 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -160.34 133.45 6.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.605 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -148.97 172.2 15.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.075 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -165.49 -179.4 39.21 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.695 178.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 16.5 m -125.69 133.11 52.26 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.718 0.294 . . . . 0.0 110.378 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -140.07 126.12 11.89 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.382 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -85.38 158.22 10.99 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.958 2.438 . . . . 0.0 112.801 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -99.3 137.68 37.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.148 177.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -147.28 156.94 43.37 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.134 -175.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -96.47 115.53 27.58 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -57.55 136.01 56.7 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 123.681 0.613 . . . . 0.0 111.331 -177.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -69.8 139.15 53.17 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.278 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -126.87 82.28 2.07 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.819 173.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -75.01 81.09 2.2 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.89 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -92.7 167.62 11.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.724 -178.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 56.2 49.93 14.43 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.773 0.797 . . . . 0.0 110.919 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -84.24 56.54 3.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.894 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 24.1 tptm 69.67 113.81 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.674 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -96.28 -167.92 1.66 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.629 178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -54.56 136.04 45.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.14 0.495 . . . . 0.0 110.694 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 19.5 m -93.4 113.03 25.09 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.854 -175.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -107.09 129.27 54.85 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.693 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -127.66 124.53 38.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.988 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 56.4 m 59.06 80.42 0.19 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.744 0.652 . . . . 0.0 112.648 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -103.58 76.98 1.45 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 174.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -83.23 -45.63 13.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.809 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 2.4 t70 55.29 32.69 19.15 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 123.777 0.673 . . . . 0.0 110.647 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 66.6 mtt -93.09 34.85 1.09 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.575 -175.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 64.45 40.21 97.53 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.67 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 61.68 35.29 17.08 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 122.754 0.422 . . . . 0.0 111.271 178.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . -80.73 65.97 3.82 Favored Glycine 0 C--O 1.227 -0.324 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.477 -178.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 6.8 mp -105.21 27.03 8.63 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.433 0.635 . . . . 0.0 109.533 175.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 314' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -99.71 -15.44 18.51 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.418 -173.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 C--O 1.252 1.2 0 CA-C-O 118.774 -0.632 . . . . 0.0 110.019 -179.494 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.424 ' HG2' ' OE2' ' B' ' 252' ' ' GLU . 16.4 mmt . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.653 0.263 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.55 -80.63 0.57 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.691 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.436 ' HB2' ' HG2' ' A' ' 6' ' ' GLU . 3.8 p -126.24 86.53 2.54 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.566 0.698 . . . . 0.0 110.857 -177.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.536 HG13 ' HB2' ' B' ' 212' ' ' LEU . 21.1 t -67.47 -27.22 37.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.398 -172.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.677 ' HB3' HG23 ' A' ' 39' ' ' VAL . 7.0 m -61.68 -57.99 9.82 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.21 -177.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.436 ' HG2' ' HB2' ' A' ' 3' ' ' SER . 9.6 pt-20 -72.98 -29.3 62.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.596 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.536 HD12 ' HA ' ' A' ' 4' ' ' VAL . 39.8 mt -53.91 -52.92 59.02 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 170.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.446 ' HA ' HD21 ' B' ' 212' ' ' LEU . . . -55.3 -53.18 59.31 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.122 178.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.604 ' SG ' HG21 ' A' ' 39' ' ' VAL . 31.6 m -63.48 -33.21 75.08 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.548 -177.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.419 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 1.1 tp -72.65 -40.36 62.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.689 0.28 . . . . 0.0 111.309 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -75.64 -18.69 59.59 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.306 -0.558 . . . . 0.0 109.662 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.499 ' HB3' HG12 ' A' ' 28' ' ' ILE . 47.8 m -72.24 -44.89 62.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 170.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.405 ' HB3' HD12 ' A' ' 59' ' ' LEU . . . -50.58 -46.27 57.7 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 171.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.586 HD23 HD11 ' A' ' 56' ' ' ILE . 67.9 mt -59.38 -52.95 63.41 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.586 178.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.522 HD12 HD21 ' A' ' 31' ' ' LEU . 30.2 mt -62.02 -31.19 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -177.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.572 ' HB3' ' HA ' ' A' ' 23' ' ' VAL . 3.4 mm? -98.75 -0.98 41.58 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -124.9 53.18 1.51 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.379 0.609 . . . . 0.0 110.278 174.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.589 ' OD1' ' HA ' ' B' ' 200' ' ' ALA . 24.3 t70 -136.96 -58.3 0.72 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.871 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.429 ' CG ' ' H ' ' A' ' 20' ' ' GLU . 24.0 t70 -73.72 -174.51 1.79 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.58 175.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.429 ' H ' ' CG ' ' A' ' 19' ' ' ASP . 33.0 tt0 -77.25 -17.48 58.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.436 0.636 . . . . 0.0 109.659 178.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 79.7 t -61.19 124.25 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.941 174.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.6 p -82.61 149.98 27.11 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.076 -177.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.572 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 2.5 m -60.81 124.73 15.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.198 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.1 p -145.89 143.61 29.69 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.942 -174.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.447 ' HG3' ' H ' ' A' ' 26' ' ' ASP . 7.7 pt-20 -45.96 -50.85 14.31 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 123.706 0.629 . . . . 0.0 111.234 -177.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.447 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 13.5 t70 -53.68 -43.67 69.07 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.531 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.508 ' O ' HG12 ' B' ' 230' ' ' VAL . 2.9 mptp? -78.35 -40.68 35.68 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.33 -172.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.745 ' O ' HG12 ' A' ' 32' ' ' ILE . 5.7 mt -62.98 -50.06 81.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 119.774 -0.771 . . . . 0.0 109.947 176.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -54.41 -44.79 72.66 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.866 0.365 . . . . 0.0 110.576 177.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.33 -45.94 83.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.983 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.574 ' HB2' ' CG1' ' B' ' 230' ' ' VAL . 44.0 tp -69.06 -40.14 78.68 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 121.194 0.521 . . . . 0.0 111.03 -176.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.745 HG12 ' O ' ' A' ' 28' ' ' ILE . 18.5 mm -62.52 -38.27 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.941 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -82.72 -17.49 44.16 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.579 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 31' ' ' LEU . . . -62.62 -46.35 88.63 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 174.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.35 -47.77 11.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.9 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.2 64.84 0.98 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.934 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.0 m -120.86 179.26 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.879 0.371 . . . . 0.0 111.012 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -113.38 113.6 25.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.224 -177.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.677 HG23 ' HB3' ' A' ' 5' ' ' SER . 4.4 p -145.91 137.18 19.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.765 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -56.78 123.87 60.71 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.221 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -56.41 -8.55 2.79 Favored 'Trans proline' 0 C--O 1.241 0.629 0 C-N-CA 123.57 2.847 . . . . 0.0 113.004 -174.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.45 -25.52 50.68 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.598 -177.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.425 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 97.0 m95 -66.84 -60.05 6.87 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.393 175.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.425 ' CD ' ' HB2' ' A' ' 43' ' ' TRP . 10.3 Cg_endo -55.87 -42.17 69.79 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 121.882 1.721 . . . . 0.0 112.276 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.73 -54.26 39.36 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.75 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.9 tt -59.12 -45.34 91.17 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.582 ' HA ' HD13 ' A' ' 51' ' ' LEU . 4.0 m-85 -54.58 -54.59 39.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.697 0.284 . . . . 0.0 111.643 -178.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.27 -24.79 61.4 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.959 -176.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -99.95 -1.68 36.57 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.03 -17.38 4.86 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.582 HD13 ' HA ' ' A' ' 47' ' ' PHE . 8.4 mp -80.25 -113.46 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.958 -0.464 . . . . 0.0 109.819 175.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 59.39 2.79 0.34 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 177.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -145.01 -52.68 0.28 Allowed 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 122.21 1.005 . . . . 0.0 108.593 -173.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.488 HG11 ' HG ' ' A' ' 51' ' ' LEU . 2.4 p -18.42 110.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 111.861 -2.427 . . . . 0.0 114.553 173.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -56.71 130.98 47.77 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 163.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.64 ' O ' HD22 ' A' ' 59' ' ' LEU . 5.5 tp -47.63 -58.62 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -166.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.62 -29.11 60.71 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.005 -0.617 . . . . 0.0 113.297 -176.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.2 m -59.36 -16.8 24.9 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.64 HD22 ' O ' ' A' ' 56' ' ' ILE . 1.0 OUTLIER -60.63 -17.71 48.85 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.389 0.144 . . . . 0.0 111.389 -179.45 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.508 ' N ' HD23 ' A' ' 59' ' ' LEU . 15.7 tt -65.21 -22.16 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 120.882 0.373 . . . . 0.0 111.004 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.4 t -127.69 73.22 1.44 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.232 0.539 . . . . 0.0 110.22 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -107.48 -12.75 15.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.067 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.7 t -74.51 -42.19 49.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.518 -175.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.06 -80.52 1.23 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.654 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -123.47 -48.9 1.92 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.955 0.407 . . . . 0.0 110.797 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 162.57 -144.1 9.33 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -177.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.49 163.05 29.67 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.326 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -89.62 155.42 5.23 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.088 2.525 . . . . 0.0 112.818 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.446 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . . . -116.37 120.77 34.37 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.01 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 69' ' ' ALA . 13.9 Cg_exo -71.51 -21.6 25.73 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.457 2.105 . . . . 0.0 112.34 177.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 66.32 -158.49 0.25 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.846 176.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.36 137.45 56.9 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.091 0.472 . . . . 0.0 111.324 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.77 -34.82 17.82 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.603 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 65.56 102.46 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.13 0.572 . . . . 0.0 111.928 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.475 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . 73.86 138.66 0.06 OUTLIER Pre-proline 0 N--CA 1.471 0.588 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.437 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 32.4 Cg_exo -63.85 161.11 34.06 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.178 2.585 . . . . 0.0 113.243 -177.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 76' ' ' PRO . . . 79.39 146.61 0.09 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.256 0.972 . . . . 0.0 111.342 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.98 0.07 80.22 Favored Glycine 0 C--N 1.33 0.247 0 CA-C-N 115.699 -0.682 . . . . 0.0 113.235 -175.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.0 -97.23 0.77 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.74 177.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -68.07 105.12 1.13 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.627 2.218 . . . . 0.0 112.097 -177.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -129.97 91.45 39.61 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.568 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.44 -54.38 2.59 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.878 2.385 . . . . 0.0 112.043 176.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.0 t -165.39 167.74 17.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.471 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 97.6 m -162.29 -44.95 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.421 0.629 . . . . 0.0 109.57 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -96.72 107.55 20.04 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.791 177.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 66.33 -172.54 0.19 Allowed 'General case' 0 C--O 1.235 0.307 0 O-C-N 124.083 0.864 . . . . 0.0 110.459 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.41 70.64 1.5 Allowed Pre-proline 0 CA--C 1.533 0.299 0 O-C-N 123.335 0.397 . . . . 0.0 111.673 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -57.59 140.15 92.46 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.011 2.474 . . . . 0.0 112.731 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -127.26 37.6 4.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.841 0.353 . . . . 0.0 111.376 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -83.54 161.72 21.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.018 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 92' ' ' LYS . 1.1 pm0 -88.09 -165.4 1.31 Allowed 'General case' 0 CA--C 1.536 0.404 0 O-C-N 123.277 0.36 . . . . 0.0 111.94 -173.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 91' ' ' GLU . 35.7 mmtp 74.96 174.38 0.25 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.674 0.79 . . . . 0.0 111.414 -177.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -142.36 141.35 32.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.798 176.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 8.9 p -84.67 -27.19 6.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.603 -172.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 54.4 86.02 0.05 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.891 0.853 . . . . 0.0 111.432 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -133.79 158.25 43.82 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.461 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -85.48 133.05 34.11 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.568 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -77.6 -26.82 50.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.549 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 56.39 86.85 0.06 Allowed 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.589 0.556 . . . . 0.0 111.653 173.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -92.38 30.33 1.51 Allowed 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.531 0.681 . . . . 0.0 111.132 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.2 m 71.04 87.64 0.11 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.283 -1.326 . . . . 0.0 113.093 171.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -146.38 145.13 30.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.992 167.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -170.9 176.9 3.95 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.375 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 83.2 p 59.78 124.51 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.944 1.403 . . . . 0.0 113.105 178.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -85.74 56.93 4.19 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.49 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.82 -56.47 11.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.823 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -68.7 128.92 38.36 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.943 0.401 . . . . 0.0 111.202 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 11.2 tpt 65.58 25.39 11.69 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.149 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -65.97 133.16 34.21 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.1 176.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -77.9 142.0 38.71 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 173.55 131.13 1.35 Allowed Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 120.033 -1.08 . . . . 0.0 112.965 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.1 tp -101.8 2.2 38.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.323 0.582 . . . . 0.0 109.733 175.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -73.48 151.21 41.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.97 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.4 t70 . . . . . 0 C--O 1.244 0.781 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.081 -179.06 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 200' ' ' ALA . . . . . 0.589 ' HA ' ' OD1' ' A' ' 18' ' ' ASP . . . . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 121.482 0.658 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.442 ' SD ' ' HA ' ' B' ' 263' ' ' ALA . 4.9 mpp? -112.07 58.97 0.63 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.936 -177.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 202' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -33.25 -76.56 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 O-C-N 124.638 1.211 . . . . 0.0 113.172 -170.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 203' ' ' TYR . . . . . 0.506 ' CD2' ' HA ' ' B' ' 239' ' ' LEU . 93.0 m-85 -134.93 14.67 3.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.579 0.704 . . . . 0.0 109.88 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.578 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 31.5 t -68.51 -54.52 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.418 -176.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 205' ' ' ALA . . . . . 0.527 ' HA ' HD12 ' B' ' 208' ' ' LEU . . . -72.13 -13.9 61.69 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.558 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 206' ' ' SER . . . . . 0.451 ' HB3' HG23 ' B' ' 223' ' ' ILE . 3.5 m -72.3 -43.02 64.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 172.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 207' ' ' TYR . . . . . 0.485 ' CE1' HD11 ' B' ' 251' ' ' ILE . 24.4 t80 -62.64 -44.14 97.03 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 174.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 64.1 mt -59.51 -46.84 87.67 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.018 177.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 209' ' ' LEU . . . . . 0.422 ' O ' ' HG ' ' B' ' 212' ' ' LEU . 0.1 OUTLIER -57.09 -53.45 57.89 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.575 -179.67 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -62.96 -34.68 78.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.291 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 211' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -63.27 -53.54 51.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.218 177.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 212' ' ' LEU . . . . . 0.536 ' HB2' HG13 ' A' ' 4' ' ' VAL . 4.3 pp -65.76 -21.65 66.53 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.759 0.314 . . . . 0.0 110.753 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.97 -16.05 38.28 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.676 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 120.37 4.98 10.65 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.448 178.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 215' ' ' ASN . . . . . 0.633 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 28.1 t30 -117.66 108.8 15.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.188 0.518 . . . . 0.0 110.274 -178.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 216' ' ' SER . . . . . 0.428 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 5.8 m -68.05 -15.2 63.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.799 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 17.6 p -125.66 67.75 59.55 Favored Pre-proline 0 N--CA 1.441 -0.881 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.417 -175.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 218' ' ' PRO . . . . . 0.428 ' HD3' ' C ' ' B' ' 216' ' ' SER . 50.9 Cg_exo -59.85 121.09 9.27 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.72 2.28 . . . . 0.0 112.025 177.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 89.2 p -102.33 -178.95 3.84 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.782 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -58.93 -36.67 75.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.02 0.438 . . . . 0.0 110.84 -177.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.54 -35.25 63.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.76 -176.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -59.35 -54.99 40.46 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.256 0.551 . . . . 0.0 109.746 175.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.451 HG23 ' HB3' ' B' ' 206' ' ' SER . 1.8 mp -63.47 -42.14 95.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.209 -178.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 224' ' ' LYS . . . . . 0.548 ' O ' ' HB2' ' B' ' 228' ' ' ASP . 27.7 tptp -57.06 -50.85 71.48 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 121.312 -0.155 . . . . 0.0 110.752 178.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -60.99 -41.16 95.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.909 0.385 . . . . 0.0 110.708 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 0.504 HG23 HD11 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -63.93 -42.94 97.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.543 -178.039 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 227' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' B' ' 234' ' ' ALA . 26.9 tp -81.16 -23.22 38.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.23 0.538 . . . . 0.0 110.413 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 228' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' B' ' 224' ' ' LYS . 2.7 t70 -72.37 -28.27 62.91 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.636 176.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 8.4 t -65.25 -53.33 45.87 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.556 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 230' ' ' VAL . . . . . 0.574 ' CG1' ' HB2' ' A' ' 31' ' ' LEU . 22.2 m -61.6 -33.13 55.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-O 120.802 0.334 . . . . 0.0 111.744 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 102.94 39.06 2.76 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.944 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 232' ' ' ILE . . . . . 0.421 HG13 HG23 ' B' ' 230' ' ' VAL . 16.9 mt -116.01 125.53 73.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -54.65 143.6 24.39 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.089 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 234' ' ' ALA . . . . . 0.569 ' HB2' HD23 ' B' ' 227' ' ' LEU . . . -140.93 117.08 10.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.028 0.442 . . . . 0.0 111.932 -173.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 235' ' ' ASP . . . . . 0.444 ' HB2' ' HB2' ' B' ' 238' ' ' ARG . 1.7 m-20 -67.88 113.41 5.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.495 174.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -56.75 -40.18 75.31 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.913 0.387 . . . . 0.0 110.986 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.41 -58.55 6.7 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.241 0.543 . . . . 0.0 111.04 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.666 ' O ' HG23 ' B' ' 242' ' ' VAL . 4.7 mpt_? -63.97 -29.44 70.6 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.914 -177.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 239' ' ' LEU . . . . . 0.506 ' HA ' ' CD2' ' B' ' 203' ' ' TYR . 9.3 tt -57.59 -61.42 2.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.168 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -64.38 -27.31 68.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.797 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 241' ' ' LYS . . . . . 0.45 ' HB2' ' HA ' ' B' ' 238' ' ' ARG . 38.1 mttp -63.46 -47.91 79.88 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.694 175.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 242' ' ' VAL . . . . . 0.703 ' O ' HD12 ' B' ' 246' ' ' LEU . 46.6 t -70.13 -33.16 53.68 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 243' ' ' ILE . . . . . 0.633 ' HA ' ' CD1' ' B' ' 246' ' ' LEU . 4.7 mt -64.2 -35.97 75.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.153 178.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 21.8 m -75.62 -25.92 57.34 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.317 0.58 . . . . 0.0 109.938 172.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 245' ' ' GLU . . . . . 0.448 ' HB3' ' O ' ' B' ' 242' ' ' VAL . 44.2 tt0 -71.3 -40.88 70.55 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.129 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 246' ' ' LEU . . . . . 0.703 HD12 ' O ' ' B' ' 242' ' ' VAL . 0.0 OUTLIER -108.22 18.1 21.49 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.262 0.553 . . . . 0.0 111.578 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -61.99 120.39 10.71 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.049 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -153.09 147.43 16.96 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.527 -0.845 . . . . 0.0 112.479 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -84.42 -24.16 29.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.071 0.462 . . . . 0.0 110.101 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 250' ' ' ASN . . . . . 0.482 ' HB3' ' HB3' ' B' ' 253' ' ' ASP . 4.9 m-20 -80.25 55.71 2.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.779 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.498 ' O ' HG12 ' B' ' 254' ' ' VAL . 1.3 mm -68.2 -49.52 66.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.159 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 252' ' ' GLU . . . . . 0.424 ' OE2' ' HG2' ' A' ' 1' ' ' MET . 38.7 tt0 -67.95 -25.32 65.39 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.188 0.518 . . . . 0.0 110.01 -176.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 253' ' ' ASP . . . . . 0.482 ' HB3' ' HB3' ' B' ' 250' ' ' ASN . 20.4 t70 -73.33 -48.61 32.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.104 174.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 254' ' ' VAL . . . . . 0.635 ' O ' ' HA3' ' B' ' 258' ' ' GLY . 2.3 p -66.53 -18.2 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.171 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 255' ' ' ILE . . . . . 0.424 HG21 HD13 ' A' ' 7' ' ' LEU . 66.4 mt -84.77 -52.27 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.856 0.36 . . . . 0.0 110.598 174.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -61.12 -31.72 71.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.082 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -126.83 35.69 4.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.833 0.349 . . . . 0.0 111.294 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 258' ' ' GLY . . . . . 0.636 ' O ' HD21 ' B' ' 262' ' ' LEU . . . -133.67 55.03 0.75 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.721 -175.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 49.7 mt -94.03 -25.66 4.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.617 0.722 . . . . 0.0 109.477 171.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -116.89 38.79 2.88 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.598 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 261' ' ' LYS . . . . . 0.538 ' H ' HD22 ' B' ' 262' ' ' LEU . 61.0 mttp -124.44 16.39 8.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.107 0.479 . . . . 0.0 110.175 176.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 262' ' ' LEU . . . . . 0.636 HD21 ' O ' ' B' ' 258' ' ' GLY . 0.2 OUTLIER -118.98 -68.93 0.88 Allowed 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.755 0.788 . . . . 0.0 109.755 -175.845 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 263' ' ' ALA . . . . . 0.442 ' HA ' ' SD ' ' B' ' 201' ' ' MET . . . -61.45 -29.85 70.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.474 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 13.2 t -137.22 128.7 28.36 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.602 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 88.8 t 58.74 95.2 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.25 0 O-C-N 124.128 0.892 . . . . 0.0 111.298 -176.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.16 -21.61 36.02 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.592 2.195 . . . . 0.0 112.444 -175.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . 176.76 -40.04 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.622 -177.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 130.45 -23.37 4.55 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.067 -177.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -178.84 -168.63 38.31 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -98.71 96.14 7.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.742 0.306 . . . . 0.0 110.733 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 14.3 t -115.32 138.07 46.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -140.52 144.16 35.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.81 0.338 . . . . 0.0 111.039 -178.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 18.4 m -91.56 35.75 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.367 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 9.9 m -119.73 106.21 11.91 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.163 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -98.13 63.56 1.6 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.401 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . 68.07 100.18 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.269 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.143 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 277' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -78.73 67.36 8.47 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.074 2.516 . . . . 0.0 112.044 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 133.12 -174.65 20.5 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.91 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 25.9 m 64.2 -170.67 0.19 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.723 0.297 . . . . 0.0 110.44 -178.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 61.02 33.17 19.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.556 174.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -72.57 137.13 80.55 Favored Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.179 177.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.22 56.92 2.69 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.897 2.398 . . . . 0.0 112.575 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -127.79 31.19 5.17 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.736 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -131.6 98.36 4.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.613 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -148.96 -58.96 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.011 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 16.6 m -71.82 90.32 1.1 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.994 0.425 . . . . 0.0 110.836 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 287' ' ' ALA . . . . . 0.463 ' HB3' ' HD3' ' B' ' 288' ' ' PRO . . . -85.91 -51.95 0.47 Allowed Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 288' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' B' ' 287' ' ' ALA . 2.5 Cg_endo -78.3 131.53 10.76 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 121.877 1.718 . . . . 0.0 111.921 -176.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -140.97 136.79 32.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.594 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -92.77 142.96 26.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.562 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -133.22 28.52 4.08 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.91 0.386 . . . . 0.0 110.52 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -63.7 97.92 0.17 Allowed 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.515 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -76.79 51.41 0.77 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.958 0.408 . . . . 0.0 110.796 175.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt 55.51 78.45 0.19 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.674 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 295' ' ' LYS . . . . . 0.404 ' C ' ' HD2' ' B' ' 295' ' ' LYS . 0.0 OUTLIER -93.82 155.62 17.1 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.836 177.879 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -128.52 145.59 51.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.399 173.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -156.27 -31.3 0.09 Allowed 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.283 0.989 . . . . 0.0 109.098 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -142.98 30.96 1.42 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.931 -171.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 19.7 tptp -85.4 -59.17 2.4 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.73 176.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 55.86 76.15 0.3 Allowed 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.605 0.565 . . . . 0.0 111.999 171.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 301' ' ' GLU . . . . . 0.517 ' H ' ' CD ' ' B' ' 301' ' ' GLU . 0.3 OUTLIER -99.99 33.08 2.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.474 0.654 . . . . 0.0 111.306 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 19.0 t -115.49 139.87 49.66 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.121 -176.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -78.85 123.73 27.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.996 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -89.73 172.67 8.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.459 -177.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 305' ' ' SER . . . . . 0.469 ' HB3' ' OD1' ' B' ' 307' ' ' ASP . 13.8 m -104.46 107.36 18.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.854 0.359 . . . . 0.0 111.041 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -103.27 27.44 7.26 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.229 0.537 . . . . 0.0 110.478 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 307' ' ' ASP . . . . . 0.469 ' OD1' ' HB3' ' B' ' 305' ' ' SER . 8.9 p-10 -76.96 74.26 3.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.326 -174.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -81.23 72.44 8.26 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 173.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 42.72 31.18 0.28 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.688 1.195 . . . . 0.0 113.038 -176.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 54.87 46.39 76.65 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 116.024 -0.535 . . . . 0.0 113.346 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 63.31 23.77 13.94 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.872 0.368 . . . . 0.0 111.353 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 312' ' ' GLY . . . . . 0.492 ' O ' ' HD1' ' B' ' 314' ' ' PHE . . . 78.94 -75.21 2.07 Favored Glycine 0 N--CA 1.441 -1.026 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 20.4 tp 54.92 28.04 9.97 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.254 0.622 . . . . 0.0 111.103 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 314' ' ' PHE . . . . . 0.492 ' HD1' ' O ' ' B' ' 312' ' ' GLY . 17.8 m-85 -139.4 -54.21 0.56 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.916 -177.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 11.3 t70 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 117.956 -1.021 . . . . 0.0 108.811 -179.902 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 mpp? . . . . . 0 N--CA 1.477 0.908 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.29 -178.65 4.24 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.473 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 25.6 p 50.88 30.14 4.96 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.374 0.67 . . . . 0.0 112.26 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.494 ' HA ' HD12 ' A' ' 7' ' ' LEU . 5.6 m -72.45 -24.67 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.692 -176.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.559 ' HB3' HG23 ' A' ' 39' ' ' VAL . 14.5 m -64.64 -55.92 17.12 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.724 177.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.418 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 35.1 tt0 -59.79 -43.42 94.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.306 178.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 4' ' ' VAL . 90.6 mt -52.61 -52.51 55.04 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.896 0.379 . . . . 0.0 110.594 175.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.04 -51.0 71.92 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.621 -176.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.6 t -72.06 -23.8 61.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.376 -176.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.418 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 1.5 tp -82.72 -39.1 15.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.282 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.465 ' CZ ' HD23 ' B' ' 208' ' ' LEU . 20.9 m-85 -68.63 -38.76 80.76 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.3 p -64.65 -46.58 81.89 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.038 174.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -44.74 -53.81 6.96 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.625 0.37 . . . . 0.0 111.496 173.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.539 ' HA ' ' HB2' ' A' ' 17' ' ' HIS . 3.6 pp -79.43 -27.11 41.7 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.505 -178.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.498 HD11 ' HA ' ' B' ' 206' ' ' SER . 17.2 mt -65.0 -41.03 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.051 0.453 . . . . 0.0 110.621 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.92 -27.75 55.03 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 174.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.539 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -78.4 13.95 1.39 Allowed 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 176.54 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -83.92 -31.22 25.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.316 0.579 . . . . 0.0 109.75 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.523 ' CG ' ' H ' ' A' ' 20' ' ' GLU . 19.7 t70 -126.92 -157.01 0.78 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.5 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.523 ' H ' ' CG ' ' A' ' 19' ' ' ASP . 31.5 mt-10 -86.57 -5.64 59.09 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.184 0.516 . . . . 0.0 110.668 -178.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.5 t -57.7 132.54 22.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.913 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.39 151.25 47.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.345 -175.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.5 m -100.83 35.85 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.48 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.9 p -88.14 179.35 6.41 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.252 -173.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.506 ' HG3' ' N ' ' A' ' 26' ' ' ASP . 14.0 pt-20 -43.84 -50.66 7.84 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.631 -177.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.506 ' N ' ' HG3' ' A' ' 25' ' ' GLU . 10.6 t70 -55.86 -41.3 74.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.151 -175.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.576 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 3.4 mptp? -83.83 -45.33 13.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.552 -170.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.55 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 9.3 mt -66.33 -42.9 91.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.35 178.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -61.75 -46.4 89.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.133 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.29 -44.08 97.35 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.403 HD21 ' HG ' ' B' ' 209' ' ' LEU . 0.7 OUTLIER -74.48 -39.3 62.57 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-O 121.598 0.713 . . . . 0.0 110.595 -175.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.55 ' HB ' ' O ' ' A' ' 28' ' ' ILE . 1.1 mp -60.52 -34.03 56.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.119 173.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -75.5 -29.04 59.41 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.679 174.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.04 -36.29 83.52 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.774 178.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -94.33 -41.39 9.45 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.178 -0.609 . . . . 0.0 112.039 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.76 46.07 4.37 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.639 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.594 HG22 ' HA2' ' B' ' 213' ' ' GLY . 0.2 OUTLIER -97.68 164.44 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.959 0.409 . . . . 0.0 110.857 -176.288 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -102.42 98.91 8.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.365 -176.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.559 HG23 ' HB3' ' A' ' 5' ' ' SER . 9.0 p -131.7 129.03 61.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.517 176.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 16.8 pt-20 -62.25 133.88 94.48 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -178.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 40' ' ' GLU . 53.5 Cg_exo -53.43 -7.92 0.59 Allowed 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 123.969 3.113 . . . . 0.0 113.828 -174.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.4 -36.8 77.1 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.072 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.58 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 89.1 m95 -70.93 -54.37 7.7 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 119.248 -0.406 . . . . 0.0 111.227 178.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.58 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 78.4 Cg_exo -49.98 -50.3 13.7 Favored 'Trans proline' 0 C--N 1.363 1.33 0 C-N-CA 122.004 1.803 . . . . 0.0 112.839 174.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.48 -50.06 71.73 Favored Glycine 0 C--O 1.24 0.523 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.209 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.477 HD21 ' HA2' ' A' ' 64' ' ' GLY . 60.8 tp -55.96 -53.11 60.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.511 -0.345 . . . . 0.0 110.776 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -59.92 -40.8 90.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.791 -177.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.59 -38.21 90.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.663 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -92.18 -8.51 45.31 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.65 -46.62 4.29 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.714 ' HA ' HG23 ' A' ' 54' ' ' VAL . 2.0 mp -84.05 -130.41 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.231 -175.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 66.94 3.62 3.17 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.375 0.67 . . . . 0.0 112.735 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -145.7 -51.4 0.25 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.714 HG23 ' HA ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -53.07 121.92 2.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 113.901 -1.499 . . . . 0.0 111.512 174.904 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -58.01 158.36 6.82 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.481 175.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.461 ' O ' HD13 ' A' ' 59' ' ' LEU . 3.8 tp -40.53 -46.46 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 124.828 1.251 . . . . 0.0 114.371 -172.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.41 -20.3 22.17 Favored Glycine 0 N--CA 1.467 0.705 0 C-N-CA 121.272 -0.489 . . . . 0.0 113.587 -174.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 43.5 t -55.44 -25.34 35.66 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 122.467 0.307 . . . . 0.0 111.066 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 56' ' ' ILE . 9.8 mp -55.61 -32.29 62.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.311 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.442 HG23 HD12 ' B' ' 259' ' ' ILE . 33.3 mt -94.14 -3.64 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.522 0.677 . . . . 0.0 110.722 -175.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 55.1 m -114.85 -56.67 2.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.025 0.44 . . . . 0.0 111.187 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -97.25 66.47 2.07 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.155 -173.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.9 m -76.79 -16.4 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.77 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.477 ' HA2' HD21 ' A' ' 46' ' ' LEU . . . 163.63 120.82 0.54 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.303 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -156.62 -166.31 2.09 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -99.58 -84.08 1.77 Allowed Glycine 0 CA--C 1.518 0.22 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.045 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.75 79.75 0.1 Allowed Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.077 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -84.32 70.41 5.88 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.525 2.15 . . . . 0.0 112.161 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.81 135.92 74.14 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.869 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -64.72 -57.22 0.32 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.9 2.4 . . . . 0.0 112.51 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 62.79 176.57 0.15 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.504 0.502 . . . . 0.0 111.939 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -157.05 154.0 28.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.769 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 161.8 -172.05 37.88 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.06 -0.59 . . . . 0.0 111.955 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -91.66 86.05 5.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.071 0.462 . . . . 0.0 111.239 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.451 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -94.49 135.2 24.35 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.711 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 50.2 Cg_exo -58.02 163.77 9.19 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 124.016 3.144 . . . . 0.0 113.349 -178.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.31 128.66 36.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.468 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -136.79 77.0 0.36 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.678 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 163.7 -78.8 0.14 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.303 -178.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.51 155.01 70.52 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.033 2.489 . . . . 0.0 112.913 -176.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.44 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . . . -109.19 123.76 35.91 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.497 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 81' ' ' ALA . 19.0 Cg_exo -68.46 56.04 0.88 Allowed 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.186 2.59 . . . . 0.0 113.358 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.4 ' O ' ' HB ' ' A' ' 84' ' ' THR . 43.3 t -133.59 141.52 47.71 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.015 178.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 83' ' ' SER . 96.5 m 72.29 123.43 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.501 0.667 . . . . 0.0 111.558 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -99.74 47.6 0.95 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.367 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 64.78 -179.28 0.18 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.153 176.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.21 115.54 3.15 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.708 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -57.41 104.7 0.16 Allowed 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 123.044 2.496 . . . . 0.0 112.772 177.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -96.56 80.65 3.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.936 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -100.4 130.1 46.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.81 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -103.11 -76.54 0.58 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 172.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 93.4 mttt 60.17 83.04 0.14 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.142 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -61.96 124.57 21.15 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.291 -178.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.0 m -64.68 142.5 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.41 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -91.06 13.48 16.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.756 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.17 109.98 9.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.113 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -64.22 146.91 53.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.847 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 99' ' ' GLU . 47.0 mmtm -81.03 -42.33 21.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.255 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 7.1 tp10 174.01 -74.57 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 O-C-N 123.757 0.661 . . . . 0.0 109.798 178.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 71.38 134.57 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.921 0.763 . . . . 0.0 111.725 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.8 t -139.79 125.93 19.92 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.364 -178.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 44.5 mt-10 -128.09 12.86 6.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.065 177.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 102' ' ' GLU . 34.8 mm-40 67.43 178.19 0.24 Allowed 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.759 0.662 . . . . 0.0 110.231 -170.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.5 t -91.85 76.73 5.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.005 0.431 . . . . 0.0 110.536 -177.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -88.03 113.06 23.29 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.594 176.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -87.61 -179.75 6.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.117 0.484 . . . . 0.0 111.28 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -138.79 61.76 1.56 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.669 0.747 . . . . 0.0 109.807 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 26.3 ttt -136.43 137.56 40.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.647 178.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -70.54 125.15 13.54 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.457 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.41 -174.74 5.34 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.591 0.234 . . . . 0.0 111.242 -178.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.18 -100.23 0.02 OUTLIER Glycine 0 C--N 1.333 0.377 0 C-N-CA 121.266 -0.492 . . . . 0.0 113.251 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.0 tp -148.36 68.26 1.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.435 -0.45 . . . . 0.0 111.31 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -92.74 8.72 38.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.224 169.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.367 -0.825 . . . . 0.0 110.25 179.655 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.443 ' HG3' ' H ' ' B' ' 264' ' ' SER . 81.6 mtp -117.46 163.69 16.0 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 202' ' ' ARG . . . . . 0.485 ' HD3' HG13 ' B' ' 242' ' ' VAL . 12.8 ptp180 175.89 -168.11 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 O-C-N 123.9 0.75 . . . . 0.0 109.594 -178.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 203' ' ' TYR . . . . . 0.593 ' CD2' ' HA ' ' B' ' 239' ' ' LEU . 48.0 m-85 -66.59 3.74 0.93 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.962 0.411 . . . . 0.0 112.014 -177.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.59 ' O ' HD13 ' B' ' 208' ' ' LEU . 5.4 p -56.46 -55.47 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.209 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 205' ' ' ALA . . . . . 0.504 ' CB ' HD11 ' A' ' 14' ' ' LEU . . . -74.12 -8.15 55.12 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.989 -176.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 206' ' ' SER . . . . . 0.611 ' OG ' HG23 ' B' ' 223' ' ' ILE . 8.0 t -78.96 -37.8 38.59 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 173.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 207' ' ' TYR . . . . . 0.549 ' HD1' HD11 ' B' ' 251' ' ' ILE . 21.3 t80 -64.25 -42.84 96.32 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 172.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.59 HD13 ' O ' ' B' ' 204' ' ' VAL . 7.5 mp -56.82 -48.28 78.35 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.927 174.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 209' ' ' LEU . . . . . 0.437 ' CD2' ' HB2' ' A' ' 11' ' ' TYR . 0.3 OUTLIER -54.93 -53.43 55.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.356 -179.75 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -61.67 -39.33 91.01 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.094 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 211' ' ' ALA . . . . . 0.727 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -69.32 -51.87 32.83 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.04 0.448 . . . . 0.0 110.931 -178.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.8 -35.86 69.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.645 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 213' ' ' GLY . . . . . 0.594 ' HA2' HG22 ' A' ' 37' ' ' VAL . . . -54.49 -52.43 45.02 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.294 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 163.08 31.29 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.279 -0.963 . . . . 0.0 112.336 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 215' ' ' ASN . . . . . 0.727 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 50.5 m-20 -136.02 105.24 5.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.699 0.285 . . . . 0.0 110.479 -176.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 16.4 m -61.21 -21.69 64.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.944 0.402 . . . . 0.0 111.339 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 20.3 m -128.54 73.99 80.36 Favored Pre-proline 0 N--CA 1.443 -0.788 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.563 -174.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -58.69 121.12 9.43 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.62 2.88 . . . . 0.0 112.72 175.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 15.1 m -89.95 158.57 17.33 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.46 -36.01 66.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.512 0.672 . . . . 0.0 109.738 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -62.05 -34.82 76.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.921 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -73.58 -47.54 39.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.702 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.611 HG23 ' OG ' ' B' ' 206' ' ' SER . 1.8 mp -59.78 -45.41 94.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 224' ' ' LYS . . . . . 0.413 ' HG3' ' OD1' ' B' ' 228' ' ' ASP . 7.3 ttmm -62.25 -36.7 82.83 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.117 175.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 225' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' B' ' 229' ' ' SER . 6.4 ttpm? -60.48 -45.55 93.32 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.764 176.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.07 -38.35 82.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.7 0.286 . . . . 0.0 111.149 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 87.6 mt -76.44 -46.25 27.86 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 228' ' ' ASP . . . . . 0.413 ' OD1' ' HG3' ' B' ' 224' ' ' LYS . 1.3 m-20 -74.59 -14.57 60.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.883 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 229' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' B' ' 225' ' ' LYS . 23.0 t -54.35 -47.1 72.94 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.089 0.471 . . . . 0.0 109.938 172.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 29.0 t -90.29 -34.05 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 121.471 0.653 . . . . 0.0 109.612 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 91.87 72.68 1.23 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.539 176.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 8.4 mt -95.53 -97.46 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 122.522 -0.399 . . . . 0.0 109.926 176.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -136.09 -78.17 0.42 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 173.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . 60.41 81.64 0.18 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.623 0.577 . . . . 0.0 112.231 174.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 235' ' ' ASP . . . . . 0.475 ' C ' ' H ' ' B' ' 237' ' ' ASP . 0.6 OUTLIER -62.15 133.12 54.82 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.357 179.533 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.81 36.69 0.11 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.697 0.761 . . . . 0.0 111.255 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 237' ' ' ASP . . . . . 0.475 ' H ' ' C ' ' B' ' 235' ' ' ASP . 15.9 t70 -147.92 -57.65 0.24 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.669 -1.15 . . . . 0.0 107.914 176.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.427 ' O ' HG23 ' B' ' 242' ' ' VAL . 8.5 ttm-85 -57.56 -42.0 82.15 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.52 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 239' ' ' LEU . . . . . 0.593 ' HA ' ' CD2' ' B' ' 203' ' ' TYR . 10.1 tt -57.85 -62.22 1.96 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.381 -176.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -67.83 -20.0 65.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.362 -178.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -66.91 -47.2 72.5 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.288 0.566 . . . . 0.0 109.945 174.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 242' ' ' VAL . . . . . 0.649 ' O ' HD12 ' B' ' 246' ' ' LEU . 91.7 t -66.35 -39.26 83.7 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.393 179.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 243' ' ' ILE . . . . . 0.596 ' HA ' ' CD1' ' B' ' 246' ' ' LEU . 13.1 mt -65.52 -32.87 60.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.401 177.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 34.4 t -61.59 -39.24 90.48 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 171.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 245' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' B' ' 242' ' ' VAL . 93.1 mt-10 -63.91 -58.05 7.93 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.844 174.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 246' ' ' LEU . . . . . 0.649 HD12 ' O ' ' B' ' 242' ' ' VAL . 0.0 OUTLIER -103.65 37.18 2.09 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -170.033 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -57.6 154.74 10.86 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.043 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -51.69 107.62 0.48 Allowed Glycine 0 CA--C 1.519 0.294 0 CA-C-N 115.556 -0.747 . . . . 0.0 114.315 -173.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -135.07 -74.39 0.46 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -108.94 58.91 0.6 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.545 0.688 . . . . 0.0 109.191 175.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.549 HD11 ' HD1' ' B' ' 207' ' ' TYR . 0.3 OUTLIER -64.81 -39.7 86.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.698 -176.036 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -66.63 -37.14 84.23 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.435 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.49 -49.43 75.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.943 0.402 . . . . 0.0 110.179 175.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 254' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' B' ' 251' ' ' ILE . 6.2 p -68.3 -22.28 27.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.893 -176.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 255' ' ' ILE . . . . . . . . . . . . . 56.1 mt -79.19 -45.25 24.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 120.938 0.399 . . . . 0.0 110.631 173.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -61.55 -28.47 69.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.854 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -120.33 50.66 1.28 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 258' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' B' ' 254' ' ' VAL . . . -71.0 -47.16 39.8 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.377 -0.829 . . . . 0.0 113.784 -171.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 259' ' ' ILE . . . . . 0.442 HD12 HG23 ' A' ' 60' ' ' ILE . 6.6 pt -64.18 -45.9 95.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.869 0.334 . . . . 0.0 111.043 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 46.89 -110.61 0.57 Allowed Glycine 0 C--N 1.335 0.492 0 O-C-N 123.626 0.579 . . . . 0.0 113.018 175.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -129.04 45.47 2.79 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 262' ' ' LEU . . . . . . . . . . . . . 9.2 mp -77.2 89.88 3.68 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 122.106 0.955 . . . . 0.0 110.926 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -139.22 17.0 2.6 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.22 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 264' ' ' SER . . . . . 0.443 ' H ' ' HG3' ' B' ' 201' ' ' MET . 8.0 t 71.09 -49.35 0.68 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.447 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 45.1 t -55.0 134.0 67.64 Favored Pre-proline 0 C--N 1.329 -0.297 0 O-C-N 123.432 0.458 . . . . 0.0 111.087 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.05 -50.49 2.91 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.223 2.615 . . . . 0.0 112.574 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . -169.21 149.92 4.27 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.886 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . -90.64 77.07 1.53 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.906 -178.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -73.39 72.4 1.2 Allowed Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.764 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -102.18 89.52 3.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.943 0.401 . . . . 0.0 110.862 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 10.5 t -95.61 137.16 24.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.223 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -116.0 141.52 48.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.62 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.66 136.47 55.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.025 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 4.8 m -105.48 148.38 27.26 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.46 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -109.5 164.56 12.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.0 0.429 . . . . 0.0 111.125 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -136.03 97.57 12.2 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.444 0.64 . . . . 0.0 110.668 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 277' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -83.93 152.62 12.87 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 123.487 2.792 . . . . 0.0 113.485 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -103.06 -176.4 26.6 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.436 177.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 58.6 m -122.84 -167.66 1.62 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.474 0.637 . . . . 0.0 112.369 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . -60.4 148.65 36.52 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.98 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -130.79 89.4 43.27 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.625 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -67.11 135.25 36.7 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.705 2.27 . . . . 0.0 112.283 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -112.39 133.89 54.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.639 -178.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.13 118.16 10.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.77 0.319 . . . . 0.0 110.604 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -88.28 -56.03 2.11 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.9 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 35.0 t 71.96 127.63 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.388 0.613 . . . . 0.0 111.573 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 287' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' B' ' 288' ' ' PRO . . . -129.32 109.89 17.84 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.112 177.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 288' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' B' ' 287' ' ' ALA . 5.9 Cg_exo -70.11 142.42 46.36 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.924 2.416 . . . . 0.0 113.144 -174.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -100.79 119.73 39.07 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.82 122.06 16.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.288 -175.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -75.08 151.19 38.67 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 292' ' ' GLU . . . . . 0.523 ' O ' ' HG2' ' B' ' 294' ' ' LYS . 44.3 mt-10 -49.74 -70.72 0.08 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.248 0.342 . . . . 0.0 110.906 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 52.59 31.46 10.09 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.81 0.814 . . . . 0.0 110.694 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 294' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' B' ' 292' ' ' GLU . 31.9 mmmt -120.44 129.04 53.71 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 176.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -87.08 127.33 35.12 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.893 0.378 . . . . 0.0 110.231 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -107.83 136.69 47.13 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.342 0.592 . . . . 0.0 110.583 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -124.44 159.41 30.53 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.453 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -141.84 162.03 36.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.909 0.385 . . . . 0.0 110.705 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -121.88 -177.61 3.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.463 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 69.05 179.48 0.24 Allowed 'General case' 0 N--CA 1.466 0.329 0 O-C-N 124.021 0.826 . . . . 0.0 111.433 -178.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 45.3 37.18 2.64 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.348 1.059 . . . . 0.0 112.625 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 48.8 m -151.26 102.4 2.92 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.836 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -103.7 156.22 17.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.38 -177.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -92.0 166.04 12.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.427 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.41 103.15 13.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.846 0.355 . . . . 0.0 110.446 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -92.08 32.59 1.14 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.101 0.477 . . . . 0.0 110.894 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.99 -45.45 85.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.325 -176.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -62.27 -61.35 2.52 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.106 0.409 . . . . 0.0 112.106 -173.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -78.39 58.9 2.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.931 0.396 . . . . 0.0 111.425 -177.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . -86.31 -70.24 1.32 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.175 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -112.0 20.22 17.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.719 0.295 . . . . 0.0 111.296 -178.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . -87.69 49.31 3.84 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.137 -177.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 7.2 mp -94.65 4.53 53.72 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 175.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 314' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -98.62 -47.89 5.18 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.442 -170.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 28.6 t70 . . . . . 0 C--O 1.244 0.813 0 O-C-N 124.178 0.924 . . . . 0.0 111.104 -177.108 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.2 mtp . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.32 -106.69 0.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -175.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.466 ' HB3' ' HG2' ' A' ' 6' ' ' GLU . 24.7 m -97.41 69.04 2.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.341 0.591 . . . . 0.0 111.575 -174.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.422 HG13 ' CD2' ' B' ' 212' ' ' LEU . 20.7 t -67.1 -26.61 36.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.342 0.591 . . . . 0.0 109.684 -175.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.586 ' OG ' HG23 ' A' ' 39' ' ' VAL . 31.9 t -61.02 -65.62 0.66 Allowed 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.928 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.696 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 10.7 pt-20 -68.57 -31.55 70.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.64 -175.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 35.7 mt -55.92 -53.63 54.55 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 172.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.624 ' HB2' HG11 ' A' ' 37' ' ' VAL . . . -56.91 -52.69 64.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.91 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.696 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 24.6 p -70.73 -26.87 63.57 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.586 -173.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.508 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 1.1 tp -78.26 -38.52 23.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.698 0.285 . . . . 0.0 111.408 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.43 ' HB2' HD22 ' B' ' 209' ' ' LEU . 21.8 m-85 -72.34 -26.78 62.05 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.8 t -69.59 -51.6 33.73 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.219 171.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -47.96 -54.03 14.13 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.353 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.619 ' O ' ' HE3' ' B' ' 201' ' ' MET . 2.9 pp -76.54 -29.95 56.92 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.651 -176.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.558 ' N ' HD12 ' A' ' 14' ' ' LEU . 3.8 mt -59.47 -31.0 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 118.522 0.601 . . . . 0.0 110.487 173.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.455 HD12 HG22 ' A' ' 15' ' ' ILE . 6.7 mp -86.73 -25.59 24.65 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.205 176.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -85.17 62.54 7.56 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -177.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -138.29 -57.27 0.65 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 120.856 -0.337 . . . . 0.0 111.506 172.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.589 ' CG ' ' H ' ' A' ' 20' ' ' GLU . 17.3 t70 -91.47 -151.3 0.26 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.743 0.306 . . . . 0.0 111.393 -176.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.589 ' H ' ' CG ' ' A' ' 19' ' ' ASP . 16.9 tp10 -88.67 -6.6 57.37 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.584 0.707 . . . . 0.0 109.634 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.414 HG21 HG12 ' B' ' 232' ' ' ILE . 68.7 t -64.76 106.61 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.655 178.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.572 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 2.7 p -66.11 150.63 48.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.075 -177.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.448 ' HA ' HD23 ' A' ' 16' ' ' LEU . 29.8 m -84.31 49.51 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.358 -174.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.4 p -81.83 164.12 21.85 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -49.77 -46.25 50.47 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.415 -178.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -58.57 -34.94 71.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.059 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.572 ' HG3' ' O ' ' A' ' 22' ' ' THR . 32.7 mmtp -75.71 -51.36 12.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.759 -175.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.439 HG23 HD13 ' A' ' 32' ' ' ILE . 5.1 mt -62.07 -41.28 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.151 176.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.458 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 6.9 t30 -53.81 -52.2 61.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.812 173.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.19 -44.95 79.92 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.761 0.315 . . . . 0.0 111.815 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.447 HD21 HG23 ' B' ' 226' ' ' ILE . 2.6 tm? -65.09 -46.03 82.76 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.495 0.665 . . . . 0.0 109.883 -178.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.439 HD13 HG23 ' A' ' 28' ' ' ILE . 1.6 mp -62.04 -33.25 57.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.959 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.458 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 31.2 mmmt -77.68 -25.06 49.21 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.756 0.312 . . . . 0.0 111.006 176.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.13 -42.38 72.68 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.239 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.74 -41.66 11.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.702 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.51 10.92 56.42 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 121.034 -0.603 . . . . 0.0 113.253 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.662 HG22 ' HA3' ' B' ' 213' ' ' GLY . 3.2 t -70.7 140.77 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 O-C-N 122.467 -0.431 . . . . 0.0 110.577 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -94.69 89.72 5.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.296 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.586 HG23 ' OG ' ' A' ' 5' ' ' SER . 7.6 p -110.93 127.58 67.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 172.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.487 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 12.3 pt-20 -59.53 134.71 88.93 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.261 -174.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 40' ' ' GLU . 50.5 Cg_exo -54.31 -5.2 0.36 Allowed 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 124.398 3.399 . . . . 0.0 114.634 -172.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.36 -41.72 72.76 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.685 177.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.624 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 94.8 m95 -68.73 -57.42 8.13 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.796 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.624 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 56.8 Cg_exo -52.15 -41.28 66.11 Favored 'Trans proline' 0 C--N 1.366 1.5 0 C-N-CA 121.749 1.633 . . . . 0.0 112.324 174.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.531 ' O ' ' HG2' ' A' ' 49' ' ' LYS . . . -59.71 -54.79 34.66 Favored Glycine 0 C--O 1.242 0.639 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.488 -179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.449 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 57.6 mt -58.47 -50.6 73.16 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.664 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 6.2 m-85 -55.35 -51.01 68.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.365 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.09 -47.99 81.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.751 -0.658 . . . . 0.0 112.165 -176.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 45' ' ' GLY . 22.2 pttm -100.79 5.57 43.57 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 119.56 -0.856 . . . . 0.0 113.136 -174.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 46' ' ' LEU . . . -134.24 1.85 3.24 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' A' ' 47' ' ' PHE . 57.9 mt -84.99 -133.04 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 118.476 -1.29 . . . . 0.0 109.345 170.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 62.59 -13.16 0.07 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.507 ' H ' ' C ' ' A' ' 51' ' ' LEU . 18.5 m120 -128.2 3.99 5.8 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.575 ' CG2' ' HA ' ' A' ' 51' ' ' LEU . 61.5 t -95.88 103.03 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.154 -174.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -52.19 132.19 33.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.482 173.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.42 HD11 ' HB3' ' A' ' 14' ' ' LEU . 4.1 tp -45.04 -45.42 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -170.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.14 -26.01 57.93 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.364 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.0 t -65.49 -11.89 47.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.804 0.335 . . . . 0.0 110.492 -176.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 64.8 mt -57.69 -28.05 63.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.71 0.29 . . . . 0.0 110.675 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.3 tt -103.13 31.22 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.851 0.834 . . . . 0.0 110.926 -178.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.9 p -83.79 -177.45 6.69 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.966 173.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -78.15 48.37 0.73 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.718 0.294 . . . . 0.0 110.981 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.9 p -70.96 -34.09 54.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.084 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.98 64.03 4.34 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.741 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -129.35 152.55 48.78 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.902 0.382 . . . . 0.0 110.688 -178.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -87.36 72.03 2.59 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.893 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -163.6 165.61 36.91 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 121.1 -0.572 . . . . 0.0 111.988 -179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.02 -28.02 13.41 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 122.665 2.243 . . . . 0.0 112.839 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.468 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . . . -147.27 133.74 9.79 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.175 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 69' ' ' ALA . 2.1 Cg_endo -82.75 53.32 4.38 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.632 2.222 . . . . 0.0 112.219 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 65.78 -170.04 0.2 Allowed 'General case' 0 N--CA 1.463 0.187 0 O-C-N 123.538 0.524 . . . . 0.0 111.096 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 57.17 72.93 0.48 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.277 0.56 . . . . 0.0 111.872 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.56 38.3 3.17 Favored Glycine 0 C--O 1.229 -0.16 0 C-N-CA 120.854 -0.689 . . . . 0.0 111.587 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.38 159.43 15.01 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.48 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -122.93 117.81 28.42 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-O 120.786 0.327 . . . . 0.0 110.674 -178.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 24.0 Cg_exo -68.86 60.71 1.24 Allowed 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 123.804 3.003 . . . . 0.0 113.178 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -154.52 106.12 2.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.99 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -107.23 89.17 0.57 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.604 -176.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.6 165.03 11.13 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.005 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -78.92 -61.11 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.935 2.423 . . . . 0.0 112.207 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -140.78 90.6 9.59 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.801 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -50.47 126.2 17.24 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.144 2.563 . . . . 0.0 113.256 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.6 t -156.94 136.1 11.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.838 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.2 t -110.44 69.68 0.7 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.016 0.912 . . . . 0.0 110.221 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.04 98.99 1.03 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.822 -177.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 58.6 45.15 16.55 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.859 175.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -126.84 109.36 22.31 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.241 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -55.65 148.07 56.44 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.11 2.54 . . . . 0.0 112.463 176.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -113.04 8.52 18.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.398 0.618 . . . . 0.0 110.263 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -77.9 69.65 4.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.765 0.793 . . . . 0.0 110.646 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -87.75 174.78 8.19 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.902 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -71.91 110.23 6.28 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.392 -174.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -121.75 94.29 4.27 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.852 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.3 t -131.24 100.97 4.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.228 -178.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.8 -32.5 5.45 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.102 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.87 -73.86 0.1 Allowed 'General case' 0 C--N 1.332 -0.184 0 O-C-N 123.16 0.288 . . . . 0.0 111.743 -176.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt 64.09 172.44 0.18 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.38 0.61 . . . . 0.0 111.828 -175.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -145.55 150.05 35.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.771 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.496 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 1.1 pm0 -75.15 148.53 39.54 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.841 178.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.8 24.78 4.33 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.818 0.818 . . . . 0.0 111.398 178.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.3 m -108.35 127.27 53.73 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.91 -177.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -124.46 69.24 1.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.479 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 57.5 70.28 0.67 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.632 0.73 . . . . 0.0 111.955 176.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.4 p -128.1 139.1 52.7 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.117 -178.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -113.82 -165.45 1.0 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.105 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -60.52 -50.24 74.33 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.3 t70 58.25 78.09 0.26 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.683 0.754 . . . . 0.0 110.795 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 72.3 mtm -104.49 140.94 37.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.298 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -72.99 -26.04 72.11 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.606 -176.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -93.63 101.0 13.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.139 0.469 . . . . 0.0 110.5 176.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -76.17 1.93 58.26 Favored Glycine 0 CA--C 1.519 0.286 0 CA-C-N 115.791 -0.64 . . . . 0.0 113.341 -177.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.9 tp 59.67 65.47 1.14 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 121.453 0.644 . . . . 0.0 110.964 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -75.65 -33.34 60.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.201 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 . . . . . 0 C--O 1.247 0.938 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.749 178.424 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.619 ' HE3' ' O ' ' A' ' 14' ' ' LEU . 25.5 ptt? -132.38 166.51 21.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.013 -176.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 202' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' B' ' 201' ' ' MET . 20.9 mtm180 -176.54 -65.07 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 O-C-N 123.824 0.702 . . . . 0.0 109.942 171.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 203' ' ' TYR . . . . . 0.6 ' HB2' HG11 ' B' ' 242' ' ' VAL . 8.1 m-85 -89.58 -21.12 23.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.633 -174.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.58 ' O ' HD13 ' B' ' 208' ' ' LEU . 47.0 t -56.54 -65.36 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.63 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 205' ' ' ALA . . . . . 0.587 ' HA ' ' HB2' ' B' ' 208' ' ' LEU . . . -69.38 -6.56 30.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.215 -177.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 206' ' ' SER . . . . . 0.542 ' OG ' HG23 ' B' ' 223' ' ' ILE . 8.6 t -78.94 -42.44 26.93 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 207' ' ' TYR . . . . . 0.593 ' HD1' HD13 ' B' ' 251' ' ' ILE . 29.3 t80 -65.47 -39.18 91.66 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 172.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.587 ' HB2' ' HA ' ' B' ' 205' ' ' ALA . 9.1 mp -55.3 -51.11 67.77 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.416 173.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 209' ' ' LEU . . . . . 0.43 HD22 ' HB2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -56.51 -59.81 4.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.952 -178.354 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -60.75 -32.33 71.62 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -177.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 211' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -81.19 -32.0 33.73 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 122.015 -0.428 . . . . 0.0 111.308 178.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 212' ' ' LEU . . . . . 0.422 ' CD2' HG13 ' A' ' 4' ' ' VAL . 2.3 tm? -64.84 -43.12 94.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.718 177.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 213' ' ' GLY . . . . . 0.662 ' HA3' HG22 ' A' ' 37' ' ' VAL . . . -152.82 90.15 0.13 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.239 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 172.33 -62.91 0.14 Allowed Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 111.829 -0.508 . . . . 0.0 111.829 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 215' ' ' ASN . . . . . 0.455 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 56.4 t30 -161.4 142.61 11.37 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 216' ' ' SER . . . . . 0.408 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 8.6 m -64.4 -24.56 67.68 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.23 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 12.3 t -124.04 73.15 56.15 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.708 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 218' ' ' PRO . . . . . 0.53 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 57.9 Cg_exo -56.57 116.54 3.27 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.183 2.589 . . . . 0.0 112.438 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 83.4 p -82.84 162.21 21.7 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.048 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -54.91 -35.53 64.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.016 0.436 . . . . 0.0 110.332 177.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -68.76 -34.87 76.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.467 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -70.28 -43.71 69.88 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.359 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.542 HG23 ' OG ' ' B' ' 206' ' ' SER . 1.8 mp -64.85 -44.39 96.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 123.271 0.357 . . . . 0.0 110.085 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 224' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' B' ' 228' ' ' ASP . 26.7 tptp -55.56 -43.49 75.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.162 173.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -56.6 -51.25 69.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.077 178.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 0.447 HG23 HD21 ' A' ' 31' ' ' LEU . 1.1 mp -68.47 -35.47 70.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.771 -177.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 227' ' ' LEU . . . . . 0.414 ' CD1' ' HB ' ' B' ' 232' ' ' ILE . 0.2 OUTLIER -75.43 -35.11 61.02 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.549 0.69 . . . . 0.0 109.947 -179.431 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 228' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' B' ' 224' ' ' LYS . 5.2 t70 -76.19 -30.04 57.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.584 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 85.5 p -55.33 -45.3 76.38 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.556 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 59.4 t -75.84 -33.3 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 121.117 0.484 . . . . 0.0 110.663 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 103.98 38.83 2.62 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.862 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 232' ' ' ILE . . . . . 0.414 HG12 HG21 ' A' ' 21' ' ' VAL . 4.3 mt -109.38 135.41 48.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -66.54 118.33 10.0 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.655 0.74 . . . . 0.0 112.219 -173.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -117.5 135.55 53.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.03 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 235' ' ' ASP . . . . . 0.496 ' HB2' ' HB2' ' B' ' 238' ' ' ARG . 51.4 m-20 -86.43 115.21 23.79 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.185 -176.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 236' ' ' ASP . . . . . 0.598 ' O ' ' HG ' ' B' ' 239' ' ' LEU . 9.5 t70 -45.86 -60.53 2.18 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.131 0.894 . . . . 0.0 112.415 -170.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -63.92 -42.61 97.34 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.496 ' HB2' ' HB2' ' B' ' 235' ' ' ASP . 77.5 mtt180 -66.21 -36.0 81.92 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.15 -172.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 239' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' B' ' 236' ' ' ASP . 4.4 pp -68.44 -44.85 74.03 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.689 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 240' ' ' ASN . . . . . 0.499 ' N ' HD12 ' B' ' 239' ' ' LEU . 51.3 t30 -66.14 -33.21 75.26 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 121.34 -0.144 . . . . 0.0 110.759 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -62.15 -52.45 63.79 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-O 121.224 0.535 . . . . 0.0 110.315 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 242' ' ' VAL . . . . . 0.6 HG11 ' HB2' ' B' ' 203' ' ' TYR . 12.5 p -66.48 -37.84 80.45 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.654 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -176.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 243' ' ' ILE . . . . . 0.602 ' HA ' ' HB2' ' B' ' 246' ' ' LEU . 57.3 mt -66.6 -31.61 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.513 176.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 8.8 t -65.06 -33.69 76.63 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 175.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -86.65 -26.16 24.48 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.731 175.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 246' ' ' LEU . . . . . 0.602 ' HB2' ' HA ' ' B' ' 243' ' ' ILE . 9.5 mt -75.45 -19.5 59.42 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.666 0.386 . . . . 0.0 110.657 175.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -63.49 97.85 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.874 -173.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 175.66 -175.78 47.34 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.135 -177.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -85.89 0.68 52.47 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -79.62 -0.52 34.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.956 0.408 . . . . 0.0 110.797 -175.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.593 HD13 ' HD1' ' B' ' 207' ' ' TYR . 7.7 tp -61.72 -38.31 80.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.289 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -65.11 -34.91 79.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.106 0.479 . . . . 0.0 110.153 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -67.58 -45.45 75.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.632 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 254' ' ' VAL . . . . . 0.533 HG22 ' HA ' ' B' ' 251' ' ' ILE . 26.0 m -74.64 -10.94 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.2 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 255' ' ' ILE . . . . . 0.496 HG12 ' O ' ' B' ' 251' ' ' ILE . 24.0 mm -78.25 -53.15 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.003 0.43 . . . . 0.0 109.881 168.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -63.05 -42.41 99.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.328 -176.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -119.51 56.99 0.92 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.585 0.707 . . . . 0.0 109.887 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -105.79 -99.36 2.6 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.034 177.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 259' ' ' ILE . . . . . 0.441 ' O ' ' HG ' ' B' ' 262' ' ' LEU . 23.4 mt 20.25 -88.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.998 1.319 . . . . 0.0 113.334 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 48.99 -118.43 5.04 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-O 121.547 0.526 . . . . 0.0 114.328 170.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.24 54.47 1.45 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 262' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' B' ' 259' ' ' ILE . 8.4 mt -54.62 -33.63 60.81 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.318 -173.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -58.86 -52.24 66.57 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.718 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 19.5 t 72.07 129.7 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 O-C-N 124.243 0.965 . . . . 0.0 110.249 -175.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 6.3 m -65.2 140.35 97.88 Favored Pre-proline 0 N--CA 1.448 -0.575 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.684 -177.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.85 3.63 5.88 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.342 2.695 . . . . 0.0 113.273 -174.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . 41.89 63.03 1.42 Allowed 'General case' 0 N--CA 1.466 0.345 0 O-C-N 124.098 0.874 . . . . 0.0 112.347 173.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 115.15 -48.35 0.95 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.402 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . 113.02 51.05 0.53 Allowed Glycine 0 N--CA 1.454 -0.143 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.53 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -139.62 73.66 1.44 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.197 0.522 . . . . 0.0 110.529 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 11.0 t -121.07 147.68 24.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.267 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . 60.18 45.92 11.05 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.794 0.807 . . . . 0.0 111.866 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 24.7 t -109.8 79.75 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.462 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 12.9 m -139.69 122.6 16.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.944 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . 56.38 48.98 15.91 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.912 0.757 . . . . 0.0 111.394 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -81.77 117.13 67.1 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.778 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 277' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -71.34 81.44 1.22 Allowed 'Trans proline' 0 CA--C 1.515 -0.44 0 C-N-CA 123.107 2.538 . . . . 0.0 111.765 178.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -139.73 31.49 2.3 Favored Glycine 0 N--CA 1.436 -1.357 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.348 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 25.1 m -100.22 153.59 19.15 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 177.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 64.96 -169.68 0.2 Allowed 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 124.116 0.885 . . . . 0.0 111.466 174.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . 56.59 75.29 0.59 Allowed Pre-proline 0 N--CA 1.467 0.381 0 O-C-N 123.623 0.577 . . . . 0.0 111.226 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.53 110.88 1.34 Allowed 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.894 2.396 . . . . 0.0 113.6 -173.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . 67.52 162.72 0.19 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.514 174.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -114.26 18.92 16.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.618 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -132.83 19.51 4.42 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.935 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.65 114.38 13.0 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.21 0.529 . . . . 0.0 111.22 -178.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -142.67 132.5 12.15 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.616 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -62.53 102.66 0.29 Allowed 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.965 2.443 . . . . 0.0 112.665 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -126.99 72.48 1.36 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.182 0.515 . . . . 0.0 110.911 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -85.59 129.57 34.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.753 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -147.05 68.0 1.15 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.355 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -67.6 -55.03 14.99 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.335 -177.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -75.83 78.47 2.75 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.585 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -144.44 20.25 1.7 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -126.88 117.87 23.44 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 122.324 -0.235 . . . . 0.0 110.487 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -158.97 99.92 1.55 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.929 0.395 . . . . 0.0 110.751 176.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -97.31 68.58 2.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 171.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -52.87 163.78 0.45 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.564 178.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? 65.48 34.57 7.89 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.321 0.581 . . . . 0.0 109.693 -176.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -72.71 -41.08 65.64 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.55 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -54.33 121.9 9.25 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.361 177.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 9.8 p -76.86 81.98 3.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.896 0.379 . . . . 0.0 111.286 -177.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 67.93 178.09 0.24 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.594 177.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.1 109.88 0.73 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.295 0.569 . . . . 0.0 111.335 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 24.8 p -103.55 119.01 38.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.989 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -84.03 -12.5 55.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.62 0.724 . . . . 0.0 109.869 176.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 307' ' ' ASP . . . . . 0.508 ' CG ' ' H ' ' B' ' 308' ' ' ASP . 12.4 t70 63.67 -159.04 0.31 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.829 175.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 308' ' ' ASP . . . . . 0.508 ' H ' ' CG ' ' B' ' 307' ' ' ASP . 27.1 t70 -142.46 26.92 1.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 122.079 0.942 . . . . 0.0 109.243 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 22.6 ptt? -86.24 -11.66 51.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.671 176.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 111.58 88.57 1.82 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.792 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 100.0 m-85 62.69 76.67 0.36 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.95 0.405 . . . . 0.0 111.745 175.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . -92.64 35.73 3.95 Favored Glycine 0 N--CA 1.453 -0.19 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 313' ' ' LEU . . . . . 0.516 ' O ' HD13 ' B' ' 313' ' ' LEU . 2.6 tm? -72.24 -14.54 61.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.536 0.684 . . . . 0.0 109.287 178.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 314' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -71.94 -81.25 0.05 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.108 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.218 -0.896 . . . . 0.0 109.382 178.871 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mmt . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.94 -73.52 0.62 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.787 0.327 . . . . 0.0 110.365 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.593 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 5.6 m -78.65 54.62 1.52 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.543 177.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.439 HG23 ' HB2' ' B' ' 212' ' ' LEU . 13.3 p -71.68 -29.79 35.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.246 0.546 . . . . 0.0 109.753 -174.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.512 ' HB3' HG23 ' A' ' 39' ' ' VAL . 51.7 m -64.62 -52.06 59.39 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.944 176.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.427 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 35.6 tt0 -57.85 -45.45 86.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.04 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 3' ' ' SER . 82.6 mt -54.03 -53.78 48.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.356 176.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.07 -55.34 24.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.895 -177.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 21.6 p -67.43 -31.22 71.25 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.73 -176.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.553 HG13 HD23 ' A' ' 59' ' ' LEU . 0.9 OUTLIER -77.65 -37.64 24.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.921 0.391 . . . . 0.0 111.068 -176.892 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.636 ' O ' HG12 ' A' ' 15' ' ' ILE . 23.1 m-85 -74.61 -26.37 59.86 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.7 t -69.56 -44.78 70.16 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 172.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.94 -40.29 60.58 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.387 171.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.799 ' O ' ' HE1' ' B' ' 201' ' ' MET . 97.3 mt -60.48 -59.97 4.56 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 173.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.636 HG12 ' O ' ' A' ' 11' ' ' TYR . 36.3 mm -46.09 -34.4 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.3 mt -115.13 7.26 15.34 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -174.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -48.25 -62.47 1.47 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -120.73 -82.12 0.64 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.356 -176.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.584 ' OD2' ' HD2' ' B' ' 202' ' ' ARG . 5.2 t0 47.37 -152.59 0.09 Allowed 'General case' 0 CA--C 1.536 0.431 0 O-C-N 123.628 0.58 . . . . 0.0 111.28 178.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -112.05 22.52 14.74 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 168.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.561 HG11 HD11 ' B' ' 232' ' ' ILE . 4.1 p -128.41 158.67 40.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.59 -177.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.1 p -105.49 130.86 53.48 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 121.241 -0.183 . . . . 0.0 111.332 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.548 HG21 HD23 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -65.38 105.11 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.408 0.623 . . . . 0.0 110.52 175.562 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.419 ' OG1' ' HG2' ' A' ' 27' ' ' LYS . 22.3 p -133.91 168.48 18.69 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.379 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 26' ' ' ASP . 9.1 pt-20 -48.18 -48.53 34.56 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 123.659 0.599 . . . . 0.0 111.648 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.435 ' N ' ' HG3' ' A' ' 25' ' ' GLU . 7.5 p-10 -68.31 -27.84 66.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.251 -175.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.419 ' HG2' ' OG1' ' A' ' 24' ' ' THR . 46.2 mmtm -78.21 -45.1 23.93 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -176.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.511 HG23 HD13 ' A' ' 32' ' ' ILE . 6.5 mt -67.48 -41.7 86.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.779 176.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -55.57 -45.85 77.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.705 175.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.81 -49.6 72.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.324 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.407 ' CD1' ' HG ' ' B' ' 209' ' ' LEU . 0.2 OUTLIER -65.69 -38.6 89.7 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.211 0.529 . . . . 0.0 110.24 -177.276 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.511 HD13 HG23 ' A' ' 28' ' ' ILE . 1.3 mp -63.97 -35.86 74.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.255 176.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.453 ' NZ ' ' HB3' ' A' ' 33' ' ' LYS . 6.1 ttpm? -76.02 -21.69 56.57 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.919 0.39 . . . . 0.0 110.351 175.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.51 -48.71 21.35 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.659 ' HB3' HD12 ' B' ' 209' ' ' LEU . . . -143.27 8.27 1.6 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.38 89.93 1.55 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.115 -176.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.2 p -50.17 -50.8 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -175.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -161.63 126.52 3.47 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.946 0.403 . . . . 0.0 111.246 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.512 HG23 ' HB3' ' A' ' 5' ' ' SER . 7.2 p -139.17 127.53 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.431 173.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 24.8 mm-40 -57.07 125.62 70.8 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.029 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 40' ' ' GLU . 50.3 Cg_exo -52.99 -11.12 1.3 Allowed 'Trans proline' 0 N--CA 1.481 0.792 0 C-N-CA 124.042 3.162 . . . . 0.0 115.046 -168.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.571 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 0.7 OUTLIER -80.12 -28.18 39.02 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -174.94 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.428 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 98.7 m95 -64.68 -60.48 8.21 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.293 175.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.428 ' CD ' ' HB2' ' A' ' 43' ' ' TRP . 19.3 Cg_endo -59.74 -34.45 96.04 Favored 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 121.835 1.69 . . . . 0.0 111.939 178.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.91 -49.17 81.53 Favored Glycine 0 C--O 1.241 0.562 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.253 176.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 42' ' ' PHE . 89.8 mt -64.08 -47.18 81.09 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -60.72 -47.02 88.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.843 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.72 -37.52 86.64 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.608 -176.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -91.49 -26.76 18.64 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 119.8 -0.76 . . . . 0.0 113.033 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -116.11 -20.13 10.0 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -171.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.76 ' HA ' HG23 ' A' ' 54' ' ' VAL . 2.2 tp -83.99 -133.87 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.425 ' HA ' HG13 ' A' ' 23' ' ' VAL . . . 58.08 3.16 0.22 Allowed 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -176.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -145.57 -44.15 0.21 Allowed 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -177.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.76 HG23 ' HA ' ' A' ' 51' ' ' LEU . 48.7 t -40.91 112.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 114.0 -1.454 . . . . 0.0 110.745 172.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -54.67 140.47 35.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.071 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.602 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 3.4 tp -43.85 -51.94 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 124.043 0.84 . . . . 0.0 112.903 -173.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.28 -30.89 75.23 Favored Glycine 0 C--O 1.243 0.688 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.661 -176.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.5 t -65.25 -11.55 42.38 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -176.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.602 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 1.7 mp -43.06 -48.38 6.13 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.164 170.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.583 HD11 HG21 ' B' ' 259' ' ' ILE . 24.7 mm -110.05 44.46 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.628 0.728 . . . . 0.0 109.82 -178.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 48.9 t -119.58 -36.47 3.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.117 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -100.36 4.0 43.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.43 -177.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.1 p -62.7 -29.95 48.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 121.015 0.436 . . . . 0.0 111.299 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.76 -78.13 1.98 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.141 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -164.84 -53.78 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.845 0.355 . . . . 0.0 110.962 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.37 -125.08 8.15 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.464 -0.655 . . . . 0.0 111.464 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -167.14 156.29 28.01 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.828 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -86.64 -68.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.658 2.239 . . . . 0.0 112.558 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.63 96.63 2.77 Favored Pre-proline 0 N--CA 1.452 -0.326 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.1 178.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.72 169.69 18.28 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.61 2.207 . . . . 0.0 112.399 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 69.58 -71.68 0.12 Allowed 'General case' 0 N--CA 1.469 0.517 0 O-C-N 123.726 0.641 . . . . 0.0 111.503 -178.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 56.49 61.94 2.5 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.196 0.522 . . . . 0.0 111.286 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.05 -68.14 3.54 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.856 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 55.07 48.53 19.53 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 122.874 0.469 . . . . 0.0 111.716 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 68.17 117.03 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.861 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -48.26 131.94 23.09 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 124.12 3.213 . . . . 0.0 113.154 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.31 -177.22 3.96 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.271 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.44 164.97 40.74 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.94 -0.647 . . . . 0.0 113.075 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 160.95 -168.44 36.3 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.68 -0.568 . . . . 0.0 111.68 177.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.83 155.54 39.18 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 123.133 2.556 . . . . 0.0 111.981 178.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . . . -84.71 141.78 38.92 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.214 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 81' ' ' ALA . 49.1 Cg_exo -60.53 78.19 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.467 2.778 . . . . 0.0 113.949 -179.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.0 m 71.11 140.61 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.731 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.4 p -84.36 52.52 2.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.653 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -91.16 -39.94 11.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.047 177.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 60.39 -166.39 0.2 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.623 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.15 86.68 5.54 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.549 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -55.94 104.15 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.505 2.803 . . . . 0.0 112.671 177.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.48 78.98 9.72 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.932 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -82.08 128.92 34.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.72 175.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -94.62 -168.0 1.75 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.071 -175.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.439 ' HE2' ' HA ' ' A' ' 92' ' ' LYS . 12.0 mmpt? -71.51 -65.42 0.76 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.169 -175.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -141.41 139.8 33.51 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.8 p -137.56 126.47 34.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.148 0.499 . . . . 0.0 110.8 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -159.29 146.47 17.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.676 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 63.62 82.18 0.19 Allowed 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.724 0.64 . . . . 0.0 111.732 176.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -64.96 146.39 55.05 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.877 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -84.45 150.41 25.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.946 177.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -146.24 148.31 32.34 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 66.49 175.96 0.23 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.707 0.629 . . . . 0.0 111.399 -172.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.5 p -144.0 19.06 1.78 Allowed 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.568 0.699 . . . . 0.0 112.657 -171.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -106.47 104.91 14.72 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.858 -176.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -85.31 54.53 3.14 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.376 -177.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.484 ' HB3' HD12 ' A' ' 112' ' ' LEU . 2.0 p -95.09 27.39 3.23 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.938 -178.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.4 t70 53.15 42.77 32.17 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.619 -178.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.0 t0 66.53 112.63 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.345 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -70.99 71.51 0.55 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.045 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 88.7 mmm -83.15 65.32 8.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.581 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.64 -25.77 25.6 Favored Glycine 0 C--O 1.227 -0.287 0 C-N-CA 120.589 -0.815 . . . . 0.0 114.119 170.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -94.57 -164.22 1.14 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.191 0.495 . . . . 0.0 110.945 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -117.66 -158.86 11.16 Favored Glycine 0 N--CA 1.436 -1.334 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.387 178.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.484 HD12 ' HB3' ' A' ' 104' ' ' SER . 18.0 tp -100.12 68.08 1.43 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 120.786 0.327 . . . . 0.0 111.575 -171.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -145.7 49.88 1.21 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 177.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.8 t70 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.356 -0.83 . . . . 0.0 110.196 178.079 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.799 ' HE1' ' O ' ' A' ' 14' ' ' LEU . 5.1 ppp? -135.82 -32.45 0.89 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -177.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 202' ' ' ARG . . . . . 0.584 ' HD2' ' OD2' ' A' ' 19' ' ' ASP . 49.6 ttp180 -74.95 1.29 13.18 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.039 0.447 . . . . 0.0 111.857 -172.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 203' ' ' TYR . . . . . 0.419 ' CD1' HD23 ' B' ' 239' ' ' LEU . 29.3 m-85 -126.07 -36.81 2.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.305 0.574 . . . . 0.0 110.647 -178.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.639 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 38.7 t -65.24 -44.54 95.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.235 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 205' ' ' ALA . . . . . 0.545 ' HA ' HD12 ' B' ' 208' ' ' LEU . . . -72.74 -20.19 61.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.901 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 206' ' ' SER . . . . . 0.497 ' CB ' HG23 ' B' ' 223' ' ' ILE . 4.0 m -70.62 -42.42 70.93 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 173.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 207' ' ' TYR . . . . . 0.653 ' CE1' HD11 ' B' ' 251' ' ' ILE . 20.7 t80 -60.42 -41.58 94.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.163 174.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 75.7 mt -62.59 -42.06 99.34 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.814 177.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 209' ' ' LEU . . . . . 0.659 HD12 ' HB3' ' A' ' 35' ' ' ALA . 0.6 OUTLIER -55.8 -54.52 43.44 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.741 177.767 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -67.15 -27.33 67.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.376 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 211' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -65.81 -50.04 66.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.16 177.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 212' ' ' LEU . . . . . 0.439 ' HB2' HG23 ' A' ' 4' ' ' VAL . 4.1 pp -73.78 -24.85 59.9 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.727 0.299 . . . . 0.0 110.783 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.91 -13.68 53.19 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 116.005 -0.543 . . . . 0.0 113.265 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 118.65 35.48 0.98 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.886 177.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 215' ' ' ASN . . . . . 0.647 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 33.9 t30 -152.42 114.83 4.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.912 0.387 . . . . 0.0 110.31 176.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 216' ' ' SER . . . . . 0.49 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 8.1 m -76.28 -11.24 59.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.176 -178.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 217' ' ' SER . . . . . 0.406 ' N ' ' HD3' ' B' ' 218' ' ' PRO . 26.4 t -123.55 63.48 26.78 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.674 -176.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 218' ' ' PRO . . . . . 0.49 ' HD3' ' C ' ' B' ' 216' ' ' SER . 52.4 Cg_exo -60.22 144.96 99.48 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.029 2.486 . . . . 0.0 111.88 175.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 219' ' ' SER . . . . . 0.414 ' O ' HD13 ' B' ' 223' ' ' ILE . 21.5 m -129.51 168.53 16.23 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.794 178.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -47.76 -40.37 20.47 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.922 0.392 . . . . 0.0 111.659 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 221' ' ' LYS . . . . . 0.581 ' HB3' ' HZ3' ' B' ' 221' ' ' LYS . 4.2 ttpm? -58.1 -49.99 75.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.727 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.03 -39.4 69.15 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.281 -173.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.497 HG23 ' CB ' ' B' ' 206' ' ' SER . 1.7 mp -64.55 -40.28 88.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.584 176.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -56.25 -45.65 79.95 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.198 173.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -58.9 -43.98 91.11 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.151 0.5 . . . . 0.0 111.337 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 0.647 HD11 ' HB2' ' A' ' 35' ' ' ALA . 1.3 mp -63.57 -40.23 88.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.156 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 76.7 mt -76.54 -19.28 58.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.199 0.523 . . . . 0.0 110.581 176.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -73.84 -36.51 64.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.297 178.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 94.6 p -55.43 -40.96 72.17 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.634 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 3.3 m -90.02 -14.42 9.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 111.9 0.334 . . . . 0.0 111.9 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 77.7 32.84 44.51 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.586 175.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 232' ' ' ILE . . . . . 0.561 HD11 HG11 ' A' ' 21' ' ' VAL . 61.6 mt -90.48 130.43 39.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 177.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -67.01 100.22 0.72 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.318 0.58 . . . . 0.0 110.787 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -89.78 111.69 22.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.22 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 235' ' ' ASP . . . . . 0.466 ' HB2' ' HG2' ' B' ' 238' ' ' ARG . 5.3 m-20 -53.56 104.52 0.1 Allowed 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.727 0.642 . . . . 0.0 110.607 177.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -54.95 -38.14 67.35 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -174.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 237' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' B' ' 241' ' ' LYS . 15.9 t70 -55.81 -68.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.052 0.453 . . . . 0.0 111.276 178.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.481 ' HA ' ' HB2' ' B' ' 241' ' ' LYS . 13.7 ptp180 -68.76 -17.02 63.97 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.821 0.343 . . . . 0.0 111.039 -174.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 239' ' ' LEU . . . . . 0.455 HD13 HD12 ' B' ' 243' ' ' ILE . 3.3 tm? -61.22 -67.94 0.36 Allowed 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.854 176.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -75.1 -16.25 60.56 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.369 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 241' ' ' LYS . . . . . 0.481 ' HB2' ' HA ' ' B' ' 238' ' ' ARG . 29.9 mmtp -64.07 -56.02 17.95 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.257 171.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 242' ' ' VAL . . . . . 0.51 ' O ' ' HB3' ' B' ' 246' ' ' LEU . 34.7 m -67.26 -34.98 72.6 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.81 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -175.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 243' ' ' ILE . . . . . 0.455 HD12 HD13 ' B' ' 239' ' ' LEU . 58.4 mt -74.03 -23.87 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.473 178.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 25.3 t -72.0 -31.66 66.45 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 172.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -83.1 -22.7 33.33 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.35 0.595 . . . . 0.0 110.454 173.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 246' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' B' ' 246' ' ' LEU . 9.3 tp -116.11 71.44 0.78 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.466 -174.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -125.3 80.91 1.92 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.145 0.498 . . . . 0.0 111.949 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 87.04 -15.96 50.36 Favored Glycine 0 CA--C 1.52 0.406 0 CA-C-N 115.773 -0.649 . . . . 0.0 113.412 175.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -67.46 110.21 3.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.995 0.426 . . . . 0.0 111.524 -176.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 60.27 42.22 15.39 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.808 174.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.653 HD11 ' CE1' ' B' ' 207' ' ' TYR . 2.5 mm -58.25 -53.07 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -176.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -67.42 -26.18 66.29 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.378 -176.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -72.91 -46.03 54.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.4 177.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 254' ' ' VAL . . . . . . . . . . . . . 22.9 m -68.28 -20.57 25.67 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.989 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 255' ' ' ILE . . . . . 0.405 ' HA ' ' OH ' ' A' ' 11' ' ' TYR . 54.5 mt -74.04 -56.02 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-O 121.026 0.441 . . . . 0.0 110.759 172.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -67.98 -38.4 82.65 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -173.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 17.0 tp60 -101.54 -14.73 17.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.87 0.367 . . . . 0.0 111.701 -174.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 258' ' ' GLY . . . . . 0.583 ' O ' HD11 ' B' ' 262' ' ' LEU . . . -105.63 56.82 0.51 Allowed Glycine 0 C--O 1.227 -0.298 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.275 -172.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 259' ' ' ILE . . . . . 0.583 HG21 HD11 ' A' ' 60' ' ' ILE . 1.3 mt -85.2 -68.85 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.893 0.378 . . . . 0.0 111.668 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -116.03 25.28 9.51 Favored Glycine 0 C--O 1.227 -0.317 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.552 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -102.82 6.94 39.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.615 0.721 . . . . 0.0 110.602 -178.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 262' ' ' LEU . . . . . 0.583 HD11 ' O ' ' B' ' 258' ' ' GLY . 5.0 mp -84.97 -62.93 1.42 Allowed 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 122.28 1.038 . . . . 0.0 109.883 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 263' ' ' ALA . . . . . 0.531 ' HB2' ' CE ' ' B' ' 201' ' ' MET . . . -80.59 85.41 6.0 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 113.314 -1.766 . . . . 0.0 111.431 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 22.7 t -132.08 129.24 39.71 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.015 177.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 6.0 p -144.21 123.7 7.27 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.918 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.22 96.43 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.676 2.251 . . . . 0.0 112.787 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . 70.22 -47.76 0.63 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.186 0.994 . . . . 0.0 112.704 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 136.66 -15.52 3.84 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . 123.04 157.7 9.97 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -118.68 131.51 56.16 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 2.2 t -104.86 125.54 59.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -90.03 81.96 6.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.183 0.516 . . . . 0.0 110.804 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 59.9 t -105.84 109.52 28.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.132 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 34.9 t -132.12 136.31 47.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.054 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -135.86 133.17 37.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.44 -178.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 276' ' ' ALA . . . . . 0.486 ' HA ' ' HD3' ' B' ' 277' ' ' PRO . . . -132.99 128.47 20.65 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.662 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 277' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' B' ' 276' ' ' ALA . 17.4 Cg_exo -67.58 148.23 77.99 Favored 'Trans proline' 0 CA--C 1.517 -0.352 0 C-N-CA 122.939 2.426 . . . . 0.0 111.779 176.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -60.44 128.45 45.61 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.481 -178.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 2.4 p -79.96 161.56 25.42 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 71.71 174.8 0.29 Allowed 'General case' 0 N--CA 1.46 0.071 0 O-C-N 124.398 1.061 . . . . 0.0 111.928 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -147.99 109.24 3.74 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.44 -178.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -85.09 160.75 11.59 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.868 2.379 . . . . 0.0 112.428 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -126.99 113.31 16.31 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.815 0.34 . . . . 0.0 110.645 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -91.06 66.47 5.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.133 -177.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 152.55 179.66 28.3 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.561 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 21.1 p -157.84 167.75 29.12 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -139.69 112.85 7.74 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.908 -178.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.57 113.01 3.69 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.487 2.125 . . . . 0.0 111.596 178.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -122.24 52.18 1.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.119 178.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -102.15 -76.33 0.58 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.271 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -173.47 -28.55 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.37 0.605 . . . . 0.0 109.916 -175.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 66.88 20.49 10.55 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 114.393 -1.276 . . . . 0.0 112.202 171.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -126.53 -132.17 0.24 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.723 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -69.89 160.49 31.73 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -140.46 82.25 1.85 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.293 0.568 . . . . 0.0 111.749 -177.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -142.13 151.53 42.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.503 178.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -84.01 73.94 10.3 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.392 0.615 . . . . 0.0 111.279 -176.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -139.6 134.6 32.32 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.354 175.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -62.53 128.28 35.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.909 0.385 . . . . 0.0 110.861 177.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -55.36 114.31 1.76 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.6 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 62.5 93.34 0.05 Allowed 'General case' 0 N--CA 1.464 0.267 0 O-C-N 124.122 0.889 . . . . 0.0 110.792 -172.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 9.5 t -90.34 -175.77 4.6 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.634 -176.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -75.51 -82.55 0.07 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.751 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 304' ' ' GLU . . . . . 0.442 ' HG2' ' H ' ' B' ' 305' ' ' SER . 26.0 tt0 63.54 169.87 0.16 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.287 0.635 . . . . 0.0 111.488 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 305' ' ' SER . . . . . 0.442 ' H ' ' HG2' ' B' ' 304' ' ' GLU . 73.2 m 65.61 -178.17 0.19 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.924 -178.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -136.5 27.45 3.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.162 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -81.53 78.01 8.33 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.062 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -83.07 82.35 8.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.567 0.699 . . . . 0.0 111.064 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 23.0 mmt 55.82 28.06 11.81 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.089 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 66.01 27.89 73.22 Favored Glycine 0 CA--C 1.508 -0.372 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.671 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 62.54 19.54 11.31 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.284 0.634 . . . . 0.0 111.723 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . 135.9 125.9 2.53 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.219 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 20.3 mt -77.2 47.98 0.59 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.345 0.593 . . . . 0.0 110.083 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 314' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -131.22 -49.65 1.01 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.837 -173.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 25.0 t70 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.993 179.143 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.2 ttm . . . . . 0 N--CA 1.478 0.962 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.53 -67.46 0.54 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -176.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.611 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 5.8 p -78.97 62.55 3.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.997 -174.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.504 ' HA ' HD12 ' A' ' 7' ' ' LEU . 21.9 t -66.09 -31.02 51.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.213 0.53 . . . . 0.0 110.005 -174.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.508 ' HB3' HG23 ' A' ' 39' ' ' VAL . 1.1 m -61.76 -55.54 29.05 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.417 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -61.15 -42.06 97.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.97 178.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 3' ' ' SER . 96.0 mt -56.15 -55.61 30.97 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.619 178.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.26 -49.73 76.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.086 -178.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.427 ' HA ' HD11 ' A' ' 32' ' ' ILE . 24.1 t -66.15 -38.36 87.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.291 -176.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.419 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 1.3 tp -75.16 -39.56 43.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.932 0.396 . . . . 0.0 110.998 -177.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.741 ' HD1' HD21 ' A' ' 14' ' ' LEU . 20.1 m-85 -74.91 -19.31 60.19 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.2 t -70.94 -50.97 28.84 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 170.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.452 ' HB3' HD21 ' A' ' 59' ' ' LEU . . . -49.43 -48.21 47.57 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.109 175.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.909 HD22 HD12 ' B' ' 262' ' ' LEU . 4.2 pp -81.09 -18.16 47.49 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 11' ' ' TYR . 2.8 mt -62.14 -41.98 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.274 0.559 . . . . 0.0 109.543 168.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 23' ' ' VAL . 57.7 mt -80.82 -27.56 36.5 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.183 -178.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.534 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 10.2 m80 -79.78 64.73 4.72 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 177.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' B' ' 201' ' ' MET . 15.9 t0 -129.93 -51.35 1.13 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 171.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.49 ' OD1' HG21 ' B' ' 232' ' ' ILE . 8.8 m-20 -102.32 10.67 38.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.406 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 54.18 51.26 14.78 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.398 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -87.11 162.12 2.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.214 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.484 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 10.6 p -56.31 110.98 0.85 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.31 0.576 . . . . 0.0 112.246 -175.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.431 ' HA ' HD13 ' A' ' 16' ' ' LEU . 33.9 m -84.87 47.35 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.556 0.693 . . . . 0.0 110.935 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.414 HG22 ' HG2' ' A' ' 27' ' ' LYS . 10.1 t -87.31 169.32 12.39 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.071 -171.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -52.93 -42.26 65.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.903 -177.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -49.82 -45.58 50.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.677 177.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 22' ' ' THR . 66.4 mmtt -76.48 -48.92 17.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.945 -173.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.3 mt -62.45 -46.1 97.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.019 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -60.37 -46.09 91.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.902 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.65 ' HB3' HG11 ' B' ' 230' ' ' VAL . . . -71.21 -34.37 70.78 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.708 HD11 HG23 ' B' ' 226' ' ' ILE . 0.1 OUTLIER -70.69 -46.02 63.93 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.712 0.768 . . . . 0.0 109.478 178.568 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.427 HD11 ' HA ' ' A' ' 9' ' ' CYS . 1.5 mp -58.65 -37.3 64.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.53 175.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -74.39 -31.38 62.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.177 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.34 -45.4 91.48 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.471 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.579 ' HA ' HD11 ' B' ' 226' ' ' ILE . . . -76.32 -31.82 58.36 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.169 177.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.07 16.48 47.36 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.27 175.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.568 ' CG2' ' HA2' ' B' ' 213' ' ' GLY . 53.1 t -95.19 138.98 19.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.822 0.344 . . . . 0.0 110.71 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -93.41 97.47 10.59 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.873 0.368 . . . . 0.0 111.461 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.508 HG23 ' HB3' ' A' ' 5' ' ' SER . 7.7 p -97.09 136.68 27.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 171.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -59.92 126.24 82.85 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.65 -5.65 0.48 Allowed 'Trans proline' 0 N--CA 1.482 0.815 0 C-N-CA 124.053 3.169 . . . . 0.0 114.146 -172.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.64 -36.36 80.63 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.64 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 94.6 m95 -71.69 -56.6 4.78 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.995 177.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.64 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 74.0 Cg_exo -51.12 -43.77 46.42 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.093 1.862 . . . . 0.0 112.334 176.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.88 -57.1 15.18 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.143 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 45.5 tp -57.37 -43.61 83.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.659 0.266 . . . . 0.0 110.348 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.585 ' HA ' HD13 ' A' ' 51' ' ' LEU . 3.0 m-85 -59.97 -49.73 76.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.295 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.42 -34.27 76.44 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.043 -178.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -97.49 -1.71 43.54 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.86 -16.55 7.07 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.585 HD13 ' HA ' ' A' ' 47' ' ' PHE . 9.4 mp -84.75 -131.77 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 O-C-N 121.945 -0.472 . . . . 0.0 110.098 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 61.02 2.22 0.54 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.502 0.721 . . . . 0.0 112.887 -178.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.495 ' H ' HG12 ' A' ' 54' ' ' VAL . 87.5 m-20 -139.49 -58.49 0.58 Allowed 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.542 HG11 ' HG ' ' A' ' 51' ' ' LEU . 2.5 p -1.01 96.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 113.217 -1.81 . . . . 0.0 114.48 164.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -59.38 128.75 38.65 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.205 169.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 5.1 tp -47.73 -45.25 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -169.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.414 ' O ' HG22 ' A' ' 60' ' ' ILE . . . -58.85 -37.38 90.52 Favored Glycine 0 C--O 1.239 0.407 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.595 -177.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.9 m -61.57 -11.01 9.38 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.474 -0.363 . . . . 0.0 111.599 -178.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 13' ' ' ALA . 9.2 tp -63.04 -24.86 68.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.802 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 60' ' ' ILE . 11.0 tt -99.86 22.43 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 121.991 0.901 . . . . 0.0 110.301 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 81.8 m -140.94 -62.38 0.48 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.16 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -101.1 66.33 1.13 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.978 0.418 . . . . 0.0 110.701 -176.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.1 m -62.42 -9.29 3.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.137 177.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -84.58 -23.65 49.61 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.616 178.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -179.09 -71.82 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.95 0.405 . . . . 0.0 111.222 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.5 -135.18 11.37 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.504 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -158.2 150.37 21.13 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -88.81 100.29 0.38 Allowed 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.882 2.388 . . . . 0.0 113.331 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.02 68.36 28.02 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.952 0.406 . . . . 0.0 110.756 174.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -82.6 104.39 1.31 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.599 2.199 . . . . 0.0 112.797 -175.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.06 -36.78 9.99 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.356 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 70.35 12.37 7.53 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.251 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 106.03 167.62 23.19 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.52 176.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -100.25 84.73 2.87 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.135 0.493 . . . . 0.0 110.276 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.488 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -114.88 141.52 26.98 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.804 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 26.5 Cg_exo -68.1 76.12 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.707 2.938 . . . . 0.0 113.108 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.06 125.43 29.78 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.982 0.42 . . . . 0.0 110.891 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.93 167.1 15.1 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.1 149.55 17.97 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.369 -0.92 . . . . 0.0 112.367 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -77.12 -40.33 0.48 Allowed 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.822 2.348 . . . . 0.0 112.967 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 52.27 75.57 0.63 Allowed Pre-proline 0 N--CA 1.466 0.364 0 O-C-N 123.287 0.367 . . . . 0.0 110.887 -175.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -50.01 101.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.358 2.705 . . . . 0.0 113.132 -176.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.2 m -135.19 84.3 2.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.544 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.0 t -155.22 162.33 40.95 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.353 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 56.55 40.35 29.49 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.119 0.485 . . . . 0.0 110.963 -177.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.473 ' O ' ' HD3' ' A' ' 88' ' ' PRO . . . -56.93 134.91 55.96 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.575 -177.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -110.9 96.04 27.24 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.715 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 86' ' ' ALA . 45.8 Cg_exo -64.16 165.9 18.2 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.137 2.558 . . . . 0.0 112.42 175.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.14 25.96 3.98 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 53.64 73.54 0.37 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.532 0.682 . . . . 0.0 111.948 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -103.66 -176.27 3.04 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.608 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 61.7 mttp 65.0 102.64 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 O-C-N 123.818 0.699 . . . . 0.0 110.856 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -79.8 75.55 6.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.229 0.537 . . . . 0.0 111.282 -177.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.4 t -113.84 114.75 47.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.349 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -128.28 -79.91 0.58 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.892 0.377 . . . . 0.0 110.924 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -109.07 -47.11 3.48 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.249 0.547 . . . . 0.0 110.789 -176.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -120.97 146.96 46.11 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.413 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -88.74 170.07 11.1 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -44.06 105.63 0.06 Allowed 'General case' 0 C--O 1.233 0.228 0 O-C-N 123.248 0.343 . . . . 0.0 111.046 177.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -69.01 133.98 48.86 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 120.938 0.399 . . . . 0.0 110.522 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.4 m -79.46 74.33 6.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.712 -174.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -90.84 166.56 13.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.571 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 39.96 43.99 1.35 Allowed 'General case' 0 N--CA 1.474 0.726 0 O-C-N 124.466 1.104 . . . . 0.0 113.123 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.3 t -125.59 161.11 27.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.483 -177.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -134.11 91.21 2.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.284 0.564 . . . . 0.0 109.482 174.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.49 78.62 9.1 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.176 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 63.61 60.81 1.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.265 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 27.2 ttt 70.41 100.38 0.06 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.104 175.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -101.57 -173.79 28.29 Favored Glycine 0 CA--C 1.522 0.486 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.291 175.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -64.3 164.82 10.51 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.942 0.401 . . . . 0.0 111.122 177.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -164.48 -96.32 0.11 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.377 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.1 mp -84.83 -1.59 56.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.694 0.283 . . . . 0.0 111.082 -177.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -140.8 164.59 29.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.457 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.7 t70 . . . . . 0 C--O 1.244 0.81 0 CA-C-O 118.622 -0.704 . . . . 0.0 110.184 -178.008 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 119.715 -0.183 . . . . 0.0 110.699 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.532 ' HE2' ' O ' ' A' ' 17' ' ' HIS . 62.4 mmm -6.38 -73.46 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.577 1.551 . . . . 0.0 114.862 171.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 202' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -63.81 -20.1 65.53 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -168.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -95.19 -52.87 4.01 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.355 0.598 . . . . 0.0 111.026 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.529 ' O ' HD13 ' B' ' 208' ' ' LEU . 8.6 p -58.28 -47.79 86.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.147 -174.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 205' ' ' ALA . . . . . 0.565 ' HB1' ' HB3' ' A' ' 11' ' ' TYR . . . -72.95 -19.22 61.28 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.471 -177.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 206' ' ' SER . . . . . 0.563 ' OG ' HG23 ' B' ' 223' ' ' ILE . 24.4 t -66.09 -43.33 87.63 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 207' ' ' TYR . . . . . 0.559 ' CE1' HD11 ' B' ' 251' ' ' ILE . 21.5 t80 -60.47 -44.31 96.04 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.721 173.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.541 ' HB2' ' HA ' ' B' ' 205' ' ' ALA . 6.3 mp -56.26 -49.07 75.23 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.035 177.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 209' ' ' LEU . . . . . 0.506 HD22 HD12 ' A' ' 31' ' ' LEU . 3.7 mp -62.54 -43.13 99.57 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.56 0.219 . . . . 0.0 111.379 -178.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -62.74 -34.0 76.3 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.19 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 211' ' ' ALA . . . . . 0.716 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -71.44 -53.77 12.9 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.701 0.286 . . . . 0.0 111.05 178.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 212' ' ' LEU . . . . . 0.451 HD22 ' HB3' ' A' ' 7' ' ' LEU . 4.6 pp -68.61 -17.79 64.18 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.045 0.45 . . . . 0.0 110.904 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 213' ' ' GLY . . . . . 0.568 ' HA2' ' CG2' ' A' ' 37' ' ' VAL . . . -66.88 -19.63 69.81 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.103 177.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 130.71 6.91 3.55 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.111 177.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 215' ' ' ASN . . . . . 0.716 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 7.9 m-20 -119.52 119.05 32.7 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.841 0.353 . . . . 0.0 110.996 -178.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 8.5 m -81.74 -0.87 44.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.71 0.29 . . . . 0.0 111.365 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 217' ' ' SER . . . . . 0.452 ' N ' ' HD3' ' B' ' 218' ' ' PRO . 24.5 m -135.98 62.16 44.75 Favored Pre-proline 0 N--CA 1.444 -0.764 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.342 -176.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 218' ' ' PRO . . . . . 0.452 ' HD3' ' N ' ' B' ' 217' ' ' SER . 35.0 Cg_exo -63.87 130.98 29.31 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.987 2.458 . . . . 0.0 112.483 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 219' ' ' SER . . . . . 0.496 ' O ' HD13 ' B' ' 223' ' ' ILE . 33.0 t -110.25 169.53 8.67 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.762 0.315 . . . . 0.0 110.49 177.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -56.02 -29.1 59.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.72 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -62.39 -53.1 59.92 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.612 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -62.36 -48.04 81.54 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.252 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.563 HG23 ' OG ' ' B' ' 206' ' ' SER . 1.7 mp -61.18 -48.49 88.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.784 -178.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -62.21 -38.11 87.9 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.499 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -56.93 -52.52 64.86 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.049 176.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 0.708 HG23 HD11 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -60.25 -43.73 94.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.222 -177.673 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 227' ' ' LEU . . . . . 0.406 HD13 ' HB2' ' B' ' 234' ' ' ALA . 1.1 tt -69.99 -43.02 72.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.68 0.276 . . . . 0.0 110.497 -177.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -69.43 -25.51 64.15 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.998 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 58.7 m -51.08 -49.41 60.71 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 230' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' A' ' 30' ' ' ALA . 3.4 p -171.46 19.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.914 -175.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -82.93 -94.75 0.57 Allowed Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 119.973 -1.108 . . . . 0.0 112.04 -173.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 232' ' ' ILE . . . . . 0.49 HG21 ' OD1' ' A' ' 19' ' ' ASP . 51.4 mt -143.17 -88.87 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 120.543 0.211 . . . . 0.0 110.549 -176.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -148.17 160.7 42.65 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 174.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 234' ' ' ALA . . . . . 0.406 ' HB2' HD13 ' B' ' 227' ' ' LEU . . . -151.21 98.91 2.61 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.054 0.454 . . . . 0.0 111.676 -177.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 235' ' ' ASP . . . . . 0.479 ' CG ' ' HD3' ' B' ' 238' ' ' ARG . 0.0 OUTLIER -67.74 127.54 33.18 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.77 174.422 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -65.69 -39.86 91.73 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -165.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -80.71 -38.62 28.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.312 0.577 . . . . 0.0 110.21 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.479 ' HD3' ' CG ' ' B' ' 235' ' ' ASP . 68.2 ttt180 -66.68 -39.47 88.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.677 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 239' ' ' LEU . . . . . 0.421 HD11 HG22 ' B' ' 223' ' ' ILE . 8.6 tt -59.01 -51.84 68.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.07 178.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -69.3 -29.53 67.41 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -67.15 -46.37 74.26 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 242' ' ' VAL . . . . . . . . . . . . . 35.8 m -70.13 -32.17 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 243' ' ' ILE . . . . . 0.476 ' HA ' ' CD2' ' B' ' 246' ' ' LEU . 12.5 mt -64.25 -38.54 82.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.981 170.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 28.1 t -72.07 -13.64 61.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.616 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -89.31 -30.29 18.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.036 0.446 . . . . 0.0 110.402 172.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 246' ' ' LEU . . . . . 0.559 HD12 ' O ' ' B' ' 246' ' ' LEU . 1.4 pp -98.84 3.72 47.4 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.617 -178.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -78.16 40.02 0.33 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -171.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -86.63 -121.23 1.32 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.17 -175.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -139.15 -174.44 3.86 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 250' ' ' ASN . . . . . 0.509 ' HB3' ' HB3' ' B' ' 253' ' ' ASP . 89.6 m-20 64.5 49.63 2.37 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.625 0.578 . . . . 0.0 111.428 176.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.559 HD11 ' CE1' ' B' ' 207' ' ' TYR . 1.3 mm -60.19 -48.39 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.297 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -68.96 -22.27 64.12 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.422 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 253' ' ' ASP . . . . . 0.509 ' HB3' ' HB3' ' B' ' 250' ' ' ASN . 5.8 t70 -70.88 -47.01 61.56 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 254' ' ' VAL . . . . . 0.487 HG22 ' O ' ' B' ' 251' ' ' ILE . 11.4 m -69.67 -25.11 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.119 178.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 255' ' ' ILE . . . . . 0.512 ' CG2' HD13 ' A' ' 7' ' ' LEU . 61.4 mt -78.98 -32.04 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.782 174.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -77.84 -41.69 36.15 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -127.1 36.96 4.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.271 0.558 . . . . 0.0 111.123 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 258' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' B' ' 262' ' ' LEU . . . -124.66 36.57 2.84 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.218 -0.992 . . . . 0.0 111.955 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 67.8 mt -71.82 -77.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 CA-C-O 120.814 0.34 . . . . 0.0 110.724 -178.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -82.47 -3.23 90.61 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.111 -1.042 . . . . 0.0 112.205 -178.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 261' ' ' LYS . . . . . 0.5 ' HB3' ' O ' ' B' ' 264' ' ' SER . 32.3 mmtp -129.96 49.96 2.23 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 262' ' ' LEU . . . . . 0.909 HD12 HD22 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -43.79 -37.19 2.61 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.091 -1.413 . . . . 0.0 114.155 -174.152 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 263' ' ' ALA . . . . . 0.53 ' H ' HD22 ' B' ' 262' ' ' LEU . . . -132.07 31.57 4.13 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.004 0.431 . . . . 0.0 110.969 178.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 264' ' ' SER . . . . . 0.5 ' O ' ' HB3' ' B' ' 261' ' ' LYS . 36.6 m -141.88 87.64 2.06 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.06 0.457 . . . . 0.0 110.812 -178.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 29.4 t -68.73 116.09 37.3 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.617 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.69 -40.93 2.5 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.694 2.262 . . . . 0.0 113.006 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . 46.96 65.81 1.14 Allowed 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.655 0.597 . . . . 0.0 112.362 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 139.42 -24.17 2.8 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.214 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -73.82 -12.18 80.91 Favored Glycine 0 C--O 1.23 -0.125 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.314 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -136.02 78.55 1.72 Allowed 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 27.0 m -76.97 168.62 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.863 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -124.16 169.65 11.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.995 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 78.3 t 69.32 102.28 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 O-C-N 123.893 0.746 . . . . 0.0 111.961 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 4.8 m -79.97 135.41 36.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.309 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -104.58 80.18 1.64 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.934 0.397 . . . . 0.0 111.442 -176.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 276' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' B' ' 277' ' ' PRO . . . -102.81 115.11 64.76 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.722 177.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 277' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 276' ' ' ALA . 3.5 Cg_exo -75.6 86.6 1.46 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.252 2.635 . . . . 0.0 112.178 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 88.35 38.57 7.13 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.55 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 49.2 m 67.12 -160.57 0.23 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.042 0.449 . . . . 0.0 111.365 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . -51.57 125.41 14.59 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.333 177.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 281' ' ' ALA . . . . . 0.481 ' HA ' ' HD3' ' B' ' 282' ' ' PRO . . . -133.75 135.04 24.08 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.599 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 282' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' B' ' 281' ' ' ALA . 16.0 Cg_exo -67.36 144.82 69.37 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.838 2.359 . . . . 0.0 112.088 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -101.99 42.89 1.1 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.064 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . 62.68 -163.84 0.26 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.862 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 145.36 -100.65 0.23 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.276 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 12.6 m -75.62 85.32 2.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.721 0.296 . . . . 0.0 110.727 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 287' ' ' ALA . . . . . 0.541 ' H ' ' HD2' ' B' ' 288' ' ' PRO . . . -157.56 -57.12 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 178.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 288' ' ' PRO . . . . . 0.541 ' HD2' ' H ' ' B' ' 287' ' ' ALA . 85.3 Cg_endo -78.04 69.86 7.31 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.755 1.637 . . . . 0.0 113.154 -174.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -102.07 29.11 5.27 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.237 0.541 . . . . 0.0 110.362 178.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -82.98 67.04 8.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.379 -177.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -143.67 20.52 1.84 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.147 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -68.67 -53.29 23.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.462 -178.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.55 -176.68 0.14 Allowed 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 61.63 -101.27 0.1 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.205 178.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp 71.19 161.37 0.23 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.318 0.647 . . . . 0.0 111.707 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 45.74 -158.65 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.213 1.005 . . . . 0.0 112.524 -177.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -84.45 -168.66 2.26 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -172.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -70.01 134.4 48.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.415 0.626 . . . . 0.0 112.121 -174.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.55 118.02 35.89 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.453 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -69.7 134.17 48.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.883 174.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -96.91 88.19 4.48 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.074 0.464 . . . . 0.0 110.729 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 23.0 t -130.15 119.76 23.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.595 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -135.41 155.28 50.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.176 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -96.62 145.17 25.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.491 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 35.4 m -147.24 140.14 25.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.251 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -80.82 77.94 7.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 177.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.34 152.64 35.42 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 120.819 0.342 . . . . 0.0 110.519 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -112.52 135.17 53.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.36 0.6 . . . . 0.0 110.744 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 309' ' ' MET . . . . . 0.402 ' SD ' ' N ' ' B' ' 309' ' ' MET . 0.0 OUTLIER -111.57 14.39 21.32 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.901 -179.519 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 111.89 -38.45 3.26 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.84 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -111.08 21.93 15.84 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.541 -0.329 . . . . 0.0 110.685 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 312' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' B' ' 314' ' ' PHE . . . -93.67 53.25 2.33 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.323 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 313' ' ' LEU . . . . . 0.501 HD23 ' H ' ' B' ' 313' ' ' LEU . 2.6 pt? -78.35 28.81 0.19 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.692 0.758 . . . . 0.0 110.537 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 314' ' ' PHE . . . . . 0.469 ' H ' ' C ' ' B' ' 312' ' ' GLY . 77.9 m-85 -103.44 -39.78 6.63 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.801 -174.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.399 -173.588 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.82 -160.73 0.82 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -70.57 89.05 0.7 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.208 0.528 . . . . 0.0 110.89 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.604 ' HA ' HD12 ' A' ' 7' ' ' LEU . 2.4 m -66.09 -18.01 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.481 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.451 ' HB3' HG23 ' A' ' 39' ' ' VAL . 16.7 m -61.37 -62.67 1.66 Allowed 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.51 176.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.602 ' O ' HG23 ' A' ' 10' ' ' ILE . 9.9 pt-20 -69.93 -34.9 74.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.446 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.604 HD12 ' HA ' ' A' ' 4' ' ' VAL . 66.6 mt -49.19 -64.72 0.72 Allowed 'General case' 0 C--O 1.222 -0.348 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 172.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.31 86.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.683 -176.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.2 t -62.21 -51.79 66.37 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -176.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.602 HG23 ' O ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -83.19 -16.58 11.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 119.166 -1.013 . . . . 0.0 111.158 -177.869 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.415 ' HB2' HD21 ' B' ' 209' ' ' LEU . 15.9 m-30 -69.89 -32.41 70.73 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 169.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.412 ' HA ' HD23 ' A' ' 31' ' ' LEU . 28.1 t -66.58 -43.91 83.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.298 169.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 10' ' ' ILE . . . -48.96 -45.19 41.59 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 120.98 0.419 . . . . 0.0 110.376 171.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 10' ' ' ILE . 85.7 mt -58.46 -56.03 27.41 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.614 177.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.627 HD12 HD21 ' A' ' 31' ' ' LEU . 56.5 mt -60.15 -32.45 50.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.619 -174.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.429 HD11 HG11 ' B' ' 230' ' ' VAL . 2.5 mm? -88.79 -24.34 22.64 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 121.758 -0.589 . . . . 0.0 112.41 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.549 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 54.6 t-80 -59.38 -51.25 70.73 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -174.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.442 ' HB2' ' SD ' ' B' ' 201' ' ' MET . 18.5 t70 -92.52 -21.19 20.26 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -164.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.488 ' OD2' ' HD3' ' B' ' 202' ' ' ARG . 3.7 m-20 -86.12 29.08 0.76 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -171.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 65.32 8.26 4.81 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.846 0.459 . . . . 0.0 111.933 174.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 19' ' ' ASP . 71.7 t -104.74 141.23 20.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.138 0.494 . . . . 0.0 110.721 -176.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.483 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 7.1 p -73.02 126.75 30.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.079 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.6 p -76.44 87.0 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.564 0.697 . . . . 0.0 110.917 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.1 p -112.46 175.6 5.37 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.353 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -59.74 -36.53 76.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.768 -178.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -53.14 -45.02 68.19 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.897 176.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 22' ' ' THR . 69.2 mmtt -78.29 -47.59 17.5 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.678 -169.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.444 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 21.6 mt -65.47 -46.49 89.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.362 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -63.15 -38.81 92.64 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.86 -43.6 75.08 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.128 0.489 . . . . 0.0 111.232 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.627 HD21 HD12 ' A' ' 15' ' ' ILE . 27.3 tp -70.87 -31.92 68.74 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.336 0.589 . . . . 0.0 110.011 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 28' ' ' ILE . 1.4 mp -73.05 -27.99 25.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.092 174.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -69.71 -34.32 73.72 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 172.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.96 -63.06 1.15 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.161 178.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.504 ' HB2' HD11 ' B' ' 226' ' ' ILE . . . -129.45 26.22 5.38 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -175.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -100.96 94.72 1.3 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.27 -0.967 . . . . 0.0 111.339 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.495 ' HB ' ' HA2' ' B' ' 213' ' ' GLY . 7.7 p -55.05 -50.15 65.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -161.91 130.03 4.15 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.226 0.536 . . . . 0.0 111.725 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.451 HG23 ' HB3' ' A' ' 5' ' ' SER . 10.9 p -157.56 131.95 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.06 174.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -73.0 132.1 83.08 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.56 -4.84 0.59 Allowed 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.846 3.031 . . . . 0.0 114.462 -171.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.55 -37.75 77.19 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 93.2 m95 -68.4 -55.01 12.98 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.839 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.589 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 87.5 Cg_exo -50.25 -50.77 12.52 Favored 'Trans proline' 0 C--N 1.364 1.366 0 C-N-CA 121.99 1.793 . . . . 0.0 112.972 174.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.8 -49.91 72.89 Favored Glycine 0 C--O 1.242 0.622 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.092 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 56.9 tp -53.57 -62.16 1.83 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.239 177.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.481 ' CZ ' HG22 ' A' ' 10' ' ' ILE . 3.5 m-85 -52.41 -46.19 66.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.237 -177.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.26 -38.52 91.5 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.732 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -105.52 10.33 33.18 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.894 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -115.38 -32.82 5.49 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 175.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.671 ' HA ' ' CG2' ' A' ' 54' ' ' VAL . 47.5 mt -80.86 -133.61 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.411 -177.281 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 66.66 -12.45 0.21 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.827 0.851 . . . . 0.0 113.245 177.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 51' ' ' LEU . 52.2 m-80 -141.17 7.38 1.99 Allowed 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.833 0.825 . . . . 0.0 108.87 178.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.671 ' CG2' ' HA ' ' A' ' 51' ' ' LEU . 0.6 OUTLIER -112.92 114.45 47.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.814 -173.411 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -43.95 136.91 3.47 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.635 1.209 . . . . 0.0 110.101 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.773 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 4.9 tp -47.7 -43.52 9.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.186 -169.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -53.35 -22.78 16.22 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.556 -177.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.2 t -53.36 -34.83 59.11 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 122.527 0.331 . . . . 0.0 111.535 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.773 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -61.23 -13.44 18.51 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -175.037 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.433 ' N ' HD12 ' A' ' 59' ' ' LEU . 18.5 mt -66.09 -24.81 34.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.902 0.382 . . . . 0.0 110.421 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.5 t -159.69 72.0 0.51 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.421 0.629 . . . . 0.0 109.833 174.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -94.08 37.12 1.1 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.679 0.752 . . . . 0.0 110.099 -178.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.7 p -136.85 -36.2 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.93 177.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.98 -92.75 0.83 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.76 178.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 71.45 128.95 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.675 0.79 . . . . 0.0 110.969 -173.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -87.57 29.87 5.16 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.989 -176.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.24 175.29 47.67 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.835 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.93 139.67 36.65 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.187 2.591 . . . . 0.0 111.988 177.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -105.74 98.28 17.38 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.399 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -79.86 99.86 1.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.411 2.074 . . . . 0.0 112.341 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.94 117.68 7.96 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.681 174.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -126.02 164.92 19.79 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.887 -175.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.9 -159.22 9.04 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.102 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.04 138.12 31.77 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.594 0.235 . . . . 0.0 110.868 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -91.18 118.84 68.77 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.1 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -41.76 -55.32 2.4 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 124.628 3.552 . . . . 0.0 113.985 -172.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 56.29 79.81 0.16 Allowed 'General case' 0 N--CA 1.462 0.169 0 O-C-N 124.118 0.886 . . . . 0.0 111.53 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -179.67 169.81 40.91 Favored Glycine 0 N--CA 1.454 -0.152 0 N-CA-C 111.489 -0.645 . . . . 0.0 111.489 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 167.97 177.22 39.09 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.089 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -85.64 160.15 10.73 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.787 2.325 . . . . 0.0 112.611 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -116.76 151.8 47.7 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.705 177.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -36.88 -58.41 0.54 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 124.069 3.179 . . . . 0.0 114.076 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.0 t 58.14 57.45 4.0 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.125 0.488 . . . . 0.0 110.865 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.9 m -95.19 93.04 7.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.646 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -93.86 137.81 32.69 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.91 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -135.37 125.99 27.05 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.618 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.15 87.71 3.56 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.91 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -65.82 149.18 86.88 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 123.408 2.739 . . . . 0.0 112.264 173.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -121.59 12.25 10.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.786 0.327 . . . . 0.0 111.346 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 58.59 77.79 0.28 Allowed 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.493 -177.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 67.05 -172.71 0.19 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 114.451 -1.249 . . . . 0.0 112.385 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -94.1 -52.0 4.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.943 -175.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -98.73 111.53 23.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.209 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.7 t -88.07 -36.76 9.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.144 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.8 pm0 -82.7 133.84 35.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.383 0.611 . . . . 0.0 110.563 -177.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -127.4 -76.44 0.57 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.329 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -143.37 146.06 33.2 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -176.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -118.53 -5.97 10.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.041 0.448 . . . . 0.0 110.231 173.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -76.35 -40.5 51.08 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.259 176.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 61.16 -164.27 0.24 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.221 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.3 t -94.61 -173.51 3.05 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.093 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -66.93 117.58 9.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.958 177.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 65.34 -175.75 0.18 Allowed 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.54 0.525 . . . . 0.0 110.925 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.4 m -109.41 62.16 0.6 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.192 -177.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 68.03 125.25 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.78 176.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -78.01 134.9 37.72 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.674 176.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 70.7 128.79 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 O-C-N 124.056 0.848 . . . . 0.0 111.962 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 44.4 ttp -86.05 104.76 15.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.747 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -179.47 -150.16 8.86 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.459 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -75.91 98.0 4.11 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.223 0.535 . . . . 0.0 111.038 -178.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.45 -115.93 4.13 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.655 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.4 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 27.4 tp -105.0 26.33 9.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.134 0.493 . . . . 0.0 110.952 -176.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -135.93 37.52 2.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.796 0.332 . . . . 0.0 111.687 -177.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.1 t70 . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.507 -0.759 . . . . 0.0 109.731 179.415 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 120.691 0.282 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.469 ' HE2' ' O ' ' A' ' 14' ' ' LEU . 23.5 ptm -134.85 2.61 3.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.745 0.307 . . . . 0.0 111.495 -174.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 202' ' ' ARG . . . . . 0.488 ' HD3' ' OD2' ' A' ' 19' ' ' ASP . 89.4 mtt180 -75.0 -74.77 0.19 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.928 -174.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 203' ' ' TYR . . . . . 0.523 ' OH ' ' HB2' ' B' ' 235' ' ' ASP . 1.3 m-85 -78.95 -19.39 51.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.115 0.483 . . . . 0.0 111.678 -170.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.663 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 26.8 m -65.19 -42.48 94.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.664 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 205' ' ' ALA . . . . . 0.71 ' O ' ' HG ' ' B' ' 209' ' ' LEU . . . -73.8 -22.23 59.88 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.319 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 206' ' ' SER . . . . . 0.489 ' CB ' HG23 ' B' ' 223' ' ' ILE . 6.9 m -64.26 -47.74 78.43 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 171.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 207' ' ' TYR . . . . . 0.557 ' CZ ' ' HD2' ' B' ' 218' ' ' PRO . 36.9 t80 -60.53 -40.42 91.41 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.313 176.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 82.5 mt -57.96 -51.07 71.15 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.8 178.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 209' ' ' LEU . . . . . 0.71 ' HG ' ' O ' ' B' ' 205' ' ' ALA . 70.4 mt -59.01 -56.04 27.35 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.816 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 210' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' B' ' 218' ' ' PRO . . . -58.13 -31.29 67.04 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.599 -178.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 211' ' ' ALA . . . . . 0.654 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -74.58 -50.83 16.43 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.408 178.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 212' ' ' LEU . . . . . 0.472 ' HB2' HG12 ' A' ' 4' ' ' VAL . 4.0 pp -66.17 -20.12 66.04 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.64 0.257 . . . . 0.0 110.719 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 213' ' ' GLY . . . . . 0.495 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -68.22 -20.03 72.77 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.595 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 128.22 33.3 0.59 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.784 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 215' ' ' ASN . . . . . 0.654 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 18.3 m120 -144.74 114.25 7.15 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 216' ' ' SER . . . . . 0.407 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 6.3 m -70.24 -17.87 63.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.846 0.355 . . . . 0.0 111.478 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 54.6 p -125.46 71.98 66.18 Favored Pre-proline 0 N--CA 1.444 -0.749 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.969 -175.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 218' ' ' PRO . . . . . 0.557 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 42.5 Cg_exo -62.54 112.12 1.51 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.131 2.554 . . . . 0.0 112.167 176.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 29.2 p -75.74 137.12 40.39 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.344 0.592 . . . . 0.0 110.444 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -54.29 -30.16 49.91 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.85 -177.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -68.25 -37.08 80.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.809 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -78.69 -30.84 46.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.982 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.489 HG23 ' CB ' ' B' ' 206' ' ' SER . 1.7 mp -62.15 -45.57 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.282 0.563 . . . . 0.0 109.507 171.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -61.11 -42.37 98.41 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.037 177.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -57.4 -42.72 82.79 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.31 174.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 0.504 HD11 ' HB2' ' A' ' 35' ' ' ALA . 1.0 OUTLIER -61.48 -35.9 69.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.815 178.644 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 227' ' ' LEU . . . . . 0.536 HD23 ' HB2' ' B' ' 234' ' ' ALA . 11.8 tp -75.96 -39.22 56.45 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.53 -32.0 71.05 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.211 174.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 28.2 t -52.18 -54.69 27.77 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.742 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 230' ' ' VAL . . . . . 0.429 HG11 HD11 ' A' ' 16' ' ' LEU . 40.9 t -74.4 -34.27 35.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.355 0.598 . . . . 0.0 110.803 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 104.52 43.95 1.63 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.836 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 232' ' ' ILE . . . . . 0.406 ' HB ' ' HG ' ' B' ' 227' ' ' LEU . 2.5 mm -104.01 145.72 12.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -69.56 118.02 11.91 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.025 0.44 . . . . 0.0 110.213 -178.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 234' ' ' ALA . . . . . 0.536 ' HB2' HD23 ' B' ' 227' ' ' LEU . . . -99.21 99.41 10.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.208 -175.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 235' ' ' ASP . . . . . 0.523 ' HB2' ' OH ' ' B' ' 203' ' ' TYR . 2.2 m-20 -61.52 109.84 1.3 Allowed 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 170.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.77 -38.29 90.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.698 -172.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.55 -60.15 4.31 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.769 177.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -62.38 -35.74 80.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.662 -172.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 239' ' ' LEU . . . . . . . . . . . . . 9.3 tt -55.71 -61.34 2.42 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.108 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -70.03 -26.38 64.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.679 -177.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -61.89 -52.71 62.98 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.284 175.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 242' ' ' VAL . . . . . 0.545 ' O ' ' HG ' ' B' ' 246' ' ' LEU . 34.0 m -72.5 -30.98 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.581 -175.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 243' ' ' ILE . . . . . 0.421 ' HA ' HD12 ' B' ' 246' ' ' LEU . 30.0 mt -69.3 -36.2 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.636 174.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 30.3 t -60.34 -38.17 82.96 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 174.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -70.29 -37.06 74.74 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.298 174.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 246' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' B' ' 242' ' ' VAL . 64.1 mt -71.26 -31.74 67.88 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.96 0.41 . . . . 0.0 111.056 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -53.38 -34.88 59.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.374 -175.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -108.81 35.46 4.93 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.892 -177.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -134.62 153.54 51.92 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.631 0.253 . . . . 0.0 110.412 178.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 250' ' ' ASN . . . . . 0.404 ' ND2' ' HB2' ' B' ' 253' ' ' ASP . 8.8 p-10 -74.54 83.35 2.01 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.894 0.854 . . . . 0.0 111.614 -176.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.622 ' O ' HG12 ' B' ' 254' ' ' VAL . 5.2 tp -57.68 -39.03 67.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 114.446 -1.252 . . . . 0.0 112.265 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -63.7 -38.42 91.06 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.874 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 253' ' ' ASP . . . . . 0.52 ' O ' ' HG2' ' B' ' 257' ' ' GLN . 43.4 m-20 -73.78 -40.08 63.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.801 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 254' ' ' VAL . . . . . 0.622 HG12 ' O ' ' B' ' 251' ' ' ILE . 3.1 p -62.29 -31.22 50.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.271 -177.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 255' ' ' ILE . . . . . 0.583 ' CG2' HD13 ' A' ' 7' ' ' LEU . 77.0 mt -78.79 -37.97 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 173.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -64.84 -19.9 66.11 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 257' ' ' GLN . . . . . 0.52 ' HG2' ' O ' ' B' ' 253' ' ' ASP . 31.2 mm-40 -71.55 -80.69 0.06 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.586 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 177.31 -59.53 0.1 OUTLIER Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.344 -0.931 . . . . 0.0 113.168 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 259' ' ' ILE . . . . . 0.468 HG12 ' H ' ' B' ' 260' ' ' GLY . 0.0 OUTLIER -134.57 -70.1 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.857 0.36 . . . . 0.0 110.71 -177.466 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 260' ' ' GLY . . . . . 0.468 ' H ' HG12 ' B' ' 259' ' ' ILE . . . 109.0 -173.66 17.57 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.03 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -81.68 46.51 0.98 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.604 0.716 . . . . 0.0 110.564 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 262' ' ' LEU . . . . . 0.402 HD11 HD11 ' B' ' 208' ' ' LEU . 4.6 mt -103.9 -23.42 13.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.474 -177.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -101.66 9.03 41.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.456 -174.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 22.8 t -156.42 153.44 28.88 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 4.6 p -74.7 117.06 59.38 Favored Pre-proline 0 C--N 1.327 -0.399 0 O-C-N 123.271 0.357 . . . . 0.0 110.716 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -59.59 99.19 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.999 2.466 . . . . 0.0 112.456 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . -59.91 93.96 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.384 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 95.1 -10.39 69.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.459 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . 77.34 -80.9 1.24 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.997 -0.621 . . . . 0.0 111.851 -177.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -99.97 114.31 27.5 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.864 0.364 . . . . 0.0 110.277 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 13.0 t -120.31 141.68 39.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.866 -178.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -136.96 112.62 9.42 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.942 0.401 . . . . 0.0 110.942 -178.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 60.3 t -81.97 119.23 31.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.873 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 1.9 p -134.57 169.51 17.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.017 -176.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . 72.44 159.65 0.22 Allowed 'General case' 0 N--CA 1.467 0.379 0 O-C-N 124.069 0.856 . . . . 0.0 110.991 -177.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . 60.14 76.71 0.41 Allowed Pre-proline 0 N--CA 1.467 0.375 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.282 -177.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 277' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.74 96.6 0.06 OUTLIER 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.321 2.681 . . . . 0.0 113.218 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -121.38 -4.59 9.86 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.317 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 16.1 m -117.92 175.48 5.65 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 65.95 65.41 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 O-C-N 124.19 0.931 . . . . 0.0 111.688 172.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -68.6 124.66 90.55 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.238 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -44.32 -54.06 4.3 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.567 2.845 . . . . 0.0 113.643 -172.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . 55.1 66.98 1.09 Allowed 'General case' 0 C--O 1.234 0.248 0 O-C-N 123.575 0.547 . . . . 0.0 111.031 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -82.1 56.82 3.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.024 0.44 . . . . 0.0 110.681 -177.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 154.09 109.74 0.37 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.309 -177.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 21.9 t -76.4 84.43 3.15 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.332 0.587 . . . . 0.0 110.124 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -92.29 134.61 28.03 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.168 -178.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -77.07 107.26 2.4 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.627 2.218 . . . . 0.0 111.289 176.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -59.95 -28.19 67.43 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -175.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -80.67 -11.54 59.62 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . 56.51 29.25 15.09 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.056 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 65.27 -73.78 0.06 Allowed 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.662 0.785 . . . . 0.0 111.531 -176.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 54.59 47.34 22.86 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 123.544 0.528 . . . . 0.0 111.003 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -168.79 -44.89 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.964 -174.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -86.25 142.45 28.56 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.064 0.459 . . . . 0.0 112.054 -173.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -76.59 49.43 0.61 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.319 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 53.95 -106.66 0.32 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 122.841 0.456 . . . . 0.0 111.466 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 298' ' ' LYS . . . . . 0.523 ' O ' ' HG2' ' B' ' 299' ' ' LYS . 21.6 ttmm -131.08 13.68 5.18 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.586 0.708 . . . . 0.0 109.349 173.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 299' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' B' ' 298' ' ' LYS . 19.9 pttm 50.92 29.09 4.17 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.711 -1.132 . . . . 0.0 113.318 176.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -124.26 -50.0 1.79 Allowed 'General case' 0 C--N 1.33 -0.26 0 O-C-N 121.646 -0.659 . . . . 0.0 111.316 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -70.63 90.09 0.75 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.003 0.43 . . . . 0.0 111.933 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 16.3 t -143.88 121.63 11.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.035 178.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 176.33 -30.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.249 -179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 69.81 170.95 0.31 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.56 -1.2 . . . . 0.0 113.421 167.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 1.7 t 68.84 176.62 0.27 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.32 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -121.81 23.16 10.22 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.819 -173.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -92.37 73.61 5.27 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.128 0.489 . . . . 0.0 111.674 -174.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -74.94 -1.22 21.52 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.106 177.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 81.3 mtp -70.92 -21.83 62.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.931 -174.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 78.85 -58.06 4.26 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.225 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -84.54 18.67 2.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.855 0.359 . . . . 0.0 111.326 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . -103.69 54.96 0.65 Allowed Glycine 0 C--O 1.224 -0.473 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 178.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 3.1 pp -93.56 17.97 10.76 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.755 0.788 . . . . 0.0 110.504 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 314' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -97.16 -11.34 24.41 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.348 -174.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.873 -0.584 . . . . 0.0 110.644 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.27 -4.55 45.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.855 0.359 . . . . 0.0 111.3 -175.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.409 ' O ' HD13 ' A' ' 7' ' ' LEU . 3.4 p -64.31 -20.03 65.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.793 -178.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.425 ' HA ' ' HB2' ' A' ' 7' ' ' LEU . 6.4 m -65.4 -17.19 21.59 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.957 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.562 ' HB3' HG23 ' A' ' 39' ' ' VAL . 14.2 m -62.43 -67.13 0.44 Allowed 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.517 0.675 . . . . 0.0 110.447 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -67.25 -31.92 72.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.703 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.438 ' HB3' HD22 ' B' ' 212' ' ' LEU . 5.4 mp -60.41 -49.52 77.23 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.115 0.483 . . . . 0.0 110.224 176.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.85 -49.77 74.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.113 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.714 ' SG ' HG21 ' A' ' 39' ' ' VAL . 48.9 m -62.11 -35.86 79.98 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.701 -0.4 . . . . 0.0 112.055 -178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -74.35 -36.54 42.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.989 -0.285 . . . . 0.0 111.288 -178.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.622 ' O ' HG12 ' A' ' 15' ' ' ILE . 22.5 m-85 -77.52 -25.19 50.03 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.364 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.9 m -73.44 -38.7 65.43 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 172.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.25 -43.86 71.28 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.6 171.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.672 HD11 HD13 ' B' ' 262' ' ' LEU . 95.0 mt -57.04 -58.62 7.38 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.381 173.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.622 HG12 ' O ' ' A' ' 11' ' ' TYR . 36.6 mm -49.83 -35.86 10.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.279 -176.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.464 ' HB2' HG12 ' A' ' 23' ' ' VAL . 58.5 mt -106.08 -2.64 22.44 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -175.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.57 -20.79 66.09 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.822 -0.549 . . . . 0.0 112.309 -178.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.441 ' HB3' ' H ' ' A' ' 19' ' ' ASP . 0.2 OUTLIER -125.88 -117.76 0.27 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.648 -174.535 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.441 ' H ' ' HB3' ' A' ' 18' ' ' ASP . 1.0 OUTLIER 20.2 -138.93 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -170.397 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.424 ' H ' ' HB3' ' A' ' 19' ' ' ASP . 32.1 tt0 -117.14 23.46 11.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.98 0.895 . . . . 0.0 109.039 177.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.42 HG21 HG12 ' B' ' 232' ' ' ILE . 78.3 t -116.26 122.49 69.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.573 -176.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.437 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 4.5 p -80.08 147.13 31.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.077 -176.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 23' ' ' VAL . 30.9 m -75.03 103.66 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 121.507 0.67 . . . . 0.0 111.062 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.9 p -130.11 157.78 41.45 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 121.746 -0.596 . . . . 0.0 111.204 177.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -51.95 -49.55 62.93 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.709 0.631 . . . . 0.0 109.871 -177.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -34.09 65.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.886 -176.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.437 ' HD2' ' O ' ' A' ' 22' ' ' THR . 69.1 mttm -85.18 -41.74 15.37 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.24 -172.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.421 HG13 HD12 ' A' ' 16' ' ' LEU . 3.2 mt -63.37 -43.94 98.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 173.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.578 ' OD1' ' HE3' ' A' ' 33' ' ' LYS . 19.6 t-20 -58.07 -44.38 87.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.753 176.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.0 -44.41 94.56 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.492 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.2 mt -64.93 -44.29 89.97 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.677 0.275 . . . . 0.0 111.308 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 mp -59.27 -44.94 93.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.106 0.479 . . . . 0.0 110.426 178.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.578 ' HE3' ' OD1' ' A' ' 29' ' ' ASN . 97.7 mttt -66.43 -32.32 73.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.796 178.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.501 ' HB1' ' HA ' ' B' ' 226' ' ' ILE . . . -64.44 -38.07 89.73 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.265 177.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.419 ' HA ' HD11 ' B' ' 226' ' ' ILE . . . -79.93 -27.43 39.84 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.986 177.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.7 6.5 56.25 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.28 173.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.522 HG13 ' HA2' ' B' ' 213' ' ' GLY . 6.8 m -91.32 -178.93 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.05 0.452 . . . . 0.0 111.643 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -134.52 120.86 20.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.541 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.714 HG21 ' SG ' ' A' ' 9' ' ' CYS . 12.6 p -119.99 144.28 29.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.855 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.34 122.96 58.48 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -52.29 -13.32 2.03 Favored 'Trans proline' 0 N--CA 1.484 0.921 0 C-N-CA 123.735 2.956 . . . . 0.0 114.699 -170.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.01 -24.72 43.51 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -175.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.477 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 95.2 m95 -67.86 -59.57 6.44 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 175.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.477 ' CD ' ' HB2' ' A' ' 43' ' ' TRP . 11.3 Cg_endo -56.48 -37.29 97.54 Favored 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 121.862 1.708 . . . . 0.0 112.11 176.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.462 ' O ' ' HG2' ' A' ' 49' ' ' LYS . . . -66.0 -50.67 50.9 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.593 178.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.2 tt -59.23 -46.39 88.59 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.597 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 11.3 m-85 -60.05 -42.81 95.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.942 0.401 . . . . 0.0 110.844 177.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.98 -49.64 76.62 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -177.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 45' ' ' GLY . 19.0 ptmt -105.03 0.42 27.62 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -172.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.04 -11.55 3.32 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.688 ' HA ' HG23 ' A' ' 54' ' ' VAL . 3.4 tp -90.47 -133.16 0.11 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.464 ' H ' ' CG ' ' A' ' 51' ' ' LEU . . . 61.65 -12.68 0.05 Allowed 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.555 ' H ' ' C ' ' A' ' 51' ' ' LEU . 88.2 m-20 -128.23 -34.42 2.09 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -178.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.688 HG23 ' HA ' ' A' ' 51' ' ' LEU . 41.0 t -50.92 109.45 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-N 114.407 -1.269 . . . . 0.0 109.848 170.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -51.12 150.01 3.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.727 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.541 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 2.6 tp -53.83 -49.48 58.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -173.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.17 -26.43 65.89 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.781 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 61' ' ' CYS . 19.3 m -65.97 -2.19 3.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.661 -0.269 . . . . 0.0 111.484 -178.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 42.6 mt -57.36 -24.99 58.72 Favored 'General case' 0 N--CA 1.46 0.074 0 CA-C-O 120.771 0.319 . . . . 0.0 110.483 171.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.8 mt -89.69 28.15 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 121.421 0.629 . . . . 0.0 109.787 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 58' ' ' SER . 33.1 t -63.59 154.58 32.28 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.642 176.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -77.17 54.34 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.88 0.848 . . . . 0.0 110.017 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.2 p -118.81 -22.75 3.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.504 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.19 -162.98 33.25 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.091 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -123.96 -46.24 1.97 Allowed 'General case' 0 C--N 1.318 -0.769 0 O-C-N 122.895 -0.179 . . . . 0.0 111.033 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.06 65.16 3.07 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.881 -177.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -86.45 130.56 10.03 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 121.11 -0.566 . . . . 0.0 112.398 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.41 166.7 23.9 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.748 2.299 . . . . 0.0 112.398 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.16 117.48 68.82 Favored Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.332 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.99 -25.04 12.26 Favored 'Trans proline' 0 CA--C 1.529 0.231 0 C-N-CA 122.476 2.118 . . . . 0.0 113.128 -176.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -170.59 -173.11 1.33 Allowed 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 67.49 -173.48 0.19 Allowed 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.733 0.645 . . . . 0.0 111.243 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 151.5 -157.5 27.25 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.894 -0.67 . . . . 0.0 111.828 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -150.7 150.62 31.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.76 0.28 . . . . 0.0 110.529 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.499 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -136.91 137.38 23.04 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.296 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 46.5 Cg_exo -60.41 97.85 0.12 Allowed 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 123.319 2.679 . . . . 0.0 112.605 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.4 91.65 1.02 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.05 0.452 . . . . 0.0 111.185 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.46 -89.17 1.29 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.697 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.27 171.38 12.94 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.685 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -82.31 171.53 12.41 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.444 2.096 . . . . 0.0 112.468 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.53 101.98 45.63 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.546 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -57.44 -55.94 2.14 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.178 2.585 . . . . 0.0 112.361 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.5 t 63.46 97.25 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.751 0.657 . . . . 0.0 111.079 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.9 p 52.29 75.87 0.21 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.039 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.09 38.7 0.61 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.209 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . -120.87 84.87 2.3 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.51 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . 73.02 160.02 0.16 Allowed Pre-proline 0 CA--C 1.536 0.432 0 O-C-N 124.055 0.847 . . . . 0.0 110.069 -175.104 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -51.63 -61.74 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.397 2.064 . . . . 0.0 113.061 -177.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -172.7 -42.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.441 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -68.82 130.38 42.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.242 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -79.22 151.9 30.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.36 177.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.1 tmtp? -144.46 105.87 4.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.098 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -117.49 141.73 48.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.719 -175.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.513 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 13.6 p -88.84 141.13 14.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 175.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 94' ' ' VAL . 10.0 pt-20 53.55 -177.47 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.629 1.172 . . . . 0.0 112.547 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.73 145.91 37.06 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.7 -175.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -88.32 139.7 30.23 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.729 -177.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -65.79 146.33 54.89 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 174.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.77 -4.06 41.48 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 120.931 0.396 . . . . 0.0 110.407 177.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 69.0 -171.88 0.18 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.159 177.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.1 m -142.57 135.94 28.74 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.011 -173.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.1 23.03 15.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.491 177.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -58.54 134.58 56.84 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.565 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.4 t 71.31 103.31 0.06 Allowed 'General case' 0 C--O 1.236 0.343 0 O-C-N 123.857 0.723 . . . . 0.0 111.151 176.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.0 t0 70.5 89.85 0.1 Allowed 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.975 0.797 . . . . 0.0 110.298 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -64.29 123.77 20.0 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.766 -175.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -67.04 128.41 36.24 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.004 -176.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -84.69 72.96 10.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.598 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -82.13 91.13 1.5 Allowed Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.351 176.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -54.39 126.75 24.56 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.629 0.252 . . . . 0.0 110.434 176.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -154.91 -89.56 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.207 -176.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.2 mt -79.61 -22.32 43.82 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.044 0.45 . . . . 0.0 110.27 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -116.02 149.14 39.35 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.64 176.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.9 t70 . . . . . 0 C--O 1.245 0.864 0 CA-C-O 118.359 -0.829 . . . . 0.0 109.326 -178.694 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 19.1 mtt -105.39 -169.82 1.65 Allowed 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 121.546 0.688 . . . . 0.0 111.077 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 202' ' ' ARG . . . . . 0.436 ' C ' ' H ' ' B' ' 204' ' ' VAL . 33.2 mtm180 -118.44 155.91 29.95 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.5 178.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 203' ' ' TYR . . . . . 0.408 ' OH ' ' HA ' ' B' ' 234' ' ' ALA . 73.6 m-85 -70.4 17.69 0.06 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.112 0.565 . . . . 0.0 112.284 -172.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.613 ' O ' HD13 ' B' ' 208' ' ' LEU . 58.5 t -65.25 -53.48 40.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.49 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 205' ' ' ALA . . . . . 0.495 ' HA ' HD22 ' B' ' 208' ' ' LEU . . . -70.54 -16.4 62.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.163 0.506 . . . . 0.0 110.673 -178.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 206' ' ' SER . . . . . 0.414 ' CB ' HG23 ' B' ' 223' ' ' ILE . 5.8 m -69.59 -47.23 64.24 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 171.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 207' ' ' TYR . . . . . 0.552 ' CD1' HD11 ' B' ' 251' ' ' ILE . 32.3 t80 -57.17 -39.68 75.78 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.254 174.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.613 HD13 ' O ' ' B' ' 204' ' ' VAL . 7.0 mp -60.71 -49.49 77.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.324 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 209' ' ' LEU . . . . . 0.515 ' CD2' ' HB2' ' A' ' 11' ' ' TYR . 25.3 mt -56.29 -48.78 75.97 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 120.936 0.398 . . . . 0.0 110.585 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 210' ' ' ALA . . . . . 0.536 ' HB3' ' HB3' ' B' ' 218' ' ' PRO . . . -66.56 -29.76 69.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.328 -177.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 211' ' ' ALA . . . . . 0.659 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -72.65 -52.26 16.07 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.933 0.396 . . . . 0.0 111.055 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 212' ' ' LEU . . . . . 0.438 HD22 ' HB3' ' A' ' 7' ' ' LEU . 2.9 pp -69.13 -19.97 64.04 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 213' ' ' GLY . . . . . 0.522 ' HA2' HG13 ' A' ' 37' ' ' VAL . . . -60.15 -19.68 52.33 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.824 176.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 127.73 3.9 5.84 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.665 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 215' ' ' ASN . . . . . 0.659 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 28.3 t30 -122.56 114.01 20.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.92 0.391 . . . . 0.0 110.654 -177.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 216' ' ' SER . . . . . 0.427 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 18.6 m -70.76 -12.51 61.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.636 -178.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 10.1 p -122.98 67.49 32.63 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.492 -178.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 218' ' ' PRO . . . . . 0.536 ' HB3' ' HB3' ' B' ' 210' ' ' ALA . 80.7 Cg_exo -53.38 106.33 0.15 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.261 2.641 . . . . 0.0 113.09 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 16.0 m -77.9 148.74 34.44 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.158 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -56.63 -29.49 62.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.348 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -68.62 -30.05 68.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.342 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -86.64 -30.46 21.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.342 -177.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.414 HG23 ' CB ' ' B' ' 206' ' ' SER . 1.8 mp -66.47 -44.78 90.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 171.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 224' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' B' ' 228' ' ' ASP . 38.7 tttp -60.47 -43.4 96.96 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.799 175.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -56.72 -45.59 81.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.903 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 0.501 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . 1.0 OUTLIER -61.26 -44.88 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.071 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 227' ' ' LEU . . . . . 0.436 HD23 ' HB2' ' B' ' 234' ' ' ALA . 10.0 tp -76.36 -32.65 58.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.686 0.279 . . . . 0.0 110.652 -176.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 228' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' B' ' 224' ' ' LYS . 1.1 t0 -72.15 -29.78 64.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.319 0.58 . . . . 0.0 109.635 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 32.2 t -60.08 -37.79 80.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.051 177.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 9.6 p -98.74 -23.67 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 120.997 0.427 . . . . 0.0 111.313 -174.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 102.32 57.36 0.8 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.777 -0.725 . . . . 0.0 114.214 172.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 232' ' ' ILE . . . . . 0.42 HG12 HG21 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -130.51 147.33 33.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 173.069 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -66.1 130.23 42.54 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.72 0.295 . . . . 0.0 111.742 -175.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 234' ' ' ALA . . . . . 0.436 ' HB2' HD23 ' B' ' 227' ' ' LEU . . . -128.04 106.99 9.45 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.904 -177.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -81.72 124.07 29.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.745 178.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -63.38 -43.69 96.89 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.497 -171.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.29 -45.19 81.27 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -63.61 -49.94 71.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.015 -177.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 239' ' ' LEU . . . . . 0.607 HD12 ' N ' ' B' ' 240' ' ' ASN . 4.5 pp -64.03 -41.3 97.47 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 121.152 -0.219 . . . . 0.0 111.339 -176.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 240' ' ' ASN . . . . . 0.607 ' N ' HD12 ' B' ' 239' ' ' LEU . 25.5 t-20 -70.36 -34.99 73.28 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.658 -178.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 241' ' ' LYS . . . . . 0.691 ' O ' ' HG2' ' B' ' 245' ' ' GLU . 5.1 mmmp? -71.43 -39.74 70.86 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.808 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 242' ' ' VAL . . . . . . . . . . . . . 19.9 m -69.84 -31.51 48.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 119.566 -0.853 . . . . 0.0 108.949 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 243' ' ' ILE . . . . . 0.483 ' HA ' ' CD2' ' B' ' 246' ' ' LEU . 20.5 mt -68.79 -36.42 74.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.945 175.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 97.0 p -71.4 -32.46 68.45 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.638 178.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 245' ' ' GLU . . . . . 0.691 ' HG2' ' O ' ' B' ' 241' ' ' LYS . 7.1 mm-40 -74.76 -34.97 62.57 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.444 178.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 246' ' ' LEU . . . . . 0.483 ' CD2' ' HA ' ' B' ' 243' ' ' ILE . 1.0 OUTLIER -85.4 -10.1 56.68 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.139 0.495 . . . . 0.0 110.639 178.75 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -52.44 -54.01 37.84 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.596 -176.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -94.4 58.35 1.96 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.596 -176.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -135.77 163.03 31.13 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 250' ' ' ASN . . . . . 0.402 ' O ' HG13 ' B' ' 254' ' ' VAL . 5.4 m-20 -70.01 84.52 0.51 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.581 -178.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.552 HD11 ' CD1' ' B' ' 207' ' ' TYR . 0.6 OUTLIER -55.27 -39.26 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.674 0.749 . . . . 0.0 111.112 176.57 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.02 -35.76 82.23 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.075 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -72.0 -45.56 60.51 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.576 0.227 . . . . 0.0 110.54 177.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 254' ' ' VAL . . . . . 0.459 HG22 ' HA ' ' B' ' 251' ' ' ILE . 12.3 m -64.63 -32.36 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.326 -176.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 255' ' ' ILE . . . . . 0.533 ' HA ' ' OH ' ' A' ' 11' ' ' TYR . 56.3 mt -82.45 -36.14 13.36 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-O 120.985 0.421 . . . . 0.0 111.139 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -68.5 -54.17 18.54 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.72 -178.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -152.33 38.19 0.55 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -175.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 258' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' B' ' 254' ' ' VAL . . . -104.08 37.76 3.6 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.144 -1.026 . . . . 0.0 112.792 -177.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 259' ' ' ILE . . . . . 0.421 ' O ' HD12 ' B' ' 262' ' ' LEU . 13.0 mt -62.74 -19.17 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 120.988 0.423 . . . . 0.0 110.818 -178.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -115.77 40.28 2.48 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 119.686 -1.245 . . . . 0.0 112.885 178.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -124.61 25.46 7.53 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 171.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 262' ' ' LEU . . . . . 0.672 HD13 HD11 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -128.05 -60.38 1.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.292 -173.156 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -129.62 -177.17 4.15 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.396 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 30.7 t -162.33 156.6 21.62 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.128 0.267 . . . . 0.0 110.494 -177.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 7.5 p -105.01 129.19 25.24 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.875 0.369 . . . . 0.0 110.43 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -74.2 116.01 4.5 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.552 2.168 . . . . 0.0 112.362 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . 61.35 -171.3 0.15 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.043 177.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . -90.18 62.29 3.22 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.641 -178.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -84.58 117.75 4.56 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.311 177.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.8 137.5 41.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.758 0.313 . . . . 0.0 110.692 -178.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 14.2 t -117.35 143.34 28.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.218 -177.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -90.32 118.08 29.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.698 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 20.0 m -67.12 136.39 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.234 0.54 . . . . 0.0 110.855 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 8.3 p -129.38 -178.37 4.64 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.447 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . 65.57 27.97 11.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.515 0.674 . . . . 0.0 111.286 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -121.65 105.68 38.17 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.565 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 277' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.44 58.61 7.08 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.386 2.724 . . . . 0.0 112.176 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 75.76 -138.09 22.51 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.361 175.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 50.7 m -154.97 160.62 41.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 64.24 -166.82 0.22 Allowed 'General case' 0 C--N 1.332 -0.186 0 O-C-N 123.96 0.787 . . . . 0.0 110.854 175.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -146.18 83.01 8.76 Favored Pre-proline 0 C--O 1.236 0.35 0 CA-C-O 120.646 0.26 . . . . 0.0 110.971 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -84.04 118.0 2.3 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.748 2.299 . . . . 0.0 112.154 178.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -97.04 74.34 2.58 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.607 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -136.99 154.2 50.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.761 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.76 173.74 24.68 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.896 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 8.7 p -89.59 44.63 1.22 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.007 0.432 . . . . 0.0 111.155 -177.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 287' ' ' ALA . . . . . 0.451 ' HB3' ' HD3' ' B' ' 288' ' ' PRO . . . -73.18 -51.08 6.15 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.282 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 288' ' ' PRO . . . . . 0.451 ' HD3' ' HB3' ' B' ' 287' ' ' ALA . 20.8 Cg_endo -86.36 43.42 1.08 Allowed 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.433 1.422 . . . . 0.0 111.949 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -145.43 20.31 1.53 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.691 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -77.59 133.88 38.36 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.977 -179.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -136.74 98.09 3.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.721 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -100.7 19.51 16.91 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.901 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -73.84 -179.12 3.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.203 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.25 41.52 1.92 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.249 0.547 . . . . 0.0 111.306 -174.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -133.0 116.69 16.71 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.169 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 69.64 179.88 0.24 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.245 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -142.84 -47.67 0.32 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.007 -174.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 67.5 mttm 54.35 58.51 4.88 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.458 0.647 . . . . 0.0 110.224 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 299' ' ' LYS . . . . . 0.465 ' CD ' ' H ' ' B' ' 299' ' ' LYS . 0.0 OUTLIER -78.09 174.75 10.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.229 -177.093 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -64.79 142.88 58.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.727 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 53.64 56.54 7.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.517 -178.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 58.1 m -72.84 112.75 9.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.584 176.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -64.39 -36.41 84.06 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.433 177.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -82.94 133.62 35.1 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 20.2 m -76.09 149.6 37.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.117 -174.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -60.17 -59.99 4.53 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.27 0.356 . . . . 0.0 110.203 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 12.7 t70 66.36 108.42 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.269 0.981 . . . . 0.0 111.986 177.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -80.04 -18.98 48.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.95 -174.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 19.0 ptp -89.49 -28.67 19.5 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.688 -0.405 . . . . 0.0 112.02 -170.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 29.2 -89.23 0.01 OUTLIER Glycine 0 C--N 1.339 0.743 0 O-C-N 124.813 1.32 . . . . 0.0 115.56 173.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -123.89 35.26 4.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.066 -0.567 . . . . 0.0 110.902 -174.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . -91.63 27.26 10.0 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.865 -0.683 . . . . 0.0 113.066 -177.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.63 50.56 2.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.167 0.508 . . . . 0.0 109.812 177.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 314' ' ' PHE . . . . . 0.441 ' O ' ' HB3' ' B' ' 315' ' ' ASP . 62.5 m-85 -132.03 -47.48 0.93 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.217 -175.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 315' ' ' ASP . . . . . 0.441 ' HB3' ' O ' ' B' ' 314' ' ' PHE . 28.4 t70 . . . . . 0 C--O 1.247 0.923 0 O-C-N 124.137 0.898 . . . . 0.0 111.334 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.9 mtp . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.25 -78.4 0.58 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.933 0.397 . . . . 0.0 111.363 -177.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 m -78.31 76.33 4.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.585 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.571 ' HA ' HD12 ' A' ' 7' ' ' LEU . 2.8 m -70.02 -25.06 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 CA-C-O 120.992 0.425 . . . . 0.0 110.537 -177.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.602 ' HB2' HG23 ' A' ' 39' ' ' VAL . 3.4 p -68.36 -52.73 29.93 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 121.48 0.657 . . . . 0.0 110.015 175.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.558 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 41.8 tt0 -62.56 -41.57 99.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.174 178.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.633 HD13 ' CG2' ' B' ' 255' ' ' ILE . 49.2 mt -53.98 -47.31 71.51 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.314 174.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.418 ' HB2' HG11 ' A' ' 37' ' ' VAL . . . -57.34 -53.12 61.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.685 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.558 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 7.2 p -67.54 -28.3 67.69 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.7 -176.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.446 HG13 HD23 ' A' ' 59' ' ' LEU . 0.7 OUTLIER -76.06 -40.76 37.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 120.895 0.379 . . . . 0.0 111.09 179.708 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.409 ' HB2' ' CD1' ' B' ' 209' ' ' LEU . 19.9 m-85 -71.03 -28.63 64.53 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.5 m -68.66 -45.86 70.63 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.102 173.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.5 -51.18 28.59 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.057 0.456 . . . . 0.0 110.572 173.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 10' ' ' ILE . 35.5 mt -61.23 -48.82 79.72 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.921 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.492 HD11 ' HA ' ' B' ' 206' ' ' SER . 83.8 mt -62.57 -37.29 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.789 0.328 . . . . 0.0 111.453 -178.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.706 HD23 ' HA ' ' A' ' 23' ' ' VAL . 10.8 mp -74.11 -22.14 59.6 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.895 177.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.496 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 51.4 t-80 -94.16 61.03 2.85 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.831 172.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -124.81 -55.62 1.6 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 174.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -117.19 -161.88 0.83 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -81.48 43.65 0.75 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.482 0.658 . . . . 0.0 111.845 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.522 HG11 HD11 ' B' ' 232' ' ' ILE . 7.6 p -94.05 128.54 45.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.099 0.476 . . . . 0.0 110.102 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.403 ' C ' ' H ' ' A' ' 24' ' ' THR . 33.5 p -56.08 123.69 15.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.81 -178.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.706 ' HA ' HD23 ' A' ' 16' ' ' LEU . 8.6 p -76.87 24.73 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-O 121.643 0.735 . . . . 0.0 111.144 -177.164 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.403 ' H ' ' C ' ' A' ' 22' ' ' THR . 6.6 t -92.49 168.13 11.48 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 121.679 0.752 . . . . 0.0 110.938 -174.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -25.83 67.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.778 -168.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -49.04 -50.89 34.17 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.521 0.677 . . . . 0.0 109.311 170.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -82.13 -38.14 25.2 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.931 -172.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.59 HG13 HD22 ' A' ' 16' ' ' LEU . 1.5 mt -62.93 -48.77 86.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.519 177.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -63.62 -39.58 94.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.125 177.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.92 -49.01 76.91 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.036 0.446 . . . . 0.0 110.914 176.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.407 HD21 HD12 ' A' ' 15' ' ' ILE . 44.0 tp -67.68 -36.01 79.9 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.294 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.3 mp -58.72 -37.04 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.193 174.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -77.06 -29.78 55.23 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.645 176.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.423 ' HB1' ' HA ' ' B' ' 226' ' ' ILE . . . -57.7 -45.27 85.89 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.936 176.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.44 -51.54 6.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.096 178.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.74 38.9 2.65 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.029 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.57 HG22 ' HA3' ' B' ' 213' ' ' GLY . 3.5 t -98.37 135.01 34.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.769 0.319 . . . . 0.0 110.688 -177.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -86.61 94.59 9.51 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.232 0.539 . . . . 0.0 110.504 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.602 HG23 ' HB2' ' A' ' 5' ' ' SER . 5.1 p -113.51 135.05 54.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.196 177.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -48.29 108.92 1.01 Allowed Pre-proline 0 N--CA 1.466 0.371 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.473 174.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -47.53 -18.49 0.9 Allowed 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 124.189 3.259 . . . . 0.0 114.266 -173.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -68.03 -38.74 82.9 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.723 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.566 ' O ' ' HB2' ' A' ' 47' ' ' PHE . 62.8 m95 -66.38 -59.08 8.98 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.387 178.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.552 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 73.0 Cg_exo -52.09 -47.69 25.4 Favored 'Trans proline' 0 C--N 1.363 1.324 0 C-N-CA 122.253 1.969 . . . . 0.0 112.715 177.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.17 -57.48 18.24 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.054 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.74 -43.91 85.7 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.63 ' O ' HD13 ' A' ' 51' ' ' LEU . 1.1 t80 -59.61 -55.23 37.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.092 0.473 . . . . 0.0 110.678 -177.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.475 ' HB2' HD12 ' A' ' 28' ' ' ILE . . . -61.99 -32.4 72.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.53 -176.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.486 ' HE2' ' HA ' ' A' ' 49' ' ' LYS . 9.1 mmpt? -87.04 -14.94 40.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.607 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.89 -27.85 16.85 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.656 ' HA ' HG23 ' A' ' 54' ' ' VAL . 5.8 mp -75.21 -113.32 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.817 177.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 61.42 -6.93 0.11 Allowed 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 178.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.434 ' H ' ' C ' ' A' ' 51' ' ' LEU . 47.3 t30 -144.08 -39.2 0.29 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.656 HG23 ' HA ' ' A' ' 51' ' ' LEU . 16.0 t -44.95 104.43 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.838 174.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -39.99 -82.66 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 O-C-N 124.312 1.007 . . . . 0.0 111.515 -176.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.592 ' O ' HD12 ' A' ' 59' ' ' LEU . 0.9 OUTLIER -157.08 -66.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.58 172.408 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.21 -23.87 53.88 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.287 -0.482 . . . . 0.0 113.603 -171.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.495 ' HB2' ' CG1' ' A' ' 54' ' ' VAL . 14.5 m -60.69 -14.21 19.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.595 0.236 . . . . 0.0 111.587 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.602 HD13 ' N ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -62.88 -14.54 47.52 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.983 0.42 . . . . 0.0 110.543 179.386 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.602 ' N ' HD13 ' A' ' 59' ' ' LEU . 9.0 tt -77.61 -4.6 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.055 -178.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 98.9 m -69.22 104.2 2.14 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.336 0.589 . . . . 0.0 110.866 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -75.88 65.33 1.96 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.218 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 63' ' ' VAL . 5.1 t -77.15 6.77 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.213 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -61.46 -67.09 2.27 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.745 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.85 -87.38 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.427 0.156 . . . . 0.0 110.943 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.431 ' O ' ' HD3' ' A' ' 68' ' ' PRO . . . 81.31 69.69 1.38 Allowed Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.554 177.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -102.97 102.23 2.21 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.446 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 66' ' ' GLY . 20.6 Cg_endo -88.14 104.62 0.5 Allowed 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.627 2.218 . . . . 0.0 112.46 -177.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.28 84.35 63.49 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.285 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -93.09 168.24 2.39 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.297 2.664 . . . . 0.0 112.645 176.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -166.59 157.6 12.6 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.961 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 66.11 177.72 0.22 Allowed 'General case' 0 CA--C 1.534 0.363 0 O-C-N 123.68 0.613 . . . . 0.0 111.876 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.64 62.88 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.777 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.91 137.09 32.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.561 0.22 . . . . 0.0 111.06 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.07 114.19 4.93 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.292 0.567 . . . . 0.0 110.647 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.83 128.44 30.31 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 123.988 3.125 . . . . 0.0 112.948 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.67 20.62 10.2 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.312 0.577 . . . . 0.0 110.652 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -143.22 151.55 23.32 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -138.82 -88.34 0.18 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.434 -0.888 . . . . 0.0 113.204 -178.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.09 149.51 90.13 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.664 2.243 . . . . 0.0 112.604 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -126.42 101.73 27.43 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.762 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.11 149.25 81.28 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.22 2.613 . . . . 0.0 113.138 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.6 m -137.54 21.23 2.92 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.327 0.584 . . . . 0.0 109.761 175.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.0 t -108.65 127.0 53.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.774 -176.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -163.09 119.67 1.84 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.098 177.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 68.02 167.1 0.25 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.789 0.681 . . . . 0.0 112.121 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.28 105.68 3.57 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.974 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -56.15 130.57 40.93 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.315 2.677 . . . . 0.0 113.359 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -135.95 89.63 2.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.772 175.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -106.54 126.73 52.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.662 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -83.09 176.6 9.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.444 0.64 . . . . 0.0 112.32 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -162.22 160.74 27.35 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.711 177.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm 71.03 81.99 0.15 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.343 0.657 . . . . 0.0 110.733 -172.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 m -111.33 6.53 8.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.832 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -102.58 166.0 10.77 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 178.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 97' ' ' LYS . . . -134.96 -75.82 0.46 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.802 -178.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 96' ' ' ALA . 45.4 mtmt 65.93 167.1 0.2 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.982 0.42 . . . . 0.0 111.074 -174.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -155.81 147.39 22.9 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.176 0.512 . . . . 0.0 112.15 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.86 42.94 3.23 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.083 173.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -53.32 143.91 17.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.931 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.6 t -71.88 104.58 3.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.22 0.533 . . . . 0.0 109.952 176.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -76.73 -172.05 2.11 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.371 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -55.59 122.26 10.94 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.42 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.58 56.22 1.81 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.489 0.662 . . . . 0.0 110.613 -177.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -98.88 52.52 0.98 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.481 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -68.42 114.3 6.74 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.728 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -84.78 159.71 20.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.083 0.468 . . . . 0.0 111.041 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 15.8 tpt -98.84 93.84 6.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.597 -177.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 169.21 -177.11 43.05 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.172 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.85 60.78 4.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.046 0.45 . . . . 0.0 110.904 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -132.63 59.2 0.69 Allowed Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.43 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.3 mt -117.7 20.15 13.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.282 0.563 . . . . 0.0 110.614 -175.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -138.32 15.89 2.78 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.206 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 C--O 1.249 1.076 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.494 -176.919 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 120.274 0.083 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 78.0 mmm -56.3 121.19 8.95 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 123.289 0.368 . . . . 0.0 110.221 176.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 202' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -150.73 -176.32 5.47 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.148 -179.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 203' ' ' TYR . . . . . 0.495 ' CD2' ' HA ' ' B' ' 239' ' ' LEU . 59.0 m-85 -71.26 9.2 0.81 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.896 0.478 . . . . 0.0 111.669 -178.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.755 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 15.5 m -59.52 -49.05 85.05 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.193 177.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 205' ' ' ALA . . . . . 0.491 ' HA ' HD12 ' B' ' 208' ' ' LEU . . . -73.31 -15.59 61.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.064 0.459 . . . . 0.0 110.618 -177.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 206' ' ' SER . . . . . 0.493 ' HB3' HG23 ' B' ' 223' ' ' ILE . 6.5 m -71.02 -49.22 47.45 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 172.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 207' ' ' TYR . . . . . 0.507 ' CZ ' ' HD2' ' B' ' 218' ' ' PRO . 24.4 t80 -60.76 -40.87 94.09 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 174.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.755 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 79.3 mt -59.71 -51.68 68.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.168 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 209' ' ' LEU . . . . . 0.409 ' CD1' ' HB2' ' A' ' 11' ' ' TYR . 8.4 tp -59.7 -49.75 76.51 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.862 0.363 . . . . 0.0 110.612 -178.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -61.84 -34.03 75.22 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.2 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 211' ' ' ALA . . . . . . . . . . . . . . . -79.4 -36.25 39.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.032 0.444 . . . . 0.0 110.79 178.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 212' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.32 -46.69 85.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.202 177.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 213' ' ' GLY . . . . . 0.57 ' HA3' HG22 ' A' ' 37' ' ' VAL . . . -150.38 69.59 0.32 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.694 -1.241 . . . . 0.0 112.929 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . -168.71 -66.51 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.276 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 215' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -156.89 132.05 9.09 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -178.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 2.1 m -51.34 -30.83 19.87 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.652 -178.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 18.0 p -121.79 76.62 38.28 Favored Pre-proline 0 N--CA 1.442 -0.867 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.667 -177.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 218' ' ' PRO . . . . . 0.507 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 75.6 Cg_exo -54.41 108.53 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.579 2.853 . . . . 0.0 112.651 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 30.8 m -84.66 155.93 21.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.695 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -51.62 -40.04 59.15 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.174 0.512 . . . . 0.0 110.706 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -60.55 -32.5 71.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.566 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -85.42 -30.75 23.32 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -177.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.53 HG22 HD11 ' B' ' 239' ' ' LEU . 1.8 mp -66.91 -42.06 88.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 172.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -60.71 -46.14 91.55 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.097 174.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -55.99 -43.92 78.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.375 177.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 226' ' ' ILE . . . . . 0.423 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . 1.0 OUTLIER -60.42 -42.39 90.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 178.706 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 93.5 mt -71.91 -39.02 69.81 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 121.214 -0.195 . . . . 0.0 111.378 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -67.45 -30.49 70.23 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.769 0.318 . . . . 0.0 111.146 177.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 56.1 m -69.36 -47.57 63.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.293 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 11.4 p -79.53 -27.21 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.075 0.464 . . . . 0.0 111.362 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 103.55 56.98 0.76 Allowed Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.374 174.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 232' ' ' ILE . . . . . 0.522 HD11 HG11 ' A' ' 21' ' ' VAL . 31.5 mt -133.65 125.98 50.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 176.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -60.17 131.1 49.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.917 0.389 . . . . 0.0 110.769 176.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -118.24 152.62 35.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.904 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -117.04 114.97 24.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.144 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -55.33 -37.65 67.7 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.64 -173.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.37 -62.0 1.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.01 0.433 . . . . 0.0 110.312 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.664 ' O ' HG23 ' B' ' 242' ' ' VAL . 86.5 mtm180 -63.62 -34.34 77.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.665 -177.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 239' ' ' LEU . . . . . 0.53 HD11 HG22 ' B' ' 223' ' ' ILE . 9.9 tt -62.6 -57.66 10.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.07 0.462 . . . . 0.0 110.939 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -66.62 -23.34 66.16 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.127 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 241' ' ' LYS . . . . . 0.412 ' HB2' ' HE3' ' B' ' 241' ' ' LYS . 35.3 ttmt -68.34 -46.88 68.98 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 120.983 0.421 . . . . 0.0 110.74 176.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 242' ' ' VAL . . . . . 0.664 HG23 ' O ' ' B' ' 238' ' ' ARG . 52.2 t -67.44 -32.95 59.46 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 40.1 mt -75.9 -22.57 15.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.704 176.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 36.1 t -71.19 -37.41 72.14 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.656 174.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -85.86 -26.0 25.91 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.325 0.583 . . . . 0.0 110.353 175.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 246' ' ' LEU . . . . . 0.687 HD13 ' O ' ' B' ' 246' ' ' LEU . 0.0 OUTLIER -121.51 97.56 5.56 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.88 0.848 . . . . 0.0 109.678 -177.41 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 247' ' ' ASN . . . . . 0.505 ' CG ' ' H ' ' B' ' 248' ' ' GLY . 25.2 p-10 -146.79 -74.92 0.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.108 177.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 248' ' ' GLY . . . . . 0.505 ' H ' ' CG ' ' B' ' 247' ' ' ASN . . . -106.72 55.06 0.55 Allowed Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -177.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -117.07 57.85 0.78 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.731 -0.234 . . . . 0.0 110.83 -177.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 60.81 67.5 0.82 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.655 0.597 . . . . 0.0 111.477 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.501 ' HA ' HG22 ' B' ' 254' ' ' VAL . 1.8 mm -60.93 -48.79 87.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.97 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -60.44 -29.4 68.99 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.524 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 253' ' ' ASP . . . . . 0.531 ' O ' ' HG2' ' B' ' 257' ' ' GLN . 27.9 t70 -76.66 -47.49 21.95 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.961 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 254' ' ' VAL . . . . . 0.501 HG22 ' HA ' ' B' ' 251' ' ' ILE . 28.8 m -62.47 -29.86 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.597 0.237 . . . . 0.0 111.164 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 255' ' ' ILE . . . . . 0.633 ' CG2' HD13 ' A' ' 7' ' ' LEU . 61.9 mt -88.03 -24.89 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-O 120.827 0.346 . . . . 0.0 110.746 175.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -66.74 -38.99 87.75 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.018 -0.426 . . . . 0.0 111.281 177.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 257' ' ' GLN . . . . . 0.557 ' HG3' ' H ' ' B' ' 258' ' ' GLY . 4.6 pt20 -69.5 -81.96 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 258' ' ' GLY . . . . . 0.557 ' H ' ' HG3' ' B' ' 257' ' ' GLN . . . 175.44 -90.39 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.249 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 259' ' ' ILE . . . . . 0.447 ' CD1' HG13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -100.57 -97.19 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.91 -0.645 . . . . 0.0 110.732 -179.018 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 120.8 -149.4 17.48 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.628 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.54 23.61 0.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.257 0.551 . . . . 0.0 110.657 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 262' ' ' LEU . . . . . . . . . . . . . 3.1 mt -77.55 -53.05 8.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.736 -175.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -143.03 52.95 1.37 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.612 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 3.1 p -112.12 -83.14 0.59 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.321 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 15.4 t -126.93 123.39 23.61 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.022 0.439 . . . . 0.0 110.424 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -57.58 -32.6 94.8 Favored 'Trans proline' 0 N--CA 1.476 0.463 0 C-N-CA 123.988 3.125 . . . . 0.0 113.777 -174.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . -121.6 24.41 9.82 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 120.894 0.378 . . . . 0.0 111.232 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 81.14 -32.62 2.5 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 121.026 -0.607 . . . . 0.0 113.188 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . 86.72 43.8 5.97 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.872 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . 68.12 179.29 0.23 Allowed 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.219 0.608 . . . . 0.0 110.847 -176.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 7.9 t -118.74 134.26 62.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.833 0.349 . . . . 0.0 110.703 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -137.35 135.21 36.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.371 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 14.8 p -68.41 143.02 15.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.179 0.514 . . . . 0.0 110.978 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 18.8 p -108.2 179.45 4.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.384 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . 62.35 74.95 0.42 Allowed 'General case' 0 C--O 1.23 0.073 0 CA-C-O 121.283 0.563 . . . . 0.0 111.516 178.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -115.01 104.54 53.93 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.226 177.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 277' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -80.41 141.51 14.22 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.219 2.613 . . . . 0.0 112.448 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -109.26 -38.74 1.76 Allowed Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.8 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 41.6 m 66.19 -172.29 0.19 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.851 0.358 . . . . 0.0 110.922 -176.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 52.53 56.75 7.22 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.166 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 281' ' ' ALA . . . . . 0.56 ' H ' ' HD2' ' B' ' 282' ' ' PRO . . . -158.09 -54.36 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.853 -176.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 282' ' ' PRO . . . . . 0.56 ' HD2' ' H ' ' B' ' 281' ' ' ALA . 59.4 Cg_endo -70.34 155.37 64.17 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 121.548 1.499 . . . . 0.0 112.562 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -87.62 119.2 27.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.848 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -132.19 47.46 2.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.409 177.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -76.75 81.75 1.12 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.289 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 21.6 t -75.79 79.25 2.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.193 0.521 . . . . 0.0 110.232 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -139.61 77.78 27.53 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.846 176.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.91 88.97 0.29 Allowed 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.45 2.1 . . . . 0.0 112.708 -178.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -92.02 99.63 12.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.294 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -75.39 118.74 18.6 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 173.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -109.56 -81.39 0.57 Allowed 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 121.171 -0.211 . . . . 0.0 110.625 -176.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 57.2 -171.92 0.09 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.497 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 59.1 104.87 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -86.61 29.58 0.78 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.482 0.658 . . . . 0.0 110.055 177.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -138.92 110.26 6.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.535 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -94.24 -171.11 2.44 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 174.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 64.39 47.74 2.98 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -170.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -75.29 65.26 1.59 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.68 -173.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -170.64 86.15 0.11 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.188 0.518 . . . . 0.0 111.008 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -110.37 -27.83 8.86 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -57.32 98.41 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.581 176.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 12.4 p -148.61 151.74 35.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.463 -177.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -103.04 -6.2 22.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.971 0.415 . . . . 0.0 110.758 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 304' ' ' GLU . . . . . 0.441 ' HG2' ' H ' ' B' ' 304' ' ' GLU . 5.9 pt-20 -83.68 70.53 10.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.4 0.619 . . . . 0.0 111.673 -175.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 36.1 t -80.01 135.16 36.31 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.625 176.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -84.91 -27.75 26.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.633 -176.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -76.23 103.1 6.09 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.075 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -88.2 -49.94 6.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.052 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -86.75 45.3 1.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.196 -176.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . -64.44 -43.01 97.34 Favored Glycine 0 CA--C 1.517 0.213 0 CA-C-N 115.745 -0.661 . . . . 0.0 113.18 -176.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -112.53 56.0 0.68 Allowed 'General case' 0 C--N 1.327 -0.386 0 O-C-N 122.493 -0.416 . . . . 0.0 110.966 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . -134.04 53.81 0.78 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.949 -178.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.26 -39.22 17.99 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 314' ' ' PHE . . . . . . . . . . . . . 34.1 p90 52.29 17.72 0.78 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.052 1.341 . . . . 0.0 113.832 172.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 30.1 t70 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.653 -0.689 . . . . 0.0 109.868 -179.594 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.1 mtp . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.46 171.06 14.66 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.878 -0.146 . . . . 0.0 110.654 -177.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.548 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 36.7 m 60.63 28.07 17.77 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.732 0.645 . . . . 0.0 112.411 178.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.465 HG12 ' CD1' ' B' ' 212' ' ' LEU . 15.4 m -72.26 -16.26 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.76 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -68.67 0.36 Allowed 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.674 176.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.478 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 3.2 pm0 -56.2 -43.03 78.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.46 178.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.55 HD22 ' OH ' ' A' ' 11' ' ' TYR . 38.2 mt -54.32 -57.89 9.51 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.327 176.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.44 ' HB2' HD21 ' B' ' 212' ' ' LEU . . . -54.93 -50.33 69.11 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -176.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.478 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 26.4 p -70.7 -33.8 71.27 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.763 -173.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.454 HG21 ' O ' ' B' ' 262' ' ' LEU . 0.5 OUTLIER -79.36 -25.49 12.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.946 0.403 . . . . 0.0 110.576 -179.676 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.581 ' OH ' HG23 ' B' ' 255' ' ' ILE . 20.7 m-30 -76.05 -28.78 57.8 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 172.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.415 ' OG ' HG12 ' A' ' 28' ' ' ILE . 7.5 t -68.3 -50.64 52.15 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.669 174.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.21 -47.95 68.52 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 173.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.658 HD21 HG22 ' B' ' 259' ' ' ILE . 11.4 mt -52.06 -61.64 2.13 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.057 177.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.588 HD11 ' HA ' ' B' ' 206' ' ' SER . 56.5 mt -62.72 -46.29 96.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.197 0.522 . . . . 0.0 111.297 -176.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.451 ' HG ' HG12 ' A' ' 23' ' ' VAL . 25.1 tp -70.65 -15.29 62.72 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.601 -173.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -125.62 37.92 4.27 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 119.362 -0.935 . . . . 0.0 112.112 173.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.472 ' OD2' ' HB2' ' B' ' 201' ' ' MET . 12.3 t0 -81.21 -57.75 3.36 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 167.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -81.5 174.1 11.76 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.332 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -84.23 39.04 0.69 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.33 0.586 . . . . 0.0 111.171 -175.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.401 HG11 ' CD1' ' B' ' 232' ' ' ILE . 14.6 p -92.57 142.72 12.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.028 177.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.0 p -72.17 133.88 45.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.43 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.451 HG12 ' HG ' ' A' ' 16' ' ' LEU . 16.0 m -87.8 132.67 32.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.359 -179.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.5 p -147.06 158.39 43.92 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.907 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -45.76 -55.91 5.95 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.909 0.755 . . . . 0.0 111.361 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.43 -31.52 64.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.807 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -80.14 -39.1 30.13 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.494 -177.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.415 HG12 ' OG ' ' A' ' 12' ' ' SER . 4.0 mt -63.88 -47.03 92.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -55.1 -43.75 74.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.767 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.87 -47.88 83.95 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.682 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.4 mt -63.4 -39.49 94.65 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.855 0.359 . . . . 0.0 111.007 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 mp -60.01 -45.5 95.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.433 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -72.35 -25.41 61.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.811 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.81 -37.25 81.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.3 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.68 -37.73 19.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.035 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 123.0 -41.95 1.7 Allowed Glycine 0 CA--C 1.519 0.322 0 C-N-CA 119.946 -1.121 . . . . 0.0 114.005 173.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.2 m -95.01 151.63 3.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.754 0.277 . . . . 0.0 111.235 -176.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -109.47 -176.05 2.92 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.605 0.717 . . . . 0.0 111.391 -171.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.0 p -153.46 152.76 9.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.919 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -47.37 116.46 4.3 Favored Pre-proline 0 N--CA 1.47 0.535 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 175.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.406 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 88.8 Cg_exo -49.31 -14.49 0.56 Allowed 'Trans proline' 0 N--CA 1.485 0.986 0 C-N-CA 124.175 3.25 . . . . 0.0 114.863 -172.001 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.475 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -79.57 -21.0 45.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.015 -175.734 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.463 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 69.0 m95 -72.75 -52.41 6.12 Favored Pre-proline 0 CA--C 1.537 0.448 0 O-C-N 123.003 0.189 . . . . 0.0 110.548 175.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 74.5 Cg_exo -51.45 -51.5 11.06 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 122.137 1.891 . . . . 0.0 111.569 171.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.45 -37.85 92.66 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.117 177.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 39.3 tp -60.98 -56.62 18.93 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -60.01 -36.29 76.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.588 0.232 . . . . 0.0 111.022 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.6 -39.54 94.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.871 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -92.72 -11.43 33.97 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.45 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.33 -50.87 5.43 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.748 ' HA ' HG23 ' A' ' 54' ' ' VAL . 9.2 mt -85.61 -130.94 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.904 -175.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 75.79 -10.61 1.24 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.842 0.857 . . . . 0.0 113.047 175.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -143.8 -45.55 0.27 Allowed 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.748 HG23 ' HA ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -51.2 129.62 10.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 113.428 -1.714 . . . . 0.0 111.609 174.78 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -51.7 157.53 1.14 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.84 -1.527 . . . . 0.0 111.381 175.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.514 ' O ' HD22 ' A' ' 59' ' ' LEU . 3.4 tp -46.98 -50.82 5.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.803 -175.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.15 -15.48 10.77 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.627 -0.32 . . . . 0.0 113.722 -173.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.6 t -62.18 -23.3 66.53 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.514 HD22 ' O ' ' A' ' 56' ' ' ILE . 1.1 pt? -74.33 -10.36 59.51 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.359 -177.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.577 HG12 HD12 ' B' ' 259' ' ' ILE . 14.7 mt -86.86 -6.59 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-O 121.757 0.789 . . . . 0.0 109.527 176.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 66.0 m -82.72 90.45 6.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.563 176.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -77.67 69.91 3.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.121 0.962 . . . . 0.0 110.259 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.4 t -64.96 -20.49 27.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.023 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.11 -169.96 46.48 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.223 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -121.09 116.19 24.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.063 0.432 . . . . 0.0 111.327 -177.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -97.07 137.8 13.53 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.676 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -154.77 91.27 0.12 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.952 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.66 -63.73 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.687 2.258 . . . . 0.0 111.961 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -165.76 137.82 3.24 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.756 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -67.79 -47.31 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.597 2.198 . . . . 0.0 112.014 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 61.53 176.2 0.12 Allowed 'General case' 0 N--CA 1.465 0.312 0 O-C-N 123.636 0.585 . . . . 0.0 112.574 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 54.42 66.04 1.34 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.942 176.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -135.75 102.74 0.43 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.079 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -135.03 120.55 19.27 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.695 0.283 . . . . 0.0 110.559 178.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -150.57 130.02 6.51 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.495 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 50.1 Cg_exo -57.56 -21.5 46.68 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 124.068 3.179 . . . . 0.0 114.167 -176.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.68 95.4 1.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.958 0.408 . . . . 0.0 110.959 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.01 -17.22 38.4 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.679 -178.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.33 88.34 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.478 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -82.15 119.75 3.2 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.908 2.406 . . . . 0.0 111.869 176.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -112.61 95.89 34.39 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.538 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -50.29 -51.73 10.39 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.812 3.008 . . . . 0.0 113.511 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.4 t 58.63 37.51 25.29 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.227 0.536 . . . . 0.0 110.54 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.4 p -104.52 37.64 2.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.307 -178.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.89 162.65 37.27 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.171 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 58.3 74.48 0.43 Allowed 'General case' 0 N--CA 1.464 0.268 0 O-C-N 123.742 0.651 . . . . 0.0 110.654 -175.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 73.6 82.92 0.13 Allowed Pre-proline 0 N--CA 1.468 0.439 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.359 -177.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -53.43 131.42 43.45 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.005 2.47 . . . . 0.0 112.493 174.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.51 -28.31 34.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.109 -176.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -110.63 99.73 8.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.87 0.367 . . . . 0.0 111.597 -175.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -114.73 -172.75 2.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.488 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -99.13 176.04 5.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.274 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -74.89 126.2 30.45 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.056 0.455 . . . . 0.0 110.938 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.7 t -118.56 -64.86 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.246 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.416 ' HG2' ' H ' ' A' ' 97' ' ' LYS . 33.8 tt0 -128.78 155.82 44.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.541 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 97' ' ' LYS . . . -124.0 38.43 4.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.614 178.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 96' ' ' ALA . 35.9 mtmm 68.41 154.34 0.11 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.777 -176.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -156.47 173.36 17.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.035 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 59.82 96.39 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 O-C-N 123.998 0.812 . . . . 0.0 110.973 176.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -69.65 175.37 4.23 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.357 -173.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.4 t 76.01 142.87 0.08 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.03 -173.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -82.57 77.78 9.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.901 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 68.88 167.43 0.27 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.575 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.2 m -157.21 169.06 25.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.103 -175.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.8 t0 69.63 16.42 8.02 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.098 0.874 . . . . 0.0 110.929 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.1 t70 58.47 -157.84 0.31 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.893 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -91.74 167.51 12.12 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 40.2 tpp -119.36 56.29 0.93 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.293 0.568 . . . . 0.0 110.064 -176.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -149.66 177.0 28.1 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.395 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -99.81 -171.05 1.98 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.681 0.277 . . . . 0.0 110.583 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 94.73 39.05 4.76 Favored Glycine 0 CA--C 1.516 0.156 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.735 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 46.8 tp -131.36 -44.23 1.02 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.395 0.617 . . . . 0.0 110.628 -175.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -108.64 -4.32 17.19 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.829 0.823 . . . . 0.0 109.329 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 C--O 1.251 1.146 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.449 -175.226 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.94 0 CA-C-O 120.503 0.192 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.472 ' HB2' ' OD2' ' A' ' 18' ' ' ASP . 76.9 mtm -93.36 -111.89 0.11 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.202 -179.107 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 202' ' ' ARG . . . . . 0.431 ' C ' ' H ' ' B' ' 204' ' ' VAL . 67.9 mtt180 -153.76 157.55 39.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -176.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 203' ' ' TYR . . . . . 0.523 ' CD1' ' HA ' ' B' ' 239' ' ' LEU . 71.8 m-85 -79.19 30.16 0.22 Allowed 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.177 0.513 . . . . 0.0 110.52 178.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.802 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 2.5 m -58.11 -65.2 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.635 178.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 205' ' ' ALA . . . . . 0.577 ' H ' HG23 ' B' ' 204' ' ' VAL . . . -64.6 -13.67 54.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 206' ' ' SER . . . . . 0.588 ' HA ' HD11 ' A' ' 15' ' ' ILE . 4.1 m -75.74 -50.68 14.6 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 175.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 207' ' ' TYR . . . . . 0.498 ' HD1' HD11 ' B' ' 251' ' ' ILE . 15.7 t80 -62.71 -35.21 79.0 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 174.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.802 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 71.3 mt -64.3 -49.3 72.34 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.983 176.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 209' ' ' LEU . . . . . 0.53 HD21 ' HB2' ' A' ' 11' ' ' TYR . 11.4 mt -54.64 -49.91 69.43 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.785 0.326 . . . . 0.0 110.857 177.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 210' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' B' ' 218' ' ' PRO . . . -59.93 -48.69 80.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.233 -177.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 211' ' ' ALA . . . . . 0.651 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -65.18 -43.87 90.3 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.831 0.348 . . . . 0.0 110.977 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 212' ' ' LEU . . . . . 0.465 ' CD1' HG12 ' A' ' 4' ' ' VAL . 2.3 tp -61.44 -32.46 72.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.162 178.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -76.09 -11.78 84.57 Favored Glycine 0 N--CA 1.454 -0.135 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.769 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 122.22 1.14 10.38 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.278 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 215' ' ' ASN . . . . . 0.651 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 93.8 m-20 -98.44 102.91 14.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.115 0.458 . . . . 0.0 110.758 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 216' ' ' SER . . . . . 0.408 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 5.3 m -66.34 -17.78 64.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.213 178.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 14.2 t -128.07 69.74 77.67 Favored Pre-proline 0 N--CA 1.443 -0.816 0 CA-C-O 120.96 0.409 . . . . 0.0 110.355 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 218' ' ' PRO . . . . . 0.453 ' HB3' ' HB3' ' B' ' 210' ' ' ALA . 50.2 Cg_exo -58.85 102.49 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.072 2.515 . . . . 0.0 112.738 178.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 18.0 m -72.32 144.03 48.46 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.267 178.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 220' ' ' ALA . . . . . 0.456 ' HB1' HD21 ' B' ' 239' ' ' LEU . . . -56.52 -28.64 60.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.723 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -73.65 -27.03 61.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.494 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -79.8 -38.63 32.59 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.508 HG23 ' HB3' ' B' ' 206' ' ' SER . 1.8 mp -63.45 -45.2 98.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 173.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -58.02 -41.2 82.66 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.244 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -61.32 -41.7 97.44 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.317 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.73 -25.31 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.593 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -78.04 -44.7 25.69 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.765 0.316 . . . . 0.0 110.94 173.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -70.29 -15.79 62.93 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.489 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 86.8 p -51.47 -51.65 53.18 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.91 0.386 . . . . 0.0 110.633 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 60.9 t -87.28 -23.85 6.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.347 0.594 . . . . 0.0 110.371 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 101.92 41.0 2.55 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.143 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 232' ' ' ILE . . . . . 0.401 ' CD1' HG11 ' A' ' 21' ' ' VAL . 36.5 mt -103.84 136.7 35.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -73.66 145.87 44.97 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -143.0 121.65 12.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.383 -175.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 235' ' ' ASP . . . . . 0.495 ' HB2' ' HB2' ' B' ' 238' ' ' ARG . 8.0 m-20 -58.26 113.82 2.12 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.105 177.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 236' ' ' ASP . . . . . 0.52 ' O ' ' HB3' ' B' ' 239' ' ' LEU . 6.8 m-20 -61.75 -37.48 84.42 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.816 0.341 . . . . 0.0 111.648 -177.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -73.76 -46.77 43.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.921 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.495 ' HB2' ' HB2' ' B' ' 235' ' ' ASP . 41.8 mtp-105 -64.54 -29.03 70.05 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 239' ' ' LEU . . . . . 0.523 ' HA ' ' CD1' ' B' ' 203' ' ' TYR . 13.5 tp -54.07 -69.54 0.12 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.96 175.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -66.47 -24.28 66.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.463 -176.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -60.96 -53.91 51.5 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 120.866 0.365 . . . . 0.0 111.173 175.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 242' ' ' VAL . . . . . 0.509 HG21 ' H ' ' B' ' 203' ' ' TYR . 33.0 m -73.62 -28.37 24.7 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -176.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 243' ' ' ILE . . . . . 0.472 ' HA ' HD12 ' B' ' 246' ' ' LEU . 37.4 mt -70.67 -31.41 45.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.438 175.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 71.6 m -66.71 -35.25 79.69 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 172.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.79 -40.7 75.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.219 175.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 246' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' B' ' 243' ' ' ILE . 39.9 mt -67.48 -29.78 69.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.488 174.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -59.77 -32.8 70.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.131 -171.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -112.41 17.43 23.77 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.346 -175.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -124.41 151.97 43.82 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 250' ' ' ASN . . . . . 0.401 HD21 ' HB3' ' B' ' 252' ' ' GLU . 48.8 t30 -64.91 119.71 11.2 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 121.241 0.543 . . . . 0.0 110.875 -178.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.498 HD11 ' HD1' ' B' ' 207' ' ' TYR . 0.4 OUTLIER -59.16 -31.8 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.67 -177.818 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 252' ' ' GLU . . . . . 0.401 ' HB3' HD21 ' B' ' 250' ' ' ASN . 40.9 tt0 -69.88 -40.93 75.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.814 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -65.8 -38.16 88.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.802 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 254' ' ' VAL . . . . . 0.41 HG22 ' HA ' ' B' ' 251' ' ' ILE . 17.7 m -76.2 -22.11 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.457 176.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 255' ' ' ILE . . . . . 0.581 HG23 ' OH ' ' A' ' 11' ' ' TYR . 27.9 mt -64.12 -43.43 97.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-O 121.431 0.634 . . . . 0.0 109.613 169.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 256' ' ' ALA . . . . . 0.558 ' HA ' ' HB3' ' B' ' 263' ' ' ALA . . . -78.06 -27.27 48.64 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.981 -178.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -130.52 76.17 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -176.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 258' ' ' GLY . . . . . 0.592 ' H ' ' CD2' ' B' ' 262' ' ' LEU . . . -108.31 -66.85 0.6 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 172.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 259' ' ' ILE . . . . . 0.658 HG22 HD21 ' A' ' 14' ' ' LEU . 1.6 pt -85.53 -28.43 6.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 122.181 0.991 . . . . 0.0 108.665 169.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 260' ' ' GLY . . . . . 0.489 ' H ' HD22 ' B' ' 262' ' ' LEU . . . 122.27 -55.82 0.66 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 113.751 -1.568 . . . . 0.0 110.902 -176.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 261' ' ' LYS . . . . . 0.509 ' HD2' ' O ' ' A' ' 60' ' ' ILE . 91.8 mttt -102.12 24.73 9.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.826 -0.187 . . . . 0.0 110.974 177.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 262' ' ' LEU . . . . . 0.592 ' CD2' ' H ' ' B' ' 258' ' ' GLY . 1.2 pt? -79.18 -14.59 58.99 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.524 0.678 . . . . 0.0 109.945 -178.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 263' ' ' ALA . . . . . 0.558 ' HB3' ' HA ' ' B' ' 256' ' ' ALA . . . -144.79 -44.13 0.24 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.768 176.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 9.8 t 74.19 161.68 0.25 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.912 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 40.6 t -131.42 116.73 16.44 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.492 -176.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.95 -22.21 23.44 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.66 2.24 . . . . 0.0 111.724 178.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . 49.5 63.46 2.15 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.127 173.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 78.57 -51.39 3.69 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.42 177.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . 92.5 42.82 4.43 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.201 -176.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . 62.16 51.97 3.37 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.191 0.52 . . . . 0.0 111.425 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 9.6 p -83.93 149.1 4.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.186 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -141.83 155.05 45.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.82 -178.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 273' ' ' VAL . . . . . 0.406 HG22 ' O ' ' B' ' 273' ' ' VAL . 13.1 p -127.63 37.42 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 122.341 1.067 . . . . 0.0 109.961 -178.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 4.7 p -82.07 118.22 22.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.093 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -97.35 135.6 39.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.391 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 276' ' ' ALA . . . . . 0.471 ' HA ' ' HD3' ' B' ' 277' ' ' PRO . . . -129.75 139.54 35.97 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.801 -177.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 277' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' B' ' 276' ' ' ALA . 7.9 Cg_exo -72.44 102.84 1.44 Allowed 'Trans proline' 0 CA--C 1.516 -0.391 0 C-N-CA 122.616 2.21 . . . . 0.0 112.293 177.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -120.4 13.73 10.18 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.09 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 20.2 m -134.24 163.84 28.71 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 62.3 65.36 0.87 Allowed 'General case' 0 C--O 1.233 0.197 0 O-C-N 123.831 0.707 . . . . 0.0 112.11 171.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -133.48 79.84 59.01 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.409 176.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -76.54 126.33 8.9 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.412 2.074 . . . . 0.0 112.206 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -97.89 22.36 9.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.698 -177.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -133.06 117.34 17.45 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.497 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -158.58 21.8 0.33 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.03 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 30.8 p -141.31 97.76 3.23 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -177.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -114.78 115.44 43.78 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.116 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -60.0 149.44 84.24 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.701 2.267 . . . . 0.0 112.334 177.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -69.27 92.27 0.57 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.864 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -70.34 171.62 9.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.949 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -159.86 -169.14 2.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.277 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 61.18 33.61 19.21 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.049 0.452 . . . . 0.0 111.005 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 293' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' B' ' 295' ' ' LYS . 40.6 mt-10 -79.1 77.61 5.58 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.032 -178.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp 64.4 32.32 12.07 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.408 0.442 . . . . 0.0 111.074 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 295' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' B' ' 293' ' ' GLU . 91.9 mttt -126.2 99.62 5.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.779 -0.191 . . . . 0.0 110.812 -176.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -145.19 84.83 1.72 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.363 0.602 . . . . 0.0 111.034 178.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -101.08 92.22 4.9 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.645 172.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -141.44 169.46 17.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.651 -172.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt 71.47 84.68 0.13 Allowed 'General case' 0 C--O 1.233 0.219 0 O-C-N 123.868 0.73 . . . . 0.0 110.897 174.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 17.5 mp0 -74.68 48.15 0.35 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.753 -178.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 47.49 49.85 15.49 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.54 0.736 . . . . 0.0 112.704 174.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 5.4 p -91.04 114.81 27.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.072 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -94.35 98.95 11.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.24 0.543 . . . . 0.0 110.326 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -95.1 75.22 3.46 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.632 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 63.5 m 67.99 172.31 0.28 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.628 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -138.63 84.88 2.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.809 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 4.5 t70 65.45 -178.77 0.19 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.25 175.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -138.32 17.35 2.77 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.867 0.365 . . . . 0.0 110.671 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 14.9 tpt -67.56 87.06 0.2 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.749 174.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . -91.96 -128.75 4.49 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.942 174.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 61.2 15.89 6.77 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.041 0.536 . . . . 0.0 112.004 178.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . 103.34 -27.72 18.72 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.209 174.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 313' ' ' LEU . . . . . 0.488 ' O ' ' HG ' ' B' ' 313' ' ' LEU . 0.0 OUTLIER 65.61 3.65 2.51 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.194 0.521 . . . . 0.0 111.89 -179.453 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 314' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -97.45 4.2 50.61 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.796 -169.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 36.4 t70 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.488 -178.868 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.578 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 3.8 p . . . . . 0 C--O 1.235 0.34 0 CA-C-O 120.985 0.421 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.8 p -63.87 -33.02 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.649 -172.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.407 ' HB3' HG23 ' A' ' 39' ' ' VAL . 3.9 m -58.71 -66.1 0.55 Allowed 'General case' 0 C--O 1.244 0.781 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.132 -177.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -64.91 -30.85 71.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.3 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 3' ' ' SER . 54.1 mt -57.27 -60.18 4.01 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.592 173.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.411 ' HB2' HD11 ' B' ' 212' ' ' LEU . . . -55.89 -45.55 78.59 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.854 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 48.6 t -63.3 -36.78 84.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.848 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.49 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 0.9 OUTLIER -73.87 -40.04 52.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 120.621 0.248 . . . . 0.0 111.347 -179.003 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.554 ' OH ' ' HA ' ' B' ' 255' ' ' ILE . 22.1 m-85 -68.69 -37.69 79.74 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.482 ' OG ' ' HA ' ' A' ' 28' ' ' ILE . 46.1 t -64.36 -44.28 91.94 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.659 175.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.49 -57.51 11.08 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.129 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.498 HD11 ' CB ' ' B' ' 205' ' ' ALA . 3.7 pp -70.43 -22.1 62.75 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.623 -0.431 . . . . 0.0 112.038 -177.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.42 ' N ' HD12 ' A' ' 14' ' ' LEU . 13.4 mt -71.3 -33.92 52.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.233 174.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.6 mt -86.94 -8.51 57.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.062 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -17.27 -78.26 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 115.319 1.599 . . . . 0.0 115.319 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -158.97 73.61 0.61 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.261 0.553 . . . . 0.0 109.951 -168.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.448 ' HB2' HG12 ' A' ' 21' ' ' VAL . 3.7 m-20 -132.46 -158.56 0.9 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.637 -174.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -69.11 -13.57 62.51 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.264 0.554 . . . . 0.0 109.782 172.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.493 ' HB ' HG12 ' B' ' 232' ' ' ILE . 5.1 p -96.28 160.85 2.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.528 -174.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.9 p -107.61 143.14 36.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.135 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.3 t -78.28 83.91 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.0 p -131.95 163.58 28.05 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -52.2 -49.96 62.86 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.93 -176.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -54.81 -36.19 64.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.317 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.541 ' HD2' ' HB ' ' B' ' 230' ' ' VAL . 75.4 mmtt -79.9 -44.03 21.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.315 -171.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.482 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 9.1 mt -62.02 -46.07 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.037 173.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -57.8 -39.07 76.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.488 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.25 -40.35 86.27 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.817 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.435 HD22 HG23 ' B' ' 226' ' ' ILE . 60.8 mt -70.35 -42.61 71.62 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 120.939 0.399 . . . . 0.0 110.391 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.454 HD13 ' O ' ' A' ' 28' ' ' ILE . 1.7 mp -59.84 -37.95 74.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.156 174.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -70.76 -37.53 73.4 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.771 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.41 -34.51 77.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.244 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.463 ' HB2' HD12 ' B' ' 209' ' ' LEU . . . -90.82 -31.73 16.36 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.659 -0.417 . . . . 0.0 111.813 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.66 35.48 6.86 Favored Glycine 0 CA--C 1.517 0.162 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.958 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.686 HG13 ' HA2' ' B' ' 213' ' ' GLY . 0.0 OUTLIER -97.32 173.77 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.025 0.441 . . . . 0.0 111.698 -178.017 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -121.46 106.43 11.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.571 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.407 HG23 ' HB3' ' A' ' 5' ' ' SER . 14.4 p -129.66 137.94 55.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 174.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.56 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 12.8 pt-20 -67.16 135.24 93.65 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.495 ' HA ' ' HG2' ' A' ' 44' ' ' PRO . 9.5 Cg_endo -52.75 -11.57 1.42 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 124.097 3.198 . . . . 0.0 113.745 -173.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.04 -41.23 82.38 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.056 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.418 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 89.4 m95 -68.08 -58.24 8.05 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.236 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HD2' ' O ' ' A' ' 40' ' ' GLU . 12.5 Cg_endo -56.43 -43.83 51.76 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.411 2.074 . . . . 0.0 112.753 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.94 -52.98 46.57 Favored Glycine 0 C--O 1.24 0.493 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.913 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 52.4 tp -59.94 -48.49 81.5 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.454 ' CD2' HD11 ' A' ' 51' ' ' LEU . 1.7 m-85 -56.42 -46.8 80.07 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.286 0.367 . . . . 0.0 111.865 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.62 -30.11 66.68 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -89.33 -12.69 39.79 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.442 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.5 -32.29 10.02 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.674 ' HA ' HG23 ' A' ' 54' ' ' VAL . 52.6 mt -88.38 -131.02 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.293 -176.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 68.97 -12.61 0.38 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.953 0.901 . . . . 0.0 112.901 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -143.76 6.02 1.39 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.904 0.859 . . . . 0.0 110.171 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.674 HG23 ' HA ' ' A' ' 51' ' ' LEU . 1.5 t -103.05 87.55 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.802 -174.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -7.46 -95.55 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.724 1.61 . . . . 0.0 114.689 -168.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.719 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 1.2 tp -153.69 -66.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.278 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.439 ' H ' HG23 ' A' ' 56' ' ' ILE . . . -59.03 -14.72 25.82 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.799 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.658 ' CB ' HG12 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -47.73 -42.63 25.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.567 -0.816 . . . . 0.0 111.598 175.205 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.719 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 0.9 OUTLIER -65.15 -12.33 49.82 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -174.507 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.563 HG12 ' HB ' ' B' ' 259' ' ' ILE . 65.2 mt -68.29 -29.01 42.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 121.2 0.524 . . . . 0.0 110.239 176.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 83.7 m -135.5 34.08 2.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.364 -176.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.438 ' HB2' ' HA ' ' A' ' 59' ' ' LEU . 2.9 t-20 -70.63 -21.08 62.67 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.212 0.53 . . . . 0.0 110.721 -177.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.4 t . . . . . 0 C--N 1.322 -0.607 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.393 179.888 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 C--O 1.233 0.196 0 CA-C-O 121.057 0.456 . . . . 0.0 110.019 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.536 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 58.2 t -62.33 -50.68 78.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.708 -173.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 205' ' ' ALA . . . . . 0.504 ' HA ' HD12 ' B' ' 208' ' ' LEU . . . -69.34 -18.61 63.82 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.174 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . 0.501 ' OG ' HG23 ' B' ' 223' ' ' ILE . 9.4 t -73.01 -40.08 65.47 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 207' ' ' TYR . . . . . 0.695 ' CE1' HD11 ' B' ' 251' ' ' ILE . 57.0 t80 -61.01 -37.45 82.57 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 171.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.568 ' O ' ' HB3' ' B' ' 212' ' ' LEU . 83.1 mt -66.18 -40.46 90.45 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.728 176.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 209' ' ' LEU . . . . . 0.463 HD12 ' HB2' ' A' ' 35' ' ' ALA . 3.2 mm? -57.27 -45.26 84.21 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 174.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -63.37 -48.96 75.75 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.587 0.232 . . . . 0.0 111.562 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.93 -50.09 52.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.757 0.313 . . . . 0.0 111.611 -176.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 212' ' ' LEU . . . . . 0.568 ' HB3' ' O ' ' B' ' 208' ' ' LEU . 0.0 OUTLIER -67.22 -25.0 65.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.048 -178.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . 0.686 ' HA2' HG13 ' A' ' 37' ' ' VAL . . . -56.79 -22.07 39.18 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.344 -0.455 . . . . 0.0 112.54 175.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 112.47 22.65 5.72 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.562 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 215' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -138.83 95.05 2.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.126 0.488 . . . . 0.0 110.201 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 17.7 m -78.04 57.61 1.82 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.806 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 17.6 t -147.06 100.28 3.92 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . 0.428 ' HB3' ' HE2' ' B' ' 207' ' ' TYR . 51.6 Cg_exo -59.82 92.69 0.09 OUTLIER 'Trans proline' 0 N--CA 1.474 0.353 0 C-N-CA 123.478 2.785 . . . . 0.0 113.992 -176.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 50.1 m -96.14 103.15 15.02 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 171.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . 0.438 ' HB1' ' CD1' ' B' ' 239' ' ' LEU . . . -54.18 -31.16 52.08 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.376 0.608 . . . . 0.0 110.706 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -62.4 -36.58 82.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.877 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -80.47 -28.02 37.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.116 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.501 HG23 ' OG ' ' B' ' 206' ' ' SER . 1.8 mp -62.0 -48.68 87.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 168.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 224' ' ' LYS . . . . . 0.46 ' HE2' ' O ' ' B' ' 234' ' ' ALA . 3.3 tppp? -57.02 -41.1 77.92 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.328 173.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -58.31 -46.13 86.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.023 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 0.435 HG23 HD22 ' A' ' 31' ' ' LEU . 1.3 mp -65.23 -40.41 88.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.737 178.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.26 -42.93 92.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.023 0.439 . . . . 0.0 111.273 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -79.92 -22.11 43.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.585 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 99.3 p -53.14 -41.19 64.85 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.968 0.413 . . . . 0.0 111.482 -177.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 230' ' ' VAL . . . . . 0.541 ' HB ' ' HD2' ' A' ' 27' ' ' LYS . 8.1 m -100.9 -12.88 8.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.233 -176.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 100.58 67.99 0.84 Allowed Glycine 0 C--O 1.228 -0.267 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.107 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . 0.493 HG12 ' HB ' ' A' ' 21' ' ' VAL . 12.9 mt -129.19 141.22 47.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 175.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -79.23 83.89 5.24 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.384 0.611 . . . . 0.0 111.524 -176.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . 0.46 ' O ' ' HE2' ' B' ' 224' ' ' LYS . . . -93.68 143.01 26.71 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.738 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . 0.487 ' OD2' ' HG3' ' B' ' 238' ' ' ARG . 17.3 t70 -107.51 129.99 54.9 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.242 0.544 . . . . 0.0 110.991 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.85 -38.44 90.82 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.487 -172.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -71.63 -51.03 25.29 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -177.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.487 ' HG3' ' OD2' ' B' ' 235' ' ' ASP . 77.5 mtp180 -57.64 -41.53 81.61 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.461 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 239' ' ' LEU . . . . . 0.56 HD12 ' N ' ' B' ' 240' ' ' ASN . 4.5 pp -68.55 -44.04 75.35 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.996 -177.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 240' ' ' ASN . . . . . 0.56 ' N ' HD12 ' B' ' 239' ' ' LEU . 50.0 t30 -66.96 -32.1 73.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.0 0.428 . . . . 0.0 110.201 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 241' ' ' LYS . . . . . 0.513 ' O ' ' HG3' ' B' ' 245' ' ' GLU . 1.0 OUTLIER -67.13 -45.25 77.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.948 178.21 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 242' ' ' VAL . . . . . . . . . . . . . 18.1 m -71.79 -27.16 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.386 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . 0.502 HG13 ' O ' ' B' ' 239' ' ' LEU . 27.7 mt -71.48 -36.52 60.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.607 177.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 5.1 p -78.95 -14.48 59.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.79 0.329 . . . . 0.0 111.025 176.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 245' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' B' ' 241' ' ' LYS . 51.5 mt-10 -82.17 -30.76 30.82 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.988 0.423 . . . . 0.0 110.392 169.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . 0.592 ' O ' HD12 ' B' ' 246' ' ' LEU . 1.1 pp -99.58 2.56 44.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.343 -176.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -58.84 109.43 0.82 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.578 0.704 . . . . 0.0 112.045 -171.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 71.52 30.48 66.6 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.885 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -90.16 -160.93 0.74 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 110.493 -0.188 . . . . 0.0 110.493 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . 0.436 ' HB3' ' HB2' ' B' ' 253' ' ' ASP . 14.0 m-20 -72.9 81.33 1.18 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.929 0.395 . . . . 0.0 111.913 -174.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.695 HD11 ' CE1' ' B' ' 207' ' ' TYR . 2.0 mm -72.29 -54.4 16.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.827 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -61.53 -29.64 70.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.634 0.731 . . . . 0.0 110.448 -177.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' B' ' 250' ' ' ASN . 5.6 m-20 -77.22 -44.81 28.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.711 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 254' ' ' VAL . . . . . 0.469 HG12 ' O ' ' B' ' 251' ' ' ILE . 7.0 p -66.73 -23.79 31.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 121.054 0.454 . . . . 0.0 110.155 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 255' ' ' ILE . . . . . 0.554 ' HA ' ' OH ' ' A' ' 11' ' ' TYR . 44.8 mt -76.89 -55.61 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.933 175.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -66.3 -45.3 80.86 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -173.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -139.19 50.14 1.82 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.268 0.556 . . . . 0.0 111.156 -174.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -141.97 55.4 0.6 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.358 -178.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 259' ' ' ILE . . . . . 0.563 ' HB ' HG12 ' A' ' 60' ' ' ILE . 1.2 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.888 0.375 . . . . 0.0 111.073 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 t . . . . . 0 CA--C 1.534 0.365 0 CA-C-O 121.456 0.646 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.44 HG13 ' HG ' ' B' ' 212' ' ' LEU . 45.1 t -67.11 -33.73 65.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.895 -174.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.589 ' HB3' HG23 ' A' ' 39' ' ' VAL . 7.1 m -62.15 -51.33 68.28 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.528 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.499 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 39.4 tt0 -63.87 -49.42 72.83 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.822 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.404 ' HB3' HD22 ' B' ' 212' ' ' LEU . 8.4 mp -51.98 -46.64 64.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.485 174.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.431 ' HB2' HG11 ' A' ' 37' ' ' VAL . . . -61.75 -52.05 65.85 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.672 -177.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.499 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 26.2 p -64.51 -26.76 68.57 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.982 -177.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.57 -36.07 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.115 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.659 ' HB2' HD21 ' B' ' 209' ' ' LEU . 16.3 m-85 -74.96 -24.54 58.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.279 0.562 . . . . 0.0 109.929 177.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.9 m -75.26 -42.05 55.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.132 173.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.12 -39.86 63.77 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.384 169.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.522 HD12 ' HA ' ' A' ' 11' ' ' TYR . 83.2 mt -61.01 -56.97 14.83 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.646 175.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.6 mt -58.42 -31.65 43.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.66 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 46.5 mt -115.81 12.27 15.82 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -173.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -44.86 -48.5 11.13 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.785 0.326 . . . . 0.0 111.608 174.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -154.31 -84.68 0.07 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 46.3 42.46 10.37 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.501 176.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 64.41 25.43 13.37 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.295 178.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.541 HG22 ' H ' ' A' ' 22' ' ' THR . 5.4 p -149.62 173.03 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.541 ' H ' HG22 ' A' ' 21' ' ' VAL . 5.3 p -107.49 127.43 53.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.808 0.337 . . . . 0.0 111.786 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.66 ' HB ' ' O ' ' A' ' 16' ' ' LEU . 3.9 p -67.17 95.21 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.368 0.604 . . . . 0.0 110.587 176.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.504 ' OG1' ' HG2' ' A' ' 27' ' ' LYS . 39.0 p -123.46 167.22 14.14 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.315 0.579 . . . . 0.0 112.14 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -49.22 -52.74 25.15 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.591 -174.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -62.13 -30.52 71.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.368 -177.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.504 ' HG2' ' OG1' ' A' ' 24' ' ' THR . 45.0 mmtm -71.48 -49.69 38.88 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.45 HG23 HD13 ' A' ' 32' ' ' ILE . 9.5 mt -62.94 -44.4 99.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.939 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -56.05 -45.52 79.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.776 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.77 -41.63 95.73 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.527 HD11 HG23 ' B' ' 226' ' ' ILE . 0.2 OUTLIER -66.82 -41.97 86.64 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.516 0.674 . . . . 0.0 109.919 -178.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.45 HD13 HG23 ' A' ' 28' ' ' ILE . 1.6 mp -62.17 -39.46 84.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.274 176.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -66.03 -31.98 73.18 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.087 0.47 . . . . 0.0 110.287 177.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.499 ' HB1' ' HA ' ' B' ' 226' ' ' ILE . . . -65.64 -47.21 76.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.498 176.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.585 ' HA ' HD11 ' B' ' 226' ' ' ILE . . . -84.79 -17.1 39.27 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -177.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.38 12.89 83.33 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.541 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.431 HG11 ' HB2' ' A' ' 8' ' ' ALA . 19.6 t -81.7 154.14 4.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -108.95 105.23 14.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.121 0.486 . . . . 0.0 111.219 -173.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.589 HG23 ' HB3' ' A' ' 5' ' ' SER . 12.7 p -120.99 135.25 61.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.406 174.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -59.89 124.49 76.91 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.483 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.529 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 81.0 Cg_exo -47.13 -17.11 0.41 Allowed 'Trans proline' 0 N--CA 1.481 0.776 0 C-N-CA 124.554 3.503 . . . . 0.0 115.434 -171.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -75.3 -26.47 58.73 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -175.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.603 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 95.8 m95 -65.66 -54.24 31.12 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.332 174.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.603 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 75.6 Cg_exo -51.08 -52.47 9.02 Favored 'Trans proline' 0 C--N 1.364 1.381 0 C-N-CA 122.315 2.01 . . . . 0.0 112.773 173.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.29 -50.48 66.17 Favored Glycine 0 C--O 1.241 0.576 0 C-N-CA 120.571 -0.824 . . . . 0.0 112.086 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 56.5 tp -56.37 -52.49 64.41 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.29 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.428 ' O ' HD13 ' A' ' 51' ' ' LEU . 3.2 m-85 -57.53 -44.03 84.79 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -177.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.31 -39.65 95.16 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.297 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -97.42 7.3 46.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.978 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -112.38 -43.27 3.54 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.755 ' HA ' HG23 ' A' ' 54' ' ' VAL . 2.6 mp -83.16 -128.29 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.826 -175.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 65.41 -1.47 0.96 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -144.56 -46.74 0.25 Allowed 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.755 HG23 ' HA ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -55.91 119.26 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 113.626 -1.624 . . . . 0.0 111.323 177.334 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -52.96 146.27 11.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.765 174.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.444 HD11 HD23 ' A' ' 14' ' ' LEU . 1.7 tp -45.86 -37.34 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -169.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.403 ' O ' HG22 ' A' ' 60' ' ' ILE . . . -54.8 -22.12 25.29 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.788 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.432 ' HB3' HG12 ' A' ' 54' ' ' VAL . 44.5 p -51.46 -31.65 24.1 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 122.987 0.515 . . . . 0.0 111.321 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.427 HD13 ' O ' ' A' ' 56' ' ' ILE . 9.6 mp -49.53 -39.94 36.29 Favored 'General case' 0 CA--C 1.519 -0.22 0 O-C-N 123.721 0.638 . . . . 0.0 112.359 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 60' ' ' ILE . 13.3 tt -87.73 23.07 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 122.052 0.93 . . . . 0.0 110.744 -174.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.8 t -126.02 2.95 7.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.04 173.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -88.75 34.18 0.77 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.664 -176.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.2 t . . . . . 0 C--N 1.321 -0.655 0 CA-C-O 121.91 0.862 . . . . 0.0 109.876 -178.564 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 . . . . . 0 C--O 1.24 0.562 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.779 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 11.9 p -62.84 -49.83 82.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.041 -174.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 205' ' ' ALA . . . . . 0.51 ' HA ' HD12 ' B' ' 208' ' ' LEU . . . -72.58 -18.86 61.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.619 0.247 . . . . 0.0 111.09 -176.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . 0.443 ' HB3' HG23 ' B' ' 223' ' ' ILE . 45.8 m -70.37 -47.39 61.17 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 120.93 0.395 . . . . 0.0 109.968 174.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 207' ' ' TYR . . . . . 0.554 ' CZ ' ' HD2' ' B' ' 218' ' ' PRO . 29.5 t80 -62.51 -35.95 81.01 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.779 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 62.9 mt -60.83 -53.42 57.59 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.003 178.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 209' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 11' ' ' TYR . 78.7 mt -58.79 -50.84 72.43 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.054 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -61.16 -33.22 73.08 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.99 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 211' ' ' ALA . . . . . 0.671 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -76.97 -40.14 48.0 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.889 178.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 212' ' ' LEU . . . . . 0.44 ' HG ' HG13 ' A' ' 4' ' ' VAL . 52.0 tp -59.97 -55.33 35.36 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.492 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -126.26 53.37 0.79 Allowed Glycine 0 CA--C 1.507 -0.421 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.855 -174.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . -166.08 -77.85 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.494 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 215' ' ' ASN . . . . . 0.671 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 44.4 t30 -148.56 140.63 23.97 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.741 0.305 . . . . 0.0 110.201 -175.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 216' ' ' SER . . . . . 0.472 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 8.3 m -63.95 -23.92 67.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.329 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 5.2 p -120.05 70.55 15.1 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.18 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . 0.554 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 82.8 Cg_exo -52.56 131.69 42.12 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.541 2.827 . . . . 0.0 113.28 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 219' ' ' SER . . . . . 0.48 ' HB3' ' OD2' ' B' ' 222' ' ' ASP . 38.9 t -87.02 145.75 26.37 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.335 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -59.15 -21.32 59.19 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.042 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -69.6 -50.09 47.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.363 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 222' ' ' ASP . . . . . 0.48 ' OD2' ' HB3' ' B' ' 219' ' ' SER . 20.0 m-20 -67.27 -40.78 86.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.952 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.519 HD11 ' HB3' ' B' ' 218' ' ' PRO . 1.8 mp -60.34 -45.58 96.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 175.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 224' ' ' LYS . . . . . 0.422 ' O ' ' HB3' ' B' ' 228' ' ' ASP . 37.7 tptt -52.35 -46.2 66.03 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.45 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . 0.48 ' O ' ' HD3' ' B' ' 225' ' ' LYS . 7.8 tmtm? -63.68 -36.32 83.46 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 123.273 0.358 . . . . 0.0 110.469 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 0.585 HD11 ' HA ' ' A' ' 35' ' ' ALA . 1.3 mp -60.89 -44.18 97.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.098 176.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 6.8 mp -75.74 -23.76 56.07 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.984 177.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 228' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' B' ' 224' ' ' LYS . 0.0 OUTLIER -78.45 -28.1 46.56 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.78 -177.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 80.8 p -52.76 -56.81 12.94 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.973 0.416 . . . . 0.0 111.125 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 230' ' ' VAL . . . . . 0.45 HG23 HG13 ' B' ' 232' ' ' ILE . 7.3 m -79.83 -27.24 12.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.883 175.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 67.9 64.65 3.05 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.97 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . 0.45 HG13 HG23 ' B' ' 230' ' ' VAL . 55.1 mt -99.25 -89.13 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.738 0.304 . . . . 0.0 110.431 177.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -148.51 142.1 25.46 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 175.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -160.93 93.06 0.96 Allowed 'General case' 0 C--N 1.33 -0.262 0 O-C-N 123.298 0.374 . . . . 0.0 111.05 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . 0.498 ' OD2' ' HD2' ' B' ' 238' ' ' ARG . 25.6 m-20 -62.84 126.49 27.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.0 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -74.64 -12.1 60.35 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -175.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -92.37 -52.53 4.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.181 0.515 . . . . 0.0 109.765 175.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.498 ' HD2' ' OD2' ' B' ' 235' ' ' ASP . 86.3 mtt180 -65.94 -33.16 75.19 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.18 -176.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 239' ' ' LEU . . . . . . . . . . . . . 8.8 tt -59.94 -62.99 1.46 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.822 0.344 . . . . 0.0 111.052 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 240' ' ' ASN . . . . . 0.416 ' O ' ' HB2' ' B' ' 244' ' ' SER . 26.9 p-10 -74.43 -19.24 60.47 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 121.993 -0.442 . . . . 0.0 110.671 -176.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -71.63 -48.65 46.46 Favored 'General case' 0 C--O 1.244 0.781 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.831 173.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 242' ' ' VAL . . . . . 0.606 ' O ' ' HB3' ' B' ' 246' ' ' LEU . 28.4 m -66.13 -33.43 63.51 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.885 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 30.8 mt -73.19 -31.79 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 O-C-N 123.627 0.579 . . . . 0.0 111.271 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' B' ' 240' ' ' ASN . 18.3 t -64.73 -28.5 69.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.679 0.276 . . . . 0.0 110.663 176.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -87.78 -47.88 8.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.651 0.738 . . . . 0.0 109.628 172.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . 0.664 ' O ' ' HG ' ' B' ' 246' ' ' LEU . 8.8 tp -79.5 56.37 2.16 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 124.716 1.206 . . . . 0.0 109.89 177.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -100.25 37.29 1.69 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.986 -174.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . 0.479 ' HA2' HG22 ' B' ' 251' ' ' ILE . . . 99.54 2.81 56.47 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.594 -0.813 . . . . 0.0 114.043 173.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -74.98 -1.68 23.72 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -177.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -159.32 8.11 0.11 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.569 ' HA ' HG12 ' B' ' 254' ' ' VAL . 5.2 tp -65.87 -46.93 87.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -172.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -58.59 -43.87 89.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.308 0.575 . . . . 0.0 110.972 -176.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -74.54 -38.7 62.69 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.874 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 254' ' ' VAL . . . . . 0.569 HG12 ' HA ' ' B' ' 251' ' ' ILE . 6.6 p -71.06 -21.37 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 120.992 0.425 . . . . 0.0 110.351 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 255' ' ' ILE . . . . . 0.529 HG12 ' O ' ' B' ' 251' ' ' ILE . 35.2 mm -76.95 -48.48 25.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 171.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -62.83 -35.28 79.42 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -174.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -147.5 28.92 0.96 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.845 -176.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 258' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' B' ' 254' ' ' VAL . . . -110.51 56.64 0.45 Allowed Glycine 0 C--O 1.226 -0.376 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.238 -174.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 26.8 mt . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 121.35 0.595 . . . . 0.0 110.674 177.724 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.434 ' O ' HD13 ' A' ' 7' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 121.021 0.439 . . . . 0.0 110.858 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.593 HG12 HD11 ' B' ' 212' ' ' LEU . 6.0 m -62.91 -27.52 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.277 -176.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.464 ' HB3' HG23 ' A' ' 39' ' ' VAL . 1.8 m -61.64 -63.16 1.36 Allowed 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.408 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -59.24 -50.23 74.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.348 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.584 ' O ' HG22 ' A' ' 10' ' ' ILE . 9.8 mp -47.99 -54.65 12.22 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.69 0.281 . . . . 0.0 110.666 178.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.473 ' HB2' HG11 ' A' ' 37' ' ' VAL . . . -59.67 -52.77 64.11 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -177.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 40.6 t -66.0 -30.61 71.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.761 0.315 . . . . 0.0 110.92 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.584 HG22 ' O ' ' A' ' 7' ' ' LEU . 2.4 tp -74.75 -35.77 38.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.154 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.82 ' HB2' HD21 ' B' ' 209' ' ' LEU . 19.5 m-30 -66.43 -36.17 82.13 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 177.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.1 m -69.35 -46.47 66.95 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.128 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.449 ' HB1' HD21 ' A' ' 59' ' ' LEU . . . -54.65 -49.6 70.18 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.562 176.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.71 HD22 HG23 ' B' ' 259' ' ' ILE . 4.5 pp -75.67 -29.03 58.92 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.213 -177.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -65.14 -38.68 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.796 0.331 . . . . 0.0 110.788 175.287 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.562 HD13 ' HA ' ' A' ' 23' ' ' VAL . 93.1 mt -78.23 -28.28 47.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.759 178.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.8 m80 -79.21 68.85 5.29 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -165.21 -49.11 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.903 0.382 . . . . 0.0 110.429 173.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -83.69 -172.17 4.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.722 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -89.3 16.45 7.39 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.1 0.476 . . . . 0.0 110.307 175.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.492 HG21 HG12 ' B' ' 232' ' ' ILE . 41.3 t -88.8 125.94 41.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.095 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 p -77.59 147.34 35.71 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.198 -172.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.562 ' HA ' HD13 ' A' ' 16' ' ' LEU . 32.6 m -83.69 41.74 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.06 -174.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.443 ' OG1' ' HG2' ' A' ' 27' ' ' LYS . 39.1 p -67.13 159.85 28.01 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -177.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -57.72 -42.65 84.26 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -176.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -49.78 -42.65 47.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.331 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.443 ' HG2' ' OG1' ' A' ' 24' ' ' THR . 45.8 mmtm -77.74 -47.75 18.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.394 -173.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.403 ' O ' HD13 ' A' ' 32' ' ' ILE . 5.2 mt -61.55 -44.81 99.23 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.154 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.332 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -60.05 -40.61 90.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.634 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.92 -40.93 99.11 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.423 HD12 HD13 ' B' ' 209' ' ' LEU . 0.1 OUTLIER -68.83 -41.79 78.08 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.337 0.589 . . . . 0.0 110.05 -179.662 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.403 HD13 ' O ' ' A' ' 28' ' ' ILE . 1.7 mp -59.94 -37.73 73.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.601 175.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -75.58 -30.43 59.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.108 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.45 -51.2 70.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.448 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.88 -27.21 25.17 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.777 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.7 22.02 56.7 Favored Glycine 0 C--N 1.321 -0.264 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.777 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.473 HG11 ' HB2' ' A' ' 8' ' ' ALA . 12.9 t -82.34 137.17 21.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.848 0.356 . . . . 0.0 110.119 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -88.21 92.03 9.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.997 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.464 HG23 ' HB3' ' A' ' 5' ' ' SER . 7.7 p -102.41 136.18 35.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.573 175.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.47 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -54.2 125.3 49.72 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.046 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.76 -6.15 2.3 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.6 2.866 . . . . 0.0 113.507 -171.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.49 -31.25 47.65 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -177.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -65.99 -60.72 6.59 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.622 175.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.47 ' HD2' ' O ' ' A' ' 40' ' ' GLU . 19.6 Cg_endo -58.86 -40.91 67.69 Favored 'Trans proline' 0 C--N 1.361 1.197 0 C-N-CA 121.783 1.656 . . . . 0.0 112.178 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.38 -55.04 32.33 Favored Glycine 0 C--O 1.241 0.552 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.159 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.7 tt -59.87 -50.54 73.38 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.581 ' O ' HD13 ' A' ' 51' ' ' LEU . 2.6 m-85 -53.61 -53.6 49.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.01 0.433 . . . . 0.0 111.832 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.91 -27.94 67.07 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -173.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm -93.59 -11.62 31.37 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.451 -0.5 . . . . 0.0 112.15 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -106.54 -26.26 11.48 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.864 ' HA ' HG23 ' A' ' 54' ' ' VAL . 4.8 mp -81.23 -132.53 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.41 ' H ' ' HB3' ' A' ' 51' ' ' LEU . . . 57.27 6.49 0.37 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.372 0.669 . . . . 0.0 112.095 -175.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.411 ' H ' ' C ' ' A' ' 51' ' ' LEU . 37.2 m-80 -143.67 -40.76 0.29 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.864 HG23 ' HA ' ' A' ' 51' ' ' LEU . 58.7 t -45.14 108.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 113.881 -1.509 . . . . 0.0 111.622 173.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -67.51 169.71 8.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.678 173.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.6 tp -54.62 -53.25 33.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.954 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.63 -43.35 86.12 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.457 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.469 ' HB2' HG13 ' A' ' 54' ' ' VAL . 16.4 m -58.54 -28.55 65.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.662 0.268 . . . . 0.0 111.141 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.503 HD13 ' O ' ' A' ' 59' ' ' LEU . 2.5 tm? -64.06 -22.74 67.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.678 -176.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.718 HG23 HD12 ' B' ' 259' ' ' ILE . 18.3 mt -92.25 -5.28 10.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.301 0.572 . . . . 0.0 110.682 -176.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 22.4 t -137.55 51.22 1.93 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.351 0.596 . . . . 0.0 110.017 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -90.99 -34.21 15.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.548 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 C--N 1.311 -1.107 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.176 178.794 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 . . . . . 0 C--O 1.238 0.478 0 CA-C-O 120.913 0.387 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.791 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 18.1 m -58.28 -51.94 65.02 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.529 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.783 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 205' ' ' ALA . . . . . 0.541 ' CB ' HD11 ' A' ' 14' ' ' LEU . . . -64.7 -25.33 67.89 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -176.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . 0.548 ' CB ' HG23 ' B' ' 223' ' ' ILE . 6.0 m -67.11 -48.91 66.69 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 173.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 207' ' ' TYR . . . . . 0.477 ' CZ ' ' HD2' ' B' ' 218' ' ' PRO . 17.0 t80 -61.68 -35.22 77.36 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.383 175.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.791 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 39.5 mt -63.26 -53.34 54.44 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.963 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 209' ' ' LEU . . . . . 0.82 HD21 ' HB2' ' A' ' 11' ' ' TYR . 15.2 mt -52.57 -50.62 62.59 Favored 'General case' 0 C--O 1.245 0.864 0 CA-C-O 121.264 0.554 . . . . 0.0 110.003 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -62.5 -41.13 98.62 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.668 -178.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 211' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -77.77 -24.68 48.87 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.929 -0.482 . . . . 0.0 111.481 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 212' ' ' LEU . . . . . 0.593 HD11 HG12 ' A' ' 4' ' ' VAL . 33.5 tp -71.23 -47.84 54.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.669 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -141.16 20.56 2.64 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 118.954 -1.593 . . . . 0.0 114.628 -176.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . -121.05 -66.07 0.26 Allowed Glycine 0 C--N 1.321 -0.284 0 C-N-CA 119.959 -1.115 . . . . 0.0 112.772 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 215' ' ' ASN . . . . . 0.5 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 34.0 t30 -154.42 146.66 23.8 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -177.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 7.0 m -67.95 -21.62 65.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.355 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 5.6 p -125.19 70.91 62.74 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.618 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . 0.477 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 65.2 Cg_exo -57.75 132.99 53.38 Favored 'Trans proline' 0 N--CA 1.477 0.552 0 C-N-CA 122.989 2.459 . . . . 0.0 112.152 176.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 219' ' ' SER . . . . . 0.463 ' HB3' ' OD1' ' B' ' 222' ' ' ASP . 28.3 t -110.18 172.96 6.55 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.919 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -56.1 -38.9 71.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.007 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -65.98 -43.33 88.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.685 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 222' ' ' ASP . . . . . 0.463 ' OD1' ' HB3' ' B' ' 219' ' ' SER . 3.3 m-20 -62.23 -49.48 75.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.138 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.548 HG23 ' CB ' ' B' ' 206' ' ' SER . 1.8 mp -63.79 -40.23 88.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.586 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -54.43 -50.9 66.55 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.187 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -63.71 -42.64 97.91 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.075 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.14 -36.04 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 120.686 0.279 . . . . 0.0 110.73 176.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . 0.47 ' CD1' ' HB ' ' B' ' 232' ' ' ILE . 0.2 OUTLIER -75.82 -43.85 44.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.68 -178.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -86.64 -0.77 56.86 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.631 -177.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 15.4 t -55.07 -44.74 75.06 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.987 0.422 . . . . 0.0 110.51 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 230' ' ' VAL . . . . . 0.56 HG23 HG13 ' B' ' 232' ' ' ILE . 12.5 m -95.88 0.74 10.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.218 0.532 . . . . 0.0 111.16 178.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 81.65 54.98 3.3 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.616 -0.72 . . . . 0.0 113.739 175.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . 0.56 HG13 HG23 ' B' ' 230' ' ' VAL . 4.3 mt -115.64 140.07 39.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 172.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -70.74 119.85 15.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.302 0.573 . . . . 0.0 111.576 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -118.18 132.64 56.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.383 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -83.78 111.95 19.65 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -60.67 -33.69 73.22 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.458 -174.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -67.91 -58.31 4.77 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.456 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -63.92 -30.85 71.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.688 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 239' ' ' LEU . . . . . . . . . . . . . 8.7 tt -57.42 -60.72 3.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.313 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -64.25 -32.46 74.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.897 -178.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 241' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' B' ' 245' ' ' GLU . 84.3 mttt -67.77 -41.54 83.14 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 242' ' ' VAL . . . . . 0.456 ' HA ' ' OE1' ' B' ' 245' ' ' GLU . 32.9 m -73.92 -31.15 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 119.969 -0.693 . . . . 0.0 109.559 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . 0.454 ' HA ' ' CD2' ' B' ' 246' ' ' LEU . 7.5 mt -65.16 -37.09 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.077 173.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 12.1 t -63.56 -40.22 96.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.241 174.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 245' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' B' ' 241' ' ' LYS . 47.0 mt-10 -59.42 -45.54 91.25 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.439 0.638 . . . . 0.0 110.266 176.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . 0.454 ' CD2' ' HA ' ' B' ' 243' ' ' ILE . 2.9 pp -87.6 -0.11 56.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.831 -175.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -67.04 -8.23 28.7 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.051 0.453 . . . . 0.0 111.719 -170.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -80.33 -170.93 42.54 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.149 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . 0.402 ' HD2' ' N ' ' B' ' 249' ' ' LYS . 11.3 mptt -82.31 67.4 8.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.922 0.391 . . . . 0.0 110.688 -177.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -131.72 27.68 4.62 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.686 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.409 ' O ' HG13 ' B' ' 255' ' ' ILE . 23.9 mm -53.46 -66.42 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -173.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 252' ' ' GLU . . . . . 0.456 ' O ' ' HB ' ' B' ' 255' ' ' ILE . 5.0 tp10 -62.03 -32.51 73.01 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 121.138 0.494 . . . . 0.0 111.412 -174.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' B' ' 257' ' ' GLN . 8.4 t70 -67.73 -47.27 69.79 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.11 -178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 254' ' ' VAL . . . . . 0.422 HG23 HD21 ' B' ' 208' ' ' LEU . 30.0 m -67.95 -24.46 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.065 0 C-N-CA 120.239 -0.585 . . . . 0.0 110.455 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 255' ' ' ILE . . . . . 0.652 HG23 ' OH ' ' A' ' 11' ' ' TYR . 40.1 mt -61.47 -37.71 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 CA-C-O 121.468 0.651 . . . . 0.0 109.433 172.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -94.78 -2.91 50.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.42 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 257' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' B' ' 253' ' ' ASP . 0.9 OUTLIER -106.72 76.29 1.11 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.138 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -143.08 -99.16 0.3 Allowed Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.266 -0.969 . . . . 0.0 112.011 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 259' ' ' ILE . . . . . 0.718 HD12 HG23 ' A' ' 60' ' ' ILE . 1.0 OUTLIER . . . . . 0 C--N 1.346 0.451 0 CA-C-O 122.167 0.984 . . . . 0.0 108.59 171.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.569 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 23.3 t . . . . . 0 C--O 1.236 0.356 0 CA-C-O 121.162 0.506 . . . . 0.0 111.289 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.0 p -69.55 -26.27 30.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.842 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.472 ' HA ' HG22 ' A' ' 39' ' ' VAL . 8.4 p -66.83 -55.47 14.67 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.528 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.618 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 35.3 mt-10 -62.67 -39.49 94.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.733 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 3' ' ' SER . 38.3 mt -54.99 -55.41 31.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.111 0.481 . . . . 0.0 109.922 175.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.3 -44.79 95.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.994 -175.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.618 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 26.7 p -70.94 -34.62 71.65 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.416 -176.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.48 HG12 ' CG2' ' B' ' 259' ' ' ILE . 0.8 OUTLIER -75.26 -33.94 29.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.973 0.416 . . . . 0.0 110.888 -179.404 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.513 ' HB2' ' CD1' ' B' ' 209' ' ' LEU . 23.0 m-30 -77.51 -26.47 51.19 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 177.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.436 ' HA ' HD23 ' A' ' 31' ' ' LEU . 23.0 t -65.62 -51.71 57.52 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.01 -42.82 29.1 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.4 171.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.518 HD11 ' O ' ' B' ' 259' ' ' ILE . 82.6 mt -59.01 -58.29 9.32 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.781 0.324 . . . . 0.0 110.914 175.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 69.6 mt -56.62 -29.84 30.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.275 -176.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.9 mt -100.95 -9.58 21.39 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.68 -35.64 76.77 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -176.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -164.32 116.83 1.34 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -174.7 43.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.286 170.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 57.02 28.37 14.72 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.192 -174.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.0 p -126.44 161.53 32.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.651 -176.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.0 p -106.27 132.55 52.19 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -173.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.731 HG11 HD23 ' A' ' 51' ' ' LEU . 61.9 t -75.15 108.24 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -152.62 158.94 43.15 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-O 121.309 0.576 . . . . 0.0 111.894 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -43.77 -61.67 1.35 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.206 -173.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -62.86 -24.77 67.96 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.5 -173.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -77.43 -45.81 24.61 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.388 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.449 HG23 HD13 ' A' ' 32' ' ' ILE . 5.7 mt -62.46 -45.53 98.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.214 -0.595 . . . . 0.0 109.926 175.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -53.61 -45.78 70.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.194 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.0 -44.36 92.87 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 12' ' ' SER . 29.6 tp -71.22 -30.03 65.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.342 0.592 . . . . 0.0 110.316 -178.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.449 HD13 HG23 ' A' ' 28' ' ' ILE . 1.4 mp -69.66 -31.56 49.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.917 173.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -70.44 -29.83 66.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.87 -67.47 0.45 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.013 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.489 ' HB2' HD11 ' B' ' 226' ' ' ILE . . . -129.78 23.66 5.38 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -174.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -101.66 99.27 1.88 Allowed Glycine 0 C--N 1.314 -0.662 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.076 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.605 ' CG2' ' HA2' ' B' ' 213' ' ' GLY . 57.8 t -42.49 -70.07 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 122.516 0.326 . . . . 0.0 111.43 177.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -161.98 113.72 1.69 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 177.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.472 HG22 ' HA ' ' A' ' 5' ' ' SER . 11.8 t -121.65 137.52 55.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.463 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 0.7 OUTLIER -70.09 128.17 91.79 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.69 0.57 0.38 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.14 2.56 . . . . 0.0 113.116 -174.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.431 ' H ' ' C ' ' A' ' 40' ' ' GLU . 2.6 t80 -71.42 -39.72 70.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.014 176.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.526 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 68.2 m95 -72.42 -56.72 3.9 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.928 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 73.5 Cg_exo -49.95 -46.22 28.96 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 122.015 1.81 . . . . 0.0 112.321 173.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.46 -41.61 99.25 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.36 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.2 tp -61.87 -42.57 99.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.975 0.417 . . . . 0.0 110.096 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.441 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 3.2 m-85 -66.56 -40.05 88.8 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.992 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.61 -28.27 65.79 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -95.1 -30.74 13.9 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.79 -18.15 7.17 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -169.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.759 ' HA ' HG23 ' A' ' 54' ' ' VAL . 2.2 tp -89.54 -134.46 0.1 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.6 -176.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.444 ' H ' ' CG ' ' A' ' 51' ' ' LEU . . . 60.07 -13.28 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -176.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.547 ' H ' ' C ' ' A' ' 51' ' ' LEU . 48.0 m-80 -127.09 -31.38 2.6 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.759 HG23 ' HA ' ' A' ' 51' ' ' LEU . 61.0 t -49.99 103.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.382 172.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -46.74 146.32 1.62 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.671 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.468 HD11 HD23 ' A' ' 14' ' ' LEU . 4.0 tp -49.71 -51.77 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -170.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.27 -24.21 63.14 Favored Glycine 0 C--O 1.24 0.474 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.041 -176.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.3 t -68.81 -2.83 10.39 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 122.107 0.163 . . . . 0.0 111.225 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 46.3 mt -62.35 -26.02 68.22 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.192 0.52 . . . . 0.0 109.961 172.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.469 HG23 HD12 ' B' ' 259' ' ' ILE . 8.9 mt -95.74 16.26 2.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.607 0.718 . . . . 0.0 110.092 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.0 t -108.98 -45.01 3.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.381 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -87.74 5.89 37.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.036 -177.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 0 C--N 1.321 -0.671 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.897 179.644 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 121.402 0.62 . . . . 0.0 111.432 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.626 ' O ' HD13 ' B' ' 208' ' ' LEU . 60.8 t -60.09 -56.76 15.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.538 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 205' ' ' ALA . . . . . 0.556 ' HA ' HD22 ' B' ' 208' ' ' LEU . . . -69.31 -14.53 62.98 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.729 0.299 . . . . 0.0 111.27 -176.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . 0.501 ' HB3' HG23 ' B' ' 223' ' ' ILE . 8.5 m -76.61 -45.07 31.7 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 174.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 207' ' ' TYR . . . . . 0.592 ' CE1' HD11 ' B' ' 251' ' ' ILE . 36.1 t80 -62.87 -41.91 99.57 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 174.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.626 HD13 ' O ' ' B' ' 204' ' ' VAL . 2.7 mp -56.77 -49.25 75.85 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.523 175.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 209' ' ' LEU . . . . . 0.513 ' CD1' ' HB2' ' A' ' 11' ' ' TYR . 3.6 tp -59.39 -49.65 76.99 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.603 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -66.46 -28.44 68.59 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 211' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -73.94 -43.24 58.92 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.257 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 212' ' ' LEU . . . . . 0.4 HD22 ' HB3' ' A' ' 7' ' ' LEU . 4.3 pp -75.15 -35.64 61.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.765 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . 0.605 ' HA2' ' CG2' ' A' ' 37' ' ' VAL . . . -124.02 47.55 1.01 Allowed Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.312 -0.947 . . . . 0.0 114.07 -172.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . -175.95 -66.63 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.206 0 C-N-CA 119.683 -1.246 . . . . 0.0 113.309 176.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 215' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 54.9 t30 -153.12 149.28 27.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.91 0.386 . . . . 0.0 110.533 -173.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 7.6 m -71.45 -18.52 62.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.256 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 17.6 p -125.76 69.99 65.05 Favored Pre-proline 0 N--CA 1.443 -0.808 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.848 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . 0.46 ' HB3' HD11 ' B' ' 223' ' ' ILE . 76.3 Cg_exo -54.18 135.83 65.94 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.072 2.515 . . . . 0.0 112.162 178.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 15.9 m -107.84 154.18 21.93 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.789 -177.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -49.22 -49.26 43.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.13 0.49 . . . . 0.0 111.757 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -64.76 -32.28 73.89 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.116 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -70.47 -43.64 69.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.898 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.501 HG23 ' HB3' ' B' ' 206' ' ' SER . 1.8 mp -61.74 -39.56 83.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.252 0.549 . . . . 0.0 109.75 174.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -60.33 -38.1 82.67 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.564 177.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . 0.656 ' O ' ' HD3' ' B' ' 225' ' ' LYS . 6.4 tmtm? -70.32 -36.74 74.46 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 0.489 HD11 ' HB2' ' A' ' 35' ' ' ALA . 1.0 OUTLIER -61.36 -36.52 73.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.502 179.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 97.2 mt -77.04 -34.37 57.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.838 0.352 . . . . 0.0 110.272 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 228' ' ' ASP . . . . . 0.508 ' HB3' ' HA ' ' B' ' 225' ' ' LYS . 0.8 OUTLIER -56.01 -36.23 67.7 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.377 173.707 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 23.8 m -55.81 -46.89 77.96 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.789 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 230' ' ' VAL . . . . . 0.422 HG11 ' HB2' ' A' ' 31' ' ' LEU . 1.2 m -90.06 -4.08 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 83.33 29.3 33.75 Favored Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.293 176.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 41.9 mt -98.07 130.84 46.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 176.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -77.59 159.43 29.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.658 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -154.66 121.35 5.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.491 -175.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . 0.457 ' HB3' ' OD1' ' B' ' 237' ' ' ASP . 5.0 m-20 -66.7 111.2 3.56 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 171.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 236' ' ' ASP . . . . . 0.493 ' HA ' ' HB3' ' B' ' 239' ' ' LEU . 2.5 p30 -69.21 -16.92 63.72 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.71 -174.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 237' ' ' ASP . . . . . 0.457 ' OD1' ' HB3' ' B' ' 235' ' ' ASP . 6.9 p-10 -69.48 -48.96 59.03 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 174.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.574 ' O ' HG23 ' B' ' 242' ' ' VAL . 15.9 mmt180 -66.4 -43.76 84.9 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.929 177.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 239' ' ' LEU . . . . . 0.493 ' HB3' ' HA ' ' B' ' 236' ' ' ASP . 9.6 tt -54.38 -57.58 10.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.882 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -68.12 -25.96 65.56 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 122.438 -0.163 . . . . 0.0 110.773 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -69.64 -46.07 67.0 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.266 0.555 . . . . 0.0 110.338 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 242' ' ' VAL . . . . . 0.574 HG23 ' O ' ' B' ' 238' ' ' ARG . 57.3 t -66.78 -27.82 41.13 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.679 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' B' ' 246' ' ' LEU . 39.0 mt -84.18 -25.29 7.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.935 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 63.6 p -75.21 -27.02 59.4 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.642 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -86.52 -55.96 3.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.565 0.698 . . . . 0.0 109.712 173.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . 0.704 ' O ' HD13 ' B' ' 246' ' ' LEU . 0.0 OUTLIER -90.63 111.44 22.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.919 176.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -153.99 -143.23 0.13 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -176.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -73.2 37.82 0.8 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.209 -0.519 . . . . 0.0 113.412 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -107.92 95.76 5.91 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . 0.485 ' HB3' ' HB3' ' B' ' 253' ' ' ASP . 16.9 m120 61.81 52.71 3.37 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.559 0.537 . . . . 0.0 110.835 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.592 HD11 ' CE1' ' B' ' 207' ' ' TYR . 1.4 mm -59.92 -51.01 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -175.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -75.56 -11.6 60.05 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.974 -176.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . 0.485 ' HB3' ' HB3' ' B' ' 250' ' ' ASN . 22.6 t70 -84.31 -42.23 16.01 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 254' ' ' VAL . . . . . 0.516 HG12 ' O ' ' B' ' 251' ' ' ILE . 9.1 p -67.34 -22.35 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 255' ' ' ILE . . . . . 0.43 HG23 HD22 ' A' ' 7' ' ' LEU . 37.8 mt -71.97 -57.55 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.567 170.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -59.64 -36.19 75.9 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -175.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -105.13 6.2 32.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.878 0.371 . . . . 0.0 110.848 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -116.76 46.42 1.15 Allowed Glycine 0 C--O 1.229 -0.204 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.267 -174.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 259' ' ' ILE . . . . . 0.518 ' O ' HD11 ' A' ' 14' ' ' LEU . 18.9 mt . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 120.92 0.391 . . . . 0.0 111.087 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.54 ' O ' HD13 ' A' ' 7' ' ' LEU . 3.7 p . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 120.83 0.347 . . . . 0.0 111.391 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.5 m -69.67 -21.3 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.191 -176.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.465 ' HB3' HG23 ' A' ' 39' ' ' VAL . 2.3 m -65.34 -54.58 26.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.735 0.778 . . . . 0.0 110.065 177.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -65.6 -43.33 89.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.699 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.54 HD13 ' O ' ' A' ' 3' ' ' SER . 6.4 mp -55.71 -53.59 54.68 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.629 177.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.64 -50.55 72.8 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.488 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 45.6 t -63.69 -37.37 87.08 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.323 -176.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.461 HG13 HD13 ' A' ' 59' ' ' LEU . 0.6 OUTLIER -72.63 -40.89 62.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 120.564 0.221 . . . . 0.0 111.013 -177.749 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.56 ' HB2' ' CD2' ' B' ' 209' ' ' LEU . 21.0 m-85 -69.76 -27.86 65.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.508 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.423 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 8.9 t -64.72 -48.7 73.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.826 174.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.72 -42.5 62.29 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.636 172.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.588 HD23 HD11 ' A' ' 56' ' ' ILE . 95.2 mt -57.58 -59.16 5.61 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.238 0.542 . . . . 0.0 110.892 176.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.436 HG21 ' CD1' ' A' ' 31' ' ' LEU . 98.2 mt -52.29 -43.56 40.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.601 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.492 HD13 ' HA ' ' A' ' 23' ' ' VAL . 73.1 mt -75.14 -27.02 59.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.906 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -88.1 41.14 0.99 Allowed 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.836 -0.54 . . . . 0.0 111.485 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -127.1 -26.7 3.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.749 0.309 . . . . 0.0 110.683 174.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -118.21 -161.87 0.86 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -100.05 25.82 7.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.559 0.695 . . . . 0.0 110.687 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -81.19 143.49 12.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.0 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.1 p -83.06 144.8 29.66 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.825 0.345 . . . . 0.0 111.545 -177.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.612 HG21 HD23 ' A' ' 51' ' ' LEU . 35.9 m -91.62 48.24 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 121.146 0.498 . . . . 0.0 111.77 -176.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.0 p -84.5 159.28 20.75 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.32 -178.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -55.27 -36.53 66.2 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -54.37 -44.75 72.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.434 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.469 ' HD2' HG13 ' B' ' 230' ' ' VAL . 75.5 mmtt -77.98 -41.73 35.04 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 120.838 0.352 . . . . 0.0 110.369 -174.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.401 HG12 ' OG ' ' A' ' 12' ' ' SER . 4.6 mt -60.13 -45.6 95.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.647 175.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.53 -36.8 84.87 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 111.364 0.135 . . . . 0.0 111.364 176.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.12 -54.17 50.02 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 120.978 0.418 . . . . 0.0 111.122 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.514 ' CD2' ' HG ' ' B' ' 209' ' ' LEU . 5.8 tt -68.93 -35.31 76.65 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.978 -178.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.65 -36.3 59.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.848 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -78.4 -30.26 47.65 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.874 0.368 . . . . 0.0 110.719 177.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.22 -31.56 72.12 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.624 172.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.493 ' HB2' HD12 ' B' ' 209' ' ' LEU . . . -84.12 -73.46 0.42 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.745 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.08 -49.69 0.48 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.787 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.552 HG22 ' HA2' ' B' ' 213' ' ' GLY . 34.7 m -81.72 154.14 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.957 0.408 . . . . 0.0 110.616 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -121.88 -174.82 2.96 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.597 -174.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.465 HG23 ' HB3' ' A' ' 5' ' ' SER . 7.6 p -151.31 137.7 12.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.842 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.466 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 12.2 pt-20 -59.39 134.4 88.49 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-O 120.533 0.206 . . . . 0.0 110.845 -175.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 40' ' ' GLU . 73.5 Cg_exo -50.66 -13.76 0.94 Allowed 'Trans proline' 0 N--CA 1.484 0.94 0 C-N-CA 124.485 3.457 . . . . 0.0 115.574 -166.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -74.47 -31.3 62.18 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.776 0.322 . . . . 0.0 110.341 -176.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.575 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 86.7 m95 -71.03 -54.3 7.55 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-O 119.058 -0.496 . . . . 0.0 111.258 176.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.575 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 50.2 Cg_exo -55.21 -37.21 94.45 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 121.73 1.62 . . . . 0.0 111.68 173.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.61 -51.04 61.23 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.821 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.416 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 56.1 mt -60.95 -44.39 97.34 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 120.635 0.255 . . . . 0.0 111.117 178.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.554 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 8.3 m-85 -62.81 -47.68 82.38 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.057 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.86 -34.59 76.98 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -112.33 1.07 15.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -170.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 46' ' ' LEU . . . -136.76 -17.71 1.44 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 177.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.677 ' HA ' HG23 ' A' ' 54' ' ' VAL . 3.4 tp -86.73 -132.42 0.06 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.418 ' H ' ' CG ' ' A' ' 51' ' ' LEU . . . 58.31 1.04 0.15 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.413 ' H ' ' C ' ' A' ' 51' ' ' LEU . 3.7 t-20 -143.22 -41.07 0.3 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.677 HG23 ' HA ' ' A' ' 51' ' ' LEU . 59.1 t -38.56 108.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 114.132 -1.394 . . . . 0.0 110.609 169.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -53.19 129.59 31.78 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 121.836 0.827 . . . . 0.0 109.274 176.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.588 HD11 HD23 ' A' ' 14' ' ' LEU . 7.3 tp -48.98 -38.63 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 114.25 -1.341 . . . . 0.0 113.731 -166.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.16 -28.22 68.69 Favored Glycine 0 C--O 1.242 0.597 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.434 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.4 t -65.78 -5.24 8.26 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.774 -0.213 . . . . 0.0 110.562 -177.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 31.5 mt -54.73 -38.59 67.31 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 120.812 0.339 . . . . 0.0 110.725 173.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.8 tt -82.19 4.99 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.533 0.683 . . . . 0.0 110.822 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.2 m -129.47 7.03 5.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.842 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.02 -0.54 44.72 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.969 0.414 . . . . 0.0 111.798 -173.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.806 -177.152 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 203' ' ' TYR . . . . . 0.592 ' HB2' HG21 ' B' ' 242' ' ' VAL . 41.9 m-85 . . . . . 0 C--O 1.238 0.491 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.619 ' O ' HD13 ' B' ' 208' ' ' LEU . 11.7 p -66.41 -47.13 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.044 -177.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 205' ' ' ALA . . . . . 0.491 ' HA ' ' HB2' ' B' ' 208' ' ' LEU . . . -74.6 -14.71 60.81 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.538 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . 0.411 ' HB3' HG23 ' B' ' 223' ' ' ILE . 37.6 m -74.83 -38.13 62.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.026 172.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 207' ' ' TYR . . . . . 0.412 ' HE1' HD11 ' B' ' 251' ' ' ILE . 14.5 t80 -65.16 -42.85 93.34 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 173.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.619 HD13 ' O ' ' B' ' 204' ' ' VAL . 8.1 mp -54.52 -52.12 63.02 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.784 173.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 209' ' ' LEU . . . . . 0.56 ' CD2' ' HB2' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -56.16 -48.08 77.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.443 -178.443 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -62.55 -35.3 79.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.696 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 211' ' ' ALA . . . . . 0.731 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -67.13 -57.76 6.17 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.862 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 212' ' ' LEU . . . . . 0.485 HD12 ' O ' ' B' ' 208' ' ' LEU . 0.0 OUTLIER -74.53 -14.27 60.78 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.262 -178.81 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . 0.552 ' HA2' HG22 ' A' ' 37' ' ' VAL . . . -68.88 -14.91 68.53 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.661 175.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 129.85 1.41 5.45 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.955 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 215' ' ' ASN . . . . . 0.731 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 84.2 m-20 -113.08 95.32 5.33 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 3.9 m -57.14 -31.06 64.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.356 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 10.2 t -126.67 77.96 73.34 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.745 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . 0.479 ' HB3' HD11 ' B' ' 223' ' ' ILE . 52.7 Cg_exo -56.3 140.82 88.79 Favored 'Trans proline' 0 N--CA 1.476 0.452 0 C-N-CA 123.759 2.973 . . . . 0.0 113.579 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 33.6 p -107.1 146.27 31.44 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -54.49 -31.83 56.7 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.066 0.46 . . . . 0.0 111.594 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -67.99 -39.23 83.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.504 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -72.79 -39.01 67.07 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.479 HD11 ' HB3' ' B' ' 218' ' ' PRO . 1.8 mp -59.72 -46.17 93.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 174.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -58.04 -38.89 77.11 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.483 176.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . 0.501 ' NZ ' HD12 ' B' ' 226' ' ' ILE . 14.7 ttpp -57.85 -49.5 76.46 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.626 0.25 . . . . 0.0 110.673 174.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 0.501 HD12 ' NZ ' ' B' ' 225' ' ' LYS . 0.6 OUTLIER -58.54 -37.28 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.938 -177.477 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 94.9 mt -75.72 -38.79 58.23 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.869 0.366 . . . . 0.0 111.238 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -69.66 -28.66 66.07 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.967 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 46.8 m -62.51 -31.65 72.45 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.654 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 230' ' ' VAL . . . . . 0.469 HG13 ' HD2' ' A' ' 27' ' ' LYS . 99.1 t -92.27 -34.75 6.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.745 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 109.91 29.58 3.76 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.007 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 11.6 mt -98.41 126.56 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -67.42 136.67 55.08 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.857 0.36 . . . . 0.0 110.198 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -138.02 114.45 10.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.177 -174.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -66.2 121.28 14.86 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -70.27 -27.22 64.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.272 -173.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -74.84 -46.96 32.99 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -64.79 -37.57 88.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.761 0.315 . . . . 0.0 110.163 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 239' ' ' LEU . . . . . . . . . . . . . 8.3 tt -58.5 -62.02 2.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.68 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -65.72 -28.71 69.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.907 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -66.09 -46.0 79.24 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 120.656 0.265 . . . . 0.0 111.488 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 242' ' ' VAL . . . . . 0.592 HG21 ' HB2' ' B' ' 203' ' ' TYR . 27.1 m -75.12 -25.73 18.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -178.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 13.5 mt -70.49 -41.86 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.248 173.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 46.7 p -70.62 -22.88 62.48 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.304 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -69.26 -46.14 67.98 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.71 171.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 2.2 pp -87.7 -17.11 32.49 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.148 -174.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -55.23 125.79 22.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.026 0.441 . . . . 0.0 111.843 -171.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 174.98 -168.79 41.53 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.688 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.98 12.37 28.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.122 0.487 . . . . 0.0 110.304 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -88.46 25.55 1.66 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.721 0.772 . . . . 0.0 110.061 -175.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.501 ' O ' HG12 ' B' ' 254' ' ' VAL . 34.2 mm -58.66 -62.75 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.768 -177.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -66.0 -29.64 70.05 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.437 -173.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.07 -51.68 66.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.166 175.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 254' ' ' VAL . . . . . 0.501 HG12 ' O ' ' B' ' 251' ' ' ILE . 8.9 p -71.09 -22.81 22.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.981 -176.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 255' ' ' ILE . . . . . 0.401 HG12 ' O ' ' B' ' 251' ' ' ILE . 44.2 mm -75.21 -50.59 23.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.274 0.559 . . . . 0.0 110.528 173.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -71.48 -25.96 62.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.342 -173.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -140.44 46.49 1.81 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.346 0.593 . . . . 0.0 110.802 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 258' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' B' ' 254' ' ' VAL . . . -130.94 53.39 0.81 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.666 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 20.0 mt . . . . . 0 C--N 1.327 -0.401 0 CA-C-O 121.172 0.51 . . . . 0.0 110.625 178.317 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.8 m . . . . . 0 N--CA 1.45 -0.475 0 CA-C-O 120.809 0.338 . . . . 0.0 111.494 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.548 HG12 HG21 ' A' ' 37' ' ' VAL . 41.3 t -68.43 -34.35 65.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 122.052 0.93 . . . . 0.0 108.801 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.653 ' HB3' HG23 ' A' ' 39' ' ' VAL . 4.2 m -66.93 -54.62 20.22 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.041 -178.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.502 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 37.4 mt-10 -62.96 -37.11 85.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.573 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.478 HD23 ' CG2' ' B' ' 255' ' ' ILE . 4.3 mp -60.75 -50.66 72.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.384 174.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.64 -49.6 74.53 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.041 0.448 . . . . 0.0 110.799 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.406 ' HB2' HG11 ' A' ' 39' ' ' VAL . 48.9 t -65.56 -31.55 72.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.633 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.502 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 1.2 tp -74.73 -41.28 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.826 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -64.36 -37.84 88.94 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.3 m -67.59 -46.66 71.99 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.472 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' A' ' 17' ' ' HIS . . . -48.95 -52.58 23.96 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.467 176.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.462 HD11 ' CB ' ' B' ' 205' ' ' ALA . 4.1 pp -77.93 -30.23 50.39 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.797 -176.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.448 ' N ' HD12 ' A' ' 14' ' ' LEU . 9.8 mt -56.35 -40.6 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.333 0.587 . . . . 0.0 110.185 173.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.8 mt -77.25 -31.62 55.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.29 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.505 ' HB2' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -82.85 50.85 1.78 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -175.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -146.32 -45.72 0.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.875 0.369 . . . . 0.0 110.775 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -86.87 -160.89 0.62 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.736 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -88.52 -17.09 31.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.325 0.583 . . . . 0.0 109.589 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.4 t -59.2 130.48 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.116 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.2 p -83.98 147.36 27.49 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.691 -176.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.4 m -78.05 116.05 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.601 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.421 ' OG1' ' HD3' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -150.7 162.49 40.59 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -176.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 53.0 mp0 -48.58 -54.95 12.54 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 123.369 0.418 . . . . 0.0 111.334 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -50.92 -34.81 30.1 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 124.0 0.812 . . . . 0.0 110.778 -178.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.465 ' HG3' HG13 ' B' ' 230' ' ' VAL . 14.2 mptt -78.39 -50.43 11.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.182 -175.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.45 HG23 HD13 ' A' ' 32' ' ' ILE . 7.8 mt -64.33 -40.69 89.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.131 0.491 . . . . 0.0 110.125 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.57 -46.19 89.63 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.351 175.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.19 -46.99 87.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.148 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.8 mt -65.26 -43.55 90.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.521 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.45 HD13 HG23 ' A' ' 28' ' ' ILE . 1.5 mp -59.09 -47.59 89.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 120.868 0.366 . . . . 0.0 110.786 176.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -71.56 -22.09 61.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.012 0.434 . . . . 0.0 110.915 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.36 -39.13 62.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.835 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.59 -47.1 10.17 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 138.96 -61.92 0.57 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 119.978 -1.106 . . . . 0.0 114.025 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.742 HG12 ' HA2' ' B' ' 213' ' ' GLY . 8.3 p -61.03 129.77 24.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.216 0.531 . . . . 0.0 111.912 -175.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -105.72 104.98 14.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.375 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.653 HG23 ' HB3' ' A' ' 5' ' ' SER . 3.1 p -76.12 140.89 16.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.322 172.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 11.4 pt-20 -52.94 125.93 41.25 Favored Pre-proline 0 CA--C 1.531 0.242 0 O-C-N 123.212 0.32 . . . . 0.0 110.593 -178.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 40' ' ' GLU . 75.7 Cg_exo -50.76 -13.19 0.75 Allowed 'Trans proline' 0 N--CA 1.485 0.98 0 C-N-CA 124.367 3.378 . . . . 0.0 115.229 -167.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -68.76 -35.07 76.62 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.529 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 76.6 m95 -69.59 -54.22 11.17 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.007 177.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.529 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 83.3 Cg_exo -50.85 -48.54 20.33 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 122.223 1.949 . . . . 0.0 112.868 175.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.47 -47.65 87.82 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.216 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.2 tp -58.68 -49.5 77.33 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.46 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 2.6 m-85 -54.04 -54.94 32.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.867 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.2 -39.41 92.66 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -175.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -88.49 -12.21 43.6 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.88 -18.23 14.11 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.545 ' HA ' HG23 ' A' ' 54' ' ' VAL . 26.6 mt -83.89 -131.99 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 119.331 -0.948 . . . . 0.0 109.98 177.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 59.3 7.42 0.91 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.17 0.51 . . . . 0.0 111.979 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -143.56 -42.15 0.29 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.545 HG23 ' HA ' ' A' ' 51' ' ' LEU . 7.5 t -54.88 115.84 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.609 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.245 177.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -53.63 152.6 5.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.697 171.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.728 ' O ' HD12 ' A' ' 59' ' ' LEU . 2.0 tp -46.5 -71.87 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -174.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.488 ' H ' HG23 ' A' ' 56' ' ' ILE . . . -63.17 -23.8 66.55 Favored Glycine 0 C--O 1.24 0.516 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.781 -172.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.3 t -59.54 -21.24 59.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.236 -0.482 . . . . 0.0 110.579 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -59.18 -19.24 43.56 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.567 -177.454 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.577 ' N ' HD13 ' A' ' 59' ' ' LEU . 48.1 mt -64.96 -27.59 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 121.173 -0.211 . . . . 0.0 111.32 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 75.2 m -139.26 23.4 2.55 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -175.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -132.82 51.32 2.17 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.461 HG11 ' CZ3' ' A' ' 43' ' ' TRP . 85.4 t . . . . . 0 C--N 1.323 -0.58 0 CA-C-O 121.063 0.458 . . . . 0.0 110.255 173.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 203' ' ' TYR . . . . . 0.816 ' CE2' ' HA ' ' B' ' 239' ' ' LEU . 4.3 m-85 . . . . . 0 N--CA 1.463 0.2 0 CA-C-O 120.736 0.303 . . . . 0.0 111.654 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.751 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 3.8 m -52.84 -54.45 16.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.295 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 205' ' ' ALA . . . . . 0.462 ' CB ' HD11 ' A' ' 14' ' ' LEU . . . -80.14 -15.52 56.91 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.126 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . 0.492 ' CB ' HG23 ' B' ' 223' ' ' ILE . 14.9 m -68.14 -42.17 80.51 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 170.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 207' ' ' TYR . . . . . 0.543 ' CD1' HD11 ' B' ' 251' ' ' ILE . 24.1 t80 -66.27 -40.25 90.0 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.268 174.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.751 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 54.3 mt -63.12 -36.01 82.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.544 176.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 209' ' ' LEU . . . . . . . . . . . . . 1.2 mp -62.37 -44.8 95.63 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.855 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -56.58 -39.15 73.0 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.501 177.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 211' ' ' ALA . . . . . . . . . . . . . . . -87.12 -63.35 1.32 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 212' ' ' LEU . . . . . 0.507 HD11 ' O ' ' A' ' 4' ' ' VAL . 3.4 tm? -54.11 -39.82 66.76 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . 0.742 ' HA2' HG12 ' A' ' 37' ' ' VAL . . . -52.39 -20.42 7.21 Favored Glycine 0 C--N 1.33 0.244 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.165 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 99.4 26.68 8.55 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.147 174.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 215' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -117.48 -29.47 5.8 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.959 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 37.9 m 60.66 35.08 19.93 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.027 172.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 217' ' ' SER . . . . . 0.404 ' C ' ' H ' ' B' ' 219' ' ' SER . 32.2 p -120.03 104.48 43.89 Favored Pre-proline 0 C--N 1.314 -0.968 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.275 -172.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . 0.405 ' HB3' ' OH ' ' B' ' 207' ' ' TYR . 26.2 Cg_exo -70.9 19.22 0.23 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.929 2.42 . . . . 0.0 113.256 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 219' ' ' SER . . . . . 0.418 ' HB2' ' CG ' ' B' ' 222' ' ' ASP . 1.1 m -63.52 119.27 9.47 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.436 0.636 . . . . 0.0 110.46 -176.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . 0.521 ' HB1' HD21 ' B' ' 239' ' ' LEU . . . -56.2 -29.35 60.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.86 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -73.46 -30.11 62.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.495 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 222' ' ' ASP . . . . . 0.418 ' CG ' ' HB2' ' B' ' 219' ' ' SER . 93.5 m-20 -70.94 -43.93 67.17 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.492 HG23 ' CB ' ' B' ' 206' ' ' SER . 1.8 mp -58.69 -52.42 60.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-O 121.056 0.455 . . . . 0.0 110.013 174.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -56.5 -40.83 75.62 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.878 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -65.23 -37.48 87.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.284 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 1.1 mp -62.58 -42.83 97.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.539 175.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 66.0 mt -75.83 -35.71 59.89 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.447 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.37 -20.7 62.94 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.723 0.297 . . . . 0.0 110.72 177.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 16.2 t -58.26 -26.87 63.45 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.313 0.577 . . . . 0.0 109.559 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 230' ' ' VAL . . . . . 0.465 HG13 ' HG3' ' A' ' 27' ' ' LYS . 98.8 t -110.11 -39.51 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.025 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 108.35 27.03 5.19 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.545 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 5.3 mt -83.28 147.4 5.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -57.81 114.48 2.32 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.124 0.488 . . . . 0.0 112.075 -174.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . 0.494 ' HB1' ' OH ' ' B' ' 203' ' ' TYR . . . -138.66 91.01 2.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.248 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -73.24 155.38 39.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.36 -177.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 236' ' ' ASP . . . . . 0.541 ' O ' ' HB3' ' B' ' 239' ' ' LEU . 24.0 t70 -69.01 -48.34 63.26 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.635 0.255 . . . . 0.0 111.425 -175.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 237' ' ' ASP . . . . . 0.709 ' O ' ' HB2' ' B' ' 241' ' ' LYS . 8.0 t70 -58.56 -54.39 47.6 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.392 0.615 . . . . 0.0 109.627 176.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.605 ' O ' HG22 ' B' ' 242' ' ' VAL . 25.0 ttm180 -58.6 -31.92 68.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.149 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 239' ' ' LEU . . . . . 0.816 ' HA ' ' CE2' ' B' ' 203' ' ' TYR . 3.0 tp -50.6 -76.52 0.02 OUTLIER 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.353 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -73.78 -20.14 60.56 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.528 -174.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 241' ' ' LYS . . . . . 0.709 ' HB2' ' O ' ' B' ' 237' ' ' ASP . 15.9 tttt -61.71 -58.44 8.01 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-O 121.303 0.573 . . . . 0.0 110.775 176.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 242' ' ' VAL . . . . . 0.605 HG22 ' O ' ' B' ' 238' ' ' ARG . 34.1 m -73.27 -32.37 37.64 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -174.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . 0.677 ' HA ' ' CD1' ' B' ' 246' ' ' LEU . 6.9 mt -60.83 -41.61 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.609 174.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 19.5 t -63.82 -32.17 73.59 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 177.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -76.32 -48.42 20.12 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . 0.677 ' CD1' ' HA ' ' B' ' 243' ' ' ILE . 0.0 OUTLIER -88.33 -10.01 50.86 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.433 0.56 . . . . 0.0 112.338 -173.115 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 247' ' ' ASN . . . . . 0.517 ' HB2' ' O ' ' B' ' 243' ' ' ILE . 63.5 t30 -44.69 -73.22 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 O-C-N 123.688 0.617 . . . . 0.0 111.725 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 58.55 -163.53 9.52 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.51 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -135.62 20.94 3.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.298 0.57 . . . . 0.0 109.734 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -115.81 38.78 3.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.411 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.543 HD11 ' CD1' ' B' ' 207' ' ' TYR . 1.1 mm -62.79 -51.36 72.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.322 -177.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -60.36 -30.36 69.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.115 0.483 . . . . 0.0 109.771 -177.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -76.09 -51.91 11.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.942 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 254' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' B' ' 251' ' ' ILE . 9.5 p -57.88 -30.7 38.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.758 0.313 . . . . 0.0 110.888 -177.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 255' ' ' ILE . . . . . 0.478 ' CG2' HD23 ' A' ' 7' ' ' LEU . 64.9 mt -85.05 -47.32 17.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.481 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -68.17 -15.32 63.53 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -176.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -57.28 -70.83 0.11 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.917 175.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 176.84 -99.72 0.13 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.243 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 259' ' ' ILE . . . . . 0.463 HD13 HG23 ' A' ' 60' ' ' ILE . 5.4 mp . . . . . 0 C--N 1.325 -0.461 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.464 ' O ' HD13 ' A' ' 7' ' ' LEU . 23.1 p . . . . . 0 C--O 1.239 0.527 0 CA-C-O 121.238 0.542 . . . . 0.0 112.162 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.433 ' HA ' ' HB2' ' A' ' 7' ' ' LEU . 3.5 m -67.26 -16.74 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.557 -177.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.476 ' HB2' HG23 ' A' ' 39' ' ' VAL . 3.3 p -64.77 -62.02 1.82 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.558 176.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -58.2 -45.42 87.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.12 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 3' ' ' SER . 7.0 mp -51.47 -58.01 7.45 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.621 176.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.42 -47.12 76.45 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.065 -177.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 49.1 t -65.98 -34.67 78.64 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.948 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.401 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 0.9 OUTLIER -74.03 -33.65 36.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.617 0.246 . . . . 0.0 111.234 -179.003 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.704 ' HB2' HD21 ' B' ' 209' ' ' LEU . 21.4 m-85 -79.06 -23.62 44.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.187 0.518 . . . . 0.0 110.025 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.517 ' HA ' HD23 ' A' ' 31' ' ' LEU . 19.3 t -68.89 -47.24 66.35 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 171.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.5 -42.09 63.99 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.712 172.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.425 HD11 ' O ' ' B' ' 259' ' ' ILE . 20.0 mt -58.54 -54.49 46.43 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 120.922 0.391 . . . . 0.0 111.108 176.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.538 HD12 HD21 ' A' ' 31' ' ' LEU . 10.3 mt -59.54 -40.76 82.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.166 -177.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.8 mt -77.83 -22.56 49.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.413 ' CE1' ' HB ' ' A' ' 56' ' ' ILE . 25.1 t-80 -61.87 -36.35 80.97 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -73.28 -69.7 0.41 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -168.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.436 ' C ' ' H ' ' A' ' 21' ' ' VAL . 23.1 t70 -64.83 148.1 51.95 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.088 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -77.23 46.24 0.49 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.903 0.859 . . . . 0.0 110.451 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.436 ' H ' ' C ' ' A' ' 19' ' ' ASP . 9.9 p -81.3 157.37 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.303 175.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.6 t -59.02 -20.16 50.51 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -168.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.6 t 55.14 78.45 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 121.403 0.62 . . . . 0.0 109.732 -175.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.1 p -136.05 168.17 19.86 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -174.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -51.55 -48.06 63.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.568 -1.197 . . . . 0.0 110.707 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -52.45 -39.29 60.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.197 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 2.8 mptp? -80.88 -41.35 23.25 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.431 -173.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.414 HG23 HD13 ' A' ' 32' ' ' ILE . 10.8 mt -64.03 -45.39 96.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.054 174.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -60.17 -40.9 91.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.696 178.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.29 -52.55 65.17 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 111.394 177.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.594 ' HB2' HG22 ' B' ' 230' ' ' VAL . 45.4 tp -66.54 -40.98 89.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.265 0.555 . . . . 0.0 111.182 -176.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.414 HD13 HG23 ' A' ' 28' ' ' ILE . 1.5 mp -62.73 -37.21 78.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.399 177.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -74.4 -29.11 61.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 0.0 110.137 177.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.51 -45.86 92.42 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.582 175.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.423 ' HA ' HD11 ' B' ' 226' ' ' ILE . . . -80.74 -33.06 35.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.797 0.332 . . . . 0.0 111.547 177.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.52 23.43 28.75 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.812 173.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.5 t -94.89 130.15 44.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 117.327 0.563 . . . . 0.0 110.708 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -79.72 90.8 5.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.98 -177.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.476 HG23 ' HB2' ' A' ' 5' ' ' SER . 10.7 p -98.52 130.09 47.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 169.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -63.28 136.49 96.72 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.04 -177.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.475 ' HA ' ' HG2' ' A' ' 44' ' ' PRO . 82.9 Cg_exo -48.75 -14.08 0.34 Allowed 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 124.716 3.611 . . . . 0.0 115.021 -171.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.19 -36.87 77.76 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -177.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -67.44 -58.96 7.77 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 121.011 -0.275 . . . . 0.0 111.359 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.475 ' HG2' ' HA ' ' A' ' 41' ' ' PRO . 10.9 Cg_endo -54.54 -46.1 35.95 Favored 'Trans proline' 0 C--N 1.361 1.237 0 C-N-CA 122.286 1.991 . . . . 0.0 112.754 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.73 -45.99 95.11 Favored Glycine 0 C--O 1.242 0.639 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.033 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.4 tp -51.99 -59.37 4.43 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 176.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -58.99 -40.39 84.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.711 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.0 -44.61 91.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.217 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -95.62 -11.7 26.81 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.772 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.548 ' O ' HG21 ' A' ' 54' ' ' VAL . . . -104.15 -12.28 16.81 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -175.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.586 ' HA ' HG23 ' A' ' 54' ' ' VAL . 42.9 mt -101.79 -132.34 0.27 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.429 173.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 65.96 -12.61 0.17 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -144.69 12.74 1.49 Allowed 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.586 HG23 ' HA ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -128.23 120.81 54.24 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.944 -170.082 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -55.07 155.52 4.57 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.034 -1.439 . . . . 0.0 112.448 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.545 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 3.7 tp -44.53 -41.91 2.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -173.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -54.29 -23.81 27.31 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 121.611 -0.328 . . . . 0.0 113.494 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.6 t -53.84 -26.71 25.69 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 122.542 0.337 . . . . 0.0 111.264 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 34.3 mt -56.9 -36.06 69.71 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.664 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.472 HG12 HD13 ' B' ' 259' ' ' ILE . 1.1 mp -103.27 18.38 4.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.445 0.64 . . . . 0.0 109.539 -175.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 69.7 m -119.91 -6.53 10.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.393 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -100.56 -17.4 17.11 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.145 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.879 177.981 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 . . . . . 0 C--O 1.237 0.415 0 CA-C-O 121.578 0.704 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.621 ' O ' HD13 ' B' ' 208' ' ' LEU . 94.3 t -59.67 -62.1 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.158 177.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 205' ' ' ALA . . . . . 0.611 ' O ' ' HG ' ' B' ' 209' ' ' LEU . . . -61.7 -21.49 64.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.561 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . 0.407 ' CB ' HG23 ' B' ' 223' ' ' ILE . 5.7 m -66.87 -47.9 70.45 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.003 0.43 . . . . 0.0 109.88 173.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 207' ' ' TYR . . . . . 0.644 ' HD2' HD13 ' B' ' 251' ' ' ILE . 34.0 t80 -59.98 -38.89 83.87 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.667 ' O ' ' HG ' ' B' ' 212' ' ' LEU . 9.3 mp -56.57 -56.49 20.7 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.778 175.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 209' ' ' LEU . . . . . 0.704 HD21 ' HB2' ' A' ' 11' ' ' TYR . 58.0 mt -52.36 -47.5 66.1 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 123.532 0.52 . . . . 0.0 111.066 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -63.98 -32.81 74.49 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.264 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 211' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -68.8 -44.82 72.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.494 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 212' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' B' ' 208' ' ' LEU . 15.1 mt -64.81 -29.01 69.96 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.733 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -62.68 -7.18 14.13 Favored Glycine 0 C--N 1.337 0.603 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.957 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 110.66 20.82 7.1 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.485 174.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 215' ' ' ASN . . . . . 0.656 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 27.5 m-80 -130.32 111.67 12.59 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 6.3 m -65.89 -20.77 66.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.279 0.561 . . . . 0.0 110.684 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 12.0 p -123.71 70.58 47.9 Favored Pre-proline 0 N--CA 1.443 -0.806 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.859 -175.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . 0.484 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 50.4 Cg_exo -60.39 135.68 63.02 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.069 2.512 . . . . 0.0 112.599 173.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 219' ' ' SER . . . . . 0.41 ' O ' HD13 ' B' ' 223' ' ' ILE . 49.4 m -102.66 157.22 17.09 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.736 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -51.4 -41.68 60.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.198 0.523 . . . . 0.0 111.224 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -60.79 -42.55 97.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.972 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -67.82 -39.55 83.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.506 -177.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.428 HD11 ' CB ' ' B' ' 218' ' ' PRO . 1.7 mp -68.03 -39.8 82.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 120.867 0.365 . . . . 0.0 110.553 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -62.07 -42.99 99.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.953 0.406 . . . . 0.0 110.35 176.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 16.6 ttpp -64.42 -39.57 94.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.371 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 0.438 HG23 HD11 ' A' ' 31' ' ' LEU . 0.8 OUTLIER -62.65 -41.21 91.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.392 178.295 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . 0.426 ' HA ' HD22 ' B' ' 227' ' ' LEU . 0.5 OUTLIER -71.93 -45.39 61.29 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -176.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.98 -24.35 62.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.831 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 18.5 t -56.68 -42.41 78.99 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.792 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 230' ' ' VAL . . . . . 0.594 HG22 ' HB2' ' A' ' 31' ' ' LEU . 7.0 t -64.28 -29.39 47.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.526 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 105.65 10.35 31.11 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.424 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 24.9 mt -104.57 139.37 25.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -71.74 151.48 43.53 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -173.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -132.07 143.49 50.07 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.757 -176.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -91.27 114.97 27.63 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.089 0.471 . . . . 0.0 110.249 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -58.07 -51.89 67.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.407 -175.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -54.9 -56.76 16.02 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.167 0.508 . . . . 0.0 110.953 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.411 ' O ' HG13 ' B' ' 242' ' ' VAL . 18.7 mmt180 -61.39 -32.77 72.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.862 -175.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 239' ' ' LEU . . . . . . . . . . . . . 6.9 tt -61.83 -60.87 3.0 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.051 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -67.16 -29.81 69.61 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.578 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -60.12 -53.73 54.31 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 120.786 0.327 . . . . 0.0 110.94 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 242' ' ' VAL . . . . . 0.52 ' HA ' ' OE2' ' B' ' 245' ' ' GLU . 22.2 m -72.87 -25.95 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-O 121.327 0.584 . . . . 0.0 110.134 -175.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 34.9 mt -74.54 -31.18 26.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.504 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 23.3 t -64.87 -34.99 79.7 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 173.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 245' ' ' GLU . . . . . 0.52 ' OE2' ' HA ' ' B' ' 242' ' ' VAL . 36.0 mt-10 -67.42 -45.19 76.82 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.237 171.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . 0.551 HD11 ' HA ' ' B' ' 204' ' ' VAL . 52.1 mt -70.61 -95.34 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.083 -177.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 58.66 174.21 0.07 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.068 0.547 . . . . 0.0 110.448 -175.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -76.14 50.54 2.73 Favored Glycine 0 CA--C 1.516 0.127 0 O-C-N 122.091 -0.381 . . . . 0.0 113.383 -173.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -109.29 -64.84 1.2 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.508 0.67 . . . . 0.0 110.21 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -103.7 8.29 37.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.413 -174.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.644 HD13 ' HD2' ' B' ' 207' ' ' TYR . 6.0 tp -57.58 -45.57 86.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.519 -173.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -60.58 -40.08 90.39 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.258 0.551 . . . . 0.0 110.606 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -70.03 -45.25 67.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.838 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 254' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' B' ' 251' ' ' ILE . 8.9 p -66.36 -27.96 42.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.916 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 255' ' ' ILE . . . . . 0.521 HG12 ' HG ' ' B' ' 208' ' ' LEU . 96.4 mt -70.86 -52.1 30.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 121.1 0.476 . . . . 0.0 110.219 173.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -76.23 -5.36 46.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.01 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -52.59 -59.6 4.26 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.43 0.456 . . . . 0.0 111.708 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 178.73 -102.39 0.17 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.152 -1.023 . . . . 0.0 113.412 175.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 259' ' ' ILE . . . . . 0.472 HD13 HG12 ' A' ' 60' ' ' ILE . 3.4 mp . . . . . 0 N--CA 1.467 0.407 0 CA-C-N 117.061 0.43 . . . . 0.0 112.011 -175.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.235 0.315 0 CA-C-O 121.253 0.549 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.422 HG13 ' HG ' ' B' ' 212' ' ' LEU . 18.9 t -65.81 -28.44 44.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.461 -174.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.561 ' HB2' HG23 ' A' ' 39' ' ' VAL . 1.5 p -61.94 -64.11 1.04 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.36 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -56.66 -49.63 74.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.577 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.492 ' HB3' HD22 ' B' ' 212' ' ' LEU . 7.3 mp -54.96 -44.91 74.8 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.445 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.71 -45.46 89.88 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.749 0.309 . . . . 0.0 110.949 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.87 -39.0 92.84 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.694 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 tp -73.26 -39.24 55.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.353 -176.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.479 ' CB ' HD12 ' B' ' 209' ' ' LEU . 22.1 m-30 -63.99 -42.23 97.26 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.483 ' HA ' ' CD2' ' A' ' 31' ' ' LEU . 42.1 m -60.74 -43.06 98.41 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.126 0.489 . . . . 0.0 110.011 176.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.44 -56.54 18.95 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.124 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.529 HD11 ' CB ' ' B' ' 205' ' ' ALA . 3.8 pp -78.77 -7.33 57.7 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.234 -177.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 35.5 mt -83.33 -26.26 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.178 0.513 . . . . 0.0 110.105 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.533 HD12 HG13 ' A' ' 28' ' ' ILE . 56.1 mt -100.4 -3.04 31.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.957 175.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.491 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 8.1 t-80 -31.19 -70.69 0.06 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.52 20.32 1.34 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.422 0.629 . . . . 0.0 109.435 -173.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.487 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 2.3 m-20 -83.45 54.21 2.76 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.349 -171.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 19' ' ' ASP . 9.2 pt-20 47.41 29.87 1.44 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.233 1.013 . . . . 0.0 111.913 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.525 HG21 HD13 ' B' ' 232' ' ' ILE . 73.2 t -143.71 150.54 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.205 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.4 p -88.69 142.09 27.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.96 0.41 . . . . 0.0 111.846 -176.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.6 m -75.03 39.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.047 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.5 p -74.44 151.06 39.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.002 0.43 . . . . 0.0 111.736 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.58 -31.25 70.39 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.174 -177.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -53.77 -44.32 69.96 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 123.696 0.623 . . . . 0.0 110.407 173.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -81.09 -40.83 23.49 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.096 -174.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.533 HG13 HD12 ' A' ' 16' ' ' LEU . 1.5 mt -60.27 -48.08 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 174.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -57.2 -42.84 82.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.79 175.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.77 -43.21 90.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.281 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.576 HD11 HG23 ' B' ' 226' ' ' ILE . 14.3 tp -72.44 -39.79 67.57 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 120.97 0.414 . . . . 0.0 110.458 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -54.87 -43.16 66.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.29 175.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -82.54 -17.53 44.66 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.214 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.479 ' HB1' ' HA ' ' B' ' 226' ' ' ILE . . . -62.24 -47.52 84.04 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 172.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.578 ' HA ' HD11 ' B' ' 226' ' ' ILE . . . -84.27 -31.9 24.7 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.354 178.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.08 38.65 5.07 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.001 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.4 t -104.43 157.01 5.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -121.41 112.53 18.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.931 0.396 . . . . 0.0 110.782 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.561 HG23 ' HB2' ' A' ' 5' ' ' SER . 3.0 p -119.29 135.13 60.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.077 175.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.48 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 8.0 tp10 -42.95 111.41 1.02 Allowed Pre-proline 0 N--CA 1.464 0.256 0 O-C-N 123.965 0.791 . . . . 0.0 110.656 173.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.425 ' HA ' ' HG2' ' A' ' 44' ' ' PRO . 85.0 Cg_exo -49.25 -15.01 0.61 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 124.438 3.425 . . . . 0.0 114.682 -172.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.11 -34.89 75.79 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.525 ' O ' ' HB2' ' A' ' 47' ' ' PHE . 95.7 m95 -68.03 -61.31 4.25 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.375 177.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.48 ' HD2' ' O ' ' A' ' 40' ' ' GLU . 13.6 Cg_endo -57.56 -38.21 94.52 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 121.913 1.742 . . . . 0.0 112.117 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.38 -59.25 9.69 Favored Glycine 0 C--O 1.24 0.481 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.786 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 27.9 tp -55.51 -47.91 75.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.722 0.296 . . . . 0.0 110.246 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.727 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -56.32 -62.19 1.88 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.462 -177.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.97 -30.18 71.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.609 -173.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -83.85 -22.85 31.57 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.559 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.17 -4.62 17.48 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -173.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.727 ' HG ' ' O ' ' A' ' 47' ' ' PHE . 73.4 mt -79.13 -131.93 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.811 176.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 68.21 -10.64 0.42 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.645 0.778 . . . . 0.0 113.086 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -141.18 12.03 2.18 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.607 ' CG2' ' HA ' ' A' ' 51' ' ' LEU . 31.9 t -103.08 107.46 22.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.383 -173.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -54.09 150.11 8.57 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.875 172.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.832 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 1.9 tp -52.56 -60.96 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -170.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.531 ' O ' HG22 ' A' ' 60' ' ' ILE . . . -52.96 -30.47 37.45 Favored Glycine 0 C--O 1.239 0.449 0 C-N-CA 121.043 -0.598 . . . . 0.0 113.319 -173.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.3 t -50.1 -33.43 18.64 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.911 0.484 . . . . 0.0 111.965 -176.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.832 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 0.6 OUTLIER -66.45 -14.13 61.78 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -170.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.531 HG22 ' O ' ' A' ' 57' ' ' GLY . 11.3 tt -82.48 -2.62 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.763 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.6 p -150.27 47.5 0.9 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.429 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.601 ' OD1' ' HA ' ' A' ' 59' ' ' LEU . 7.9 m120 -93.41 -1.04 56.26 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.7 t . . . . . 0 C--N 1.326 -0.441 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 -178.609 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 . . . . . 0 C--O 1.238 0.47 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.547 ' O ' HD13 ' B' ' 208' ' ' LEU . 2.4 p -57.17 -62.31 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 205' ' ' ALA . . . . . 0.609 ' HA ' ' HB2' ' B' ' 208' ' ' LEU . . . -71.81 -12.15 61.15 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.96 -177.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 3.0 m -68.3 -44.93 74.35 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 172.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 207' ' ' TYR . . . . . 0.498 ' CD1' HD11 ' B' ' 251' ' ' ILE . 24.5 t80 -63.64 -45.94 87.93 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.507 173.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.609 ' HB2' ' HA ' ' B' ' 205' ' ' ALA . 7.6 mp -52.98 -50.69 63.63 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.173 177.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 209' ' ' LEU . . . . . 0.479 HD12 ' CB ' ' A' ' 11' ' ' TYR . 1.2 tt -64.7 -46.5 82.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.808 -176.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -57.13 -37.24 71.71 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.861 176.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 211' ' ' ALA . . . . . 0.726 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -79.76 -34.85 39.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.996 0.426 . . . . 0.0 111.025 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 212' ' ' LEU . . . . . 0.492 HD22 ' HB3' ' A' ' 7' ' ' LEU . 50.2 tp -56.65 -51.62 68.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.003 177.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -143.65 76.03 0.3 Allowed Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.049 -1.072 . . . . 0.0 112.438 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 176.19 -72.77 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.495 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 215' ' ' ASN . . . . . 0.726 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 94.0 m-20 -134.91 138.24 43.92 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -176.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 3.7 m -67.24 -28.02 67.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.342 0.592 . . . . 0.0 110.483 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 12.5 m -127.87 74.76 78.6 Favored Pre-proline 0 N--CA 1.442 -0.833 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.8 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.52 117.43 3.81 Favored 'Trans proline' 0 N--CA 1.474 0.369 0 C-N-CA 123.388 2.725 . . . . 0.0 112.577 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 89.1 p -88.19 164.21 15.78 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.148 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . 0.414 ' HB1' HD21 ' B' ' 239' ' ' LEU . . . -52.14 -36.16 50.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.225 0.536 . . . . 0.0 110.449 177.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -67.0 -40.94 87.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.654 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -63.14 -45.37 92.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.342 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.413 HD12 ' N ' ' B' ' 223' ' ' ILE . 1.8 mp -67.29 -40.39 84.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.124 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 224' ' ' LYS . . . . . 0.455 ' HD3' HD22 ' B' ' 239' ' ' LEU . 11.6 mmmm -57.13 -47.23 81.64 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 175.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' B' ' 229' ' ' SER . 9.0 tmtm? -62.12 -41.72 98.52 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 0.578 HD11 ' HA ' ' A' ' 35' ' ' ALA . 1.0 OUTLIER -63.17 -42.86 98.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.737 0.303 . . . . 0.0 110.833 178.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . 0.589 ' HG ' ' HB ' ' B' ' 232' ' ' ILE . 13.7 tp -76.93 -40.29 47.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.239 0.543 . . . . 0.0 110.116 -174.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.11 -32.34 73.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.865 176.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 229' ' ' SER . . . . . 0.493 ' HB2' ' O ' ' B' ' 225' ' ' LYS . 5.1 t -55.08 -42.61 73.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.438 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 94.0 t -79.9 -40.51 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-O 121.291 0.567 . . . . 0.0 110.629 176.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 115.94 33.97 1.45 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.033 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . 0.589 ' HB ' ' HG ' ' B' ' 227' ' ' LEU . 1.9 mm -91.38 128.29 43.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -57.41 119.63 6.82 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . 0.548 ' HB2' HD23 ' B' ' 227' ' ' LEU . . . -110.81 128.38 55.74 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.162 0.506 . . . . 0.0 111.86 -175.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -93.1 102.7 15.03 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 174.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -55.15 -30.76 60.49 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -176.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 237' ' ' ASP . . . . . 0.43 ' OD1' ' HD3' ' B' ' 238' ' ' ARG . 6.3 t70 -62.1 -63.11 1.35 Allowed 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.494 0.664 . . . . 0.0 110.164 174.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.642 ' O ' HG23 ' B' ' 242' ' ' VAL . 20.8 mmt180 -64.46 -26.7 68.56 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.115 -175.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 239' ' ' LEU . . . . . 0.455 HD22 ' HD3' ' B' ' 224' ' ' LYS . 8.0 tp -53.54 -63.65 1.08 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.782 174.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -66.64 -24.21 66.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.379 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -66.93 -48.0 69.96 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.251 0.548 . . . . 0.0 110.818 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 242' ' ' VAL . . . . . 0.642 HG23 ' O ' ' B' ' 238' ' ' ARG . 60.4 t -69.72 -30.18 43.82 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 43.2 mt -81.89 -24.42 9.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.994 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 6.5 p -75.91 -31.8 59.33 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 121.557 -0.715 . . . . 0.0 110.428 172.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -73.28 -56.53 4.96 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.15 0.5 . . . . 0.0 110.608 169.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . 0.722 ' O ' HD13 ' B' ' 246' ' ' LEU . 0.0 OUTLIER -100.83 122.77 43.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.574 0.702 . . . . 0.0 110.079 -176.255 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -159.7 -164.79 1.39 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.528 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . 0.476 ' HA2' HG12 ' B' ' 251' ' ' ILE . . . -75.82 37.09 1.24 Allowed Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.48 -0.39 . . . . 0.0 113.876 -175.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -81.39 -57.5 3.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.093 0.473 . . . . 0.0 110.089 176.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -131.63 51.9 2.11 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.514 ' HA ' HG22 ' B' ' 254' ' ' VAL . 1.0 OUTLIER -64.81 -51.98 60.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -170.444 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -65.39 -24.31 67.19 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.397 -175.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.19 -52.68 13.22 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.102 175.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 254' ' ' VAL . . . . . 0.514 HG22 ' HA ' ' B' ' 251' ' ' ILE . 29.7 m -66.33 -19.93 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.213 -178.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 255' ' ' ILE . . . . . . . . . . . . . 38.7 mt -84.69 -42.84 16.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.714 176.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -63.64 -43.2 97.49 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -177.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -112.36 32.45 5.57 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.286 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -100.65 54.38 0.86 Allowed Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.438 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 1.1 mt . . . . . 0 C--N 1.33 -0.242 0 CA-C-O 121.242 0.544 . . . . 0.0 111.028 177.804 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.465 ' O ' HD13 ' A' ' 7' ' ' LEU . 7.7 t . . . . . 0 CA--C 1.536 0.431 0 CA-C-O 121.123 0.487 . . . . 0.0 111.484 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.534 ' HA ' ' HB2' ' A' ' 7' ' ' LEU . 1.7 m -67.27 -16.06 20.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.213 0.53 . . . . 0.0 110.204 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.655 ' OG ' HG23 ' A' ' 39' ' ' VAL . 30.8 t -60.67 -67.79 0.36 Allowed 'General case' 0 C--O 1.25 1.115 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.349 176.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -66.21 -34.92 79.12 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.818 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 4' ' ' VAL . 6.1 mp -51.27 -54.64 24.04 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.659 173.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.05 -44.46 91.82 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.501 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' A' ' 43' ' ' TRP . 57.0 m -61.07 -38.08 84.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.097 0.475 . . . . 0.0 111.302 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.685 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -72.71 -42.36 62.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.671 -178.169 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.673 ' HD1' HD12 ' A' ' 14' ' ' LEU . 31.2 m-85 -75.37 -21.95 57.9 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.643 -176.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.6 p -75.33 -40.36 58.43 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.238 171.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -49.38 -51.01 37.67 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.471 0.653 . . . . 0.0 109.887 169.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 10' ' ' ILE . 56.0 mt -59.99 -49.86 76.0 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.241 -179.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.8 mt -54.54 -64.87 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.974 0.416 . . . . 0.0 111.381 178.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 86.8 mt -63.27 -24.72 67.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.316 -170.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.531 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 55.3 t-80 -63.54 -36.78 84.93 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -104.0 -7.86 20.01 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.194 0.521 . . . . 0.0 111.615 -167.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.476 ' HB3' HG21 ' B' ' 232' ' ' ILE . 1.1 m-20 -85.53 37.96 0.72 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.43 -175.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 50.58 29.2 3.91 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.929 0.395 . . . . 0.0 110.723 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -136.3 148.96 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.034 -169.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.1 p -86.62 136.21 33.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.733 175.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -76.44 116.6 19.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.985 0.421 . . . . 0.0 110.518 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.2 p -133.19 163.62 28.87 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.512 ' HG3' ' H ' ' A' ' 26' ' ' ASP . 6.6 pt-20 -45.29 -54.01 7.66 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.864 0.727 . . . . 0.0 111.958 -177.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.512 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 2.7 t70 -55.73 -40.06 71.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.473 -178.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -78.75 -41.57 30.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.394 -171.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.518 HG23 HD13 ' A' ' 32' ' ' ILE . 3.2 mt -63.47 -47.59 90.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.997 175.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -61.79 -33.39 74.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.265 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.77 -52.57 35.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.842 0.353 . . . . 0.0 110.891 176.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.508 HD11 HG23 ' B' ' 226' ' ' ILE . 0.2 OUTLIER -61.89 -32.31 72.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.226 0.536 . . . . 0.0 110.21 177.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.518 HD13 HG23 ' A' ' 28' ' ' ILE . 1.3 mp -69.47 -33.88 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.128 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -74.15 -27.74 60.98 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.052 174.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.73 -50.15 46.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.936 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.482 ' HB3' ' HB3' ' B' ' 209' ' ' LEU . . . -133.85 16.21 3.91 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -175.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.05 93.95 1.86 Allowed Glycine 0 C--N 1.314 -0.661 0 C-N-CA 120.317 -0.944 . . . . 0.0 111.657 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.7 p -56.43 -42.12 73.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 120.648 0.261 . . . . 0.0 111.537 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -160.97 127.4 3.98 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.029 0.442 . . . . 0.0 110.527 172.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.655 HG23 ' OG ' ' A' ' 5' ' ' SER . 8.0 p -165.07 120.45 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.795 178.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.431 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 1.7 pm0 -65.89 129.63 94.31 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.79 -8.87 0.96 Allowed 'Trans proline' 0 N--CA 1.485 0.991 0 C-N-CA 123.778 2.985 . . . . 0.0 113.755 -172.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.77 -38.16 76.65 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.649 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.482 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 70.2 m95 -69.4 -55.03 10.21 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.979 177.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.482 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 85.0 Cg_exo -49.01 -51.0 11.38 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 122.364 2.043 . . . . 0.0 113.003 176.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.55 -49.6 68.23 Favored Glycine 0 C--O 1.243 0.683 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.738 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.9 tp -54.05 -48.52 70.47 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 115.449 -0.375 . . . . 0.0 110.599 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.69 ' O ' HD12 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -67.86 -44.48 77.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.879 -173.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.1 -35.28 74.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.12 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -93.39 -1.97 55.23 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.819 175.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.83 -42.39 17.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.552 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.717 ' HA ' HG23 ' A' ' 54' ' ' VAL . 2.1 mp -86.99 -131.7 0.06 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 118.7 -1.2 . . . . 0.0 109.654 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 65.59 -9.96 0.23 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.213 0.605 . . . . 0.0 112.293 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.472 ' H ' ' C ' ' A' ' 51' ' ' LEU . 23.5 t-20 -127.59 -41.4 1.7 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.717 HG23 ' HA ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -81.77 117.16 27.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.314 168.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.437 ' OD1' HG22 ' A' ' 56' ' ' ILE . 8.6 t-20 -43.95 -67.9 0.24 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.874 0.734 . . . . 0.0 112.73 -172.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.635 ' O ' HD12 ' A' ' 59' ' ' LEU . 2.4 tp -156.24 -48.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.291 -177.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.39 -21.52 8.9 Favored Glycine 0 N--CA 1.469 0.866 0 O-C-N 123.32 0.388 . . . . 0.0 113.689 -173.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.2 t -60.97 -14.51 23.29 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 122.545 0.338 . . . . 0.0 111.155 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -68.2 -18.64 64.64 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.107 -178.27 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.506 HG22 ' O ' ' A' ' 60' ' ' ILE . 29.9 mt -100.91 29.94 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 122.254 1.026 . . . . 0.0 109.511 174.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.9 t -71.96 132.29 44.12 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 121.743 -0.598 . . . . 0.0 110.307 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -73.69 64.37 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.064 0.459 . . . . 0.0 110.678 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.6 t . . . . . 0 C--N 1.322 -0.614 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.653 176.185 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 203' ' ' TYR . . . . . 0.43 ' CE1' ' HB3' ' B' ' 239' ' ' LEU . 30.5 m-85 . . . . . 0 C--O 1.242 0.671 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.713 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 6.5 p -58.44 -50.5 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.536 -177.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 205' ' ' ALA . . . . . 0.62 ' HA ' HD12 ' B' ' 208' ' ' LEU . . . -72.65 -15.63 61.71 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.703 0.287 . . . . 0.0 110.902 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 1.7 m -70.47 -48.51 55.47 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.087 0.47 . . . . 0.0 109.736 174.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 207' ' ' TYR . . . . . 0.551 ' CZ ' ' HD2' ' B' ' 218' ' ' PRO . 33.0 t80 -61.97 -41.21 97.75 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.713 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 88.4 mt -56.82 -53.49 57.25 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.101 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 209' ' ' LEU . . . . . 0.673 ' CD2' ' HB2' ' A' ' 11' ' ' TYR . 56.0 mt -57.74 -54.83 42.43 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.956 0.408 . . . . 0.0 111.067 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 210' ' ' ALA . . . . . 0.401 ' HB3' ' HB3' ' B' ' 218' ' ' PRO . . . -58.22 -32.94 68.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.287 -176.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 211' ' ' ALA . . . . . 0.463 ' HB3' HD11 ' B' ' 255' ' ' ILE . . . -76.88 -44.58 31.39 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.158 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 212' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' B' ' 209' ' ' LEU . 2.8 pp -64.66 -22.96 67.11 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.875 0.369 . . . . 0.0 110.405 177.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.09 -13.96 58.41 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.822 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 118.49 10.87 8.33 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.348 -0.93 . . . . 0.0 113.227 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 215' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -121.48 100.42 7.01 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 122.33 -0.512 . . . . 0.0 111.216 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 2.0 m -44.74 -49.81 10.37 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -168.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 19.0 m -114.24 85.37 10.4 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 123.495 0.497 . . . . 0.0 110.446 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . 0.551 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 73.6 Cg_exo -46.01 121.91 4.77 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 123.821 3.014 . . . . 0.0 113.57 176.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 46.8 t -76.39 148.42 37.37 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.808 178.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.84 -29.11 59.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.319 176.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -66.45 -38.41 87.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.389 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -73.31 -42.53 62.24 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.127 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.484 HD11 ' CB ' ' B' ' 218' ' ' PRO . 1.7 mp -64.26 -43.88 97.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -52.15 -60.43 3.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.313 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -52.07 -50.32 61.76 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.174 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 0.508 HG23 HD11 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -56.25 -38.04 52.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.51 -177.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . 0.766 HD23 ' HB2' ' B' ' 234' ' ' ALA . 13.5 tp -75.91 -46.92 27.43 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.87 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -87.36 12.15 12.74 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 119.761 -0.775 . . . . 0.0 111.826 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 72.5 m -57.15 -34.14 68.13 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.324 165.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 54.1 t -93.5 -52.31 9.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.475 175.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 138.93 30.38 0.21 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.903 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . 0.476 HG21 ' HB3' ' A' ' 19' ' ' ASP . 3.4 mp -101.92 149.65 6.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 174.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -86.8 150.54 24.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.313 0.578 . . . . 0.0 111.742 -171.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . 0.766 ' HB2' HD23 ' B' ' 227' ' ' LEU . . . -134.68 160.85 36.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.749 -177.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -112.87 125.82 54.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.119 0.485 . . . . 0.0 110.286 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -62.36 -51.15 68.76 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 114.766 -1.106 . . . . 0.0 113.146 -170.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -75.08 -33.46 61.67 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.494 -173.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 26.5 tpt180 -68.21 -44.97 74.6 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.886 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 239' ' ' LEU . . . . . 0.497 HD12 ' N ' ' B' ' 240' ' ' ASN . 4.5 pp -66.27 -37.59 85.81 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.363 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 240' ' ' ASN . . . . . 0.497 ' N ' HD12 ' B' ' 239' ' ' LEU . 26.1 t-20 -67.78 -36.91 81.33 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 121.311 -0.156 . . . . 0.0 110.651 178.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -65.36 -45.58 83.6 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 120.612 0.244 . . . . 0.0 110.94 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 242' ' ' VAL . . . . . 0.427 ' O ' ' HG ' ' B' ' 246' ' ' LEU . 33.9 m -70.89 -32.26 48.15 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 CA-C-O 121.493 0.663 . . . . 0.0 109.616 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 32.1 mt -72.36 -29.58 32.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.538 175.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 47.1 t -66.01 -32.08 73.35 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 172.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -74.28 -31.42 62.52 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.084 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' B' ' 242' ' ' VAL . 32.2 mt -85.88 1.36 50.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.553 178.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -78.87 -11.31 59.99 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -166.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -88.08 -132.82 4.07 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.828 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -98.93 -156.67 0.56 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 18.9 m120 75.37 -25.38 0.2 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.081 0.552 . . . . 0.0 112.456 174.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.636 ' HA ' HG12 ' B' ' 254' ' ' VAL . 5.9 tp -56.52 -38.67 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.466 0.651 . . . . 0.0 110.416 175.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -54.28 -50.88 66.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.037 176.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.2 -45.91 75.46 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.063 -177.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 254' ' ' VAL . . . . . 0.636 HG12 ' HA ' ' B' ' 251' ' ' ILE . 9.6 p -62.5 -33.9 61.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.259 -175.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 255' ' ' ILE . . . . . 0.463 HD11 ' HB3' ' B' ' 211' ' ' ALA . 63.4 mt -80.07 -40.33 20.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.815 176.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -57.18 -51.71 68.23 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.749 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -160.78 75.65 0.55 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.918 0.39 . . . . 0.0 110.448 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -176.32 56.37 0.11 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.733 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 259' ' ' ILE . . . . . 0.451 ' H ' HG13 ' B' ' 259' ' ' ILE . 27.7 mt . . . . . 0 N--CA 1.48 1.044 0 C-N-CA 123.808 0.843 . . . . 0.0 111.898 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.476 ' O ' HD13 ' A' ' 7' ' ' LEU . 3.4 p . . . . . 0 CA--C 1.533 0.302 0 CA-C-O 121.281 0.563 . . . . 0.0 111.457 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.4 -22.78 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.955 -175.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.474 ' HB2' HG23 ' A' ' 39' ' ' VAL . 3.4 p -61.67 -63.68 1.19 Allowed 'General case' 0 C--O 1.242 0.667 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.111 178.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -62.43 -41.75 98.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.088 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.476 HD13 ' O ' ' A' ' 3' ' ' SER . 5.2 mp -49.45 -59.27 3.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.341 176.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.8 -53.18 60.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.668 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 35.7 t -64.79 -37.52 87.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.775 -175.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.419 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 1.3 tp -75.77 -35.46 30.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.898 0.38 . . . . 0.0 110.951 -175.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.766 ' OH ' ' HA2' ' B' ' 258' ' ' GLY . 17.3 m-30 -74.55 -28.32 60.9 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.769 177.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 64.3 m -66.04 -41.98 90.17 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 173.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.441 ' HB3' HD21 ' A' ' 59' ' ' LEU . . . -53.74 -45.09 70.43 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.101 171.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 10' ' ' ILE . 72.8 mt -59.46 -55.15 38.27 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.788 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.404 HD11 ' HA ' ' B' ' 206' ' ' SER . 73.4 mt -52.35 -45.62 45.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.243 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.3 mt -76.19 -18.42 59.08 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.365 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -98.3 18.37 16.55 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.957 -0.464 . . . . 0.0 112.162 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -117.48 -51.98 2.49 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.009 178.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -74.42 29.22 0.08 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 50.86 40.29 24.48 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.742 0.417 . . . . 0.0 111.864 178.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.8 p -121.72 164.69 18.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.79 0.329 . . . . 0.0 111.026 -173.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.2 p -90.48 135.25 33.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.021 0.438 . . . . 0.0 111.777 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.627 HG11 HD23 ' A' ' 51' ' ' LEU . 91.8 t -77.82 123.34 34.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.414 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.26 158.49 43.81 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 177.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -50.91 -55.29 17.85 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.48 -177.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -51.73 -33.7 35.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.594 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -73.76 -50.34 21.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.534 0.207 . . . . 0.0 110.64 -176.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.409 ' O ' HD13 ' A' ' 32' ' ' ILE . 9.1 mt -65.34 -43.3 94.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.13 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -60.63 -36.61 79.06 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.988 175.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.57 -44.33 87.04 Favored 'General case' 0 C--O 1.227 -0.111 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.95 -42.98 89.29 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.239 0.542 . . . . 0.0 110.774 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.409 HD13 ' O ' ' A' ' 28' ' ' ILE . 1.6 mp -60.88 -44.0 96.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.411 177.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -73.31 -27.96 61.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.662 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.407 ' HB3' HG13 ' B' ' 226' ' ' ILE . . . -66.4 -37.63 85.66 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.361 176.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.423 ' HB2' HD12 ' B' ' 209' ' ' LEU . . . -82.39 -35.89 27.27 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.674 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.9 31.39 4.8 Favored Glycine 0 N--CA 1.454 -0.144 0 C-N-CA 120.755 -0.736 . . . . 0.0 113.428 175.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.511 HG13 ' HA2' ' B' ' 213' ' ' GLY . 22.3 m -114.52 175.08 2.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 122.725 -0.279 . . . . 0.0 110.732 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -132.96 106.94 7.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.902 0.382 . . . . 0.0 110.612 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.474 HG23 ' HB2' ' A' ' 5' ' ' SER . 7.4 p -102.64 135.25 40.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 174.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -53.8 130.28 56.36 Favored Pre-proline 0 C--O 1.236 0.361 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.51 -2.82 1.11 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.41 2.74 . . . . 0.0 113.721 -170.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.8 -37.48 70.39 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.032 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.578 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 94.9 m95 -70.7 -54.38 8.24 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 119.194 -0.431 . . . . 0.0 110.74 177.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.578 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 75.4 Cg_exo -51.88 -45.31 39.31 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 121.705 1.603 . . . . 0.0 112.213 175.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.77 -43.68 95.88 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.333 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.0 -43.26 95.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.196 0.522 . . . . 0.0 110.286 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.474 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 2.8 m-85 -70.24 -41.08 74.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.803 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.81 -35.95 81.26 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -98.77 -23.14 15.52 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -174.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.08 -24.8 5.46 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -174.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.709 ' HA ' HG23 ' A' ' 54' ' ' VAL . 2.0 tp -86.65 -133.35 0.06 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.475 ' H ' ' CG ' ' A' ' 51' ' ' LEU . . . 60.7 -12.13 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.615 0.766 . . . . 0.0 112.773 -177.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.538 ' H ' ' C ' ' A' ' 51' ' ' LEU . 18.3 m120 -125.99 -34.94 2.51 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.709 HG23 ' HA ' ' A' ' 51' ' ' LEU . 61.2 t -45.0 108.26 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.517 174.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -47.39 140.21 5.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.735 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.9 tp -52.39 -48.58 45.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.896 -173.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.93 -40.67 93.57 Favored Glycine 0 C--O 1.239 0.457 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.601 177.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.4 t -59.0 -17.81 28.5 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 122.76 0.424 . . . . 0.0 111.012 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.441 HD21 ' HB3' ' A' ' 13' ' ' ALA . 15.4 tp -62.01 -21.52 64.94 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.193 -176.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.3 tt -71.18 -13.4 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.117 0.484 . . . . 0.0 110.893 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 62.5 m -103.41 55.52 0.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.124 0.488 . . . . 0.0 110.304 177.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -74.97 -4.47 38.39 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.753 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 C--N 1.322 -0.618 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.399 -177.134 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 . . . . . 0 N--CA 1.473 0.701 0 CA-C-O 121.169 0.509 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.557 ' O ' HD13 ' B' ' 208' ' ' LEU . 57.7 t -59.1 -54.35 35.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.144 177.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 205' ' ' ALA . . . . . 0.459 ' HA ' HD22 ' B' ' 208' ' ' LEU . . . -65.53 -20.61 66.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.727 0.299 . . . . 0.0 111.069 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . 0.404 ' HA ' HD11 ' A' ' 15' ' ' ILE . 1.5 m -68.14 -43.61 77.92 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 173.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 207' ' ' TYR . . . . . 0.507 ' HD2' HD13 ' B' ' 251' ' ' ILE . 35.7 t80 -62.3 -39.96 94.73 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.557 HD13 ' O ' ' B' ' 204' ' ' VAL . 8.8 mp -56.69 -52.81 63.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.955 175.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 209' ' ' LEU . . . . . 0.551 ' CD2' ' HB2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -55.15 -52.75 62.31 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.87 -178.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 210' ' ' ALA . . . . . 0.422 ' CB ' ' HB3' ' B' ' 218' ' ' PRO . . . -65.72 -31.09 71.88 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.57 -177.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 211' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -69.77 -47.87 61.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.003 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 212' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' B' ' 209' ' ' LEU . 4.6 pp -67.21 -22.15 65.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.978 0.418 . . . . 0.0 109.897 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . 0.511 ' HA2' HG13 ' A' ' 37' ' ' VAL . . . -55.22 -25.79 41.08 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.909 174.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 123.86 17.21 3.15 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.633 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 215' ' ' ASN . . . . . 0.579 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 34.2 t30 -133.1 124.0 26.76 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.817 0.341 . . . . 0.0 110.587 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 216' ' ' SER . . . . . 0.517 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 15.5 m -75.41 -21.96 57.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.11 -178.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 8.4 t -121.44 68.02 20.12 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.999 -176.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . 0.517 ' HD3' ' C ' ' B' ' 216' ' ' SER . 75.4 Cg_exo -56.54 -60.78 0.41 Allowed 'Trans proline' 0 N--CA 1.481 0.762 0 C-N-CA 123.731 2.954 . . . . 0.0 113.24 177.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 219' ' ' SER . . . . . 0.558 ' O ' HD13 ' B' ' 223' ' ' ILE . 21.0 t 59.52 -174.87 0.1 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.204 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . 0.603 ' O ' ' HB2' ' B' ' 224' ' ' LYS . . . -54.07 -34.87 61.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.196 -176.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -58.32 -59.82 4.73 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.454 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -71.75 -35.0 69.98 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -175.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.558 HD13 ' O ' ' B' ' 219' ' ' SER . 1.7 mp -69.48 -40.61 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 120.166 -0.613 . . . . 0.0 110.173 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 224' ' ' LYS . . . . . 0.603 ' HB2' ' O ' ' B' ' 220' ' ' ALA . 14.7 mmtt -60.23 -43.76 95.76 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 174.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -55.57 -49.25 73.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.56 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 0.407 HG13 ' HB3' ' A' ' 34' ' ' ALA . 1.2 mp -65.98 -40.73 88.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.012 -177.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 4.1 mp -71.74 -43.17 66.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.731 0.301 . . . . 0.0 111.603 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.34 -21.15 61.36 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.883 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 33.3 t -57.08 -43.5 82.21 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.039 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -90.17 -31.95 5.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -176.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 103.63 69.65 0.8 Allowed Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.165 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.98 -174.04 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 170.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -80.17 -169.18 1.94 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -172.15 -22.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 119.435 -0.317 . . . . 0.0 111.6 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 50.11 96.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 O-C-N 123.515 0.51 . . . . 0.0 111.678 177.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -57.63 -25.43 60.12 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -172.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -64.07 -66.45 0.54 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.395 0.616 . . . . 0.0 110.243 171.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.46 ' O ' HG23 ' B' ' 242' ' ' VAL . 96.4 mtt180 -57.16 -40.58 77.56 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.315 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 239' ' ' LEU . . . . . 0.401 HD21 HG22 ' B' ' 223' ' ' ILE . 2.4 tm? -48.97 -64.5 0.79 Allowed 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.425 0.631 . . . . 0.0 110.762 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -72.42 -25.74 61.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.685 -176.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -65.94 -46.99 76.18 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.299 -0.56 . . . . 0.0 109.973 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 242' ' ' VAL . . . . . 0.46 HG23 ' O ' ' B' ' 238' ' ' ARG . 80.7 t -66.29 -41.05 88.35 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . 0.571 ' HA ' ' CD2' ' B' ' 246' ' ' LEU . 19.7 mt -65.71 -42.62 92.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.769 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . 0.437 ' HA ' ' HB2' ' B' ' 247' ' ' ASN . 28.2 t -71.87 -22.15 61.56 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.756 0.313 . . . . 0.0 110.825 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -86.55 -22.87 26.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.281 0.562 . . . . 0.0 109.955 177.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . 0.613 ' O ' HD12 ' B' ' 246' ' ' LEU . 1.3 pp -101.1 2.62 40.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.735 176.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 247' ' ' ASN . . . . . 0.437 ' HB2' ' HA ' ' B' ' 244' ' ' SER . 6.7 t30 -72.86 69.44 0.94 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.688 -173.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -134.6 -175.49 13.9 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.032 -178.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -89.41 -3.35 58.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.175 0.512 . . . . 0.0 110.646 -176.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . 0.486 ' HA ' ' OD1' ' B' ' 253' ' ' ASP . 4.4 p-10 -79.33 12.16 2.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.805 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.527 ' HA ' HG12 ' B' ' 254' ' ' VAL . 6.2 tp -67.06 -37.3 79.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 176.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -61.52 -42.08 98.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.583 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . 0.486 ' OD1' ' HA ' ' B' ' 250' ' ' ASN . 2.7 m-20 -60.46 -49.96 75.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.662 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 254' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' B' ' 251' ' ' ILE . 8.3 p -70.58 -25.49 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.444 -176.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 255' ' ' ILE . . . . . 0.448 HG13 ' O ' ' B' ' 251' ' ' ILE . 59.7 mt -77.46 -38.33 26.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.112 0.482 . . . . 0.0 110.278 176.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -78.24 -20.27 52.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.548 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -113.26 27.26 9.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.112 176.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 258' ' ' GLY . . . . . 0.766 ' HA2' ' OH ' ' A' ' 11' ' ' TYR . . . 20.38 -96.56 0.01 OUTLIER Glycine 0 C--N 1.336 0.543 0 N-CA-C 116.781 1.472 . . . . 0.0 116.781 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 259' ' ' ILE . . . . . 0.623 ' H ' HD13 ' B' ' 259' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.393 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -172.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 121.426 0.632 . . . . 0.0 111.44 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.4 t -65.76 -26.74 39.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.48 0.657 . . . . 0.0 109.843 -176.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.444 ' HB3' HG23 ' A' ' 39' ' ' VAL . 3.3 m -58.06 -66.65 0.44 Allowed 'General case' 0 C--O 1.242 0.709 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.591 -178.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.596 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -77.06 -20.62 55.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.764 -176.884 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.44 ' CD2' HG23 ' B' ' 255' ' ' ILE . 17.7 tp -57.09 -57.51 12.24 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 169.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.587 ' HB2' HD21 ' B' ' 212' ' ' LEU . . . -58.33 -48.72 79.63 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.413 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 49.3 t -65.43 -34.62 78.73 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.364 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.596 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 0.7 OUTLIER -70.2 -38.99 76.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 120.898 0.38 . . . . 0.0 110.352 -179.711 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.629 ' OH ' ' HA ' ' B' ' 255' ' ' ILE . 19.5 m-30 -67.65 -31.75 71.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.049 177.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.2 m -64.33 -46.17 84.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.188 174.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.609 ' HB1' HD21 ' A' ' 59' ' ' LEU . . . -53.49 -44.72 69.25 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.981 174.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.0 mt -61.34 -49.54 76.54 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.788 177.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 11' ' ' TYR . 30.5 mm -54.75 -42.38 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.531 -178.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 16' ' ' LEU . 4.4 mm? -68.23 -35.33 77.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.988 0.423 . . . . 0.0 111.227 175.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -80.29 10.79 4.1 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -174.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -81.87 -79.61 0.17 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 118.452 0.569 . . . . 0.0 111.085 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.12 40.45 0.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 50.01 44.97 25.67 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.689 0.756 . . . . 0.0 111.623 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 79.7 t -92.34 138.74 19.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.55 177.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 p -62.21 111.86 2.15 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -171.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.411 HG11 ' HB2' ' A' ' 51' ' ' LEU . 57.2 t -56.56 107.56 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.794 172.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.2 p -139.92 155.65 47.07 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -176.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -52.07 -54.48 29.75 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.532 -177.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -51.5 -35.02 38.45 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.396 177.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.581 ' HG3' HG13 ' B' ' 230' ' ' VAL . 13.1 mptt -75.95 -45.05 36.99 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.404 -173.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.467 ' O ' HD13 ' A' ' 32' ' ' ILE . 5.4 mt -63.43 -42.35 95.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.306 -0.558 . . . . 0.0 109.825 176.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -58.72 -41.07 85.53 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.949 175.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.47 -49.48 77.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.241 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.47 -38.84 92.67 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.0 0.429 . . . . 0.0 111.164 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.467 HD13 ' O ' ' A' ' 28' ' ' ILE . 1.5 mp -59.61 -37.19 69.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.699 176.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -74.12 -30.88 62.52 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.703 0.287 . . . . 0.0 110.64 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.587 ' CB ' HD13 ' B' ' 226' ' ' ILE . . . -63.58 -44.32 94.39 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.958 176.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.478 ' HB2' ' CD1' ' B' ' 209' ' ' LEU . . . -77.01 -50.51 12.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.551 177.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.45 -4.53 31.21 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.646 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.414 HG23 ' HA2' ' B' ' 213' ' ' GLY . 48.2 t -82.63 131.31 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.627 0.251 . . . . 0.0 110.443 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -97.97 98.67 9.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.823 0.82 . . . . 0.0 110.377 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.444 HG23 ' HB3' ' A' ' 5' ' ' SER . 7.3 p -83.85 140.54 16.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.985 177.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.41 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 10.1 tp10 -44.53 111.38 1.21 Allowed Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.046 174.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -46.49 -16.06 0.23 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 124.483 3.455 . . . . 0.0 115.108 -174.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.474 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -70.18 -32.25 70.09 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -179.356 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.485 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 84.3 m95 -71.9 -51.76 8.4 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.43 177.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 81.1 Cg_exo -49.64 -47.13 24.08 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 122.258 1.972 . . . . 0.0 112.19 170.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.28 -49.81 63.73 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.933 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -52.69 -53.1 52.12 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.684 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.404 ' CZ ' HD12 ' A' ' 10' ' ' ILE . 5.9 m-85 -61.93 -38.13 87.27 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.57 -34.71 78.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.735 -0.212 . . . . 0.0 111.19 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -100.47 -7.16 24.53 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -99.33 -37.66 9.16 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 121.951 -0.468 . . . . 0.0 112.224 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.619 ' HA ' ' CG1' ' A' ' 54' ' ' VAL . 1.6 mp -93.74 -128.51 0.12 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.41 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 66.7 -11.65 0.24 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.421 ' H ' ' C ' ' A' ' 51' ' ' LEU . 27.2 t-20 -137.34 3.62 2.6 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.619 ' CG1' ' HA ' ' A' ' 51' ' ' LEU . 34.1 m -89.88 121.11 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.037 -170.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -40.0 -87.6 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.957 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.3 tp -157.81 -57.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 121.222 -0.191 . . . . 0.0 111.458 175.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.41 -21.87 60.54 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.242 -0.504 . . . . 0.0 112.55 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.461 ' HB2' ' HB ' ' A' ' 54' ' ' VAL . 1.5 m -52.97 -20.09 3.13 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.034 0.534 . . . . 0.0 110.997 176.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.609 HD21 ' HB1' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -49.51 -42.99 45.2 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.848 176.714 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.549 HG23 HD13 ' B' ' 259' ' ' ILE . 37.2 mt -83.48 -7.13 10.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.604 0.716 . . . . 0.0 110.461 -173.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 47.5 t -89.18 -26.79 21.08 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.785 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -82.91 -16.3 48.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.35 0.595 . . . . 0.0 111.044 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 C--N 1.319 -0.721 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.793 -179.538 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 203' ' ' TYR . . . . . 0.421 ' HD2' HG21 ' B' ' 242' ' ' VAL . 76.4 m-85 . . . . . 0 C--O 1.239 0.51 0 CA-C-O 121.282 0.563 . . . . 0.0 111.412 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.673 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 64.6 t -64.08 -54.27 33.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.262 177.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 205' ' ' ALA . . . . . 0.653 ' HA ' HD12 ' B' ' 208' ' ' LEU . . . -70.45 -12.81 61.82 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 -178.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . 0.625 ' OG ' HG23 ' B' ' 223' ' ' ILE . 9.5 t -79.39 -39.86 31.47 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 175.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 207' ' ' TYR . . . . . 0.802 ' HB2' HD21 ' B' ' 246' ' ' LEU . 34.4 t80 -63.1 -40.35 97.37 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 173.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 33.3 mt -59.01 -51.96 67.84 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.154 176.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 209' ' ' LEU . . . . . 0.914 HD12 HD12 ' B' ' 226' ' ' ILE . 0.2 OUTLIER -51.6 -50.74 59.62 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.627 179.533 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -65.48 -32.97 74.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.415 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 211' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -65.57 -55.08 19.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.901 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 212' ' ' LEU . . . . . 0.587 HD21 ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -76.24 -13.01 60.18 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.366 -179.278 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . 0.414 ' HA2' HG23 ' A' ' 37' ' ' VAL . . . -57.2 -16.82 21.46 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.271 170.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 121.35 4.81 9.78 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.621 -0.591 . . . . 0.0 111.621 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 215' ' ' ASN . . . . . 0.589 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 38.6 t30 -117.95 100.95 7.89 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.97 0.414 . . . . 0.0 110.183 -175.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 216' ' ' SER . . . . . 0.45 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 15.2 m -72.22 -7.98 52.26 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.269 -177.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 217' ' ' SER . . . . . 0.402 ' N ' ' HD3' ' B' ' 218' ' ' PRO . 31.2 m -130.01 64.37 72.04 Favored Pre-proline 0 C--N 1.319 -0.718 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.399 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . 0.458 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 53.2 Cg_exo -57.12 137.36 81.48 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.315 2.677 . . . . 0.0 113.209 -177.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 28.9 t -115.33 165.76 12.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.281 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -53.73 -42.58 68.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.134 0.492 . . . . 0.0 110.784 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -59.34 -43.77 92.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.466 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -65.2 -52.34 55.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.933 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.625 HG23 ' OG ' ' B' ' 206' ' ' SER . 1.8 mp -58.08 -48.27 84.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.87 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 224' ' ' LYS . . . . . 0.537 ' HE3' ' CG ' ' B' ' 236' ' ' ASP . 60.1 tttm -68.5 -22.65 64.52 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 122.258 -0.276 . . . . 0.0 111.448 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -69.79 -42.99 73.03 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 0.914 HD12 HD12 ' B' ' 209' ' ' LEU . 1.5 mm -66.36 -38.26 81.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 113.797 -1.547 . . . . 0.0 111.299 176.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . 0.476 ' CD1' ' HB ' ' B' ' 232' ' ' ILE . 0.2 OUTLIER -71.96 -42.03 67.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.888 0.375 . . . . 0.0 110.487 179.455 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 228' ' ' ASP . . . . . 0.461 ' OD2' ' HG2' ' B' ' 224' ' ' LYS . 10.2 m-20 -75.08 -20.63 59.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.578 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 61.2 p -56.39 -35.1 67.37 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.751 0.31 . . . . 0.0 111.157 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 230' ' ' VAL . . . . . 0.581 HG13 ' HG3' ' A' ' 27' ' ' LYS . 63.4 t -89.68 -41.07 13.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.163 0.506 . . . . 0.0 111.145 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 110.3 34.96 2.2 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.332 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . 0.476 ' HB ' ' CD1' ' B' ' 227' ' ' LEU . 3.9 mt -98.02 123.76 50.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -61.87 107.99 0.94 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.003 0.43 . . . . 0.0 111.9 -170.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -106.16 132.26 52.43 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.824 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . 0.57 ' O ' HD12 ' B' ' 239' ' ' LEU . 10.9 m-20 -79.3 121.51 25.19 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 236' ' ' ASP . . . . . 0.537 ' CG ' ' HE3' ' B' ' 224' ' ' LYS . 3.3 m-20 -59.78 -14.33 14.18 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.514 0.509 . . . . 0.0 112.229 -178.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -98.98 -49.61 4.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.301 0.572 . . . . 0.0 110.683 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.559 ' O ' HG23 ' B' ' 242' ' ' VAL . 19.4 mmm180 -66.8 -36.43 82.37 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.346 -172.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 239' ' ' LEU . . . . . 0.591 HD13 ' H ' ' B' ' 240' ' ' ASN . 0.0 OUTLIER -65.38 -34.83 79.22 Favored 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.279 -176.125 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 240' ' ' ASN . . . . . 0.591 ' H ' HD13 ' B' ' 239' ' ' LEU . 55.0 t30 -79.91 -32.62 40.17 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -65.05 -40.25 94.49 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.486 174.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 242' ' ' VAL . . . . . 0.659 ' O ' ' HB3' ' B' ' 246' ' ' LEU . 87.7 t -64.02 -49.35 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . 0.544 ' HA ' HD23 ' B' ' 246' ' ' LEU . 35.4 mt -53.96 -39.04 39.01 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.753 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.522 174.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 56.1 m -59.43 -42.43 91.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.754 0.311 . . . . 0.0 110.749 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -77.82 -21.29 51.76 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.443 0.64 . . . . 0.0 110.968 176.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . 0.802 HD21 ' HB2' ' B' ' 207' ' ' TYR . 0.3 OUTLIER -102.92 -12.23 17.66 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.919 -168.042 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 247' ' ' ASN . . . . . 0.434 HD22 ' C ' ' B' ' 247' ' ' ASN . 0.3 OUTLIER -78.26 48.15 0.73 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.351 0.596 . . . . 0.0 111.402 -179.574 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -93.11 156.59 22.92 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.143 -0.551 . . . . 0.0 111.822 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . 0.669 ' HD3' ' H ' ' B' ' 249' ' ' LYS . 0.3 OUTLIER -80.1 39.65 0.45 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.045 0.45 . . . . 0.0 111.966 -175.075 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -118.59 27.61 8.82 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.49 HD11 ' CE1' ' B' ' 207' ' ' TYR . 3.5 mm -64.57 -50.79 74.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -172.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -63.65 -30.08 71.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.231 0.539 . . . . 0.0 110.652 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.5 -48.7 63.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.976 176.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 254' ' ' VAL . . . . . 0.415 HG22 ' HA ' ' B' ' 251' ' ' ILE . 34.9 m -65.34 -27.37 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.046 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 255' ' ' ILE . . . . . 0.629 ' HA ' ' OH ' ' A' ' 11' ' ' TYR . 30.2 mt -69.63 -52.92 27.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.119 0.485 . . . . 0.0 110.583 174.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -69.38 -15.79 63.38 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.768 -177.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -82.91 40.44 0.69 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.427 174.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 20.34 -98.97 0.01 OUTLIER Glycine 0 N--CA 1.472 1.069 0 N-CA-C 115.833 1.093 . . . . 0.0 115.833 -172.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 259' ' ' ILE . . . . . 0.549 HD13 HG23 ' A' ' 60' ' ' ILE . 2.7 mp . . . . . 0 N--CA 1.465 0.284 0 CA-C-O 121.035 0.445 . . . . 0.0 111.117 -174.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.436 ' HB2' ' HG2' ' A' ' 6' ' ' GLU . 3.8 p . . . . . 0 N--CA 1.45 -0.458 0 CA-C-O 121.566 0.698 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.536 ' HA ' HD12 ' A' ' 7' ' ' LEU . 21.1 t -67.47 -27.22 37.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.398 -172.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.677 ' HB3' HG23 ' A' ' 39' ' ' VAL . 7.0 m -61.68 -57.99 9.82 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.21 -177.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.436 ' HG2' ' HB2' ' A' ' 3' ' ' SER . 9.6 pt-20 -72.98 -29.3 62.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.596 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.536 HD12 ' HA ' ' A' ' 4' ' ' VAL . 39.8 mt -53.91 -52.92 59.02 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 170.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.446 ' HA ' HD21 ' B' ' 212' ' ' LEU . . . -55.3 -53.18 59.31 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.122 178.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.604 ' SG ' HG21 ' A' ' 39' ' ' VAL . 31.6 m -63.48 -33.21 75.08 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.548 -177.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.419 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 1.1 tp -72.65 -40.36 62.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.689 0.28 . . . . 0.0 111.309 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -75.64 -18.69 59.59 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.306 -0.558 . . . . 0.0 109.662 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.499 ' HB3' HG12 ' A' ' 28' ' ' ILE . 47.8 m -72.24 -44.89 62.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 170.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.405 ' HB3' HD12 ' A' ' 59' ' ' LEU . . . -50.58 -46.27 57.7 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 171.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.586 HD23 HD11 ' A' ' 56' ' ' ILE . 67.9 mt -59.38 -52.95 63.41 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.586 178.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.522 HD12 HD21 ' A' ' 31' ' ' LEU . 30.2 mt -62.02 -31.19 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -177.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.572 ' HB3' ' HA ' ' A' ' 23' ' ' VAL . 3.4 mm? -98.75 -0.98 41.58 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -124.9 53.18 1.51 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.379 0.609 . . . . 0.0 110.278 174.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -136.96 -58.3 0.72 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.871 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.429 ' CG ' ' H ' ' A' ' 20' ' ' GLU . 24.0 t70 -73.72 -174.51 1.79 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.58 175.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.429 ' H ' ' CG ' ' A' ' 19' ' ' ASP . 33.0 tt0 -77.25 -17.48 58.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.436 0.636 . . . . 0.0 109.659 178.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 79.7 t -61.19 124.25 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.941 174.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.6 p -82.61 149.98 27.11 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.076 -177.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.572 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 2.5 m -60.81 124.73 15.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.198 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.1 p -145.89 143.61 29.69 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.942 -174.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.447 ' HG3' ' H ' ' A' ' 26' ' ' ASP . 7.7 pt-20 -45.96 -50.85 14.31 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 123.706 0.629 . . . . 0.0 111.234 -177.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.447 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 13.5 t70 -53.68 -43.67 69.07 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.531 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.508 ' O ' HG12 ' B' ' 230' ' ' VAL . 2.9 mptp? -78.35 -40.68 35.68 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.33 -172.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.745 ' O ' HG12 ' A' ' 32' ' ' ILE . 5.7 mt -62.98 -50.06 81.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 119.774 -0.771 . . . . 0.0 109.947 176.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -54.41 -44.79 72.66 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.866 0.365 . . . . 0.0 110.576 177.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.33 -45.94 83.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.983 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.574 ' HB2' ' CG1' ' B' ' 230' ' ' VAL . 44.0 tp -69.06 -40.14 78.68 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 121.194 0.521 . . . . 0.0 111.03 -176.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.745 HG12 ' O ' ' A' ' 28' ' ' ILE . 18.5 mm -62.52 -38.27 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.941 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -82.72 -17.49 44.16 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.579 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 31' ' ' LEU . . . -62.62 -46.35 88.63 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 174.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.35 -47.77 11.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.9 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.2 64.84 0.98 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.934 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.0 m -120.86 179.26 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.879 0.371 . . . . 0.0 111.012 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -113.38 113.6 25.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.224 -177.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.677 HG23 ' HB3' ' A' ' 5' ' ' SER . 4.4 p -145.91 137.18 19.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.765 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -56.78 123.87 60.71 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.221 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -56.41 -8.55 2.79 Favored 'Trans proline' 0 C--O 1.241 0.629 0 C-N-CA 123.57 2.847 . . . . 0.0 113.004 -174.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.45 -25.52 50.68 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.598 -177.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.425 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 97.0 m95 -66.84 -60.05 6.87 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.393 175.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.425 ' CD ' ' HB2' ' A' ' 43' ' ' TRP . 10.3 Cg_endo -55.87 -42.17 69.79 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 121.882 1.721 . . . . 0.0 112.276 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.73 -54.26 39.36 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.75 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.9 tt -59.12 -45.34 91.17 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.582 ' HA ' HD13 ' A' ' 51' ' ' LEU . 4.0 m-85 -54.58 -54.59 39.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.697 0.284 . . . . 0.0 111.643 -178.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.27 -24.79 61.4 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.959 -176.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -99.95 -1.68 36.57 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.03 -17.38 4.86 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.582 HD13 ' HA ' ' A' ' 47' ' ' PHE . 8.4 mp -80.25 -113.46 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.958 -0.464 . . . . 0.0 109.819 175.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 59.39 2.79 0.34 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 177.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -145.01 -52.68 0.28 Allowed 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 122.21 1.005 . . . . 0.0 108.593 -173.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.488 HG11 ' HG ' ' A' ' 51' ' ' LEU . 2.4 p -18.42 110.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 111.861 -2.427 . . . . 0.0 114.553 173.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -56.71 130.98 47.77 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 163.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.64 ' O ' HD22 ' A' ' 59' ' ' LEU . 5.5 tp -47.63 -58.62 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -166.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.62 -29.11 60.71 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.005 -0.617 . . . . 0.0 113.297 -176.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.2 m -59.36 -16.8 24.9 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.64 HD22 ' O ' ' A' ' 56' ' ' ILE . 1.0 OUTLIER -60.63 -17.71 48.85 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.389 0.144 . . . . 0.0 111.389 -179.45 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.508 ' N ' HD23 ' A' ' 59' ' ' LEU . 15.7 tt -65.21 -22.16 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 120.882 0.373 . . . . 0.0 111.004 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.4 t -127.69 73.22 1.44 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.232 0.539 . . . . 0.0 110.22 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -107.48 -12.75 15.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.067 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.7 t . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.518 -175.024 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 203' ' ' TYR . . . . . 0.506 ' CD2' ' HA ' ' B' ' 239' ' ' LEU . 93.0 m-85 . . . . . 0 C--O 1.235 0.3 0 CA-C-O 121.579 0.704 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.578 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 31.5 t -68.51 -54.52 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.418 -176.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 205' ' ' ALA . . . . . 0.527 ' HA ' HD12 ' B' ' 208' ' ' LEU . . . -72.13 -13.9 61.69 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.558 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . 0.451 ' HB3' HG23 ' B' ' 223' ' ' ILE . 3.5 m -72.3 -43.02 64.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 172.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 207' ' ' TYR . . . . . 0.485 ' CE1' HD11 ' B' ' 251' ' ' ILE . 24.4 t80 -62.64 -44.14 97.03 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 174.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 64.1 mt -59.51 -46.84 87.67 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.018 177.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 209' ' ' LEU . . . . . 0.422 ' O ' ' HG ' ' B' ' 212' ' ' LEU . 0.1 OUTLIER -57.09 -53.45 57.89 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.575 -179.67 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -62.96 -34.68 78.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.291 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 211' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -63.27 -53.54 51.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.218 177.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 212' ' ' LEU . . . . . 0.536 ' HB2' HG13 ' A' ' 4' ' ' VAL . 4.3 pp -65.76 -21.65 66.53 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.759 0.314 . . . . 0.0 110.753 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.97 -16.05 38.28 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.676 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 120.37 4.98 10.65 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.448 178.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 215' ' ' ASN . . . . . 0.633 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 28.1 t30 -117.66 108.8 15.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.188 0.518 . . . . 0.0 110.274 -178.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 216' ' ' SER . . . . . 0.428 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 5.8 m -68.05 -15.2 63.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.799 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 17.6 p -125.66 67.75 59.55 Favored Pre-proline 0 N--CA 1.441 -0.881 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.417 -175.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . 0.428 ' HD3' ' C ' ' B' ' 216' ' ' SER . 50.9 Cg_exo -59.85 121.09 9.27 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.72 2.28 . . . . 0.0 112.025 177.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 89.2 p -102.33 -178.95 3.84 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.782 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -58.93 -36.67 75.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.02 0.438 . . . . 0.0 110.84 -177.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.54 -35.25 63.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.76 -176.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -59.35 -54.99 40.46 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.256 0.551 . . . . 0.0 109.746 175.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.451 HG23 ' HB3' ' B' ' 206' ' ' SER . 1.8 mp -63.47 -42.14 95.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.209 -178.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 224' ' ' LYS . . . . . 0.548 ' O ' ' HB2' ' B' ' 228' ' ' ASP . 27.7 tptp -57.06 -50.85 71.48 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 121.312 -0.155 . . . . 0.0 110.752 178.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -60.99 -41.16 95.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.909 0.385 . . . . 0.0 110.708 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 0.504 HG23 HD11 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -63.93 -42.94 97.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.543 -178.039 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' B' ' 234' ' ' ALA . 26.9 tp -81.16 -23.22 38.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.23 0.538 . . . . 0.0 110.413 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 228' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' B' ' 224' ' ' LYS . 2.7 t70 -72.37 -28.27 62.91 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.636 176.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 8.4 t -65.25 -53.33 45.87 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.556 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 230' ' ' VAL . . . . . 0.574 ' CG1' ' HB2' ' A' ' 31' ' ' LEU . 22.2 m -61.6 -33.13 55.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-O 120.802 0.334 . . . . 0.0 111.744 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 102.94 39.06 2.76 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.944 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . 0.421 HG13 HG23 ' B' ' 230' ' ' VAL . 16.9 mt -116.01 125.53 73.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -54.65 143.6 24.39 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.089 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . 0.569 ' HB2' HD23 ' B' ' 227' ' ' LEU . . . -140.93 117.08 10.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.028 0.442 . . . . 0.0 111.932 -173.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . 0.444 ' HB2' ' HB2' ' B' ' 238' ' ' ARG . 1.7 m-20 -67.88 113.41 5.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.495 174.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -56.75 -40.18 75.31 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.913 0.387 . . . . 0.0 110.986 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.41 -58.55 6.7 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.241 0.543 . . . . 0.0 111.04 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.666 ' O ' HG23 ' B' ' 242' ' ' VAL . 4.7 mpt_? -63.97 -29.44 70.6 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.914 -177.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 239' ' ' LEU . . . . . 0.506 ' HA ' ' CD2' ' B' ' 203' ' ' TYR . 9.3 tt -57.59 -61.42 2.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.168 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -64.38 -27.31 68.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.797 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 241' ' ' LYS . . . . . 0.45 ' HB2' ' HA ' ' B' ' 238' ' ' ARG . 38.1 mttp -63.46 -47.91 79.88 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.694 175.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 242' ' ' VAL . . . . . 0.703 ' O ' HD12 ' B' ' 246' ' ' LEU . 46.6 t -70.13 -33.16 53.68 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . 0.633 ' HA ' ' CD1' ' B' ' 246' ' ' LEU . 4.7 mt -64.2 -35.97 75.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.153 178.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 21.8 m -75.62 -25.92 57.34 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.317 0.58 . . . . 0.0 109.938 172.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 245' ' ' GLU . . . . . 0.448 ' HB3' ' O ' ' B' ' 242' ' ' VAL . 44.2 tt0 -71.3 -40.88 70.55 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.129 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . 0.703 HD12 ' O ' ' B' ' 242' ' ' VAL . 0.0 OUTLIER -108.22 18.1 21.49 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.262 0.553 . . . . 0.0 111.578 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -61.99 120.39 10.71 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.049 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -153.09 147.43 16.96 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.527 -0.845 . . . . 0.0 112.479 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -84.42 -24.16 29.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.071 0.462 . . . . 0.0 110.101 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . 0.482 ' HB3' ' HB3' ' B' ' 253' ' ' ASP . 4.9 m-20 -80.25 55.71 2.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.779 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.498 ' O ' HG12 ' B' ' 254' ' ' VAL . 1.3 mm -68.2 -49.52 66.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.159 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -67.95 -25.32 65.39 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.188 0.518 . . . . 0.0 110.01 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . 0.482 ' HB3' ' HB3' ' B' ' 250' ' ' ASN . 20.4 t70 -73.33 -48.61 32.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.104 174.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 254' ' ' VAL . . . . . 0.635 ' O ' ' HA3' ' B' ' 258' ' ' GLY . 2.3 p -66.53 -18.2 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.171 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 255' ' ' ILE . . . . . 0.424 HG21 HD13 ' A' ' 7' ' ' LEU . 66.4 mt -84.77 -52.27 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.856 0.36 . . . . 0.0 110.598 174.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -61.12 -31.72 71.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.082 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -126.83 35.69 4.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.833 0.349 . . . . 0.0 111.294 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 258' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' B' ' 254' ' ' VAL . . . -133.67 55.03 0.75 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.721 -175.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 49.7 mt . . . . . 0 C--N 1.325 -0.473 0 CA-C-O 121.617 0.722 . . . . 0.0 109.477 171.928 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.473 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 25.6 p . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 112.26 0.466 . . . . 0.0 112.26 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.494 ' HA ' HD12 ' A' ' 7' ' ' LEU . 5.6 m -72.45 -24.67 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.692 -176.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.559 ' HB3' HG23 ' A' ' 39' ' ' VAL . 14.5 m -64.64 -55.92 17.12 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.724 177.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.418 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 35.1 tt0 -59.79 -43.42 94.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.306 178.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 4' ' ' VAL . 90.6 mt -52.61 -52.51 55.04 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.896 0.379 . . . . 0.0 110.594 175.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.04 -51.0 71.92 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.621 -176.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.6 t -72.06 -23.8 61.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.376 -176.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.418 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 1.5 tp -82.72 -39.1 15.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.282 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.465 ' CZ ' HD23 ' B' ' 208' ' ' LEU . 20.9 m-85 -68.63 -38.76 80.76 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.3 p -64.65 -46.58 81.89 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.038 174.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -44.74 -53.81 6.96 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.625 0.37 . . . . 0.0 111.496 173.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.539 ' HA ' ' HB2' ' A' ' 17' ' ' HIS . 3.6 pp -79.43 -27.11 41.7 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.505 -178.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.498 HD11 ' HA ' ' B' ' 206' ' ' SER . 17.2 mt -65.0 -41.03 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.051 0.453 . . . . 0.0 110.621 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.92 -27.75 55.03 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 174.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.539 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -78.4 13.95 1.39 Allowed 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 176.54 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -83.92 -31.22 25.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.316 0.579 . . . . 0.0 109.75 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.523 ' CG ' ' H ' ' A' ' 20' ' ' GLU . 19.7 t70 -126.92 -157.01 0.78 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.5 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.523 ' H ' ' CG ' ' A' ' 19' ' ' ASP . 31.5 mt-10 -86.57 -5.64 59.09 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.184 0.516 . . . . 0.0 110.668 -178.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.5 t -57.7 132.54 22.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.913 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.39 151.25 47.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.345 -175.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.5 m -100.83 35.85 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.48 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.9 p -88.14 179.35 6.41 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.252 -173.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.506 ' HG3' ' N ' ' A' ' 26' ' ' ASP . 14.0 pt-20 -43.84 -50.66 7.84 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.631 -177.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.506 ' N ' ' HG3' ' A' ' 25' ' ' GLU . 10.6 t70 -55.86 -41.3 74.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.151 -175.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.576 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 3.4 mptp? -83.83 -45.33 13.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.552 -170.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.55 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 9.3 mt -66.33 -42.9 91.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.35 178.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -61.75 -46.4 89.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.133 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.29 -44.08 97.35 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.403 HD21 ' HG ' ' B' ' 209' ' ' LEU . 0.7 OUTLIER -74.48 -39.3 62.57 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-O 121.598 0.713 . . . . 0.0 110.595 -175.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.55 ' HB ' ' O ' ' A' ' 28' ' ' ILE . 1.1 mp -60.52 -34.03 56.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.119 173.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -75.5 -29.04 59.41 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.679 174.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.04 -36.29 83.52 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.774 178.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -94.33 -41.39 9.45 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.178 -0.609 . . . . 0.0 112.039 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.76 46.07 4.37 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.639 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.594 HG22 ' HA2' ' B' ' 213' ' ' GLY . 0.2 OUTLIER -97.68 164.44 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.959 0.409 . . . . 0.0 110.857 -176.288 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -102.42 98.91 8.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.365 -176.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.559 HG23 ' HB3' ' A' ' 5' ' ' SER . 9.0 p -131.7 129.03 61.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.517 176.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 16.8 pt-20 -62.25 133.88 94.48 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -178.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 40' ' ' GLU . 53.5 Cg_exo -53.43 -7.92 0.59 Allowed 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 123.969 3.113 . . . . 0.0 113.828 -174.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.4 -36.8 77.1 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.072 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.58 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 89.1 m95 -70.93 -54.37 7.7 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 119.248 -0.406 . . . . 0.0 111.227 178.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.58 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 78.4 Cg_exo -49.98 -50.3 13.7 Favored 'Trans proline' 0 C--N 1.363 1.33 0 C-N-CA 122.004 1.803 . . . . 0.0 112.839 174.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.48 -50.06 71.73 Favored Glycine 0 C--O 1.24 0.523 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.209 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.8 tp -55.96 -53.11 60.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.511 -0.345 . . . . 0.0 110.776 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -59.92 -40.8 90.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.791 -177.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.59 -38.21 90.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.663 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -92.18 -8.51 45.31 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.65 -46.62 4.29 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.714 ' HA ' HG23 ' A' ' 54' ' ' VAL . 2.0 mp -84.05 -130.41 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.231 -175.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 66.94 3.62 3.17 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.375 0.67 . . . . 0.0 112.735 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -145.7 -51.4 0.25 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.714 HG23 ' HA ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -53.07 121.92 2.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 113.901 -1.499 . . . . 0.0 111.512 174.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.408 HD22 ' C ' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -58.01 158.36 6.82 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.481 175.461 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.461 ' O ' HD13 ' A' ' 59' ' ' LEU . 3.8 tp -40.53 -46.46 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 124.828 1.251 . . . . 0.0 114.371 -172.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.41 -20.3 22.17 Favored Glycine 0 N--CA 1.467 0.705 0 C-N-CA 121.272 -0.489 . . . . 0.0 113.587 -174.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 43.5 t -55.44 -25.34 35.66 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 122.467 0.307 . . . . 0.0 111.066 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 56' ' ' ILE . 9.8 mp -55.61 -32.29 62.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.311 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.442 HG23 HD12 ' B' ' 259' ' ' ILE . 33.3 mt -94.14 -3.64 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.522 0.677 . . . . 0.0 110.722 -175.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 55.1 m -114.85 -56.67 2.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.025 0.44 . . . . 0.0 111.187 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -97.25 66.47 2.07 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.155 -173.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.446 -0.636 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.77 176.551 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 203' ' ' TYR . . . . . 0.593 ' CD2' ' HA ' ' B' ' 239' ' ' LEU . 48.0 m-85 . . . . . 0 N--CA 1.469 0.523 0 CA-C-O 120.962 0.411 . . . . 0.0 112.014 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.59 ' O ' HD13 ' B' ' 208' ' ' LEU . 5.4 p -56.46 -55.47 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.209 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 205' ' ' ALA . . . . . 0.504 ' CB ' HD11 ' A' ' 14' ' ' LEU . . . -74.12 -8.15 55.12 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.989 -176.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . 0.611 ' OG ' HG23 ' B' ' 223' ' ' ILE . 8.0 t -78.96 -37.8 38.59 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 173.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 207' ' ' TYR . . . . . 0.549 ' HD1' HD11 ' B' ' 251' ' ' ILE . 21.3 t80 -64.25 -42.84 96.32 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 172.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.59 HD13 ' O ' ' B' ' 204' ' ' VAL . 7.5 mp -56.82 -48.28 78.35 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.927 174.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 209' ' ' LEU . . . . . 0.437 HD23 ' CB ' ' A' ' 11' ' ' TYR . 0.3 OUTLIER -54.93 -53.43 55.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.356 -179.75 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -61.67 -39.33 91.01 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.094 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 211' ' ' ALA . . . . . 0.727 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -69.32 -51.87 32.83 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.04 0.448 . . . . 0.0 110.931 -178.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.8 -35.86 69.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.645 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . 0.594 ' HA2' HG22 ' A' ' 37' ' ' VAL . . . -54.49 -52.43 45.02 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.294 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 163.08 31.29 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.279 -0.963 . . . . 0.0 112.336 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 215' ' ' ASN . . . . . 0.727 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 50.5 m-20 -136.02 105.24 5.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.699 0.285 . . . . 0.0 110.479 -176.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 16.4 m -61.21 -21.69 64.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.944 0.402 . . . . 0.0 111.339 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 20.3 m -128.54 73.99 80.36 Favored Pre-proline 0 N--CA 1.443 -0.788 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.563 -174.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -58.69 121.12 9.43 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.62 2.88 . . . . 0.0 112.72 175.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 15.1 m -89.95 158.57 17.33 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.46 -36.01 66.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.512 0.672 . . . . 0.0 109.738 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -62.05 -34.82 76.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.921 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -73.58 -47.54 39.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.702 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.611 HG23 ' OG ' ' B' ' 206' ' ' SER . 1.8 mp -59.78 -45.41 94.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 224' ' ' LYS . . . . . 0.413 ' HG3' ' OD1' ' B' ' 228' ' ' ASP . 7.3 ttmm -62.25 -36.7 82.83 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.117 175.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' B' ' 229' ' ' SER . 6.4 ttpm? -60.48 -45.55 93.32 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.764 176.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.07 -38.35 82.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.7 0.286 . . . . 0.0 111.149 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 87.6 mt -76.44 -46.25 27.86 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 228' ' ' ASP . . . . . 0.413 ' OD1' ' HG3' ' B' ' 224' ' ' LYS . 1.3 m-20 -74.59 -14.57 60.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.883 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 229' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' B' ' 225' ' ' LYS . 23.0 t -54.35 -47.1 72.94 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.089 0.471 . . . . 0.0 109.938 172.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 29.0 t -90.29 -34.05 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 121.471 0.653 . . . . 0.0 109.612 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 91.87 72.68 1.23 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.539 176.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 8.4 mt -95.53 -97.46 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 122.522 -0.399 . . . . 0.0 109.926 176.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -136.09 -78.17 0.42 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 173.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . 60.41 81.64 0.18 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.623 0.577 . . . . 0.0 112.231 174.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . 0.475 ' C ' ' H ' ' B' ' 237' ' ' ASP . 0.6 OUTLIER -62.15 133.12 54.82 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.357 179.533 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.81 36.69 0.11 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.697 0.761 . . . . 0.0 111.255 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 237' ' ' ASP . . . . . 0.475 ' H ' ' C ' ' B' ' 235' ' ' ASP . 15.9 t70 -147.92 -57.65 0.24 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.669 -1.15 . . . . 0.0 107.914 176.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.427 ' O ' HG23 ' B' ' 242' ' ' VAL . 8.5 ttm-85 -57.56 -42.0 82.15 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.52 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 239' ' ' LEU . . . . . 0.593 ' HA ' ' CD2' ' B' ' 203' ' ' TYR . 10.1 tt -57.85 -62.22 1.96 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.381 -176.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -67.83 -20.0 65.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.362 -178.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -66.91 -47.2 72.5 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.288 0.566 . . . . 0.0 109.945 174.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 242' ' ' VAL . . . . . 0.649 ' O ' HD12 ' B' ' 246' ' ' LEU . 91.7 t -66.35 -39.26 83.7 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.393 179.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . 0.596 ' HA ' ' CD1' ' B' ' 246' ' ' LEU . 13.1 mt -65.52 -32.87 60.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.401 177.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 34.4 t -61.59 -39.24 90.48 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 171.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 245' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' B' ' 242' ' ' VAL . 93.1 mt-10 -63.91 -58.05 7.93 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.844 174.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . 0.649 HD12 ' O ' ' B' ' 242' ' ' VAL . 0.0 OUTLIER -103.65 37.18 2.09 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -170.033 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -57.6 154.74 10.86 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.043 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -51.69 107.62 0.48 Allowed Glycine 0 CA--C 1.519 0.294 0 CA-C-N 115.556 -0.747 . . . . 0.0 114.315 -173.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -135.07 -74.39 0.46 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -108.94 58.91 0.6 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.545 0.688 . . . . 0.0 109.191 175.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.549 HD11 ' HD1' ' B' ' 207' ' ' TYR . 0.3 OUTLIER -64.81 -39.7 86.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.698 -176.036 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -66.63 -37.14 84.23 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.435 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.49 -49.43 75.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.943 0.402 . . . . 0.0 110.179 175.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 254' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' B' ' 251' ' ' ILE . 6.2 p -68.3 -22.28 27.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.893 -176.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 255' ' ' ILE . . . . . . . . . . . . . 56.1 mt -79.19 -45.25 24.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 120.938 0.399 . . . . 0.0 110.631 173.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -61.55 -28.47 69.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.854 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -120.33 50.66 1.28 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 258' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' B' ' 254' ' ' VAL . . . -71.0 -47.16 39.8 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.377 -0.829 . . . . 0.0 113.784 -171.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 259' ' ' ILE . . . . . 0.442 HD12 HG23 ' A' ' 60' ' ' ILE . 6.6 pt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.869 0.334 . . . . 0.0 111.043 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.466 ' HB3' ' HG2' ' A' ' 6' ' ' GLU . 24.7 m . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 121.341 0.591 . . . . 0.0 111.575 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.422 HG13 ' CD2' ' B' ' 212' ' ' LEU . 20.7 t -67.1 -26.61 36.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.342 0.591 . . . . 0.0 109.684 -175.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.586 ' OG ' HG23 ' A' ' 39' ' ' VAL . 31.9 t -61.02 -65.62 0.66 Allowed 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.928 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.696 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 10.7 pt-20 -68.57 -31.55 70.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.64 -175.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 35.7 mt -55.92 -53.63 54.55 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 172.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.624 ' HB2' HG11 ' A' ' 37' ' ' VAL . . . -56.91 -52.69 64.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.91 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.696 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 24.6 p -70.73 -26.87 63.57 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.586 -173.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.508 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 1.1 tp -78.26 -38.52 23.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.698 0.285 . . . . 0.0 111.408 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.43 ' HB2' HD22 ' B' ' 209' ' ' LEU . 21.8 m-85 -72.34 -26.78 62.05 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.8 t -69.59 -51.6 33.73 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.219 171.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -47.96 -54.03 14.13 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.353 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 15' ' ' ILE . 2.9 pp -76.54 -29.95 56.92 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.651 -176.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.558 ' N ' HD12 ' A' ' 14' ' ' LEU . 3.8 mt -59.47 -31.0 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 118.522 0.601 . . . . 0.0 110.487 173.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.455 HD12 HG22 ' A' ' 15' ' ' ILE . 6.7 mp -86.73 -25.59 24.65 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.205 176.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -85.17 62.54 7.56 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -177.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -138.29 -57.27 0.65 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 120.856 -0.337 . . . . 0.0 111.506 172.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.589 ' CG ' ' H ' ' A' ' 20' ' ' GLU . 17.3 t70 -91.47 -151.3 0.26 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.743 0.306 . . . . 0.0 111.393 -176.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.589 ' H ' ' CG ' ' A' ' 19' ' ' ASP . 16.9 tp10 -88.67 -6.6 57.37 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.584 0.707 . . . . 0.0 109.634 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.414 HG21 HG12 ' B' ' 232' ' ' ILE . 68.7 t -64.76 106.61 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.655 178.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.572 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 2.7 p -66.11 150.63 48.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.075 -177.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.448 ' HA ' HD23 ' A' ' 16' ' ' LEU . 29.8 m -84.31 49.51 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.358 -174.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.4 p -81.83 164.12 21.85 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -49.77 -46.25 50.47 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.415 -178.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -58.57 -34.94 71.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.059 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.572 ' HG3' ' O ' ' A' ' 22' ' ' THR . 32.7 mmtp -75.71 -51.36 12.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.759 -175.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.439 HG23 HD13 ' A' ' 32' ' ' ILE . 5.1 mt -62.07 -41.28 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.151 176.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.458 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 6.9 t30 -53.81 -52.2 61.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.812 173.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.19 -44.95 79.92 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.761 0.315 . . . . 0.0 111.815 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.447 HD21 HG23 ' B' ' 226' ' ' ILE . 2.6 tm? -65.09 -46.03 82.76 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.495 0.665 . . . . 0.0 109.883 -178.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.439 HD13 HG23 ' A' ' 28' ' ' ILE . 1.6 mp -62.04 -33.25 57.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.959 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.458 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 31.2 mmmt -77.68 -25.06 49.21 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.756 0.312 . . . . 0.0 111.006 176.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.13 -42.38 72.68 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.239 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.74 -41.66 11.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.702 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.51 10.92 56.42 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 121.034 -0.603 . . . . 0.0 113.253 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.662 HG22 ' HA3' ' B' ' 213' ' ' GLY . 3.2 t -70.7 140.77 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 O-C-N 122.467 -0.431 . . . . 0.0 110.577 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.69 89.72 5.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.296 -177.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.586 HG23 ' OG ' ' A' ' 5' ' ' SER . 7.6 p -110.93 127.58 67.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 172.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.487 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 12.3 pt-20 -59.53 134.71 88.93 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.261 -174.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 40' ' ' GLU . 50.5 Cg_exo -54.31 -5.2 0.36 Allowed 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 124.398 3.399 . . . . 0.0 114.634 -172.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.36 -41.72 72.76 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.685 177.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.624 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 94.8 m95 -68.73 -57.42 8.13 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.796 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.624 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 56.8 Cg_exo -52.15 -41.28 66.11 Favored 'Trans proline' 0 C--N 1.366 1.5 0 C-N-CA 121.749 1.633 . . . . 0.0 112.324 174.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.531 ' O ' ' HG2' ' A' ' 49' ' ' LYS . . . -59.71 -54.79 34.66 Favored Glycine 0 C--O 1.242 0.639 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.488 -179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.449 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 57.6 mt -58.47 -50.6 73.16 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.664 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 6.2 m-85 -55.35 -51.01 68.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.365 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.09 -47.99 81.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.751 -0.658 . . . . 0.0 112.165 -176.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 45' ' ' GLY . 22.2 pttm -100.79 5.57 43.57 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 119.56 -0.856 . . . . 0.0 113.136 -174.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 46' ' ' LEU . . . -134.24 1.85 3.24 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' A' ' 47' ' ' PHE . 57.9 mt -84.99 -133.04 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 118.476 -1.29 . . . . 0.0 109.345 170.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 62.59 -13.16 0.07 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.507 ' H ' ' C ' ' A' ' 51' ' ' LEU . 18.5 m120 -128.2 3.99 5.8 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.575 ' CG2' ' HA ' ' A' ' 51' ' ' LEU . 61.5 t -95.88 103.03 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.154 -174.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -52.19 132.19 33.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.482 173.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.42 HD11 ' HB3' ' A' ' 14' ' ' LEU . 4.1 tp -45.04 -45.42 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -170.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.14 -26.01 57.93 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.364 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.0 t -65.49 -11.89 47.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.804 0.335 . . . . 0.0 110.492 -176.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 64.8 mt -57.69 -28.05 63.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.71 0.29 . . . . 0.0 110.675 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.3 tt -103.13 31.22 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.851 0.834 . . . . 0.0 110.926 -178.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.9 p -83.79 -177.45 6.69 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.966 173.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -78.15 48.37 0.73 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.718 0.294 . . . . 0.0 110.981 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.084 -178.532 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 203' ' ' TYR . . . . . 0.6 ' HB2' HG11 ' B' ' 242' ' ' VAL . 8.1 m-85 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.769 0.318 . . . . 0.0 111.633 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.58 ' O ' HD13 ' B' ' 208' ' ' LEU . 47.0 t -56.54 -65.36 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.63 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 205' ' ' ALA . . . . . 0.587 ' HA ' ' HB2' ' B' ' 208' ' ' LEU . . . -69.38 -6.56 30.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.215 -177.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . 0.542 ' OG ' HG23 ' B' ' 223' ' ' ILE . 8.6 t -78.94 -42.44 26.93 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 207' ' ' TYR . . . . . 0.593 ' HD1' HD13 ' B' ' 251' ' ' ILE . 29.3 t80 -65.47 -39.18 91.66 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 172.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.587 ' HB2' ' HA ' ' B' ' 205' ' ' ALA . 9.1 mp -55.3 -51.11 67.77 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.416 173.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 209' ' ' LEU . . . . . 0.43 HD22 ' HB2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -56.51 -59.81 4.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.952 -178.354 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -60.75 -32.33 71.62 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -177.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 211' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -81.19 -32.0 33.73 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 122.015 -0.428 . . . . 0.0 111.308 178.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 212' ' ' LEU . . . . . 0.422 ' CD2' HG13 ' A' ' 4' ' ' VAL . 2.3 tm? -64.84 -43.12 94.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.718 177.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . 0.662 ' HA3' HG22 ' A' ' 37' ' ' VAL . . . -152.82 90.15 0.13 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.239 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 172.33 -62.91 0.14 Allowed Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 111.829 -0.508 . . . . 0.0 111.829 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 215' ' ' ASN . . . . . 0.455 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 56.4 t30 -161.4 142.61 11.37 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 216' ' ' SER . . . . . 0.408 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 8.6 m -64.4 -24.56 67.68 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.23 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 12.3 t -124.04 73.15 56.15 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.708 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . 0.53 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 57.9 Cg_exo -56.57 116.54 3.27 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.183 2.589 . . . . 0.0 112.438 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 83.4 p -82.84 162.21 21.7 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.048 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -54.91 -35.53 64.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.016 0.436 . . . . 0.0 110.332 177.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -68.76 -34.87 76.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.467 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -70.28 -43.71 69.88 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.359 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.542 HG23 ' OG ' ' B' ' 206' ' ' SER . 1.8 mp -64.85 -44.39 96.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 123.271 0.357 . . . . 0.0 110.085 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 224' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' B' ' 228' ' ' ASP . 26.7 tptp -55.56 -43.49 75.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.162 173.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -56.6 -51.25 69.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.077 178.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 0.447 HG23 HD21 ' A' ' 31' ' ' LEU . 1.1 mp -68.47 -35.47 70.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.771 -177.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . 0.414 ' CD1' ' HB ' ' B' ' 232' ' ' ILE . 0.2 OUTLIER -75.43 -35.11 61.02 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.549 0.69 . . . . 0.0 109.947 -179.431 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 228' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' B' ' 224' ' ' LYS . 5.2 t70 -76.19 -30.04 57.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.584 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 85.5 p -55.33 -45.3 76.38 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.556 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 59.4 t -75.84 -33.3 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 121.117 0.484 . . . . 0.0 110.663 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 103.98 38.83 2.62 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.862 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . 0.414 ' HB ' ' CD1' ' B' ' 227' ' ' LEU . 4.3 mt -109.38 135.41 48.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -66.54 118.33 10.0 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.655 0.74 . . . . 0.0 112.219 -173.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -117.5 135.55 53.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.03 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . 0.496 ' HB2' ' HB2' ' B' ' 238' ' ' ARG . 51.4 m-20 -86.43 115.21 23.79 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.185 -176.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 236' ' ' ASP . . . . . 0.598 ' O ' ' HG ' ' B' ' 239' ' ' LEU . 9.5 t70 -45.86 -60.53 2.18 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.131 0.894 . . . . 0.0 112.415 -170.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -63.92 -42.61 97.34 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.496 ' HB2' ' HB2' ' B' ' 235' ' ' ASP . 77.5 mtt180 -66.21 -36.0 81.92 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.15 -172.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 239' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' B' ' 236' ' ' ASP . 4.4 pp -68.44 -44.85 74.03 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.689 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 240' ' ' ASN . . . . . 0.499 ' N ' HD12 ' B' ' 239' ' ' LEU . 3.9 t-20 -66.14 -33.21 75.26 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 121.34 -0.144 . . . . 0.0 110.759 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -62.15 -52.45 63.79 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-O 121.224 0.535 . . . . 0.0 110.315 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 242' ' ' VAL . . . . . 0.6 HG11 ' HB2' ' B' ' 203' ' ' TYR . 12.5 p -66.48 -37.84 80.45 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.654 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -176.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . 0.602 ' HA ' ' HB2' ' B' ' 246' ' ' LEU . 57.3 mt -66.6 -31.61 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.513 176.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 8.8 t -65.06 -33.69 76.63 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 175.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -86.65 -26.16 24.48 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.731 175.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . 0.602 ' HB2' ' HA ' ' B' ' 243' ' ' ILE . 9.5 mt -75.45 -19.5 59.42 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.666 0.386 . . . . 0.0 110.657 175.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -63.49 97.85 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.874 -173.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 175.66 -175.78 47.34 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.135 -177.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -85.89 0.68 52.47 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -79.62 -0.52 34.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.956 0.408 . . . . 0.0 110.797 -175.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.593 HD13 ' HD1' ' B' ' 207' ' ' TYR . 7.7 tp -61.72 -38.31 80.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.289 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -65.11 -34.91 79.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.106 0.479 . . . . 0.0 110.153 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -67.58 -45.45 75.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.632 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 254' ' ' VAL . . . . . 0.533 HG22 ' HA ' ' B' ' 251' ' ' ILE . 26.0 m -74.64 -10.94 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.2 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 255' ' ' ILE . . . . . 0.496 HG12 ' O ' ' B' ' 251' ' ' ILE . 24.0 mm -78.25 -53.15 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.003 0.43 . . . . 0.0 109.881 168.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -63.05 -42.41 99.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.328 -176.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -119.51 56.99 0.92 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.585 0.707 . . . . 0.0 109.887 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -105.79 -99.36 2.6 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.034 177.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 23.4 mt . . . . . 0 N--CA 1.481 1.098 0 C-N-CA 124.998 1.319 . . . . 0.0 113.334 -179.637 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.593 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 5.6 m . . . . . 0 N--CA 1.453 -0.321 0 CA-C-O 120.767 0.318 . . . . 0.0 110.543 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.439 HG23 ' HB2' ' B' ' 212' ' ' LEU . 13.3 p -71.68 -29.79 35.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.246 0.546 . . . . 0.0 109.753 -174.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.512 ' HB3' HG23 ' A' ' 39' ' ' VAL . 51.7 m -64.62 -52.06 59.39 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.944 176.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.427 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 35.6 tt0 -57.85 -45.45 86.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.04 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 3' ' ' SER . 82.6 mt -54.03 -53.78 48.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.356 176.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.07 -55.34 24.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.895 -177.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 21.6 p -67.43 -31.22 71.25 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.73 -176.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.553 HG13 HD23 ' A' ' 59' ' ' LEU . 0.9 OUTLIER -77.65 -37.64 24.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.921 0.391 . . . . 0.0 111.068 -176.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.636 ' O ' HG12 ' A' ' 15' ' ' ILE . 23.1 m-85 -74.61 -26.37 59.86 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.7 t -69.56 -44.78 70.16 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 172.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.94 -40.29 60.58 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.387 171.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.3 mt -60.48 -59.97 4.56 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 173.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.636 HG12 ' O ' ' A' ' 11' ' ' TYR . 36.3 mm -46.09 -34.4 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.3 mt -115.13 7.26 15.34 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -174.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -48.25 -62.47 1.47 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -120.73 -82.12 0.64 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.356 -176.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.554 ' OD2' HG21 ' B' ' 232' ' ' ILE . 5.2 t0 47.37 -152.59 0.09 Allowed 'General case' 0 CA--C 1.536 0.431 0 O-C-N 123.628 0.58 . . . . 0.0 111.28 178.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -112.05 22.52 14.74 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 168.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.561 HG11 HD11 ' B' ' 232' ' ' ILE . 4.1 p -128.41 158.67 40.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.59 -177.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.1 p -105.49 130.86 53.48 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 121.241 -0.183 . . . . 0.0 111.332 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.548 HG21 HD23 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -65.38 105.11 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.408 0.623 . . . . 0.0 110.52 175.562 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.419 ' OG1' ' HG2' ' A' ' 27' ' ' LYS . 22.3 p -133.91 168.48 18.69 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.379 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 26' ' ' ASP . 9.1 pt-20 -48.18 -48.53 34.56 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 123.659 0.599 . . . . 0.0 111.648 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.435 ' N ' ' HG3' ' A' ' 25' ' ' GLU . 7.5 p-10 -68.31 -27.84 66.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.251 -175.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.419 ' HG2' ' OG1' ' A' ' 24' ' ' THR . 46.2 mmtm -78.21 -45.1 23.93 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -176.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.511 HG23 HD13 ' A' ' 32' ' ' ILE . 6.5 mt -67.48 -41.7 86.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.779 176.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -55.57 -45.85 77.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.705 175.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.81 -49.6 72.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.324 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.407 ' CD1' ' HG ' ' B' ' 209' ' ' LEU . 0.2 OUTLIER -65.69 -38.6 89.7 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.211 0.529 . . . . 0.0 110.24 -177.276 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.511 HD13 HG23 ' A' ' 28' ' ' ILE . 1.3 mp -63.97 -35.86 74.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.255 176.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.453 ' HB3' ' NZ ' ' A' ' 33' ' ' LYS . 6.1 ttpm? -76.02 -21.69 56.57 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.919 0.39 . . . . 0.0 110.351 175.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.51 -48.71 21.35 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.659 ' HB3' HD12 ' B' ' 209' ' ' LEU . . . -143.27 8.27 1.6 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.38 89.93 1.55 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.115 -176.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.2 p -50.17 -50.8 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -175.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -161.63 126.52 3.47 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.946 0.403 . . . . 0.0 111.246 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.512 HG23 ' HB3' ' A' ' 5' ' ' SER . 7.2 p -139.17 127.53 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.431 173.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 24.8 mm-40 -57.07 125.62 70.8 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.029 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 40' ' ' GLU . 50.3 Cg_exo -52.99 -11.12 1.3 Allowed 'Trans proline' 0 N--CA 1.481 0.792 0 C-N-CA 124.042 3.162 . . . . 0.0 115.046 -168.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.571 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 0.7 OUTLIER -80.12 -28.18 39.02 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -174.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.428 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 98.7 m95 -64.68 -60.48 8.21 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.293 175.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.428 ' CD ' ' HB2' ' A' ' 43' ' ' TRP . 19.3 Cg_endo -59.74 -34.45 96.04 Favored 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 121.835 1.69 . . . . 0.0 111.939 178.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.91 -49.17 81.53 Favored Glycine 0 C--O 1.241 0.562 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.253 176.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 42' ' ' PHE . 89.8 mt -64.08 -47.18 81.09 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -60.72 -47.02 88.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.843 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.72 -37.52 86.64 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.608 -176.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -91.49 -26.76 18.64 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 119.8 -0.76 . . . . 0.0 113.033 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -116.11 -20.13 10.0 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -171.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.76 ' HA ' HG23 ' A' ' 54' ' ' VAL . 2.2 tp -83.99 -133.87 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.425 ' HA ' HG13 ' A' ' 23' ' ' VAL . . . 58.08 3.16 0.22 Allowed 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -176.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -145.57 -44.15 0.21 Allowed 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -177.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.76 HG23 ' HA ' ' A' ' 51' ' ' LEU . 48.7 t -40.91 112.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 114.0 -1.454 . . . . 0.0 110.745 172.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -54.67 140.47 35.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.071 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.602 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 3.4 tp -43.85 -51.94 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 124.043 0.84 . . . . 0.0 112.903 -173.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.28 -30.89 75.23 Favored Glycine 0 C--O 1.243 0.688 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.661 -176.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.5 t -65.25 -11.55 42.38 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -176.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.602 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 1.7 mp -43.06 -48.38 6.13 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.164 170.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.583 HD11 HG21 ' B' ' 259' ' ' ILE . 24.7 mm -110.05 44.46 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.628 0.728 . . . . 0.0 109.82 -178.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 48.9 t -119.58 -36.47 3.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.117 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -100.36 4.0 43.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.43 -177.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 CA--C 1.533 0.297 0 CA-C-O 121.015 0.436 . . . . 0.0 111.299 179.028 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 203' ' ' TYR . . . . . 0.419 ' CD1' HD23 ' B' ' 239' ' ' LEU . 29.3 m-85 . . . . . 0 C--O 1.236 0.37 0 CA-C-O 121.305 0.574 . . . . 0.0 110.647 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.639 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 38.7 t -65.24 -44.54 95.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.235 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 205' ' ' ALA . . . . . 0.545 ' HA ' HD12 ' B' ' 208' ' ' LEU . . . -72.74 -20.19 61.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.901 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . 0.497 ' CB ' HG23 ' B' ' 223' ' ' ILE . 4.0 m -70.62 -42.42 70.93 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 173.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 207' ' ' TYR . . . . . 0.653 ' CE1' HD11 ' B' ' 251' ' ' ILE . 20.7 t80 -60.42 -41.58 94.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.163 174.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 75.7 mt -62.59 -42.06 99.34 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.814 177.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 209' ' ' LEU . . . . . 0.659 HD12 ' HB3' ' A' ' 35' ' ' ALA . 0.6 OUTLIER -55.8 -54.52 43.44 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.741 177.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -67.15 -27.33 67.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.376 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 211' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -65.81 -50.04 66.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.16 177.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 212' ' ' LEU . . . . . 0.439 ' HB2' HG23 ' A' ' 4' ' ' VAL . 4.1 pp -73.78 -24.85 59.9 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.727 0.299 . . . . 0.0 110.783 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.91 -13.68 53.19 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 116.005 -0.543 . . . . 0.0 113.265 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 118.65 35.48 0.98 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.886 177.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 215' ' ' ASN . . . . . 0.647 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 33.9 t30 -152.42 114.83 4.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.912 0.387 . . . . 0.0 110.31 176.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 216' ' ' SER . . . . . 0.49 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 8.1 m -76.28 -11.24 59.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.176 -178.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 217' ' ' SER . . . . . 0.406 ' N ' ' HD3' ' B' ' 218' ' ' PRO . 26.4 t -123.55 63.48 26.78 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.674 -176.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . 0.49 ' HD3' ' C ' ' B' ' 216' ' ' SER . 52.4 Cg_exo -60.22 144.96 99.48 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.029 2.486 . . . . 0.0 111.88 175.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 219' ' ' SER . . . . . 0.414 ' O ' HD13 ' B' ' 223' ' ' ILE . 21.5 m -129.51 168.53 16.23 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.794 178.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -47.76 -40.37 20.47 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.922 0.392 . . . . 0.0 111.659 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 221' ' ' LYS . . . . . 0.581 ' HZ3' ' HB3' ' B' ' 221' ' ' LYS . 4.2 ttpm? -58.1 -49.99 75.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.727 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.03 -39.4 69.15 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.281 -173.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.497 HG23 ' CB ' ' B' ' 206' ' ' SER . 1.7 mp -64.55 -40.28 88.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.584 176.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -56.25 -45.65 79.95 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.198 173.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -58.9 -43.98 91.11 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.151 0.5 . . . . 0.0 111.337 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 0.647 HD11 ' HB2' ' A' ' 35' ' ' ALA . 1.3 mp -63.57 -40.23 88.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.156 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 76.7 mt -76.54 -19.28 58.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.199 0.523 . . . . 0.0 110.581 176.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -73.84 -36.51 64.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.297 178.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 94.6 p -55.43 -40.96 72.17 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.634 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 3.3 m -90.02 -14.42 9.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 111.9 0.334 . . . . 0.0 111.9 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 77.7 32.84 44.51 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.586 175.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . 0.561 HD11 HG11 ' A' ' 21' ' ' VAL . 61.6 mt -90.48 130.43 39.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 177.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -67.01 100.22 0.72 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.318 0.58 . . . . 0.0 110.787 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -89.78 111.69 22.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.22 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . 0.466 ' HB2' ' HG2' ' B' ' 238' ' ' ARG . 5.3 m-20 -53.56 104.52 0.1 Allowed 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.727 0.642 . . . . 0.0 110.607 177.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -54.95 -38.14 67.35 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -174.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 237' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' B' ' 241' ' ' LYS . 15.9 t70 -55.81 -68.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.052 0.453 . . . . 0.0 111.276 178.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.481 ' HA ' ' HB2' ' B' ' 241' ' ' LYS . 13.7 ptp180 -68.76 -17.02 63.97 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.821 0.343 . . . . 0.0 111.039 -174.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 239' ' ' LEU . . . . . 0.455 HD13 HD12 ' B' ' 243' ' ' ILE . 3.3 tm? -61.22 -67.94 0.36 Allowed 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.854 176.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -75.1 -16.25 60.56 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.369 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 241' ' ' LYS . . . . . 0.481 ' HB2' ' HA ' ' B' ' 238' ' ' ARG . 29.9 mmtp -64.07 -56.02 17.95 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.257 171.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 242' ' ' VAL . . . . . 0.51 ' O ' ' HB3' ' B' ' 246' ' ' LEU . 34.7 m -67.26 -34.98 72.6 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.81 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -175.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . 0.455 HD12 HD13 ' B' ' 239' ' ' LEU . 58.4 mt -74.03 -23.87 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.473 178.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 25.3 t -72.0 -31.66 66.45 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 172.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -83.1 -22.7 33.33 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.35 0.595 . . . . 0.0 110.454 173.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . 0.564 ' O ' ' HG ' ' B' ' 246' ' ' LEU . 9.3 tp -116.11 71.44 0.78 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.466 -174.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -125.3 80.91 1.92 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.145 0.498 . . . . 0.0 111.949 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 87.04 -15.96 50.36 Favored Glycine 0 CA--C 1.52 0.406 0 CA-C-N 115.773 -0.649 . . . . 0.0 113.412 175.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -67.46 110.21 3.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.995 0.426 . . . . 0.0 111.524 -176.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 60.27 42.22 15.39 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.808 174.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.653 HD11 ' CE1' ' B' ' 207' ' ' TYR . 2.5 mm -58.25 -53.07 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -176.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -67.42 -26.18 66.29 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.378 -176.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -72.91 -46.03 54.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.4 177.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 254' ' ' VAL . . . . . . . . . . . . . 22.9 m -68.28 -20.57 25.67 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.989 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 255' ' ' ILE . . . . . 0.405 ' HA ' ' OH ' ' A' ' 11' ' ' TYR . 54.5 mt -74.04 -56.02 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-O 121.026 0.441 . . . . 0.0 110.759 172.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -67.98 -38.4 82.65 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -173.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 17.0 tp60 -101.54 -14.73 17.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.87 0.367 . . . . 0.0 111.701 -174.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -105.63 56.82 0.51 Allowed Glycine 0 C--O 1.227 -0.298 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.275 -172.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 259' ' ' ILE . . . . . 0.583 HG21 HD11 ' A' ' 60' ' ' ILE . 1.3 mt . . . . . 0 C--N 1.327 -0.387 0 CA-C-O 120.893 0.378 . . . . 0.0 111.668 -179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.611 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 5.8 p . . . . . 0 CA--C 1.529 0.167 0 CA-C-O 120.946 0.403 . . . . 0.0 111.997 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.504 ' HA ' HD12 ' A' ' 7' ' ' LEU . 21.9 t -66.09 -31.02 51.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.213 0.53 . . . . 0.0 110.005 -174.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.508 ' HB3' HG23 ' A' ' 39' ' ' VAL . 1.1 m -61.76 -55.54 29.05 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.417 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -61.15 -42.06 97.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.97 178.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 3' ' ' SER . 96.0 mt -56.15 -55.61 30.97 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.619 178.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.26 -49.73 76.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.086 -178.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.427 ' HA ' HD11 ' A' ' 32' ' ' ILE . 24.1 t -66.15 -38.36 87.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.291 -176.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.419 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 1.3 tp -75.16 -39.56 43.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.932 0.396 . . . . 0.0 110.998 -177.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.741 ' HD1' HD21 ' A' ' 14' ' ' LEU . 20.1 m-85 -74.91 -19.31 60.19 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.2 t -70.94 -50.97 28.84 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 170.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.452 ' HB3' HD21 ' A' ' 59' ' ' LEU . . . -49.43 -48.21 47.57 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.109 175.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.741 HD21 ' HD1' ' A' ' 11' ' ' TYR . 4.2 pp -81.09 -18.16 47.49 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 11' ' ' TYR . 2.8 mt -62.14 -41.98 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.274 0.559 . . . . 0.0 109.543 168.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 23' ' ' VAL . 57.7 mt -80.82 -27.56 36.5 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.183 -178.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.534 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 10.2 m80 -79.78 64.73 4.72 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 177.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -129.93 -51.35 1.13 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 171.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.49 ' OD1' HG21 ' B' ' 232' ' ' ILE . 8.8 m-20 -102.32 10.67 38.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.406 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 54.18 51.26 14.78 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.398 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -87.11 162.12 2.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.214 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.484 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 10.6 p -56.31 110.98 0.85 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.31 0.576 . . . . 0.0 112.246 -175.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.431 ' HA ' HD13 ' A' ' 16' ' ' LEU . 33.9 m -84.87 47.35 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.556 0.693 . . . . 0.0 110.935 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.414 HG22 ' HG2' ' A' ' 27' ' ' LYS . 10.1 t -87.31 169.32 12.39 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.071 -171.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -52.93 -42.26 65.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.903 -177.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -49.82 -45.58 50.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.677 177.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 22' ' ' THR . 66.4 mmtt -76.48 -48.92 17.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.945 -173.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.3 mt -62.45 -46.1 97.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.019 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -60.37 -46.09 91.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.902 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.65 ' HB3' HG11 ' B' ' 230' ' ' VAL . . . -71.21 -34.37 70.78 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.708 HD11 HG23 ' B' ' 226' ' ' ILE . 0.1 OUTLIER -70.69 -46.02 63.93 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.712 0.768 . . . . 0.0 109.478 178.568 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.427 HD11 ' HA ' ' A' ' 9' ' ' CYS . 1.5 mp -58.65 -37.3 64.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.53 175.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -74.39 -31.38 62.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.177 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.34 -45.4 91.48 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.471 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.579 ' HA ' HD11 ' B' ' 226' ' ' ILE . . . -76.32 -31.82 58.36 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.169 177.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.07 16.48 47.36 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.27 175.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.568 ' CG2' ' HA2' ' B' ' 213' ' ' GLY . 53.1 t -95.19 138.98 19.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.822 0.344 . . . . 0.0 110.71 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -93.41 97.47 10.59 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.873 0.368 . . . . 0.0 111.461 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.508 HG23 ' HB3' ' A' ' 5' ' ' SER . 7.7 p -97.09 136.68 27.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 171.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -59.92 126.24 82.85 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.65 -5.65 0.48 Allowed 'Trans proline' 0 N--CA 1.482 0.815 0 C-N-CA 124.053 3.169 . . . . 0.0 114.146 -172.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.64 -36.36 80.63 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.64 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 94.6 m95 -71.69 -56.6 4.78 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.995 177.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.64 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 74.0 Cg_exo -51.12 -43.77 46.42 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.093 1.862 . . . . 0.0 112.334 176.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.88 -57.1 15.18 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.143 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 45.5 tp -57.37 -43.61 83.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.659 0.266 . . . . 0.0 110.348 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.585 ' HA ' HD13 ' A' ' 51' ' ' LEU . 3.0 m-85 -59.97 -49.73 76.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.295 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.42 -34.27 76.44 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.043 -178.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -97.49 -1.71 43.54 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.86 -16.55 7.07 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.585 HD13 ' HA ' ' A' ' 47' ' ' PHE . 9.4 mp -84.75 -131.77 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 O-C-N 121.945 -0.472 . . . . 0.0 110.098 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 61.02 2.22 0.54 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.502 0.721 . . . . 0.0 112.887 -178.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.495 ' H ' HG12 ' A' ' 54' ' ' VAL . 9.3 m120 -139.49 -58.49 0.58 Allowed 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.542 HG11 ' HG ' ' A' ' 51' ' ' LEU . 2.5 p -1.01 96.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 113.217 -1.81 . . . . 0.0 114.48 164.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -59.38 128.75 38.65 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.205 169.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 5.1 tp -47.73 -45.25 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -169.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.414 ' O ' HG22 ' A' ' 60' ' ' ILE . . . -58.85 -37.38 90.52 Favored Glycine 0 C--O 1.239 0.407 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.595 -177.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.9 m -61.57 -11.01 9.38 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.474 -0.363 . . . . 0.0 111.599 -178.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 13' ' ' ALA . 9.2 tp -63.04 -24.86 68.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.802 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.51 ' O ' HG12 ' A' ' 60' ' ' ILE . 11.0 tt -99.86 22.43 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 121.991 0.901 . . . . 0.0 110.301 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 81.8 m -140.94 -62.38 0.48 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.16 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -101.1 66.33 1.13 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.978 0.418 . . . . 0.0 110.701 -176.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.137 177.979 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 . . . . . 0 C--O 1.24 0.567 0 CA-C-O 121.355 0.598 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.529 ' O ' HD13 ' B' ' 208' ' ' LEU . 8.6 p -58.28 -47.79 86.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.147 -174.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 205' ' ' ALA . . . . . 0.565 ' HB1' ' HB3' ' A' ' 11' ' ' TYR . . . -72.95 -19.22 61.28 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.471 -177.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . 0.563 ' OG ' HG23 ' B' ' 223' ' ' ILE . 24.4 t -66.09 -43.33 87.63 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 207' ' ' TYR . . . . . 0.559 ' CE1' HD11 ' B' ' 251' ' ' ILE . 21.5 t80 -60.47 -44.31 96.04 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.721 173.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.541 ' HB2' ' HA ' ' B' ' 205' ' ' ALA . 6.3 mp -56.26 -49.07 75.23 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.035 177.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 209' ' ' LEU . . . . . 0.506 HD22 HD12 ' A' ' 31' ' ' LEU . 3.7 mp -62.54 -43.13 99.57 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.56 0.219 . . . . 0.0 111.379 -178.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -62.74 -34.0 76.3 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.19 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 211' ' ' ALA . . . . . 0.716 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -71.44 -53.77 12.9 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.701 0.286 . . . . 0.0 111.05 178.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 212' ' ' LEU . . . . . 0.451 HD22 ' HB3' ' A' ' 7' ' ' LEU . 4.6 pp -68.61 -17.79 64.18 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.045 0.45 . . . . 0.0 110.904 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . 0.568 ' HA2' ' CG2' ' A' ' 37' ' ' VAL . . . -66.88 -19.63 69.81 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.103 177.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 130.71 6.91 3.55 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.111 177.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 215' ' ' ASN . . . . . 0.716 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 7.9 m-20 -119.52 119.05 32.7 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.841 0.353 . . . . 0.0 110.996 -178.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 8.5 m -81.74 -0.87 44.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.71 0.29 . . . . 0.0 111.365 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 217' ' ' SER . . . . . 0.452 ' N ' ' HD3' ' B' ' 218' ' ' PRO . 24.5 m -135.98 62.16 44.75 Favored Pre-proline 0 N--CA 1.444 -0.764 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.342 -176.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . 0.452 ' HD3' ' N ' ' B' ' 217' ' ' SER . 35.0 Cg_exo -63.87 130.98 29.31 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.987 2.458 . . . . 0.0 112.483 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 219' ' ' SER . . . . . 0.496 ' O ' HD13 ' B' ' 223' ' ' ILE . 33.0 t -110.25 169.53 8.67 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.762 0.315 . . . . 0.0 110.49 177.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -56.02 -29.1 59.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.72 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -62.39 -53.1 59.92 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.612 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -62.36 -48.04 81.54 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.252 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.563 HG23 ' OG ' ' B' ' 206' ' ' SER . 1.7 mp -61.18 -48.49 88.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.784 -178.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -62.21 -38.11 87.9 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.499 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -56.93 -52.52 64.86 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.049 176.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 0.708 HG23 HD11 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -60.25 -43.73 94.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.222 -177.673 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . 0.406 HD13 ' HB2' ' B' ' 234' ' ' ALA . 1.1 tt -69.99 -43.02 72.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.68 0.276 . . . . 0.0 110.497 -177.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -69.43 -25.51 64.15 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.998 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 58.7 m -51.08 -49.41 60.71 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 230' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' A' ' 30' ' ' ALA . 3.4 p -171.46 19.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.914 -175.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -82.93 -94.75 0.57 Allowed Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 119.973 -1.108 . . . . 0.0 112.04 -173.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . 0.49 HG21 ' OD1' ' A' ' 19' ' ' ASP . 51.4 mt -143.17 -88.87 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 120.543 0.211 . . . . 0.0 110.549 -176.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -148.17 160.7 42.65 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 174.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . 0.406 ' HB2' HD13 ' B' ' 227' ' ' LEU . . . -151.21 98.91 2.61 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.054 0.454 . . . . 0.0 111.676 -177.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . 0.479 ' CG ' ' HD3' ' B' ' 238' ' ' ARG . 0.0 OUTLIER -67.74 127.54 33.18 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.77 174.422 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -65.69 -39.86 91.73 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -165.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -80.71 -38.62 28.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.312 0.577 . . . . 0.0 110.21 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.479 ' HD3' ' CG ' ' B' ' 235' ' ' ASP . 68.2 ttt180 -66.68 -39.47 88.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.677 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 239' ' ' LEU . . . . . 0.421 HD11 HG22 ' B' ' 223' ' ' ILE . 8.6 tt -59.01 -51.84 68.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.07 178.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -69.3 -29.53 67.41 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -67.15 -46.37 74.26 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 242' ' ' VAL . . . . . . . . . . . . . 35.8 m -70.13 -32.17 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . 0.476 ' HA ' ' CD2' ' B' ' 246' ' ' LEU . 12.5 mt -64.25 -38.54 82.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.981 170.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 28.1 t -72.07 -13.64 61.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.616 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -89.31 -30.29 18.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.036 0.446 . . . . 0.0 110.402 172.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . 0.559 ' O ' HD12 ' B' ' 246' ' ' LEU . 1.4 pp -98.84 3.72 47.4 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.617 -178.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -78.16 40.02 0.33 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -171.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -86.63 -121.23 1.32 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.17 -175.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -139.15 -174.44 3.86 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . 0.509 ' HB3' ' HB3' ' B' ' 253' ' ' ASP . 89.6 m-20 64.5 49.63 2.37 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.625 0.578 . . . . 0.0 111.428 176.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.559 HD11 ' CE1' ' B' ' 207' ' ' TYR . 1.3 mm -60.19 -48.39 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.297 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -68.96 -22.27 64.12 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.422 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . 0.509 ' HB3' ' HB3' ' B' ' 250' ' ' ASN . 5.8 t70 -70.88 -47.01 61.56 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 254' ' ' VAL . . . . . 0.487 HG22 ' O ' ' B' ' 251' ' ' ILE . 11.4 m -69.67 -25.11 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.119 178.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 255' ' ' ILE . . . . . 0.512 ' CG2' HD13 ' A' ' 7' ' ' LEU . 61.4 mt -78.98 -32.04 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.782 174.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -77.84 -41.69 36.15 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -127.1 36.96 4.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.271 0.558 . . . . 0.0 111.123 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -124.66 36.57 2.84 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.218 -0.992 . . . . 0.0 111.955 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--O 1.222 -0.383 0 CA-C-O 120.814 0.34 . . . . 0.0 110.724 -178.573 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 CA--C 1.537 0.472 0 CA-C-O 121.208 0.528 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.604 ' HA ' HD12 ' A' ' 7' ' ' LEU . 2.4 m -66.09 -18.01 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.481 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.451 ' HB3' HG23 ' A' ' 39' ' ' VAL . 16.7 m -61.37 -62.67 1.66 Allowed 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.51 176.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.602 ' O ' HG23 ' A' ' 10' ' ' ILE . 9.9 pt-20 -69.93 -34.9 74.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.446 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.604 HD12 ' HA ' ' A' ' 4' ' ' VAL . 66.6 mt -49.19 -64.72 0.72 Allowed 'General case' 0 C--O 1.222 -0.348 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 172.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.31 86.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.683 -176.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.2 t -62.21 -51.79 66.37 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -176.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.602 HG23 ' O ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -83.19 -16.58 11.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 119.166 -1.013 . . . . 0.0 111.158 -177.869 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.415 ' HB2' HD21 ' B' ' 209' ' ' LEU . 15.9 m-30 -69.89 -32.41 70.73 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 169.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.412 ' HA ' HD23 ' A' ' 31' ' ' LEU . 28.1 t -66.58 -43.91 83.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.298 169.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 10' ' ' ILE . . . -48.96 -45.19 41.59 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 120.98 0.419 . . . . 0.0 110.376 171.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 10' ' ' ILE . 85.7 mt -58.46 -56.03 27.41 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.614 177.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.627 HD12 HD21 ' A' ' 31' ' ' LEU . 56.5 mt -60.15 -32.45 50.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.619 -174.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.429 HD11 HG11 ' B' ' 230' ' ' VAL . 2.5 mm? -88.79 -24.34 22.64 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 121.758 -0.589 . . . . 0.0 112.41 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.549 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 54.6 t-80 -59.38 -51.25 70.73 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -174.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -92.52 -21.19 20.26 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -164.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.44 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.7 m-20 -86.12 29.08 0.76 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -171.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 65.32 8.26 4.81 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.846 0.459 . . . . 0.0 111.933 174.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 19' ' ' ASP . 71.7 t -104.74 141.23 20.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.138 0.494 . . . . 0.0 110.721 -176.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.483 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 7.1 p -73.02 126.75 30.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.079 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.6 p -76.44 87.0 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.564 0.697 . . . . 0.0 110.917 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.1 p -112.46 175.6 5.37 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.353 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -59.74 -36.53 76.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.768 -178.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -53.14 -45.02 68.19 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.897 176.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 22' ' ' THR . 69.2 mmtt -78.29 -47.59 17.5 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.678 -169.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.444 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 21.6 mt -65.47 -46.49 89.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.362 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -63.15 -38.81 92.64 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.86 -43.6 75.08 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.128 0.489 . . . . 0.0 111.232 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.627 HD21 HD12 ' A' ' 15' ' ' ILE . 27.3 tp -70.87 -31.92 68.74 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.336 0.589 . . . . 0.0 110.011 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 28' ' ' ILE . 1.4 mp -73.05 -27.99 25.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.092 174.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -69.71 -34.32 73.72 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 172.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.96 -63.06 1.15 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.161 178.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.504 ' HB2' HD11 ' B' ' 226' ' ' ILE . . . -129.45 26.22 5.38 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -175.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -100.96 94.72 1.3 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.27 -0.967 . . . . 0.0 111.339 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.501 HG22 HD22 ' A' ' 38' ' ' ASN . 7.7 p -55.05 -50.15 65.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.501 HD22 HG22 ' A' ' 37' ' ' VAL . 9.2 p30 -161.91 130.03 4.15 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.226 0.536 . . . . 0.0 111.725 176.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.451 HG23 ' HB3' ' A' ' 5' ' ' SER . 10.9 p -157.56 131.95 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.06 174.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -73.0 132.1 83.08 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.56 -4.84 0.59 Allowed 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.846 3.031 . . . . 0.0 114.462 -171.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.55 -37.75 77.19 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 93.2 m95 -68.4 -55.01 12.98 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.839 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.589 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 87.5 Cg_exo -50.25 -50.77 12.52 Favored 'Trans proline' 0 C--N 1.364 1.366 0 C-N-CA 121.99 1.793 . . . . 0.0 112.972 174.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.8 -49.91 72.89 Favored Glycine 0 C--O 1.242 0.622 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.092 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 56.9 tp -53.57 -62.16 1.83 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.239 177.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.481 ' CZ ' HG22 ' A' ' 10' ' ' ILE . 3.5 m-85 -52.41 -46.19 66.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.237 -177.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.26 -38.52 91.5 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.732 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -105.52 10.33 33.18 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.894 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -115.38 -32.82 5.49 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 175.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.671 ' HA ' ' CG2' ' A' ' 54' ' ' VAL . 47.5 mt -80.86 -133.61 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.411 -177.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 66.66 -12.45 0.21 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.827 0.851 . . . . 0.0 113.245 177.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 51' ' ' LEU . 52.2 m-80 -141.17 7.38 1.99 Allowed 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.833 0.825 . . . . 0.0 108.87 178.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.671 ' CG2' ' HA ' ' A' ' 51' ' ' LEU . 0.6 OUTLIER -112.92 114.45 47.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.814 -173.411 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -43.95 136.91 3.47 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.635 1.209 . . . . 0.0 110.101 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.773 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 4.9 tp -47.7 -43.52 9.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.186 -169.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -53.35 -22.78 16.22 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.556 -177.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.2 t -53.36 -34.83 59.11 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 122.527 0.331 . . . . 0.0 111.535 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.773 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -61.23 -13.44 18.51 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -175.037 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.433 ' N ' HD12 ' A' ' 59' ' ' LEU . 18.5 mt -66.09 -24.81 34.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.902 0.382 . . . . 0.0 110.421 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.5 t -159.69 72.0 0.51 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.421 0.629 . . . . 0.0 109.833 174.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -94.08 37.12 1.1 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.679 0.752 . . . . 0.0 110.099 -178.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.93 177.563 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 203' ' ' TYR . . . . . 0.523 ' OH ' ' HB2' ' B' ' 235' ' ' ASP . 1.3 m-85 . . . . . 0 C--O 1.236 0.376 0 CA-C-O 121.115 0.483 . . . . 0.0 111.678 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.663 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 26.8 m -65.19 -42.48 94.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.664 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 205' ' ' ALA . . . . . 0.71 ' O ' ' HG ' ' B' ' 209' ' ' LEU . . . -73.8 -22.23 59.88 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.319 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . 0.489 ' CB ' HG23 ' B' ' 223' ' ' ILE . 6.9 m -64.26 -47.74 78.43 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 171.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 207' ' ' TYR . . . . . 0.557 ' CZ ' ' HD2' ' B' ' 218' ' ' PRO . 36.9 t80 -60.53 -40.42 91.41 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.313 176.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 82.5 mt -57.96 -51.07 71.15 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.8 178.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 209' ' ' LEU . . . . . 0.71 ' HG ' ' O ' ' B' ' 205' ' ' ALA . 70.4 mt -59.01 -56.04 27.35 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.816 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 210' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' B' ' 218' ' ' PRO . . . -58.13 -31.29 67.04 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.599 -178.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 211' ' ' ALA . . . . . 0.654 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -74.58 -50.83 16.43 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.408 178.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 212' ' ' LEU . . . . . 0.472 ' HB2' HG12 ' A' ' 4' ' ' VAL . 4.0 pp -66.17 -20.12 66.04 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.64 0.257 . . . . 0.0 110.719 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . 0.495 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -68.22 -20.03 72.77 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.595 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 128.22 33.3 0.59 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.784 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 215' ' ' ASN . . . . . 0.654 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 18.3 m120 -144.74 114.25 7.15 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 216' ' ' SER . . . . . 0.407 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 6.3 m -70.24 -17.87 63.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.846 0.355 . . . . 0.0 111.478 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 54.6 p -125.46 71.98 66.18 Favored Pre-proline 0 N--CA 1.444 -0.749 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.969 -175.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . 0.557 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 42.5 Cg_exo -62.54 112.12 1.51 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.131 2.554 . . . . 0.0 112.167 176.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 29.2 p -75.74 137.12 40.39 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.344 0.592 . . . . 0.0 110.444 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -54.29 -30.16 49.91 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.85 -177.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -68.25 -37.08 80.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.809 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -78.69 -30.84 46.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.982 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.489 HG23 ' CB ' ' B' ' 206' ' ' SER . 1.7 mp -62.15 -45.57 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.282 0.563 . . . . 0.0 109.507 171.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -61.11 -42.37 98.41 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.037 177.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -57.4 -42.72 82.79 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.31 174.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 0.504 HD11 ' HB2' ' A' ' 35' ' ' ALA . 1.0 OUTLIER -61.48 -35.9 69.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.815 178.644 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . 0.536 HD23 ' HB2' ' B' ' 234' ' ' ALA . 11.8 tp -75.96 -39.22 56.45 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.53 -32.0 71.05 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.211 174.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 28.2 t -52.18 -54.69 27.77 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.742 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 230' ' ' VAL . . . . . 0.429 HG11 HD11 ' A' ' 16' ' ' LEU . 40.9 t -74.4 -34.27 35.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.355 0.598 . . . . 0.0 110.803 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 104.52 43.95 1.63 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.836 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . 0.406 ' HB ' ' HG ' ' B' ' 227' ' ' LEU . 2.5 mm -104.01 145.72 12.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -69.56 118.02 11.91 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.025 0.44 . . . . 0.0 110.213 -178.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . 0.536 ' HB2' HD23 ' B' ' 227' ' ' LEU . . . -99.21 99.41 10.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.208 -175.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . 0.523 ' HB2' ' OH ' ' B' ' 203' ' ' TYR . 2.2 m-20 -61.52 109.84 1.3 Allowed 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 170.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.77 -38.29 90.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.698 -172.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.55 -60.15 4.31 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.769 177.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -62.38 -35.74 80.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.662 -172.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 239' ' ' LEU . . . . . . . . . . . . . 9.3 tt -55.71 -61.34 2.42 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.108 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -70.03 -26.38 64.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.679 -177.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -61.89 -52.71 62.98 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.284 175.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 242' ' ' VAL . . . . . 0.545 ' O ' ' HG ' ' B' ' 246' ' ' LEU . 34.0 m -72.5 -30.98 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.581 -175.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . 0.421 ' HA ' HD12 ' B' ' 246' ' ' LEU . 30.0 mt -69.3 -36.2 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.636 174.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 30.3 t -60.34 -38.17 82.96 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 174.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -70.29 -37.06 74.74 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.298 174.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' B' ' 242' ' ' VAL . 64.1 mt -71.26 -31.74 67.88 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.96 0.41 . . . . 0.0 111.056 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -53.38 -34.88 59.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.374 -175.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -108.81 35.46 4.93 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.892 -177.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -134.62 153.54 51.92 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.631 0.253 . . . . 0.0 110.412 178.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . 0.404 ' ND2' ' HB2' ' B' ' 253' ' ' ASP . 8.8 p-10 -74.54 83.35 2.01 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.894 0.854 . . . . 0.0 111.614 -176.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.622 ' O ' HG12 ' B' ' 254' ' ' VAL . 5.2 tp -57.68 -39.03 67.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 114.446 -1.252 . . . . 0.0 112.265 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -63.7 -38.42 91.06 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.874 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . 0.52 ' O ' ' HG2' ' B' ' 257' ' ' GLN . 43.4 m-20 -73.78 -40.08 63.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.801 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 254' ' ' VAL . . . . . 0.622 HG12 ' O ' ' B' ' 251' ' ' ILE . 3.1 p -62.29 -31.22 50.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.271 -177.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 255' ' ' ILE . . . . . 0.583 ' CG2' HD13 ' A' ' 7' ' ' LEU . 77.0 mt -78.79 -37.97 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 173.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -64.84 -19.9 66.11 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 257' ' ' GLN . . . . . 0.52 ' HG2' ' O ' ' B' ' 253' ' ' ASP . 31.2 mm-40 -71.55 -80.69 0.06 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.586 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 177.31 -59.53 0.1 OUTLIER Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.344 -0.931 . . . . 0.0 113.168 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 259' ' ' ILE . . . . . 0.423 ' CD1' HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.256 0 CA-C-O 120.857 0.36 . . . . 0.0 110.71 -177.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.409 ' O ' HD13 ' A' ' 7' ' ' LEU . 3.4 p . . . . . 0 CA--C 1.533 0.31 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.425 ' HA ' ' HB2' ' A' ' 7' ' ' LEU . 6.4 m -65.4 -17.19 21.59 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.957 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.562 ' HB3' HG23 ' A' ' 39' ' ' VAL . 14.2 m -62.43 -67.13 0.44 Allowed 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.517 0.675 . . . . 0.0 110.447 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -67.25 -31.92 72.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.703 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.438 ' HB3' HD22 ' B' ' 212' ' ' LEU . 5.4 mp -60.41 -49.52 77.23 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.115 0.483 . . . . 0.0 110.224 176.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.85 -49.77 74.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.113 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.714 ' SG ' HG21 ' A' ' 39' ' ' VAL . 48.9 m -62.11 -35.86 79.98 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.701 -0.4 . . . . 0.0 112.055 -178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -74.35 -36.54 42.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.989 -0.285 . . . . 0.0 111.288 -178.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.622 ' O ' HG12 ' A' ' 15' ' ' ILE . 22.5 m-85 -77.52 -25.19 50.03 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.364 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.9 m -73.44 -38.7 65.43 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 172.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.25 -43.86 71.28 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.6 171.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.0 mt -57.04 -58.62 7.38 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.381 173.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.622 HG12 ' O ' ' A' ' 11' ' ' TYR . 36.6 mm -49.83 -35.86 10.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.279 -176.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.464 ' HB2' HG12 ' A' ' 23' ' ' VAL . 58.5 mt -106.08 -2.64 22.44 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -175.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.57 -20.79 66.09 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.822 -0.549 . . . . 0.0 112.309 -178.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.441 ' HB3' ' H ' ' A' ' 19' ' ' ASP . 0.2 OUTLIER -125.88 -117.76 0.27 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.648 -174.535 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.441 ' H ' ' HB3' ' A' ' 18' ' ' ASP . 1.0 OUTLIER 20.2 -138.93 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -170.397 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.424 ' H ' ' HB3' ' A' ' 19' ' ' ASP . 32.1 tt0 -117.14 23.46 11.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.98 0.895 . . . . 0.0 109.039 177.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.42 HG21 HG12 ' B' ' 232' ' ' ILE . 78.3 t -116.26 122.49 69.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.573 -176.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.437 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 4.5 p -80.08 147.13 31.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.077 -176.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 23' ' ' VAL . 30.9 m -75.03 103.66 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 121.507 0.67 . . . . 0.0 111.062 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.9 p -130.11 157.78 41.45 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 121.746 -0.596 . . . . 0.0 111.204 177.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -51.95 -49.55 62.93 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.709 0.631 . . . . 0.0 109.871 -177.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -34.09 65.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.886 -176.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.437 ' HD2' ' O ' ' A' ' 22' ' ' THR . 69.1 mttm -85.18 -41.74 15.37 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.24 -172.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.421 HG13 HD12 ' A' ' 16' ' ' LEU . 3.2 mt -63.37 -43.94 98.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 173.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.578 ' OD1' ' HE3' ' A' ' 33' ' ' LYS . 19.6 t-20 -58.07 -44.38 87.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.753 176.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.0 -44.41 94.56 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.492 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.2 mt -64.93 -44.29 89.97 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.677 0.275 . . . . 0.0 111.308 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 mp -59.27 -44.94 93.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.106 0.479 . . . . 0.0 110.426 178.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.578 ' HE3' ' OD1' ' A' ' 29' ' ' ASN . 97.7 mttt -66.43 -32.32 73.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.796 178.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.501 ' HB1' ' HA ' ' B' ' 226' ' ' ILE . . . -64.44 -38.07 89.73 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.265 177.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.419 ' HA ' HD11 ' B' ' 226' ' ' ILE . . . -79.93 -27.43 39.84 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.986 177.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.7 6.5 56.25 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.28 173.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.522 HG13 ' HA2' ' B' ' 213' ' ' GLY . 6.8 m -91.32 -178.93 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.05 0.452 . . . . 0.0 111.643 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -134.52 120.86 20.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.541 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.714 HG21 ' SG ' ' A' ' 9' ' ' CYS . 12.6 p -119.99 144.28 29.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.855 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.34 122.96 58.48 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -52.29 -13.32 2.03 Favored 'Trans proline' 0 N--CA 1.484 0.921 0 C-N-CA 123.735 2.956 . . . . 0.0 114.699 -170.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.01 -24.72 43.51 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -175.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.477 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 95.2 m95 -67.86 -59.57 6.44 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 175.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.477 ' CD ' ' HB2' ' A' ' 43' ' ' TRP . 11.3 Cg_endo -56.48 -37.29 97.54 Favored 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 121.862 1.708 . . . . 0.0 112.11 176.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.462 ' O ' ' HG2' ' A' ' 49' ' ' LYS . . . -66.0 -50.67 50.9 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.593 178.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.2 tt -59.23 -46.39 88.59 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.597 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 11.3 m-85 -60.05 -42.81 95.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.942 0.401 . . . . 0.0 110.844 177.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.98 -49.64 76.62 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -177.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 45' ' ' GLY . 19.0 ptmt -105.03 0.42 27.62 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -172.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.04 -11.55 3.32 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.688 ' HA ' HG23 ' A' ' 54' ' ' VAL . 3.4 tp -90.47 -133.16 0.11 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.464 ' H ' ' CG ' ' A' ' 51' ' ' LEU . . . 61.65 -12.68 0.05 Allowed 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.555 ' H ' ' C ' ' A' ' 51' ' ' LEU . 88.2 m-20 -128.23 -34.42 2.09 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -178.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.688 HG23 ' HA ' ' A' ' 51' ' ' LEU . 41.0 t -50.92 109.45 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-N 114.407 -1.269 . . . . 0.0 109.848 170.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -51.12 150.01 3.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.727 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.541 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 2.6 tp -53.83 -49.48 58.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -173.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.17 -26.43 65.89 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.781 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 61' ' ' CYS . 19.3 m -65.97 -2.19 3.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.661 -0.269 . . . . 0.0 111.484 -178.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 42.6 mt -57.36 -24.99 58.72 Favored 'General case' 0 N--CA 1.46 0.074 0 CA-C-O 120.771 0.319 . . . . 0.0 110.483 171.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.8 mt -89.69 28.15 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 121.421 0.629 . . . . 0.0 109.787 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 58' ' ' SER . 33.1 t -63.59 154.58 32.28 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.642 176.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -77.17 54.34 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.88 0.848 . . . . 0.0 110.017 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 C--N 1.319 -0.728 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.504 178.076 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 203' ' ' TYR . . . . . 0.408 ' OH ' ' HA ' ' B' ' 234' ' ' ALA . 73.6 m-85 . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.613 ' O ' HD13 ' B' ' 208' ' ' LEU . 58.5 t -65.25 -53.48 40.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.49 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 205' ' ' ALA . . . . . 0.495 ' HA ' HD22 ' B' ' 208' ' ' LEU . . . -70.54 -16.4 62.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.163 0.506 . . . . 0.0 110.673 -178.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . 0.414 ' CB ' HG23 ' B' ' 223' ' ' ILE . 5.8 m -69.59 -47.23 64.24 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 171.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 207' ' ' TYR . . . . . 0.552 ' CD1' HD11 ' B' ' 251' ' ' ILE . 32.3 t80 -57.17 -39.68 75.78 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.254 174.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.613 HD13 ' O ' ' B' ' 204' ' ' VAL . 7.0 mp -60.71 -49.49 77.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.324 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 209' ' ' LEU . . . . . 0.515 ' CD2' ' HB2' ' A' ' 11' ' ' TYR . 25.3 mt -56.29 -48.78 75.97 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 120.936 0.398 . . . . 0.0 110.585 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 210' ' ' ALA . . . . . 0.536 ' HB3' ' HB3' ' B' ' 218' ' ' PRO . . . -66.56 -29.76 69.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.328 -177.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 211' ' ' ALA . . . . . 0.659 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -72.65 -52.26 16.07 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.933 0.396 . . . . 0.0 111.055 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 212' ' ' LEU . . . . . 0.438 HD22 ' HB3' ' A' ' 7' ' ' LEU . 2.9 pp -69.13 -19.97 64.04 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . 0.522 ' HA2' HG13 ' A' ' 37' ' ' VAL . . . -60.15 -19.68 52.33 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.824 176.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 127.73 3.9 5.84 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.665 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 215' ' ' ASN . . . . . 0.659 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 28.3 t30 -122.56 114.01 20.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.92 0.391 . . . . 0.0 110.654 -177.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 216' ' ' SER . . . . . 0.427 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 18.6 m -70.76 -12.51 61.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.636 -178.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 10.1 p -122.98 67.49 32.63 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.492 -178.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . 0.536 ' HB3' ' HB3' ' B' ' 210' ' ' ALA . 80.7 Cg_exo -53.38 106.33 0.15 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.261 2.641 . . . . 0.0 113.09 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 16.0 m -77.9 148.74 34.44 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.158 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -56.63 -29.49 62.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.348 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -68.62 -30.05 68.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.342 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -86.64 -30.46 21.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.342 -177.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.414 HG23 ' CB ' ' B' ' 206' ' ' SER . 1.8 mp -66.47 -44.78 90.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 171.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 224' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' B' ' 228' ' ' ASP . 38.7 tttp -60.47 -43.4 96.96 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.799 175.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -56.72 -45.59 81.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.903 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 0.501 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . 1.0 OUTLIER -61.26 -44.88 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.071 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . 0.436 HD23 ' HB2' ' B' ' 234' ' ' ALA . 10.0 tp -76.36 -32.65 58.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.686 0.279 . . . . 0.0 110.652 -176.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 228' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' B' ' 224' ' ' LYS . 1.1 t0 -72.15 -29.78 64.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.319 0.58 . . . . 0.0 109.635 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 32.2 t -60.08 -37.79 80.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.051 177.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 9.6 p -98.74 -23.67 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 120.997 0.427 . . . . 0.0 111.313 -174.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 102.32 57.36 0.8 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.777 -0.725 . . . . 0.0 114.214 172.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . 0.42 HG12 HG21 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -130.51 147.33 33.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 173.069 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -66.1 130.23 42.54 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.72 0.295 . . . . 0.0 111.742 -175.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . 0.436 ' HB2' HD23 ' B' ' 227' ' ' LEU . . . -128.04 106.99 9.45 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.904 -177.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -81.72 124.07 29.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.745 178.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -63.38 -43.69 96.89 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.497 -171.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.29 -45.19 81.27 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -63.61 -49.94 71.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.015 -177.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 239' ' ' LEU . . . . . 0.607 HD12 ' N ' ' B' ' 240' ' ' ASN . 4.5 pp -64.03 -41.3 97.47 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 121.152 -0.219 . . . . 0.0 111.339 -176.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 240' ' ' ASN . . . . . 0.607 ' N ' HD12 ' B' ' 239' ' ' LEU . 25.5 t-20 -70.36 -34.99 73.28 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.658 -178.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 241' ' ' LYS . . . . . 0.691 ' O ' ' HG2' ' B' ' 245' ' ' GLU . 5.1 mmmp? -71.43 -39.74 70.86 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.808 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 242' ' ' VAL . . . . . . . . . . . . . 19.9 m -69.84 -31.51 48.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 119.566 -0.853 . . . . 0.0 108.949 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . 0.483 ' HA ' ' CD2' ' B' ' 246' ' ' LEU . 20.5 mt -68.79 -36.42 74.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.945 175.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 97.0 p -71.4 -32.46 68.45 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.638 178.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 245' ' ' GLU . . . . . 0.691 ' HG2' ' O ' ' B' ' 241' ' ' LYS . 7.1 mm-40 -74.76 -34.97 62.57 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.444 178.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . 0.483 ' CD2' ' HA ' ' B' ' 243' ' ' ILE . 1.0 OUTLIER -85.4 -10.1 56.68 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.139 0.495 . . . . 0.0 110.639 178.75 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -52.44 -54.01 37.84 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.596 -176.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -94.4 58.35 1.96 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.596 -176.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -135.77 163.03 31.13 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . 0.402 ' O ' HG13 ' B' ' 254' ' ' VAL . 0.9 OUTLIER -70.01 84.52 0.51 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.581 -178.264 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.552 HD11 ' CD1' ' B' ' 207' ' ' TYR . 0.6 OUTLIER -55.27 -39.26 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.674 0.749 . . . . 0.0 111.112 176.57 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.02 -35.76 82.23 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.075 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -72.0 -45.56 60.51 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.576 0.227 . . . . 0.0 110.54 177.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 254' ' ' VAL . . . . . 0.459 HG22 ' HA ' ' B' ' 251' ' ' ILE . 12.3 m -64.63 -32.36 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.326 -176.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 255' ' ' ILE . . . . . 0.533 ' HA ' ' OH ' ' A' ' 11' ' ' TYR . 56.3 mt -82.45 -36.14 13.36 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-O 120.985 0.421 . . . . 0.0 111.139 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -68.5 -54.17 18.54 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.72 -178.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -152.33 38.19 0.55 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -175.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 258' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' B' ' 254' ' ' VAL . . . -104.08 37.76 3.6 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.144 -1.026 . . . . 0.0 112.792 -177.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 259' ' ' ILE . . . . . 0.41 ' H ' HG13 ' B' ' 259' ' ' ILE . 13.0 mt . . . . . 0 N--CA 1.467 0.414 0 CA-C-O 120.988 0.423 . . . . 0.0 110.818 -178.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 120.771 0.319 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.571 ' HA ' HD12 ' A' ' 7' ' ' LEU . 2.8 m -70.02 -25.06 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 CA-C-O 120.992 0.425 . . . . 0.0 110.537 -177.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.602 ' HB2' HG23 ' A' ' 39' ' ' VAL . 3.4 p -68.36 -52.73 29.93 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 121.48 0.657 . . . . 0.0 110.015 175.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.558 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 41.8 tt0 -62.56 -41.57 99.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.174 178.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.633 HD13 ' CG2' ' B' ' 255' ' ' ILE . 49.2 mt -53.98 -47.31 71.51 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.314 174.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.418 ' HB2' HG11 ' A' ' 37' ' ' VAL . . . -57.34 -53.12 61.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.685 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.558 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 7.2 p -67.54 -28.3 67.69 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.7 -176.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.446 HG13 HD23 ' A' ' 59' ' ' LEU . 0.7 OUTLIER -76.06 -40.76 37.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 120.895 0.379 . . . . 0.0 111.09 179.708 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.409 ' HB2' ' CD1' ' B' ' 209' ' ' LEU . 19.9 m-85 -71.03 -28.63 64.53 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.5 m -68.66 -45.86 70.63 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.102 173.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.5 -51.18 28.59 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.057 0.456 . . . . 0.0 110.572 173.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 10' ' ' ILE . 35.5 mt -61.23 -48.82 79.72 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.921 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.492 HD11 ' HA ' ' B' ' 206' ' ' SER . 83.8 mt -62.57 -37.29 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.789 0.328 . . . . 0.0 111.453 -178.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.706 HD23 ' HA ' ' A' ' 23' ' ' VAL . 10.8 mp -74.11 -22.14 59.6 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.895 177.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.496 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 51.4 t-80 -94.16 61.03 2.85 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.831 172.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -124.81 -55.62 1.6 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 174.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -117.19 -161.88 0.83 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -81.48 43.65 0.75 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.482 0.658 . . . . 0.0 111.845 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.522 HG11 HD11 ' B' ' 232' ' ' ILE . 7.6 p -94.05 128.54 45.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.099 0.476 . . . . 0.0 110.102 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.403 ' C ' ' H ' ' A' ' 24' ' ' THR . 33.5 p -56.08 123.69 15.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.81 -178.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.706 ' HA ' HD23 ' A' ' 16' ' ' LEU . 8.6 p -76.87 24.73 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-O 121.643 0.735 . . . . 0.0 111.144 -177.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.403 ' H ' ' C ' ' A' ' 22' ' ' THR . 6.6 t -92.49 168.13 11.48 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 121.679 0.752 . . . . 0.0 110.938 -174.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -25.83 67.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.778 -168.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -49.04 -50.89 34.17 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.521 0.677 . . . . 0.0 109.311 170.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -82.13 -38.14 25.2 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.931 -172.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.59 HG13 HD22 ' A' ' 16' ' ' LEU . 1.5 mt -62.93 -48.77 86.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.519 177.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -63.62 -39.58 94.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.125 177.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.92 -49.01 76.91 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.036 0.446 . . . . 0.0 110.914 176.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.407 HD21 HD12 ' A' ' 15' ' ' ILE . 44.0 tp -67.68 -36.01 79.9 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.294 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.3 mp -58.72 -37.04 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.193 174.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -77.06 -29.78 55.23 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.645 176.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.423 ' HB1' ' HA ' ' B' ' 226' ' ' ILE . . . -57.7 -45.27 85.89 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.936 176.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.44 -51.54 6.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.096 178.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.74 38.9 2.65 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.029 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.57 HG22 ' HA3' ' B' ' 213' ' ' GLY . 3.5 t -98.37 135.01 34.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.769 0.319 . . . . 0.0 110.688 -177.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -86.61 94.59 9.51 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.232 0.539 . . . . 0.0 110.504 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.602 HG23 ' HB2' ' A' ' 5' ' ' SER . 5.1 p -113.51 135.05 54.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.196 177.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -48.29 108.92 1.01 Allowed Pre-proline 0 N--CA 1.466 0.371 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.473 174.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -47.53 -18.49 0.9 Allowed 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 124.189 3.259 . . . . 0.0 114.266 -173.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -68.03 -38.74 82.9 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.723 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.566 ' O ' ' HB2' ' A' ' 47' ' ' PHE . 62.8 m95 -66.38 -59.08 8.98 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.387 178.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.552 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 73.0 Cg_exo -52.09 -47.69 25.4 Favored 'Trans proline' 0 C--N 1.363 1.324 0 C-N-CA 122.253 1.969 . . . . 0.0 112.715 177.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.17 -57.48 18.24 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.054 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.74 -43.91 85.7 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.63 ' O ' HD13 ' A' ' 51' ' ' LEU . 1.1 t80 -59.61 -55.23 37.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.092 0.473 . . . . 0.0 110.678 -177.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.475 ' HB2' HD12 ' A' ' 28' ' ' ILE . . . -61.99 -32.4 72.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.53 -176.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.486 ' HA ' ' HE2' ' A' ' 49' ' ' LYS . 9.1 mmpt? -87.04 -14.94 40.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.607 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.89 -27.85 16.85 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.656 ' HA ' HG23 ' A' ' 54' ' ' VAL . 5.8 mp -75.21 -113.32 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.817 177.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 61.42 -6.93 0.11 Allowed 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 178.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.434 ' H ' ' C ' ' A' ' 51' ' ' LEU . 47.3 t30 -144.08 -39.2 0.29 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.656 HG23 ' HA ' ' A' ' 51' ' ' LEU . 16.0 t -44.95 104.43 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.838 174.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -39.99 -82.66 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 O-C-N 124.312 1.007 . . . . 0.0 111.515 -176.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.592 ' O ' HD12 ' A' ' 59' ' ' LEU . 0.9 OUTLIER -157.08 -66.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.58 172.408 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.21 -23.87 53.88 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.287 -0.482 . . . . 0.0 113.603 -171.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.495 ' HB2' ' CG1' ' A' ' 54' ' ' VAL . 14.5 m -60.69 -14.21 19.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.595 0.236 . . . . 0.0 111.587 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.602 HD13 ' N ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -62.88 -14.54 47.52 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.983 0.42 . . . . 0.0 110.543 179.386 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.602 ' N ' HD13 ' A' ' 59' ' ' LEU . 9.0 tt -77.61 -4.6 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.055 -178.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 98.9 m -69.22 104.2 2.14 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.336 0.589 . . . . 0.0 110.866 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -75.88 65.33 1.96 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.218 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.42 ' O ' HG12 ' A' ' 63' ' ' VAL . 5.1 t . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.213 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 203' ' ' TYR . . . . . 0.495 ' CD2' ' HA ' ' B' ' 239' ' ' LEU . 59.0 m-85 . . . . . 0 N--CA 1.471 0.617 0 CA-C-O 121.097 0.475 . . . . 0.0 111.669 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.755 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 15.5 m -59.52 -49.05 85.05 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.193 177.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 205' ' ' ALA . . . . . 0.491 ' HA ' HD12 ' B' ' 208' ' ' LEU . . . -73.31 -15.59 61.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.064 0.459 . . . . 0.0 110.618 -177.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . 0.493 ' HB3' HG23 ' B' ' 223' ' ' ILE . 6.5 m -71.02 -49.22 47.45 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 172.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 207' ' ' TYR . . . . . 0.507 ' CZ ' ' HD2' ' B' ' 218' ' ' PRO . 24.4 t80 -60.76 -40.87 94.09 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 174.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.755 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 79.3 mt -59.71 -51.68 68.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.168 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 209' ' ' LEU . . . . . 0.409 ' CD1' ' HB2' ' A' ' 11' ' ' TYR . 8.4 tp -59.7 -49.75 76.51 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.862 0.363 . . . . 0.0 110.612 -178.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -61.84 -34.03 75.22 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.2 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 211' ' ' ALA . . . . . . . . . . . . . . . -79.4 -36.25 39.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.032 0.444 . . . . 0.0 110.79 178.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 212' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.32 -46.69 85.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.202 177.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . 0.57 ' HA3' HG22 ' A' ' 37' ' ' VAL . . . -150.38 69.59 0.32 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.694 -1.241 . . . . 0.0 112.929 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . -168.71 -66.51 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.276 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 215' ' ' ASN . . . . . 0.653 HD22 ' N ' ' B' ' 216' ' ' SER . 0.2 OUTLIER -156.89 132.05 9.09 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -178.681 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 216' ' ' SER . . . . . 0.653 ' N ' HD22 ' B' ' 215' ' ' ASN . 2.1 m -51.34 -30.83 19.87 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.652 -178.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 18.0 p -121.79 76.62 38.28 Favored Pre-proline 0 N--CA 1.442 -0.867 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.667 -177.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . 0.507 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 75.6 Cg_exo -54.41 108.53 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.579 2.853 . . . . 0.0 112.651 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 30.8 m -84.66 155.93 21.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.695 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -51.62 -40.04 59.15 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.174 0.512 . . . . 0.0 110.706 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -60.55 -32.5 71.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.566 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -85.42 -30.75 23.32 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -177.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.53 HG22 HD11 ' B' ' 239' ' ' LEU . 1.8 mp -66.91 -42.06 88.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 172.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -60.71 -46.14 91.55 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.097 174.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -55.99 -43.92 78.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.375 177.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . 0.423 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . 1.0 OUTLIER -60.42 -42.39 90.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 178.706 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 93.5 mt -71.91 -39.02 69.81 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 121.214 -0.195 . . . . 0.0 111.378 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -67.45 -30.49 70.23 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.769 0.318 . . . . 0.0 111.146 177.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 56.1 m -69.36 -47.57 63.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.293 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 11.4 p -79.53 -27.21 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.075 0.464 . . . . 0.0 111.362 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 103.55 56.98 0.76 Allowed Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.374 174.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . 0.522 HD11 HG11 ' A' ' 21' ' ' VAL . 31.5 mt -133.65 125.98 50.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 176.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -60.17 131.1 49.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.917 0.389 . . . . 0.0 110.769 176.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -118.24 152.62 35.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.904 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -117.04 114.97 24.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.144 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -55.33 -37.65 67.7 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.64 -173.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.37 -62.0 1.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.01 0.433 . . . . 0.0 110.312 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.664 ' O ' HG23 ' B' ' 242' ' ' VAL . 86.5 mtm180 -63.62 -34.34 77.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.665 -177.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 239' ' ' LEU . . . . . 0.53 HD11 HG22 ' B' ' 223' ' ' ILE . 9.9 tt -62.6 -57.66 10.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.07 0.462 . . . . 0.0 110.939 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -66.62 -23.34 66.16 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.127 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 241' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' B' ' 241' ' ' LYS . 35.3 ttmt -68.34 -46.88 68.98 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 120.983 0.421 . . . . 0.0 110.74 176.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 242' ' ' VAL . . . . . 0.664 HG23 ' O ' ' B' ' 238' ' ' ARG . 52.2 t -67.44 -32.95 59.46 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 40.1 mt -75.9 -22.57 15.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.704 176.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 36.1 t -71.19 -37.41 72.14 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.656 174.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -85.86 -26.0 25.91 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.325 0.583 . . . . 0.0 110.353 175.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . 0.687 ' O ' HD13 ' B' ' 246' ' ' LEU . 0.0 OUTLIER -121.51 97.56 5.56 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.88 0.848 . . . . 0.0 109.678 -177.41 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 247' ' ' ASN . . . . . 0.505 ' CG ' ' H ' ' B' ' 248' ' ' GLY . 25.2 p-10 -146.79 -74.92 0.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.108 177.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . 0.505 ' H ' ' CG ' ' B' ' 247' ' ' ASN . . . -106.72 55.06 0.55 Allowed Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -177.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -117.07 57.85 0.78 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.731 -0.234 . . . . 0.0 110.83 -177.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 60.81 67.5 0.82 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.655 0.597 . . . . 0.0 111.477 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.501 ' HA ' HG22 ' B' ' 254' ' ' VAL . 1.8 mm -60.93 -48.79 87.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.97 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -60.44 -29.4 68.99 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.524 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . 0.531 ' O ' ' HG2' ' B' ' 257' ' ' GLN . 27.9 t70 -76.66 -47.49 21.95 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.961 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 254' ' ' VAL . . . . . 0.501 HG22 ' HA ' ' B' ' 251' ' ' ILE . 28.8 m -62.47 -29.86 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.597 0.237 . . . . 0.0 111.164 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 255' ' ' ILE . . . . . 0.633 ' CG2' HD13 ' A' ' 7' ' ' LEU . 61.9 mt -88.03 -24.89 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-O 120.827 0.346 . . . . 0.0 110.746 175.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -66.74 -38.99 87.75 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.018 -0.426 . . . . 0.0 111.281 177.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 257' ' ' GLN . . . . . 0.557 ' HG3' ' H ' ' B' ' 258' ' ' GLY . 4.6 pt20 -69.5 -81.96 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 258' ' ' GLY . . . . . 0.557 ' H ' ' HG3' ' B' ' 257' ' ' GLN . . . 175.44 -90.39 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.249 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 259' ' ' ILE . . . . . 0.447 ' CD1' HG13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 114.91 -0.645 . . . . 0.0 110.732 -179.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.548 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 36.7 m . . . . . 0 N--CA 1.469 0.522 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.465 HG12 ' CD1' ' B' ' 212' ' ' LEU . 15.4 m -72.26 -16.26 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.76 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -68.67 0.36 Allowed 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.674 176.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.478 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 3.2 pm0 -56.2 -43.03 78.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.46 178.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.55 HD22 ' OH ' ' A' ' 11' ' ' TYR . 38.2 mt -54.32 -57.89 9.51 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.327 176.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.44 ' HB2' HD21 ' B' ' 212' ' ' LEU . . . -54.93 -50.33 69.11 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -176.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.478 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 26.4 p -70.7 -33.8 71.27 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.763 -173.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.36 -25.49 12.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.946 0.403 . . . . 0.0 110.576 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.581 ' OH ' HG23 ' B' ' 255' ' ' ILE . 20.7 m-30 -76.05 -28.78 57.8 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 172.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.415 ' OG ' HG12 ' A' ' 28' ' ' ILE . 7.5 t -68.3 -50.64 52.15 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.669 174.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.21 -47.95 68.52 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 173.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.658 HD21 HG22 ' B' ' 259' ' ' ILE . 11.4 mt -52.06 -61.64 2.13 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.057 177.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.588 HD11 ' HA ' ' B' ' 206' ' ' SER . 56.5 mt -62.72 -46.29 96.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.197 0.522 . . . . 0.0 111.297 -176.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.451 ' HG ' HG12 ' A' ' 23' ' ' VAL . 25.1 tp -70.65 -15.29 62.72 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.601 -173.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -125.62 37.92 4.27 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 119.362 -0.935 . . . . 0.0 112.112 173.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -81.21 -57.75 3.36 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 167.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -81.5 174.1 11.76 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.332 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -84.23 39.04 0.69 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.33 0.586 . . . . 0.0 111.171 -175.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.401 HG11 ' CD1' ' B' ' 232' ' ' ILE . 14.6 p -92.57 142.72 12.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.028 177.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.0 p -72.17 133.88 45.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.43 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.451 HG12 ' HG ' ' A' ' 16' ' ' LEU . 16.0 m -87.8 132.67 32.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.359 -179.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.5 p -147.06 158.39 43.92 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.907 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -45.76 -55.91 5.95 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.909 0.755 . . . . 0.0 111.361 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.43 -31.52 64.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.807 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -80.14 -39.1 30.13 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.494 -177.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.415 HG12 ' OG ' ' A' ' 12' ' ' SER . 4.0 mt -63.88 -47.03 92.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -55.1 -43.75 74.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.767 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.87 -47.88 83.95 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.682 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.4 mt -63.4 -39.49 94.65 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.855 0.359 . . . . 0.0 111.007 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 mp -60.01 -45.5 95.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.433 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -72.35 -25.41 61.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.811 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.81 -37.25 81.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.3 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.68 -37.73 19.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.035 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 123.0 -41.95 1.7 Allowed Glycine 0 CA--C 1.519 0.322 0 C-N-CA 119.946 -1.121 . . . . 0.0 114.005 173.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.2 m -95.01 151.63 3.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.754 0.277 . . . . 0.0 111.235 -176.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -109.47 -176.05 2.92 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.605 0.717 . . . . 0.0 111.391 -171.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.0 p -153.46 152.76 9.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.919 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -47.37 116.46 4.3 Favored Pre-proline 0 N--CA 1.47 0.535 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 175.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.406 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 88.8 Cg_exo -49.31 -14.49 0.56 Allowed 'Trans proline' 0 N--CA 1.485 0.986 0 C-N-CA 124.175 3.25 . . . . 0.0 114.863 -172.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.475 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -79.57 -21.0 45.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.015 -175.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.463 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 69.0 m95 -72.75 -52.41 6.12 Favored Pre-proline 0 CA--C 1.537 0.448 0 O-C-N 123.003 0.189 . . . . 0.0 110.548 175.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 74.5 Cg_exo -51.45 -51.5 11.06 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 122.137 1.891 . . . . 0.0 111.569 171.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.45 -37.85 92.66 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.117 177.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 39.3 tp -60.98 -56.62 18.93 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -60.01 -36.29 76.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.588 0.232 . . . . 0.0 111.022 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.6 -39.54 94.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.871 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -92.72 -11.43 33.97 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.45 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.33 -50.87 5.43 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.748 ' HA ' HG23 ' A' ' 54' ' ' VAL . 9.2 mt -85.61 -130.94 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.904 -175.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 75.79 -10.61 1.24 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.842 0.857 . . . . 0.0 113.047 175.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -143.8 -45.55 0.27 Allowed 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.748 HG23 ' HA ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -51.2 129.62 10.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 113.428 -1.714 . . . . 0.0 111.609 174.78 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -51.7 157.53 1.14 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.84 -1.527 . . . . 0.0 111.381 175.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.514 ' O ' HD22 ' A' ' 59' ' ' LEU . 3.4 tp -46.98 -50.82 5.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.803 -175.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.15 -15.48 10.77 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.627 -0.32 . . . . 0.0 113.722 -173.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.6 t -62.18 -23.3 66.53 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.514 HD22 ' O ' ' A' ' 56' ' ' ILE . 1.1 pt? -74.33 -10.36 59.51 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.359 -177.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.577 HG12 HD12 ' B' ' 259' ' ' ILE . 14.7 mt -86.86 -6.59 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-O 121.757 0.789 . . . . 0.0 109.527 176.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 66.0 m -82.72 90.45 6.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.563 176.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -77.67 69.91 3.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.121 0.962 . . . . 0.0 110.259 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.4 t . . . . . 0 C--N 1.32 -0.685 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.023 178.798 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 203' ' ' TYR . . . . . 0.523 ' CD1' ' HA ' ' B' ' 239' ' ' LEU . 71.8 m-85 . . . . . 0 C--O 1.239 0.514 0 CA-C-O 121.177 0.513 . . . . 0.0 110.52 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.802 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 2.5 m -58.11 -65.2 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.635 178.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 205' ' ' ALA . . . . . 0.577 ' H ' HG23 ' B' ' 204' ' ' VAL . . . -64.6 -13.67 54.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . 0.588 ' HA ' HD11 ' A' ' 15' ' ' ILE . 4.1 m -75.74 -50.68 14.6 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 175.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 207' ' ' TYR . . . . . 0.498 ' HD1' HD11 ' B' ' 251' ' ' ILE . 15.7 t80 -62.71 -35.21 79.0 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 174.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.802 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 71.3 mt -64.3 -49.3 72.34 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.983 176.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 209' ' ' LEU . . . . . 0.53 HD21 ' HB2' ' A' ' 11' ' ' TYR . 11.4 mt -54.64 -49.91 69.43 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.785 0.326 . . . . 0.0 110.857 177.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 210' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' B' ' 218' ' ' PRO . . . -59.93 -48.69 80.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.233 -177.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 211' ' ' ALA . . . . . 0.651 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -65.18 -43.87 90.3 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.831 0.348 . . . . 0.0 110.977 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 212' ' ' LEU . . . . . 0.465 ' CD1' HG12 ' A' ' 4' ' ' VAL . 2.3 tp -61.44 -32.46 72.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.162 178.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -76.09 -11.78 84.57 Favored Glycine 0 N--CA 1.454 -0.135 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.769 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 122.22 1.14 10.38 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.278 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 215' ' ' ASN . . . . . 0.651 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 93.8 m-20 -98.44 102.91 14.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.115 0.458 . . . . 0.0 110.758 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 216' ' ' SER . . . . . 0.408 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 5.3 m -66.34 -17.78 64.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.213 178.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 14.2 t -128.07 69.74 77.67 Favored Pre-proline 0 N--CA 1.443 -0.816 0 CA-C-O 120.96 0.409 . . . . 0.0 110.355 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . 0.453 ' HB3' ' HB3' ' B' ' 210' ' ' ALA . 50.2 Cg_exo -58.85 102.49 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.072 2.515 . . . . 0.0 112.738 178.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 18.0 m -72.32 144.03 48.46 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.267 178.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . 0.456 ' HB1' HD21 ' B' ' 239' ' ' LEU . . . -56.52 -28.64 60.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.723 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -73.65 -27.03 61.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.494 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -79.8 -38.63 32.59 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.508 HG23 ' HB3' ' B' ' 206' ' ' SER . 1.8 mp -63.45 -45.2 98.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 173.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -58.02 -41.2 82.66 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.244 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -61.32 -41.7 97.44 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.317 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.73 -25.31 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.593 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -78.04 -44.7 25.69 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.765 0.316 . . . . 0.0 110.94 173.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -70.29 -15.79 62.93 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.489 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 86.8 p -51.47 -51.65 53.18 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.91 0.386 . . . . 0.0 110.633 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 60.9 t -87.28 -23.85 6.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.347 0.594 . . . . 0.0 110.371 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 101.92 41.0 2.55 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.143 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 232' ' ' ILE . . . . . 0.401 ' CD1' HG11 ' A' ' 21' ' ' VAL . 36.5 mt -103.84 136.7 35.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -73.66 145.87 44.97 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -143.0 121.65 12.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.383 -175.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . 0.495 ' HB2' ' HB2' ' B' ' 238' ' ' ARG . 8.0 m-20 -58.26 113.82 2.12 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.105 177.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 236' ' ' ASP . . . . . 0.52 ' O ' ' HB3' ' B' ' 239' ' ' LEU . 6.8 m-20 -61.75 -37.48 84.42 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.816 0.341 . . . . 0.0 111.648 -177.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -73.76 -46.77 43.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.921 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.495 ' HB2' ' HB2' ' B' ' 235' ' ' ASP . 41.8 mtp-105 -64.54 -29.03 70.05 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 239' ' ' LEU . . . . . 0.523 ' HA ' ' CD1' ' B' ' 203' ' ' TYR . 13.5 tp -54.07 -69.54 0.12 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.96 175.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -66.47 -24.28 66.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.463 -176.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -60.96 -53.91 51.5 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 120.866 0.365 . . . . 0.0 111.173 175.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 242' ' ' VAL . . . . . . . . . . . . . 33.0 m -73.62 -28.37 24.7 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -176.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . 0.472 ' HA ' HD12 ' B' ' 246' ' ' LEU . 37.4 mt -70.67 -31.41 45.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.438 175.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 71.6 m -66.71 -35.25 79.69 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 172.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.79 -40.7 75.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.219 175.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 246' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' B' ' 243' ' ' ILE . 39.9 mt -67.48 -29.78 69.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.488 174.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -59.77 -32.8 70.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.131 -171.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -112.41 17.43 23.77 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.346 -175.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -124.41 151.97 43.82 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . 0.401 HD21 ' HB3' ' B' ' 252' ' ' GLU . 48.8 t30 -64.91 119.71 11.2 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 121.241 0.543 . . . . 0.0 110.875 -178.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.498 HD11 ' HD1' ' B' ' 207' ' ' TYR . 0.4 OUTLIER -59.16 -31.8 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.67 -177.818 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 252' ' ' GLU . . . . . 0.401 ' HB3' HD21 ' B' ' 250' ' ' ASN . 40.9 tt0 -69.88 -40.93 75.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.814 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -65.8 -38.16 88.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.802 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 254' ' ' VAL . . . . . 0.41 HG22 ' HA ' ' B' ' 251' ' ' ILE . 17.7 m -76.2 -22.11 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.457 176.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 255' ' ' ILE . . . . . 0.581 HG23 ' OH ' ' A' ' 11' ' ' TYR . 27.9 mt -64.12 -43.43 97.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-O 121.431 0.634 . . . . 0.0 109.613 169.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -78.06 -27.27 48.64 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.981 -178.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -130.52 76.17 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -176.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -108.31 -66.85 0.6 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 172.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 259' ' ' ILE . . . . . 0.658 HG22 HD21 ' A' ' 14' ' ' LEU . 1.6 pt . . . . . 0 C--N 1.331 -0.2 0 CA-C-O 122.181 0.991 . . . . 0.0 108.665 169.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ppp? . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 110.546 -0.168 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.0 -7.6 1.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 172.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.578 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 3.8 p -86.03 52.29 2.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.985 0.421 . . . . 0.0 111.276 -175.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.8 p -63.87 -33.02 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.649 -172.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.407 ' HB3' HG23 ' A' ' 39' ' ' VAL . 3.9 m -58.71 -66.1 0.55 Allowed 'General case' 0 C--O 1.244 0.781 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.132 -177.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -64.91 -30.85 71.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.3 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 3' ' ' SER . 54.1 mt -57.27 -60.18 4.01 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.592 173.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.411 ' HB2' HD11 ' B' ' 212' ' ' LEU . . . -55.89 -45.55 78.59 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.854 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 48.6 t -63.3 -36.78 84.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.848 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.49 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 0.9 OUTLIER -73.87 -40.04 52.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 120.621 0.248 . . . . 0.0 111.347 -179.003 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.554 ' OH ' ' HA ' ' B' ' 255' ' ' ILE . 22.1 m-85 -68.69 -37.69 79.74 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.482 ' OG ' ' HA ' ' A' ' 28' ' ' ILE . 46.1 t -64.36 -44.28 91.94 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.659 175.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.49 -57.51 11.08 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.129 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.498 HD11 ' CB ' ' B' ' 205' ' ' ALA . 3.7 pp -70.43 -22.1 62.75 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.623 -0.431 . . . . 0.0 112.038 -177.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.42 ' N ' HD12 ' A' ' 14' ' ' LEU . 13.4 mt -71.3 -33.92 52.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.233 174.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.6 mt -86.94 -8.51 57.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.062 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -17.27 -78.26 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 115.319 1.599 . . . . 0.0 115.319 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -158.97 73.61 0.61 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.261 0.553 . . . . 0.0 109.951 -168.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.448 ' HB2' HG12 ' A' ' 21' ' ' VAL . 3.7 m-20 -132.46 -158.56 0.9 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.637 -174.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -69.11 -13.57 62.51 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.264 0.554 . . . . 0.0 109.782 172.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.493 ' HB ' HG12 ' B' ' 232' ' ' ILE . 5.1 p -96.28 160.85 2.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.528 -174.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.9 p -107.61 143.14 36.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.135 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.3 t -78.28 83.91 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.0 p -131.95 163.58 28.05 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -52.2 -49.96 62.86 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.93 -176.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -54.81 -36.19 64.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.317 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.541 ' HD2' ' HB ' ' B' ' 230' ' ' VAL . 75.4 mmtt -79.9 -44.03 21.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.315 -171.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.482 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 9.1 mt -62.02 -46.07 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.037 173.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -57.8 -39.07 76.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.488 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.25 -40.35 86.27 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.817 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.435 HD22 HG23 ' B' ' 226' ' ' ILE . 60.8 mt -70.35 -42.61 71.62 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 120.939 0.399 . . . . 0.0 110.391 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.454 HD13 ' O ' ' A' ' 28' ' ' ILE . 1.7 mp -59.84 -37.95 74.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.156 174.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -70.76 -37.53 73.4 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.771 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.41 -34.51 77.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.244 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.463 ' HB2' HD12 ' B' ' 209' ' ' LEU . . . -90.82 -31.73 16.36 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.659 -0.417 . . . . 0.0 111.813 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.66 35.48 6.86 Favored Glycine 0 CA--C 1.517 0.162 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.958 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.686 HG13 ' HA2' ' B' ' 213' ' ' GLY . 0.0 OUTLIER -97.32 173.77 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.025 0.441 . . . . 0.0 111.698 -178.017 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -121.46 106.43 11.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.571 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.407 HG23 ' HB3' ' A' ' 5' ' ' SER . 14.4 p -129.66 137.94 55.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 174.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.56 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 12.8 pt-20 -67.16 135.24 93.65 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.495 ' HA ' ' HG2' ' A' ' 44' ' ' PRO . 9.5 Cg_endo -52.75 -11.57 1.42 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 124.097 3.198 . . . . 0.0 113.745 -173.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.04 -41.23 82.38 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.056 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.418 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 89.4 m95 -68.08 -58.24 8.05 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.236 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HD2' ' O ' ' A' ' 40' ' ' GLU . 12.5 Cg_endo -56.43 -43.83 51.76 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.411 2.074 . . . . 0.0 112.753 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.94 -52.98 46.57 Favored Glycine 0 C--O 1.24 0.493 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.913 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 52.4 tp -59.94 -48.49 81.5 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.454 ' CD2' HD11 ' A' ' 51' ' ' LEU . 1.7 m-85 -56.42 -46.8 80.07 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.286 0.367 . . . . 0.0 111.865 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.62 -30.11 66.68 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -89.33 -12.69 39.79 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.442 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -102.5 -32.29 10.02 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.674 ' HA ' HG23 ' A' ' 54' ' ' VAL . 52.6 mt -88.38 -131.02 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.293 -176.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 68.97 -12.61 0.38 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.953 0.901 . . . . 0.0 112.901 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -143.76 6.02 1.39 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.904 0.859 . . . . 0.0 110.171 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.674 HG23 ' HA ' ' A' ' 51' ' ' LEU . 1.5 t -103.05 87.55 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.802 -174.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -7.46 -95.55 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.724 1.61 . . . . 0.0 114.689 -168.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.719 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 1.2 tp -153.69 -66.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.278 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.439 ' H ' HG23 ' A' ' 56' ' ' ILE . . . -59.03 -14.72 25.82 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.799 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.658 ' CB ' HG12 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -47.73 -42.63 25.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.567 -0.816 . . . . 0.0 111.598 175.205 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.719 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 0.9 OUTLIER -65.15 -12.33 49.82 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -174.507 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.563 HG12 ' HB ' ' B' ' 259' ' ' ILE . 65.2 mt -68.29 -29.01 42.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 121.2 0.524 . . . . 0.0 110.239 176.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 83.7 m -135.5 34.08 2.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.364 -176.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.438 ' HB2' ' HA ' ' A' ' 59' ' ' LEU . 2.9 t-20 -70.63 -21.08 62.67 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.212 0.53 . . . . 0.0 110.721 -177.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.4 t -76.04 -20.48 15.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.393 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.78 -56.44 0.67 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.573 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -165.89 -70.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.039 0.447 . . . . 0.0 110.441 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.6 -138.12 11.7 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.723 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 165.57 178.41 38.59 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.81 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -86.71 -177.76 2.4 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.781 2.321 . . . . 0.0 112.456 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.52 124.72 9.76 Favored Pre-proline 0 N--CA 1.45 -0.434 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.23 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.73 146.69 54.87 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.915 2.41 . . . . 0.0 112.337 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -134.66 176.47 8.6 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.656 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.62 163.78 37.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.36 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.81 152.29 21.65 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.905 -0.665 . . . . 0.0 111.75 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.46 138.32 38.62 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.919 0.39 . . . . 0.0 110.778 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.432 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -112.77 128.71 25.24 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.966 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 27.6 Cg_exo -69.07 158.09 59.22 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.57 2.847 . . . . 0.0 113.119 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -145.69 166.0 27.12 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.646 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -179.37 -153.33 11.6 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.606 -0.598 . . . . 0.0 111.606 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 164.19 161.08 12.63 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.97 130.42 14.39 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.845 2.363 . . . . 0.0 112.633 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.09 92.58 31.75 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.008 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -62.71 151.1 85.65 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.957 2.438 . . . . 0.0 113.114 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.0 t -149.78 130.79 14.36 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.681 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 p 54.25 168.85 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.49 1.119 . . . . 0.0 113.412 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -176.53 167.89 2.7 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.562 -177.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 67.9 143.96 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.984 0.802 . . . . 0.0 112.656 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.22 132.82 7.54 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.351 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -53.76 115.91 2.65 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.07 2.514 . . . . 0.0 112.901 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -128.3 80.08 1.94 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.373 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -70.99 98.52 1.63 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.434 0.635 . . . . 0.0 111.579 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -111.63 172.07 7.11 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.347 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.41 132.1 6.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.971 175.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -107.77 151.34 25.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.985 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.9 p -83.17 97.21 4.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.787 0.804 . . . . 0.0 110.976 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -142.27 138.49 31.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.291 176.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -120.18 -62.81 1.43 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.046 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.79 133.58 43.27 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.259 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -130.11 122.11 27.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.786 -176.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 52.97 28.57 6.79 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.198 0.599 . . . . 0.0 111.933 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -133.04 179.02 6.44 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.014 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 26.4 t -160.51 146.61 15.19 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -86.17 36.8 0.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.627 0.727 . . . . 0.0 110.013 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -170.3 122.92 0.67 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.102 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.1 t -162.95 143.17 9.27 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -139.37 -127.3 0.12 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -67.6 -39.79 84.78 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.324 0.583 . . . . 0.0 109.488 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 54.59 20.56 2.94 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.305 -1.316 . . . . 0.0 112.889 174.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 63.4 mtt -135.91 153.7 51.36 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 63.97 44.34 96.1 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.969 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -94.16 137.12 33.71 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.805 -0.232 . . . . 0.0 110.564 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -79.61 73.58 2.38 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.859 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.0 mt -130.15 32.09 4.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.938 0.399 . . . . 0.0 110.264 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -129.38 157.6 41.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.409 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.2 t70 . . . . . 0 C--O 1.247 0.958 0 CA-C-O 118.453 -0.784 . . . . 0.0 108.999 -179.194 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 200' ' ' ALA . . . . . 0.503 ' HB1' ' HB2' ' B' ' 267' ' ' ALA . . . . . . . . 0 N--CA 1.477 0.896 0 CA-C-O 120.797 0.332 . . . . 0.0 110.336 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 55.4 mtp -133.39 154.79 50.45 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 202' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' B' ' 263' ' ' ALA . 73.7 mtt180 -128.34 -128.39 0.22 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.758 0.313 . . . . 0.0 111.212 -176.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -115.61 16.7 16.47 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.057 0.456 . . . . 0.0 110.019 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.536 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 58.2 t -62.33 -50.68 78.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.708 -173.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 205' ' ' ALA . . . . . 0.8 ' HB2' ' HB3' ' B' ' 262' ' ' LEU . . . -69.34 -18.61 63.82 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.174 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . 0.501 ' OG ' HG23 ' B' ' 223' ' ' ILE . 9.4 t -73.01 -40.08 65.47 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 207' ' ' TYR . . . . . 0.695 ' CE1' HD11 ' B' ' 251' ' ' ILE . 57.0 t80 -61.01 -37.45 82.57 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 171.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.568 ' O ' ' HB3' ' B' ' 212' ' ' LEU . 83.1 mt -66.18 -40.46 90.45 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.728 176.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 209' ' ' LEU . . . . . 0.463 HD12 ' HB2' ' A' ' 35' ' ' ALA . 3.2 mm? -57.27 -45.26 84.21 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 174.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -63.37 -48.96 75.75 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.587 0.232 . . . . 0.0 111.562 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.93 -50.09 52.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.757 0.313 . . . . 0.0 111.611 -176.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 212' ' ' LEU . . . . . 0.568 ' HB3' ' O ' ' B' ' 208' ' ' LEU . 0.0 OUTLIER -67.22 -25.0 65.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.048 -178.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . 0.686 ' HA2' HG13 ' A' ' 37' ' ' VAL . . . -56.79 -22.07 39.18 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.344 -0.455 . . . . 0.0 112.54 175.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 112.47 22.65 5.72 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.562 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 215' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -138.83 95.05 2.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.126 0.488 . . . . 0.0 110.201 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 17.7 m -78.04 57.61 1.82 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.806 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 17.6 t -147.06 100.28 3.92 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . 0.428 ' HB3' ' HE2' ' B' ' 207' ' ' TYR . 51.6 Cg_exo -59.82 92.69 0.09 OUTLIER 'Trans proline' 0 N--CA 1.474 0.353 0 C-N-CA 123.478 2.785 . . . . 0.0 113.992 -176.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 50.1 m -96.14 103.15 15.02 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 171.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . 0.438 ' HB1' ' CD1' ' B' ' 239' ' ' LEU . . . -54.18 -31.16 52.08 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.376 0.608 . . . . 0.0 110.706 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -62.4 -36.58 82.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.877 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -80.47 -28.02 37.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.116 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.501 HG23 ' OG ' ' B' ' 206' ' ' SER . 1.8 mp -62.0 -48.68 87.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 168.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 224' ' ' LYS . . . . . 0.46 ' HE2' ' O ' ' B' ' 234' ' ' ALA . 3.3 tppp? -57.02 -41.1 77.92 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.328 173.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -58.31 -46.13 86.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.023 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 0.435 HG23 HD22 ' A' ' 31' ' ' LEU . 1.3 mp -65.23 -40.41 88.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.737 178.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.26 -42.93 92.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.023 0.439 . . . . 0.0 111.273 177.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -79.92 -22.11 43.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.585 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 99.3 p -53.14 -41.19 64.85 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.968 0.413 . . . . 0.0 111.482 -177.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 230' ' ' VAL . . . . . 0.541 ' HB ' ' HD2' ' A' ' 27' ' ' LYS . 8.1 m -100.9 -12.88 8.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.233 -176.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 100.58 67.99 0.84 Allowed Glycine 0 C--O 1.228 -0.267 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.107 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . 0.493 HG12 ' HB ' ' A' ' 21' ' ' VAL . 12.9 mt -129.19 141.22 47.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 175.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -79.23 83.89 5.24 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.384 0.611 . . . . 0.0 111.524 -176.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . 0.46 ' O ' ' HE2' ' B' ' 224' ' ' LYS . . . -93.68 143.01 26.71 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.738 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . 0.487 ' OD2' ' HG3' ' B' ' 238' ' ' ARG . 17.3 t70 -107.51 129.99 54.9 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.242 0.544 . . . . 0.0 110.991 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.85 -38.44 90.82 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.487 -172.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -71.63 -51.03 25.29 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -177.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.487 ' HG3' ' OD2' ' B' ' 235' ' ' ASP . 77.5 mtp180 -57.64 -41.53 81.61 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.461 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 239' ' ' LEU . . . . . 0.56 HD12 ' N ' ' B' ' 240' ' ' ASN . 4.5 pp -68.55 -44.04 75.35 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.996 -177.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 240' ' ' ASN . . . . . 0.56 ' N ' HD12 ' B' ' 239' ' ' LEU . 50.0 t30 -66.96 -32.1 73.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.0 0.428 . . . . 0.0 110.201 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 241' ' ' LYS . . . . . 0.513 ' O ' ' HG3' ' B' ' 245' ' ' GLU . 1.0 OUTLIER -67.13 -45.25 77.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.948 178.21 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 242' ' ' VAL . . . . . . . . . . . . . 18.1 m -71.79 -27.16 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.386 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . 0.502 HG13 ' O ' ' B' ' 239' ' ' LEU . 27.7 mt -71.48 -36.52 60.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.607 177.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 5.1 p -78.95 -14.48 59.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.79 0.329 . . . . 0.0 111.025 176.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 245' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' B' ' 241' ' ' LYS . 51.5 mt-10 -82.17 -30.76 30.82 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.988 0.423 . . . . 0.0 110.392 169.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . 0.592 ' O ' HD12 ' B' ' 246' ' ' LEU . 1.1 pp -99.58 2.56 44.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.343 -176.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -58.84 109.43 0.82 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.578 0.704 . . . . 0.0 112.045 -171.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 71.52 30.48 66.6 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.885 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -90.16 -160.93 0.74 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 110.493 -0.188 . . . . 0.0 110.493 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . 0.436 ' HB3' ' HB2' ' B' ' 253' ' ' ASP . 14.0 m-20 -72.9 81.33 1.18 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.929 0.395 . . . . 0.0 111.913 -174.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.695 HD11 ' CE1' ' B' ' 207' ' ' TYR . 2.0 mm -72.29 -54.4 16.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.827 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -61.53 -29.64 70.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.634 0.731 . . . . 0.0 110.448 -177.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' B' ' 250' ' ' ASN . 5.6 m-20 -77.22 -44.81 28.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.711 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 254' ' ' VAL . . . . . 0.469 HG12 ' O ' ' B' ' 251' ' ' ILE . 7.0 p -66.73 -23.79 31.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 121.054 0.454 . . . . 0.0 110.155 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 255' ' ' ILE . . . . . 0.554 ' HA ' ' OH ' ' A' ' 11' ' ' TYR . 44.8 mt -76.89 -55.61 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.933 175.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -66.3 -45.3 80.86 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -173.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -139.19 50.14 1.82 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.268 0.556 . . . . 0.0 111.156 -174.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . 0.531 ' O ' HD21 ' B' ' 262' ' ' LEU . . . -141.97 55.4 0.6 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.358 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 259' ' ' ILE . . . . . 0.563 ' HB ' HG12 ' A' ' 60' ' ' ILE . 1.2 mt -91.71 18.77 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.888 0.375 . . . . 0.0 111.073 -176.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -92.68 -94.21 1.44 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.808 -0.711 . . . . 0.0 114.078 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -90.39 94.57 9.79 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.551 -0.382 . . . . 0.0 110.63 -175.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 262' ' ' LEU . . . . . 0.8 ' HB3' ' HB2' ' B' ' 205' ' ' ALA . 3.4 mm? -114.16 -98.05 0.44 Allowed 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -176.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' B' ' 202' ' ' ARG . . . -136.76 140.83 42.85 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -175.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' B' ' 263' ' ' ALA . 32.3 t 168.98 -150.96 0.0 OUTLIER 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 3.2 p -50.09 117.13 7.24 Favored Pre-proline 0 C--O 1.239 0.509 0 O-C-N 123.542 0.526 . . . . 0.0 110.691 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.15 119.03 5.99 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.794 2.33 . . . . 0.0 112.165 -174.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 267' ' ' ALA . . . . . 0.503 ' HB2' ' HB1' ' B' ' 200' ' ' ALA . . . -47.08 135.49 9.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.66 -1.154 . . . . 0.0 112.204 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 143.13 -20.51 2.29 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.025 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . 83.48 -52.56 4.74 Favored Glycine 0 C--O 1.227 -0.313 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.322 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . 63.57 55.85 1.68 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 122.898 0.479 . . . . 0.0 111.587 176.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 5.2 p 43.83 112.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -150.22 116.51 5.72 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.722 -1.581 . . . . 0.0 110.706 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 46.4 t 51.98 75.36 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 121.459 0.647 . . . . 0.0 111.135 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 32.6 p -161.04 135.19 7.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.641 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -158.96 156.23 29.06 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.373 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . 0.466 ' HA ' ' HD3' ' B' ' 277' ' ' PRO . . . -108.12 142.66 25.78 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.956 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 277' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' B' ' 276' ' ' ALA . 19.6 Cg_exo -66.11 85.92 0.25 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.837 2.358 . . . . 0.0 112.442 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -138.72 76.27 0.35 Allowed Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.21 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 2.5 p -94.59 -166.39 1.47 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.913 0.387 . . . . 0.0 111.484 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . -45.73 126.36 6.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.763 175.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' B' ' 282' ' ' PRO . . . -71.27 126.35 91.88 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.44 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' B' ' 281' ' ' ALA . 25.5 Cg_exo -62.9 153.79 70.88 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.665 2.243 . . . . 0.0 111.801 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -76.12 -178.73 4.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.661 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -62.78 -23.29 67.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.091 0.472 . . . . 0.0 111.49 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 142.71 -19.92 2.38 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 25.8 t -113.1 -175.69 2.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.393 -0.404 . . . . 0.0 109.958 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . 66.32 85.87 0.15 Allowed Pre-proline 0 N--CA 1.472 0.631 0 C-N-CA 123.584 0.754 . . . . 0.0 112.175 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -80.86 155.59 20.37 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.317 2.011 . . . . 0.0 111.991 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -90.86 76.53 6.31 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.083 0.468 . . . . 0.0 110.789 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -72.85 156.86 38.45 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.645 176.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -53.89 -65.44 0.57 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.899 -174.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -117.72 65.21 0.74 Allowed 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.157 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -73.94 86.86 1.79 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.12 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' B' ' 294' ' ' LYS . 24.1 ttmm -162.4 5.5 0.05 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.495 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -119.58 110.11 16.48 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.83 0.348 . . . . 0.0 111.359 -174.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 66.61 96.06 0.06 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.682 174.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -54.02 120.33 6.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.656 175.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -121.25 125.28 46.7 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.631 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -105.83 107.86 19.07 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.779 177.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -124.53 -89.59 0.58 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 174.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 58.84 78.83 0.24 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.232 0.539 . . . . 0.0 112.241 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 35.0 p -139.52 115.58 10.32 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.222 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -150.77 -73.86 0.16 Allowed 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.037 0.446 . . . . 0.0 110.599 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -131.29 137.78 48.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.629 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 16.3 m -139.02 131.66 28.91 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.392 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -145.26 92.91 2.31 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.837 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 26.2 t70 67.55 117.26 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 124.501 1.126 . . . . 0.0 111.953 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . 0.418 ' C ' ' H ' ' B' ' 310' ' ' GLY . 15.7 m-20 -101.93 22.48 12.95 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.791 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 27.6 ttt 70.32 -34.79 0.3 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.936 0.894 . . . . 0.0 111.764 -177.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 310' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' B' ' 308' ' ' ASP . . . 55.41 65.51 3.5 Favored Glycine 0 N--CA 1.457 0.039 0 C-N-CA 121.416 -0.421 . . . . 0.0 112.824 175.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -139.6 -160.33 1.05 Allowed 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -177.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . 153.43 36.43 0.03 OUTLIER Glycine 0 C--N 1.313 -0.702 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.99 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 20.0 tp -104.42 76.49 1.31 Allowed 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 174.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 314' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -99.03 -2.41 37.31 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 112.764 -2.016 . . . . 0.0 110.997 -172.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 . . . . . 0 C--O 1.244 0.812 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.441 -176.183 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.9 153.58 35.56 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.54 -0.171 . . . . 0.0 110.54 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 t 57.5 52.07 8.95 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.456 0.646 . . . . 0.0 110.285 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.44 HG13 ' HG ' ' B' ' 212' ' ' LEU . 45.1 t -67.11 -33.73 65.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.895 -174.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.589 ' HB3' HG23 ' A' ' 39' ' ' VAL . 7.1 m -62.15 -51.33 68.28 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.528 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.499 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 39.4 tt0 -63.87 -49.42 72.83 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.822 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.404 ' HB3' HD22 ' B' ' 212' ' ' LEU . 8.4 mp -51.98 -46.64 64.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.485 174.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.431 ' HB2' HG11 ' A' ' 37' ' ' VAL . . . -61.75 -52.05 65.85 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.672 -177.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.499 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 26.2 p -64.51 -26.76 68.57 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.982 -177.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.57 -36.07 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.115 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.659 ' HB2' HD21 ' B' ' 209' ' ' LEU . 16.3 m-85 -74.96 -24.54 58.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.279 0.562 . . . . 0.0 109.929 177.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.9 m -75.26 -42.05 55.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.132 173.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.12 -39.86 63.77 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.384 169.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.615 ' CD1' ' HG ' ' B' ' 262' ' ' LEU . 83.2 mt -61.01 -56.97 14.83 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.646 175.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.6 mt -58.42 -31.65 43.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.66 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 46.5 mt -115.81 12.27 15.82 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -173.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -44.86 -48.5 11.13 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.785 0.326 . . . . 0.0 111.608 174.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -154.31 -84.68 0.07 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 46.3 42.46 10.37 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.501 176.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 64.41 25.43 13.37 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.295 178.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.541 HG22 ' H ' ' A' ' 22' ' ' THR . 5.4 p -149.62 173.03 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.541 ' H ' HG22 ' A' ' 21' ' ' VAL . 5.3 p -107.49 127.43 53.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.808 0.337 . . . . 0.0 111.786 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.66 ' HB ' ' O ' ' A' ' 16' ' ' LEU . 3.9 p -67.17 95.21 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.368 0.604 . . . . 0.0 110.587 176.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.504 ' OG1' ' HG2' ' A' ' 27' ' ' LYS . 39.0 p -123.46 167.22 14.14 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.315 0.579 . . . . 0.0 112.14 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -49.22 -52.74 25.15 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.591 -174.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -62.13 -30.52 71.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.368 -177.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.504 ' HG2' ' OG1' ' A' ' 24' ' ' THR . 45.0 mmtm -71.48 -49.69 38.88 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.45 HG23 HD13 ' A' ' 32' ' ' ILE . 9.5 mt -62.94 -44.4 99.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.939 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -56.05 -45.52 79.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.776 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.77 -41.63 95.73 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.527 HD11 HG23 ' B' ' 226' ' ' ILE . 0.2 OUTLIER -66.82 -41.97 86.64 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.516 0.674 . . . . 0.0 109.919 -178.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.45 HD13 HG23 ' A' ' 28' ' ' ILE . 1.6 mp -62.17 -39.46 84.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.274 176.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -66.03 -31.98 73.18 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.087 0.47 . . . . 0.0 110.287 177.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.499 ' HB1' ' HA ' ' B' ' 226' ' ' ILE . . . -65.64 -47.21 76.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.498 176.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.585 ' HA ' HD11 ' B' ' 226' ' ' ILE . . . -84.79 -17.1 39.27 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -177.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.38 12.89 83.33 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.541 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.431 HG11 ' HB2' ' A' ' 8' ' ' ALA . 19.6 t -81.7 154.14 4.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -108.95 105.23 14.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.121 0.486 . . . . 0.0 111.219 -173.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.589 HG23 ' HB3' ' A' ' 5' ' ' SER . 12.7 p -120.99 135.25 61.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.406 174.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -59.89 124.49 76.91 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.483 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.529 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 81.0 Cg_exo -47.13 -17.11 0.41 Allowed 'Trans proline' 0 N--CA 1.481 0.776 0 C-N-CA 124.554 3.503 . . . . 0.0 115.434 -171.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -75.3 -26.47 58.73 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -175.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.603 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 95.8 m95 -65.66 -54.24 31.12 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.332 174.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.603 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 75.6 Cg_exo -51.08 -52.47 9.02 Favored 'Trans proline' 0 C--N 1.364 1.381 0 C-N-CA 122.315 2.01 . . . . 0.0 112.773 173.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.29 -50.48 66.17 Favored Glycine 0 C--O 1.241 0.576 0 C-N-CA 120.571 -0.824 . . . . 0.0 112.086 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 56.5 tp -56.37 -52.49 64.41 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.29 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.428 ' O ' HD13 ' A' ' 51' ' ' LEU . 3.2 m-85 -57.53 -44.03 84.79 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -177.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.31 -39.65 95.16 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.297 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -97.42 7.3 46.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.978 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -112.38 -43.27 3.54 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.755 ' HA ' HG23 ' A' ' 54' ' ' VAL . 2.6 mp -83.16 -128.29 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.826 -175.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 65.41 -1.47 0.96 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -144.56 -46.74 0.25 Allowed 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.755 HG23 ' HA ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -55.91 119.26 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 113.626 -1.624 . . . . 0.0 111.323 177.334 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -52.96 146.27 11.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.765 174.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.444 HD11 HD23 ' A' ' 14' ' ' LEU . 1.7 tp -45.86 -37.34 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -169.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.403 ' O ' HG22 ' A' ' 60' ' ' ILE . . . -54.8 -22.12 25.29 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.788 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.432 ' HB3' HG12 ' A' ' 54' ' ' VAL . 44.5 p -51.46 -31.65 24.1 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 122.987 0.515 . . . . 0.0 111.321 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.427 HD13 ' O ' ' A' ' 56' ' ' ILE . 9.6 mp -49.53 -39.94 36.29 Favored 'General case' 0 CA--C 1.519 -0.22 0 O-C-N 123.721 0.638 . . . . 0.0 112.359 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 60' ' ' ILE . 13.3 tt -87.73 23.07 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 122.052 0.93 . . . . 0.0 110.744 -174.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.8 t -126.02 2.95 7.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.04 173.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -88.75 34.18 0.77 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.664 -176.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.2 t -80.57 68.18 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.91 0.862 . . . . 0.0 109.876 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.16 24.3 26.71 Favored Glycine 0 C--N 1.314 -0.66 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.421 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.38 74.18 3.94 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.212 0.53 . . . . 0.0 110.825 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.98 59.21 5.01 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.197 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 144.81 76.21 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 111.884 -0.486 . . . . 0.0 111.884 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -64.27 -52.33 1.61 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.689 2.259 . . . . 0.0 112.728 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 50.92 75.46 0.65 Allowed Pre-proline 0 N--CA 1.468 0.439 0 O-C-N 123.607 0.567 . . . . 0.0 112.04 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -60.88 -64.52 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.749 2.299 . . . . 0.0 112.371 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 64.3 114.87 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.97 0.794 . . . . 0.0 111.783 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -137.13 122.64 19.62 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.536 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.84 90.28 0.09 OUTLIER Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 111.184 -0.767 . . . . 0.0 111.184 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.13 143.61 40.43 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.806 0.336 . . . . 0.0 110.437 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -76.55 123.03 87.63 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.89 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 30.8 Cg_exo -66.79 -7.54 18.63 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.788 2.992 . . . . 0.0 113.218 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.16 96.19 9.83 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.915 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -143.42 89.29 0.17 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.509 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -132.25 69.86 0.53 Allowed Glycine 0 CA--C 1.519 0.315 0 C-N-CA 121.166 -0.54 . . . . 0.0 111.967 176.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -94.18 178.65 0.95 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.156 2.571 . . . . 0.0 113.328 -176.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.66 78.03 71.64 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.31 175.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.32 -32.98 94.81 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.895 2.397 . . . . 0.0 112.673 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.4 t -83.26 58.59 4.55 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.854 -176.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.5 m 71.27 122.83 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.934 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.05 93.31 3.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.242 0.544 . . . . 0.0 110.443 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.18 148.0 44.22 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.841 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.85 153.75 57.89 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.22 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -63.6 73.09 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.546 2.831 . . . . 0.0 113.761 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 67.07 -85.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.388 0.675 . . . . 0.0 111.3 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 47.34 74.05 0.17 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 122.056 0.931 . . . . 0.0 111.132 -177.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.23 176.74 8.93 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.805 -175.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.54 28.87 8.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.378 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -117.13 92.02 3.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.332 0.587 . . . . 0.0 109.907 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.7 p -130.92 144.14 38.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.464 -175.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -120.45 169.92 9.87 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.581 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -163.32 88.1 0.57 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.831 178.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -65.04 138.44 58.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.618 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -132.79 -48.0 0.87 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.843 -175.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 57.85 72.23 0.53 Allowed 'General case' 0 C--O 1.238 0.479 0 O-C-N 123.706 0.629 . . . . 0.0 111.936 173.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -73.57 154.08 39.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.891 0.377 . . . . 0.0 110.707 173.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.1 m -95.58 140.31 30.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.694 -174.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -137.7 41.65 2.34 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.638 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 63.62 101.94 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.579 -176.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.8 t -148.38 139.18 22.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.668 -177.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -123.01 126.19 46.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.378 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -95.09 -26.29 16.09 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.369 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -107.34 125.82 51.68 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 173.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 58.5 mtt -113.82 27.72 9.32 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.1 -172.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.9 119.12 3.3 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.324 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -81.68 59.31 4.13 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.161 0.505 . . . . 0.0 111.389 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 153.25 128.69 1.31 Allowed Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.058 177.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -104.89 31.13 4.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.836 0.35 . . . . 0.0 110.334 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -106.26 138.39 42.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.023 176.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.5 t70 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.559 -0.734 . . . . 0.0 110.037 -175.124 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 200' ' ' ALA . . . . . 0.492 ' O ' HG12 ' B' ' 204' ' ' VAL . . . . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 119.896 -0.097 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.517 ' SD ' ' HB2' ' B' ' 263' ' ' ALA . 36.1 mmm -50.16 -59.0 4.35 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 123.828 0.705 . . . . 0.0 112.465 -171.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 202' ' ' ARG . . . . . 0.431 HH11 HD23 ' B' ' 227' ' ' LEU . 4.2 mmp_? -34.05 -64.06 0.25 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -170.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -98.97 -32.5 11.27 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -163.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.779 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 11.9 p -62.84 -49.83 82.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.041 -174.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 205' ' ' ALA . . . . . 0.51 ' HA ' HD12 ' B' ' 208' ' ' LEU . . . -72.58 -18.86 61.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.619 0.247 . . . . 0.0 111.09 -176.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . 0.443 ' HB3' HG23 ' B' ' 223' ' ' ILE . 45.8 m -70.37 -47.39 61.17 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 120.93 0.395 . . . . 0.0 109.968 174.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 207' ' ' TYR . . . . . 0.554 ' CZ ' ' HD2' ' B' ' 218' ' ' PRO . 29.5 t80 -62.51 -35.95 81.01 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.779 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 62.9 mt -60.83 -53.42 57.59 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.003 178.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 209' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 11' ' ' TYR . 78.7 mt -58.79 -50.84 72.43 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.054 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -61.16 -33.22 73.08 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.99 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 211' ' ' ALA . . . . . 0.671 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -76.97 -40.14 48.0 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.889 178.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 212' ' ' LEU . . . . . 0.44 ' HG ' HG13 ' A' ' 4' ' ' VAL . 52.0 tp -59.97 -55.33 35.36 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.492 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -126.26 53.37 0.79 Allowed Glycine 0 CA--C 1.507 -0.421 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.855 -174.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . -166.08 -77.85 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.494 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 215' ' ' ASN . . . . . 0.671 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 44.4 t30 -148.56 140.63 23.97 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.741 0.305 . . . . 0.0 110.201 -175.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . 0.472 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 8.3 m -63.95 -23.92 67.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.329 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 5.2 p -120.05 70.55 15.1 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.18 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . 0.554 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 82.8 Cg_exo -52.56 131.69 42.12 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.541 2.827 . . . . 0.0 113.28 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . 0.48 ' HB3' ' OD2' ' B' ' 222' ' ' ASP . 38.9 t -87.02 145.75 26.37 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.335 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -59.15 -21.32 59.19 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.042 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -69.6 -50.09 47.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.363 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 222' ' ' ASP . . . . . 0.48 ' OD2' ' HB3' ' B' ' 219' ' ' SER . 20.0 m-20 -67.27 -40.78 86.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.952 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.519 HD11 ' HB3' ' B' ' 218' ' ' PRO . 1.8 mp -60.34 -45.58 96.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 175.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 224' ' ' LYS . . . . . 0.422 ' O ' ' HB3' ' B' ' 228' ' ' ASP . 37.7 tptt -52.35 -46.2 66.03 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.45 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . 0.48 ' O ' ' HD3' ' B' ' 225' ' ' LYS . 7.8 tmtm? -63.68 -36.32 83.46 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 123.273 0.358 . . . . 0.0 110.469 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 0.585 HD11 ' HA ' ' A' ' 35' ' ' ALA . 1.3 mp -60.89 -44.18 97.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.098 176.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . 0.431 HD23 HH11 ' B' ' 202' ' ' ARG . 6.8 mp -75.74 -23.76 56.07 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.984 177.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 228' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' B' ' 224' ' ' LYS . 0.0 OUTLIER -78.45 -28.1 46.56 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.78 -177.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 80.8 p -52.76 -56.81 12.94 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.973 0.416 . . . . 0.0 111.125 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 230' ' ' VAL . . . . . 0.45 HG23 HG13 ' B' ' 232' ' ' ILE . 7.3 m -79.83 -27.24 12.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.883 175.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 67.9 64.65 3.05 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.97 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . 0.45 HG13 HG23 ' B' ' 230' ' ' VAL . 55.1 mt -99.25 -89.13 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.738 0.304 . . . . 0.0 110.431 177.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -148.51 142.1 25.46 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 175.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -160.93 93.06 0.96 Allowed 'General case' 0 C--N 1.33 -0.262 0 O-C-N 123.298 0.374 . . . . 0.0 111.05 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . 0.498 ' OD2' ' HD2' ' B' ' 238' ' ' ARG . 25.6 m-20 -62.84 126.49 27.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.0 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -74.64 -12.1 60.35 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -175.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -92.37 -52.53 4.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.181 0.515 . . . . 0.0 109.765 175.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.498 ' HD2' ' OD2' ' B' ' 235' ' ' ASP . 86.3 mtt180 -65.94 -33.16 75.19 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.18 -176.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 239' ' ' LEU . . . . . . . . . . . . . 8.8 tt -59.94 -62.99 1.46 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.822 0.344 . . . . 0.0 111.052 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 240' ' ' ASN . . . . . 0.416 ' O ' ' HB2' ' B' ' 244' ' ' SER . 26.9 p-10 -74.43 -19.24 60.47 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 121.993 -0.442 . . . . 0.0 110.671 -176.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -71.63 -48.65 46.46 Favored 'General case' 0 C--O 1.244 0.781 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.831 173.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 242' ' ' VAL . . . . . 0.606 ' O ' ' HB3' ' B' ' 246' ' ' LEU . 28.4 m -66.13 -33.43 63.51 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.885 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 30.8 mt -73.19 -31.79 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 O-C-N 123.627 0.579 . . . . 0.0 111.271 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' B' ' 240' ' ' ASN . 18.3 t -64.73 -28.5 69.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.679 0.276 . . . . 0.0 110.663 176.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -87.78 -47.88 8.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.651 0.738 . . . . 0.0 109.628 172.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . 0.664 ' O ' ' HG ' ' B' ' 246' ' ' LEU . 8.8 tp -79.5 56.37 2.16 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 124.716 1.206 . . . . 0.0 109.89 177.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -100.25 37.29 1.69 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.986 -174.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . 0.479 ' HA2' HG22 ' B' ' 251' ' ' ILE . . . 99.54 2.81 56.47 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.594 -0.813 . . . . 0.0 114.043 173.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -74.98 -1.68 23.72 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -177.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -159.32 8.11 0.11 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.569 ' HA ' HG12 ' B' ' 254' ' ' VAL . 5.2 tp -65.87 -46.93 87.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -172.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -58.59 -43.87 89.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.308 0.575 . . . . 0.0 110.972 -176.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -74.54 -38.7 62.69 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.874 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 254' ' ' VAL . . . . . 0.569 HG12 ' HA ' ' B' ' 251' ' ' ILE . 6.6 p -71.06 -21.37 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 120.992 0.425 . . . . 0.0 110.351 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 255' ' ' ILE . . . . . 0.529 HG12 ' O ' ' B' ' 251' ' ' ILE . 35.2 mm -76.95 -48.48 25.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 171.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -62.83 -35.28 79.42 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -174.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -147.5 28.92 0.96 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.845 -176.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . 0.502 ' O ' HD21 ' B' ' 262' ' ' LEU . . . -110.51 56.64 0.45 Allowed Glycine 0 C--O 1.226 -0.376 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.238 -174.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 26.8 mt -94.69 -11.68 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.35 0.595 . . . . 0.0 110.674 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -107.99 -45.52 1.1 Allowed Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.289 -176.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -88.64 75.93 8.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.988 0.423 . . . . 0.0 110.87 -174.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 262' ' ' LEU . . . . . 0.615 ' HG ' ' CD1' ' A' ' 14' ' ' LEU . 3.3 mm? -123.72 -73.05 0.65 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.634 0.73 . . . . 0.0 111.464 -176.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . 0.517 ' HB2' ' SD ' ' B' ' 201' ' ' MET . . . -50.33 -74.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.547 177.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 23.9 t 61.73 121.44 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.352 1.032 . . . . 0.0 112.387 176.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 2.7 p -78.39 114.23 41.07 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.395 175.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.31 143.38 17.42 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.488 2.125 . . . . 0.0 112.645 -177.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . -127.23 135.94 51.33 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.355 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 73.73 38.97 49.45 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.389 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -77.04 93.64 1.08 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.759 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -76.13 80.07 2.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.904 0.383 . . . . 0.0 110.454 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 16.9 t -79.13 141.76 14.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.565 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -140.61 130.31 24.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.095 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 37.0 t -74.8 116.8 17.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.574 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 4.9 p -77.88 129.93 35.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.675 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -100.75 146.75 26.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.628 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . 0.428 ' HA ' ' HD2' ' B' ' 277' ' ' PRO . . . -112.39 115.81 49.26 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-O 121.154 0.502 . . . . 0.0 111.188 -178.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 277' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' B' ' 276' ' ' ALA . 55.5 Cg_endo -70.46 146.71 56.59 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.176 2.584 . . . . 0.0 112.709 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -113.14 160.04 13.35 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.15 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 15.8 m -91.66 -170.68 2.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.766 0.283 . . . . 0.0 111.022 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 69.36 67.94 0.26 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.84 0.828 . . . . 0.0 111.225 174.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -95.12 160.49 30.74 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.266 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -44.95 -64.6 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.216 2.611 . . . . 0.0 113.2 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . 62.92 110.79 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 O-C-N 123.952 0.783 . . . . 0.0 112.091 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -102.64 -170.38 1.79 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.624 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -85.61 -121.3 1.13 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.955 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 58.1 p 47.34 75.45 0.13 Allowed 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.155 0.582 . . . . 0.0 111.721 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -51.68 110.62 1.92 Allowed Pre-proline 0 C--O 1.233 0.213 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.85 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.25 100.54 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.84 2.36 . . . . 0.0 112.725 -175.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -95.65 -170.1 2.08 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.585 176.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -61.61 -68.53 0.31 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.693 177.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -176.29 160.02 2.1 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.372 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 60.26 110.83 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 174.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -60.35 108.36 0.79 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.184 172.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -136.77 118.71 15.27 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -176.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -80.42 132.69 35.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.0 0.429 . . . . 0.0 111.45 -177.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -164.59 103.9 0.82 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -78.71 173.97 11.91 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -171.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -90.69 -79.4 0.36 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.456 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 57.62 63.21 1.89 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.434 0.635 . . . . 0.0 111.207 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -84.75 177.62 7.95 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.641 -175.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 63.73 97.31 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.203 0 O-C-N 123.995 0.81 . . . . 0.0 112.382 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 21.3 t -134.17 141.7 47.17 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.347 0.594 . . . . 0.0 110.949 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -98.17 107.52 20.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.678 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -94.93 65.85 2.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.67 -176.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 23.7 m -67.0 142.52 57.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.084 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.99 12.96 34.4 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.944 -177.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 18.7 t70 70.1 -64.86 0.34 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.972 0.909 . . . . 0.0 111.656 -178.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -90.62 171.54 9.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.483 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 25.5 ptm -147.2 24.5 1.14 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.597 0.236 . . . . 0.0 111.045 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . -76.27 49.92 2.69 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.316 -0.468 . . . . 0.0 113.132 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -130.77 18.01 5.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.09 0.472 . . . . 0.0 110.399 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . 100.62 -74.72 0.41 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.01 -177.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 313' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' B' ' 313' ' ' LEU . 1.7 mt 48.83 83.02 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 122.03 0.919 . . . . 0.0 110.714 -173.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 314' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -131.15 18.64 4.94 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.35 -1.296 . . . . 0.0 109.908 -167.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 . . . . . 0 C--O 1.249 1.029 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.843 -174.796 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmt . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.571 0.224 . . . . 0.0 110.484 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.55 -77.09 0.37 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.802 0.334 . . . . 0.0 110.695 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.434 ' O ' HD13 ' A' ' 7' ' ' LEU . 0.9 OUTLIER -81.91 73.76 8.93 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.858 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.593 HG12 HD11 ' B' ' 212' ' ' LEU . 6.0 m -62.91 -27.52 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.277 -176.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.464 ' HB3' HG23 ' A' ' 39' ' ' VAL . 1.8 m -61.64 -63.16 1.36 Allowed 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.408 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -59.24 -50.23 74.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.348 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.584 ' O ' HG22 ' A' ' 10' ' ' ILE . 9.8 mp -47.99 -54.65 12.22 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.69 0.281 . . . . 0.0 110.666 178.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.473 ' HB2' HG11 ' A' ' 37' ' ' VAL . . . -59.67 -52.77 64.11 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -177.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 40.6 t -66.0 -30.61 71.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.761 0.315 . . . . 0.0 110.92 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.584 HG22 ' O ' ' A' ' 7' ' ' LEU . 2.4 tp -74.75 -35.77 38.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.154 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.82 ' HB2' HD21 ' B' ' 209' ' ' LEU . 19.5 m-30 -66.43 -36.17 82.13 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 177.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.1 m -69.35 -46.47 66.95 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.128 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.449 ' HB1' HD21 ' A' ' 59' ' ' LEU . . . -54.65 -49.6 70.18 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.562 176.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.71 HD22 HG23 ' B' ' 259' ' ' ILE . 4.5 pp -75.67 -29.03 58.92 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.213 -177.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 11' ' ' TYR . 0.7 OUTLIER -65.14 -38.68 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.796 0.331 . . . . 0.0 110.788 175.287 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.562 HD13 ' HA ' ' A' ' 23' ' ' VAL . 93.1 mt -78.23 -28.28 47.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.759 178.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.8 m80 -79.21 68.85 5.29 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -165.21 -49.11 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.903 0.382 . . . . 0.0 110.429 173.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -83.69 -172.17 4.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.722 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -89.3 16.45 7.39 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.1 0.476 . . . . 0.0 110.307 175.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.492 HG21 HG12 ' B' ' 232' ' ' ILE . 41.3 t -88.8 125.94 41.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.095 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 p -77.59 147.34 35.71 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.198 -172.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.562 ' HA ' HD13 ' A' ' 16' ' ' LEU . 32.6 m -83.69 41.74 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.06 -174.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.443 ' OG1' ' HG2' ' A' ' 27' ' ' LYS . 39.1 p -67.13 159.85 28.01 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -177.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -57.72 -42.65 84.26 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -176.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -49.78 -42.65 47.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.331 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.443 ' HG2' ' OG1' ' A' ' 24' ' ' THR . 45.8 mmtm -77.74 -47.75 18.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.394 -173.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.403 ' O ' HD13 ' A' ' 32' ' ' ILE . 5.2 mt -61.55 -44.81 99.23 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.154 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.332 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -60.05 -40.61 90.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.634 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.92 -40.93 99.11 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.423 HD12 HD13 ' B' ' 209' ' ' LEU . 0.1 OUTLIER -68.83 -41.79 78.08 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.337 0.589 . . . . 0.0 110.05 -179.662 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.403 HD13 ' O ' ' A' ' 28' ' ' ILE . 1.7 mp -59.94 -37.73 73.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.601 175.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -75.58 -30.43 59.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.108 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.45 -51.2 70.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.448 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.88 -27.21 25.17 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.777 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.7 22.02 56.7 Favored Glycine 0 C--N 1.321 -0.264 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.777 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.473 HG11 ' HB2' ' A' ' 8' ' ' ALA . 12.9 t -82.34 137.17 21.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.848 0.356 . . . . 0.0 110.119 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -88.21 92.03 9.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.997 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.464 HG23 ' HB3' ' A' ' 5' ' ' SER . 7.7 p -102.41 136.18 35.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.573 175.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.47 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -54.2 125.3 49.72 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.046 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.76 -6.15 2.3 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.6 2.866 . . . . 0.0 113.507 -171.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.49 -31.25 47.65 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -177.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -65.99 -60.72 6.59 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.622 175.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.47 ' HD2' ' O ' ' A' ' 40' ' ' GLU . 19.6 Cg_endo -58.86 -40.91 67.69 Favored 'Trans proline' 0 C--N 1.361 1.197 0 C-N-CA 121.783 1.656 . . . . 0.0 112.178 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.38 -55.04 32.33 Favored Glycine 0 C--O 1.241 0.552 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.159 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.7 tt -59.87 -50.54 73.38 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.581 ' O ' HD13 ' A' ' 51' ' ' LEU . 2.6 m-85 -53.61 -53.6 49.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.01 0.433 . . . . 0.0 111.832 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.91 -27.94 67.07 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -173.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm -93.59 -11.62 31.37 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.451 -0.5 . . . . 0.0 112.15 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -106.54 -26.26 11.48 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.864 ' HA ' HG23 ' A' ' 54' ' ' VAL . 4.8 mp -81.23 -132.53 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.41 ' H ' ' HB3' ' A' ' 51' ' ' LEU . . . 57.27 6.49 0.37 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.372 0.669 . . . . 0.0 112.095 -175.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.411 ' H ' ' C ' ' A' ' 51' ' ' LEU . 37.2 m-80 -143.67 -40.76 0.29 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.864 HG23 ' HA ' ' A' ' 51' ' ' LEU . 58.7 t -45.14 108.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 113.881 -1.509 . . . . 0.0 111.622 173.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -67.51 169.71 8.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.678 173.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.6 tp -54.62 -53.25 33.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.954 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.63 -43.35 86.12 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.457 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.469 ' HB2' HG13 ' A' ' 54' ' ' VAL . 16.4 m -58.54 -28.55 65.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.662 0.268 . . . . 0.0 111.141 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.503 HD13 ' O ' ' A' ' 59' ' ' LEU . 2.5 tm? -64.06 -22.74 67.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.678 -176.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.718 HG23 HD12 ' B' ' 259' ' ' ILE . 18.3 mt -92.25 -5.28 10.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.301 0.572 . . . . 0.0 110.682 -176.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 22.4 t -137.55 51.22 1.93 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.351 0.596 . . . . 0.0 110.017 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -90.99 -34.21 15.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.548 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.3 p -106.94 -12.57 10.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.176 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 115.37 -169.38 12.88 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -175.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -149.06 119.87 7.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 117.336 0.568 . . . . 0.0 111.193 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -96.22 -98.82 1.85 Allowed Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.748 174.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.457 ' HA2' ' HD3' ' A' ' 68' ' ' PRO . . . 150.34 144.36 3.92 Favored Glycine 0 C--O 1.227 -0.289 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.105 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.457 ' HD3' ' HA2' ' A' ' 67' ' ' GLY . 2.8 Cg_endo -80.98 82.47 2.45 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.832 2.355 . . . . 0.0 112.291 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.95 76.62 75.69 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.423 176.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.79 -42.6 0.77 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.454 2.102 . . . . 0.0 112.888 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 63.62 165.44 0.13 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.213 0.605 . . . . 0.0 111.664 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -155.9 133.17 10.79 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.898 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.77 151.42 20.44 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.88 135.08 27.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.75 0.275 . . . . 0.0 110.626 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -139.86 126.24 12.17 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.163 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -50.45 -30.09 26.28 Favored 'Trans proline' 0 CA--C 1.527 0.166 0 C-N-CA 124.226 3.284 . . . . 0.0 113.349 -177.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 58.94 75.76 0.38 Allowed 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.671 0.607 . . . . 0.0 111.892 174.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -108.32 160.22 13.89 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.324 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -146.61 173.87 26.68 Favored Glycine 0 N--CA 1.451 -0.329 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.6 164.12 26.17 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.501 2.134 . . . . 0.0 112.109 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.52 108.5 61.95 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.601 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -57.94 146.43 86.88 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.638 2.225 . . . . 0.0 112.111 178.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.0 t 62.11 77.9 0.31 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.281 0.562 . . . . 0.0 110.857 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.6 m -94.63 116.56 28.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.085 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 70.24 -73.84 0.09 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.563 0.745 . . . . 0.0 111.623 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 67.05 111.53 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.932 0.77 . . . . 0.0 112.377 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 65.23 95.26 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.326 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.077 175.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -54.7 -47.06 28.79 Favored 'Trans proline' 0 N--CA 1.473 0.282 0 C-N-CA 123.278 2.652 . . . . 0.0 112.598 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 55.49 44.52 26.76 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.375 0.607 . . . . 0.0 110.897 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -89.27 142.45 27.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.995 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -108.98 -174.86 2.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.997 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -151.14 75.13 1.18 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.992 0.901 . . . . 0.0 109.838 175.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -88.18 134.96 33.65 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.4 -174.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 13.6 p -152.92 148.5 14.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.188 175.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 73.45 144.91 0.07 Allowed 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.785 0.678 . . . . 0.0 111.887 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.44 118.28 7.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.165 -178.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.4 mttp 65.26 163.37 0.15 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.448 0.642 . . . . 0.0 112.087 -177.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -139.2 -76.3 0.36 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.463 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 50.43 56.72 7.51 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 123.823 0.702 . . . . 0.0 111.026 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.32 144.19 57.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.16 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.0 t -113.98 42.03 2.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.369 0.604 . . . . 0.0 111.192 -174.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -115.68 33.03 5.71 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.866 175.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -45.24 126.24 6.1 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.415 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.2 m -122.17 121.79 37.69 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.059 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.509 ' CG ' ' H ' ' A' ' 106' ' ' ASP . 13.9 t70 -143.41 -156.46 0.69 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -176.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.509 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 9.1 t70 59.63 73.15 0.49 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.91 0.862 . . . . 0.0 110.05 -173.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -80.47 72.52 7.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.516 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 17.1 tpt 68.48 77.61 0.24 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.808 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -82.45 -159.43 25.86 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-N 115.945 -0.57 . . . . 0.0 113.164 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -58.12 130.89 48.71 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.421 0.629 . . . . 0.0 111.944 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.481 ' HA2' ' CE2' ' A' ' 113' ' ' PHE . . . -83.5 72.0 2.91 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.671 -178.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.5 mt -92.69 47.87 1.33 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.241 0.543 . . . . 0.0 110.408 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.481 ' CE2' ' HA2' ' A' ' 111' ' ' GLY . 2.0 p90 -138.24 51.65 1.86 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.255 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 36.1 t70 . . . . . 0 C--O 1.248 0.995 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.752 -178.437 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.689 ' HE3' ' O ' ' A' ' 14' ' ' LEU . 38.5 mtt -48.73 -66.64 0.37 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.473 0.654 . . . . 0.0 111.552 -173.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 202' ' ' ARG . . . . . 0.509 ' HB3' HG22 ' B' ' 204' ' ' VAL . 7.1 tpt180 -151.68 147.04 26.24 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -74.83 5.67 4.79 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 120.913 0.387 . . . . 0.0 111.805 -174.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.791 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 18.1 m -58.28 -51.94 65.02 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.529 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.783 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 205' ' ' ALA . . . . . 0.541 ' CB ' HD11 ' A' ' 14' ' ' LEU . . . -64.7 -25.33 67.89 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -176.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . 0.548 ' CB ' HG23 ' B' ' 223' ' ' ILE . 6.0 m -67.11 -48.91 66.69 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 173.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 207' ' ' TYR . . . . . 0.477 ' CZ ' ' HD2' ' B' ' 218' ' ' PRO . 17.0 t80 -61.68 -35.22 77.36 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.383 175.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.791 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 39.5 mt -63.26 -53.34 54.44 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.963 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 209' ' ' LEU . . . . . 0.82 HD21 ' HB2' ' A' ' 11' ' ' TYR . 15.2 mt -52.57 -50.62 62.59 Favored 'General case' 0 C--O 1.245 0.864 0 CA-C-O 121.264 0.554 . . . . 0.0 110.003 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -62.5 -41.13 98.62 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.668 -178.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 211' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -77.77 -24.68 48.87 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.929 -0.482 . . . . 0.0 111.481 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 212' ' ' LEU . . . . . 0.593 HD11 HG12 ' A' ' 4' ' ' VAL . 33.5 tp -71.23 -47.84 54.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.669 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -141.16 20.56 2.64 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 118.954 -1.593 . . . . 0.0 114.628 -176.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . -121.05 -66.07 0.26 Allowed Glycine 0 C--N 1.321 -0.284 0 C-N-CA 119.959 -1.115 . . . . 0.0 112.772 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 215' ' ' ASN . . . . . 0.5 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 34.0 t30 -154.42 146.66 23.8 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -177.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 7.0 m -67.95 -21.62 65.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.355 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 5.6 p -125.19 70.91 62.74 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.618 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . 0.477 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 65.2 Cg_exo -57.75 132.99 53.38 Favored 'Trans proline' 0 N--CA 1.477 0.552 0 C-N-CA 122.989 2.459 . . . . 0.0 112.152 176.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . 0.463 ' HB3' ' OD1' ' B' ' 222' ' ' ASP . 28.3 t -110.18 172.96 6.55 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.919 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -56.1 -38.9 71.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.007 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -65.98 -43.33 88.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.685 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 222' ' ' ASP . . . . . 0.463 ' OD1' ' HB3' ' B' ' 219' ' ' SER . 3.3 m-20 -62.23 -49.48 75.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.138 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.548 HG23 ' CB ' ' B' ' 206' ' ' SER . 1.8 mp -63.79 -40.23 88.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.586 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -54.43 -50.9 66.55 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.187 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -63.71 -42.64 97.91 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.075 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.14 -36.04 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 120.686 0.279 . . . . 0.0 110.73 176.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . 0.47 ' CD1' ' HB ' ' B' ' 232' ' ' ILE . 0.2 OUTLIER -75.82 -43.85 44.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.68 -178.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -86.64 -0.77 56.86 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.631 -177.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 15.4 t -55.07 -44.74 75.06 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.987 0.422 . . . . 0.0 110.51 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 230' ' ' VAL . . . . . 0.56 HG23 HG13 ' B' ' 232' ' ' ILE . 12.5 m -95.88 0.74 10.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.218 0.532 . . . . 0.0 111.16 178.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 81.65 54.98 3.3 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.616 -0.72 . . . . 0.0 113.739 175.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . 0.56 HG13 HG23 ' B' ' 230' ' ' VAL . 4.3 mt -115.64 140.07 39.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 172.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -70.74 119.85 15.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.302 0.573 . . . . 0.0 111.576 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -118.18 132.64 56.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.383 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -83.78 111.95 19.65 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -60.67 -33.69 73.22 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.458 -174.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -67.91 -58.31 4.77 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.456 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -63.92 -30.85 71.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.688 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 239' ' ' LEU . . . . . . . . . . . . . 8.7 tt -57.42 -60.72 3.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.313 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -64.25 -32.46 74.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.897 -178.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 241' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' B' ' 245' ' ' GLU . 84.3 mttt -67.77 -41.54 83.14 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 242' ' ' VAL . . . . . 0.456 ' HA ' ' OE1' ' B' ' 245' ' ' GLU . 32.9 m -73.92 -31.15 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 119.969 -0.693 . . . . 0.0 109.559 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . 0.454 ' HA ' ' CD2' ' B' ' 246' ' ' LEU . 7.5 mt -65.16 -37.09 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.077 173.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 12.1 t -63.56 -40.22 96.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.241 174.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 245' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' B' ' 241' ' ' LYS . 47.0 mt-10 -59.42 -45.54 91.25 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.439 0.638 . . . . 0.0 110.266 176.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . 0.454 ' CD2' ' HA ' ' B' ' 243' ' ' ILE . 2.9 pp -87.6 -0.11 56.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.831 -175.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -67.04 -8.23 28.7 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.051 0.453 . . . . 0.0 111.719 -170.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -80.33 -170.93 42.54 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.149 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . 0.402 ' HD2' ' N ' ' B' ' 249' ' ' LYS . 11.3 mptt -82.31 67.4 8.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.922 0.391 . . . . 0.0 110.688 -177.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -131.72 27.68 4.62 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.686 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.409 ' O ' HG13 ' B' ' 255' ' ' ILE . 23.9 mm -53.46 -66.42 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -173.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 252' ' ' GLU . . . . . 0.456 ' O ' ' HB ' ' B' ' 255' ' ' ILE . 5.0 tp10 -62.03 -32.51 73.01 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 121.138 0.494 . . . . 0.0 111.412 -174.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' B' ' 257' ' ' GLN . 8.4 t70 -67.73 -47.27 69.79 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.11 -178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 254' ' ' VAL . . . . . 0.422 HG23 HD21 ' B' ' 208' ' ' LEU . 30.0 m -67.95 -24.46 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.065 0 C-N-CA 120.239 -0.585 . . . . 0.0 110.455 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 255' ' ' ILE . . . . . 0.652 HG23 ' OH ' ' A' ' 11' ' ' TYR . 40.1 mt -61.47 -37.71 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 CA-C-O 121.468 0.651 . . . . 0.0 109.433 172.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -94.78 -2.91 50.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.42 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' B' ' 253' ' ' ASP . 0.9 OUTLIER -106.72 76.29 1.11 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.138 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . 0.634 ' HA3' HD13 ' B' ' 262' ' ' LEU . . . -143.08 -99.16 0.3 Allowed Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.266 -0.969 . . . . 0.0 112.011 177.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 259' ' ' ILE . . . . . 0.718 HD12 HG23 ' A' ' 60' ' ' ILE . 1.0 OUTLIER -60.67 -38.42 78.51 Favored 'Isoleucine or valine' 0 C--N 1.346 0.451 0 CA-C-O 122.167 0.984 . . . . 0.0 108.59 171.318 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . 0.408 ' H ' HD22 ' B' ' 262' ' ' LEU . . . 137.43 -37.17 1.87 Allowed Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.988 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 261' ' ' LYS . . . . . 0.543 ' H ' HD12 ' B' ' 259' ' ' ILE . 28.9 mmmt -122.06 22.2 10.33 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 262' ' ' LEU . . . . . 0.634 HD13 ' HA3' ' B' ' 258' ' ' GLY . 2.3 pt? -69.06 -2.56 10.37 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.236 0.541 . . . . 0.0 111.171 -176.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -123.97 53.1 1.41 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 170.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 11.6 t -64.63 110.73 2.45 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.844 -177.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 45.4 t -107.39 104.13 51.35 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.045 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.9 118.21 3.38 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.688 2.258 . . . . 0.0 112.71 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . -78.24 57.39 1.86 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.405 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 77.99 -47.81 2.91 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 121.546 -0.359 . . . . 0.0 112.938 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . 100.14 43.75 2.34 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.621 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . 69.63 88.43 0.11 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.667 0.787 . . . . 0.0 111.379 -177.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 22.9 t -89.32 143.22 11.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.904 178.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -97.57 131.85 43.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.84 0.352 . . . . 0.0 111.146 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 58.7 t -97.95 125.91 51.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.001 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 8.0 m -76.64 123.1 25.61 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.227 0.537 . . . . 0.0 111.249 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -151.04 151.06 31.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.972 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -99.42 118.6 62.01 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 120.535 0.207 . . . . 0.0 110.705 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 277' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -70.6 145.38 52.17 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.936 2.424 . . . . 0.0 112.093 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -89.12 117.55 4.94 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.306 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 69.7 m -96.8 -165.59 1.29 Allowed 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.273 0.559 . . . . 0.0 111.47 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . -54.93 152.67 7.15 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.208 176.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' B' ' 282' ' ' PRO . . . -137.21 136.98 21.45 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.346 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' B' ' 281' ' ' ALA . 14.7 Cg_exo -67.81 95.81 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.553 2.168 . . . . 0.0 112.292 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -121.06 37.39 4.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.371 0.605 . . . . 0.0 110.652 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -149.19 177.23 9.81 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.173 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 176.5 -35.04 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.096 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 35.9 p 50.15 77.32 0.12 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.273 0.558 . . . . 0.0 111.685 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -100.02 120.44 56.88 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.349 -176.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.77 141.87 42.13 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.582 2.188 . . . . 0.0 111.922 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -90.0 -54.25 4.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.121 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . 47.33 69.39 0.51 Allowed 'General case' 0 CA--C 1.531 0.239 0 O-C-N 123.476 0.485 . . . . 0.0 112.115 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -86.29 -58.41 2.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.286 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 54.77 60.23 3.62 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.324 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -56.62 117.87 4.3 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.484 172.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -146.6 164.24 33.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.444 -175.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt 73.77 148.29 0.09 Allowed 'General case' 0 N--CA 1.473 0.722 0 O-C-N 124.064 0.852 . . . . 0.0 111.531 177.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -138.13 123.95 19.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.301 0.572 . . . . 0.0 110.714 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -75.47 145.31 41.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.38 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.78 11.17 17.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.147 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -123.66 127.88 48.86 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.31 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -103.33 108.47 19.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.934 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 43.76 65.2 1.05 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.443 175.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.02 -172.73 3.4 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.936 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 65.33 78.27 0.28 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.378 0.608 . . . . 0.0 110.356 -177.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -155.8 151.6 27.42 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.186 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 68.4 m -150.69 125.79 9.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.164 0.507 . . . . 0.0 110.86 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.97 -54.76 10.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.338 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -77.77 -75.67 0.21 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.745 -172.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 18.3 t0 62.9 88.03 0.1 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.578 0.704 . . . . 0.0 111.276 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 16.1 tpt -73.31 -6.35 45.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.625 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 94.6 121.11 3.44 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.125 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -75.88 58.13 1.11 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.299 0.571 . . . . 0.0 110.954 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . -94.56 -82.27 1.57 Allowed Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.865 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 10.7 mp 46.75 64.05 1.68 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.962 0.887 . . . . 0.0 110.018 -177.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 314' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -128.77 13.34 6.37 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 113.967 -1.47 . . . . 0.0 108.804 -170.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--O 1.249 1.074 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.356 -173.588 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.6 tpp . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.4 -91.9 0.04 OUTLIER 'General case' 0 C--O 1.234 0.25 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.569 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 23.3 t -90.52 96.44 10.65 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.162 0.506 . . . . 0.0 111.289 -172.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.0 p -69.55 -26.27 30.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.842 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.472 ' HA ' HG22 ' A' ' 39' ' ' VAL . 8.4 p -66.83 -55.47 14.67 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.528 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.618 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 35.3 mt-10 -62.67 -39.49 94.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.733 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 3' ' ' SER . 38.3 mt -54.99 -55.41 31.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.111 0.481 . . . . 0.0 109.922 175.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.3 -44.79 95.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.994 -175.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.618 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 26.7 p -70.94 -34.62 71.65 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.416 -176.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.48 HG12 ' CG2' ' B' ' 259' ' ' ILE . 0.8 OUTLIER -75.26 -33.94 29.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.973 0.416 . . . . 0.0 110.888 -179.404 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.513 ' HB2' ' CD1' ' B' ' 209' ' ' LEU . 23.0 m-30 -77.51 -26.47 51.19 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 177.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.436 ' HA ' HD23 ' A' ' 31' ' ' LEU . 23.0 t -65.62 -51.71 57.52 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.01 -42.82 29.1 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.4 171.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.61 HD21 ' HA2' ' B' ' 260' ' ' GLY . 82.6 mt -59.01 -58.29 9.32 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.781 0.324 . . . . 0.0 110.914 175.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 69.6 mt -56.62 -29.84 30.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.275 -176.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.9 mt -100.95 -9.58 21.39 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.68 -35.64 76.77 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -176.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -164.32 116.83 1.34 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -174.7 43.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.286 170.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 57.02 28.37 14.72 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.192 -174.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.0 p -126.44 161.53 32.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.651 -176.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.0 p -106.27 132.55 52.19 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -173.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.731 HG11 HD23 ' A' ' 51' ' ' LEU . 61.9 t -75.15 108.24 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -152.62 158.94 43.15 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-O 121.309 0.576 . . . . 0.0 111.894 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -43.77 -61.67 1.35 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.206 -173.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -62.86 -24.77 67.96 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.5 -173.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -77.43 -45.81 24.61 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.388 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.449 HG23 HD13 ' A' ' 32' ' ' ILE . 5.7 mt -62.46 -45.53 98.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.214 -0.595 . . . . 0.0 109.926 175.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -53.61 -45.78 70.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.194 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.0 -44.36 92.87 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 12' ' ' SER . 29.6 tp -71.22 -30.03 65.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.342 0.592 . . . . 0.0 110.316 -178.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.449 HD13 HG23 ' A' ' 28' ' ' ILE . 1.4 mp -69.66 -31.56 49.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.917 173.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -70.44 -29.83 66.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.87 -67.47 0.45 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.013 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.489 ' HB2' HD11 ' B' ' 226' ' ' ILE . . . -129.78 23.66 5.38 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -174.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -101.66 99.27 1.88 Allowed Glycine 0 C--N 1.314 -0.662 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.076 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.605 ' CG2' ' HA2' ' B' ' 213' ' ' GLY . 57.8 t -42.49 -70.07 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 122.516 0.326 . . . . 0.0 111.43 177.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -161.98 113.72 1.69 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 177.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.472 HG22 ' HA ' ' A' ' 5' ' ' SER . 11.8 t -121.65 137.52 55.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.463 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 0.7 OUTLIER -70.09 128.17 91.79 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.69 0.57 0.38 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.14 2.56 . . . . 0.0 113.116 -174.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.431 ' H ' ' C ' ' A' ' 40' ' ' GLU . 2.6 t80 -71.42 -39.72 70.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.014 176.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.526 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 68.2 m95 -72.42 -56.72 3.9 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.928 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 73.5 Cg_exo -49.95 -46.22 28.96 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 122.015 1.81 . . . . 0.0 112.321 173.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.46 -41.61 99.25 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.36 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.2 tp -61.87 -42.57 99.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.975 0.417 . . . . 0.0 110.096 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.441 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 3.2 m-85 -66.56 -40.05 88.8 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.992 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.61 -28.27 65.79 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -95.1 -30.74 13.9 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.79 -18.15 7.17 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -169.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.759 ' HA ' HG23 ' A' ' 54' ' ' VAL . 2.2 tp -89.54 -134.46 0.1 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.6 -176.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.444 ' H ' ' CG ' ' A' ' 51' ' ' LEU . . . 60.07 -13.28 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -176.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.547 ' H ' ' C ' ' A' ' 51' ' ' LEU . 48.0 m-80 -127.09 -31.38 2.6 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.759 HG23 ' HA ' ' A' ' 51' ' ' LEU . 61.0 t -49.99 103.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.382 172.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -46.74 146.32 1.62 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.671 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.468 HD11 HD23 ' A' ' 14' ' ' LEU . 4.0 tp -49.71 -51.77 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -170.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.27 -24.21 63.14 Favored Glycine 0 C--O 1.24 0.474 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.041 -176.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.3 t -68.81 -2.83 10.39 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 122.107 0.163 . . . . 0.0 111.225 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 46.3 mt -62.35 -26.02 68.22 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.192 0.52 . . . . 0.0 109.961 172.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.469 HG23 HD12 ' B' ' 259' ' ' ILE . 8.9 mt -95.74 16.26 2.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.607 0.718 . . . . 0.0 110.092 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.0 t -108.98 -45.01 3.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.381 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -87.74 5.89 37.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.036 -177.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.9 p -61.67 -29.84 47.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.897 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.0 40.75 2.32 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.212 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.76 -34.01 52.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.813 0.34 . . . . 0.0 110.972 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.81 -141.36 16.92 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.816 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 109.04 -167.98 13.19 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.826 -177.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -89.68 177.99 2.51 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.104 2.536 . . . . 0.0 112.488 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.42 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . . . -171.55 -50.93 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.309 177.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.42 ' HD3' ' HB3' ' A' ' 69' ' ' ALA . 81.5 Cg_endo -77.53 143.85 22.03 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 121.705 1.603 . . . . 0.0 111.641 171.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 67.84 115.47 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.384 0.674 . . . . 0.0 112.279 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -155.14 178.93 9.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.218 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.78 174.61 24.96 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.507 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -137.61 140.37 40.9 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.504 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -62.39 125.75 86.5 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.157 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 32.3 Cg_exo -60.76 97.81 0.13 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.518 2.812 . . . . 0.0 113.487 -177.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.63 142.53 49.94 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.919 173.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.29 -80.16 0.35 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.494 -174.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.6 -178.09 16.49 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.955 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.41 158.87 54.81 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.756 2.304 . . . . 0.0 112.492 -178.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -99.95 116.66 64.46 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.776 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -54.09 108.58 0.29 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.446 2.764 . . . . 0.0 112.671 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.4 t -82.87 84.39 7.41 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.179 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 27.5 m -151.1 -68.73 0.18 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.756 177.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 60.32 59.4 2.3 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.643 0.589 . . . . 0.0 111.614 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 65.48 -167.2 0.22 Allowed 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.781 0.676 . . . . 0.0 111.708 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -132.9 141.39 40.86 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.802 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -47.75 -60.19 0.97 Allowed 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.176 2.584 . . . . 0.0 113.802 -174.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 72.71 -36.6 0.36 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.53 114.24 3.14 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.098 0.475 . . . . 0.0 111.996 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -70.18 173.05 7.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.284 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -132.19 -78.35 0.5 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.903 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -129.72 133.07 46.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.962 0.411 . . . . 0.0 111.047 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.4 t -108.09 -61.57 2.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.33 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 68.82 133.48 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.598 0.713 . . . . 0.0 111.845 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -174.29 -52.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.02 -177.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -145.9 140.25 26.85 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.091 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -138.9 141.11 38.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.159 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 57.87 83.0 0.12 Allowed 'General case' 0 C--O 1.234 0.246 0 O-C-N 123.953 0.783 . . . . 0.0 110.929 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -64.12 142.71 58.31 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.331 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.6 t -100.52 141.64 33.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.583 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -104.28 -164.87 1.09 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.3 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -46.26 137.01 6.6 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.991 0.424 . . . . 0.0 111.724 177.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.6 t -159.29 141.11 13.36 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.913 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -108.77 30.56 6.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.656 0.741 . . . . 0.0 109.329 173.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.2 t70 57.98 54.88 5.67 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 114.069 -1.423 . . . . 0.0 111.661 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -91.52 145.06 24.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.464 172.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -105.56 155.46 19.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.813 0.34 . . . . 0.0 110.977 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -79.23 99.17 1.68 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.195 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -81.34 148.49 29.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.64 0.257 . . . . 0.0 110.598 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -168.28 117.38 0.72 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.208 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.6 mp -92.1 86.59 5.84 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -70.77 128.67 36.86 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.007 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.807 -0.616 . . . . 0.0 110.701 -178.791 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 121.03 0.443 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.455 ' HG3' ' O ' ' A' ' 14' ' ' LEU . 0.1 OUTLIER -89.31 -176.17 5.0 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.053 -178.02 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 202' ' ' ARG . . . . . 0.457 ' HD2' ' N ' ' B' ' 202' ' ' ARG . 8.6 mpt_? -113.38 136.61 52.58 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.096 -176.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -71.05 3.6 3.29 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.402 0.62 . . . . 0.0 111.432 -176.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.626 ' O ' HD13 ' B' ' 208' ' ' LEU . 60.8 t -60.09 -56.76 15.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.538 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 205' ' ' ALA . . . . . 0.556 ' HA ' HD22 ' B' ' 208' ' ' LEU . . . -69.31 -14.53 62.98 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.729 0.299 . . . . 0.0 111.27 -176.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . 0.501 ' HB3' HG23 ' B' ' 223' ' ' ILE . 8.5 m -76.61 -45.07 31.7 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 174.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 207' ' ' TYR . . . . . 0.592 ' CE1' HD11 ' B' ' 251' ' ' ILE . 36.1 t80 -62.87 -41.91 99.57 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 174.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.626 HD13 ' O ' ' B' ' 204' ' ' VAL . 2.7 mp -56.77 -49.25 75.85 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.523 175.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 209' ' ' LEU . . . . . 0.513 ' CD1' ' HB2' ' A' ' 11' ' ' TYR . 3.6 tp -59.39 -49.65 76.99 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.603 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -66.46 -28.44 68.59 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 211' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -73.94 -43.24 58.92 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.257 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 212' ' ' LEU . . . . . 0.4 HD22 ' HB3' ' A' ' 7' ' ' LEU . 4.3 pp -75.15 -35.64 61.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.765 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . 0.605 ' HA2' ' CG2' ' A' ' 37' ' ' VAL . . . -124.02 47.55 1.01 Allowed Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.312 -0.947 . . . . 0.0 114.07 -172.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . -175.95 -66.63 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.206 0 C-N-CA 119.683 -1.246 . . . . 0.0 113.309 176.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 215' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 54.9 t30 -153.12 149.28 27.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.91 0.386 . . . . 0.0 110.533 -173.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 7.6 m -71.45 -18.52 62.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.256 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 17.6 p -125.76 69.99 65.05 Favored Pre-proline 0 N--CA 1.443 -0.808 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.848 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . 0.46 ' HB3' HD11 ' B' ' 223' ' ' ILE . 76.3 Cg_exo -54.18 135.83 65.94 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.072 2.515 . . . . 0.0 112.162 178.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 15.9 m -107.84 154.18 21.93 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.789 -177.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -49.22 -49.26 43.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.13 0.49 . . . . 0.0 111.757 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -64.76 -32.28 73.89 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.116 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -70.47 -43.64 69.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.898 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.501 HG23 ' HB3' ' B' ' 206' ' ' SER . 1.8 mp -61.74 -39.56 83.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.252 0.549 . . . . 0.0 109.75 174.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -60.33 -38.1 82.67 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.564 177.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . 0.656 ' O ' ' HD3' ' B' ' 225' ' ' LYS . 6.4 tmtm? -70.32 -36.74 74.46 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 0.489 HD11 ' HB2' ' A' ' 35' ' ' ALA . 1.0 OUTLIER -61.36 -36.52 73.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.502 179.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 97.2 mt -77.04 -34.37 57.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.838 0.352 . . . . 0.0 110.272 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 228' ' ' ASP . . . . . 0.508 ' HB3' ' HA ' ' B' ' 225' ' ' LYS . 0.8 OUTLIER -56.01 -36.23 67.7 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.377 173.707 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 23.8 m -55.81 -46.89 77.96 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.789 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 230' ' ' VAL . . . . . 0.422 HG11 ' HB2' ' A' ' 31' ' ' LEU . 1.2 m -90.06 -4.08 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 83.33 29.3 33.75 Favored Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.293 176.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 41.9 mt -98.07 130.84 46.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 176.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -77.59 159.43 29.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.658 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -154.66 121.35 5.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.491 -175.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . 0.457 ' HB3' ' OD1' ' B' ' 237' ' ' ASP . 5.0 m-20 -66.7 111.2 3.56 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 171.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 236' ' ' ASP . . . . . 0.493 ' HA ' ' HB3' ' B' ' 239' ' ' LEU . 2.5 p30 -69.21 -16.92 63.72 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.71 -174.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 237' ' ' ASP . . . . . 0.457 ' OD1' ' HB3' ' B' ' 235' ' ' ASP . 6.9 p-10 -69.48 -48.96 59.03 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 174.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.574 ' O ' HG23 ' B' ' 242' ' ' VAL . 15.9 mmt180 -66.4 -43.76 84.9 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.929 177.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 239' ' ' LEU . . . . . 0.493 ' HB3' ' HA ' ' B' ' 236' ' ' ASP . 9.6 tt -54.38 -57.58 10.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.882 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -68.12 -25.96 65.56 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 122.438 -0.163 . . . . 0.0 110.773 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -69.64 -46.07 67.0 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.266 0.555 . . . . 0.0 110.338 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 242' ' ' VAL . . . . . 0.574 HG23 ' O ' ' B' ' 238' ' ' ARG . 57.3 t -66.78 -27.82 41.13 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.679 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' B' ' 246' ' ' LEU . 39.0 mt -84.18 -25.29 7.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.935 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 63.6 p -75.21 -27.02 59.4 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.642 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -86.52 -55.96 3.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.565 0.698 . . . . 0.0 109.712 173.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . 0.704 ' O ' HD13 ' B' ' 246' ' ' LEU . 0.0 OUTLIER -90.63 111.44 22.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.919 176.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -153.99 -143.23 0.13 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -176.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -73.2 37.82 0.8 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.209 -0.519 . . . . 0.0 113.412 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -107.92 95.76 5.91 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . 0.485 ' HB3' ' HB3' ' B' ' 253' ' ' ASP . 16.9 m120 61.81 52.71 3.37 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.559 0.537 . . . . 0.0 110.835 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.592 HD11 ' CE1' ' B' ' 207' ' ' TYR . 1.4 mm -59.92 -51.01 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -175.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -75.56 -11.6 60.05 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.974 -176.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . 0.485 ' HB3' ' HB3' ' B' ' 250' ' ' ASN . 22.6 t70 -84.31 -42.23 16.01 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 254' ' ' VAL . . . . . 0.516 HG12 ' O ' ' B' ' 251' ' ' ILE . 9.1 p -67.34 -22.35 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 255' ' ' ILE . . . . . 0.43 HG23 HD22 ' A' ' 7' ' ' LEU . 37.8 mt -71.97 -57.55 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.567 170.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -59.64 -36.19 75.9 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -175.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -105.13 6.2 32.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.878 0.371 . . . . 0.0 110.848 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -116.76 46.42 1.15 Allowed Glycine 0 C--O 1.229 -0.204 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.267 -174.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 259' ' ' ILE . . . . . 0.518 ' O ' HD11 ' A' ' 14' ' ' LEU . 18.9 mt -67.57 -63.76 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.92 0.391 . . . . 0.0 111.087 178.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . 0.61 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . -148.32 27.43 1.38 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.069 -1.062 . . . . 0.0 112.742 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -103.95 42.15 1.22 Allowed 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 170.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 262' ' ' LEU . . . . . 0.547 HD22 HD13 ' A' ' 14' ' ' LEU . 1.0 OUTLIER -72.17 88.61 1.13 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.152 -1.386 . . . . 0.0 111.312 -172.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -132.71 91.25 2.88 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.789 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 35.1 p -85.7 -161.31 0.6 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.605 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 45.2 t -48.28 123.78 10.9 Favored Pre-proline 0 CA--C 1.536 0.404 0 O-C-N 123.146 0.278 . . . . 0.0 111.095 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.26 96.5 0.47 Allowed 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.806 2.337 . . . . 0.0 112.95 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . 72.92 -32.68 0.25 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.841 0.856 . . . . 0.0 113.043 172.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 117.47 -8.05 15.63 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . 90.37 -139.46 14.96 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.057 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -151.95 145.37 24.81 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 3.7 p -131.21 142.99 42.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.694 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -137.61 141.86 41.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.316 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 24.9 t -92.35 126.98 44.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.508 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 3.0 m -74.4 67.36 1.44 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.855 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -81.97 154.29 25.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.68 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -121.31 89.19 46.58 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.651 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 277' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -61.53 105.91 0.39 Allowed 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.093 2.528 . . . . 0.0 112.367 176.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 124.93 -11.09 7.83 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.922 175.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 31.9 m -102.12 167.36 10.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.851 0.358 . . . . 0.0 111.657 -177.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 63.37 64.68 0.81 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.574 172.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -130.07 91.92 37.92 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.625 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -65.48 -53.31 0.81 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.184 2.589 . . . . 0.0 112.72 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . 51.29 55.62 9.2 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.515 0.509 . . . . 0.0 112.108 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -85.91 133.46 33.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.695 -176.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -107.82 100.57 1.51 Allowed Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 121.072 -0.585 . . . . 0.0 111.839 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 24.8 p -102.13 106.12 16.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.843 0.354 . . . . 0.0 111.247 -176.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -115.25 100.69 53.94 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.416 177.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -75.0 71.22 5.08 Favored 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 123.145 2.563 . . . . 0.0 112.861 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -112.57 55.09 0.7 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.221 0.534 . . . . 0.0 110.954 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -81.39 80.47 7.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.236 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -128.41 61.74 1.47 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.428 0.632 . . . . 0.0 110.656 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -76.09 91.55 3.13 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.086 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -84.29 132.08 34.66 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.549 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -103.13 153.34 20.42 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 176.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 14.6 mmtp -114.2 78.85 1.19 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.94 0.4 . . . . 0.0 110.891 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -146.63 99.3 3.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.17 0.509 . . . . 0.0 110.351 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -137.09 164.87 27.4 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.624 178.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 298' ' ' LYS . . . . . 0.428 ' HE2' ' HG3' ' B' ' 301' ' ' GLU . 25.6 pttm -80.85 -31.24 35.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.274 -178.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 299' ' ' LYS . . . . . 0.402 ' HG3' ' N ' ' B' ' 300' ' ' GLU . 12.5 tppt? 63.37 170.08 0.15 Allowed 'General case' 0 CA--C 1.541 0.619 0 O-C-N 123.469 0.48 . . . . 0.0 111.632 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 300' ' ' GLU . . . . . 0.402 ' N ' ' HG3' ' B' ' 299' ' ' LYS . 41.4 mt-10 56.74 -108.07 0.41 Allowed 'General case' 0 C--O 1.237 0.424 0 C-N-CA 122.904 0.482 . . . . 0.0 112.021 176.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 301' ' ' GLU . . . . . 0.428 ' HG3' ' HE2' ' B' ' 298' ' ' LYS . 19.0 mm-40 48.73 68.69 0.66 Allowed 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.598 0.561 . . . . 0.0 111.98 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 19.1 p -99.53 173.0 6.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.883 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -75.4 -60.11 2.45 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 69.16 131.95 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.917 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 16.8 m -112.72 134.76 54.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.233 -173.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -86.35 70.66 10.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.795 173.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.67 -79.39 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.092 0.472 . . . . 0.0 111.311 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -143.01 118.67 10.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.445 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -100.01 43.81 1.04 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.112 0.482 . . . . 0.0 111.01 -175.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . -78.23 69.09 2.79 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.736 -177.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 60.65 26.9 16.62 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 122.859 0.464 . . . . 0.0 111.964 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . -79.0 6.79 55.2 Favored Glycine 0 CA--C 1.521 0.469 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.607 -175.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 313' ' ' LEU . . . . . 0.789 ' H ' HD13 ' B' ' 313' ' ' LEU . 0.0 OUTLIER -83.26 -22.86 32.93 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 174.13 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 314' ' ' PHE . . . . . 0.579 ' N ' HD22 ' B' ' 313' ' ' LEU . 14.7 p90 32.43 46.6 0.07 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.342 1.457 . . . . 0.0 114.248 175.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 10.8 t70 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.629 -0.7 . . . . 0.0 110.054 179.71 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 ttt . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.73 21.74 12.34 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.038 0.447 . . . . 0.0 111.265 -177.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.54 ' O ' HD13 ' A' ' 7' ' ' LEU . 3.7 p -98.46 14.07 29.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.391 -177.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.5 m -69.67 -21.3 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.191 -176.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.465 ' HB3' HG23 ' A' ' 39' ' ' VAL . 2.3 m -65.34 -54.58 26.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.735 0.778 . . . . 0.0 110.065 177.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -65.6 -43.33 89.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.699 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.54 HD13 ' O ' ' A' ' 3' ' ' SER . 6.4 mp -55.71 -53.59 54.68 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.629 177.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.64 -50.55 72.8 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.488 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 45.6 t -63.69 -37.37 87.08 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.323 -176.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.461 HG13 HD13 ' A' ' 59' ' ' LEU . 0.6 OUTLIER -72.63 -40.89 62.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 120.564 0.221 . . . . 0.0 111.013 -177.749 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.56 ' HB2' ' CD2' ' B' ' 209' ' ' LEU . 21.0 m-85 -69.76 -27.86 65.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.508 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.423 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 8.9 t -64.72 -48.7 73.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.826 174.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.72 -42.5 62.29 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.636 172.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.588 HD23 HD11 ' A' ' 56' ' ' ILE . 95.2 mt -57.58 -59.16 5.61 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.238 0.542 . . . . 0.0 110.892 176.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.436 HG21 ' CD1' ' A' ' 31' ' ' LEU . 98.2 mt -52.29 -43.56 40.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.601 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.492 HD13 ' HA ' ' A' ' 23' ' ' VAL . 73.1 mt -75.14 -27.02 59.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.906 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -88.1 41.14 0.99 Allowed 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.836 -0.54 . . . . 0.0 111.485 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -127.1 -26.7 3.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.749 0.309 . . . . 0.0 110.683 174.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -118.21 -161.87 0.86 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -100.05 25.82 7.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.559 0.695 . . . . 0.0 110.687 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -81.19 143.49 12.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.0 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.1 p -83.06 144.8 29.66 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.825 0.345 . . . . 0.0 111.545 -177.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.612 HG21 HD23 ' A' ' 51' ' ' LEU . 35.9 m -91.62 48.24 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 121.146 0.498 . . . . 0.0 111.77 -176.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.0 p -84.5 159.28 20.75 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.32 -178.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -55.27 -36.53 66.2 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -54.37 -44.75 72.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.434 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.469 ' HD2' HG13 ' B' ' 230' ' ' VAL . 75.5 mmtt -77.98 -41.73 35.04 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 120.838 0.352 . . . . 0.0 110.369 -174.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.401 HG12 ' OG ' ' A' ' 12' ' ' SER . 4.6 mt -60.13 -45.6 95.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.647 175.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.53 -36.8 84.87 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 111.364 0.135 . . . . 0.0 111.364 176.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.12 -54.17 50.02 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 120.978 0.418 . . . . 0.0 111.122 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.514 ' CD2' ' HG ' ' B' ' 209' ' ' LEU . 5.8 tt -68.93 -35.31 76.65 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.978 -178.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.65 -36.3 59.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.848 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -78.4 -30.26 47.65 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.874 0.368 . . . . 0.0 110.719 177.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.22 -31.56 72.12 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.624 172.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.493 ' HB2' HD12 ' B' ' 209' ' ' LEU . . . -84.12 -73.46 0.42 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.745 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.08 -49.69 0.48 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.787 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.552 HG22 ' HA2' ' B' ' 213' ' ' GLY . 34.7 m -81.72 154.14 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.957 0.408 . . . . 0.0 110.616 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -121.88 -174.82 2.96 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.597 -174.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.465 HG23 ' HB3' ' A' ' 5' ' ' SER . 7.6 p -151.31 137.7 12.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.842 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.466 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 12.2 pt-20 -59.39 134.4 88.49 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-O 120.533 0.206 . . . . 0.0 110.845 -175.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 40' ' ' GLU . 73.5 Cg_exo -50.66 -13.76 0.94 Allowed 'Trans proline' 0 N--CA 1.484 0.94 0 C-N-CA 124.485 3.457 . . . . 0.0 115.574 -166.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -74.47 -31.3 62.18 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.776 0.322 . . . . 0.0 110.341 -176.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.575 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 86.7 m95 -71.03 -54.3 7.55 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-O 119.058 -0.496 . . . . 0.0 111.258 176.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.575 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 50.2 Cg_exo -55.21 -37.21 94.45 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 121.73 1.62 . . . . 0.0 111.68 173.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.61 -51.04 61.23 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.821 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.416 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 56.1 mt -60.95 -44.39 97.34 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 120.635 0.255 . . . . 0.0 111.117 178.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.554 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 8.3 m-85 -62.81 -47.68 82.38 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.057 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.86 -34.59 76.98 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -112.33 1.07 15.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -170.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 46' ' ' LEU . . . -136.76 -17.71 1.44 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 177.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.677 ' HA ' HG23 ' A' ' 54' ' ' VAL . 3.4 tp -86.73 -132.42 0.06 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.418 ' H ' ' CG ' ' A' ' 51' ' ' LEU . . . 58.31 1.04 0.15 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.413 ' H ' ' C ' ' A' ' 51' ' ' LEU . 3.7 t-20 -143.22 -41.07 0.3 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.677 HG23 ' HA ' ' A' ' 51' ' ' LEU . 59.1 t -38.56 108.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 114.132 -1.394 . . . . 0.0 110.609 169.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -53.19 129.59 31.78 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 121.836 0.827 . . . . 0.0 109.274 176.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.588 HD11 HD23 ' A' ' 14' ' ' LEU . 7.3 tp -48.98 -38.63 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 114.25 -1.341 . . . . 0.0 113.731 -166.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.16 -28.22 68.69 Favored Glycine 0 C--O 1.242 0.597 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.434 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.4 t -65.78 -5.24 8.26 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.774 -0.213 . . . . 0.0 110.562 -177.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 31.5 mt -54.73 -38.59 67.31 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 120.812 0.339 . . . . 0.0 110.725 173.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.8 tt -82.19 4.99 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.533 0.683 . . . . 0.0 110.822 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.2 m -129.47 7.03 5.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.842 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.02 -0.54 44.72 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.969 0.414 . . . . 0.0 111.798 -173.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.9 p -82.46 -7.75 10.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.806 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.11 148.22 19.65 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.31 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.22 52.71 2.56 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.037 0.446 . . . . 0.0 110.655 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.55 -32.91 59.04 Favored Glycine 0 CA--C 1.519 0.294 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.738 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -161.3 101.71 0.2 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.734 -177.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.05 -30.53 25.43 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.782 2.321 . . . . 0.0 112.11 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 48.27 72.08 1.38 Allowed Pre-proline 0 CA--C 1.535 0.378 0 O-C-N 123.825 0.703 . . . . 0.0 112.545 177.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.64 97.73 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.153 2.569 . . . . 0.0 112.998 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.12 -43.95 97.71 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.731 174.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.6 139.92 28.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.776 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 174.84 -131.32 1.94 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.549 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.85 153.53 25.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.04 0.448 . . . . 0.0 111.46 -177.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.413 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -93.14 118.62 67.82 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.77 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 15.5 Cg_exo -74.82 -162.0 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 123.632 2.888 . . . . 0.0 112.876 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.33 -178.61 3.53 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.14 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -75.25 -169.43 25.35 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.006 -177.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 178.59 -72.89 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.937 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.66 164.17 23.5 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.695 2.264 . . . . 0.0 112.998 -175.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -135.23 92.38 18.02 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.398 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -45.68 -43.69 18.36 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.55 2.833 . . . . 0.0 113.085 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.7 m 52.72 68.35 0.84 Allowed 'General case' 0 CA--C 1.534 0.331 0 O-C-N 123.699 0.625 . . . . 0.0 111.472 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.7 m -61.8 -27.03 68.47 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.209 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.451 ' HB1' ' HG3' ' A' ' 88' ' ' PRO . . . -140.11 -65.89 0.45 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.555 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 62.29 88.16 0.09 Allowed 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.77 0.669 . . . . 0.0 111.379 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 60.77 70.57 0.94 Allowed Pre-proline 0 N--CA 1.467 0.398 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.468 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.451 ' HG3' ' HB1' ' A' ' 85' ' ' ALA . 47.4 Cg_exo -60.57 -63.18 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.287 2.658 . . . . 0.0 113.073 -178.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -178.7 -46.69 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.031 -177.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 57.39 63.72 1.79 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 122.013 0.911 . . . . 0.0 110.849 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.23 -38.27 4.77 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.465 177.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -59.43 125.52 23.94 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.829 175.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -134.4 126.08 28.82 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.056 178.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.7 m -71.04 120.25 18.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.275 0.56 . . . . 0.0 111.504 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.453 ' OE2' ' HG3' ' A' ' 97' ' ' LYS . 9.8 tp10 -75.14 123.92 26.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.42 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -170.78 38.79 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.443 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HG3' ' OE2' ' A' ' 95' ' ' GLU . 52.3 mtmt -58.47 136.07 57.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.825 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -113.67 145.25 41.6 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -143.97 -47.04 0.27 Allowed 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -174.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 65.18 -162.49 0.26 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.368 170.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.7 t -67.52 137.67 55.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.881 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -86.12 -161.66 0.66 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.704 175.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.48 -176.84 1.33 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 120.727 0.299 . . . . 0.0 110.577 175.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.8 m -138.37 36.67 2.28 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.361 0.6 . . . . 0.0 110.213 -176.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -108.58 1.91 21.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.411 -177.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -79.0 134.2 36.8 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.169 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 51.1 38.1 19.89 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.671 0.607 . . . . 0.0 112.48 175.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 49.4 ttm -75.23 -33.13 61.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.203 0.525 . . . . 0.0 110.997 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 146.32 -163.19 28.45 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.833 -177.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -102.95 137.67 40.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.805 0.336 . . . . 0.0 110.62 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.03 123.22 3.39 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.229 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -86.21 77.42 9.56 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.942 0.401 . . . . 0.0 110.578 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -127.31 -171.76 2.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.013 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 C--O 1.249 1.044 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.925 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 110.576 -0.157 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.652 ' SD ' ' HB3' ' B' ' 262' ' ' LEU . 25.8 ptt? -129.77 12.32 5.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.281 0.562 . . . . 0.0 110.357 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 202' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -55.84 -21.16 18.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.97 -1.014 . . . . 0.0 113.251 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 203' ' ' TYR . . . . . 0.592 ' HB2' HG21 ' B' ' 242' ' ' VAL . 41.9 m-85 -115.04 -31.98 5.88 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.731 -173.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.619 ' O ' HD13 ' B' ' 208' ' ' LEU . 11.7 p -66.41 -47.13 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.044 -177.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 205' ' ' ALA . . . . . 0.491 ' HA ' ' HB2' ' B' ' 208' ' ' LEU . . . -74.6 -14.71 60.81 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.538 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . 0.411 ' HB3' HG23 ' B' ' 223' ' ' ILE . 37.6 m -74.83 -38.13 62.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.026 172.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 207' ' ' TYR . . . . . 0.412 ' HE1' HD11 ' B' ' 251' ' ' ILE . 14.5 t80 -65.16 -42.85 93.34 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 173.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.619 HD13 ' O ' ' B' ' 204' ' ' VAL . 8.1 mp -54.52 -52.12 63.02 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.784 173.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 209' ' ' LEU . . . . . 0.56 ' CD2' ' HB2' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -56.16 -48.08 77.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.443 -178.443 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -62.55 -35.3 79.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.696 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 211' ' ' ALA . . . . . 0.731 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -67.13 -57.76 6.17 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.862 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 212' ' ' LEU . . . . . 0.485 HD12 ' O ' ' B' ' 208' ' ' LEU . 0.0 OUTLIER -74.53 -14.27 60.78 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.262 -178.81 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . 0.552 ' HA2' HG22 ' A' ' 37' ' ' VAL . . . -68.88 -14.91 68.53 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.661 175.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 129.85 1.41 5.45 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.955 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 215' ' ' ASN . . . . . 0.731 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 84.2 m-20 -113.08 95.32 5.33 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 3.9 m -57.14 -31.06 64.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.356 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 10.2 t -126.67 77.96 73.34 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.745 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . 0.479 ' HB3' HD11 ' B' ' 223' ' ' ILE . 52.7 Cg_exo -56.3 140.82 88.79 Favored 'Trans proline' 0 N--CA 1.476 0.452 0 C-N-CA 123.759 2.973 . . . . 0.0 113.579 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 33.6 p -107.1 146.27 31.44 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -54.49 -31.83 56.7 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.066 0.46 . . . . 0.0 111.594 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -67.99 -39.23 83.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.504 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -72.79 -39.01 67.07 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.479 HD11 ' HB3' ' B' ' 218' ' ' PRO . 1.8 mp -59.72 -46.17 93.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 174.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -58.04 -38.89 77.11 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.483 176.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . 0.501 ' NZ ' HD12 ' B' ' 226' ' ' ILE . 14.7 ttpp -57.85 -49.5 76.46 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.626 0.25 . . . . 0.0 110.673 174.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 0.501 HD12 ' NZ ' ' B' ' 225' ' ' LYS . 0.6 OUTLIER -58.54 -37.28 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.938 -177.477 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 94.9 mt -75.72 -38.79 58.23 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.869 0.366 . . . . 0.0 111.238 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -69.66 -28.66 66.07 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.967 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 46.8 m -62.51 -31.65 72.45 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.654 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 230' ' ' VAL . . . . . 0.469 HG13 ' HD2' ' A' ' 27' ' ' LYS . 99.1 t -92.27 -34.75 6.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.745 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 109.91 29.58 3.76 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.007 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 11.6 mt -98.41 126.56 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -67.42 136.67 55.08 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.857 0.36 . . . . 0.0 110.198 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -138.02 114.45 10.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.177 -174.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -66.2 121.28 14.86 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -70.27 -27.22 64.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.272 -173.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -74.84 -46.96 32.99 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -64.79 -37.57 88.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.761 0.315 . . . . 0.0 110.163 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 239' ' ' LEU . . . . . . . . . . . . . 8.3 tt -58.5 -62.02 2.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.68 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -65.72 -28.71 69.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.907 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -66.09 -46.0 79.24 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 120.656 0.265 . . . . 0.0 111.488 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 242' ' ' VAL . . . . . 0.592 HG21 ' HB2' ' B' ' 203' ' ' TYR . 27.1 m -75.12 -25.73 18.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -178.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 13.5 mt -70.49 -41.86 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.248 173.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 46.7 p -70.62 -22.88 62.48 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.304 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -69.26 -46.14 67.98 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.71 171.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . . . . . . . . . 2.2 pp -87.7 -17.11 32.49 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.148 -174.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -55.23 125.79 22.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.026 0.441 . . . . 0.0 111.843 -171.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 174.98 -168.79 41.53 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.688 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.98 12.37 28.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.122 0.487 . . . . 0.0 110.304 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -88.46 25.55 1.66 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.721 0.772 . . . . 0.0 110.061 -175.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.501 ' O ' HG12 ' B' ' 254' ' ' VAL . 34.2 mm -58.66 -62.75 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.768 -177.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -66.0 -29.64 70.05 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.437 -173.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.07 -51.68 66.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.166 175.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 254' ' ' VAL . . . . . 0.501 HG12 ' O ' ' B' ' 251' ' ' ILE . 8.9 p -71.09 -22.81 22.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.981 -176.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 255' ' ' ILE . . . . . 0.401 HG12 ' O ' ' B' ' 251' ' ' ILE . 44.2 mm -75.21 -50.59 23.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.274 0.559 . . . . 0.0 110.528 173.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -71.48 -25.96 62.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.342 -173.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -140.44 46.49 1.81 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.346 0.593 . . . . 0.0 110.802 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' B' ' 254' ' ' VAL . . . -130.94 53.39 0.81 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.666 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 20.0 mt -111.26 -20.39 6.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.172 0.51 . . . . 0.0 110.625 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -121.99 21.34 7.89 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.272 -0.966 . . . . 0.0 113.309 -176.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -130.19 44.46 2.96 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.032 0.444 . . . . 0.0 110.044 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 262' ' ' LEU . . . . . 0.652 ' HB3' ' SD ' ' B' ' 201' ' ' MET . 3.6 mm? -104.7 -97.34 0.32 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.347 -174.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . 0.425 ' HB2' ' SD ' ' B' ' 201' ' ' MET . . . -79.22 -38.61 35.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.858 0.361 . . . . 0.0 111.451 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 23.1 t -158.36 154.23 26.68 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.015 -177.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 265' ' ' VAL . . . . . 0.406 ' HA ' ' HD3' ' B' ' 266' ' ' PRO . 23.0 t -116.54 123.74 30.22 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.431 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' B' ' 265' ' ' VAL . 66.2 Cg_exo -53.22 -25.05 28.55 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.816 3.01 . . . . 0.0 113.994 -176.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . 54.07 80.65 0.11 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.142 0.496 . . . . 0.0 111.778 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 128.2 -40.66 1.69 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.09 -177.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -88.29 -61.67 1.46 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.958 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -89.41 94.22 9.81 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 7.0 p -116.82 142.94 28.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.317 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -85.4 135.8 33.72 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.436 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 15.0 p -142.95 153.84 17.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 9.3 m 60.18 49.8 6.97 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.604 0.716 . . . . 0.0 110.608 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -154.02 163.86 39.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.982 -178.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . 0.401 ' HA ' ' HD2' ' B' ' 277' ' ' PRO . . . 61.48 87.42 0.13 Allowed Pre-proline 0 C--O 1.234 0.247 0 O-C-N 123.615 0.572 . . . . 0.0 111.557 178.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 277' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' B' ' 276' ' ' ALA . 36.1 Cg_endo -63.97 143.74 86.01 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.023 2.482 . . . . 0.0 112.959 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -95.02 173.24 31.58 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.39 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 31.1 m -138.82 172.16 13.27 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 55.28 45.33 25.87 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.723 0.639 . . . . 0.0 111.442 175.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -70.72 140.52 86.7 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.916 -178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.14 67.69 7.56 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.792 2.328 . . . . 0.0 112.181 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -128.67 26.75 5.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.681 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -132.29 123.87 27.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.431 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -145.08 40.81 1.1 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.22 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 23.3 t -157.22 158.37 36.06 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -153.24 145.44 17.03 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.313 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.42 110.83 0.86 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.796 2.331 . . . . 0.0 112.686 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -103.32 110.86 23.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.241 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -95.1 169.54 10.03 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.943 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -82.92 -76.48 0.27 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.839 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 177.09 -65.59 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.45 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -55.97 -66.81 0.36 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.282 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . 0.499 ' O ' ' HB2' ' B' ' 295' ' ' LYS . 24.0 tptm 75.09 140.88 0.07 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.879 0.737 . . . . 0.0 110.934 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 295' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' B' ' 294' ' ' LYS . 66.3 mttm 76.0 157.46 0.19 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.593 -174.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 52.12 72.14 0.41 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.332 0.587 . . . . 0.0 111.86 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 297' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' B' ' 298' ' ' LYS . 16.7 pt-20 -67.33 161.58 24.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.574 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 298' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' B' ' 297' ' ' GLU . 23.9 ttmm 72.18 150.91 0.1 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.953 0.783 . . . . 0.0 110.818 -174.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -140.45 129.73 23.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.194 0.521 . . . . 0.0 111.353 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.39 96.01 4.75 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.396 -177.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -56.65 119.45 6.15 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.872 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 21.5 m -130.69 65.79 1.53 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.835 -174.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -116.02 18.49 15.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.314 0.578 . . . . 0.0 110.723 175.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -105.38 116.07 31.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.657 176.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 53.2 m -154.5 83.79 1.11 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.849 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.9 55.35 1.4 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.367 0.603 . . . . 0.0 110.113 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -82.65 170.65 14.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.158 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 55.11 -115.46 0.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.637 0.375 . . . . 0.0 110.7 -172.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 20.6 ttt 44.21 41.35 4.22 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.057 0.943 . . . . 0.0 112.403 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 57.66 38.91 90.04 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.944 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 59.04 72.83 0.51 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 122.813 0.445 . . . . 0.0 111.377 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . -68.08 -68.83 1.53 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.771 176.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 44.87 64.3 1.42 Allowed 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.699 0.761 . . . . 0.0 110.152 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 314' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -125.9 39.36 3.97 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.726 -166.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.289 -0.863 . . . . 0.0 109.954 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 tmt? . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 121.318 0.58 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.0 16.54 1.93 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 170.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.8 m -90.97 68.59 6.22 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 114.097 -1.411 . . . . 0.0 111.494 -171.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.548 HG12 HG21 ' A' ' 37' ' ' VAL . 41.3 t -68.43 -34.35 65.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 122.052 0.93 . . . . 0.0 108.801 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.653 ' HB3' HG23 ' A' ' 39' ' ' VAL . 4.2 m -66.93 -54.62 20.22 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.041 -178.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.502 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 37.4 mt-10 -62.96 -37.11 85.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.573 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.478 HD23 ' CG2' ' B' ' 255' ' ' ILE . 4.3 mp -60.75 -50.66 72.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.384 174.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.64 -49.6 74.53 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.041 0.448 . . . . 0.0 110.799 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.406 ' HB2' HG11 ' A' ' 39' ' ' VAL . 48.9 t -65.56 -31.55 72.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.633 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.502 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 1.2 tp -74.73 -41.28 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.826 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -64.36 -37.84 88.94 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.3 m -67.59 -46.66 71.99 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.472 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' A' ' 17' ' ' HIS . . . -48.95 -52.58 23.96 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.467 176.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.658 ' O ' ' HE1' ' B' ' 201' ' ' MET . 4.1 pp -77.93 -30.23 50.39 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.797 -176.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.448 ' N ' HD12 ' A' ' 14' ' ' LEU . 9.8 mt -56.35 -40.6 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.333 0.587 . . . . 0.0 110.185 173.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.8 mt -77.25 -31.62 55.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.29 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.505 ' HB2' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -82.85 50.85 1.78 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -175.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -146.32 -45.72 0.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.875 0.369 . . . . 0.0 110.775 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -86.87 -160.89 0.62 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.736 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -88.52 -17.09 31.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.325 0.583 . . . . 0.0 109.589 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.4 t -59.2 130.48 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.116 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.2 p -83.98 147.36 27.49 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.691 -176.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.4 m -78.05 116.05 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.601 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.421 ' OG1' ' HD3' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -150.7 162.49 40.59 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -176.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 53.0 mp0 -48.58 -54.95 12.54 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 123.369 0.418 . . . . 0.0 111.334 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -50.92 -34.81 30.1 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 124.0 0.812 . . . . 0.0 110.778 -178.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.465 ' HG3' HG13 ' B' ' 230' ' ' VAL . 14.2 mptt -78.39 -50.43 11.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.182 -175.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.45 HG23 HD13 ' A' ' 32' ' ' ILE . 7.8 mt -64.33 -40.69 89.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.131 0.491 . . . . 0.0 110.125 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.57 -46.19 89.63 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.351 175.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.19 -46.99 87.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.148 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.8 mt -65.26 -43.55 90.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.521 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.45 HD13 HG23 ' A' ' 28' ' ' ILE . 1.5 mp -59.09 -47.59 89.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 120.868 0.366 . . . . 0.0 110.786 176.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -71.56 -22.09 61.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.012 0.434 . . . . 0.0 110.915 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.36 -39.13 62.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.835 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.59 -47.1 10.17 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 138.96 -61.92 0.57 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 119.978 -1.106 . . . . 0.0 114.025 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.742 HG12 ' HA2' ' B' ' 213' ' ' GLY . 8.3 p -61.03 129.77 24.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.216 0.531 . . . . 0.0 111.912 -175.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -105.72 104.98 14.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.375 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.653 HG23 ' HB3' ' A' ' 5' ' ' SER . 3.1 p -76.12 140.89 16.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.322 172.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 11.4 pt-20 -52.94 125.93 41.25 Favored Pre-proline 0 CA--C 1.531 0.242 0 O-C-N 123.212 0.32 . . . . 0.0 110.593 -178.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 40' ' ' GLU . 75.7 Cg_exo -50.76 -13.19 0.75 Allowed 'Trans proline' 0 N--CA 1.485 0.98 0 C-N-CA 124.367 3.378 . . . . 0.0 115.229 -167.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -68.76 -35.07 76.62 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.529 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 76.6 m95 -69.59 -54.22 11.17 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.007 177.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.529 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 83.3 Cg_exo -50.85 -48.54 20.33 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 122.223 1.949 . . . . 0.0 112.868 175.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.47 -47.65 87.82 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.216 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.2 tp -58.68 -49.5 77.33 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.46 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 2.6 m-85 -54.04 -54.94 32.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.867 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.2 -39.41 92.66 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -175.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -88.49 -12.21 43.6 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.88 -18.23 14.11 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.545 ' HA ' HG23 ' A' ' 54' ' ' VAL . 26.6 mt -83.89 -131.99 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 119.331 -0.948 . . . . 0.0 109.98 177.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 59.3 7.42 0.91 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.17 0.51 . . . . 0.0 111.979 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -143.56 -42.15 0.29 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.545 HG23 ' HA ' ' A' ' 51' ' ' LEU . 7.5 t -54.88 115.84 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.609 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.245 177.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -53.63 152.6 5.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.697 171.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.728 ' O ' HD12 ' A' ' 59' ' ' LEU . 2.0 tp -46.5 -71.87 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -174.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.488 ' H ' HG23 ' A' ' 56' ' ' ILE . . . -63.17 -23.8 66.55 Favored Glycine 0 C--O 1.24 0.516 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.781 -172.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.3 t -59.54 -21.24 59.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.236 -0.482 . . . . 0.0 110.579 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -59.18 -19.24 43.56 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.567 -177.454 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.577 ' N ' HD13 ' A' ' 59' ' ' LEU . 48.1 mt -64.96 -27.59 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 121.173 -0.211 . . . . 0.0 111.32 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 75.2 m -139.26 23.4 2.55 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -175.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -132.82 51.32 2.17 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.461 HG11 ' CZ3' ' A' ' 43' ' ' TRP . 85.4 t -72.03 -42.56 68.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.063 0.458 . . . . 0.0 110.255 173.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -92.65 21.45 38.74 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.506 -177.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 58.61 -156.02 0.34 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 122.495 0.318 . . . . 0.0 111.14 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 137.36 -105.78 0.52 Allowed Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.135 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 146.6 115.01 0.88 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.486 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -72.48 102.8 1.44 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.794 2.329 . . . . 0.0 111.876 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 57.27 74.14 0.7 Allowed Pre-proline 0 N--CA 1.463 0.217 0 O-C-N 123.416 0.448 . . . . 0.0 111.088 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -60.23 -21.92 68.38 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.042 2.495 . . . . 0.0 113.598 -175.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.29 -30.27 68.32 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.693 0.282 . . . . 0.0 111.553 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 66.09 4.05 2.92 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.354 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.41 153.75 21.38 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.621 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.17 115.37 16.93 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.458 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -146.49 145.05 22.18 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.229 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 24.3 Cg_exo -68.05 -10.74 29.85 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.241 2.627 . . . . 0.0 113.205 -178.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 70.4 173.05 0.31 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.011 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.93 -169.94 31.46 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.11 178.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.28 -74.41 0.41 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.9 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.45 137.34 77.41 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.78 2.32 . . . . 0.0 112.828 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -107.66 152.27 41.41 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.401 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -38.86 -53.12 2.0 Allowed 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 123.748 2.965 . . . . 0.0 113.294 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.0 m 58.91 38.35 24.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.181 0.515 . . . . 0.0 111.177 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 p -102.16 -4.18 26.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.805 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 63.51 -171.74 0.17 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.434 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -165.92 67.33 0.12 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.48 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -117.59 99.18 52.32 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.94 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -57.35 142.2 94.92 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.15 2.567 . . . . 0.0 112.605 176.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.31 50.01 1.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.96 0.41 . . . . 0.0 111.124 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -83.94 120.73 26.45 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.606 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -62.01 -58.74 6.72 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.498 175.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -179.31 -60.03 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.378 -176.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? 70.92 141.76 0.05 Allowed 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.983 0.802 . . . . 0.0 110.368 -174.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.7 t -74.81 99.53 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.995 -175.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -83.27 121.08 26.64 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.946 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -159.39 117.86 2.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.162 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp 63.77 145.99 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.475 0.71 . . . . 0.0 111.929 -176.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.5 pttt -161.8 -47.83 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.524 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -167.05 117.96 0.9 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -148.65 135.07 19.53 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.608 -173.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 68.7 m -149.71 80.98 1.39 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.227 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -76.77 133.69 39.36 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -54.74 127.85 30.15 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.039 -175.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.1 p -133.9 177.92 7.35 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.727 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -96.57 -166.09 1.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -79.92 152.42 29.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -92.26 114.51 27.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.107 0.48 . . . . 0.0 111.037 -176.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 87.5 mtp -129.96 136.26 49.25 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.974 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -81.48 159.05 40.27 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.583 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -83.85 179.43 7.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.692 0.282 . . . . 0.0 110.796 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.08 -2.36 61.46 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.638 -176.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 53.0 tp -72.28 -29.8 64.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.338 0.59 . . . . 0.0 110.024 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -105.32 153.08 22.11 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.012 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.3 t70 . . . . . 0 C--O 1.248 0.978 0 O-C-N 124.52 1.137 . . . . 0.0 110.066 -176.717 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 120.701 0.286 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.658 ' HE1' ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -124.4 156.03 37.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.625 -176.805 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 202' ' ' ARG . . . . . 0.436 ' HG3' ' H ' ' B' ' 203' ' ' TYR . 13.9 ptp180 -177.09 -64.48 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.774 -0.193 . . . . 0.0 110.917 177.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 203' ' ' TYR . . . . . 0.816 ' CE2' ' HA ' ' B' ' 239' ' ' LEU . 4.3 m-85 -57.34 -33.3 67.6 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.573 0.349 . . . . 0.0 111.654 -177.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.751 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 3.8 m -52.84 -54.45 16.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.295 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 205' ' ' ALA . . . . . 0.462 ' CB ' HD11 ' A' ' 14' ' ' LEU . . . -80.14 -15.52 56.91 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.126 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . 0.492 ' CB ' HG23 ' B' ' 223' ' ' ILE . 14.9 m -68.14 -42.17 80.51 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 170.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 207' ' ' TYR . . . . . 0.543 ' CD1' HD11 ' B' ' 251' ' ' ILE . 24.1 t80 -66.27 -40.25 90.0 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.268 174.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.751 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 54.3 mt -63.12 -36.01 82.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.544 176.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 209' ' ' LEU . . . . . . . . . . . . . 1.2 mp -62.37 -44.8 95.63 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.855 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -56.58 -39.15 73.0 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.501 177.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 211' ' ' ALA . . . . . . . . . . . . . . . -87.12 -63.35 1.32 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 212' ' ' LEU . . . . . 0.507 HD11 ' O ' ' A' ' 4' ' ' VAL . 3.4 tm? -54.11 -39.82 66.76 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . 0.742 ' HA2' HG12 ' A' ' 37' ' ' VAL . . . -52.39 -20.42 7.21 Favored Glycine 0 C--N 1.33 0.244 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.165 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 99.4 26.68 8.55 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.147 174.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 215' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -117.48 -29.47 5.8 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.959 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 37.9 m 60.66 35.08 19.93 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.027 172.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 217' ' ' SER . . . . . 0.404 ' C ' ' H ' ' B' ' 219' ' ' SER . 32.2 p -120.03 104.48 43.89 Favored Pre-proline 0 C--N 1.314 -0.968 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.275 -172.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . 0.405 ' HB3' ' OH ' ' B' ' 207' ' ' TYR . 26.2 Cg_exo -70.9 19.22 0.23 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.929 2.42 . . . . 0.0 113.256 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . 0.418 ' HB2' ' CG ' ' B' ' 222' ' ' ASP . 1.1 m -63.52 119.27 9.47 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.436 0.636 . . . . 0.0 110.46 -176.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . 0.521 ' HB1' HD21 ' B' ' 239' ' ' LEU . . . -56.2 -29.35 60.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.86 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -73.46 -30.11 62.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.495 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 222' ' ' ASP . . . . . 0.418 ' CG ' ' HB2' ' B' ' 219' ' ' SER . 93.5 m-20 -70.94 -43.93 67.17 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.492 HG23 ' CB ' ' B' ' 206' ' ' SER . 1.8 mp -58.69 -52.42 60.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-O 121.056 0.455 . . . . 0.0 110.013 174.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -56.5 -40.83 75.62 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.878 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -65.23 -37.48 87.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.284 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 1.1 mp -62.58 -42.83 97.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.539 175.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 66.0 mt -75.83 -35.71 59.89 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.447 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.37 -20.7 62.94 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.723 0.297 . . . . 0.0 110.72 177.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 16.2 t -58.26 -26.87 63.45 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.313 0.577 . . . . 0.0 109.559 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 230' ' ' VAL . . . . . 0.465 HG13 ' HG3' ' A' ' 27' ' ' LYS . 98.8 t -110.11 -39.51 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.025 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 108.35 27.03 5.19 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.545 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 5.3 mt -83.28 147.4 5.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -57.81 114.48 2.32 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.124 0.488 . . . . 0.0 112.075 -174.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . 0.494 ' HB1' ' OH ' ' B' ' 203' ' ' TYR . . . -138.66 91.01 2.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.248 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -73.24 155.38 39.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.36 -177.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 236' ' ' ASP . . . . . 0.541 ' O ' ' HB3' ' B' ' 239' ' ' LEU . 24.0 t70 -69.01 -48.34 63.26 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.635 0.255 . . . . 0.0 111.425 -175.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 237' ' ' ASP . . . . . 0.709 ' O ' ' HB2' ' B' ' 241' ' ' LYS . 8.0 t70 -58.56 -54.39 47.6 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.392 0.615 . . . . 0.0 109.627 176.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.605 ' O ' HG22 ' B' ' 242' ' ' VAL . 25.0 ttm180 -58.6 -31.92 68.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.149 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 239' ' ' LEU . . . . . 0.816 ' HA ' ' CE2' ' B' ' 203' ' ' TYR . 3.0 tp -50.6 -76.52 0.02 OUTLIER 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.353 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -73.78 -20.14 60.56 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.528 -174.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 241' ' ' LYS . . . . . 0.709 ' HB2' ' O ' ' B' ' 237' ' ' ASP . 15.9 tttt -61.71 -58.44 8.01 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-O 121.303 0.573 . . . . 0.0 110.775 176.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 242' ' ' VAL . . . . . 0.605 HG22 ' O ' ' B' ' 238' ' ' ARG . 34.1 m -73.27 -32.37 37.64 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -174.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . 0.677 ' HA ' ' CD1' ' B' ' 246' ' ' LEU . 6.9 mt -60.83 -41.61 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.609 174.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 19.5 t -63.82 -32.17 73.59 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 177.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -76.32 -48.42 20.12 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . 0.677 ' CD1' ' HA ' ' B' ' 243' ' ' ILE . 0.0 OUTLIER -88.33 -10.01 50.86 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.433 0.56 . . . . 0.0 112.338 -173.115 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 247' ' ' ASN . . . . . 0.517 ' HB2' ' O ' ' B' ' 243' ' ' ILE . 63.5 t30 -44.69 -73.22 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 O-C-N 123.688 0.617 . . . . 0.0 111.725 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 58.55 -163.53 9.52 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.51 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -135.62 20.94 3.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.298 0.57 . . . . 0.0 109.734 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -115.81 38.78 3.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.411 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.543 HD11 ' CD1' ' B' ' 207' ' ' TYR . 1.1 mm -62.79 -51.36 72.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.322 -177.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -60.36 -30.36 69.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.115 0.483 . . . . 0.0 109.771 -177.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -76.09 -51.91 11.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.942 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 254' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' B' ' 251' ' ' ILE . 9.5 p -57.88 -30.7 38.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.758 0.313 . . . . 0.0 110.888 -177.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 255' ' ' ILE . . . . . 0.478 ' CG2' HD23 ' A' ' 7' ' ' LEU . 64.9 mt -85.05 -47.32 17.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.481 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -68.17 -15.32 63.53 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -176.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -57.28 -70.83 0.11 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.917 175.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 176.84 -99.72 0.13 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.243 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 259' ' ' ILE . . . . . 0.463 HD13 HG23 ' A' ' 60' ' ' ILE . 5.4 mp -93.51 -33.47 5.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 176.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 102.05 174.58 27.77 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.946 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 18.8 pttm -81.56 39.42 0.54 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.433 0.635 . . . . 0.0 110.186 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 262' ' ' LEU . . . . . 0.483 HD22 HG21 ' B' ' 204' ' ' VAL . 6.4 mt -99.15 -49.11 4.6 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.387 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -126.58 54.76 1.57 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.603 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 22.7 t -107.68 154.71 21.08 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.078 0.466 . . . . 0.0 110.695 -176.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 17.9 t -114.67 119.78 38.9 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.844 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.54 -24.22 30.94 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.453 2.102 . . . . 0.0 112.348 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . 59.69 -155.95 0.35 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.463 177.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . -79.57 68.5 3.17 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.436 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -70.27 -26.92 73.53 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 121.265 -0.493 . . . . 0.0 112.29 178.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -77.75 88.41 4.0 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.013 0.435 . . . . 0.0 110.488 178.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 44.2 t -106.01 145.98 13.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.902 -178.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -143.44 160.57 40.34 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.915 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.52 130.33 67.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.907 0.384 . . . . 0.0 110.223 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 7.0 p -120.94 95.75 4.83 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.153 0.501 . . . . 0.0 110.778 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -93.58 135.68 34.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.629 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' B' ' 277' ' ' PRO . . . -97.04 123.84 51.82 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.371 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 277' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' B' ' 276' ' ' ALA . 3.0 Cg_exo -74.28 109.36 2.88 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.708 2.272 . . . . 0.0 112.041 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -125.34 85.59 0.35 Allowed Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.616 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 19.4 m -152.28 -176.85 5.86 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -177.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 62.58 64.33 0.93 Allowed 'General case' 0 C--N 1.331 -0.211 0 O-C-N 124.024 0.828 . . . . 0.0 111.847 174.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -112.65 99.44 47.64 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.593 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.46 116.69 2.01 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.087 2.524 . . . . 0.0 112.455 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -116.31 27.81 8.99 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.037 0.446 . . . . 0.0 110.785 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -148.04 162.39 39.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.661 -177.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -163.91 141.79 7.36 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 31.3 p -93.48 98.78 11.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.696 0.284 . . . . 0.0 111.393 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -85.88 133.25 41.79 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.288 175.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -81.06 63.78 8.8 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.611 2.207 . . . . 0.0 112.419 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -99.27 77.81 2.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.849 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -93.09 -5.95 49.18 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.186 0.517 . . . . 0.0 111.08 178.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . 64.3 64.38 0.72 Allowed 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.802 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -72.46 -3.42 24.2 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.514 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -59.57 107.16 0.55 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.513 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -124.45 123.06 39.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.223 0.535 . . . . 0.0 111.009 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -126.69 136.43 52.45 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.371 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 61.41 57.35 2.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.545 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -80.27 -15.18 57.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.363 0.601 . . . . 0.0 109.592 174.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 298' ' ' LYS . . . . . 0.523 ' O ' ' HD2' ' B' ' 298' ' ' LYS . 0.0 OUTLIER -76.75 143.08 40.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.138 -178.456 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 299' ' ' LYS . . . . . 0.406 ' HB3' ' HE2' ' B' ' 299' ' ' LYS . 16.3 ptpt -155.4 28.96 0.39 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.808 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -127.26 -66.82 0.87 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 53.59 47.28 24.26 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.898 176.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 9.2 p -108.09 128.91 55.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.931 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -118.6 -78.82 0.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.148 0.499 . . . . 0.0 110.418 -177.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -127.25 151.61 48.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.199 -176.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 20.2 m -84.21 140.53 31.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.796 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -140.11 83.26 1.91 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.606 0.717 . . . . 0.0 109.539 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -129.15 120.74 26.36 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.833 -175.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.7 120.33 18.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.963 0.411 . . . . 0.0 110.782 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 24.5 ptp -80.5 -9.2 59.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.699 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . -63.58 -30.26 77.08 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.42 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -105.57 11.58 32.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.02 0.438 . . . . 0.0 110.308 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . -148.53 39.64 0.96 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.839 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 313' ' ' LEU . . . . . 0.737 ' H ' HD23 ' B' ' 313' ' ' LEU . 2.3 pt? -80.22 43.73 0.64 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 122.296 1.046 . . . . 0.0 110.476 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 314' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -126.64 -40.6 1.91 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.172 -1.376 . . . . 0.0 110.273 -176.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 36.3 t70 . . . . . 0 C--O 1.247 0.937 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.281 -179.954 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 mmt . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 120.691 0.281 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.1 154.8 17.68 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.464 ' O ' HD13 ' A' ' 7' ' ' LEU . 23.1 p 44.03 60.13 2.88 Favored 'General case' 0 C--O 1.239 0.527 0 O-C-N 123.897 0.748 . . . . 0.0 112.162 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.433 ' HA ' ' HB2' ' A' ' 7' ' ' LEU . 3.5 m -67.26 -16.74 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.557 -177.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.476 ' HB2' HG23 ' A' ' 39' ' ' VAL . 3.3 p -64.77 -62.02 1.82 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.558 176.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -58.2 -45.42 87.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.12 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 3' ' ' SER . 7.0 mp -51.47 -58.01 7.45 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.621 176.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.42 -47.12 76.45 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.065 -177.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 49.1 t -65.98 -34.67 78.64 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.948 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.401 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 0.9 OUTLIER -74.03 -33.65 36.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.617 0.246 . . . . 0.0 111.234 -179.003 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.704 ' HB2' HD21 ' B' ' 209' ' ' LEU . 21.4 m-85 -79.06 -23.62 44.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.187 0.518 . . . . 0.0 110.025 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.517 ' HA ' HD23 ' A' ' 31' ' ' LEU . 19.3 t -68.89 -47.24 66.35 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 171.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.5 -42.09 63.99 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.712 172.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.429 ' O ' ' HE2' ' B' ' 201' ' ' MET . 20.0 mt -58.54 -54.49 46.43 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 120.922 0.391 . . . . 0.0 111.108 176.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.538 HD12 HD21 ' A' ' 31' ' ' LEU . 10.3 mt -59.54 -40.76 82.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.166 -177.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.8 mt -77.83 -22.56 49.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.413 ' CE1' ' HB ' ' A' ' 56' ' ' ILE . 25.1 t-80 -61.87 -36.35 80.97 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.65 ' HB2' ' HG3' ' B' ' 201' ' ' MET . 31.8 t70 -73.28 -69.7 0.41 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -168.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.436 ' C ' ' H ' ' A' ' 21' ' ' VAL . 23.1 t70 -64.83 148.1 51.95 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.088 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -77.23 46.24 0.49 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.903 0.859 . . . . 0.0 110.451 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.436 ' H ' ' C ' ' A' ' 19' ' ' ASP . 9.9 p -81.3 157.37 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.303 175.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.6 t -59.02 -20.16 50.51 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -168.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.6 t 55.14 78.45 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 121.403 0.62 . . . . 0.0 109.732 -175.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.1 p -136.05 168.17 19.86 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -174.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -51.55 -48.06 63.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.568 -1.197 . . . . 0.0 110.707 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -52.45 -39.29 60.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.197 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 2.8 mptp? -80.88 -41.35 23.25 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.431 -173.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.414 HG23 HD13 ' A' ' 32' ' ' ILE . 10.8 mt -64.03 -45.39 96.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.054 174.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -60.17 -40.9 91.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.696 178.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.29 -52.55 65.17 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 111.394 177.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.594 ' HB2' HG22 ' B' ' 230' ' ' VAL . 45.4 tp -66.54 -40.98 89.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.265 0.555 . . . . 0.0 111.182 -176.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.414 HD13 HG23 ' A' ' 28' ' ' ILE . 1.5 mp -62.73 -37.21 78.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.399 177.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -74.4 -29.11 61.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 0.0 110.137 177.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.51 -45.86 92.42 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.582 175.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.423 ' HA ' HD11 ' B' ' 226' ' ' ILE . . . -80.74 -33.06 35.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.797 0.332 . . . . 0.0 111.547 177.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.52 23.43 28.75 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.812 173.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.5 t -94.89 130.15 44.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 117.327 0.563 . . . . 0.0 110.708 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -79.72 90.8 5.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.98 -177.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.476 HG23 ' HB2' ' A' ' 5' ' ' SER . 10.7 p -98.52 130.09 47.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 169.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -63.28 136.49 96.72 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.04 -177.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.475 ' HA ' ' HG2' ' A' ' 44' ' ' PRO . 82.9 Cg_exo -48.75 -14.08 0.34 Allowed 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 124.716 3.611 . . . . 0.0 115.021 -171.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.19 -36.87 77.76 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -177.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -67.44 -58.96 7.77 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 121.011 -0.275 . . . . 0.0 111.359 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.475 ' HG2' ' HA ' ' A' ' 41' ' ' PRO . 10.9 Cg_endo -54.54 -46.1 35.95 Favored 'Trans proline' 0 C--N 1.361 1.237 0 C-N-CA 122.286 1.991 . . . . 0.0 112.754 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.73 -45.99 95.11 Favored Glycine 0 C--O 1.242 0.639 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.033 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.4 tp -51.99 -59.37 4.43 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 176.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -58.99 -40.39 84.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.711 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.0 -44.61 91.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.217 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -95.62 -11.7 26.81 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.772 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.548 ' O ' HG21 ' A' ' 54' ' ' VAL . . . -104.15 -12.28 16.81 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -175.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.586 ' HA ' HG23 ' A' ' 54' ' ' VAL . 42.9 mt -101.79 -132.34 0.27 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.429 173.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 65.96 -12.61 0.17 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -144.69 12.74 1.49 Allowed 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.586 HG23 ' HA ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -128.23 120.81 54.24 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.944 -170.082 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -55.07 155.52 4.57 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.034 -1.439 . . . . 0.0 112.448 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.545 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 3.7 tp -44.53 -41.91 2.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -173.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -54.29 -23.81 27.31 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 121.611 -0.328 . . . . 0.0 113.494 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.6 t -53.84 -26.71 25.69 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 122.542 0.337 . . . . 0.0 111.264 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 34.3 mt -56.9 -36.06 69.71 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.664 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.472 HG12 HD13 ' B' ' 259' ' ' ILE . 1.1 mp -103.27 18.38 4.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.445 0.64 . . . . 0.0 109.539 -175.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 69.7 m -119.91 -6.53 10.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.393 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -100.56 -17.4 17.11 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.145 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.8 m -84.74 -3.9 8.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.879 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 166.39 148.0 5.41 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -129.08 -179.67 5.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.586 0.232 . . . . 0.0 110.624 -177.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.16 -139.5 5.36 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.185 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -98.91 165.95 21.17 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.151 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -76.36 60.3 6.36 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 122.819 2.346 . . . . 0.0 112.439 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.414 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . . . -102.58 -48.52 0.17 Allowed Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -177.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' A' ' 69' ' ' ALA . 6.4 Cg_exo -73.23 92.46 0.83 Allowed 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 121.992 1.795 . . . . 0.0 112.665 -177.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -120.01 134.09 55.35 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.56 177.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -129.69 115.11 16.85 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.871 -177.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.08 149.39 18.72 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.017 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.7 136.33 33.0 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.433 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -126.43 135.07 26.69 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.83 -177.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 38.1 Cg_exo -65.12 129.15 22.22 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.403 2.735 . . . . 0.0 112.974 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 71.01 176.65 0.28 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.003 176.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 176.42 105.86 0.19 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.945 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.94 76.9 1.28 Allowed Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.559 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -90.71 103.0 0.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.975 2.45 . . . . 0.0 112.032 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -122.7 85.38 49.3 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.282 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.23 -66.54 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.635 2.223 . . . . 0.0 111.949 175.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.9 m 54.73 45.31 26.99 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.111 0.481 . . . . 0.0 111.674 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 46.5 p -83.51 107.26 15.87 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.144 178.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -112.53 -36.92 5.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.041 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.28 123.78 23.03 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.066 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.58 158.84 45.94 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.065 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -49.34 -37.98 41.69 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.644 2.229 . . . . 0.0 113.685 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 73.36 -55.16 0.68 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.696 0.798 . . . . 0.0 112.869 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 66.47 85.94 0.14 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.323 0.583 . . . . 0.0 111.459 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -100.99 161.29 13.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.464 177.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.1 mttt 54.38 64.83 1.68 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.794 0.684 . . . . 0.0 111.543 173.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -117.62 128.3 54.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.931 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.9 p -110.41 140.36 29.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.55 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.43 ' HG2' ' H ' ' A' ' 96' ' ' ALA . 6.7 tt0 -105.37 -176.27 3.03 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.43 ' H ' ' HG2' ' A' ' 95' ' ' GLU . . . 79.37 170.01 0.18 Allowed 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.035 0.934 . . . . 0.0 110.838 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 98' ' ' LYS . 25.3 pttm -129.64 142.03 50.81 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.051 -174.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 13.8 mptt 69.26 -85.76 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.994 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 54.67 -148.04 0.49 Allowed 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.495 0.497 . . . . 0.0 110.776 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -66.43 143.49 57.08 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.988 0.423 . . . . 0.0 110.725 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.5 m -154.05 106.67 2.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.137 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -90.57 -71.62 0.61 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.538 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 65.41 107.13 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.958 0.786 . . . . 0.0 111.488 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.6 p -80.48 147.35 30.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.692 -177.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 64.61 91.3 0.08 Allowed 'General case' 0 C--O 1.233 0.211 0 O-C-N 123.923 0.765 . . . . 0.0 112.334 175.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -58.13 -61.16 2.76 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.175 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 54.34 57.08 6.17 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.051 0.453 . . . . 0.0 111.209 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 53.2 ttp -61.22 -30.07 70.22 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.832 175.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.66 -91.65 1.74 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.792 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -79.69 111.1 15.66 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.15 0.5 . . . . 0.0 111.387 -175.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.26 54.57 0.16 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.099 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 67.4 mt -111.9 -2.31 15.21 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.695 0.283 . . . . 0.0 110.888 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -132.91 10.12 4.22 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.722 -173.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.295 -0.859 . . . . 0.0 110.768 -176.097 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.65 ' HG3' ' HB2' ' A' ' 18' ' ' ASP . 73.9 mtm -54.37 -33.0 58.26 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.322 -173.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 202' ' ' ARG . . . . . 0.49 ' HB2' ' O ' ' B' ' 201' ' ' MET . 55.8 ttt180 175.69 154.08 0.17 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 172.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -76.8 10.69 2.07 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.578 0.704 . . . . 0.0 110.944 -175.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.621 ' O ' HD13 ' B' ' 208' ' ' LEU . 94.3 t -59.67 -62.1 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.158 177.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 205' ' ' ALA . . . . . 0.611 ' O ' ' HG ' ' B' ' 209' ' ' LEU . . . -61.7 -21.49 64.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.561 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . 0.407 ' CB ' HG23 ' B' ' 223' ' ' ILE . 5.7 m -66.87 -47.9 70.45 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.003 0.43 . . . . 0.0 109.88 173.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 207' ' ' TYR . . . . . 0.644 ' HD2' HD13 ' B' ' 251' ' ' ILE . 34.0 t80 -59.98 -38.89 83.87 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.667 ' O ' ' HG ' ' B' ' 212' ' ' LEU . 9.3 mp -56.57 -56.49 20.7 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.778 175.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 209' ' ' LEU . . . . . 0.704 HD21 ' HB2' ' A' ' 11' ' ' TYR . 58.0 mt -52.36 -47.5 66.1 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 123.532 0.52 . . . . 0.0 111.066 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -63.98 -32.81 74.49 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.264 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 211' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -68.8 -44.82 72.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.494 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 212' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' B' ' 208' ' ' LEU . 15.1 mt -64.81 -29.01 69.96 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.733 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -62.68 -7.18 14.13 Favored Glycine 0 C--N 1.337 0.603 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.957 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 110.66 20.82 7.1 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.485 174.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 215' ' ' ASN . . . . . 0.656 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 27.5 m-80 -130.32 111.67 12.59 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 6.3 m -65.89 -20.77 66.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.279 0.561 . . . . 0.0 110.684 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 12.0 p -123.71 70.58 47.9 Favored Pre-proline 0 N--CA 1.443 -0.806 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.859 -175.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . 0.484 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 50.4 Cg_exo -60.39 135.68 63.02 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.069 2.512 . . . . 0.0 112.599 173.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . 0.41 ' O ' HD13 ' B' ' 223' ' ' ILE . 49.4 m -102.66 157.22 17.09 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.736 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -51.4 -41.68 60.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.198 0.523 . . . . 0.0 111.224 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -60.79 -42.55 97.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.972 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -67.82 -39.55 83.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.506 -177.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.428 HD11 ' CB ' ' B' ' 218' ' ' PRO . 1.7 mp -68.03 -39.8 82.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 120.867 0.365 . . . . 0.0 110.553 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -62.07 -42.99 99.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.953 0.406 . . . . 0.0 110.35 176.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 16.6 ttpp -64.42 -39.57 94.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.371 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 0.438 HG23 HD11 ' A' ' 31' ' ' LEU . 0.8 OUTLIER -62.65 -41.21 91.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.392 178.295 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . 0.426 ' HA ' HD22 ' B' ' 227' ' ' LEU . 0.5 OUTLIER -71.93 -45.39 61.29 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -176.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.98 -24.35 62.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.831 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 18.5 t -56.68 -42.41 78.99 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.792 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 230' ' ' VAL . . . . . 0.594 HG22 ' HB2' ' A' ' 31' ' ' LEU . 7.0 t -64.28 -29.39 47.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.526 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 105.65 10.35 31.11 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.424 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 24.9 mt -104.57 139.37 25.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -71.74 151.48 43.53 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -173.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -132.07 143.49 50.07 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.757 -176.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -91.27 114.97 27.63 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.089 0.471 . . . . 0.0 110.249 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -58.07 -51.89 67.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.407 -175.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -54.9 -56.76 16.02 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.167 0.508 . . . . 0.0 110.953 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.411 ' O ' HG13 ' B' ' 242' ' ' VAL . 18.7 mmt180 -61.39 -32.77 72.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.862 -175.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 239' ' ' LEU . . . . . . . . . . . . . 6.9 tt -61.83 -60.87 3.0 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.051 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -67.16 -29.81 69.61 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.578 -178.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -60.12 -53.73 54.31 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 120.786 0.327 . . . . 0.0 110.94 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 242' ' ' VAL . . . . . 0.52 ' HA ' ' OE2' ' B' ' 245' ' ' GLU . 22.2 m -72.87 -25.95 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-O 121.327 0.584 . . . . 0.0 110.134 -175.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 34.9 mt -74.54 -31.18 26.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.504 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 23.3 t -64.87 -34.99 79.7 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 173.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 245' ' ' GLU . . . . . 0.52 ' OE2' ' HA ' ' B' ' 242' ' ' VAL . 36.0 mt-10 -67.42 -45.19 76.82 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.237 171.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . 0.551 HD11 ' HA ' ' B' ' 204' ' ' VAL . 52.1 mt -70.61 -95.34 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.083 -177.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 58.66 174.21 0.07 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.068 0.547 . . . . 0.0 110.448 -175.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -76.14 50.54 2.73 Favored Glycine 0 CA--C 1.516 0.127 0 O-C-N 122.091 -0.381 . . . . 0.0 113.383 -173.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -109.29 -64.84 1.2 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.508 0.67 . . . . 0.0 110.21 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -103.7 8.29 37.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.413 -174.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.644 HD13 ' HD2' ' B' ' 207' ' ' TYR . 6.0 tp -57.58 -45.57 86.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.519 -173.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -60.58 -40.08 90.39 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.258 0.551 . . . . 0.0 110.606 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -70.03 -45.25 67.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.838 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 254' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' B' ' 251' ' ' ILE . 8.9 p -66.36 -27.96 42.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.916 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 255' ' ' ILE . . . . . 0.521 HG12 ' HG ' ' B' ' 208' ' ' LEU . 96.4 mt -70.86 -52.1 30.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 121.1 0.476 . . . . 0.0 110.219 173.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -76.23 -5.36 46.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.01 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -52.59 -59.6 4.26 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.43 0.456 . . . . 0.0 111.708 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 178.73 -102.39 0.17 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.152 -1.023 . . . . 0.0 113.412 175.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 259' ' ' ILE . . . . . 0.566 ' O ' HD13 ' B' ' 262' ' ' LEU . 3.4 mp -150.5 -75.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 117.061 0.43 . . . . 0.0 112.011 -175.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -118.62 40.9 2.15 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 119.279 -1.439 . . . . 0.0 114.834 -165.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 17.4 tptt -138.36 39.08 2.27 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 168.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 262' ' ' LEU . . . . . 0.566 HD13 ' O ' ' B' ' 259' ' ' ILE . 6.6 mp -89.77 97.01 10.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.402 -1.272 . . . . 0.0 113.006 -166.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -144.43 25.14 1.53 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.852 -1.522 . . . . 0.0 109.092 175.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 11.1 t 69.68 -155.74 0.15 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.828 -172.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 5.1 p -58.92 111.55 3.83 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 121.449 0.642 . . . . 0.0 111.154 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -85.21 33.4 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.156 2.571 . . . . 0.0 113.67 -174.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . 53.09 66.48 1.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.693 177.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 97.28 -60.25 1.1 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.478 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . 101.3 -26.29 25.12 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.625 175.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -135.19 143.83 46.65 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.112 0.482 . . . . 0.0 111.778 -174.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 22.1 t -125.57 139.37 51.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.459 174.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -118.86 159.93 22.85 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.468 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 8.4 p -118.35 138.41 49.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.2 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 1.5 p -91.5 135.23 34.0 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.791 0.329 . . . . 0.0 110.763 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.55 144.91 49.4 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.251 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . 0.443 ' HA ' ' HD3' ' B' ' 277' ' ' PRO . . . -80.12 123.91 83.12 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.904 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 277' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' B' ' 276' ' ' ALA . 10.7 Cg_exo -71.97 160.87 46.49 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 123.282 2.655 . . . . 0.0 113.556 -178.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -126.2 174.33 17.86 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.512 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 10.8 m -131.23 -171.15 2.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 117.074 0.437 . . . . 0.0 111.37 -175.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 66.28 64.95 0.5 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.033 172.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . 0.531 ' H ' ' HD2' ' B' ' 282' ' ' PRO . . . -124.49 -47.76 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.191 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . 0.531 ' HD2' ' H ' ' B' ' 281' ' ' ALA . 89.3 Cg_endo -88.73 -169.55 0.42 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 121.654 1.57 . . . . 0.0 112.488 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . 66.27 40.47 3.75 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.87 177.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -132.1 177.04 7.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.638 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 110.4 130.47 5.83 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.189 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 8.3 p -134.34 139.73 45.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.559 0.219 . . . . 0.0 110.867 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -143.53 106.52 5.08 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.23 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -88.8 153.73 6.08 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.68 2.253 . . . . 0.0 111.91 175.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -156.78 -68.37 0.1 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.059 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -71.67 132.1 44.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.13 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -138.49 15.91 2.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.037 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 56.02 46.86 20.97 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.581 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -61.55 125.77 24.99 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.721 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -150.3 77.58 1.31 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.926 176.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -93.58 97.0 10.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.995 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -51.38 113.41 0.95 Allowed 'General case' 0 CA--C 1.519 -0.212 0 O-C-N 123.745 0.653 . . . . 0.0 109.409 175.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -104.67 -61.84 1.41 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.828 -173.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -98.28 108.53 21.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.147 0.499 . . . . 0.0 110.704 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -110.57 142.28 42.61 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.53 175.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -81.59 115.87 21.07 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.861 0.363 . . . . 0.0 110.458 -177.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -73.96 121.29 20.78 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.741 -178.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 16.2 p -85.43 78.04 9.8 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 175.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -80.52 -33.03 36.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.891 -175.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -71.06 149.53 46.44 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.3 -176.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 13.8 m -124.94 140.73 52.65 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.464 -177.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -106.34 68.29 0.76 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.427 0.632 . . . . 0.0 110.677 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -83.22 -39.3 21.11 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.166 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -79.32 76.68 5.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.836 0.827 . . . . 0.0 112.35 -173.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 50.1 ttp -81.39 -23.52 37.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.609 172.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 127.4 132.76 3.67 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.229 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -84.02 56.27 3.64 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.205 0.526 . . . . 0.0 110.718 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . 128.21 106.37 1.31 Allowed Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.535 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 6.4 mp -100.71 8.49 43.28 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 172.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 314' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -87.8 -59.55 2.21 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.01 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 9.5 t70 . . . . . 0 C--O 1.252 1.226 0 CA-C-O 117.96 -1.019 . . . . 0.0 108.385 176.127 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptm . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 120.628 0.251 . . . . 0.0 110.452 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.51 -176.13 5.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.79 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.7 m 57.71 41.02 25.91 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.635 0.584 . . . . 0.0 111.021 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.422 HG13 ' HG ' ' B' ' 212' ' ' LEU . 18.9 t -65.81 -28.44 44.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.461 -174.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.561 ' HB2' HG23 ' A' ' 39' ' ' VAL . 1.5 p -61.94 -64.11 1.04 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.36 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -56.66 -49.63 74.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.577 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.492 ' HB3' HD22 ' B' ' 212' ' ' LEU . 7.3 mp -54.96 -44.91 74.8 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.445 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.71 -45.46 89.88 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.749 0.309 . . . . 0.0 110.949 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.87 -39.0 92.84 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.694 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 tp -73.26 -39.24 55.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.353 -176.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.479 ' CB ' HD12 ' B' ' 209' ' ' LEU . 22.1 m-30 -63.99 -42.23 97.26 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.483 ' HA ' ' CD2' ' A' ' 31' ' ' LEU . 42.1 m -60.74 -43.06 98.41 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.126 0.489 . . . . 0.0 110.011 176.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.44 -56.54 18.95 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.124 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.529 HD11 ' CB ' ' B' ' 205' ' ' ALA . 3.8 pp -78.77 -7.33 57.7 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.234 -177.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 35.5 mt -83.33 -26.26 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.178 0.513 . . . . 0.0 110.105 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.533 HD12 HG13 ' A' ' 28' ' ' ILE . 56.1 mt -100.4 -3.04 31.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.957 175.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.491 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 8.1 t-80 -31.19 -70.69 0.06 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.52 20.32 1.34 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.422 0.629 . . . . 0.0 109.435 -173.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.487 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 2.3 m-20 -83.45 54.21 2.76 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.349 -171.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 19' ' ' ASP . 9.2 pt-20 47.41 29.87 1.44 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.233 1.013 . . . . 0.0 111.913 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.525 HG21 HD13 ' B' ' 232' ' ' ILE . 73.2 t -143.71 150.54 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.205 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.4 p -88.69 142.09 27.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.96 0.41 . . . . 0.0 111.846 -176.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.6 m -75.03 39.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.047 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.5 p -74.44 151.06 39.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.002 0.43 . . . . 0.0 111.736 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.58 -31.25 70.39 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.174 -177.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -53.77 -44.32 69.96 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 123.696 0.623 . . . . 0.0 110.407 173.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -81.09 -40.83 23.49 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.096 -174.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.533 HG13 HD12 ' A' ' 16' ' ' LEU . 1.5 mt -60.27 -48.08 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 174.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -57.2 -42.84 82.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.79 175.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.77 -43.21 90.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.281 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.576 HD11 HG23 ' B' ' 226' ' ' ILE . 14.3 tp -72.44 -39.79 67.57 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 120.97 0.414 . . . . 0.0 110.458 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mp -54.87 -43.16 66.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.29 175.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -82.54 -17.53 44.66 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.214 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.479 ' HB1' ' HA ' ' B' ' 226' ' ' ILE . . . -62.24 -47.52 84.04 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 172.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.578 ' HA ' HD11 ' B' ' 226' ' ' ILE . . . -84.27 -31.9 24.7 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.354 178.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.08 38.65 5.07 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.001 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.4 t -104.43 157.01 5.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -121.41 112.53 18.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.931 0.396 . . . . 0.0 110.782 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.561 HG23 ' HB2' ' A' ' 5' ' ' SER . 3.0 p -119.29 135.13 60.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.077 175.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.48 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 8.0 tp10 -42.95 111.41 1.02 Allowed Pre-proline 0 N--CA 1.464 0.256 0 O-C-N 123.965 0.791 . . . . 0.0 110.656 173.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.425 ' HA ' ' HG2' ' A' ' 44' ' ' PRO . 85.0 Cg_exo -49.25 -15.01 0.61 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 124.438 3.425 . . . . 0.0 114.682 -172.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.11 -34.89 75.79 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.525 ' O ' ' HB2' ' A' ' 47' ' ' PHE . 95.7 m95 -68.03 -61.31 4.25 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.375 177.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.48 ' HD2' ' O ' ' A' ' 40' ' ' GLU . 13.6 Cg_endo -57.56 -38.21 94.52 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 121.913 1.742 . . . . 0.0 112.117 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.38 -59.25 9.69 Favored Glycine 0 C--O 1.24 0.481 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.786 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 27.9 tp -55.51 -47.91 75.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.722 0.296 . . . . 0.0 110.246 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.727 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -56.32 -62.19 1.88 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.462 -177.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.97 -30.18 71.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.609 -173.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -83.85 -22.85 31.57 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.559 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.17 -4.62 17.48 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -173.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.727 ' HG ' ' O ' ' A' ' 47' ' ' PHE . 73.4 mt -79.13 -131.93 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.811 176.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 68.21 -10.64 0.42 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.645 0.778 . . . . 0.0 113.086 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -141.18 12.03 2.18 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.607 ' CG2' ' HA ' ' A' ' 51' ' ' LEU . 31.9 t -103.08 107.46 22.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.383 -173.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -54.09 150.11 8.57 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.875 172.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.832 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 1.9 tp -52.56 -60.96 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -170.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.531 ' O ' HG22 ' A' ' 60' ' ' ILE . . . -52.96 -30.47 37.45 Favored Glycine 0 C--O 1.239 0.449 0 C-N-CA 121.043 -0.598 . . . . 0.0 113.319 -173.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.3 t -50.1 -33.43 18.64 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.911 0.484 . . . . 0.0 111.965 -176.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.832 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 0.6 OUTLIER -66.45 -14.13 61.78 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -170.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.531 HG22 ' O ' ' A' ' 57' ' ' GLY . 11.3 tt -82.48 -2.62 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.763 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.6 p -150.27 47.5 0.9 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.429 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.601 ' OD1' ' HA ' ' A' ' 59' ' ' LEU . 7.9 m120 -93.41 -1.04 56.26 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.7 t -84.78 -37.56 12.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -154.87 149.04 20.21 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.503 -177.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -78.9 -50.8 10.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.681 0.277 . . . . 0.0 111.215 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 151.23 -97.67 0.18 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.4 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.54 94.73 1.52 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -173.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.82 -20.73 6.37 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.355 2.037 . . . . 0.0 113.453 -174.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 55.28 79.18 0.35 Allowed Pre-proline 0 N--CA 1.467 0.419 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -72.35 158.86 50.73 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.954 2.436 . . . . 0.0 112.346 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -170.47 -33.44 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.765 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.06 122.42 25.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.298 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.29 68.29 0.44 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.852 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -127.29 140.16 52.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.679 0.276 . . . . 0.0 110.469 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.502 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -142.31 139.08 17.21 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.95 -178.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 51.4 Cg_exo -59.17 105.71 0.26 Allowed 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 123.252 2.635 . . . . 0.0 112.744 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.5 177.59 6.33 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.993 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.76 -97.58 0.25 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.383 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 117.05 100.33 2.12 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.876 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -69.62 84.08 0.65 Allowed 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.652 2.235 . . . . 0.0 111.865 178.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.456 ' HB3' ' HD3' ' A' ' 82' ' ' PRO . . . -84.11 -48.04 0.7 Allowed Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.241 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.456 ' HD3' ' HB3' ' A' ' 81' ' ' ALA . 82.3 Cg_exo -48.98 118.15 3.3 Favored 'Trans proline' 0 C--N 1.364 1.353 0 C-N-CA 122.125 1.884 . . . . 0.0 113.201 176.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.7 p -157.3 133.36 9.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.959 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.6 m 54.74 72.4 0.47 Allowed 'General case' 0 CA--C 1.531 0.223 0 O-C-N 123.891 0.744 . . . . 0.0 111.747 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -102.08 -2.03 30.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.421 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.3 89.41 2.07 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.322 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.89 106.62 5.34 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.523 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -53.38 119.07 5.58 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.077 2.518 . . . . 0.0 112.797 177.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -121.06 63.08 0.88 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.272 177.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -100.38 118.77 37.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.676 -178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -73.28 -60.67 2.13 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.76 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -103.53 157.72 16.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.32 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -115.91 131.73 56.85 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.23 78.38 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.983 0.42 . . . . 0.0 111.065 -176.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -106.1 -36.81 6.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.965 174.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.48 166.44 13.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.053 176.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.495 ' N ' ' HD3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -127.52 119.74 26.72 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp 65.11 179.93 0.19 Allowed 'General case' 0 C--N 1.323 -0.568 0 O-C-N 123.918 0.761 . . . . 0.0 109.943 -172.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -89.2 77.37 7.51 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 121.201 0.524 . . . . 0.0 110.591 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -72.1 144.56 48.63 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.187 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.9 t -101.55 145.99 28.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.209 -176.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -124.68 17.37 8.76 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.853 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -61.32 143.07 56.36 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.951 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.0 p -129.8 138.78 51.22 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -173.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -77.38 92.65 3.96 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 173.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.06 129.6 42.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.028 -173.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.4 t0 50.26 45.15 26.2 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 124.032 0.833 . . . . 0.0 111.23 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 64.5 mtt 66.75 9.76 6.98 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.129 -0.942 . . . . 0.0 112.326 178.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.47 101.96 0.96 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.198 173.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -78.58 177.03 8.9 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 175.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.82 -20.5 24.4 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.182 -1.009 . . . . 0.0 111.927 -178.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.436 HD13 ' O ' ' A' ' 112' ' ' LEU . 2.1 tm? -63.19 -37.71 88.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.331 0.586 . . . . 0.0 109.729 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -111.5 24.97 12.17 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 174.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 38.8 t70 . . . . . 0 C--O 1.251 1.153 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.575 -173.307 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 121.018 0.437 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.562 ' O ' ' HB2' ' B' ' 202' ' ' ARG . 22.4 ttt -82.11 104.13 12.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.734 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 202' ' ' ARG . . . . . 0.562 ' HB2' ' O ' ' B' ' 201' ' ' MET . 14.4 ttp180 168.37 -19.07 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 O-C-N 124.477 1.111 . . . . 0.0 110.921 176.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -125.43 -27.18 3.48 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -174.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.547 ' O ' HD13 ' B' ' 208' ' ' LEU . 2.4 p -57.17 -62.31 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 205' ' ' ALA . . . . . 0.609 ' HA ' ' HB2' ' B' ' 208' ' ' LEU . . . -71.81 -12.15 61.15 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.96 -177.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 3.0 m -68.3 -44.93 74.35 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 172.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 207' ' ' TYR . . . . . 0.498 ' CD1' HD11 ' B' ' 251' ' ' ILE . 24.5 t80 -63.64 -45.94 87.93 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.507 173.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.609 ' HB2' ' HA ' ' B' ' 205' ' ' ALA . 7.6 mp -52.98 -50.69 63.63 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.173 177.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 209' ' ' LEU . . . . . 0.479 HD12 ' CB ' ' A' ' 11' ' ' TYR . 1.2 tt -64.7 -46.5 82.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.808 -176.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -57.13 -37.24 71.71 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.861 176.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 211' ' ' ALA . . . . . 0.726 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -79.76 -34.85 39.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.996 0.426 . . . . 0.0 111.025 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 212' ' ' LEU . . . . . 0.492 HD22 ' HB3' ' A' ' 7' ' ' LEU . 50.2 tp -56.65 -51.62 68.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.003 177.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -143.65 76.03 0.3 Allowed Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.049 -1.072 . . . . 0.0 112.438 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 176.19 -72.77 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.495 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 215' ' ' ASN . . . . . 0.726 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 94.0 m-20 -134.91 138.24 43.92 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -176.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 3.7 m -67.24 -28.02 67.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.342 0.592 . . . . 0.0 110.483 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 12.5 m -127.87 74.76 78.6 Favored Pre-proline 0 N--CA 1.442 -0.833 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.8 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.52 117.43 3.81 Favored 'Trans proline' 0 N--CA 1.474 0.369 0 C-N-CA 123.388 2.725 . . . . 0.0 112.577 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 89.1 p -88.19 164.21 15.78 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.148 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . 0.414 ' HB1' HD21 ' B' ' 239' ' ' LEU . . . -52.14 -36.16 50.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.225 0.536 . . . . 0.0 110.449 177.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -67.0 -40.94 87.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.654 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -63.14 -45.37 92.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.342 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.413 HD12 ' N ' ' B' ' 223' ' ' ILE . 1.8 mp -67.29 -40.39 84.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.124 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 224' ' ' LYS . . . . . 0.455 ' HD3' HD22 ' B' ' 239' ' ' LEU . 11.6 mmmm -57.13 -47.23 81.64 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 175.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' B' ' 229' ' ' SER . 9.0 tmtm? -62.12 -41.72 98.52 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 0.578 HD11 ' HA ' ' A' ' 35' ' ' ALA . 1.0 OUTLIER -63.17 -42.86 98.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.737 0.303 . . . . 0.0 110.833 178.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . 0.589 ' HG ' ' HB ' ' B' ' 232' ' ' ILE . 13.7 tp -76.93 -40.29 47.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.239 0.543 . . . . 0.0 110.116 -174.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.11 -32.34 73.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.865 176.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 229' ' ' SER . . . . . 0.493 ' HB2' ' O ' ' B' ' 225' ' ' LYS . 5.1 t -55.08 -42.61 73.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.438 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 94.0 t -79.9 -40.51 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-O 121.291 0.567 . . . . 0.0 110.629 176.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 115.94 33.97 1.45 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.033 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . 0.589 ' HB ' ' HG ' ' B' ' 227' ' ' LEU . 1.9 mm -91.38 128.29 43.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -57.41 119.63 6.82 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . 0.548 ' HB2' HD23 ' B' ' 227' ' ' LEU . . . -110.81 128.38 55.74 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.162 0.506 . . . . 0.0 111.86 -175.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -93.1 102.7 15.03 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 174.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -55.15 -30.76 60.49 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -176.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 237' ' ' ASP . . . . . 0.43 ' OD1' ' HD3' ' B' ' 238' ' ' ARG . 6.3 t70 -62.1 -63.11 1.35 Allowed 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.494 0.664 . . . . 0.0 110.164 174.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.642 ' O ' HG23 ' B' ' 242' ' ' VAL . 20.8 mmt180 -64.46 -26.7 68.56 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.115 -175.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 239' ' ' LEU . . . . . 0.455 HD22 ' HD3' ' B' ' 224' ' ' LYS . 8.0 tp -53.54 -63.65 1.08 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.782 174.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -66.64 -24.21 66.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.379 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -66.93 -48.0 69.96 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.251 0.548 . . . . 0.0 110.818 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 242' ' ' VAL . . . . . 0.642 HG23 ' O ' ' B' ' 238' ' ' ARG . 60.4 t -69.72 -30.18 43.82 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 43.2 mt -81.89 -24.42 9.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.994 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 6.5 p -75.91 -31.8 59.33 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 121.557 -0.715 . . . . 0.0 110.428 172.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -73.28 -56.53 4.96 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.15 0.5 . . . . 0.0 110.608 169.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . 0.722 ' O ' HD13 ' B' ' 246' ' ' LEU . 0.0 OUTLIER -100.83 122.77 43.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.574 0.702 . . . . 0.0 110.079 -176.255 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -159.7 -164.79 1.39 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.528 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . 0.476 ' HA2' HG12 ' B' ' 251' ' ' ILE . . . -75.82 37.09 1.24 Allowed Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.48 -0.39 . . . . 0.0 113.876 -175.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -81.39 -57.5 3.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.093 0.473 . . . . 0.0 110.089 176.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -131.63 51.9 2.11 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.514 ' HA ' HG22 ' B' ' 254' ' ' VAL . 1.0 OUTLIER -64.81 -51.98 60.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -170.444 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -65.39 -24.31 67.19 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.397 -175.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.19 -52.68 13.22 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.102 175.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 254' ' ' VAL . . . . . 0.514 HG22 ' HA ' ' B' ' 251' ' ' ILE . 29.7 m -66.33 -19.93 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.213 -178.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 255' ' ' ILE . . . . . . . . . . . . . 38.7 mt -84.69 -42.84 16.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.714 176.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -63.64 -43.2 97.49 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -177.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -112.36 32.45 5.57 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.286 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -100.65 54.38 0.86 Allowed Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.438 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 1.1 mt -120.51 -0.38 7.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.242 0.544 . . . . 0.0 111.028 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -70.62 -165.37 5.75 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.854 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 16.7 pttm -69.36 83.62 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.646 0.736 . . . . 0.0 109.966 174.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 262' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.84 97.84 5.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.686 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -115.75 -5.28 12.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.322 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 6.8 p -169.12 -66.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.384 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 13.5 p -144.3 137.96 14.39 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -68.54 64.15 1.18 Allowed 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.747 2.298 . . . . 0.0 113.33 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . -122.03 15.44 10.76 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.629 174.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . -107.8 25.07 22.02 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.037 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -129.29 -166.23 11.87 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 176.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -95.78 132.09 41.38 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 15.1 t -86.74 139.43 17.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.061 -177.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -95.35 80.62 3.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.885 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 96.8 t 69.43 142.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 O-C-N 124.082 0.864 . . . . 0.0 111.632 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 20.3 m -105.49 145.38 30.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.385 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -82.69 -173.88 4.9 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.06 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . 0.41 ' HA ' ' HD2' ' B' ' 277' ' ' PRO . . . 64.38 82.82 0.21 Allowed Pre-proline 0 N--CA 1.466 0.342 0 O-C-N 123.729 0.643 . . . . 0.0 110.636 -173.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 277' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' B' ' 276' ' ' ALA . 27.5 Cg_endo -60.56 137.42 73.61 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.552 2.835 . . . . 0.0 113.344 -178.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -112.54 128.78 8.64 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.935 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 66.5 m -126.07 -167.56 1.72 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.116 0.484 . . . . 0.0 111.524 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . -50.32 117.12 2.2 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.675 175.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -86.42 -43.64 0.57 Allowed Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.616 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -52.11 120.44 7.25 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 122.206 1.937 . . . . 0.0 113.256 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -107.75 147.35 30.92 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.076 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -97.04 145.3 26.1 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.607 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 132.92 -51.41 0.85 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.231 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 5.2 p -83.72 62.35 6.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.11 0.481 . . . . 0.0 110.92 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 287' ' ' ALA . . . . . 0.437 ' H ' ' CD ' ' B' ' 288' ' ' PRO . . . -114.52 -46.33 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.982 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 288' ' ' PRO . . . . . 0.437 ' CD ' ' H ' ' B' ' 287' ' ' ALA . 11.7 Cg_exo -71.79 158.62 52.68 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 121.88 1.72 . . . . 0.0 111.875 176.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -115.62 169.59 9.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.767 -176.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . 63.5 -178.72 0.15 Allowed 'General case' 0 C--O 1.233 0.216 0 O-C-N 124.067 0.854 . . . . 0.0 112.285 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . 57.15 71.89 0.55 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.46 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -54.35 118.14 3.87 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.933 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -83.73 134.83 34.73 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.43 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.05 157.21 43.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.323 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -127.49 95.52 4.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.858 0.361 . . . . 0.0 110.145 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -138.78 86.89 2.18 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.082 0.468 . . . . 0.0 109.768 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -135.38 140.01 44.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.823 -174.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 298' ' ' LYS . . . . . 0.491 ' HE2' ' HB2' ' B' ' 300' ' ' GLU . 87.3 tttt -156.66 115.72 3.41 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 -178.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.44 9.84 6.71 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -175.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 300' ' ' GLU . . . . . 0.491 ' HB2' ' HE2' ' B' ' 298' ' ' LYS . 37.5 mt-10 -108.86 -3.94 17.23 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -172.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -93.71 115.63 28.08 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.148 0.499 . . . . 0.0 110.382 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 16.9 m -64.95 128.05 34.12 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.718 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -44.92 -58.88 2.86 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 123.658 0.599 . . . . 0.0 111.821 -174.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -159.17 175.76 13.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.959 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 18.2 m -94.78 156.81 16.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.138 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -49.94 -63.86 0.98 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.609 0.568 . . . . 0.0 111.838 -178.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -171.62 -79.92 0.01 OUTLIER 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.741 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -113.42 149.49 34.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.496 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 23.0 mmt -114.37 31.66 6.45 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -176.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . -58.84 -31.48 68.06 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.357 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -106.1 17.48 23.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.156 0.503 . . . . 0.0 110.626 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . -138.69 34.7 2.07 Favored Glycine 0 C--O 1.229 -0.203 0 C-N-CA 121.097 -0.573 . . . . 0.0 111.689 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 17.7 tp -80.38 42.18 0.58 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.268 0.556 . . . . 0.0 110.363 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 314' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -134.67 -73.35 0.47 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.915 -173.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.253 1.239 0 CA-C-O 118.488 -0.768 . . . . 0.0 111.261 -174.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.0 tmm? . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.51 44.52 0.29 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.762 0.315 . . . . 0.0 111.568 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.465 ' O ' HD13 ' A' ' 7' ' ' LEU . 7.7 t 55.76 42.21 29.42 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.484 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.534 ' HA ' ' HB2' ' A' ' 7' ' ' LEU . 1.7 m -67.27 -16.06 20.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.213 0.53 . . . . 0.0 110.204 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.655 ' OG ' HG23 ' A' ' 39' ' ' VAL . 30.8 t -60.67 -67.79 0.36 Allowed 'General case' 0 C--O 1.25 1.115 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.349 176.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -66.21 -34.92 79.12 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.818 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 4' ' ' VAL . 6.1 mp -51.27 -54.64 24.04 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.659 173.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.05 -44.46 91.82 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.501 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' A' ' 43' ' ' TRP . 57.0 m -61.07 -38.08 84.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.097 0.475 . . . . 0.0 111.302 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.685 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -72.71 -42.36 62.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.671 -178.169 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.673 ' HD1' HD12 ' A' ' 14' ' ' LEU . 31.2 m-85 -75.37 -21.95 57.9 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.643 -176.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.6 p -75.33 -40.36 58.43 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.238 171.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -49.38 -51.01 37.67 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.471 0.653 . . . . 0.0 109.887 169.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 10' ' ' ILE . 56.0 mt -59.99 -49.86 76.0 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.241 -179.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.8 mt -54.54 -64.87 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.974 0.416 . . . . 0.0 111.381 178.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 86.8 mt -63.27 -24.72 67.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.316 -170.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.679 ' HB3' ' HE1' ' B' ' 201' ' ' MET . 55.3 t-80 -63.54 -36.78 84.93 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.606 ' HB2' ' SD ' ' B' ' 201' ' ' MET . 34.3 t70 -104.0 -7.86 20.01 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.194 0.521 . . . . 0.0 111.615 -167.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.476 ' HB3' HG21 ' B' ' 232' ' ' ILE . 1.1 m-20 -85.53 37.96 0.72 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.43 -175.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 50.58 29.2 3.91 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.929 0.395 . . . . 0.0 110.723 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -136.3 148.96 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.034 -169.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.1 p -86.62 136.21 33.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.733 175.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -76.44 116.6 19.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.985 0.421 . . . . 0.0 110.518 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.2 p -133.19 163.62 28.87 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.512 ' HG3' ' H ' ' A' ' 26' ' ' ASP . 6.6 pt-20 -45.29 -54.01 7.66 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.864 0.727 . . . . 0.0 111.958 -177.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.512 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 2.7 t70 -55.73 -40.06 71.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.473 -178.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -78.75 -41.57 30.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.394 -171.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.518 HG23 HD13 ' A' ' 32' ' ' ILE . 3.2 mt -63.47 -47.59 90.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.997 175.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -61.79 -33.39 74.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.265 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.77 -52.57 35.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.842 0.353 . . . . 0.0 110.891 176.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.508 HD11 HG23 ' B' ' 226' ' ' ILE . 0.2 OUTLIER -61.89 -32.31 72.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.226 0.536 . . . . 0.0 110.21 177.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.518 HD13 HG23 ' A' ' 28' ' ' ILE . 1.3 mp -69.47 -33.88 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.128 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -74.15 -27.74 60.98 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.052 174.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.73 -50.15 46.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.936 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.482 ' HB3' ' HB3' ' B' ' 209' ' ' LEU . . . -133.85 16.21 3.91 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -175.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.05 93.95 1.86 Allowed Glycine 0 C--N 1.314 -0.661 0 C-N-CA 120.317 -0.944 . . . . 0.0 111.657 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.7 p -56.43 -42.12 73.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 120.648 0.261 . . . . 0.0 111.537 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -160.97 127.4 3.98 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.029 0.442 . . . . 0.0 110.527 172.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.655 HG23 ' OG ' ' A' ' 5' ' ' SER . 8.0 p -165.07 120.45 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.795 178.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.431 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 1.7 pm0 -65.89 129.63 94.31 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.79 -8.87 0.96 Allowed 'Trans proline' 0 N--CA 1.485 0.991 0 C-N-CA 123.778 2.985 . . . . 0.0 113.755 -172.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.77 -38.16 76.65 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.649 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.482 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 70.2 m95 -69.4 -55.03 10.21 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.979 177.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.482 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 85.0 Cg_exo -49.01 -51.0 11.38 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 122.364 2.043 . . . . 0.0 113.003 176.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.55 -49.6 68.23 Favored Glycine 0 C--O 1.243 0.683 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.738 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.9 tp -54.05 -48.52 70.47 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 115.449 -0.375 . . . . 0.0 110.599 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.69 ' O ' HD12 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -67.86 -44.48 77.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.879 -173.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.1 -35.28 74.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.12 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -93.39 -1.97 55.23 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.819 175.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.83 -42.39 17.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.552 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.717 ' HA ' HG23 ' A' ' 54' ' ' VAL . 2.1 mp -86.99 -131.7 0.06 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 118.7 -1.2 . . . . 0.0 109.654 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 65.59 -9.96 0.23 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.213 0.605 . . . . 0.0 112.293 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.472 ' H ' ' C ' ' A' ' 51' ' ' LEU . 23.5 t-20 -127.59 -41.4 1.7 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.717 HG23 ' HA ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -81.77 117.16 27.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.314 168.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.437 ' OD1' HG22 ' A' ' 56' ' ' ILE . 8.6 t-20 -43.95 -67.9 0.24 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.874 0.734 . . . . 0.0 112.73 -172.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.635 ' O ' HD12 ' A' ' 59' ' ' LEU . 2.4 tp -156.24 -48.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.291 -177.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.39 -21.52 8.9 Favored Glycine 0 N--CA 1.469 0.866 0 O-C-N 123.32 0.388 . . . . 0.0 113.689 -173.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.2 t -60.97 -14.51 23.29 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 122.545 0.338 . . . . 0.0 111.155 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -68.2 -18.64 64.64 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.107 -178.27 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.506 HG22 ' O ' ' A' ' 60' ' ' ILE . 29.9 mt -100.91 29.94 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 122.254 1.026 . . . . 0.0 109.511 174.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.9 t -71.96 132.29 44.12 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 121.743 -0.598 . . . . 0.0 110.307 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -73.69 64.37 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.064 0.459 . . . . 0.0 110.678 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.6 t -58.67 -73.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.653 176.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 69.87 172.66 10.22 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.843 -0.694 . . . . 0.0 113.051 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -160.1 140.02 11.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.797 0.332 . . . . 0.0 110.461 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.7 61.4 4.27 Favored Glycine 0 N--CA 1.453 -0.214 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.229 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.81 -65.97 1.52 Allowed Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 112.066 -0.414 . . . . 0.0 112.066 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.52 81.9 0.96 Allowed 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 122.761 2.307 . . . . 0.0 111.821 177.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.6 155.75 45.68 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.93 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -48.71 -59.23 1.33 Allowed 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.696 2.264 . . . . 0.0 112.958 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 63.35 112.29 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.908 0.861 . . . . 0.0 111.81 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -107.28 112.54 25.44 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.035 -176.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -119.29 67.77 0.38 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.118 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.98 134.19 17.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.469 0.176 . . . . 0.0 110.846 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.478 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -152.78 128.9 5.24 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.419 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 35.4 Cg_exo -64.49 -10.67 25.09 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 123.717 2.945 . . . . 0.0 113.077 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.75 94.71 9.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.033 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.59 -26.58 50.25 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.127 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.13 71.9 0.09 OUTLIER Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.069 -1.063 . . . . 0.0 112.708 177.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -86.3 109.35 0.93 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.232 1.955 . . . . 0.0 112.857 -177.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -127.64 83.83 65.01 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.44 176.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -60.84 95.24 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.424 2.749 . . . . 0.0 112.728 176.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.2 m -92.38 24.24 3.52 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.291 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 74.7 m 72.79 -60.11 0.54 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.366 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -137.53 147.77 45.43 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 120.684 0.278 . . . . 0.0 110.533 -178.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -159.53 102.7 1.55 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.31 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -134.89 151.7 76.07 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.92 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -57.11 142.08 94.28 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.833 2.356 . . . . 0.0 112.145 173.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.3 40.7 0.65 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.944 -175.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -112.29 124.4 52.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.164 0.507 . . . . 0.0 109.936 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -108.57 -149.16 0.43 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.174 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -62.14 108.62 1.1 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.531 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.6 mtpt -107.62 136.41 47.42 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 176.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.1 m -100.59 130.65 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 121.239 0.542 . . . . 0.0 111.935 -174.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -93.34 -20.76 20.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.824 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -115.72 -62.7 1.56 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -169.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.555 ' H ' ' HD2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -116.34 150.11 38.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 122.388 -0.195 . . . . 0.0 111.184 -173.748 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt 71.95 -176.92 0.19 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 124.148 0.905 . . . . 0.0 111.581 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 74.92 153.53 0.14 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.878 0.871 . . . . 0.0 111.098 -177.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -77.78 142.03 38.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.158 -172.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.1 m -134.82 -171.28 2.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.074 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.453 ' C ' ' HG3' ' A' ' 103' ' ' GLU . 12.7 pt-20 -93.15 157.9 16.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.616 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.453 ' HG3' ' C ' ' A' ' 102' ' ' GLU . 0.2 OUTLIER 39.13 46.85 1.25 Allowed 'General case' 0 N--CA 1.477 0.914 0 O-C-N 124.355 1.034 . . . . 0.0 113.122 178.473 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.3 p -154.21 163.33 40.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.037 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -134.85 -179.06 5.37 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.481 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.12 136.26 24.09 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.827 0.851 . . . . 0.0 112.874 -174.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -104.28 144.42 31.64 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 171.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -80.77 64.4 5.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.018 0.437 . . . . 0.0 110.827 -175.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -114.39 102.78 1.22 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.619 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -59.53 135.36 57.65 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 175.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.504 ' HA2' ' HB2' ' A' ' 114' ' ' ASP . . . 113.67 6.93 20.85 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -169.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.1 tp -87.49 -27.76 22.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.061 0.458 . . . . 0.0 110.127 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -125.95 20.33 7.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.544 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.504 ' HB2' ' HA2' ' A' ' 111' ' ' GLY . 4.9 m-20 . . . . . 0 C--O 1.248 0.976 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.447 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 120.807 0.337 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.679 ' HE1' ' HB3' ' A' ' 17' ' ' HIS . 26.4 mtp -123.23 -3.77 8.46 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.963 0.411 . . . . 0.0 110.835 -175.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 202' ' ' ARG . . . . . 0.448 ' HD3' ' HA ' ' A' ' 19' ' ' ASP . 50.1 mtm-85 -78.3 -1.46 33.27 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -167.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 203' ' ' TYR . . . . . 0.43 ' CE1' ' HB3' ' B' ' 239' ' ' LEU . 30.5 m-85 -129.88 -43.09 1.23 Allowed 'General case' 0 C--O 1.242 0.671 0 O-C-N 121.739 -0.601 . . . . 0.0 112.146 -176.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.713 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 6.5 p -58.44 -50.5 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.536 -177.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 205' ' ' ALA . . . . . 0.62 ' HA ' HD12 ' B' ' 208' ' ' LEU . . . -72.65 -15.63 61.71 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.703 0.287 . . . . 0.0 110.902 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 1.7 m -70.47 -48.51 55.47 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.087 0.47 . . . . 0.0 109.736 174.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 207' ' ' TYR . . . . . 0.551 ' CZ ' ' HD2' ' B' ' 218' ' ' PRO . 33.0 t80 -61.97 -41.21 97.75 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.713 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 88.4 mt -56.82 -53.49 57.25 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.101 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 209' ' ' LEU . . . . . 0.673 ' CD2' ' HB2' ' A' ' 11' ' ' TYR . 56.0 mt -57.74 -54.83 42.43 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.956 0.408 . . . . 0.0 111.067 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 210' ' ' ALA . . . . . 0.401 ' HB3' ' HB3' ' B' ' 218' ' ' PRO . . . -58.22 -32.94 68.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.287 -176.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 211' ' ' ALA . . . . . 0.463 ' HB3' HD11 ' B' ' 255' ' ' ILE . . . -76.88 -44.58 31.39 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.158 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 212' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' B' ' 209' ' ' LEU . 2.8 pp -64.66 -22.96 67.11 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.875 0.369 . . . . 0.0 110.405 177.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.09 -13.96 58.41 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.822 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 118.49 10.87 8.33 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.348 -0.93 . . . . 0.0 113.227 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 215' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -121.48 100.42 7.01 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 122.33 -0.512 . . . . 0.0 111.216 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 2.0 m -44.74 -49.81 10.37 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -168.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 19.0 m -114.24 85.37 10.4 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 123.495 0.497 . . . . 0.0 110.446 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . 0.551 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 73.6 Cg_exo -46.01 121.91 4.77 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 123.821 3.014 . . . . 0.0 113.57 176.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 46.8 t -76.39 148.42 37.37 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.808 178.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.84 -29.11 59.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.319 176.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -66.45 -38.41 87.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.389 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -73.31 -42.53 62.24 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.127 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.484 HD11 ' CB ' ' B' ' 218' ' ' PRO . 1.7 mp -64.26 -43.88 97.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -52.15 -60.43 3.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.313 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -52.07 -50.32 61.76 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.174 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 0.508 HG23 HD11 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -56.25 -38.04 52.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.51 -177.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . 0.766 HD23 ' HB2' ' B' ' 234' ' ' ALA . 13.5 tp -75.91 -46.92 27.43 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.87 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -87.36 12.15 12.74 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 119.761 -0.775 . . . . 0.0 111.826 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 72.5 m -57.15 -34.14 68.13 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.324 165.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 54.1 t -93.5 -52.31 9.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.475 175.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 138.93 30.38 0.21 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.903 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . 0.476 HG21 ' HB3' ' A' ' 19' ' ' ASP . 3.4 mp -101.92 149.65 6.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 174.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -86.8 150.54 24.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.313 0.578 . . . . 0.0 111.742 -171.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . 0.766 ' HB2' HD23 ' B' ' 227' ' ' LEU . . . -134.68 160.85 36.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.749 -177.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -112.87 125.82 54.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.119 0.485 . . . . 0.0 110.286 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -62.36 -51.15 68.76 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 114.766 -1.106 . . . . 0.0 113.146 -170.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -75.08 -33.46 61.67 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.494 -173.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 26.5 tpt180 -68.21 -44.97 74.6 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.886 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 239' ' ' LEU . . . . . 0.497 HD12 ' N ' ' B' ' 240' ' ' ASN . 4.5 pp -66.27 -37.59 85.81 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.363 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 240' ' ' ASN . . . . . 0.497 ' N ' HD12 ' B' ' 239' ' ' LEU . 26.1 t-20 -67.78 -36.91 81.33 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 121.311 -0.156 . . . . 0.0 110.651 178.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -65.36 -45.58 83.6 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 120.612 0.244 . . . . 0.0 110.94 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 242' ' ' VAL . . . . . 0.427 ' O ' ' HG ' ' B' ' 246' ' ' LEU . 33.9 m -70.89 -32.26 48.15 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 CA-C-O 121.493 0.663 . . . . 0.0 109.616 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 32.1 mt -72.36 -29.58 32.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.538 175.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 47.1 t -66.01 -32.08 73.35 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 172.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -74.28 -31.42 62.52 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.084 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' B' ' 242' ' ' VAL . 32.2 mt -85.88 1.36 50.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.553 178.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -78.87 -11.31 59.99 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -166.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -88.08 -132.82 4.07 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.828 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -98.93 -156.67 0.56 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 18.9 m120 75.37 -25.38 0.2 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.081 0.552 . . . . 0.0 112.456 174.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.636 ' HA ' HG12 ' B' ' 254' ' ' VAL . 5.9 tp -56.52 -38.67 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.466 0.651 . . . . 0.0 110.416 175.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -54.28 -50.88 66.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.037 176.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.2 -45.91 75.46 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.063 -177.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 254' ' ' VAL . . . . . 0.636 HG12 ' HA ' ' B' ' 251' ' ' ILE . 9.6 p -62.5 -33.9 61.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.259 -175.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 255' ' ' ILE . . . . . 0.463 HD11 ' HB3' ' B' ' 211' ' ' ALA . 63.4 mt -80.07 -40.33 20.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.815 176.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -57.18 -51.71 68.23 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.749 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -160.78 75.65 0.55 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.918 0.39 . . . . 0.0 110.448 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -176.32 56.37 0.11 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.733 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 259' ' ' ILE . . . . . 0.451 ' H ' HG13 ' B' ' 259' ' ' ILE . 27.7 mt -30.64 -55.01 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.808 0.843 . . . . 0.0 111.898 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 140.51 -170.78 24.29 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 119.721 -1.228 . . . . 0.0 113.529 165.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -84.89 11.41 9.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.421 -0.39 . . . . 0.0 110.23 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 262' ' ' LEU . . . . . 0.677 ' HG ' HD13 ' A' ' 14' ' ' LEU . 2.8 mm? -54.55 -74.98 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.355 0.598 . . . . 0.0 110.371 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -138.75 73.76 1.45 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.065 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 3.0 p -83.37 101.02 11.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.419 0.628 . . . . 0.0 111.321 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 40.8 t -106.56 133.19 20.36 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.427 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.97 115.09 3.08 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.43 2.087 . . . . 0.0 112.223 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . -61.34 144.92 53.13 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.829 175.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . -78.38 53.48 3.9 Favored Glycine 0 CA--C 1.517 0.174 0 C-N-CA 121.378 -0.439 . . . . 0.0 113.754 -175.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . 59.62 -127.42 44.53 Favored Glycine 0 CA--C 1.517 0.193 0 C-N-CA 121.852 -0.213 . . . . 0.0 113.472 176.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . 56.59 56.91 5.19 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.365 0.602 . . . . 0.0 111.516 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 10.6 t -93.74 136.2 26.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.857 -175.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -150.33 127.78 11.47 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.017 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 40.7 t -116.46 84.02 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.212 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 8.2 p 43.08 58.82 3.15 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -79.59 84.17 5.48 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.7 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . 0.429 ' HA ' ' HD2' ' B' ' 277' ' ' PRO . . . -111.09 112.74 55.14 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.804 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 277' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' B' ' 276' ' ' ALA . 32.9 Cg_endo -66.33 142.54 66.68 Favored 'Trans proline' 0 CA--C 1.52 -0.218 0 C-N-CA 122.762 2.308 . . . . 0.0 112.103 175.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -164.14 171.79 39.79 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.171 -1.014 . . . . 0.0 112.473 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 71.9 m -159.75 -167.99 2.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.831 0.348 . . . . 0.0 110.553 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . -53.88 147.55 11.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.863 175.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -86.92 131.56 44.63 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.877 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -68.21 140.71 49.91 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.735 2.29 . . . . 0.0 112.647 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -132.91 159.05 41.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.664 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -153.46 148.87 27.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.706 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -121.66 -74.98 0.36 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.231 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 80.5 p 61.87 120.61 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.84 1.256 . . . . 0.0 112.852 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 287' ' ' ALA . . . . . 0.42 ' HA ' ' HD3' ' B' ' 288' ' ' PRO . . . -124.13 144.8 46.38 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.517 178.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 288' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' B' ' 287' ' ' ALA . 8.1 Cg_exo -70.35 139.63 38.62 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.97 2.447 . . . . 0.0 112.517 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -114.49 132.7 56.2 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.459 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -99.77 -177.81 3.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.563 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -120.53 88.49 2.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.582 0.23 . . . . 0.0 111.309 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.0 147.15 35.58 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.105 175.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 65.64 107.73 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 O-C-N 123.959 0.787 . . . . 0.0 111.54 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -129.02 -39.68 1.55 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.575 -176.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -117.45 76.22 1.04 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -173.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -161.14 130.74 4.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.375 168.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 178.24 -29.9 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.87 -174.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -133.44 114.07 13.23 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.074 -177.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 17.0 pttm -147.46 -51.18 0.19 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.565 176.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 61.99 -90.07 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.808 0.692 . . . . 0.0 110.975 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -57.62 116.02 3.14 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 123.029 0.531 . . . . 0.0 110.7 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 31.1 m -112.04 164.08 13.54 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.735 -177.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 65.76 -169.46 0.2 Allowed 'General case' 0 CA--C 1.531 0.219 0 O-C-N 123.992 0.807 . . . . 0.0 110.23 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -117.12 145.79 43.57 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 5.1 t -64.94 135.67 55.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.723 -172.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -122.81 75.14 1.25 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.236 -178.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -88.55 65.58 7.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.972 -172.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -111.81 170.27 8.26 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 173.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 23.0 ptt? -86.94 35.71 0.7 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.106 0.479 . . . . 0.0 110.811 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 70.25 19.93 76.25 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.626 -0.716 . . . . 0.0 113.166 176.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 53.78 26.33 5.93 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 122.925 0.49 . . . . 0.0 112.035 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . -155.79 101.06 0.2 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.911 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 313' ' ' LEU . . . . . 0.415 ' HG ' ' H ' ' B' ' 313' ' ' LEU . 1.1 pp -74.21 6.62 3.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.198 0.523 . . . . 0.0 111.42 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 314' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -72.46 -46.51 54.58 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.282 -176.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 35.4 t70 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.21 -178.31 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.4 tpt . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.1 -155.9 0.66 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 111.181 0.067 . . . . 0.0 111.181 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.476 ' O ' HD13 ' A' ' 7' ' ' LEU . 3.4 p -63.66 103.32 0.53 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.281 0.563 . . . . 0.0 111.457 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.4 -22.78 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.955 -175.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.474 ' HB2' HG23 ' A' ' 39' ' ' VAL . 3.4 p -61.67 -63.68 1.19 Allowed 'General case' 0 C--O 1.242 0.667 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.111 178.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -62.43 -41.75 98.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.088 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.476 HD13 ' O ' ' A' ' 3' ' ' SER . 5.2 mp -49.45 -59.27 3.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.341 176.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.8 -53.18 60.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.668 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 35.7 t -64.79 -37.52 87.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.775 -175.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.419 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 1.3 tp -75.77 -35.46 30.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.898 0.38 . . . . 0.0 110.951 -175.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.766 ' OH ' ' HA2' ' B' ' 258' ' ' GLY . 17.3 m-30 -74.55 -28.32 60.9 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.769 177.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 64.3 m -66.04 -41.98 90.17 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 173.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.441 ' HB3' HD21 ' A' ' 59' ' ' LEU . . . -53.74 -45.09 70.43 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.101 171.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 10' ' ' ILE . 72.8 mt -59.46 -55.15 38.27 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.788 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.404 HD11 ' HA ' ' B' ' 206' ' ' SER . 73.4 mt -52.35 -45.62 45.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.243 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.3 mt -76.19 -18.42 59.08 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.365 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -98.3 18.37 16.55 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.957 -0.464 . . . . 0.0 112.162 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.574 ' OD1' ' HG3' ' B' ' 201' ' ' MET . 15.9 t70 -117.48 -51.98 2.49 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.009 178.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -74.42 29.22 0.08 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 50.86 40.29 24.48 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.742 0.417 . . . . 0.0 111.864 178.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.8 p -121.72 164.69 18.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.79 0.329 . . . . 0.0 111.026 -173.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.2 p -90.48 135.25 33.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.021 0.438 . . . . 0.0 111.777 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.627 HG11 HD23 ' A' ' 51' ' ' LEU . 91.8 t -77.82 123.34 34.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.414 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.26 158.49 43.81 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 177.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -50.91 -55.29 17.85 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.48 -177.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -51.73 -33.7 35.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.594 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -73.76 -50.34 21.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.534 0.207 . . . . 0.0 110.64 -176.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.409 ' O ' HD13 ' A' ' 32' ' ' ILE . 9.1 mt -65.34 -43.3 94.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.13 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -60.63 -36.61 79.06 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.988 175.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.57 -44.33 87.04 Favored 'General case' 0 C--O 1.227 -0.111 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.95 -42.98 89.29 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.239 0.542 . . . . 0.0 110.774 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.409 HD13 ' O ' ' A' ' 28' ' ' ILE . 1.6 mp -60.88 -44.0 96.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.411 177.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -73.31 -27.96 61.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.662 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.407 ' HB3' HG13 ' B' ' 226' ' ' ILE . . . -66.4 -37.63 85.66 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.361 176.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.423 ' HB2' HD12 ' B' ' 209' ' ' LEU . . . -82.39 -35.89 27.27 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.674 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.9 31.39 4.8 Favored Glycine 0 N--CA 1.454 -0.144 0 C-N-CA 120.755 -0.736 . . . . 0.0 113.428 175.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.511 HG13 ' HA2' ' B' ' 213' ' ' GLY . 22.3 m -114.52 175.08 2.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 122.725 -0.279 . . . . 0.0 110.732 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -132.96 106.94 7.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.902 0.382 . . . . 0.0 110.612 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.474 HG23 ' HB2' ' A' ' 5' ' ' SER . 7.4 p -102.64 135.25 40.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 174.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -53.8 130.28 56.36 Favored Pre-proline 0 C--O 1.236 0.361 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.51 -2.82 1.11 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.41 2.74 . . . . 0.0 113.721 -170.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.8 -37.48 70.39 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.032 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.578 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 94.9 m95 -70.7 -54.38 8.24 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 119.194 -0.431 . . . . 0.0 110.74 177.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.578 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 75.4 Cg_exo -51.88 -45.31 39.31 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 121.705 1.603 . . . . 0.0 112.213 175.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.77 -43.68 95.88 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.333 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.0 -43.26 95.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.196 0.522 . . . . 0.0 110.286 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.474 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 2.8 m-85 -70.24 -41.08 74.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.803 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.81 -35.95 81.26 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -98.77 -23.14 15.52 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -174.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.08 -24.8 5.46 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -174.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.709 ' HA ' HG23 ' A' ' 54' ' ' VAL . 2.0 tp -86.65 -133.35 0.06 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.475 ' H ' ' CG ' ' A' ' 51' ' ' LEU . . . 60.7 -12.13 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.615 0.766 . . . . 0.0 112.773 -177.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.538 ' H ' ' C ' ' A' ' 51' ' ' LEU . 18.3 m120 -125.99 -34.94 2.51 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.709 HG23 ' HA ' ' A' ' 51' ' ' LEU . 61.2 t -45.0 108.26 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.517 174.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -47.39 140.21 5.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.933 -1.485 . . . . 0.0 111.735 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.9 tp -52.39 -48.58 45.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.896 -173.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.93 -40.67 93.57 Favored Glycine 0 C--O 1.239 0.457 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.601 177.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.4 t -59.0 -17.81 28.5 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 122.76 0.424 . . . . 0.0 111.012 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.441 HD21 ' HB3' ' A' ' 13' ' ' ALA . 15.4 tp -62.01 -21.52 64.94 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.193 -176.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.3 tt -71.18 -13.4 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.117 0.484 . . . . 0.0 110.893 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 62.5 m -103.41 55.52 0.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.124 0.488 . . . . 0.0 110.304 177.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -74.97 -4.47 38.39 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.753 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.3 p -75.98 -12.01 14.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.399 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -80.29 52.79 4.37 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.728 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -78.65 -25.79 45.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.776 0.322 . . . . 0.0 111.24 -177.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -96.5 -9.66 56.4 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.513 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.407 ' HA2' ' HD3' ' A' ' 68' ' ' PRO . . . 131.0 134.56 3.66 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.839 -178.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.461 ' O ' ' HD3' ' A' ' 70' ' ' PRO . 7.9 Cg_exo -72.42 134.2 22.19 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.562 2.175 . . . . 0.0 112.287 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.57 92.96 12.93 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.265 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 68' ' ' PRO . 25.7 Cg_endo -92.52 -162.96 0.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.134 2.556 . . . . 0.0 112.926 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.93 152.67 35.88 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.234 177.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -91.64 91.84 8.19 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.916 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.85 -156.3 15.67 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.699 175.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -116.84 144.73 44.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.715 0.293 . . . . 0.0 110.72 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -130.51 123.06 20.15 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 121.249 0.547 . . . . 0.0 110.57 -177.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 50.9 Cg_exo -57.53 -53.4 4.67 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 124.002 3.135 . . . . 0.0 112.939 -177.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 53.41 36.81 23.99 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.17 0.509 . . . . 0.0 111.632 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -114.67 28.26 8.26 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.745 -177.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.89 101.47 0.22 Allowed Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.564 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.89 84.57 0.52 Allowed 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 122.981 2.454 . . . . 0.0 112.378 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.534 ' H ' ' HD2' ' A' ' 82' ' ' PRO . . . -129.13 -49.36 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.275 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.534 ' HD2' ' H ' ' A' ' 81' ' ' ALA . 71.8 Cg_exo -52.31 116.9 3.12 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 122.369 2.046 . . . . 0.0 113.05 177.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.1 t -91.78 137.68 32.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.119 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.6 m -154.98 138.63 16.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.473 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -127.98 -77.6 0.57 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.852 0.358 . . . . 0.0 110.91 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.32 138.11 47.11 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.892 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.53 108.71 8.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.609 0.243 . . . . 0.0 111.629 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -59.53 156.98 33.69 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.201 2.601 . . . . 0.0 112.262 174.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.2 21.68 0.72 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -175.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 69.99 116.45 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.757 0.823 . . . . 0.0 112.535 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.418 ' HG3' ' H ' ' A' ' 92' ' ' LYS . 6.4 pt-20 -118.41 -66.44 1.08 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.778 172.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.418 ' H ' ' HG3' ' A' ' 91' ' ' GLU . 26.4 mtpp 60.97 -167.47 0.19 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.678 0.275 . . . . 0.0 110.955 177.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt 67.04 -171.91 0.19 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.486 0.66 . . . . 0.0 111.318 176.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.4 p -56.97 119.7 2.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.665 174.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -84.05 -15.38 47.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.096 0.474 . . . . 0.0 110.277 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.68 64.52 2.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.08 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -113.41 130.54 56.27 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.526 175.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -81.3 -52.31 7.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.518 -170.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 50.58 70.13 0.55 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.658 0.599 . . . . 0.0 111.357 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -89.99 -169.05 2.3 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.601 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.5 t -47.15 134.75 10.63 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.881 0.738 . . . . 0.0 112.801 -172.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -79.54 154.33 28.87 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.881 173.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 67.61 169.8 0.26 Allowed 'General case' 0 N--CA 1.471 0.586 0 O-C-N 123.793 0.683 . . . . 0.0 111.272 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.2 m 53.07 43.36 31.77 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.446 0.641 . . . . 0.0 110.558 -176.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -73.08 -41.26 64.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.272 -175.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -118.87 -57.98 1.99 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.363 -177.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -96.22 157.68 15.79 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.879 174.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 51.9 ttm -76.07 -27.32 57.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.518 -175.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.71 176.67 41.32 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.767 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -101.01 153.48 19.5 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 122.245 0.218 . . . . 0.0 110.484 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -155.88 20.79 0.51 Allowed Glycine 0 C--N 1.329 0.188 0 C-N-CA 120.428 -0.891 . . . . 0.0 113.132 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 45.2 mt 47.29 48.48 16.2 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.208 0.528 . . . . 0.0 112.061 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -108.79 20.24 18.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.38 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.1 t70 . . . . . 0 C--O 1.255 1.364 0 CA-C-O 118.572 -0.727 . . . . 0.0 109.633 -178.393 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.574 ' HG3' ' OD1' ' A' ' 18' ' ' ASP . 9.4 tpt 66.98 112.41 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.172 0.92 . . . . 0.0 111.975 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 202' ' ' ARG . . . . . 0.571 ' HB2' ' O ' ' B' ' 201' ' ' MET . 14.8 tpp180 170.21 -139.88 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 203' ' ' TYR . . . . . 0.436 ' H ' ' HG3' ' B' ' 202' ' ' ARG . 28.9 m-85 -67.72 1.53 2.44 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.169 0.509 . . . . 0.0 111.628 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.557 ' O ' HD13 ' B' ' 208' ' ' LEU . 57.7 t -59.1 -54.35 35.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.144 177.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 205' ' ' ALA . . . . . 0.459 ' HA ' HD22 ' B' ' 208' ' ' LEU . . . -65.53 -20.61 66.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.727 0.299 . . . . 0.0 111.069 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . 0.404 ' HA ' HD11 ' A' ' 15' ' ' ILE . 1.5 m -68.14 -43.61 77.92 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 173.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 207' ' ' TYR . . . . . 0.507 ' HD2' HD13 ' B' ' 251' ' ' ILE . 35.7 t80 -62.3 -39.96 94.73 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.557 HD13 ' O ' ' B' ' 204' ' ' VAL . 8.8 mp -56.69 -52.81 63.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.955 175.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 209' ' ' LEU . . . . . 0.551 ' CD2' ' HB2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -55.15 -52.75 62.31 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.87 -178.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 210' ' ' ALA . . . . . 0.422 ' CB ' ' HB3' ' B' ' 218' ' ' PRO . . . -65.72 -31.09 71.88 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.57 -177.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 211' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -69.77 -47.87 61.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.003 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 212' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' B' ' 209' ' ' LEU . 4.6 pp -67.21 -22.15 65.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.978 0.418 . . . . 0.0 109.897 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . 0.511 ' HA2' HG13 ' A' ' 37' ' ' VAL . . . -55.22 -25.79 41.08 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.909 174.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 123.86 17.21 3.15 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.633 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 215' ' ' ASN . . . . . 0.579 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 34.2 t30 -133.1 124.0 26.76 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.817 0.341 . . . . 0.0 110.587 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . 0.517 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 15.5 m -75.41 -21.96 57.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.11 -178.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 8.4 t -121.44 68.02 20.12 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.999 -176.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . 0.517 ' HD3' ' C ' ' B' ' 216' ' ' SER . 75.4 Cg_exo -56.54 -60.78 0.41 Allowed 'Trans proline' 0 N--CA 1.481 0.762 0 C-N-CA 123.731 2.954 . . . . 0.0 113.24 177.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . 0.558 ' O ' HD13 ' B' ' 223' ' ' ILE . 21.0 t 59.52 -174.87 0.1 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.204 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . 0.603 ' O ' ' HB2' ' B' ' 224' ' ' LYS . . . -54.07 -34.87 61.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.196 -176.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -58.32 -59.82 4.73 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.454 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -71.75 -35.0 69.98 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -175.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.558 HD13 ' O ' ' B' ' 219' ' ' SER . 1.7 mp -69.48 -40.61 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 120.166 -0.613 . . . . 0.0 110.173 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 224' ' ' LYS . . . . . 0.603 ' HB2' ' O ' ' B' ' 220' ' ' ALA . 14.7 mmtt -60.23 -43.76 95.76 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 174.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -55.57 -49.25 73.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.56 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 0.407 HG13 ' HB3' ' A' ' 34' ' ' ALA . 1.2 mp -65.98 -40.73 88.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.012 -177.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 4.1 mp -71.74 -43.17 66.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.731 0.301 . . . . 0.0 111.603 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.34 -21.15 61.36 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.883 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 33.3 t -57.08 -43.5 82.21 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.039 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -90.17 -31.95 5.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -176.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 103.63 69.65 0.8 Allowed Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.165 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.98 -174.04 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 170.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -80.17 -169.18 1.94 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -172.15 -22.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 119.435 -0.317 . . . . 0.0 111.6 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 50.11 96.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 O-C-N 123.515 0.51 . . . . 0.0 111.678 177.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -57.63 -25.43 60.12 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -172.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -64.07 -66.45 0.54 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.395 0.616 . . . . 0.0 110.243 171.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.46 ' O ' HG23 ' B' ' 242' ' ' VAL . 96.4 mtt180 -57.16 -40.58 77.56 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.315 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 239' ' ' LEU . . . . . 0.401 HD21 HG22 ' B' ' 223' ' ' ILE . 2.4 tm? -48.97 -64.5 0.79 Allowed 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.425 0.631 . . . . 0.0 110.762 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -72.42 -25.74 61.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.685 -176.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -65.94 -46.99 76.18 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.299 -0.56 . . . . 0.0 109.973 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 242' ' ' VAL . . . . . 0.46 HG23 ' O ' ' B' ' 238' ' ' ARG . 80.7 t -66.29 -41.05 88.35 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . 0.571 ' HA ' ' CD2' ' B' ' 246' ' ' LEU . 19.7 mt -65.71 -42.62 92.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.769 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . 0.437 ' HA ' ' HB2' ' B' ' 247' ' ' ASN . 28.2 t -71.87 -22.15 61.56 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.756 0.313 . . . . 0.0 110.825 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -86.55 -22.87 26.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.281 0.562 . . . . 0.0 109.955 177.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . 0.613 ' O ' HD12 ' B' ' 246' ' ' LEU . 1.3 pp -101.1 2.62 40.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.735 176.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 247' ' ' ASN . . . . . 0.437 ' HB2' ' HA ' ' B' ' 244' ' ' SER . 6.7 t30 -72.86 69.44 0.94 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.688 -173.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -134.6 -175.49 13.9 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.032 -178.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -89.41 -3.35 58.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.175 0.512 . . . . 0.0 110.646 -176.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . 0.486 ' HA ' ' OD1' ' B' ' 253' ' ' ASP . 4.4 p-10 -79.33 12.16 2.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.805 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.527 ' HA ' HG12 ' B' ' 254' ' ' VAL . 6.2 tp -67.06 -37.3 79.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 176.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -61.52 -42.08 98.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.583 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . 0.486 ' OD1' ' HA ' ' B' ' 250' ' ' ASN . 2.7 m-20 -60.46 -49.96 75.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.662 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 254' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' B' ' 251' ' ' ILE . 8.3 p -70.58 -25.49 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.444 -176.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 255' ' ' ILE . . . . . 0.448 HG13 ' O ' ' B' ' 251' ' ' ILE . 59.7 mt -77.46 -38.33 26.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.112 0.482 . . . . 0.0 110.278 176.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -78.24 -20.27 52.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.548 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -113.26 27.26 9.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.112 176.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . 0.766 ' HA2' ' OH ' ' A' ' 11' ' ' TYR . . . 20.38 -96.56 0.01 OUTLIER Glycine 0 C--N 1.336 0.543 0 N-CA-C 116.781 1.472 . . . . 0.0 116.781 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 259' ' ' ILE . . . . . 0.706 ' O ' ' HG ' ' B' ' 262' ' ' LEU . 0.0 OUTLIER -56.33 -41.05 69.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -172.131 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 54.48 -122.98 26.67 Favored Glycine 0 C--N 1.329 0.184 0 C-N-CA 121.138 -0.553 . . . . 0.0 113.24 174.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -116.83 27.75 8.96 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 262' ' ' LEU . . . . . 0.706 ' HG ' ' O ' ' B' ' 259' ' ' ILE . 0.6 OUTLIER -88.71 -25.83 22.12 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -178.243 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -92.64 134.75 34.71 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.853 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 14.7 t -149.22 -167.03 2.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.783 0.325 . . . . 0.0 110.889 -176.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 47.9 t -77.63 131.91 69.93 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.565 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.71 131.96 40.33 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.575 2.183 . . . . 0.0 112.813 175.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . -147.0 -52.5 0.21 Allowed 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.016 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . -81.93 62.49 4.53 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.412 176.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -89.91 -34.86 8.02 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.124 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -154.99 123.01 5.83 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 11.2 t -106.55 136.73 40.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . 68.85 160.54 0.19 Allowed 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.927 0.767 . . . . 0.0 110.874 -175.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 9.5 p -128.54 138.64 54.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.162 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 48.4 t -132.3 150.19 52.21 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.002 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -151.97 162.41 41.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.181 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -107.8 111.96 62.18 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 121.065 0.459 . . . . 0.0 111.02 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 277' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.1 56.86 5.59 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 123.345 2.697 . . . . 0.0 111.914 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 147.76 169.73 15.22 Favored Glycine 0 N--CA 1.436 -1.32 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.611 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 73.8 m -153.96 170.56 20.77 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.784 0.292 . . . . 0.0 110.389 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 61.24 37.11 17.57 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 123.859 0.724 . . . . 0.0 111.831 176.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -129.48 93.67 34.76 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.497 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -78.45 -55.4 0.05 OUTLIER 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.543 2.162 . . . . 0.0 113.089 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -164.64 159.64 19.18 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -84.74 115.49 22.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.687 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 149.12 -64.89 0.4 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.587 -0.815 . . . . 0.0 112.458 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 18.0 m 57.73 34.7 24.77 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.149 0.5 . . . . 0.0 111.184 -178.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 287' ' ' ALA . . . . . 0.455 ' HB3' ' HD3' ' B' ' 288' ' ' PRO . . . -82.36 -48.99 0.86 Allowed Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.795 -176.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 288' ' ' PRO . . . . . 0.455 ' HD3' ' HB3' ' B' ' 287' ' ' ALA . 6.6 Cg_exo -73.85 63.56 4.9 Favored 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 122.135 1.89 . . . . 0.0 112.315 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -127.5 136.41 51.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.62 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -154.61 160.24 41.34 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.453 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -102.64 111.35 23.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.758 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -94.38 -74.54 0.54 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.725 -175.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 48.56 30.34 2.43 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 123.685 0.615 . . . . 0.0 112.448 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -114.69 96.92 5.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.116 0.484 . . . . 0.0 110.556 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -92.82 59.55 3.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.562 0.696 . . . . 0.0 109.601 175.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -144.48 115.58 7.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.055 -177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -157.72 83.88 0.89 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.32 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -170.83 -39.18 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -127.33 127.74 44.77 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.786 0.327 . . . . 0.0 111.036 -175.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -96.51 127.7 42.75 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.696 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -77.47 101.82 6.6 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.176 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 4.8 m -90.26 55.53 3.1 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -173.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -129.04 44.22 3.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.426 0.631 . . . . 0.0 110.431 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -85.71 85.12 7.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.832 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 8.9 t -165.31 74.73 0.23 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.313 0.577 . . . . 0.0 109.503 176.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -97.27 53.81 1.19 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.959 0.885 . . . . 0.0 109.041 -177.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -92.15 79.17 5.14 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.711 -174.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -109.33 145.6 35.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.544 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 20.3 ptp -142.3 13.21 1.99 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.338 176.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 84.35 129.53 1.84 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.793 -0.717 . . . . 0.0 113.012 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -92.05 39.62 1.02 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.0 0.429 . . . . 0.0 110.765 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 312' ' ' GLY . . . . . 0.403 ' C ' ' H ' ' B' ' 314' ' ' PHE . . . -164.5 45.28 0.3 Allowed Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 313' ' ' LEU . . . . . 0.469 ' CD2' ' H ' ' B' ' 313' ' ' LEU . 1.7 pt? -79.18 36.66 0.3 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.836 0.827 . . . . 0.0 110.578 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 314' ' ' PHE . . . . . 0.403 ' H ' ' C ' ' B' ' 312' ' ' GLY . 43.1 p90 -97.25 19.54 12.93 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.632 -174.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 21.8 t70 . . . . . 0 C--O 1.246 0.908 0 CA-C-O 118.584 -0.722 . . . . 0.0 109.712 178.488 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.9 mtp . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.81 -95.96 0.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.513 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 p -125.98 84.63 2.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.426 0.632 . . . . 0.0 111.44 -175.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.4 t -65.76 -26.74 39.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.48 0.657 . . . . 0.0 109.843 -176.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.444 ' HB3' HG23 ' A' ' 39' ' ' VAL . 3.3 m -58.06 -66.65 0.44 Allowed 'General case' 0 C--O 1.242 0.709 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.591 -178.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.596 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -77.06 -20.62 55.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.764 -176.884 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.44 ' CD2' HG23 ' B' ' 255' ' ' ILE . 17.7 tp -57.09 -57.51 12.24 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 169.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.587 ' HB2' HD21 ' B' ' 212' ' ' LEU . . . -58.33 -48.72 79.63 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.413 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 49.3 t -65.43 -34.62 78.73 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.364 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.596 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 0.7 OUTLIER -70.2 -38.99 76.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 120.898 0.38 . . . . 0.0 110.352 -179.711 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.629 ' OH ' ' HA ' ' B' ' 255' ' ' ILE . 19.5 m-30 -67.65 -31.75 71.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.049 177.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.2 m -64.33 -46.17 84.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.188 174.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.609 ' HB1' HD21 ' A' ' 59' ' ' LEU . . . -53.49 -44.72 69.25 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.981 174.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.408 ' CD1' HD12 ' B' ' 262' ' ' LEU . 40.0 mt -61.34 -49.54 76.54 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.788 177.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 11' ' ' TYR . 30.5 mm -54.75 -42.38 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.531 -178.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 16' ' ' LEU . 4.4 mm? -68.23 -35.33 77.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.988 0.423 . . . . 0.0 111.227 175.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -80.29 10.79 4.1 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -174.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.408 ' OD1' ' HG2' ' B' ' 202' ' ' ARG . 27.2 t70 -81.87 -79.61 0.17 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 118.452 0.569 . . . . 0.0 111.085 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.12 40.45 0.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 50.01 44.97 25.67 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.689 0.756 . . . . 0.0 111.623 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 79.7 t -92.34 138.74 19.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.55 177.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 p -62.21 111.86 2.15 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -171.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.411 HG11 ' HB2' ' A' ' 51' ' ' LEU . 57.2 t -56.56 107.56 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.794 172.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.2 p -139.92 155.65 47.07 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -176.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -52.07 -54.48 29.75 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.532 -177.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -51.5 -35.02 38.45 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.396 177.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.581 ' HG3' HG13 ' B' ' 230' ' ' VAL . 13.1 mptt -75.95 -45.05 36.99 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.404 -173.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.467 ' O ' HD13 ' A' ' 32' ' ' ILE . 5.4 mt -63.43 -42.35 95.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.306 -0.558 . . . . 0.0 109.825 176.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -58.72 -41.07 85.53 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.949 175.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.47 -49.48 77.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.241 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.47 -38.84 92.67 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.0 0.429 . . . . 0.0 111.164 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.467 HD13 ' O ' ' A' ' 28' ' ' ILE . 1.5 mp -59.61 -37.19 69.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.699 176.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -74.12 -30.88 62.52 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.703 0.287 . . . . 0.0 110.64 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.587 ' CB ' HD13 ' B' ' 226' ' ' ILE . . . -63.58 -44.32 94.39 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.958 176.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.478 ' HB2' ' CD1' ' B' ' 209' ' ' LEU . . . -77.01 -50.51 12.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.551 177.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.45 -4.53 31.21 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.646 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.414 HG23 ' HA2' ' B' ' 213' ' ' GLY . 48.2 t -82.63 131.31 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.627 0.251 . . . . 0.0 110.443 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -97.97 98.67 9.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.823 0.82 . . . . 0.0 110.377 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.444 HG23 ' HB3' ' A' ' 5' ' ' SER . 7.3 p -83.85 140.54 16.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.985 177.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.41 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 10.1 tp10 -44.53 111.38 1.21 Allowed Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.046 174.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -46.49 -16.06 0.23 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 124.483 3.455 . . . . 0.0 115.108 -174.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.474 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -70.18 -32.25 70.09 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -179.356 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.485 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 84.3 m95 -71.9 -51.76 8.4 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.43 177.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 81.1 Cg_exo -49.64 -47.13 24.08 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 122.258 1.972 . . . . 0.0 112.19 170.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.28 -49.81 63.73 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.933 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -52.69 -53.1 52.12 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.684 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.404 ' CZ ' HD12 ' A' ' 10' ' ' ILE . 5.9 m-85 -61.93 -38.13 87.27 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.57 -34.71 78.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.735 -0.212 . . . . 0.0 111.19 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -100.47 -7.16 24.53 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -99.33 -37.66 9.16 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 121.951 -0.468 . . . . 0.0 112.224 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.619 ' HA ' ' CG1' ' A' ' 54' ' ' VAL . 1.6 mp -93.74 -128.51 0.12 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.41 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 66.7 -11.65 0.24 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.421 ' H ' ' C ' ' A' ' 51' ' ' LEU . 27.2 t-20 -137.34 3.62 2.6 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.619 ' CG1' ' HA ' ' A' ' 51' ' ' LEU . 34.1 m -89.88 121.11 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.037 -170.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -40.0 -87.6 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.957 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.3 tp -157.81 -57.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 121.222 -0.191 . . . . 0.0 111.458 175.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.41 -21.87 60.54 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.242 -0.504 . . . . 0.0 112.55 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.461 ' HB2' ' HB ' ' A' ' 54' ' ' VAL . 1.5 m -52.97 -20.09 3.13 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.034 0.534 . . . . 0.0 110.997 176.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.609 HD21 ' HB1' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -49.51 -42.99 45.2 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.848 176.714 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.549 HG23 HD13 ' B' ' 259' ' ' ILE . 37.2 mt -83.48 -7.13 10.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.604 0.716 . . . . 0.0 110.461 -173.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 47.5 t -89.18 -26.79 21.08 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.785 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -82.91 -16.3 48.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.35 0.595 . . . . 0.0 111.044 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.7 p -78.84 -12.04 13.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.793 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.41 -66.41 0.37 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.862 177.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.25 149.71 36.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.719 0.295 . . . . 0.0 111.058 -175.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -173.72 112.27 0.41 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.352 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.21 163.49 11.6 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.2 -0.524 . . . . 0.0 111.887 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -83.45 161.71 14.84 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.614 2.209 . . . . 0.0 112.064 179.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -117.18 107.85 44.86 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-O 120.678 0.275 . . . . 0.0 110.351 177.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.86 166.76 11.42 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.401 2.068 . . . . 0.0 112.403 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -162.25 175.95 11.11 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.351 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.84 104.67 4.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.303 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.66 -68.98 0.99 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.991 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.78 152.82 20.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.59 0.219 . . . . 0.0 111.59 -176.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -150.91 139.16 12.71 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.045 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 53.2 Cg_exo -55.82 96.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.586 2.857 . . . . 0.0 113.094 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.75 146.32 25.71 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.262 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -151.19 160.24 28.58 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.03 176.98 44.23 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.23 178.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.5 123.65 7.76 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.46 2.107 . . . . 0.0 112.441 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.438 ' H ' ' HD2' ' A' ' 82' ' ' PRO . . . -106.32 -46.72 0.12 Allowed Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.116 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.438 ' HD2' ' H ' ' A' ' 81' ' ' ALA . 83.2 Cg_exo -49.19 131.08 25.83 Favored 'Trans proline' 0 C--N 1.365 1.435 0 C-N-CA 122.152 1.902 . . . . 0.0 113.039 176.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.8 t -87.97 117.94 27.17 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.908 177.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.6 p -73.96 126.14 29.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.521 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.71 146.93 46.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.155 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -172.57 178.27 2.75 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.065 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 62.67 87.24 0.13 Allowed Pre-proline 0 N--CA 1.467 0.419 0 O-C-N 123.964 0.79 . . . . 0.0 112.14 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.75 147.49 91.99 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.988 2.459 . . . . 0.0 113.049 176.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.4 92.52 8.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.843 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -83.82 112.79 20.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.504 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.64 151.86 46.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.592 176.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -97.11 -7.67 32.1 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.283 0.563 . . . . 0.0 110.366 -176.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -140.56 124.66 17.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.079 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.8 t -110.86 -65.26 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.164 0.507 . . . . 0.0 110.323 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -142.32 169.94 16.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.935 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 97' ' ' LYS . . . -137.86 -71.55 0.43 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.514 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 96' ' ' ALA . 83.8 mttt 65.74 137.25 0.02 OUTLIER 'General case' 0 C--N 1.343 0.3 0 O-C-N 123.834 0.709 . . . . 0.0 111.578 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -89.47 -18.2 27.19 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.143 -0.348 . . . . 0.0 111.346 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 59.77 -88.47 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.835 0.709 . . . . 0.0 112.059 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -88.51 -170.24 2.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.05 0.453 . . . . 0.0 111.553 -173.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.7 m -147.86 135.33 20.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.856 -177.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -86.17 73.39 10.24 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.04 0.448 . . . . 0.0 111.116 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -162.7 69.21 0.24 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.813 0.816 . . . . 0.0 109.608 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 52.5 m -147.51 147.35 30.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.543 -177.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 62.08 -160.46 0.31 Allowed 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.779 0.674 . . . . 0.0 110.849 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.23 125.46 23.77 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.804 0.335 . . . . 0.0 110.816 -177.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -90.39 69.37 6.95 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.715 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 23.0 ptp 38.08 49.01 1.17 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.342 1.057 . . . . 0.0 113.564 176.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -148.91 160.17 28.3 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.842 177.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -86.38 111.0 20.08 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.974 0.416 . . . . 0.0 110.318 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -86.27 -52.75 3.14 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.537 -0.84 . . . . 0.0 113.473 -176.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.1 mt -117.69 -6.09 11.11 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -172.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -67.05 -57.21 7.27 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.471 0.175 . . . . 0.0 111.471 -176.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 . . . . . 0 C--O 1.251 1.135 0 CA-C-O 117.742 -1.123 . . . . 0.0 109.97 179.009 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 200' ' ' ALA . . . . . 0.573 ' O ' ' HG2' ' B' ' 201' ' ' MET . . . . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 119.593 -0.241 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.573 ' HG2' ' O ' ' B' ' 200' ' ' ALA . 26.1 ptm 61.63 -23.08 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 169.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 202' ' ' ARG . . . . . 0.408 ' HG2' ' OD1' ' A' ' 18' ' ' ASP . 73.0 mtp180 -33.38 -68.78 0.1 Allowed 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -172.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 203' ' ' TYR . . . . . 0.421 ' HD2' HG21 ' B' ' 242' ' ' VAL . 76.4 m-85 -112.27 0.2 15.68 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.282 0.563 . . . . 0.0 111.412 -175.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.673 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 64.6 t -64.08 -54.27 33.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.262 177.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 205' ' ' ALA . . . . . 0.653 ' HA ' HD12 ' B' ' 208' ' ' LEU . . . -70.45 -12.81 61.82 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 -178.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . 0.625 ' OG ' HG23 ' B' ' 223' ' ' ILE . 9.5 t -79.39 -39.86 31.47 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 175.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 207' ' ' TYR . . . . . 0.802 ' HB2' HD21 ' B' ' 246' ' ' LEU . 34.4 t80 -63.1 -40.35 97.37 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 173.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 33.3 mt -59.01 -51.96 67.84 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.154 176.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 209' ' ' LEU . . . . . 0.914 HD12 HD12 ' B' ' 226' ' ' ILE . 0.2 OUTLIER -51.6 -50.74 59.62 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.627 179.533 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -65.48 -32.97 74.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.415 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 211' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -65.57 -55.08 19.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.901 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 212' ' ' LEU . . . . . 0.587 HD21 ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -76.24 -13.01 60.18 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.366 -179.278 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . 0.414 ' HA2' HG23 ' A' ' 37' ' ' VAL . . . -57.2 -16.82 21.46 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.271 170.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 121.35 4.81 9.78 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.621 -0.591 . . . . 0.0 111.621 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 215' ' ' ASN . . . . . 0.589 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 38.6 t30 -117.95 100.95 7.89 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.97 0.414 . . . . 0.0 110.183 -175.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . 0.45 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 15.2 m -72.22 -7.98 52.26 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.269 -177.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 217' ' ' SER . . . . . 0.402 ' N ' ' HD3' ' B' ' 218' ' ' PRO . 31.2 m -130.01 64.37 72.04 Favored Pre-proline 0 C--N 1.319 -0.718 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.399 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . 0.458 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 53.2 Cg_exo -57.12 137.36 81.48 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.315 2.677 . . . . 0.0 113.209 -177.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 28.9 t -115.33 165.76 12.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.281 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -53.73 -42.58 68.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.134 0.492 . . . . 0.0 110.784 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -59.34 -43.77 92.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.466 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -65.2 -52.34 55.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.933 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.625 HG23 ' OG ' ' B' ' 206' ' ' SER . 1.8 mp -58.08 -48.27 84.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.87 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 224' ' ' LYS . . . . . 0.537 ' HE3' ' CG ' ' B' ' 236' ' ' ASP . 60.1 tttm -68.5 -22.65 64.52 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 122.258 -0.276 . . . . 0.0 111.448 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -69.79 -42.99 73.03 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 0.914 HD12 HD12 ' B' ' 209' ' ' LEU . 1.5 mm -66.36 -38.26 81.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 113.797 -1.547 . . . . 0.0 111.299 176.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . 0.476 ' CD1' ' HB ' ' B' ' 232' ' ' ILE . 0.2 OUTLIER -71.96 -42.03 67.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.888 0.375 . . . . 0.0 110.487 179.455 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 228' ' ' ASP . . . . . 0.461 ' OD2' ' HG2' ' B' ' 224' ' ' LYS . 10.2 m-20 -75.08 -20.63 59.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.578 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 61.2 p -56.39 -35.1 67.37 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.751 0.31 . . . . 0.0 111.157 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 230' ' ' VAL . . . . . 0.581 HG13 ' HG3' ' A' ' 27' ' ' LYS . 63.4 t -89.68 -41.07 13.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.163 0.506 . . . . 0.0 111.145 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 110.3 34.96 2.2 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.332 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . 0.476 ' HB ' ' CD1' ' B' ' 227' ' ' LEU . 3.9 mt -98.02 123.76 50.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -61.87 107.99 0.94 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.003 0.43 . . . . 0.0 111.9 -170.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -106.16 132.26 52.43 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.824 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . 0.57 ' O ' HD12 ' B' ' 239' ' ' LEU . 10.9 m-20 -79.3 121.51 25.19 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 236' ' ' ASP . . . . . 0.537 ' CG ' ' HE3' ' B' ' 224' ' ' LYS . 3.3 m-20 -59.78 -14.33 14.18 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.514 0.509 . . . . 0.0 112.229 -178.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -98.98 -49.61 4.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.301 0.572 . . . . 0.0 110.683 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.559 ' O ' HG23 ' B' ' 242' ' ' VAL . 19.4 mmm180 -66.8 -36.43 82.37 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.346 -172.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 239' ' ' LEU . . . . . 0.591 HD13 ' H ' ' B' ' 240' ' ' ASN . 0.0 OUTLIER -65.38 -34.83 79.22 Favored 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.279 -176.125 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 240' ' ' ASN . . . . . 0.591 ' H ' HD13 ' B' ' 239' ' ' LEU . 55.0 t30 -79.91 -32.62 40.17 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -65.05 -40.25 94.49 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.486 174.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 242' ' ' VAL . . . . . 0.659 ' O ' ' HB3' ' B' ' 246' ' ' LEU . 87.7 t -64.02 -49.35 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . 0.544 ' HA ' HD23 ' B' ' 246' ' ' LEU . 35.4 mt -53.96 -39.04 39.01 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.753 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.522 174.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 56.1 m -59.43 -42.43 91.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.754 0.311 . . . . 0.0 110.749 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -77.82 -21.29 51.76 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.443 0.64 . . . . 0.0 110.968 176.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . 0.802 HD21 ' HB2' ' B' ' 207' ' ' TYR . 0.3 OUTLIER -102.92 -12.23 17.66 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.919 -168.042 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 247' ' ' ASN . . . . . 0.434 HD22 ' C ' ' B' ' 247' ' ' ASN . 0.3 OUTLIER -78.26 48.15 0.73 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.351 0.596 . . . . 0.0 111.402 -179.574 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -93.11 156.59 22.92 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.143 -0.551 . . . . 0.0 111.822 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . 0.669 ' HD3' ' H ' ' B' ' 249' ' ' LYS . 0.3 OUTLIER -80.1 39.65 0.45 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.045 0.45 . . . . 0.0 111.966 -175.075 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -118.59 27.61 8.82 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.49 HD11 ' CE1' ' B' ' 207' ' ' TYR . 3.5 mm -64.57 -50.79 74.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -172.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -63.65 -30.08 71.23 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.231 0.539 . . . . 0.0 110.652 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.5 -48.7 63.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.976 176.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 254' ' ' VAL . . . . . 0.415 HG22 ' HA ' ' B' ' 251' ' ' ILE . 34.9 m -65.34 -27.37 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.046 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 255' ' ' ILE . . . . . 0.629 ' HA ' ' OH ' ' A' ' 11' ' ' TYR . 30.2 mt -69.63 -52.92 27.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.119 0.485 . . . . 0.0 110.583 174.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -69.38 -15.79 63.38 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.768 -177.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -82.91 40.44 0.69 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.427 174.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 20.34 -98.97 0.01 OUTLIER Glycine 0 N--CA 1.472 1.069 0 N-CA-C 115.833 1.093 . . . . 0.0 115.833 -172.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 259' ' ' ILE . . . . . 0.549 HD13 HG23 ' A' ' 60' ' ' ILE . 2.7 mp -86.1 -25.51 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.035 0.445 . . . . 0.0 111.117 -174.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 72.51 -170.05 51.22 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.205 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -87.76 25.6 1.47 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 175.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 262' ' ' LEU . . . . . 0.408 HD12 ' CD1' ' A' ' 14' ' ' LEU . 6.7 mt -80.71 -43.46 20.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.325 -176.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -99.27 62.15 1.24 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.5 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 25.6 t -130.5 124.69 32.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.061 0.458 . . . . 0.0 111.114 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 87.5 t -132.85 117.43 15.05 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.258 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.06 -26.63 12.71 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.71 2.274 . . . . 0.0 112.684 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.12 114.0 3.17 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.301 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 123.51 -48.89 0.93 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.42 -178.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -86.43 42.66 3.17 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.189 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -137.65 48.73 2.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.398 0.618 . . . . 0.0 110.453 -177.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 16.6 t -94.56 135.42 28.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.102 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -157.45 121.17 4.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.469 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 15.8 m -85.24 134.55 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.657 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 13.6 p -129.54 100.65 5.62 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.692 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -111.83 122.03 46.67 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.225 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -93.26 117.91 67.56 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.769 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 277' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.38 140.43 63.76 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.64 2.227 . . . . 0.0 112.102 177.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -108.97 110.37 3.0 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.423 -178.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 73.1 m -159.21 177.47 11.01 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 63.05 79.79 0.25 Allowed 'General case' 0 CA--C 1.53 0.206 0 O-C-N 123.924 0.765 . . . . 0.0 112.362 173.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -72.78 123.61 89.76 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.705 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.87 108.04 2.46 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.583 2.188 . . . . 0.0 112.356 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -160.34 133.45 6.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.605 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -148.97 172.2 15.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.075 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -165.49 -179.4 39.21 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.695 178.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 16.5 m -125.69 133.11 52.26 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.718 0.294 . . . . 0.0 110.378 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -140.07 126.12 11.89 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.382 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -85.38 158.22 10.99 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.958 2.438 . . . . 0.0 112.801 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -99.3 137.68 37.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.148 177.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -147.28 156.94 43.37 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.134 -175.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -96.47 115.53 27.58 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -57.55 136.01 56.7 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 123.681 0.613 . . . . 0.0 111.331 -177.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -69.8 139.15 53.17 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.278 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -126.87 82.28 2.07 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.819 173.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -75.01 81.09 2.2 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.89 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -92.7 167.62 11.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.724 -178.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 56.2 49.93 14.43 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.773 0.797 . . . . 0.0 110.919 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -84.24 56.54 3.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.894 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 24.1 tptm 69.67 113.81 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.674 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -96.28 -167.92 1.66 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.629 178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -54.56 136.04 45.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.14 0.495 . . . . 0.0 110.694 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 19.5 m -93.4 113.03 25.09 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.854 -175.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -107.09 129.27 54.85 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.693 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -127.66 124.53 38.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.988 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 56.4 m 59.06 80.42 0.19 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.744 0.652 . . . . 0.0 112.648 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -103.58 76.98 1.45 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 174.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -83.23 -45.63 13.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.809 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 2.4 t70 55.29 32.69 19.15 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 123.777 0.673 . . . . 0.0 110.647 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 66.6 mtt -93.09 34.85 1.09 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.575 -175.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 64.45 40.21 97.53 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.67 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 61.68 35.29 17.08 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 122.754 0.422 . . . . 0.0 111.271 178.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . -80.73 65.97 3.82 Favored Glycine 0 C--O 1.227 -0.324 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.477 -178.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 6.8 mp -105.21 27.03 8.63 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.433 0.635 . . . . 0.0 109.533 175.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 314' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -99.71 -15.44 18.51 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.418 -173.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 C--O 1.252 1.2 0 CA-C-O 118.774 -0.632 . . . . 0.0 110.019 -179.494 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.424 ' HG2' ' OE2' ' B' ' 252' ' ' GLU . 16.4 mmt . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.653 0.263 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.55 -80.63 0.57 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.691 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.436 ' HB2' ' HG2' ' A' ' 6' ' ' GLU . 3.8 p -126.24 86.53 2.54 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.566 0.698 . . . . 0.0 110.857 -177.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.536 ' HA ' HD12 ' A' ' 7' ' ' LEU . 21.1 t -67.47 -27.22 37.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.398 -172.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.677 ' HB3' HG23 ' A' ' 39' ' ' VAL . 7.0 m -61.68 -57.99 9.82 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.21 -177.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.436 ' HG2' ' HB2' ' A' ' 3' ' ' SER . 9.6 pt-20 -72.98 -29.3 62.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.596 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.536 HD12 ' HA ' ' A' ' 4' ' ' VAL . 39.8 mt -53.91 -52.92 59.02 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 170.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.446 ' HA ' HD21 ' B' ' 212' ' ' LEU . . . -55.3 -53.18 59.31 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.122 178.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.604 ' SG ' HG21 ' A' ' 39' ' ' VAL . 31.6 m -63.48 -33.21 75.08 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.548 -177.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.419 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 1.1 tp -72.65 -40.36 62.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.689 0.28 . . . . 0.0 111.309 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -75.64 -18.69 59.59 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.306 -0.558 . . . . 0.0 109.662 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.499 ' HB3' HG12 ' A' ' 28' ' ' ILE . 47.8 m -72.24 -44.89 62.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 170.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.405 ' HB3' HD12 ' A' ' 59' ' ' LEU . . . -50.58 -46.27 57.7 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 171.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.586 HD23 HD11 ' A' ' 56' ' ' ILE . 67.9 mt -59.38 -52.95 63.41 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.586 178.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.522 HD12 HD21 ' A' ' 31' ' ' LEU . 30.2 mt -62.02 -31.19 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -177.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.572 ' HB3' ' HA ' ' A' ' 23' ' ' VAL . 3.4 mm? -98.75 -0.98 41.58 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -124.9 53.18 1.51 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.379 0.609 . . . . 0.0 110.278 174.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.589 ' OD1' ' HA ' ' B' ' 200' ' ' ALA . 24.3 t70 -136.96 -58.3 0.72 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.871 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.429 ' CG ' ' H ' ' A' ' 20' ' ' GLU . 24.0 t70 -73.72 -174.51 1.79 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.58 175.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.429 ' H ' ' CG ' ' A' ' 19' ' ' ASP . 33.0 tt0 -77.25 -17.48 58.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.436 0.636 . . . . 0.0 109.659 178.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 79.7 t -61.19 124.25 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.941 174.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.6 p -82.61 149.98 27.11 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.076 -177.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.572 ' HA ' ' HB3' ' A' ' 16' ' ' LEU . 2.5 m -60.81 124.73 15.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.198 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.1 p -145.89 143.61 29.69 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.942 -174.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.447 ' HG3' ' H ' ' A' ' 26' ' ' ASP . 7.7 pt-20 -45.96 -50.85 14.31 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 123.706 0.629 . . . . 0.0 111.234 -177.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.447 ' H ' ' HG3' ' A' ' 25' ' ' GLU . 13.5 t70 -53.68 -43.67 69.07 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.531 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.508 ' O ' HG12 ' B' ' 230' ' ' VAL . 2.9 mptp? -78.35 -40.68 35.68 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.33 -172.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.745 ' O ' HG12 ' A' ' 32' ' ' ILE . 5.7 mt -62.98 -50.06 81.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 119.774 -0.771 . . . . 0.0 109.947 176.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -54.41 -44.79 72.66 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.866 0.365 . . . . 0.0 110.576 177.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.33 -45.94 83.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.983 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.574 ' HB2' ' CG1' ' B' ' 230' ' ' VAL . 44.0 tp -69.06 -40.14 78.68 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 121.194 0.521 . . . . 0.0 111.03 -176.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.745 HG12 ' O ' ' A' ' 28' ' ' ILE . 18.5 mm -62.52 -38.27 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.941 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -82.72 -17.49 44.16 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.579 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 31' ' ' LEU . . . -62.62 -46.35 88.63 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 174.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.35 -47.77 11.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.9 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.2 64.84 0.98 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.934 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.0 m -120.86 179.26 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.879 0.371 . . . . 0.0 111.012 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -113.38 113.6 25.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.224 -177.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.677 HG23 ' HB3' ' A' ' 5' ' ' SER . 4.4 p -145.91 137.18 19.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.765 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -56.78 123.87 60.71 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.221 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -56.41 -8.55 2.79 Favored 'Trans proline' 0 C--O 1.241 0.629 0 C-N-CA 123.57 2.847 . . . . 0.0 113.004 -174.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.45 -25.52 50.68 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.598 -177.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.425 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 97.0 m95 -66.84 -60.05 6.87 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.393 175.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.425 ' CD ' ' HB2' ' A' ' 43' ' ' TRP . 10.3 Cg_endo -55.87 -42.17 69.79 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 121.882 1.721 . . . . 0.0 112.276 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.73 -54.26 39.36 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.75 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.9 tt -59.12 -45.34 91.17 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.582 ' HA ' HD13 ' A' ' 51' ' ' LEU . 4.0 m-85 -54.58 -54.59 39.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.697 0.284 . . . . 0.0 111.643 -178.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.27 -24.79 61.4 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.959 -176.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -99.95 -1.68 36.57 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.03 -17.38 4.86 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.582 HD13 ' HA ' ' A' ' 47' ' ' PHE . 8.4 mp -80.25 -113.46 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.958 -0.464 . . . . 0.0 109.819 175.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 59.39 2.79 0.34 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 177.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -145.01 -52.68 0.28 Allowed 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 122.21 1.005 . . . . 0.0 108.593 -173.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.488 HG11 ' HG ' ' A' ' 51' ' ' LEU . 2.4 p -18.42 110.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 111.861 -2.427 . . . . 0.0 114.553 173.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -56.71 130.98 47.77 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 163.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.64 ' O ' HD22 ' A' ' 59' ' ' LEU . 5.5 tp -47.63 -58.62 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -166.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.62 -29.11 60.71 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.005 -0.617 . . . . 0.0 113.297 -176.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.2 m -59.36 -16.8 24.9 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.64 HD22 ' O ' ' A' ' 56' ' ' ILE . 1.0 OUTLIER -60.63 -17.71 48.85 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.389 0.144 . . . . 0.0 111.389 -179.45 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.508 ' N ' HD23 ' A' ' 59' ' ' LEU . 15.7 tt -65.21 -22.16 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 120.882 0.373 . . . . 0.0 111.004 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.4 t -127.69 73.22 1.44 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.232 0.539 . . . . 0.0 110.22 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -107.48 -12.75 15.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.067 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.7 t -74.51 -42.19 49.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.518 -175.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.06 -80.52 1.23 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.654 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -123.47 -48.9 1.92 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.955 0.407 . . . . 0.0 110.797 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 162.57 -144.1 9.33 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -177.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.49 163.05 29.67 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.326 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -89.62 155.42 5.23 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.088 2.525 . . . . 0.0 112.818 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.446 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . . . -116.37 120.77 34.37 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.01 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 69' ' ' ALA . 13.9 Cg_exo -71.51 -21.6 25.73 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.457 2.105 . . . . 0.0 112.34 177.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 66.32 -158.49 0.25 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.846 176.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.36 137.45 56.9 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.091 0.472 . . . . 0.0 111.324 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.77 -34.82 17.82 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.603 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 65.56 102.46 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.13 0.572 . . . . 0.0 111.928 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.475 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . 73.86 138.66 0.06 OUTLIER Pre-proline 0 N--CA 1.471 0.588 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.437 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 32.4 Cg_exo -63.85 161.11 34.06 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.178 2.585 . . . . 0.0 113.243 -177.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 76' ' ' PRO . . . 79.39 146.61 0.09 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.256 0.972 . . . . 0.0 111.342 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.98 0.07 80.22 Favored Glycine 0 C--N 1.33 0.247 0 CA-C-N 115.699 -0.682 . . . . 0.0 113.235 -175.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.0 -97.23 0.77 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.74 177.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -68.07 105.12 1.13 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.627 2.218 . . . . 0.0 112.097 -177.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -129.97 91.45 39.61 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.568 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.44 -54.38 2.59 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.878 2.385 . . . . 0.0 112.043 176.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.0 t -165.39 167.74 17.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.471 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 97.6 m -162.29 -44.95 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.421 0.629 . . . . 0.0 109.57 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -96.72 107.55 20.04 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.791 177.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 66.33 -172.54 0.19 Allowed 'General case' 0 C--O 1.235 0.307 0 O-C-N 124.083 0.864 . . . . 0.0 110.459 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.41 70.64 1.5 Allowed Pre-proline 0 CA--C 1.533 0.299 0 O-C-N 123.335 0.397 . . . . 0.0 111.673 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -57.59 140.15 92.46 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.011 2.474 . . . . 0.0 112.731 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -127.26 37.6 4.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.841 0.353 . . . . 0.0 111.376 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -83.54 161.72 21.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.018 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 92' ' ' LYS . 1.1 pm0 -88.09 -165.4 1.31 Allowed 'General case' 0 CA--C 1.536 0.404 0 O-C-N 123.277 0.36 . . . . 0.0 111.94 -173.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 91' ' ' GLU . 35.7 mmtp 74.96 174.38 0.25 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.674 0.79 . . . . 0.0 111.414 -177.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -142.36 141.35 32.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.798 176.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 8.9 p -84.67 -27.19 6.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.603 -172.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 54.4 86.02 0.05 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.891 0.853 . . . . 0.0 111.432 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -133.79 158.25 43.82 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.461 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -85.48 133.05 34.11 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.568 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -77.6 -26.82 50.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.549 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 56.39 86.85 0.06 Allowed 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.589 0.556 . . . . 0.0 111.653 173.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -92.38 30.33 1.51 Allowed 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.531 0.681 . . . . 0.0 111.132 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.2 m 71.04 87.64 0.11 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.283 -1.326 . . . . 0.0 113.093 171.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -146.38 145.13 30.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.992 167.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -170.9 176.9 3.95 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.375 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 83.2 p 59.78 124.51 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.944 1.403 . . . . 0.0 113.105 178.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -85.74 56.93 4.19 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.49 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.82 -56.47 11.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.823 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -68.7 128.92 38.36 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.943 0.401 . . . . 0.0 111.202 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 11.2 tpt 65.58 25.39 11.69 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.149 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -65.97 133.16 34.21 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.1 176.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -77.9 142.0 38.71 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 173.55 131.13 1.35 Allowed Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 120.033 -1.08 . . . . 0.0 112.965 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.1 tp -101.8 2.2 38.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.323 0.582 . . . . 0.0 109.733 175.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -73.48 151.21 41.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.97 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.4 t70 . . . . . 0 C--O 1.244 0.781 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.081 -179.06 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 200' ' ' ALA . . . . . 0.589 ' HA ' ' OD1' ' A' ' 18' ' ' ASP . . . . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 121.482 0.658 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.442 ' SD ' ' HA ' ' B' ' 263' ' ' ALA . 4.9 mpp? -112.07 58.97 0.63 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.936 -177.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 202' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -33.25 -76.56 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 O-C-N 124.638 1.211 . . . . 0.0 113.172 -170.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 203' ' ' TYR . . . . . 0.506 ' CD2' ' HA ' ' B' ' 239' ' ' LEU . 93.0 m-85 -134.93 14.67 3.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.579 0.704 . . . . 0.0 109.88 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.578 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 31.5 t -68.51 -54.52 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.418 -176.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 205' ' ' ALA . . . . . 0.527 ' HA ' HD12 ' B' ' 208' ' ' LEU . . . -72.13 -13.9 61.69 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.558 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . 0.451 ' HB3' HG23 ' B' ' 223' ' ' ILE . 3.5 m -72.3 -43.02 64.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 172.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 207' ' ' TYR . . . . . 0.485 ' CE1' HD11 ' B' ' 251' ' ' ILE . 24.4 t80 -62.64 -44.14 97.03 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 174.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 64.1 mt -59.51 -46.84 87.67 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.018 177.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 209' ' ' LEU . . . . . 0.422 ' O ' ' HG ' ' B' ' 212' ' ' LEU . 0.1 OUTLIER -57.09 -53.45 57.89 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.575 -179.67 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -62.96 -34.68 78.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.291 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 211' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -63.27 -53.54 51.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.218 177.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 212' ' ' LEU . . . . . 0.536 ' HB2' HG13 ' A' ' 4' ' ' VAL . 4.3 pp -65.76 -21.65 66.53 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.759 0.314 . . . . 0.0 110.753 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.97 -16.05 38.28 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.676 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 120.37 4.98 10.65 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.448 178.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 215' ' ' ASN . . . . . 0.633 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 28.1 t30 -117.66 108.8 15.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.188 0.518 . . . . 0.0 110.274 -178.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . 0.428 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 5.8 m -68.05 -15.2 63.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.799 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 17.6 p -125.66 67.75 59.55 Favored Pre-proline 0 N--CA 1.441 -0.881 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.417 -175.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . 0.428 ' HD3' ' C ' ' B' ' 216' ' ' SER . 50.9 Cg_exo -59.85 121.09 9.27 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.72 2.28 . . . . 0.0 112.025 177.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 89.2 p -102.33 -178.95 3.84 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.782 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -58.93 -36.67 75.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.02 0.438 . . . . 0.0 110.84 -177.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.54 -35.25 63.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.76 -176.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -59.35 -54.99 40.46 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.256 0.551 . . . . 0.0 109.746 175.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.451 HG23 ' HB3' ' B' ' 206' ' ' SER . 1.8 mp -63.47 -42.14 95.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.209 -178.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 224' ' ' LYS . . . . . 0.548 ' O ' ' HB2' ' B' ' 228' ' ' ASP . 27.7 tptp -57.06 -50.85 71.48 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 121.312 -0.155 . . . . 0.0 110.752 178.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -60.99 -41.16 95.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.909 0.385 . . . . 0.0 110.708 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 0.504 HG23 HD11 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -63.93 -42.94 97.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.543 -178.039 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' B' ' 234' ' ' ALA . 26.9 tp -81.16 -23.22 38.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.23 0.538 . . . . 0.0 110.413 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 228' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' B' ' 224' ' ' LYS . 2.7 t70 -72.37 -28.27 62.91 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.636 176.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 8.4 t -65.25 -53.33 45.87 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.556 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 230' ' ' VAL . . . . . 0.574 ' CG1' ' HB2' ' A' ' 31' ' ' LEU . 22.2 m -61.6 -33.13 55.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-O 120.802 0.334 . . . . 0.0 111.744 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 102.94 39.06 2.76 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.944 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . 0.421 HG13 HG23 ' B' ' 230' ' ' VAL . 16.9 mt -116.01 125.53 73.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -54.65 143.6 24.39 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.089 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . 0.569 ' HB2' HD23 ' B' ' 227' ' ' LEU . . . -140.93 117.08 10.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.028 0.442 . . . . 0.0 111.932 -173.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . 0.444 ' HB2' ' HB2' ' B' ' 238' ' ' ARG . 1.7 m-20 -67.88 113.41 5.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.495 174.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -56.75 -40.18 75.31 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.913 0.387 . . . . 0.0 110.986 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.41 -58.55 6.7 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.241 0.543 . . . . 0.0 111.04 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.666 ' O ' HG23 ' B' ' 242' ' ' VAL . 4.7 mpt_? -63.97 -29.44 70.6 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.914 -177.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 239' ' ' LEU . . . . . 0.506 ' HA ' ' CD2' ' B' ' 203' ' ' TYR . 9.3 tt -57.59 -61.42 2.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.168 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -64.38 -27.31 68.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.797 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 241' ' ' LYS . . . . . 0.45 ' HB2' ' HA ' ' B' ' 238' ' ' ARG . 38.1 mttp -63.46 -47.91 79.88 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.694 175.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 242' ' ' VAL . . . . . 0.703 ' O ' HD12 ' B' ' 246' ' ' LEU . 46.6 t -70.13 -33.16 53.68 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . 0.633 ' HA ' ' CD1' ' B' ' 246' ' ' LEU . 4.7 mt -64.2 -35.97 75.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.153 178.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 21.8 m -75.62 -25.92 57.34 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.317 0.58 . . . . 0.0 109.938 172.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 245' ' ' GLU . . . . . 0.448 ' HB3' ' O ' ' B' ' 242' ' ' VAL . 44.2 tt0 -71.3 -40.88 70.55 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.129 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . 0.703 HD12 ' O ' ' B' ' 242' ' ' VAL . 0.0 OUTLIER -108.22 18.1 21.49 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.262 0.553 . . . . 0.0 111.578 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -61.99 120.39 10.71 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.049 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -153.09 147.43 16.96 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.527 -0.845 . . . . 0.0 112.479 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -84.42 -24.16 29.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.071 0.462 . . . . 0.0 110.101 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . 0.482 ' HB3' ' HB3' ' B' ' 253' ' ' ASP . 4.9 m-20 -80.25 55.71 2.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.779 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.498 ' O ' HG12 ' B' ' 254' ' ' VAL . 1.3 mm -68.2 -49.52 66.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.159 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 252' ' ' GLU . . . . . 0.424 ' OE2' ' HG2' ' A' ' 1' ' ' MET . 38.7 tt0 -67.95 -25.32 65.39 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.188 0.518 . . . . 0.0 110.01 -176.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . 0.482 ' HB3' ' HB3' ' B' ' 250' ' ' ASN . 20.4 t70 -73.33 -48.61 32.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.104 174.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 254' ' ' VAL . . . . . 0.635 ' O ' ' HA3' ' B' ' 258' ' ' GLY . 2.3 p -66.53 -18.2 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.171 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 255' ' ' ILE . . . . . 0.424 HG21 HD13 ' A' ' 7' ' ' LEU . 66.4 mt -84.77 -52.27 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.856 0.36 . . . . 0.0 110.598 174.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -61.12 -31.72 71.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.082 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -126.83 35.69 4.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.833 0.349 . . . . 0.0 111.294 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . 0.636 ' O ' HD21 ' B' ' 262' ' ' LEU . . . -133.67 55.03 0.75 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.721 -175.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 49.7 mt -94.03 -25.66 4.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.617 0.722 . . . . 0.0 109.477 171.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -116.89 38.79 2.88 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.598 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 261' ' ' LYS . . . . . 0.538 ' H ' HD22 ' B' ' 262' ' ' LEU . 61.0 mttp -124.44 16.39 8.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.107 0.479 . . . . 0.0 110.175 176.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 262' ' ' LEU . . . . . 0.636 HD21 ' O ' ' B' ' 258' ' ' GLY . 0.2 OUTLIER -118.98 -68.93 0.88 Allowed 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.755 0.788 . . . . 0.0 109.755 -175.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . 0.442 ' HA ' ' SD ' ' B' ' 201' ' ' MET . . . -61.45 -29.85 70.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.474 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 13.2 t -137.22 128.7 28.36 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.602 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 88.8 t 58.74 95.2 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.25 0 O-C-N 124.128 0.892 . . . . 0.0 111.298 -176.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.16 -21.61 36.02 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.592 2.195 . . . . 0.0 112.444 -175.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . 176.76 -40.04 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.622 -177.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 130.45 -23.37 4.55 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.067 -177.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -178.84 -168.63 38.31 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -98.71 96.14 7.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.742 0.306 . . . . 0.0 110.733 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 14.3 t -115.32 138.07 46.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -140.52 144.16 35.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.81 0.338 . . . . 0.0 111.039 -178.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 18.4 m -91.56 35.75 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.367 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 9.9 m -119.73 106.21 11.91 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.163 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -98.13 63.56 1.6 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.401 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . 68.07 100.18 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.269 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.143 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 277' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -78.73 67.36 8.47 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.074 2.516 . . . . 0.0 112.044 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 133.12 -174.65 20.5 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.91 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 25.9 m 64.2 -170.67 0.19 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.723 0.297 . . . . 0.0 110.44 -178.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 61.02 33.17 19.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.556 174.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -72.57 137.13 80.55 Favored Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.179 177.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.22 56.92 2.69 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.897 2.398 . . . . 0.0 112.575 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -127.79 31.19 5.17 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.736 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -131.6 98.36 4.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.613 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -148.96 -58.96 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.011 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 16.6 m -71.82 90.32 1.1 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.994 0.425 . . . . 0.0 110.836 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 287' ' ' ALA . . . . . 0.463 ' HB3' ' HD3' ' B' ' 288' ' ' PRO . . . -85.91 -51.95 0.47 Allowed Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 288' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' B' ' 287' ' ' ALA . 2.5 Cg_endo -78.3 131.53 10.76 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 121.877 1.718 . . . . 0.0 111.921 -176.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -140.97 136.79 32.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.594 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -92.77 142.96 26.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.562 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -133.22 28.52 4.08 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.91 0.386 . . . . 0.0 110.52 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -63.7 97.92 0.17 Allowed 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.515 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -76.79 51.41 0.77 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.958 0.408 . . . . 0.0 110.796 175.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt 55.51 78.45 0.19 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.674 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 295' ' ' LYS . . . . . 0.404 ' HD2' ' C ' ' B' ' 295' ' ' LYS . 0.0 OUTLIER -93.82 155.62 17.1 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.836 177.879 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -128.52 145.59 51.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.399 173.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -156.27 -31.3 0.09 Allowed 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.283 0.989 . . . . 0.0 109.098 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -142.98 30.96 1.42 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.931 -171.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 19.7 tptp -85.4 -59.17 2.4 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.73 176.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 55.86 76.15 0.3 Allowed 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.605 0.565 . . . . 0.0 111.999 171.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 301' ' ' GLU . . . . . 0.517 ' CD ' ' H ' ' B' ' 301' ' ' GLU . 0.3 OUTLIER -99.99 33.08 2.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.474 0.654 . . . . 0.0 111.306 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 19.0 t -115.49 139.87 49.66 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.121 -176.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -78.85 123.73 27.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.996 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -89.73 172.67 8.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.459 -177.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 305' ' ' SER . . . . . 0.469 ' HB3' ' OD1' ' B' ' 307' ' ' ASP . 13.8 m -104.46 107.36 18.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.854 0.359 . . . . 0.0 111.041 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -103.27 27.44 7.26 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.229 0.537 . . . . 0.0 110.478 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 307' ' ' ASP . . . . . 0.469 ' OD1' ' HB3' ' B' ' 305' ' ' SER . 8.9 p-10 -76.96 74.26 3.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.326 -174.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -81.23 72.44 8.26 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 173.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 42.72 31.18 0.28 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.688 1.195 . . . . 0.0 113.038 -176.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 54.87 46.39 76.65 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 116.024 -0.535 . . . . 0.0 113.346 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 63.31 23.77 13.94 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.872 0.368 . . . . 0.0 111.353 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 312' ' ' GLY . . . . . 0.492 ' O ' ' HD1' ' B' ' 314' ' ' PHE . . . 78.94 -75.21 2.07 Favored Glycine 0 N--CA 1.441 -1.026 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 20.4 tp 54.92 28.04 9.97 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.254 0.622 . . . . 0.0 111.103 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 314' ' ' PHE . . . . . 0.492 ' HD1' ' O ' ' B' ' 312' ' ' GLY . 17.8 m-85 -139.4 -54.21 0.56 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.916 -177.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 11.3 t70 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 117.956 -1.021 . . . . 0.0 108.811 -179.902 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 mpp? . . . . . 0 N--CA 1.477 0.908 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.29 -178.65 4.24 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.473 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 25.6 p 50.88 30.14 4.96 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.374 0.67 . . . . 0.0 112.26 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.494 ' HA ' HD12 ' A' ' 7' ' ' LEU . 5.6 m -72.45 -24.67 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.692 -176.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.559 ' HB3' HG23 ' A' ' 39' ' ' VAL . 14.5 m -64.64 -55.92 17.12 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.724 177.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.418 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 35.1 tt0 -59.79 -43.42 94.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.306 178.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 4' ' ' VAL . 90.6 mt -52.61 -52.51 55.04 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.896 0.379 . . . . 0.0 110.594 175.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.04 -51.0 71.92 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.621 -176.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 42.6 t -72.06 -23.8 61.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.376 -176.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.418 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 1.5 tp -82.72 -39.1 15.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.282 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.465 ' CZ ' HD23 ' B' ' 208' ' ' LEU . 20.9 m-85 -68.63 -38.76 80.76 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.3 p -64.65 -46.58 81.89 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.038 174.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -44.74 -53.81 6.96 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.625 0.37 . . . . 0.0 111.496 173.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.539 ' HA ' ' HB2' ' A' ' 17' ' ' HIS . 3.6 pp -79.43 -27.11 41.7 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.505 -178.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.498 HD11 ' HA ' ' B' ' 206' ' ' SER . 17.2 mt -65.0 -41.03 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.051 0.453 . . . . 0.0 110.621 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.92 -27.75 55.03 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 174.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.539 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -78.4 13.95 1.39 Allowed 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 176.54 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -83.92 -31.22 25.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.316 0.579 . . . . 0.0 109.75 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.523 ' CG ' ' H ' ' A' ' 20' ' ' GLU . 19.7 t70 -126.92 -157.01 0.78 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.5 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.523 ' H ' ' CG ' ' A' ' 19' ' ' ASP . 31.5 mt-10 -86.57 -5.64 59.09 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.184 0.516 . . . . 0.0 110.668 -178.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.5 t -57.7 132.54 22.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.913 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.39 151.25 47.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.345 -175.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.5 m -100.83 35.85 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.48 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.9 p -88.14 179.35 6.41 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.252 -173.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.506 ' HG3' ' N ' ' A' ' 26' ' ' ASP . 14.0 pt-20 -43.84 -50.66 7.84 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.631 -177.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.506 ' N ' ' HG3' ' A' ' 25' ' ' GLU . 10.6 t70 -55.86 -41.3 74.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.151 -175.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.576 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 3.4 mptp? -83.83 -45.33 13.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.552 -170.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.55 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 9.3 mt -66.33 -42.9 91.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.35 178.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -61.75 -46.4 89.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.133 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.29 -44.08 97.35 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.403 HD21 ' HG ' ' B' ' 209' ' ' LEU . 0.7 OUTLIER -74.48 -39.3 62.57 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-O 121.598 0.713 . . . . 0.0 110.595 -175.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.55 ' HB ' ' O ' ' A' ' 28' ' ' ILE . 1.1 mp -60.52 -34.03 56.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.119 173.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -75.5 -29.04 59.41 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.679 174.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.04 -36.29 83.52 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.774 178.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -94.33 -41.39 9.45 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.178 -0.609 . . . . 0.0 112.039 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.76 46.07 4.37 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.639 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.594 HG22 ' HA2' ' B' ' 213' ' ' GLY . 0.2 OUTLIER -97.68 164.44 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.959 0.409 . . . . 0.0 110.857 -176.288 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -102.42 98.91 8.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.365 -176.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.559 HG23 ' HB3' ' A' ' 5' ' ' SER . 9.0 p -131.7 129.03 61.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.517 176.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 16.8 pt-20 -62.25 133.88 94.48 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -178.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 40' ' ' GLU . 53.5 Cg_exo -53.43 -7.92 0.59 Allowed 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 123.969 3.113 . . . . 0.0 113.828 -174.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.4 -36.8 77.1 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.072 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.58 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 89.1 m95 -70.93 -54.37 7.7 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 119.248 -0.406 . . . . 0.0 111.227 178.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.58 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 78.4 Cg_exo -49.98 -50.3 13.7 Favored 'Trans proline' 0 C--N 1.363 1.33 0 C-N-CA 122.004 1.803 . . . . 0.0 112.839 174.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.48 -50.06 71.73 Favored Glycine 0 C--O 1.24 0.523 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.209 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.477 HD21 ' HA2' ' A' ' 64' ' ' GLY . 60.8 tp -55.96 -53.11 60.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.511 -0.345 . . . . 0.0 110.776 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -59.92 -40.8 90.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.791 -177.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.59 -38.21 90.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.663 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -92.18 -8.51 45.31 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.65 -46.62 4.29 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.714 ' HA ' HG23 ' A' ' 54' ' ' VAL . 2.0 mp -84.05 -130.41 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.231 -175.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 66.94 3.62 3.17 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.375 0.67 . . . . 0.0 112.735 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -145.7 -51.4 0.25 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.714 HG23 ' HA ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -53.07 121.92 2.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 113.901 -1.499 . . . . 0.0 111.512 174.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.408 HD22 ' C ' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -58.01 158.36 6.82 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.481 175.461 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.461 ' O ' HD13 ' A' ' 59' ' ' LEU . 3.8 tp -40.53 -46.46 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 124.828 1.251 . . . . 0.0 114.371 -172.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.41 -20.3 22.17 Favored Glycine 0 N--CA 1.467 0.705 0 C-N-CA 121.272 -0.489 . . . . 0.0 113.587 -174.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 43.5 t -55.44 -25.34 35.66 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 122.467 0.307 . . . . 0.0 111.066 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 56' ' ' ILE . 9.8 mp -55.61 -32.29 62.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.311 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.442 HG23 HD12 ' B' ' 259' ' ' ILE . 33.3 mt -94.14 -3.64 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.522 0.677 . . . . 0.0 110.722 -175.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 55.1 m -114.85 -56.67 2.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.025 0.44 . . . . 0.0 111.187 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -97.25 66.47 2.07 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.155 -173.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.9 m -76.79 -16.4 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.77 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.477 ' HA2' HD21 ' A' ' 46' ' ' LEU . . . 163.63 120.82 0.54 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.303 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -156.62 -166.31 2.09 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -99.58 -84.08 1.77 Allowed Glycine 0 CA--C 1.518 0.22 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.045 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.75 79.75 0.1 Allowed Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.077 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -84.32 70.41 5.88 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.525 2.15 . . . . 0.0 112.161 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.81 135.92 74.14 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.869 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -64.72 -57.22 0.32 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.9 2.4 . . . . 0.0 112.51 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 62.79 176.57 0.15 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.504 0.502 . . . . 0.0 111.939 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -157.05 154.0 28.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.769 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 161.8 -172.05 37.88 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.06 -0.59 . . . . 0.0 111.955 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -91.66 86.05 5.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.071 0.462 . . . . 0.0 111.239 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.451 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -94.49 135.2 24.35 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.711 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 50.2 Cg_exo -58.02 163.77 9.19 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 124.016 3.144 . . . . 0.0 113.349 -178.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.31 128.66 36.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.468 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -136.79 77.0 0.36 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.678 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 163.7 -78.8 0.14 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.303 -178.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.51 155.01 70.52 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.033 2.489 . . . . 0.0 112.913 -176.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.44 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . . . -109.19 123.76 35.91 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.497 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 81' ' ' ALA . 19.0 Cg_exo -68.46 56.04 0.88 Allowed 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.186 2.59 . . . . 0.0 113.358 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.4 ' O ' ' HB ' ' A' ' 84' ' ' THR . 43.3 t -133.59 141.52 47.71 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.015 178.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 83' ' ' SER . 96.5 m 72.29 123.43 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.501 0.667 . . . . 0.0 111.558 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -99.74 47.6 0.95 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.367 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 64.78 -179.28 0.18 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.153 176.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.21 115.54 3.15 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.708 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -57.41 104.7 0.16 Allowed 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 123.044 2.496 . . . . 0.0 112.772 177.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -96.56 80.65 3.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.936 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -100.4 130.1 46.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.81 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -103.11 -76.54 0.58 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 172.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 93.4 mttt 60.17 83.04 0.14 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.142 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -61.96 124.57 21.15 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.291 -178.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.0 m -64.68 142.5 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.41 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -91.06 13.48 16.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.756 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.17 109.98 9.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.113 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -64.22 146.91 53.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.847 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 99' ' ' GLU . 47.0 mmtm -81.03 -42.33 21.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.255 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 7.1 tp10 174.01 -74.57 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 O-C-N 123.757 0.661 . . . . 0.0 109.798 178.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 71.38 134.57 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.921 0.763 . . . . 0.0 111.725 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.8 t -139.79 125.93 19.92 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.364 -178.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 44.5 mt-10 -128.09 12.86 6.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.065 177.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 102' ' ' GLU . 34.8 mm-40 67.43 178.19 0.24 Allowed 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.759 0.662 . . . . 0.0 110.231 -170.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.5 t -91.85 76.73 5.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.005 0.431 . . . . 0.0 110.536 -177.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -88.03 113.06 23.29 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.594 176.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -87.61 -179.75 6.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.117 0.484 . . . . 0.0 111.28 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -138.79 61.76 1.56 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.669 0.747 . . . . 0.0 109.807 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 26.3 ttt -136.43 137.56 40.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.647 178.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -70.54 125.15 13.54 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.457 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.41 -174.74 5.34 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.591 0.234 . . . . 0.0 111.242 -178.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.18 -100.23 0.02 OUTLIER Glycine 0 C--N 1.333 0.377 0 C-N-CA 121.266 -0.492 . . . . 0.0 113.251 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.0 tp -148.36 68.26 1.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.435 -0.45 . . . . 0.0 111.31 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -92.74 8.72 38.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.224 169.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.367 -0.825 . . . . 0.0 110.25 179.655 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.443 ' HG3' ' H ' ' B' ' 264' ' ' SER . 81.6 mtp -117.46 163.69 16.0 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 202' ' ' ARG . . . . . 0.485 ' HD3' HG13 ' B' ' 242' ' ' VAL . 12.8 ptp180 175.89 -168.11 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 O-C-N 123.9 0.75 . . . . 0.0 109.594 -178.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 203' ' ' TYR . . . . . 0.593 ' CD2' ' HA ' ' B' ' 239' ' ' LEU . 48.0 m-85 -66.59 3.74 0.93 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.962 0.411 . . . . 0.0 112.014 -177.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.59 ' O ' HD13 ' B' ' 208' ' ' LEU . 5.4 p -56.46 -55.47 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.209 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 205' ' ' ALA . . . . . 0.504 ' CB ' HD11 ' A' ' 14' ' ' LEU . . . -74.12 -8.15 55.12 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.989 -176.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . 0.611 ' OG ' HG23 ' B' ' 223' ' ' ILE . 8.0 t -78.96 -37.8 38.59 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 173.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 207' ' ' TYR . . . . . 0.549 ' HD1' HD11 ' B' ' 251' ' ' ILE . 21.3 t80 -64.25 -42.84 96.32 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 172.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.59 HD13 ' O ' ' B' ' 204' ' ' VAL . 7.5 mp -56.82 -48.28 78.35 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.927 174.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 209' ' ' LEU . . . . . 0.437 HD23 ' CB ' ' A' ' 11' ' ' TYR . 0.3 OUTLIER -54.93 -53.43 55.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.356 -179.75 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -61.67 -39.33 91.01 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.094 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 211' ' ' ALA . . . . . 0.727 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -69.32 -51.87 32.83 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.04 0.448 . . . . 0.0 110.931 -178.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.8 -35.86 69.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.645 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . 0.594 ' HA2' HG22 ' A' ' 37' ' ' VAL . . . -54.49 -52.43 45.02 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.294 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 163.08 31.29 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.279 -0.963 . . . . 0.0 112.336 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 215' ' ' ASN . . . . . 0.727 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 50.5 m-20 -136.02 105.24 5.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.699 0.285 . . . . 0.0 110.479 -176.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 16.4 m -61.21 -21.69 64.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.944 0.402 . . . . 0.0 111.339 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 20.3 m -128.54 73.99 80.36 Favored Pre-proline 0 N--CA 1.443 -0.788 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.563 -174.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -58.69 121.12 9.43 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.62 2.88 . . . . 0.0 112.72 175.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 15.1 m -89.95 158.57 17.33 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.46 -36.01 66.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.512 0.672 . . . . 0.0 109.738 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -62.05 -34.82 76.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.921 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -73.58 -47.54 39.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.702 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.611 HG23 ' OG ' ' B' ' 206' ' ' SER . 1.8 mp -59.78 -45.41 94.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 224' ' ' LYS . . . . . 0.413 ' HG3' ' OD1' ' B' ' 228' ' ' ASP . 7.3 ttmm -62.25 -36.7 82.83 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.117 175.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' B' ' 229' ' ' SER . 6.4 ttpm? -60.48 -45.55 93.32 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.764 176.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.07 -38.35 82.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.7 0.286 . . . . 0.0 111.149 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 87.6 mt -76.44 -46.25 27.86 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 228' ' ' ASP . . . . . 0.413 ' OD1' ' HG3' ' B' ' 224' ' ' LYS . 1.3 m-20 -74.59 -14.57 60.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.883 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 229' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' B' ' 225' ' ' LYS . 23.0 t -54.35 -47.1 72.94 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.089 0.471 . . . . 0.0 109.938 172.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 29.0 t -90.29 -34.05 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 121.471 0.653 . . . . 0.0 109.612 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 91.87 72.68 1.23 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.539 176.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . . . . . . . . . 8.4 mt -95.53 -97.46 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 122.522 -0.399 . . . . 0.0 109.926 176.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -136.09 -78.17 0.42 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 173.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . 60.41 81.64 0.18 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.623 0.577 . . . . 0.0 112.231 174.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . 0.475 ' C ' ' H ' ' B' ' 237' ' ' ASP . 0.6 OUTLIER -62.15 133.12 54.82 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.357 179.533 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.81 36.69 0.11 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.697 0.761 . . . . 0.0 111.255 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 237' ' ' ASP . . . . . 0.475 ' H ' ' C ' ' B' ' 235' ' ' ASP . 15.9 t70 -147.92 -57.65 0.24 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.669 -1.15 . . . . 0.0 107.914 176.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.427 ' O ' HG23 ' B' ' 242' ' ' VAL . 8.5 ttm-85 -57.56 -42.0 82.15 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.52 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 239' ' ' LEU . . . . . 0.593 ' HA ' ' CD2' ' B' ' 203' ' ' TYR . 10.1 tt -57.85 -62.22 1.96 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.381 -176.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -67.83 -20.0 65.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.362 -178.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -66.91 -47.2 72.5 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.288 0.566 . . . . 0.0 109.945 174.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 242' ' ' VAL . . . . . 0.649 ' O ' HD12 ' B' ' 246' ' ' LEU . 91.7 t -66.35 -39.26 83.7 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.393 179.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . 0.596 ' HA ' ' CD1' ' B' ' 246' ' ' LEU . 13.1 mt -65.52 -32.87 60.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.401 177.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 34.4 t -61.59 -39.24 90.48 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 171.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 245' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' B' ' 242' ' ' VAL . 93.1 mt-10 -63.91 -58.05 7.93 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.844 174.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . 0.649 HD12 ' O ' ' B' ' 242' ' ' VAL . 0.0 OUTLIER -103.65 37.18 2.09 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -170.033 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -57.6 154.74 10.86 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.043 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -51.69 107.62 0.48 Allowed Glycine 0 CA--C 1.519 0.294 0 CA-C-N 115.556 -0.747 . . . . 0.0 114.315 -173.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -135.07 -74.39 0.46 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -108.94 58.91 0.6 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.545 0.688 . . . . 0.0 109.191 175.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.549 HD11 ' HD1' ' B' ' 207' ' ' TYR . 0.3 OUTLIER -64.81 -39.7 86.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.698 -176.036 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -66.63 -37.14 84.23 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.435 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.49 -49.43 75.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.943 0.402 . . . . 0.0 110.179 175.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 254' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' B' ' 251' ' ' ILE . 6.2 p -68.3 -22.28 27.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.893 -176.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 255' ' ' ILE . . . . . . . . . . . . . 56.1 mt -79.19 -45.25 24.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 120.938 0.399 . . . . 0.0 110.631 173.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -61.55 -28.47 69.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.854 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -120.33 50.66 1.28 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' B' ' 254' ' ' VAL . . . -71.0 -47.16 39.8 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.377 -0.829 . . . . 0.0 113.784 -171.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 259' ' ' ILE . . . . . 0.442 HD12 HG23 ' A' ' 60' ' ' ILE . 6.6 pt -64.18 -45.9 95.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.869 0.334 . . . . 0.0 111.043 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 46.89 -110.61 0.57 Allowed Glycine 0 C--N 1.335 0.492 0 O-C-N 123.626 0.579 . . . . 0.0 113.018 175.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -129.04 45.47 2.79 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 262' ' ' LEU . . . . . . . . . . . . . 9.2 mp -77.2 89.88 3.68 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 122.106 0.955 . . . . 0.0 110.926 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -139.22 17.0 2.6 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.22 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . 0.443 ' H ' ' HG3' ' B' ' 201' ' ' MET . 8.0 t 71.09 -49.35 0.68 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.447 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 45.1 t -55.0 134.0 67.64 Favored Pre-proline 0 C--N 1.329 -0.297 0 O-C-N 123.432 0.458 . . . . 0.0 111.087 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.05 -50.49 2.91 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.223 2.615 . . . . 0.0 112.574 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . -169.21 149.92 4.27 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.886 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . -90.64 77.07 1.53 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.906 -178.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -73.39 72.4 1.2 Allowed Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.764 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -102.18 89.52 3.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.943 0.401 . . . . 0.0 110.862 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 10.5 t -95.61 137.16 24.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.223 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -116.0 141.52 48.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.62 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.66 136.47 55.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.025 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 4.8 m -105.48 148.38 27.26 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.46 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -109.5 164.56 12.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.0 0.429 . . . . 0.0 111.125 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -136.03 97.57 12.2 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.444 0.64 . . . . 0.0 110.668 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 277' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -83.93 152.62 12.87 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 123.487 2.792 . . . . 0.0 113.485 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -103.06 -176.4 26.6 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.436 177.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 58.6 m -122.84 -167.66 1.62 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.474 0.637 . . . . 0.0 112.369 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . -60.4 148.65 36.52 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.98 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -130.79 89.4 43.27 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.625 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -67.11 135.25 36.7 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.705 2.27 . . . . 0.0 112.283 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -112.39 133.89 54.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.639 -178.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.13 118.16 10.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.77 0.319 . . . . 0.0 110.604 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -88.28 -56.03 2.11 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.9 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 35.0 t 71.96 127.63 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.388 0.613 . . . . 0.0 111.573 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 287' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' B' ' 288' ' ' PRO . . . -129.32 109.89 17.84 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.112 177.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 288' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' B' ' 287' ' ' ALA . 5.9 Cg_exo -70.11 142.42 46.36 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.924 2.416 . . . . 0.0 113.144 -174.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -100.79 119.73 39.07 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.82 122.06 16.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.288 -175.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -75.08 151.19 38.67 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . 0.523 ' O ' ' HG2' ' B' ' 294' ' ' LYS . 44.3 mt-10 -49.74 -70.72 0.08 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.248 0.342 . . . . 0.0 110.906 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 52.59 31.46 10.09 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.81 0.814 . . . . 0.0 110.694 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' B' ' 292' ' ' GLU . 31.9 mmmt -120.44 129.04 53.71 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 176.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -87.08 127.33 35.12 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.893 0.378 . . . . 0.0 110.231 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -107.83 136.69 47.13 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.342 0.592 . . . . 0.0 110.583 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -124.44 159.41 30.53 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.453 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -141.84 162.03 36.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.909 0.385 . . . . 0.0 110.705 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -121.88 -177.61 3.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.463 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 69.05 179.48 0.24 Allowed 'General case' 0 N--CA 1.466 0.329 0 O-C-N 124.021 0.826 . . . . 0.0 111.433 -178.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 45.3 37.18 2.64 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.348 1.059 . . . . 0.0 112.625 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 48.8 m -151.26 102.4 2.92 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.836 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -103.7 156.22 17.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.38 -177.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -92.0 166.04 12.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.427 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.41 103.15 13.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.846 0.355 . . . . 0.0 110.446 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -92.08 32.59 1.14 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.101 0.477 . . . . 0.0 110.894 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.99 -45.45 85.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.325 -176.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -62.27 -61.35 2.52 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.106 0.409 . . . . 0.0 112.106 -173.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -78.39 58.9 2.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.931 0.396 . . . . 0.0 111.425 -177.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . -86.31 -70.24 1.32 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.175 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -112.0 20.22 17.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.719 0.295 . . . . 0.0 111.296 -178.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . -87.69 49.31 3.84 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.137 -177.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 7.2 mp -94.65 4.53 53.72 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 175.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 314' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -98.62 -47.89 5.18 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.442 -170.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 28.6 t70 . . . . . 0 C--O 1.244 0.813 0 O-C-N 124.178 0.924 . . . . 0.0 111.104 -177.108 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.2 mtp . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.32 -106.69 0.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -175.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.466 ' HB3' ' HG2' ' A' ' 6' ' ' GLU . 24.7 m -97.41 69.04 2.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.341 0.591 . . . . 0.0 111.575 -174.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.422 HG13 ' CD2' ' B' ' 212' ' ' LEU . 20.7 t -67.1 -26.61 36.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.342 0.591 . . . . 0.0 109.684 -175.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.586 ' OG ' HG23 ' A' ' 39' ' ' VAL . 31.9 t -61.02 -65.62 0.66 Allowed 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.928 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.696 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 10.7 pt-20 -68.57 -31.55 70.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.64 -175.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 35.7 mt -55.92 -53.63 54.55 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 172.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.624 ' HB2' HG11 ' A' ' 37' ' ' VAL . . . -56.91 -52.69 64.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.91 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.696 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 24.6 p -70.73 -26.87 63.57 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.586 -173.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.508 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 1.1 tp -78.26 -38.52 23.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.698 0.285 . . . . 0.0 111.408 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.43 ' HB2' HD22 ' B' ' 209' ' ' LEU . 21.8 m-85 -72.34 -26.78 62.05 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.8 t -69.59 -51.6 33.73 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.219 171.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -47.96 -54.03 14.13 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.353 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.619 ' O ' ' HE3' ' B' ' 201' ' ' MET . 2.9 pp -76.54 -29.95 56.92 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.651 -176.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.558 ' N ' HD12 ' A' ' 14' ' ' LEU . 3.8 mt -59.47 -31.0 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 118.522 0.601 . . . . 0.0 110.487 173.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.455 HD12 HG22 ' A' ' 15' ' ' ILE . 6.7 mp -86.73 -25.59 24.65 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.205 176.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -85.17 62.54 7.56 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -177.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -138.29 -57.27 0.65 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 120.856 -0.337 . . . . 0.0 111.506 172.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.589 ' CG ' ' H ' ' A' ' 20' ' ' GLU . 17.3 t70 -91.47 -151.3 0.26 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.743 0.306 . . . . 0.0 111.393 -176.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.589 ' H ' ' CG ' ' A' ' 19' ' ' ASP . 16.9 tp10 -88.67 -6.6 57.37 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.584 0.707 . . . . 0.0 109.634 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.414 HG21 HG12 ' B' ' 232' ' ' ILE . 68.7 t -64.76 106.61 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.655 178.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.572 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 2.7 p -66.11 150.63 48.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.075 -177.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.448 ' HA ' HD23 ' A' ' 16' ' ' LEU . 29.8 m -84.31 49.51 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.358 -174.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.4 p -81.83 164.12 21.85 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -49.77 -46.25 50.47 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.415 -178.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -58.57 -34.94 71.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.059 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.572 ' HG3' ' O ' ' A' ' 22' ' ' THR . 32.7 mmtp -75.71 -51.36 12.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.759 -175.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.439 HG23 HD13 ' A' ' 32' ' ' ILE . 5.1 mt -62.07 -41.28 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.151 176.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.458 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 6.9 t30 -53.81 -52.2 61.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.812 173.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.19 -44.95 79.92 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.761 0.315 . . . . 0.0 111.815 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.447 HD21 HG23 ' B' ' 226' ' ' ILE . 2.6 tm? -65.09 -46.03 82.76 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.495 0.665 . . . . 0.0 109.883 -178.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.439 HD13 HG23 ' A' ' 28' ' ' ILE . 1.6 mp -62.04 -33.25 57.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.959 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.458 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 31.2 mmmt -77.68 -25.06 49.21 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.756 0.312 . . . . 0.0 111.006 176.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.13 -42.38 72.68 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.239 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.74 -41.66 11.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.702 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.51 10.92 56.42 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 121.034 -0.603 . . . . 0.0 113.253 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.662 HG22 ' HA3' ' B' ' 213' ' ' GLY . 3.2 t -70.7 140.77 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 O-C-N 122.467 -0.431 . . . . 0.0 110.577 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.69 89.72 5.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.296 -177.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.586 HG23 ' OG ' ' A' ' 5' ' ' SER . 7.6 p -110.93 127.58 67.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 172.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.487 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 12.3 pt-20 -59.53 134.71 88.93 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.261 -174.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 40' ' ' GLU . 50.5 Cg_exo -54.31 -5.2 0.36 Allowed 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 124.398 3.399 . . . . 0.0 114.634 -172.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.36 -41.72 72.76 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.685 177.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.624 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 94.8 m95 -68.73 -57.42 8.13 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.796 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.624 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 56.8 Cg_exo -52.15 -41.28 66.11 Favored 'Trans proline' 0 C--N 1.366 1.5 0 C-N-CA 121.749 1.633 . . . . 0.0 112.324 174.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.531 ' O ' ' HG2' ' A' ' 49' ' ' LYS . . . -59.71 -54.79 34.66 Favored Glycine 0 C--O 1.242 0.639 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.488 -179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.449 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 57.6 mt -58.47 -50.6 73.16 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.664 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 6.2 m-85 -55.35 -51.01 68.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.365 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.09 -47.99 81.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.751 -0.658 . . . . 0.0 112.165 -176.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 45' ' ' GLY . 22.2 pttm -100.79 5.57 43.57 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 119.56 -0.856 . . . . 0.0 113.136 -174.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 46' ' ' LEU . . . -134.24 1.85 3.24 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' A' ' 47' ' ' PHE . 57.9 mt -84.99 -133.04 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 118.476 -1.29 . . . . 0.0 109.345 170.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 62.59 -13.16 0.07 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.507 ' H ' ' C ' ' A' ' 51' ' ' LEU . 18.5 m120 -128.2 3.99 5.8 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.575 ' CG2' ' HA ' ' A' ' 51' ' ' LEU . 61.5 t -95.88 103.03 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.154 -174.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -52.19 132.19 33.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.482 173.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.42 HD11 ' HB3' ' A' ' 14' ' ' LEU . 4.1 tp -45.04 -45.42 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -170.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.14 -26.01 57.93 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.364 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.0 t -65.49 -11.89 47.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.804 0.335 . . . . 0.0 110.492 -176.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 64.8 mt -57.69 -28.05 63.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.71 0.29 . . . . 0.0 110.675 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.3 tt -103.13 31.22 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.851 0.834 . . . . 0.0 110.926 -178.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.9 p -83.79 -177.45 6.69 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.966 173.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -78.15 48.37 0.73 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.718 0.294 . . . . 0.0 110.981 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.9 p -70.96 -34.09 54.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.084 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.98 64.03 4.34 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.741 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -129.35 152.55 48.78 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.902 0.382 . . . . 0.0 110.688 -178.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -87.36 72.03 2.59 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.893 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -163.6 165.61 36.91 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 121.1 -0.572 . . . . 0.0 111.988 -179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.02 -28.02 13.41 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 122.665 2.243 . . . . 0.0 112.839 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.468 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . . . -147.27 133.74 9.79 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.175 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 69' ' ' ALA . 2.1 Cg_endo -82.75 53.32 4.38 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.632 2.222 . . . . 0.0 112.219 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 65.78 -170.04 0.2 Allowed 'General case' 0 N--CA 1.463 0.187 0 O-C-N 123.538 0.524 . . . . 0.0 111.096 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 57.17 72.93 0.48 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.277 0.56 . . . . 0.0 111.872 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.56 38.3 3.17 Favored Glycine 0 C--O 1.229 -0.16 0 C-N-CA 120.854 -0.689 . . . . 0.0 111.587 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.38 159.43 15.01 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.48 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -122.93 117.81 28.42 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-O 120.786 0.327 . . . . 0.0 110.674 -178.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 24.0 Cg_exo -68.86 60.71 1.24 Allowed 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 123.804 3.003 . . . . 0.0 113.178 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -154.52 106.12 2.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.99 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -107.23 89.17 0.57 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.604 -176.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.6 165.03 11.13 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.005 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -78.92 -61.11 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.935 2.423 . . . . 0.0 112.207 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -140.78 90.6 9.59 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.801 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -50.47 126.2 17.24 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.144 2.563 . . . . 0.0 113.256 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.6 t -156.94 136.1 11.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.838 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.2 t -110.44 69.68 0.7 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.016 0.912 . . . . 0.0 110.221 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.04 98.99 1.03 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.822 -177.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 58.6 45.15 16.55 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.859 175.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -126.84 109.36 22.31 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.241 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -55.65 148.07 56.44 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.11 2.54 . . . . 0.0 112.463 176.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -113.04 8.52 18.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.398 0.618 . . . . 0.0 110.263 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -77.9 69.65 4.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.765 0.793 . . . . 0.0 110.646 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -87.75 174.78 8.19 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.902 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -71.91 110.23 6.28 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.392 -174.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -121.75 94.29 4.27 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.852 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.3 t -131.24 100.97 4.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.228 -178.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.8 -32.5 5.45 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.102 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.87 -73.86 0.1 Allowed 'General case' 0 C--N 1.332 -0.184 0 O-C-N 123.16 0.288 . . . . 0.0 111.743 -176.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt 64.09 172.44 0.18 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.38 0.61 . . . . 0.0 111.828 -175.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -145.55 150.05 35.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.771 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.496 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 1.1 pm0 -75.15 148.53 39.54 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.841 178.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.8 24.78 4.33 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.818 0.818 . . . . 0.0 111.398 178.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.3 m -108.35 127.27 53.73 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.91 -177.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -124.46 69.24 1.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.479 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 57.5 70.28 0.67 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.632 0.73 . . . . 0.0 111.955 176.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.4 p -128.1 139.1 52.7 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.117 -178.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -113.82 -165.45 1.0 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.105 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -60.52 -50.24 74.33 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.3 t70 58.25 78.09 0.26 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.683 0.754 . . . . 0.0 110.795 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 72.3 mtm -104.49 140.94 37.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.298 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -72.99 -26.04 72.11 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.606 -176.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -93.63 101.0 13.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.139 0.469 . . . . 0.0 110.5 176.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -76.17 1.93 58.26 Favored Glycine 0 CA--C 1.519 0.286 0 CA-C-N 115.791 -0.64 . . . . 0.0 113.341 -177.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.9 tp 59.67 65.47 1.14 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 121.453 0.644 . . . . 0.0 110.964 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -75.65 -33.34 60.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.201 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 . . . . . 0 C--O 1.247 0.938 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.749 178.424 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.619 ' HE3' ' O ' ' A' ' 14' ' ' LEU . 25.5 ptt? -132.38 166.51 21.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.013 -176.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 202' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' B' ' 201' ' ' MET . 20.9 mtm180 -176.54 -65.07 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 O-C-N 123.824 0.702 . . . . 0.0 109.942 171.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 203' ' ' TYR . . . . . 0.6 ' HB2' HG11 ' B' ' 242' ' ' VAL . 8.1 m-85 -89.58 -21.12 23.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.633 -174.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.58 ' O ' HD13 ' B' ' 208' ' ' LEU . 47.0 t -56.54 -65.36 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.63 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 205' ' ' ALA . . . . . 0.587 ' HA ' ' HB2' ' B' ' 208' ' ' LEU . . . -69.38 -6.56 30.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.215 -177.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . 0.542 ' OG ' HG23 ' B' ' 223' ' ' ILE . 8.6 t -78.94 -42.44 26.93 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 207' ' ' TYR . . . . . 0.593 ' HD1' HD13 ' B' ' 251' ' ' ILE . 29.3 t80 -65.47 -39.18 91.66 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 172.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.587 ' HB2' ' HA ' ' B' ' 205' ' ' ALA . 9.1 mp -55.3 -51.11 67.77 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.416 173.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 209' ' ' LEU . . . . . 0.43 HD22 ' HB2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -56.51 -59.81 4.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.952 -178.354 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -60.75 -32.33 71.62 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -177.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 211' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -81.19 -32.0 33.73 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 122.015 -0.428 . . . . 0.0 111.308 178.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 212' ' ' LEU . . . . . 0.422 ' CD2' HG13 ' A' ' 4' ' ' VAL . 2.3 tm? -64.84 -43.12 94.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.718 177.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . 0.662 ' HA3' HG22 ' A' ' 37' ' ' VAL . . . -152.82 90.15 0.13 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.239 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 172.33 -62.91 0.14 Allowed Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 111.829 -0.508 . . . . 0.0 111.829 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 215' ' ' ASN . . . . . 0.455 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 56.4 t30 -161.4 142.61 11.37 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . 0.408 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 8.6 m -64.4 -24.56 67.68 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.23 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 12.3 t -124.04 73.15 56.15 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.708 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . 0.53 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 57.9 Cg_exo -56.57 116.54 3.27 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.183 2.589 . . . . 0.0 112.438 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 83.4 p -82.84 162.21 21.7 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 120.609 -0.437 . . . . 0.0 110.048 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -54.91 -35.53 64.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.016 0.436 . . . . 0.0 110.332 177.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -68.76 -34.87 76.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.467 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -70.28 -43.71 69.88 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.359 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.542 HG23 ' OG ' ' B' ' 206' ' ' SER . 1.8 mp -64.85 -44.39 96.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 123.271 0.357 . . . . 0.0 110.085 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 224' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' B' ' 228' ' ' ASP . 26.7 tptp -55.56 -43.49 75.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.162 173.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -56.6 -51.25 69.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.077 178.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 0.447 HG23 HD21 ' A' ' 31' ' ' LEU . 1.1 mp -68.47 -35.47 70.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.771 -177.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . 0.414 ' CD1' ' HB ' ' B' ' 232' ' ' ILE . 0.2 OUTLIER -75.43 -35.11 61.02 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.549 0.69 . . . . 0.0 109.947 -179.431 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 228' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' B' ' 224' ' ' LYS . 5.2 t70 -76.19 -30.04 57.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.584 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 85.5 p -55.33 -45.3 76.38 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.556 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 59.4 t -75.84 -33.3 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 121.117 0.484 . . . . 0.0 110.663 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 103.98 38.83 2.62 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.862 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . 0.414 ' HB ' ' CD1' ' B' ' 227' ' ' LEU . 4.3 mt -109.38 135.41 48.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -66.54 118.33 10.0 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.655 0.74 . . . . 0.0 112.219 -173.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -117.5 135.55 53.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.03 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . 0.496 ' HB2' ' HB2' ' B' ' 238' ' ' ARG . 51.4 m-20 -86.43 115.21 23.79 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.185 -176.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 236' ' ' ASP . . . . . 0.598 ' O ' ' HG ' ' B' ' 239' ' ' LEU . 9.5 t70 -45.86 -60.53 2.18 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.131 0.894 . . . . 0.0 112.415 -170.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -63.92 -42.61 97.34 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.496 ' HB2' ' HB2' ' B' ' 235' ' ' ASP . 77.5 mtt180 -66.21 -36.0 81.92 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.15 -172.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 239' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' B' ' 236' ' ' ASP . 4.4 pp -68.44 -44.85 74.03 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.689 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 240' ' ' ASN . . . . . 0.499 ' N ' HD12 ' B' ' 239' ' ' LEU . 3.9 t-20 -66.14 -33.21 75.26 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 121.34 -0.144 . . . . 0.0 110.759 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -62.15 -52.45 63.79 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-O 121.224 0.535 . . . . 0.0 110.315 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 242' ' ' VAL . . . . . 0.6 HG11 ' HB2' ' B' ' 203' ' ' TYR . 12.5 p -66.48 -37.84 80.45 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.654 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -176.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . 0.602 ' HA ' ' HB2' ' B' ' 246' ' ' LEU . 57.3 mt -66.6 -31.61 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.513 176.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 8.8 t -65.06 -33.69 76.63 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 175.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -86.65 -26.16 24.48 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.731 175.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . 0.602 ' HB2' ' HA ' ' B' ' 243' ' ' ILE . 9.5 mt -75.45 -19.5 59.42 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.666 0.386 . . . . 0.0 110.657 175.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -63.49 97.85 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.874 -173.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 175.66 -175.78 47.34 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.135 -177.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -85.89 0.68 52.47 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -79.62 -0.52 34.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.956 0.408 . . . . 0.0 110.797 -175.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.593 HD13 ' HD1' ' B' ' 207' ' ' TYR . 7.7 tp -61.72 -38.31 80.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.289 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -65.11 -34.91 79.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.106 0.479 . . . . 0.0 110.153 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -67.58 -45.45 75.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.632 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 254' ' ' VAL . . . . . 0.533 HG22 ' HA ' ' B' ' 251' ' ' ILE . 26.0 m -74.64 -10.94 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.2 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 255' ' ' ILE . . . . . 0.496 HG12 ' O ' ' B' ' 251' ' ' ILE . 24.0 mm -78.25 -53.15 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.003 0.43 . . . . 0.0 109.881 168.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -63.05 -42.41 99.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.328 -176.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -119.51 56.99 0.92 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.585 0.707 . . . . 0.0 109.887 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . -105.79 -99.36 2.6 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.034 177.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 259' ' ' ILE . . . . . 0.441 ' O ' ' HG ' ' B' ' 262' ' ' LEU . 23.4 mt 20.25 -88.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.998 1.319 . . . . 0.0 113.334 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 48.99 -118.43 5.04 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-O 121.547 0.526 . . . . 0.0 114.328 170.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.24 54.47 1.45 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 262' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' B' ' 259' ' ' ILE . 8.4 mt -54.62 -33.63 60.81 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.318 -173.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -58.86 -52.24 66.57 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.718 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 19.5 t 72.07 129.7 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 O-C-N 124.243 0.965 . . . . 0.0 110.249 -175.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 6.3 m -65.2 140.35 97.88 Favored Pre-proline 0 N--CA 1.448 -0.575 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.684 -177.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.85 3.63 5.88 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.342 2.695 . . . . 0.0 113.273 -174.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . 41.89 63.03 1.42 Allowed 'General case' 0 N--CA 1.466 0.345 0 O-C-N 124.098 0.874 . . . . 0.0 112.347 173.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 115.15 -48.35 0.95 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.402 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . 113.02 51.05 0.53 Allowed Glycine 0 N--CA 1.454 -0.143 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.53 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -139.62 73.66 1.44 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.197 0.522 . . . . 0.0 110.529 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 11.0 t -121.07 147.68 24.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.267 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . 60.18 45.92 11.05 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.794 0.807 . . . . 0.0 111.866 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 24.7 t -109.8 79.75 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.462 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 12.9 m -139.69 122.6 16.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.944 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . 56.38 48.98 15.91 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.912 0.757 . . . . 0.0 111.394 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -81.77 117.13 67.1 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.778 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 277' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -71.34 81.44 1.22 Allowed 'Trans proline' 0 CA--C 1.515 -0.44 0 C-N-CA 123.107 2.538 . . . . 0.0 111.765 178.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -139.73 31.49 2.3 Favored Glycine 0 N--CA 1.436 -1.357 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.348 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 25.1 m -100.22 153.59 19.15 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 177.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 64.96 -169.68 0.2 Allowed 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 124.116 0.885 . . . . 0.0 111.466 174.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . 56.59 75.29 0.59 Allowed Pre-proline 0 N--CA 1.467 0.381 0 O-C-N 123.623 0.577 . . . . 0.0 111.226 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.53 110.88 1.34 Allowed 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.894 2.396 . . . . 0.0 113.6 -173.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . 67.52 162.72 0.19 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.514 174.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -114.26 18.92 16.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.618 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -132.83 19.51 4.42 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.935 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.65 114.38 13.0 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.21 0.529 . . . . 0.0 111.22 -178.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -142.67 132.5 12.15 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.616 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -62.53 102.66 0.29 Allowed 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.965 2.443 . . . . 0.0 112.665 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -126.99 72.48 1.36 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.182 0.515 . . . . 0.0 110.911 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -85.59 129.57 34.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.753 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -147.05 68.0 1.15 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.355 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -67.6 -55.03 14.99 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.335 -177.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -75.83 78.47 2.75 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.585 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -144.44 20.25 1.7 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -126.88 117.87 23.44 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 122.324 -0.235 . . . . 0.0 110.487 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -158.97 99.92 1.55 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.929 0.395 . . . . 0.0 110.751 176.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -97.31 68.58 2.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 171.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -52.87 163.78 0.45 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.564 178.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? 65.48 34.57 7.89 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.321 0.581 . . . . 0.0 109.693 -176.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -72.71 -41.08 65.64 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.55 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -54.33 121.9 9.25 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.361 177.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 9.8 p -76.86 81.98 3.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.896 0.379 . . . . 0.0 111.286 -177.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 67.93 178.09 0.24 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.594 177.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.1 109.88 0.73 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.295 0.569 . . . . 0.0 111.335 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 24.8 p -103.55 119.01 38.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.989 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -84.03 -12.5 55.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.62 0.724 . . . . 0.0 109.869 176.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 307' ' ' ASP . . . . . 0.508 ' CG ' ' H ' ' B' ' 308' ' ' ASP . 12.4 t70 63.67 -159.04 0.31 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.829 175.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . 0.508 ' H ' ' CG ' ' B' ' 307' ' ' ASP . 27.1 t70 -142.46 26.92 1.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 122.079 0.942 . . . . 0.0 109.243 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 22.6 ptt? -86.24 -11.66 51.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.671 176.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 111.58 88.57 1.82 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.792 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 100.0 m-85 62.69 76.67 0.36 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.95 0.405 . . . . 0.0 111.745 175.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . -92.64 35.73 3.95 Favored Glycine 0 N--CA 1.453 -0.19 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 313' ' ' LEU . . . . . 0.516 HD13 ' O ' ' B' ' 313' ' ' LEU . 2.6 tm? -72.24 -14.54 61.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.536 0.684 . . . . 0.0 109.287 178.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 314' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -71.94 -81.25 0.05 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.108 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.218 -0.896 . . . . 0.0 109.382 178.871 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mmt . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.94 -73.52 0.62 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.787 0.327 . . . . 0.0 110.365 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.593 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 5.6 m -78.65 54.62 1.52 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.543 177.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.439 HG23 ' HB2' ' B' ' 212' ' ' LEU . 13.3 p -71.68 -29.79 35.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.246 0.546 . . . . 0.0 109.753 -174.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.512 ' HB3' HG23 ' A' ' 39' ' ' VAL . 51.7 m -64.62 -52.06 59.39 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.944 176.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.427 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 35.6 tt0 -57.85 -45.45 86.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.04 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 3' ' ' SER . 82.6 mt -54.03 -53.78 48.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.356 176.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.07 -55.34 24.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.895 -177.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 21.6 p -67.43 -31.22 71.25 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.73 -176.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.553 HG13 HD23 ' A' ' 59' ' ' LEU . 0.9 OUTLIER -77.65 -37.64 24.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.921 0.391 . . . . 0.0 111.068 -176.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.636 ' O ' HG12 ' A' ' 15' ' ' ILE . 23.1 m-85 -74.61 -26.37 59.86 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.7 t -69.56 -44.78 70.16 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 172.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.94 -40.29 60.58 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.387 171.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.799 ' O ' ' HE1' ' B' ' 201' ' ' MET . 97.3 mt -60.48 -59.97 4.56 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 173.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.636 HG12 ' O ' ' A' ' 11' ' ' TYR . 36.3 mm -46.09 -34.4 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.3 mt -115.13 7.26 15.34 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -174.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -48.25 -62.47 1.47 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -120.73 -82.12 0.64 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.356 -176.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.584 ' OD2' ' HD2' ' B' ' 202' ' ' ARG . 5.2 t0 47.37 -152.59 0.09 Allowed 'General case' 0 CA--C 1.536 0.431 0 O-C-N 123.628 0.58 . . . . 0.0 111.28 178.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -112.05 22.52 14.74 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 168.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.561 HG11 HD11 ' B' ' 232' ' ' ILE . 4.1 p -128.41 158.67 40.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.59 -177.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.1 p -105.49 130.86 53.48 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 121.241 -0.183 . . . . 0.0 111.332 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.548 HG21 HD23 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -65.38 105.11 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.408 0.623 . . . . 0.0 110.52 175.562 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.419 ' OG1' ' HG2' ' A' ' 27' ' ' LYS . 22.3 p -133.91 168.48 18.69 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.379 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 26' ' ' ASP . 9.1 pt-20 -48.18 -48.53 34.56 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 123.659 0.599 . . . . 0.0 111.648 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.435 ' N ' ' HG3' ' A' ' 25' ' ' GLU . 7.5 p-10 -68.31 -27.84 66.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.251 -175.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.419 ' HG2' ' OG1' ' A' ' 24' ' ' THR . 46.2 mmtm -78.21 -45.1 23.93 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -176.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.511 HG23 HD13 ' A' ' 32' ' ' ILE . 6.5 mt -67.48 -41.7 86.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.779 176.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -55.57 -45.85 77.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.705 175.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.81 -49.6 72.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.324 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.407 ' CD1' ' HG ' ' B' ' 209' ' ' LEU . 0.2 OUTLIER -65.69 -38.6 89.7 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.211 0.529 . . . . 0.0 110.24 -177.276 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.511 HD13 HG23 ' A' ' 28' ' ' ILE . 1.3 mp -63.97 -35.86 74.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.255 176.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.453 ' HB3' ' NZ ' ' A' ' 33' ' ' LYS . 6.1 ttpm? -76.02 -21.69 56.57 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.919 0.39 . . . . 0.0 110.351 175.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.51 -48.71 21.35 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.659 ' HB3' HD12 ' B' ' 209' ' ' LEU . . . -143.27 8.27 1.6 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.38 89.93 1.55 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.115 -176.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.2 p -50.17 -50.8 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -175.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -161.63 126.52 3.47 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.946 0.403 . . . . 0.0 111.246 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.512 HG23 ' HB3' ' A' ' 5' ' ' SER . 7.2 p -139.17 127.53 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.431 173.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 24.8 mm-40 -57.07 125.62 70.8 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.029 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 40' ' ' GLU . 50.3 Cg_exo -52.99 -11.12 1.3 Allowed 'Trans proline' 0 N--CA 1.481 0.792 0 C-N-CA 124.042 3.162 . . . . 0.0 115.046 -168.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.571 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 0.7 OUTLIER -80.12 -28.18 39.02 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -174.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.428 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 98.7 m95 -64.68 -60.48 8.21 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.293 175.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.428 ' CD ' ' HB2' ' A' ' 43' ' ' TRP . 19.3 Cg_endo -59.74 -34.45 96.04 Favored 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 121.835 1.69 . . . . 0.0 111.939 178.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.91 -49.17 81.53 Favored Glycine 0 C--O 1.241 0.562 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.253 176.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 42' ' ' PHE . 89.8 mt -64.08 -47.18 81.09 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -60.72 -47.02 88.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.843 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.72 -37.52 86.64 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.608 -176.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -91.49 -26.76 18.64 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 119.8 -0.76 . . . . 0.0 113.033 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -116.11 -20.13 10.0 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -171.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.76 ' HA ' HG23 ' A' ' 54' ' ' VAL . 2.2 tp -83.99 -133.87 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.425 ' HA ' HG13 ' A' ' 23' ' ' VAL . . . 58.08 3.16 0.22 Allowed 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -176.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -145.57 -44.15 0.21 Allowed 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -177.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.76 HG23 ' HA ' ' A' ' 51' ' ' LEU . 48.7 t -40.91 112.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 114.0 -1.454 . . . . 0.0 110.745 172.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -54.67 140.47 35.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.071 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.602 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 3.4 tp -43.85 -51.94 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 124.043 0.84 . . . . 0.0 112.903 -173.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.28 -30.89 75.23 Favored Glycine 0 C--O 1.243 0.688 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.661 -176.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.5 t -65.25 -11.55 42.38 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -176.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.602 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 1.7 mp -43.06 -48.38 6.13 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.164 170.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.583 HD11 HG21 ' B' ' 259' ' ' ILE . 24.7 mm -110.05 44.46 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.628 0.728 . . . . 0.0 109.82 -178.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 48.9 t -119.58 -36.47 3.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.117 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -100.36 4.0 43.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.43 -177.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.1 p -62.7 -29.95 48.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 121.015 0.436 . . . . 0.0 111.299 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.76 -78.13 1.98 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.141 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -164.84 -53.78 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.845 0.355 . . . . 0.0 110.962 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.37 -125.08 8.15 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.464 -0.655 . . . . 0.0 111.464 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -167.14 156.29 28.01 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.828 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -86.64 -68.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.658 2.239 . . . . 0.0 112.558 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.63 96.63 2.77 Favored Pre-proline 0 N--CA 1.452 -0.326 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.1 178.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.72 169.69 18.28 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.61 2.207 . . . . 0.0 112.399 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 69.58 -71.68 0.12 Allowed 'General case' 0 N--CA 1.469 0.517 0 O-C-N 123.726 0.641 . . . . 0.0 111.503 -178.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 56.49 61.94 2.5 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.196 0.522 . . . . 0.0 111.286 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.05 -68.14 3.54 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.856 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 55.07 48.53 19.53 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 122.874 0.469 . . . . 0.0 111.716 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 68.17 117.03 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.861 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -48.26 131.94 23.09 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 124.12 3.213 . . . . 0.0 113.154 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.31 -177.22 3.96 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.271 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.44 164.97 40.74 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.94 -0.647 . . . . 0.0 113.075 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 160.95 -168.44 36.3 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.68 -0.568 . . . . 0.0 111.68 177.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.83 155.54 39.18 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 123.133 2.556 . . . . 0.0 111.981 178.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . . . -84.71 141.78 38.92 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.214 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 81' ' ' ALA . 49.1 Cg_exo -60.53 78.19 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.467 2.778 . . . . 0.0 113.949 -179.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.0 m 71.11 140.61 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.731 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.4 p -84.36 52.52 2.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.653 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -91.16 -39.94 11.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.047 177.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 60.39 -166.39 0.2 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.623 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.15 86.68 5.54 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.549 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -55.94 104.15 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.505 2.803 . . . . 0.0 112.671 177.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.48 78.98 9.72 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.932 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -82.08 128.92 34.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.72 175.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -94.62 -168.0 1.75 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.071 -175.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.439 ' HE2' ' HA ' ' A' ' 92' ' ' LYS . 12.0 mmpt? -71.51 -65.42 0.76 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.169 -175.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -141.41 139.8 33.51 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.8 p -137.56 126.47 34.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.148 0.499 . . . . 0.0 110.8 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -159.29 146.47 17.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.676 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 63.62 82.18 0.19 Allowed 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.724 0.64 . . . . 0.0 111.732 176.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -64.96 146.39 55.05 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.877 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -84.45 150.41 25.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.946 177.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -146.24 148.31 32.34 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 66.49 175.96 0.23 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.707 0.629 . . . . 0.0 111.399 -172.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.5 p -144.0 19.06 1.78 Allowed 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.568 0.699 . . . . 0.0 112.657 -171.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -106.47 104.91 14.72 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.858 -176.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -85.31 54.53 3.14 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.376 -177.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.484 ' HB3' HD12 ' A' ' 112' ' ' LEU . 2.0 p -95.09 27.39 3.23 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.938 -178.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.4 t70 53.15 42.77 32.17 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.619 -178.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.0 t0 66.53 112.63 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.345 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -70.99 71.51 0.55 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.045 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 88.7 mmm -83.15 65.32 8.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.581 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.64 -25.77 25.6 Favored Glycine 0 C--O 1.227 -0.287 0 C-N-CA 120.589 -0.815 . . . . 0.0 114.119 170.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -94.57 -164.22 1.14 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.191 0.495 . . . . 0.0 110.945 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -117.66 -158.86 11.16 Favored Glycine 0 N--CA 1.436 -1.334 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.387 178.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.484 HD12 ' HB3' ' A' ' 104' ' ' SER . 18.0 tp -100.12 68.08 1.43 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 120.786 0.327 . . . . 0.0 111.575 -171.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -145.7 49.88 1.21 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 177.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.8 t70 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.356 -0.83 . . . . 0.0 110.196 178.079 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.799 ' HE1' ' O ' ' A' ' 14' ' ' LEU . 5.1 ppp? -135.82 -32.45 0.89 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -177.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 202' ' ' ARG . . . . . 0.584 ' HD2' ' OD2' ' A' ' 19' ' ' ASP . 49.6 ttp180 -74.95 1.29 13.18 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.039 0.447 . . . . 0.0 111.857 -172.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 203' ' ' TYR . . . . . 0.419 ' CD1' HD23 ' B' ' 239' ' ' LEU . 29.3 m-85 -126.07 -36.81 2.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.305 0.574 . . . . 0.0 110.647 -178.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.639 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 38.7 t -65.24 -44.54 95.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.235 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 205' ' ' ALA . . . . . 0.545 ' HA ' HD12 ' B' ' 208' ' ' LEU . . . -72.74 -20.19 61.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.901 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . 0.497 ' CB ' HG23 ' B' ' 223' ' ' ILE . 4.0 m -70.62 -42.42 70.93 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 173.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 207' ' ' TYR . . . . . 0.653 ' CE1' HD11 ' B' ' 251' ' ' ILE . 20.7 t80 -60.42 -41.58 94.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.163 174.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 75.7 mt -62.59 -42.06 99.34 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.814 177.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 209' ' ' LEU . . . . . 0.659 HD12 ' HB3' ' A' ' 35' ' ' ALA . 0.6 OUTLIER -55.8 -54.52 43.44 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.741 177.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -67.15 -27.33 67.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.376 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 211' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -65.81 -50.04 66.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.16 177.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 212' ' ' LEU . . . . . 0.439 ' HB2' HG23 ' A' ' 4' ' ' VAL . 4.1 pp -73.78 -24.85 59.9 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.727 0.299 . . . . 0.0 110.783 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -63.91 -13.68 53.19 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 116.005 -0.543 . . . . 0.0 113.265 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 118.65 35.48 0.98 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.886 177.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 215' ' ' ASN . . . . . 0.647 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 33.9 t30 -152.42 114.83 4.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.912 0.387 . . . . 0.0 110.31 176.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . 0.49 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 8.1 m -76.28 -11.24 59.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.176 -178.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 217' ' ' SER . . . . . 0.406 ' N ' ' HD3' ' B' ' 218' ' ' PRO . 26.4 t -123.55 63.48 26.78 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.674 -176.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . 0.49 ' HD3' ' C ' ' B' ' 216' ' ' SER . 52.4 Cg_exo -60.22 144.96 99.48 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.029 2.486 . . . . 0.0 111.88 175.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . 0.414 ' O ' HD13 ' B' ' 223' ' ' ILE . 21.5 m -129.51 168.53 16.23 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.794 178.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -47.76 -40.37 20.47 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.922 0.392 . . . . 0.0 111.659 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 221' ' ' LYS . . . . . 0.581 ' HZ3' ' HB3' ' B' ' 221' ' ' LYS . 4.2 ttpm? -58.1 -49.99 75.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.727 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.03 -39.4 69.15 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.281 -173.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.497 HG23 ' CB ' ' B' ' 206' ' ' SER . 1.7 mp -64.55 -40.28 88.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.584 176.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -56.25 -45.65 79.95 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.198 173.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -58.9 -43.98 91.11 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.151 0.5 . . . . 0.0 111.337 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 0.647 HD11 ' HB2' ' A' ' 35' ' ' ALA . 1.3 mp -63.57 -40.23 88.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.156 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 76.7 mt -76.54 -19.28 58.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.199 0.523 . . . . 0.0 110.581 176.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -73.84 -36.51 64.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.297 178.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 94.6 p -55.43 -40.96 72.17 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.634 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 3.3 m -90.02 -14.42 9.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 111.9 0.334 . . . . 0.0 111.9 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 77.7 32.84 44.51 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.586 175.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . 0.561 HD11 HG11 ' A' ' 21' ' ' VAL . 61.6 mt -90.48 130.43 39.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 177.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -67.01 100.22 0.72 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.318 0.58 . . . . 0.0 110.787 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -89.78 111.69 22.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.22 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . 0.466 ' HB2' ' HG2' ' B' ' 238' ' ' ARG . 5.3 m-20 -53.56 104.52 0.1 Allowed 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.727 0.642 . . . . 0.0 110.607 177.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -54.95 -38.14 67.35 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -174.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 237' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' B' ' 241' ' ' LYS . 15.9 t70 -55.81 -68.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.052 0.453 . . . . 0.0 111.276 178.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.481 ' HA ' ' HB2' ' B' ' 241' ' ' LYS . 13.7 ptp180 -68.76 -17.02 63.97 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.821 0.343 . . . . 0.0 111.039 -174.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 239' ' ' LEU . . . . . 0.455 HD13 HD12 ' B' ' 243' ' ' ILE . 3.3 tm? -61.22 -67.94 0.36 Allowed 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.854 176.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -75.1 -16.25 60.56 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.369 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 241' ' ' LYS . . . . . 0.481 ' HB2' ' HA ' ' B' ' 238' ' ' ARG . 29.9 mmtp -64.07 -56.02 17.95 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.257 171.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 242' ' ' VAL . . . . . 0.51 ' O ' ' HB3' ' B' ' 246' ' ' LEU . 34.7 m -67.26 -34.98 72.6 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.81 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -175.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . 0.455 HD12 HD13 ' B' ' 239' ' ' LEU . 58.4 mt -74.03 -23.87 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.473 178.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 25.3 t -72.0 -31.66 66.45 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 172.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -83.1 -22.7 33.33 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.35 0.595 . . . . 0.0 110.454 173.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . 0.564 ' O ' ' HG ' ' B' ' 246' ' ' LEU . 9.3 tp -116.11 71.44 0.78 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.466 -174.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -125.3 80.91 1.92 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.145 0.498 . . . . 0.0 111.949 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . 87.04 -15.96 50.36 Favored Glycine 0 CA--C 1.52 0.406 0 CA-C-N 115.773 -0.649 . . . . 0.0 113.412 175.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -67.46 110.21 3.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.995 0.426 . . . . 0.0 111.524 -176.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 60.27 42.22 15.39 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.808 174.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.653 HD11 ' CE1' ' B' ' 207' ' ' TYR . 2.5 mm -58.25 -53.07 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -176.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -67.42 -26.18 66.29 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.378 -176.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -72.91 -46.03 54.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.4 177.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 254' ' ' VAL . . . . . . . . . . . . . 22.9 m -68.28 -20.57 25.67 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.989 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 255' ' ' ILE . . . . . 0.405 ' HA ' ' OH ' ' A' ' 11' ' ' TYR . 54.5 mt -74.04 -56.02 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-O 121.026 0.441 . . . . 0.0 110.759 172.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -67.98 -38.4 82.65 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -173.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 17.0 tp60 -101.54 -14.73 17.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.87 0.367 . . . . 0.0 111.701 -174.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . 0.583 ' O ' HD11 ' B' ' 262' ' ' LEU . . . -105.63 56.82 0.51 Allowed Glycine 0 C--O 1.227 -0.298 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.275 -172.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 259' ' ' ILE . . . . . 0.583 HG21 HD11 ' A' ' 60' ' ' ILE . 1.3 mt -85.2 -68.85 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.893 0.378 . . . . 0.0 111.668 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -116.03 25.28 9.51 Favored Glycine 0 C--O 1.227 -0.317 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.552 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -102.82 6.94 39.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.615 0.721 . . . . 0.0 110.602 -178.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 262' ' ' LEU . . . . . 0.583 HD11 ' O ' ' B' ' 258' ' ' GLY . 5.0 mp -84.97 -62.93 1.42 Allowed 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 122.28 1.038 . . . . 0.0 109.883 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . 0.531 ' HB2' ' CE ' ' B' ' 201' ' ' MET . . . -80.59 85.41 6.0 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 113.314 -1.766 . . . . 0.0 111.431 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 22.7 t -132.08 129.24 39.71 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.015 177.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 6.0 p -144.21 123.7 7.27 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.918 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.22 96.43 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.676 2.251 . . . . 0.0 112.787 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . 70.22 -47.76 0.63 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.186 0.994 . . . . 0.0 112.704 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 136.66 -15.52 3.84 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . 123.04 157.7 9.97 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -118.68 131.51 56.16 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 2.2 t -104.86 125.54 59.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -90.03 81.96 6.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.183 0.516 . . . . 0.0 110.804 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 59.9 t -105.84 109.52 28.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.132 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 34.9 t -132.12 136.31 47.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.054 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -135.86 133.17 37.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.44 -178.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . 0.486 ' HA ' ' HD3' ' B' ' 277' ' ' PRO . . . -132.99 128.47 20.65 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.662 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 277' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' B' ' 276' ' ' ALA . 17.4 Cg_exo -67.58 148.23 77.99 Favored 'Trans proline' 0 CA--C 1.517 -0.352 0 C-N-CA 122.939 2.426 . . . . 0.0 111.779 176.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -60.44 128.45 45.61 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.481 -178.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 2.4 p -79.96 161.56 25.42 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 71.71 174.8 0.29 Allowed 'General case' 0 N--CA 1.46 0.071 0 O-C-N 124.398 1.061 . . . . 0.0 111.928 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -147.99 109.24 3.74 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.44 -178.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -85.09 160.75 11.59 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.868 2.379 . . . . 0.0 112.428 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -126.99 113.31 16.31 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.815 0.34 . . . . 0.0 110.645 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -91.06 66.47 5.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.133 -177.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 152.55 179.66 28.3 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.561 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 21.1 p -157.84 167.75 29.12 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -139.69 112.85 7.74 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.908 -178.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.57 113.01 3.69 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.487 2.125 . . . . 0.0 111.596 178.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -122.24 52.18 1.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.119 178.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -102.15 -76.33 0.58 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.271 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -173.47 -28.55 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.37 0.605 . . . . 0.0 109.916 -175.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 66.88 20.49 10.55 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 114.393 -1.276 . . . . 0.0 112.202 171.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -126.53 -132.17 0.24 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.723 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -69.89 160.49 31.73 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -140.46 82.25 1.85 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.293 0.568 . . . . 0.0 111.749 -177.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -142.13 151.53 42.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.503 178.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -84.01 73.94 10.3 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.392 0.615 . . . . 0.0 111.279 -176.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -139.6 134.6 32.32 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.354 175.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -62.53 128.28 35.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.909 0.385 . . . . 0.0 110.861 177.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -55.36 114.31 1.76 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.6 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 62.5 93.34 0.05 Allowed 'General case' 0 N--CA 1.464 0.267 0 O-C-N 124.122 0.889 . . . . 0.0 110.792 -172.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 9.5 t -90.34 -175.77 4.6 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.634 -176.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -75.51 -82.55 0.07 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.751 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . 0.442 ' HG2' ' H ' ' B' ' 305' ' ' SER . 26.0 tt0 63.54 169.87 0.16 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.287 0.635 . . . . 0.0 111.488 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 305' ' ' SER . . . . . 0.442 ' H ' ' HG2' ' B' ' 304' ' ' GLU . 73.2 m 65.61 -178.17 0.19 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.924 -178.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -136.5 27.45 3.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.162 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -81.53 78.01 8.33 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.062 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -83.07 82.35 8.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.567 0.699 . . . . 0.0 111.064 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 23.0 mmt 55.82 28.06 11.81 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.089 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 66.01 27.89 73.22 Favored Glycine 0 CA--C 1.508 -0.372 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.671 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 62.54 19.54 11.31 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.284 0.634 . . . . 0.0 111.723 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . 135.9 125.9 2.53 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.219 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 20.3 mt -77.2 47.98 0.59 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.345 0.593 . . . . 0.0 110.083 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 314' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -131.22 -49.65 1.01 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.837 -173.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 25.0 t70 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.993 179.143 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.2 ttm . . . . . 0 N--CA 1.478 0.962 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.53 -67.46 0.54 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -176.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.611 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 5.8 p -78.97 62.55 3.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.997 -174.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.504 ' HA ' HD12 ' A' ' 7' ' ' LEU . 21.9 t -66.09 -31.02 51.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.213 0.53 . . . . 0.0 110.005 -174.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.508 ' HB3' HG23 ' A' ' 39' ' ' VAL . 1.1 m -61.76 -55.54 29.05 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.417 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -61.15 -42.06 97.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.97 178.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 3' ' ' SER . 96.0 mt -56.15 -55.61 30.97 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.619 178.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.26 -49.73 76.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.086 -178.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.427 ' HA ' HD11 ' A' ' 32' ' ' ILE . 24.1 t -66.15 -38.36 87.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.291 -176.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.419 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 1.3 tp -75.16 -39.56 43.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.932 0.396 . . . . 0.0 110.998 -177.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.741 ' HD1' HD21 ' A' ' 14' ' ' LEU . 20.1 m-85 -74.91 -19.31 60.19 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.2 t -70.94 -50.97 28.84 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 170.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.452 ' HB3' HD21 ' A' ' 59' ' ' LEU . . . -49.43 -48.21 47.57 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.109 175.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.909 HD22 HD12 ' B' ' 262' ' ' LEU . 4.2 pp -81.09 -18.16 47.49 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 11' ' ' TYR . 2.8 mt -62.14 -41.98 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.274 0.559 . . . . 0.0 109.543 168.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 23' ' ' VAL . 57.7 mt -80.82 -27.56 36.5 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.183 -178.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.534 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 10.2 m80 -79.78 64.73 4.72 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 177.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' B' ' 201' ' ' MET . 15.9 t0 -129.93 -51.35 1.13 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 171.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.49 ' OD1' HG21 ' B' ' 232' ' ' ILE . 8.8 m-20 -102.32 10.67 38.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.406 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 54.18 51.26 14.78 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.398 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -87.11 162.12 2.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.214 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.484 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 10.6 p -56.31 110.98 0.85 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.31 0.576 . . . . 0.0 112.246 -175.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.431 ' HA ' HD13 ' A' ' 16' ' ' LEU . 33.9 m -84.87 47.35 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.556 0.693 . . . . 0.0 110.935 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.414 HG22 ' HG2' ' A' ' 27' ' ' LYS . 10.1 t -87.31 169.32 12.39 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.071 -171.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -52.93 -42.26 65.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.903 -177.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -49.82 -45.58 50.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.677 177.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 22' ' ' THR . 66.4 mmtt -76.48 -48.92 17.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.945 -173.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.3 mt -62.45 -46.1 97.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.019 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -60.37 -46.09 91.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.902 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.65 ' HB3' HG11 ' B' ' 230' ' ' VAL . . . -71.21 -34.37 70.78 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.708 HD11 HG23 ' B' ' 226' ' ' ILE . 0.1 OUTLIER -70.69 -46.02 63.93 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.712 0.768 . . . . 0.0 109.478 178.568 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.427 HD11 ' HA ' ' A' ' 9' ' ' CYS . 1.5 mp -58.65 -37.3 64.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.53 175.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -74.39 -31.38 62.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.177 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.34 -45.4 91.48 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.471 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.579 ' HA ' HD11 ' B' ' 226' ' ' ILE . . . -76.32 -31.82 58.36 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.169 177.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.07 16.48 47.36 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.27 175.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.568 ' CG2' ' HA2' ' B' ' 213' ' ' GLY . 53.1 t -95.19 138.98 19.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.822 0.344 . . . . 0.0 110.71 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -93.41 97.47 10.59 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.873 0.368 . . . . 0.0 111.461 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.508 HG23 ' HB3' ' A' ' 5' ' ' SER . 7.7 p -97.09 136.68 27.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 171.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -59.92 126.24 82.85 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.65 -5.65 0.48 Allowed 'Trans proline' 0 N--CA 1.482 0.815 0 C-N-CA 124.053 3.169 . . . . 0.0 114.146 -172.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.64 -36.36 80.63 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.64 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 94.6 m95 -71.69 -56.6 4.78 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.995 177.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.64 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 74.0 Cg_exo -51.12 -43.77 46.42 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.093 1.862 . . . . 0.0 112.334 176.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.88 -57.1 15.18 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.143 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 45.5 tp -57.37 -43.61 83.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.659 0.266 . . . . 0.0 110.348 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.585 ' HA ' HD13 ' A' ' 51' ' ' LEU . 3.0 m-85 -59.97 -49.73 76.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.295 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.42 -34.27 76.44 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.043 -178.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -97.49 -1.71 43.54 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.86 -16.55 7.07 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.585 HD13 ' HA ' ' A' ' 47' ' ' PHE . 9.4 mp -84.75 -131.77 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 O-C-N 121.945 -0.472 . . . . 0.0 110.098 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 61.02 2.22 0.54 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.502 0.721 . . . . 0.0 112.887 -178.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.495 ' H ' HG12 ' A' ' 54' ' ' VAL . 9.3 m120 -139.49 -58.49 0.58 Allowed 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.542 HG11 ' HG ' ' A' ' 51' ' ' LEU . 2.5 p -1.01 96.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 113.217 -1.81 . . . . 0.0 114.48 164.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -59.38 128.75 38.65 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.205 169.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 5.1 tp -47.73 -45.25 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -169.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.414 ' O ' HG22 ' A' ' 60' ' ' ILE . . . -58.85 -37.38 90.52 Favored Glycine 0 C--O 1.239 0.407 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.595 -177.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.9 m -61.57 -11.01 9.38 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.474 -0.363 . . . . 0.0 111.599 -178.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 13' ' ' ALA . 9.2 tp -63.04 -24.86 68.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.802 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.51 ' O ' HG12 ' A' ' 60' ' ' ILE . 11.0 tt -99.86 22.43 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 121.991 0.901 . . . . 0.0 110.301 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 81.8 m -140.94 -62.38 0.48 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.16 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -101.1 66.33 1.13 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.978 0.418 . . . . 0.0 110.701 -176.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.1 m -62.42 -9.29 3.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.137 177.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -84.58 -23.65 49.61 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.616 178.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -179.09 -71.82 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.95 0.405 . . . . 0.0 111.222 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.5 -135.18 11.37 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.504 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -158.2 150.37 21.13 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -88.81 100.29 0.38 Allowed 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.882 2.388 . . . . 0.0 113.331 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.02 68.36 28.02 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.952 0.406 . . . . 0.0 110.756 174.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -82.6 104.39 1.31 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.599 2.199 . . . . 0.0 112.797 -175.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.06 -36.78 9.99 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.356 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 70.35 12.37 7.53 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.251 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 106.03 167.62 23.19 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.52 176.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -100.25 84.73 2.87 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.135 0.493 . . . . 0.0 110.276 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.488 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -114.88 141.52 26.98 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.804 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 26.5 Cg_exo -68.1 76.12 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.707 2.938 . . . . 0.0 113.108 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.06 125.43 29.78 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.982 0.42 . . . . 0.0 110.891 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.93 167.1 15.1 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.1 149.55 17.97 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.369 -0.92 . . . . 0.0 112.367 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -77.12 -40.33 0.48 Allowed 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.822 2.348 . . . . 0.0 112.967 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 52.27 75.57 0.63 Allowed Pre-proline 0 N--CA 1.466 0.364 0 O-C-N 123.287 0.367 . . . . 0.0 110.887 -175.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -50.01 101.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.358 2.705 . . . . 0.0 113.132 -176.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.2 m -135.19 84.3 2.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.544 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.0 t -155.22 162.33 40.95 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.353 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 56.55 40.35 29.49 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.119 0.485 . . . . 0.0 110.963 -177.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.473 ' O ' ' HD3' ' A' ' 88' ' ' PRO . . . -56.93 134.91 55.96 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.575 -177.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -110.9 96.04 27.24 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.715 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 86' ' ' ALA . 45.8 Cg_exo -64.16 165.9 18.2 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.137 2.558 . . . . 0.0 112.42 175.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.14 25.96 3.98 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 53.64 73.54 0.37 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.532 0.682 . . . . 0.0 111.948 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -103.66 -176.27 3.04 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.608 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 61.7 mttp 65.0 102.64 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 O-C-N 123.818 0.699 . . . . 0.0 110.856 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -79.8 75.55 6.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.229 0.537 . . . . 0.0 111.282 -177.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.4 t -113.84 114.75 47.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.349 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -128.28 -79.91 0.58 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.892 0.377 . . . . 0.0 110.924 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -109.07 -47.11 3.48 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.249 0.547 . . . . 0.0 110.789 -176.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -120.97 146.96 46.11 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.413 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -88.74 170.07 11.1 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -44.06 105.63 0.06 Allowed 'General case' 0 C--O 1.233 0.228 0 O-C-N 123.248 0.343 . . . . 0.0 111.046 177.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -69.01 133.98 48.86 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 120.938 0.399 . . . . 0.0 110.522 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.4 m -79.46 74.33 6.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.712 -174.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -90.84 166.56 13.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.571 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 39.96 43.99 1.35 Allowed 'General case' 0 N--CA 1.474 0.726 0 O-C-N 124.466 1.104 . . . . 0.0 113.123 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.3 t -125.59 161.11 27.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.483 -177.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -134.11 91.21 2.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.284 0.564 . . . . 0.0 109.482 174.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.49 78.62 9.1 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.176 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 63.61 60.81 1.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.265 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 27.2 ttt 70.41 100.38 0.06 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.104 175.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -101.57 -173.79 28.29 Favored Glycine 0 CA--C 1.522 0.486 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.291 175.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -64.3 164.82 10.51 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.942 0.401 . . . . 0.0 111.122 177.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -164.48 -96.32 0.11 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.377 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.1 mp -84.83 -1.59 56.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.694 0.283 . . . . 0.0 111.082 -177.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -140.8 164.59 29.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.457 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.7 t70 . . . . . 0 C--O 1.244 0.81 0 CA-C-O 118.622 -0.704 . . . . 0.0 110.184 -178.008 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 119.715 -0.183 . . . . 0.0 110.699 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.532 ' HE2' ' O ' ' A' ' 17' ' ' HIS . 62.4 mmm -6.38 -73.46 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.577 1.551 . . . . 0.0 114.862 171.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 202' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -63.81 -20.1 65.53 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -168.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -95.19 -52.87 4.01 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.355 0.598 . . . . 0.0 111.026 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.529 ' O ' HD13 ' B' ' 208' ' ' LEU . 8.6 p -58.28 -47.79 86.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.147 -174.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 205' ' ' ALA . . . . . 0.565 ' HB1' ' HB3' ' A' ' 11' ' ' TYR . . . -72.95 -19.22 61.28 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.471 -177.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . 0.563 ' OG ' HG23 ' B' ' 223' ' ' ILE . 24.4 t -66.09 -43.33 87.63 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 207' ' ' TYR . . . . . 0.559 ' CE1' HD11 ' B' ' 251' ' ' ILE . 21.5 t80 -60.47 -44.31 96.04 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.721 173.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.541 ' HB2' ' HA ' ' B' ' 205' ' ' ALA . 6.3 mp -56.26 -49.07 75.23 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.035 177.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 209' ' ' LEU . . . . . 0.506 HD22 HD12 ' A' ' 31' ' ' LEU . 3.7 mp -62.54 -43.13 99.57 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.56 0.219 . . . . 0.0 111.379 -178.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -62.74 -34.0 76.3 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.19 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 211' ' ' ALA . . . . . 0.716 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -71.44 -53.77 12.9 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.701 0.286 . . . . 0.0 111.05 178.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 212' ' ' LEU . . . . . 0.451 HD22 ' HB3' ' A' ' 7' ' ' LEU . 4.6 pp -68.61 -17.79 64.18 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.045 0.45 . . . . 0.0 110.904 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . 0.568 ' HA2' ' CG2' ' A' ' 37' ' ' VAL . . . -66.88 -19.63 69.81 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.103 177.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 130.71 6.91 3.55 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.111 177.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 215' ' ' ASN . . . . . 0.716 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 7.9 m-20 -119.52 119.05 32.7 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.841 0.353 . . . . 0.0 110.996 -178.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 8.5 m -81.74 -0.87 44.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.71 0.29 . . . . 0.0 111.365 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 217' ' ' SER . . . . . 0.452 ' N ' ' HD3' ' B' ' 218' ' ' PRO . 24.5 m -135.98 62.16 44.75 Favored Pre-proline 0 N--CA 1.444 -0.764 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.342 -176.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . 0.452 ' HD3' ' N ' ' B' ' 217' ' ' SER . 35.0 Cg_exo -63.87 130.98 29.31 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.987 2.458 . . . . 0.0 112.483 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . 0.496 ' O ' HD13 ' B' ' 223' ' ' ILE . 33.0 t -110.25 169.53 8.67 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.762 0.315 . . . . 0.0 110.49 177.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -56.02 -29.1 59.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.72 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -62.39 -53.1 59.92 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.612 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -62.36 -48.04 81.54 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.252 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.563 HG23 ' OG ' ' B' ' 206' ' ' SER . 1.7 mp -61.18 -48.49 88.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.784 -178.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -62.21 -38.11 87.9 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.499 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -56.93 -52.52 64.86 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.049 176.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 0.708 HG23 HD11 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -60.25 -43.73 94.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.222 -177.673 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . 0.406 HD13 ' HB2' ' B' ' 234' ' ' ALA . 1.1 tt -69.99 -43.02 72.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.68 0.276 . . . . 0.0 110.497 -177.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -69.43 -25.51 64.15 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.998 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 58.7 m -51.08 -49.41 60.71 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 230' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' A' ' 30' ' ' ALA . 3.4 p -171.46 19.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.914 -175.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -82.93 -94.75 0.57 Allowed Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 119.973 -1.108 . . . . 0.0 112.04 -173.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . 0.49 HG21 ' OD1' ' A' ' 19' ' ' ASP . 51.4 mt -143.17 -88.87 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 120.543 0.211 . . . . 0.0 110.549 -176.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -148.17 160.7 42.65 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 174.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . 0.406 ' HB2' HD13 ' B' ' 227' ' ' LEU . . . -151.21 98.91 2.61 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.054 0.454 . . . . 0.0 111.676 -177.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . 0.479 ' CG ' ' HD3' ' B' ' 238' ' ' ARG . 0.0 OUTLIER -67.74 127.54 33.18 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.77 174.422 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -65.69 -39.86 91.73 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -165.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -80.71 -38.62 28.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.312 0.577 . . . . 0.0 110.21 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.479 ' HD3' ' CG ' ' B' ' 235' ' ' ASP . 68.2 ttt180 -66.68 -39.47 88.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.677 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 239' ' ' LEU . . . . . 0.421 HD11 HG22 ' B' ' 223' ' ' ILE . 8.6 tt -59.01 -51.84 68.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.07 178.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -69.3 -29.53 67.41 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -67.15 -46.37 74.26 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 242' ' ' VAL . . . . . . . . . . . . . 35.8 m -70.13 -32.17 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . 0.476 ' HA ' ' CD2' ' B' ' 246' ' ' LEU . 12.5 mt -64.25 -38.54 82.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.981 170.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 28.1 t -72.07 -13.64 61.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.616 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -89.31 -30.29 18.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.036 0.446 . . . . 0.0 110.402 172.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . 0.559 ' O ' HD12 ' B' ' 246' ' ' LEU . 1.4 pp -98.84 3.72 47.4 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.617 -178.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -78.16 40.02 0.33 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -171.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -86.63 -121.23 1.32 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.17 -175.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -139.15 -174.44 3.86 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . 0.509 ' HB3' ' HB3' ' B' ' 253' ' ' ASP . 89.6 m-20 64.5 49.63 2.37 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.625 0.578 . . . . 0.0 111.428 176.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.559 HD11 ' CE1' ' B' ' 207' ' ' TYR . 1.3 mm -60.19 -48.39 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.297 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -68.96 -22.27 64.12 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.422 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . 0.509 ' HB3' ' HB3' ' B' ' 250' ' ' ASN . 5.8 t70 -70.88 -47.01 61.56 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 254' ' ' VAL . . . . . 0.487 HG22 ' O ' ' B' ' 251' ' ' ILE . 11.4 m -69.67 -25.11 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.119 178.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 255' ' ' ILE . . . . . 0.512 ' CG2' HD13 ' A' ' 7' ' ' LEU . 61.4 mt -78.98 -32.04 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.782 174.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -77.84 -41.69 36.15 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -127.1 36.96 4.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.271 0.558 . . . . 0.0 111.123 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' B' ' 262' ' ' LEU . . . -124.66 36.57 2.84 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.218 -0.992 . . . . 0.0 111.955 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 259' ' ' ILE . . . . . . . . . . . . . 67.8 mt -71.82 -77.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 CA-C-O 120.814 0.34 . . . . 0.0 110.724 -178.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -82.47 -3.23 90.61 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.111 -1.042 . . . . 0.0 112.205 -178.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 261' ' ' LYS . . . . . 0.5 ' HB3' ' O ' ' B' ' 264' ' ' SER . 32.3 mmtp -129.96 49.96 2.23 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 262' ' ' LEU . . . . . 0.909 HD12 HD22 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -43.79 -37.19 2.61 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.091 -1.413 . . . . 0.0 114.155 -174.152 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . 0.53 ' H ' HD22 ' B' ' 262' ' ' LEU . . . -132.07 31.57 4.13 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.004 0.431 . . . . 0.0 110.969 178.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . 0.5 ' O ' ' HB3' ' B' ' 261' ' ' LYS . 36.6 m -141.88 87.64 2.06 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.06 0.457 . . . . 0.0 110.812 -178.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 29.4 t -68.73 116.09 37.3 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.617 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.69 -40.93 2.5 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.694 2.262 . . . . 0.0 113.006 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . 46.96 65.81 1.14 Allowed 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.655 0.597 . . . . 0.0 112.362 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 139.42 -24.17 2.8 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.214 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -73.82 -12.18 80.91 Favored Glycine 0 C--O 1.23 -0.125 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.314 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -136.02 78.55 1.72 Allowed 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 27.0 m -76.97 168.62 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.863 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -124.16 169.65 11.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.995 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 78.3 t 69.32 102.28 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 O-C-N 123.893 0.746 . . . . 0.0 111.961 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 4.8 m -79.97 135.41 36.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.309 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -104.58 80.18 1.64 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.934 0.397 . . . . 0.0 111.442 -176.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' B' ' 277' ' ' PRO . . . -102.81 115.11 64.76 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.722 177.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 277' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 276' ' ' ALA . 3.5 Cg_exo -75.6 86.6 1.46 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.252 2.635 . . . . 0.0 112.178 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 88.35 38.57 7.13 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.55 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 49.2 m 67.12 -160.57 0.23 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.042 0.449 . . . . 0.0 111.365 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . -51.57 125.41 14.59 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.333 177.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . 0.481 ' HA ' ' HD3' ' B' ' 282' ' ' PRO . . . -133.75 135.04 24.08 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.599 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' B' ' 281' ' ' ALA . 16.0 Cg_exo -67.36 144.82 69.37 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.838 2.359 . . . . 0.0 112.088 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -101.99 42.89 1.1 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.064 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . 62.68 -163.84 0.26 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.862 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 145.36 -100.65 0.23 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.276 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 12.6 m -75.62 85.32 2.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.721 0.296 . . . . 0.0 110.727 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 287' ' ' ALA . . . . . 0.541 ' H ' ' HD2' ' B' ' 288' ' ' PRO . . . -157.56 -57.12 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 178.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 288' ' ' PRO . . . . . 0.541 ' HD2' ' H ' ' B' ' 287' ' ' ALA . 85.3 Cg_endo -78.04 69.86 7.31 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.755 1.637 . . . . 0.0 113.154 -174.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -102.07 29.11 5.27 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.237 0.541 . . . . 0.0 110.362 178.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -82.98 67.04 8.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.379 -177.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -143.67 20.52 1.84 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.147 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -68.67 -53.29 23.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.462 -178.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.55 -176.68 0.14 Allowed 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 61.63 -101.27 0.1 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.205 178.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp 71.19 161.37 0.23 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.318 0.647 . . . . 0.0 111.707 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 45.74 -158.65 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.213 1.005 . . . . 0.0 112.524 -177.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -84.45 -168.66 2.26 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -172.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -70.01 134.4 48.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.415 0.626 . . . . 0.0 112.121 -174.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.55 118.02 35.89 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.453 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -69.7 134.17 48.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.883 174.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -96.91 88.19 4.48 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.074 0.464 . . . . 0.0 110.729 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 23.0 t -130.15 119.76 23.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.595 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -135.41 155.28 50.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.176 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -96.62 145.17 25.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.491 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 35.4 m -147.24 140.14 25.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.251 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -80.82 77.94 7.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 177.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.34 152.64 35.42 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 120.819 0.342 . . . . 0.0 110.519 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -112.52 135.17 53.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.36 0.6 . . . . 0.0 110.744 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 309' ' ' MET . . . . . 0.402 ' SD ' ' N ' ' B' ' 309' ' ' MET . 0.0 OUTLIER -111.57 14.39 21.32 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.901 -179.519 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 111.89 -38.45 3.26 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.84 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -111.08 21.93 15.84 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.541 -0.329 . . . . 0.0 110.685 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 312' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' B' ' 314' ' ' PHE . . . -93.67 53.25 2.33 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.323 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 313' ' ' LEU . . . . . 0.501 ' H ' HD23 ' B' ' 313' ' ' LEU . 2.6 pt? -78.35 28.81 0.19 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.692 0.758 . . . . 0.0 110.537 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 314' ' ' PHE . . . . . 0.469 ' H ' ' C ' ' B' ' 312' ' ' GLY . 77.9 m-85 -103.44 -39.78 6.63 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.801 -174.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.399 -173.588 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.82 -160.73 0.82 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -70.57 89.05 0.7 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.208 0.528 . . . . 0.0 110.89 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.604 ' HA ' HD12 ' A' ' 7' ' ' LEU . 2.4 m -66.09 -18.01 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.481 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.451 ' HB3' HG23 ' A' ' 39' ' ' VAL . 16.7 m -61.37 -62.67 1.66 Allowed 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.51 176.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.602 ' O ' HG23 ' A' ' 10' ' ' ILE . 9.9 pt-20 -69.93 -34.9 74.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.446 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.604 HD12 ' HA ' ' A' ' 4' ' ' VAL . 66.6 mt -49.19 -64.72 0.72 Allowed 'General case' 0 C--O 1.222 -0.348 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 172.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.31 86.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.683 -176.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.2 t -62.21 -51.79 66.37 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -176.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.602 HG23 ' O ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -83.19 -16.58 11.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 119.166 -1.013 . . . . 0.0 111.158 -177.869 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.415 ' HB2' HD21 ' B' ' 209' ' ' LEU . 15.9 m-30 -69.89 -32.41 70.73 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 169.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.412 ' HA ' HD23 ' A' ' 31' ' ' LEU . 28.1 t -66.58 -43.91 83.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.298 169.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 10' ' ' ILE . . . -48.96 -45.19 41.59 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 120.98 0.419 . . . . 0.0 110.376 171.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 10' ' ' ILE . 85.7 mt -58.46 -56.03 27.41 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.614 177.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.627 HD12 HD21 ' A' ' 31' ' ' LEU . 56.5 mt -60.15 -32.45 50.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.619 -174.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.429 HD11 HG11 ' B' ' 230' ' ' VAL . 2.5 mm? -88.79 -24.34 22.64 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 121.758 -0.589 . . . . 0.0 112.41 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.549 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 54.6 t-80 -59.38 -51.25 70.73 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -174.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.442 ' HB2' ' SD ' ' B' ' 201' ' ' MET . 18.5 t70 -92.52 -21.19 20.26 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -164.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.488 ' OD2' ' HD3' ' B' ' 202' ' ' ARG . 3.7 m-20 -86.12 29.08 0.76 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -171.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 65.32 8.26 4.81 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.846 0.459 . . . . 0.0 111.933 174.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 19' ' ' ASP . 71.7 t -104.74 141.23 20.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.138 0.494 . . . . 0.0 110.721 -176.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.483 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 7.1 p -73.02 126.75 30.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.079 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.6 p -76.44 87.0 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.564 0.697 . . . . 0.0 110.917 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.1 p -112.46 175.6 5.37 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.353 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -59.74 -36.53 76.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.768 -178.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -53.14 -45.02 68.19 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.897 176.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 22' ' ' THR . 69.2 mmtt -78.29 -47.59 17.5 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.678 -169.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.444 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 21.6 mt -65.47 -46.49 89.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.362 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -63.15 -38.81 92.64 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.86 -43.6 75.08 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.128 0.489 . . . . 0.0 111.232 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.627 HD21 HD12 ' A' ' 15' ' ' ILE . 27.3 tp -70.87 -31.92 68.74 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.336 0.589 . . . . 0.0 110.011 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 28' ' ' ILE . 1.4 mp -73.05 -27.99 25.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.092 174.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -69.71 -34.32 73.72 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 172.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.96 -63.06 1.15 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.161 178.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.504 ' HB2' HD11 ' B' ' 226' ' ' ILE . . . -129.45 26.22 5.38 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -175.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -100.96 94.72 1.3 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.27 -0.967 . . . . 0.0 111.339 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.501 HG22 HD22 ' A' ' 38' ' ' ASN . 7.7 p -55.05 -50.15 65.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.501 HD22 HG22 ' A' ' 37' ' ' VAL . 9.2 p30 -161.91 130.03 4.15 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.226 0.536 . . . . 0.0 111.725 176.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.451 HG23 ' HB3' ' A' ' 5' ' ' SER . 10.9 p -157.56 131.95 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.06 174.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -73.0 132.1 83.08 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.56 -4.84 0.59 Allowed 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.846 3.031 . . . . 0.0 114.462 -171.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.55 -37.75 77.19 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.589 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 93.2 m95 -68.4 -55.01 12.98 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.839 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.589 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 87.5 Cg_exo -50.25 -50.77 12.52 Favored 'Trans proline' 0 C--N 1.364 1.366 0 C-N-CA 121.99 1.793 . . . . 0.0 112.972 174.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.8 -49.91 72.89 Favored Glycine 0 C--O 1.242 0.622 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.092 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 56.9 tp -53.57 -62.16 1.83 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.239 177.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.481 ' CZ ' HG22 ' A' ' 10' ' ' ILE . 3.5 m-85 -52.41 -46.19 66.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.237 -177.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.26 -38.52 91.5 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.732 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -105.52 10.33 33.18 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.894 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -115.38 -32.82 5.49 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 175.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.671 ' HA ' ' CG2' ' A' ' 54' ' ' VAL . 47.5 mt -80.86 -133.61 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.411 -177.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 66.66 -12.45 0.21 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.827 0.851 . . . . 0.0 113.245 177.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 51' ' ' LEU . 52.2 m-80 -141.17 7.38 1.99 Allowed 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.833 0.825 . . . . 0.0 108.87 178.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.671 ' CG2' ' HA ' ' A' ' 51' ' ' LEU . 0.6 OUTLIER -112.92 114.45 47.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.814 -173.411 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -43.95 136.91 3.47 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.635 1.209 . . . . 0.0 110.101 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.773 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 4.9 tp -47.7 -43.52 9.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.186 -169.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -53.35 -22.78 16.22 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.556 -177.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.2 t -53.36 -34.83 59.11 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 122.527 0.331 . . . . 0.0 111.535 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.773 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -61.23 -13.44 18.51 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -175.037 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.433 ' N ' HD12 ' A' ' 59' ' ' LEU . 18.5 mt -66.09 -24.81 34.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.902 0.382 . . . . 0.0 110.421 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.5 t -159.69 72.0 0.51 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.421 0.629 . . . . 0.0 109.833 174.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -94.08 37.12 1.1 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.679 0.752 . . . . 0.0 110.099 -178.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.7 p -136.85 -36.2 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.93 177.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.98 -92.75 0.83 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.76 178.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 71.45 128.95 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.675 0.79 . . . . 0.0 110.969 -173.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -87.57 29.87 5.16 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.989 -176.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.24 175.29 47.67 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.835 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.93 139.67 36.65 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.187 2.591 . . . . 0.0 111.988 177.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -105.74 98.28 17.38 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.399 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -79.86 99.86 1.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.411 2.074 . . . . 0.0 112.341 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.94 117.68 7.96 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.681 174.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -126.02 164.92 19.79 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.887 -175.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.9 -159.22 9.04 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.102 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.04 138.12 31.77 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.594 0.235 . . . . 0.0 110.868 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -91.18 118.84 68.77 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.1 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -41.76 -55.32 2.4 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 124.628 3.552 . . . . 0.0 113.985 -172.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 56.29 79.81 0.16 Allowed 'General case' 0 N--CA 1.462 0.169 0 O-C-N 124.118 0.886 . . . . 0.0 111.53 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -179.67 169.81 40.91 Favored Glycine 0 N--CA 1.454 -0.152 0 N-CA-C 111.489 -0.645 . . . . 0.0 111.489 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 167.97 177.22 39.09 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.089 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -85.64 160.15 10.73 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.787 2.325 . . . . 0.0 112.611 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -116.76 151.8 47.7 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.705 177.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -36.88 -58.41 0.54 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 124.069 3.179 . . . . 0.0 114.076 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.0 t 58.14 57.45 4.0 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.125 0.488 . . . . 0.0 110.865 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.9 m -95.19 93.04 7.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.646 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -93.86 137.81 32.69 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.91 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -135.37 125.99 27.05 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.618 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.15 87.71 3.56 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.91 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -65.82 149.18 86.88 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 123.408 2.739 . . . . 0.0 112.264 173.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -121.59 12.25 10.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.786 0.327 . . . . 0.0 111.346 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 58.59 77.79 0.28 Allowed 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.493 -177.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 67.05 -172.71 0.19 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 114.451 -1.249 . . . . 0.0 112.385 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -94.1 -52.0 4.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.943 -175.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -98.73 111.53 23.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.209 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.7 t -88.07 -36.76 9.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.144 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.8 pm0 -82.7 133.84 35.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.383 0.611 . . . . 0.0 110.563 -177.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -127.4 -76.44 0.57 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.329 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -143.37 146.06 33.2 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -176.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -118.53 -5.97 10.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.041 0.448 . . . . 0.0 110.231 173.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -76.35 -40.5 51.08 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.259 176.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 61.16 -164.27 0.24 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.221 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.3 t -94.61 -173.51 3.05 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.093 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -66.93 117.58 9.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.958 177.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 65.34 -175.75 0.18 Allowed 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.54 0.525 . . . . 0.0 110.925 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 42.4 m -109.41 62.16 0.6 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.192 -177.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 68.03 125.25 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.78 176.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -78.01 134.9 37.72 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.674 176.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 70.7 128.79 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 O-C-N 124.056 0.848 . . . . 0.0 111.962 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 44.4 ttp -86.05 104.76 15.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.747 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -179.47 -150.16 8.86 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.459 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -75.91 98.0 4.11 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.223 0.535 . . . . 0.0 111.038 -178.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.45 -115.93 4.13 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.655 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.4 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 27.4 tp -105.0 26.33 9.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.134 0.493 . . . . 0.0 110.952 -176.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -135.93 37.52 2.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.796 0.332 . . . . 0.0 111.687 -177.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.1 t70 . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.507 -0.759 . . . . 0.0 109.731 179.415 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 120.691 0.282 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.469 ' HE2' ' O ' ' A' ' 14' ' ' LEU . 23.5 ptm -134.85 2.61 3.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.745 0.307 . . . . 0.0 111.495 -174.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 202' ' ' ARG . . . . . 0.488 ' HD3' ' OD2' ' A' ' 19' ' ' ASP . 89.4 mtt180 -75.0 -74.77 0.19 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.928 -174.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 203' ' ' TYR . . . . . 0.523 ' OH ' ' HB2' ' B' ' 235' ' ' ASP . 1.3 m-85 -78.95 -19.39 51.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.115 0.483 . . . . 0.0 111.678 -170.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.663 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 26.8 m -65.19 -42.48 94.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.664 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 205' ' ' ALA . . . . . 0.71 ' O ' ' HG ' ' B' ' 209' ' ' LEU . . . -73.8 -22.23 59.88 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.319 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . 0.489 ' CB ' HG23 ' B' ' 223' ' ' ILE . 6.9 m -64.26 -47.74 78.43 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 171.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 207' ' ' TYR . . . . . 0.557 ' CZ ' ' HD2' ' B' ' 218' ' ' PRO . 36.9 t80 -60.53 -40.42 91.41 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.313 176.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 82.5 mt -57.96 -51.07 71.15 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.8 178.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 209' ' ' LEU . . . . . 0.71 ' HG ' ' O ' ' B' ' 205' ' ' ALA . 70.4 mt -59.01 -56.04 27.35 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.816 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 210' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' B' ' 218' ' ' PRO . . . -58.13 -31.29 67.04 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.599 -178.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 211' ' ' ALA . . . . . 0.654 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -74.58 -50.83 16.43 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.408 178.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 212' ' ' LEU . . . . . 0.472 ' HB2' HG12 ' A' ' 4' ' ' VAL . 4.0 pp -66.17 -20.12 66.04 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.64 0.257 . . . . 0.0 110.719 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . 0.495 ' HA2' ' HB ' ' A' ' 37' ' ' VAL . . . -68.22 -20.03 72.77 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.595 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 128.22 33.3 0.59 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.784 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 215' ' ' ASN . . . . . 0.654 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 18.3 m120 -144.74 114.25 7.15 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . 0.407 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 6.3 m -70.24 -17.87 63.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.846 0.355 . . . . 0.0 111.478 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 54.6 p -125.46 71.98 66.18 Favored Pre-proline 0 N--CA 1.444 -0.749 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.969 -175.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . 0.557 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 42.5 Cg_exo -62.54 112.12 1.51 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.131 2.554 . . . . 0.0 112.167 176.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 29.2 p -75.74 137.12 40.39 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.344 0.592 . . . . 0.0 110.444 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -54.29 -30.16 49.91 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.85 -177.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -68.25 -37.08 80.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.809 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -78.69 -30.84 46.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.982 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.489 HG23 ' CB ' ' B' ' 206' ' ' SER . 1.7 mp -62.15 -45.57 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.282 0.563 . . . . 0.0 109.507 171.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -61.11 -42.37 98.41 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.037 177.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -57.4 -42.72 82.79 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.31 174.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 0.504 HD11 ' HB2' ' A' ' 35' ' ' ALA . 1.0 OUTLIER -61.48 -35.9 69.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.815 178.644 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . 0.536 HD23 ' HB2' ' B' ' 234' ' ' ALA . 11.8 tp -75.96 -39.22 56.45 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.53 -32.0 71.05 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.211 174.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 28.2 t -52.18 -54.69 27.77 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.742 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 230' ' ' VAL . . . . . 0.429 HG11 HD11 ' A' ' 16' ' ' LEU . 40.9 t -74.4 -34.27 35.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.355 0.598 . . . . 0.0 110.803 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 104.52 43.95 1.63 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.836 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . 0.406 ' HB ' ' HG ' ' B' ' 227' ' ' LEU . 2.5 mm -104.01 145.72 12.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -69.56 118.02 11.91 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.025 0.44 . . . . 0.0 110.213 -178.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . 0.536 ' HB2' HD23 ' B' ' 227' ' ' LEU . . . -99.21 99.41 10.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.208 -175.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . 0.523 ' HB2' ' OH ' ' B' ' 203' ' ' TYR . 2.2 m-20 -61.52 109.84 1.3 Allowed 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 170.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.77 -38.29 90.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.698 -172.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.55 -60.15 4.31 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.769 177.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -62.38 -35.74 80.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.662 -172.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 239' ' ' LEU . . . . . . . . . . . . . 9.3 tt -55.71 -61.34 2.42 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.108 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -70.03 -26.38 64.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.679 -177.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -61.89 -52.71 62.98 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.284 175.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 242' ' ' VAL . . . . . 0.545 ' O ' ' HG ' ' B' ' 246' ' ' LEU . 34.0 m -72.5 -30.98 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.581 -175.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . 0.421 ' HA ' HD12 ' B' ' 246' ' ' LEU . 30.0 mt -69.3 -36.2 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.636 174.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 30.3 t -60.34 -38.17 82.96 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 174.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -70.29 -37.06 74.74 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.298 174.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' B' ' 242' ' ' VAL . 64.1 mt -71.26 -31.74 67.88 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.96 0.41 . . . . 0.0 111.056 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -53.38 -34.88 59.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.374 -175.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -108.81 35.46 4.93 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.892 -177.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -134.62 153.54 51.92 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.631 0.253 . . . . 0.0 110.412 178.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . 0.404 ' ND2' ' HB2' ' B' ' 253' ' ' ASP . 8.8 p-10 -74.54 83.35 2.01 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.894 0.854 . . . . 0.0 111.614 -176.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.622 ' O ' HG12 ' B' ' 254' ' ' VAL . 5.2 tp -57.68 -39.03 67.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 114.446 -1.252 . . . . 0.0 112.265 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -63.7 -38.42 91.06 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.874 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . 0.52 ' O ' ' HG2' ' B' ' 257' ' ' GLN . 43.4 m-20 -73.78 -40.08 63.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.801 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 254' ' ' VAL . . . . . 0.622 HG12 ' O ' ' B' ' 251' ' ' ILE . 3.1 p -62.29 -31.22 50.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.271 -177.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 255' ' ' ILE . . . . . 0.583 ' CG2' HD13 ' A' ' 7' ' ' LEU . 77.0 mt -78.79 -37.97 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 173.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -64.84 -19.9 66.11 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . 0.52 ' HG2' ' O ' ' B' ' 253' ' ' ASP . 31.2 mm-40 -71.55 -80.69 0.06 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.586 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . . . . . . . . . . . 177.31 -59.53 0.1 OUTLIER Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.344 -0.931 . . . . 0.0 113.168 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 259' ' ' ILE . . . . . 0.468 HG12 ' H ' ' B' ' 260' ' ' GLY . 0.0 OUTLIER -134.57 -70.1 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.857 0.36 . . . . 0.0 110.71 -177.466 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . 0.468 ' H ' HG12 ' B' ' 259' ' ' ILE . . . 109.0 -173.66 17.57 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.03 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -81.68 46.51 0.98 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.604 0.716 . . . . 0.0 110.564 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 262' ' ' LEU . . . . . 0.402 HD11 HD11 ' B' ' 208' ' ' LEU . 4.6 mt -103.9 -23.42 13.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.474 -177.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -101.66 9.03 41.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.456 -174.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 22.8 t -156.42 153.44 28.88 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 4.6 p -74.7 117.06 59.38 Favored Pre-proline 0 C--N 1.327 -0.399 0 O-C-N 123.271 0.357 . . . . 0.0 110.716 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -59.59 99.19 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.999 2.466 . . . . 0.0 112.456 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . -59.91 93.96 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.384 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 95.1 -10.39 69.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.459 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . 77.34 -80.9 1.24 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.997 -0.621 . . . . 0.0 111.851 -177.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -99.97 114.31 27.5 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.864 0.364 . . . . 0.0 110.277 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 13.0 t -120.31 141.68 39.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.866 -178.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -136.96 112.62 9.42 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.942 0.401 . . . . 0.0 110.942 -178.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 60.3 t -81.97 119.23 31.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.873 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 1.9 p -134.57 169.51 17.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.017 -176.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . 72.44 159.65 0.22 Allowed 'General case' 0 N--CA 1.467 0.379 0 O-C-N 124.069 0.856 . . . . 0.0 110.991 -177.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . 60.14 76.71 0.41 Allowed Pre-proline 0 N--CA 1.467 0.375 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.282 -177.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 277' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.74 96.6 0.06 OUTLIER 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.321 2.681 . . . . 0.0 113.218 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -121.38 -4.59 9.86 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.317 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 16.1 m -117.92 175.48 5.65 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 65.95 65.41 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 O-C-N 124.19 0.931 . . . . 0.0 111.688 172.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -68.6 124.66 90.55 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.238 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -44.32 -54.06 4.3 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.567 2.845 . . . . 0.0 113.643 -172.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . 55.1 66.98 1.09 Allowed 'General case' 0 C--O 1.234 0.248 0 O-C-N 123.575 0.547 . . . . 0.0 111.031 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -82.1 56.82 3.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.024 0.44 . . . . 0.0 110.681 -177.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 154.09 109.74 0.37 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.309 -177.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 21.9 t -76.4 84.43 3.15 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.332 0.587 . . . . 0.0 110.124 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -92.29 134.61 28.03 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.168 -178.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -77.07 107.26 2.4 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.627 2.218 . . . . 0.0 111.289 176.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -59.95 -28.19 67.43 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -175.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -80.67 -11.54 59.62 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . 56.51 29.25 15.09 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.056 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 65.27 -73.78 0.06 Allowed 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.662 0.785 . . . . 0.0 111.531 -176.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 54.59 47.34 22.86 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 123.544 0.528 . . . . 0.0 111.003 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -168.79 -44.89 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.964 -174.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -86.25 142.45 28.56 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.064 0.459 . . . . 0.0 112.054 -173.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -76.59 49.43 0.61 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.319 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 53.95 -106.66 0.32 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 122.841 0.456 . . . . 0.0 111.466 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 298' ' ' LYS . . . . . 0.523 ' O ' ' HG2' ' B' ' 299' ' ' LYS . 21.6 ttmm -131.08 13.68 5.18 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.586 0.708 . . . . 0.0 109.349 173.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 299' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' B' ' 298' ' ' LYS . 19.9 pttm 50.92 29.09 4.17 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.711 -1.132 . . . . 0.0 113.318 176.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -124.26 -50.0 1.79 Allowed 'General case' 0 C--N 1.33 -0.26 0 O-C-N 121.646 -0.659 . . . . 0.0 111.316 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -70.63 90.09 0.75 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.003 0.43 . . . . 0.0 111.933 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 16.3 t -143.88 121.63 11.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.035 178.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 176.33 -30.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.249 -179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 69.81 170.95 0.31 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.56 -1.2 . . . . 0.0 113.421 167.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 1.7 t 68.84 176.62 0.27 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.32 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -121.81 23.16 10.22 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.819 -173.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -92.37 73.61 5.27 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.128 0.489 . . . . 0.0 111.674 -174.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -74.94 -1.22 21.52 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.106 177.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 81.3 mtp -70.92 -21.83 62.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.931 -174.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 78.85 -58.06 4.26 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.225 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -84.54 18.67 2.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.855 0.359 . . . . 0.0 111.326 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . -103.69 54.96 0.65 Allowed Glycine 0 C--O 1.224 -0.473 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 178.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 3.1 pp -93.56 17.97 10.76 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.755 0.788 . . . . 0.0 110.504 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 314' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -97.16 -11.34 24.41 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.348 -174.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.873 -0.584 . . . . 0.0 110.644 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.27 -4.55 45.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.855 0.359 . . . . 0.0 111.3 -175.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.409 ' O ' HD13 ' A' ' 7' ' ' LEU . 3.4 p -64.31 -20.03 65.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.793 -178.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.425 ' HA ' ' HB2' ' A' ' 7' ' ' LEU . 6.4 m -65.4 -17.19 21.59 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.957 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.562 ' HB3' HG23 ' A' ' 39' ' ' VAL . 14.2 m -62.43 -67.13 0.44 Allowed 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.517 0.675 . . . . 0.0 110.447 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -67.25 -31.92 72.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.703 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.438 ' HB3' HD22 ' B' ' 212' ' ' LEU . 5.4 mp -60.41 -49.52 77.23 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.115 0.483 . . . . 0.0 110.224 176.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.85 -49.77 74.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.113 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.714 ' SG ' HG21 ' A' ' 39' ' ' VAL . 48.9 m -62.11 -35.86 79.98 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.701 -0.4 . . . . 0.0 112.055 -178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -74.35 -36.54 42.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.989 -0.285 . . . . 0.0 111.288 -178.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.622 ' O ' HG12 ' A' ' 15' ' ' ILE . 22.5 m-85 -77.52 -25.19 50.03 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.364 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.9 m -73.44 -38.7 65.43 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 172.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.25 -43.86 71.28 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.6 171.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.672 HD11 HD13 ' B' ' 262' ' ' LEU . 95.0 mt -57.04 -58.62 7.38 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.381 173.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.622 HG12 ' O ' ' A' ' 11' ' ' TYR . 36.6 mm -49.83 -35.86 10.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.279 -176.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.464 ' HB2' HG12 ' A' ' 23' ' ' VAL . 58.5 mt -106.08 -2.64 22.44 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -175.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.57 -20.79 66.09 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.822 -0.549 . . . . 0.0 112.309 -178.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.441 ' HB3' ' H ' ' A' ' 19' ' ' ASP . 0.2 OUTLIER -125.88 -117.76 0.27 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.648 -174.535 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.441 ' H ' ' HB3' ' A' ' 18' ' ' ASP . 1.0 OUTLIER 20.2 -138.93 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -170.397 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.424 ' H ' ' HB3' ' A' ' 19' ' ' ASP . 32.1 tt0 -117.14 23.46 11.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.98 0.895 . . . . 0.0 109.039 177.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.42 HG21 HG12 ' B' ' 232' ' ' ILE . 78.3 t -116.26 122.49 69.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.573 -176.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.437 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 4.5 p -80.08 147.13 31.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.077 -176.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 23' ' ' VAL . 30.9 m -75.03 103.66 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 121.507 0.67 . . . . 0.0 111.062 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.9 p -130.11 157.78 41.45 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 121.746 -0.596 . . . . 0.0 111.204 177.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -51.95 -49.55 62.93 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.709 0.631 . . . . 0.0 109.871 -177.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -34.09 65.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.886 -176.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.437 ' HD2' ' O ' ' A' ' 22' ' ' THR . 69.1 mttm -85.18 -41.74 15.37 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.24 -172.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.421 HG13 HD12 ' A' ' 16' ' ' LEU . 3.2 mt -63.37 -43.94 98.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 173.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.578 ' OD1' ' HE3' ' A' ' 33' ' ' LYS . 19.6 t-20 -58.07 -44.38 87.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.753 176.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.0 -44.41 94.56 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.492 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.2 mt -64.93 -44.29 89.97 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.677 0.275 . . . . 0.0 111.308 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 mp -59.27 -44.94 93.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.106 0.479 . . . . 0.0 110.426 178.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.578 ' HE3' ' OD1' ' A' ' 29' ' ' ASN . 97.7 mttt -66.43 -32.32 73.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.796 178.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.501 ' HB1' ' HA ' ' B' ' 226' ' ' ILE . . . -64.44 -38.07 89.73 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.265 177.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.419 ' HA ' HD11 ' B' ' 226' ' ' ILE . . . -79.93 -27.43 39.84 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.986 177.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.7 6.5 56.25 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.28 173.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.522 HG13 ' HA2' ' B' ' 213' ' ' GLY . 6.8 m -91.32 -178.93 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.05 0.452 . . . . 0.0 111.643 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -134.52 120.86 20.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.541 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.714 HG21 ' SG ' ' A' ' 9' ' ' CYS . 12.6 p -119.99 144.28 29.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.855 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.34 122.96 58.48 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -52.29 -13.32 2.03 Favored 'Trans proline' 0 N--CA 1.484 0.921 0 C-N-CA 123.735 2.956 . . . . 0.0 114.699 -170.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.01 -24.72 43.51 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -175.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.477 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 95.2 m95 -67.86 -59.57 6.44 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 175.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.477 ' CD ' ' HB2' ' A' ' 43' ' ' TRP . 11.3 Cg_endo -56.48 -37.29 97.54 Favored 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 121.862 1.708 . . . . 0.0 112.11 176.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.462 ' O ' ' HG2' ' A' ' 49' ' ' LYS . . . -66.0 -50.67 50.9 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.593 178.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.2 tt -59.23 -46.39 88.59 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.597 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 11.3 m-85 -60.05 -42.81 95.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.942 0.401 . . . . 0.0 110.844 177.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.98 -49.64 76.62 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -177.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 45' ' ' GLY . 19.0 ptmt -105.03 0.42 27.62 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -172.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.04 -11.55 3.32 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.688 ' HA ' HG23 ' A' ' 54' ' ' VAL . 3.4 tp -90.47 -133.16 0.11 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.464 ' H ' ' CG ' ' A' ' 51' ' ' LEU . . . 61.65 -12.68 0.05 Allowed 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.555 ' H ' ' C ' ' A' ' 51' ' ' LEU . 88.2 m-20 -128.23 -34.42 2.09 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -178.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.688 HG23 ' HA ' ' A' ' 51' ' ' LEU . 41.0 t -50.92 109.45 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-N 114.407 -1.269 . . . . 0.0 109.848 170.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -51.12 150.01 3.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.727 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.541 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 2.6 tp -53.83 -49.48 58.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -173.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.17 -26.43 65.89 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.781 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 61' ' ' CYS . 19.3 m -65.97 -2.19 3.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.661 -0.269 . . . . 0.0 111.484 -178.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 42.6 mt -57.36 -24.99 58.72 Favored 'General case' 0 N--CA 1.46 0.074 0 CA-C-O 120.771 0.319 . . . . 0.0 110.483 171.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.8 mt -89.69 28.15 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 121.421 0.629 . . . . 0.0 109.787 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 58' ' ' SER . 33.1 t -63.59 154.58 32.28 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.642 176.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -77.17 54.34 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.88 0.848 . . . . 0.0 110.017 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.2 p -118.81 -22.75 3.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.504 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.19 -162.98 33.25 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.091 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -123.96 -46.24 1.97 Allowed 'General case' 0 C--N 1.318 -0.769 0 O-C-N 122.895 -0.179 . . . . 0.0 111.033 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.06 65.16 3.07 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.881 -177.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -86.45 130.56 10.03 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 121.11 -0.566 . . . . 0.0 112.398 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.41 166.7 23.9 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.748 2.299 . . . . 0.0 112.398 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.16 117.48 68.82 Favored Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.332 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.99 -25.04 12.26 Favored 'Trans proline' 0 CA--C 1.529 0.231 0 C-N-CA 122.476 2.118 . . . . 0.0 113.128 -176.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -170.59 -173.11 1.33 Allowed 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 67.49 -173.48 0.19 Allowed 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.733 0.645 . . . . 0.0 111.243 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 151.5 -157.5 27.25 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.894 -0.67 . . . . 0.0 111.828 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -150.7 150.62 31.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.76 0.28 . . . . 0.0 110.529 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.499 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -136.91 137.38 23.04 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.296 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 46.5 Cg_exo -60.41 97.85 0.12 Allowed 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 123.319 2.679 . . . . 0.0 112.605 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.4 91.65 1.02 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.05 0.452 . . . . 0.0 111.185 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.46 -89.17 1.29 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.697 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.27 171.38 12.94 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.685 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -82.31 171.53 12.41 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.444 2.096 . . . . 0.0 112.468 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.53 101.98 45.63 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.546 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -57.44 -55.94 2.14 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.178 2.585 . . . . 0.0 112.361 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.5 t 63.46 97.25 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.751 0.657 . . . . 0.0 111.079 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.9 p 52.29 75.87 0.21 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.039 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.09 38.7 0.61 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.209 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . -120.87 84.87 2.3 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.51 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . 73.02 160.02 0.16 Allowed Pre-proline 0 CA--C 1.536 0.432 0 O-C-N 124.055 0.847 . . . . 0.0 110.069 -175.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -51.63 -61.74 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.397 2.064 . . . . 0.0 113.061 -177.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -172.7 -42.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.441 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -68.82 130.38 42.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.242 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -79.22 151.9 30.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.36 177.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.1 tmtp? -144.46 105.87 4.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.098 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -117.49 141.73 48.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.719 -175.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.513 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 13.6 p -88.84 141.13 14.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 175.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 94' ' ' VAL . 10.0 pt-20 53.55 -177.47 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.629 1.172 . . . . 0.0 112.547 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.73 145.91 37.06 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.7 -175.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -88.32 139.7 30.23 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.729 -177.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -65.79 146.33 54.89 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 174.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.77 -4.06 41.48 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 120.931 0.396 . . . . 0.0 110.407 177.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 69.0 -171.88 0.18 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.159 177.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.1 m -142.57 135.94 28.74 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.011 -173.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.1 23.03 15.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.491 177.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -58.54 134.58 56.84 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.565 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.4 t 71.31 103.31 0.06 Allowed 'General case' 0 C--O 1.236 0.343 0 O-C-N 123.857 0.723 . . . . 0.0 111.151 176.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.0 t0 70.5 89.85 0.1 Allowed 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.975 0.797 . . . . 0.0 110.298 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -64.29 123.77 20.0 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.766 -175.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -67.04 128.41 36.24 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.004 -176.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -84.69 72.96 10.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.598 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -82.13 91.13 1.5 Allowed Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.351 176.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -54.39 126.75 24.56 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.629 0.252 . . . . 0.0 110.434 176.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -154.91 -89.56 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.207 -176.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.2 mt -79.61 -22.32 43.82 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.044 0.45 . . . . 0.0 110.27 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -116.02 149.14 39.35 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.64 176.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.9 t70 . . . . . 0 C--O 1.245 0.864 0 CA-C-O 118.359 -0.829 . . . . 0.0 109.326 -178.694 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 19.1 mtt -105.39 -169.82 1.65 Allowed 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 121.546 0.688 . . . . 0.0 111.077 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 202' ' ' ARG . . . . . 0.436 ' C ' ' H ' ' B' ' 204' ' ' VAL . 33.2 mtm180 -118.44 155.91 29.95 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.5 178.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 203' ' ' TYR . . . . . 0.408 ' OH ' ' HA ' ' B' ' 234' ' ' ALA . 73.6 m-85 -70.4 17.69 0.06 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.112 0.565 . . . . 0.0 112.284 -172.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.613 ' O ' HD13 ' B' ' 208' ' ' LEU . 58.5 t -65.25 -53.48 40.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.49 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 205' ' ' ALA . . . . . 0.495 ' HA ' HD22 ' B' ' 208' ' ' LEU . . . -70.54 -16.4 62.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.163 0.506 . . . . 0.0 110.673 -178.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . 0.414 ' CB ' HG23 ' B' ' 223' ' ' ILE . 5.8 m -69.59 -47.23 64.24 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 171.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 207' ' ' TYR . . . . . 0.552 ' CD1' HD11 ' B' ' 251' ' ' ILE . 32.3 t80 -57.17 -39.68 75.78 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.254 174.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.613 HD13 ' O ' ' B' ' 204' ' ' VAL . 7.0 mp -60.71 -49.49 77.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.324 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 209' ' ' LEU . . . . . 0.515 ' CD2' ' HB2' ' A' ' 11' ' ' TYR . 25.3 mt -56.29 -48.78 75.97 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 120.936 0.398 . . . . 0.0 110.585 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 210' ' ' ALA . . . . . 0.536 ' HB3' ' HB3' ' B' ' 218' ' ' PRO . . . -66.56 -29.76 69.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.328 -177.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 211' ' ' ALA . . . . . 0.659 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -72.65 -52.26 16.07 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.933 0.396 . . . . 0.0 111.055 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 212' ' ' LEU . . . . . 0.438 HD22 ' HB3' ' A' ' 7' ' ' LEU . 2.9 pp -69.13 -19.97 64.04 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . 0.522 ' HA2' HG13 ' A' ' 37' ' ' VAL . . . -60.15 -19.68 52.33 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.824 176.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 127.73 3.9 5.84 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.665 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 215' ' ' ASN . . . . . 0.659 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 28.3 t30 -122.56 114.01 20.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.92 0.391 . . . . 0.0 110.654 -177.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . 0.427 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 18.6 m -70.76 -12.51 61.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.636 -178.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 10.1 p -122.98 67.49 32.63 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.492 -178.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . 0.536 ' HB3' ' HB3' ' B' ' 210' ' ' ALA . 80.7 Cg_exo -53.38 106.33 0.15 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.261 2.641 . . . . 0.0 113.09 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 16.0 m -77.9 148.74 34.44 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.158 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -56.63 -29.49 62.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.348 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -68.62 -30.05 68.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.342 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -86.64 -30.46 21.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.342 -177.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.414 HG23 ' CB ' ' B' ' 206' ' ' SER . 1.8 mp -66.47 -44.78 90.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 171.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 224' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' B' ' 228' ' ' ASP . 38.7 tttp -60.47 -43.4 96.96 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.799 175.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -56.72 -45.59 81.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.903 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 0.501 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . 1.0 OUTLIER -61.26 -44.88 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.071 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . 0.436 HD23 ' HB2' ' B' ' 234' ' ' ALA . 10.0 tp -76.36 -32.65 58.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.686 0.279 . . . . 0.0 110.652 -176.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 228' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' B' ' 224' ' ' LYS . 1.1 t0 -72.15 -29.78 64.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.319 0.58 . . . . 0.0 109.635 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 32.2 t -60.08 -37.79 80.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.051 177.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 9.6 p -98.74 -23.67 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 120.997 0.427 . . . . 0.0 111.313 -174.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 102.32 57.36 0.8 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.777 -0.725 . . . . 0.0 114.214 172.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . 0.42 HG12 HG21 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -130.51 147.33 33.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 173.069 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -66.1 130.23 42.54 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.72 0.295 . . . . 0.0 111.742 -175.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . 0.436 ' HB2' HD23 ' B' ' 227' ' ' LEU . . . -128.04 106.99 9.45 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.904 -177.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -81.72 124.07 29.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.745 178.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -63.38 -43.69 96.89 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.497 -171.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.29 -45.19 81.27 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -63.61 -49.94 71.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.015 -177.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 239' ' ' LEU . . . . . 0.607 HD12 ' N ' ' B' ' 240' ' ' ASN . 4.5 pp -64.03 -41.3 97.47 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 121.152 -0.219 . . . . 0.0 111.339 -176.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 240' ' ' ASN . . . . . 0.607 ' N ' HD12 ' B' ' 239' ' ' LEU . 25.5 t-20 -70.36 -34.99 73.28 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.658 -178.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 241' ' ' LYS . . . . . 0.691 ' O ' ' HG2' ' B' ' 245' ' ' GLU . 5.1 mmmp? -71.43 -39.74 70.86 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.808 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 242' ' ' VAL . . . . . . . . . . . . . 19.9 m -69.84 -31.51 48.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 119.566 -0.853 . . . . 0.0 108.949 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . 0.483 ' HA ' ' CD2' ' B' ' 246' ' ' LEU . 20.5 mt -68.79 -36.42 74.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.945 175.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 97.0 p -71.4 -32.46 68.45 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.638 178.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 245' ' ' GLU . . . . . 0.691 ' HG2' ' O ' ' B' ' 241' ' ' LYS . 7.1 mm-40 -74.76 -34.97 62.57 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.444 178.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . 0.483 ' CD2' ' HA ' ' B' ' 243' ' ' ILE . 1.0 OUTLIER -85.4 -10.1 56.68 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.139 0.495 . . . . 0.0 110.639 178.75 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -52.44 -54.01 37.84 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.596 -176.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -94.4 58.35 1.96 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.596 -176.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -135.77 163.03 31.13 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . 0.402 ' O ' HG13 ' B' ' 254' ' ' VAL . 0.9 OUTLIER -70.01 84.52 0.51 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.581 -178.264 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.552 HD11 ' CD1' ' B' ' 207' ' ' TYR . 0.6 OUTLIER -55.27 -39.26 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.674 0.749 . . . . 0.0 111.112 176.57 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.02 -35.76 82.23 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.075 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -72.0 -45.56 60.51 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.576 0.227 . . . . 0.0 110.54 177.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 254' ' ' VAL . . . . . 0.459 HG22 ' HA ' ' B' ' 251' ' ' ILE . 12.3 m -64.63 -32.36 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.326 -176.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 255' ' ' ILE . . . . . 0.533 ' HA ' ' OH ' ' A' ' 11' ' ' TYR . 56.3 mt -82.45 -36.14 13.36 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-O 120.985 0.421 . . . . 0.0 111.139 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -68.5 -54.17 18.54 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.72 -178.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -152.33 38.19 0.55 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -175.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' B' ' 254' ' ' VAL . . . -104.08 37.76 3.6 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.144 -1.026 . . . . 0.0 112.792 -177.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 259' ' ' ILE . . . . . 0.421 ' O ' HD12 ' B' ' 262' ' ' LEU . 13.0 mt -62.74 -19.17 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 120.988 0.423 . . . . 0.0 110.818 -178.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -115.77 40.28 2.48 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 119.686 -1.245 . . . . 0.0 112.885 178.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -124.61 25.46 7.53 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 171.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 262' ' ' LEU . . . . . 0.672 HD13 HD11 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -128.05 -60.38 1.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.292 -173.156 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -129.62 -177.17 4.15 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.396 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 30.7 t -162.33 156.6 21.62 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.128 0.267 . . . . 0.0 110.494 -177.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 7.5 p -105.01 129.19 25.24 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.875 0.369 . . . . 0.0 110.43 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -74.2 116.01 4.5 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.552 2.168 . . . . 0.0 112.362 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . 61.35 -171.3 0.15 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.043 177.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . -90.18 62.29 3.22 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.641 -178.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -84.58 117.75 4.56 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.311 177.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -103.8 137.5 41.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.758 0.313 . . . . 0.0 110.692 -178.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 14.2 t -117.35 143.34 28.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.218 -177.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -90.32 118.08 29.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.698 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 20.0 m -67.12 136.39 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.234 0.54 . . . . 0.0 110.855 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 8.3 p -129.38 -178.37 4.64 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.447 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . 65.57 27.97 11.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.515 0.674 . . . . 0.0 111.286 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -121.65 105.68 38.17 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.565 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 277' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.44 58.61 7.08 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.386 2.724 . . . . 0.0 112.176 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 75.76 -138.09 22.51 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.361 175.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 50.7 m -154.97 160.62 41.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 64.24 -166.82 0.22 Allowed 'General case' 0 C--N 1.332 -0.186 0 O-C-N 123.96 0.787 . . . . 0.0 110.854 175.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -146.18 83.01 8.76 Favored Pre-proline 0 C--O 1.236 0.35 0 CA-C-O 120.646 0.26 . . . . 0.0 110.971 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -84.04 118.0 2.3 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.748 2.299 . . . . 0.0 112.154 178.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -97.04 74.34 2.58 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.607 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -136.99 154.2 50.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.761 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.76 173.74 24.68 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.896 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 8.7 p -89.59 44.63 1.22 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.007 0.432 . . . . 0.0 111.155 -177.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 287' ' ' ALA . . . . . 0.451 ' HB3' ' HD3' ' B' ' 288' ' ' PRO . . . -73.18 -51.08 6.15 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.282 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 288' ' ' PRO . . . . . 0.451 ' HD3' ' HB3' ' B' ' 287' ' ' ALA . 20.8 Cg_endo -86.36 43.42 1.08 Allowed 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.433 1.422 . . . . 0.0 111.949 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -145.43 20.31 1.53 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.691 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -77.59 133.88 38.36 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.977 -179.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -136.74 98.09 3.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.721 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -100.7 19.51 16.91 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.901 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -73.84 -179.12 3.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.203 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.25 41.52 1.92 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.249 0.547 . . . . 0.0 111.306 -174.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -133.0 116.69 16.71 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.169 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 69.64 179.88 0.24 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.245 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -142.84 -47.67 0.32 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.007 -174.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 67.5 mttm 54.35 58.51 4.88 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.458 0.647 . . . . 0.0 110.224 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 299' ' ' LYS . . . . . 0.465 ' CD ' ' H ' ' B' ' 299' ' ' LYS . 0.0 OUTLIER -78.09 174.75 10.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.229 -177.093 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -64.79 142.88 58.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.727 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 53.64 56.54 7.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.517 -178.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 58.1 m -72.84 112.75 9.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.584 176.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -64.39 -36.41 84.06 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.433 177.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -82.94 133.62 35.1 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 20.2 m -76.09 149.6 37.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.117 -174.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -60.17 -59.99 4.53 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.27 0.356 . . . . 0.0 110.203 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 12.7 t70 66.36 108.42 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.269 0.981 . . . . 0.0 111.986 177.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -80.04 -18.98 48.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.95 -174.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 19.0 ptp -89.49 -28.67 19.5 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.688 -0.405 . . . . 0.0 112.02 -170.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . 29.2 -89.23 0.01 OUTLIER Glycine 0 C--N 1.339 0.743 0 O-C-N 124.813 1.32 . . . . 0.0 115.56 173.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -123.89 35.26 4.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.066 -0.567 . . . . 0.0 110.902 -174.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . -91.63 27.26 10.0 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.865 -0.683 . . . . 0.0 113.066 -177.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.63 50.56 2.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.167 0.508 . . . . 0.0 109.812 177.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 314' ' ' PHE . . . . . 0.441 ' O ' ' HB3' ' B' ' 315' ' ' ASP . 62.5 m-85 -132.03 -47.48 0.93 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.217 -175.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 315' ' ' ASP . . . . . 0.441 ' HB3' ' O ' ' B' ' 314' ' ' PHE . 28.4 t70 . . . . . 0 C--O 1.247 0.923 0 O-C-N 124.137 0.898 . . . . 0.0 111.334 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.9 mtp . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.25 -78.4 0.58 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.933 0.397 . . . . 0.0 111.363 -177.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 m -78.31 76.33 4.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.585 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.571 ' HA ' HD12 ' A' ' 7' ' ' LEU . 2.8 m -70.02 -25.06 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 CA-C-O 120.992 0.425 . . . . 0.0 110.537 -177.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.602 ' HB2' HG23 ' A' ' 39' ' ' VAL . 3.4 p -68.36 -52.73 29.93 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 121.48 0.657 . . . . 0.0 110.015 175.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.558 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 41.8 tt0 -62.56 -41.57 99.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.174 178.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.633 HD13 ' CG2' ' B' ' 255' ' ' ILE . 49.2 mt -53.98 -47.31 71.51 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.314 174.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.418 ' HB2' HG11 ' A' ' 37' ' ' VAL . . . -57.34 -53.12 61.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.685 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.558 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 7.2 p -67.54 -28.3 67.69 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.7 -176.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.446 HG13 HD23 ' A' ' 59' ' ' LEU . 0.7 OUTLIER -76.06 -40.76 37.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 120.895 0.379 . . . . 0.0 111.09 179.708 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.409 ' HB2' ' CD1' ' B' ' 209' ' ' LEU . 19.9 m-85 -71.03 -28.63 64.53 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.5 m -68.66 -45.86 70.63 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.102 173.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.5 -51.18 28.59 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.057 0.456 . . . . 0.0 110.572 173.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 10' ' ' ILE . 35.5 mt -61.23 -48.82 79.72 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.921 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.492 HD11 ' HA ' ' B' ' 206' ' ' SER . 83.8 mt -62.57 -37.29 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.789 0.328 . . . . 0.0 111.453 -178.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.706 HD23 ' HA ' ' A' ' 23' ' ' VAL . 10.8 mp -74.11 -22.14 59.6 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.895 177.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.496 ' CD2' ' HB ' ' A' ' 56' ' ' ILE . 51.4 t-80 -94.16 61.03 2.85 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.831 172.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -124.81 -55.62 1.6 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 174.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -117.19 -161.88 0.83 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -81.48 43.65 0.75 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.482 0.658 . . . . 0.0 111.845 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.522 HG11 HD11 ' B' ' 232' ' ' ILE . 7.6 p -94.05 128.54 45.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.099 0.476 . . . . 0.0 110.102 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.403 ' C ' ' H ' ' A' ' 24' ' ' THR . 33.5 p -56.08 123.69 15.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.81 -178.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.706 ' HA ' HD23 ' A' ' 16' ' ' LEU . 8.6 p -76.87 24.73 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-O 121.643 0.735 . . . . 0.0 111.144 -177.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.403 ' H ' ' C ' ' A' ' 22' ' ' THR . 6.6 t -92.49 168.13 11.48 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 121.679 0.752 . . . . 0.0 110.938 -174.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -25.83 67.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.778 -168.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -49.04 -50.89 34.17 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.521 0.677 . . . . 0.0 109.311 170.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -82.13 -38.14 25.2 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.931 -172.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.59 HG13 HD22 ' A' ' 16' ' ' LEU . 1.5 mt -62.93 -48.77 86.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.519 177.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -63.62 -39.58 94.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.125 177.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.92 -49.01 76.91 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.036 0.446 . . . . 0.0 110.914 176.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.407 HD21 HD12 ' A' ' 15' ' ' ILE . 44.0 tp -67.68 -36.01 79.9 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.294 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.3 mp -58.72 -37.04 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.193 174.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -77.06 -29.78 55.23 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.645 176.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.423 ' HB1' ' HA ' ' B' ' 226' ' ' ILE . . . -57.7 -45.27 85.89 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.936 176.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.44 -51.54 6.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.096 178.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.74 38.9 2.65 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.029 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.57 HG22 ' HA3' ' B' ' 213' ' ' GLY . 3.5 t -98.37 135.01 34.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.769 0.319 . . . . 0.0 110.688 -177.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -86.61 94.59 9.51 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.232 0.539 . . . . 0.0 110.504 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.602 HG23 ' HB2' ' A' ' 5' ' ' SER . 5.1 p -113.51 135.05 54.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.196 177.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -48.29 108.92 1.01 Allowed Pre-proline 0 N--CA 1.466 0.371 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.473 174.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -47.53 -18.49 0.9 Allowed 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 124.189 3.259 . . . . 0.0 114.266 -173.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -68.03 -38.74 82.9 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.723 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.566 ' O ' ' HB2' ' A' ' 47' ' ' PHE . 62.8 m95 -66.38 -59.08 8.98 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.387 178.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.552 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 73.0 Cg_exo -52.09 -47.69 25.4 Favored 'Trans proline' 0 C--N 1.363 1.324 0 C-N-CA 122.253 1.969 . . . . 0.0 112.715 177.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.17 -57.48 18.24 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.054 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.74 -43.91 85.7 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.63 ' O ' HD13 ' A' ' 51' ' ' LEU . 1.1 t80 -59.61 -55.23 37.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.092 0.473 . . . . 0.0 110.678 -177.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.475 ' HB2' HD12 ' A' ' 28' ' ' ILE . . . -61.99 -32.4 72.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.53 -176.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.486 ' HA ' ' HE2' ' A' ' 49' ' ' LYS . 9.1 mmpt? -87.04 -14.94 40.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.607 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.89 -27.85 16.85 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.656 ' HA ' HG23 ' A' ' 54' ' ' VAL . 5.8 mp -75.21 -113.32 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.817 177.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 61.42 -6.93 0.11 Allowed 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 178.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.434 ' H ' ' C ' ' A' ' 51' ' ' LEU . 47.3 t30 -144.08 -39.2 0.29 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.656 HG23 ' HA ' ' A' ' 51' ' ' LEU . 16.0 t -44.95 104.43 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.838 174.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -39.99 -82.66 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 O-C-N 124.312 1.007 . . . . 0.0 111.515 -176.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.592 ' O ' HD12 ' A' ' 59' ' ' LEU . 0.9 OUTLIER -157.08 -66.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.58 172.408 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.21 -23.87 53.88 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.287 -0.482 . . . . 0.0 113.603 -171.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.495 ' HB2' ' CG1' ' A' ' 54' ' ' VAL . 14.5 m -60.69 -14.21 19.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.595 0.236 . . . . 0.0 111.587 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.602 HD13 ' N ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -62.88 -14.54 47.52 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.983 0.42 . . . . 0.0 110.543 179.386 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.602 ' N ' HD13 ' A' ' 59' ' ' LEU . 9.0 tt -77.61 -4.6 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.055 -178.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 98.9 m -69.22 104.2 2.14 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.336 0.589 . . . . 0.0 110.866 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -75.88 65.33 1.96 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.218 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.42 ' O ' HG12 ' A' ' 63' ' ' VAL . 5.1 t -77.15 6.77 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.213 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -61.46 -67.09 2.27 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.745 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.85 -87.38 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.427 0.156 . . . . 0.0 110.943 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.431 ' O ' ' HD3' ' A' ' 68' ' ' PRO . . . 81.31 69.69 1.38 Allowed Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.554 177.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -102.97 102.23 2.21 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.446 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 66' ' ' GLY . 20.6 Cg_endo -88.14 104.62 0.5 Allowed 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.627 2.218 . . . . 0.0 112.46 -177.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.28 84.35 63.49 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.285 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -93.09 168.24 2.39 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.297 2.664 . . . . 0.0 112.645 176.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -166.59 157.6 12.6 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.961 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 66.11 177.72 0.22 Allowed 'General case' 0 CA--C 1.534 0.363 0 O-C-N 123.68 0.613 . . . . 0.0 111.876 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.64 62.88 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.777 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.91 137.09 32.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.561 0.22 . . . . 0.0 111.06 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.07 114.19 4.93 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.292 0.567 . . . . 0.0 110.647 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.83 128.44 30.31 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 123.988 3.125 . . . . 0.0 112.948 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.67 20.62 10.2 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.312 0.577 . . . . 0.0 110.652 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -143.22 151.55 23.32 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -138.82 -88.34 0.18 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.434 -0.888 . . . . 0.0 113.204 -178.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.09 149.51 90.13 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.664 2.243 . . . . 0.0 112.604 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -126.42 101.73 27.43 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.762 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.11 149.25 81.28 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.22 2.613 . . . . 0.0 113.138 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.6 m -137.54 21.23 2.92 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.327 0.584 . . . . 0.0 109.761 175.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.0 t -108.65 127.0 53.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.774 -176.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -163.09 119.67 1.84 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.098 177.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 68.02 167.1 0.25 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.789 0.681 . . . . 0.0 112.121 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.28 105.68 3.57 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.974 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -56.15 130.57 40.93 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.315 2.677 . . . . 0.0 113.359 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -135.95 89.63 2.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.772 175.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -106.54 126.73 52.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.662 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -83.09 176.6 9.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.444 0.64 . . . . 0.0 112.32 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -162.22 160.74 27.35 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.711 177.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm 71.03 81.99 0.15 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.343 0.657 . . . . 0.0 110.733 -172.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 m -111.33 6.53 8.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.832 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -102.58 166.0 10.77 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 178.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 97' ' ' LYS . . . -134.96 -75.82 0.46 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.802 -178.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 96' ' ' ALA . 45.4 mtmt 65.93 167.1 0.2 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.982 0.42 . . . . 0.0 111.074 -174.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -155.81 147.39 22.9 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.176 0.512 . . . . 0.0 112.15 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.86 42.94 3.23 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.083 173.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -53.32 143.91 17.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.931 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.6 t -71.88 104.58 3.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.22 0.533 . . . . 0.0 109.952 176.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -76.73 -172.05 2.11 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.371 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -55.59 122.26 10.94 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.42 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.58 56.22 1.81 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.489 0.662 . . . . 0.0 110.613 -177.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -98.88 52.52 0.98 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.481 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -68.42 114.3 6.74 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.728 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -84.78 159.71 20.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.083 0.468 . . . . 0.0 111.041 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 15.8 tpt -98.84 93.84 6.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.597 -177.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 169.21 -177.11 43.05 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.172 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.85 60.78 4.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.046 0.45 . . . . 0.0 110.904 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -132.63 59.2 0.69 Allowed Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.43 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.3 mt -117.7 20.15 13.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.282 0.563 . . . . 0.0 110.614 -175.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -138.32 15.89 2.78 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.206 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 C--O 1.249 1.076 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.494 -176.919 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 120.274 0.083 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 78.0 mmm -56.3 121.19 8.95 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 123.289 0.368 . . . . 0.0 110.221 176.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 202' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -150.73 -176.32 5.47 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.148 -179.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 203' ' ' TYR . . . . . 0.495 ' CD2' ' HA ' ' B' ' 239' ' ' LEU . 59.0 m-85 -71.26 9.2 0.81 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.896 0.478 . . . . 0.0 111.669 -178.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.755 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 15.5 m -59.52 -49.05 85.05 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.193 177.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 205' ' ' ALA . . . . . 0.491 ' HA ' HD12 ' B' ' 208' ' ' LEU . . . -73.31 -15.59 61.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.064 0.459 . . . . 0.0 110.618 -177.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . 0.493 ' HB3' HG23 ' B' ' 223' ' ' ILE . 6.5 m -71.02 -49.22 47.45 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 172.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 207' ' ' TYR . . . . . 0.507 ' CZ ' ' HD2' ' B' ' 218' ' ' PRO . 24.4 t80 -60.76 -40.87 94.09 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 174.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.755 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 79.3 mt -59.71 -51.68 68.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.168 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 209' ' ' LEU . . . . . 0.409 ' CD1' ' HB2' ' A' ' 11' ' ' TYR . 8.4 tp -59.7 -49.75 76.51 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.862 0.363 . . . . 0.0 110.612 -178.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 210' ' ' ALA . . . . . . . . . . . . . . . -61.84 -34.03 75.22 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.2 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 211' ' ' ALA . . . . . . . . . . . . . . . -79.4 -36.25 39.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.032 0.444 . . . . 0.0 110.79 178.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 212' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.32 -46.69 85.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.202 177.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . 0.57 ' HA3' HG22 ' A' ' 37' ' ' VAL . . . -150.38 69.59 0.32 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.694 -1.241 . . . . 0.0 112.929 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . -168.71 -66.51 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.276 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 215' ' ' ASN . . . . . 0.653 HD22 ' N ' ' B' ' 216' ' ' SER . 0.2 OUTLIER -156.89 132.05 9.09 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -178.681 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . 0.653 ' N ' HD22 ' B' ' 215' ' ' ASN . 2.1 m -51.34 -30.83 19.87 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.652 -178.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 18.0 p -121.79 76.62 38.28 Favored Pre-proline 0 N--CA 1.442 -0.867 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.667 -177.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . 0.507 ' HD2' ' CZ ' ' B' ' 207' ' ' TYR . 75.6 Cg_exo -54.41 108.53 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.579 2.853 . . . . 0.0 112.651 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 30.8 m -84.66 155.93 21.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.695 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -51.62 -40.04 59.15 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.174 0.512 . . . . 0.0 110.706 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -60.55 -32.5 71.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.566 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -85.42 -30.75 23.32 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -177.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.53 HG22 HD11 ' B' ' 239' ' ' LEU . 1.8 mp -66.91 -42.06 88.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 172.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -60.71 -46.14 91.55 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.097 174.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -55.99 -43.92 78.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.375 177.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . 0.423 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . 1.0 OUTLIER -60.42 -42.39 90.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 178.706 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 93.5 mt -71.91 -39.02 69.81 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 121.214 -0.195 . . . . 0.0 111.378 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -67.45 -30.49 70.23 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.769 0.318 . . . . 0.0 111.146 177.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 56.1 m -69.36 -47.57 63.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.293 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 11.4 p -79.53 -27.21 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.075 0.464 . . . . 0.0 111.362 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 103.55 56.98 0.76 Allowed Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.374 174.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . 0.522 HD11 HG11 ' A' ' 21' ' ' VAL . 31.5 mt -133.65 125.98 50.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 176.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -60.17 131.1 49.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.917 0.389 . . . . 0.0 110.769 176.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -118.24 152.62 35.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.904 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -117.04 114.97 24.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.144 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 236' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -55.33 -37.65 67.7 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.64 -173.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.37 -62.0 1.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.01 0.433 . . . . 0.0 110.312 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.664 ' O ' HG23 ' B' ' 242' ' ' VAL . 86.5 mtm180 -63.62 -34.34 77.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.665 -177.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 239' ' ' LEU . . . . . 0.53 HD11 HG22 ' B' ' 223' ' ' ILE . 9.9 tt -62.6 -57.66 10.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.07 0.462 . . . . 0.0 110.939 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -66.62 -23.34 66.16 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.127 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 241' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' B' ' 241' ' ' LYS . 35.3 ttmt -68.34 -46.88 68.98 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 120.983 0.421 . . . . 0.0 110.74 176.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 242' ' ' VAL . . . . . 0.664 HG23 ' O ' ' B' ' 238' ' ' ARG . 52.2 t -67.44 -32.95 59.46 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . . . . . . . . . 40.1 mt -75.9 -22.57 15.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.704 176.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 36.1 t -71.19 -37.41 72.14 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.656 174.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -85.86 -26.0 25.91 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.325 0.583 . . . . 0.0 110.353 175.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . 0.687 ' O ' HD13 ' B' ' 246' ' ' LEU . 0.0 OUTLIER -121.51 97.56 5.56 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.88 0.848 . . . . 0.0 109.678 -177.41 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 247' ' ' ASN . . . . . 0.505 ' CG ' ' H ' ' B' ' 248' ' ' GLY . 25.2 p-10 -146.79 -74.92 0.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.108 177.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . 0.505 ' H ' ' CG ' ' B' ' 247' ' ' ASN . . . -106.72 55.06 0.55 Allowed Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -177.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -117.07 57.85 0.78 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.731 -0.234 . . . . 0.0 110.83 -177.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 60.81 67.5 0.82 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.655 0.597 . . . . 0.0 111.477 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.501 ' HA ' HG22 ' B' ' 254' ' ' VAL . 1.8 mm -60.93 -48.79 87.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.97 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 252' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -60.44 -29.4 68.99 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.524 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . 0.531 ' O ' ' HG2' ' B' ' 257' ' ' GLN . 27.9 t70 -76.66 -47.49 21.95 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.961 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 254' ' ' VAL . . . . . 0.501 HG22 ' HA ' ' B' ' 251' ' ' ILE . 28.8 m -62.47 -29.86 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.597 0.237 . . . . 0.0 111.164 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 255' ' ' ILE . . . . . 0.633 ' CG2' HD13 ' A' ' 7' ' ' LEU . 61.9 mt -88.03 -24.89 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-O 120.827 0.346 . . . . 0.0 110.746 175.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 256' ' ' ALA . . . . . . . . . . . . . . . -66.74 -38.99 87.75 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.018 -0.426 . . . . 0.0 111.281 177.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . 0.557 ' HG3' ' H ' ' B' ' 258' ' ' GLY . 4.6 pt20 -69.5 -81.96 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . 0.557 ' H ' ' HG3' ' B' ' 257' ' ' GLN . . . 175.44 -90.39 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.249 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 259' ' ' ILE . . . . . 0.447 ' CD1' HG13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -100.57 -97.19 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.91 -0.645 . . . . 0.0 110.732 -179.018 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 120.8 -149.4 17.48 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.628 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.54 23.61 0.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.257 0.551 . . . . 0.0 110.657 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 262' ' ' LEU . . . . . . . . . . . . . 3.1 mt -77.55 -53.05 8.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.736 -175.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -143.03 52.95 1.37 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.612 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 3.1 p -112.12 -83.14 0.59 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.321 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 15.4 t -126.93 123.39 23.61 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.022 0.439 . . . . 0.0 110.424 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -57.58 -32.6 94.8 Favored 'Trans proline' 0 N--CA 1.476 0.463 0 C-N-CA 123.988 3.125 . . . . 0.0 113.777 -174.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . -121.6 24.41 9.82 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 120.894 0.378 . . . . 0.0 111.232 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 81.14 -32.62 2.5 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 121.026 -0.607 . . . . 0.0 113.188 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . 86.72 43.8 5.97 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.872 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . 68.12 179.29 0.23 Allowed 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.219 0.608 . . . . 0.0 110.847 -176.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 7.9 t -118.74 134.26 62.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.833 0.349 . . . . 0.0 110.703 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -137.35 135.21 36.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.371 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 273' ' ' VAL . . . . . . . . . . . . . 14.8 p -68.41 143.02 15.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.179 0.514 . . . . 0.0 110.978 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 18.8 p -108.2 179.45 4.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.384 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . 62.35 74.95 0.42 Allowed 'General case' 0 C--O 1.23 0.073 0 CA-C-O 121.283 0.563 . . . . 0.0 111.516 178.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -115.01 104.54 53.93 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.226 177.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 277' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -80.41 141.51 14.22 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.219 2.613 . . . . 0.0 112.448 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -109.26 -38.74 1.76 Allowed Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.8 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 41.6 m 66.19 -172.29 0.19 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.851 0.358 . . . . 0.0 110.922 -176.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 52.53 56.75 7.22 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.166 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . 0.56 ' H ' ' HD2' ' B' ' 282' ' ' PRO . . . -158.09 -54.36 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.853 -176.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . 0.56 ' HD2' ' H ' ' B' ' 281' ' ' ALA . 59.4 Cg_endo -70.34 155.37 64.17 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 121.548 1.499 . . . . 0.0 112.562 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -87.62 119.2 27.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.848 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -132.19 47.46 2.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.409 177.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -76.75 81.75 1.12 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.289 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 21.6 t -75.79 79.25 2.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.193 0.521 . . . . 0.0 110.232 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -139.61 77.78 27.53 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.846 176.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.91 88.97 0.29 Allowed 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.45 2.1 . . . . 0.0 112.708 -178.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -92.02 99.63 12.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.294 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -75.39 118.74 18.6 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 173.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -109.56 -81.39 0.57 Allowed 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 121.171 -0.211 . . . . 0.0 110.625 -176.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 57.2 -171.92 0.09 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.497 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 59.1 104.87 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -86.61 29.58 0.78 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.482 0.658 . . . . 0.0 110.055 177.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 295' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -138.92 110.26 6.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.535 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -94.24 -171.11 2.44 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 174.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 64.39 47.74 2.98 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -170.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -75.29 65.26 1.59 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.68 -173.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -170.64 86.15 0.11 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.188 0.518 . . . . 0.0 111.008 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -110.37 -27.83 8.86 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -57.32 98.41 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.581 176.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 12.4 p -148.61 151.74 35.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.463 -177.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -103.04 -6.2 22.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.971 0.415 . . . . 0.0 110.758 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . 0.441 ' HG2' ' H ' ' B' ' 304' ' ' GLU . 5.9 pt-20 -83.68 70.53 10.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.4 0.619 . . . . 0.0 111.673 -175.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 36.1 t -80.01 135.16 36.31 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.625 176.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -84.91 -27.75 26.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.633 -176.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -76.23 103.1 6.09 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.075 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -88.2 -49.94 6.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.052 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -86.75 45.3 1.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.196 -176.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . -64.44 -43.01 97.34 Favored Glycine 0 CA--C 1.517 0.213 0 CA-C-N 115.745 -0.661 . . . . 0.0 113.18 -176.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -112.53 56.0 0.68 Allowed 'General case' 0 C--N 1.327 -0.386 0 O-C-N 122.493 -0.416 . . . . 0.0 110.966 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . -134.04 53.81 0.78 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.949 -178.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 313' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.26 -39.22 17.99 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 314' ' ' PHE . . . . . . . . . . . . . 34.1 p90 52.29 17.72 0.78 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.052 1.341 . . . . 0.0 113.832 172.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 30.1 t70 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.653 -0.689 . . . . 0.0 109.868 -179.594 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.1 mtp . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.46 171.06 14.66 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.878 -0.146 . . . . 0.0 110.654 -177.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.548 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 36.7 m 60.63 28.07 17.77 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.732 0.645 . . . . 0.0 112.411 178.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.465 HG12 ' CD1' ' B' ' 212' ' ' LEU . 15.4 m -72.26 -16.26 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.76 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -68.67 0.36 Allowed 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.674 176.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.478 ' HA ' ' SG ' ' A' ' 9' ' ' CYS . 3.2 pm0 -56.2 -43.03 78.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.46 178.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.55 HD22 ' OH ' ' A' ' 11' ' ' TYR . 38.2 mt -54.32 -57.89 9.51 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.327 176.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.44 ' HB2' HD21 ' B' ' 212' ' ' LEU . . . -54.93 -50.33 69.11 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -176.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.478 ' SG ' ' HA ' ' A' ' 6' ' ' GLU . 26.4 p -70.7 -33.8 71.27 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.763 -173.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.454 HG21 ' O ' ' B' ' 262' ' ' LEU . 0.5 OUTLIER -79.36 -25.49 12.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.946 0.403 . . . . 0.0 110.576 -179.676 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.581 ' OH ' HG23 ' B' ' 255' ' ' ILE . 20.7 m-30 -76.05 -28.78 57.8 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 172.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.415 ' OG ' HG12 ' A' ' 28' ' ' ILE . 7.5 t -68.3 -50.64 52.15 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.669 174.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.21 -47.95 68.52 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 173.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.658 HD21 HG22 ' B' ' 259' ' ' ILE . 11.4 mt -52.06 -61.64 2.13 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.057 177.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.588 HD11 ' HA ' ' B' ' 206' ' ' SER . 56.5 mt -62.72 -46.29 96.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.197 0.522 . . . . 0.0 111.297 -176.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.451 ' HG ' HG12 ' A' ' 23' ' ' VAL . 25.1 tp -70.65 -15.29 62.72 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.601 -173.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -125.62 37.92 4.27 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 119.362 -0.935 . . . . 0.0 112.112 173.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.472 ' OD2' ' HB2' ' B' ' 201' ' ' MET . 12.3 t0 -81.21 -57.75 3.36 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 167.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -81.5 174.1 11.76 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.332 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -84.23 39.04 0.69 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.33 0.586 . . . . 0.0 111.171 -175.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.401 HG11 ' CD1' ' B' ' 232' ' ' ILE . 14.6 p -92.57 142.72 12.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.028 177.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.0 p -72.17 133.88 45.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.43 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.451 HG12 ' HG ' ' A' ' 16' ' ' LEU . 16.0 m -87.8 132.67 32.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.359 -179.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.5 p -147.06 158.39 43.92 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.907 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -45.76 -55.91 5.95 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.909 0.755 . . . . 0.0 111.361 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.43 -31.52 64.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.807 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -80.14 -39.1 30.13 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.494 -177.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.415 HG12 ' OG ' ' A' ' 12' ' ' SER . 4.0 mt -63.88 -47.03 92.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -55.1 -43.75 74.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.767 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.87 -47.88 83.95 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.682 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.4 mt -63.4 -39.49 94.65 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.855 0.359 . . . . 0.0 111.007 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 mp -60.01 -45.5 95.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.433 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -72.35 -25.41 61.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.811 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.81 -37.25 81.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.3 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.68 -37.73 19.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.035 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 123.0 -41.95 1.7 Allowed Glycine 0 CA--C 1.519 0.322 0 C-N-CA 119.946 -1.121 . . . . 0.0 114.005 173.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.2 m -95.01 151.63 3.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.754 0.277 . . . . 0.0 111.235 -176.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -109.47 -176.05 2.92 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.605 0.717 . . . . 0.0 111.391 -171.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.0 p -153.46 152.76 9.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.919 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -47.37 116.46 4.3 Favored Pre-proline 0 N--CA 1.47 0.535 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 175.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.406 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 88.8 Cg_exo -49.31 -14.49 0.56 Allowed 'Trans proline' 0 N--CA 1.485 0.986 0 C-N-CA 124.175 3.25 . . . . 0.0 114.863 -172.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.475 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -79.57 -21.0 45.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.015 -175.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.463 ' HB2' ' HD3' ' A' ' 44' ' ' PRO . 69.0 m95 -72.75 -52.41 6.12 Favored Pre-proline 0 CA--C 1.537 0.448 0 O-C-N 123.003 0.189 . . . . 0.0 110.548 175.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 74.5 Cg_exo -51.45 -51.5 11.06 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 122.137 1.891 . . . . 0.0 111.569 171.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.45 -37.85 92.66 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.117 177.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 39.3 tp -60.98 -56.62 18.93 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -60.01 -36.29 76.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.588 0.232 . . . . 0.0 111.022 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.6 -39.54 94.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.871 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -92.72 -11.43 33.97 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.45 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.33 -50.87 5.43 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.748 ' HA ' HG23 ' A' ' 54' ' ' VAL . 9.2 mt -85.61 -130.94 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.904 -175.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 75.79 -10.61 1.24 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.842 0.857 . . . . 0.0 113.047 175.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -143.8 -45.55 0.27 Allowed 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.748 HG23 ' HA ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -51.2 129.62 10.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 113.428 -1.714 . . . . 0.0 111.609 174.78 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -51.7 157.53 1.14 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.84 -1.527 . . . . 0.0 111.381 175.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.514 ' O ' HD22 ' A' ' 59' ' ' LEU . 3.4 tp -46.98 -50.82 5.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.803 -175.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.15 -15.48 10.77 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.627 -0.32 . . . . 0.0 113.722 -173.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.6 t -62.18 -23.3 66.53 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.514 HD22 ' O ' ' A' ' 56' ' ' ILE . 1.1 pt? -74.33 -10.36 59.51 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.359 -177.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.577 HG12 HD12 ' B' ' 259' ' ' ILE . 14.7 mt -86.86 -6.59 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-O 121.757 0.789 . . . . 0.0 109.527 176.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 66.0 m -82.72 90.45 6.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.563 176.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -77.67 69.91 3.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.121 0.962 . . . . 0.0 110.259 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.4 t -64.96 -20.49 27.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.023 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.11 -169.96 46.48 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.223 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -121.09 116.19 24.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.063 0.432 . . . . 0.0 111.327 -177.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -97.07 137.8 13.53 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.676 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -154.77 91.27 0.12 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.952 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.66 -63.73 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.687 2.258 . . . . 0.0 111.961 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -165.76 137.82 3.24 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.756 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -67.79 -47.31 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.597 2.198 . . . . 0.0 112.014 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 61.53 176.2 0.12 Allowed 'General case' 0 N--CA 1.465 0.312 0 O-C-N 123.636 0.585 . . . . 0.0 112.574 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 54.42 66.04 1.34 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.942 176.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -135.75 102.74 0.43 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.079 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -135.03 120.55 19.27 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.695 0.283 . . . . 0.0 110.559 178.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -150.57 130.02 6.51 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.495 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 50.1 Cg_exo -57.56 -21.5 46.68 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 124.068 3.179 . . . . 0.0 114.167 -176.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.68 95.4 1.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.958 0.408 . . . . 0.0 110.959 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.01 -17.22 38.4 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.679 -178.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.33 88.34 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.478 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -82.15 119.75 3.2 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.908 2.406 . . . . 0.0 111.869 176.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -112.61 95.89 34.39 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.538 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -50.29 -51.73 10.39 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.812 3.008 . . . . 0.0 113.511 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.4 t 58.63 37.51 25.29 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.227 0.536 . . . . 0.0 110.54 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.4 p -104.52 37.64 2.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.307 -178.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.89 162.65 37.27 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.171 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 58.3 74.48 0.43 Allowed 'General case' 0 N--CA 1.464 0.268 0 O-C-N 123.742 0.651 . . . . 0.0 110.654 -175.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 73.6 82.92 0.13 Allowed Pre-proline 0 N--CA 1.468 0.439 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.359 -177.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -53.43 131.42 43.45 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.005 2.47 . . . . 0.0 112.493 174.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.51 -28.31 34.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.109 -176.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -110.63 99.73 8.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.87 0.367 . . . . 0.0 111.597 -175.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -114.73 -172.75 2.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.488 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -99.13 176.04 5.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.274 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -74.89 126.2 30.45 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.056 0.455 . . . . 0.0 110.938 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.7 t -118.56 -64.86 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.246 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.416 ' HG2' ' H ' ' A' ' 97' ' ' LYS . 33.8 tt0 -128.78 155.82 44.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.541 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 97' ' ' LYS . . . -124.0 38.43 4.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.614 178.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 96' ' ' ALA . 35.9 mtmm 68.41 154.34 0.11 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.777 -176.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -156.47 173.36 17.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.035 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 59.82 96.39 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 O-C-N 123.998 0.812 . . . . 0.0 110.973 176.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -69.65 175.37 4.23 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.357 -173.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.4 t 76.01 142.87 0.08 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.03 -173.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -82.57 77.78 9.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.901 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 68.88 167.43 0.27 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.575 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.2 m -157.21 169.06 25.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.103 -175.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.8 t0 69.63 16.42 8.02 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.098 0.874 . . . . 0.0 110.929 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.1 t70 58.47 -157.84 0.31 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.893 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -91.74 167.51 12.12 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 40.2 tpp -119.36 56.29 0.93 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.293 0.568 . . . . 0.0 110.064 -176.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -149.66 177.0 28.1 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.395 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -99.81 -171.05 1.98 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.681 0.277 . . . . 0.0 110.583 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 94.73 39.05 4.76 Favored Glycine 0 CA--C 1.516 0.156 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.735 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 46.8 tp -131.36 -44.23 1.02 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.395 0.617 . . . . 0.0 110.628 -175.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -108.64 -4.32 17.19 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.829 0.823 . . . . 0.0 109.329 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 C--O 1.251 1.146 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.449 -175.226 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.94 0 CA-C-O 120.503 0.192 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.472 ' HB2' ' OD2' ' A' ' 18' ' ' ASP . 76.9 mtm -93.36 -111.89 0.11 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.202 -179.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 202' ' ' ARG . . . . . 0.431 ' C ' ' H ' ' B' ' 204' ' ' VAL . 67.9 mtt180 -153.76 157.55 39.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -176.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 203' ' ' TYR . . . . . 0.523 ' CD1' ' HA ' ' B' ' 239' ' ' LEU . 71.8 m-85 -79.19 30.16 0.22 Allowed 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.177 0.513 . . . . 0.0 110.52 178.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.802 ' O ' ' HG ' ' B' ' 208' ' ' LEU . 2.5 m -58.11 -65.2 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.635 178.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 205' ' ' ALA . . . . . 0.577 ' H ' HG23 ' B' ' 204' ' ' VAL . . . -64.6 -13.67 54.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . 0.588 ' HA ' HD11 ' A' ' 15' ' ' ILE . 4.1 m -75.74 -50.68 14.6 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 175.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 207' ' ' TYR . . . . . 0.498 ' HD1' HD11 ' B' ' 251' ' ' ILE . 15.7 t80 -62.71 -35.21 79.0 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 174.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.802 ' HG ' ' O ' ' B' ' 204' ' ' VAL . 71.3 mt -64.3 -49.3 72.34 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.983 176.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 209' ' ' LEU . . . . . 0.53 HD21 ' HB2' ' A' ' 11' ' ' TYR . 11.4 mt -54.64 -49.91 69.43 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.785 0.326 . . . . 0.0 110.857 177.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 210' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' B' ' 218' ' ' PRO . . . -59.93 -48.69 80.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.233 -177.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 211' ' ' ALA . . . . . 0.651 ' HA ' ' O ' ' B' ' 215' ' ' ASN . . . -65.18 -43.87 90.3 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.831 0.348 . . . . 0.0 110.977 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 212' ' ' LEU . . . . . 0.465 ' CD1' HG12 ' A' ' 4' ' ' VAL . 2.3 tp -61.44 -32.46 72.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.162 178.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -76.09 -11.78 84.57 Favored Glycine 0 N--CA 1.454 -0.135 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.769 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 122.22 1.14 10.38 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.278 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 215' ' ' ASN . . . . . 0.651 ' O ' ' HA ' ' B' ' 211' ' ' ALA . 93.8 m-20 -98.44 102.91 14.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.115 0.458 . . . . 0.0 110.758 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . 0.408 ' C ' ' HD3' ' B' ' 218' ' ' PRO . 5.3 m -66.34 -17.78 64.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.213 178.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 14.2 t -128.07 69.74 77.67 Favored Pre-proline 0 N--CA 1.443 -0.816 0 CA-C-O 120.96 0.409 . . . . 0.0 110.355 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . 0.453 ' HB3' ' HB3' ' B' ' 210' ' ' ALA . 50.2 Cg_exo -58.85 102.49 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.072 2.515 . . . . 0.0 112.738 178.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 219' ' ' SER . . . . . . . . . . . . . 18.0 m -72.32 144.03 48.46 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.267 178.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . 0.456 ' HB1' HD21 ' B' ' 239' ' ' LEU . . . -56.52 -28.64 60.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.723 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 221' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -73.65 -27.03 61.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.494 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 222' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -79.8 -38.63 32.59 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.508 HG23 ' HB3' ' B' ' 206' ' ' SER . 1.8 mp -63.45 -45.2 98.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 173.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 224' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -58.02 -41.2 82.66 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.244 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 225' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -61.32 -41.7 97.44 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.317 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.73 -25.31 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.593 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -78.04 -44.7 25.69 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.765 0.316 . . . . 0.0 110.94 173.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 228' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -70.29 -15.79 62.93 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.489 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 229' ' ' SER . . . . . . . . . . . . . 86.8 p -51.47 -51.65 53.18 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.91 0.386 . . . . 0.0 110.633 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 230' ' ' VAL . . . . . . . . . . . . . 60.9 t -87.28 -23.85 6.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.347 0.594 . . . . 0.0 110.371 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . 101.92 41.0 2.55 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.143 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 232' ' ' ILE . . . . . 0.401 ' CD1' HG11 ' A' ' 21' ' ' VAL . 36.5 mt -103.84 136.7 35.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -73.66 145.87 44.97 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -143.0 121.65 12.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.383 -175.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . 0.495 ' HB2' ' HB2' ' B' ' 238' ' ' ARG . 8.0 m-20 -58.26 113.82 2.12 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.105 177.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 236' ' ' ASP . . . . . 0.52 ' O ' ' HB3' ' B' ' 239' ' ' LEU . 6.8 m-20 -61.75 -37.48 84.42 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.816 0.341 . . . . 0.0 111.648 -177.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 237' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -73.76 -46.77 43.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.921 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.495 ' HB2' ' HB2' ' B' ' 235' ' ' ASP . 41.8 mtp-105 -64.54 -29.03 70.05 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 239' ' ' LEU . . . . . 0.523 ' HA ' ' CD1' ' B' ' 203' ' ' TYR . 13.5 tp -54.07 -69.54 0.12 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.96 175.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 240' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -66.47 -24.28 66.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.463 -176.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 241' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -60.96 -53.91 51.5 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 120.866 0.365 . . . . 0.0 111.173 175.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 242' ' ' VAL . . . . . 0.509 HG21 ' H ' ' B' ' 203' ' ' TYR . 33.0 m -73.62 -28.37 24.7 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -176.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . 0.472 ' HA ' HD12 ' B' ' 246' ' ' LEU . 37.4 mt -70.67 -31.41 45.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.438 175.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . . . . . . . . . 71.6 m -66.71 -35.25 79.69 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 172.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 245' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.79 -40.7 75.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.219 175.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 246' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' B' ' 243' ' ' ILE . 39.9 mt -67.48 -29.78 69.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.488 174.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 247' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -59.77 -32.8 70.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.131 -171.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 248' ' ' GLY . . . . . . . . . . . . . . . -112.41 17.43 23.77 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.346 -175.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -124.41 151.97 43.82 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . 0.401 HD21 ' HB3' ' B' ' 252' ' ' GLU . 48.8 t30 -64.91 119.71 11.2 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 121.241 0.543 . . . . 0.0 110.875 -178.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.498 HD11 ' HD1' ' B' ' 207' ' ' TYR . 0.4 OUTLIER -59.16 -31.8 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.67 -177.818 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 252' ' ' GLU . . . . . 0.401 ' HB3' HD21 ' B' ' 250' ' ' ASN . 40.9 tt0 -69.88 -40.93 75.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.814 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -65.8 -38.16 88.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.802 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 254' ' ' VAL . . . . . 0.41 HG22 ' HA ' ' B' ' 251' ' ' ILE . 17.7 m -76.2 -22.11 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.457 176.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 255' ' ' ILE . . . . . 0.581 HG23 ' OH ' ' A' ' 11' ' ' TYR . 27.9 mt -64.12 -43.43 97.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-O 121.431 0.634 . . . . 0.0 109.613 169.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 256' ' ' ALA . . . . . 0.558 ' HA ' ' HB3' ' B' ' 263' ' ' ALA . . . -78.06 -27.27 48.64 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.981 -178.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -130.52 76.17 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -176.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 258' ' ' GLY . . . . . 0.592 ' H ' ' CD2' ' B' ' 262' ' ' LEU . . . -108.31 -66.85 0.6 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 172.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 259' ' ' ILE . . . . . 0.658 HG22 HD21 ' A' ' 14' ' ' LEU . 1.6 pt -85.53 -28.43 6.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 122.181 0.991 . . . . 0.0 108.665 169.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . 0.489 ' H ' HD22 ' B' ' 262' ' ' LEU . . . 122.27 -55.82 0.66 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 113.751 -1.568 . . . . 0.0 110.902 -176.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 261' ' ' LYS . . . . . 0.509 ' HD2' ' O ' ' A' ' 60' ' ' ILE . 91.8 mttt -102.12 24.73 9.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.826 -0.187 . . . . 0.0 110.974 177.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 262' ' ' LEU . . . . . 0.592 ' CD2' ' H ' ' B' ' 258' ' ' GLY . 1.2 pt? -79.18 -14.59 58.99 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.524 0.678 . . . . 0.0 109.945 -178.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . 0.558 ' HB3' ' HA ' ' B' ' 256' ' ' ALA . . . -144.79 -44.13 0.24 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.768 176.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 9.8 t 74.19 161.68 0.25 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.912 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 265' ' ' VAL . . . . . . . . . . . . . 40.6 t -131.42 116.73 16.44 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.492 -176.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 266' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.95 -22.21 23.44 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.66 2.24 . . . . 0.0 111.724 178.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 267' ' ' ALA . . . . . . . . . . . . . . . 49.5 63.46 2.15 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.127 173.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 268' ' ' GLY . . . . . . . . . . . . . . . 78.57 -51.39 3.69 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.42 177.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . 92.5 42.82 4.43 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.201 -176.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . 62.16 51.97 3.37 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.191 0.52 . . . . 0.0 111.425 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 271' ' ' VAL . . . . . . . . . . . . . 9.6 p -83.93 149.1 4.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.186 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 272' ' ' ALA . . . . . . . . . . . . . . . -141.83 155.05 45.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.82 -178.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 273' ' ' VAL . . . . . 0.406 HG22 ' O ' ' B' ' 273' ' ' VAL . 13.1 p -127.63 37.42 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 122.341 1.067 . . . . 0.0 109.961 -178.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 274' ' ' SER . . . . . . . . . . . . . 4.7 p -82.07 118.22 22.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.093 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 275' ' ' ALA . . . . . . . . . . . . . . . -97.35 135.6 39.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.391 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . 0.471 ' HA ' ' HD3' ' B' ' 277' ' ' PRO . . . -129.75 139.54 35.97 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.801 -177.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 277' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' B' ' 276' ' ' ALA . 7.9 Cg_exo -72.44 102.84 1.44 Allowed 'Trans proline' 0 CA--C 1.516 -0.391 0 C-N-CA 122.616 2.21 . . . . 0.0 112.293 177.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . -120.4 13.73 10.18 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.09 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 279' ' ' SER . . . . . . . . . . . . . 20.2 m -134.24 163.84 28.71 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 280' ' ' ALA . . . . . . . . . . . . . . . 62.3 65.36 0.87 Allowed 'General case' 0 C--O 1.233 0.197 0 O-C-N 123.831 0.707 . . . . 0.0 112.11 171.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -133.48 79.84 59.01 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.409 176.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -76.54 126.33 8.9 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.412 2.074 . . . . 0.0 112.206 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 283' ' ' ALA . . . . . . . . . . . . . . . -97.89 22.36 9.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.698 -177.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 284' ' ' ALA . . . . . . . . . . . . . . . -133.06 117.34 17.45 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.497 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -158.58 21.8 0.33 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.03 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 286' ' ' SER . . . . . . . . . . . . . 30.8 p -141.31 97.76 3.23 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -177.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 287' ' ' ALA . . . . . . . . . . . . . . . -114.78 115.44 43.78 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.116 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 288' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -60.0 149.44 84.24 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.701 2.267 . . . . 0.0 112.334 177.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 289' ' ' ALA . . . . . . . . . . . . . . . -69.27 92.27 0.57 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.864 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -70.34 171.62 9.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.949 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 291' ' ' ALA . . . . . . . . . . . . . . . -159.86 -169.14 2.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.277 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 61.18 33.61 19.21 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.049 0.452 . . . . 0.0 111.005 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 293' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' B' ' 295' ' ' LYS . 40.6 mt-10 -79.1 77.61 5.58 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.032 -178.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp 64.4 32.32 12.07 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.408 0.442 . . . . 0.0 111.074 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 295' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' B' ' 293' ' ' GLU . 91.9 mttt -126.2 99.62 5.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.779 -0.191 . . . . 0.0 110.812 -176.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 296' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -145.19 84.83 1.72 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.363 0.602 . . . . 0.0 111.034 178.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 297' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -101.08 92.22 4.9 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.645 172.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 298' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -141.44 169.46 17.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.651 -172.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt 71.47 84.68 0.13 Allowed 'General case' 0 C--O 1.233 0.219 0 O-C-N 123.868 0.73 . . . . 0.0 110.897 174.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 300' ' ' GLU . . . . . . . . . . . . . 17.5 mp0 -74.68 48.15 0.35 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.753 -178.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 47.49 49.85 15.49 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.54 0.736 . . . . 0.0 112.704 174.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 302' ' ' SER . . . . . . . . . . . . . 5.4 p -91.04 114.81 27.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.072 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -94.35 98.95 11.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.24 0.543 . . . . 0.0 110.326 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -95.1 75.22 3.46 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.632 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 305' ' ' SER . . . . . . . . . . . . . 63.5 m 67.99 172.31 0.28 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.628 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 306' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -138.63 84.88 2.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.809 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 307' ' ' ASP . . . . . . . . . . . . . 4.5 t70 65.45 -178.77 0.19 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.25 175.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -138.32 17.35 2.77 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.867 0.365 . . . . 0.0 110.671 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 309' ' ' MET . . . . . . . . . . . . . 14.9 tpt -67.56 87.06 0.2 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.749 174.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 310' ' ' GLY . . . . . . . . . . . . . . . -91.96 -128.75 4.49 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.942 174.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 311' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 61.2 15.89 6.77 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.041 0.536 . . . . 0.0 112.004 178.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 312' ' ' GLY . . . . . . . . . . . . . . . 103.34 -27.72 18.72 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.209 174.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 313' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' B' ' 313' ' ' LEU . 0.0 OUTLIER 65.61 3.65 2.51 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.194 0.521 . . . . 0.0 111.89 -179.453 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 314' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -97.45 4.2 50.61 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.796 -169.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 315' ' ' ASP . . . . . . . . . . . . . 36.4 t70 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.488 -178.868 . . . . . . . . 0 0 . 1 stop_ save_